1 . 4 0.4524
1 acids 1 0.2474
1 appears 1 0.216
1 coefficients 2 0.8046
1 collected 1 0.362
1 correlation 3 0.7611
1 correlations 1 0.362
1 delivery 3 0.9887
1 dependent 2 0.6466
1 determined 1 0.2284
1 fatty 1 0.2515
1 fetal 6 1.7214
1 ffa 3 1.1586
1 free 1 0.2381
1 glucose 4 1.0524
1 level 4 0.7761
1 levels 4 0.787
1 lines 1 0.2905
1 maternal 6 1.7433
1 obtained 1 0.1791
1 plasma 3 0.6077
1 regression 1 0.3233
1 significant 1 0.1764
1 size 1 0.2631
1 slightly 1 0.2869
1 slopes 1 0.423
1 strongly 1 0.3233
1 upon 2 0.4509
1 whereas 1 0.2515
2 (700 1 0.3015
2 - 3 0.5299
2 . 8 0.5428
2 1. 1 0.1579
2 1100 1 0.3015
2 1400 1 0.3015
2 15th 4 1.2058
2 18th 2 0.5428
2 19th 2 0.5428
2 2. 1 0.1579
2 280 1 0.3015
2 3. 1 0.1627
2 3rd 2 0.4344
2 4. 1 0.1721
2 5 1 0.1143
2 5. 1 0.1977
2 6. 1 0.2114
2 820 1 0.3015
2 abruptly 1 0.3015
2 acid 1 0.1164
2 birth 1 0.1536
2 cellular 1 0.1644
2 changes 1 0.0902
2 characterize 1 0.2414
2 concentration 3 0.3802
2 contents 1 0.2018
2 course 1 0.137
2 cyto/dna 2 0.6029
2 day 10 1.4967
2 day, 1 0.2317
2 days 1 0.1197
2 decreases 2 0.388
2 development 3 0.3302
2 dna 1 0.1439
2 dna, 1 0.1977
2 enable 1 0.3015
2 evolution 1 0.2172
2 facts.. 1 0.3015
2 fetal 1 0.1721
2 fifteenth 1 0.3015
2 foetal 4 0.8688
2 foeti 1 0.3015
2 followed 1 0.1379
2 following 1 0.0999
2 gestation 1 0.2238
2 growth 2 0.2055
2 high 1 0.1079
2 hyperplasia 2 0.3401
2 hypertrophy 1 0.1594
2 hypertrophy, 1 0.2172
2 increase 1 0.1024
2 increases 1 0.1408
2 levels 1 0.118
2 life 3 0.4782
2 life,. 1 0.3015
2 life.. 2 0.6029
2 liver.. 1 0.3015
2 livers 2 0.5076
2 low 1 0.1319
2 newly-born 1 0.3015
2 nuclear 1 0.1743
2 nucleic 1 0.1977
2 observe 1 0.2317
2 p 2 0.4477
2 period 1 0.1143
2 phospholipid 1 0.2114
2 pl 4 1.2058
2 post-natal 2 0.6029
2 postnatal 1 0.2414
2 rat 2 0.2481
2 ratios 1 0.1977
2 rats 1 0.1164
2 reaches 1 0.2414
2 regularly 1 0.2172
2 removed 1 0.1701
2 reorganisation, 1 0.3015
2 results 1 0.0863
2 rna 4 0.6648
2 stage 3 0.4384
2 stages 1 0.1662
2 three 1 0.1133
2 throughout 1 0.1721
2 twenty-first 1 0.3015
2 ug 3 0.6952
2 ug) 1 0.3015
2 us 1 0.1977
2 value 1 0.1389
2 weaning 2 0.6029
2 without 1 0.1138
2 young 1 0.1522
3 . 6 0.6785
3 1 1 0.1897
3 10 1 0.1849
3 100 1 0.2834
3 146 1 0.5024
3 198 1 0.5024
3 30 1 0.2399
3 40 1 0.2944
3 active 1 0.2315
3 activity 2 0.3596
3 administration 1 0.2212
3 alter 1 0.3364
3 analyses 1 0.3364
3 analysis 1 0.2417
3 cent 2 0.5165
3 cesarean 1 0.5024
3 circulation 1 0.2631
3 component 1 0.3233
3 contain 1 0.3233
3 contained 1 0.2559
3 delivered 2 0.8046
3 delivery 1 0.3296
3 disease 1 0.1805
3 ewe 1 0.5024
3 factors 1 0.2124
3 fetal 4 1.1476
3 filling 1 0.4523
3 fluid 5 1.1904
3 high 1 0.1798
3 hour 1 0.362
3 hyaline 1 0.3731
3 intact 1 0.277
3 intrauterine 1 0.362
3 investigations 1 0.3123
3 lamb 1 0.423
3 lambs 3 1.2069
3 less 1 0.1881
3 lipid 1 0.3074
3 material 1 0.2331
3 membrane 1 0.2711
3 mg. 1 0.3176
3 ml., 1 0.4523
3 model 1 0.3524
3 near 1 0.3028
3 offer 1 0.3233
3 oxygen 1 0.2559
3 part 1 0.2347
3 pathogenesis 1 0.2834
3 per 3 0.5875
3 phospholipid, 1 0.423
3 possible 1 0.2015
3 premature 1 0.3439
3 prior 1 0.2683
3 properties 1 0.2683
3 reported 1 0.2036
3 research 1 0.3296
3 revealed 2 0.4871
3 section 1 0.4023
3 surface 2 0.5422
3 surfactant 3 1.086
3 term, 1 0.423
3 trachea 1 0.423
3 tracheal 3 1.357
3 two 1 0.1539
4 . 6 0.6785
4 1. 1 0.2631
4 2. 1 0.2631
4 21/2 1 0.4523
4 26 1 0.3176
4 3. 1 0.2711
4 4. 1 0.2869
4 5. 1 0.3296
4 accompany 1 0.423
4 activity 1 0.1798
4 births 1 0.5024
4 blood 4 0.621
4 cholesterol, 1 0.4023
4 comparison 1 0.2606
4 contained 1 0.2559
4 content 2 0.4727
4 cord 4 1.3758
4 death 1 0.274
4 determinations 2 0.724
4 double 2 0.6591
4 except 1 0.2834
4 fetal 1 0.2869
4 fractions 1 0.2683
4 free 1 0.2381
4 highest 1 0.3176
4 includes 1 0.3731
4 increased 1 0.1562
4 infant 2 0.5669
4 intrauterine 1 0.362
4 laboratory 1 0.2905
4 levels 1 0.1967
4 lipase 1 0.5024
4 lipid 1 0.3074
4 lipids.. 1 0.5024
4 lipoprotein 1 0.4523
4 live 1 0.3439
4 live-born 3 1.5073
4 made 2 0.3639
4 may 1 0.1257
4 much 2 0.4452
4 nefa 3 1.1586
4 occurred 1 0.2186
4 one 2 0.2811
4 one-third 1 0.3862
4 ovum 2 0.9046
4 phospholipid 1 0.3524
4 phospholipid, 1 0.423
4 placenta 1 0.362
4 placental 2 0.6879
4 serum 1 0.1949
4 set 2 0.8046
4 similarities 1 0.3731
4 stillbirth 1 0.5024
4 stillborn 3 1.5073
4 studied 2 0.3501
4 suggestion 1 0.3731
4 times 1 0.2417
4 tissue 1 0.1744
4 total 2 0.3916
4 triglyceride 3 1.2691
4 twins, 2 1.0048
5 . 6 0.6785
5 191/2 1 0.5024
5 200 1 0.3296
5 211/2 1 0.5024
5 3 1 0.1713
5 abnormally 1 0.3731
5 accumulation 1 0.3524
5 acid 3 0.5821
5 acids 1 0.2474
5 ascribed 1 0.5024
5 babies 1 0.4023
5 blood 1 0.1552
5 body 3 0.6077
5 change 1 0.2331
5 changes 1 0.1503
5 composition 1 0.2944
5 concentration 2 0.4225
5 concentrations 1 0.2582
5 content 1 0.2364
5 daily 1 0.274
5 days 1 0.1996
5 determines 1 0.4523
5 diabetes 1 0.2474
5 elevations 1 0.423
5 fat 3 0.9221
5 fatty 4 1.0062
5 female 1 0.2905
5 fetal 2 0.5738
5 fetuses 2 0.724
5 free 4 0.9524
5 gestation, 1 0.4523
5 glucose 1 0.2631
5 group 1 0.1857
5 group, 1 0.3233
5 heparin 2 0.7724
5 high 1 0.1798
5 hypothesis 1 0.2683
5 injection 1 0.2101
5 injections 1 0.2834
5 large 1 0.1986
5 maternal 3 0.8716
5 might 1 0.2631
5 mothers 3 0.9083
5 noted 1 0.2657
5 part 1 0.2347
5 plasma 3 0.6077
5 pregnancy 1 0.2944
5 pregnant 1 0.3028
5 presented 1 0.1949
5 produced 1 0.2046
5 proposed 1 0.3296
5 rats 2 0.388
5 received 1 0.2834
5 significant 1 0.1764
5 significantly 1 0.2112
5 sprague-dawley 1 0.423
5 subcutaneous 1 0.3233
5 sustained 1 0.3862
5 throughout 1 0.2869
5 thus 1 0.2606
5 times 1 0.2417
5 u.s.p. 1 0.5024
5 uninjected 1 0.5024
5 units 1 0.3439
6 (dose.. 1 0.6029
6 - 2 0.7065
6 . 5 0.6785
6 17th 1 0.6029
6 2 1 0.1841
6 20th 1 0.6029
6 22nd 1 0.5428
6 40 1 0.3533
6 400r, 1 0.6029
6 40r/min) 1 0.6029
6 50 1 0.2878
6 absent 1 0.3955
6 acids 4 1.1876
6 alloxan 1 0.4634
6 alloxan-diabetic 1 0.5428
6 amounted 1 0.5428
6 average 1 0.2705
6 beginning 1 0.3811
6 cent 1 0.3099
6 changes 1 0.1804
6 concentration 3 0.7604
6 concentrations 2 0.6198
6 day 2 0.5987
6 days 1 0.2395
6 depending 1 0.4827
6 determinations 1 0.4344
6 diabetes 1 0.2969
6 dose 1 0.2878
6 exist 1 0.4127
6 exposures 1 0.4827
6 fatty 4 1.2074
6 female 1 0.3487
6 fetal 3 1.0328
6 fivefold, 1 0.6029
6 immediately 1 0.3689
6 increased 2 0.3748
6 increases 1 0.2816
6 intact, 1 0.4827
6 irradiation 1 0.3253
6 maternal 3 1.046
6 non-esterified 4 1.931
6 non-pregnant 1 0.5428
6 output.. 1 0.6029
6 per 1 0.235
6 period 1 0.2287
6 plasma 5 1.2153
6 pregnancy 3 1.0598
6 pregnant 2 0.7267
6 prior 1 0.322
6 produced 1 0.2455
6 rats 3 0.6985
6 result 1 0.2608
6 rise 1 0.2993
6 showed 1 0.2149
6 significant 1 0.2116
6 slightly 1 0.3443
6 test 1 0.2608
6 three- 1 0.6029
6 time 1 0.2124
6 values 2 0.6089
6 whole-body 1 0.4344
6 x-ray 1 0.3955
6 x-ray-irradiated 1 0.6029
7 . 8 0.6785
7 acid 3 0.4365
7 also 1 0.1054
7 amount 1 0.1856
7 animals 1 0.1602
7 arachidonic 1 0.3392
7 basis 1 0.1649
7 compared 1 0.1462
7 composition 2 0.4416
7 developing 1 0.2033
7 early 1 0.1381
7 eclampsia 1 0.3768
7 elevated 2 0.485
7 essential 1 0.2208
7 examined 2 0.3805
7 experimental 1 0.1748
7 extract 1 0.2382
7 fatty 2 0.3773
7 findings 1 0.1497
7 first, 1 0.3017
7 hypertension 2 0.4764
7 increased 1 0.1171
7 less 1 0.1411
7 lipid 5 1.1527
7 metabolism 1 0.1786
7 mild 1 0.2472
7 mildly 1 0.3017
7 normal 3 0.304
7 obtained 1 0.1343
7 palmitate 1 0.3173
7 patients 1 0.0906
7 period, 1 0.2523
7 placentas 2 0.6785
7 postpartum 1 0.3392
7 preeclampsia 3 1.1304
7 preeclamptic 1 0.3173
7 pregnancy 2 0.4416
7 pregnant 1 0.2271
7 pronounced 1 0.2238
7 rise 1 0.1871
7 second, 1 0.2897
7 serum 3 0.4386
7 severe 1 0.167
7 significantly 1 0.1584
7 term 1 0.2101
7 third 1 0.2055
7 total 4 0.5875
7 toxemia 1 0.3392
7 trimesters, 1 0.3768
7 women 2 0.4066
7 women, 1 0.2798
8 . 5 0.6785
8 7-14 1 0.6029
8 able 1 0.3401
8 acid 2 0.4656
8 acids 4 1.1876
8 barrier 1 0.4634
8 contents 2 0.8073
8 essential 2 0.7065
8 estimated 1 0.3748
8 fat 3 1.1066
8 fatty 2 0.6037
8 g, 1 0.5076
8 immature 1 0.4037
8 investigation 1 0.3401
8 linolenic 1 0.6029
8 linolic 1 0.6029
8 low 1 0.2639
8 made 1 0.2183
8 newborn 3 0.9863
8 ones 1 0.4229
8 penetration 1 0.6029
8 placental 1 0.4127
8 rising 1 0.4827
8 show 1 0.2608
8 spectrophotometrically 1 0.6029
8 subcutaneous 2 0.776
8 trans-configuration 2 1.2058
8 trend. 1 0.6029
8 visceral 2 0.8954
9 . 3 0.6785
9 17-week-old 1 1.0048
9 8-17 2 2.0097
9 acetate 1 0.7462
9 acetoacetate 3 3.0145
9 addition 1 0.5119
9 aged 2 1.2111
9 demonstrate 1 0.5811
9 fetuses 2 1.448
9 fetuses, 1 0.8461
9 formation 3 1.3526
9 homogenates 1 0.7462
9 human 2 0.6707
9 incubation 1 0.6148
9 injured 1 0.7724
9 isolated 1 0.4372
9 isolation 1 0.6466
9 liver 1 0.3953
9 livers 2 1.6922
9 low 1 0.4398
9 medium 1 0.5366
9 mitochondria 2 1.3758
9 octanoate 1 1.0048
9 possible 1 0.4031
9 probably 1 0.4568
9 raised 1 0.5969
9 rate 1 0.3699
9 slices 1 0.8046
9 weeks 2 1.0524
10 . 4 0.5428
10 acids 4 1.1876
10 adrenaline 5 2.7139
10 adult 2 0.5481
10 age 1 0.2494
10 birth 1 0.3071
10 blood 4 0.7452
10 changes 2 0.3608
10 ed 1 0.4127
10 either 1 0.2578
10 fatty 4 1.2074
10 first 1 0.221
10 foetal 1 0.4344
10 foetal, 1 0.6029
10 foetus 1 0.5428
10 glucose 4 1.2628
10 gradually 1 0.3811
10 hours 1 0.29
10 immediately 1 0.3689
10 increase 1 0.2048
10 increased 1 0.1874
10 injection 1 0.2521
10 intravenous 1 0.322
10 lamb 1 0.5076
10 levels 1 0.2361
10 little 1 0.322
10 measured 1 0.2639
10 newborn 2 0.6575
10 non-esterifi- 1 0.6029
10 non-esterified 3 1.4482
10 reached 1 0.3955
10 response 2 0.4402
10 sheep 1 0.4344
10 twenty-four 1 0.5428
10 week 1 0.3955
11 . 6 0.6785
11 1) 1 0.3233
11 2) 1 0.3439
11 activity 1 0.1798
11 almost 1 0.2582
11 authors 2 0.4629
11 basement 1 0.3862
11 believe 1 0.3364
11 biological 2 0.5366
11 bring 1 0.3862
11 cell 1 0.17
11 change 1 0.2331
11 clue 1 0.5024
11 conclusions 1 0.3176
11 dissociation 1 0.4523
11 dissolution-like 1 0.5024
11 due 1 0.1777
11 electron 1 0.2537
11 electron-microscopic 1 0.5024
11 explain 1 0.3364
11 facts 1 0.362
11 fat 4 1.2295
11 following 1 0.1665
11 found 1 0.1323
11 human 3 0.5031
11 materials 1 0.3524
11 means 1 0.2226
11 mechanism 1 0.2315
11 membrane 1 0.2711
11 microscopy, 1 0.3524
11 neutral 1 0.362
11 newly 1 0.3364
11 observatations 1 0.5024
11 obtained 1 0.1791
11 permeate 1 0.5024
11 permeation 1 0.5024
11 pinocytosis 1 0.5024
11 placenta 4 1.448
11 present 1 0.1654
11 previous 1 0.2711
11 processes 1 0.2985
11 representative, 1 0.5024
11 results 2 0.2878
11 seem 1 0.274
11 several 1 0.2173
11 stroma 1 0.4023
11 studied 1 0.175
11 transference 1 0.4523
11 transport 1 0.3028
11 transportation 2 0.8461
11 via 1 0.3364
11 without 1 0.1897
12 (lecithin, 1 0.3015
12 . 10 0.6785
12 19th 2 0.5428
12 22nd 2 0.5428
12 50 1 0.1439
12 adult 2 0.2741
12 birth 1 0.1536
12 cent 1 0.1549
12 cephalin 1 0.2538
12 cephalin, 1 0.3015
12 changes 1 0.0902
12 cholesterol 4 0.9269
12 cholesterol, 1 0.2414
12 colamine 2 0.5428
12 compared 1 0.1169
12 concentrations 3 0.4648
12 conditioned 1 0.2714
12 considerable 1 0.1564
12 contains 1 0.1844
12 content 5 0.7091
12 correspond 1 0.2714
12 day 3 0.449
12 decrease 1 0.1379
12 difference 1 0.1509
12 different 1 0.1066
12 drops 1 0.3015
12 dry 1 0.2238
12 end 1 0.1844
12 esterified 1 0.2414
12 examinations 1 0.2064
12 examined 1 0.1522
12 fetal 3 0.5164
12 food, 1 0.3015
12 fractions 1 0.161
12 fractions, 1 0.2538
12 free 3 0.4286
12 higher 1 0.1296
12 however, 1 0.1092
12 immediately 1 0.1844
12 increase 2 0.2048
12 influence 1 0.1379
12 leads 1 0.1681
12 lecithin, 1 0.2714
12 less 1 0.1129
12 lipid 2 0.3689
12 little 1 0.161
12 liver 5 0.593
12 lower 1 0.137
12 lysolecithin) 1 0.3015
12 maternal 1 0.1743
12 maternal, 1 0.3015
12 milk 1 0.2317
12 moreover, 1 0.1977
12 mother 1 0.1721
12 new-born 1 0.2714
12 occurs 1 0.161
12 per 1 0.1175
12 phosphatide 2 0.5076
12 phosphatides, 1 0.3015
12 phospholipid- 1 0.3015
12 phosphorus 2 0.3955
12 placenta 1 0.2172
12 placentas, 1 0.3015
12 pregnancy 1 0.1766
12 rat 3 0.3721
12 rats 1 0.1164
12 rats, 1 0.2064
12 referred 1 0.1791
12 results 1 0.0863
12 rise 3 0.449
12 showed 1 0.1075
12 significant 1 0.1058
12 slight 1 0.1791
12 solely 1 0.2238
12 sphingomyelin 1 0.2414
12 striking 1 0.1906
12 thin-layer-chromatographic 1 0.3015
12 towards 1 0.2172
12 triglyceride 3 0.7615
12 triglycerides 4 1.0856
12 values 2 0.3044
12 weight, 1 0.2018
12 well 1 0.1054
12 which, 1 0.2172
12 white 1 0.1874
13 . 5 0.6785
13 11-20 1 0.6029
13 5-11, 1 0.6029
13 a-crystallin 1 0.4344
13 analysis 1 0.29
13 analyzed 1 0.4127
13 analyzing 1 0.6029
13 b-crystallin 1 0.5076
13 components 1 0.3443
13 components, 1 0.4827
13 detected 1 0.3127
13 differences 1 0.2759
13 different 1 0.2133
13 electrophoresis 2 0.8954
13 five 1 0.3188
13 fractionation 1 0.4634
13 fractions 1 0.322
13 gel 1 0.3487
13 lens 3 0.8571
13 mammalian 2 0.8255
13 means 1 0.2671
13 method 1 0.2395
13 number 1 0.2307
13 proteins 3 0.9382
13 provides 1 0.3811
13 resolved 1 0.6029
13 sensitive 1 0.3253
13 species 2 0.6575
13 starch 1 0.4634
13 technique 1 0.2836
13 three 2 0.4534
13 two 1 0.1846
13 two-dimensional 1 0.6029
13 varied 1 0.3811
13 y-crystallin 1 0.4827
14 (0.4 1 0.274
14 . 11 0.6785
14 30-60 1 0.274
14 4 5 0.4847
14 8 2 0.2475
14 age 1 0.1134
14 alloxan 2 0.4213
14 animals 1 0.1165
14 appears 1 0.1178
14 appendix 1 0.274
14 arc 1 0.274
14 area 1 0.1422
14 autoradiographic 1 0.1798
14 autoradiography 1 0.2107
14 beginning 1 0.1732
14 best 1 0.1449
14 body 1 0.1105
14 cataract 1 0.1974
14 cell 2 0.1855
14 cells 1 0.0827
14 collaboration 1 0.274
14 controls 1 0.1652
14 counted 1 0.274
14 counts 1 0.1922
14 days 3 0.3266
14 diabetic 5 0.9174
14 diagrams 1 0.274
14 distance 1 0.2107
14 effect 1 0.0837
14 epithelium 2 0.3303
14 equal 1 0.1798
14 experimental 2 0.2542
14 eye 2 0.3527
14 frequency 2 0.287
14 front 1 0.274
14 generation 1 0.2467
14 gertraude 1 0.274
14 given 2 0.2009
14 grain 2 0.4615
14 h3-thymidine 1 0.2194
14 histotechnique 1 0.274
14 hours 2 0.2636
14 hours, 1 0.2194
14 increased 1 0.0852
14 injection 2 0.2292
14 interpreted 1 0.1876
14 intraperitoneal 1 0.1974
14 investigated 1 0.1565
14 labelled 3 0.5923
14 lens 3 0.3896
14 lenses 1 0.1703
14 longer 1 0.1922
14 lower 1 0.1246
14 made 1 0.0992
14 may 1 0.0685
14 migration 1 0.1835
14 moewis 1 0.274
14 mrs. 1 0.2467
14 normal 2 0.1474
14 noted 1 0.1449
14 nuclear 1 0.1585
14 nuclei 3 0.5197
14 numbers 1 0.1628
14 observed 1 0.0934
14 peak 1 0.1585
14 peaks 1 0.2307
14 periods 2 0.3056
14 position 1 0.1876
14 predominant 1 0.2107
14 prior 1 0.1464
14 rats 4 0.4233
14 restricted 1 0.2307
14 result 1 0.1185
14 shift 2 0.407
14 study 1 0.0844
14 successive 1 0.2194
14 three 1 0.103
14 thymidine 1 0.1922
14 time 1 0.0966
14 towards 1 0.1974
14 uc/g 1 0.274
14 weeks 1 0.1435
14 weight) 1 0.2467
14 without 1 0.1035
15 (a) 1 0.2155
15 (b) 1 0.2155
15 (c) 1 0.2349
15 . 9 0.6785
15 1. 1 0.1754
15 2. 1 0.1754
15 3. 1 0.1807
15 4. 1 0.1913
15 amount 2 0.3299
15 architecture 1 0.282
15 autonomous 1 0.2487
15 behavior 1 0.1913
15 capable 1 0.2049
15 cavity 1 0.282
15 cells 3 0.3033
15 cellular 1 0.1827
15 changes 1 0.1002
15 chick 2 0.4699
15 coelom 1 0.3349
15 coelomic 1 0.3349
15 complete 1 0.1554
15 culture 2 0.3354
15 cultured 1 0.2197
15 cytodifferentiation 1 0.3349
15 determinant 1 0.3015
15 determined 1 0.1523
15 developing 1 0.1807
15 development.. 1 0.3349
15 different 2 0.237
15 differentiation 1 0.1913
15 differentiation, 1 0.3015
15 embryonic 5 1.0587
15 embryos 1 0.2487
15 environment, 1 0.282
15 epithelial 4 0.7084
15 examined 1 0.1691
15 experimental 1 0.1554
15 explantation 3 1.0048
15 explants 1 0.2575
15 eye 1 0.2155
15 eyes, 1 0.3015
15 fail 1 0.282
15 fiber 1 0.3015
15 fibers 1 0.2682
15 fluid 1 0.1587
15 followed 2 0.3065
15 follows.. 1 0.3015
15 form 1 0.1457
15 formation 2 0.3006
15 growth, 1 0.2243
15 histologically, 1 0.282
15 independent 1 0.2019
15 initiation 1 0.282
15 internal 1 0.189
15 interpreted 1 0.2293
15 least 1 0.1722
15 lens 8 1.2698
15 lensectomized 1 0.3349
15 limited 1 0.1827
15 material 1 0.1554
15 maturation 1 0.2682
15 media, 1 0.3015
15 medium, 1 0.2682
15 morphogenetic 1 0.3349
15 necessary 1 0.1963
15 overall 1 0.2197
15 planimetry 1 0.3349
15 protein 2 0.3045
15 reimplantation 2 0.6699
15 respond 1 0.2049
15 responses 1 0.1868
15 results 1 0.0959
15 resumption 1 0.3349
15 returned 1 0.2413
15 sections 1 0.2293
15 serial 1 0.2049
15 several 1 0.1449
15 shape 1 0.2155
15 situations.. 1 0.3349
15 six-day 1 0.3349
15 small 1 0.1344
15 specimen 1 0.2413
15 specimens 1 0.2155
15 studied 1 0.1167
15 sufficient 1 0.2019
15 supplement 2 0.6031
15 support 1 0.1847
15 three 1 0.1259
15 total 1 0.1305
15 undergo 1 0.2487
15 vitro 1 0.1722
15 vivo 1 0.199
15 volume 1 0.1706
15 without 1 0.1265
16 ('imuran') 1 0.6785
16 . 4 0.6785
16 1 1 0.2846
16 2 1 0.2301
16 3 1 0.2569
16 6-mercaptopurine 2 1.2069
16 abolition 1 0.7536
16 action 2 0.6558
16 active 2 0.6944
16 allowed 1 0.5286
16 analogous 1 0.6034
16 anti-immune 1 0.7536
16 azothioprine 2 1.5073
16 chronic 3 1.0793
16 corticosteroid 1 0.5286
16 discomforting 1 0.7536
16 drugs 1 0.4155
16 even 1 0.3299
16 hepatitis 4 2.0183
16 hepatitis, 1 0.5596
16 homograft 1 0.6346
16 lupoid 2 1.357
16 may 1 0.1885
16 modification 1 0.5596
16 patients 1 0.1812
16 periods 1 0.4202
16 regimes 1 0.6785
16 rejection 1 0.5793
16 successfully 1 0.5159
16 suppressing 1 0.6785
16 treatment 1 0.2223
16 used 1 0.2846
16 year 1 0.3909
17 ('imuran') 1 0.5428
17 ('purinethol') 1 0.6029
17 (range 1 0.6029
17 . 5 0.6785
17 17 1 0.3581
17 20 1 0.2723
17 22 2 0.8255
17 3 1 0.2055
17 6-mercaptopurine 1 0.4827
17 alternative 1 0.4229
17 and, 1 0.3127
17 antimetabolites 1 0.5076
17 average 1 0.2705
17 azathioprine 1 0.5076
17 careful 1 0.3811
17 collagen 2 0.9655
17 complications 1 0.3533
17 could 1 0.2166
17 cytostatic 1 0.6029
17 cytostatics 1 0.6029
17 deaths 1 0.4344
17 discontinued 1 0.5428
17 diseases 3 0.9863
17 eleven 1 0.4634
17 form 1 0.2623
17 four 1 0.2705
17 glucocorticoid 2 1.0153
17 immunological 1 0.3748
17 improvement 1 0.4037
17 indications, 1 0.5428
17 instituted, 1 0.6029
17 long-term 2 0.6973
17 medication 1 0.4827
17 medication, 1 0.5428
17 months 1 0.3044
17 months) 1 0.4827
17 obtained 1 0.2149
17 occurred, 1 0.4827
17 one 1 0.1687
17 pancytopenia 1 0.5076
17 patients 3 0.4348
17 patients, 1 0.3018
17 patients,. 1 0.6029
17 period 1 0.2287
17 permanently 1 0.5428
17 requires 1 0.3689
17 sepsis 1 0.6029
17 serious 1 0.3633
17 steroid 1 0.3487
17 strict 1 0.6029
17 supervision 1 0.5428
17 therapy 1 0.2383
17 treated 1 0.2481
17 treatment 2 0.3558
17 two 1 0.1846
18 . 3 0.6785
18 arthritis 2 1.6091
18 articular 1 0.8461
18 bilateral 2 1.2111
18 case 1 0.361
18 connective 1 0.724
18 corticosteroid 2 1.4096
18 cysts 3 2.4137
18 discussed 1 0.4092
18 disease 1 0.361
18 effect 1 0.3068
18 joint 1 0.6466
18 knee 1 0.7462
18 long-term 1 0.5811
18 many 1 0.4051
18 medication 1 0.8046
18 multiple 1 0.554
18 patient 2 0.7556
18 periarticular 1 1.0048
18 popliteal 3 3.0145
18 relationship 1 0.4833
18 reported 1 0.4072
18 rheumatoid 2 1.6091
18 structure 1 0.5119
18 subluxations 1 1.0048
18 therapy 2 0.7945
18 tissue 1 0.3488
18 years 1 0.4568
19 . 6 0.6785
19 along 1 0.3524
19 cases 2 0.299
19 certain 1 0.2212
19 considered 1 0.224
19 death 1 0.274
19 either 1 0.2148
19 erythematosus 3 1.086
19 evidence 2 0.3684
19 hemodialysis 1 0.5024
19 immunologic 1 0.3296
19 infectious, 1 0.5024
19 kidneys 1 0.2801
19 last 1 0.3364
19 lupus 6 1.9773
19 mechanical, 1 0.5024
19 nephritis 3 1.357
19 patient, 1 0.3296
19 patients 2 0.2415
19 presented 1 0.1949
19 problems 1 0.2606
19 renal 3 0.5847
19 report 1 0.2435
19 resort 1 0.4523
19 responsible 1 0.2537
19 resurgence 1 0.5024
19 secondary 1 0.2515
19 show 1 0.2173
19 systemic 2 0.5603
19 terminal 2 0.724
19 transplantation 2 0.6591
19 transplantation.. 1 0.5024
19 transplanted 1 0.362
19 treated 1 0.2067
19 treatment 1 0.1482
19 two 2 0.3077
19 uremia 1 0.4523
20 . 3 0.6785
20 1. 1 0.5262
20 2. 1 0.5262
20 arteritis 2 1.6922
20 associated 1 0.3568
20 bone 2 0.8692
20 condition 1 0.5366
20 described 1 0.3811
20 erythematosus 1 0.724
20 evidence 1 0.3684
20 formation 2 0.9017
20 localised 2 1.8093
20 lupus 1 0.6591
20 management 1 0.5313
20 new 2 0.8796
20 patients 1 0.2415
20 periosteal 3 3.0145
20 steroid 1 0.5811
20 systemic 2 1.1206
20 therapy 1 0.3972
20 three 1 0.3778
20 valuable 1 0.6466
21 . 2 0.6785
21 anomalous 1 1.2691
21 described 1 0.5717
21 details 1 1.0318
21 fine 1 1.0572
21 forms 1 0.7196
21 phage 2 1.9399
21 sp-50 2 3.0145
21 structural 1 0.97
21 structure 1 0.7678
21 subtilis 2 1.6619
22 . 5 0.6785
22 activity 1 0.2158
22 also 1 0.1687
22 bacillus 1 0.3443
22 bacteria 1 0.388
22 changes 1 0.1804
22 characterized 1 0.3188
22 compared 1 0.2339
22 competition 1 0.4827
22 complement 1 0.4127
22 consistent 1 0.3362
22 data 1 0.2455
22 derived 1 0.3324
22 differential 1 0.3811
22 distinct 1 0.3748
22 enzymatic 1 0.4634
22 experiments 1 0.2671
22 genetic 2 0.6314
22 genome 1 0.4827
22 germination, 1 0.6029
22 hybrid 1 0.4634
22 hypothesis 1 0.322
22 indicate 1 0.2655
22 loci 1 0.5428
22 messenger 1 0.4827
22 messengers 1 0.6029
22 morphogenesis 2 1.2058
22 morphology 1 0.3689
22 observed 1 0.2055
22 occurs 1 0.322
22 previously 1 0.29
22 results 1 0.1727
22 rna's 1 0.6029
22 sporulating 1 0.6029
22 sporulation, 1 0.6029
22 step-down 1 0.6029
22 subtilis 1 0.3324
22 transcription 2 1.0153
22 transition 1 0.4634
22 undergoing 1 0.3811
23 'primary' 2 0.6699
23 'secondary' 1 0.3349
23 . 9 0.6785
23 32 1 0.2575
23 40 1 0.1963
23 abscess, 1 0.3015
23 addition 1 0.1706
23 aetiological 1 0.3015
23 albuminuria 2 0.6699
23 although 1 0.1288
23 amyloid 1 0.2293
23 amyloidosis 6 1.1938
23 amyloidosis, 1 0.2575
23 ancillary 1 0.3349
23 biopsies 1 0.2487
23 biopsy 2 0.4311
23 bronchiectasis, 1 0.3349
23 cases 6 0.5979
23 cases, 1 0.1754
23 cause 1 0.1513
23 chest 1 0.2349
23 clinical 1 0.1092
23 clinicopathological 1 0.3349
23 congo-red 1 0.3349
23 constant 1 0.1827
23 could 3 0.361
23 data 1 0.1364
23 definite 2 0.4586
23 deposits 1 0.2575
23 determined 1 0.1523
23 diagnosed 1 0.2049
23 diagnosis 1 0.1378
23 diagnostic 1 0.1663
23 discovered 1 0.2349
23 disease 2 0.2407
23 emphasised 1 0.3015
23 evidence 1 0.1228
23 factors 1 0.1416
23 failure 1 0.1807
23 feature 1 0.2349
23 fibrocaseous 1 0.3349
23 five 1 0.1771
23 foci 1 0.2413
23 frequency 1 0.1754
23 gingival 1 0.3349
23 healed 1 0.282
23 histopathological 1 0.2682
23 hypertension 1 0.2117
23 ileocaecal 1 0.3349
23 importance 1 0.1706
23 kidney 1 0.1484
23 labelled 3 0.724
23 leading 1 0.2082
23 limited 1 0.1827
23 liver 1 0.1318
23 lung 1 0.144
23 minimal 1 0.2082
23 nephrotic 1 0.2575
23 obtained 1 0.1194
23 order 1 0.1754
23 percutaneous 2 0.6031
23 predisposing 2 0.5641
23 presented 3 0.3898
23 procedure, 1 0.282
23 proved 1 0.1868
23 pulmonary 1 0.1432
23 renal 7 0.9096
23 responsible 1 0.1691
23 rest 1 0.2413
23 revealed 1 0.1624
23 skiagram 1 0.3349
23 states 1 0.2293
23 study 1 0.1032
23 suspected 1 0.2243
23 syndrome 1 0.1554
23 test, 1 0.2487
23 therefore, 1 0.2117
23 thirteen 1 0.2487
23 tool 1 0.2682
23 tuberculosis 1 0.2293
23 tuberculosis, 1 0.3015
23 twenty-two 1 0.2682
23 value 1 0.1543
23 viz., 1 0.3349
23 were, 1 0.282
24 . 8 0.6785
24 action 1 0.1639
24 albumin 1 0.2643
24 amyloidosis 1 0.2238
24 amyloidosis, 1 0.2897
24 anemia 2 0.543
24 anemia, 1 0.3392
24 antibodies 1 0.2126
24 antimetabolites 1 0.3173
24 associated 3 0.4014
24 autoimmune 3 0.9051
24 autoimmune, 1 0.3392
24 bone 1 0.163
24 case 2 0.2708
24 controlled 2 0.4303
24 deficiency 2 0.3985
24 degree 1 0.167
24 development 1 0.1376
24 diffuse 3 0.7569
24 discussed 1 0.1535
24 discussed, 1 0.3017
24 disease, 1 0.2012
24 doses 1 0.2055
24 etiology 1 0.2077
24 excessive 1 0.2425
24 exchangeable 1 0.3768
24 exist 1 0.258
24 failed 1 0.2152
24 fat 1 0.2305
24 features 2 0.4025
24 frequency 1 0.1973
24 gamma-u 1 0.3768
24 greatly 1 0.2238
24 hemolytic 3 0.8145
24 hypergammaglobulinemia, 2 0.7536
24 hypoalbuminemia 2 0.7536
24 idiopathic 3 0.7739
24 idiopathic, 1 0.3768
24 immune 1 0.2425
24 imuran 1 0.3392
24 included 1 0.2033
24 indicating 1 0.2425
24 inducing 1 0.2715
24 initially 1 0.2472
24 interrelationships 1 0.3173
24 large 1 0.149
24 lymph 1 0.2342
24 marrow, 1 0.258
24 mechanism 1 0.1736
24 neutralizing 1 0.3173
24 nodes, 1 0.2715
24 occurrence 1 0.2238
24 old 1 0.2126
24 organs, 1 0.2798
24 peritoneal 1 0.2897
24 plasmacytosis 2 0.7536
24 pool, 1 0.3392
24 prednisone, 1 0.3768
24 prognosis 1 0.2077
24 proteins 1 0.1955
24 purpura 3 1.1304
24 qualitative 1 0.2897
24 reduced 1 0.1702
24 relapse 1 0.3392
24 remission 1 0.2897
24 reported 1 0.1527
24 respond 1 0.2305
24 reviewed 1 0.2126
24 severe, 2 0.5286
24 sixty-nine 1 0.3768
24 specific 1 0.1483
24 spleen 1 0.2238
24 splenectomy 1 0.3768
24 synthesis 1 0.1871
24 thoracic 1 0.2715
24 thrombocytopenic 3 1.0177
24 total 1 0.1469
24 urine, 1 0.3173
24 variable 1 0.2271
24 viruses, 1 0.3392
24 well 1 0.1318
24 woman 1 0.2472
24 year 1 0.1955
25 (a) 1 0.194
25 (at 1 0.2714
25 (b) 1 0.194
25 (c) 1 0.2114
25 . 10 0.6785
25 12 1 0.1439
25 17.6 1 0.3015
25 18 2 0.3288
25 19 1 0.2018
25 26 1 0.1906
25 8, 1 0.2714
25 83 1 0.3015
25 actual 1 0.2172
25 additional 1 0.161
25 adrenal 1 0.1791
25 adults 2 0.3633
25 affect 1 0.1906
25 agents 1 0.1627
25 amyloid 3 0.6191
25 amyloidosis 3 0.5372
25 appear 1 0.1379
25 autopsy 1 0.1977
25 availability 1 0.2172
25 average 1 0.1353
25 azotemia 1 0.2714
25 beneficial 1 0.2114
25 biochemical 1 0.1906
25 biopsy 2 0.388
25 cases 1 0.0897
25 cent 1 0.1549
25 characteristics 1 0.1681
25 clinical 1 0.0983
25 considered 1 0.1344
25 contraindicated 1 0.2714
25 corticosteroid 2 0.4229
25 corticosteroids 3 0.6055
25 deleterious 1 0.2414
25 despite 1 0.1906
25 detrimental 1 0.2538
25 diagnosis 1 0.124
25 died 1 0.1766
25 disease 3 0.3249
25 disorder, 1 0.2414
25 diuretic 1 0.2238
25 edema 1 0.2064
25 effects 1 0.1119
25 eight 1 0.1721
25 established 1 0.1627
25 exceptions 1 0.2714
25 failure 1 0.1627
25 felt 1 0.2238
25 female 1 0.1743
25 forms 1 0.1439
25 found 1 0.0794
25 four 1 0.1353
25 helpful 1 0.2064
25 high 2 0.2158
25 hypertension 1 0.1906
25 hypotension 1 0.3015
25 incidence 3 0.4317
25 indistinguishable 1 0.2317
25 inexorable 1 0.3015
25 instances 1 0.2018
25 lesions, 1 0.2172
25 literature 1 0.1644
25 low 1 0.1319
25 majority 1 0.194
25 male 1 0.1536
25 may 1 0.0754
25 months 1 0.1522
25 negligible 1 0.2414
25 neither 1 0.1977
25 nephotic 1 0.3015
25 nephrotic 5 1.1586
25 observed 1 0.1028
25 onset 1 0.1743
25 others, 1 0.2317
25 patients 2 0.1449
25 per 1 0.1175
25 percutaneous 1 0.2714
25 persistence 1 0.2538
25 possible 1 0.1209
25 potent 1 0.2238
25 presented 1 0.1169
25 primary 1 0.1274
25 progress 1 0.2114
25 progression 1 0.2538
25 prolonged 2 0.29
25 prominent), 1 0.3015
25 purpuric 1 0.3015
25 rapid 1 0.1461
25 relieving 1 0.2714
25 renal 4 0.4678
25 results 1 0.0863
25 secondary 1 0.1509
25 seen 1 0.1274
25 series, 1 0.3015
25 side 1 0.1701
25 skin 1 0.1791
25 subjects 2 0.2878
25 summarized 1 0.2714
25 survival 1 0.145
25 syndrome 5 0.6992
25 syndrome, 1 0.2018
25 therapy 2 0.2383
25 times 1 0.145
25 treatment 2 0.1779
25 twenty-two 1 0.2414
25 view 1 0.1766
26 (11 1 0.3392
26 . 8 0.6785
26 14 1 0.2077
26 7 1 0.1736
26 abnormal 1 0.1826
26 age 1 0.1559
26 amount 2 0.3711
26 amyloid 3 0.7739
26 amyloidosis 4 0.8954
26 amyloidosis.. 1 0.3768
26 appeared 1 0.1813
26 biopsy 4 0.97
26 bone 1 0.163
26 cases 1 0.1121
26 cells 1 0.1137
26 clearly 1 0.2271
26 clinical 2 0.2457
26 correlated 1 0.2238
26 criteria 1 0.2208
26 deposition 4 1.086
26 deposits 1 0.2897
26 diagnosed 1 0.2305
26 disease 2 0.2708
26 either 1 0.1611
26 etiology 1 0.2077
26 failure 1 0.2033
26 glomerulus, 1 0.3768
26 heavier 1 0.3392
26 institution 1 0.3768
26 kidney 2 0.3339
26 large 1 0.149
26 marrow, 1 0.258
26 myeloma 1 0.3768
26 nephrotic 2 0.5793
26 numbers 1 0.2238
26 patients 4 0.3623
26 patients) 1 0.3392
26 percentage 1 0.2101
26 picture 1 0.2055
26 plasma 1 0.1519
26 primary 1 0.1593
26 probably 1 0.1713
26 proteinuria, 1 0.3392
26 range 1 0.2033
26 reflects 1 0.3017
26 relationship 1 0.1813
26 renal 7 1.0233
26 reviewed 1 0.2126
26 secondary 1 0.1887
26 seem 1 0.2055
26 severer 1 0.3768
26 severity 1 0.2305
26 study 1 0.1161
26 suspected 1 0.2523
26 syndrome 1 0.1748
26 syndrome, 1 0.2523
26 types 1 0.1826
27 . 2 0.6785
27 27 1 1.0091
27 aged 1 0.9083
27 amyloid 2 2.0636
27 case 2 1.0831
27 female, 1 1.1192
27 goitre 2 3.0145
27 indian 1 1.357
27 occurring 1 0.8716
27 pulmonary 1 0.6444
27 report 1 0.7306
27 reported 1 0.6107
27 sequelae 1 1.2691
27 tuberculosis, 1 1.357
27 years, 1 0.9528
28 . 5 0.6785
28 amyloid 5 2.0636
28 amyloid.. 1 0.6029
28 amyloidosis 2 0.7163
28 analysis 1 0.29
28 associated 1 0.2141
28 big 1 0.5428
28 common 2 0.5891
28 component 1 0.388
28 components 2 0.6886
28 comprise 1 0.6029
28 constituent 1 0.5428
28 constituents 1 0.4634
28 difficult 1 0.388
28 diseases 1 0.3288
28 dissolve 1 0.6029
28 electrophoretic 2 0.8457
28 extracted 3 1.211
28 familial 1 0.3955
28 fever 1 0.4344
28 fibrils 1 0.4634
28 gel 1 0.3487
28 give 1 0.3288
28 hearts 1 0.6029
28 however, 1 0.2183
28 known 1 0.2945
28 major 1 0.29
28 may 1 0.1508
28 mediterranean 1 0.6029
28 much 1 0.2671
28 observed 1 0.2055
28 one 1 0.1687
28 part 1 0.2816
28 patients 1 0.1449
28 present 1 0.1985
28 primary 2 0.5098
28 proteins 2 0.6255
28 question 1 0.4477
28 regularly 1 0.4344
28 remains 1 0.3157
28 secondary 3 0.9055
28 several 1 0.2608
28 starch 1 0.4634
28 strong 1 0.4037
28 tissue 1 0.2093
28 urea 1 0.4229
28 washed 1 0.5428
29 ( 1 0.1692
29 + 1 0.141
29 , 1 0.1545
29 . 15 0.6785
29 1 1 0.0759
29 1) 1 0.1293
29 2) 1 0.1376
29 3) 1 0.1545
29 4) 1 0.1609
29 45 1 0.1346
29 48 1 0.1134
29 5) 1 0.1692
29 6) 1 0.1809
29 7) 1 0.201
29 abnormal 1 0.0974
29 accuracy 1 0.1545
29 acid 1 0.0776
29 acute 1 0.0998
29 adult 2 0.1827
29 amount 2 0.1979
29 antisera, 1 0.1809
29 appears 1 0.0864
29 average 3 0.2705
29 azotemic 2 0.3384
29 better 1 0.1162
29 biopsy 1 0.1293
29 blood 2 0.1242
29 borderline 1 0.1692
29 cannot 1 0.1084
29 changes 1 0.0601
29 characteristic 1 0.1015
29 chronic 1 0.0959
29 clearance 3 0.388
29 clearance, 2 0.4019
29 clearances 1 0.1809
29 clearances, 1 0.201
29 commercially 1 0.201
29 constant 1 0.1096
29 constants 1 0.1545
29 correlation 2 0.203
29 criteria 1 0.1178
29 daily 1 0.1096
29 degree 4 0.3562
29 despite 1 0.127
29 determinations 1 0.1448
29 determined 2 0.1827
29 diffusion 1 0.1346
29 disease 2 0.1444
29 disease, 1 0.1073
29 display 1 0.1609
29 displayed 1 0.1609
29 duration 1 0.1052
29 estimated 1 0.1249
29 evident 1 0.1249
29 excreted 2 0.2498
29 excretion 5 0.4727
29 exists 1 0.1448
29 express 1 0.1609
29 expressed 2 0.2896
29 fairly 1 0.1448
29 fluctuation 1 0.201
29 frequently 1 0.1015
29 gel 1 0.1162
29 given 1 0.0737
29 glomerular 2 0.2541
29 graph 1 0.1809
29 graphically, 1 0.201
29 greater 1 0.0831
29 grossly 1 0.141
29 group 2 0.1486
29 high 1 0.0719
29 individual 1 0.1063
29 initial 2 0.1948
29 initially 3 0.3955
29 inulin 4 0.8039
29 least 1 0.1033
29 line 2 0.2422
29 log-log 1 0.201
29 low 1 0.088
29 may 1 0.0503
29 method 1 0.0798
29 molecular 1 0.1194
29 near 1 0.1211
29 near-normal 1 0.201
29 nephrotic 6 0.9269
29 nitrogen 2 0.2636
29 normal 1 0.054
29 normal, 1 0.1492
29 observed 1 0.0685
29 one 1 0.0562
29 ordinates 1 0.201
29 para-aminohippuric 1 0.201
29 pathologic 1 0.123
29 patient 1 0.0756
29 patients 7 0.3382
29 percentage 1 0.1121
29 performed 1 0.092
29 plotted 1 0.1809
29 precipitin 1 0.1545
29 predicted 1 0.1545
29 premise 1 0.201
29 prepared 1 0.1211
29 primary 1 0.085
29 protein 8 0.7308
29 proteins 1 0.1042
29 proteinuria 2 0.4019
29 ratios 1 0.1318
29 regardless 1 0.1609
29 related 1 0.085
29 remains 1 0.1052
29 renal 3 0.2339
29 required 1 0.1096
29 respective 1 0.1609
29 respond 1 0.123
29 response 2 0.1467
29 said 1 0.1609
29 satisfying 1 0.201
29 sd) 1 0.201
29 selective 2 0.2388
29 selectivity 7 1.4068
29 significance 1 0.1096
29 significant 1 0.0705
29 sixty-five 1 0.1809
29 slight 1 0.1194
29 slope 1 0.1545
29 slope, 1 0.201
29 specific 1 0.0791
29 squares, 1 0.201
29 statistically 1 0.1249
29 steroid 1 0.1162
29 straight 1 0.1809
29 studies 1 0.0615
29 subacute 1 0.1809
29 substantiate 1 0.201
29 suggested 1 0.0836
29 syndrome 5 0.4661
29 syndrome. 1 0.1545
29 technique 1 0.0945
29 therapy 2 0.1589
29 therapy, 1 0.1293
29 time 1 0.0708
29 total 1 0.0783
29 transferrin 1 0.201
29 type 4 0.3343
29 types 1 0.0974
29 unlikely, 1 0.201
29 urea 2 0.2819
29 urine/plasma 1 0.201
29 usual 1 0.1492
29 usually 1 0.0945
29 weights 1 0.141
29 whereas 1 0.1006
30 . 3 0.6785
30 activation 1 0.7462
30 administered 1 0.4797
30 aspects 1 0.5669
30 bleeding 1 0.7462
30 changes 1 0.3007
30 circulation 1 0.5262
30 coagulation 2 1.5448
30 concept 1 0.6056
30 discussed 1 0.4092
30 dosage 1 0.6056
30 due 1 0.3554
30 extracorporeal 1 0.6591
30 found 1 0.2645
30 groups 1 0.4092
30 haemostasis 1 0.9046
30 heparin 1 0.7724
30 hypothermia, 1 0.7048
30 mechanism 2 0.9258
30 open-heart 1 0.7724
30 patients 1 0.2415
30 perfusion 1 0.5888
30 polybrene 2 1.8093
30 probably 1 0.4568
30 production 1 0.5119
30 role 1 0.4661
30 surgery 1 0.4989
30 synopsis 1 1.0048
30 two 1 0.3077
30 undergoing 1 0.6352
31 . 4 0.6785
31 /mirror-image/ 1 0.7536
31 along 1 0.5286
31 also 1 0.2108
31 anomalies 1 0.4943
31 appropriate 1 0.4943
31 associated 1 0.2676
31 case 3 0.8123
31 circulation 1 0.3946
31 closure 1 0.5286
31 comment 1 0.7536
31 complexes 1 0.6034
31 defect 3 1.1134
31 dextrocardia 3 2.2609
31 dextrocardial 1 0.7536
31 discussion 1 0.4542
31 emphasis 1 0.543
31 excluded 1 0.5596
31 extracorporeal 1 0.4943
31 hypothermia 1 0.3874
31 interventricular 3 1.8103
31 intracardiac 1 0.6346
31 inversus 3 2.0354
31 kartagener's 1 0.7536
31 made 1 0.2729
31 male 1 0.3839
31 moderate 1 0.4477
31 occurrence 1 0.4477
31 old 1 0.4252
31 patient 1 0.2834
31 performed 1 0.3449
31 presented 1 0.2924
31 procedures 1 0.4252
31 radiographic 1 0.5793
31 rarity 1 0.6346
31 septal 3 1.2199
31 situs 3 1.9037
31 successfully 1 0.5159
31 surgery 1 0.3742
31 syndrome 1 0.3496
31 three 1 0.2834
31 total 1 0.2937
31 treated 1 0.3101
31 true 1 0.5046
31 twenty 1 0.5596
31 types 1 0.3653
31 year 1 0.3909
32 (a) 1 0.2425
32 (b) 1 0.2425
32 (c) 1 0.2643
32 (nonresponders) 1 0.3768
32 . 8 0.6785
32 24-hr. 1 0.3173
32 3 1 0.1284
32 38 1 0.258
32 43 1 0.3017
32 5 1 0.1429
32 administered 2 0.3598
32 advanced 1 0.1955
32 allowed 1 0.2643
32 although 1 0.1449
32 amount 2 0.3711
32 associated 1 0.1338
32 benign 4 1.086
32 breast 1 0.1992
32 carcinoma 2 0.3598
32 chromatographic 1 0.3392
32 clinically 1 0.258
32 collection 1 0.3017
32 compared 1 0.1462
32 comprised 1 0.3017
32 concentration 1 0.1584
32 defined 1 0.258
32 determination 1 0.2305
32 differed 1 0.258
32 discovered 1 0.2643
32 disease 1 0.1354
32 disease, 1 0.2012
32 distinctive 1 0.2798
32 dysplasia, 2 0.7536
32 employed 1 0.2382
32 endocrine 1 0.2643
32 enzymatically 1 0.3173
32 estradiol 2 0.6034
32 estradiol, 2 0.6346
32 estradiol-4-c14 1 0.3768
32 estradiol-4-c1j 1 0.3768
32 estriol 2 0.6034
32 estrogen 3 0.9051
32 estrogens 2 0.6785
32 estrone, 2 0.6346
32 excreted 1 0.2342
32 excretion 6 1.0637
32 extent 1 0.1992
32 failed 1 0.2152
32 former 1 0.258
32 found 2 0.1984
32 fraction 1 0.2012
32 greatest 1 0.2382
32 group 4 0.5572
32 hydrolyzed 1 0.3768
32 hydrolyzed, 1 0.3173
32 isotope 1 0.3017
32 isotopic 1 0.3392
32 large 1 0.149
32 lower 1 0.1713
32 malignant 1 0.2055
32 mammary 4 0.97
32 metabolites 5 1.4483
32 metabolizes 1 0.3768
32 method 1 0.1497
32 nonresponders 1 0.3768
32 noted 1 0.1992
32 patients 1 0.0906
32 pattern 1 0.1799
32 patterns 5 1.191
32 percentage 1 0.2101
32 periods, 1 0.3768
32 portion 1 0.2643
32 postmenopausal 2 0.5286
32 prior 1 0.2012
32 radiometabolites 1 0.3768
32 rapidly 1 0.2152
32 relative 1 0.1955
32 reported 1 0.1527
32 respond 1 0.2305
32 responders 1 0.3768
32 separation 1 0.2101
32 several 1 0.163
32 significant 1 0.1323
32 significantly 1 0.1584
32 statistically 1 0.2342
32 study 1 0.1161
32 subject-to-subject 1 0.3768
32 subsequent 1 0.2055
32 successive 1 0.3017
32 suggesting 1 0.2305
32 therapy 2 0.2979
32 total 1 0.1469
32 treatment 1 0.1112
32 urinary 5 0.8348
32 useful 1 0.2077
32 variations 1 0.2342
32 wide 1 0.2238
32 women 3 0.61
32 women, 1 0.2798
33 (simultanagnosia) 1 0.7536
33 . 4 0.6785
33 /agnosic 1 0.7536
33 /spelling 1 0.7536
33 alexia/ 1 0.7536
33 autopsy 1 0.4943
33 discussed 1 0.3069
33 disorder 1 0.4685
33 dyslexia/ 1 0.7536
33 findings 1 0.2994
33 form 2 0.6558
33 found 1 0.1984
33 function 1 0.3381
33 impairment 1 0.4943
33 inferior 1 0.5793
33 interpretation 1 0.5046
33 isolated 1 0.3279
33 left 1 0.3403
33 lesion 1 0.4252
33 limitation 1 0.7536
33 limited 1 0.411
33 lobe 1 0.5159
33 localized 1 0.5286
33 localizing 1 0.6346
33 occipital 1 0.5159
33 part 1 0.352
33 pathological 1 0.4066
33 patient 1 0.2834
33 perception 2 1.2069
33 picture 1 0.411
33 presenting 1 0.5046
33 problem 1 0.4303
33 relation 1 0.3472
33 shown 1 0.3241
33 significance 1 0.411
33 simultaneous 2 0.9221
33 studies 1 0.2308
33 tachistoscopic 1 0.7536
33 underlying 1 0.543
33 visual 1 0.411
33 within 1 0.2798
34 . 2 0.6785
34 acquaint 1 1.5073
34 anosognosia 1 1.5073
34 anton's 1 1.5073
34 bilateral 1 0.9083
34 blindness 2 2.4137
34 case 1 0.5415
34 cortical 1 0.97
34 denial 1 1.5073
34 hemianopia 1 0.97
34 neurologists 1 1.5073
34 ophthalmologists 1 1.5073
34 opthalmologists 1 1.5073
34 presented 1 0.5847
34 rarely 1 1.0572
34 seen 1 0.6372
34 symptom 2 2.1144
34 visual 1 0.8219
34 well-known 1 1.357
35 . 11 0.6785
35 18 1 0.1494
35 36 1 0.1922
35 60 1 0.1764
35 affect 1 0.1732
35 age 3 0.3401
35 also 2 0.1533
35 attachment 8 1.7554
35 attachments 4 1.0962
35 attachments, 2 0.5481
35 based 1 0.1435
35 becoming 1 0.2107
35 beginning 1 0.1732
35 behavior 1 0.1565
35 behavior,. 1 0.274
35 cases 2 0.1631
35 certain 1 0.1207
35 conditions 3 0.3737
35 core 1 0.1922
35 correlations 1 0.1974
35 data 1 0.1116
35 definition 1 0.2194
35 deprived 1 0.2107
35 development 2 0.2001
35 developmental 2 0.367
35 devoted 1 0.2467
35 differences 1 0.1254
35 differences, 1 0.2467
35 difficult,. 1 0.274
35 discussed 1 0.1116
35 early 1 0.1005
35 eliciting 1 0.2467
35 emerged 1 0.2307
35 end 1 0.1677
35 everyday 1 0.274
35 examination 1 0.1384
35 examined 1 0.1384
35 explored 1 0.2107
35 explored.. 1 0.274
35 expressed, 1 0.274
35 fear-of-strangers 2 0.5481
35 findings.. 1 0.274
35 first 3 0.3014
35 fluctuations 1 0.2194
35 follow-up, 1 0.274
35 following 2 0.1817
35 form 1 0.1192
35 formation 1 0.123
35 formed 1 0.1528
35 found 3 0.2164
35 four 1 0.123
35 four-weekly 1 0.274
35 function 2 0.2459
35 function, 1 0.2107
35 generally 1 0.1628
35 included 1 0.1479
35 increases 1 0.128
35 indicate 1 0.1207
35 indiscriminate 1 0.274
35 individual 4 0.5796
35 infancy 2 0.3844
35 infants 2 0.2617
35 influence 1 0.1254
35 instances 1 0.1835
35 intensity 2 0.3844
35 intervals 1 0.1703
35 investigated 1 0.1565
35 long-term 1 0.1585
35 longitudinal 1 0.2194
35 loss, 1 0.2107
35 made 2 0.1985
35 main 2 0.313
35 make 1 0.1628
35 manifestation 1 0.1922
35 manner 1 0.1876
35 may 1 0.0685
35 measure 1 0.1585
35 measure, 1 0.274
35 members 1 0.1835
35 month 1 0.1835
35 months 1 0.1384
35 multiplicity 1 0.274
35 nature 1 0.1361
35 necessary 1 0.1606
35 number 2 0.2097
35 objects 2 0.4213
35 occur 1 0.1339
35 onset 3 0.4754
35 operational 1 0.274
35 origins, 1 0.2307
35 parameters 2 0.3949
35 phase 1 0.1464
35 phase, 1 0.2307
35 preceded 1 0.2307
35 prediction 1 0.2035
35 presented, 1 0.2194
35 protest 3 0.8221
35 proximity 3 0.7402
35 quarter 1 0.2307
35 regard 1 0.1565
35 regarding 1 0.1732
35 relation 2 0.2525
35 remaining 1 0.1396
35 report 1 0.1328
35 represented 1 0.2194
35 results 1 0.0785
35 rule 1 0.2107
35 scale, 1 0.2307
35 seek 1 0.2467
35 separation 1 0.1528
35 setting 1 0.274
35 seven 1 0.1565
35 situations, 1 0.2194
35 social 3 0.5291
35 soon 1 0.2035
35 species 1 0.1494
35 specific 4 0.4313
35 study 1 0.0844
35 subgroup 1 0.2307
35 suggested 1 0.114
35 suggestions 1 0.2467
35 suitable 1 0.1764
35 takes 1 0.2107
35 tendency 1 0.1974
35 terminate 1 0.2467
35 themes 1 0.274
35 thereafter 2 0.4389
35 third 1 0.1494
35 three 2 0.2061
35 trends, 1 0.274
35 use 1 0.1083
35 variables 1 0.2035
35 variables, 1 0.274
35 weeks 1 0.1435
35 well 1 0.0958
35 year 1 0.1422
35 year, 1 0.2107
35 young 1 0.1384
36 . 5 0.6785
36 account 1 0.3401
36 adults 1 0.3633
36 alterations 1 0.3324
36 anxiety 3 1.1243
36 anxiety, 1 0.4827
36 attachment 1 0.4827
36 behavior 4 1.3771
36 care 1 0.3811
36 cases 1 0.1794
36 cause 1 0.2723
36 child's 1 0.3689
36 children 3 0.6423
36 develop,. 1 0.6029
36 difficulties 1 0.4477
36 discussed, 1 0.4827
36 disturbances 2 0.7163
36 disturbed 1 0.3748
36 early 2 0.442
36 emotional 1 0.3362
36 emphasis 1 0.4344
36 experience 2 0.6198
36 experience, 1 0.4827
36 feeding, 1 0.6029
36 greater 1 0.2494
36 hypotheses 1 0.4634
36 infants 1 0.2878
36 later 1 0.3099
36 lead 1 0.388
36 life 1 0.3188
36 many 1 0.2431
36 may 3 0.4523
36 mothering 1 0.4827
36 motility 1 0.5428
36 particular 1 0.3044
36 particularly 1 0.3324
36 pathologic 1 0.3689
36 presented 1 0.2339
36 problems 2 0.6255
36 proportions, 1 0.5428
36 reach 1 0.4827
36 reflected 1 0.4477
36 result 1 0.2608
36 security 1 0.5428
36 sense 1 0.4634
36 separation 4 1.3447
36 significance 1 0.3288
36 sleeping, 1 0.6029
36 stressed 1 0.6029
36 summary, 1 0.5076
36 threatening 1 0.5076
36 three 1 0.2267
36 various 1 0.2383
37 . 2 0.6785
37 differentiated 1 1.0091
37 injected 1 0.7306
37 intramuscularly 1 1.5073
37 malignant 1 0.8219
37 metallic 1 1.2691
37 muscle 1 0.831
37 nickel 2 1.7433
37 origin, 1 1.0572
37 powdered 1 1.5073
37 produced 1 0.6138
37 production 1 0.7678
37 rat 1 0.6202
37 rats 1 0.5821
37 striated 1 1.5073
37 tumours 2 1.9056
37 well 1 0.5271
38 (rna) 1 0.3392
38 (sephadex 1 0.3768
38 . 5 0.4241
38 acids 1 0.1856
38 acute 1 0.1871
38 bound 1 0.258
38 carbonyl 1 0.3017
38 carbonyl, 1 0.3768
38 carcinogenesis 1 0.3173
38 carcinogenic 1 0.2897
38 chromatographic 1 0.3392
38 chromatography 1 0.2523
38 chronic 1 0.1799
38 columns 1 0.3392
38 concentrations 2 0.3874
38 consistent 1 0.2101
38 constituents 1 0.2897
38 demonstrated 1 0.1611
38 demonstration 1 0.2425
38 dextran 2 0.6785
38 findings 1 0.1497
38 firmly 1 0.3017
38 following 2 0.2498
38 fractionations 2 0.7536
38 fractions 1 0.2012
38 g-100) 1 0.3768
38 gel 2 0.4358
38 high-molecular 1 0.3768
38 homogenates 1 0.2798
38 increased 1 0.1171
38 increases 1 0.176
38 inhalation 2 0.5596
38 levels 1 0.1476
38 liver 3 0.4448
38 lung 3 0.4861
38 macromolecular 2 0.6785
38 major 1 0.1813
38 means 1 0.167
38 nickel 8 1.7433
38 observation 1 0.1973
38 observed 1 0.1284
38 performed 1 0.1724
38 predominant 1 0.2897
38 preparations 1 0.2271
38 previous 1 0.2033
38 proportion 1 0.2342
38 purified 1 0.2382
38 rat 2 0.3101
38 ribonucleic 1 0.2643
38 rna 1 0.2077
38 several 1 0.163
38 studies 1 0.1154
38 supernatants 3 1.0177
38 tissue 1 0.1308
38 tissues, 1 0.2643
38 ultracentrifugal 2 0.6785
38 use 1 0.149
38 weight 1 0.1773
39 . 4 0.6785
39 1. 1 0.3946
39 2. 1 0.3946
39 3. 1 0.4066
39 acid 2 0.5821
39 alteration 1 0.4943
39 diminution 1 0.5286
39 discussed 1 0.3069
39 due 2 0.5332
39 edta 1 0.6034
39 effect 1 0.2301
39 ethylenediaminetetra-acetic 2 1.5073
39 explanations 1 0.6346
39 fibrinogen 2 1.1586
39 form, 1 0.6034
39 inhibitory 1 0.4943
39 inhibits 1 0.5046
39 ions 1 0.5596
39 means 1 0.3339
39 metal 1 0.5159
39 molecule 1 0.5286
39 phenomenon 1 0.4358
39 possible 1 0.3023
39 property 1 0.6034
39 reaction 2 0.7546
39 reactivity 1 0.5793
39 removal 1 0.4202
39 reversibly 1 0.6034
39 study 1 0.2322
39 thrombin-fibrinogen 2 1.357
39 time-dependent 1 0.7536
39 trace 1 0.543
39 unchelated 1 0.7536
40 . 7 0.6785
40 10 2 0.3171
40 10, 1 0.331
40 24-hour 1 0.3626
40 48 1 0.2429
40 96 1 0.3448
40 allergics 1 0.4306
40 allergy 4 1.7226
40 appear 1 0.1971
40 appears 1 0.1852
40 chloride 5 1.5514
40 cobalt 7 2.7139
40 combined 1 0.2213
40 controls 2 0.519
40 degree 1 0.1908
40 dilutions 1 0.3877
40 discussed 1 0.1754
40 excluded 1 0.3198
40 first 1 0.1579
40 flare 1 0.4306
40 give 1 0.2348
40 greater 1 0.1781
40 group 1 0.1592
40 groups 1 0.1754
40 hours 2 0.4143
40 impure 1 0.4306
40 injection, 1 0.3198
40 intradermal 1 0.3448
40 intradermally 1 0.4306
40 make 1 0.2558
40 misleading 1 0.3877
40 nickel 2 0.4981
40 nickel-cobalt 1 0.4306
40 normal 1 0.1158
40 papular 1 0.4306
40 patients 2 0.207
40 preferable 1 0.3626
40 purity 1 0.3877
40 question 1 0.3198
40 reaction 1 0.2156
40 reactions 2 0.4208
40 read 1 0.331
40 reading 1 0.3198
40 reliable 1 0.2883
40 response 1 0.1572
40 selected 1 0.2523
40 slightly 1 0.2459
40 somewhat 1 0.3198
40 stronger 1 0.3877
40 study, 1 0.2771
40 ten 1 0.2595
40 test 2 0.3725
40 tested 1 0.2595
40 times 1 0.2071
40 type 1 0.1791
40 using 1 0.1958
40 well 1 0.1506
40 wheal 1 0.4306
40 would 1 0.2138
41 (0.10 1 0.2319
41 (rna), 1 0.2319
41 (s.d. 2 0.4638
41 . 12 0.6263
41 0.4 1 0.2319
41 0.8), 1 0.2319
41 1.8 1 0.2088
41 10.0), 1 0.2319
41 100 1 0.1308
41 101 1 0.2088
41 104 1 0.2088
41 17 1 0.1377
41 19.8 1 0.2319
41 21 1 0.1466
41 24 1 0.1203
41 24-hr. 1 0.1952
41 29 1 0.1587
41 3.1 1 0.2319
41 34 1 0.1626
41 37.6 1 0.2319
41 39 1 0.1671
41 48 1 0.1308
41 5 2 0.1759
41 5.9 1 0.2088
41 6.3 1 0.2319
41 64 1 0.1952
41 7.2 1 0.2088
41 94 1 0.1952
41 96 2 0.3713
41 97, 1 0.2319
41 = 2 0.3905
41 absorption 4 0.5766
41 acids 2 0.2284
41 added 2 0.2883
41 atomic 4 0.9275
41 averaged 2 0.3713
41 b- 1 0.1952
41 b-globulin 1 0.2319
41 b-globulins 1 0.2319
41 biological 2 0.2477
41 cent, 3 0.5347
41 coefficients 1 0.1857
41 cold-ethanol 1 0.2319
41 collections 1 0.1952
41 concentrate 1 0.1857
41 concentration 3 0.2925
41 concentrations 1 0.1192
41 continuous-flow 1 0.2319
41 detection 1 0.1441
41 developed 1 0.1054
41 dimethylglyoxime 1 0.2319
41 direct 1 0.1091
41 electrophoresis, 1 0.2088
41 employ 1 0.2088
41 excretion 1 0.1091
41 extraction 1 0.1671
41 facilitates 1 0.2319
41 found 1 0.061
41 fractions 1 0.1238
41 globulins 1 0.1952
41 gm. 2 0.4175
41 highest 1 0.1466
41 homogenates 2 0.3444
41 hr. 1 0.1341
41 human 3 0.2322
41 including 1 0.1251
41 insufficient 1 0.1857
41 liver 1 0.0912
41 lung 1 0.0997
41 materials 1 0.1626
41 materials, 1 0.2088
41 mean 4 0.4462
41 measurements 5 0.7461
41 ml. 1 0.1553
41 necessary 1 0.1359
41 ni 2 0.3565
41 nickel 13 1.7433
41 nickel, 1 0.1857
41 normal 2 0.1247
41 p.p.m.) 1 0.2088
41 per 7 0.6326
41 performed 1 0.1061
41 permit 1 0.1857
41 precipitation 1 0.1952
41 preparations 3 0.4192
41 prepared 1 0.1397
41 prior 1 0.1238
41 procedure 2 0.2362
41 proteins 1 0.1203
41 proteins, 1 0.1782
41 quantitative 1 0.1226
41 range 6 0.7507
41 rat 2 0.1908
41 recovery 2 0.2557
41 respectively 1 0.1587
41 ribonucleic 2 0.3253
41 rna 1 0.1278
41 rna, 2 0.3713
41 sensitivity 1 0.1397
41 serum 3 0.2699
41 spectrometer 1 0.2319
41 spectrometry 2 0.4638
41 subjects 1 0.1107
41 supernatants 2 0.4175
41 therefore, 1 0.1466
41 ug. 4 0.9275
41 ultracentrifugal 2 0.4175
41 upon 1 0.104
41 urinary 1 0.1027
41 urine 4 0.4767
41 urine, 1 0.1952
41 variation 1 0.1466
42 , 2 1.1586
42 . 4 0.6785
42 5'-nucleotidase 3 2.2609
42 5'-nucleotidase, 1 0.7536
42 activity 2 0.5394
42 alkaline 2 1.086
42 applications 1 0.5596
42 assay 1 0.4943
42 bone 1 0.326
42 diagnosis 1 0.3101
42 enzymes 1 0.4764
42 evaluated 1 0.4358
42 evaluation 1 0.4066
42 extent 1 0.3985
42 findings 1 0.2994
42 human 1 0.2515
42 influence 1 0.3449
42 intestinal 1 0.543
42 l-histidine 1 0.7536
42 l-histodine 1 0.7536
42 mg 1 0.4477
42 mixtures 1 0.6034
42 ni 1 0.5793
42 phosphatase 1 0.5596
42 phosphatases 1 0.7536
42 possible 1 0.3023
42 preparations 1 0.4542
42 presented 1 0.2924
42 properties 1 0.4025
42 purified 1 0.4764
42 quantitative 1 0.3985
42 results 1 0.2158
42 serum 2 0.5847
42 serum, 1 0.5793
42 simultaneous 1 0.4611
42 studied 1 0.2626
42 utilization 1 0.5286
42 utilized 1 0.5793
42 various 1 0.2979
43 . 3 0.6785
43 2-alkylidenehydrazones 1 1.0048
43 2-iminoselenazolidin-4-ones 1 1.0048
43 2-iminoselenazolidin-4-ones, 1 1.0048
43 activity 1 0.3596
43 biological 1 0.5366
43 compounds 2 1.448
43 failed 1 0.5738
43 promise 1 0.8461
43 related 1 0.4248
43 reveal 1 0.6728
43 screening 1 0.8461
43 selenazolidine-2,4-diones 1 1.0048
43 series 1 0.4727
43 synthesised 1 1.0048
43 wide-range 1 1.0048
44 (15 1 0.3017
44 (34 1 0.3768
44 (between 1 0.3392
44 (papp) 1 0.3768
44 ) 1 0.2715
44 . 8 0.6785
44 1. 1 0.1973
44 10 1 0.1387
44 40 1 0.2208
44 5 1 0.1429
44 achieved 2 0.5159
44 action 1 0.1639
44 administered 1 0.1799
44 afford 1 0.3768
44 although 1 0.1449
44 amounts 1 0.1871
44 anions, 1 0.3768
44 antidotal 1 0.3768
44 appropriate 1 0.2472
44 azide 2 0.7536
44 azide-methemoglobin 1 0.3768
44 blood 1 0.1164
44 borate, 1 0.3768
44 cells, 1 0.1826
44 characterized 1 0.1992
44 circumstances 1 0.3017
44 comparable 1 0.2077
44 complex 2 0.4358
44 course 1 0.1713
44 cyanate, 1 0.3768
44 cytochrome 1 0.3392
44 date 1 0.2798
44 death 1 0.2055
44 decline 1 0.2643
44 degree 1 0.167
44 demonstrated 2 0.3222
44 established 1 0.2033
44 extent 1 0.1992
44 female 1 0.2179
44 fluoride 1 0.3768
44 fluoride, 1 0.3768
44 formation 2 0.3381
44 identified 1 0.2208
44 important 1 0.1702
44 induced 1 0.1602
44 influence 1 0.1724
44 inhibitors 1 0.2798
44 intact 1 0.2077
44 intraperitoneal 1 0.2715
44 lethality 1 0.3768
44 levels 1 0.1476
44 methemoglobin 1 0.3392
44 methemoglobinemia 4 1.5073
44 mg/kg) 1 0.3768
44 mice 2 0.3711
44 minutes 1 0.2472
44 minutes) 1 0.3392
44 mouse 1 0.2101
44 nitrite 1 0.3768
44 nitrite- 1 0.3768
44 normal 1 0.1013
44 oxidase 1 0.3768
44 p-aminopropiophenone 1 0.3768
44 papp 1 0.3768
44 papp-induced 1 0.3768
44 peak 1 0.2179
44 poisoning 1 0.258
44 possible 1 0.1512
44 prolongation 1 0.2897
44 protect 1 0.2798
44 protection 1 0.2425
44 protective 1 0.3173
44 quickly 1 0.3173
44 rapidly 1 0.2152
44 red 1 0.2238
44 seen 1 0.1593
44 selenate, 1 0.3768
44 sequence 1 0.2897
44 significant 1 0.1323
44 situation 1 0.3017
44 small 1 0.1512
44 sodium 2 0.3625
44 survival 1 0.1813
44 think 1 0.3173
44 thiocyanate, 1 0.3768
44 time 3 0.3983
44 toxic 1 0.2305
44 vivo 1 0.2238
44 within 1 0.1399
45 . 4 0.5428
45 account 1 0.3401
45 also 1 0.1687
45 amounts 1 0.2993
45 animals 1 0.2563
45 animals, 1 0.3633
45 behaviour 1 0.4827
45 berzelius 1 0.6029
45 discovery 1 0.5428
45 element 1 0.4634
45 finally, 1 0.4127
45 gahn 1 0.6029
45 given 2 0.442
45 importance 1 0.3071
45 large 1 0.2383
45 man 1 0.3099
45 mentioned 1 0.4344
45 myopathies 1 0.6029
45 prevention 1 0.4127
45 quantities 1 0.4229
45 recent 1 0.3157
45 retinal 1 0.4477
45 review 1 0.3324
45 role 1 0.2797
45 selenium 5 1.8167
45 soils 1 0.6029
45 surveyed 1 0.5076
45 theories 1 0.4229
45 toxic 1 0.3689
45 trace 2 0.8688
45 upon 1 0.2705
45 vegetation, 1 0.6029
45 vision 1 0.4827
46 . 5 0.6785
46 0.5 1 0.4477
46 1.8-2.0 1 0.6029
46 14-day 1 0.6029
46 64-68 1 0.6029
46 air 1 0.3362
46 alone 1 0.3633
46 based 1 0.3157
46 caused 1 0.2639
46 cell 1 0.204
46 chick 2 0.8457
46 contents, 1 0.5428
46 depression 1 0.4229
46 effects 2 0.4476
46 egg 1 0.4827
46 embryos 3 1.3431
46 evident 1 0.3748
46 greater 1 0.2494
46 gross 1 0.4037
46 growth 2 0.411
46 hour 1 0.4344
46 injection 1 0.2521
46 inorganic 1 0.4127
46 ld 1 0.5428
46 mortality 2 0.7267
46 period 1 0.2287
46 ppm 1 0.4634
46 ppm, 1 0.6029
46 prominent 1 0.4477
46 salts 1 0.4634
46 selenate 1 0.4827
46 selenate-se 1 0.6029
46 selenite 3 1.3032
46 selenite-se 1 0.5428
46 selenium 1 0.3633
46 studied 1 0.2101
46 sulfate 1 0.4229
46 together 1 0.3443
46 toxicity 1 0.3955
46 treatment 3 0.5336
46 treatments, 1 0.6029
46 weight 1 0.2836
47 (dogs 1 0.7536
47 . 4 0.6785
47 act 1 0.4685
47 administered 2 0.7196
47 alloxan,. 1 0.7536
47 analogous 1 0.6034
47 animals 1 0.3204
47 b 2 1.0318
47 cells 2 0.4549
47 changes 1 0.2255
47 completely 1 0.4416
47 deficiency 1 0.3985
47 development 1 0.2752
47 diabetic 1 0.5046
47 dogs 1 0.3909
47 examination 1 0.3805
47 existence 1 0.4611
47 first 1 0.2763
47 granules 1 0.4943
47 groups, 1 0.5046
47 histological 1 0.4477
47 inactivating 1 0.7536
47 injections 2 0.8503
47 intravenously 2 1.0572
47 islets 2 1.357
47 langerhans 1 0.6785
47 langerhans, 1 0.7536
47 lead 1 0.485
47 leads 1 0.4202
47 lesions 2 0.6481
47 lose 1 0.6346
47 mostly 1 0.5286
47 ones 1 0.5286
47 pancreas 1 0.543
47 partly 1 0.5793
47 poisoned 1 0.6346
47 poisons 1 0.7536
47 produced 1 0.3069
47 rabbit 1 0.4252
47 rabbits 1 0.4303
47 rabbits) 1 0.7536
47 repeated 1 0.4477
47 seem 1 0.411
47 selenite 2 1.086
47 sensitive 1 0.4066
47 sh 1 0.6785
47 shown 1 0.3241
47 sodium 2 0.725
47 syndrome 1 0.3496
47 two 1 0.2308
48 (1600 1 0.4306
48 . 5 0.4847
48 20 1 0.1945
48 24 2 0.4468
48 30 1 0.2056
48 4-day 1 0.4306
48 4th 1 0.3198
48 8-day 1 0.4306
48 8th 1 0.4306
48 abnormalities 3 0.7204
48 administered 2 0.4112
48 avian 2 0.7754
48 chick 1 0.3021
48 containing 1 0.2277
48 continuous 1 0.2429
48 day 1 0.2138
48 eggs 1 0.3198
48 embryos 7 2.2385
48 embryos, 1 0.4306
48 greater 1 0.1781
48 highest 1 0.2722
48 hours 1 0.2071
48 hours.. 1 0.4306
48 incubation 1 0.2635
48 injected 1 0.2087
48 injection 1 0.1801
48 internal 1 0.2429
48 irradiation 1 0.2324
48 kill 1 0.3626
48 killed 1 0.3626
48 level 3 0.4989
48 levels 1 0.1686
48 morphological 1 0.2635
48 nearly 1 0.2635
48 observed 2 0.2936
48 produced 3 0.5262
48 radiosulfur 1 0.4306
48 required 1 0.2348
48 selenium 4 1.0381
48 selenium, 1 0.3626
48 severe 1 0.1908
48 similar 1 0.1612
48 stable 1 0.3103
48 sulfur-35 2 0.8613
48 sulfur-35, 1 0.4306
48 tellurium 2 0.8613
48 tellurium-injected 1 0.4306
48 times 1 0.2071
48 tolerated 1 0.3103
48 toxicity 1 0.2825
48 toxicosis 1 0.3626
48 uc) 1 0.4306
48 ug 1 0.331
48 within 2 0.3197
49 . 8 0.6785
49 also 1 0.1054
49 another 1 0.2055
49 arcs 1 0.3768
49 changes 2 0.2255
49 chronic 2 0.3598
49 country 1 0.3392
49 days 1 0.1497
49 describe 1 0.2897
49 due 1 0.1333
49 effect 2 0.2301
49 emphasize 2 0.6346
49 epiglotis 1 0.3768
49 examination 2 0.3805
49 exposed 1 0.1973
49 external 1 0.2271
49 finding 1 0.2305
49 findings 2 0.2994
49 first 1 0.1381
49 frequent 1 0.2271
49 healed 1 0.3173
49 however 1 0.2715
49 literature 1 0.2055
49 occurrence 2 0.4477
49 otitis 1 0.3768
49 owing 1 0.2523
49 palatinal 1 0.3768
49 particularly 1 0.2077
49 passages 2 0.5596
49 patient 1 0.1417
49 poisoning 2 0.5159
49 posterior 1 0.2208
49 profesional 1 0.3768
49 reference 1 0.2077
49 report 1 0.1826
49 reported 2 0.3054
49 respiratory 2 0.3909
49 results 1 0.1079
49 secondary 1 0.1887
49 selenium 4 0.9083
49 selenium, 1 0.3173
49 shop 1 0.3768
49 special 1 0.1992
49 symptomatic 1 0.2643
49 symptoms 1 0.1786
49 teleangiectasias 1 0.3768
49 toxic 1 0.2305
49 transferred 1 0.2897
49 treatment 1 0.1112
49 upper 1 0.2425
49 uvula 1 0.3768
49 within 1 0.1399
49 workers 1 0.2715
49 xyde 1 0.3768
50 (10 1 0.5793
50 . 4 0.6785
50 10 1 0.2774
50 50 2 0.7196
50 absent 1 0.4943
50 degeneration 1 0.543
50 dose 1 0.3598
50 doses 1 0.411
50 effect 2 0.4602
50 ethionine 1 0.7536
50 fatty 1 0.3773
50 increased 2 0.4686
50 influence 1 0.3449
50 influenced 1 0.4685
50 level 1 0.291
50 lipides 1 0.7536
50 lipotropic 1 0.7536
50 liver 2 0.593
50 manifests 1 0.6785
50 rat 1 0.3101
50 selenite 3 1.629
50 selenite/kg 1 0.7536
50 selenite/kg. 1 0.7536
50 significantly 1 0.3168
50 small 1 0.3023
50 sodium 1 0.3625
50 tetrachlorocarbon 1 0.7536
50 total 1 0.2937
50 toxic 1 0.4611
50 toxication 2 1.5073
50 ug 2 1.1586
50 ug/kg 1 0.7536
50 ug/kg) 1 0.7536
50 upon 1 0.3381
51 (containing 1 0.6029
51 (with 1 0.4634
51 . 5 0.6785
51 1 1 0.2277
51 10 2 0.4439
51 12 1 0.2878
51 14-19 1 0.6029
51 18 1 0.3288
51 23 1 0.4037
51 adenoma 1 0.4344
51 administered 1 0.2878
51 along 1 0.4229
51 animals 1 0.2563
51 another 1 0.3288
51 antagonistic 1 0.5428
51 cancer 1 0.2383
51 caused 1 0.2639
51 changes 1 0.1804
51 compounds 1 0.4344
51 due 1 0.2133
51 experiment 1 0.4037
51 extent 1 0.3188
51 fed 1 0.3955
51 food 1 0.4634
51 heterozygous 1 0.4827
51 higher 1 0.2593
51 incompleted 1 0.6029
51 kg 1 0.5076
51 liver 1 0.2372
51 lungs) 1 0.6029
51 lymphatic 1 0.4344
51 mediastinum 1 0.5076
51 metastases 1 0.4127
51 methionine 1 0.5428
51 mg 1 0.3581
51 months 1 0.3044
51 months, 1 0.4634
51 na 1 0.3811
51 nodes, 1 0.4344
51 noted.. 1 0.6029
51 one- 1 0.6029
51 per 1 0.235
51 protein 1 0.2741
51 protein) 1 0.6029
51 quantities 1 0.4229
51 rats 1 0.2328
51 recorded 1 0.3443
51 relationship 1 0.29
51 sarcoma 3 1.2382
51 selenium 2 0.7267
51 selenium-caused 1 0.6029
51 seo 1 0.6029
51 series 1 0.2836
51 suggested 1 0.2507
51 surviving 1 0.4477
51 three 1 0.2267
51 toward 1 0.388
51 tumours 1 0.3811
51 two 1 0.1846
51 yet 1 0.3188
52 . 3 0.6785
52 biochemistry 1 0.8461
52 blood 3 0.9315
52 bone 2 0.8692
52 briefly 1 0.6056
52 caused 1 0.4398
52 cells 1 0.3033
52 contributions 1 0.8046
52 damage 1 0.5119
52 drug 1 0.5262
52 drugs 1 0.554
52 effects 2 0.746
52 embrace 1 1.0048
52 immunology, 1 1.0048
52 important 1 0.4538
52 knowledge 1 0.6591
52 made 1 0.3639
52 marrow 2 1.0062
52 mechanisms, 1 0.9046
52 metabolism 1 0.4762
52 pathogenetic 1 0.7724
52 recent 1 0.5262
52 reviewed 1 0.5669
52 side 1 0.5669
52 study 1 0.3096
52 symptoms 1 0.4762
52 variety 1 0.5422
52 wide 1 0.5969
52 years 1 0.4568
53 . 3 0.6785
53 application 2 1.1337
53 background, 1 1.0048
53 clinical 1 0.3275
53 complications 1 0.5888
53 effects 1 0.373
53 effects, 1 0.8046
53 hypothermia 1 0.5165
53 hypothermia.. 1 1.0048
53 indications 1 0.6879
53 indications, 1 0.9046
53 levels 1 0.3935
53 physiologic 2 1.2933
53 presented 1 0.3898
53 proper 2 1.3455
53 safe 1 0.6591
53 straightforward 1 1.0048
53 survey 1 0.7048
53 technique 2 0.9455
53 used 1 0.3795
54 (eac) 2 1.2058
54 (eaca) 2 1.2058
54 . 5 0.6785
54 account 1 0.3401
54 acetyl 2 1.2058
54 acid 2 0.4656
54 active 1 0.2778
54 activity 1 0.2158
54 affect 1 0.3811
54 agglutination 1 0.6029
54 agglutination.. 1 0.6029
54 alter 1 0.4037
54 alteration 1 0.3955
54 alternations 1 0.6029
54 antigen 1 0.3581
54 antigen-antibody 2 1.2058
54 antigenic 1 0.3533
54 antigens 2 0.6973
54 antiserum 1 0.4037
54 ascites 2 0.9655
54 cells 2 0.3639
54 compared, 1 0.5428
54 derivative 2 1.0856
54 direct 1 0.2836
54 drugs 1 0.3324
54 due 1 0.2133
54 eac 2 1.2058
54 eaca 2 1.2058
54 ehrlich 2 1.2058
54 epsilon-aminocaproic 1 0.5428
54 epsilonaminocaproic 1 0.6029
54 exerted 1 0.5428
54 found 1 0.1587
54 globulins 1 0.5076
54 globulins, 1 0.6029
54 immune 2 0.776
54 induced 2 0.5126
54 inhibit 1 0.4127
54 inhibition 1 0.3018
54 interference 2 0.8073
54 level 1 0.2328
54 membrane 3 0.9759
54 much 1 0.2671
54 mustard 2 1.0856
54 nitrogen 2 0.7909
54 observed, 1 0.5076
54 partially 1 0.3748
54 prominently 1 0.6029
54 reaction 2 0.6037
54 reactions, 1 0.4827
54 represents 1 0.4127
54 specific 2 0.4744
54 studied 1 0.2101
54 taking 1 0.4344
54 toxicity.. 1 0.6029
54 tumor 2 0.5376
54 vitro 1 0.3099
55 . 2 0.3393
55 behavior 1 0.4303
55 cells 4 0.9098
55 chambers 1 0.5793
55 chambers, 1 0.6785
55 destroyed 1 0.5046
55 diffusion 2 1.0091
55 filters 2 1.357
55 host 2 0.7819
55 immunized 1 0.543
55 implanted 1 0.6785
55 large 1 0.2979
55 membrane 1 0.4066
55 penetrating 2 1.5073
55 pore 2 1.357
55 rats 1 0.291
55 rats, 1 0.5159
55 remained 1 0.4303
55 size 2 0.7893
55 small 1 0.3023
55 study 1 0.2322
55 survived 1 0.4943
55 tissue 1 0.2616
55 tumor 1 0.336
55 tumor-resistant 1 0.7536
55 tumour 2 0.9369
55 tumour-resistant 1 0.7536
55 used, 1 0.485
55 virulent 1 0.6034
55 whereas 1 0.3773
56 . 7 0.6785
56 /relaxed/ 1 0.4306
56 acute 2 0.4276
56 anesthetized 1 0.3448
56 anticipated.. 1 0.4306
56 arrest.. 1 0.4306
56 association 1 0.2324
56 asystole 1 0.4306
56 blood 1 0.1331
56 body 1 0.1736
56 brain 1 0.2194
56 cardiac 3 0.5797
56 care 1 0.2722
56 certain 2 0.3793
56 circulation 3 0.6765
56 complete 1 0.1998
56 conditions 1 0.1958
56 controlled 1 0.2459
56 current 1 0.2677
56 development 1 0.1572
56 extracorporeal 1 0.2825
56 feature 1 0.3021
56 following 1 0.1427
56 general 1 0.2194
56 great 1 0.2459
56 groups 1 0.1754
56 hazard 1 0.3877
56 hypothermia 4 0.8854
56 hypoxia 1 0.2771
56 important 1 0.1945
56 inadvertent 1 0.4306
56 indicated 1 0.2026
56 interrupted 1 0.3626
56 interruption 1 0.4306
56 justified 1 0.3626
56 light 1 0.2429
56 loss 1 0.2087
56 major 1 0.2071
56 many 1 0.1736
56 massive, 1 0.4306
56 may 2 0.2154
56 moderate 1 0.2558
56 moment 1 0.3626
56 monitoring 1 0.3448
56 neurosurgical 2 0.8613
56 operating 1 0.3448
56 operations 3 0.8474
56 patient 2 0.3238
56 patients 1 0.1035
56 perhaps 1 0.2374
56 periods.. 1 0.4306
56 premises, 1 0.4306
56 procedures 2 0.4859
56 profound 1 0.2948
56 questioned 1 0.3626
56 recommended 1 0.2883
56 recovery 1 0.2374
56 required 1 0.2348
56 required.. 1 0.4306
56 rests 1 0.3877
56 room 1 0.331
56 seen 1 0.1821
56 septicemic 1 0.3877
56 shakier 1 0.4306
56 shock 1 0.3448
56 short 1 0.249
56 status 1 0.2722
56 sudden 1 0.2771
56 surgical 1 0.1945
56 temperature 1 0.23
56 theater 1 0.4306
56 therapy 1 0.1702
56 today 1 0.3626
56 unrecognized 1 0.3626
56 use 1 0.1702
56 value 2 0.3968
56 varied 1 0.2722
57 . 5 0.6785
57 10 1 0.2219
57 28 1 0.4127
57 37, 1 0.6029
57 84 1 0.4827
57 alteration 1 0.3955
57 animal 1 0.3689
57 anoxic 1 0.6029
57 aortic 1 0.322
57 associated 1 0.2141
57 bypass 1 0.4344
57 c 1 0.3288
57 cardiopulmonary 1 0.4634
57 compared 1 0.2339
57 concentration 1 0.2535
57 considerable 1 0.3127
57 contractile 1 0.5076
57 controls 1 0.3633
57 coronary 2 0.776
57 data 1 0.2455
57 degrees 1 0.3811
57 effect 2 0.3682
57 enzyme 1 0.3581
57 evaluated 1 0.3487
57 experiments 1 0.2671
57 force 1 0.5428
57 function 2 0.541
57 gave 1 0.3811
57 glucose 2 0.6314
57 glucose-perfused 1 0.6029
57 groups 1 0.2455
57 heart 2 0.5593
57 high 1 0.2158
57 higher 2 0.5185
57 hyperglycemic 2 1.2058
57 hypothermia 1 0.3099
57 hypothesis 1 0.322
57 lower 1 0.2741
57 may 1 0.1508
57 metabolic 2 0.5757
57 myocardial 3 1.2686
57 observed 1 0.2055
57 occlusion 1 0.388
57 pathway 1 0.4827
57 pco 1 0.5428
57 perfusion 1 0.3533
57 perfusion.. 1 0.6029
57 ph, 1 0.4477
57 po 1 0.5428
57 protection 2 0.776
57 protective 1 0.5076
57 revealed 1 0.2922
57 series 1 0.2836
57 significant 1 0.2116
57 studies 1 0.1846
57 support 1 0.3324
57 systems 1 0.4229
57 uptake, 1 0.4827
57 utilization 1 0.4229
57 ventricular 1 0.2623
58 . 8 0.6785
58 /carcinoembryonic/ 1 0.3768
58 2 1 0.1151
58 6 1 0.1576
58 absent 1 0.2472
58 adult 3 0.5138
58 agar 1 0.2643
58 also 1 0.1054
58 antigen(s) 1 0.3392
58 antigenic 1 0.2208
58 antigens 7 1.5254
58 basis 1 0.1649
58 cancer 2 0.2979
58 cancers 1 0.2523
58 carcinoembryonic 2 0.7536
58 cells 1 0.1137
58 cells, 1 0.1826
58 cellular 1 0.2055
58 colonic 1 0.3768
58 common 1 0.1841
58 components 1 0.2152
58 concluded 1 0.1724
58 constituents 1 0.2897
58 constituents, 1 0.3768
58 contained 1 0.1919
58 control 1 0.1417
58 corresponding 1 0.2208
58 course 1 0.1713
58 demonstrated 3 0.4833
58 derepressive-dedifferentiation 1 0.3768
58 derived 1 0.2077
58 determine 1 0.2126
58 differentiation 1 0.2152
58 digestive 4 1.2691
58 entodermally 1 0.3768
58 epithelium 2 0.4542
58 experiments 1 0.167
58 expression 1 0.2715
58 fetal 3 0.6455
58 findings 1 0.1497
58 found 1 0.0992
58 gastro-intestinal 1 0.3173
58 gel 1 0.2179
58 genetic 2 0.3946
58 gestation 1 0.2798
58 gut, 1 0.3768
58 human 4 0.5031
58 humans 1 0.3173
58 identical 2 0.4477
58 immunodiffusion 1 0.3017
58 liver, 1 0.258
58 malignant 2 0.411
58 months 1 0.1903
58 named 1 0.3392
58 normal 1 0.1013
58 pancreas 1 0.2715
58 pancreas, 1 0.3392
58 potentialities 2 0.6785
58 present 3 0.3722
58 previously 2 0.3625
58 process 1 0.1724
58 reappear 1 0.3768
58 recent 1 0.1973
58 regarding 1 0.2382
58 represent 2 0.4764
58 repressed 1 0.3392
58 specific 1 0.1483
58 specimens 1 0.2425
58 studied 1 0.1313
58 system 4 0.7041
58 system-specific 2 0.7536
58 techniques 1 0.2055
58 tested 2 0.4542
58 therefore, 1 0.2382
58 tissues 4 0.6897
58 tract 1 0.2179
58 tumor-specific 1 0.3768
58 tumors 1 0.1973
58 types 1 0.1826
58 variety 1 0.2033
58 various 2 0.2979
58 whether 1 0.1871
58 wide 1 0.2238
58 work 1 0.258
59 . 4 0.6785
59 8 1 0.3403
59 closely 1 0.4303
59 contained 1 0.3839
59 could 1 0.2708
59 course 1 0.3426
59 electron 2 0.7611
59 forms 1 0.3598
59 frequently 1 0.3805
59 inclusions 3 1.7379
59 infected 2 0.8219
59 infection 1 0.3546
59 influenza 2 1.357
59 liver 2 0.593
59 lungs 1 0.411
59 mice 2 0.7423
59 mice.. 1 0.6785
59 microscope 2 1.1192
59 might 1 0.3946
59 multiplication 1 0.5596
59 organ 2 1.0572
59 particles 1 0.543
59 perhaps 1 0.4155
59 possibility 1 0.4303
59 pr 1 0.7536
59 presence 2 0.5742
59 resembling 1 0.5793
59 seen 1 0.3186
59 shape 1 0.485
59 shown 1 0.3241
59 size 1 0.3946
59 speak 1 0.6034
59 strain 1 0.3985
59 tested 1 0.4542
59 tissue 1 0.2616
59 tissues 1 0.3449
59 using 1 0.3426
59 virus 3 1.1839
60 . 9 0.6785
60 26 1 0.2117
60 addition 1 0.1706
60 affecting 1 0.282
60 also 1 0.0937
60 area 1 0.1737
60 aspirated 1 0.3349
60 aspiration 2 0.5364
60 biopsy 2 0.4311
60 blood 1 0.1035
60 bone 6 0.8692
60 comparative 2 0.4098
60 conditions 1 0.1523
60 core 1 0.2349
60 crest 1 0.3349
60 described 1 0.127
60 devised 1 0.2575
60 diagnosis 2 0.2757
60 difference 1 0.1677
60 discomfort 3 1.0048
60 diseases 1 0.1827
60 dry 1 0.2487
60 efficient 1 0.2413
60 equally 1 0.2413
60 experienced 2 0.4974
60 fact, 1 0.2682
60 found 1 0.0882
60 four 1 0.1503
60 hematologic 1 0.2682
60 however, 1 0.1213
60 iliac 2 0.5641
60 illinois 1 0.3349
60 inability 1 0.2413
60 indicate 1 0.1475
60 instances 1 0.2243
60 less 2 0.2508
60 little 1 0.1789
60 major 1 0.1611
60 many 1 0.135
60 marrow 6 1.0062
60 microscopic 1 0.2082
60 might 1 0.1754
60 needle 3 0.7724
60 needles 1 0.3349
60 number 1 0.1282
60 objection 1 0.3349
60 observation 1 0.1754
60 observed 1 0.1142
60 obtain 1 0.2349
60 obtained 1 0.1194
60 obtaining 2 0.5149
60 paper 1 0.1807
60 patient 2 0.2519
60 patients 2 0.161
60 primarily 1 0.2117
60 relatively 1 0.1611
60 reliable 2 0.4485
60 sets 1 0.3015
60 show 1 0.1449
60 significant 1 0.1176
60 simultaneously 1 0.2019
60 site 2 0.3874
60 sites 1 0.2243
60 specimen 1 0.2413
60 sternal 1 0.282
60 sternum 2 0.6031
60 studies 1 0.1026
60 study 3 0.3096
60 suitable 1 0.2155
60 system 1 0.1565
60 tap 1 0.3349
60 techniques 1 0.1827
60 two 3 0.3077
60 university 1 0.282
60 use 1 0.1324
60 used 2 0.253
60 used, 1 0.2155
60 using 1 0.1523
60 widely 1 0.2243
61 . 5 0.6785
61 1880000 1 0.6029
61 25 1 0.3443
61 26 1 0.3811
61 27 1 0.4037
61 31 1 0.4477
61 400g 1 0.6029
61 agreement 1 0.4127
61 animals 1 0.2563
61 average 1 0.2705
61 based 1 0.3157
61 body 1 0.2431
61 bone 2 0.5215
61 c. 1 0.3188
61 cell 1 0.204
61 cell-populations 1 0.6029
61 cells 1 0.182
61 computed 1 0.6029
61 data 1 0.2455
61 discussed 1 0.2455
61 erythrocyte 1 0.4477
61 findings 1 0.2395
61 found 1 0.1587
61 good 1 0.3362
61 granulocyte 1 0.5428
61 groups 1 0.2455
61 guinea-pig 2 0.8688
61 implications 1 0.388
61 independent 1 0.3633
61 lymphocytes, 1 0.4344
61 marrow 2 0.6037
61 mm. 1 0.3955
61 normal 2 0.3242
61 nucleated 2 0.9269
61 observations 1 0.2535
61 obtained 1 0.2149
61 per 1 0.235
61 populations 2 0.8954
61 precursors 2 0.8954
61 quantitative 1 0.3188
61 study 1 0.1857
61 total, 1 0.6029
61 two 1 0.1846
61 whole 1 0.3362
62 . 5 0.6785
62 2 1 0.1841
62 46-year-old 1 0.5428
62 51/2-month-old 1 0.6029
62 agents, 1 0.4477
62 association 1 0.3253
62 autopsy 1 0.3955
62 carinii 2 1.2058
62 case 1 0.2166
62 clinicopathologic 1 0.5428
62 cytomegalic 1 0.4827
62 cytotoxic 1 0.4229
62 deals 1 0.4634
62 disease 3 0.6498
62 electron 2 0.6089
62 example 1 0.4827
62 female 1 0.3487
62 findings 1 0.2395
62 first 1 0.221
62 hodgkin's 1 0.6029
62 inclusion 1 0.388
62 infant 1 0.3401
62 irradiation 1 0.3253
62 lungs, 1 0.4634
62 microscope 1 0.4477
62 microscopy 1 0.388
62 morphology 1 0.3689
62 occurred, 1 0.4827
62 organisms 1 0.3689
62 paper 1 0.3253
62 patients 1 0.1449
62 pneumocystis 2 1.2058
62 pneumonia 1 0.4037
62 pneumonia.. 1 0.6029
62 received 1 0.3401
62 removed 1 0.3401
62 second 1 0.3071
62 steroid 1 0.3487
62 studies 1 0.1846
62 study 1 0.1857
62 therapy, 1 0.388
62 thorax 1 0.5428
62 tissue 1 0.2093
62 underlying 1 0.4344
62 used 1 0.2277
62 white 2 0.7495
62 without 1 0.2277
62 woman 1 0.3955
63 (stage 1 0.3877
63 . 7 0.6785
63 12 1 0.2056
63 6 1 0.1801
63 accelerated 1 0.3103
63 advanced 2 0.4468
63 already 2 0.6206
63 attributed 1 0.2883
63 average, 1 0.3626
63 behaved 1 0.3626
63 being, 1 0.4306
63 breast 6 1.3662
63 cancer 6 1.0215
63 corticosteroid 1 0.3021
63 corticosteroids 1 0.2883
63 dehydroepiandrosterone 5 1.9385
63 dehydroxycorticosteroids 1 0.4306
63 depressing 1 0.3877
63 effect 4 0.526
63 found 1 0.1134
63 group 4 0.6368
63 groups 1 0.1754
63 hours 2 0.4143
63 i/ii 1 0.4306
63 infusion 1 0.2429
63 initial 2 0.4175
63 intermediately 1 0.4306
63 is, 1 0.2883
63 iv 2 0.6621
63 iv) 1 0.3877
63 lasting 1 0.3877
63 less 1 0.1612
63 level 2 0.3326
63 lowest 1 0.3448
63 mastopathy 1 0.3877
63 mastopathy, 1 0.4306
63 patients 1 0.1035
63 phosphate 1 0.2175
63 plasma 1 0.1736
63 plasms 1 0.4306
63 provable 1 0.3877
63 reached 2 0.5649
63 shortened 1 0.3626
63 stage 3 0.6262
63 stages 1 0.2374
63 still 1 0.2012
63 suffering 1 0.2558
63 three 1 0.1619
63 time 2 0.3035
63 transformation 1 0.2348
63 values 3 0.6524
63 various 1 0.1702
64 'average' 1 0.3768
64 'body', 1 0.3768
64 'core' 1 0.3768
64 'correction 1 0.3768
64 'mean', 1 0.3768
64 . 8 0.6785
64 accurate 1 0.2305
64 acid 1 0.1455
64 acid-base 1 0.3173
64 alterations 1 0.2077
64 appear 1 0.1724
64 applied 1 0.2271
64 autogenous 1 0.3173
64 base 1 0.2643
64 bicarbonate 1 0.3173
64 blood 5 0.5822
64 body 2 0.3038
64 changes 3 0.3382
64 circulation 2 0.3946
64 circumstances 1 0.3017
64 complicated 1 0.2643
64 component 1 0.2425
64 concentrations 1 0.1937
64 concluded 1 0.1724
64 considering 1 0.2897
64 cooled 1 0.2715
64 describing 1 0.3768
64 different 1 0.1333
64 discarded 1 0.3768
64 discussed 1 0.1535
64 equilibrated 1 0.3768
64 events 1 0.2798
64 examples 1 0.2798
64 existing 1 0.3173
64 experiments 1 0.167
64 extra-corporeal 2 0.7536
64 factors 1 0.1593
64 factors' 1 0.3768
64 fundamental 1 0.3017
64 gases 1 0.3392
64 general, 1 0.2715
64 given, 1 0.3768
64 gradients 1 0.3392
64 hypothermia 3 0.581
64 hypothermia, 1 0.2643
64 influence 2 0.3449
64 involving 1 0.2425
64 ion 1 0.2897
64 living 2 0.543
64 low 1 0.1649
64 lung 1 0.162
64 made 1 0.1365
64 main 2 0.4303
64 meaning 1 0.3017
64 measured 2 0.3299
64 measurement 1 0.2126
64 metabolic 1 0.1799
64 methods 2 0.3403
64 numerical 1 0.3173
64 occur 2 0.3682
64 occurring 1 0.2179
64 one 1 0.1054
64 particular 1 0.1903
64 pco2 1 0.3017
64 perfusion 1 0.2208
64 ph 4 0.8133
64 place 1 0.2305
64 producing 1 0.2425
64 profound 3 0.7739
64 protein 1 0.1713
64 pump-oxygenator 1 0.3392
64 quoted 1 0.3392
64 readings 1 0.2897
64 reasons 1 0.2523
64 reference 1 0.2077
64 referred 1 0.2238
64 reflect 1 0.2897
64 regard 1 0.2152
64 respiratory 1 0.1955
64 review 1 0.2077
64 reviewed 1 0.2126
64 reviewed, 1 0.3173
64 sequences 1 0.3017
64 site 1 0.2179
64 sufficiently 1 0.3173
64 taking 1 0.2715
64 temperature 4 0.805
64 temperatures 1 0.2382
64 terms 1 0.2305
64 together 1 0.2152
64 tonometry 1 0.3768
64 two 1 0.1154
64 undergoing 1 0.2382
64 understood 1 0.3392
64 upon 1 0.1691
64 use 1 0.149
64 using 1 0.1713
64 values 2 0.3805
64 way 1 0.2382
64 whole 1 0.2101
65 . 13 0.6785
65 /immunity/ 1 0.2319
65 /wag/ 1 0.2319
65 aborted 1 0.2319
65 abortions 1 0.2088
65 active 1 0.1068
65 active, 1 0.1722
65 adult 1 0.1054
65 antigen, 2 0.3341
65 antigens 1 0.1341
65 antisubstances 1 0.2319
65 benzpyrene-induced 1 0.2319
65 cases 2 0.138
65 causing 1 0.1722
65 certain 1 0.1021
65 challenge 3 0.5857
65 challenging 1 0.2319
65 characteristic 1 0.1171
65 continued 1 0.1341
65 cortisone 1 0.1857
65 crocker 1 0.2319
65 disease 1 0.0833
65 effect 1 0.0708
65 embryonic 3 0.4398
65 except 2 0.2616
65 experiments 1 0.1027
65 experiments, 1 0.2088
65 extensive 1 0.1308
65 fifty 1 0.1671
65 five 1 0.1226
65 foetal 1 0.1671
65 found,. 1 0.2319
65 given 1 0.085
65 groups 1 0.0944
65 growing 1 0.1553
65 grown 1 0.1587
65 growth 2 0.1581
65 hand 1 0.1857
65 hs 2 0.4638
65 human 5 0.387
65 immune 1 0.1492
65 inactive 1 0.1587
65 increased 1 0.0721
65 induced 2 0.1972
65 injection 2 0.1939
65 irondextran 1 0.2319
65 isolated 1 0.1009
65 line 1 0.1397
65 liver 1 0.0912
65 made 1 0.084
65 malignant 1 0.1265
65 may 1 0.058
65 mice, 1 0.1722
65 modified 1 0.1671
65 mouse 4 0.5172
65 muscle 1 0.1278
65 negative 1 0.1359
65 obtained 2 0.1653
65 part 1 0.1083
65 passive 1 0.1587
65 patients 1 0.0557
65 placenta 2 0.3341
65 plasma 1 0.0935
65 play 1 0.1377
65 pregnancy 1 0.1359
65 present 1 0.0763
65 prior 2 0.2477
65 produced 3 0.2833
65 protection 1 0.1492
65 proved 1 0.1293
65 puerperium 1 0.2319
65 pure 1 0.1492
65 pure-line 1 0.2319
65 rapidly 1 0.1324
65 rat 2 0.1908
65 rats 3 0.2686
65 reactions 1 0.1133
65 resistance 2 0.2586
65 response 1 0.0847
65 results 2 0.1328
65 sarcoma 1 0.1587
65 sarcoma, 1 0.2088
65 sera 2 0.3042
65 showed 1 0.0827
65 similar 1 0.0868
65 spleen 1 0.1377
65 suggested 1 0.0964
65 suspensions 1 0.1782
65 term, 1 0.1952
65 time 1 0.0817
65 tissue 2 0.161
65 tissues 2 0.2122
65 treated 1 0.0954
65 tumour 4 0.5766
65 tumour, 2 0.4175
65 tumour,. 1 0.2319
65 tumours 1 0.1466
65 two 1 0.071
65 using 5 0.527
65 variable 1 0.1397
65 varied.. 1 0.2319
65 various 1 0.0917
65 walker 1 0.1952
65 weanling 1 0.1782
65 whereas 1 0.1161
65 women 1 0.1251
65 yet 1 0.1226
66 . 6 0.5089
66 adrenalectomy 5 1.3215
66 advanced 1 0.1955
66 assessing 1 0.3173
66 better 2 0.4358
66 breast 1 0.1992
66 cancer 1 0.149
66 carried 1 0.1887
66 clinical 1 0.1228
66 difference 1 0.1887
66 discriminant 1 0.3768
66 discriminants 5 1.8841
66 estimations 1 0.3173
66 hypophysectomy 4 1.086
66 much 1 0.167
66 negative 3 0.6624
66 operation 2 0.3946
66 patients 8 0.7246
66 positive 2 0.4025
66 prediction 1 0.2798
66 prognosis 1 0.2077
66 random 2 0.6346
66 recommended 1 0.2523
66 response 3 0.4127
66 sample 1 0.2798
66 sample, 1 0.3768
66 selected 4 0.8832
66 significant 1 0.1323
66 significantly 1 0.1584
66 steroid 1 0.2179
66 submitted 2 0.6785
66 suitability 1 0.3768
66 tend 1 0.2715
66 test 1 0.163
66 trial 1 0.2798
66 urinary 1 0.167
66 use 1 0.149
66 worse 1 0.3392
67 . 4 0.5428
67 account 1 0.3401
67 allows 1 0.4827
67 analogical 1 0.6029
67 and/or 1 0.3811
67 basal 1 0.3955
67 better 1 0.3487
67 body 1 0.2431
67 bronchial 3 1.3431
67 cancer 1 0.2383
67 causal 1 0.4827
67 cells 5 0.9098
67 certain 1 0.2655
67 cytoplasmic 1 0.3633
67 derived 1 0.3324
67 desmosomes 1 0.6029
67 early 1 0.221
67 epidermoid 1 0.4827
67 epidermoidic 2 1.2058
67 epithelioma 2 1.2058
67 epithelium 1 0.3633
67 evolution 1 0.4344
67 germinativum 1 0.6029
67 gives 1 0.4344
67 human 1 0.2012
67 initiated 1 0.4827
67 it, 1 0.4827
67 lung 1 0.2593
67 lung.. 1 0.5428
67 malpighian 1 0.6029
67 medium 1 0.322
67 metaplasis 1 0.6029
67 modificated 1 0.6029
67 modifications 1 0.6029
67 normal 1 0.1621
67 nuclear 1 0.3487
67 possibility 1 0.3443
67 presence 1 0.2297
67 primary 1 0.2549
67 proliferation 1 0.3487
67 stratum 1 0.6029
67 structure 1 0.3071
67 study 1 0.1857
67 suggest 1 0.2741
67 tonofibrils 1 0.5428
67 ultrastructural 1 0.5076
67 understanding 1 0.3955
67 us 1 0.3955
67 virus 1 0.3157
67 wall 2 0.7622
67 whose 1 0.3533
68 (microsomes 1 0.4306
68 . 7 0.6785
68 80 1 0.2948
68 accumulating 1 0.3877
68 accumulation 1 0.3021
68 acid-soluble 1 0.4306
68 active 1 0.1984
68 administered 2 0.4112
68 appears 1 0.1852
68 appreciable 1 0.3021
68 biosynthesis 1 0.3198
68 blood 1 0.1331
68 c 2 0.4697
68 chains 1 0.3877
68 components 1 0.2459
68 compound 1 0.2948
68 concluded 1 0.1971
68 conversion 1 0.3103
68 converted 1 0.3626
68 derivatives 1 0.3198
68 far 1 0.2771
68 fed 1 0.2825
68 first 1 0.1579
68 followed 1 0.1971
68 fraction 2 0.46
68 glucosamine 2 0.8613
68 glucosamine- 1 0.4306
68 glucosamine-1- 1 0.4306
68 glycoproteins 2 0.7754
68 i. 1 0.2558
68 incorporation 1 0.2722
68 intravenously 1 0.3021
68 least 1 0.2213
68 liver 5 0.8472
68 macromolecules 1 0.4306
68 mitochondria) 1 0.4306
68 organ 1 0.3021
68 particulate 2 0.8613
68 peptide 1 0.3626
68 plasma 2 0.3472
68 protein-bound 1 0.4306
68 proteins 3 0.6702
68 rapidly 2 0.4918
68 rat 1 0.1772
68 rats 1 0.1663
68 recovered 1 0.2677
68 released 2 0.7252
68 removed 1 0.2429
68 shown 1 0.1852
68 soluble 1 0.2558
68 stage 1 0.2087
68 stream 1 0.3448
68 tissues 2 0.3941
68 transferred 1 0.331
68 trichloroacetic 1 0.4306
68 without 1 0.1626
69 (type 1 1.357
69 . 2 0.6785
69 acute 1 0.7483
69 alveolar 2 1.6439
69 capillaries 2 2.4137
69 cell 1 0.5101
69 electron 1 0.7611
69 endothelial 1 1.1586
69 epithelial 1 0.797
69 eventually 1 1.2691
69 experimental 2 1.3983
69 i) 1 1.357
69 intercellular 1 1.2069
69 interstitial 1 1.0318
69 junctions 1 1.5073
69 leucocytes 2 2.7139
69 membranes 1 0.97
69 microscope 1 1.1192
69 migration 1 1.0091
69 mouse 1 0.8404
69 mouse.. 1 1.5073
69 observed 1 0.5138
69 pass 1 1.1192
69 pneumococcal 2 3.0145
69 pneumonia 2 2.0183
69 preliminary 1 0.8607
69 pulmonary 2 1.2888
69 revealed 1 0.7306
69 spaces 2 2.1144
69 study 1 0.4643
69 tissue 1 0.5232
70 'air' 1 0.2153
70 'duct' 1 0.2153
70 (endodermal) 1 0.2153
70 . 14 0.6785
70 1. 1 0.1128
70 10. 1 0.1939
70 2. 1 0.1128
70 3. 1 0.1162
70 4. 1 0.123
70 40 1 0.1262
70 45 1 0.1442
70 5. 1 0.1412
70 6. 1 0.151
70 7. 1 0.1724
70 8. 1 0.1939
70 9. 1 0.1939
70 absorption 1 0.1338
70 adult 1 0.0979
70 also 2 0.1205
70 alveolar 3 0.3523
70 always 1 0.115
70 amniotic 1 0.2153
70 appearance 1 0.1069
70 barrier, 1 0.1939
70 becomes 1 0.1298
70 birth 1 0.1097
70 blood 1 0.0665
70 blood-air 1 0.1655
70 bodies 1 0.1317
70 c.r. 1 0.2153
70 canada, 1 0.1939
70 canalicular 2 0.4306
70 cells 3 0.195
70 complete 2 0.1998
70 consisting 1 0.1724
70 continuous 1 0.1215
70 council 1 0.2153
70 cytoplasm 1 0.1338
70 developing 1 0.1162
70 development 2 0.1572
70 development, 1 0.1442
70 different 1 0.0762
70 differentiated 1 0.1442
70 diffusa 1 0.2153
70 discussed 2 0.1754
70 distension 1 0.1939
70 e.g. 1 0.1813
70 early 1 0.0789
70 electron 3 0.3262
70 endothelial 1 0.1655
70 endothelium 1 0.1724
70 endothelium, 1 0.2153
70 epithelial 2 0.2277
70 epithelium, 2 0.4306
70 expressed 2 0.3103
70 fact 1 0.1139
70 fluid 1 0.102
70 foetus 1 0.1939
70 fully 1 0.1599
70 glandular 1 0.1599
70 glandular, 1 0.2153
70 glycogen 1 0.1551
70 grants 1 0.2153
70 gratitude 2 0.4306
70 human 1 0.0719
70 identified 1 0.1262
70 immature 3 0.4325
70 importance 1 0.1097
70 inclusion 1 0.1386
70 indicate 1 0.0948
70 individual 1 0.1139
70 infants 1 0.1028
70 lamellated 1 0.2153
70 large 1 0.0851
70 length 1 0.1412
70 light 3 0.3644
70 lined 1 0.1813
70 lung 4 0.3704
70 manuscript 1 0.2153
70 may 2 0.1077
70 mechanism 1 0.0992
70 medical 1 0.1279
70 micropinocytotic 1 0.2153
70 microscope 1 0.1599
70 microscopic 1 0.1338
70 microscopy 3 0.4157
70 miss 1 0.1939
70 mm. 1 0.1412
70 nature 1 0.1069
70 numbers 1 0.1279
70 observations 1 0.0905
70 one 1 0.0602
70 organelles 1 0.1599
70 parts 1 0.1474
70 performed 1 0.0985
70 presence 1 0.082
70 present 4 0.2836
70 project 1 0.1939
70 rat 3 0.2658
70 receipt 1 0.2153
70 remains 1 0.1128
70 research 1 0.1412
70 respect 1 0.1262
70 respiratory 2 0.2234
70 shown 1 0.0926
70 smith 1 0.2153
70 spaces 2 0.3021
70 stage 1 0.1044
70 stage, 2 0.331
70 stages 3 0.3561
70 study 1 0.0663
70 suggested 1 0.0895
70 sylvia 1 0.2153
70 thickness 1 0.1724
70 three 1 0.081
70 throughout 1 0.123
70 time, 1 0.1245
70 tissue 4 0.299
70 typing 1 0.1939
70 uncertain 1 0.1599
70 us 1 0.1412
70 varies 1 0.1551
70 vascular 1 0.1187
70 vesicles 1 0.1724
70 vessels 1 0.1551
70 whilst 1 0.1599
70 zona 1 0.1724
71 . 13 0.6785
71 1 1 0.0876
71 1.5 1 0.1782
71 3 1 0.079
71 affected 1 0.1203
71 alveolar 3 0.3794
71 apical 1 0.1952
71 appreciable 1 0.1626
71 areas 2 0.2452
71 basement 1 0.1782
71 became 1 0.1377
71 blood-air 1 0.1782
71 bronchiolar 4 0.835
71 capillary 1 0.1671
71 caused 1 0.1015
71 cells 3 0.2099
71 cells, 3 0.3372
71 central 1 0.1251
71 ciliated 1 0.2319
71 complete 1 0.1076
71 considerable 1 0.1203
71 consolidation, 1 0.2319
71 correlated 1 0.1377
71 cytoplasmic 1 0.1397
71 days 1 0.0921
71 degeneration 2 0.3341
71 desquamation 1 0.2319
71 differently 1 0.2319
71 earliest 1 0.1722
71 edema 2 0.3175
71 electron 2 0.2342
71 elongated 1 0.2319
71 endoplasmic 1 0.1722
71 endothelium 1 0.1857
71 epithelium 1 0.1397
71 evaluate 1 0.1722
71 flattened 1 0.1857
71 focal 1 0.1722
71 gradually 1 0.1466
71 hyperplasia 1 0.1308
71 hypertrophy, 1 0.1671
71 infection 1 0.1091
71 infection, 1 0.1626
71 infiltrated 1 0.2319
71 influenza 1 0.2088
71 influenzal 2 0.4638
71 inoculated 1 0.1671
71 inoculation 1 0.1553
71 interposed 1 0.2319
71 interstitial 1 0.1587
71 intervals 1 0.1441
71 killed 1 0.1952
71 ld 1 0.2088
71 lesions 2 0.1994
71 light 1 0.1308
71 lining 2 0.3105
71 lumen 3 0.5857
71 lung 1 0.0997
71 macrophages 1 0.1553
71 matured 1 0.2319
71 membrane 1 0.1251
71 mice 3 0.3426
71 microscopy 3 0.4477
71 mononuclear 1 0.1952
71 mostly 1 0.1626
71 nonciliated 1 0.2319
71 nonciliated, 1 0.2319
71 observations 1 0.0975
71 order 1 0.1214
71 particles 1 0.1671
71 pathogenesis 2 0.2616
71 pathway 1 0.1857
71 peribronchiolar 1 0.2319
71 periphery, 1 0.2319
71 pneumonia 2 0.3105
71 pr8 1 0.2319
71 produced 1 0.0944
71 progressive 1 0.1293
71 proliferation 1 0.1341
71 regenerating 1 0.2088
71 released 1 0.1952
71 resulted 1 0.1124
71 reticulum 1 0.1782
71 showed 1 0.0827
71 sloughed 1 0.2088
71 somewhat 1 0.1722
71 stratified, 1 0.2319
71 studied 1 0.0808
71 surface 2 0.2502
71 thickening 1 0.1782
71 tissue 1 0.0805
71 totally 1 0.1626
71 type 1 0.0964
71 underwent 1 0.1671
71 varying 1 0.1251
71 viral 2 0.2795
71 virus 1 0.1214
71 week 1 0.1521
72 -dash 2 1.0318
72 . 3 0.5089
72 acid 1 0.291
72 acids 1 0.3711
72 age 1 0.3118
72 aging 1 0.5793
72 amino 2 0.9528
72 biomorphosis 2 1.5073
72 change 1 0.3496
72 chemical 1 0.4542
72 composition 2 0.8832
72 content 1 0.3546
72 continuous 1 0.4252
72 contribution 1 0.543
72 course 1 0.3426
72 crystalline 4 2.2385
72 effects 1 0.2798
72 electrophoretic 1 0.5286
72 gel 1 0.4358
72 horse 3 1.8103
72 individual 2 0.797
72 lens 3 1.0714
72 lenses 1 0.4685
72 life 1 0.3985
72 mammalian 1 0.5159
72 material 1 0.3496
72 methods 1 0.3403
72 occur 1 0.3682
72 organs 1 0.4155
72 paperchromatographic 1 0.7536
72 qualitative 1 0.5793
72 quantitative 1 0.3985
72 quite 1 0.4303
72 remains 1 0.3946
72 respect 1 0.4416
72 same, 1 0.7536
72 shown 1 0.3241
72 stages 1 0.4155
72 studied 1 0.2626
72 studies 1 0.2308
72 subject 1 0.485
72 substantial 1 0.5793
72 tissues 1 0.3449
72 variations 2 0.9369
72 within 1 0.2798
73 . 10 0.5654
73 /lamellar 1 0.2512
73 /secreted/ 1 0.2512
73 accretion 1 0.2262
73 acid 1 0.097
73 active 1 0.1157
73 also 1 0.0703
73 alteration 1 0.1648
73 alveolar 6 0.8219
73 appear 1 0.115
73 associated 1 0.0892
73 basically 1 0.1931
73 basis 1 0.11
73 bodies 11 1.6906
73 body 1 0.1013
73 certain 1 0.1106
73 changing 1 0.1865
73 characteristic 1 0.1268
73 characteristics 1 0.1401
73 complex 1 0.1453
73 concluded 1 0.115
73 consist 1 0.1865
73 contains 2 0.3074
73 cuboidal 2 0.4523
73 cytoplasmic 2 0.3028
73 degradation 1 0.2011
73 developing 4 0.5422
73 differentiating 1 0.2115
73 discussed 1 0.1023
73 distribution 1 0.1291
73 early 2 0.1842
73 enlarge 1 0.2115
73 epithelium 4 0.6056
73 evidence 2 0.1842
73 extruded 1 0.2262
73 fetal 1 0.1434
73 finally 1 0.172
73 flattened 1 0.2011
73 focal 1 0.1865
73 formation 1 0.1127
73 formed 1 0.1401
73 forms 1 0.1199
73 golgi 1 0.1865
73 greater 1 0.1039
73 heterogeneous 1 0.2011
73 however, 1 0.091
73 i.e., 1 0.1931
73 images 1 0.2262
73 inclusion 12 1.9399
73 infancy, 1 0.1865
73 interpreted 1 0.172
73 interrelationship 1 0.2262
73 involved 1 0.128
73 late 1 0.1492
73 latter 1 0.1303
73 life 1 0.1328
73 limiting 1 0.1865
73 lung 2 0.216
73 lysosomal 1 0.2262
73 man 1 0.1291
73 mature 1 0.1562
73 may 1 0.0628
73 membrane 1 0.1355
73 membranes 2 0.3233
73 membranous 1 0.1865
73 mitochondria./ 1 0.2512
73 morphologic 1 0.181
73 number 1 0.0961
73 occurs 1 0.1342
73 phosphatase 1 0.1865
73 possible 1 0.1008
73 presented 1 0.0975
73 process 1 0.115
73 profiles 1 0.2011
73 pulmonary 1 0.1074
73 rapidly 1 0.1434
73 rat 2 0.2067
73 reaction, 1 0.2115
73 remodeling 1 0.2262
73 result 1 0.1087
73 role 1 0.1165
73 similar 1 0.094
73 so-called 1 0.181
73 space 1 0.1865
73 structures 2 0.3364
73 suggesting 1 0.1537
73 surfactant 1 0.181
73 system 1 0.1173
73 time 1 0.0885
73 transformed 1 0.1931
73 type 2 0.2089
73 unit 1 0.1762
74 . 3 0.6785
74 already 1 0.724
74 authors 1 0.4629
74 belong 1 0.9046
74 besides 1 0.9046
74 cataract 1 0.724
74 cataract, 1 0.9046
74 changes 1 0.3007
74 complex 2 1.1622
74 describe 1 0.7724
74 detachment, 2 1.8093
74 eczema 2 1.6091
74 encountered 1 0.6352
74 endogenous 2 1.3758
74 keratoconjunctivitis 1 1.0048
74 keratoconus 2 2.0097
74 known 1 0.4909
74 long 1 0.5212
74 observations 1 0.4225
74 occur 1 0.4909
74 ocular 1 0.6879
74 ovular 1 1.0048
74 personal 1 0.7048
74 reference 1 0.554
74 retinal 2 1.4923
74 still 1 0.4694
74 symptom 2 1.4096
74 time, 1 0.5811
75 (+56 1 0.2319
75 (-25 1 0.2319
75 (-26 1 0.2319
75 (1) 1 0.1124
75 (2) 1 0.1124
75 (3) 1 0.1226
75 (4) 1 0.1341
75 ) 3 0.5012
75 -13 1 0.2319
75 -35 2 0.4638
75 . 13 0.6785
75 /abdomen/ 1 0.2319
75 /head/, 1 0.2319
75 /heart/ 1 0.2319
75 /liver/ 1 0.2319
75 /lung/ 2 0.4638
75 /palm/, 1 0.2319
75 /thigh/ 2 0.4638
75 10 1 0.0854
75 16 1 0.1441
75 18 1 0.1265
75 2 1 0.0708
75 6 1 0.097
75 added 1 0.1441
75 adjusted, 1 0.2319
75 although 1 0.0891
75 arterioles, 1 0.2319
75 asthenia 2 0.4638
75 average 2 0.2081
75 blood 6 0.4299
75 body 1 0.0935
75 capillaries 1 0.1857
75 cardiac 7 0.7283
75 case 1 0.0833
75 cases 3 0.207
75 cases, 1 0.1214
75 cent 1 0.1192
75 change 3 0.3227
75 changes 4 0.2775
75 compared 1 0.09
75 compensate 1 0.2319
75 content 3 0.3273
75 control 2 0.1744
75 correlation 1 0.1171
75 counting 1 0.1722
75 data 1 0.0944
75 decrease 2 0.2122
75 decreased 1 0.1047
75 difference 1 0.1161
75 disease 1 0.0833
75 diseases 1 0.1265
75 distribution 2 0.2384
75 doubt 1 0.2088
75 external 1 0.1397
75 extreme, 1 0.2088
75 follows 1 0.1492
75 follows.. 1 0.2088
75 heart 1 0.1076
75 hyperthyroidism 1 0.2319
75 idiopathic 1 0.1587
75 implies 1 0.2088
75 including 1 0.1251
75 increase 2 0.1575
75 indices 1 0.1626
75 induced 3 0.2957
75 influenced 1 0.1441
75 latter 1 0.1203
75 linear 1 0.1492
75 measured 1 0.1015
75 might 1 0.1214
75 minimal 1 0.1441
75 neurocirculatory 2 0.4638
75 nodal 1 0.1952
75 observed 1 0.079
75 ordinary 1 0.1722
75 output 7 0.9511
75 parameters 1 0.1671
75 parts 1 0.1587
75 patients 1 0.0557
75 per 1 0.0904
75 postural 1 0.2088
75 posture, 1 0.2088
75 pressure 1 0.1061
75 previously 1 0.1115
75 probably 1 0.1054
75 produced 1 0.0944
75 radioisotope 1 0.1722
75 reactivity 1 0.1782
75 recent 1 0.1214
75 relation 1 0.1068
75 remains 1 0.1214
75 reported 1 0.094
75 response 1 0.0847
75 revealed 2 0.2248
75 rhythm, 1 0.1952
75 several 1 0.1003
75 shift 1 0.1722
75 significant 4 0.3256
75 standing 5 1.1594
75 statistically 2 0.2883
75 stroke 2 0.3253
75 subjects 1 0.1107
75 substantial 1 0.1782
75 techniques 1 0.1265
75 transmural 1 0.2319
75 treated 1 0.0954
75 using 1 0.1054
75 various 1 0.0917
75 veins 1 0.1782
75 versa 1 0.2319
75 vice 1 0.2319
75 volume 2 0.2362
75 whether 1 0.1151
76 (the 1 0.2238
76 . 10 0.6785
76 achieved 1 0.2064
76 also 1 0.0843
76 asphyxia 3 0.9044
76 becomes 1 0.1817
76 blood 3 0.2794
76 brain 4 0.6142
76 causes 1 0.1701
76 combined 1 0.1549
76 combined, 1 0.2714
76 comparative 1 0.1844
76 concentration 1 0.1267
76 conditions 1 0.137
76 content 2 0.2836
76 contrary 1 0.2114
76 control 1 0.1133
76 dependent 1 0.194
76 depot 1 0.2414
76 determination 1 0.1844
76 differences 1 0.1379
76 discussed 1 0.1228
76 examined 1 0.1522
76 glycogen 8 1.7375
76 greater 1 0.1247
76 group 1 0.1114
76 heart 3 0.4195
76 heart, 2 0.4634
76 hostacortine 2 0.6029
76 increase 1 0.1024
76 inorganic 1 0.2064
76 insulin 1 0.1817
76 insulin, 1 0.2172
76 iodine 5 1.5073
76 iodine, 1 0.3015
76 level 2 0.2328
76 levels 1 0.118
76 liver 3 0.3558
76 lowering 3 0.6516
76 minutes) 1 0.2714
76 muscle 2 0.3324
76 noticeable, 1 0.3015
76 organs 1 0.1662
76 phenomenon 1 0.1743
76 pinched 1 0.3015
76 possible 1 0.1209
76 preliminary 1 0.1721
76 rabbits 1 0.1721
76 remains 1 0.1579
76 repeated 1 0.1791
76 second 1 0.1536
76 series 2 0.2836
76 show 1 0.1304
76 shows 1 0.1662
76 significant 2 0.2116
76 stopping 1 0.2538
76 studies 1 0.0923
76 succeeds 1 0.3015
76 sugar 3 0.6952
76 test 2 0.2608
76 therefore 1 0.1844
76 three 2 0.2267
76 trachea 1 0.2538
76 treatment 4 0.3558
76 untreated 1 0.2238
76 upon 1 0.1353
76 variations 1 0.1874
77 . 7 0.6785
77 16 1 0.2677
77 activity 2 0.3082
77 agent 1 0.2523
77 alterations 2 0.4748
77 altered 2 0.46
77 characteristic 1 0.2175
77 clinical 1 0.1404
77 complement 1 0.2948
77 cultured 1 0.2825
77 delayed 1 0.2523
77 disease 1 0.1547
77 disproportionate 1 0.3877
77 evidence 1 0.1579
77 formulated 1 0.4306
77 found 2 0.2267
77 hemolytic 1 0.3103
77 hyperglobulinemia 1 0.4306
77 hypersensitivity 1 0.3198
77 hypothesis 1 0.23
77 iga 1 0.3877
77 immune 1 0.2771
77 immunity 1 0.3103
77 immunologic 3 0.8474
77 impaired 1 0.2948
77 impairment 1 0.2825
77 important 1 0.1945
77 increase 1 0.1463
77 increased 1 0.1339
77 indicate 1 0.1896
77 infectious 1 0.331
77 interaction 1 0.2635
77 kind 1 0.3021
77 lymphocytes 1 0.2523
77 may 1 0.1077
77 might 1 0.2255
77 observations 1 0.1811
77 observed 1 0.1468
77 parallel 1 0.2771
77 pathogenesis 1 0.2429
77 patients 2 0.207
77 phytohemagglutinin 1 0.4306
77 presented 1 0.1671
77 response 2 0.3145
77 result 1 0.1863
77 revealed 1 0.2087
77 sarcoidosis 5 2.1532
77 serum 2 0.3341
77 severity 1 0.2635
77 simple 1 0.2348
77 specific 1 0.1694
77 stimulation 1 0.2429
77 studies 1 0.1319
77 transient 1 0.2948
78 . 9 0.6785
78 /macrophages/ 1 0.3349
78 additional 1 0.1789
78 alterations 1 0.1847
78 appear 1 0.1533
78 around 1 0.2243
78 arranged 1 0.2487
78 asbestos 1 0.3349
78 atmospheric 1 0.3015
78 bodies 3 0.6148
78 cell 5 0.5668
78 cells 2 0.2022
78 clear 1 0.2019
78 concentric 1 0.3349
78 constructed 1 0.282
78 core 1 0.2349
78 could 1 0.1203
78 currently 1 0.2487
78 cytologic 1 0.2487
78 cytoplasm 1 0.2082
78 cytoplasmic 1 0.2019
78 described 2 0.2541
78 differences 1 0.1533
78 differentiation 1 0.1913
78 digestion 1 0.2682
78 discrete, 1 0.3349
78 distinctions 1 0.3015
78 due 1 0.1185
78 electron 2 0.3383
78 evidence 1 0.1228
78 exact 1 0.2413
78 exist 1 0.2293
78 experimental 1 0.1554
78 filaments 1 0.3015
78 fine 1 0.2349
78 found 1 0.0882
78 granule 1 0.3349
78 granules 2 0.4394
78 granules, 1 0.2682
78 granules,. 1 0.3349
78 highly 1 0.1807
78 human 2 0.2236
78 inclusion 1 0.2155
78 inclusions 5 1.2873
78 ingestants 1 0.3349
78 ingested 1 0.3015
78 ingestion 1 0.282
78 intracellular 1 0.2197
78 known 1 0.1636
78 laden 1 0.3349
78 lamella 1 0.3349
78 lamellae 1 0.3015
78 lipid 1 0.2049
78 lung, 1 0.2575
78 lymph 1 0.2082
78 macrophage 1 0.3349
78 macrophages 3 0.6728
78 mast 6 1.4923
78 membranes 1 0.2155
78 microscopic 1 0.2082
78 microscopy 1 0.2155
78 morphology 1 0.2049
78 nature 1 0.1663
78 node, 1 0.3015
78 obscure 1 0.282
78 parallel 1 0.2155
78 partial 1 0.1868
78 particles, 1 0.3015
78 phagocytized 1 0.3349
78 phase 1 0.1789
78 pollutants 1 0.3349
78 possibly 1 0.2082
78 proper, 1 0.3349
78 rectum 1 0.3015
78 remains 2 0.3508
78 represent 1 0.2117
78 requires 1 0.2049
78 resemblance 1 0.282
78 resemble 2 0.5149
78 respectively 1 0.2293
78 similarities 1 0.2487
78 skin, 1 0.3015
78 speculative 1 0.3349
78 spleen, 1 0.2243
78 structure 1 0.1706
78 structured 1 0.3349
78 systems 1 0.2349
78 tissue 2 0.2325
78 two 1 0.1026
78 types 1 0.1624
78 variations 1 0.2082
78 virus-like 1 0.3349
78 viruses 1 0.2487
78 well 1 0.1171
78 whorled 1 0.3349
78 within 2 0.2487
79 (6.500, 1 0.6029
79 . 5 0.6785
79 24 1 0.3127
79 8.000, 1 0.6029
79 9.500 1 0.6029
79 accumulation 1 0.4229
79 activity 3 0.6473
79 altitudes 1 0.5428
79 cells 1 0.182
79 chamber 1 0.4477
79 changes 1 0.1804
79 condition 1 0.322
79 decompression 1 0.4477
79 depressed 1 0.4634
79 discussed 1 0.2455
79 effect 1 0.1841
79 epithelium 3 1.09
79 examined 2 0.6089
79 histological 1 0.3581
79 hypoxia 2 0.776
79 hypoxia, 1 0.4827
79 lens 3 0.8571
79 m),. 1 0.6029
79 marked 1 0.2705
79 metaphase 1 0.5076
79 mitotic 3 1.164
79 number 1 0.2307
79 observed 1 0.2055
79 obtained 1 0.2149
79 particular, 1 0.5428
79 prophases 1 0.6029
79 rats 1 0.2328
79 reduction 1 0.2969
79 research 1 0.3955
79 results 2 0.3453
79 show 1 0.2608
79 standpoint 1 0.4827
79 statistical 1 0.388
79 strain 1 0.3188
79 studied 1 0.2101
79 weight 1 0.2836
80 (maximum 1 0.1154
80 (mean 4 0.4934
80 (mitchell 1 0.137
80 . 22 0.6785
80 0.2 1 0.1234
80 0.5) 1 0.137
80 0.9 1 0.1097
80 1 1 0.0517
80 1. 1 0.0718
80 1.6 1 0.137
80 11.6) 2 0.274
80 14.7 2 0.274
80 14.8 1 0.137
80 15 2 0.1361
80 1963) 1 0.1234
80 2. 1 0.0718
80 2.1, 1 0.137
80 2.3) 1 0.137
80 20 1 0.0619
80 20-25 1 0.137
80 25.7 1 0.137
80 3. 1 0.0739
80 3.8 1 0.137
80 30 1 0.0654
80 38.1 1 0.137
80 39.4 1 0.137
80 4. 1 0.0782
80 4.2 1 0.1234
80 4.3 1 0.137
80 40 1 0.0803
80 5 1 0.052
80 5. 1 0.0899
80 50 1 0.0654
80 53.2, 1 0.137
80 57.5, 1 0.137
80 6. 1 0.0961
80 6.7 2 0.2467
80 65.9 1 0.137
80 68.1-61.6 1 0.137
80 68.5 1 0.137
80 76.1 1 0.137
80 76.2 1 0.137
80 89 1 0.1234
80 administration 6 0.362
80 administration, 1 0.1053
80 affected 1 0.0711
80 air 1 0.0764
80 al. 1 0.0987
80 also 1 0.0383
80 anaesthetized 1 0.137
80 antero-lateral 1 0.137
80 area 2 0.1422
80 arterial 5 0.3554
80 blood 11 0.4657
80 blood, 1 0.0938
80 breathing 1 0.0987
80 c.s.f 2 0.274
80 c.s.f. 6 0.7402
80 c.s.f., 1 0.137
80 carbon 2 0.1835
80 cerebrospinal 1 0.0826
80 change 4 0.2542
80 changes 4 0.164
80 cisternal 2 0.2107
80 co 7 0.6911
80 compared 1 0.0532
80 complete 1 0.0636
80 component 3 0.2645
80 consisted 2 0.1628
80 constant 1 0.0747
80 constants 3 0.316
80 delay 1 0.1053
80 delay, 1 0.137
80 dioxide 2 0.1876
80 due 1 0.0485
80 eight 1 0.0782
80 encephalography 1 0.137
80 et 1 0.0917
80 experiment 1 0.0917
80 experiments 7 0.425
80 explain 1 0.0917
80 exponential 1 0.1154
80 fast 1 0.137
80 final 4 0.3595
80 five 1 0.0725
80 fluid 1 0.0649
80 following 3 0.1363
80 hg 1 0.0938
80 increase 2 0.0931
80 increases 2 0.128
80 jugular 8 0.814
80 maintained 1 0.0764
80 may 1 0.0343
80 mean 1 0.0659
80 measured 2 0.1199
80 medulla 1 0.0987
80 min 8 0.8777
80 min, 1 0.1154
80 mm 1 0.0882
80 one 2 0.0767
80 overlying 1 0.1234
80 p 20 2.035
80 patients 1 0.0329
80 percent 7 0.6422
80 percent) 1 0.1097
80 ph 1 0.0739
80 predicted 1 0.1053
80 probable 1 0.0866
80 procedure 1 0.0698
80 range 1 0.0739
80 rate 4 0.2018
80 remaining 1 0.0698
80 respirator 1 0.137
80 rise 11 0.7483
80 rises 1 0.1017
80 routine 1 0.0987
80 samples 4 0.3465
80 sensitive 1 0.0739
80 slow 2 0.1798
80 smaller 1 0.0987
80 start 3 0.3291
80 stimulation 1 0.0773
80 superficial 1 0.1017
80 surface 1 0.0739
80 take 1 0.0938
80 taken 4 0.3092
80 tension 1 0.0826
80 three 3 0.1546
80 throughout 1 0.0782
80 time 4 0.1931
80 two 1 0.042
80 undergoing 1 0.0866
80 varied 4 0.3465
80 varying 1 0.0739
80 venous 8 0.6184
80 ventilation 4 0.407
80 whilst 1 0.1017
81 (lysophosphatide 1 0.3768
81 -labeled 3 1.0177
81 . 6 0.5089
81 30 1 0.1799
81 accelerate 1 0.3392
81 act 2 0.4685
81 action 3 0.4918
81 also 2 0.2108
81 animal, 1 0.3392
81 biochemical 2 0.4764
81 biological 2 0.4025
81 bone 3 0.4889
81 causes 1 0.2126
81 cell 2 0.2551
81 clarify 1 0.3017
81 compound 8 2.0636
81 concerning 1 0.2342
81 conducted 2 0.5159
81 consecutive 1 0.2643
81 days 1 0.1497
81 discussion 1 0.2271
81 disturbances 2 0.4477
81 energy 1 0.258
81 experiments 1 0.167
81 extracted 1 0.2523
81 female 1 0.2179
81 followed 2 0.3449
81 following 1 0.1249
81 formation 1 0.1691
81 found 2 0.1984
81 fraction 1 0.2012
81 fraction) 1 0.3768
81 further, 1 0.2897
81 given 1 0.1381
81 greatest 2 0.4764
81 group 1 0.1393
81 group, 1 0.2425
81 groups 1 0.1535
81 hemolytic 1 0.2715
81 high 1 0.1348
81 ii. 1 0.2179
81 impede 1 0.3768
81 induce 1 0.2523
81 inhibit 1 0.258
81 inhibitory 1 0.2472
81 injections 1 0.2126
81 intravenous 1 0.2012
81 irradiated 5 1.0895
81 isolated 1 0.1639
81 l 1 0.2897
81 lipid 2 0.4611
81 lipids 7 1.9587
81 liver 4 0.593
81 male 1 0.1919
81 marked 2 0.3381
81 marrow 1 0.1887
81 marrow, 2 0.5159
81 mentioned 1 0.2715
81 metabolism 1 0.1786
81 mitochondria 1 0.258
81 mitochondria, 1 0.3173
81 non-irradiated 1 0.3392
81 normal 1 0.1013
81 observed 1 0.1284
81 obtained 1 0.1343
81 order 1 0.1973
81 organ 1 0.2643
81 organs 2 0.4155
81 organs, 1 0.2798
81 oxidative 2 0.6785
81 p 3 0.8394
81 pancreas 1 0.2715
81 phosphate 1 0.1903
81 phosphorylation 1 0.3173
81 phosphorylation, 1 0.3768
81 possess 1 0.3392
81 previously 1 0.1813
81 proliferation 2 0.4358
81 properties 2 0.4025
81 proven 1 0.3173
81 purpose 1 0.2523
81 rabbit 4 0.8503
81 rabbits 1 0.2152
81 reference 1 0.2077
81 relation 1 0.1736
81 respiration 1 0.3173
81 results 2 0.2158
81 rich 1 0.2897
81 see 1 0.3017
81 series 1 0.1773
81 special 1 0.1992
81 spleen 1 0.2238
81 spleen, 3 0.7569
81 strong 1 0.2523
81 studies 1 0.1154
81 swelling 1 0.3173
81 test 1 0.163
81 uncoupler 1 0.3768
81 uncoupling 1 0.3768
81 uptake 3 0.7415
81 uptake, 1 0.3017
81 various 1 0.149
81 vivo 1 0.2238
81 well 2 0.2636
81 whereas 1 0.1887
81 x-ray 6 1.483
82 . 4 0.6785
82 104 1 0.6785
82 able 1 0.4252
82 actual 1 0.543
82 adjunctive 1 0.7536
82 agent 1 0.4416
82 analysis 1 0.3625
82 areas 1 0.3985
82 autopsy 2 0.9887
82 believe 1 0.5046
82 cardiac 3 1.0144
82 cesium-131 3 2.0354
82 clinical 1 0.2457
82 cold 1 0.5159
82 concentration 1 0.3168
82 cool 1 0.7536
82 could 1 0.2708
82 damage 1 0.3839
82 detectable 1 0.4764
82 diagnostic 1 0.3742
82 disease 1 0.2708
82 distribution 1 0.3874
82 earlier 1 0.5596
82 evaluation 1 0.4066
82 examined 1 0.3805
82 heart 1 0.3496
82 heart.. 1 0.7536
82 histologic 1 0.5046
82 human 1 0.2515
82 infarction 1 0.6346
82 leaves 1 0.6785
82 location 1 0.5793
82 may 2 0.377
82 means 1 0.3339
82 measure 1 0.4358
82 methods 1 0.3403
82 morphology 1 0.4611
82 occur 1 0.3682
82 patients 2 0.3623
82 perhaps 1 0.4155
82 photoscanning, 1 0.6785
82 previously 1 0.3625
82 procedure 1 0.3839
82 properly 1 0.6034
82 reported 1 0.3054
82 results 1 0.2158
82 satisfactory 1 0.4943
82 scanning 1 0.5046
82 scans 1 0.6785
82 sections 1 0.5159
82 size, 1 0.5159
82 studies 1 0.2308
82 study 1 0.2322
82 subclinical 1 0.7536
82 suggest 1 0.3426
82 symptoms 1 0.3571
82 technique 1 0.3546
82 thought 1 0.4252
82 type, 1 0.5046
82 uptake 1 0.4943
82 used, 1 0.485
82 useful 1 0.4155
82 variance 1 0.6346
82 yet 1 0.3985
83 (d-tubocurarine 1 0.5024
83 . 6 0.6785
83 1. 1 0.2631
83 2. 1 0.2631
83 3. 1 0.2711
83 31/2 1 0.4523
83 4. 1 0.2869
83 80-210 1 0.5024
83 almost 1 0.2582
83 carbon 3 1.0091
83 cold 1 0.3439
83 completely 1 0.2944
83 consistent 1 0.2801
83 consumption 4 1.4096
83 cooled 1 0.362
83 cooled, 2 1.0048
83 cooling 1 0.3028
83 damage 1 0.2559
83 dioxide 3 1.0318
83 disease 1 0.1805
83 doses 1 0.274
83 drugs 2 0.554
83 exposed 1 0.2631
83 gallamine) 1 0.5024
83 hr 1 0.2905
83 human 1 0.1677
83 increase 1 0.1706
83 increased 1 0.1562
83 intracranial 1 0.3296
83 man 1 0.2582
83 measured 1 0.2199
83 men 1 0.3862
83 metabolism 1 0.2381
83 min 1 0.4023
83 muscle 2 0.554
83 neck 1 0.362
83 normal 1 0.1351
83 normal, 1 0.3731
83 observations 1 0.2112
83 observed 1 0.1713
83 occurs 1 0.2683
83 one 1 0.1406
83 output 3 0.8832
83 oxygen 4 1.0237
83 paralysed 3 1.357
83 paralysing 1 0.5024
83 periods 1 0.2801
83 poliomyelitis, 1 0.423
83 receiving 1 0.277
83 relaxants 1 0.5024
83 result 1 0.2173
83 rose 1 0.3524
83 skeletal 1 0.3439
83 solely 1 0.3731
83 subjects 5 1.1993
83 two 2 0.3077
83 unconscious 2 0.9046
83 view 1 0.2944
83 without 1 0.1897
84 . 10 0.6785
84 /rebound/ 1 0.3015
84 1. 1 0.1579
84 13/4 1 0.3015
84 2. 1 0.1579
84 21/2 1 0.2714
84 22.6 1 0.2714
84 3. 1 0.1627
84 31.5 1 0.3015
84 4. 1 0.1721
84 45 1 0.2018
84 5 1 0.1143
84 5. 1 0.1977
84 6. 1 0.2114
84 7. 1 0.2414
84 8. 1 0.2714
84 accurate 1 0.1844
84 agent 1 0.1766
84 agent, 1 0.2172
84 although 1 0.1159
84 approximately 1 0.1579
84 average 1 0.1353
84 blood 1 0.0931
84 c. 1 0.1594
84 calculated 1 0.2018
84 cases 1 0.0897
84 circulation 1 0.1579
84 circulation, 1 0.2714
84 clotting-time 1 0.3015
84 complete 1 0.1398
84 concentration 1 0.1267
84 conducted 1 0.2064
84 crude 1 0.2238
84 degree 1 0.1336
84 detected 1 0.1564
84 divided 1 0.2114
84 dosage 2 0.3633
84 effective 1 0.1509
84 efficient 1 0.2172
84 end 1 0.1844
84 estimation 1 0.2238
84 evident 1 0.1874
84 exact 1 0.2172
84 excess 1 0.2064
84 extracorporeal 2 0.3955
84 factor 1 0.1429
84 free-heparin 1 0.3015
84 half-lives 1 0.3015
84 heparin 4 0.9269
84 heparin-loss 2 0.6029
84 hours 2 0.29
84 hypothermic 1 0.2064
84 important 1 0.1361
84 inconstant 1 0.2714
84 individual, 1 0.2714
84 individuals, 1 0.2317
84 influences 1 0.2317
84 instance 1 0.2538
84 less 1 0.1129
84 level 1 0.1164
84 levels 2 0.2361
84 likely 1 0.1766
84 losses 1 0.2538
84 may 1 0.0754
84 means 1 0.1336
84 minimizing 1 0.3015
84 monitoring 1 0.2414
84 neutralization 2 0.5076
84 neutralizing 2 0.5076
84 one 1 0.0843
84 perfusion 2 0.3533
84 perfusion-temperature 1 0.3015
84 perfusions 1 0.2714
84 polybrene 1 0.2714
84 postoperative 1 0.1817
84 present 1 0.0993
84 prolongation 1 0.2317
84 protamine 2 0.6029
84 provides 1 0.1906
84 rate 2 0.2219
84 re-heparinization 1 0.3015
84 requirement 1 0.2714
84 requires 1 0.1844
84 respectively 1 0.2064
84 resulting 1 0.1536
84 satisfactory 1 0.1977
84 significant 2 0.2116
84 simple 1 0.1644
84 studied, 1 0.2238
84 study 1 0.0929
84 temperatures 1 0.1906
84 test 1 0.1304
84 therefore, 1 0.1906
84 titration 1 0.2714
84 variable 1 0.1817
85 (average, 1 0.3015
85 (edta) 1 0.2714
85 ), 1 0.3015
85 . 10 0.6785
85 36 1 0.2114
85 50 1 0.1439
85 6.5 1 0.2414
85 62 1 0.2414
85 85 1 0.2714
85 acid-citrate 1 0.3015
85 activity 1 0.1079
85 anticoagulant 1 0.2714
85 anticoagulant, 1 0.3015
85 buffered 1 0.3015
85 cause 1 0.1361
85 chiefly 1 0.2172
85 chromium 1 0.2414
85 circulating 1 0.2114
85 circulation 1 0.1579
85 concept 1 0.1817
85 cr 1 0.3015
85 current 1 0.1874
85 data 1 0.1228
85 destroyed 2 0.4037
85 die 1 0.2317
85 edta 1 0.2414
85 ethylenediamine 1 0.3015
85 evidence 1 0.1105
85 external 1 0.1817
85 found 1 0.0794
85 hepatic 1 0.1701
85 i. 1 0.1791
85 indicates 1 0.1977
85 injurious 1 0.3015
85 labeled 1 0.1817
85 labeling 1 0.1977
85 less 1 0.1129
85 liver 1 0.1186
85 majority 1 0.194
85 man 1 0.1549
85 marked 1 0.1353
85 measures 1 0.1977
85 medium 1 0.161
85 methods 2 0.2723
85 nearly 1 0.1844
85 normal 1 0.0811
85 normally 1 0.1906
85 occur 1 0.1473
85 one-third 1 0.2317
85 organs 1 0.1662
85 partially 1 0.1874
85 persons 1 0.1906
85 ph 1 0.1627
85 plasma 1 0.1215
85 platelet 2 0.6029
85 platelets 8 2.4116
85 presented 1 0.1169
85 process 1 0.1379
85 rapid 1 0.1461
85 returned 1 0.2172
85 scanning 1 0.2018
85 scintillation 1 0.2414
85 senescence 1 0.3015
85 sequestration 4 1.2058
85 showed 1 0.1075
85 spleen 1 0.1791
85 studied 1 0.105
85 studies 1 0.0923
85 subjects 1 0.1439
85 suggests 1 0.161
85 support 1 0.1662
85 survival 3 0.435
85 survived 2 0.3955
85 temporary 1 0.2172
85 tetraacetate 1 0.3015
85 thrombocytopenic 1 0.2714
85 transfused 2 0.4477
85 true 1 0.2018
85 used 1 0.1138
85 using 1 0.137
85 various 1 0.1192
86 (1960) 1 0.4306
86 . 7 0.6785
86 15 1 0.2138
86 16 1 0.2677
86 acute 2 0.4276
86 agranulocytosis, 1 0.4306
86 amplified 1 0.3877
86 anaemia 1 0.3448
86 aplastic 1 0.3877
86 associated 2 0.3058
86 association 2 0.4647
86 attributable 1 0.2948
86 bean 1 0.4306
86 case 2 0.3094
86 causal 1 0.3448
86 complications 1 0.2523
86 controls, 1 0.3626
86 deaths 1 0.3103
86 definite 1 0.2948
86 development 1 0.1572
86 diagnosed 1 0.2635
86 disease 1 0.1547
86 drug 2 0.451
86 factors 1 0.1821
86 first 1 0.1579
86 given 2 0.3157
86 haematological 1 0.4306
86 histories 1 0.3198
86 history 1 0.249
86 however, 1 0.156
86 include 1 0.2558
86 indicated, 1 0.3448
86 ingestion 1 0.3626
86 leukaemia 4 1.3793
86 leukaemogenic 1 0.4306
86 leukemia 1 0.331
86 listed, 1 0.4306
86 literature 2 0.4697
86 matched 1 0.3198
86 may 1 0.1077
86 nine, 1 0.4306
86 opinion 1 0.2883
86 patients 1 0.1035
86 phenylbutazone 4 1.7226
86 possible 2 0.3455
86 presented 1 0.1671
86 reactions 1 0.2104
86 recorded 1 0.2459
86 recorded, 1 0.4306
86 relationship 1 0.2071
86 remaining 1 0.2194
86 report 1 0.2087
86 reports, 1 0.3877
86 required 1 0.2348
86 review 2 0.4748
86 reviewed 1 0.2429
86 short 1 0.249
86 shown 1 0.1852
86 studies, 1 0.3626
86 suggested 1 0.1791
86 three 1 0.1619
86 three, 1 0.3877
86 thrombocytopenia 1 0.3877
86 time 1 0.1517
86 toxic 1 0.2635
86 treatment.. 1 0.4306
87 -dash 1 0.5159
87 . 4 0.6785
87 absorbed 3 1.629
87 absorption 1 0.4685
87 administration 1 0.3319
87 amount 1 0.3711
87 and, 1 0.3909
87 cardiac 1 0.3381
87 catharsis 1 0.7536
87 cesium-131 3 2.0354
87 data 1 0.3069
87 diagnostic 1 0.3742
87 diuretic 1 0.5596
87 dose 3 1.0793
87 effective 1 0.3773
87 excellent 1 0.543
87 excretion 2 0.7091
87 gastrointestinal 1 0.543
87 half-life, 1 0.7536
87 humans 1 0.6346
87 low 1 0.3299
87 material 1 0.3496
87 one 1 0.2108
87 order 1 0.3946
87 presented 1 0.2924
87 probably, 1 0.6785
87 radiation 3 1.2329
87 radiation, 1 0.6785
87 rates 1 0.4542
87 received 1 0.4252
87 reduced 1 0.3403
87 relating 1 0.5596
87 scan 1 0.6034
87 scanning, 1 0.6346
87 since 1 0.3279
87 studies 1 0.2308
87 thiazide 1 0.5596
87 tract 1 0.4358
87 twentieth 1 0.7536
87 type 1 0.3134
87 x-ray 1 0.4943
88 . 5 0.6785
88 aa 1 0.6029
88 area 1 0.3127
88 aspects, 1 0.5428
88 behind 1 0.4827
88 blood 2 0.3726
88 calculate 1 0.4827
88 cardiac 2 0.541
88 catheter, 1 0.5428
88 collect 1 0.6029
88 collimator 1 0.5428
88 concerned 1 0.4037
88 constants 1 0.4634
88 curve, 1 0.6029
88 data 1 0.2455
88 discussed 1 0.2455
88 evaluate 1 0.4477
88 finally, 1 0.4127
88 first 1 0.221
88 formula 1 0.4827
88 importance 1 0.3071
88 important 1 0.2723
88 injection 1 0.2521
88 isotopes 1 0.5076
88 method 1 0.2395
88 methods 1 0.2723
88 near 1 0.3633
88 output, 2 1.0856
88 paper 1 0.3253
88 paper, 1 0.5428
88 particulary 1 0.5428
88 position 1 0.4127
88 precordium, 1 0.6029
88 present 1 0.1985
88 principles 1 0.4127
88 pulmonary 2 0.5155
88 radiocardiography, 1 0.6029
88 radiocardiography.. 1 0.6029
88 ratemeter 1 0.6029
88 read 1 0.4634
88 recorder 1 0.5428
88 selection 1 0.4127
88 show 1 0.2608
88 specially 1 0.6029
88 technical 1 0.4344
88 tricuspid 1 0.4634
88 used 1 0.2277
88 valve, 1 0.4634
88 velocity 1 0.6029
88 ventricle 1 0.3487
88 ventricular 2 0.5246
88 volume 1 0.3071
88 volumes 3 1.3903
88 way 1 0.3811
89 (nembutal) 1 0.3015
89 . 10 0.6785
89 adrenal 1 0.1791
89 adrenocortical 1 0.2414
89 alone 2 0.3633
89 always 1 0.161
89 amount 2 0.2969
89 and, 1 0.1564
89 anesthesia 3 0.7615
89 anesthetize 1 0.3015
89 animal, 1 0.2714
89 animals 1 0.1282
89 animals, 2 0.3633
89 attributed 1 0.2018
89 barbiturate 1 0.2714
89 brought 1 0.1977
89 cases, 1 0.1579
89 caused 1 0.1319
89 changes 1 0.0902
89 controlled 2 0.3443
89 cortex 1 0.1662
89 cortical 1 0.194
89 denoting 1 0.3015
89 distribution 2 0.3099
89 ether 2 0.4477
89 evaluation 1 0.1627
89 experimental 1 0.1398
89 experiments 1 0.1336
89 extent 1 0.1594
89 fact 1 0.1594
89 five 1 0.1594
89 followed 1 0.1379
89 further, 1 0.2317
89 given 2 0.221
89 hypothermia 6 0.9296
89 icebath 1 0.3015
89 immersion 1 0.3015
89 indicator 1 0.2414
89 inhibit 1 0.2064
89 intraperitoneally, 1 0.3015
89 lipids 1 0.2238
89 lipids, 1 0.2714
89 may 1 0.0754
89 occurred 2 0.2623
89 partly 2 0.4634
89 pentobarbitone 2 0.6029
89 placed 1 0.1791
89 produced 1 0.1228
89 rabbits 2 0.3443
89 rabbits, 1 0.2317
89 re-warmed 1 0.3015
89 reaction 6 0.9055
89 refrigerator 1 0.3015
89 seem 1 0.1644
89 served 1 0.1977
89 shivering 1 0.2538
89 sodium 1 0.145
89 stress 5 1.0318
89 studied 2 0.2101
89 subjected 1 0.1644
89 test 1 0.1304
89 tests 1 0.1485
89 three 2 0.2267
89 variation 1 0.1906
90 -n 1 0.3349
90 -o 1 0.3349
90 . 9 0.6785
90 abolished 1 0.2197
90 administering 1 0.282
90 aid 1 0.2413
90 air 1 0.1868
90 although 1 0.1288
90 apneic 1 0.3349
90 arterial 1 0.1737
90 artificial 1 0.2243
90 best 1 0.1771
90 bilateral 2 0.4037
90 blood 2 0.207
90 carotid 1 0.2197
90 caused 1 0.1466
90 cephalic 1 0.3349
90 cerebrospinal 1 0.2019
90 co 3 0.724
90 correlated 1 0.199
90 cross-circulated 1 0.3349
90 cross-circulation 1 0.3349
90 dog 6 1.2492
90 dog's 1 0.3349
90 dogs 1 0.1737
90 donor 6 1.4096
90 effect 1 0.1023
90 fluid 1 0.1587
90 gas 1 0.2682
90 head 2 0.4394
90 hypercapnia 3 0.9046
90 hypercapnic 1 0.3015
90 hyperventilated, 1 0.3349
90 hyperventilating 1 0.3349
90 hyperventilation 1 0.3015
90 hypocapnia 2 0.6031
90 hypocapnic 2 0.6699
90 increase 1 0.1138
90 independent 1 0.2019
90 influence 1 0.1533
90 inspired 1 0.3015
90 investigated 1 0.1913
90 level 1 0.1293
90 maintained 1 0.1868
90 mixtures 1 0.2682
90 neck 1 0.2413
90 pco 2 0.6031
90 perfused 2 0.5364
90 ph 1 0.1807
90 produced 2 0.2728
90 pump 1 0.2487
90 qualitatively 1 0.282
90 receptors 1 0.3349
90 recipient 5 1.1213
90 reduction 1 0.1649
90 regions 1 0.2682
90 removal 1 0.1868
90 respiratory 2 0.3475
90 response 2 0.2446
90 responses 1 0.1868
90 resting 1 0.2575
90 states 1 0.2293
90 studying 1 0.2575
90 suspended 1 0.3015
90 technique 1 0.1576
90 use 1 0.1324
90 vagotomy 2 0.6031
90 ventilation 5 1.2436
91 . 7 0.6785
91 13 1 0.249
91 15 1 0.2138
91 action 2 0.3747
91 activity 1 0.1541
91 affected 1 0.2234
91 appear 1 0.1971
91 appearance 1 0.2138
91 basophil 1 0.4306
91 cases 2 0.2563
91 cells 4 0.5199
91 cellular 1 0.2348
91 change 2 0.3995
91 chronic 3 0.6168
91 comparative 1 0.2635
91 elements 1 0.331
91 groups 1 0.1754
91 higher 1 0.1852
91 incapable 1 0.3877
91 initial 1 0.2087
91 investigation 1 0.2429
91 large 1 0.1702
91 leucocytosis 1 0.3877
91 leukaemia 3 1.0345
91 leukaemia, 1 0.3877
91 leukaemic 1 0.3626
91 lower 1 0.1958
91 lymphatic 3 0.9308
91 lymphocytes 2 0.5047
91 lymphoid 3 0.8314
91 mitotic 1 0.2771
91 normal 3 0.3474
91 nucleolated 1 0.4306
91 occurs 1 0.23
91 percentage 1 0.2401
91 phenomena 1 0.3021
91 phytohaemagglutinin 2 0.8613
91 residual 1 0.3198
91 results 1 0.1233
91 showing 1 0.2825
91 shown 1 0.1852
91 slowly 1 0.2948
91 striking 1 0.2722
91 subjects 2 0.4112
91 subjects, 1 0.2883
91 suggest, 1 0.4306
91 transformation 3 0.7045
91 two 1 0.1319
91 undergoing 1 0.2722
91 vitro 2 0.4427
92 -labeled 1 0.3877
92 . 7 0.6785
92 14 1 0.2374
92 4, 1 0.3626
92 5, 2 0.6621
92 absence 1 0.2056
92 also 2 0.2409
92 aneurysm 6 1.6628
92 aneurysm, 1 0.4306
92 aneurysms 1 0.3198
92 another 1 0.2348
92 anteroposterior 1 0.3877
92 apparent 1 0.2255
92 appears 1 0.1852
92 area, 1 0.3448
92 blood 3 0.3992
92 cardiac 1 0.1932
92 carried 1 0.2156
92 chest 1 0.3021
92 clot 1 0.3877
92 could 1 0.1547
92 demonstrated 1 0.1841
92 demonstrating 1 0.331
92 demonstration 1 0.2771
92 detectable 1 0.2722
92 diagnosis 1 0.1772
92 enter 1 0.331
92 filled 1 0.3626
92 film 1 0.331
92 findings 1 0.1711
92 formed 1 0.2401
92 injection 1 0.1801
92 intraluminal 1 0.3877
92 intravenous 1 0.23
92 iodipamide 1 0.4306
92 neither 1 0.2825
92 patients 2 0.207
92 pool 3 0.9931
92 presence 1 0.1641
92 presumably 1 0.2825
92 radioactivity 1 0.3103
92 radiograph, 1 0.4306
92 radioisotope 3 0.9593
92 roentgenogram 1 0.3448
92 scan 2 0.6896
92 scanning 3 0.865
92 seen 1 0.1821
92 showed 1 0.1535
92 suggesting 1 0.2635
92 thrombus 2 0.7754
92 tool 1 0.3448
92 useful 1 0.2374
92 ventricular 3 0.5621
92 within 2 0.3197
92 yet 1 0.2277
93 . 6 0.6785
93 2-3 2 0.8461
93 20 1 0.2269
93 accompanied 1 0.2801
93 acids 1 0.2474
93 adult 1 0.2284
93 alterations 1 0.277
93 case 1 0.1805
93 cause 1 0.2269
93 cell 1 0.17
93 cells 2 0.3033
93 changes 2 0.3007
93 continuously 1 0.3862
93 corresponded 1 0.3862
93 culture 1 0.2515
93 cultures 3 0.7546
93 cytologic 1 0.3731
93 dehydrogenase-elevating 2 1.0048
93 detectable 1 0.3176
93 either 1 0.2148
93 embryo 2 0.7048
93 infection 1 0.2364
93 lactic 2 0.7048
93 ldh 1 0.4523
93 liver 1 0.1977
93 lung 1 0.216
93 lung, 1 0.3862
93 mouse 2 0.5603
93 multiplication 2 0.7462
93 nucleic 1 0.3296
93 primary 1 0.2124
93 produced 1 0.2046
93 production 1 0.2559
93 propagation 1 0.5024
93 protein 1 0.2284
93 rate 1 0.1849
93 release 1 0.3233
93 spleen 1 0.2985
93 spleen, 1 0.3364
93 subcultured 1 0.4523
93 support 1 0.277
93 synthesis 1 0.2494
93 times 1 0.2417
93 viral 1 0.3028
93 virus 3 0.7893
93 weeks 2 0.5262
94 (sv 1 0.5024
94 . 6 0.6785
94 40 4 1.1776
94 40) 1 0.5024
94 acid 3 0.5821
94 amounts 1 0.2494
94 attempts 1 0.3233
94 bovine 2 0.5738
94 cell 1 0.17
94 cells 4 0.6065
94 changes 1 0.1503
94 characteristic 1 0.2537
94 conditions 1 0.2284
94 control 1 0.1889
94 culture 1 0.2515
94 cultures 3 0.7546
94 dnase 1 0.423
94 embryonic 1 0.3176
94 exposed 1 0.2631
94 extract 1 0.3176
94 fibroblastic 1 0.5024
94 growing 1 0.3364
94 growth 1 0.1713
94 high 1 0.1798
94 induced 1 0.2136
94 infected 1 0.274
94 inoculated 2 0.724
94 inoculation 1 0.3364
94 isolate 1 0.423
94 lines 1 0.2905
94 lung 1 0.216
94 maintained 1 0.2801
94 minute 1 0.3731
94 morphological 1 0.3074
94 negative, 1 0.4523
94 non-infected 1 0.4523
94 nucleic 3 0.9887
94 obtained 1 0.1791
94 occasional 1 0.362
94 passages 1 0.3731
94 phenol 1 0.4523
94 preparation 2 0.6466
94 proliferative 1 0.362
94 rapidly 1 0.2869
94 recovered 1 0.3123
94 regular 1 0.3731
94 showed 1 0.1791
94 simian 2 0.7724
94 suspension 1 0.362
94 sv 2 1.0048
94 tissue 1 0.1744
94 titer 1 0.3731
94 transformation 2 0.548
94 transformed 2 0.7724
94 virus 5 1.3155
94 vitro 1 0.2582
95 . 7 0.6785
95 1.5 1 0.331
95 12 2 0.4112
95 40 1 0.2523
95 5,833 1 0.4306
95 66 1 0.3877
95 754 1 0.4306
95 8 1 0.1945
95 anticoagulant 1 0.3877
95 assessed 1 0.3198
95 atrial 3 0.8314
95 cardiac 1 0.1932
95 chronic 1 0.2056
95 cultures 1 0.2156
95 danger 1 0.3626
95 disease 1 0.1547
95 duration 1 0.2255
95 eliminate 1 0.3448
95 emboli 1 0.4306
95 embolic 3 1.0878
95 embolism 3 1.2919
95 episode 1 0.3448
95 fibrillation 3 1.0345
95 fibroblast 1 0.3877
95 followed 1 0.1971
95 found 1 0.1134
95 group 2 0.3184
95 heart 1 0.1998
95 higher 1 0.1852
95 human 1 0.1437
95 incidence 4 0.8224
95 initial 1 0.2087
95 irrespective 1 0.2948
95 known, 1 0.3877
95 mitral 1 0.2883
95 month 1 0.2883
95 months 2 0.4349
95 nature 1 0.2138
95 occurred 1 0.1874
95 one 1 0.1205
95 one-third 1 0.331
95 onset 1 0.249
95 patient-year 1 0.4306
95 patient-year, 1 0.4306
95 patient-years 1 0.4306
95 patients 1 0.1035
95 per 2 0.3357
95 period 1 0.1633
95 place 1 0.2635
95 questionable 1 0.3626
95 rapid 1 0.2087
95 recurrences 3 1.0878
95 reduced 2 0.389
95 rheumatic 1 0.331
95 rhythm 1 0.3103
95 rhythm, 1 0.3626
95 risk 1 0.2883
95 seven 1 0.2459
95 simian 1 0.331
95 sinus 1 0.3103
95 systemic 1 0.2401
95 times 1 0.2071
95 took 1 0.3103
95 transformation 1 0.2348
95 treatment 1 0.1271
95 two-thirds 1 0.3626
95 valvotomy 1 0.4306
95 virus 1 0.2255
95 whether 1 0.2138
95 whole 1 0.2401
95 within 3 0.4796
96 . 5 0.6785
96 appears 1 0.2593
96 application 1 0.3401
96 clinical 1 0.1965
96 damages 1 0.5428
96 depend 1 0.4827
96 effect 1 0.1841
96 exposed 1 0.3157
96 exposure 1 0.3581
96 hyperbaric 3 1.4482
96 involved 1 0.3071
96 limited 1 0.3288
96 may 2 0.3016
96 oxygen 4 1.2285
96 per 1 0.235
96 pressure 1 0.2759
96 raised 1 0.3581
96 rather 1 0.2836
96 reaction 2 0.6037
96 recover 1 0.5428
96 se 1 0.4827
96 sensitivity 1 0.3633
96 tension 1 0.3633
96 tissue 2 0.4186
96 tissues 2 0.5518
96 varies 1 0.4344
96 vitro, 1 0.4477
97 . 7 0.6785
97 addition 1 0.2194
97 adjustment 1 0.3626
97 among 1 0.2012
97 anxiety 3 0.8031
97 anxiety, 1 0.3448
97 attitudes, 1 0.4306
97 attitudinal 1 0.4306
97 behavioral 1 0.3198
97 best 1 0.2277
97 cardiac 2 0.3865
97 changes 1 0.1289
97 child 3 0.6214
97 child, 1 0.2948
97 condition 1 0.23
97 congenital 2 0.3941
97 considers 1 0.3626
97 cyanotic 1 0.3626
97 degree 1 0.1908
97 dependence 1 0.3626
97 diagnosis 1 0.1772
97 disease 4 0.6189
97 effects 1 0.1599
97 explored 1 0.331
97 factors 1 0.1821
97 failed 1 0.2459
97 family 1 0.2595
97 found 1 0.1134
97 greater 1 0.1781
97 group 2 0.3184
97 heart 3 0.5993
97 highest 1 0.2722
97 highly 1 0.2324
97 illustrated 1 0.3448
97 impact 1 0.3626
97 implications 1 0.2771
97 improve 1 0.3448
97 incapacity 3 1.2919
97 individuals 1 0.2948
97 induced 1 0.1831
97 interplay 1 0.4306
97 maternal 5 1.2452
97 necessarily 1 0.2948
97 normal 1 0.1158
97 pampering 2 0.8613
97 parents 2 0.6206
97 patient, 1 0.2825
97 pediatric 1 0.3626
97 physician's 1 0.4306
97 poorer 1 0.4306
97 prediction 1 0.3198
97 predictor 1 0.3877
97 presence 1 0.1641
97 protectiveness 2 0.8613
97 rather 1 0.2026
97 related 3 0.5462
97 seemed 1 0.2771
97 severity 2 0.5269
97 siblings, 2 0.8613
97 significant 1 0.1512
97 significantly 1 0.1811
97 study 1 0.1327
97 substantially 1 0.3626
97 variables 1 0.3198
98 . 14 0.6785
98 /high 4 0.8613
98 /low 3 0.646
98 8 1 0.0972
98 8-month 1 0.2153
98 adequacy 1 0.2153
98 adjustment 2 0.3626
98 administered 1 0.1028
98 also 2 0.1205
98 also, 1 0.1551
98 although 1 0.0828
98 anxiety 2 0.2677
98 anxiety/ 2 0.4306
98 anxious 3 0.646
98 anxious/ 5 1.0766
98 approximately 1 0.1128
98 aspect 1 0.151
98 assessment 3 0.4325
98 attitudes 2 0.3877
98 basis 3 0.2827
98 battery 1 0.1813
98 child 1 0.1036
98 child's 1 0.1317
98 childbirth 1 0.2153
98 childbirth, 1 0.2153
98 childrearing 1 0.2153
98 children 6 0.4588
98 consistent 1 0.1201
98 control 1 0.081
98 desirable 1 0.1813
98 development 2 0.1572
98 developmental 2 0.2883
98 dichotomized 1 0.2153
98 difference 3 0.3234
98 early 1 0.0789
98 eight 2 0.2459
98 emotional 2 0.2401
98 evidence 1 0.0789
98 evidenced 1 0.1655
98 examiner 1 0.2153
98 examiner's 1 0.2153
98 factors 1 0.091
98 fare 1 0.2153
98 favorable 4 0.5896
98 fifty 1 0.1551
98 finding, 1 0.1813
98 findings 2 0.1711
98 following 3 0.2141
98 found 3 0.1701
98 general 1 0.1097
98 general, 1 0.1551
98 group 3 0.2388
98 groups 2 0.1754
98 higher 3 0.2778
98 highly 3 0.3485
98 hostility 1 0.2153
98 indicative 1 0.1655
98 indices 1 0.151
98 infant 1 0.1215
98 intellectual 2 0.2883
98 interaction 1 0.1317
98 is, 1 0.1442
98 keeping 2 0.4306
98 less 4 0.3225
98 manifest 1 0.1599
98 maternal 1 0.1245
98 measured 1 0.0942
98 mental 1 0.1215
98 months 3 0.3262
98 moreover, 1 0.1412
98 mother 1 0.123
98 mother's 1 0.1724
98 mother-child 1 0.1939
98 mothers 6 0.7786
98 mothers, 1 0.1724
98 motor 1 0.1599
98 much 1 0.0954
98 negative 1 0.1262
98 observation 1 0.1128
98 obtained 3 0.2303
98 offspring 1 0.1939
98 parental 1 0.1551
98 pari 1 0.2153
98 personality 3 0.5439
98 picture 1 0.1174
98 prediction 1 0.1599
98 predictions 1 0.1939
98 pregnancy 5 0.6308
98 pregnant 2 0.2595
98 present 1 0.0709
98 proportions 1 0.1813
98 psychological 2 0.2722
98 quotient 2 0.3448
98 rating 1 0.2153
98 ratings 2 0.3877
98 reared 1 0.2153
98 receive 1 0.1724
98 received 3 0.3644
98 scale 1 0.1813
98 scale, 2 0.3626
98 score 1 0.1813
98 scores 2 0.3448
98 seen 1 0.091
98 session 1 0.1939
98 significant 3 0.2268
98 significantly 3 0.2716
98 statistically 2 0.2677
98 studying 1 0.1655
98 tended 1 0.1724
98 tests 2 0.2121
98 time 2 0.1517
98 tone 1 0.1939
98 traits, 1 0.2153
98 two 2 0.1319
98 well 1 0.0753
98 women 6 0.6971
98 would 3 0.3207
99 (as 1 0.2238
99 . 7 0.475
99 absence 1 0.1439
99 account 1 0.1701
99 aspect 1 0.2114
99 associated 1 0.107
99 before, 1 0.2317
99 behavior 1 0.1721
99 behaviors 1 0.2714
99 children 1 0.107
99 children, 1 0.1766
99 clear 1 0.1817
99 complex 1 0.1743
99 considerable 1 0.1564
99 crucial 1 0.2538
99 decreases 1 0.194
99 detachment 1 0.2714
99 disturbance 2 0.4344
99 drastic 1 0.2714
99 eight 1 0.1721
99 emotional 2 0.3362
99 factors 1 0.1274
99 following 1 0.0999
99 human 4 0.4024
99 important 1 0.1361
99 indicate 1 0.1327
99 infant 1 0.1701
99 infant-mother 2 0.6029
99 infants 4 0.5757
99 involved 1 0.1536
99 macaque 1 0.3015
99 maternal 2 0.3487
99 may 1 0.0754
99 measurement 1 0.1701
99 monkey 4 0.8073
99 monkeys 2 0.4229
99 mother 2 0.3443
99 mother-infant 1 0.3015
99 mothers 1 0.1817
99 mothers, 1 0.2414
99 obtained 1 0.1075
99 overall 1 0.1977
99 pairs 1 0.2317
99 part 1 0.1408
99 pattern) 1 0.3015
99 patterns 1 0.1906
99 period 1 0.1143
99 physical 1 0.1743
99 play 1 0.1791
99 present 1 0.0993
99 produces 1 0.1906
99 rarity 1 0.2538
99 response 2 0.2201
99 responses 2 0.3362
99 results 2 0.1727
99 reunion 2 0.6029
99 rhesus 1 0.2538
99 seen 1 0.1274
99 separated 2 0.3955
99 separation 10 1.6808
99 sheer 1 0.3015
99 show 1 0.1304
99 showed 1 0.1075
99 similar 1 0.1129
99 similarity 1 0.2317
99 social 1 0.194
99 species 1 0.1644
99 stage 1 0.1461
99 studies 1 0.0923
99 study 1 0.0929
99 two 1 0.0923
99 undoubtedly 1 0.2538
99 vitally 1 0.2714
99 weeks 1 0.1579
100 . 18 0.6785
100 /language 1 0.1675
100 /poor 1 0.1675
100 /reading 1 0.1675
100 abilities 1 0.141
100 ability 4 0.3412
100 able 1 0.0945
100 abnormalities 1 0.0934
100 adjust 1 0.1508
100 advise 1 0.1675
100 age/ 1 0.1675
100 aids 1 0.1508
100 also 1 0.0469
100 and/or 2 0.2117
100 aniseikonia 1 0.1675
100 anomalies 1 0.1099
100 area,/ 1 0.1675
100 associated 1 0.0595
100 available 1 0.0913
100 average 4 0.3006
100 become 1 0.0923
100 brain 2 0.1706
100 cases 2 0.0997
100 causes 2 0.189
100 cerebral 1 0.0794
100 characterized 1 0.0886
100 child's 1 0.1025
100 children 2 0.1189
100 clinical 1 0.0546
100 compensating 1 0.141
100 complete 2 0.1554
100 condition 1 0.0894
100 consultation 3 0.4523
100 corrected 1 0.141
100 corrective 1 0.1341
100 damage 1 0.0853
100 damage, 1 0.1508
100 degree 1 0.0742
100 depends 1 0.1341
100 determine 2 0.189
100 develop 1 0.1009
100 different 2 0.1185
100 difficulty 1 0.1121
100 disease 1 0.0602
100 disorientation 1 0.1508
100 disturbances, 2 0.3349
100 dominance 1 0.1341
100 dyslexia 2 0.282
100 educational 1 0.141
100 emotional 2 0.1868
100 entity 1 0.1341
100 etiology 1 0.0923
100 evaluation 2 0.1807
100 evaluation, 1 0.1341
100 examination 1 0.0846
100 factors 1 0.0708
100 factors,. 1 0.1675
100 favorable 1 0.1146
100 fields 1 0.1341
100 first 2 0.1228
100 frequently 1 0.0846
100 general 1 0.0853
100 good 1 0.0934
100 group 1 0.0619
100 hand, 1 0.1009
100 health 1 0.1175
100 hearing 1 0.1099
100 helped 1 0.141
100 hemianopia 1 0.1078
100 hereditary 2 0.2413
100 however, 1 0.0607
100 hyperopia, 1 0.1675
100 imbalance, 1 0.1675
100 immaturity 2 0.3015
100 inability 1 0.1207
100 include 1 0.0995
100 individual 1 0.0886
100 information 1 0.0904
100 intelligence 1 0.1244
100 intelligence,. 1 0.1675
100 large 1 0.0662
100 learned 1 0.1341
100 left 1 0.0756
100 maladjustments 1 0.1675
100 managed 1 0.1675
100 management 1 0.0886
100 many 1 0.0675
100 may 4 0.1675
100 medical 2 0.199
100 muscle 1 0.0923
100 musical 1 0.1675
100 nearly 1 0.1025
100 necessary 1 0.0981
100 needs 1 0.1341
100 neurologic 1 0.1287
100 neurologic, 1 0.1675
100 not, 1 0.1121
100 notes 1 0.141
100 numbers, 1 0.1341
100 ocular, 1 0.1675
100 often 1 0.0812
100 one, 1 0.1244
100 ophthalmic 2 0.3015
100 ophthalmologist 3 0.5024
100 ophthalmologist's 1 0.1675
100 opinion 1 0.1121
100 organic 1 0.0995
100 otolaryngologist 1 0.1675
100 parents 1 0.1207
100 patient's 1 0.1121
100 patients 2 0.0805
100 pediatric 1 0.141
100 percentage 1 0.0934
100 performed 1 0.0766
100 person 1 0.1244
100 personality 1 0.141
100 play 1 0.0995
100 poor 3 0.2905
100 possible 1 0.0672
100 predisposition 1 0.1675
100 present 1 0.0551
100 present, 1 0.1099
100 prognosis 1 0.0923
100 psychiatric 2 0.2155
100 psycho-physiologic 1 0.1675
100 psychologic 1 0.1675
100 psychometric 1 0.1675
100 reaches 1 0.1341
100 reaction 1 0.0838
100 read 2 0.2575
100 reader/ 1 0.1675
100 readers, 1 0.1508
100 reading 5 0.6218
100 recognized 1 0.1041
100 recommend 1 0.1508
100 remedial 1 0.1675
100 reveal 1 0.1121
100 right 1 0.0869
100 role 3 0.2331
100 school 2 0.2487
100 since 1 0.0729
100 spite 1 0.1121
100 status 1 0.1059
100 strong 1 0.1121
100 subnormal 1 0.1675
100 symptom 1 0.1175
100 symptoms 1 0.0794
100 teachers 1 0.1675
100 tendency 1 0.1207
100 therapy 1 0.0662
100 time 1 0.059
100 unfavorable 1 0.1508
100 universal 1 0.1508
100 upon 1 0.0751
100 visual 3 0.274
100 want 1 0.1508
100 well 1 0.0586
100 work-up 1 0.1675
100 write 1 0.1508
100 writing 1 0.1675
100 writing, 1 0.1675
100 year 1 0.0869
101 . 4 0.5428
101 abnormal 1 0.2922
101 abnormalities 1 0.3362
101 accompanied 1 0.3362
101 angiograms 1 0.6029
101 arteries 2 0.9269
101 artery 1 0.3443
101 bitemporal 2 0.8954
101 carotid 5 1.9773
101 case 2 0.4332
101 change 1 0.2797
101 compression 1 0.4477
101 corresponding 1 0.3533
101 could 1 0.2166
101 course 1 0.2741
101 course, 1 0.5076
101 craniotomy 1 0.5428
101 detected 1 0.3127
101 evaluation 1 0.3253
101 exposed 1 0.3157
101 hemianopia 1 0.388
101 hemianopia, 1 0.5428
101 indicated 1 0.2836
101 internal 2 0.6802
101 measured 1 0.2639
101 nerve's 1 0.6029
101 nerves 2 0.9269
101 optic 3 1.2382
101 pneumograms, 1 0.6029
101 relationship, 1 0.5428
101 relative 1 0.3127
101 reported 1 0.2443
101 resultant 1 0.4344
101 reviewing 1 0.5428
101 shape 1 0.388
101 showing 1 0.3955
101 siphon, 1 0.6029
101 siphons 1 0.6029
101 unusual 2 0.7622
102 (area 1 0.4306
102 (which 1 0.4306
102 . 7 0.6785
102 8) 1 0.4306
102 abscess, 1 0.3877
102 acuity,. 1 0.4306
102 aforementioned 1 0.4306
102 agnosia 2 0.6621
102 also 1 0.1205
102 animals 1 0.1831
102 anthropoid 1 0.4306
102 ape, 1 0.4306
102 assumed 1 0.2948
102 based 1 0.2255
102 brain 1 0.2194
102 capacities 1 0.4306
102 case 2 0.3094
102 combination 1 0.2459
102 connections 1 0.3877
102 continued 1 0.249
102 contrary 1 0.3021
102 data 1 0.1754
102 defect 1 0.2121
102 defects 1 0.2374
102 deficits 1 0.3198
102 development 1 0.1572
102 diminution 1 0.3021
102 discussed 1 0.1754
102 discussion 1 0.2595
102 disturbances 2 0.5116
102 field 1 0.2558
102 findings 1 0.1711
102 follow-up 1 0.2883
102 frontal 6 1.9862
102 fronto-occipital 1 0.4306
102 full 1 0.2883
102 gain 1 0.3103
102 give 1 0.2348
102 gradually 1 0.2722
102 hemianopia 1 0.2771
102 hemianopic 1 0.331
102 hope 1 0.3021
102 indicate 1 0.1896
102 influence 1 0.1971
102 insight 1 0.3448
102 intellectual 1 0.2883
102 latter 1 0.2234
102 led 1 0.2523
102 lobe 3 0.8844
102 lobe,. 1 0.4306
102 lobes 1 0.3626
102 long-term 1 0.249
102 many 1 0.1736
102 may 1 0.1077
102 neuroanatomical 1 0.4306
102 neurophysiological 1 0.3626
102 never 1 0.2825
102 observation 2 0.451
102 observations 1 0.1811
102 operation 1 0.2255
102 originate 1 0.331
102 others 1 0.2348
102 papilledema, 1 0.4306
102 partial 2 0.4802
102 patient 2 0.3238
102 patient,. 1 0.4306
102 patients 1 0.1035
102 perhaps 1 0.2374
102 pertinent 1 0.3626
102 point 2 0.4981
102 possibility 1 0.2459
102 presentation 1 0.3626
102 primates 1 0.4306
102 prompt 1 0.3198
102 prompted 1 0.3626
102 pronounced 1 0.2558
102 psychological 1 0.2722
102 rather 1 0.2026
102 regressed 1 0.3448
102 regressing 1 0.4306
102 remained 1 0.2459
102 return 1 0.3198
102 right 1 0.2234
102 role 2 0.3995
102 seem 1 0.2348
102 sense 2 0.6621
102 similar 1 0.1612
102 single 1 0.2138
102 studies 1 0.1319
102 subhuman 1 0.4306
102 symptoms 1 0.2041
102 temporary 1 0.3103
102 unusual 1 0.2722
102 vision 2 0.6896
102 vision, 1 0.3626
102 visual 5 1.1742
102 well) 1 0.4306
102 would 1 0.2138
103 . 4 0.6785
103 accomplished 1 0.5596
103 acuity 1 0.6785
103 bitemporal 2 1.1192
103 briefly 1 0.4542
103 case 1 0.2708
103 complete 1 0.3496
103 course 1 0.3426
103 delivery 1 0.4943
103 entity 1 0.6034
103 fields 1 0.6034
103 hemianopsia 2 1.2069
103 illustrated 1 0.6034
103 late 1 0.4477
103 occurring 1 0.4358
103 pathologic 1 0.4611
103 patient 1 0.2834
103 physiologic 1 0.485
103 physiology 1 0.5596
103 pregnancy 2 0.8832
103 presented 1 0.2924
103 presumed 1 0.6034
103 progressive 1 0.4202
103 rapid 1 0.3653
103 rapidly 1 0.4303
103 recovery 1 0.4155
103 return 1 0.5596
103 reviewed 1 0.4252
103 severe 1 0.3339
103 typical 1 0.4943
103 visual 2 0.8219
104 . 17 0.6785
104 1. 1 0.0929
104 10 1 0.0653
104 100 1 0.1
104 12.5 1 0.1773
104 19 1 0.1187
104 2. 1 0.0929
104 3. 1 0.0957
104 4. 1 0.1013
104 45 1 0.1187
104 5. 1 0.1163
104 50 1 0.0847
104 6. 1 0.1244
104 67 1 0.1493
104 7. 1 0.142
104 97 1 0.1773
104 aberrant 1 0.1317
104 alteration 1 0.1163
104 although 1 0.0682
104 arising 1 0.1363
104 associated 3 0.1889
104 asymmetrical 1 0.1773
104 asymmetry 3 0.426
104 average 1 0.0796
104 bilateral 2 0.2137
104 blindness 1 0.142
104 campimetry 1 0.1596
104 central 1 0.0957
104 cerebral 1 0.084
104 changes 1 0.0531
104 chiasmal 1 0.1773
104 compared 1 0.0688
104 complete 1 0.0823
104 components 1 0.1013
104 composed 1 0.1363
104 conclusively, 1 0.1773
104 contained 1 0.0903
104 contralateral 2 0.2633
104 contribute 1 0.1317
104 cortical 1 0.1141
104 criterion 1 0.142
104 defects 2 0.1955
104 demonstrated 1 0.0758
104 depression 1 0.1244
104 determined 1 0.0806
104 diffuse 3 0.3562
104 disease 5 0.3185
104 disorders 1 0.1013
104 early 2 0.13
104 electrodes 1 0.1493
104 erg 3 0.532
104 evoked 1 0.1596
104 eye 2 0.2282
104 eyelid 1 0.1773
104 felt 1 0.1317
104 fibres 1 0.1493
104 field 2 0.2107
104 forms 1 0.0847
104 found 2 0.0934
104 grossly 1 0.1244
104 hemianopic 2 0.2726
104 identifies 1 0.1773
104 ii 3 0.3562
104 iii 1 0.1363
104 inconstant 1 0.1596
104 indicated 2 0.1668
104 involved 2 0.1807
104 involvement 2 0.2326
104 involving 1 0.1141
104 ipsilateral 1 0.1773
104 larger 2 0.2107
104 late 2 0.2107
104 latency 1 0.1596
104 later 1 0.0911
104 lateral 1 0.1187
104 left 1 0.0801
104 loss 3 0.2579
104 lost, 1 0.1773
104 monocular 2 0.3546
104 msec. 1 0.1773
104 nasal 1 0.1244
104 nerve 1 0.1187
104 nonspecific 1 0.1278
104 normal 4 0.1907
104 observed 1 0.0604
104 occipital 2 0.2428
104 optic 1 0.1214
104 overall 1 0.1163
104 patients 2 0.0852
104 percent 5 0.5936
104 percent, 1 0.1493
104 photic 1 0.1773
104 potential 1 0.1163
104 prechiasmal 1 0.1773
104 predominant 1 0.1363
104 preponderance 1 0.1596
104 present 1 0.0584
104 preservation 1 0.1596
104 probably, 1 0.1596
104 projections 1 0.1493
104 recorded 1 0.1013
104 reference 1 0.0978
104 reflecting 1 0.1493
104 region 1 0.1187
104 regularly 1 0.1278
104 representation 1 0.1596
104 response 4 0.259
104 retinal 3 0.395
104 retrogeniculate 1 0.1773
104 reversal 1 0.1493
104 right 1 0.092
104 screen 1 0.1773
104 seen 1 0.075
104 severe 1 0.0786
104 side 1 0.1
104 six 1 0.0978
104 smaller 1 0.1278
104 statistically 1 0.1102
104 stimulation 6 0.6002
104 stroboscopic 1 0.1773
104 subjects 1 0.0847
104 subjects, 2 0.2374
104 successfully 1 0.1214
104 suppression 2 0.2282
104 tangent 1 0.1596
104 temporal 1 0.1363
104 triphasic 1 0.1773
104 ver 9 1.3438
104 vertex 1 0.1596
104 visual 2 0.1934
104 wave 5 0.7099
104 waves 2 0.284
105 . 5 0.6785
105 accompanying 1 0.4229
105 asymmetry 1 0.4827
105 cases 1 0.1794
105 converse 1 0.6029
105 corroborative 1 0.6029
105 defect 1 0.2969
105 diagnosing 1 0.4477
105 etiology 1 0.3324
105 evidence 1 0.221
105 experience, 1 0.4827
105 field 1 0.3581
105 helpful, 1 0.5428
105 hemianopias 1 0.6029
105 horizontal 1 0.4827
105 horizontally 1 0.6029
105 indicate 1 0.2655
105 indication 1 0.4229
105 invalidate 1 0.6029
105 is, 2 0.8073
105 lesion 1 0.3401
105 lesions 1 0.2593
105 lobe 2 0.8255
105 mass 1 0.4477
105 may 1 0.1508
105 nystagmus 2 0.9655
105 observation 1 0.3157
105 occipital 4 1.6509
105 optokinetic 4 2.1711
105 patients 1 0.1449
105 presented 1 0.2339
105 responses 2 0.6723
105 rule 2 0.9269
105 ruling 1 0.5428
105 six 1 0.3324
105 still 1 0.2816
105 strong 1 0.4037
105 symmetric 1 0.6029
105 therefore, 1 0.3811
105 tumor 1 0.2688
105 type 2 0.5015
105 valuable 1 0.388
105 vascular 1 0.3324
106 . 4 0.6785
106 46-year-old 1 0.6785
106 anaphylactoid 2 1.5073
106 briefly 1 0.4542
106 confusion 1 0.6785
106 described.. 1 0.7536
106 diagnosis, 1 0.5046
106 discussed, 1 0.6034
106 generally 1 0.4477
106 gerstmann's 2 1.2069
106 hours 1 0.3625
106 induced 1 0.3204
106 left 1 0.3403
106 less 1 0.2821
106 literature 1 0.411
106 mechanism 1 0.3472
106 oral 2 0.9221
106 penicillin 2 1.2069
106 rare 1 0.4477
106 reaction 1 0.3773
106 reactions 1 0.3682
106 relevant 1 0.543
106 residual 1 0.5596
106 resulting 1 0.3839
106 reviewed 1 0.4252
106 shock 1 0.6034
106 supposed 1 0.6034
106 symptomatology, 1 0.7536
106 syndrome 2 0.6992
106 treatment, 1 0.485
106 unconsciousness 1 0.7536
106 weeks 1 0.3946
106 woman 1 0.4943
107 (all 1 0.1341
107 (case 2 0.3015
107 (cases 2 0.3349
107 . 18 0.6785
107 /finger 1 0.1675
107 1) 2 0.2155
107 1-4) 1 0.1675
107 1. 1 0.0877
107 2. 1 0.0877
107 3, 1 0.1341
107 3. 1 0.0904
107 4 1 0.0592
107 4. 1 0.0956
107 5) 1 0.141
107 abstract 1 0.1675
107 acalculia 1 0.1675
107 according 1 0.0904
107 affected 1 0.0869
107 affected, 1 0.141
107 agnosia/ 1 0.1675
107 along 1 0.1175
107 among 1 0.0782
107 angular 1 0.1508
107 aphasia 3 0.3731
107 aphasic 4 0.6031
107 apparently 1 0.0913
107 application 1 0.0945
107 area 1 0.0869
107 areas 1 0.0886
107 arising 1 0.1287
107 associated 2 0.1189
107 association 1 0.0904
107 assumed 1 0.1146
107 assumption 1 0.1341
107 attention 1 0.1078
107 background 1 0.1244
107 best 1 0.0886
107 body 12 0.8102
107 cases 1 0.0498
107 categories 3 0.3731
107 cause 1 0.0756
107 classical 1 0.1175
107 clinical 1 0.0546
107 compared 1 0.065
107 compensated 1 0.1341
107 complete 1 0.0777
107 concrete 1 0.1341
107 confirm 1 0.141
107 consists 1 0.1059
107 contralateral 1 0.1244
107 corticosubcortical 1 0.1675
107 defining 1 0.1508
107 depth 1 0.1341
107 described 2 0.127
107 development 1 0.0611
107 differentiated 1 0.1121
107 differentiation 1 0.0956
107 differs 1 0.1146
107 difficulties 1 0.1244
107 difficulty 1 0.1121
107 disease, 1 0.0894
107 disintegration 2 0.3015
107 disturbances 4 0.3979
107 dominant 1 0.1146
107 drawn 1 0.1244
107 dyscalculia, 1 0.1675
107 dysgraphia, 1 0.1675
107 dyslexia 1 0.141
107 elicit 1 0.1675
107 even 1 0.0733
107 experience 2 0.1722
107 extensive 2 0.189
107 extent 1 0.0886
107 far 1 0.1078
107 finger 2 0.3015
107 forming 1 0.1244
107 found 2 0.0882
107 function 1 0.0751
107 functions 1 0.1041
107 gerstmann's 2 0.2682
107 gnosis 1 0.1675
107 gnostic 2 0.3015
107 greater 1 0.0693
107 hemisphere 1 0.141
107 here) 1 0.1675
107 here, 1 0.141
107 however, 1 0.0607
107 image 9 1.2691
107 image, 1 0.1675
107 image.. 1 0.1675
107 impairment 5 0.5493
107 importance 1 0.0853
107 initial 1 0.0812
107 interrelation 2 0.3349
107 investigated 1 0.0956
107 investigation 1 0.0945
107 lack 1 0.0968
107 latter 1 0.0869
107 leads 1 0.0934
107 lesion 3 0.2834
107 lesions 1 0.072
107 less 1 0.0627
107 limited 2 0.1827
107 lobe 1 0.1146
107 loss 1 0.0812
107 mainly 1 0.1099
107 manifestations 1 0.0956
107 may 3 0.1257
107 methods 1 0.0756
107 mildest 1 0.1675
107 minor 2 0.2155
107 naming 4 0.6699
107 naming, 1 0.1675
107 needed 1 0.1146
107 nomination 1 0.1675
107 non-verbal 1 0.141
107 owing 1 0.1121
107 parietal 2 0.2487
107 partial 1 0.0934
107 particular 1 0.0846
107 parts 1 0.1146
107 patients 2 0.0805
107 persist 1 0.141
107 physiologic 1 0.1078
107 presence 1 0.0638
107 presented 1 0.065
107 preserved 1 0.141
107 proprioceptive, 1 0.1675
107 pto 2 0.3349
107 quantitative 1 0.0886
107 regard 1 0.0956
107 regular 1 0.1244
107 repetition 1 0.141
107 repetition, 1 0.1675
107 represent 1 0.1059
107 scales 1 0.1508
107 seem 1 0.0913
107 selectively 1 0.1675
107 sensory 2 0.2487
107 separate, 1 0.1675
107 show 2 0.1449
107 signs 1 0.0934
107 specific 1 0.0659
107 speech 2 0.1754
107 subsiding, 1 0.1675
107 supramarginal 1 0.1675
107 symbols 1 0.1675
107 syndrome 6 0.4661
107 syndrome, 1 0.1121
107 tactile 1 0.1508
107 telereceptive 1 0.1675
107 testing 1 0.1175
107 thus 1 0.0869
107 understanding 6 0.6591
107 unimpaired 1 0.1675
107 usually 1 0.0788
107 vague 1 0.1675
107 varies 1 0.1207
107 variety 1 0.0904
107 verbal 9 1.0091
107 vestibular 1 0.1508
107 well 1 0.0586
107 wide 1 0.0995
107 words 2 0.2575
107 words, 1 0.1508
107 worse 1 0.1508
108 . 9 0.6785
108 /plateau/ 1 0.3349
108 46, 1 0.3349
108 aberrant 1 0.2487
108 aberrations 2 0.5641
108 abnormalities 1 0.1868
108 affected 1 0.1737
108 allow 1 0.2349
108 apparent 1 0.1754
108 appearance 1 0.1663
108 appears 1 0.144
108 assessed 1 0.2487
108 before, 1 0.2575
108 blood 1 0.1035
108 blood-forming 1 0.3349
108 cancer 2 0.2648
108 cancers, 1 0.3015
108 cell 2 0.2267
108 cells 2 0.2022
108 cells, 1 0.1624
108 change 1 0.1554
108 chromosomal 2 0.4974
108 chromosomes 4 1.0728
108 correlation 1 0.1691
108 counting 1 0.2487
108 course 1 0.1523
108 cultures 2 0.3354
108 damage 3 0.5119
108 damages 1 0.3015
108 determine 1 0.189
108 differ 1 0.2197
108 different 1 0.1185
108 during, 1 0.3349
108 enables 1 0.3349
108 examined 1 0.1691
108 frequency 2 0.3508
108 grown 1 0.2293
108 however, 1 0.1213
108 human 1 0.1118
108 incidence 1 0.1599
108 intervals 1 0.2082
108 irradiated 1 0.1937
108 large 1 0.1324
108 largely 1 0.2349
108 may 3 0.2513
108 microscopically 1 0.3349
108 normal 1 0.0901
108 number 1 0.1282
108 patients 2 0.161
108 patterns 1 0.2117
108 peak 1 0.1937
108 persistent 1 0.2575
108 portions 1 0.2487
108 preparations 1 0.2019
108 prior 1 0.1789
108 qualitative, 1 0.3015
108 quantitative 1 0.1771
108 radiation 1 0.1827
108 radiotherapy 1 0.2349
108 random 1 0.282
108 recognize 1 0.2575
108 remain 1 0.2413
108 seem 1 0.1827
108 selected 1 0.1963
108 short-term 1 0.2487
108 showing 1 0.2197
108 specific 1 0.1318
108 stained 1 0.2682
108 structural 1 0.2155
108 study 1 0.1032
108 therapy 1 0.1324
108 thereby 1 0.2575
108 tissues 1 0.1533
108 treatment 3 0.2965
108 unchanged, 1 0.3015
108 us 2 0.4394
108 variation 1 0.2117
108 variations 1 0.2082
108 white 1 0.2082
109 . 3 0.6785
109 alarming 1 1.0048
109 bizarre 1 0.8461
109 changes 1 0.3007
109 clinical 1 0.3275
109 complex 1 0.5811
109 either 1 0.4296
109 examples 1 0.7462
109 genetic 1 0.5262
109 induced 1 0.4272
109 interesting 2 1.448
109 interference 1 0.6728
109 manifestations 2 1.1476
109 many 1 0.4051
109 migraine 2 2.0097
109 neurologic 3 2.3172
109 origin 1 0.5738
109 phenomenon 1 0.5811
109 pictures 1 1.0048
109 presumably 1 0.6591
109 produce 1 0.5366
109 result 1 0.4346
109 shown 1 0.4321
109 system 1 0.4694
109 vascular 1 0.554
109 vasoconstriction 1 0.9046
109 vasodilitation, 1 1.0048
109 which, 1 0.724
110 -dash 1 0.258
110 . 8 0.6785
110 accidents 1 0.3768
110 activities 1 0.2179
110 adaptive 2 0.6034
110 adopting 1 0.3768
110 adults 2 0.4542
110 also 1 0.1054
110 apparent 1 0.1973
110 authors 1 0.1736
110 battery 1 0.3173
110 bear 1 0.3768
110 becomes 1 0.2271
110 behavioral 1 0.2798
110 boston 1 0.3768
110 boston, 1 0.3768
110 brain-injured 1 0.3768
110 care 1 0.2382
110 cerebral 2 0.3571
110 clinical 1 0.1228
110 collected 1 0.2715
110 college 1 0.3768
110 college, 1 0.3768
110 compensatory 1 0.2101
110 daily 1 0.2055
110 data 1 0.1535
110 degree 1 0.167
110 designed 1 0.2715
110 develop 2 0.4542
110 difference 2 0.3773
110 dimension 1 0.3768
110 direction 1 0.2643
110 diversity 1 0.3768
110 effective 1 0.1887
110 estimates 1 0.3173
110 exercises 1 0.3768
110 experimental 1 0.1748
110 extent 1 0.1992
110 fixation 1 0.3017
110 follow 1 0.3017
110 formal 1 0.2798
110 habit 1 0.3768
110 habituation(11) 1 0.3768
110 hospitalization 1 0.3017
110 however, 1 0.1365
110 indication 1 0.2643
110 inquiry 1 0.3768
110 insult 1 0.3768
110 intervals 1 0.2342
110 involved 1 0.1919
110 kind 1 0.2643
110 less 1 0.1411
110 level 1 0.1455
110 mass., 1 0.3768
110 material 1 0.1748
110 measure 1 0.2179
110 measurements 1 0.2425
110 might 1 0.1973
110 mind 1 0.3392
110 must 1 0.1841
110 neglect 4 1.5073
110 new 1 0.1649
110 nonbrain-injured 1 0.3768
110 normal 1 0.1013
110 nurses 1 0.3768
110 nursing 3 0.9518
110 observed 1 0.1284
110 obtained 1 0.1343
110 often 2 0.3653
110 one 1 0.1054
110 patient 1 0.1417
110 patients 3 0.2717
110 patterns 1 0.2382
110 peers 1 0.3768
110 periodic 1 0.2715
110 personnel 1 0.3173
110 pilot 1 0.3017
110 program 2 0.5286
110 provide 1 0.2208
110 psychology 1 0.3173
110 rather 1 0.1773
110 re-administering 1 0.3768
110 reduce(12) 1 0.3768
110 regression 1 0.2425
110 rehabilitative 1 0.3173
110 response 1 0.1376
110 shown 1 0.162
110 simmons 1 0.3768
110 skilled 1 0.3173
110 slowly 1 0.258
110 spatial 1 0.3392
110 suffering 1 0.2238
110 tests 1 0.1856
110 therapeutics 2 0.7536
110 trainees 1 0.3768
110 used 1 0.1423
110 usually 1 0.1773
110 vascular 1 0.2077
110 visual 4 0.8219
111 . 4 0.6785
111 50 1 0.3598
111 abnormality 1 0.5286
111 admixture 1 0.7536
111 alveolar-arterial 1 0.7536
111 anatomical 1 0.6034
111 appear 1 0.3449
111 bypass 1 0.543
111 cardiac 1 0.3381
111 cardiopulmonary 1 0.5793
111 cardiothoracic 1 0.7536
111 changes 3 0.6765
111 circulation 1 0.3946
111 completely 1 0.4416
111 develop 1 0.4542
111 differences 1 0.3449
111 due 2 0.5332
111 early 1 0.2763
111 extracorporeal 1 0.4943
111 found 1 0.1984
111 inequality 1 0.7536
111 initiating 1 0.6346
111 left 1 0.3403
111 likely 1 0.4416
111 lungs.. 1 0.7536
111 magnitude 1 0.4685
111 may 1 0.1885
111 open-heart 1 0.5793
111 oxygen 1 0.3839
111 pathology, 1 0.7536
111 patients 2 0.3623
111 period 1 0.2859
111 post-operative 1 0.6785
111 procedure 1 0.3839
111 remainder 1 0.7536
111 required 1 0.411
111 respiratory 1 0.3909
111 responsible 1 0.3805
111 reversible 1 0.5596
111 right 1 0.3909
111 shunting 1 0.5159
111 significant 1 0.2646
111 since 1 0.3279
111 surgery 3 1.1225
111 technique 1 0.3546
111 tension 1 0.4542
111 undergo 1 0.5596
111 underlying 1 0.543
111 venous 1 0.4252
111 ventilation-perfusion 1 0.7536
112 (1) 1 0.1624
112 (2) 1 0.1624
112 (3) 1 0.1771
112 (4) 1 0.1937
112 . 9 0.6785
112 46 1 0.282
112 additional 1 0.1789
112 angiocardiography 2 0.4974
112 angiocardiography, 1 0.3015
112 anomalies 4 0.8788
112 anomaly 1 0.2413
112 another 1 0.1827
112 aortic 1 0.1789
112 aortography 1 0.2682
112 aortography, 1 0.282
112 approach 1 0.2082
112 arrive 1 0.3349
112 associated 5 0.5947
112 cardiac 4 0.6011
112 cases 2 0.1993
112 catheterization 3 0.6728
112 causing 1 0.2487
112 classified 1 0.2019
112 clinical 1 0.1092
112 clinical, 1 0.2155
112 coexist 1 0.3349
112 commonly 1 0.2349
112 complete 3 0.4661
112 complex 1 0.1937
112 considered 1 0.1493
112 defect 4 0.6598
112 defect, 2 0.4827
112 diagnosis 3 0.4135
112 diagnostic 1 0.1663
112 electrocardiographic, 1 0.282
112 entirely 1 0.2155
112 erroneous 1 0.282
112 even 1 0.1466
112 failure 1 0.1807
112 findings 3 0.3992
112 frequently 1 0.1691
112 great 1 0.1913
112 helpful 1 0.2293
112 identifying 1 0.2682
112 including 2 0.3615
112 incomplete 1 0.282
112 insufficiency 1 0.199
112 intraventricular 1 0.2575
112 isolated 1 0.1457
112 leading 1 0.2082
112 led 1 0.1963
112 left 2 0.3025
112 left-sided 1 0.3015
112 lesion 1 0.189
112 made 1 0.1213
112 malformations 3 0.6466
112 may 1 0.0838
112 necropsy-proved 1 0.3349
112 obscure 1 0.282
112 observed 1 0.1142
112 obstruction 1 0.2117
112 obstructive 1 0.2243
112 occult 1 0.3349
112 often 2 0.3247
112 outlined 1 0.2682
112 part 1 0.1565
112 positional 1 0.3349
112 preoperatively, 1 0.3349
112 presented 1 0.1299
112 procedures 1 0.189
112 recognized 1 0.2082
112 recommended 1 0.2243
112 related 1 0.1416
112 responsible 1 0.1691
112 right-sided 1 0.2682
112 selected 1 0.1963
112 selective 1 0.199
112 septal 6 1.0844
112 shunts, 1 0.3015
112 special 1 0.1771
112 studies 1 0.1026
112 studies, 2 0.5641
112 study, 1 0.2155
112 therefore 1 0.2049
112 typical 1 0.2197
112 valvular 1 0.2243
112 varies 1 0.2413
112 ventricular 8 1.1658
112 vessels, 1 0.3349
113 (1) 1 0.1124
113 (10 1 0.1782
113 (13 1 0.2319
113 (15 1 0.1857
113 (2) 1 0.1124
113 (3 1 0.1857
113 (3) 1 0.1226
113 (4) 1 0.1341
113 (42 1 0.2319
113 (43 1 0.2319
113 (5 1 0.1857
113 (7 1 0.2088
113 (78 1 0.2088
113 (83 1 0.2319
113 (dextro, 1 0.2319
113 (levo 1 0.2319
113 (solitus) 1 0.2319
113 (type 1 0.2088
113 . 11 0.5741
113 1,. 1 0.2319
113 2 1 0.0708
113 25 1 0.1324
113 26 1 0.1466
113 3 1 0.079
113 4 1 0.082
113 47 1 0.2088
113 50 1 0.1107
113 6 1 0.097
113 60 3 0.4477
113 8 1 0.1047
113 9 1 0.1214
113 a) 1 0.2088
113 a,. 1 0.2319
113 absence 4 0.4428
113 absent 1 0.1521
113 according 1 0.1251
113 anatomic 1 0.1553
113 anatomy 2 0.4175
113 angiocardiographic, 1 0.2319
113 anteroposterior 1 0.2088
113 aortic 2 0.2477
113 apparent 1 0.1214
113 applications 1 0.1722
113 approach 2 0.2883
113 arteries 2 0.3565
113 arteries, 1 0.2088
113 aspects 1 0.1308
113 asplenia, 1 0.2319
113 associated 1 0.0823
113 atria 1 0.2088
113 atrial 3 0.4477
113 b,. 1 0.2319
113 c,. 1 0.2319
113 cardiac 2 0.2081
113 cases 13 0.8969
113 chamber 1 0.1722
113 characteristics 1 0.1293
113 classic 1 0.1782
113 classified 1 0.1397
113 common 2 0.2266
113 d), 1 0.2319
113 d-transposition, 1 0.2319
113 designated 2 0.3444
113 development 1 0.0847
113 displayed 1 0.1857
113 distinctive 1 0.1722
113 electrocardiographic 1 0.1857
113 embryologic 1 0.2319
113 exact 1 0.1671
113 found 1 0.061
113 found.. 2 0.4638
113 four 1 0.104
113 geometric 2 0.4175
113 great 3 0.3972
113 gross 1 0.1553
113 heterotaxy, 1 0.2319
113 horizontal 1 0.1857
113 identified 1 0.1359
113 ii,. 1 0.2319
113 iii 1 0.1782
113 image 1 0.1952
113 infundibulum, 2 0.4638
113 interrelationship, 2 0.4638
113 inversus 1 0.2088
113 inversus, 1 0.2088
113 iv, 1 0.2088
113 l), 1 0.2319
113 l-transposition, 1 0.2319
113 large 1 0.0917
113 left 4 0.4189
113 line 1 0.1397
113 lying 2 0.4175
113 major 1 0.1115
113 malformations 1 0.1492
113 man 1 0.1192
113 man, 1 0.1722
113 measured 1 0.1015
113 mirror 1 0.2319
113 morphologic 3 0.5012
113 morphologically 1 0.1952
113 myocardium 1 0.1782
113 necropsied 2 0.4638
113 none 1 0.1397
113 normal 1 0.0624
113 normal, 2 0.3444
113 outlet 1 0.2088
113 percent) 1 0.1857
113 percent), 7 1.6232
113 percent),. 2 0.4638
113 plane, 1 0.2319
113 planes 1 0.2088
113 present.. 1 0.2088
113 presented 1 0.09
113 projections 1 0.1952
113 pulmonary 2 0.1983
113 relationship 1 0.1115
113 relationships 1 0.1492
113 relative 3 0.3609
113 right 6 0.7217
113 rudimentary 2 0.4638
113 segmental, 1 0.2319
113 segmentally, 1 0.2319
113 segments.. 1 0.2319
113 semilunar 1 0.2319
113 septa, 1 0.2319
113 septum, 2 0.4638
113 single 3 0.3454
113 sinus 2 0.3341
113 sinus, 3 0.6263
113 sinuses 1 0.1952
113 sinuses, 1 0.2088
113 situs 2 0.3905
113 solitus, 1 0.2319
113 three 3 0.2616
113 transposed 4 0.835
113 type 8 0.7715
113 types 3 0.3372
113 uncertain 1 0.1722
113 unrelated 1 0.1626
113 upon 1 0.104
113 valve 2 0.2837
113 valve, 2 0.3565
113 valves, 1 0.2319
113 ventricle 5 0.6705
113 ventricular 12 1.2107
113 visceral 2 0.3444
114 . 12 0.6785
114 310 1 0.2512
114 ability 1 0.128
114 accurate 1 0.1537
114 acquired 1 0.1562
114 active, 1 0.1865
114 acyanotic 1 0.2512
114 adult 2 0.2284
114 adults 1 0.1514
114 almost 1 0.1291
114 alter 1 0.1682
114 although 1 0.0966
114 anomalies 1 0.1648
114 appearance 1 0.1247
114 arteriosclerotic 1 0.2512
114 arteriosus 1 0.1931
114 associated 1 0.0892
114 atrial 1 0.1617
114 attributed 1 0.1682
114 bacterial 1 0.1472
114 basic 1 0.172
114 cardiac 4 0.4509
114 cardiovascular 1 0.1588
114 cause 2 0.2269
114 characteristic 1 0.1268
114 clinical 1 0.0819
114 common 1 0.1227
114 complications 1 0.1472
114 comprised 1 0.2011
114 congenital 5 0.5748
114 continue 1 0.1931
114 course 1 0.1142
114 death 3 0.411
114 death, 1 0.2512
114 decompensation 1 0.2512
114 defect 3 0.3711
114 determine 1 0.1417
114 disease 4 0.361
114 disorder 1 0.1562
114 ductus 1 0.1865
114 efficacy 1 0.2011
114 eisenmenger 1 0.2512
114 encountered 1 0.1588
114 endocarditis, 1 0.2262
114 entire 1 0.1648
114 especially 1 0.1291
114 essential 1 0.1472
114 evaluation 1 0.1355
114 events 1 0.1865
114 failure, 1 0.1931
114 features 1 0.1342
114 frequently 2 0.2537
114 greatest 1 0.1588
114 group 1 0.0929
114 heart 5 0.5826
114 impressive 1 0.2262
114 incidence, 1 0.2262
114 included 1 0.1355
114 instances 1 0.1682
114 intervention 1 0.2011
114 lesions 2 0.216
114 live 1 0.172
114 lives 1 0.2262
114 long 1 0.1303
114 longevity, 1 0.2512
114 made 1 0.091
114 malformation, 1 0.2115
114 manifestations 1 0.1434
114 many 1 0.1013
114 may 1 0.0628
114 minimal 1 0.1562
114 misdiagnosed 1 0.2512
114 natural 1 0.1472
114 non-cardiac, 1 0.2512
114 observation 2 0.2631
114 occurred 1 0.1093
114 often 2 0.2435
114 older 2 0.3123
114 one 1 0.0703
114 patent 1 0.181
114 patient 1 0.0945
114 patients 5 0.3019
114 patients, 1 0.1258
114 pregnancy 1 0.1472
114 presenting 1 0.1682
114 productive 1 0.2512
114 proved 1 0.1401
114 pulmonic 1 0.2115
114 quarter 1 0.2115
114 quarters 1 0.2512
114 reviewed 1 0.1417
114 rheumatic,. 1 0.2512
114 secondary 1 0.1258
114 septal 3 0.4066
114 series 1 0.1182
114 shunting 1 0.172
114 significant 1 0.0882
114 stenosis 1 0.1588
114 stress, 1 0.2262
114 sudden 2 0.3233
114 surgery 1 0.1247
114 surgery, 1 0.1931
114 surgical 1 0.1134
114 survive 1 0.2262
114 symptoms 1 0.119
114 syndrome 2 0.2331
114 term 1 0.1401
114 third 1 0.137
114 threats 1 0.2262
114 three 1 0.0945
114 times 1 0.1208
114 twenty-two 1 0.2011
114 usually 1 0.1182
114 variety 1 0.1355
114 ventricular 2 0.2186
114 without 1 0.0949
114 withstand 1 0.2262
114 young 1 0.1268
115 . 6 0.6785
115 11 1 0.2683
115 12 1 0.2399
115 2 1 0.1534
115 4 1 0.1777
115 6 1 0.2101
115 7 1 0.2315
115 age 1 0.2078
115 all, 1 0.3862
115 aortic 6 1.6099
115 aortography 1 0.4023
115 appear 1 0.2299
115 appeared 1 0.2417
115 associated 1 0.1784
115 average 1 0.2254
115 cardiac 1 0.2254
115 childhood, 1 0.4523
115 children 1 0.1784
115 clinical 1 0.1638
115 clinical, 1 0.3233
115 combination 1 0.2869
115 common 1 0.2454
115 concomitant 1 0.3862
115 defect 2 0.4948
115 determined 1 0.2284
115 diastolic 1 0.3862
115 dilatation 1 0.3524
115 disability 1 0.3862
115 documented 1 0.362
115 electrocardiographic, 1 0.423
115 electrocardiographically, 1 0.5024
115 examination 1 0.2537
115 findings 1 0.1996
115 first 1 0.1842
115 hemodynamic 2 0.6728
115 however 1 0.362
115 hypertrophy 2 0.5313
115 indication 1 0.3524
115 insufficiency 4 1.1938
115 left 1 0.2269
115 left-to-right 1 0.5024
115 manifested 1 0.3862
115 moderate 1 0.2985
115 murmur 1 0.3862
115 noted 1 0.2657
115 patients 2 0.2415
115 patients, 1 0.2515
115 presented 1 0.1949
115 pressure 1 0.2299
115 progression 1 0.423
115 progressive 2 0.5603
115 pulse 1 0.362
115 radiographic, 1 0.5024
115 septal 2 0.5422
115 shunt 1 0.3364
115 significant 1 0.1764
115 small 1 0.2015
115 study 1 0.1548
115 ventricular 3 0.6558
115 widening 1 0.423
115 x-ray 1 0.3296
115 years 1 0.2284
116 . 9 0.6785
116 abnormalities 1 0.1868
116 acquired 1 0.2082
116 anatomic 1 0.2243
116 and, 2 0.3475
116 angiographic 1 0.2682
116 aortic 9 1.6099
116 aortography 1 0.2682
116 appearance 1 0.1663
116 appears 1 0.144
116 basis 1 0.1466
116 become 1 0.1847
116 cardiac 1 0.1503
116 cardiovascular 1 0.2117
116 careful 1 0.2117
116 catheterization 1 0.2243
116 childhood 1 0.189
116 clinical, 2 0.4311
116 combination 1 0.1913
116 complicated 1 0.2349
116 complication 1 0.3015
116 considerations 1 0.2293
116 continuous 1 0.189
116 defect 7 1.1546
116 defects 1 0.1847
116 development 1 0.1223
116 diagnostic 1 0.1663
116 differentiation 1 0.1913
116 distinguished 1 0.2243
116 early 1 0.1228
116 failure 1 0.1807
116 fifteen 1 0.3015
116 findings 1 0.1331
116 following 1 0.111
116 helpful 1 0.2293
116 hemodynamic 1 0.2243
116 hemodynamic, 1 0.3349
116 important 1 0.1513
116 indicated 1 0.1576
116 leaflet 1 0.282
116 leaflets 1 0.3349
116 left 1 0.1513
116 location 1 0.2575
116 magnitude 1 0.2082
116 malformations 1 0.2155
116 management 1 0.1771
116 murmur 1 0.2575
116 must 1 0.1636
116 observation 1 0.1754
116 occurs 1 0.1789
116 onset 1 0.1937
116 operative 1 0.1868
116 patients 2 0.161
116 plans 1 0.3349
116 present 1 0.1103
116 present, 1 0.2197
116 presented 2 0.2599
116 pressure 1 0.1533
116 previously 1 0.1611
116 procedures 1 0.189
116 producing 1 0.2155
116 progression 1 0.282
116 prolapse 1 0.3349
116 pulse 1 0.2413
116 rapid 1 0.1624
116 regurgitation 7 1.5379
116 relation 1 0.1543
116 reported 1 0.1357
116 results 1 0.0959
116 results, 1 0.2682
116 reviewed 1 0.189
116 septal 6 1.0844
116 severe 2 0.2968
116 shunt 1 0.2243
116 since 1 0.1457
116 size 1 0.1754
116 strategic 1 0.3349
116 suggested 1 0.1393
116 surgical 2 0.3025
116 tends 1 0.2575
116 thoracic 1 0.2413
116 to-and-fro 1 0.3349
116 treatment 1 0.0988
116 uncommon 1 0.2575
116 valve 1 0.2049
116 ventricular 5 0.7286
116 wide 1 0.199
117 (thirty 1 0.4306
117 . 7 0.6785
117 1. 1 0.2255
117 2. 1 0.2255
117 3. 1 0.2324
117 4. 1 0.2459
117 absence 1 0.2056
117 adds 1 0.4306
117 aortic 5 1.1499
117 appearance 1 0.2138
117 approach 1 0.2677
117 arteries 1 0.331
117 ball-valve 2 0.8613
117 calcific 1 0.3877
117 cases 1 0.1281
117 contraction 1 0.3626
117 coronary 1 0.2771
117 current 1 0.2677
117 date 1 0.3198
117 deaths 1 0.3103
117 decreased 1 0.1945
117 device 1 0.3877
117 disease 4 0.6189
117 feel 1 0.3448
117 follow-up 1 0.2883
117 good 1 0.2401
117 immediate 1 0.2722
117 influenced 1 0.2677
117 intact 1 0.2374
117 late 1 0.2558
117 leaflet 1 0.3626
117 leaving 1 0.4306
117 long-term 1 0.249
117 low-output 1 0.4306
117 mitral 4 1.1533
117 months) 1 0.3448
117 muscle-chordae 1 0.4306
117 operated 1 0.2771
117 outcome 1 0.331
117 papillary 1 0.3877
117 patient 1 0.1619
117 patients 1 0.1035
117 period 2 0.3267
117 postoperative 1 0.2595
117 postoperatively 1 0.3877
117 presence 2 0.3281
117 primarily 1 0.2722
117 prosthesis 1 0.3877
117 prosthetic 1 0.4306
117 relationship 1 0.2071
117 replaced 1 0.331
117 replacement 1 0.2722
117 reported 1 0.1745
117 results 1 0.1233
117 seventy-four 1 0.4306
117 severe 1 0.1908
117 significantly 1 0.1811
117 stenosis 1 0.2722
117 strength 1 0.3198
117 successfully 1 0.2948
117 suffering 1 0.2558
117 surgical 1 0.1945
117 syndrome 1 0.1998
117 techniques 1 0.2348
117 tendineae-mural 1 0.4306
117 totally 1 0.3021
117 type 1 0.1791
117 upon 1 0.1932
117 valves 2 0.7252
117 valvular 2 0.5767
117 well 1 0.1506
118 (average 1 0.2153
118 ) 1 0.1551
118 . 14 0.6785
118 /m 1 0.2153
118 0.13 1 0.2153
118 0.44 1 0.2153
118 10 1 0.0793
118 13 1 0.1245
118 14 1 0.1187
118 24 1 0.1117
118 26 1 0.1361
118 29 1 0.1474
118 34 1 0.151
118 4.8 1 0.1939
118 42 1 0.1655
118 49 1 0.1813
118 60 1 0.1386
118 63 1 0.1939
118 72 1 0.1551
118 75 1 0.151
118 89 1 0.1939
118 absence 1 0.1028
118 afterward 1 0.2153
118 afterward, 1 0.2153
118 aorta 1 0.1442
118 aortic 13 1.4949
118 areas 1 0.1139
118 ascending 1 0.1655
118 assessed 1 0.1599
118 associated 2 0.1529
118 average 3 0.2898
118 averaged 1 0.1724
118 blood 4 0.2661
118 calculated 1 0.1442
118 changes 1 0.0644
118 closely 1 0.123
118 cm 1 0.1724
118 comprised 1 0.1724
118 concerning 1 0.1338
118 definitive 1 0.1655
118 degrees 1 0.1361
118 described 1 0.0817
118 determinations 1 0.1551
118 diastole 1 0.2153
118 direct 1 0.1013
118 disease 1 0.0774
118 document 1 0.2153
118 effects 3 0.2398
118 eight 3 0.3689
118 electromagnetic 1 0.2153
118 elevated 1 0.1386
118 every 2 0.2401
118 extremely 1 0.151
118 favorable 1 0.1474
118 fell 2 0.2948
118 five 2 0.2277
118 flow 6 0.6581
118 flow, 1 0.1551
118 flowmeter 1 0.2153
118 flows 1 0.1655
118 follow 1 0.1724
118 forward 5 0.862
118 four 1 0.0966
118 g-m 2 0.4306
118 group, 1 0.1386
118 high 2 0.1541
118 immediately 1 0.1317
118 increased 1 0.0669
118 information 1 0.1162
118 instantaneous 1 0.2153
118 kinetic 2 0.3626
118 left 8 0.7779
118 made 1 0.078
118 man 1 0.1107
118 mean 1 0.1036
118 measured 1 0.0942
118 net 2 0.3448
118 normal 1 0.0579
118 observations 1 0.0905
118 operation 2 0.2255
118 orifice 1 0.1939
118 patient 1 0.081
118 patient, 1 0.1412
118 patients 7 0.3623
118 percent 8 1.1533
118 percent, 2 0.3626
118 performance 3 0.4422
118 preoperatively 2 0.4306
118 present 1 0.0709
118 pressure 3 0.2956
118 pressure, 1 0.1412
118 pressures 1 0.1412
118 prosthesis, 1 0.1939
118 proved 1 0.1201
118 provide 1 0.1262
118 ranged 1 0.1655
118 ranging 1 0.1474
118 records 1 0.151
118 regurgitant 4 0.6621
118 regurgitated 1 0.2153
118 regurgitation 4 0.5649
118 regurgitation, 1 0.1655
118 replaced, 1 0.2153
118 replacement 6 0.8167
118 resembled 1 0.1551
118 residual 1 0.1599
118 rose 2 0.3021
118 seen 1 0.091
118 seven 1 0.123
118 severity 1 0.1317
118 significantly 1 0.0905
118 similar 1 0.0806
118 simultaneously 1 0.1298
118 sine-wave 1 0.2153
118 starr-edwards 1 0.2153
118 stenosis 1 0.1361
118 stenosis, 1 0.1655
118 stroke 4 0.6041
118 stroke/m 1 0.2153
118 studies 1 0.0659
118 succeeding 1 0.1939
118 total 5 0.4196
118 valve 7 0.9221
118 valves 1 0.1813
118 variable 1 0.1298
118 varying 1 0.1162
118 ventricle 2 0.249
118 ventricular 7 0.6558
118 volume 4 0.4387
118 without 1 0.0813
118 work 7 1.0318
119 . 3 0.6785
119 26 2 1.2704
119 52 1 0.7724
119 absence 1 0.4797
119 absorbed 1 0.724
119 absorption 2 1.2492
119 affected 1 0.5212
119 associated 1 0.3568
119 b 2 1.3758
119 bilharziasis 3 3.0145
119 co 1 0.724
119 disease, 1 0.5366
119 hepatic 3 1.7006
119 hepato-splenic 1 1.0048
119 hepatosplenic 1 1.0048
119 indicate 1 0.4425
119 ingested 2 1.8093
119 irrespective 1 0.6879
119 limits 1 0.7724
119 measured 1 0.4398
119 neuritis 1 1.0048
119 normal 1 0.2702
119 normals 1 0.7724
119 orally 2 1.5448
119 organs 1 0.554
119 peripheral 1 0.5969
119 plasma 1 0.4051
119 presence 1 0.3828
119 present 1 0.3308
119 radioactive 1 0.6246
119 radioactivity 1 0.724
119 results 1 0.2878
119 size 1 0.5262
119 stage 1 0.4871
119 subjects, 1 0.6728
119 suffering 1 0.5969
119 tagged 1 0.9046
119 uptake 3 1.9773
119 vitamin 3 1.8443
119 within 1 0.373
119 work 1 0.6879
120 . 7 0.6785
120 1. 1 0.2255
120 2. 1 0.2255
120 3. 1 0.2324
120 4. 1 0.2459
120 7 1 0.1984
120 accompanied 1 0.2401
120 administration 1 0.1896
120 blood 1 0.1331
120 c 1 0.2348
120 cardiac 1 0.1932
120 central 1 0.2324
120 decrease, 1 0.3626
120 diastolic 1 0.331
120 digitalis 1 0.4306
120 drug 1 0.2255
120 early 2 0.3157
120 effect 1 0.1315
120 effects 1 0.1599
120 effects.. 1 0.4306
120 emptying 2 0.7754
120 end-diastolic 2 0.7252
120 filling 1 0.3877
120 following 1 0.1427
120 heart 1 0.1998
120 hemodynamics 1 0.3626
120 increase 4 0.5851
120 increases, 1 0.3877
120 initially 1 0.2825
120 inotropic 1 0.3877
120 intravenous 1 0.23
120 lanatoside 1 0.4306
120 later 1 0.2213
120 lengthening 1 0.3626
120 normal 2 0.2316
120 on, 1 0.3626
120 output 1 0.2523
120 parallel 1 0.2771
120 passive 1 0.2948
120 period 1 0.1633
120 pulmonary 1 0.1841
120 rate 3 0.4756
120 reduction 2 0.4241
120 related 1 0.1821
120 relation 1 0.1984
120 rise 1 0.2138
120 seems 1 0.2277
120 significant 5 0.7559
120 stroke 2 0.6041
120 subjects 2 0.4112
120 suggesting 1 0.2635
120 suggestive 1 0.3198
120 systolic 2 0.6396
120 transient 1 0.2948
120 two 1 0.1319
120 unchanged 1 0.331
120 variables 1 0.3198
120 ventricular 1 0.1874
120 volume 3 0.6581
120 volume, 2 0.5896
120 volumes 1 0.331
121 -cholografin 1 0.4306
121 . 7 0.6785
121 0.80, 1 0.4306
121 100 1 0.2429
121 11 1 0.23
121 200 1 0.2825
121 200-300 1 0.4306
121 23 1 0.2883
121 accurate 1 0.2635
121 accurately 1 0.3877
121 additional 1 0.23
121 aided 1 0.3877
121 although 1 0.1655
121 and/or 1 0.2722
121 autopsy 1 0.2825
121 blood 1 0.1331
121 cardiac 3 0.5797
121 cardiomegaly 1 0.4306
121 cases 1 0.1281
121 cc 3 1.2919
121 contents 1 0.2883
121 correlated 2 0.5116
121 decrease 1 0.1971
121 definite 1 0.2948
121 detected 1 0.2234
121 diagnosis 3 0.5316
121 diameters 1 0.4306
121 diameters, 1 0.4306
121 difference 1 0.2156
121 dilatation 1 0.3021
121 effusion 3 0.9931
121 effusions 1 0.3626
121 even 1 0.1885
121 examined 1 0.2175
121 exists 1 0.3103
121 fluid 2 0.4082
121 found 1 0.1134
121 greater 2 0.3563
121 heart 2 0.3995
121 hypertrophy 1 0.2277
121 ihsa 1 0.4306
121 isotopic 2 0.7754
121 less 2 0.3225
121 liver 1 0.1694
121 made 2 0.3119
121 maximum 1 0.2374
121 means 1 0.1908
121 measured, 1 0.3877
121 measurement 2 0.4859
121 open-heart 1 0.331
121 patients 3 0.3106
121 pericardial 6 1.9187
121 pericardiocentesis, 1 0.4306
121 photoscanning 1 0.3626
121 photoscans 1 0.3877
121 pool 1 0.331
121 pulmonary 1 0.1841
121 ratio 2 0.451
121 results 1 0.1233
121 roentgenogram 1 0.3448
121 scan 2 0.6896
121 sensitivity 1 0.2595
121 separation 1 0.2401
121 somewhat, 1 0.4306
121 surgery 1 0.2138
121 technique 1 0.2026
121 transverse 1 0.3877
121 undergoing 1 0.2722
121 vasculature 1 0.3877
121 visible 1 0.3626
122 . 12 0.6785
122 1. 1 0.1315
122 2. 1 0.1315
122 3. 1 0.1355
122 4. 1 0.1434
122 5. 1 0.1648
122 abnormality 1 0.1762
122 aneurysm 3 0.485
122 aneurysms 5 0.9327
122 angiocardiogram 1 0.2512
122 angiocardiography 1 0.1865
122 angiographic 1 0.2011
122 aortic 2 0.2683
122 arising 1 0.1931
122 associated 1 0.0892
122 atrium 2 0.423
122 bacterial 1 0.1472
122 basis 1 0.11
122 beneath 1 0.2262
122 bulge 1 0.2512
122 cardiac 1 0.1127
122 cause 1 0.1134
122 complex 1 0.1453
122 congenital 2 0.2299
122 cushion 2 0.5024
122 defect 3 0.3711
122 defects, 1 0.1762
122 deformities 1 0.2011
122 developing 1 0.1355
122 diagnostic 2 0.2494
122 endocardial 1 0.2262
122 endocarditis 1 0.2512
122 established 1 0.1355
122 features 2 0.2683
122 formation 1 0.1127
122 however, 1 0.091
122 immediately 1 0.1537
122 insufficiency 1 0.1492
122 isolated 1 0.1093
122 leaflet 1 0.2115
122 left 3 0.3403
122 lesions 1 0.108
122 many 1 0.1013
122 may 5 0.3141
122 membranous 5 0.9327
122 obstruction 1 0.1588
122 occur 1 0.1227
122 originate 1 0.1931
122 others 1 0.137
122 outflow 1 0.1931
122 part 1 0.1173
122 particularly 1 0.1385
122 presence 1 0.0957
122 presented 1 0.0975
122 presumably 1 0.1648
122 produce 1 0.1342
122 produced 1 0.1023
122 rare 1 0.1492
122 recognized 1 0.1562
122 relatively 1 0.1208
122 resembling 1 0.1931
122 result 1 0.1087
122 resulting 1 0.128
122 right 4 0.5212
122 rupture 1 0.2262
122 seen 1 0.1062
122 septal 4 0.5422
122 septum 4 0.7724
122 shunt 1 0.1682
122 site 1 0.1453
122 still 1 0.1173
122 symptoms 1 0.119
122 thrombus 1 0.2262
122 tract 1 0.1453
122 tricuspid 1 0.1931
122 valve 2 0.3074
122 valvular 1 0.1682
122 ventricle 3 0.4358
122 ventricle, 1 0.1865
122 ventricular 2 0.2186
123 (2 1 0.2682
123 . 9 0.6785
123 1,000 1 0.282
123 10 1 0.1233
123 27-51 1 0.3349
123 550 1 0.3015
123 75 1 0.2349
123 allow 1 0.2349
123 animals 1 0.1424
123 appeared 1 0.1611
123 architecture 1 0.282
123 area 1 0.1737
123 areas 2 0.3542
123 assumption 1 0.2682
123 autoradiographically 1 0.3015
123 average 1 0.1503
123 bed 1 0.282
123 beyond 1 0.2293
123 blood 1 0.1035
123 body 1 0.135
123 bone 2 0.2897
123 cells 4 0.4043
123 cells, 2 0.3247
123 cells/ 1 0.3349
123 cells/hr.) 1 0.3349
123 changes 1 0.1002
123 circulation 2 0.3508
123 control 1 0.1259
123 corresponded 1 0.2575
123 cytidine-labeled 1 0.3349
123 defined 1 0.2293
123 density 1 0.2197
123 despite 2 0.4235
123 destroyed 1 0.2243
123 difficult 1 0.2155
123 diminished 1 0.2243
123 distinguish, 1 0.3349
123 distribution 1 0.1722
123 enter 1 0.2575
123 erythrocytes 1 0.2487
123 expected 1 0.2197
123 fate 1 0.2487
123 following 2 0.2221
123 free-flowing 2 0.6699
123 greatly 1 0.199
123 hr 1 0.1937
123 hr., 1 0.2575
123 increased 2 0.2082
123 intact 1 0.1847
123 irradiated 1 0.1937
123 irradiation 4 0.7229
123 labeled 4 0.8074
123 least 1 0.1722
123 less 1 0.1254
123 leukocytes 1 0.3349
123 lymphocyte-like 1 0.3349
123 marrow 4 0.6708
123 marrow, 1 0.2293
123 migrated 1 0.282
123 migration 1 0.2243
123 minimum 1 0.2575
123 nonlabeled 1 0.3349
123 normal 3 0.2702
123 nucleated 2 0.5149
123 observed 2 0.2283
123 parenchyma 3 0.724
123 parenchymal 3 0.9046
123 per 1 0.1305
123 percent 1 0.2243
123 peripheral 1 0.199
123 presence 1 0.1276
123 present 1 0.1103
123 r 1 0.2197
123 rarely 1 0.2349
123 rat 1 0.1378
123 rats 1 0.1293
123 readily 1 0.2155
123 red 3 0.5969
123 relatively 1 0.1611
123 sinusoidal 1 0.282
123 sinusoids 1 0.3349
123 structure 1 0.1706
123 such, 1 0.3015
123 technique 1 0.1576
123 time, 1 0.1937
123 times, 1 0.2575
123 total 1 0.1305
123 transfused 2 0.4974
123 tritiated 1 0.2243
123 us 1 0.2197
123 used 1 0.1265
123 values 1 0.1691
123 vascular 1 0.1847
123 wall, 1 0.282
123 within 1 0.1243
123 x-rays, 1 0.3349
124 . 5 0.6785
124 22 1 0.4127
124 83.3 1 0.6029
124 added, 1 0.6029
124 animals 1 0.2563
124 arrest 1 0.4344
124 better 1 0.3487
124 brain 2 0.6142
124 circulatory 3 1.2686
124 conclusion 1 0.4037
124 conditions 1 0.2741
124 coronary 2 0.776
124 damage 1 0.3071
124 easily 1 0.388
124 evidence 1 0.221
124 factors 1 0.2549
124 fibrillation 1 0.4827
124 heart 1 0.2797
124 hyperbaric 2 0.9655
124 hypothermia 2 0.6198
124 leads 1 0.3362
124 limiting 1 0.4477
124 mild 1 0.3955
124 minutes 1 0.3955
124 mortality 2 0.7267
124 much 1 0.2671
124 occlusion 2 0.776
124 oxygen 1 0.3071
124 oxygenation 1 0.6029
124 percent 2 0.8073
124 perfusion 2 0.7065
124 rate 1 0.2219
124 reservoir 1 0.5076
124 resulted 1 0.2922
124 reversed 1 0.4477
124 survival 1 0.29
124 survivors 1 0.4344
124 thirty 1 0.5428
124 tolerates 1 0.5428
124 ventilation 1 0.4477
124 ventricular 1 0.2623
125 . 6 0.6785
125 28 2 0.6879
125 abolished 1 0.3296
125 although 1 0.1931
125 aortic 1 0.2683
125 appears 1 0.216
125 arteriolar 1 0.5024
125 baroceptor 1 0.5024
125 baroceptors, 1 0.5024
125 c. 2 0.5313
125 cardiovascular 1 0.3176
125 carotid 1 0.3296
125 circulatory 2 0.7048
125 clinical 1 0.1638
125 cooling 1 0.3028
125 critical 1 0.3364
125 degrees 2 0.6352
125 depressed, 1 0.5024
125 depression 2 0.7048
125 effect 1 0.1534
125 hemodynamic 1 0.3364
125 human 1 0.1677
125 hypothermia 2 0.5165
125 important 1 0.2269
125 include 1 0.2985
125 index 1 0.2985
125 integrity 1 0.5024
125 level 3 0.5821
125 limit 1 0.4023
125 may 1 0.1257
125 moderate 1 0.2985
125 occlusion 1 0.3233
125 phenomena 1 0.3524
125 physiological 1 0.2944
125 probably 1 0.2284
125 provide 1 0.2944
125 reactivity 1 0.3862
125 reflexes 2 1.0048
125 release 1 0.3233
125 represent 1 0.3176
125 result 1 0.2173
125 significantly 1 0.2112
125 sinus 1 0.362
125 sympathetic, 1 0.5024
125 tone, 1 0.5024
125 total 1 0.1958
125 totally 1 0.3524
125 use 1 0.1986
125 vasomotor 1 0.5024
125 vasomotor, 1 0.5024
125 venomotor 1 0.5024
126 . 12 0.6785
126 /deep 1 0.2512
126 /deep/ 1 0.2512
126 1. 1 0.1315
126 2. 1 0.1315
126 25 1 0.1434
126 3. 1 0.1355
126 30 1 0.1199
126 4. 1 0.1434
126 5. 1 0.1648
126 6 1 0.105
126 7. 1 0.2011
126 accentuated 1 0.2115
126 acid 2 0.194
126 acidosis 2 0.3731
126 alone 1 0.1514
126 animal 1 0.1537
126 appear 1 0.115
126 arrest 3 0.543
126 arteriovenous 1 0.2011
126 average 3 0.3381
126 basal 1 0.1648
126 blood 1 0.0776
126 body 7 0.7089
126 brought 1 0.1648
126 c 1 0.137
126 calculated 1 0.1682
126 circulatory 3 0.5286
126 cold 1 0.172
126 coldest 1 0.2512
126 combining 1 0.2115
126 continuing 1 0.2262
126 cooled 1 0.181
126 cooling 2 0.3028
126 cooling, 1 0.2115
126 core 3 0.5286
126 difference 2 0.2515
126 differentially 1 0.2262
126 diluents 1 0.2512
126 effect 2 0.1534
126 exceeds 1 0.2512
126 exchange 1 0.1682
126 external 1 0.1514
126 extracorporeal 1 0.1648
126 flow 1 0.128
126 flows 1 0.1931
126 gradients 1 0.2262
126 greater 1 0.1039
126 heat 1 0.1931
126 high 2 0.1798
126 hypothermia 5 0.6456
126 hypothermia, 1 0.1762
126 hypothermia/ 1 0.2512
126 impair 1 0.2262
126 important 1 0.1134
126 lactic 2 0.3524
126 large 1 0.0993
126 lead 1 0.1617
126 little 1 0.1342
126 low 1 0.11
126 may 3 0.1885
126 measure 1 0.1453
126 metabolic 1 0.1199
126 metabolism 1 0.119
126 minimized 1 0.2262
126 minutes 1 0.1648
126 much 1 0.1113
126 muscle 1 0.1385
126 normal 1 0.0676
126 obtainable 1 0.2011
126 occurs 1 0.1342
126 organs 2 0.277
126 perfusion 8 1.1776
126 periods 1 0.1401
126 portion 1 0.1762
126 produces 1 0.1588
126 production 1 0.128
126 profound 1 0.172
126 progressive 2 0.2801
126 prolonged 1 0.1208
126 proper 1 0.1682
126 proportion 1 0.1562
126 provides 1 0.1588
126 range, 1 0.2262
126 rate 1 0.0925
126 readily 1 0.1617
126 reasonable 1 0.2011
126 reference 1 0.1385
126 relatively 1 0.1208
126 remain 1 0.181
126 rise 1 0.1247
126 roughly 1 0.2512
126 since 1 0.1093
126 special 1 0.1328
126 studies 1 0.0769
126 temperature 3 0.4025
126 temperature, 1 0.1931
126 temperatures 3 0.4764
126 though 1 0.1472
126 thus 1 0.1303
126 tissue, 1 0.181
126 total 3 0.2937
126 true 1 0.1682
126 uniform 1 0.2262
126 warmest 1 0.2512
126 warming 1 0.2262
126 whereas 1 0.1258
126 within 1 0.0933
127 . 5 0.6785
127 also 1 0.1687
127 analyses 1 0.4037
127 analysis 2 0.58
127 analytical 1 0.4634
127 animal 1 0.3689
127 application 1 0.3401
127 applications 2 0.8954
127 body 1 0.2431
127 brief 1 0.4229
127 constituents 1 0.4634
127 descriptions 1 0.5076
127 discussion 1 0.3633
127 dusts 1 0.6029
127 emission 2 1.0856
127 environmental 1 0.4477
127 examples 1 0.4477
127 fluids 1 0.4634
127 fumes 1 0.6029
127 human 1 0.2012
127 hygiene 2 1.2058
127 include 1 0.3581
127 industrial 3 1.8087
127 laboratory 1 0.3487
127 made 1 0.2183
127 materials, 1 0.5428
127 metallic 1 0.5076
127 methods 2 0.5445
127 needs 1 0.4827
127 ores, 1 0.6029
127 preparation 1 0.388
127 presented 2 0.4678
127 principles 1 0.4127
127 problems 1 0.3127
127 process 1 0.2759
127 provided 1 0.3689
127 qualitative, 1 0.5428
127 quantitative 1 0.3188
127 representative 1 0.5428
127 required 1 0.3288
127 sample 1 0.4477
127 semiquantitative 1 0.6029
127 spectrograph 1 0.6029
127 spectrographic 1 0.6029
127 spectroscopy 1 0.6029
127 subjects, 1 0.4037
127 successful 1 0.4127
127 techniques 1 0.3288
127 tissues 1 0.2759
127 unique 1 0.388
128 (or 1 0.423
128 . 6 0.6785
128 0.001 1 0.5024
128 accuracy, 1 0.5024
128 adjustment, 1 0.4523
128 air 1 0.2801
128 alpha-furildioxime, 1 0.5024
128 also 1 0.1406
128 aqueous 1 0.362
128 associated 1 0.1784
128 carbonyl 4 1.6091
128 carbonyl.. 1 0.5024
128 chloroform 1 0.5024
128 co 1 0.362
128 collection 1 0.4023
128 color 1 0.3862
128 compared 1 0.1949
128 complex 1 0.2905
128 concentrations 1 0.2582
128 concentrations, 1 0.4523
128 considered 1 0.224
128 control 1 0.1889
128 design 1 0.4023
128 detailed 1 0.3176
128 detection 1 0.3123
128 development 2 0.3669
128 dilute 1 0.5024
128 exposures 1 0.4023
128 extraction 1 0.362
128 field 1 0.2985
128 formation 2 0.4509
128 formed 1 0.2801
128 gases 1 0.4523
128 greater 1 0.2078
128 hcl, 1 0.4523
128 intensity 1 0.3524
128 involves 1 0.362
128 liquid 1 0.423
128 maximum 1 0.277
128 may 1 0.1257
128 method 2 0.3992
128 nickel 6 1.7433
128 obtainable 1 0.4023
128 order 1 0.2631
128 ph 1 0.2711
128 potential 1 0.3296
128 ppm 1 0.3862
128 presented 1 0.1949
128 pressures 1 0.3296
128 process 1 0.2299
128 range 1 0.2711
128 recent 1 0.2631
128 recommendations 1 0.4523
128 sampling 1 0.4523
128 sensitive 1 0.2711
128 sensitivities 1 0.5024
128 show 1 0.2173
128 simple, 1 0.423
128 spectrophotometrically) 1 0.5024
128 standards 1 0.5024
128 temperatures 1 0.3176
128 thermodynamics 1 0.5024
128 visually 1 0.4523
128 wide 1 0.2985
129 . 4 0.6785
129 adequate 1 0.4685
129 air 2 0.8404
129 analysis 2 0.725
129 antimony, 1 0.7536
129 basis 1 0.3299
129 cadmium, 1 0.6346
129 choice 1 0.485
129 chromium, 1 0.6346
129 cobalt, 1 0.6785
129 commercial 1 0.6785
129 compared 1 0.2924
129 copper, 1 0.7536
129 determination 1 0.4611
129 determinations 1 0.543
129 found 1 0.1984
129 heavy 2 1.2691
129 lead 1 0.485
129 lead, 1 0.6785
129 made 1 0.2729
129 make 1 0.4477
129 manganese, 1 0.7536
129 may 1 0.1885
129 metals 2 1.2691
129 method 1 0.2994
129 nickel, 1 0.6034
129 others 1 0.411
129 polarograph 1 0.7536
129 polarographic 1 0.7536
129 polarographs 1 0.7536
129 possesses 1 0.6785
129 required 1 0.411
129 samples 1 0.4764
129 sensitivity 1 0.4542
129 specificity 1 0.543
129 two 1 0.2308
129 variety 1 0.4066
130 . 7 0.6785
130 also 1 0.1205
130 analysis 1 0.2071
130 applied 1 0.2595
130 bone 4 0.745
130 buccal 1 0.3877
130 ca, 1 0.331
130 calcium 1 0.2558
130 cl, 1 0.3877
130 compares 1 0.3877
130 composition 1 0.2523
130 consisted 1 0.2558
130 constituents 1 0.331
130 contained 2 0.4387
130 cortical 1 0.2771
130 crushed 1 0.4306
130 dentine 2 0.8613
130 eight 1 0.2459
130 eighteen 1 0.331
130 elemental 1 0.3877
130 elements, 1 0.4306
130 emission 2 0.7754
130 enamel 1 0.4306
130 enamel, 1 0.4306
130 examined 1 0.2175
130 favourably 1 0.4306
130 fe, 1 0.4306
130 fillings 1 0.4306
130 found 1 0.1134
130 four 1 0.1932
130 human 2 0.2875
130 inorganic 1 0.2948
130 k, 1 0.3626
130 main 1 0.2459
130 mandibular 1 0.4306
130 material 2 0.3995
130 material, 1 0.3448
130 methods 1 0.1945
130 needed 2 0.5896
130 ni 1 0.331
130 nineteen 1 0.3626
130 ones 1 0.3021
130 p, 1 0.3626
130 phosphorus 1 0.2825
130 pieces 1 0.3626
130 powder 1 0.3877
130 samples 1 0.2722
130 semi-quantitative 1 0.4306
130 separated 1 0.2825
130 spectrography 2 0.8613
130 sr 1 0.3877
130 study 1 0.1327
130 teeth 2 0.7754
130 teeth, 3 1.2919
130 time 1 0.1517
130 tooth 1 0.4306
130 whole 1 0.2401
130 x-ray 2 0.5649
130 zn, 1 0.4306
131 (complex) 1 0.4306
131 (complex)(edta) 1 0.4306
131 (edta) 1 0.3877
131 (h) 1 0.3877
131 + 1 0.3021
131 -10 1 0.3877
131 . 7 0.6785
131 10 2 0.3171
131 2.5 1 0.3198
131 = 1 0.3626
131 acid 4 0.6652
131 acid-catalyzed 1 0.4306
131 agrees 1 0.4306
131 amino 3 0.8167
131 basis 1 0.1885
131 characteristic 1 0.2175
131 complexes 7 2.4137
131 configuration 1 0.3448
131 containing 1 0.2277
131 contains 1 0.2635
131 coordination 2 0.8613
131 diethylenetriamine 1 0.4306
131 differences 1 0.1971
131 edta 1 0.3448
131 edta, 1 0.4306
131 edta-independent 1 0.4306
131 equilibrium 1 0.3021
131 ester) 1 0.4306
131 ether 1 0.3198
131 ether, 1 0.3877
131 ethers 1 0.4306
131 ethylenediaminetetraacetic 1 0.4306
131 exchange 2 0.5767
131 expression 3 0.9308
131 faster 1 0.3103
131 give 1 0.2348
131 groups 2 0.3508
131 is.. 1 0.4306
131 k 1 0.3103
131 k(complex) 1 0.4306
131 kedta 2 0.8613
131 kinetic 3 1.0878
131 kn 1 0.4306
131 ligand 3 1.2919
131 magnitude 1 0.2677
131 methyl 1 0.3877
131 mixed-ligand 1 0.4306
131 ni(cysteine) 3 1.2919
131 nickel(cysteine) 1 0.4306
131 nickel(ii), 1 0.4306
131 nickel-methionine 1 0.4306
131 octahedral 1 0.4306
131 order 1 0.2255
131 orders 1 0.3877
131 planar 3 1.1631
131 products 1 0.3021
131 rate 4 0.6341
131 reaction 3 0.6468
131 reactions 1 0.2104
131 reported 1 0.1745
131 results 1 0.1233
131 sec 2 0.7754
131 several 1 0.1863
131 similar 1 0.1612
131 spectral 1 0.4306
131 square 3 1.0878
131 striking 1 0.2722
131 studies 2 0.2638
131 study 2 0.2653
131 suggest 1 0.1958
131 sulfhydryl 2 0.7754
131 sulfur 3 1.2919
131 sulfur-containing 2 0.8613
131 support 1 0.2374
131 term 2 0.4802
131 thiol 3 1.1631
131 triethylenetetramine, 1 0.4306
131 two-term 1 0.4306
131 value 2 0.3968
131 written 1 0.4306
131 x 1 0.2722
132 (tmv-rna) 1 0.5024
132 . 6 0.6785
132 5.8 1 0.4523
132 6.5 1 0.4023
132 65 2 0.6879
132 8.5, 1 0.5024
132 absorbancy 1 0.5024
132 acid 3 0.5821
132 action 1 0.2186
132 activity 3 0.5394
132 added 1 0.3123
132 affecting 1 0.423
132 biological 3 0.805
132 bonds 1 0.4523
132 calcium 1 0.2985
132 catalyzed 1 0.5024
132 caused 2 0.4398
132 change 1 0.2331
132 due 1 0.1777
132 elements 1 0.3862
132 evidenced 1 0.3862
132 first-transition 1 0.5024
132 formed 1 0.2801
132 heated 1 0.5024
132 heating 1 0.3862
132 heavy 1 0.423
132 hydrolysis 2 0.9046
132 i'(3')- 1 0.5024
132 iib 1 0.4523
132 ions 5 1.8654
132 ions, 1 0.423
132 lead 1 0.3233
132 long 1 0.2606
132 loss 3 0.7306
132 magnesium 1 0.4023
132 metal 4 1.3758
132 mononucleotides,. 1 0.5024
132 mosaic 2 1.0048
132 nucleic 1 0.3296
132 nucleosides 1 0.5024
132 ph 3 0.8133
132 phosphodiester 1 0.5024
132 presence 1 0.1914
132 rapid 2 0.4871
132 reduction 1 0.2474
132 results 1 0.1439
132 ribonucleic 2 0.7048
132 rna 1 0.277
132 room 1 0.3862
132 secondary 3 0.7546
132 solutions 1 0.362
132 spite 1 0.3364
132 stabilization 1 0.423
132 stabilize 1 0.4523
132 standing, 1 0.5024
132 structure 2 0.5119
132 structure, 1 0.423
132 studied 1 0.175
132 temperature 1 0.2683
132 thus, 1 0.362
132 tmv-rna 1 0.5024
132 tobacco 2 1.0048
132 transition 1 0.3862
132 virus 2 0.5262
133 . 12 0.6785
133 10 1 0.0925
133 5 2 0.1906
133 700 1 0.2512
133 age 1 0.1039
133 appeared 1 0.1208
133 body 1 0.1013
133 cadmium 6 1.357
133 cadmium, 3 0.6346
133 carcinogenic,. 1 0.2512
133 chromium 4 0.8046
133 chromium, 2 0.423
133 comparable 1 0.1385
133 compared 4 0.3898
133 concentrations 2 0.2582
133 controls 3 0.4542
133 death 1 0.137
133 decreased 1 0.1134
133 deficient 1 0.1617
133 diet 1 0.1648
133 differences 1 0.115
133 drinking 1 0.181
133 effect 1 0.0767
133 except 1 0.1417
133 exhibited 1 0.1537
133 fed 1 0.1648
133 females 2 0.3524
133 given 2 0.1842
133 greater 1 0.1039
133 group, 2 0.3233
133 groups 1 0.1023
133 groups, 1 0.1682
133 higher 1 0.108
133 incidence 1 0.1199
133 increase 1 0.0853
133 increased 1 0.0781
133 increments 3 0.6785
133 innate 1 0.2011
133 large 1 0.0993
133 lead 5 0.8083
133 lead, 3 0.6785
133 less 1 0.094
133 lesser 1 0.172
133 levels 1 0.0984
133 lives 1 0.2262
133 longevity 1 0.2512
133 low 1 0.11
133 males 3 0.5159
133 man 1 0.1291
133 markedly 1 0.1342
133 metal 1 0.172
133 metals 3 0.6346
133 mice 2 0.2474
133 mice.. 1 0.2262
133 moderate 1 0.1492
133 mortality 2 0.3028
133 mortality, 1 0.2262
133 nickel 4 0.5811
133 nickel, 1 0.2011
133 observed 2 0.1713
133 occurred 1 0.1093
133 oldest 1 0.2115
133 one 1 0.0703
133 organs, 1 0.1865
133 ppm 1 0.1931
133 sex 1 0.1682
133 sexes 1 0.2262
133 signs 1 0.1401
133 throughout 1 0.1434
133 tissue 2 0.1744
133 tissues 1 0.115
133 titanium 4 1.0048
133 titanium, 2 0.5024
133 toxicity 1 0.1648
133 tumors 2 0.2631
133 unaffected 1 0.2011
133 water 1 0.1328
133 weights 1 0.1762
133 younger 1 0.1682
134 . 4 0.6785
134 a-tocopheryl 1 0.7536
134 acetate, 1 0.6346
134 also 1 0.2108
134 amounts 1 0.3742
134 antioxidants 3 2.0354
134 chicks 1 0.6034
134 combined 1 0.3874
134 compounds 1 0.543
134 death 1 0.411
134 deficiency 2 0.797
134 diet 1 0.4943
134 e 2 1.1586
134 effect 1 0.2301
134 effects 1 0.2798
134 either 1 0.3222
134 eliminated 1 0.5286
134 evidenced 1 0.5793
134 experimental 1 0.3496
134 exudates 1 0.7536
134 fed 1 0.4943
134 given 1 0.2763
134 hemorrhages 1 0.6785
134 high 1 0.2697
134 individually 1 0.6034
134 ineffective 1 0.5286
134 levels 1 0.2951
134 little 1 0.4025
134 mortality 2 0.9083
134 prevented, 1 0.7536
134 preventing 1 0.5793
134 relatively 1 0.3625
134 selenite 1 0.543
134 selenium 2 0.9083
134 several 1 0.326
134 signs 1 0.4202
134 subcutaneous 1 0.485
134 sudden 1 0.485
134 symptoms, 1 0.543
134 synergistic 1 0.6346
134 toxic, 1 0.7536
134 toxicity 1 0.4943
134 vitamin 2 0.9221
135 (particularly 1 0.3877
135 -dash 1 0.2948
135 . 7 0.6785
135 1.016, 1 0.4306
135 1.024 1 0.4306
135 analyses 1 0.2883
135 analysis 3 0.6214
135 apply 1 0.3626
135 around 1 0.2883
135 based 1 0.2255
135 certain 1 0.1896
135 concentration 2 0.3621
135 considerably 1 0.2771
135 correction 3 0.9062
135 discussed 1 0.1754
135 easiest 1 0.3877
135 effect 1 0.1315
135 employed 1 0.2722
135 essential 1 0.2523
135 exposure 1 0.2558
135 expressing 1 0.4306
135 expression 1 0.3103
135 extent 1 0.2277
135 figure 1 0.3626
135 found 1 0.1134
135 gravity 3 1.1631
135 implications 1 0.2771
135 indicated 1 0.2026
135 industry, 1 0.4306
135 lower 1 0.1958
135 many 1 0.1736
135 mean 2 0.4143
135 measuring 1 0.3448
135 observations 1 0.1811
135 obtainable 1 0.3448
135 persons 2 0.5445
135 resident 1 0.3626
135 results 3 0.37
135 shown 1 0.1852
135 specific 3 0.5083
135 specimen 1 0.3103
135 substances 1 0.3021
135 toxic 1 0.2635
135 types 1 0.2087
135 u.k. 1 0.4306
135 u.s.a.) 1 0.4306
135 urine 3 0.664
135 use 1 0.1702
135 used 1 0.1626
135 useful 1 0.2374
135 variations 1 0.2677
135 workers 1 0.3103
136 (cu 1 0.4306
136 (ec 1 0.4306
136 (fe 1 0.3877
136 . 7 0.6785
136 1,10- 1 0.4306
136 1,10-phenanthroline-treated 1 0.4306
136 1. 1 0.2255
136 1.99.1.14) 1 0.4306
136 2,9-dimethyl-1,10-phenanthroline 1 0.4306
136 2. 1 0.2255
136 3. 1 0.2324
136 4,7-diphenyl-1,10-phenanthroline 1 0.4306
136 activation 1 0.3198
136 activity 3 0.4623
136 agent, 1 0.3103
136 agents 3 0.6971
136 ammonium 1 0.3626
136 ase 1 0.4306
136 conditions 1 0.1958
136 dialysis, 1 0.4306
136 enzyme 4 1.0233
136 fe 2 0.8613
136 fractionation, 1 0.4306
136 hydroxyl- 1 0.4306
136 hydroxylase 2 0.8613
136 inactivated 1 0.3448
136 inactivation 1 0.2883
136 inactive 1 0.2948
136 indicating 1 0.2771
136 inhibit 1 0.2948
136 inhibited 1 0.2722
136 inhibited, 1 0.4306
136 involving 1 0.2771
136 materially 1 0.4306
136 metal-chelating 1 0.4306
136 nonoxidative 1 0.4306
136 oxidizing 1 0.4306
136 p-hydroxyphenylpyruvate 3 1.2919
136 phenanthroline 1 0.4306
136 presence 1 0.1641
136 purification 1 0.331
136 reactivated 2 0.8613
136 reagents 1 0.3877
136 reducing 2 0.6621
136 reversibly 1 0.3448
136 role 1 0.1998
136 sensitive) 1 0.4306
136 specific) 1 0.4306
136 specifically 1 0.3198
136 storage, 1 0.4306
136 strongly 1 0.2771
136 sulfate 1 0.3021
136 sulfhydryl 1 0.3877
136 treatment 1 0.1271
136 various 2 0.3405
137 (atcc 4 0.6029
137 . 9 0.3053
137 0.1 1 0.1357
137 1 1 0.0569
137 1. 1 0.0789
137 10 3 0.1665
137 10,000 2 0.3015
137 18x10 1 0.1507
137 2,000 1 0.1269
137 2. 1 0.0789
137 20 1 0.0681
137 3,200 1 0.1507
137 3. 1 0.0813
137 4. 1 0.0861
137 558) 4 0.6029
137 6. 1 0.1057
137 7.8 1 0.1507
137 among 1 0.0704
137 author 1 0.0883
137 b. 4 0.3362
137 becomes 2 0.1817
137 cell 3 0.153
137 cell, 1 0.1159
137 cells 4 0.182
137 chose 1 0.1507
137 concentration 6 0.3802
137 concentration, 1 0.1269
137 decline 1 0.1057
137 declines 2 0.2538
137 dependent 5 0.485
137 detail 1 0.1159
137 divide 1 0.1269
137 elongates 1 0.1507
137 entirely 1 0.097
137 experiments 1 0.0668
137 extremely 1 0.1057
137 filamentous 2 0.2714
137 follows 1 0.097
137 form 1 0.0656
137 formation 1 0.0676
137 formed 1 0.084
137 forms 3 0.2159
137 found 1 0.0397
137 germinated 1 0.1507
137 germination 4 0.6029
137 get 1 0.1357
137 grow 2 0.2714
137 grows 1 0.1507
137 growth 7 0.3596
137 influence 1 0.069
137 irregular 1 0.1119
137 l, 2 0.2714
137 length 1 0.0989
137 low 2 0.1319
137 made 1 0.0546
137 much 1 0.0668
137 mutant 1 0.1086
137 nearly 1 0.0922
137 normal 4 0.1621
137 observe 1 0.1159
137 one 1 0.0422
137 outgrowth 3 0.4522
137 r/m 2 0.3015
137 r/ml 3 0.4522
137 r/ml, 4 0.6029
137 r/ml-20 2 0.3015
137 r/ml-sm 1 0.1507
137 rapidly 2 0.1721
137 reaches 1 0.1207
137 reference 1 0.0831
137 relation 1 0.0694
137 resistant 2 0.1844
137 responses 2 0.1681
137 results 1 0.0432
137 several 2 0.1304
137 shape 1 0.097
137 shows 2 0.1662
137 slow 1 0.0989
137 slower, 1 0.1507
137 sm 20 3.0145
137 special 1 0.0797
137 spore 1 0.1507
137 spores 3 0.4071
137 stop 1 0.1269
137 stopped 1 0.1159
137 stops 1 0.1269
137 streptomycin 2 0.2714
137 streptomycin, 1 0.1507
137 substilis 1 0.1507
137 subtilis 3 0.2493
137 ten 1 0.0908
137 times 1 0.0725
137 times, 1 0.1159
137 together 1 0.0861
137 type 5 0.3134
137 type, 1 0.1009
137 well 1 0.0527
137 wild 1 0.1357
137 worth 1 0.1357
138 . 4 0.6785
138 16..0, 1 0.7536
138 18..1, 1 0.7536
138 24..1 1 0.7536
138 acid 1 0.291
138 also 1 0.2108
138 around 1 0.5046
138 bovine, 2 1.5073
138 but, 1 0.6346
138 centering 1 0.7536
138 cephalin 1 0.6346
138 component 1 0.485
138 composition 1 0.4416
138 contain 1 0.485
138 differences 1 0.3449
138 differs 2 1.0318
138 distribution 1 0.3874
138 evidence 1 0.2763
138 fatty 1 0.3773
138 human 2 0.5031
138 lecithin, 1 0.6785
138 lens 1 0.3571
138 lens, 1 0.6034
138 lenses 1 0.4685
138 may 1 0.1885
138 minor 1 0.485
138 phospholipid 2 1.0572
138 phospholipids 2 1.2069
138 plasmalogen 1 0.7536
138 rabbit, 2 1.2069
138 represents 1 0.5159
138 so, 1 0.6785
138 species 1 0.411
138 species, 1 0.5596
138 sphingomyelin 1 0.6034
138 suggestive 1 0.5596
139 . 6 0.6785
139 aspects 1 0.2834
139 blood 1 0.1552
139 cardiac 1 0.2254
139 carefully 1 0.362
139 damage 1 0.2559
139 develops 1 0.4523
139 disability 1 0.3862
139 disease 2 0.361
139 dominant 1 0.3439
139 especially 1 0.2582
139 expanded 1 0.4523
139 experience 1 0.2582
139 feasible 1 0.4023
139 fetus 1 0.3524
139 first 1 0.1842
139 flow 1 0.2559
139 heart 2 0.4661
139 ideal 1 0.423
139 indicated 1 0.2364
139 lesion 1 0.2834
139 lesions 1 0.216
139 management 1 0.2657
139 may 1 0.1257
139 measured 1 0.2199
139 medical, 1 0.4523
139 mitral 2 0.6728
139 must 1 0.2454
139 operative 1 0.2801
139 oxygenator 1 0.4023
139 perfusion, 1 0.4023
139 placental 1 0.3439
139 pregnancy 2 0.5888
139 pregnant 1 0.3028
139 present, 1 0.3296
139 procedure 1 0.2559
139 progressive 1 0.2801
139 proven 1 0.423
139 pump 1 0.3731
139 reduced 1 0.2269
139 requiring 1 0.362
139 result 1 0.2173
139 risk 1 0.3364
139 second 1 0.2559
139 stenosis 1 0.3176
139 surgical 1 0.2269
139 trimester 1 0.423
139 valvulotomy 1 0.5024
139 woman 1 0.3296
140 . 6 0.6785
140 appearance 1 0.2494
140 bitemporal 2 0.7462
140 case 1 0.1805
140 cases 1 0.1495
140 chiasm 1 0.4523
140 chiasma.. 1 0.5024
140 complete 1 0.2331
140 consistent 1 0.2801
140 crossed 1 0.5024
140 defect 1 0.2474
140 discussed 1 0.2046
140 disintegrated 1 0.5024
140 explain 1 0.3364
140 fibres 1 0.423
140 field 1 0.2985
140 four 2 0.4509
140 head 1 0.3296
140 hemianopia 1 0.3233
140 histories 1 0.3731
140 lesions 1 0.216
140 markedly 1 0.2683
140 median 1 0.4023
140 minute 1 0.3731
140 multiple 1 0.277
140 one 1 0.1406
140 optic 2 0.6879
140 patient 1 0.1889
140 patients 1 0.1208
140 plane 1 0.423
140 presented 1 0.1949
140 report 1 0.2435
140 resulting 1 0.2559
140 sagittal 1 0.4023
140 severe 1 0.2226
140 suffered 1 0.3439
140 swollen 1 0.4523
140 tears 1 0.4523
140 theories 1 0.3524
140 trauma 1 0.3862
140 traumatic 1 0.3524
140 visualized 1 0.5024
141 (a) 1 0.6466
141 (b) 1 0.6466
141 (c) 1 0.7048
141 . 3 0.6785
141 approach 1 0.6246
141 cancer 1 0.3972
141 cancer,. 1 1.0048
141 cancer.. 1 0.9046
141 changes 1 0.3007
141 cigarettes 1 0.9046
141 contrast 1 0.6728
141 controlling 1 0.8461
141 defined.. 1 1.0048
141 environmental 1 0.7462
141 evolutionary 1 1.0048
141 example 1 0.8046
141 following 1 0.3331
141 found 1 0.2645
141 growth 1 0.3425
141 lung 2 0.8642
141 lungs 1 0.548
141 major 1 0.4833
141 mechanism,. 1 1.0048
141 mutant 1 0.724
141 mutation 2 1.5448
141 patients 1 0.2415
141 presented 1 0.3898
141 previous 1 0.5422
141 select 1 0.9046
141 smoke 1 1.0048
141 somatic 1 0.7724
141 theories 1 0.7048
142 . 12 0.6785
142 0.03 1 0.2262
142 10-b, 1 0.2512
142 5-ul 1 0.2512
142 8.6, 1 0.2512
142 aberrant 1 0.1865
142 activity 1 0.0899
142 addition 1 0.128
142 addition, 2 0.2905
142 adult 1 0.1142
142 amido 1 0.2512
142 anesthetized 1 0.2011
142 anode 1 0.2512
142 anode, 1 0.2512
142 appeared 1 0.1208
142 area 1 0.1303
142 areas 2 0.2657
142 bands 2 0.4023
142 black 1 0.2512
142 blocks 1 0.1931
142 borate 1 0.2512
142 buffer 1 0.1931
142 case 1 0.0903
142 cathode 1 0.2512
142 centered 1 0.2115
142 centers 1 0.1762
142 considerations 1 0.172
142 containing 1 0.1328
142 data 1 0.1023
142 day 1 0.1247
142 destroyed 1 0.1682
142 diemyctylus 1 0.2512
142 discussed 1 0.1023
142 distinct 1 0.1562
142 double 1 0.1648
142 effect 1 0.0767
142 effects 1 0.0933
142 either 1 0.1074
142 electrophoresis 1 0.1865
142 electrophoretically 1 0.2512
142 experiments, 1 0.2262
142 eyes 3 0.5596
142 five 1 0.1328
142 following 1 0.0833
142 freshly 1 0.2512
142 gel 1 0.1453
142 homogenate 1 0.2115
142 homogenates 2 0.3731
142 induced 1 0.1068
142 inhibited 1 0.1588
142 injected 2 0.2435
142 injection 1 0.105
142 lens 4 0.4762
142 lenses 4 0.6246
142 lentectomized 1 0.2262
142 lentectomy 1 0.2512
142 macerated 1 0.2512
142 markedly, 1 0.2512
142 material 1 0.1165
142 millimeter 2 0.5024
142 moiety 1 0.2512
142 moved 2 0.5024
142 negative 2 0.2944
142 newts, 1 0.2262
142 one 1 0.0703
142 opposed 1 0.2115
142 period 1 0.0953
142 ph 1 0.1355
142 placed 1 0.1492
142 plain 1 0.2115
142 plugs 3 0.6785
142 polarity 2 0.5024
142 positive 1 0.1342
142 present 1 0.0827
142 protein 2 0.2284
142 proteinase 1 0.2262
142 proteinasedigested 1 0.2512
142 proteins 2 0.2606
142 regeneration 4 0.724
142 removed 2 0.2834
142 represented 1 0.2011
142 samples 1 0.1588
142 separated 2 0.3296
142 seven 1 0.1434
142 seventh 1 0.2512
142 significant 1 0.0882
142 six 1 0.1385
142 smear 1 0.2512
142 staining 2 0.3364
142 starch 1 0.1931
142 stimulated 1 0.1682
142 stimulatory 1 0.2011
142 strongly 1 0.1617
142 study, 1 0.1617
142 tenths 1 0.2512
142 theoretical 1 0.2115
142 three 3 0.2834
142 times 1 0.1208
142 toward 3 0.485
142 upon 1 0.1127
142 viridescens 1 0.2115
142 weakly 2 0.4523
143 (schildkraut, 1 0.3349
143 + 1 0.2349
143 . 6 0.4524
143 1964) 1 0.3015
143 acid 1 0.1293
143 activity 1 0.1199
143 activity, 1 0.2413
143 analysis, 1 0.3015
143 appearance 1 0.1663
143 appearance, 1 0.3015
143 attached 1 0.2487
143 branched 1 0.3349
143 coli 1 0.3015
143 covalently 2 0.6699
143 cscl 1 0.3349
143 degraded 1 0.282
143 denaturability 1 0.3349
143 density-gradient 1 0.3349
143 deoxyribonucleic 1 0.2349
143 digestion 1 0.2682
143 dna 9 1.4391
143 dna, 1 0.2197
143 double-stranded 1 0.3349
143 electron 1 0.1691
143 enzymic 1 0.282
143 escherichia 1 0.3349
143 exonuclease 1 0.3349
143 faster 1 0.2413
143 follows 1 0.2155
143 fully 2 0.4974
143 genetic 2 0.3508
143 iii, 1 0.2575
143 judged 1 0.2413
143 kornberg, 1 0.3349
143 lack 1 0.1937
143 limited 1 0.1827
143 linked 1 0.2349
143 micrographs, 1 0.3349
143 native 3 0.7462
143 native, 1 0.3349
143 newly 1 0.2243
143 nondenaturability, 1 0.3349
143 observed 1 0.1142
143 obtained 1 0.1194
143 original 1 0.1913
143 partially 3 0.6246
143 phase 1 0.1789
143 polymerase 3 0.9046
143 prepared 1 0.2019
143 primer 4 1.3398
143 produces 1 0.2117
143 product 1 0.2487
143 rate 1 0.1233
143 repair 3 0.6728
143 repaired 1 0.2682
143 resembles 1 0.2487
143 resembles, 1 0.3349
143 restored 1 0.2349
143 richardson 1 0.3349
143 seen 1 0.1416
143 single-stranded 2 0.6031
143 strand 1 0.3015
143 structure 2 0.3412
143 synthesis 3 0.4989
143 synthesized 1 0.282
143 system 1 0.1565
143 templates 1 0.3015
143 xviii. 1 0.3349
144 ( 1 0.2115
144 . 9 0.5089
144 aggregation 1 0.2115
144 allowed 1 0.1762
144 analysis 1 0.1208
144 appearing 1 0.1865
144 association 1 0.1355
144 b. 1 0.1401
144 bacillus 3 0.4303
144 bacteria 2 0.3233
144 cells 1 0.0758
144 centrifuged 1 0.2512
144 cereus 1 0.2512
144 cesium 1 0.2262
144 chloride 1 0.181
144 collected 1 0.181
144 competent 2 0.362
144 concluded 2 0.2299
144 contribution 1 0.181
144 corresponding 1 0.1472
144 degradation 1 0.2011
144 density 1 0.1648
144 detected, 1 0.2115
144 differentiation 1 0.1434
144 dna 12 1.4391
144 dna, 1 0.1648
144 donor 3 0.5286
144 drop 1 0.1931
144 effected 1 0.2115
144 employing 1 0.2115
144 equilibrium 1 0.1762
144 evidence 1 0.0921
144 fate 1 0.1865
144 fractions 1 0.1342
144 genetic 3 0.3946
144 genetically 1 0.2011
144 homologous 1 0.172
144 incorporate 1 0.2512
144 incorporation 1 0.1588
144 inert 1 0.2262
144 input 1 0.2262
144 intracellularly 1 0.2512
144 isolated 1 0.1093
144 isotopes 1 0.2115
144 labeled 1 0.1514
144 material 2 0.2331
144 mechanism 1 0.1157
144 metabolic 1 0.1199
144 molecular 1 0.1492
144 n 3 0.6785
144 non-specific 1 0.1931
144 normal 1 0.0676
144 observed 1 0.0856
144 occur 1 0.1227
144 occurs 1 0.1342
144 origin 1 0.1434
144 p 2 0.3731
144 p)dna 1 0.2512
144 p-labeled 1 0.2512
144 physical 2 0.2905
144 presence 1 0.0957
144 processes 1 0.1492
144 radioactivity 2 0.362
144 recipient 5 0.841
144 recombination 2 0.3862
144 region 1 0.1682
144 resident 2 0.423
144 result 2 0.2173
144 showed 1 0.0895
144 since 1 0.1093
144 single-stranded 1 0.2262
144 studied 1 0.0875
144 subsequent 1 0.137
144 substituted 1 0.2512
144 subtilis 3 0.4155
144 transformed 1 0.1931
144 transforming 5 0.8598
144 unlabeled 1 0.2262
145 . 4 0.6785
145 11.6 1 0.7536
145 active 1 0.3472
145 activities 1 0.4358
145 auxotrophs 1 0.6785
145 average 1 0.3381
145 bacillus 1 0.4303
145 biological 1 0.4025
145 biologically 1 0.5596
145 chemical 1 0.4542
145 composition, 1 0.7536
145 described, 1 0.6034
145 dna 3 1.0793
145 fractionate 1 0.7536
145 heterogeneous, 1 0.7536
145 higher 1 0.3241
145 judged 1 0.543
145 method 1 0.2994
145 million 1 0.6346
145 molecular 1 0.4477
145 molecules 1 0.5286
145 physical 1 0.4358
145 prepared 1 0.4542
145 properties 2 0.805
145 pyenographic 1 0.7536
145 respective 1 0.6034
145 show 1 0.326
145 specific 1 0.2965
145 studies 1 0.2308
145 subtilis 1 0.4155
145 thermo-spectral 1 0.7536
145 transforming 3 1.5477
145 used 1 0.2846
145 weight 1 0.3546
146 . 6 0.6785
146 1/3 1 0.4523
146 acid 2 0.388
146 acid, 1 0.3233
146 acid,. 1 0.5024
146 agent 1 0.2944
146 agents, 1 0.3731
146 arrhenius 1 0.5024
146 bacillus 1 0.2869
146 bacteriophage 1 0.3731
146 comparison 1 0.2606
146 contrast, 1 0.3862
146 denaturated 1 0.5024
146 denatured 1 0.4523
146 differed 1 0.3439
146 different 1 0.1777
146 dna 3 0.7196
146 dna, 1 0.3296
146 even 1 0.2199
146 exposure 1 0.2985
146 frequency 1 0.2631
146 frequent 1 0.3028
146 gave 1 0.3176
146 genetic 1 0.2631
146 greatly 1 0.2985
146 histidine, 1 0.4523
146 hits 1 0.5024
146 hits, 1 0.5024
146 hydroxylamine 2 1.0048
146 inactivation 3 1.0091
146 increased 1 0.1562
146 independent 1 0.3028
146 induced 1 0.2136
146 intermediate 1 0.3233
146 interrupted 1 0.423
146 interrupting 1 0.5024
146 latter 1 0.2606
146 lethal 1 0.423
146 linear 1 0.3233
146 linearly 1 0.4523
146 linkage 1 0.4523
146 logarithm 1 0.5024
146 low 4 0.8796
146 measured 1 0.2199
146 mutagens 1 0.5024
146 mutants 1 0.3862
146 mutation 4 1.5448
146 native 1 0.3731
146 nitrous 4 1.8093
146 obtained 1 0.1791
146 ph 3 0.8133
146 ph, 1 0.3731
146 phage 1 0.3233
146 phages 1 0.3862
146 plot 2 1.0048
146 rates 4 1.2111
146 remained 1 0.2869
146 showed 1 0.1791
146 slope 1 0.3862
146 slopes 1 0.423
146 state 1 0.2582
146 subtilis 1 0.277
146 survival 1 0.2417
146 t4 2 1.0048
146 temperature 1 0.2683
146 temperatures 1 0.3176
146 three 1 0.1889
146 time 1 0.177
146 transforming 2 0.6879
146 treated 2 0.4135
146 treatment 2 0.2965
146 tryptophan 1 0.5024
146 unaltered 1 0.4523
146 various 1 0.1986
146 whereas 1 0.2515
147 . 5 0.6785
147 autolysis 1 0.5428
147 autolytic 1 0.5428
147 bacillus 2 0.6886
147 carbon 1 0.4037
147 caused 1 0.2639
147 cell 1 0.204
147 cells 3 0.5459
147 completely 1 0.3533
147 consumed 1 0.6029
147 cultures 1 0.3018
147 damage 1 0.3071
147 depletion 1 0.3955
147 died 1 0.3533
147 e.g. 1 0.5076
147 enzymes 2 0.7622
147 excreted 1 0.3748
147 glucose 2 0.6314
147 glucose, 1 0.4634
147 immediately 1 0.3689
147 lyse 1 0.5428
147 lysis 1 0.6029
147 material 1 0.2797
147 medium 1 0.322
147 medium, 1 0.4827
147 minimal 1 0.3748
147 observed 1 0.2055
147 presence 2 0.4594
147 rapid 1 0.2922
147 repaired 1 0.4827
147 results 1 0.1727
147 soon 1 0.4477
147 source, 1 0.5076
147 subtilis 2 0.6648
147 suggest 1 0.2741
147 ultraviolet-absorbing 1 0.6029
147 wall 1 0.3811
148 (1) 1 0.1624
148 (17-ohcs) 1 0.3015
148 (2) 1 0.1624
148 (3) 1 0.1771
148 (4) 1 0.1937
148 (5) 1 0.2197
148 (6) 1 0.2413
148 . 9 0.6785
148 11-deoxy- 1 0.3349
148 17- 1 0.282
148 17-hydroxycorticosteroids 2 0.6031
148 17-ohcs 3 0.9046
148 17-oxosteroid 1 0.3349
148 17-oxosteroids 4 1.3398
148 advanced 4 0.695
148 amounts 1 0.1663
148 breast 4 0.7084
148 cancer 4 0.5296
148 cancer, 1 0.2117
148 correlated 1 0.199
148 correlation 2 0.3383
148 different 1 0.1185
148 discussed 1 0.1364
148 disease 3 0.361
148 early 3 0.3684
148 findings 1 0.1331
148 found 3 0.2645
148 greater 1 0.1386
148 groups 1 0.1364
148 increased 1 0.1041
148 level 3 0.388
148 levels 1 0.1312
148 mean 2 0.3222
148 measured 1 0.1466
148 metastatic 1 0.2155
148 normal 6 0.5404
148 oxosteroids 1 0.3349
148 patients 6 0.4831
148 physiological 1 0.1963
148 plasma 7 0.9452
148 raised 1 0.199
148 significance 1 0.1827
148 significant 1 0.1176
148 significantly 3 0.4225
148 stages 1 0.1847
148 urinary 1 0.1484
148 urine 1 0.1722
148 variance 2 0.5641
148 women 3 0.5422
148 women, 1 0.2487
149 (3-5 1 0.4306
149 (ca. 1 0.3877
149 . 7 0.6785
149 20 2 0.389
149 31/2 1 0.3877
149 breast 2 0.4554
149 cancer.. 1 0.3877
149 carcinoma 1 0.2056
149 case 1 0.1547
149 cases 1 0.1281
149 changes 1 0.1289
149 clinical 4 0.5615
149 consisted 1 0.2558
149 correlation 1 0.2175
149 degree 1 0.1908
149 des 2 0.6206
149 des, 1 0.4306
149 diethylstilboestrol, 1 0.4306
149 difficulties 1 0.3198
149 dose 1 0.2056
149 emphasised 1 0.3877
149 environment 1 0.2883
149 every 1 0.2401
149 except 1 0.2429
149 exception 1 0.2825
149 exhibited 1 0.2635
149 following 1 0.1427
149 found, 1 0.3021
149 gonadotrophin 4 1.7226
149 gonadotrophins 1 0.4306
149 good 1 0.2401
149 group 2 0.3184
149 hormonal 1 0.3198
149 hormone 3 0.5262
149 however, 1 0.156
149 importance 1 0.2194
149 independent 1 0.2595
149 indicative 1 0.331
149 initially 1 0.2825
149 level 1 0.1663
149 levels 1 0.1686
149 low 2 0.377
149 lower 1 0.1958
149 maintained 1 0.2401
149 menopausal 1 0.3877
149 metastatic 2 0.5543
149 mg/d) 1 0.4306
149 mg/d), 1 0.4306
149 mg/d, 1 0.4306
149 months 1 0.2175
149 necessarily 1 0.2948
149 not, 1 0.2883
149 objective 2 0.5649
149 output 4 1.0093
149 patient 1 0.1619
149 patients 1 0.1035
149 period 2 0.3267
149 periods 1 0.2401
149 post 1 0.3021
149 pre-treatment 1 0.4306
149 rather 1 0.2026
149 receiving 1 0.2374
149 recovery 1 0.2374
149 regression 1 0.2771
149 relating 1 0.3198
149 remained 1 0.2459
149 remission 2 0.6621
149 remissions 1 0.3198
149 response 4 0.6289
149 rule 1 0.331
149 seven 1 0.2459
149 several 1 0.1863
149 showed 1 0.1535
149 showing 1 0.2825
149 site 1 0.249
149 small 1 0.1728
149 specificity 1 0.3103
149 studied 1 0.15
149 study 1 0.1327
149 suppression 1 0.2771
149 therapy 1 0.1702
149 therapy, 3 0.8314
149 throughout 1 0.2459
149 total 1 0.1678
149 treatment 1 0.1271
149 undergoing 1 0.2722
149 underlines 1 0.4306
149 urinary 4 0.7632
149 varying 1 0.2324
149 whole 1 0.2401
149 withdrawal 1 0.3103
149 women 1 0.2324
149 years 1 0.1958
150 (1955) 1 0.3015
150 (1961) 1 0.2714
150 + 1 0.2114
150 . 10 0.6785
150 .016 1 0.3015
150 .06 1 0.3015
150 .11 1 0.3015
150 1. 1 0.1579
150 11.8 1 0.3015
150 15.5 1 0.3015
150 17 1 0.1791
150 18 1 0.1644
150 2. 1 0.1579
150 20 1 0.1361
150 29.5 1 0.3015
150 3. 1 0.1627
150 38, 1 0.3015
150 4. 1 0.1721
150 5.5 1 0.2714
150 8 1 0.1361
150 adrenalectomized 3 0.7241
150 affect 1 0.1906
150 affected 1 0.1564
150 age 1 0.1247
150 al. 1 0.2172
150 androgens 2 0.5428
150 androsterone 3 0.7615
150 androsterone, 1 0.3015
150 average 1 0.1353
150 baseline 2 0.5428
150 conjugated 7 2.1102
150 conjugates 1 0.3015
150 could 1 0.1083
150 demonstrated 1 0.1289
150 detectable 1 0.1906
150 determined 1 0.137
150 dexamethasone 2 0.5076
150 dhea 3 0.9044
150 disorders, 1 0.2172
150 effect 1 0.092
150 essentially 1 0.2064
150 et 1 0.2018
150 females 2 0.4229
150 females, 1 0.2714
150 finkelstein 1 0.3015
150 genito-urinary 1 0.3015
150 group 1 0.1114
150 hcg 1 0.3015
150 hirsute 1 0.3015
150 however, 1 0.1092
150 i. 1 0.1791
150 levels 1 0.118
150 low 1 0.1319
150 mean 1 0.145
150 measured 1 0.1319
150 method 2 0.2395
150 migeon 1 0.3015
150 ml 4 0.9655
150 modified 1 0.2172
150 non- 1 0.2172
150 non-hirsute 3 0.9044
150 normal 3 0.2432
150 normals 1 0.2317
150 oophorectomized 3 0.9044
150 patients 5 0.3623
150 pattern 1 0.1439
150 plager 1 0.3015
150 plasma 2 0.2431
150 range 1 0.1627
150 response 1 0.1101
150 seem 1 0.1644
150 seen 1 0.1274
150 showed 1 0.1075
150 significant 1 0.1058
150 significantly, 1 0.3015
150 testosterone 2 0.4344
150 testosterone, 2 0.6029
150 ug/100 4 1.2058
150 values 2 0.3044
150 varied 1 0.1906
150 women 2 0.3253
151 (32 1 0.3015
151 . 10 0.6785
151 17- 1 0.2538
151 4 1 0.1066
151 5 1 0.1143
151 50 1 0.1439
151 55 1 0.2414
151 56 1 0.2538
151 91 1 0.2714
151 adequate 2 0.3748
151 administered 1 0.1439
151 adrenal 1 0.1791
151 age 2 0.2494
151 age, 1 0.1977
151 also 1 0.0843
151 alternative 1 0.2114
151 amounts 1 0.1497
151 breast 5 0.797
151 cancer 5 0.5959
151 caused 1 0.1319
151 combined 2 0.3099
151 compensatory 1 0.1681
151 corresponding 1 0.1766
151 cortisone 6 1.4482
151 day 1 0.1497
151 decrease 1 0.1379
151 depletion 1 0.1977
151 depressed 1 0.2317
151 discontinued 1 0.2714
151 disease 1 0.1083
151 disseminating 1 0.2714
151 dosage 1 0.1817
151 dose, 1 0.2414
151 eliminate 1 0.2414
151 eliminating 1 0.2538
151 estimated 1 0.1874
151 excreted 1 0.1874
151 excreting 1 0.2714
151 excretion 5 0.7091
151 extensive 1 0.1701
151 followed 1 0.1379
151 given 1 0.1105
151 h 1 0.2317
151 healthy 2 0.4344
151 hydroxycorticosteroids 1 0.3015
151 increase, 1 0.2538
151 increased 1 0.0937
151 irrespective 1 0.2064
151 larger 1 0.1791
151 level 2 0.2328
151 long 1 0.1564
151 metastasising 1 0.2714
151 method 1 0.1197
151 mg 1 0.1791
151 month 1 0.2018
151 number 1 0.1154
151 oestradiol-17b 1 0.3015
151 oestradiol-17b, 1 0.3015
151 oestriol 1 0.3015
151 oestriol, 1 0.3015
151 oestrogen 6 1.6283
151 oestrogens 1 0.2714
151 oestrone 1 0.2538
151 oestrone, 1 0.2538
151 offer 1 0.194
151 oophorectomy 5 1.5073
151 origin 1 0.1721
151 output 2 0.3533
151 particularly 1 0.1662
151 patient 1 0.1133
151 patients 5 0.3623
151 patients, 1 0.1509
151 per 1 0.1175
151 porcedures 1 0.3015
151 possibly 1 0.1874
151 postmenopausal 4 0.8457
151 pre- 1 0.194
151 premenopausal 3 0.7615
151 production 2 0.3071
151 quantities 1 0.2114
151 quite 1 0.1721
151 rapidly 2 0.3443
151 reduced 1 0.1361
151 rise 1 0.1497
151 secondary 1 0.1509
151 seems 1 0.1594
151 significant 1 0.1058
151 significantly 1 0.1267
151 similar 1 0.1129
151 stages 1 0.1662
151 still 1 0.1408
151 studied 1 0.105
151 subjects 1 0.1439
151 subjects) 1 0.3015
151 surgical 1 0.1361
151 therapy 1 0.1192
151 transient 1 0.2064
151 treatment 4 0.3558
151 tumours 1 0.1906
151 ug/24 1 0.3015
151 unchanged 1 0.2317
151 undertaken 1 0.2414
151 urinary 1 0.1336
151 various 1 0.1192
151 whether 1 0.1497
151 within 1 0.1119
151 women 3 0.488
152 . 8 0.6785
152 6c3hed 2 0.7536
152 absorption 1 0.2342
152 additional 1 0.2012
152 also 1 0.1054
152 another 1 0.2055
152 anti 4 1.5073
152 antibodies 3 0.6377
152 antibody 1 0.2305
152 antigens 2 0.4358
152 antiserum 2 0.5046
152 appears 1 0.162
152 bp8. 1 0.3768
152 c3h/go 1 0.3768
152 c3h/he 3 1.1304
152 c3h/st 3 1.1304
152 carcinoma 1 0.1799
152 cells 2 0.2274
152 cells. 1 0.168
152 complex 1 0.2179
152 contains 2 0.4611
152 cytotoxic 1 0.2643
152 cytotoxin 1 0.3768
152 cytotoxins 2 0.7536
152 different 1 0.1333
152 directed 1 0.2523
152 even 1 0.1649
152 h-5a 1 0.3768
152 h-6a 1 0.3768
152 hemagglutinating 1 0.3768
152 hemagglutinin 1 0.3392
152 immunization 1 0.3017
152 inbred 1 0.3017
152 isoantigens 1 0.3392
152 least 1 0.1937
152 long 1 0.1955
152 lymphosarcoma 1 0.3392
152 many 1 0.1519
152 may 1 0.0942
152 mc1m 2 0.7536
152 mixture 1 0.2798
152 mouse 1 0.2101
152 one 1 0.1054
152 present 2 0.2481
152 previously 1 0.1813
152 produced 1 0.1535
152 production 1 0.1919
152 properties 1 0.2012
152 reacting 1 0.3173
152 reactions 1 0.1841
152 reacts 1 0.3392
152 reciprocal 1 0.3392
152 red 2 0.4477
152 removed 1 0.2126
152 result 1 0.163
152 sarcoma 1 0.258
152 significance 1 0.2055
152 specific 1 0.1483
152 specificities 1 0.3768
152 strain 1 0.1992
152 sublines 1 0.3017
152 tissue 1 0.1308
152 tissues 2 0.3449
152 transplanted 1 0.2715
152 tumor 1 0.168
152 two 2 0.2308
152 unknown 1 0.2798
152 unrelated 1 0.2643
152 v 1 0.3768
152 variety 2 0.4066
153 (15 1 0.6034
153 (l-phenylalanine 1 0.7536
153 . 4 0.6785
153 2 1 0.2301
153 24 1 0.3909
153 4 1 0.2666
153 7 1 0.3472
153 a-strain 1 0.7536
153 action 2 0.6558
153 administered 1 0.3598
153 adult 2 0.6851
153 also 1 0.2108
153 body 1 0.3038
153 carcinoma 1 0.3598
153 cba-p 1 0.7536
153 challenged 1 0.6785
153 combined 1 0.3874
153 days, 1 0.4943
153 discussed 1 0.3069
153 dose 1 0.3598
153 doses 1 0.411
153 findings 1 0.2994
153 found 1 0.1984
153 given 1 0.2763
153 hours 1 0.3625
153 immunosuppressive 2 1.2069
153 ineffective 1 0.5286
153 injection 1 0.3151
153 mammary 1 0.485
153 means 2 0.6678
153 melphalan 3 2.2609
153 melphalan, 1 0.7536
153 mg/kg 1 0.6034
153 mice 2 0.7423
153 multiple 1 0.4155
153 mustard) 1 0.7536
153 performed 1 0.3449
153 potentiating 2 1.5073
153 prior 2 0.805
153 single 1 0.3742
153 thymectomy 4 2.5382
153 transplantation 1 0.4943
153 transplantation, 1 0.7536
153 transplants 1 0.6785
153 true 1 0.5046
153 tumour 2 0.9369
153 value 1 0.3472
153 weeks 2 0.7893
153 weight) 1 0.6785
154 (10 1 0.2575
154 (i.d.) 1 0.3349
154 . 9 0.6785
154 2 2 0.2045
154 24 1 0.1737
154 48 1 0.189
154 8-10 1 0.3349
154 activity 1 0.1199
154 allogeneic 1 0.3015
154 also 1 0.0937
154 although 1 0.1288
154 always 1 0.1789
154 animals 1 0.1424
154 antigenic 4 0.785
154 applied 1 0.2019
154 appreciable 1 0.2349
154 caused 1 0.1466
154 cells 2 0.2022
154 comparable 1 0.1847
154 correlation 1 0.1691
154 curves 1 0.2082
154 cytotoxic 1 0.2349
154 days 2 0.2661
154 degree 2 0.2968
154 degree, 1 0.282
154 differences 1 0.1533
154 different 1 0.1185
154 duration 1 0.1754
154 earlier 1 0.2487
154 early 1 0.1228
154 effect 1 0.1023
154 elicited 1 0.2349
154 end 1 0.2049
154 force 2 0.6031
154 found 2 0.1764
154 given 2 0.2456
154 grafts 2 0.5641
154 growth 4 0.4567
154 hr 1 0.1937
154 i.d. 3 1.0048
154 immunity 4 0.9653
154 influenced 1 0.2082
154 inocula 1 0.3015
154 inoculation 4 0.897
154 inoculation, 1 0.3349
154 inoculation.. 1 0.3349
154 inoculum 1 0.3015
154 intense 1 0.2413
154 intervals 1 0.2082
154 intradermal 1 0.2682
154 kinetics 1 0.2682
154 large 1 0.1324
154 largely 1 0.2349
154 marked 1 0.1503
154 massive 1 0.2487
154 method 1 0.1331
154 month 1 0.2243
154 necessary 1 0.1963
154 number 1 0.1282
154 numbers 1 0.199
154 obtained 2 0.2388
154 onset, 1 0.282
154 parallel 1 0.2155
154 parameter 1 0.2575
154 pattern 1 0.1599
154 peak 1 0.1937
154 percent) 1 0.2682
154 preceded 1 0.282
154 primary 1 0.1416
154 produce 1 0.1789
154 quantitative 1 0.1771
154 reached 1 0.2197
154 resulted 1 0.1624
154 resulting 1 0.1706
154 results 1 0.0959
154 route 2 0.5641
154 routes 2 0.5641
154 s.c. 5 1.341
154 simultaneously 1 0.2019
154 size, 1 0.2293
154 skin 2 0.3979
154 stimulation 3 0.5669
154 stimulation, 1 0.282
154 studied 1 0.1167
154 studies 1 0.1026
154 study 1 0.1032
154 subsided 1 0.282
154 suppression 1 0.2155
154 time 1 0.118
154 transplantation 1 0.2197
154 tumor 3 0.448
154 tumor, 1 0.2575
154 tumors 2 0.3508
154 used 1 0.1265
154 using 1 0.1523
154 varying 1 0.1807
155 . 8 0.5428
155 .-j 1 0.3015
155 1966 1 0.3015
155 29-35, 1 0.3015
155 3 1 0.1028
155 36.. 1 0.3015
155 ability 1 0.1536
155 actively 2 0.4477
155 animal 1 0.1844
155 animals 5 0.6408
155 antitumor 1 0.3015
155 autochthonous 3 0.8142
155 autograft 3 0.9044
155 autografts 1 0.3015
155 back 1 0.2238
155 behave 1 0.2538
155 behaved 1 0.2538
155 benzo(a)pyrene-induced 1 0.3015
155 builds 1 0.3015
155 cancer 1 0.1192
155 cell 1 0.102
155 cells 7 0.6368
155 concentration 1 0.1267
155 directed 1 0.2018
155 every 1 0.1681
155 evidence 1 0.1105
155 exhausts 1 0.3015
155 experiments 1 0.1336
155 fibrosarcomas 1 0.3015
155 grew 2 0.4037
155 grow 1 0.2714
155 growing 2 0.4037
155 growth 2 0.2055
155 host 2 0.3127
155 however, 1 0.1092
155 immunized 3 0.6516
155 immunological 1 0.1874
155 injected 2 0.2922
155 injection, 1 0.2238
155 inst 1 0.2714
155 instance 1 0.2538
155 interfere 1 0.2238
155 isolated 1 0.1312
155 left 1 0.1361
155 like 2 0.388
155 line 1 0.1817
155 long 1 0.1564
155 lymphocytes 2 0.3533
155 major 1 0.145
155 mixed 1 0.1906
155 nat 1 0.2714
155 occasionally 1 0.2018
155 part 1 0.1408
155 prevented 1 0.1977
155 primary 4 0.5098
155 prior 1 0.161
155 pure 1 0.194
155 rats 2 0.2328
155 react 1 0.2317
155 reaction 2 0.3018
155 recipients 2 0.4827
155 reject 1 0.2538
155 removal 1 0.1681
155 removed 2 0.3401
155 removed, 1 0.3015
155 responsible 1 0.1522
155 results 1 0.0863
155 retarded 1 0.194
155 sarcoma 2 0.4127
155 spleen 8 1.4326
155 suggest 1 0.137
155 supply 1 0.2238
155 syngeneic 1 0.2317
155 take 1 0.2064
155 taken 2 0.3401
155 test 1 0.1304
155 tested 1 0.1817
155 time, 1 0.1743
155 tumor 10 1.344
155 tumors, 1 0.2317
155 vitro, 1 0.2238
155 weeks 1 0.1579
156 . 3 0.6785
156 active 2 0.9258
156 arrest 1 0.724
156 cells 1 0.3033
156 colchicine 1 1.0048
156 comparison 2 1.0425
156 culture 2 1.0062
156 cytologic 2 1.4923
156 degree 1 0.4452
156 demecolcine 1 1.0048
156 drugs 1 0.554
156 duration 1 0.5262
156 effect, 1 0.7462
156 effects 1 0.373
156 four 1 0.4509
156 included 1 0.5422
156 leurosine 2 2.0097
156 longest 1 0.9046
156 made,. 1 1.0048
156 metaphases 1 0.9046
156 methiodide 2 2.0097
156 period 1 0.3811
156 produced 1 0.4092
156 purposes 1 0.7462
156 reference 1 0.554
156 remained 1 0.5738
156 similar 1 0.3762
156 time 1 0.3541
156 tissue 2 0.6976
156 vinblastine 3 2.7139
157 . 6 0.6785
157 100 1 0.2834
157 22.6 1 0.4523
157 43 1 0.4023
157 50 1 0.2399
157 aorta 2 0.6728
157 aortic 5 1.3416
157 artery 3 0.8607
157 average 1 0.2254
157 brachial 2 0.9046
157 cases 3 0.4484
157 catheterization 1 0.3364
157 central 3 0.8133
157 compared 1 0.1949
157 comparison 1 0.2606
157 consecutive 1 0.3524
157 could 1 0.1805
157 curves 1 0.3123
157 difference 1 0.2515
157 differences 3 0.6897
157 equal 1 0.3296
157 erroneous 1 0.423
157 estimation 1 0.3731
157 exceeded 1 0.423
157 exceeding 1 0.4523
157 existed, 1 0.5024
157 extreme, 1 0.4523
157 fact 1 0.2657
157 greatest 1 0.3176
157 heart 1 0.2331
157 hg 2 0.6879
157 identical 1 0.2985
157 instances 1 0.3364
157 leading 1 0.3123
157 least 1 0.2582
157 left 1 0.2269
157 mm. 2 0.6591
157 necessarily 1 0.3439
157 occasionally 1 0.3364
157 occurred 2 0.4372
157 order 1 0.2631
157 orifice 1 0.4523
157 patients 1 0.1208
157 peaks 1 0.423
157 peripheral 1 0.2985
157 pressure 5 1.1495
157 pressures 3 0.9887
157 rather 1 0.2364
157 re-emphasize 1 0.4523
157 regurgitation 1 0.3296
157 retrograde 1 0.3862
157 seven 1 0.2869
157 significant 1 0.1764
157 size 1 0.2631
157 stenosis 1 0.3176
157 subjected 1 0.274
157 systemic 2 0.5603
157 systolic 3 1.1192
157 two 1 0.1539
157 used 1 0.1897
157 valve 1 0.3074
158 (i) 1 0.2307
158 (ii) 1 0.2307
158 (iii) 1 0.2307
158 -sphingosine 5 1.3702
158 . 11 0.6785
158 1 1 0.1035
158 2 2 0.1674
158 5 3 0.3118
158 accumulated 1 0.2107
158 acid 5 0.5291
158 age 1 0.1134
158 almost 2 0.2817
158 amounts 1 0.1361
158 appearance 2 0.2721
158 base 1 0.1922
158 birth 1 0.1396
158 birth, 1 0.2107
158 brain 6 0.8376
158 c 8 1.1955
158 ceramide 1 0.274
158 cerebroside 2 0.5481
158 cerebrosides 1 0.274
158 changes 2 0.164
158 component 1 0.1764
158 components 1 0.1565
158 constant 1 0.1494
158 contained 2 0.2792
158 content 2 0.2579
158 declined 2 0.5481
158 designated 1 0.2035
158 developing 1 0.1479
158 diminished 1 0.1835
158 disease, 1 0.1464
158 equal 1 0.1798
158 exclusively 2 0.4213
158 fatty 5 0.686
158 first 2 0.2009
158 found 1 0.0721
158 ganglioside 2 0.5481
158 gangliosides 5 1.3702
158 growth 1 0.0934
158 high 1 0.0981
158 human 2 0.1829
158 ii, 1 0.2194
158 iii, 1 0.2107
158 increased 1 0.0852
158 increases 1 0.128
158 iv 1 0.2107
158 iv, 1 0.2467
158 large 1 0.1083
158 level, 1 0.2307
158 linearly 1 0.2467
158 lower 2 0.2491
158 maintains 1 0.274
158 major 1 0.1318
158 measurable 2 0.4934
158 months 1 0.1384
158 nearly 1 0.1677
158 negligible 1 0.2194
158 period, 1 0.1835
158 predominantly, 1 0.274
158 proportion 1 0.1703
158 quantities 1 0.1922
158 quantity 1 0.2035
158 rapidly 2 0.313
158 rat 4 0.4511
158 rate 2 0.2018
158 remained 1 0.1565
158 resemble 1 0.2107
158 slowly 2 0.3752
158 sphingolipids 1 0.274
158 sphingomyelin 3 0.6583
158 sphingosine 1 0.274
158 stages 1 0.1511
158 stages.. 1 0.274
158 still 1 0.128
158 subsequently 1 0.1835
158 succeeded 1 0.2307
158 succeeding 1 0.2467
158 tay-sachs 1 0.274
158 three 2 0.2061
158 type 1 0.114
158 upon 1 0.123
158 weeks 1 0.1435
158 weeks, 2 0.5481
158 weight 2 0.2579
158 year 1 0.1422
159 (1) 1 0.1826
159 (2) 1 0.1826
159 (3) 1 0.1992
159 (4) 1 0.2179
159 (5) 1 0.2472
159 . 6 0.5089
159 acetate 1 0.2798
159 acid 2 0.291
159 acids 2 0.3711
159 also 1 0.1054
159 alterations 1 0.2077
159 amount 1 0.1856
159 appearance 1 0.1871
159 arachidonate 2 0.6785
159 cholesterol,. 1 0.3768
159 composition 2 0.4416
159 contain 1 0.2425
159 content 1 0.1773
159 decrease 3 0.5173
159 decreased 1 0.1702
159 decreased,. 1 0.3768
159 depot 3 0.9051
159 diet 1 0.2472
159 dietary 1 0.2715
159 due 1 0.1333
159 effects 1 0.1399
159 elevation 3 0.7929
159 fat 3 0.6916
159 fat,. 2 0.7536
159 fatty 4 0.7546
159 free 2 0.3571
159 generalized 1 0.258
159 higher 1 0.162
159 increase 1 0.128
159 increased 4 0.4686
159 increased, 1 0.2798
159 induced 3 0.4806
159 induces 1 0.3392
159 intake 1 0.2643
159 kidney 2 0.3339
159 lipid 3 0.6916
159 lipid, 1 0.3768
159 lipogenesis 1 0.3768
159 liver 5 0.7413
159 liver,. 2 0.7536
159 long-chain 1 0.3768
159 may 1 0.0942
159 mitochondrial 1 0.2715
159 mobilization 1 0.2798
159 oleate 1 0.3768
159 organs 1 0.2077
159 palmitate 2 0.6346
159 phospholipid, 1 0.3173
159 placentas 1 0.3392
159 pool 1 0.2897
159 pregnancy 4 0.8832
159 pregnant 1 0.2271
159 profound 1 0.258
159 proportion 1 0.2342
159 rat 1 0.1551
159 reaction 1 0.1887
159 relative 1 0.1955
159 serum 8 1.1695
159 serum, 1 0.2897
159 shwartzman 1 0.3768
159 stearate 3 1.1304
159 studies 1 0.1154
159 suggest 1 0.1713
159 suggests 2 0.4025
159 synthesis 1 0.1871
159 tissues 2 0.3449
159 total 4 0.5875
159 triglyceride, 1 0.3768
159 vi. 1 0.3768
159 water 1 0.1992
160 , 1 0.2317
160 . 10 0.6785
160 20 1 0.1361
160 adjacent 1 0.2172
160 aggregates 1 0.2714
160 alveolar 2 0.3288
160 barrier 2 0.4634
160 basement 2 0.4634
160 blood-air 2 0.4634
160 bovine 1 0.1721
160 capillary 2 0.4344
160 cattle 1 0.2414
160 caveolae 1 0.3015
160 cell 1 0.102
160 cells 2 0.182
160 cellular 1 0.1644
160 connective 1 0.2172
160 consistency 1 0.2714
160 contained 2 0.3071
160 continued 1 0.1743
160 continuous 3 0.5102
160 cytoplasm 1 0.1874
160 elastin 1 0.3015
160 electron 2 0.3044
160 embedded 1 0.2538
160 endothelial 1 0.2317
160 endothelium 2 0.4827
160 epithelial 2 0.3188
160 epithelium 2 0.3633
160 fenestrated,. 1 0.3015
160 fibroblasts, 1 0.3015
160 fixed 1 0.2172
160 granules 1 0.1977
160 healthy, 1 0.3015
160 included 1 0.1627
160 lining 1 0.2018
160 little 1 0.161
160 lung.. 1 0.2714
160 lungs 1 0.1644
160 lymphocytes, 1 0.2172
160 macrophages, 1 0.2538
160 mast 1 0.2238
160 mature 1 0.1874
160 may 1 0.0754
160 membrane 1 0.1627
160 membrane, 2 0.5076
160 membrane-bound 1 0.2714
160 merging 1 0.3015
160 microscopy 2 0.388
160 normal 1 0.0811
160 numerous 1 0.1791
160 observed 1 0.1028
160 occasional 1 0.2172
160 oso 1 0.3015
160 pinocytotic 1 0.3015
160 polyester 1 0.2714
160 resin, 1 0.3015
160 rested 2 0.5428
160 secretory 1 0.2114
160 structures 1 0.2018
160 studied 1 0.105
160 thickness 1 0.2414
160 tissue 1 0.1046
160 turn 1 0.2714
160 variable 1 0.1817
160 vesicles 1 0.2414
160 via 1 0.2018
160 wall 1 0.1906
160 widely 1 0.2018
161 . 4 0.4524
161 acid 1 0.194
161 adrenal 1 0.2985
161 amine 1 0.5024
161 assay 1 0.3296
161 biological 1 0.2683
161 described 1 0.1906
161 detected 1 0.2606
161 distribution 1 0.2582
161 eight 1 0.2869
161 endogenous 1 0.3439
161 estimation 1 0.3731
161 fluorescence 3 1.2069
161 form 1 0.2186
161 glands 1 0.3233
161 intense 1 0.362
161 materials 1 0.3524
161 measure 1 0.2905
161 method 2 0.3992
161 method, 1 0.3731
161 native 1 0.3731
161 ninhydrin 1 0.5024
161 organs 1 0.277
161 pineal 1 0.5024
161 possible 1 0.2015
161 previously 1 0.2417
161 product 1 0.3731
161 rat 1 0.2067
161 reacted 1 0.4023
161 sensitive 2 0.5422
161 serotonin 6 2.7139
161 solution 1 0.3074
161 specific 2 0.3953
161 strong 1 0.3364
161 study 1 0.1548
161 subcellular 1 0.4023
161 times 1 0.2417
161 tissue 1 0.1744
161 whose 1 0.2944
162 (pcv), 1 0.274
162 . 11 0.6785
162 10 1 0.1009
162 acute 1 0.1361
162 arterial 2 0.2843
162 arterial, 1 0.274
162 arteriovenous 1 0.2194
162 associated 1 0.0973
162 blood 3 0.254
162 calculated 1 0.1835
162 cannulated 1 0.274
162 carbon 1 0.1835
162 carotid 1 0.1798
162 caused 2 0.2399
162 cell 1 0.0927
162 central 1 0.1479
162 cerebral 7 0.9091
162 cerebrospinal 2 0.3303
162 cerebrovascular 2 0.4615
162 changes 1 0.082
162 circulation 1 0.1435
162 compartments, 1 0.274
162 concentration 2 0.2304
162 conclusions 1 0.1732
162 confluence 1 0.274
162 consequent 1 0.2307
162 content 1 0.1289
162 contents, 1 0.2467
162 could 1 0.0985
162 decrease 2 0.2508
162 decreased 1 0.1238
162 demonstrated, 1 0.2307
162 difference 1 0.1372
162 dioxide 1 0.1876
162 due 1 0.0969
162 effect 1 0.0837
162 effects 2 0.2035
162 elevated 1 0.1764
162 factors 1 0.1159
162 factors, 1 0.1974
162 flow 1 0.1396
162 flow, 1 0.1974
162 fluid 3 0.3896
162 goat 1 0.274
162 goats 2 0.4934
162 hemoglobin 2 0.4213
162 however, 1 0.0992
162 hypertensive 1 0.2194
162 hypoxia 1 0.1764
162 included 1 0.1479
162 increased 5 0.426
162 increases 1 0.128
162 influence 1 0.1254
162 insufflation 2 0.4934
162 intraruminal 3 0.8221
162 involved 1 0.1396
162 little 1 0.1464
162 made 1 0.0992
162 may 2 0.1371
162 mean 2 0.2636
162 measured 1 0.1199
162 mechanical 1 0.1974
162 mechanism 1 0.1263
162 metabolism 1 0.1299
162 multiple 1 0.1511
162 nature 1 0.1361
162 nervous 1 0.1677
162 nitrogen 1 0.1798
162 oxygen 1 0.1396
162 packed 1 0.2467
162 parameters 1 0.1974
162 pcv 1 0.274
162 pressure 7 0.8778
162 pressure, 2 0.3595
162 pressures 1 0.1798
162 reduction 1 0.135
162 related 1 0.1159
162 resistance 2 0.3056
162 responses 1 0.1528
162 rumen 1 0.274
162 ruminal 4 0.9869
162 signs 1 0.1528
162 sinus, 1 0.2467
162 sinuses, 1 0.2467
162 studied 1 0.0955
162 system 1 0.128
162 tympany 1 0.274
162 utilization 2 0.3844
162 values 1 0.1384
162 venous 1 0.1546
162 volume 1 0.1396
163 . 4 0.5428
163 absolute 2 0.8457
163 alveolar 1 0.3288
163 alveoli 1 0.4344
163 arguments 1 0.5076
163 breathing 1 0.4344
163 comparison 1 0.3127
163 connection 1 0.4344
163 deposited 1 0.6029
163 deposition 3 1.3032
163 dioxide 1 0.4127
163 discussed 1 0.2455
163 due 1 0.2133
163 dust 5 3.0145
163 experimental 1 0.2797
163 experiments 1 0.2671
163 extent, 1 0.5428
163 give 2 0.6575
163 health 1 0.4229
163 human 2 0.4024
163 indicate 1 0.2655
163 information 1 0.3253
163 inhaled 1 0.5428
163 inhaling 1 0.6029
163 insoluble 2 0.9269
163 large 1 0.2383
163 loss 1 0.2922
163 lungs 3 0.9863
163 lymphatic 1 0.4344
163 may 1 0.1508
163 measurements 1 0.388
163 mortem 1 0.5428
163 particles 1 0.4344
163 particles, 1 0.5428
163 plutonium 1 0.6029
163 post 1 0.4229
163 probably 1 0.2741
163 qualitative 1 0.4634
163 recovered 2 0.7495
163 respiratory 1 0.3127
163 results 2 0.3453
163 retention 2 0.7495
163 risk 1 0.4037
163 shifted, 1 0.6029
163 subjection 1 0.5428
163 subsequently 1 0.4037
163 total 2 0.47
163 tract,. 1 0.6029
163 vessels 1 0.4344
164 , 1 0.331
164 . 7 0.6785
164 10 1 0.1585
164 2.5 1 0.3198
164 5 2 0.3267
164 55 1 0.3448
164 7.4 1 0.3626
164 activation 3 0.9593
164 activity 1 0.1541
164 alone 1 0.2595
164 autolysis 2 0.7754
164 autolytic 1 0.3877
164 average 1 0.1932
164 basal 1 0.2825
164 basis 1 0.1885
164 best 1 0.2277
164 bovine 2 0.4918
164 c. 1 0.2277
164 cation 1 0.3448
164 cations 3 1.1631
164 combination 1 0.2459
164 divalent 1 0.3626
164 dual 1 0.3877
164 extracts 1 0.2635
164 influenced 1 0.2677
164 k 1 0.3103
164 laboratories, 1 0.4306
164 lens 3 0.6122
164 lenticular 1 0.3877
164 level 1 0.1663
164 levels 1 0.1686
164 made 1 0.156
164 markedly 1 0.23
164 may 1 0.1077
164 mg 3 0.7675
164 mm 1 0.2771
164 mm. 1 0.2825
164 mono- 1 0.3877
164 na 2 0.5445
164 neutral 1 0.3103
164 obtainable 1 0.3448
164 obtained 1 0.1535
164 ph 1 0.2324
164 physiologic 1 0.2771
164 presence 3 0.4922
164 produce 1 0.23
164 proteinase 1 0.3877
164 required 1 0.2348
164 results 1 0.1233
164 shown 1 0.1852
164 simultaneous 1 0.2635
164 stimulation 1 0.2429
164 suggestion 1 0.3198
164 suppressed 1 0.2948
164 synergistic 1 0.3626
164 tested, 1 0.3626
165 (1,500 1 0.3015
165 (after 1 0.282
165 (as 1 0.2487
165 (on 1 0.2682
165 . 9 0.6785
165 0.9 1 0.2682
165 1 1 0.1265
165 1,500 1 0.2682
165 3 1 0.1142
165 6 1 0.1401
165 acid 1 0.1293
165 acids 1 0.1649
165 activities 1 0.1937
165 activity 1 0.1199
165 albuminoid 4 1.1281
165 albuminoid, 1 0.3015
165 also 2 0.1874
165 animal 1 0.2049
165 animals 1 0.1424
165 body 1 0.135
165 c-14-adenine 2 0.6031
165 capsules 2 0.5641
165 cent 1 0.1722
165 chromatographed 1 0.3015
165 communication 1 0.1847
165 control 1 0.1259
165 derived 1 0.1847
165 determined 2 0.3045
165 dodecyl 1 0.282
165 effect 3 0.3068
165 experiment 1 0.2243
165 experiments 1 0.1484
165 exposed 1 0.1754
165 extracted 2 0.4485
165 formaldehyde 1 0.282
165 fraction 1 0.1789
165 fractions 5 0.8944
165 fractions) 1 0.3349
165 heating 1 0.2575
165 hour 2 0.4827
165 hours 1 0.1611
165 hydrolyzed, 1 0.282
165 iii. 1 0.2349
165 incorporation 2 0.4235
165 increased 1 0.1041
165 incubation 1 0.2049
165 indicate 1 0.1475
165 individual 1 0.1771
165 irradiated 1 0.1937
165 lens 3 0.4762
165 lenses 1 0.2082
165 less 1 0.1254
165 markedly 1 0.1789
165 matter 1 0.2487
165 measured 1 0.1466
165 metabolism 1 0.1587
165 much 1 0.1484
165 nacl 1 0.2487
165 normal 1 0.0901
165 nucleic 2 0.4394
165 nucleotides 1 0.2575
165 p-32 3 0.9046
165 paper), 1 0.3015
165 per 1 0.1305
165 performed 1 0.1533
165 period) 1 0.3015
165 present 1 0.1103
165 previous 1 0.1807
165 r 1 0.2197
165 r) 1 0.282
165 radiation 1 0.1827
165 rat 2 0.2757
165 remaining 1 0.1706
165 removed 1 0.189
165 reported 1 0.1357
165 results 1 0.0959
165 ribosomal 1 0.282
165 ribosomal, 1 0.3015
165 rna 9 1.6619
165 significant 1 0.1176
165 sodium 1 0.1611
165 soluble 2 0.3979
165 specific 2 0.2636
165 stimulated 1 0.2243
165 study, 1 0.2155
165 sulfate 1 0.2349
165 three 1 0.1259
165 uptake 1 0.2197
165 vitro 1 0.1722
165 vivo 1 0.199
165 well 1 0.1171
165 whole 1 0.1868
165 x- 1 0.282
165 x-irradiated 1 0.2575
165 x-radiation 2 0.5641
166 . 8 0.6785
166 anterior 1 0.2382
166 autoradiographic 1 0.2472
166 became 1 0.2238
166 birth 1 0.1919
166 cell 1 0.1275
166 cells 5 0.5686
166 changes 1 0.1127
166 constant 1 0.2055
166 decreased 1 0.1702
166 developing 3 0.61
166 dna 3 0.5397
166 dna, 2 0.4943
166 embryonic 2 0.4764
166 entire 1 0.2472
166 epithelial 3 0.5977
166 equator 1 0.3768
166 eye 1 0.2425
166 eyelids 1 0.3768
166 eyes 1 0.2798
166 found 1 0.0992
166 germinative 1 0.3173
166 h 2 0.5793
166 incorporated 1 0.2798
166 incorporation 1 0.2382
166 l- 1 0.3768
166 l-leucine 1 0.3392
166 later 1 0.1937
166 lens 6 1.0714
166 lens, 1 0.3017
166 leucine 1 0.3768
166 localized 1 0.2643
166 maturity 1 0.3173
166 mouse 2 0.4202
166 nearly 1 0.2305
166 nucleated 1 0.2897
166 occurred 1 0.1639
166 opened 2 0.6785
166 pattern 1 0.1799
166 percentage 2 0.4202
166 protein 2 0.3426
166 rapidly 1 0.2152
166 region 1 0.2523
166 rna 2 0.4155
166 rna, 2 0.6034
166 seen 1 0.1593
166 similar 1 0.1411
166 stage 1 0.1826
166 studied 1 0.1313
166 superficial 1 0.2798
166 surface 1 0.2033
166 synthesis 6 1.1225
166 techniques 1 0.2055
166 thymidine, 1 0.3392
166 tritium 1 0.3768
166 tritium-labeled 1 0.3768
166 undergoing 3 0.7146
166 uridine 1 0.3392
166 uridine, 1 0.3768
166 use 1 0.149
166 zone 1 0.2472
167 . 3 0.6785
167 acid 1 0.388
167 acids 2 0.9897
167 also 1 0.2811
167 amino 3 1.9056
167 apparently 1 0.548
167 aqueous 1 0.724
167 cataract 1 0.724
167 cataracts 1 1.0048
167 concentration 1 0.4225
167 concentrations 1 0.5165
167 containing 1 0.5313
167 diabetic 1 0.6728
167 direct 1 0.4727
167 distribution 1 0.5165
167 doubtful 1 1.0048
167 effect 1 0.3068
167 fed 1 0.6591
167 formation 1 0.4509
167 free 1 0.4762
167 galactose 1 1.0048
167 high 2 0.7192
167 humor 1 0.9046
167 lens 3 1.4285
167 level 1 0.388
167 rabbits 1 0.5738
167 rations 1 1.0048
167 rats 1 0.388
167 reduced 1 0.4538
167 reduction 1 0.4948
167 related 1 0.4248
167 relation 1 0.4629
167 significantly 1 0.4225
167 state 1 0.5165
167 steady 1 0.724
167 sugar 1 0.7724
167 sugars, 1 1.0048
167 transport 1 0.6056
167 whether 1 0.4989
167 xylose 1 1.0048
168 (young 1 0.5024
168 -10 2 0.9046
168 -55 1 0.5024
168 . 6 0.6785
168 0.01-25 1 0.5024
168 0.02 1 0.423
168 0.03 1 0.4523
168 0.3-0.4 1 0.5024
168 0.3-0.6 1 0.5024
168 10 2 0.3699
168 15 1 0.2494
168 amplitude 2 0.7462
168 apparent 1 0.2631
168 c 1 0.274
168 c/ 1 0.5024
168 dependence 1 0.423
168 dynamic 2 0.8046
168 dyne/cm 2 1.0048
168 elastic 2 0.9046
168 elasticity 1 0.5024
168 exceeded 1 0.423
168 found 1 0.1323
168 frequency 1 0.2631
168 human 1 0.1677
168 human, 1 0.5024
168 humans 1 0.423
168 lens 3 0.7143
168 lenses 4 1.2492
168 linear 1 0.3233
168 loss 2 0.4871
168 measured 1 0.2199
168 mm 1 0.3233
168 mm, 1 0.5024
168 moduli 1 0.5024
168 modulus 1 0.5024
168 modulus) 1 0.5024
168 monkey 2 0.6728
168 monkeys 1 0.3524
168 nonlinear 1 0.5024
168 oscillation 2 1.0048
168 poor 1 0.2905
168 properties 2 0.5366
168 rabbit 2 0.5669
168 rabbits 1 0.2869
168 rheometer 1 0.5024
168 showed 3 0.5373
168 tangent 1 0.4523
168 tangents 1 0.5024
168 temperature 1 0.2683
168 value 2 0.4629
168 visco- 1 0.5024
168 visco-elastic 2 1.0048
168 visco-elasticity 1 0.5024
169 ( 5 2.5382
169 . 4 0.5428
169 /kg 1 0.6029
169 0 1 0.6029
169 1571 1 0.6029
169 159 1 0.6029
169 2484 1 0.6029
169 256), 1 0.6029
169 39) 1 0.6029
169 49) 1 0.6029
169 545 1 0.6029
169 65 1 0.4127
169 87), 1 0.6029
169 93), 1 0.6029
169 activities 1 0.3487
169 activity 1 0.2158
169 anhydrase 3 1.8087
169 anterior 2 0.7622
169 available 1 0.3288
169 basis 1 0.2639
169 c 1 0.3288
169 cannot 1 0.3253
169 capsule 1 0.4827
169 capsule, 2 0.9269
169 carbonic 3 1.8087
169 cation 1 0.4827
169 co 1 0.4344
169 concluded, 1 0.6029
169 cortex, 1 0.5076
169 determined 1 0.2741
169 distribution 2 0.6198
169 epithelium 1 0.3633
169 evidence, 1 0.6029
169 hr 1 0.3487
169 lens 3 0.8571
169 mature 1 0.3748
169 moles 1 0.6029
169 nucleus, 1 0.5076
169 per 1 0.235
169 play 1 0.3581
169 posterior 1 0.3533
169 primary 1 0.2549
169 rabbit 2 0.6802
169 respectively, 1 0.4344
169 role 1 0.2797
169 system 1 0.2816
169 tissue 1 0.2093
169 transport 1 0.3633
169 were, 1 0.5076
169 wet 1 0.4634
169 wt 1 0.6029
170 . 5 0.6785
170 accompanied 1 0.3362
170 accumulated 1 0.4634
170 adenosine 2 1.0856
170 apparent 1 0.3157
170 atp 1 0.5428
170 cataract 2 0.8688
170 cataractous 1 0.5428
170 changes 1 0.1804
170 changes, 1 0.4827
170 concentration 1 0.2535
170 content 1 0.2836
170 days 1 0.2395
170 decrease 1 0.2759
170 degree 1 0.2671
170 highest 1 0.3811
170 increase 1 0.2048
170 lens 3 0.8571
170 level 2 0.4656
170 loss 1 0.2922
170 maximum 1 0.3324
170 occurred 1 0.2623
170 polyol 1 0.6029
170 polyols 1 0.6029
170 rat 3 0.7443
170 regression 1 0.388
170 restoration 1 0.4477
170 sorbitol 1 0.5428
170 triphosphate 1 0.6029
170 triphosphate, 1 0.6029
170 two 1 0.1846
170 usually 1 0.2836
170 weight 2 0.5673
170 xylitol 1 0.6029
170 xylose-fed 3 1.8087
171 - 1 0.2944
171 . 6 0.6785
171 a-crystallin 1 0.362
171 antigen 1 0.2985
171 antigens 4 1.1622
171 antiserum 1 0.3364
171 b- 1 0.423
171 bovine 2 0.5738
171 cross 1 0.4023
171 cross-reacting 1 0.4523
171 diffusion 1 0.3364
171 found 1 0.1323
171 gel 1 0.2905
171 identification 1 0.3233
171 identified 1 0.2944
171 immunoelectrophoresis 1 0.423
171 investigated 1 0.2869
171 lens 5 1.1904
171 major 2 0.4833
171 minor 1 0.3233
171 mobility 1 0.423
171 organ-specific 3 1.357
171 proteins 1 0.2606
171 rabbit 1 0.2834
171 reaction 1 0.2515
171 showed 1 0.1791
171 species-specific 2 0.9046
171 techniques 1 0.274
171 tissues 1 0.2299
171 two 1 0.1539
171 y-crystallins 1 0.5024
172 (about 1 0.2262
172 . 12 0.6785
172 50 1 0.1199
172 abundance 1 0.2512
172 acquires 1 0.2512
172 addition, 1 0.1453
172 adult 2 0.2284
172 almost 1 0.1291
172 also 1 0.0703
172 analyses 1 0.1682
172 appear 1 0.115
172 become 1 0.1385
172 cell 1 0.085
172 cells 4 0.3033
172 changes 3 0.2255
172 characterized 1 0.1328
172 completely 1 0.1472
172 components 1 0.1434
172 core 1 0.1762
172 corresponding 1 0.1472
172 cortex 1 0.1385
172 cytoplasm 1 0.1562
172 cytoplasmic 1 0.1514
172 density, 1 0.2115
172 detected 1 0.1303
172 disappears 1 0.2115
172 discussed 1 0.1023
172 disintegrates 1 0.2512
172 distinguished 1 0.1682
172 electron 3 0.3805
172 elements 1 0.1931
172 endoplasmic 2 0.3731
172 enlarge 1 0.2115
172 epithelium 1 0.1514
172 extensive 1 0.1417
172 extruded 1 0.2262
172 fibrous 2 0.3862
172 finally 1 0.172
172 first 1 0.0921
172 gradually 1 0.1588
172 granular 1 0.1931
172 granules 1 0.1648
172 granules, 1 0.2011
172 increase 2 0.1706
172 indentations 1 0.2512
172 intercellular 1 0.2011
172 involve 1 0.181
172 iris 3 0.6785
172 irregular 1 0.1865
172 later, 2 0.4023
172 lens 4 0.4762
172 leucocytes 1 0.2262
172 low 1 0.11
172 main 1 0.1434
172 matrix 1 0.2262
172 mediodorsal 1 0.2512
172 melanin 1 0.2512
172 membrane 1 0.1355
172 micrographs 1 0.2011
172 microscope 1 0.1865
172 microscopic 1 0.1562
172 morphology 1 0.1537
172 nature 1 0.1247
172 newt 2 0.5024
172 normal 3 0.2027
172 nuclear 1 0.1453
172 nuclei 2 0.3176
172 nucleoli 4 1.0048
172 number 1 0.0961
172 performed 1 0.115
172 pigment 1 0.2262
172 pigmented 1 0.2262
172 presence 1 0.0957
172 primary 1 0.1062
172 probably 1 0.1142
172 prominent 1 0.1865
172 quantitative 1 0.1328
172 regeneration 1 0.181
172 regenerative 1 0.2262
172 removal, 1 0.2262
172 reticulum 1 0.1931
172 reticulum, 1 0.2262
172 ribosomes 1 0.2115
172 sections 1 0.172
172 seem 1 0.137
172 significant 1 0.0882
172 smooth-- 1 0.2512
172 spaces 1 0.1762
172 spherical, 1 0.2512
172 studied 1 0.0875
172 study 1 0.0774
172 subsequently 1 0.1682
172 surfaced 1 0.2512
172 surrounding 1 0.1762
172 taken 1 0.1417
172 tissue 1 0.0872
172 transformation 1 0.137
172 transforming 1 0.172
172 triturus 1 0.2115
172 ultrathin 1 0.2262
172 using 1 0.1142
172 viridescens 1 0.2115
172 visible 1 0.2115
172 wide) 1 0.2512
172 wolffian 1 0.2512
173 -dash 4 2.0636
173 . 3 0.5089
173 1 1 0.2846
173 1, 1 0.485
173 2, 2 1.0318
173 21 1 0.4764
173 212, 1 0.7536
173 41, 1 0.7536
173 5-8 1 0.7536
173 50 1 0.3598
173 6, 1 0.6034
173 adeno 1 0.7536
173 amnion 1 0.5793
173 animals 1 0.3204
173 b 1 0.5159
173 cancer 1 0.2979
173 carcinoma 1 0.3598
173 caused 2 0.6597
173 cell 3 0.7652
173 cent 1 0.3874
173 commonly 1 0.5286
173 cx 1 0.7536
173 death 2 0.8219
173 detroit 1 0.7536
173 eight 1 0.4303
173 frequently 1 0.3805
173 grew 2 1.0091
173 growth 1 0.2569
173 h.ep. 2 1.5073
173 human 3 0.7546
173 illness 1 0.5793
173 injected 1 0.3653
173 intravenously 1 0.5286
173 j-111, 1 0.7536
173 less 1 0.2821
173 lines 3 1.3074
173 lung 1 0.3241
173 mac 1 0.7536
173 newborn 2 0.8219
173 normal 1 0.2027
173 organs 1 0.4155
173 ovary 1 0.7536
173 per 1 0.2937
173 presumably 1 0.4943
173 progressively 1 0.5596
173 rarely 1 0.5286
173 rats 1 0.291
173 rats, 1 0.5159
173 rp 2 1.357
173 several 1 0.326
173 tissue-cultured 1 0.7536
173 two 1 0.2308
173 weeks 1 0.3946
174 (h.ad. 1 0.5024
174 (tem) 1 0.5024
174 . 6 0.6785
174 1 2 0.3795
174 1) 1 0.3233
174 1/20 1 0.5024
174 2 1 0.1534
174 20 1 0.2269
174 6-mercaptopurine, 1 0.4523
174 a-42 1 0.5024
174 achieve 1 0.3524
174 acid 4 0.7761
174 acid, 2 0.6466
174 active 1 0.2315
174 adenocarcinoma 1 0.3439
174 agent 1 0.2944
174 aid 1 0.362
174 alternaria 2 1.0048
174 another 1 0.274
174 aspergillustamarii 1 0.5024
174 auct. 1 0.5024
174 azaserine, 1 0.5024
174 basis, 1 0.4523
174 broth 1 0.3862
174 compared 2 0.3898
174 culture 1 0.2515
174 effective 1 0.2515
174 egg 2 0.8046
174 egg-tumor 2 1.0048
174 embryonated 1 0.4523
174 fermented 1 0.5024
174 growth 3 0.5138
174 h.ad. 2 1.0048
174 hadacidin 1 0.5024
174 host 1 0.2606
174 human 3 0.5031
174 identified 1 0.2944
174 iii. 1 0.3524
174 inhibited 2 0.6352
174 inhibition 1 0.2515
174 isolated 1 0.2186
174 isolates 1 0.3731
174 molar 1 0.5024
174 much 3 0.6678
174 number 1 0.1923
174 phoma 1 0.5024
174 produced 1 0.2046
174 properties 1 0.2683
174 puromycin, 1 0.5024
174 required 1 0.274
174 sp 1 0.4023
174 specifically 1 0.3731
174 studies 1 0.1539
174 system 3 0.7041
174 tenuazonic 6 3.0145
174 tenuis 1 0.5024
174 times 2 0.4833
174 transplantable 1 0.423
174 triethylenemelamine 1 0.5024
174 tumor 2 0.448
174 tumor, 1 0.3862
174 tumor-egg 1 0.5024
174 tumor-inhibitory 1 0.5024
175 'dialysis 1 0.5024
175 . 6 0.6785
175 accelerated 1 0.362
175 biologic 1 0.423
175 c3h/hej 2 1.0048
175 carcinoma 1 0.2399
175 compartment' 1 0.5024
175 contained 1 0.2559
175 crystalline 1 0.3731
175 crystals 5 2.5121
175 culture 1 0.2515
175 cultures 4 1.0062
175 development 1 0.1834
175 essential 1 0.2944
175 exception 1 0.3296
175 formation 1 0.2254
175 found 2 0.2645
175 incidence 1 0.2399
175 kidney 1 0.2226
175 mammary 1 0.3233
175 medium 1 0.2683
175 mice 2 0.4948
175 modification 1 0.3731
175 neoplastic 1 0.3524
175 non-neoplastic 1 0.4523
175 nontumor 1 0.5024
175 occurrence 1 0.2985
175 primary 1 0.2124
175 several 1 0.2173
175 structures 1 0.3364
175 tissue 2 0.3488
175 tissues 2 0.4598
175 tumor 1 0.224
175 types 1 0.2435
175 various 1 0.1986
175 varying 1 0.2711
176 (mac-21) 1 0.4306
176 . 7 0.6785
176 accumulations 1 0.3877
176 adenocarcinoma 1 0.2948
176 amounts 1 0.2138
176 apparatus 1 0.331
176 areas 1 0.2277
176 bodies 1 0.2635
176 bodies, 1 0.3448
176 cell 6 0.8745
176 cells 1 0.13
176 compared 1 0.1671
176 comparison 1 0.2234
176 considerably 1 0.2771
176 contained 2 0.4387
176 cultured 2 0.5649
176 cytoplasm 1 0.2677
176 density, 1 0.3626
176 described 1 0.1633
176 development, 1 0.2883
176 differed, 1 0.4306
176 differences 1 0.1971
176 fine 4 1.2082
176 following 1 0.1427
176 formation 1 0.1932
176 found 1 0.1134
176 golgi 1 0.3198
176 hela 3 0.9062
176 however, 1 0.156
176 human 1 0.1437
176 increased 1 0.1339
176 invaginations, 1 0.4306
176 inversely 1 0.4306
176 involved 1 0.2194
176 lamellae 1 0.3877
176 larger 2 0.5116
176 limiting 1 0.3198
176 lipide-rich, 1 0.4306
176 low 1 0.1885
176 lung 1 0.1852
176 mac-21 3 1.2919
176 may 1 0.1077
176 medium 1 0.23
176 membrane 1 0.2324
176 membrane, 1 0.3626
176 mucin 1 0.4306
176 mucoid 1 0.4306
176 multivesicular 1 0.3626
176 myelinated 2 0.7754
176 nuclear 1 0.249
176 nucleus 1 0.331
176 number 1 0.1648
176 numerous 1 0.2558
176 observed 1 0.1468
176 organelles 1 0.3198
176 perinuclear 1 0.4306
176 ph 1 0.2324
176 primarily 1 0.2722
176 proportional 1 0.3448
176 quantitative 1 0.2277
176 respects.. 1 0.4306
176 spindle-shaped 1 0.4306
176 stages 1 0.2374
176 strains 2 0.5116
176 structure 4 0.8775
176 structures 1 0.2883
176 suggesting 1 0.2635
176 thought 1 0.2429
176 two 2 0.2638
176 undefined 1 0.4306
176 various 1 0.1702
177 . 5 0.6785
177 activity 1 0.2158
177 adenoma 1 0.4344
177 amounts 1 0.2993
177 around 1 0.4037
177 bone 2 0.5215
177 bones 1 0.4344
177 calvaria 1 0.5076
177 calvarium, 1 0.6029
177 capacity 1 0.3288
177 carcinoma 1 0.2878
177 cell 1 0.204
177 combination 1 0.3443
177 consistently 1 0.388
177 culture 2 0.6037
177 determine 1 0.3401
177 effect 2 0.3682
177 enhance 1 0.5428
177 enhanced 2 0.7495
177 enhancing 1 0.5076
177 except 1 0.3401
177 factors 1 0.2549
177 fragments 4 1.7908
177 frontal 1 0.4634
177 glandular 1 0.4477
177 grown 1 0.4127
177 halo 1 0.6029
177 hand, 1 0.3633
177 human 4 0.8049
177 lesser 1 0.4127
177 lung 1 0.2593
177 mouse 1 0.3362
177 multiple 2 0.6648
177 one 1 0.1687
177 parathyroid 2 0.644
177 parietal 1 0.4477
177 placed 1 0.3581
177 presence 1 0.2297
177 resorption 4 1.931
177 resorption-enhancing 1 0.6029
177 single 3 0.898
177 squamous-- 1 0.6029
177 suggesting 1 0.3689
177 tested 1 0.3633
177 tissue 3 0.6278
177 tissues 5 1.3794
177 tumors 2 0.6314
177 variety 1 0.3253
178 . 3 0.6785
178 1964 1 1.0048
178 2 1 0.3068
178 227-236, 1 1.0048
178 23 1 0.6728
178 33.. 1 1.0048
178 40 2 1.1776
178 although 1 0.3863
178 appear 1 0.4598
178 attained 1 0.7462
178 autonomous 1 0.7462
178 cancer 1 0.3972
178 cell 3 1.0202
178 changes 1 0.3007
178 cultures 1 0.5031
178 cytology 1 0.9046
178 described 1 0.3811
178 enhanced 1 0.6246
178 greatly 1 0.5969
178 growth 2 0.685
178 growth.--j 1 1.0048
178 human 2 0.6707
178 induced 1 0.4272
178 inst 1 0.9046
178 investigators 1 0.8461
178 limited 1 0.548
178 lines 1 0.5811
178 lung 1 0.4321
178 morphology 1 0.6148
178 nat 1 0.9046
178 period 1 0.3811
178 potentials 1 0.8461
178 previous 1 0.5422
178 replication 1 0.7462
178 simian 2 1.5448
178 strains 1 0.5969
178 strains, 1 0.7724
178 summary--infection 1 1.0048
178 transformation 2 1.0959
178 transformed 2 1.5448
178 virus 3 1.5786
179 . 4 0.6785
179 activity 1 0.2697
179 aethiops.. 1 0.7536
179 bacteria 2 0.97
179 bacteria, 2 1.5073
179 bacteriological 1 0.6785
179 bacteriophages 2 1.2069
179 carcinoma 1 0.3598
179 cells 4 0.9098
179 cercopithecus 2 1.5073
179 certain 1 0.3319
179 cobacteria 1 0.7536
179 communication 1 0.4155
179 coryne- 1 0.7536
179 coryne-my- 1 0.7536
179 corynebacteria 1 0.7536
179 corynebacteria, 1 0.7536
179 corynebacteriophages 1 0.7536
179 could 1 0.2708
179 cultures 2 0.7546
179 cytopathogenic 3 1.7379
179 described 1 0.2859
179 disease, 1 0.4025
179 effect 3 0.6903
179 either 1 0.3222
179 features 1 0.4025
179 found 1 0.1984
179 hela 1 0.5286
179 induced 1 0.3204
179 isolated 2 0.6558
179 lung 1 0.3241
179 lyse 2 1.357
179 lysogenic 1 0.6034
179 lytic 1 0.6034
179 mycobacteria 2 1.5073
179 mycobacteria, 1 0.7536
179 mycobacterio- 1 0.7536
179 neoplastic 1 0.5286
179 pa- 1 0.4416
179 particles 1 0.543
179 patients 1 0.1812
179 phage-immune 1 0.7536
179 phages 1 0.5793
179 phagolytic 1 0.7536
179 preliminary 1 0.4303
179 produce 2 0.805
179 renal 2 0.5847
179 resection 1 0.5596
179 sensitive 1 0.4066
179 shared 1 0.5793
179 show 1 0.326
179 species 1 0.411
179 specimens 1 0.485
179 sputum 1 0.6785
179 suffering 1 0.4477
179 tients 1 0.485
179 tissue 2 0.5232
180 (e.g., 1 0.3768
180 -crystallin) 1 0.3768
180 . 8 0.6785
180 3 1 0.1284
180 4 1 0.1333
180 according 1 0.2033
180 area 1 0.1955
180 cataract 2 0.543
180 cataractous 3 1.0177
180 completely 1 0.2208
180 compo- 1 0.3392
180 decrease 1 0.1724
180 different 2 0.2666
180 disappeared 1 0.2715
180 distributed 1 0.3173
180 electrophoretic 1 0.2643
180 evolution 1 0.2715
180 ferential 1 0.3768
180 filtration 1 0.2523
180 fractions 1 0.2012
180 g-100 1 0.3173
180 gel 2 0.4358
180 hand, 1 0.2271
180 high 1 0.1348
180 human 1 0.1258
180 hypermature 1 0.3768
180 immunoelectrophoresis, 1 0.3768
180 large 1 0.149
180 led 1 0.2208
180 lens 2 0.3571
180 lenses 3 0.7027
180 lines 1 0.2179
180 low 2 0.3299
180 mature 1 0.2342
180 mobility 1 0.3173
180 molecular 4 0.8954
180 nents 1 0.3768
180 normal 4 0.4053
180 obtained 2 0.2686
180 pathological 1 0.2033
180 pattern 1 0.1799
180 polysaccharide 1 0.3392
180 pre- 1 0.2425
180 precipitin 1 0.2897
180 process 1 0.1724
180 proteins 5 0.9773
180 resistant 1 0.2305
180 revea- 1 0.3768
180 separated 1 0.2472
180 sephadex 1 0.2798
180 several 1 0.163
180 size 1 0.1973
180 soluble 2 0.4477
180 weight 3 0.5318
180 well 1 0.1318
181 -crysta- 1 0.6029
181 -crystallin, 1 0.6029
181 . 5 0.6785
181 0.9 1 0.4827
181 10.5 1 0.6029
181 10.8 2 1.2058
181 12,000 1 0.6029
181 360,000 1 0.6029
181 7.4 1 0.5076
181 acid 1 0.2328
181 adult 1 0.2741
181 aggregate 1 0.6029
181 albuminoids, 1 0.6029
181 alkaline 1 0.4344
181 also 1 0.1687
181 amino 1 0.3811
181 apparent 1 0.3157
181 approximately 1 0.3157
181 bovine 2 0.6886
181 cal 1 0.4634
181 composition 1 0.3533
181 constant 2 0.6575
181 cortex 1 0.3324
181 crystalline 1 0.4477
181 dissociated 1 0.5428
181 dissolved 1 0.5076
181 estimated 1 0.3748
181 exhibiting 1 0.5428
181 fraction, 1 0.5428
181 immunochemi- 1 0.5428
181 initial 1 0.2922
181 insoluble 3 1.3903
181 kinship 1 0.6029
181 lens 3 0.8571
181 llin 1 0.6029
181 molecular 2 0.7163
181 molecules 1 0.4229
181 nacl 1 0.4477
181 ph 2 0.6506
181 properties 1 0.322
181 protein 2 0.5481
181 proteins 1 0.3127
181 proteins, 1 0.4634
181 raising 1 0.4344
181 reducing 1 0.4634
181 rendered 1 0.5076
181 s,. 1 0.6029
181 sedimentation 2 0.8688
181 soluble 2 0.7163
181 solutions 1 0.4344
181 suggested 1 0.2507
181 suspension 1 0.4344
181 washed 1 0.5428
181 weight 1 0.2836
182 . 6 0.6785
182 /deficient/ 1 0.5024
182 6-phos- 2 1.0048
182 6-phosphate 3 1.357
182 6-phosphogluconate 3 1.5073
182 activities 1 0.2905
182 activity 5 0.899
182 blood 2 0.3105
182 considered 1 0.224
182 content 1 0.2364
182 correla- 1 0.5024
182 correlation 1 0.2537
182 dehydro- 1 0.5024
182 dehydrogenase 6 2.3172
182 different 2 0.3554
182 either 1 0.2148
182 enzyme 1 0.2985
182 erythrocytes 3 1.1192
182 genase 1 0.5024
182 glucose 5 1.3155
182 individuals 1 0.3439
182 lens 5 1.1904
182 level 1 0.194
182 man 2 0.5165
182 measured 1 0.2199
182 phate 2 0.8046
182 range 1 0.2711
182 seemed 1 0.3233
182 several 2 0.4346
182 sorbitol 1 0.4523
182 species 5 1.3699
182 species, 1 0.3731
182 ted 1 0.3731
182 variation 1 0.3176
182 wide 2 0.5969
183 (1,500 1 0.3015
183 (after 1 0.282
183 (as 1 0.2487
183 (on 1 0.2682
183 . 9 0.6785
183 0.9 1 0.2682
183 1 1 0.1265
183 1,500 1 0.2682
183 3 1 0.1142
183 6 1 0.1401
183 ac- 1 0.2155
183 acid 1 0.1293
183 acids 1 0.1649
183 activities 1 0.1937
183 albuminoid 4 1.1281
183 albuminoid, 1 0.3015
183 also 2 0.1874
183 animal 1 0.2049
183 animals 1 0.1424
183 body 1 0.135
183 c-14-adenine 2 0.6031
183 capsules 2 0.5641
183 cent 1 0.1722
183 chromatographed 1 0.3015
183 communication 1 0.1847
183 control 1 0.1259
183 derived 1 0.1847
183 determined 2 0.3045
183 dodecyl 1 0.282
183 effect 3 0.3068
183 experiment 1 0.2243
183 experiments 1 0.1484
183 exposed 1 0.1754
183 extracted 2 0.4485
183 formaldehyde 1 0.282
183 frac- 1 0.2682
183 fraction 1 0.1789
183 fractions 5 0.8944
183 heating 1 0.2575
183 hour 2 0.4827
183 hours 1 0.1611
183 hydrolyzed, 1 0.282
183 iii. 1 0.2349
183 incorporation 2 0.4235
183 increased 1 0.1041
183 incubation 1 0.2049
183 indicate 1 0.1475
183 individual 1 0.1771
183 lens 3 0.4762
183 lenses 1 0.2082
183 less 1 0.1254
183 markedly 1 0.1789
183 matter 1 0.2487
183 measured 1 0.1466
183 metabolism 1 0.1587
183 much 1 0.1484
183 nacl 1 0.2487
183 normal 1 0.0901
183 nucleic 2 0.4394
183 nucleotides 1 0.2575
183 p-32 3 0.9046
183 paper), 1 0.3015
183 per 1 0.1305
183 performed 1 0.1533
183 period) 1 0.3015
183 present 1 0.1103
183 previous 1 0.1807
183 r 1 0.2197
183 r) 1 0.282
183 radiation 1 0.1827
183 rat 2 0.2757
183 remaining 1 0.1706
183 removed 1 0.189
183 reported 1 0.1357
183 results 1 0.0959
183 ribosomal 1 0.282
183 ribosomal, 1 0.3015
183 rna 9 1.6619
183 significant 1 0.1176
183 sodium 1 0.1611
183 soluble 2 0.3979
183 specific 2 0.2636
183 stimulated 1 0.2243
183 stody, 1 0.3349
183 sulfate 1 0.2349
183 three 1 0.1259
183 tions) 1 0.3349
183 tivity 1 0.3015
183 uptake 1 0.2197
183 vitro 1 0.1722
183 vivo 1 0.199
183 well 1 0.1171
183 whole 1 0.1868
183 x-irradiated 2 0.5149
183 x-radiation 2 0.5641
184 (on 1 0.6034
184 . 4 0.6785
184 activity 1 0.2697
184 although 1 0.2897
184 associated 1 0.2676
184 basis) 1 0.7536
184 control 1 0.2834
184 cortex 1 0.4155
184 epithelium 3 1.3625
184 exists 1 0.543
184 factor 1 0.3571
184 found 1 0.1984
184 frac- 1 0.6034
184 half 1 0.4416
184 high 1 0.2697
184 inhibitory 1 0.4943
184 inhibits 1 0.5046
184 investigation 1 0.4252
184 lens 2 0.7143
184 lens, 1 0.6034
184 lenses 1 0.4685
184 less 1 0.2821
184 mitosis 1 0.5793
184 mitotic 1 0.485
184 molecular 1 0.4477
184 nuclear 1 0.4358
184 old 1 0.4252
184 present 1 0.2481
184 rabbit 3 1.2755
184 region 1 0.5046
184 relatively 1 0.3625
184 room 1 0.5793
184 soluble 1 0.4477
184 stable 1 0.543
184 substance 1 0.5286
184 tempera- 1 0.6785
184 throughout 1 0.4303
184 tion 1 0.3426
184 ture 1 0.6346
184 water 1 0.3985
184 weight 2 0.7091
184 wet 1 0.5793
184 y-crystallin 1 0.6034
184 young 2 0.7611
185 (identified 1 1.0048
185 . 3 0.6785
185 activities 1 0.5811
185 assayed 1 0.8046
185 biochemical 1 0.6352
185 bovine 2 1.1476
185 cells 1 0.3033
185 contamination 1 0.9046
185 cytoplasmic 1 0.6056
185 described 1 0.3811
185 employed 1 0.6352
185 enzymes 2 1.2704
185 enzymes) 1 1.0048
185 epithelium 2 1.2111
185 fractions 1 0.5366
185 identification 1 0.6466
185 isolation 2 1.2933
185 lens 2 0.9524
185 lysosomal 2 1.8093
185 lysosomes 1 0.7462
185 material 1 0.4661
185 mitochondrial 1 0.724
185 procedures 1 0.5669
185 showed 1 0.3582
185 soluble 1 0.5969
185 studies 1 0.3077
185 two 1 0.3077
185 various 1 0.3972
186 . 4 0.6785
186 140 1 0.6785
186 20,000 1 0.7536
186 7,000 1 0.7536
186 a, 1 0.6034
186 acid 1 0.291
186 acid, 1 0.485
186 amino 1 0.4764
186 appear 1 0.3449
186 average 1 0.3381
186 calf 2 1.1586
186 capable 1 0.4611
186 capacity 1 0.411
186 cell-free 1 0.6034
186 composed 1 0.5793
186 con- 1 0.3909
186 diameter 1 0.6785
186 electron 1 0.3805
186 examined 1 0.3805
186 fraction 2 0.805
186 incorporating 1 0.7536
186 isolated 1 0.3279
186 large 1 0.2979
186 lens 2 0.7143
186 long 1 0.3909
186 microscopy 1 0.485
186 number 1 0.2884
186 polyribosomes 3 2.2609
186 present 1 0.2481
186 protein 2 0.6851
186 protein-synthesizing 1 0.7536
186 ranging 1 0.5159
186 responsible 1 0.3805
186 ribonucleic 1 0.5286
186 ribosomal 1 0.6346
186 ribosomes 1 0.6346
186 shown 1 0.3241
186 strands 1 0.6346
186 synthesis 1 0.3742
186 system 1 0.352
186 taining 1 0.6785
187 (ohp) 1 0.3392
187 . 8 0.6785
187 2 1 0.1151
187 4 1 0.1333
187 5 1 0.1429
187 75 1 0.2643
187 abs 1 0.3392
187 addition 2 0.3839
187 affect 1 0.2382
187 air 2 0.4202
187 air, 1 0.3392
187 anesthetics 1 0.3768
187 atm 2 0.6346
187 brain 1 0.1919
187 breathing 3 0.8145
187 cerebral 6 1.0714
187 cerebrospinal 1 0.2271
187 co 1 0.2715
187 co2 1 0.2715
187 compression 1 0.2798
187 contributing 1 0.3768
187 decompression 1 0.2798
187 discussed 1 0.1535
187 exposed 3 0.592
187 factors 1 0.1593
187 fall 1 0.1973
187 faster 1 0.2715
187 following 1 0.1249
187 found 1 0.0992
187 gas 1 0.3017
187 hemoglobin 1 0.2897
187 high 3 0.4045
187 increased 1 0.1171
187 inhibition 1 0.1887
187 inspired 2 0.6785
187 level 2 0.291
187 lowered 1 0.2798
187 measured 1 0.1649
187 measurement 1 0.2126
187 mixture 1 0.2798
187 ohp 1 0.3173
187 oxygen 8 1.5356
187 para-aminopropriophenone 1 0.3768
187 pentobarbital 1 0.3173
187 percent 1 0.2523
187 po 4 1.357
187 poisoning 1 0.258
187 pressures 3 0.7415
187 raised 1 0.2238
187 rapid 1 0.1826
187 rate 3 0.4161
187 rats 6 0.8731
187 relation 1 0.1736
187 results 1 0.1079
187 rise 2 0.3742
187 saturation 1 0.3173
187 sodium 1 0.1813
187 steady 2 0.543
187 tensions 3 0.9051
187 tissues 1 0.1724
187 urethane 1 0.3768
187 various 1 0.149
188 (0-15 1 0.5024
188 (200 1 0.5024
188 (ffa) 1 0.4023
188 . 6 0.6785
188 12 1 0.2399
188 24 1 0.2606
188 3 1 0.1713
188 4 1 0.1777
188 acids 2 0.4948
188 addition 1 0.2559
188 adipose 5 2.0114
188 adults 1 0.3028
188 adults, 1 0.423
188 age 1 0.2078
188 albumin 1 0.3524
188 birth) 1 0.5024
188 birth, 1 0.3862
188 buffer 1 0.3862
188 concentrations 1 0.2582
188 containing 1 0.2657
188 could 1 0.1805
188 determined 1 0.2284
188 development 1 0.1834
188 end 1 0.3074
188 except 1 0.2834
188 fall 1 0.2631
188 fatty 2 0.5031
188 ffa 5 1.931
188 free 2 0.4762
188 glucose 1 0.2631
188 gluteal 1 0.5024
188 gradual 1 0.3731
188 groups 1 0.2046
188 high 1 0.1798
188 higher 1 0.216
188 hr 2 0.5811
188 human 1 0.1677
188 incubation 1 0.3074
188 infants 2 0.4797
188 krebs-ringer 1 0.5024
188 led 1 0.2944
188 level 3 0.5821
188 levels 1 0.1967
188 lower 1 0.2284
188 maximum 1 0.277
188 medium 1 0.2683
188 mg/100 1 0.4523
188 ml) 1 0.5024
188 mobilization 1 0.3731
188 months 2 0.5074
188 neous 1 0.5024
188 newborn 1 0.274
188 obtained 1 0.1791
188 phosphate 1 0.2537
188 pieces 1 0.423
188 played 1 0.4023
188 postnatal 1 0.4023
188 producing 1 0.3233
188 reached 1 0.3296
188 region 1 0.3364
188 release 3 0.97
188 role 1 0.2331
188 serum 3 0.5847
188 small 1 0.2015
188 still 1 0.2347
188 studied 1 0.175
188 subcuta- 1 0.5024
188 summary 1 0.4523
188 suppressed 1 0.3439
188 tissue 6 1.0464
188 typically 1 0.5024
188 within 1 0.1865
188 youngest 1 0.423
189 . 6 0.6785
189 400 1 0.4023
189 50 1 0.2399
189 albumin 1 0.3524
189 also 1 0.1406
189 and/or 2 0.6352
189 appreciate 1 0.5024
189 blood 3 0.4657
189 c. 2 0.5313
189 cardiac 3 0.6763
189 cardial 1 0.5024
189 chest 1 0.3524
189 colloidal 1 0.4523
189 consistent 1 0.2801
189 demonstrated 2 0.4296
189 detection 1 0.3123
189 determined 1 0.2284
189 difference 1 0.2515
189 effusion 2 0.7724
189 features, 1 0.4523
189 fluid 1 0.2381
189 former 1 0.3439
189 heart 1 0.2331
189 human 1 0.1677
189 interposition 1 0.5024
189 latter 1 0.2606
189 liver 2 0.3953
189 margin 1 0.423
189 marked 1 0.2254
189 normal 1 0.1351
189 observed 1 0.1713
189 outlined 1 0.4023
189 peri- 1 0.423
189 pericardial 2 0.7462
189 pericardium 1 0.5024
189 pool 2 0.7724
189 pool, 1 0.4523
189 position 1 0.3439
189 presence 1 0.1914
189 radiogold 1 0.5024
189 radioiodinated 1 0.4523
189 radioiso- 1 0.5024
189 radioisotope 1 0.3731
189 roentgenogram 1 0.4023
189 scanning 2 0.6728
189 scanning, 1 0.423
189 separated 1 0.3296
189 separation 1 0.2801
189 serum 1 0.1949
189 shown 1 0.216
189 silhouette 1 0.5024
189 six-foot 1 0.5024
189 thickening 2 0.7724
189 tope 1 0.5024
189 used 1 0.1897
190 . 6 0.6785
190 24 1 0.2606
190 24-h 1 0.5024
190 9 1 0.2631
190 action 2 0.4372
190 additional 1 0.2683
190 among 1 0.2347
190 appears 1 0.216
190 cell 2 0.3401
190 cells 5 0.7581
190 characteristics 2 0.5603
190 conditions 1 0.2284
190 contact 1 0.2905
190 continue 1 0.3862
190 cooperative 1 0.423
190 cribed 1 0.5024
190 culture 4 1.0062
190 des- 1 0.4523
190 differentiation 1 0.2869
190 disappears 1 0.423
190 discer- 1 0.5024
190 due 1 0.1777
190 effect 2 0.3068
190 enabled 1 0.5024
190 erythropoietin 6 2.7139
190 erythropoietin-induced 1 0.5024
190 fraction 1 0.2683
190 globin 1 0.4523
190 h 2 0.7724
190 hemo- 1 0.3731
190 hemoglobin 3 1.1586
190 hormone,. 1 0.5024
190 increases 1 0.2347
190 incubated 1 0.3862
190 intervals 1 0.3123
190 iv. 1 0.5024
190 lag 1 0.4023
190 large 1 0.1986
190 largely 1 0.3524
190 levels 1 0.1967
190 linear 1 0.3233
190 loss 1 0.2435
190 magnitude 1 0.3123
190 marrow 2 0.5031
190 maximal 1 0.3123
190 mechanism 1 0.2315
190 medium 2 0.5366
190 nible 1 0.5024
190 number 1 0.1923
190 one-half 1 0.3862
190 pre-- 1 0.5024
190 previously 1 0.2417
190 rat 1 0.2067
190 rate 1 0.1849
190 rather 1 0.2364
190 relationship 1 0.2417
190 replacement 1 0.3176
190 response 1 0.1834
190 rious 1 0.5024
190 sensitive 1 0.2711
190 sigmoid 1 0.5024
190 stimulation 1 0.2834
190 studied 1 0.175
190 suggesting 1 0.3074
190 synthesis 4 0.9978
190 time 3 0.5311
190 va- 1 0.423
191 . 2 0.4524
191 26 1 0.6352
191 appea- 1 1.0048
191 associated 1 0.3568
191 blood 2 0.621
191 buffy 1 1.0048
191 characteristics 1 0.5603
191 coat 1 0.9046
191 consistently 1 0.6466
191 dogs 2 1.0425
191 megakaryocytes 3 3.0145
191 occurrence 1 0.5969
191 peripheral 2 1.1938
191 rance 1 1.0048
191 revealed 1 0.4871
191 smears 1 0.8461
191 study 1 0.3096
191 unusual 1 0.6352
192 . 7 0.6785
192 11.5 1 0.4306
192 26 1 0.2722
192 30 3 0.6168
192 34 1 0.3021
192 48 1 0.2429
192 50 1 0.2056
192 76 1 0.3877
192 81 1 0.4306
192 allowed 1 0.3021
192 approximately 1 0.2255
192 atrial 1 0.2771
192 average 1 0.1932
192 basal 1 0.2825
192 blood 1 0.1331
192 c 3 0.7045
192 calculated 2 0.5767
192 cardiac 2 0.3865
192 cent 4 0.8854
192 cent, 1 0.331
192 change 2 0.3995
192 concomitant 1 0.331
192 consistent 1 0.2401
192 cooling 1 0.2595
192 correlated 1 0.2558
192 decreased 2 0.389
192 direction 1 0.3021
192 dissociation, 1 0.3877
192 effect 1 0.1315
192 effects 1 0.1599
192 estimated 1 0.2677
192 four 1 0.1932
192 haemodynamic 1 0.3626
192 hypothermia 2 0.4427
192 increase 1 0.1463
192 increased 1 0.1339
192 induction 1 0.2771
192 intracranial 1 0.2825
192 magnitude 1 0.2677
192 man.. 1 0.4306
192 mean 2 0.4143
192 metabolic 1 0.2056
192 mixed 3 0.8167
192 moderate 1 0.2558
192 observed 1 0.1468
192 occur 1 0.2104
192 opera- 1 0.331
192 output 2 0.5047
192 oxygen 7 1.5356
192 patients 1 0.1035
192 patients, 1 0.2156
192 per 5 0.8392
192 performed 1 0.1971
192 predicted 1 0.331
192 regard 1 0.2459
192 remained 1 0.2459
192 result 1 0.1863
192 resulting 1 0.2194
192 reversal 1 0.3626
192 right 1 0.2234
192 rise 1 0.2138
192 saturation 1 0.3626
192 saturations 2 0.8613
192 shivering 1 0.3626
192 studies 1 0.1319
192 surface 1 0.2324
192 svc 1 0.4306
192 temperature 1 0.23
192 tension 1 0.2595
192 time, 1 0.249
192 tion 1 0.1958
192 two 1 0.1319
192 unchanged 1 0.331
192 undergoing 1 0.2722
192 uptake 3 0.8474
192 value 1 0.1984
192 venous 3 0.7288
192 virtually 1 0.3626
192 well 1 0.1506
192 without 1 0.1626
193 -dash 1 0.3439
193 . 6 0.6785
193 adversely 1 0.4523
193 background 1 0.3731
193 bent 1 0.5024
193 blood 1 0.1552
193 brigham 1 0.5024
193 cases 1 0.1495
193 clinical 1 0.1638
193 collected 1 0.362
193 common, 1 0.4523
193 conducted 1 0.3439
193 data 1 0.2046
193 evaluation 1 0.2711
193 fifty 1 0.362
193 hospital 1 0.3176
193 incidence 1 0.2399
193 indicate 1 0.2212
193 influenced 1 0.3123
193 insufficiency 1 0.2985
193 involvement 2 0.6591
193 light 1 0.2834
193 like 1 0.3233
193 ln 1 0.5024
193 lupus 3 0.9887
193 manifestations 1 0.2869
193 may 1 0.1257
193 necessarily 1 0.3439
193 nephritis 2 0.9046
193 nephritis, 1 0.423
193 only, 1 0.4023
193 onset 1 0.2905
193 pattern 1 0.2399
193 period 1 0.1906
193 peter 1 0.4523
193 picture 1 0.274
193 poor 1 0.2905
193 present 1 0.1654
193 pressure 1 0.2299
193 prognosis 3 0.831
193 published 1 0.3364
193 raised 1 0.2985
193 renal 4 0.7797
193 reviewed 1 0.2834
193 series 1 0.2364
193 short-term 1 0.3731
193 sle 3 1.2691
193 sle, 1 0.4523
193 spectrum 2 0.8046
193 sustained 1 0.3862
193 syndrome 1 0.2331
193 ten 1 0.3028
193 therapy 1 0.1986
193 variable 1 0.3028
193 wide 1 0.2985
193 without 1 0.1897
193 year 1 0.2606
194 (hcr 1 0.3015
194 ) 1 0.2172
194 . 10 0.6785
194 168 3 0.6952
194 acid 1 0.1164
194 acriflavin 1 0.3015
194 acriflavin, 1 0.3015
194 approached 1 0.3015
194 b. 4 0.6723
194 bacillus 2 0.3443
194 bacteriophage 1 0.2238
194 cell 1 0.102
194 centers 1 0.2114
194 clear 1 0.1817
194 comparison 1 0.1564
194 competent 1 0.2172
194 concentration 1 0.1267
194 cultures 1 0.1509
194 curves 2 0.3748
194 deoxyribonucleic 1 0.2114
194 difference 2 0.3018
194 discussed 1 0.1228
194 dna 7 1.0074
194 effect 1 0.092
194 even 1 0.1319
194 explanations 1 0.2538
194 extracted 1 0.2018
194 free 3 0.4286
194 greater 3 0.3741
194 hcr 4 1.2058
194 host 5 0.7819
194 host, 1 0.3015
194 inactivation 2 0.4037
194 increased 1 0.0937
194 incubated 1 0.2317
194 infectious 6 1.3903
194 inhibits 1 0.2018
194 isolated 1 0.1312
194 less 1 0.1129
194 light 1 0.1701
194 linear 1 0.194
194 little 1 0.161
194 much 3 0.4007
194 mutant 2 0.4344
194 mutants 1 0.2317
194 non-host 1 0.3015
194 numbers 1 0.1791
194 obtained 2 0.2149
194 parental 1 0.2172
194 phage 6 1.164
194 phage, 1 0.2414
194 plaque 1 0.2714
194 possible 1 0.1209
194 rate 2 0.2219
194 reactivating 1 0.3015
194 reactivation, 1 0.3015
194 relationship 1 0.145
194 sensitivity 5 0.9083
194 spo2 2 0.6029
194 spo2, 1 0.3015
194 steeper 1 0.3015
194 still 1 0.1408
194 strain 1 0.1594
194 subtilis 6 0.9972
194 survival 2 0.29
194 temperate 1 0.2714
194 ultraviolet 5 1.1586
194 used 4 0.4554
195 . 6 0.6785
195 350 1 0.5024
195 acetobacter 3 1.5073
195 actively 1 0.3731
195 also 2 0.2811
195 apples, 1 0.5024
195 bacillus 4 1.1476
195 bacteria 1 0.3233
195 bacteriophages 2 0.8046
195 best 1 0.2657
195 capsomeres 1 0.5024
195 cell 1 0.17
195 coliphage 1 0.5024
195 conditions 1 0.2284
195 consisted 1 0.2985
195 containing 1 0.2657
195 contractile 2 0.8461
195 dividing 1 0.3862
195 found 2 0.2645
195 grass 1 0.5024
195 habitat 1 0.5024
195 head 4 1.3182
195 host 1 0.2606
195 included 1 0.2711
195 interest 1 0.3364
195 isolated,. 1 0.5024
195 isolation 1 0.3233
195 killer 1 0.5024
195 killing 1 0.5024
195 large 1 0.1986
195 long 1 0.2606
195 medium 1 0.2683
195 morphological 1 0.3074
195 morphology 1 0.3074
195 multiplying 1 0.5024
195 natural 1 0.2944
195 needle 1 0.3862
195 new 2 0.4398
195 oblong 1 0.5024
195 one 2 0.2811
195 particle 1 0.3862
195 particle, 1 0.5024
195 particular 1 0.2537
195 phage 2 0.6466
195 phages 1 0.3862
195 plate 1 0.423
195 probably 1 0.2284
195 prominence 1 0.4523
195 property 1 0.4023
195 provided 1 0.3074
195 resembled 1 0.362
195 respectively 1 0.3439
195 rotting 1 0.5024
195 semi-solid 1 0.5024
195 sensitive 1 0.2711
195 short 1 0.2905
195 so-called 1 0.362
195 species 2 0.548
195 specific 1 0.1977
195 t3 1 0.5024
195 tail 3 1.5073
195 tail, 1 0.5024
195 three-pronged 1 0.5024
195 type 1 0.2089
195 virulent 1 0.4023
195 within 1 0.1865
196 (sp5 1 0.3349
196 (university 1 0.3349
196 ) 1 0.2413
196 . 9 0.6785
196 / 1 0.3349
196 /star/ 1 0.3349
196 /transforming 1 0.3349
196 1 2 0.253
196 1, 1 0.2155
196 168 1 0.2575
196 168b, 1 0.3349
196 1965.--a 1 0.3349
196 90..1655-1663. 1 0.3349
196 able 1 0.189
196 adsorption 1 0.2682
196 alpha, 1 0.3349
196 angeles), 1 0.3349
196 anna 1 0.3349
196 another 1 0.1827
196 b. 4 0.747
196 bacillus 3 0.5738
196 bacteriol. 1 0.3349
196 bacteriophages 2 0.5364
196 beta, 1 0.3349
196 brodetsky, 1 0.3349
196 calcium 1 0.199
196 california, 1 0.3349
196 capable 1 0.2049
196 characteristics, 1 0.3015
196 characterization 2 0.5641
196 characterization, 1 0.3349
196 characterized 1 0.1771
196 designated 1 0.2487
196 efficiently 1 0.3349
196 examined 1 0.1691
196 except 1 0.189
196 first 1 0.1228
196 five 1 0.1771
196 following 1 0.111
196 group 4 0.4953
196 growth 2 0.2283
196 host 5 0.8687
196 inactivation 1 0.2243
196 inactivation, 1 0.3349
196 included 1 0.1807
196 irradiation 1 0.1807
196 isolated 1 0.1457
196 isolated, 1 0.2575
196 j. 1 0.2575
196 kinetics, 1 0.3015
196 los 1 0.3015
196 m. 1 0.1868
196 marburg 1 0.3349
196 morphology, 1 0.3349
196 mutant 1 0.2413
196 mutant, 1 0.3349
196 mutants 1 0.2575
196 neutralization, 1 0.3349
196 none 1 0.2019
196 one-step 1 0.3349
196 pbs1, 1 0.3349
196 phages 3 0.7724
196 phages, 4 1.3398
196 plaque 1 0.3015
196 properties.. 1 0.3349
196 r. 1 0.2293
196 range 1 0.1807
196 range, 1 0.3015
196 referred 1 0.199
196 replicate 1 0.3349
196 requirements, 1 0.3349
196 romig 1 0.3349
196 sb19 2 0.6699
196 sb19, 1 0.3349
196 serum 1 0.1299
196 six 1 0.1847
196 sp 2 0.5364
196 sp10, 1 0.3349
196 sp13 1 0.3349
196 sp13, 2 0.6699
196 sp3, 1 0.3349
196 sp5, 1 0.3349
196 sp6, 1 0.3349
196 sp7, 1 0.3349
196 sp8, 1 0.3015
196 sp9 1 0.3349
196 sp9, 1 0.3349
196 stability, 1 0.3015
196 star 1 0.3349
196 strain 1 0.1771
196 studies 1 0.1026
196 subtilis 7 1.2926
196 thermal 1 0.282
196 ultraviolet 1 0.2575
196 unrelated 1 0.2349
196 use 1 0.1324
196 used 1 0.1265
196 w. 1 0.2682
197 (i) 1 0.1493
197 (ii) 1 0.1493
197 (iii) 1 0.1493
197 (iv) 1 0.1596
197 (v) 1 0.1596
197 (vi) 1 0.1596
197 (vii) 1 0.1773
197 . 17 0.6785
197 /bacteriocin/-like 1 0.1773
197 1 1 0.067
197 1-type 1 0.1773
197 10 3 0.1958
197 168 2 0.2726
197 231 1 0.1773
197 active 1 0.0817
197 addition 1 0.0903
197 adequate 1 0.1102
197 advantages 1 0.1244
197 agents 1 0.0957
197 al. 1 0.1278
197 ammonia 3 0.4789
197 among 1 0.0828
197 analogous 1 0.142
197 antigenic 1 0.1039
197 assimilation 1 0.1596
197 auxotrophs 1 0.1596
197 b. 3 0.2966
197 bacillus 1 0.1013
197 bacteria 2 0.2282
197 bacteriocin 1 0.1773
197 basis 1 0.0776
197 c 1 0.0967
197 capable 1 0.1085
197 cells 1 0.0535
197 certain 1 0.0781
197 common 1 0.0866
197 comparative 1 0.1085
197 concerning 1 0.1102
197 condition 1 0.0947
197 considerably 1 0.1141
197 cultural 1 0.142
197 cultures 1 0.0888
197 defective 1 0.1214
197 derivatives 1 0.1317
197 differed 1 0.1214
197 differences 1 0.0811
197 divided 2 0.2487
197 effective 1 0.0888
197 et 1 0.1187
197 examinations 1 0.1214
197 examined 3 0.2686
197 finding 1 0.1085
197 found 1 0.0467
197 frequencies 1 0.1773
197 frequency, 1 0.1596
197 groups 2 0.1444
197 histidine 1 0.142
197 host 2 0.184
197 identical 1 0.1053
197 incapable 1 0.1596
197 ind 2 0.3546
197 indole 1 0.1773
197 induction 1 0.1141
197 influenced 1 0.1102
197 isolated 1 0.0772
197 laboratories 1 0.1596
197 laboratory 1 0.1025
197 less 1 0.0664
197 liberated 1 0.1493
197 loci 1 0.1596
197 lysates 1 0.1773
197 lysogenic 1 0.142
197 maintained 1 0.0989
197 materials 1 0.1244
197 mitomycin 1 0.1773
197 negative 1 0.1039
197 nrs 1 0.1773
197 observed 1 0.0604
197 one 1 0.0496
197 order 2 0.1857
197 owing 1 0.1187
197 partly 2 0.2726
197 pbs 2 0.3546
197 pbsx 1 0.1773
197 phage 3 0.3423
197 phage, 1 0.142
197 phages 7 0.9542
197 physiological 1 0.1039
197 prepared 1 0.1069
197 presumably 1 0.1163
197 principles 1 0.1214
197 probably 1 0.0806
197 production 1 0.0903
197 properties 1 0.0947
197 range 1 0.0957
197 ray 1 0.1773
197 revealed 1 0.086
197 seaman 1 0.1773
197 sensitive 1 0.0957
197 several 1 0.0767
197 shown 1 0.0763
197 sp 1 0.142
197 strain 3 0.2813
197 strains 2 0.2107
197 structure 1 0.0903
197 studied 1 0.0618
197 substrains 1 0.1773
197 subtilis 6 0.5866
197 suitable 1 0.1141
197 technical 1 0.1278
197 temperate 3 0.4789
197 thus 1 0.092
197 titration 1 0.1596
197 transducible 1 0.1773
197 transducing 1 0.1493
197 transductants 1 0.1773
197 transduction 4 0.7093
197 two 2 0.1086
197 ultraviolet 1 0.1363
197 use 1 0.0701
197 using 1 0.0806
197 various 1 0.0701
197 yielded 1 0.1121
198 . 12 0.6785
198 10 1 0.0925
198 60 1 0.1617
198 80 1 0.172
198 ability 1 0.128
198 activity 1 0.0899
198 antiserum 2 0.3364
198 attacks 1 0.2262
198 b. 1 0.1401
198 bacillus 2 0.2869
198 bacteria 3 0.485
198 bacterial 4 0.5888
198 bacteriophage 2 0.3731
198 bacterium 1 0.2512
198 best 1 0.1328
198 broth 1 0.1931
198 carrier 4 0.8461
198 centers 1 0.1762
198 characteristic 1 0.1268
198 chemically 1 0.1865
198 clones 1 0.2262
198 complementary 1 0.2011
198 complex 1 0.1453
198 conclusions 1 0.1588
198 contain 1 0.1617
198 containing 1 0.1328
198 cultivation 1 0.2512
198 culture 1 0.1258
198 cultures 1 0.1258
198 density 1 0.1648
198 deoxyribonuclease 1 0.2512
198 derived 1 0.1385
198 described 1 0.0953
198 detected 1 0.1303
198 different 1 0.0889
198 dna 9 1.0793
198 enzymatically 1 0.2115
198 even 1 0.11
198 extracts 1 0.1537
198 failure 1 0.1355
198 form 2 0.2186
198 four 1 0.1127
198 give 1 0.137
198 heating 1 0.1931
198 homology 2 0.5024
198 host 1 0.1303
198 hours' 1 0.2262
198 immunity 1 0.181
198 incorporated 1 0.1865
198 incubation 1 0.1537
198 infect 1 0.2115
198 infected 7 0.9589
198 infection 1 0.1182
198 infective 1 0.181
198 isolations 1 0.2262
198 lack 1 0.1453
198 leads 1 0.1401
198 loss 2 0.2435
198 lysogenic 1 0.2011
198 may 1 0.0628
198 medium 1 0.1342
198 nutrient 1 0.2262
198 organisms 2 0.3074
198 particle 1 0.1931
198 per 1 0.0979
198 phage 6 0.97
198 phage, 1 0.2011
198 phage-bacterial 1 0.2512
198 phage-induced 1 0.2512
198 prepared 1 0.1514
198 previous 1 0.1355
198 produce 2 0.2683
198 recombination 1 0.1931
198 reinforce 1 0.2512
198 relationship 1 0.1208
198 retain 1 0.2262
198 rise 1 0.1247
198 rna 1 0.1385
198 single-colony 1 0.2512
198 six 1 0.1385
198 sp10 4 1.0048
198 spores 3 0.6785
198 state 2 0.2582
198 subtilis 3 0.4155
198 successive 1 0.2011
198 system 1 0.1173
198 therefore 1 0.1537
198 transducing 3 0.6346
198 treatment 1 0.0741
198 truly 1 0.2512
198 viral 2 0.3028
198 virus 2 0.2631
198 vitro 1 0.1291
198 without 1 0.0949
198 yield 1 0.1865
198 yields 1 0.2512
199 (approximately 1 0.2153
199 . 14 0.6785
199 /marker 1 0.2153
199 10 1 0.0793
199 13 1 0.1245
199 130 1 0.2153
199 ability 1 0.1097
199 accomplished 1 0.1599
199 adsorbed 1 0.1939
199 amount 1 0.106
199 attainment 1 0.2153
199 b. 2 0.2401
199 bacillus 2 0.2459
199 bacteriophage 1 0.1599
199 bacteriophage, 1 0.2153
199 become 1 0.1187
199 breakage-reunion 1 0.2153
199 carry 1 0.1551
199 cells 2 0.13
199 center 1 0.1386
199 centers 3 0.4531
199 closely 1 0.123
199 co-operative 1 0.1939
199 competent 1 0.1551
199 concentration 2 0.1811
199 concentrations 2 0.2213
199 conditions, 1 0.1655
199 confirm 1 0.1813
199 contained 1 0.1097
199 daltons) 1 0.2153
199 denatured 1 0.1939
199 density 1 0.1412
199 described 2 0.1633
199 detected 1 0.1117
199 differs 1 0.1474
199 directly 1 0.1361
199 discussed 1 0.0877
199 dna 14 1.4391
199 dna's 1 0.2153
199 dna-infected 1 0.2153
199 dnase 2 0.3626
199 effciency 1 0.2153
199 elicited 1 0.151
199 equivalent 1 0.151
199 existence 1 0.1317
199 exposed 1 0.1128
199 extracted 1 0.1442
199 failure 1 0.1162
199 formation 1 0.0966
199 four 1 0.0966
199 genetic 1 0.1128
199 half 1 0.1262
199 however, 1 0.078
199 infecting 1 0.2153
199 infection 2 0.2026
199 infective 7 1.086
199 infectivity 1 0.2153
199 initiate 1 0.2153
199 irreversibly 1 0.1939
199 isolated 3 0.281
199 least 1 0.1107
199 low 1 0.0942
199 measured 1 0.0942
199 minutes 1 0.1412
199 mixed 1 0.1361
199 molecular 2 0.2558
199 molecules 2 0.3021
199 multiple-event 1 0.2153
199 mutant 1 0.1551
199 mutants 1 0.1655
199 nature 1 0.1069
199 newly 1 0.1442
199 non-allelic 1 0.2153
199 obligatory 1 0.2153
199 phage 7 0.97
199 phenomenon 1 0.1245
199 pieces, 1 0.2153
199 plaque-forming 1 0.2153
199 plaques 1 0.2153
199 plating 2 0.3877
199 precludes 1 0.2153
199 procedure 1 0.1097
199 process 1 0.0985
199 proportional 1 0.1724
199 reasons 1 0.1442
199 recombination 1 0.1655
199 recovered 1 0.1338
199 related 1 0.091
199 require 1 0.1474
199 required 1 0.1174
199 rescue 1 0.2153
199 rescue/ 1 0.2153
199 resistance 1 0.1201
199 resistant 1 0.1317
199 response 1 0.0786
199 sb-1 1 0.2153
199 second 1 0.1097
199 selective 1 0.1279
199 single 2 0.2138
199 sp8 1 0.2153
199 sp8, 1 0.1939
199 sp82 2 0.4306
199 sp82, 1 0.2153
199 specific 1 0.0847
199 strain 1 0.1139
199 studies 1 0.0659
199 subsequently 1 0.1442
199 subtilis 3 0.3561
199 subtilis, 1 0.1724
199 suggests 1 0.115
199 superinfecting 1 0.2153
199 system, 1 0.1813
199 temperature-sensitive 2 0.4306
199 terms 1 0.1317
199 time 1 0.0759
199 totally 1 0.151
199 two 1 0.0659
199 unaided 1 0.2153
199 utilizes 1 0.2153
199 weight 1 0.1013
199 weight, 1 0.1442
199 whole 1 0.1201
199 wild-type 1 0.2153
199 x 1 0.1361
200 'psychophylaxis 1 0.1773
200 (constitutional 1 0.1773
200 (educational 1 0.1773
200 (pressure 1 0.1773
200 (psychophylaxis) 1 0.1773
200 -dash 2 0.2428
200 . 17 0.6785
200 1. 1 0.0929
200 2. 1 0.0929
200 3. 1 0.0957
200 according 1 0.0957
200 adverse 1 0.1363
200 affected.. 1 0.1773
200 aim 2 0.3193
200 also 2 0.0992
200 always 1 0.0947
200 analysis 1 0.0853
200 anxiety 1 0.1102
200 appear 1 0.0811
200 applied 1 0.1069
200 attitude 1 0.142
200 background 1 0.1317
200 based 1 0.0929
200 basic 1 0.1214
200 beside 1 0.1596
200 better 1 0.1025
200 called 1 0.1278
200 cases 1 0.0528
200 categories 1 0.1317
200 child 6 0.5118
200 child's 2 0.217
200 children 4 0.2519
200 children's 1 0.1278
200 classed 1 0.1596
200 close 1 0.1039
200 communication 1 0.0978
200 consists 1 0.1121
200 contact 1 0.1025
200 cooperating 1 0.1773
200 correct 1 0.1214
200 deals 1 0.1363
200 dealt 1 0.142
200 degree 1 0.0786
200 demonstrates 1 0.142
200 dental 6 0.79
200 dentistry 1 0.1773
200 dentistry' 1 0.1773
200 determine 1 0.1
200 development 1 0.0647
200 difficult 3 0.3423
200 discover 1 0.142
200 due 1 0.0627
200 elicited 1 0.1244
200 emotional 2 0.1977
200 employ 1 0.1596
200 ensure 1 0.1493
200 etc 1 0.1773
200 etc.) 1 0.1773
200 exacting 1 0.1773
200 experiences 1 0.1187
200 experimental 1 0.0823
200 extremely 1 0.1244
200 extrinsic 1 0.142
200 fear 1 0.1773
200 find 1 0.1214
200 findings 1 0.0704
200 following 1 0.0588
200 frame 1 0.1773
200 groups 1 0.0722
200 hearing 1 0.1163
200 helps 2 0.3193
200 hereditary) 1 0.1773
200 impressions 1 0.1773
200 impulses 1 0.1773
200 influences 1 0.1363
200 interdependent 1 0.1773
200 intrinsic 1 0.1244
200 involved 1 0.0903
200 management 2 0.1875
200 manifest 1 0.1317
200 many 1 0.0715
200 may 2 0.0887
200 measures 1 0.1163
200 measures-psychotherapy, 1 0.1773
200 mind 1 0.1596
200 mode 1 0.1278
200 nearly 1 0.1085
200 necessary 1 0.1039
200 negative 1 0.1039
200 often 1 0.086
200 others 1 0.0967
200 pain 1 0.1163
200 part 1 0.0828
200 patients 1 0.0426
200 policy 1 0.1773
200 premedication 1 0.1773
200 prevented 1 0.1163
200 principles 1 0.1214
200 procedure 2 0.1807
200 psyche 1 0.1773
200 psychic 2 0.2986
200 psychological 4 0.4484
200 psychology 2 0.2986
200 raised 1 0.1053
200 reactions 1 0.0866
200 relatively 1 0.0853
200 response 1 0.0647
200 second 1 0.0903
200 section 1 0.142
200 seeing 1 0.1596
200 sensation), 1 0.1773
200 senses 2 0.3546
200 sensory 1 0.1317
200 series 1 0.0834
200 similar 1 0.0664
200 simple 1 0.0967
200 situation 2 0.284
200 smell 1 0.1773
200 sometimes 1 0.1141
200 state 1 0.0911
200 step 2 0.2633
200 subject 1 0.1141
200 suggestion 1 0.1317
200 summarized 1 0.1596
200 surgery 2 0.1761
200 susceptible 1 0.1596
200 taste 1 0.1773
200 tension 1 0.1069
200 touch 1 0.1773
200 traumatization 2 0.3546
200 traumatizing 1 0.1773
200 treatment 9 0.4709
200 understand 1 0.1493
200 understanding 1 0.1163
200 work 1 0.1214
200 would 1 0.088
200 yet 1 0.0938
201 . 12 0.6785
201 /abnormal/ 1 0.2512
201 /normal/ 1 0.2512
201 160 1 0.2262
201 abnormal 3 0.3653
201 activation 1 0.1865
201 addition, 1 0.1453
201 administered 1 0.1199
201 age 1 0.1039
201 anxiety 4 0.6246
201 anxiety, 1 0.2011
201 assess 1 0.2115
201 attributable 1 0.172
201 beginning 1 0.1588
201 birth 2 0.2559
201 cases 1 0.0747
201 changes 5 0.3758
201 characteristics 1 0.1401
201 classified 1 0.1514
201 clinical 2 0.1638
201 complications 2 0.2944
201 condition 1 0.1342
201 contention 1 0.2115
201 course 1 0.1142
201 defenses 1 0.2262
201 delivery, 3 0.6785
201 demonstrable 1 0.1682
201 dependent 1 0.1617
201 designed 1 0.181
201 differences 4 0.4598
201 ego 1 0.181
201 egy 1 0.2512
201 emotional 3 0.4202
201 experienced 1 0.1865
201 factors 1 0.1062
201 following 2 0.1665
201 found 2 0.1323
201 found, 1 0.1762
201 greater 2 0.2078
201 group 2 0.1857
201 group's 1 0.2512
201 groups 2 0.2046
201 however, 1 0.091
201 intelligence 2 0.3731
201 interpreted 1 0.172
201 kent 1 0.2512
201 lability 1 0.2512
201 labor 2 0.423
201 largely 1 0.1762
201 magnitude 1 0.1562
201 manifest 4 0.7462
201 mean 1 0.1208
201 mmpi 2 0.5024
201 neuroticism, 1 0.2512
201 normal 1 0.0676
201 observed 1 0.0856
201 obstetric 4 1.0048
201 offspring 1 0.2262
201 partum 1 0.2512
201 partum, 1 0.2262
201 parturition, 1 0.2512
201 patient 1 0.0945
201 patients 1 0.0604
201 personality 5 1.0576
201 physiological 1 0.1472
201 positive 1 0.1342
201 post 2 0.3524
201 postdelivery 1 0.2512
201 pre- 1 0.1617
201 predelivery 2 0.5024
201 pregnancy 2 0.2944
201 pregnancy, 2 0.3731
201 primigravidas 2 0.5024
201 psychological 1 0.1588
201 quite 1 0.1434
201 readministered 1 0.2512
201 regulator 1 0.2512
201 related 1 0.1062
201 relation 1 0.1157
201 relationship 2 0.2417
201 reliable 2 0.3364
201 respect 1 0.1472
201 ruminative 1 0.2512
201 scale, 2 0.423
201 showed 1 0.0895
201 significant 1 0.0882
201 similar 1 0.094
201 stability 1 0.1865
201 striking 1 0.1588
201 study 1 0.0774
201 subgroups 2 0.4023
201 supported 1 0.181
201 systems 1 0.1762
201 taylor 2 0.5024
201 third 1 0.137
201 time 2 0.177
201 times 1 0.1208
201 total 1 0.0979
201 trimester 1 0.2115
201 unmarried 2 0.4523
201 upset 1 0.2512
201 use 1 0.0993
201 various 1 0.0993
201 weight, 1 0.1682
201 weights 1 0.1762
201 white 1 0.1562
202 . 6 0.6785
202 19 1 0.3364
202 23 1 0.3364
202 ages 1 0.362
202 anxieties 3 1.357
202 anxiety 3 0.9369
202 benjamin 1 0.5024
202 benjamin's 1 0.5024
202 concerning 1 0.3123
202 deductive 1 0.5024
202 differences 2 0.4598
202 differentiation 1 0.2869
202 direct 1 0.2364
202 dynamics 1 0.4023
202 findings 1 0.1996
202 found 2 0.2645
202 highest 1 0.3176
202 hypotheses 1 0.3862
202 immediate 1 0.3176
202 individuals 1 0.3439
202 infancy 1 0.3524
202 infantile 1 0.274
202 infants 1 0.2399
202 intensity 1 0.3524
202 intensity, 1 0.5024
202 interviews 1 0.5024
202 longitudinally 1 0.5024
202 made 1 0.182
202 months 1 0.2537
202 mother 2 0.5738
202 observations 1 0.2112
202 onset, 1 0.423
202 period 1 0.1906
202 predictions 1 0.4523
202 ratios 1 0.3296
202 relationship 1 0.2417
202 responses 1 0.2801
202 separation 2 0.5603
202 separations 1 0.4523
202 sex 1 0.3364
202 stranger 2 1.0048
202 strangers 1 0.5024
202 studied 1 0.175
202 supported 1 0.362
202 supportive 1 0.4023
202 termination, 1 0.5024
202 tests 1 0.2474
202 three 1 0.1889
202 two 3 0.4616
203 . 10 0.6785
203 20 1 0.1361
203 40-50 1 0.3015
203 ability 1 0.1536
203 adolescents 1 0.2414
203 aetiological 1 0.2714
203 also 2 0.1687
203 anxiety 1 0.1874
203 assumed 1 0.2064
203 background 1 0.2238
203 characteristic 1 0.1522
203 children 3 0.3211
203 clearly 1 0.1817
203 congenital 1 0.1379
203 constant 1 0.1644
203 constipation 1 0.3015
203 contacts 1 0.2714
203 deficiency 1 0.1594
203 described 1 0.1143
203 detail 1 0.2317
203 disease 1 0.1083
203 distinguishable 1 0.2714
203 episodes 1 0.2317
203 establish 1 0.2538
203 facies 1 0.3015
203 factors 1 0.1274
203 failure 1 0.1627
203 forms 1 0.1439
203 great 2 0.3443
203 heart 1 0.1398
203 hypercalcaemia 2 0.6029
203 infancy, 1 0.2238
203 infantile 1 0.1644
203 insecurity 1 0.3015
203 interper- 1 0.3015
203 involved 1 0.1536
203 iq 1 0.2414
203 loquacity 1 0.3015
203 mental 2 0.3401
203 mentally 1 0.2172
203 number 1 0.1154
203 observed 1 0.1028
203 often 1 0.1461
203 ordination 1 0.3015
203 outstanding 1 0.2538
203 points 1 0.2064
203 poor 1 0.1743
203 recognise 1 0.3015
203 related 1 0.1274
203 retardation 1 0.2064
203 retarded 1 0.194
203 show 3 0.3912
203 similarities 1 0.2238
203 similarity 1 0.2317
203 sonal 1 0.3015
203 stands 1 0.3015
203 striking 1 0.1906
203 therefore 1 0.1844
203 thrive 1 0.3015
203 type 1 0.1254
203 usually 1 0.1418
203 vomiting, 1 0.2714
203 well-defined 1 0.3015
203 years 1 0.137
204 . 9 0.6785
204 act 1 0.2082
204 adaptation, 1 0.282
204 aggression 1 0.282
204 also 1 0.0937
204 anxieties, 1 0.3349
204 archaic, 1 0.3349
204 around 1 0.2243
204 arranged 1 0.2487
204 average 1 0.1503
204 castration 1 0.3015
204 cat, 1 0.3015
204 certain 1 0.1475
204 character 1 0.2349
204 child 2 0.3222
204 child's 1 0.2049
204 children, 1 0.1963
204 circumcision 1 0.3349
204 circumcision, 2 0.6699
204 coming 2 0.6031
204 concerning 1 0.2082
204 control 1 0.1259
204 controlling 1 0.282
204 dam 1 0.3349
204 defensive 2 0.6031
204 detrimental 1 0.282
204 discussed 1 0.1364
204 disturbing 1 0.3349
204 effects 3 0.373
204 ego 2 0.4827
204 ego, 1 0.282
204 evaluate 1 0.2487
204 expressed 1 0.2413
204 fears, 1 0.3349
204 feeling 1 0.3349
204 following 2 0.2221
204 forces 1 0.2575
204 formulations, 1 0.3349
204 functioning 1 0.2293
204 future 1 0.2413
204 given 1 0.1228
204 goodenough 1 0.3349
204 hidden 1 0.3015
204 impulses, 1 0.3349
204 initiating 1 0.282
204 instinctual 2 0.6699
204 insulates 1 0.3349
204 isolates 1 0.2487
204 level, 1 0.282
204 loosens 1 0.3349
204 low 1 0.1466
204 mechanisms 1 0.2019
204 operation 2 0.3508
204 order 1 0.1754
204 outside, 1 0.3349
204 particularly 1 0.1847
204 perceived 1 0.3349
204 performed 1 0.1533
204 phallic 1 0.3349
204 possibilities 1 0.2487
204 previously 1 0.1611
204 primitive, 1 0.3349
204 prior 1 0.1789
204 protection 1 0.2155
204 psychoanalytic 1 0.3349
204 psychological 2 0.4235
204 questions 1 0.2487
204 raised 1 0.199
204 reality 1 0.282
204 regression, 1 0.282
204 renders 1 0.3015
204 research 2 0.4394
204 results 2 0.1918
204 rorschach 1 0.3349
204 safety 1 0.3349
204 seeks 1 0.3349
204 sets 1 0.3015
204 showed 1 0.1194
204 small 1 0.1344
204 socio-economic 1 0.3015
204 stage 1 0.1624
204 stimuli 1 0.2413
204 stories, 1 0.3349
204 strength 1 0.2487
204 study 2 0.2064
204 suggested 1 0.1393
204 surge 1 0.3349
204 test, 1 0.2487
204 tests 1 0.1649
204 threats 1 0.3015
204 thus 1 0.1737
204 total 1 0.1305
204 twelve 1 0.2117
204 two 1 0.1026
204 unsocialized 1 0.3349
204 weakening 1 0.3349
204 withdrawal, 1 0.282
204 within 1 0.1243
205 (i) 1 0.3626
205 (ii) 1 0.3626
205 (iii) 1 0.3626
205 (iv) 1 0.3877
205 (types 1 0.4306
205 (v) 1 0.3877
205 (vi) 1 0.3877
205 -dash 2 0.5896
205 . 7 0.6785
205 387 1 0.4306
205 age, 1 0.2825
205 aggression 2 0.7252
205 analyses 2 0.5767
205 analysis 1 0.2071
205 analyzed 1 0.2948
205 and, 1 0.2234
205 anxiety 2 0.5354
205 anxiety, 3 1.0345
205 apathy-withdrawal 1 0.4306
205 authority 1 0.3877
205 authority, 1 0.4306
205 behavior 2 0.4918
205 birth 1 0.2194
205 cases, 1 0.2255
205 change 1 0.1998
205 changes 2 0.2577
205 children 1 0.1529
205 children's 3 0.9308
205 combination 1 0.2459
205 comparison 1 0.2234
205 correlates 1 0.3877
205 degree 1 0.1908
205 dimensions 1 0.3448
205 discharge 1 0.4306
205 disturbance, 1 0.4306
205 duration 1 0.2255
205 eating 1 0.4306
205 essentially 1 0.2948
205 evaluated 1 0.249
205 experience 1 0.2213
205 experienced 1 0.3198
205 factor 2 0.4082
205 factors 1 0.1821
205 following 1 0.1427
205 four 1 0.1932
205 full 1 0.2883
205 general 1 0.2194
205 general, 1 0.3103
205 hospitalization 4 1.3793
205 hospitalization, 3 1.1631
205 illness 2 0.6621
205 increased 3 0.4016
205 indicated 1 0.2026
205 indicative 1 0.331
205 levels 1 0.1686
205 mean 1 0.2071
205 means 1 0.1908
205 multivariate 1 0.3877
205 occupational 1 0.3626
205 one 1 0.1205
205 order 1 0.2255
205 overall 1 0.2825
205 pain 1 0.2825
205 parents 1 0.3103
205 prior 1 0.23
205 psychologically 1 0.4306
205 questionnaire 1 0.3877
205 regression, 1 0.3626
205 related 1 0.1821
205 response 2 0.3145
205 responses 2 0.4802
205 responses) 1 0.4306
205 resulting 1 0.2194
205 revealed 1 0.2087
205 sample 1 0.3198
205 score, 1 0.4306
205 scores 2 0.6896
205 sent 1 0.3626
205 separation 2 0.4802
205 sex, 1 0.3626
205 significantly 1 0.1811
205 six 2 0.4748
205 sleep 1 0.3877
205 sleep, 1 0.4306
205 status 1 0.2722
205 total 2 0.3357
205 toward 2 0.5543
205 type 1 0.1791
205 types 1 0.2087
205 types.. 1 0.4306
205 univariate 1 0.4306
205 unrelated 1 0.3021
205 upsetting 1 0.4306
205 variables 1 0.3198
205 variance 1 0.3626
205 week 1 0.2825
205 well 1 0.1506
206 . 12 0.6785
206 activities 1 0.1453
206 activity 4 0.3596
206 affinity 1 0.2512
206 alterations 3 0.4155
206 among 2 0.2347
206 anodal 4 0.9046
206 applications 2 0.3731
206 applied 1 0.1514
206 bands 4 0.8046
206 bands, 2 0.5024
206 biological 1 0.1342
206 cathodal 3 0.6346
206 cells 2 0.1516
206 changes 1 0.0752
206 characteristic 1 0.1268
206 characterized 1 0.1328
206 chick, 2 0.5024
206 comparative 1 0.1537
206 complement 1 0.172
206 concentrations 1 0.1291
206 concomitant 1 0.1931
206 conditions 1 0.1142
206 consisted 1 0.1492
206 contexts 1 0.2512
206 correlate 1 0.2011
206 culture 4 0.5031
206 decrease 1 0.115
206 decreased 1 0.1134
206 dehydrogenase.. 1 0.2512
206 demonstrated 1 0.1074
206 development 3 0.2752
206 diagnosis 1 0.1034
206 differences 1 0.115
206 dilution 1 0.172
206 disappear 1 0.2262
206 discussed 1 0.1023
206 disease 1 0.0903
206 distribution 1 0.1291
206 early 1 0.0921
206 electrophoretic 1 0.1762
206 enough 1 0.1931
206 erythrocyte 1 0.1865
206 examination 1 0.1268
206 explained 1 0.1417
206 extracts 1 0.1537
206 facilitated 1 0.2115
206 fetal 2 0.2869
206 full 1 0.1682
206 gel 2 0.2905
206 gene 2 0.4023
206 given 1 0.0921
206 heart 1 0.1165
206 high 1 0.0899
206 however, 1 0.091
206 human 3 0.2515
206 increased 2 0.1562
206 independently 1 0.2011
206 intensity 1 0.1762
206 involved 1 0.128
206 isozyme 5 1.2561
206 isozymes 8 2.0097
206 isozymes, 1 0.2512
206 lactic 1 0.1762
206 ldh 8 1.8093
206 liver 1 0.0988
206 long 1 0.1303
206 loss 1 0.1218
206 lower 1 0.1142
206 marked 1 0.1127
206 migrating 3 0.6346
206 mobilities 1 0.2262
206 muscle 1 0.1385
206 number 1 0.0961
206 observed 2 0.1713
206 observed,. 1 0.2512
206 obtained 1 0.0895
206 occurred 1 0.1093
206 occurs 1 0.1342
206 one 1 0.0703
206 origin, 1 0.1762
206 pathologically 1 0.2011
206 pattern 4 0.4797
206 physico-chemical 1 0.2512
206 postulating 1 0.2512
206 practical 1 0.1617
206 producing 2 0.3233
206 prominence 1 0.2262
206 rabbit, 2 0.4023
206 rapidly 3 0.4303
206 revealed 1 0.1218
206 reverse 1 0.2262
206 reviewed 1 0.1417
206 second 1 0.128
206 sequential 3 0.7536
206 series 1 0.1182
206 serum 1 0.0975
206 several 1 0.1087
206 shift 1 0.1865
206 shown 1 0.108
206 slower 1 0.181
206 species 2 0.274
206 species-specific 1 0.2262
206 starch 1 0.1931
206 states 1 0.172
206 studies 2 0.1539
206 study 1 0.0774
206 substrate 1 0.2115
206 subunit 1 0.2512
206 subunits 1 0.2115
206 term 1 0.1401
206 them, 1 0.2262
206 tissue 4 0.3488
206 tissues 2 0.2299
206 total 1 0.0979
206 toward 1 0.1617
206 variation 1 0.1588
206 various 2 0.1986
206 vertebrate 1 0.2262
206 within 1 0.0933
207 . 9 0.6785
207 1) 1 0.2155
207 10 1 0.1233
207 15 1 0.1663
207 2) 1 0.2293
207 3) 1 0.2575
207 35th 1 0.3349
207 4) 1 0.2682
207 adenocarcinoma 1 0.2293
207 animal 1 0.2049
207 atypy 1 0.3349
207 cancer 2 0.2648
207 cancer, 1 0.2117
207 carcinoma 1 0.1599
207 case 2 0.2407
207 cell 6 0.6802
207 cells 5 0.5054
207 cells, 1 0.1624
207 cent 1 0.1722
207 changes 1 0.1002
207 characterized 2 0.3542
207 cheekpouches 1 0.3349
207 chromosomal 1 0.2487
207 chromosome 1 0.2243
207 concerning 1 0.2082
207 conditioned 1 0.3015
207 constitution 1 0.282
207 course 1 0.1523
207 cultural 1 0.2682
207 culture 1 0.1677
207 cultured 1 0.2197
207 diagnosed 1 0.2049
207 diploid 2 0.5641
207 droplets 2 0.6699
207 epithelial 1 0.1771
207 established 1 0.1807
207 establishment 1 0.2487
207 even 1 0.1466
207 fat 1 0.2049
207 findings 1 0.1331
207 forming 1 0.2487
207 found 1 0.0882
207 golden 1 0.3015
207 grew 1 0.2243
207 groups 1 0.1364
207 hamsters, 1 0.3015
207 histological 1 0.199
207 human 1 0.1118
207 implanted 1 0.3015
207 inoculum 1 0.3015
207 intracytoplasmic 2 0.6699
207 invasiveness 1 0.3349
207 line 3 0.6056
207 lung 2 0.2881
207 maintained 1 0.1868
207 metastasis 1 0.282
207 mitotic 1 0.2155
207 morphological 1 0.2049
207 near 2 0.4037
207 neighbour 1 0.3349
207 number 1 0.1282
207 observed 1 0.1142
207 one 1 0.0937
207 organs 1 0.1847
207 original 1 0.1913
207 partially 1 0.2082
207 peak, 1 0.3349
207 per 1 0.1305
207 phagocytosis 1 0.3015
207 pneumonectomized 1 0.3349
207 range 1 0.1807
207 ranges 1 0.282
207 remarkable 1 0.2413
207 repeated 1 0.199
207 shapes 1 0.3349
207 sharp 1 0.3015
207 show 2 0.2897
207 specimen 1 0.2413
207 stabilized 1 0.3349
207 stage, 1 0.2575
207 tetraploid 1 0.3349
207 throughout 1 0.1913
207 tissue 1 0.1163
207 transfer 1 0.2155
207 transplanting 1 0.3349
207 two 1 0.1026
207 undifferentiated 1 0.2487
207 vitro 1 0.1722
208 (1) 1 0.0812
208 (16 1 0.1508
208 (2) 1 0.0812
208 (3) 1 0.0886
208 (4) 1 0.0968
208 (5) 1 0.1099
208 (6) 1 0.1207
208 (7) 1 0.1287
208 (trematodes) 1 0.1675
208 . 18 0.6785
208 /low/ 1 0.1675
208 100 1 0.0945
208 106 1 0.1508
208 15 1 0.0831
208 20 1 0.0756
208 30 1 0.08
208 37 1 0.1121
208 38 1 0.1146
208 43 1 0.1341
208 50 2 0.1599
208 75 1 0.1175
208 activity 1 0.0599
208 adenocarcinoma 2 0.2293
208 adrenal 1 0.0995
208 aggressive 1 0.1508
208 aided 1 0.1508
208 allowed 3 0.3524
208 among 1 0.0782
208 animals 2 0.1424
208 associated 1 0.0595
208 attachment 1 0.1341
208 bullfrog, 1 0.1675
208 c. 1 0.0886
208 c.) 1 0.141
208 cancers 1 0.1121
208 carcinoma 1 0.08
208 carcinomas 1 0.1341
208 cartilage 1 0.1287
208 cases 1 0.0498
208 cell 1 0.0567
208 cell's 1 0.1508
208 cellophane 1 0.1675
208 cent 5 0.4304
208 cent, 3 0.3862
208 cine-photography 1 0.1675
208 classed 1 0.1508
208 classical 1 0.1175
208 clearly 2 0.2019
208 correlation 1 0.0846
208 could 1 0.0602
208 culture 1 0.0838
208 daily 1 0.0913
208 demonstrable 1 0.1121
208 detailed 2 0.2117
208 developed 1 0.0761
208 development 1 0.0611
208 direct 1 0.0788
208 discs 1 0.1675
208 disease 1 0.0602
208 disturbed 1 0.1041
208 dna 2 0.1599
208 donors 1 0.1341
208 epithelioma, 1 0.1675
208 explants 1 0.1287
208 extended 1 0.1287
208 factors 1 0.0708
208 fewer 1 0.1207
208 filtrate 1 0.1341
208 filtrate, 1 0.1508
208 filtrates 1 0.1675
208 found 1 0.0441
208 frogs 4 0.6699
208 grade 1 0.1341
208 grades 1 0.1341
208 grading 1 0.1675
208 greater 1 0.0693
208 group 1 0.0619
208 growth, 1 0.1121
208 high 1 0.0599
208 higher 2 0.144
208 histological 1 0.0995
208 histologically 1 0.1287
208 host-parasite 1 0.1675
208 hyperplasias 1 0.1675
208 hypothesis 1 0.0894
208 improved 3 0.3364
208 incidence 1 0.08
208 included 1 0.0904
208 increased 1 0.0521
208 inducing 1 0.1207
208 infections 1 0.1099
208 infective 1 0.1207
208 influencing 1 0.1244
208 injected 1 0.0812
208 injection 1 0.07
208 intranuclear 1 0.1341
208 intranucleolar 1 0.1675
208 kidney 2 0.1484
208 led 1 0.0981
208 liposarcoma, 1 0.1675
208 liquid 1 0.141
208 live 1 0.1146
208 lower 2 0.1523
208 lung 4 0.2881
208 lymphosarcomas, 1 0.1675
208 malignancy 6 0.9046
208 malignant 1 0.0913
208 mechanisms 1 0.1009
208 media 1 0.1244
208 medium 1 0.0894
208 mesothelioma, 1 0.1675
208 methods 2 0.1513
208 microecology 1 0.1675
208 mixed 1 0.1059
208 months 1 0.0846
208 negative 1 0.0981
208 neoplasias 1 0.1675
208 nucleolar 1 0.1508
208 observations 1 0.0704
208 obtaining 1 0.1287
208 offer 1 0.1078
208 one 2 0.0937
208 origin 1 0.0956
208 others 1 0.0913
208 parasite 1 0.141
208 pathological 1 0.0904
208 per 8 0.5222
208 perforated 1 0.1675
208 physiology 1 0.1244
208 pipiens 1 0.1508
208 positive, 1 0.1675
208 pre-cancer 1 0.1675
208 precancer 1 0.1675
208 present.. 1 0.1508
208 primary 1 0.0708
208 probability 1 0.1244
208 production 1 0.0853
208 protected 1 0.1287
208 provable 1 0.1508
208 r. 1 0.1146
208 ranges 1 0.141
208 receiving 1 0.0923
208 related 1 0.0708
208 relationships 1 0.1078
208 remaining 1 0.0853
208 renal 2 0.1299
208 respectively 1 0.1146
208 response 1 0.0611
208 resulted 1 0.0812
208 rna 1 0.0923
208 series 1 0.0788
208 seven 1 0.0956
208 showed 2 0.1194
208 slower 1 0.1207
208 spontaneous 1 0.0968
208 study 1 0.0516
208 support 1 0.0923
208 temperatures 3 0.3176
208 theory, 1 0.141
208 three 2 0.1259
208 time-lapse 1 0.141
208 tissue 1 0.0581
208 transformation 1 0.0913
208 tumor 1 0.0747
208 tumors 7 0.6139
208 twenty-six 1 0.1508
208 types 2 0.1624
208 uncertain 1 0.1244
208 undetermined 1 0.1508
208 vermont 2 0.3349
208 vesicular 1 0.1508
208 virus 1 0.0877
208 well 1 0.0586
208 within 1 0.0622
208 worm 1 0.141
208 year 1 0.0869
208 yielded 1 0.1059
209 (/exploding/ 1 0.3015
209 . 10 0.6785
209 12 1 0.1439
209 33 1 0.2317
209 ability 1 0.1536
209 already 1 0.2172
209 attention 1 0.194
209 autologous 1 0.2414
209 bubbling, 1 0.3015
209 cancer 1 0.1192
209 cancer-bearing 1 0.2714
209 cells 1 0.091
209 cellular 1 0.1644
209 certain 1 0.1327
209 chromatin 1 0.3015
209 cinephotomicrographic 1 0.3015
209 clinicopathologic 1 0.2714
209 common 1 0.1473
209 contrast 1 0.2018
209 contributions 1 0.2414
209 culture 1 0.1509
209 cultures 2 0.3018
209 cytoplasmic 1 0.1817
209 death 1 0.1644
209 dense 1 0.2238
209 derived 3 0.4986
209 details 1 0.2064
209 differences 1 0.1379
209 discussion 1 0.1817
209 division 1 0.2114
209 early 1 0.1105
209 elaboration 1 0.2714
209 employed 1 0.1906
209 established 1 0.1627
209 explants 2 0.4634
209 findings 2 0.2395
209 formation 1 0.1353
209 human 3 0.3018
209 interest, 1 0.2714
209 lung 2 0.2593
209 lungs 2 0.3288
209 lymphocyte 2 0.4344
209 lymphocytes 5 0.8832
209 metaphase 1 0.2538
209 metaphase) 1 0.3015
209 mitoses 2 0.6029
209 mitotic 3 0.582
209 much 1 0.1336
209 namely 1 0.2414
209 neoplastic 2 0.4229
209 non-neoplastic 2 0.5428
209 nondividing 1 0.3015
209 normal 2 0.1621
209 number 1 0.1154
209 observed 2 0.2055
209 obtained 1 0.1075
209 occurrence 1 0.1791
209 outgrowths 2 0.5428
209 paid 1 0.2317
209 particular 1 0.1522
209 phase 1 0.161
209 preparations 1 0.1817
209 present 1 0.0993
209 presented 1 0.1169
209 previously 1 0.145
209 primary 1 0.1274
209 process 1 0.1379
209 promising 1 0.2538
209 records 1 0.2114
209 relationship 1 0.145
209 reported 1 0.1221
209 resected 1 0.2538
209 ring 1 0.2714
209 ritro 1 0.3015
209 special 1 0.1594
209 structural 1 0.194
209 studied 1 0.105
209 systems 2 0.4229
209 telophase, 1 0.3015
209 time-lapse 1 0.2538
209 tissue 5 0.5232
209 tools 1 0.2714
209 total 1 0.1175
209 tumor 1 0.1344
209 undergo 1 0.2238
209 used 1 0.1138
209 variable 1 0.1817
209 vitro 1 0.1549
209 well 1 0.1054
210 (sv40).. 1 0.7536
210 . 4 0.6785
210 11 1 0.4025
210 40 1 0.4416
210 acquisition 2 1.0572
210 and, 1 0.3909
210 apparently 1 0.411
210 cell 1 0.2551
210 cells 3 0.6823
210 conclusive 1 0.6346
210 cultures 1 0.3773
210 detail 1 0.5793
210 doses 1 0.411
210 efficiency, 1 0.7536
210 evidence 1 0.2763
210 exhibited 1 0.4611
210 exposed 1 0.3946
210 genome 2 1.2069
210 growth 1 0.2569
210 hamster 2 1.086
210 high 1 0.2697
210 increased 1 0.2343
210 independently 1 0.6034
210 instances, 1 0.5793
210 intervals 1 0.4685
210 large 1 0.2979
210 least 1 0.3874
210 lines 3 1.3074
210 liver 1 0.2965
210 long 1 0.3909
210 lung 1 0.3241
210 morphological 2 0.9221
210 none 1 0.4542
210 obtained 1 0.2686
210 occurred 1 0.3279
210 oncogenic 2 1.357
210 oncogenicity 1 0.7536
210 originally 1 0.5596
210 plating 1 0.6785
210 potential 2 0.9887
210 presence 1 0.2871
210 primary 1 0.3186
210 rate, 1 0.5286
210 simian 1 0.5793
210 studied 1 0.2626
210 studies 1 0.2308
210 sv40 2 1.357
210 syrian 2 1.2069
210 total 1 0.2937
210 transformation 2 0.8219
210 transformation, 1 0.7536
210 two 1 0.2308
210 unassociated 1 0.7536
210 unusually 1 0.6785
210 viral 1 0.4542
210 virus 1 0.3946
210 virus-exposed 1 0.7536
211 . 6 0.6785
211 albino 1 0.4023
211 also 1 0.1406
211 anti-uveal 1 0.5024
211 antibodies 1 0.2834
211 antigenic 4 1.1776
211 assumed 1 0.3439
211 basement 2 0.7724
211 bovine 1 0.2869
211 capsule 2 0.8046
211 common 3 0.7363
211 component(s) 2 1.0048
211 demonstrated 1 0.2148
211 discussed 1 0.2046
211 eye 2 0.6466
211 glomerulus 1 0.5024
211 heterologous 1 0.3862
211 immunofluorescence 1 0.423
211 inducing 1 0.362
211 kidney 2 0.4452
211 lens 2 0.4762
211 membrane 2 0.5422
211 ophthalmia 1 0.5024
211 participation 1 0.423
211 pigmented 1 0.4523
211 possibility 1 0.2869
211 rat 1 0.2067
211 reactions 1 0.2454
211 results 1 0.1439
211 sites 1 0.3364
211 source 1 0.3364
211 surrounding 1 0.3524
211 sympathetic 1 0.3862
211 technique 1 0.2364
211 tissue 1 0.1744
211 tissues 1 0.2299
211 trees 1 0.5024
211 uvea 2 1.0048
211 uvea, 1 0.5024
211 vascular 1 0.277
211 wistar 1 0.4023
212 . 13 0.6785
212 1. 1 0.1214
212 140 1 0.2088
212 2. 1 0.1214
212 3) 1 0.1782
212 4. 1 0.1324
212 5. 1 0.1521
212 6. 1 0.1626
212 96 1 0.1857
212 adjacent 1 0.1671
212 adult 2 0.2108
212 amount 1 0.1142
212 any, 1 0.2088
212 approximately 2 0.2429
212 aqueous 5 0.8354
212 bathing 1 0.2319
212 body 1 0.0935
212 cases 3 0.207
212 common 1 0.1133
212 control 1 0.0872
212 controls 1 0.1397
212 daily 2 0.2529
212 days 1 0.0921
212 dealing 1 0.1671
212 degrees 1 0.1466
212 devised 1 0.1782
212 difficult 1 0.1492
212 dorsal 2 0.4638
212 environment 1 0.1553
212 examine 1 0.1952
212 experiments 3 0.3082
212 eye 2 0.2985
212 eyes 7 1.2053
212 factor 1 0.1099
212 fused 1 0.2319
212 fusing 1 0.2319
212 groups 1 0.0944
212 holtfreter's 1 0.2319
212 host 1 0.1203
212 however, 1 0.084
212 humor 5 1.0438
212 influence 1 0.1061
212 inhibiting 1 0.1782
212 inhibition 1 0.1161
212 injected 1 0.1124
212 injection 1 0.097
212 injections 1 0.1308
212 intact 2 0.2557
212 involve 1 0.1671
212 iris 1 0.2088
212 irises 1 0.2319
212 large 3 0.275
212 later 1 0.1192
212 lens 8 0.8791
212 lenses 1 0.1441
212 lensless 1 0.2319
212 lentectomized 2 0.4175
212 long 1 0.1203
212 made 2 0.168
212 many 1 0.0935
212 merely 1 0.1722
212 months 1 0.1171
212 neural 1 0.1952
212 new 1 0.1015
212 newts 1 0.2319
212 newts, 1 0.2088
212 normal 2 0.1247
212 one 1 0.0649
212 openings 1 0.2319
212 operation 1 0.1214
212 others 2 0.2529
212 pair 1 0.1782
212 pairs 1 0.1782
212 perfectly 1 0.2088
212 placed 1 0.1377
212 played 1 0.1857
212 plays 1 0.1782
212 possibility 1 0.1324
212 powerful 1 0.2088
212 presence 1 0.0883
212 present 1 0.0763
212 procedures 1 0.1308
212 provide 1 0.1359
212 provided 1 0.1419
212 reappeared 1 0.2319
212 regenerate 1 0.2319
212 regenerates 1 0.2319
212 regeneration 4 0.6683
212 removed 1 0.1308
212 reservoir 1 0.1952
212 retardation 1 0.1587
212 retina 2 0.3905
212 retinal 1 0.1722
212 right 1 0.1203
212 role 2 0.2151
212 showed 1 0.0827
212 side 1 0.1308
212 six 1 0.1278
212 solution 1 0.1419
212 strong 1 0.1553
212 successful 2 0.3175
212 three 2 0.1744
212 transplanted 1 0.1671
212 triturus 1 0.1952
212 two 1 0.071
212 unions 1 0.2319
212 unit 1 0.1626
212 united 1 0.1952
212 units 1 0.1587
212 v. 1 0.1952
212 varying 1 0.1251
212 viridescens 1 0.1952
212 weeks 1 0.1214
212 what, 1 0.2319
212 withdrawn 1 0.1952
212 wound 1 0.1782
213 (tyrode 1 0.6029
213 . 5 0.6785
213 4 1 0.2133
213 authors 1 0.2778
213 available 1 0.3288
213 body 1 0.2431
213 bound 1 0.4127
213 c) 1 0.5428
213 cattle 2 0.9655
213 cell 2 0.4081
213 cells 3 0.5459
213 choroid 1 0.4477
213 ciliary 1 0.5428
213 conjunctiva, 1 0.5428
213 contain 1 0.388
213 contained 1 0.3071
213 content 3 0.8509
213 contents 1 0.4037
213 cornea 1 0.6029
213 cornea, 1 0.6029
213 correlation 1 0.3044
213 established 1 0.3253
213 examined 1 0.3044
213 exceptional 1 0.6029
213 extraction 1 0.4344
213 eye 1 0.388
213 eyes 1 0.4477
213 fewer 1 0.4344
213 form 1 0.2623
213 generally 1 0.3581
213 histamine 3 1.6283
213 however, 1 0.2183
213 iris, 1 0.5428
213 least 1 0.3099
213 lens 1 0.2857
213 mast 5 2.2385
213 mild 1 0.3955
213 muscles,. 1 0.6029
213 nerve 1 0.4037
213 occur 2 0.5891
213 ocular 2 0.8255
213 optic 1 0.4127
213 parallel 1 0.388
213 process 1 0.2759
213 readily 1 0.388
213 retina 1 0.5076
213 run 1 0.5428
213 sclera 1 0.6029
213 solution 1 0.3689
213 state 1 0.3099
213 tissues 1 0.2759
214 . 11 0.6785
214 abnormal 2 0.2657
214 actually 1 0.2107
214 anemia 1 0.1974
214 anesthesia, 1 0.2307
214 appear 1 0.1254
214 aspects 1 0.1546
214 association 1 0.1479
214 bacterial 1 0.1606
214 basis 1 0.1199
214 brain 1 0.1396
214 cannot 1 0.1479
214 cell 3 0.2782
214 cerebral 1 0.1299
214 circumstances 1 0.2194
214 clinical 1 0.0893
214 clinico-pathological 1 0.274
214 conditions 1 0.1246
214 congenital 1 0.1254
214 crisis 1 0.2035
214 deficits 1 0.2035
214 development 1 0.1001
214 diagnosed 1 0.1677
214 die 1 0.2107
214 diffuse 1 0.1835
214 disease 2 0.1969
214 due 1 0.0969
214 earliest 1 0.2035
214 electroencephalographic 1 0.2307
214 encephalitis, 1 0.274
214 endocarditis, 1 0.2467
214 episodes, 1 0.274
214 erroneously 1 0.2467
214 examination 2 0.2768
214 fact 1 0.1449
214 fails 1 0.2467
214 fever 1 0.1974
214 findings 2 0.2177
214 following 1 0.0908
214 frequent 1 0.1652
214 furthermore, 1 0.2035
214 hematoma, 1 0.274
214 hemispheres 1 0.2467
214 hemorrhage, 1 0.2194
214 hemorrhages 1 0.2467
214 however, 1 0.0992
214 include 1 0.1628
214 induce 1 0.1835
214 infarcts 1 0.274
214 infection 1 0.1289
214 involved 1 0.1396
214 involvement 2 0.3595
214 known 1 0.1339
214 lead 1 0.1764
214 malformations 1 0.1764
214 manifestations 4 0.626
214 material, 1 0.2194
214 matter 1 0.2035
214 may 2 0.1371
214 meningitis, 1 0.274
214 neoplasm, 1 0.2194
214 neurologic 1 0.2107
214 neurological 5 0.9174
214 often 1 0.1328
214 outcome 1 0.2107
214 pathological 1 0.1479
214 patient 1 0.103
214 patients 4 0.2635
214 perivascular 1 0.274
214 poliomyelitis, 1 0.2307
214 poor 1 0.1585
214 predicted 1 0.2107
214 presenting 1 0.1835
214 prognosis 1 0.1511
214 rather 1 0.1289
214 readings 1 0.2107
214 recurrent 1 0.2107
214 reveal 1 0.1835
214 severe 1 0.1214
214 sickle 3 0.8221
214 sickling 1 0.274
214 signs 1 0.1528
214 striking 1 0.1732
214 studies 1 0.0839
214 subacute 1 0.2467
214 subarachnoid 1 0.2194
214 subdural 1 0.2467
214 suggest 1 0.1246
214 suggests 1 0.1464
214 supported 1 0.1974
214 surgery 1 0.1361
214 symptoms 2 0.2597
214 thesis 1 0.2107
214 thromboses 1 0.274
214 together 1 0.1565
214 type 1 0.114
214 unpredictable, 1 0.274
214 variable 1 0.1652
214 victims 1 0.274
214 white 1 0.1703
214 xxi. 1 0.274
215 (cff) 1 0.5024
215 (cmd) 1 0.5024
215 . 6 0.6785
215 /attenuation 1 0.5024
215 2 1 0.1534
215 affords 1 0.423
215 allows 1 0.4023
215 area 1 0.2606
215 attenuation 2 1.0048
215 average 1 0.2254
215 cannot 1 0.2711
215 carried 1 0.2515
215 cff 1 0.5024
215 classical 1 0.3524
215 conditions 2 0.4568
215 critical 2 0.6728
215 curves 3 0.9369
215 curves/ 1 0.5024
215 depth 1 0.4023
215 described 1 0.1906
215 determination 1 0.3074
215 different 1 0.1777
215 equal 1 0.3296
215 experimental 1 0.2331
215 experiments 1 0.2226
215 extensive 1 0.2834
215 eye 2 0.6466
215 field 2 0.5969
215 frequency 1 0.2631
215 function 1 0.2254
215 fusion 1 0.3731
215 human 2 0.3354
215 information 1 0.2711
215 luminance 2 1.0048
215 luminance, 1 0.5024
215 means 1 0.2226
215 measuring 1 0.4023
215 method 2 0.3992
215 methods 1 0.2269
215 modulation 1 0.5024
215 normal 2 0.2702
215 number 1 0.1923
215 observers 1 0.5024
215 obtained 3 0.5373
215 pathological 1 0.2711
215 patients 1 0.1208
215 periodical 1 0.5024
215 plotting 1 0.5024
215 routine 1 0.362
215 showing 1 0.3296
215 shown 1 0.216
215 sinusoidal 1 0.423
215 surrounded 1 0.5024
215 test 2 0.4346
215 us 1 0.3296
215 variation 1 0.3176
216 (46 1 0.3877
216 . 7 0.6785
216 114 1 0.3448
216 14 1 0.2374
216 38 1 0.2948
216 53 1 0.3626
216 abnormalities 1 0.2401
216 alone, 1 0.3103
216 blurred 1 0.4306
216 brainstem 1 0.4306
216 cases 1 0.1281
216 central 4 0.9295
216 cerebral 3 0.6122
216 common 3 0.6311
216 confusional 1 0.4306
216 convulsions, 1 0.4306
216 cranial 1 0.3448
216 derangement, 1 0.4306
216 difference 1 0.2156
216 disease, 1 0.23
216 duration 1 0.2255
216 examination 1 0.2175
216 headache, 1 0.4306
216 hemiparesis, 1 0.4306
216 involvement 2 0.5649
216 lesion 1 0.2429
216 life, 1 0.2883
216 loss 1 0.2087
216 manifestation 1 0.3021
216 manifestations 2 0.4918
216 mental 1 0.2429
216 nerve 1 0.2883
216 nervous 4 1.0539
216 neuropathy 1 0.3877
216 neuropathy, 1 0.4306
216 nodosa 2 0.7252
216 onset 1 0.249
216 organic 1 0.2558
216 pathologically 1 0.3448
216 patients 2 0.207
216 percent) 1 0.3448
216 periarteritis 2 0.7754
216 proved 1 0.2401
216 psychosis 1 0.331
216 referable 1 0.4306
216 retinopathy, 1 0.4306
216 reviewed, 1 0.3626
216 signs 3 0.7204
216 state 1 0.2213
216 sudden 1 0.2771
216 symptoms 3 0.6122
216 system 4 0.8047
216 thirty-nine 1 0.3877
216 unilateral 1 0.2324
216 usually 1 0.2026
216 vertigo, 1 0.4306
216 vision, 1 0.3626
216 visual 1 0.2348
216 without 1 0.1626
217 . 4 0.6785
217 basis 1 0.3299
217 bitemporal 2 1.1192
217 case 2 0.5415
217 child 1 0.3625
217 clear, 1 0.7536
217 common 1 0.3682
217 considered 1 0.336
217 craniopharyngioma 1 0.7536
217 curious 1 0.6785
217 described, 1 0.6034
217 hemianopsia 2 1.2069
217 lesion 2 0.8503
217 lesions 1 0.3241
217 made 1 0.2729
217 must 1 0.3682
217 near 2 0.9083
217 necessary 1 0.4416
217 nystagmus 2 1.2069
217 part 1 0.352
217 points 1 0.5159
217 present 1 0.2481
217 previous 1 0.4066
217 reference 1 0.4155
217 region 1 0.5046
217 reports 1 0.485
217 see-saw 2 1.357
217 sign 3 2.0354
217 since 1 0.3279
217 site 1 0.4358
217 syndrome 1 0.3496
217 third 3 1.2329
217 unusual 1 0.4764
217 ventricle 2 0.8716
217 ventricle, 1 0.5596
218 . 10 0.6785
218 111 2 0.5428
218 23 1 0.2018
218 465 1 0.3015
218 addition 1 0.1536
218 agreement 1 0.2064
218 also 3 0.253
218 angular 2 0.5428
218 approximately 1 0.1579
218 arbitrary 1 0.2714
218 area 1 0.1564
218 associated 1 0.107
218 autonomous 1 0.2238
218 battery 1 0.2538
218 benton, 1 0.3015
218 brain 3 0.4607
218 cause 1 0.1361
218 cogency 1 0.3015
218 components 6 1.0328
218 components, 3 0.7241
218 compromise 1 0.3015
218 concurrent 1 0.2317
218 consecutive 1 0.2114
218 contained 1 0.1536
218 deficits 1 0.2238
218 deficits, 1 0.3015
218 degree 1 0.1336
218 destructive 1 0.2538
218 disease 1 0.1083
218 dysfunction 1 0.2317
218 dysphasia 2 0.6029
218 entity, 1 0.3015
218 every 1 0.1681
218 evidence 2 0.221
218 examination, 1 0.2238
218 find 1 0.2064
218 four 4 0.541
218 functions 1 0.1874
218 gerstmann 8 2.4116
218 gerstmann's 3 0.7241
218 greater 1 0.1247
218 groups 1 0.1228
218 gyrus 1 0.3015
218 gyrus, 1 0.3015
218 hemisphere 1 0.2538
218 highly 1 0.1627
218 however, 1 0.1092
218 impairment 2 0.3955
218 implications 1 0.194
218 increase 1 0.1024
218 increased 2 0.1874
218 increased, 1 0.2238
218 involved 1 0.1536
218 involvement 1 0.1977
218 justification 1 0.3015
218 larger, 1 0.2714
218 least 1 0.1549
218 left 2 0.2723
218 lesion 3 0.5102
218 lesions 2 0.2593
218 likely 1 0.1766
218 lobes 1 0.2538
218 localizing 1 0.2538
218 merges 1 0.3015
218 necropsy 1 0.2172
218 neurological 2 0.4037
218 neuropsychological 1 0.3015
218 never 1 0.1977
218 notably 1 0.2538
218 number 3 0.3461
218 numerous 1 0.1791
218 occipital 1 0.2064
218 one 2 0.1687
218 organic 1 0.1791
218 parasylvian 1 0.3015
218 parietal, 1 0.3015
218 patient 2 0.2267
218 patients 3 0.2174
218 posterior 1 0.1766
218 prepared 1 0.1817
218 probability 2 0.4477
218 recognize 1 0.2317
218 regarded 1 0.1874
218 responsible 1 0.1522
218 restricted 1 0.2538
218 separate 2 0.3811
218 severe 1 0.1336
218 shown 1 0.1296
218 significance, 1 0.3015
218 singling 1 0.3015
218 spread 1 0.2238
218 standardized 1 0.2317
218 subjected 1 0.1644
218 survival 1 0.145
218 syndrome 4 0.5593
218 syndrome, 1 0.2018
218 syndromes 1 0.2114
218 temporal, 1 0.3015
218 tended 2 0.4827
218 tests, 1 0.1977
218 three 1 0.1133
218 three, 1 0.2714
218 tissue, 1 0.2172
218 two, 1 0.3015
218 underlying 1 0.2172
218 unless 1 0.2238
218 widely 1 0.2018
219 (16 1 0.3877
219 (2 1 0.3448
219 (3 1 0.3448
219 (ver) 1 0.4306
219 . 7 0.6785
219 30 1 0.2056
219 32 1 0.331
219 50 1 0.2056
219 aberrant 1 0.3198
219 abnormal 1 0.2087
219 alterations 2 0.4748
219 amplitude 2 0.6396
219 asymmetries 1 0.4306
219 averaging 1 0.3626
219 brain-damaged 1 0.3626
219 cases) 1 0.3626
219 cases),. 2 0.8613
219 cent 1 0.2213
219 cerebral 1 0.2041
219 complex 1 0.249
219 computer 1 0.3877
219 control 1 0.1619
219 controls 1 0.2595
219 correspondence 1 0.3877
219 defects 3 0.7123
219 demonstrated 1 0.1841
219 depression 1 0.3021
219 differentiated 1 0.2883
219 disorder 1 0.2677
219 early 1 0.1579
219 electrodes 1 0.3626
219 evoked 2 0.7754
219 field 1 0.2558
219 forms 1 0.2056
219 geniculocalcarine 1 0.4306
219 greater 1 0.1781
219 groups 1 0.1754
219 hemianopic 2 0.6621
219 homonymous 2 0.6396
219 latencies 2 0.8613
219 laterally 1 0.4306
219 lesions 1 0.1852
219 lesions, 1 0.3103
219 means 1 0.1908
219 negative-positive-negative 1 0.4306
219 nineteen 1 0.3626
219 normal 1 0.1158
219 noted 1 0.2277
219 obtained 1 0.1535
219 occipital 1 0.2948
219 pathologic 1 0.2635
219 patients 6 0.6211
219 per 1 0.1678
219 placed 1 0.2558
219 positive 1 0.23
219 presence 3 0.4922
219 prolonged 2 0.4143
219 pronounced 1 0.2558
219 recorded 1 0.2459
219 recordings 1 0.3198
219 reference 1 0.2374
219 response 2 0.3145
219 side 1 0.2429
219 studied 1 0.15
219 subjects, 1 0.2883
219 system 1 0.2012
219 three 1 0.1619
219 unilateral 1 0.2324
219 ver 1 0.3626
219 verification 1 0.4306
219 vertex 1 0.3877
219 visual 6 1.409
219 wave 2 0.6896
219 without 1 0.1626
220 . 5 0.6785
220 aphasia, 1 0.6029
220 arteritis 1 0.5076
220 cerebro-vascular 1 0.6029
220 cerebrovascular 2 1.0153
220 degree 1 0.2671
220 disabilities 1 0.5428
220 disseminated 1 0.4827
220 erythematosus 1 0.4344
220 etiology 1 0.3324
220 evidence 1 0.221
220 extensive 1 0.3401
220 failed 1 0.3443
220 five 1 0.3188
220 found 1 0.1587
220 hemianopia 1 0.388
220 hemiplegia 1 0.5428
220 homonymous 1 0.4477
220 incidents 1 0.5076
220 included 1 0.3253
220 investigations 1 0.3748
220 lesions 3 0.7778
220 livedo 3 1.8087
220 lupus 1 0.3955
220 man 1 0.3099
220 neurological 2 0.8073
220 nodosa, 1 0.6029
220 observed 1 0.2055
220 occurred 1 0.2623
220 one 2 0.3373
220 patient 1 0.2267
220 polyarteritis 1 0.5428
220 presumed 1 0.4827
220 recovery 1 0.3324
220 related 1 0.2549
220 remarkable 1 0.4344
220 reticularis 2 1.2058
220 series 1 0.2836
220 show 1 0.2608
220 suffered 1 0.4127
220 suggested 1 0.2507
220 thrombocythaemia 1 0.6029
220 type 1 0.2507
220 unrecognized 1 0.5076
220 without 1 0.2277
220 women 1 0.3253
221 . 4 0.6785
221 analyzed 1 0.5159
221 brain 1 0.3839
221 case 3 0.8123
221 central 1 0.4066
221 eighth 1 0.6785
221 elucidating 1 0.7536
221 evidence 1 0.2763
221 features 1 0.4025
221 form 1 0.3279
221 indicative 1 0.5793
221 lesion 1 0.4252
221 mechanism 1 0.3472
221 nystagmus 3 1.8103
221 nystagmus, 2 1.5073
221 ocular 1 0.5159
221 offered 1 0.6785
221 origin 1 0.4303
221 rather 1 0.3546
221 recorded 1 0.4303
221 report 1 0.3653
221 reported 1 0.3054
221 see-saw 1 0.6785
221 see-saw, 1 0.7536
221 seesaw 1 0.7536
221 stem 1 0.6034
221 suggest 1 0.3426
221 true 1 0.5046
221 unlike 1 0.6346
221 vertical 1 0.7536
222 . 6 0.6785
222 1 1 0.1897
222 12 1 0.2399
222 2 1 0.1534
222 6 1 0.2101
222 although 1 0.1931
222 and, 1 0.2606
222 angiography 1 0.423
222 are.. 1 0.5024
222 author 1 0.2944
222 carotid 1 0.3296
222 cases 2 0.299
222 caused 1 0.2199
222 chief 1 0.4523
222 clinically, 1 0.5024
222 completely 1 0.2944
222 contralateral 1 0.3731
222 damage 1 0.2559
222 deficits 1 0.3731
222 describes 1 0.3439
222 development 1 0.1834
222 died 1 0.2944
222 disorders 1 0.2869
222 dominant 1 0.3439
222 easily 1 0.3233
222 free 1 0.2381
222 hemianopia, 1 0.4523
222 hemiparesis 1 0.5024
222 histological 1 0.2985
222 homonymous 1 0.3731
222 identification 1 0.3233
222 malignant, 1 0.5024
222 meningioma 2 1.0048
222 meningiomas 1 0.5024
222 months 1 0.2537
222 neurological 2 0.6728
222 occasion 1 0.5024
222 one 1 0.1406
222 operated 1 0.3233
222 operation 2 0.5262
222 paratransversal 2 1.0048
222 patient, 1 0.3296
222 patients 1 0.1208
222 permits 1 0.362
222 radiologically, 1 0.5024
222 removed 1 0.2834
222 resected, 1 0.5024
222 second 2 0.5119
222 seven 1 0.2869
222 showed 1 0.1791
222 side 1 0.2834
222 signs 1 0.2801
222 sinus 1 0.362
222 slow 1 0.3296
222 specimen 1 0.362
222 speech 1 0.2631
222 supratentorial 2 1.0048
222 surgically, 1 0.5024
222 transverse 1 0.4523
222 tumour 1 0.3123
222 tumours 3 0.9528
222 twice 1 0.3862
222 well 1 0.1757
222 whose 1 0.2944
222 years 1 0.2284
223 (h-i 2 1.2058
223 ) 2 0.8688
223 . 5 0.6785
223 across 2 0.9269
223 aging 1 0.4634
223 analogy 1 0.5076
223 barrier 1 0.4634
223 birth 1 0.3071
223 c 1 0.3288
223 cancer 1 0.2383
223 cells 1 0.182
223 cogenic 1 0.6029
223 control 1 0.2267
223 developed 1 0.2741
223 disease 3 0.6498
223 exhibited 1 0.3689
223 experiments 1 0.2671
223 findings 1 0.2395
223 given 1 0.221
223 h 1 0.4634
223 h-i 2 1.2058
223 high 1 0.2158
223 histocompatibility 2 1.0856
223 immunologic 1 0.3955
223 incidence 2 0.5757
223 injected 1 0.2922
223 injections 2 0.6802
223 interpretable 1 0.6029
223 later 1 0.3099
223 leukemia 1 0.4634
223 life 3 0.9564
223 life-shortening 1 0.6029
223 locus 1 0.5428
223 lymphoma 1 0.6029
223 lymphoma-incidence 1 0.6029
223 lymphomatous 2 1.2058
223 manifest 1 0.4477
223 mechanisms 1 0.3633
223 mice 2 0.5938
223 mid-adult 1 0.6029
223 mouse 1 0.3362
223 much 1 0.2671
223 negligible 1 0.4827
223 new-borns 1 0.6029
223 newborn 1 0.3288
223 oncogenic 1 0.5428
223 receiving 1 0.3324
223 span 1 0.5428
223 spleen 1 0.3581
223 strains 1 0.3581
223 terms 1 0.3689
223 theories 1 0.4229
223 transplantation 1 0.3955
223 variably 1 0.5428
223 virology, 1 0.6029
223 weak 2 1.0153
224 (1) 1 0.4871
224 (2) 1 0.4871
224 . 3 0.6785
224 although 1 0.3863
224 antigenic 1 0.5888
224 available 1 0.548
224 chains 2 1.8093
224 composition 1 0.5888
224 control 1 0.3778
224 currently 1 0.7462
224 described 1 0.3811
224 difficulties 1 0.7462
224 encountered 1 0.6352
224 evidence 1 0.3684
224 factors 1 0.4248
224 genetic 2 1.0524
224 globulin 2 1.6922
224 heterogeneity 1 0.8046
224 heterogeneous 1 0.8046
224 homogeneous 1 0.8046
224 mapping 1 1.0048
224 occasional 1 0.724
224 ones 1 0.7048
224 paraproteins 1 1.0048
224 pointing 1 1.0048
224 polypeptide 2 1.8093
224 preparations 1 0.6056
224 presented 1 0.3898
224 proteins 1 0.5212
224 resemble 1 0.7724
224 rf 1 1.0048
224 rheumatoid 1 0.8046
224 studies 1 0.3077
224 thus 1 0.5212
225 -dash 2 0.8255
225 . 5 0.6785
225 action 1 0.2623
225 action, 1 0.4477
225 adrenal 1 0.3581
225 androgen 1 0.5076
225 androgens 1 0.5428
225 briefly 1 0.3633
225 carcinoma 2 0.5757
225 clinical 1 0.1965
225 depot 3 1.4482
225 derivative 1 0.5428
225 described 1 0.2287
225 effect 1 0.1841
225 excretion 1 0.2836
225 form 1 0.2623
225 given 1 0.221
225 glands 1 0.388
225 group 1 0.2229
225 injection 1 0.2521
225 metabolites 1 0.4634
225 natural 1 0.3533
225 oestradiol 1 0.6029
225 oestrogen 1 0.5428
225 oestrogenic 1 0.6029
225 patients 1 0.1449
225 preparation 3 1.164
225 probably 1 0.2741
225 production 1 0.3071
225 progynon, 1 0.6029
225 progynon-depot 2 1.2058
225 prostatic 2 0.9269
225 reduce 1 0.3811
225 reduced 1 0.2723
225 results 1 0.1727
225 showed 1 0.2149
225 study 1 0.1857
225 suggest 1 0.2741
225 testicular 1 0.5428
225 treatment 1 0.1779
225 undecylate, 1 0.6029
225 urine 1 0.3099
226 (1) 1 0.3653
226 (2) 1 0.3653
226 (3) 1 0.3985
226 . 4 0.6785
226 /urinary 1 0.7536
226 11 1 0.4025
226 17-ketosteroid 2 1.2069
226 2 1 0.2301
226 breast./ 1 0.7536
226 carcinoma 1 0.3598
226 cases 1 0.2242
226 dosage 1 0.4542
226 estimation 1 0.5596
226 excretion 1 0.3546
226 function 1 0.3381
226 given 1 0.2763
226 high 1 0.2697
226 indicate 1 0.3319
226 induced 1 0.3204
226 level 1 0.291
226 menopause 1 0.6346
226 ovarian 1 0.5596
226 patients 1 0.1812
226 radiation 1 0.411
226 radiotherapeutic 1 0.7536
226 results 2 0.4316
226 sterilisation 2 1.5073
226 study 1 0.2322
226 subjected 1 0.411
226 suppression 1 0.485
226 urinary 1 0.3339
226 used 1 0.2846
226 weeks 1 0.3946
226 within 1 0.2798
227 . 3 0.6785
227 34 1 0.7048
227 cancer 1 0.3972
227 carcinoma 1 0.4797
227 case 1 0.361
227 endocrine 1 0.7048
227 environment 1 0.6728
227 estrogenic 1 0.9046
227 excess 1 0.6879
227 hypogonadism 2 2.0097
227 leading 1 0.6246
227 man 1 0.5165
227 old 1 0.5669
227 part 1 0.4694
227 pathogenesis 1 0.5669
227 person 1 0.7462
227 played 1 0.8046
227 presented 1 0.3898
227 primary 2 0.8496
227 prostatic 2 1.5448
227 relative 1 0.5212
227 suspected 1 0.6728
227 years 1 0.4568
227 young 1 0.5074
228 . 9 0.6785
228 17 1 0.199
228 17-ketosteroid 1 0.2682
228 17-ketosteroids 1 0.2575
228 21 1 0.2117
228 5 1 0.127
228 59 1 0.2682
228 alone 1 0.2019
228 androsterone 5 1.4101
228 androsterone/etiocholanolone 1 0.3349
228 appetite, 1 0.3349
228 assayed 1 0.2682
228 assigning 1 0.3349
228 associated 1 0.1189
228 benign 4 0.9653
228 cancer 4 0.5296
228 cancer, 1 0.2117
228 clinical 1 0.1092
228 clinically 3 0.6879
228 considered 1 0.1493
228 days 1 0.1331
228 definable 1 0.3015
228 determine 1 0.189
228 differences 2 0.3065
228 differences, 1 0.3015
228 different 1 0.1185
228 discussed 1 0.1364
228 disproportionately 1 0.3015
228 duration 1 0.1754
228 etiocholanolone 1 0.3015
228 excreted 5 1.041
228 excretion 2 0.3152
228 exist 1 0.2293
228 explained 1 0.189
228 extended 1 0.2575
228 findings 1 0.1331
228 fractions 1 0.1789
228 groups 1 0.1364
228 hospitalization 1 0.2682
228 hospitalization, 1 0.3015
228 hospitalized 1 0.2349
228 hypertrophy 3 0.5313
228 hypertrophy, 1 0.2413
228 interrelationships 1 0.282
228 less 2 0.2508
228 level 1 0.1293
228 levels 4 0.5246
228 loss 1 0.1624
228 lower 5 0.7613
228 metastasis, 1 0.3015
228 neutral 2 0.4827
228 patients 7 0.5636
228 period 1 0.127
228 possible 1 0.1344
228 pregnanediol 2 0.5149
228 presence 1 0.1276
228 prevent 1 0.2243
228 prostatic 5 1.2873
228 ratio 1 0.1754
228 resulted 1 0.1624
228 significantly 3 0.4225
228 singly 1 0.3349
228 specificity 1 0.2413
228 state 1 0.1722
228 subjects 3 0.4797
228 urinary 2 0.2968
228 well 3 0.3514
228 whether 1 0.1663
229 (breast 2 0.7536
229 . 7 0.5937
229 11-desoxy-17-ketosteroids 1 0.3768
229 11-oxy-17-ketosteroids 1 0.3768
229 114 1 0.3017
229 17, 1 0.3768
229 17-ketosteroid 1 0.3017
229 17-ketosteroids 1 0.2897
229 18, 1 0.3768
229 20) 1 0.3392
229 21, 1 0.3768
229 24) 1 0.3768
229 3 1 0.1284
229 4 1 0.1333
229 56 1 0.3173
229 58 1 0.3173
229 6, 1 0.3017
229 8, 1 0.3392
229 androsterone 2 0.6346
229 associated 1 0.1338
229 benign 2 0.543
229 breast 5 0.9962
229 cancer 8 1.1917
229 control 4 0.5667
229 debilitation 1 0.3768
229 determined 1 0.1713
229 differ 2 0.4943
229 disease 2 0.2708
229 disproportionately 1 0.3392
229 etiocholanolone 2 0.6785
229 excreted 5 1.1711
229 excretion 1 0.1773
229 explained 1 0.2126
229 found 1 0.0992
229 fractions 1 0.2012
229 groups 3 0.4604
229 groups, 1 0.2523
229 i. 1 0.2238
229 included 1 0.2033
229 less 1 0.1411
229 levels 6 0.8853
229 lower 3 0.5138
229 neutral 2 0.543
229 patients 6 0.5435
229 postmenopausal 3 0.7929
229 postmenopausal, 1 0.3768
229 pregnanediol 2 0.5793
229 premenopausal 7 2.221
229 ratios 2 0.4943
229 resulted 1 0.1826
229 sick 2 0.7536
229 significantly 4 0.6337
229 studied 1 0.1313
229 subjects 1 0.1799
229 urinary 2 0.3339
229 well 2 0.2636
229 women, 1 0.2798
230 . 8 0.6785
230 a-toxin 1 0.3768
230 abnormal 1 0.1826
230 abolished 1 0.2472
230 activity 1 0.1348
230 air-tissue 1 0.3768
230 also 2 0.2108
230 alveolar 5 1.0274
230 animal 1 0.2305
230 appeared 1 0.1813
230 associated 1 0.1338
230 bilateral 1 0.2271
230 cervical 1 0.3768
230 chloroform..methanol 1 0.3768
230 cl.welchii 1 0.3768
230 component 1 0.2425
230 could 2 0.2708
230 demonstrated 2 0.3222
230 demonstration 1 0.2425
230 digestion 1 0.3017
230 diminished 1 0.2523
230 diminution 1 0.2643
230 electron 1 0.1903
230 even 1 0.1649
230 extraction 1 0.2715
230 extracts 1 0.2305
230 fluorescent 4 1.1586
230 histologically 1 0.2897
230 identified 1 0.2208
230 interface 1 0.3392
230 layer 4 1.1586
230 lecithin-containing 1 0.3768
230 lecithinase, 1 0.3768
230 line 1 0.2271
230 lines 1 0.2179
230 lining 5 1.2614
230 lipid 2 0.4611
230 loss 1 0.1826
230 lung 3 0.4861
230 lungs 1 0.2055
230 material 1 0.1748
230 microscopy 1 0.2425
230 microscopy, 1 0.2643
230 might 1 0.1973
230 morphologic 1 0.2715
230 mucopolysaccharide 1 0.3768
230 phosphatide 1 0.3173
230 phosphatide, 1 0.3768
230 polysaccharide 1 0.3392
230 presence 2 0.2871
230 present 1 0.1241
230 properties 1 0.2012
230 pulmonary 1 0.1611
230 relationship 1 0.1813
230 resulted 1 0.1826
230 sections 1 0.258
230 special 1 0.1992
230 staining 1 0.2523
230 stains, 1 0.3768
230 structure 3 0.5758
230 suggested 1 0.1567
230 suggesting 2 0.4611
230 surface 2 0.4066
230 surfactant 1 0.2715
230 techniques 1 0.2055
230 tension 1 0.2271
230 thin 1 0.3017
230 ultraviolet 1 0.2897
230 use 1 0.149
230 vagotomy 1 0.3392
231 . 5 0.6785
231 absence 1 0.2878
231 action 1 0.2623
231 agent 1 0.3533
231 airspace 1 0.6029
231 airways 1 0.6029
231 altered 1 0.322
231 amounts 1 0.2993
231 anatomic 1 0.4037
231 basis, 1 0.5428
231 bed 1 0.5076
231 biologic 1 0.5076
231 capillary 1 0.4344
231 conducting 1 0.6029
231 control 1 0.2267
231 criteria 1 0.3533
231 critically 1 0.6029
231 critique 1 0.6029
231 described 1 0.2287
231 destruction, 1 0.5428
231 effects 1 0.2238
231 emphysema 3 1.6283
231 etiologic 1 0.4344
231 evaluated 1 0.3487
231 evidence 1 0.221
231 experimental 2 0.5593
231 factors 1 0.2549
231 fibrosis, 1 0.4634
231 finely 1 0.6029
231 human 1 0.2012
231 include 1 0.3581
231 influencing 1 0.4477
231 lesions 1 0.2593
231 lung 1 0.2593
231 morphologic 1 0.4344
231 necessity 1 0.4477
231 normal 1 0.1621
231 obstruction 1 0.3811
231 partitioned 1 0.5428
231 pathogenesis 1 0.3401
231 placed 1 0.3581
231 pulmonary 1 0.2578
231 relating 1 0.4477
231 remnants, 1 0.6029
231 residual 1 0.4477
231 review, 1 0.5428
231 reviewed 1 0.3401
231 rich 1 0.4634
231 significant 1 0.2116
231 specific 1 0.2372
231 stress 1 0.4127
231 structure 1 0.3071
231 studies 1 0.1846
231 surface-active 1 0.6029
231 unique 1 0.388
231 vascular 1 0.3324
231 without 1 0.2277
232 . 5 0.6785
232 abnormal 1 0.2922
232 adjuvant 1 0.4344
232 alveolar 4 1.3151
232 alveoli 2 0.8688
232 cells 5 0.9098
232 cellular 1 0.3288
232 circulation, 1 0.5428
232 complete 1 0.2797
232 contributed 1 0.4344
232 epithelial 2 0.6376
232 found 1 0.1587
232 freund's 1 0.6029
232 healing 1 0.4634
232 increase 1 0.2048
232 injected 1 0.2922
232 intravenously 1 0.4229
232 investigated 1 0.3443
232 line 1 0.3633
232 lining 4 1.6146
232 lungs 1 0.3288
232 mesenchymal 1 0.5428
232 monocytes 1 0.5428
232 normal 2 0.3242
232 number 1 0.2307
232 phase 1 0.322
232 population 1 0.388
232 progressed, 1 0.6029
232 proliferative 1 0.4344
232 pulmonary 1 0.2578
232 rabbit 1 0.3401
232 rabbits 1 0.3443
232 response 1 0.2201
232 result 1 0.2608
232 reticuloendothelial 1 0.4827
232 size 1 0.3157
232 spaces 1 0.4229
232 structurally 1 0.5076
232 system 1 0.2816
232 walls 1 0.5428
232 within 1 0.2238
233 (granular 1 0.7536
233 . 4 0.6785
233 15 1 0.3742
233 acidosis 1 0.5596
233 additional 1 0.4025
233 alterations 1 0.4155
233 alveolar 2 0.8219
233 associated 2 0.5352
233 atelectasis 1 0.6785
233 bodies 2 0.9221
233 cells 3 0.6823
233 changes 2 0.451
233 co2 1 0.543
233 co2-induced 1 0.7536
233 compensatory 1 0.4202
233 course 2 0.6851
233 decrease 1 0.3449
233 disappearance 1 0.4943
233 disease 1 0.2708
233 epithelial 1 0.3985
233 evidence 1 0.2763
233 exposure 1 0.4477
233 found 1 0.1984
233 granular 1 0.5793
233 guinea 1 0.5596
233 hyaline 2 1.1192
233 identification 1 0.485
233 indicated 1 0.3546
233 lamellar 2 1.1586
233 large 1 0.2979
233 latter 1 0.3909
233 limited 1 0.411
233 lining 1 0.5046
233 lungs 1 0.411
233 membrane 1 0.4066
233 membranes 1 0.485
233 minimal 1 0.4685
233 morphology 1 0.4611
233 parallel 1 0.485
233 percent 1 0.5046
233 phase 2 0.805
233 pigs 1 0.6034
233 pneumocytes 1 0.7536
233 pneumocytes) 1 0.7536
233 process 1 0.3449
233 produced 1 0.3069
233 provides 1 0.4764
233 respiratory 1 0.3909
233 responsible 1 0.3805
233 reversed 1 0.5596
233 rise 1 0.3742
233 secretion 1 0.4416
233 surface 3 1.2199
233 surfactant 2 1.086
233 tension 3 1.3625
233 time 2 0.5311
233 uncompensated 1 0.7536
234 (99 1 0.5024
234 . 6 0.6785
234 /epithelial/ 1 0.5024
234 420 1 0.5024
234 acid 1 0.194
234 administration 1 0.2212
234 alveolar 1 0.274
234 alveoli 1 0.362
234 animal 1 0.3074
234 animals 1 0.2136
234 animals, 1 0.3028
234 atypical 1 0.362
234 cells 3 0.4549
234 cheek 1 0.4523
234 considerably 1 0.3233
234 cortisone 5 2.0114
234 culture 1 0.2515
234 culture, 1 0.423
234 damaged 2 0.8046
234 days) 1 0.4523
234 delayed 1 0.2944
234 developed 1 0.2284
234 direct 1 0.2364
234 drug 1 0.2631
234 effect 2 0.3068
234 electron 2 0.5074
234 enhanced 1 0.3123
234 evidence 3 0.5526
234 failed 1 0.2869
234 fibrosis 1 0.4023
234 following 1 0.1665
234 greatly 1 0.2985
234 growth 1 0.1713
234 hamster 1 0.362
234 hyperplasia 1 0.2834
234 including 1 0.2711
234 indicated 1 0.2364
234 indirect 1 0.3862
234 injection 1 0.2101
234 intratracheal 1 0.4523
234 knowledge 1 0.3296
234 large 1 0.1986
234 lining 1 0.3364
234 long 1 0.2606
234 lung 2 0.4321
234 microscopic 1 0.3123
234 microscopy, 1 0.3524
234 morphologically 1 0.423
234 neoplasms 1 0.3731
234 nitric 1 0.5024
234 normal 1 0.1351
234 observation 1 0.2631
234 observation, 1 0.4523
234 observations 2 0.4225
234 one 1 0.1406
234 period 1 0.1906
234 pouch 1 0.4523
234 previous 1 0.2711
234 proliferation 4 1.1622
234 pulmonary 2 0.4296
234 rabbits 1 0.2869
234 reveal 1 0.3364
234 showed 2 0.3582
234 studies 2 0.3077
234 subsided 1 0.423
234 support 1 0.277
234 term 1 0.2801
234 thesis 1 0.3862
234 tissue 3 0.5232
234 together 1 0.2869
234 transplantation 2 0.6591
234 treated 1 0.2067
234 within 2 0.373
234 without 1 0.1897
234 work 1 0.3439
235 . 3 0.6785
235 also 1 0.2811
235 authors 1 0.4629
235 cell 1 0.3401
235 cerebrospinal 1 0.6056
235 cord 3 2.0636
235 csf 1 0.6728
235 cytological 1 0.9046
235 developing 1 0.5422
235 drawing 1 1.0048
235 etiology 2 1.108
235 exchange 2 1.3455
235 experiments 1 0.4452
235 fluid 1 0.4762
235 functions 1 0.6246
235 injury 1 0.6728
235 kitten 1 1.0048
235 lesion 2 1.1337
235 matter 2 1.4923
235 mechanism 1 0.4629
235 myelin-glial 1 1.0048
235 observations 2 0.8449
235 paper 1 0.5422
235 present 2 0.6617
235 presents 2 1.6091
235 propose 1 0.8461
235 reacting 1 0.8461
235 recent 1 0.5262
235 relationships 1 0.6466
235 sources, 1 0.8461
235 specific 1 0.3953
235 spinal 3 2.0636
235 types 1 0.4871
235 various 1 0.3972
235 white 2 1.2492
236 (ventilation 1 0.4306
236 . 7 0.6785
236 7 1 0.1984
236 anesthetized 1 0.3448
236 artificial 1 0.2883
236 augmentation 1 0.4306
236 blood 4 0.5323
236 brain 7 1.5356
236 cerebrospinal 1 0.2595
236 conditions 1 0.1958
236 conditions, 1 0.331
236 control 1 0.1619
236 could 1 0.1547
236 curarized 1 0.4306
236 decreased 1 0.1945
236 delayed 1 0.2523
236 different 1 0.1523
236 experiments 1 0.1908
236 explanation 1 0.3021
236 fluid 1 0.2041
236 give 1 0.2348
236 hyperventilation 4 1.5508
236 hypoxia 2 0.5543
236 important 1 0.1945
236 increased 2 0.2677
236 indicate 1 0.1896
236 lactate 6 2.1756
236 lactate/pyruvate 2 0.8613
236 level 1 0.1663
236 markedly 2 0.46
236 mechanism 1 0.1984
236 nitrogen) 1 0.3877
236 observations 1 0.1811
236 oxygen 1 0.2194
236 pyruvate 2 0.6896
236 ratio 2 0.451
236 rats 2 0.3326
236 remains 1 0.2255
236 responsible 1 0.2175
236 rise 3 0.6414
236 rises 1 0.3198
236 seen 1 0.1821
236 show 1 0.1863
236 shows 1 0.2374
236 small 1 0.1728
236 strongly 1 0.2771
236 systematically 1 0.4306
236 ventilation 1 0.3198
237 . 3 0.4071
237 arterial 1 0.3127
237 available 1 0.3288
237 average 1 0.2705
237 beckman 1 0.5428
237 besides 1 0.5428
237 blood 2 0.3726
237 brain 2 0.6142
237 cerebral 1 0.2857
237 changes 1 0.1804
237 cisterna 1 0.4827
237 cisternal 2 0.9269
237 conditions 1 0.2741
237 degree 1 0.2671
237 duration 1 0.3157
237 flow 1 0.3071
237 fluid 1 0.2857
237 free 1 0.2857
237 internal 1 0.3401
237 jugular 1 0.4477
237 magna, 1 0.6029
237 man 1 0.3099
237 micro-oxygen-electrode 1 0.6029
237 oxygen 5 1.5356
237 reflecting 1 0.5076
237 reflects 1 0.4827
237 registrates 1 0.6029
237 results 1 0.1727
237 short 1 0.3487
237 simultaneously 1 0.3633
237 studied 1 0.2101
237 suggest 1 0.2741
237 surrounding 1 0.4229
237 tension 4 1.4533
237 tissue 1 0.2093
237 using 1 0.2741
237 various 1 0.2383
237 vein 1 0.4477
238 . 4 0.4524
238 angiocardiography 2 0.7462
238 aortic 3 0.805
238 cardiac 1 0.2254
238 case 1 0.1805
238 catheterization 1 0.3364
238 combined 1 0.2582
238 coronary 1 0.3233
238 cusp 1 0.4523
238 defect 2 0.4948
238 defect, 1 0.362
238 demonstrated 1 0.2148
238 described 1 0.1906
238 infundibular 1 0.4523
238 lesion 1 0.2834
238 mass 1 0.3731
238 obstruction 2 0.6352
238 outflow 3 1.1586
238 polyp-like 1 0.5024
238 progressive 1 0.2801
238 prolapsed 1 0.5024
238 protruding 1 0.5024
238 pulmonic 1 0.423
238 right 4 1.0425
238 septal 3 0.8133
238 showed 1 0.1791
238 stenosis 1 0.3176
238 tract 2 0.5811
238 valve 1 0.3074
238 valve, 1 0.3862
238 valvular 1 0.3364
238 ventricular 6 1.3116
239 . 4 0.6785
239 /pulmonary 1 0.7536
239 abnormalities 1 0.4202
239 acquired 1 0.4685
239 adaptations 2 1.5073
239 advice 1 0.6785
239 better 1 0.4358
239 clinical 1 0.2457
239 concluded 1 0.3449
239 congenital 2 0.6897
239 course 1 0.3426
239 development 1 0.2752
239 discussed 1 0.3069
239 disease 1 0.2708
239 forces 1 0.5793
239 fuller 1 0.7536
239 functional 2 0.9528
239 given 1 0.2763
239 greatly 1 0.4477
239 haemodynamic 1 0.6346
239 heart 2 0.6992
239 history 1 0.4358
239 importance 1 0.3839
239 influence 1 0.3449
239 lesions 2 0.6481
239 life 1 0.3985
239 many 2 0.6077
239 may 2 0.377
239 natural 1 0.4416
239 optimal 1 0.6034
239 outflow 2 1.1586
239 patients 1 0.1812
239 physical 1 0.4358
239 picture 1 0.411
239 prognosis 1 0.4155
239 provide 1 0.4416
239 relation 1 0.3472
239 right 2 0.7819
239 serial 1 0.4611
239 stenosis/ 1 0.7536
239 stressed, 1 0.7536
239 structural 1 0.485
239 studies 1 0.2308
239 surgical 1 0.3403
239 time 1 0.2656
239 tract 2 0.8716
239 treatment 1 0.2223
239 understanding 1 0.4943
239 ventricular 2 0.6558
239 well 1 0.2636
240 (group 2 0.6029
240 . 10 0.6785
240 2 1 0.092
240 29 1 0.2064
240 3 1 0.1028
240 4 1 0.1066
240 5 3 0.343
240 among 1 0.1408
240 anomalies 2 0.3955
240 anomalous 4 1.0153
240 anomaly 1 0.2172
240 associated 1 0.107
240 atresia 3 0.5533
240 atretic 1 0.2714
240 atrium 1 0.2538
240 blood, 1 0.2064
240 case 1 0.1083
240 cases 1 0.0897
240 causative 1 0.2414
240 closure 1 0.2114
240 coexisted 3 0.8142
240 collateral 1 0.2538
240 common 1 0.1473
240 connexion 2 0.6029
240 connexions 1 0.3015
240 cor 2 0.5428
240 could 1 0.1083
240 developing 1 0.1627
240 en 1 0.2714
240 factor 1 0.1429
240 flow 1 0.1536
240 foramen 3 0.7241
240 form 1 0.1312
240 group 2 0.2229
240 i), 1 0.3015
240 ii) 1 0.3015
240 invoked 1 0.3015
240 latter 1 0.1564
240 mitral 4 0.8073
240 observed 1 0.1028
240 obstruction 2 0.3811
240 occurred 1 0.1312
240 one 1 0.0843
240 other, 1 0.2317
240 ovale 3 0.9044
240 patent 1 0.2172
240 premature 1 0.2064
240 provided 1 0.1844
240 pulmonary 9 1.16
240 remaining 2 0.3071
240 represented 1 0.2414
240 response 1 0.1101
240 routes 1 0.2538
240 specimens 1 0.194
240 took 1 0.2172
240 total 1 0.1175
240 triatriatum 2 0.6029
240 understood 1 0.2714
240 valve 1 0.1844
240 veins 1 0.2317
240 venous 8 1.3605
241 . 7 0.6785
241 8 1 0.1945
241 aortic 1 0.23
241 basal 2 0.5649
241 body 1 0.1736
241 bypass 3 0.9308
241 cardiopulmonary 2 0.6621
241 cardiovascular 2 0.5445
241 cases 1 0.1281
241 commensurate 1 0.4306
241 compared 1 0.1671
241 convalescence 2 0.8613
241 could 1 0.1547
241 days 1 0.1711
241 determined 1 0.1958
241 different 1 0.1523
241 diseases 1 0.2348
241 elevated 1 0.2771
241 equivalent 1 0.3021
241 equivalents 2 0.8613
241 explained 1 0.2429
241 greater 1 0.1781
241 increased 1 0.1339
241 majority 1 0.2771
241 metabolic 4 0.8224
241 open 1 0.3021
241 operation 2 0.451
241 operations 1 0.2825
241 particularly 1 0.2374
241 patients 5 0.5176
241 patients, 1 0.2156
241 performed 1 0.1971
241 persisted 1 0.331
241 pyrexia 1 0.4306
241 raised 1 0.2558
241 rate 3 0.4756
241 rates 1 0.2595
241 requiring 1 0.3103
241 respiratory 2 0.4468
241 results 1 0.1233
241 series 1 0.2026
241 solely 1 0.3198
241 surgery 1 0.2138
241 surgical 1 0.1945
241 temperature 1 0.23
241 throughout 1 0.2459
241 treated 2 0.3544
241 types 1 0.2087
241 undergone 1 0.3448
241 valve, 1 0.331
241 without 2 0.3253
242 (37 1 0.3768
242 . 8 0.6785
242 15 1 0.1871
242 18 1 0.2055
242 27 1 0.2523
242 4 2 0.2666
242 43 1 0.3017
242 6 1 0.1576
242 80 1 0.258
242 also 1 0.1054
242 aorta 1 0.2523
242 aortic 1 0.2012
242 approach 2 0.4685
242 block 1 0.2715
242 cases 5 0.5606
242 closed 2 0.5596
242 closure 2 0.5286
242 com- 1 0.2238
242 combined 1 0.1937
242 compared 1 0.1462
242 cyanotic 1 0.3173
242 decreased 1 0.1702
242 defect 1 0.1856
242 defects 4 0.831
242 defects, 1 0.2643
242 defects,. 1 0.3768
242 direct 2 0.3546
242 discussed 1 0.1535
242 fallot 2 0.6034
242 fallot) 1 0.3768
242 first 1 0.1381
242 follow-up 1 0.2523
242 heart 1 0.1748
242 incidence 2 0.3598
242 insufficiency 1 0.2238
242 introduced 1 0.2897
242 isolated 3 0.4918
242 larger 1 0.2238
242 light 1 0.2126
242 mortality 1 0.2271
242 operation 1 0.1973
242 operation, 1 0.2798
242 operative 1 0.2101
242 pared 1 0.3768
242 patch 2 0.6034
242 patients 1 0.0906
242 percent 4 1.0091
242 percent, 2 0.6346
242 performed 1 0.1724
242 preferred 2 0.6785
242 prosthesis 1 0.3392
242 recurrence 1 0.2798
242 reduced 1 0.1702
242 results 1 0.1079
242 second 1 0.1919
242 septal 4 0.8133
242 small 1 0.1512
242 stage 1 0.1826
242 surgical 2 0.3403
242 suture 2 0.6785
242 technique 1 0.1773
242 tetralogy 3 0.9051
242 total 1 0.1469
242 transatrial 1 0.3768
242 treatment 1 0.1112
242 use 1 0.149
242 used, 1 0.2425
242 usual 1 0.2798
242 valve 1 0.2305
242 ventricular 5 0.8197
242 way 1 0.2382
243 (1) 1 0.1328
243 (2) 1 0.1328
243 (3) 1 0.1449
243 (4) 1 0.1585
243 (5) 1 0.1798
243 (6) 1 0.1974
243 (7) 1 0.2107
243 . 10 0.6168
243 1 1 0.1035
243 100 2 0.3092
243 14 2 0.3022
243 19 1 0.1835
243 1961 1 0.2307
243 1963 1 0.274
243 2 2 0.1674
243 20 1 0.1238
243 21 1 0.1732
243 3 2 0.1868
243 35 1 0.2107
243 4 1 0.0969
243 5 2 0.2079
243 9 1 0.1435
243 according 1 0.1479
243 administration 1 0.1207
243 amyl 1 0.274
243 aorta 2 0.367
243 aortic 4 0.5854
243 arterial 3 0.4265
243 arteriosus 6 1.2639
243 arteriosus, 2 0.4934
243 artery 1 0.1565
243 artery, 1 0.2307
243 associated 2 0.1946
243 atrial 3 0.5291
243 based 1 0.1435
243 bradycardia 1 0.2194
243 cardiac 2 0.2459
243 cases 4 0.3261
243 catheter 2 0.4389
243 catheter, 1 0.2467
243 characteristic 1 0.1384
243 classified 2 0.3303
243 congenital 2 0.2508
243 considerable 1 0.1422
243 curve 4 0.7504
243 curves 1 0.1703
243 data 1 0.1116
243 december 1 0.2467
243 defect 9 1.2146
243 defect, 1 0.1974
243 department 1 0.2107
243 diastolic 3 0.632
243 dip 1 0.274
243 disease 2 0.1969
243 drugs 1 0.1511
243 ductus 8 1.628
243 effect 1 0.0837
243 fall 1 0.1435
243 fallot 1 0.2194
243 femoral 2 0.4213
243 followed 1 0.1254
243 following 1 0.0908
243 groups 1 0.1116
243 heart 2 0.2542
243 hemodynamic 3 0.5504
243 injected 1 0.1328
243 insufficiency 3 0.4884
243 intensiffication 1 0.274
243 kyoto 1 0.274
243 late 1 0.1628
243 left 1 0.1238
243 made 1 0.0992
243 malformation 1 0.2035
243 marked 1 0.123
243 may 1 0.0685
243 moderate 1 0.1628
243 murmur 2 0.4213
243 nitrite, 1 0.274
243 observations 2 0.2304
243 observed 2 0.1868
243 outstanding 1 0.2307
243 patent 3 0.5923
243 peak 1 0.1585
243 pediatrics, 1 0.274
243 phenylephrine 1 0.274
243 point 1 0.1585
243 pressure 11 1.3794
243 pulmonary 7 0.8202
243 rapid 2 0.2657
243 recorded 1 0.1565
243 reference 1 0.1511
243 regarded 1 0.1703
243 reveals 1 0.2307
243 right 2 0.2843
243 rise 2 0.2721
243 septal 10 1.4787
243 slowly 2 0.3752
243 small 2 0.2199
243 softening 1 0.274
243 sonre 1 0.274
243 special 1 0.1449
243 stenosis 5 0.8662
243 sys- 1 0.2467
243 systemic 1 0.1528
243 systolic 3 0.6105
243 tachycardia 1 0.274
243 tetralogy 1 0.2194
243 tolic 1 0.2467
243 transmission 1 0.2107
243 tried 1 0.2467
243 university 1 0.2307
243 vasoactive 1 0.274
243 ventricle 1 0.1585
243 ventricle, 1 0.2035
243 ventricular 7 0.8346
243 via 1 0.1835
243 view 1 0.1606
243 withdrawn 2 0.4615
244 (1) 1 0.1461
244 (2) 1 0.1461
244 (3) 1 0.1594
244 (4) 1 0.1743
244 (5) 1 0.1977
244 . 10 0.6785
244 120 1 0.2538
244 3 1 0.1028
244 30 1 0.1439
244 323 1 0.3015
244 8 1 0.1361
244 abnormal 5 0.7306
244 abnormally 1 0.2238
244 accompanied 1 0.1681
244 according 1 0.1627
244 acquired 1 0.1874
244 always 1 0.161
244 cardiac 1 0.1353
244 cases 3 0.2691
244 cases, 1 0.1579
244 change 1 0.1398
244 changes 2 0.1804
244 classified 1 0.1817
244 clockwise 1 0.3015
244 common 1 0.1473
244 complaints 1 0.2414
244 concept 1 0.1817
244 congenital 1 0.1379
244 counterclockwise 1 0.3015
244 deviation 1 0.2317
244 direction 3 0.6343
244 directional 1 0.3015
244 directions 1 0.2714
244 discussed 1 0.1228
244 disease 1 0.1083
244 examined 1 0.1522
244 found 1 0.0794
244 frank 1 0.2714
244 frequently 1 0.1522
244 heart 1 0.1398
244 higher 1 0.1296
244 horizontal 2 0.4827
244 hypertension 1 0.1906
244 hypertrophy 1 0.1594
244 hypertrophy, 2 0.4344
244 inscribed 2 0.6029
244 inscription 9 2.7131
244 lead 1 0.194
244 left 2 0.2723
244 majority 1 0.194
244 maximal 2 0.3748
244 normal 2 0.1621
244 observed 2 0.2055
244 oriented 1 0.3015
244 percentage 1 0.1681
244 persons 1 0.1906
244 planar 1 0.2714
244 plane 1 0.2538
244 planes 1 0.2714
244 polar 1 0.3015
244 projections 1 0.2538
244 qrs-loop 1 0.3015
244 recorded 1 0.1721
244 relatively 1 0.145
244 right 2 0.3127
244 rightward 1 0.3015
244 sagittal 1 0.2414
244 significance 1 0.1644
244 small 1 0.1209
244 study 1 0.0929
244 studying 1 0.2317
244 superior 1 0.2018
244 t-loop 9 2.7131
244 types 2 0.2922
244 usually 1 0.1418
244 valuable 1 0.194
244 vector 3 0.7615
244 vectorcardiogram 1 0.3015
244 vectorcardiographic 1 0.3015
244 ventricular 3 0.3935
245 . 8 0.6785
245 36 1 0.2643
245 39 1 0.2715
245 53-day-old 1 0.3768
245 absence 1 0.1799
245 additional 1 0.2012
245 adult 3 0.5138
245 among 1 0.176
245 appear 1 0.1724
245 arterial 3 0.5864
245 arteriosus 1 0.2897
245 associated 1 0.1338
245 atresia, 1 0.3017
245 attempt 1 0.2305
245 beyond 1 0.258
245 children, 1 0.2208
245 communication 1 0.2077
245 communications 1 0.3392
245 congenital 2 0.3449
245 contradict 1 0.3768
245 defect, 1 0.2715
245 developed 1 0.1713
245 ductus 1 0.2798
245 each, 1 0.3768
245 element 1 0.2897
245 findings 2 0.2994
245 genesis 1 0.2897
245 girl 1 0.2523
245 histologically 1 0.2897
245 hypertension, 2 0.6034
245 identified 1 0.2208
245 infant 1 0.2126
245 infants 1 0.1799
245 intimal 1 0.3392
245 jet 1 0.3768
245 lesion 3 0.6377
245 lesions 3 0.4861
245 lesions, 2 0.543
245 likely 1 0.2208
245 lungs 1 0.2055
245 made 1 0.1365
245 mitral 1 0.2523
245 nonspecific 1 0.2715
245 obstruction 1 0.2382
245 obstruction, 1 0.3392
245 one 2 0.2108
245 patent 1 0.2715
245 pathogenetic 1 0.2897
245 patients 2 0.1812
245 plexiform 7 2.6377
245 points 1 0.258
245 pulmonary 5 0.8055
245 regarding 1 0.2382
245 resulting 1 0.1919
245 septal 1 0.2033
245 showed 1 0.1343
245 stenosis 1 0.2382
245 studied 1 0.1313
245 studies 1 0.1154
245 study, 1 0.2425
245 subject 1 0.2425
245 subjects 2 0.3598
245 support 1 0.2077
245 test 1 0.163
245 theory 2 0.485
245 thickening 1 0.2897
245 three 2 0.2834
245 vascular 1 0.2077
245 venous 2 0.4252
245 ventricular 1 0.1639
245 would 1 0.1871
246 (blue 1 0.6029
246 . 5 0.6785
246 132 1 0.5428
246 4 2 0.4265
246 anatomic 1 0.4037
246 aortic 1 0.322
246 associated 1 0.2141
246 attributable 1 0.4127
246 blood 1 0.1863
246 calcific 1 0.5428
246 calcified, 1 0.6029
246 combined 1 0.3099
246 contact 1 0.3487
246 deposits 1 0.4634
246 died 1 0.3533
246 direct 2 0.5673
246 disease 2 0.4332
246 disease, 1 0.322
246 erythrocytes 1 0.4477
246 evidence 1 0.221
246 flow 1 0.3071
246 found 1 0.1587
246 frequency 1 0.3157
246 heart 2 0.5593
246 heavily 1 0.5076
246 hemolysis 1 0.5428
246 hemolysis, 1 0.6029
246 hemosiderosis 2 1.2058
246 hemosiderosis, 1 0.6029
246 i.e., 1 0.4634
246 immobile, 1 0.6029
246 increased 1 0.1874
246 intravascular 1 0.5076
246 isolated 1 0.2623
246 kidney) 1 0.6029
246 malformations 1 0.388
246 mitral 2 0.8073
246 necropsy 1 0.4344
246 observed 1 0.2055
246 patient 2 0.4534
246 patients 3 0.4348
246 portions 1 0.4477
246 regurgitant 1 0.4634
246 renal 3 0.7017
246 severe 1 0.2671
246 stenotic 1 0.5076
246 trauma 2 0.9269
246 traversing 1 0.6029
246 tricuspid 1 0.4634
246 valve 3 1.1066
246 valve, 1 0.4634
246 valvular 2 0.8073
247 (a) 1 0.3233
247 (b) 1 0.3233
247 . 6 0.6785
247 10 1 0.1849
247 48 1 0.2834
247 abdominal 1 0.3731
247 alkali 1 0.4523
247 based 1 0.2631
247 biopsy 1 0.3233
247 cancer 1 0.1986
247 carcinoma 1 0.2399
247 cesium 2 0.9046
247 content 1 0.2364
247 content.. 1 0.5024
247 correlations 1 0.362
247 counting 2 0.7462
247 cs. 1 0.5024
247 data 1 0.2046
247 due 1 0.1777
247 early 1 0.1842
247 esophagus 1 0.423
247 external 1 0.3028
247 fourteen 1 0.4023
247 greater 1 0.2078
247 hours 1 0.2417
247 injection 1 0.2101
247 large, 1 0.3862
247 later 1 0.2582
247 lymphoma, 1 0.5024
247 made 1 0.182
247 metal 1 0.3439
247 minutes 1 0.3296
247 modes 1 0.4523
247 negative 1 0.2944
247 normal 1 0.1351
247 obtained 3 0.5373
247 patients 1 0.1208
247 positive 1 0.2683
247 probably 1 0.2284
247 proportional 1 0.4023
247 pulmonary 1 0.2148
247 radioactive 2 0.6246
247 satisfactory 1 0.3296
247 scanned 1 0.5024
247 scanning 1 0.3364
247 scans 3 1.357
247 scintillation 1 0.4023
247 seven 1 0.2869
247 specimens 1 0.3233
247 stable 1 0.362
247 suggested.. 1 0.5024
247 superficial 1 0.3731
247 third 1 0.274
247 tissue 1 0.1744
247 tumor 1 0.224
247 tumors 3 0.7893
247 tumors, 1 0.3862
247 two 1 0.1539
247 upon 1 0.2254
247 upper 1 0.3233
247 uptake 3 0.9887
247 vascularity 1 0.5024
247 well 1 0.1757
248 . 3 0.6785
248 10.50 1 1.0048
248 appears 1 0.4321
248 apply 1 0.8461
248 artery 2 1.1476
248 atraumatic 1 1.0048
248 biological 1 0.5366
248 capillaries 1 0.8046
248 ceramic 1 1.0048
248 colloidal 2 1.8093
248 compared 1 0.3898
248 decrease 1 0.4598
248 delivered 1 0.8046
248 dog 1 0.6246
248 dose 1 0.4797
248 duration 1 0.5262
248 fact 1 0.5313
248 followed 1 0.4598
248 half-life 1 0.8461
248 human 1 0.3354
248 injected 1 0.4871
248 intravenously 1 0.7048
248 lung 2 0.8642
248 method 1 0.3992
248 microns 1 1.0048
248 microspheres 1 1.0048
248 occlusion 2 1.2933
248 occlusions 1 0.9046
248 offers 1 0.724
248 particle 1 0.7724
248 particles 1 0.724
248 photoscanning 1 0.8461
248 practical, 1 1.0048
248 progress 1 0.7048
248 pulmonary 3 1.2888
248 radiation 1 0.548
248 relatively 1 0.4833
248 risa 2 1.6922
248 scanning 1 0.6728
248 short 1 0.5811
248 size 1 0.5262
248 study 1 0.3096
248 technique 1 0.4727
248 use 1 0.3972
248 visualizing 1 1.0048
248 work 1 0.6879
249 . 4 0.6785
249 among 1 0.352
249 analyzed 1 0.5159
249 changes 1 0.2255
249 chronic 2 0.7196
249 clinical 1 0.2457
249 comparison 1 0.3909
249 completely 2 0.8832
249 demonstrated 2 0.6444
249 differences 1 0.3449
249 drugs 1 0.4155
249 estimate 1 0.6346
249 evaluation 2 0.8133
249 evaluations 1 0.6346
249 findings 1 0.2994
249 granulocytic 1 0.6785
249 indicates 1 0.4943
249 involve 1 0.543
249 laboratory 1 0.4358
249 leukemia 1 0.5793
249 lymphocytic 1 0.6346
249 method 1 0.2994
249 months 1 0.3805
249 multivariate 3 2.0354
249 objective 1 0.4943
249 patient, 1 0.4943
249 physiologic 1 0.485
249 procedures 1 0.4252
249 prognosis 1 0.4155
249 relationship 1 0.3625
249 rely 1 0.7536
249 results 2 0.4316
249 scoring 1 0.7536
249 several 1 0.326
249 significant 1 0.2646
249 specific 1 0.2965
249 state 1 0.3874
249 statistically 1 0.4685
249 subjective 3 1.8103
249 techniques 1 0.411
249 therapy 1 0.2979
249 three 1 0.2834
249 treatment 1 0.2223
249 trials 1 0.6034
249 used 1 0.2846
250 . 4 0.6785
250 3.0 1 0.7536
250 administering 1 0.6346
250 allergic 1 0.5596
250 antibiotics 1 0.6346
250 apparent 1 0.3946
250 appreciated 1 0.7536
250 bone 1 0.326
250 corticosteroids 1 0.5046
250 daily 1 0.411
250 depression 1 0.5286
250 developed 1 0.3426
250 discontinuing 1 0.7536
250 drug 1 0.3946
250 dysfunction 1 0.5793
250 gm. 1 0.6785
250 hematologic 1 0.6034
250 hepatic 1 0.4252
250 hepatocellular 1 0.7536
250 marrow 1 0.3773
250 months 1 0.3805
250 mouth 1 0.7536
250 nearly 1 0.4611
250 oxacillin 2 1.5073
250 oxacillin--apparent 1 0.7536
250 potentialities 1 0.6785
250 receiving 1 0.4155
250 recovery 1 0.4155
250 resulted 1 0.3653
250 sodium 1 0.3625
250 three 1 0.2834
250 toxic 1 0.4611
250 toxicity 1 0.4943
250 woman 1 0.4943
251 (gantrisin), 1 0.4306
251 . 7 0.6785
251 ability 1 0.2194
251 absorbed 1 0.3103
251 administered 1 0.2056
251 administration 1 0.1896
251 adversely 1 0.3877
251 affect 1 0.2722
251 also 1 0.1205
251 appreciable 1 0.3021
251 articles 1 0.3877
251 avoid 1 0.3198
251 bilirubin 2 0.5767
251 breast 1 0.2277
251 brief 1 0.3021
251 brown 1 0.3877
251 careful 1 0.2722
251 certain 1 0.1896
251 compound 1 0.2948
251 compounds 1 0.3103
251 concentrations 1 0.2213
251 consideration 1 0.2825
251 contribute 1 0.3198
251 definitely 1 0.3626
251 delivery 1 0.2825
251 derivatives, 1 0.4306
251 development 1 0.1572
251 drug 1 0.2255
251 drugs 4 0.9497
251 drugs, 1 0.3626
251 essential 1 0.2523
251 exaggerated 1 0.3626
251 excellent 1 0.3103
251 excreted 1 0.2677
251 exhaustive 1 0.4306
251 factors 1 0.1821
251 given 1 0.1579
251 handle 1 0.4306
251 hyperbilirubinemia 2 0.7252
251 iatrogenic 1 0.3877
251 important 1 0.1945
251 incriminated 1 0.4306
251 infant 1 0.2429
251 infant's 2 0.7754
251 intended 1 0.4306
251 interested 1 0.3877
251 jaundice 1 0.2595
251 jaundice.. 1 0.4306
251 k 1 0.3103
251 made 1 0.156
251 many 1 0.1736
251 may 5 0.5385
251 mechanism 1 0.1984
251 mention 1 0.4306
251 metabolism 1 0.2041
251 milk 1 0.331
251 mother 3 0.7377
251 neonatal 1 0.2595
251 newborn 2 0.4697
251 novobiocin 1 0.4306
251 nursing 1 0.3626
251 paper 1 0.2324
251 physiologic 1 0.2771
251 prior 1 0.23
251 reader 1 0.4306
251 referred 1 0.2558
251 remember 1 0.4306
251 result 2 0.3725
251 review 2 0.4748
251 salicylates, 1 0.4306
251 serum, 1 0.331
251 shown 1 0.1852
251 sulfasoxazole 1 0.4306
251 termed 1 0.3626
251 thereby 1 0.331
251 therefore 1 0.2635
251 time 1 0.1517
251 unequivocally 1 0.3626
251 vitamin 1 0.2635
251 water-soluble 1 0.3877
251 zuelzer 1 0.4306
252 (9 1 0.3877
252 . 7 0.6785
252 1) 1 0.2771
252 2) 1 0.2948
252 26 1 0.2722
252 3) 1 0.331
252 4) 1 0.3448
252 5) 1 0.3626
252 6) 1 0.3877
252 80 4 1.1792
252 advisable 1 0.4306
252 age 4 0.7126
252 aged 1 0.2595
252 although 1 0.1655
252 amputation 2 0.6621
252 avoidance 2 0.8613
252 careful 1 0.2722
252 choice 1 0.2771
252 cleansing, 1 0.4306
252 co-existing 2 0.8613
252 considered 1 0.192
252 considers 1 0.3626
252 contribute 1 0.3198
252 control 1 0.1619
252 correction 1 0.3021
252 deaths) 1 0.4306
252 disease, 1 0.23
252 diseases, 1 0.3626
252 elderly 1 0.3626
252 electrolytes, 1 0.3448
252 evaluation 1 0.2324
252 expected 1 0.2825
252 extremity 1 0.3448
252 extremity, 1 0.4306
252 factors 1 0.1821
252 gangrenous 1 0.4306
252 group 1 0.1592
252 hypotension, 1 0.4306
252 increase 1 0.1463
252 infection, 1 0.3021
252 lower 1 0.1958
252 lumbar 1 0.331
252 maintained 1 0.2401
252 many 1 0.1736
252 mid-thigh 1 0.4306
252 minimum 1 0.331
252 mortality 3 0.7786
252 necessitates.. 1 0.4306
252 nevertheless 1 0.3626
252 observations 1 0.1811
252 operation 1 0.2255
252 pa- 1 0.2523
252 past 1 0.3021
252 patient 1 0.1619
252 patient, 1 0.2825
252 patients 4 0.4141
252 physical 1 0.249
252 poor 1 0.249
252 postoperative 2 0.519
252 pre-existing 1 0.3626
252 procedure 1 0.2194
252 procedures 2 0.4859
252 prolonged 1 0.2071
252 prompt 1 0.3198
252 proper 1 0.2883
252 pulmonary 1 0.1841
252 questioned 1 0.3626
252 rate 1 0.1585
252 removal 1 0.2401
252 reserve 1 0.3448
252 show 1 0.1863
252 standard 1 0.2948
252 subjected 1 0.2348
252 surgeon 1 0.3448
252 surgical 2 0.389
252 sympathectomy 1 0.4306
252 tients 1 0.2771
252 tracheal 1 0.3877
252 treatment 1 0.1271
252 underwent 1 0.3103
252 undue 2 0.7754
252 ventilation 1 0.3198
252 without 2 0.3253
252 years 4 0.783
252 younger 1 0.2883
253 . 7 0.6785
253 16 1 0.2677
253 18 1 0.2348
253 addition, 1 0.249
253 advantages 1 0.3021
253 advocate 1 0.4306
253 age 1 0.1781
253 anomaly 1 0.3103
253 artificial 1 0.2883
253 cases 1 0.1281
253 cause 1 0.1945
253 children 1 0.1529
253 common 1 0.2104
253 congenital 1 0.1971
253 cooling 1 0.2595
253 defect 4 0.8483
253 early 1 0.1579
253 even 1 0.1885
253 good 1 0.2401
253 heart 1 0.1998
253 heart-lung 1 0.4306
253 hypothermia 1 0.2213
253 ill 1 0.331
253 impact 1 0.3626
253 including 1 0.2324
253 infancy 1 0.3021
253 infancy, 2 0.6396
253 infantile 1 0.2348
253 infants 2 0.4112
253 less 1 0.1612
253 machine 1 0.3626
253 method 1 0.1711
253 one 1 0.1205
253 operated 1 0.2771
253 operation 3 0.6765
253 operative 1 0.2401
253 period 1 0.1633
253 poor 1 0.249
253 present, 1 0.2825
253 prognosis 1 0.2374
253 proved 1 0.2401
253 psychological 1 0.2722
253 radical 2 0.6621
253 repair 1 0.2883
253 results 1 0.1233
253 septal 4 0.9295
253 severely 1 0.2771
253 simplicity 1 0.3877
253 successful 1 0.2948
253 sufficient 1 0.2595
253 superior 1 0.2883
253 surface 1 0.2324
253 upon 1 0.1932
253 us 1 0.2825
253 use 1 0.1702
253 ventricular 4 0.7495
253 year 1 0.2234
254 . 5 0.6785
254 activity 1 0.2158
254 capable 1 0.3689
254 cell 2 0.4081
254 cells 3 0.5459
254 cells, 2 0.5845
254 comparison 1 0.3127
254 discussed 1 0.2455
254 function 1 0.2705
254 graft 1 0.5076
254 growth 2 0.411
254 immunized 2 0.8688
254 immunologic 2 0.7909
254 injecting 1 0.5076
254 irradiated 1 0.3487
254 isolated 2 0.5246
254 lymph 1 0.3748
254 lymphocytes 1 0.3533
254 macrophages 3 1.211
254 may 1 0.1508
254 methods 1 0.2723
254 mice 3 0.8907
254 mice, 1 0.4477
254 mixture 1 0.4477
254 node 1 0.4634
254 obtained 1 0.2149
254 peritoneal 3 1.3903
254 population 1 0.388
254 possible 1 0.2419
254 presented 1 0.2339
254 rejection 1 0.4634
254 respect 1 0.3533
254 results 1 0.1727
254 specific 3 0.7116
254 subcutaneously 1 0.6029
254 suppressing 1 0.5428
254 suppression 1 0.388
254 test 1 0.2608
254 tested 1 0.3633
254 tumor 3 0.8064
254 type, 1 0.4037
255 . 8 0.6031
255 1. 1 0.1754
255 2. 1 0.1754
255 3. 1 0.1807
255 6-diphosphate, 1 0.3349
255 acrobic 1 0.3015
255 added 1 0.2082
255 alone 1 0.2019
255 amount 4 0.6598
255 amounts 1 0.1663
255 anacrobic 1 0.3349
255 antibody 1 0.2049
255 antiserum 9 2.0183
255 ascites 1 0.2682
255 beyond 1 0.2293
255 cells 8 0.8087
255 certain 1 0.1475
255 clarify 1 0.2682
255 complement 7 1.605
255 complement, 2 0.6031
255 concentration 1 0.1408
255 conditions 1 0.1523
255 consumption 1 0.2349
255 cooperation 1 0.3015
255 cytotoxic 1 0.2349
255 definite 2 0.4586
255 degree 1 0.1484
255 determined 1 0.1523
255 different 1 0.1185
255 effect 4 0.4091
255 effects 1 0.1243
255 either 1 0.1432
255 examined 1 0.1691
255 final 1 0.2197
255 found 1 0.0882
255 fructose-1, 1 0.3349
255 glucose 1 0.1754
255 glucose, 1 0.2575
255 glycolysis 1 0.2682
255 glycolytic 1 0.3015
255 hand, 1 0.2019
255 heterologous 2 0.5149
255 inhibited 1 0.2117
255 inhibition 6 1.0062
255 inhibitory 1 0.2197
255 lactate-production 5 1.6747
255 mechanism 1 0.1543
255 metabolism 1 0.1587
255 necessary 1 0.1963
255 observed 4 0.4567
255 occurred 1 0.1457
255 oxygen 1 0.1706
255 parallel 1 0.2155
255 parallelism 1 0.3015
255 presence 1 0.1276
255 process 1 0.1533
255 pyruvate 1 0.2682
255 rat 1 0.1378
255 rate 1 0.1233
255 similar 1 0.1254
255 step 1 0.2487
255 subjected 1 0.1827
255 suggested 1 0.1393
255 target 1 0.2682
255 threshold 1 0.282
255 toward 1 0.2155
255 tumor 2 0.2987
256 . 6 0.6785
256 27 1 0.3364
256 a-2 1 0.5024
256 abnormal 1 0.2435
256 adjacent 1 0.362
256 antigen 2 0.5969
256 antigenically 1 0.4023
256 antigens 2 0.5811
256 brain 1 0.2559
256 brain, 1 0.4023
256 carcinoma 1 0.2399
256 central 1 0.2711
256 cerebrospinal 1 0.3028
256 cns 1 0.3524
256 components 1 0.2869
256 contributed 1 0.362
256 csf 3 1.0091
256 cyst 1 0.3862
256 demonstrated 1 0.2148
256 derived 1 0.277
256 described 1 0.1906
256 either 1 0.2148
256 fluid 2 0.4762
256 fraction 1 0.2683
256 from, 1 0.5024
256 glioblastomas 1 0.5024
256 globulin 1 0.423
256 human 3 0.5031
256 identical 2 0.5969
256 immunologically 1 0.4023
256 least, 1 0.423
256 liver, 1 0.3439
256 major 1 0.2417
256 may 1 0.1257
256 metastatic 1 0.3233
256 nervous 1 0.3074
256 normal 2 0.2702
256 or, 1 0.4023
256 patients 1 0.1208
256 plasma 1 0.2026
256 plasma, 1 0.4523
256 present 3 0.4963
256 present, 1 0.3296
256 protein 3 0.6851
256 proteins 1 0.2606
256 represent 1 0.3176
256 soluble 1 0.2985
256 specific 1 0.1977
256 spleen, 1 0.3364
256 system 1 0.2347
256 three 1 0.1889
256 tissue 3 0.5232
256 to, 1 0.3862
256 tumor 2 0.448
256 tumors 1 0.2631
256 wbc, 1 0.5024
257 . 4 0.5428
257 alone, 1 0.4344
257 anti-rat 1 0.6029
257 apparent 1 0.3157
257 associated 1 0.2141
257 blue 1 0.4827
257 cell 1 0.204
257 cells 5 0.9098
257 conjugate 1 0.4827
257 containing 1 0.3188
257 cosinophils 2 1.2058
257 cytoplasmic 1 0.3633
257 different 1 0.2133
257 exhibited 1 0.3689
257 fitc-conjugated 1 0.6029
257 fluoresced 2 1.2058
257 fluorescein 1 0.6029
257 fluorescence 3 1.4482
257 g-globulin 2 1.2058
257 granules 1 0.3955
257 immunofluorescence 1 0.5076
257 immunologically 1 0.4827
257 light 1 0.3401
257 mast 3 1.3431
257 nonspecific 1 0.4344
257 normally 1 0.3811
257 observed 1 0.2055
257 organs 1 0.3324
257 phenomenon 1 0.3487
257 present 1 0.1985
257 protein 1 0.2741
257 rabbit 1 0.3401
257 rat 2 0.4962
257 seen 1 0.2549
257 tissue 1 0.2093
257 treatment 3 0.5336
257 violet 1 0.5428
257 whereas 1 0.3018
258 . 5 0.4847
258 5 2 0.3267
258 95 2 0.7252
258 arterial 2 0.4468
258 blood 3 0.3992
258 brain,. 1 0.4306
258 breathing 4 1.2411
258 carbon 3 0.865
258 cerebral 1 0.2041
258 cerebrospinal 7 1.8167
258 change 2 0.3995
258 changes 1 0.1289
258 chronic 3 0.6168
258 cisternal 1 0.331
258 closely 1 0.2459
258 comparable 1 0.2374
258 contributed 1 0.3103
258 cord 1 0.2948
258 determinants 1 0.3448
258 differs 1 0.2948
258 dioxide 2 0.5896
258 dioxide,. 1 0.4306
258 disease 3 0.4642
258 effects 1 0.1599
258 factors 1 0.1821
258 flow 3 0.6581
258 fluid 7 1.4285
258 following.. 1 0.4306
258 hypercapnia 1 0.3877
258 hypercapnic 1 0.3877
258 hypoxemic 1 0.4306
258 increased 1 0.1339
258 interpretation 1 0.2883
258 known 1 0.2104
258 lumbar 3 0.9931
258 lung 3 0.5555
258 may 1 0.1077
258 must 1 0.2104
258 nerve 1 0.2883
258 nitrogen 1 0.2825
258 observations 1 0.1811
258 oxygen 4 0.8775
258 patients 4 0.4141
258 pco2 1 0.3448
258 pco2, 1 0.3877
258 po2 7 2.4137
258 qualified 1 0.4306
258 regulation 1 0.3198
258 related 1 0.1821
258 relationship 2 0.4143
258 response 1 0.1572
258 roots 1 0.4306
258 similar 1 0.1612
258 spinal 1 0.2948
258 without 2 0.3253
259 (1) 2 0.2087
259 (2) 2 0.2087
259 (3) 2 0.2277
259 (4) 1 0.1245
259 (5) 1 0.1412
259 . 14 0.6785
259 /conditioned/ 1 0.2153
259 /inclusionbody/ 1 0.2153
259 /target/ 1 0.2153
259 15 1 0.1069
259 20 4 0.389
259 4 1 0.0762
259 absolute 1 0.151
259 activities 1 0.1245
259 activity 1 0.0771
259 also 1 0.0602
259 although 1 0.0828
259 ameboid 3 0.646
259 amplified 1 0.1939
259 apparent 2 0.2255
259 appearance 1 0.1069
259 around 1 0.1442
259 behavior 2 0.2459
259 ble 1 0.2153
259 cancer 3 0.2554
259 cancer-bearing 1 0.1939
259 cancers 1 0.1442
259 cases 4 0.2563
259 categories 1 0.1599
259 cell 2 0.1457
259 cells 4 0.2599
259 cells, 1 0.1044
259 cells,. 1 0.2153
259 cinematography 1 0.1939
259 clustering 1 0.2153
259 congregation,. 1 0.2153
259 considered 1 0.096
259 criteria 1 0.1262
259 criterion 1 0.1724
259 crowding 1 0.2153
259 dead 1 0.1551
259 derived 1 0.1187
259 devoid 1 0.1939
259 different 1 0.0762
259 emigrated 1 0.2153
259 emigration 1 0.1939
259 emperipolesis 2 0.4306
259 entry 1 0.1655
259 explant,. 1 0.2153
259 explanted 1 0.1939
259 explants 4 0.6621
259 finding 1 0.1317
259 findings 1 0.0855
259 five 1 0.1139
259 forms 1 0.1028
259 found 1 0.0567
259 fragments 1 0.1599
259 frequency 1 0.1128
259 frequently 1 0.1087
259 given 1 0.0789
259 human 2 0.1437
259 identifiable 1 0.1939
259 impression 1 0.1551
259 included 1 0.1162
259 indicate 1 0.0948
259 infrequently 1 0.1813
259 interest 1 0.1442
259 intimate 1 0.1939
259 introduced 1 0.1655
259 juxtanuclear 1 0.2153
259 lated 1 0.1655
259 limited 1 0.1174
259 lung 3 0.2778
259 lymphocyte 3 0.4654
259 lymphocytes 10 1.2617
259 lymphocytes,. 1 0.2153
259 lymphocytic 3 0.5439
259 major 1 0.1036
259 may 1 0.0539
259 migration 1 0.1442
259 namely.. 1 0.2153
259 nearby 1 0.2153
259 noncancerbearing 1 0.2153
259 nonviable 1 0.2153
259 numerous 1 0.1279
259 observation 1 0.1128
259 observed 1 0.0734
259 one 1 0.0602
259 outgrowths 1 0.1939
259 particular 1 0.1087
259 phenomenon 2 0.249
259 possibility 1 0.123
259 primary 1 0.091
259 produced 1 0.0877
259 reasons 1 0.1442
259 recogni- 1 0.2153
259 recorded 1 0.123
259 relationship 2 0.2071
259 resulting 1 0.1097
259 selected 1 0.1262
259 sensitization 1 0.1442
259 significant 1 0.0756
259 studied 1 0.075
259 study 2 0.1327
259 study, 1 0.1386
259 subsequent 1 0.1174
259 support 1 0.1187
259 timelapse 1 0.2153
259 tion 1 0.0979
259 tissue 3 0.2242
259 totally 1 0.151
259 transformation 1 0.1174
259 unipolar 1 0.2153
259 vacuoles 1 0.1813
259 via 1 0.1442
259 vitro 1 0.1107
259 were.. 1 0.2153
259 whether 1 0.1069
259 within 2 0.1599
260 . 9 0.6785
260 18 1 0.1827
260 absence 1 0.1599
260 accurately 1 0.3015
260 additional 2 0.3578
260 also 1 0.0937
260 aortic 4 0.7155
260 aortography 1 0.2682
260 appear 1 0.1533
260 blow 1 0.3349
260 border 1 0.3349
260 cardiac 1 0.1503
260 cases 1 0.0997
260 catheterization 1 0.2243
260 clinical 1 0.1092
260 combination 1 0.1913
260 communication 1 0.1847
260 correction 1 0.2349
260 defect 3 0.4948
260 demonstrate 1 0.1937
260 eighteen 1 0.2575
260 electrocardiogram 1 0.282
260 findings 1 0.1331
260 hemodynamic 1 0.2243
260 hypertrophy 1 0.1771
260 indicated 1 0.1576
260 infundibular 3 0.9046
260 inspection 1 0.3349
260 insufficiency 3 0.5969
260 left 1 0.1513
260 lesion 1 0.189
260 lesions 1 0.144
260 murmur 2 0.5149
260 nine 1 0.2293
260 open-heart 1 0.2575
260 operation 1 0.1754
260 operations 1 0.2197
260 patients 1 0.0805
260 physical 1 0.1937
260 presence 1 0.1276
260 pressure 1 0.1533
260 problem 1 0.1913
260 proved 1 0.1868
260 pulmonary 3 0.4296
260 pulse 1 0.2413
260 regurgitation 1 0.2197
260 retrograde 1 0.2575
260 right 1 0.1737
260 separate 1 0.2117
260 septal 2 0.3615
260 serves 1 0.2575
260 seventeen 1 0.2575
260 severity 2 0.4098
260 signs 1 0.1868
260 stenosis 2 0.4235
260 stenosis, 1 0.2575
260 sternal 1 0.282
260 strongly 1 0.2155
260 studied 1 0.1167
260 study 1 0.1032
260 subject 1 0.2155
260 sufficient 1 0.2019
260 suggestive 1 0.2487
260 surgical 1 0.1513
260 systolic 1 0.2487
260 thrill 2 0.6699
260 together 1 0.1913
260 treated 1 0.1378
260 typical 1 0.2197
260 upper 1 0.2155
260 ventricular 4 0.5829
260 wide 1 0.199
261 . 6 0.6785
261 131-sodium 1 0.5024
261 25 1 0.2869
261 300 1 0.3862
261 aid 1 0.362
261 aneurysm 2 0.6466
261 aortic 1 0.2683
261 approximately 1 0.2631
261 assess 1 0.423
261 blood 1 0.1552
261 cardiovascular 2 0.6352
261 chest 1 0.3524
261 complications 1 0.2944
261 determination 1 0.3074
261 diagnosing 1 0.3731
261 diagnosis 1 0.2067
261 diagnostic 2 0.4989
261 disease 2 0.361
261 dose 1 0.2399
261 dose, 1 0.4023
261 effects 1 0.1865
261 effusion 2 0.7724
261 greater 1 0.2078
261 intervals 1 0.3123
261 iodipamide, 1 0.5024
261 isotopes 1 0.423
261 method 2 0.3992
261 millirads 1 0.5024
261 patient 1 0.1889
261 pericardial 2 0.7462
261 photoscanning 1 0.423
261 posteroanterior 1 0.5024
261 procedure, 1 0.423
261 progress 1 0.3524
261 radiation 1 0.274
261 radioactive 1 0.3123
261 radioisotope 2 0.7462
261 received 1 0.2834
261 recommended 1 0.3364
261 repeated 1 0.2985
261 response 1 0.1834
261 roentgenogram 1 0.4023
261 safe 1 0.3296
261 safe, 2 0.9046
261 scan 1 0.4023
261 scanning 2 0.6728
261 side 1 0.2834
261 simple 1 0.274
261 simple, 1 0.423
261 standard 1 0.3439
261 tolerated 1 0.362
261 tool 1 0.4023
261 treatment 1 0.1482
261 useful 2 0.554
261 volume 1 0.2559
261 well 1 0.1757
261 whole-body 1 0.362
262 . 6 0.6785
262 abnormalities 1 0.2801
262 anemia 1 0.362
262 bone 3 0.6519
262 cells 2 0.3033
262 changes 1 0.1503
262 deficiency 1 0.2657
262 described 1 0.1906
262 disorders 1 0.2869
262 e 1 0.3862
262 e-deficient 2 0.9046
262 erythroid 1 0.4523
262 experiments 1 0.2226
262 forty-four 1 0.4523
262 found 1 0.1323
262 frequently 1 0.2537
262 giant 1 0.3364
262 granulocytosis 1 0.5024
262 hematocrit 1 0.423
262 hematologic 1 0.4023
262 hematology 1 0.5024
262 hemoglobin 1 0.3862
262 include 1 0.2985
262 leucocytosis 1 0.4523
262 low 1 0.2199
262 many 1 0.2026
262 marrow 2 0.5031
262 marrow, 1 0.3439
262 megakaryocyte 1 0.5024
262 morphology 2 0.6148
262 multinucleated 2 0.9046
262 nuclear 1 0.2905
262 observed 1 0.1713
262 occurring 1 0.2905
262 pigs 2 0.8046
262 precursors 1 0.3731
262 produce 1 0.2683
262 purpose 1 0.3364
262 state 1 0.2582
262 studies 1 0.1539
262 two 1 0.1539
262 type 1 0.2089
262 used 1 0.1897
262 values, 1 0.4023
262 vitamin 3 0.9221
262 whose 1 0.2944
263 . 5 0.6785
263 1,500 1 0.4827
263 10 1 0.2219
263 allogeneic 2 1.0856
263 antigens 2 0.6973
263 blood 1 0.1863
263 cell 1 0.204
263 concluded 1 0.2759
263 dog 1 0.3748
263 dogs 4 1.251
263 dogs, 1 0.4037
263 donor 2 0.8457
263 donors 1 0.4827
263 effort 1 0.4477
263 erythrocyte 1 0.4477
263 experiment 1 0.4037
263 four 1 0.2705
263 given 2 0.442
263 grafts 1 0.5076
263 groups 1 0.2455
263 homotransplantation 1 0.5076
263 increase 1 0.2048
263 infusion 1 0.3401
263 irradiated 1 0.3487
263 irradiation 1 0.3253
263 lethally 1 0.5428
263 longterm 1 0.5428
263 made 1 0.2183
263 marrow 3 0.9055
263 match 1 0.6029
263 matched 1 0.4477
263 matching 1 0.5076
263 methotrexate 1 0.4634
263 r 1 0.3955
263 rate 1 0.2219
263 recipient 1 0.4037
263 recipients, 1 0.6029
263 red 1 0.3581
263 reduce 1 0.3811
263 respect 1 0.3533
263 secondary 1 0.3018
263 significance 1 0.3288
263 significantly 1 0.2535
263 similar 1 0.2257
263 six 2 0.6648
263 survival 1 0.29
263 survived 2 0.7909
263 syndromes 1 0.4229
263 ten 1 0.3633
263 three 1 0.2267
263 whole-body 1 0.4344
264 . 13 0.6785
264 /transitional/ 1 0.2319
264 20 1 0.1047
264 3 2 0.1581
264 72 1 0.1671
264 account 1 0.1308
264 actively 1 0.1722
264 administered 1 0.1107
264 also 1 0.0649
264 although 1 0.0891
264 analysis 1 0.1115
264 appear 2 0.2122
264 appeared 1 0.1115
264 application 1 0.1308
264 average 1 0.104
264 bandage 1 0.2319
264 became 1 0.1377
264 blast 1 0.2088
264 blood 1 0.0717
264 bone 4 0.4012
264 cells 3 0.2099
264 cells, 2 0.2248
264 certain 1 0.1021
264 chamber 1 0.1722
264 chambers 1 0.1782
264 chambers, 1 0.2088
264 circulation 1 0.1214
264 compression 1 0.1722
264 considerable 1 0.1203
264 control 1 0.0872
264 counts 1 0.1626
264 culture 1 0.1161
264 cultures 1 0.1161
264 curves 1 0.1441
264 days 2 0.1842
264 demonstrate 1 0.1341
264 diffusion 3 0.4658
264 discussed 1 0.0944
264 division 1 0.1626
264 dna 1 0.1107
264 dynamic 1 0.1857
264 examine 1 0.1952
264 excluded 1 0.1722
264 experiments 1 0.1027
264 findings 1 0.0921
264 formed 1 0.1293
264 found 1 0.061
264 fully 1 0.1722
264 grain 1 0.1952
264 guinea-pig 1 0.1671
264 hematogenous 1 0.2088
264 high 2 0.166
264 hind 1 0.1952
264 hours 1 0.1115
264 implications 1 0.1492
264 increased 1 0.0721
264 indicates 1 0.1521
264 influx 1 0.2088
264 initially 2 0.3042
264 injection 1 0.097
264 intermediate 1 0.1492
264 intramedullary 1 0.2319
264 intraperitoneal 1 0.1671
264 intravenously 1 0.1626
264 introduced 1 0.1782
264 isolated 1 0.1009
264 labeled 7 0.9782
264 labeling 2 0.3042
264 large, 1 0.1782
264 large-scale 1 0.2319
264 less 1 0.0868
264 levels 1 0.0908
264 limb 1 0.1671
264 limb, 1 0.2319
264 locally 1 0.1952
264 lym 1 0.2319
264 lymphocyte 1 0.1671
264 lymphocytes 8 1.087
264 lymphocytes, 1 0.1671
264 lymphocytopoiesis 1 0.2319
264 maintained 1 0.1293
264 marrow 10 1.161
264 maximum 1 0.1278
264 mechanism 1 0.1068
264 migration 1 0.1553
264 minutes 1 0.1521
264 morphology 1 0.1419
264 newly 1 0.1553
264 normal 1 0.0624
264 number 1 0.0887
264 occluded 1 0.1857
264 occlusive 1 0.2319
264 one 1 0.0649
264 origin 1 0.1324
264 parenchyma 1 0.1671
264 percentage 2 0.2586
264 period 1 0.088
264 phocytes 1 0.2088
264 population 1 0.1492
264 precursor 1 0.1782
264 production 1 0.1181
264 proliferative, 1 0.2319
264 radioautographic 1 0.1952
264 radioautography 1 0.2088
264 rapidly 1 0.1324
264 rate 2 0.1707
264 result 2 0.2006
264 short-term 1 0.1722
264 single 1 0.1151
264 situated 1 0.1952
264 small 6 0.5581
264 state 1 0.1192
264 steady 1 0.1671
264 stream 1 0.1857
264 studies 1 0.071
264 subsequent 1 0.1265
264 suggest 1 0.1054
264 suspensions 1 0.1782
264 synthesize 1 0.2088
264 thereafter 1 0.1857
264 thymidine 3 0.4879
264 thymidine, 1 0.2088
264 tibial 2 0.3565
264 time 1 0.0817
264 tritiated 4 0.621
264 turnover 2 0.3105
264 uncertain 1 0.1722
264 undifferentiated 1 0.1722
264 utilized 1 0.1782
264 vivo 2 0.2755
264 whereas 1 0.1161
264 whilst 1 0.1722
264 within 1 0.0861
265 . 6 0.6785
265 3 1 0.1713
265 48 1 0.2834
265 6 1 0.2101
265 appeared 1 0.2417
265 artery 2 0.5738
265 autoradiographic 1 0.3296
265 autoradiographically 1 0.4523
265 availability 2 0.724
265 blood 1 0.1552
265 bone 4 0.8692
265 cells 5 0.7581
265 cells, 2 0.4871
265 clamped 1 0.5024
265 clamping 2 0.9046
265 contains 1 0.3074
265 control 1 0.1889
265 days 1 0.1996
265 dog 3 0.9369
265 effect 2 0.3068
265 erythroblasts 1 0.5024
265 evidence 1 0.1842
265 fate 2 0.7462
265 femoral 2 0.7724
265 first 1 0.1842
265 h3-thymidine 3 1.2069
265 heavily 1 0.423
265 hours 2 0.4833
265 however, 1 0.182
265 id 1 0.5024
265 increased 1 0.1562
265 indices 1 0.3524
265 injection 2 0.4202
265 interpretation 1 0.3364
265 labeled 1 0.3028
265 labeling 1 0.3296
265 leg 1 0.4523
265 local 1 0.3028
265 lower 1 0.2284
265 lympho 1 0.5024
265 lymphoid 4 1.2933
265 marrow 6 1.5092
265 marrow.. 1 0.5024
265 migrated 1 0.423
265 migrating 1 0.423
265 number 1 0.1923
265 observing 1 0.4523
265 one 1 0.1406
265 origin 2 0.5738
265 originating 1 0.4523
265 populations 1 0.3731
265 possible 1 0.2015
265 precursor 1 0.3862
265 significantly 1 0.2112
265 small 5 1.0077
265 stream, 1 0.5024
265 studied 1 0.175
265 study 1 0.1548
265 tracer 1 0.4023
265 transformation 1 0.274
265 two 1 0.1539
265 via 1 0.3364
265 vivo 2 0.5969
265 within 1 0.1865
266 . 7 0.6785
266 /lymphocyte 1 0.4306
266 400 1 0.3448
266 added 1 0.2677
266 affords 1 0.3626
266 also 1 0.1205
266 appearance 1 0.2138
266 blast 1 0.3877
266 bone 2 0.3725
266 cells 5 0.6498
266 characteristically 1 0.3626
266 close 1 0.2523
266 concentrated 1 0.331
266 confirms 1 0.3626
266 diffusely 1 0.3877
266 discussed 1 0.1754
266 distribution 1 0.2213
266 dna 1 0.2056
266 electron 1 0.2175
266 endothelium 1 0.3448
266 evidence 1 0.1579
266 fate 1 0.3198
266 findings 1 0.1711
266 found 1 0.1134
266 g 1 0.331
266 guinea-pig 1 0.3103
266 guinea-pigs 1 0.3448
266 identity 1 0.331
266 interrelationship 1 0.3877
266 light 1 0.2429
266 loading/ 1 0.4306
266 lymphocyte 1 0.3103
266 lymphocytes 5 1.2617
266 lymphocytes, 1 0.3103
266 marrow 4 0.8624
266 means 1 0.1908
266 microscopy, 2 0.6041
266 morphological 1 0.2635
266 normal 1 0.1158
266 often 1 0.2087
266 organization 1 0.4306
266 origin, 1 0.3021
266 parenchyma, 1 0.3877
266 particular 1 0.2175
266 possible 1 0.1728
266 presence 1 0.1641
266 proof 1 0.3448
266 proximity 1 0.3877
266 radioautography 1 0.3877
266 reference 1 0.2374
266 scattered 1 0.3448
266 series 1 0.2026
266 show 1 0.1863
266 sinusoidal 1 0.3626
266 sinusoids,. 1 0.4306
266 situated 1 0.3626
266 situations 1 0.3448
266 small 5 0.8638
266 structural 1 0.2771
266 structure 1 0.2194
266 studied 1 0.15
266 study 1 0.1327
266 synthesis 1 0.2138
266 techniques 1 0.2348
266 termed 1 0.3626
266 three 1 0.1619
266 throughout 1 0.2459
266 transitional 3 1.2919
266 unlike 1 0.3626
266 within 1 0.1599
267 . 9 0.6785
267 133 1 0.3349
267 30 2 0.3198
267 4 1 0.1185
267 accurate 1 0.2049
267 adopted 1 0.3349
267 almost 1 0.1722
267 anomalies 2 0.4394
267 anomaly 1 0.2413
267 appropriate 1 0.2197
267 associated 2 0.2379
267 atrial 3 0.6466
267 bypass 1 0.2413
267 c. 2 0.3542
267 cardio-pulmonary 1 0.3349
267 cases 2 0.1993
267 circulation 1 0.1754
267 clinical 1 0.1092
267 closure, 1 0.3349
267 combined 1 0.1722
267 consecutive 1 0.2349
267 consistently 1 0.2155
267 correction 1 0.2349
267 corrects 1 0.3349
267 defect 7 1.1546
267 defects 1 0.1847
267 derived 1 0.1847
267 desirable 1 0.282
267 diagnostic 1 0.1663
267 differentiation 1 0.1913
267 direct 1 0.1576
267 discovery 1 0.3015
267 effectively 1 0.3015
267 evaluation 1 0.1807
267 examination 1 0.1691
267 experience, 1 0.2682
267 extracorporeal 1 0.2197
267 found 1 0.0882
267 good 1 0.1868
267 highly 1 0.1807
267 hypertension 1 0.2117
267 hypothermia 4 0.6886
267 including 1 0.1807
267 inflow 1 0.3349
267 information 1 0.1807
267 minimal 1 0.2082
267 mortality 1 0.2019
267 occlusion 1 0.2155
267 open-heart 1 0.2575
267 operation 2 0.3508
267 operative 1 0.1868
267 ostium 2 0.5641
267 over-all 1 0.2487
267 patients 1 0.0805
267 patients, 1 0.1677
267 planning 1 0.282
267 post-operative 1 0.3015
267 practical 1 0.2155
267 pre-operative 2 0.6699
267 primum 4 1.1281
267 problem 1 0.1913
267 procedure 1 0.1706
267 pulmonary 1 0.1432
267 recognition 1 0.2243
267 repair 2 0.4485
267 requires 1 0.2049
267 reserved 1 0.282
267 results 1 0.0959
267 risk 1 0.2243
267 safe 1 0.2197
267 secundum 3 0.8461
267 selection 1 0.2293
267 septal 3 0.5422
267 showed 1 0.1194
267 since 1 0.1457
267 studies 1 0.1026
267 surgery 1 0.1663
267 surgical 1 0.1513
267 technique 2 0.3152
267 therefore, 1 0.2117
267 treatment 1 0.0988
267 two 1 0.1026
267 type 1 0.1393
267 unexpected 1 0.282
267 use 1 0.1324
267 variety 1 0.1807
267 visual 1 0.1827
268 . 4 0.6785
268 accomplishes 1 0.7536
268 according 1 0.4066
268 adjunct 1 0.5793
268 advantageous 1 0.7536
268 change 1 0.3496
268 control 1 0.2834
268 cooling 1 0.4542
268 deleterious 1 0.6034
268 described 1 0.2859
268 device 1 0.6785
268 effects, 1 0.6034
268 encountered 1 0.4764
268 end 1 0.4611
268 expense 1 0.7536
268 general 2 0.7678
268 hypothermia 2 0.7747
268 internal 1 0.4252
268 intragastric 1 0.7536
268 involvement, 1 0.7536
268 minimal 1 0.4685
268 minor 1 0.485
268 observations 1 0.3168
268 offered 1 0.6785
268 performed 1 0.3449
268 presentation 1 0.6346
268 rates 1 0.4542
268 recorded 1 0.4303
268 sex, 1 0.6346
268 side 1 0.4252
268 surgery 1 0.3742
268 technical 1 0.543
268 temperature 2 0.805
268 type 1 0.3134
268 use 1 0.2979
268 weight, 1 0.5046
269 . 4 0.6785
269 3 1 0.2569
269 6 1 0.3151
269 azotemia, 1 0.7536
269 blood 1 0.2329
269 cardiac 1 0.3381
269 careful 1 0.4764
269 climb, 1 0.7536
269 conclude 1 0.6346
269 created 1 0.6034
269 creatinine 1 0.6034
269 damage 1 0.3839
269 delay 1 0.5793
269 deleterious 1 0.6034
269 demonstrated 1 0.3222
269 dogs 1 0.3909
269 duration 1 0.3946
269 effects 2 0.5595
269 evidence 2 0.5526
269 failed 2 0.8607
269 following 1 0.2498
269 function, 1 0.5793
269 healing 1 0.5793
269 histological 1 0.4477
269 hours' 1 0.6785
269 hypothermia 2 0.7747
269 ischemia 1 0.6785
269 late 1 0.4477
269 microscopic 1 0.4685
269 observed 1 0.2569
269 one 1 0.2108
269 pah, 1 0.6785
269 period 1 0.2859
269 preserved 1 0.6346
269 pressure 1 0.3449
269 protected 1 0.5793
269 regional 1 0.543
269 renal 3 0.8771
269 renal, 1 0.6785
269 reveal 1 0.5046
269 safely 1 0.6034
269 studies 1 0.2308
269 summary, 1 0.6346
269 vascular 1 0.4155
269 wound 1 0.5793
269 years 1 0.3426
270 . 6 0.6785
270 1. 1 0.2631
270 15 1 0.2494
270 2. 1 0.2631
270 3. 1 0.2711
270 37 1 0.3364
270 4. 1 0.2869
270 52 1 0.3862
270 90 1 0.3731
270 94 1 0.423
270 animals 1 0.2136
270 anoxia 1 0.423
270 appeared 1 0.2417
270 approximately 1 0.2631
270 arterial 1 0.2606
270 blood 2 0.3105
270 bowel 1 0.3862
270 c. 1 0.2657
270 caused 1 0.2199
270 cellular 1 0.274
270 cent 3 0.7747
270 changes 1 0.1503
270 compared 1 0.1949
270 constriction 1 0.423
270 contributed 1 0.362
270 cooling 1 0.3028
270 damage 1 0.2559
270 distal 1 0.3524
270 dogs, 1 0.3364
270 due 1 0.1777
270 effects 1 0.1865
270 epinephrine 1 0.4023
270 evidence 1 0.1842
270 hemorrhagic 1 0.4023
270 hypothermia 1 0.2582
270 hypothermia, 1 0.3524
270 increased 2 0.3124
270 intense 1 0.362
270 mesenteric 2 1.0048
270 mesenteries 1 0.5024
270 minor 1 0.3233
270 necrosis 1 0.3439
270 per 3 0.5875
270 play 1 0.2985
270 precapillary 1 0.5024
270 resistance 3 0.8404
270 resistances 2 1.0048
270 response 1 0.1834
270 rise 1 0.2494
270 role 1 0.2331
270 segment 1 0.4023
270 segmental 1 0.5024
270 small 1 0.2015
270 studied 1 0.175
270 subsequent 1 0.274
270 suggested 1 0.2089
270 total 1 0.1958
270 vascular 1 0.277
270 vasoconstriction 1 0.4523
270 venous 1 0.2834
270 vessel 1 0.5024
270 vessels 1 0.362
270 viscosity 2 0.8046
270 wall 1 0.3176
271 . 6 0.6785
271 0.2 1 0.4523
271 1. 1 0.2631
271 10.0 1 0.5024
271 14.1 1 0.5024
271 17 1 0.2985
271 2. 1 0.2631
271 3. 1 0.2711
271 4. 1 0.2869
271 5. 1 0.3296
271 5.0 1 0.4523
271 aortic 1 0.2683
271 arrest 1 0.362
271 body, 2 0.8046
271 brain 4 1.0237
271 c. 3 0.797
271 cardiovascular 1 0.3176
271 cerebral 1 0.2381
271 chest 2 0.7048
271 circulation 1 0.2631
271 closed 2 0.7462
271 cooled 2 0.724
271 cooling 1 0.3028
271 deaths 1 0.362
271 deaths, 1 0.5024
271 disturbances 1 0.2985
271 dogs 4 1.0425
271 end 3 0.9221
271 environment 1 0.3364
271 evidence 1 0.1842
271 failure, 1 0.3862
271 five 1 0.2657
271 four 1 0.2254
271 greater 1 0.2078
271 gross 1 0.3364
271 group 1 0.1857
271 heat 1 0.3862
271 higher 1 0.216
271 hypothermic 1 0.3439
271 inclusive 1 0.5024
271 incompetence 1 0.5024
271 less 1 0.1881
271 lower 1 0.2284
271 near 1 0.3028
271 neurologic 1 0.3862
271 nine 1 0.3439
271 occurred 1 0.2186
271 passive 1 0.3439
271 perfusion 5 1.4719
271 perfusion, 1 0.4023
271 quickly 1 0.423
271 response 1 0.1834
271 resulted 1 0.2435
271 six 1 0.277
271 technique 1 0.2364
271 temperature 2 0.5366
271 temperatures 3 0.9528
271 transfer 1 0.3233
271 twenty-six 1 0.4523
271 whole 2 0.5603
271 zero 1 0.4523
272 (28 1 0.3392
272 . 8 0.6785
272 35 1 0.2897
272 78 1 0.3768
272 anesthetized 1 0.3017
272 arterial 1 0.1955
272 bled 1 0.3392
272 blood 4 0.4657
272 c.) 1 0.3173
272 carbon 1 0.2523
272 cardiac 1 0.1691
272 cardiopulmonary 1 0.2897
272 cent 2 0.3874
272 changed 1 0.258
272 comparison 1 0.1955
272 conducted 1 0.258
272 consumption 1 0.2643
272 control 1 0.1417
272 dead 1 0.2715
272 decreased 3 0.5105
272 degree 1 0.167
272 dioxide 1 0.258
272 discussed 1 0.1535
272 dogs 2 0.3909
272 effects 1 0.1399
272 estimated 2 0.4685
272 exchange 1 0.2523
272 experiments 1 0.167
272 functions 1 0.2342
272 graded 1 0.3392
272 heart 1 0.1748
272 hemorrhage 5 1.2125
272 hypothermia 2 0.3874
272 hypothermic 1 0.258
272 increased 1 0.1171
272 indicating 1 0.2425
272 influenced 2 0.4685
272 level 1 0.1455
272 made 1 0.1365
272 markedly 1 0.2012
272 moderate 1 0.2238
272 normothermia 1 0.3392
272 output 1 0.2208
272 oxygen 1 0.1919
272 per 2 0.2937
272 percentage 1 0.2101
272 percentages 1 0.3017
272 physiologic 1 0.2425
272 pressures 1 0.2472
272 production 1 0.1919
272 pulmonary 1 0.1611
272 rate 2 0.2774
272 ratio 1 0.1973
272 respiratory 3 0.5864
272 responses 1 0.2101
272 result 2 0.326
272 severe, 1 0.2643
272 shift 1 0.2798
272 significantly 1 0.1584
272 space 1 0.2798
272 subjected 1 0.2055
272 systemic 1 0.2101
272 tidal 2 0.6785
272 unchanged, 1 0.3392
272 ventilation, 1 0.3173
272 volume 4 0.7678
272 whereas 1 0.1887
272 withdrawal 2 0.543
272 withdrawn 1 0.3173
272 work 1 0.258
273 . 4 0.6785
273 1. 1 0.3946
273 2. 1 0.3946
273 28 1 0.5159
273 3. 1 0.4066
273 30 1 0.3598
273 50 1 0.3598
273 60 1 0.485
273 acute 1 0.3742
273 appear 1 0.3449
273 appears 1 0.3241
273 artery 1 0.4303
273 begun 1 0.6346
273 beneficial 1 0.5286
273 c. 1 0.3985
273 damage 1 0.3839
273 epinephrine 1 0.6034
273 failure 1 0.4066
273 following 1 0.2498
273 give 1 0.411
273 hypothermia 4 1.5494
273 immediately 1 0.4611
273 infusion 1 0.4252
273 management 1 0.3985
273 mortality 1 0.4542
273 partial 1 0.4202
273 percent 2 1.0091
273 period 1 0.2859
273 periods 1 0.4202
273 prolonged 2 0.725
273 protection 1 0.485
273 rate 1 0.2774
273 renal 3 0.8771
273 shorter 1 0.5793
274 (res) 1 0.7536
274 1 1 0.2846
274 200 2 0.9887
274 24 2 0.7819
274 25, 1 0.6785
274 2803. 1 0.7536
274 4 2 0.5332
274 5, 1 0.5793
274 activity 1 0.2697
274 activity. 1 0.5159
274 ad- 1 0.5046
274 added 1 0.4685
274 administration 1 0.3319
274 animals 2 0.6408
274 bone 1 0.326
274 capacity 1 0.411
274 cell 1 0.2551
274 cells 3 0.6823
274 changes 1 0.2255
274 circulating 1 0.5286
274 coagulated 1 0.7536
274 containing 1 0.3985
274 crease 1 0.5046
274 cultures 1 0.3773
274 depended 1 0.6785
274 different 2 0.5332
274 dition 1 0.7536
274 dosage 2 0.9083
274 dose 1 0.3598
274 dose. 1 0.6034
274 effect 1 0.2301
274 endotoxin 2 1.5073
274 endotoxin-induced 1 0.7536
274 endotoxin-injected 1 0.7536
274 endotoxin. 3 2.2609
274 explants 1 0.5793
274 extent 1 0.3985
274 following 2 0.4996
274 grown 1 0.5159
274 growth 1 0.2569
274 hibited 1 0.7536
274 host 1 0.3909
274 hr 1 0.4358
274 hr. 2 0.8716
274 i.v. 1 0.5793
274 in- 1 0.3339
274 increase 1 0.256
274 incubation. 1 0.6785
274 inhibition 1 0.3773
274 injected 1 0.3653
274 injection 1 0.3151
274 known 1 0.3682
274 large 1 0.2979
274 largest 1 0.6785
274 lung 1 0.3241
274 lymph 1 0.4685
274 macro- 1 0.7536
274 macrophages 3 1.5137
274 marked 1 0.3381
274 marrow, 1 0.5159
274 medium 2 0.805
274 migration 4 2.0183
274 node, 1 0.6785
274 normal 2 0.4053
274 numbers, 1 0.6034
274 observed 1 0.2569
274 organs 1 0.4155
274 organs. 1 0.543
274 phage 1 0.485
274 phagocytic 2 1.2691
274 plasma 1 0.3038
274 rabbits 2 0.8607
274 removed 3 1.2755
274 res 1 0.7536
274 restoration 1 0.5596
274 reticuloendothelial 2 1.2069
274 seen 1 0.3186
274 sensitive 1 0.4066
274 showed 1 0.2686
274 sites 1 0.5046
274 spleen 2 0.8954
274 stimulation 2 0.8503
274 suppressed 1 0.5159
274 system 2 0.7041
274 take 1 0.5159
274 testis, 1 0.7536
274 thymus 1 0.543
274 tissues 3 1.0346
274 ug 1 0.5793
274 ug, 1 0.7536
274 ug/ml 1 0.6785
274 vitro. 1 0.5046
274 week 1 0.4943
274 well 1 0.2636
274 widespread 1 0.6785
275 'type 2 1.0048
275 (10 1 0.3862
275 2 2 0.3068
275 300 1 0.3862
275 3075. 1 0.5024
275 4 1 0.1777
275 7 1 0.2315
275 80% 1 0.3731
275 age 1 0.2078
275 al- 1 0.3862
275 also 2 0.2811
275 alveolar 4 1.0959
275 approximately 1 0.2631
275 around 1 0.3364
275 assay 1 0.3296
275 association 1 0.2711
275 background 1 0.3731
275 blood 1 0.1552
275 bronchiolar 1 0.4523
275 bronchioles. 1 0.5024
275 capillary 1 0.362
275 cell 2 0.3401
275 cells 6 0.9098
275 cells, 2 0.4871
275 cells. 1 0.224
275 change 1 0.2331
275 changes 1 0.1503
275 characterized 1 0.2657
275 comprising 1 0.4523
275 considered 1 0.224
275 covered 1 0.4523
275 cytopathic 1 0.3731
275 cytoplasmic 1 0.3028
275 days 2 0.3992
275 density 1 0.3296
275 derived 1 0.277
275 developed 1 0.2284
275 developed; 1 0.5024
275 dilatation 1 0.3524
275 earliest 1 0.3731
275 edema 1 0.3439
275 edema, 1 0.4023
275 effect 1 0.1534
275 elec- 1 0.423
275 electron 2 0.5074
275 endoplasmic 1 0.3731
275 endothelial 1 0.3862
275 epi- 1 0.423
275 evidence 1 0.1842
275 evidenced 1 0.3862
275 extensive 1 0.2834
275 extracellular 1 0.3524
275 exudation 1 0.5024
275 fixed 1 0.362
275 fluid 1 0.2381
275 forms 1 0.2399
275 g) 1 0.4523
275 generalized 1 0.3439
275 giving 1 0.423
275 gross 1 0.3364
275 high 1 0.1798
275 histologic 1 0.3364
275 histologically, 1 0.423
275 i' 1 0.5024
275 ii' 1 0.5024
275 infected 2 0.548
275 infection 1 0.2364
275 inoculation. 1 0.5024
275 inter- 1 0.362
275 interstitial 1 0.3439
275 intracellular 1 0.3296
275 intranasal 1 0.5024
275 iod 1 0.5024
275 large 1 0.1986
275 light 1 0.2834
275 lining 1 0.3364
275 low 1 0.2199
275 lungs 1 0.274
275 lungs. 1 0.3862
275 macrophages 1 0.3364
275 marked 1 0.2254
275 material 1 0.2331
275 mice 1 0.2474
275 mice. 2 0.6352
275 microscopic 1 0.3123
275 microscopy 1 0.3233
275 mononuclear 1 0.423
275 much 1 0.2226
275 muscle 1 0.277
275 necrosis 1 0.3439
275 necrosis. 1 0.5024
275 neutrophils 1 0.4523
275 noted 2 0.5313
275 noted, 1 0.4523
275 observed 2 0.3425
275 particles 2 0.724
275 pathologic 1 0.3074
275 per 1 0.1958
275 per- 1 0.3364
275 pfu 1 0.5024
275 pneumonia 4 1.3455
275 present, 1 0.3296
275 probably 1 0.2284
275 re- 1 0.2226
275 red 1 0.2985
275 relatively 1 0.2417
275 release 1 0.3233
275 remained 1 0.2869
275 replication 1 0.3731
275 result 1 0.2173
275 resulted 1 0.2435
275 reticulum. 1 0.5024
275 rise 1 0.2494
275 scattered 1 0.4023
275 seen 1 0.2124
275 septa. 2 1.0048
275 similarly 1 0.4023
275 smooth 1 0.423
275 space. 1 0.4023
275 stitial 1 0.5024
275 stream 1 0.4023
275 study 1 0.1548
275 surrounding 1 0.3524
275 swiss 1 0.423
275 swollen 1 0.4523
275 thelium 1 0.5024
275 titers 2 0.9046
275 tron 1 0.5024
275 tural 1 0.5024
275 ultrastruc- 1 0.5024
275 usually 1 0.2364
275 vaccinia 4 1.8093
275 various 1 0.1986
275 veoli 1 0.5024
275 viral 3 0.9083
275 viremia 1 0.5024
275 virus 6 1.5786
275 walls. 1 0.4523
275 white 1 0.3123
275 widening 1 0.423
275 within 2 0.373
276 100% 1 0.6034
276 1161. 1 0.7536
276 20 1 0.3403
276 25% 1 0.5286
276 4 1 0.2666
276 acid. 1 0.5793
276 alveolar 4 1.6439
276 apparently 1 0.411
276 bovine 1 0.4303
276 cattle 1 0.6034
276 cattle, 1 0.6785
276 cattle. 1 0.7536
276 cell. 1 0.5286
276 described 1 0.2859
276 dimensions 1 0.6034
276 disease, 1 0.4025
276 disease. 1 0.3985
276 electron 2 0.7611
276 epithelial 1 0.3985
276 experiments 1 0.3339
276 extracellular. 1 0.7536
276 first 1 0.2763
276 free 2 0.7143
276 high 2 0.5394
276 injections 1 0.4252
276 intratracheal 1 0.6785
276 involving 1 0.485
276 lamellar 4 2.3172
276 lattice 4 2.5382
276 linoleic 1 0.6346
276 lumen 1 0.6346
276 lumens 2 1.5073
276 lungs 2 0.8219
276 microscopic 1 0.4685
276 microscopy 1 0.485
276 mountain 2 1.2691
276 normal 3 0.608
276 ob- 1 0.5159
276 obser- 1 0.7536
276 oleic 1 0.6034
276 one 1 0.2108
276 others 1 0.411
276 report 1 0.3653
276 samples 1 0.4764
276 served 1 0.4943
276 shape 1 0.485
276 silicon 1 0.7536
276 similar 1 0.2821
276 specimen, 1 0.7536
276 structure 1 0.3839
276 structures 4 2.0183
276 study 1 0.2322
276 vacuole 1 0.6785
276 ved 1 0.7536
276 within 1 0.2798
276 workers 1 0.543
277 'thinning' 1 0.5024
277 1162. 1 0.5024
277 2 1 0.1534
277 acute 2 0.4989
277 alveo- 1 0.5024
277 alveolar 6 1.6439
277 amorphous 1 0.5024
277 barrier 1 0.3862
277 blood-air 1 0.3862
277 bodies 1 0.3074
277 bodies, 1 0.4023
277 bovine 1 0.2869
277 cells. 1 0.224
277 collagenous 1 0.5024
277 cows 1 0.4523
277 cyto- 1 0.423
277 cytolysis, 1 0.5024
277 degenerating 1 0.4523
277 edema 1 0.3439
277 elastic 1 0.4523
277 electron 2 0.5074
277 electron-dense 1 0.5024
277 emphy- 1 0.5024
277 emphysema 1 0.4523
277 endothelial 2 0.7724
277 epithelial 3 0.797
277 excessive 1 0.3233
277 experimentally 1 0.3524
277 fibrosis, 1 0.3862
277 findings 1 0.1996
277 following 1 0.1665
277 formation, 1 0.4523
277 hyaline 1 0.3731
277 hyperplasia 1 0.2834
277 hypertrophied 1 0.4523
277 induced 1 0.2136
277 intra- 1 0.3524
277 lamellar 2 0.7724
277 lar 1 0.3862
277 lattice 2 0.8461
277 lungs 1 0.274
277 lysis, 1 0.5024
277 macrophages, 1 0.423
277 mass. 1 0.4523
277 membrane 1 0.2711
277 microscopic 1 0.3123
277 microscopy 1 0.3233
277 muscle, 1 0.423
277 numerous 2 0.5969
277 perikaryons, 1 0.5024
277 postulated 1 0.3524
277 pulmonary 2 0.4296
277 result 1 0.2173
277 secretion 1 0.2944
277 sema 1 0.5024
277 smooth 1 0.423
277 studies 1 0.1539
277 wall 2 0.6352
277 yielded 1 0.3176
278 121 1 0.5428
278 135 1 0.6029
278 1560. 1 0.6029
278 230 1 0.6029
278 69 1 0.4827
278 active 1 0.2778
278 activity 2 0.4315
278 although 1 0.2318
278 alveolar 3 0.9863
278 appearance 1 0.2993
278 appeared 1 0.29
278 appearing 1 0.4477
278 associated 1 0.2141
278 basis 1 0.2639
278 be, 1 0.6029
278 bodies 3 1.1066
278 bodies. 1 0.5428
278 body 1 0.2431
278 brin, 1 0.6029
278 bulk 1 0.5076
278 bundles 1 0.5428
278 cell, 1 0.4634
278 compo- 1 0.5428
278 component, 1 0.5428
278 considered 1 0.2688
278 consists 2 0.7622
278 constituting 1 0.5428
278 content, 1 0.5428
278 correlated 1 0.3581
278 cytologic 1 0.4477
278 days 3 0.7185
278 decrease 1 0.2759
278 dense 1 0.4477
278 density 1 0.3955
278 described. 1 0.3018
278 detectable 1 0.3811
278 detecting 1 0.5076
278 differences 1 0.2759
278 difficulty 1 0.4037
278 distress 2 0.9655
278 distress. 1 0.5428
278 due 1 0.2133
278 epithelial 1 0.3188
278 evidence 1 0.221
278 ex- 1 0.3581
278 excretory 1 0.6029
278 exists 1 0.4344
278 experimentally 1 0.4229
278 extracts 1 0.3689
278 fact 1 0.3188
278 fetal 2 0.6886
278 fetuses 1 0.4344
278 fi- 1 0.6029
278 fibrils 1 0.4634
278 fibrin 2 1.0153
278 fibrinogen 1 0.4634
278 first 1 0.221
278 following 1 0.1998
278 found, 1 0.4229
278 gestation 1 0.4477
278 gestation. 1 0.5076
278 hyaline 2 0.8954
278 ii 1 0.4037
278 immature 1 0.4037
278 immaturity 1 0.5428
278 inclusion 5 1.9399
278 inclusions 1 0.4634
278 inclusions, 1 0.6029
278 increased 1 0.1874
278 lamb 1 0.5076
278 lambs 2 0.9655
278 lambs. 2 1.0856
278 layer 5 2.3172
278 least 1 0.3099
278 lining 2 0.8073
278 loss 2 0.5845
278 lung 2 0.5185
278 lungs 2 0.6575
278 ly 1 0.3955
278 mammals 2 1.0153
278 materials 1 0.4229
278 maturation 1 0.4827
278 maturation. 1 0.6029
278 mature 2 0.7495
278 membrane 1 0.3253
278 membranes 1 0.388
278 nature 2 0.5987
278 newborn 1 0.3288
278 normal 2 0.3242
278 number 3 0.6922
278 one, 1 0.4477
278 osmiophilic 4 2.1711
278 part, 1 0.5076
278 periodicity 1 0.4344
278 phospholipid 1 0.4229
278 polymers 1 0.6029
278 presence 1 0.2297
278 probably 1 0.2741
278 produced 1 0.2455
278 protein. 1 0.4634
278 provide 1 0.3533
278 pulmonary 2 0.5155
278 rare- 1 0.6029
278 reach 1 0.4827
278 relation 1 0.2778
278 respiratory 3 0.9382
278 serum 1 0.2339
278 since 1 0.2623
278 sition 1 0.5428
278 small 1 0.2419
278 source 1 0.4037
278 species 1 0.3288
278 strong 1 0.4037
278 studied. 1 0.3401
278 substances. 1 0.5428
278 suggested 2 0.5015
278 surface 4 1.3012
278 surfactant. 2 1.0856
278 susceptibility 1 0.4634
278 tension 1 0.3633
278 thought 1 0.3401
278 total 1 0.235
278 tracts 1 0.5428
278 type 1 0.2507
278 ultrastructure 1 0.5076
278 values 1 0.3044
278 view 1 0.3533
278 well 1 0.2108
279 1685. 1 1.0048
279 2 1 0.3068
279 additional 1 0.5366
279 asso- 1 0.9046
279 broncho-alveolar 1 1.0048
279 bronchoalveolar 1 1.0048
279 cases 2 0.5979
279 changes 1 0.3007
279 ciates 1 1.0048
279 clinical, 1 0.6466
279 condition 1 0.5366
279 contention 1 0.8461
279 described 1 0.3811
279 described. 1 0.5031
279 desquamative 3 3.0145
279 diagnosis 1 0.4135
279 differences 2 0.9196
279 differential 1 0.6352
279 differentiation 1 0.5738
279 disease 3 1.0831
279 diseases 1 0.548
279 distinctive 1 0.7462
279 em- 1 1.0048
279 entity 1 0.8046
279 exfoliative 2 2.0097
279 existence 1 0.6148
279 festations 1 1.0048
279 found 1 0.2645
279 histopathologic 2 2.0097
279 interstitial 3 2.0636
279 introduced. 1 1.0048
279 liebow 1 1.0048
279 mani- 1 0.8461
279 manifestations. 1 1.0048
279 named 1 0.9046
279 phasized. 1 1.0048
279 phenomena 1 0.7048
279 pneumonia 2 1.3455
279 pneumonia. 1 0.8461
279 presented 1 0.3898
279 previously 2 0.9667
279 pulmonary 1 0.4296
279 recorded 1 0.5738
279 roentgenologic 1 1.0048
279 submitted. 1 1.0048
279 support 1 0.554
279 symptoms, 1 0.724
279 tabulated 1 1.0048
279 three 1 0.3778
280 (a) 1 0.2771
280 (b) 1 0.2771
280 (c) 1 0.3021
280 (d) 1 0.3626
280 (e) 1 0.3877
280 (primary 1 0.4306
280 (wal- 1 0.4306
280 2 2 0.263
280 3 1 0.1468
280 3831. 1 0.3877
280 accu- 1 0.4306
280 acid 2 0.3326
280 activity 1 0.1541
280 altered 2 0.46
280 apparently 2 0.4697
280 appear 1 0.1971
280 arise 1 0.3448
280 autophagic 2 0.7754
280 axoplasm 5 2.1532
280 begins, 1 0.4306
280 bodies 2 0.5269
280 body 1 0.1736
280 break- 1 0.4306
280 cells, 1 0.2087
280 cells. 2 0.384
280 close 1 0.2523
280 considered 1 0.192
280 crush 1 0.4306
280 crush. 2 0.8613
280 crushed. 1 0.4306
280 degeneration 2 0.6206
280 degeneration). 1 0.4306
280 degraded 2 0.7252
280 delimiting 1 0.4306
280 demonstrable 1 0.2883
280 dense 1 0.3198
280 described 1 0.1633
280 distal 1 0.3021
280 encloses 1 0.4306
280 endo- 1 0.3626
280 endoplasmic 1 0.3198
280 engulfed 1 0.4306
280 exposed. 1 0.4306
280 extending 1 0.3877
280 favorable 1 0.2948
280 fibers 2 0.6896
280 fibers. 1 0.3877
280 filopodia 1 0.4306
280 focally 1 0.4306
280 following 2 0.2855
280 form 1 0.1874
280 formed. 1 0.4306
280 functions 1 0.2677
280 generally 1 0.2558
280 golgi 1 0.3198
280 hours 1 0.2071
280 increases 1 0.2012
280 lamellae. 1 0.4306
280 lerian 1 0.4306
280 lies 1 0.3626
280 lysosomes 3 0.9593
280 lysosomes), 1 0.4306
280 lysosomes. 1 0.4306
280 markedly 1 0.23
280 material 1 0.1998
280 may 1 0.1077
280 mebranous 1 0.4306
280 membranes 1 0.2771
280 mm 1 0.2771
280 much 1 0.1908
280 mulate 1 0.4306
280 multivesicular 1 0.3626
280 myelin 3 1.0878
280 myelina- 1 0.4306
280 myelinated 1 0.3877
280 near 1 0.2595
280 nerve 3 0.865
280 nerves 1 0.331
280 nodes 1 0.331
280 normal 1 0.1158
280 organelles 1 0.3198
280 origins, 1 0.3626
280 peripheral 1 0.2558
280 phagocytic 2 0.7252
280 phosphatase 2 0.6396
280 plasmic 1 0.3877
280 possible 1 0.1728
280 preparatory 1 0.4306
280 proximal 1 0.2948
280 ranvier. 1 0.4306
280 rat 1 0.1772
280 regeneration. 1 0.4306
280 reorganization 1 0.3877
280 reticulum 2 0.6621
280 schwann 3 1.2919
280 sciatic 1 0.4306
280 seen 1 0.1821
280 significance 1 0.2348
280 sources 1 0.331
280 studying 1 0.331
280 ted 1 0.3198
280 thus 1 0.2234
280 type, 1 0.2883
280 types, 1 0.3626
280 undergoing 1 0.2722
280 vacuoles 7 2.5382
280 vacuoles. 1 0.3626
280 vesicles 1 0.3448
280 within 4 0.6394
280 zone 1 0.2825
281 2431. 1 1.357
281 alveolar 2 1.6439
281 bronchial 1 1.1192
281 covers 1 1.357
281 cuboidal 1 1.357
281 demonstrated 1 0.6444
281 demonstration 1 0.97
281 discussed. 1 0.6444
281 distal 1 1.0572
281 epithelial 2 1.5939
281 epithelium 1 0.9083
281 guinea 1 1.1192
281 hamster, 1 1.357
281 histochemically 1 1.5073
281 histochemistry 1 1.357
281 layer 1 1.1586
281 lung 1 0.6481
281 lung. 1 1.086
281 mammalian 1 1.0318
281 man. 1 0.97
281 mouse, 1 1.357
281 mucins 1 1.5073
281 observations 1 0.6337
281 pig, 1 1.2691
281 pleura 1 1.5073
281 pleural 1 1.2691
281 possible 1 0.6046
281 predominates 1 1.5073
281 rabbit, 1 1.2069
281 sialo- 1 1.5073
281 sialomucin 2 3.0145
281 significance 1 0.8219
281 sulfomucins 1 1.5073
281 surface 2 1.6265
281 surface. 1 1.2069
281 syrian 1 1.2069
281 tree 1 1.2691
282 11 1 0.322
282 14th 1 0.5428
282 19 1 0.4037
282 2 1 0.1841
282 6 1 0.2521
282 617. 1 0.6029
282 abnormal 1 0.2922
282 accompanied 1 0.3362
282 age. 1 0.3401
282 air 3 1.0085
282 also 2 0.3373
282 alterations 1 0.3324
282 alveolar 3 0.9863
282 alveoli 3 1.3032
282 alveolus 1 0.6029
282 appeared 1 0.29
282 associated 1 0.2141
282 barriers 1 0.5428
282 barriers. 2 1.2058
282 beyond 1 0.4127
282 blood-air 3 1.3903
282 bly 1 0.6029
282 bodies 2 0.7377
282 borns 1 0.5428
282 bronchio- 1 0.6029
282 capacity 1 0.3288
282 cells 3 0.5459
282 cells, 1 0.2922
282 changes 1 0.1804
282 clusion 1 0.5428
282 collapse 1 0.5428
282 collapsed 2 1.0856
282 component 1 0.388
282 contrast, 1 0.4634
282 controls. 1 0.3955
282 da- 1 0.5428
282 damage 1 0.3071
282 days. 1 0.3401
282 degree 1 0.2671
282 determined 1 0.2741
282 develop- 1 0.4634
282 developed 1 0.2741
282 died 1 0.3533
282 distress 4 1.931
282 distribution 1 0.3099
282 ducts 1 0.4344
282 ed 1 0.4127
282 edema 1 0.4127
282 edema. 1 0.5076
282 electron 1 0.3044
282 epithelial 5 1.5939
282 ever, 1 0.4477
282 exhibited 1 0.3689
282 expanded 1 0.5428
282 fetuses 1 0.4344
282 findings 1 0.2395
282 forma- 1 0.4827
282 formation 2 0.541
282 formed 1 0.3362
282 free 1 0.2857
282 gested 1 0.5428
282 histologic 1 0.4037
282 how- 1 0.4634
282 hr 1 0.3487
282 human 1 0.2012
282 hyaline 2 0.8954
282 hyaline-membrane 1 0.6029
282 i.e. 1 0.4634
282 idio- 1 0.6029
282 idiopathic 3 1.2382
282 ii 3 1.211
282 in- 1 0.2671
282 inclusion 1 0.388
282 increase 1 0.2048
282 infants 3 0.8635
282 intact 1 0.3324
282 lack 1 0.3487
282 les 1 0.4634
282 light-and 1 0.6029
282 lined 2 1.0153
282 lining 3 1.211
282 lung 2 0.5185
282 lung. 1 0.4344
282 lungs 2 0.6575
282 lungs, 1 0.4634
282 mage 1 0.5428
282 mal 1 0.4037
282 marked 1 0.2705
282 matura- 1 0.6029
282 maturation 2 0.9655
282 mature 2 0.7495
282 maturity 1 0.5076
282 membrane 1 0.3253
282 membranes. 1 0.5428
282 microscopy. 1 0.5428
282 new- 1 0.5076
282 newborn 1 0.3288
282 nor- 1 0.388
282 normal 1 0.1621
282 number 1 0.2307
282 numerous 1 0.3581
282 occur 1 0.2945
282 older 1 0.3748
282 par- 1 0.4827
282 pathic 1 0.6029
282 pathologic 2 0.7377
282 pattern 1 0.2878
282 pattern, 1 0.4827
282 per 1 0.235
282 plasma 1 0.2431
282 poorly 1 0.4634
282 postnatal 1 0.4827
282 predominantly 1 0.4827
282 presented 1 0.2339
282 presuma- 1 0.6029
282 presumably 1 0.3955
282 process 1 0.2759
282 produce 1 0.322
282 reduction 1 0.2969
282 related 1 0.2549
282 respiratory 5 1.5637
282 responsible 1 0.3044
282 revealed 1 0.2922
282 sacs 1 0.5428
282 sacs. 2 1.2058
282 secretion 1 0.3533
282 seemed 1 0.388
282 septal 2 0.6506
282 served 1 0.3955
282 similar 1 0.2257
282 spaces 1 0.4229
282 structurally 1 0.5076
282 studied 1 0.2101
282 study 1 0.1857
282 sug- 1 0.5076
282 suggested 1 0.2507
282 surfactant 2 0.8688
282 survival 1 0.29
282 syndrome 3 0.839
282 syndrome, 1 0.4037
282 ticipated 1 0.6029
282 tion 1 0.2741
282 tion. 1 0.4477
282 transudation 1 0.6029
282 type 4 1.0029
282 usually 1 0.2836
282 well 2 0.4217
282 whereas 1 0.3018
283 (i,t*) 1 0.6029
283 20-day 1 0.6029
283 3 2 0.411
283 903. 1 0.6029
283 air 2 0.6723
283 alveolar 5 1.6439
283 appear 1 0.2759
283 appearance 1 0.2993
283 arranged 1 0.4477
283 ated 1 0.4827
283 bodies 1 0.3689
283 cell 5 1.0202
283 cells 2 0.3639
283 cells. 1 0.2688
283 center. 1 0.5428
283 channel 1 0.5428
283 concentrically 1 0.6029
283 configuration. 1 0.5428
283 consist 1 0.4477
283 contact 1 0.3487
283 contains 1 0.3689
283 continuous 1 0.3401
283 cyto- 1 0.5076
283 cytoplas- 1 0.6029
283 cytoplasm 1 0.3748
283 cytoplasmic 1 0.3633
283 days 2 0.479
283 degeneration. 1 0.5428
283 dense 2 0.8954
283 developing 1 0.3253
283 direct 1 0.2836
283 disappear 1 0.5428
283 disrupted 1 0.6029
283 embryo 1 0.4229
283 epithelial 1 0.3188
283 extrude 1 0.6029
283 figures 1 0.4634
283 figures, 1 0.6029
283 formed 1 0.3362
283 fre- 1 0.5076
283 generally 1 0.3581
283 in- 1 0.2671
283 inclu- 1 0.6029
283 inclusions 3 1.3903
283 intracellular 1 0.3955
283 lamin- 1 0.6029
283 large 2 0.4767
283 lattice 3 1.5229
283 lungs 1 0.3288
283 ma- 1 0.4827
283 material. 1 0.4344
283 materials 2 0.8457
283 may 3 0.4523
283 membrane. 1 0.4634
283 membranes 2 0.776
283 mic 1 0.6029
283 myelin 2 1.0153
283 newborn 1 0.3288
283 numerous 1 0.3581
283 observed 1 0.2055
283 occasionally 1 0.4037
283 old. 1 0.5076
283 originate 2 0.9269
283 osmiophilic 5 2.7139
283 particularly 1 0.3324
283 partum. 1 0.5428
283 plasm 1 0.5076
283 post 1 0.4229
283 present 1 0.1985
283 process 1 0.2759
283 quently 1 0.5428
283 rat 1 0.2481
283 rats 3 0.6985
283 respiratory 1 0.3127
283 rupture 1 0.5428
283 secre- 1 0.6029
283 secretion 2 0.7065
283 seen 2 0.5098
283 side 1 0.3401
283 sions. 1 0.6029
283 size 1 0.3157
283 space 3 1.3431
283 space. 2 0.9655
283 structure 1 0.3071
283 structures 3 1.211
283 surfaces 1 0.5076
283 terial 1 0.4477
283 thought 1 0.3401
283 tion 1 0.2741
283 tissue 1 0.2093
283 usually 1 0.2836
283 variable 1 0.3633
284 (xanthoma) 2 0.8613
284 3-month-old 1 0.4306
284 454. 1 0.4306
284 51-year- 1 0.4306
284 9-month-old 1 0.4306
284 activity 1 0.1541
284 alized 1 0.4306
284 also 1 0.1205
284 authors 1 0.1984
284 becomes 1 0.2595
284 believe 1 0.2883
284 bilateral 1 0.2595
284 capability 1 0.3626
284 case 3 0.4642
284 cells 7 0.9098
284 cells, 1 0.2087
284 choroid 4 1.2791
284 choroidal 3 1.1631
284 considered 1 0.192
284 content 1 0.2026
284 detachment. 1 0.4306
284 discussed. 2 0.3682
284 disease 1 0.1547
284 disintegration 1 0.3877
284 epithelial 2 0.4554
284 epithelium 1 0.2595
284 epithelium. 1 0.3626
284 explained 1 0.2429
284 factor 1 0.2041
284 fixed 1 0.3103
284 foamy 5 2.1532
284 foreign-body 1 0.3877
284 formation 2 0.3865
284 gener- 1 0.4306
284 giant 1 0.2883
284 glycogen 1 0.3103
284 hemorrhage 1 0.2771
284 infant 2 0.4859
284 intense 1 0.3103
284 interstitium 1 0.4306
284 involved 1 0.2194
284 liferation 1 0.3877
284 lipid 1 0.2635
284 macrophages 2 0.5767
284 male 1 0.2194
284 mode 1 0.3103
284 multinucleated 1 0.3877
284 old 1 0.2429
284 origin 2 0.4918
284 particularly, 1 0.3877
284 pathogenesis 1 0.2429
284 phagocytes 1 0.4306
284 phagocytic 1 0.3626
284 plexus 1 0.3626
284 plexus, 1 0.3877
284 plexus. 1 0.4306
284 pro- 1 0.2948
284 proliferation 1 0.249
284 proliferative 1 0.3103
284 provokes 1 0.3877
284 re- 1 0.1908
284 regarded 1 0.2677
284 releases 1 0.4306
284 second 1 0.2194
284 similar 1 0.1612
284 sponse 1 0.331
284 storage 1 0.4306
284 stroma 1 0.3448
284 type. 1 0.2883
284 wandering 1 0.4306
284 xanthogranuloma 3 1.2919
284 xanthogranuloma. 1 0.4306
284 xanthoma 1 0.4306
285 'alveolar 1 1.0048
285 4. 1 0.5738
285 alveolar 1 0.548
285 analysis 1 0.4833
285 approximately 1 0.5262
285 arose 1 1.0048
285 cells 2 0.6065
285 chimeras 1 1.0048
285 chro- 1 0.9046
285 chromosome 1 0.6728
285 chromosomes. 1 0.9046
285 could 2 0.722
285 demonstrated 1 0.4296
285 dividing 1 0.7724
285 exposed 1 0.5262
285 found 1 0.2645
285 hematopoietic 3 2.5382
285 identified 1 0.5888
285 investiga- 1 1.0048
285 irritant, 1 1.0048
285 lung 1 0.4321
285 lungs 2 1.0959
285 macrophages 1 0.6728
285 macrophages' 1 1.0048
285 marker 1 1.0048
285 markers 1 0.9046
285 mixed 1 0.6352
285 mosome 1 0.9046
285 mouse 1 0.5603
285 normal 1 0.2702
285 one-third 1 0.7724
285 origin 2 1.1476
285 origin. 1 0.6728
285 pulmonary 2 0.8592
285 recovered 1 0.6246
285 system 1 0.4694
285 ted 1 0.7462
285 thirds 1 0.8046
285 two- 1 0.8461
285 washing 1 0.8461
286 4 1 0.3554
286 632. 1 1.0048
286 active, 2 1.4923
286 al- 1 0.7724
286 although 1 0.3863
286 alveolar 3 1.6439
286 alveoli 1 0.724
286 and, 1 0.5212
286 appear 1 0.4598
286 biopsies 1 0.7462
286 cells 1 0.3033
286 clear- 1 0.7724
286 concept 1 0.6056
286 consistent 1 0.5603
286 contained 1 0.5119
286 de- 1 0.5603
286 defective 1 0.6879
286 disease. 1 0.5313
286 electron 2 1.0148
286 enzymatically 1 0.8461
286 enzyme 1 0.5969
286 extracts 1 0.6148
286 fact, 1 0.8046
286 fluid 1 0.4762
286 free 1 0.4762
286 generating 1 0.9046
286 granular 2 1.5448
286 histochemical 1 0.9046
286 histochemistry, 1 1.0048
286 indicate 1 0.4425
286 ing 1 0.5422
286 inhibited 1 0.6352
286 intraalveolar 2 2.0097
286 lesions 1 0.4321
286 lined 1 0.8461
286 lipid-filled 1 1.0048
286 lipid-rich 1 1.0048
286 lung 1 0.4321
286 macrophages 1 0.6728
286 many 1 0.4051
286 margins 1 1.0048
286 mate- 1 1.0048
286 material 2 0.9322
286 me- 1 0.7724
286 mea- 1 0.8461
286 measurement 1 0.5669
286 microscopy, 2 1.4096
286 normal 1 0.2702
286 observations 1 0.4225
286 osis 1 1.0048
286 overproduction 1 1.0048
286 patients 1 0.2415
286 phospholipid. 1 1.0048
286 play 1 0.5969
286 pneumonocy- 1 1.0048
286 pneumonocytes. 1 1.0048
286 primary 1 0.4248
286 process 1 0.4598
286 protein- 1 1.0048
286 proteinosis 1 1.0048
286 proteinosis. 1 1.0048
286 proteinotic 1 1.0048
286 pulmonary 2 0.8592
286 reactions 1 0.4909
286 removal 1 0.5603
286 rial. 1 1.0048
286 role 1 0.4661
286 secreting 1 0.9046
286 sloughed 1 0.9046
286 staining 1 0.6728
286 studied 1 0.3501
286 study 1 0.3096
286 surement. 1 1.0048
286 surface 3 1.6265
286 surfactant 1 0.724
286 surfactant. 1 0.9046
286 tension 2 1.2111
286 tes, 1 1.0048
286 thods, 1 1.0048
286 tissue 1 0.3488
286 ultrastructure 1 0.8461
286 using 2 0.9135
286 veolar 1 0.9046
287 1688. 1 0.7536
287 70 1 0.5793
287 air-liquid 1 0.7536
287 al- 1 0.5793
287 altered. 1 0.6785
287 although 1 0.2897
287 alveolar 4 1.6439
287 alveolar-air 1 0.7536
287 alveoli 1 0.543
287 alveoli. 1 0.7536
287 anatomists 1 0.7536
287 anesthesiologists 1 0.7536
287 appeared 1 0.3625
287 arranged 1 0.5596
287 artificial 1 0.5046
287 ask 1 0.7536
287 asked 1 0.6785
287 assay 1 0.4943
287 atelectasis 1 0.6785
287 attempted 1 0.5046
287 authors 2 0.6944
287 became 1 0.4477
287 began 1 0.5596
287 belief 1 0.6785
287 best 1 0.3985
287 bring 1 0.5793
287 bubble 1 0.7536
287 bubbles 1 0.7536
287 cannot 1 0.4066
287 causes 1 0.4252
287 cells 1 0.2274
287 cells, 1 0.3653
287 chemists 1 0.7536
287 cialists 1 0.7536
287 clinicians 1 0.6346
287 closer 1 0.6785
287 communication 1 0.4155
287 concepts 1 0.5596
287 concerned 2 1.0091
287 contributions 2 1.2069
287 cooperative 1 0.6346
287 described 1 0.2859
287 development 1 0.2752
287 disciplines 2 1.2691
287 disease 2 0.5415
287 disease, 1 0.4025
287 disease. 2 0.797
287 doubtless 1 0.7536
287 elucidate 1 0.6785
287 end, 1 0.7536
287 environment 1 0.5046
287 errors 1 0.5286
287 evidence 1 0.2763
287 express 1 0.6034
287 film 1 0.5793
287 fine 1 0.5286
287 focus 1 0.6785
287 forces 1 0.5793
287 fundamental. 1 0.7536
287 fusion 1 0.5596
287 germane 1 0.7536
287 health 2 1.0572
287 hold 1 0.7536
287 hope 3 1.5858
287 identification 1 0.485
287 ignored 1 0.7536
287 infants. 1 0.5159
287 injury 1 0.5046
287 inquire 1 0.7536
287 insights 1 0.7536
287 interest. 1 0.6346
287 interface 2 1.357
287 isolated 1 0.3279
287 lack 1 0.4358
287 lastly, 1 0.6346
287 layer 1 0.5793
287 lining 3 1.5137
287 lung 3 0.9722
287 lungs 2 0.8219
287 m2. 1 0.7536
287 many 2 0.6077
287 material 1 0.3496
287 may 3 0.5654
287 mechanical 1 0.543
287 metabolism 3 1.0714
287 methods 1 0.3403
287 millions 1 0.6785
287 misinterpreted 1 0.7536
287 much 1 0.3339
287 multiple 1 0.4155
287 number 1 0.2884
287 nutrients 1 0.6785
287 observations 1 0.3168
287 obvious. 1 0.7536
287 occurred 1 0.3279
287 occurs 1 0.4025
287 omitted 1 0.6785
287 operate 1 0.7536
287 organ 2 1.0572
287 others 1 0.411
287 parallel. 1 0.7536
287 particular 1 0.3805
287 pathologists 1 0.7536
287 per- 1 0.5046
287 pertinent 1 0.6346
287 phenomena 2 1.0572
287 phospholipid 1 0.5286
287 physiologists 1 0.7536
287 posed 2 1.2069
287 possibilities 1 0.5596
287 possible 1 0.3023
287 premature 1 0.5159
287 problems 2 0.7819
287 processes 1 0.4477
287 produce 1 0.4025
287 promising 1 0.6346
287 properties 1 0.4025
287 provided 1 0.4611
287 qualifications 1 0.7536
287 question 1 0.5596
287 related 1 0.3186
287 relevance 1 0.6785
287 remarkable 1 0.543
287 required 1 0.411
287 requirements 1 0.7536
287 respect 1 0.4416
287 respiration. 1 0.6785
287 reviewers 1 0.7536
287 seem 2 0.8219
287 several 1 0.326
287 significant 1 0.2646
287 site 1 0.4358
287 soon 2 1.1192
287 spe- 1 0.6785
287 special 1 0.3985
287 specialties. 1 0.7536
287 stability 3 1.6788
287 structure 1 0.3839
287 students 1 0.6034
287 studies 2 0.4616
287 studies. 1 0.5793
287 study 1 0.2322
287 subject 2 0.97
287 summary, 1 0.6346
287 surfac- 1 0.7536
287 surface 3 1.2199
287 surgeons 1 0.6785
287 synthesis, 1 0.5793
287 tant 1 0.6785
287 tension 1 0.4542
287 time 1 0.2656
287 tionally; 1 0.7536
287 together 1 0.4303
287 tools 1 0.6785
287 touches 1 0.7536
287 understanding 2 0.9887
287 undertake 1 0.7536
287 unearthing 1 0.7536
287 uninten- 1 0.7536
287 veolar 1 0.6785
287 workers 1 0.543
288 1/3 1 0.4523
288 1689. 1 0.5024
288 44.5 1 0.5024
288 52 1 0.3862
288 550 1 0.4523
288 8 1 0.2269
288 acids 2 0.4948
288 acids. 1 0.3862
288 active 1 0.2315
288 activity. 1 0.3439
288 altera- 1 0.4523
288 alterations 1 0.277
288 altered 2 0.5366
288 alveolar 2 0.548
288 arachidonate 1 0.4523
288 attributed 1 0.3364
288 basement 1 0.3862
288 bodies 1 0.3074
288 cells. 1 0.224
288 composition 1 0.2944
288 consistently 1 0.3233
288 creased 1 0.3296
288 decreased 1 0.2269
288 developed 2 0.4568
288 distress 1 0.4023
288 distress, 1 0.5024
288 distribution 1 0.2582
288 dogs 4 1.0425
288 edema 1 0.3439
288 edema, 1 0.4023
288 edema. 1 0.423
288 electron 1 0.2537
288 endobronchial 3 1.5073
288 epithelial 1 0.2657
288 essentially 1 0.3439
288 esterified 3 1.2069
288 ex- 1 0.2985
288 exposure 2 0.5969
288 extracted 1 0.3364
288 fatty 3 0.7546
288 five 1 0.2657
288 frac- 1 0.4023
288 fraction 1 0.2683
288 greater 1 0.2078
288 hg 1 0.3439
288 hours. 1 0.362
288 ii 1 0.3364
288 in- 1 0.2226
288 increased 3 0.4686
288 increased, 1 0.3731
288 induced 1 0.2136
288 intra-alveolar 1 0.5024
288 lamellar 1 0.3862
288 lecithin 2 0.9046
288 levels 1 0.1967
288 lipid 3 0.9221
288 lipids 1 0.3731
288 lung 1 0.216
288 ly 1 0.3296
288 marked- 1 0.5024
288 measurement 1 0.2834
288 membrane 1 0.2711
288 micrographs 1 0.4023
288 mm 1 0.3233
288 normal 1 0.1351
288 normal. 2 0.6056
288 oxygen 3 0.7678
288 palmitate 2 0.8461
288 phospholipid 1 0.3524
288 plasma. 1 0.4023
288 posure 1 0.4523
288 pre- 1 0.3233
288 progressive 1 0.2801
288 protein, 1 0.362
288 pulmonary 6 1.2888
288 reduction 1 0.2474
288 relatively 1 0.2417
288 respiratory 2 0.5212
288 saturated 1 0.3862
288 sent 1 0.423
288 showed 1 0.1791
288 slightly 1 0.2869
288 structure 1 0.2559
288 surface 5 1.3555
288 surfactant 1 0.362
288 syndrome 1 0.2331
288 tension 3 0.9083
288 tension, 1 0.4523
288 tensions 1 0.4023
288 thickening 1 0.3862
288 three 1 0.1889
288 tion 1 0.2284
288 tions 1 0.2985
288 total 4 0.7833
288 type 1 0.2089
288 wash 1 0.5024
288 washing 1 0.423
288 washings. 1 0.5024
288 without 1 0.1897
289 3805. 1 0.201
289 5% 2 0.2896
289 95% 1 0.1692
289 accom- 1 0.1809
289 administration 1 0.0885
289 air 1 0.1121
289 alteration 1 0.1318
289 aramine 1 0.201
289 arterial 6 0.6255
289 associated 2 0.1427
289 authors 1 0.0926
289 average 1 0.0902
289 beckman 1 0.1809
289 blood 5 0.3105
289 blood. 1 0.1346
289 bulb 1 0.201
289 carbon 2 0.2691
289 cerebral 3 0.2857
289 cisterna 1 0.1609
289 cisternal 7 1.0814
289 decrease 1 0.092
289 dextran. 1 0.1809
289 dif- 1 0.1492
289 dioxide 2 0.2752
289 equilibrates 1 0.201
289 fall 2 0.2105
289 fell; 1 0.201
289 ficulties. 1 0.201
289 fluid 4 0.3809
289 followed 1 0.092
289 give 1 0.1096
289 hampered 1 0.1809
289 hypothesis 1 0.1073
289 increase 3 0.2048
289 increased 1 0.0625
289 induced 1 0.0854
289 infusion 1 0.1134
289 inhalation 2 0.2985
289 injection 1 0.084
289 internal 1 0.1134
289 intravenous 1 0.1073
289 introduced 1 0.1545
289 introduction 1 0.1448
289 jugular 1 0.1492
289 less 1 0.0752
289 magna 1 0.1692
289 man 2 0.2066
289 measure 1 0.1162
289 measured, 1 0.1809
289 measurement 2 0.2267
289 method 1 0.0798
289 microelectrode 1 0.201
289 needle 1 0.1545
289 niacinate 1 0.201
289 oxygen 15 1.5356
289 panied 1 0.1809
289 patients 1 0.0483
289 plus 1 0.1692
289 present 1 0.0662
289 pressure 4 0.3678
289 produced 2 0.1637
289 pronounced 1 0.1194
289 pure 1 0.1293
289 reliable 1 0.1346
289 rise 2 0.1996
289 rose 1 0.141
289 simultaneously 1 0.1211
289 subjects, 1 0.1346
289 suboccipital 1 0.201
289 technical 1 0.1448
289 tension 10 1.2111
289 tension. 2 0.3384
289 tension; 1 0.201
289 time 1 0.0708
289 vein, 1 0.201
289 venous 1 0.1134
289 well 2 0.1406
289 whereas 1 0.1006
289 without 1 0.0759
289 xanthinol 1 0.201
290 (higher 1 0.7536
290 10 1 0.2774
290 100 1 0.4252
290 20 1 0.3403
290 3,720 1 0.7536
290 3,720-4,820 1 0.7536
290 3,800 1 0.7536
290 30 1 0.3598
290 32.3, 1 0.7536
290 32.5, 1 0.7536
290 32.6 1 0.7536
290 4 1 0.2666
290 4,545 1 0.7536
290 4,820 1 0.7536
290 4181. 1 0.7536
290 43, 1 0.7536
290 43.5 1 0.7536
290 47 1 0.6785
290 49, 1 0.7536
290 6 1 0.3151
290 67% 1 0.6785
290 7.327, 1 0.7536
290 7.43, 1 0.7536
290 75%, 1 0.7536
290 8 1 0.3403
290 80.7, 1 0.7536
290 84.2 1 0.7536
290 89.6. 1 0.7536
290 acclimatization 1 0.7536
290 acclimatized 1 0.7536
290 acid-base 1 0.6346
290 alkaline 1 0.543
290 altitude 2 1.357
290 altitudes 1 0.6785
290 andean 1 0.7536
290 appears 1 0.3241
290 arterial 3 1.1728
290 blood 1 0.2329
290 blood. 1 0.5046
290 central 1 0.4066
290 cerebrospinal 1 0.4542
290 chemoreceptor 1 0.7536
290 chemoreceptor. 1 0.7536
290 cl-107, 1 0.7536
290 cl-124, 1 0.7536
290 constant 1 0.411
290 csf 4 2.0183
290 days 1 0.2994
290 differed 1 0.5159
290 difference 1 0.3773
290 different; 1 0.7536
290 equilibria 1 0.7536
290 essentially 1 0.5159
290 evaluate 1 0.5596
290 ex- 1 0.4477
290 expected 1 0.4943
290 fluid 1 0.3571
290 hco3-21.3, 1 0.7536
290 hco3-21.5, 1 0.7536
290 hematocrit 2 1.2691
290 hg, 1 0.6785
290 high 1 0.2697
290 hypoxia 1 0.485
290 hypoxia, 1 0.6034
290 increase 1 0.256
290 isting 1 0.7536
290 k+2.6, 1 0.7536
290 k+4.2, 1 0.7536
290 lactate 1 0.6346
290 less 2 0.5643
290 level 1 0.291
290 lowering 1 0.543
290 m, 1 0.6785
290 m. 2 0.8404
290 man 1 0.3874
290 mean 1 0.3625
290 means 1 0.3339
290 medullary 1 0.6346
290 mg/ 1 0.7536
290 ml. 1 0.5046
290 mm 1 0.485
290 na+136, 2 1.5073
290 na- 1 0.7536
290 native 1 0.5596
290 natives 1 0.7536
290 order 1 0.3946
290 pao, 1 0.7536
290 pco, 3 2.2609
290 pco,) 1 0.7536
290 peripheral 1 0.4477
290 peruvian 1 0.7536
290 ph 3 1.2199
290 possible 1 0.3023
290 prior 1 0.4025
290 rather 1 0.3546
290 recently 1 0.5159
290 regulation 1 0.5596
290 relate 1 0.6346
290 remain 1 0.543
290 report 1 0.3653
290 residents 1 0.7536
290 respectively. 2 1.0318
290 respiration, 1 0.6785
290 response 2 0.5503
290 role 1 0.3496
290 sao, 2 1.5073
290 sea- 1 0.7536
290 showing 1 0.4943
290 shown 1 0.3241
290 significant 1 0.2646
290 significantly 1 0.3168
290 studied 1 0.2626
290 subjects 2 0.7196
290 tives 1 0.7536
290 values 1 0.3805
290 variations 1 0.4685
290 ventilation 1 0.5596
291 1116. 1 0.4306
291 5 1 0.1633
291 7 2 0.3968
291 active 1 0.1984
291 actively 1 0.3198
291 also 1 0.1205
291 balance, 1 0.3877
291 basis 1 0.1885
291 be- 1 0.2635
291 ca 1 0.3021
291 ca, 3 0.9931
291 ca. 1 0.4306
291 calculated 1 0.2883
291 cation 2 0.6896
291 cations 1 0.3877
291 cations, 1 0.4306
291 cats 1 0.3877
291 cerebro- 1 0.3626
291 cerebrospinal 1 0.2595
291 charge 1 0.4306
291 choroid 5 1.5989
291 cisterna 3 1.0345
291 cisternal 1 0.331
291 cl 4 1.7226
291 cl, 1 0.3877
291 compared 1 0.1671
291 con- 1 0.2234
291 concentra- 1 0.3103
291 concentration 1 0.1811
291 concentrations 6 1.3281
291 conclusions 1 0.2722
291 considered 1 0.192
291 contained 1 0.2194
291 containing 1 0.2277
291 could 1 0.1547
291 csf 1 0.2883
291 data 1 0.1754
291 definitive 1 0.331
291 differ 1 0.2825
291 differed 2 0.5896
291 difference 1 0.2156
291 direction 1 0.3021
291 distribution 1 0.2213
291 divalent 1 0.3626
291 drawn 1 0.3198
291 ele- 1 0.3877
291 electrolytes, 1 0.3448
291 evidence 1 0.1579
291 explana- 1 0.4306
291 fact 1 0.2277
291 findings. 1 0.3626
291 fluid 7 1.4285
291 fluid, 2 0.8613
291 fluid. 2 0.8613
291 formed 1 0.2401
291 former 1 0.2948
291 function 1 0.1932
291 h2o 1 0.4306
291 hco3-concentration, 1 0.4306
291 higher 5 0.9259
291 homeostatic 1 0.4306
291 involved 1 0.2194
291 k 3 0.9308
291 k, 3 1.0878
291 likely 1 0.2523
291 lower 3 0.5873
291 magna 3 1.0878
291 markedly 1 0.23
291 measured 1 0.1885
291 measurement 1 0.2429
291 mechanisms 2 0.519
291 mg 2 0.5116
291 mg, 3 1.2919
291 mg. 1 0.2722
291 mm/kg 1 0.4306
291 monovalent 1 0.4306
291 na, 4 1.5508
291 newly 1 0.2883
291 one 1 0.1205
291 opposite 1 0.3626
291 other, 1 0.331
291 ph 1 0.2324
291 plasma 3 0.5209
291 plasma, 1 0.3877
291 plexus 5 1.813
291 potential 1 0.2825
291 proven, 1 0.3877
291 quite 1 0.2459
291 ratio 1 0.2255
291 regard 1 0.2459
291 respect 1 0.2523
291 selec- 1 0.4306
291 site. 1 0.3877
291 specific 1 0.1694
291 spinal 1 0.2948
291 subserve 1 0.4306
291 suggest 1 0.1958
291 suggesting 1 0.2635
291 taining 1 0.3877
291 taken 1 0.2429
291 though 1 0.2523
291 tion 2 0.3915
291 tive. 1 0.4306
291 transfer 2 0.5543
291 transport 1 0.2595
291 transported. 1 0.4306
291 true 1 0.2883
291 tween 1 0.3103
291 ultrafiltrate 4 1.7226
291 ultrafiltrate, 1 0.4306
291 ultrafiltrate. 1 0.4306
291 vated 1 0.3626
291 without 1 0.1626
292 (less 1 0.3349
292 1 1 0.1265
292 10 1 0.1233
292 20 1 0.1513
292 3230. 1 0.3349
292 4 1 0.1185
292 69 1 0.2682
292 altered 1 0.1789
292 altering 1 0.2682
292 arterial 4 0.695
292 associated 1 0.1189
292 availability 3 0.724
292 blood 5 0.5175
292 breath-holding 3 1.0048
292 briefly 1 0.2019
292 carbon 3 0.6728
292 cerebral 9 1.4285
292 changes 4 0.4009
292 circulation 1 0.1754
292 compare 1 0.2575
292 consistent 1 0.1868
292 continuous 1 0.189
292 control 1 0.1259
292 correlation 1 0.1691
292 decreases 1 0.2155
292 dioxide 3 0.6879
292 discussed. 1 0.1432
292 effective 1 0.1677
292 effects 1 0.1243
292 electroencephalogram 1 0.3349
292 electrolytes 1 0.282
292 expiratory 1 0.3015
292 extremely 1 0.2349
292 fall 1 0.1754
292 flow 1 0.1706
292 found 2 0.1764
292 gases, 1 0.3349
292 gen 2 0.5641
292 hemodynamics 1 0.282
292 hemodynamics, 1 0.3349
292 hg) 1 0.3349
292 increase 1 0.1138
292 increased 2 0.2082
292 increases 1 0.1565
292 inspiratory 1 0.3015
292 inter- 1 0.2413
292 internal 1 0.189
292 jpo2 1 0.3349
292 jugular 3 0.7462
292 less 1 0.1254
292 less, 1 0.3349
292 levels. 1 0.2243
292 linear 1 0.2155
292 man. 1 0.2155
292 maneuver 3 1.0048
292 mm. 2 0.4394
292 obtained 1 0.1194
292 owing 1 0.2243
292 oxy- 2 0.6031
292 oxygen 5 0.8531
292 paco2 3 1.0048
292 paco2, 1 0.3349
292 peco2, 1 0.3349
292 perfusion 1 0.1963
292 ph, 1 0.2487
292 po2, 1 0.3349
292 potassium, 1 0.3015
292 pressure 1 0.1533
292 pressure, 1 0.2197
292 procedure 1 0.1706
292 proved 1 0.1868
292 rapid 1 0.1624
292 recordings 1 0.2487
292 reduction 2 0.3299
292 resulting 1 0.1706
292 saturation, 1 0.3015
292 seconds 1 0.3015
292 seconds. 1 0.3349
292 significant 1 0.1176
292 small 1 0.1344
292 sodium 1 0.1611
292 statistically 1 0.2082
292 sudden 1 0.2155
292 tension 2 0.4037
292 tension, 2 0.6031
292 tension. 2 0.5641
292 threshold 1 0.282
292 together 1 0.1913
292 tolerated 1 0.2413
292 val 1 0.3349
292 valsalva 3 0.9046
292 venous 2 0.3779
292 within 1 0.1243
293 (from 1 0.3877
293 (vfp) 1 0.4306
293 - 2 0.5047
293 1-per-minute 2 0.8613
293 2344. 1 0.4306
293 3 1 0.1468
293 6- 1 0.4306
293 6-per-minute 2 0.8613
293 accom- 1 0.3877
293 accompanying 1 0.3021
293 accordance 2 0.7252
293 air, 1 0.3877
293 also 3 0.3614
293 amplitude 1 0.3198
293 appearance 1 0.2138
293 appearing 2 0.6396
293 arterial 3 0.6702
293 ations 1 0.4306
293 begin 1 0.3626
293 blood 4 0.5323
293 bradycardia 1 0.3448
293 breathing 1 0.3103
293 breathing. 1 0.4306
293 called 2 0.6206
293 capnia. 1 0.4306
293 cardio-vascular 1 0.4306
293 cardiovascular 1 0.2722
293 changes 3 0.3866
293 characterized 1 0.2277
293 cheyne-stokes 1 0.4306
293 combinations, 1 0.4306
293 consciousness 2 0.8613
293 considerable 1 0.2234
293 considerably 1 0.2771
293 corresponding 1 0.2523
293 crests 1 0.4306
293 critical 1 0.2883
293 curve 1 0.2948
293 deep, 1 0.3626
293 degree 1 0.1908
293 dominating 1 0.4306
293 duration 1 0.2255
293 elevated. 1 0.3877
293 elevations 1 0.3626
293 ending 1 0.3877
293 entirely 1 0.2771
293 ever, 1 0.3198
293 expiratory 1 0.3877
293 fall 2 0.451
293 final 1 0.2825
293 fluctuations. 1 0.4306
293 fluid 2 0.4082
293 form 1 0.1874
293 forms 2 0.4112
293 found 1 0.1134
293 frequency 1 0.2255
293 frequency, 1 0.3877
293 frequency. 2 0.7754
293 gular 1 0.4306
293 how- 1 0.331
293 hyperpnoea. 1 0.4306
293 hypertension 2 0.5445
293 hypo- 1 0.3103
293 hypocapnia 1 0.3877
293 induced 1 0.1831
293 inspiratory 1 0.3877
293 instances, 1 0.331
293 intracranial 2 0.5649
293 irre- 1 0.4306
293 irregularly 1 0.4306
293 lar 1 0.331
293 large 1 0.1702
293 level 1 0.1663
293 limbs 1 0.3877
293 long 2 0.4468
293 main 1 0.2459
293 midposition 1 0.4306
293 minutes 1 0.2825
293 muscu- 1 0.4306
293 muscular 1 0.3021
293 nature, 1 0.3448
293 noted. 1 0.2883
293 observed 1 0.1468
293 occurred 2 0.3747
293 ods 1 0.4306
293 often 1 0.2087
293 pa- 1 0.2523
293 panied 1 0.3877
293 patients 1 0.1035
293 pattern, 1 0.3448
293 pco2 1 0.3448
293 per-minute 1 0.4306
293 peri- 1 0.3626
293 periods 1 0.2401
293 piratory 1 0.4306
293 plateau 4 1.5508
293 preceeding 1 0.4306
293 pres- 1 0.331
293 pressure 3 0.5912
293 pressure, 2 0.5649
293 pulmonary 1 0.1841
293 pulse 3 0.9308
293 rapid 1 0.2087
293 recording, 1 0.4306
293 res- 1 0.3877
293 respectively, 1 0.3103
293 respiratory 4 0.8936
293 rhythmic 1 0.3877
293 rhythmical 1 0.4306
293 seen 1 0.1821
293 sequences 2 0.6896
293 several 1 0.1863
293 shape 1 0.2771
293 shifted 1 0.3877
293 side 1 0.2429
293 simultaneous 1 0.2635
293 simultaneously 1 0.2595
293 sometimes 1 0.2771
293 spon- 1 0.3448
293 spontaneous 1 0.249
293 stage 1 0.2087
293 studied 1 0.15
293 sudden 1 0.2771
293 sure. 1 0.4306
293 synchronous 1 0.3877
293 synchronously 2 0.8613
293 systemic 3 0.7204
293 tachycardia), 1 0.4306
293 taneous 1 0.3626
293 third 1 0.2348
293 tients 1 0.2771
293 tone 1 0.3877
293 tone. 1 0.4306
293 towards 1 0.3103
293 traube-hering-mayer 1 0.4306
293 two 1 0.1319
293 type 1 0.1791
293 type. 1 0.2883
293 usual 1 0.3198
293 vari- 1 0.3626
293 variations 4 1.0708
293 variations. 1 0.4306
293 various 1 0.1702
293 venous 2 0.4859
293 ventilation, 1 0.3626
293 ventricular 2 0.3747
293 vfp 4 1.7226
293 vfp, 1 0.4306
293 wave. 1 0.4306
293 waves 7 2.4137
293 waves, 1 0.3877
293 waves. 1 0.4306
293 well 1 0.1506
294 (1) 1 0.4871
294 (2) 1 0.4871
294 2 1 0.3068
294 82. 1 1.0048
294 adult 1 0.4568
294 area 1 0.5212
294 axons, 1 1.0048
294 bilateral 1 0.6056
294 central 1 0.5422
294 certain 1 0.4425
294 cns 1 0.7048
294 cochlear 1 1.0048
294 complete 1 0.4661
294 complex, 1 0.724
294 consistently 2 1.2933
294 cranial 1 0.8046
294 damage 1 0.5119
294 exposed 1 0.5262
294 exposures 1 0.8046
294 female 1 0.5811
294 first 1 0.3684
294 focal 1 0.7462
294 found 3 0.7936
294 frequent 2 1.2111
294 glia 1 1.0048
294 globus 1 1.0048
294 groups 1 0.4092
294 groups, 1 0.6728
294 high 2 0.7192
294 individual 1 0.5313
294 involved. 1 0.7724
294 le- 1 0.7724
294 lesions 3 1.2963
294 lidus, 1 1.0048
294 lin, 1 1.0048
294 mye- 1 1.0048
294 necrosis 2 1.3758
294 neocortex. 1 1.0048
294 nerve 1 0.6728
294 nervous 1 0.6148
294 neurons 1 1.0048
294 never 1 0.6591
294 nigra 1 1.0048
294 nuclear 2 1.1622
294 nuclei 1 0.6352
294 nuclei, 1 0.9046
294 occurred 1 0.4372
294 olivary 1 1.0048
294 oxygen 2 1.0237
294 pal- 1 0.9046
294 paralyzed 1 1.0048
294 partial 1 0.5603
294 pressure 2 0.9196
294 rats 2 0.7761
294 repeated 1 0.5969
294 rhinencephalon, 1 1.0048
294 second 1 0.5119
294 sions 1 0.7724
294 spinal 1 0.6879
294 substantia 1 1.0048
294 superior 1 0.6728
294 symmetrical. 1 1.0048
294 system 1 0.4694
294 tract 1 0.5811
294 type 2 0.8358
294 types 2 0.9741
294 usually 1 0.4727
294 v. 1 0.8461
294 ventral 1 1.0048
294 within 1 0.373
295 330-u 1 0.4306
295 4 1 0.1523
295 5 1 0.1633
295 60-u 1 0.4306
295 747. 1 0.4306
295 air 2 0.4802
295 although 1 0.1655
295 amount 1 0.2121
295 ani- 1 0.331
295 animals 1 0.1831
295 area 1 0.2234
295 atm. 1 0.4306
295 breathed 1 0.4306
295 bruising 1 0.4306
295 calibration. 1 0.4306
295 cases 1 0.1281
295 caused 1 0.1885
295 comparison 1 0.2234
295 compressed 1 0.3877
295 considered 1 0.192
295 da- 1 0.3877
295 described. 1 0.2156
295 di- 1 0.3877
295 differ- 1 0.3626
295 differ. 1 0.3877
295 difference 1 0.2156
295 due 3 0.457
295 elec- 1 0.3626
295 electrode 3 1.0878
295 electrodes 2 0.7252
295 electrodes. 1 0.3877
295 ences 1 0.4306
295 errors 2 0.6041
295 estimations 2 0.7252
295 exposed 1 0.2255
295 exposure 1 0.2558
295 flexible 1 0.4306
295 found 1 0.1134
295 give 1 0.2348
295 gold 1 0.4306
295 greatest 1 0.2722
295 high 2 0.3082
295 highly 1 0.2324
295 in- 1 0.1908
295 inserted, 1 0.4306
295 insertion. 1 0.4306
295 kidney 1 0.1908
295 large 2 0.3405
295 liver, 1 0.2948
295 macroscopic 1 0.4306
295 made 2 0.3119
295 mage 1 0.3877
295 mal 1 0.2883
295 measurement 1 0.2429
295 mensions 1 0.4306
295 outweigh 1 0.4306
295 oxygen 2 0.4387
295 oxygen, 1 0.3626
295 pattern 1 0.2056
295 physical 1 0.249
295 po2 7 2.4137
295 pressure 1 0.1971
295 pressures 1 0.2825
295 pure 1 0.2771
295 qualitatively 1 0.3626
295 quantitative 1 0.2277
295 quite 1 0.2459
295 rat 1 0.1772
295 rats 1 0.1663
295 recorded 1 0.2459
295 recordings 1 0.3198
295 reflect 1 0.331
295 response 1 0.1572
295 results, 1 0.3448
295 several 1 0.1863
295 show 2 0.3725
295 similar 1 0.1612
295 size 1 0.2255
295 sizes 1 0.3877
295 soft, 1 0.4306
295 spleen, 1 0.2883
295 thought 1 0.2429
295 tissue 5 0.7474
295 tissues 1 0.1971
295 tissues, 1 0.3021
295 trauma 1 0.331
295 trodes 1 0.3877
295 value. 1 0.3448
295 values 2 0.4349
295 varying 1 0.2324
295 vascular 1 0.2374
295 vestigation 1 0.4306
296 (hpo). 1 0.7536
296 3384. 1 0.7536
296 5 4 1.1434
296 abolished, 1 0.7536
296 abs 1 0.6785
296 adrena- 1 0.7536
296 adrenalectomized 1 0.6034
296 adrenalectomy 2 1.0572
296 adrenergic 1 0.7536
296 air 2 0.8404
296 almost 1 0.3874
296 also 1 0.2108
296 ambient 1 0.6785
296 ani- 1 0.5793
296 animals 1 0.3204
296 animals. 1 0.4252
296 atm 3 1.9037
296 atmospheres 1 0.6785
296 attempt 1 0.4611
296 blood 2 0.4657
296 bradycardia 1 0.6034
296 breathing 1 0.543
296 brety- 1 0.7536
296 bretylium 3 2.2609
296 cardiac 1 0.3381
296 com- 1 0.4477
296 combination 1 0.4303
296 complex, 1 0.543
296 compression 2 1.1192
296 conditions 1 0.3426
296 considerably 1 0.485
296 control 2 0.5667
296 effect, 1 0.5596
296 effects 1 0.2798
296 explanation 1 0.5286
296 exposure 1 0.4477
296 falling 1 0.7536
296 find 1 0.5159
296 form 1 0.3279
296 higher 1 0.3241
296 hump 3 2.2609
296 immediately 1 0.4611
296 injection 1 0.3151
296 injection, 1 0.5596
296 latter 1 0.3909
296 lectomy 1 0.7536
296 lium 1 0.7536
296 lower 1 0.3426
296 lowered 1 0.5596
296 mals 1 0.6346
296 markedly 1 0.4025
296 measured 1 0.3299
296 number 1 0.2884
296 oxygen 4 1.5356
296 oxygen. 1 0.7536
296 peak 1 0.4358
296 po2 4 2.4137
296 ponse 1 0.7536
296 potentiated 1 0.6785
296 pression, 1 0.7536
296 pressure 2 0.6897
296 produced 1 0.3069
296 rate 1 0.2774
296 rats 4 1.1641
296 reaching 1 0.543
296 reduced 1 0.3403
296 res- 1 0.6785
296 response 2 0.5503
296 response. 1 0.5286
296 responses, 1 0.6034
296 significantly 1 0.3168
296 spleens 1 0.7536
296 splenic 4 2.5382
296 studied 1 0.2626
296 tensions 1 0.6034
296 tensions, 1 0.7536
296 termed 1 0.6346
296 tosylate 2 1.5073
296 tosylate. 1 0.7536
296 unexpectedly 1 0.7536
296 usually 1 0.3546
296 value 1 0.3472
296 value. 1 0.6034
296 values 1 0.3805
297 (1,1-dimethyl- 1 0.7536
297 (ohp). 1 0.7536
297 1 1 0.2846
297 10642. 1 0.7536
297 2,5-bis 1 0.7536
297 30 1 0.3598
297 4 1 0.2666
297 5 2 0.5717
297 absolute 1 0.5286
297 also 1 0.2108
297 anesthesia 1 0.6346
297 antioxidants 3 2.0354
297 atm 3 1.9037
297 commonly 1 0.5286
297 criteria 1 0.4416
297 damage 1 0.3839
297 deep 1 0.5286
297 different 1 0.2666
297 due 1 0.2666
297 effect 1 0.2301
297 effectiveness 1 0.5286
297 effects 1 0.2798
297 ex- 1 0.4477
297 excellent 1 0.543
297 experiments. 1 0.6346
297 following 1 0.2498
297 gave 1 0.4764
297 high 2 0.5394
297 hr., 1 0.5793
297 hydroquinone 1 0.7536
297 ing 1 0.4066
297 lung 1 0.3241
297 mice 1 0.3711
297 min. 1 0.5286
297 ohp 4 2.5382
297 oxygen 4 1.5356
297 oxygen, 1 0.6346
297 paralysis 1 0.5596
297 pe- 1 0.6785
297 pentobarbital-na 1 0.7536
297 poison- 1 0.7536
297 poisoning 1 0.5159
297 posed 1 0.6034
297 post 1 0.5286
297 potency 1 0.6034
297 preconclusive 1 0.7536
297 pressure 1 0.3449
297 pressures 1 0.4943
297 propyl) 1 0.7536
297 protected 1 0.5793
297 protection 1 0.485
297 rats 2 0.5821
297 riod 1 0.7536
297 several 2 0.6519
297 survival 1 0.3625
297 tested 2 0.9083
297 tests 1 0.3711
297 tests, 1 0.4943
297 time 1 0.2656
297 toxicity 3 1.483
297 used 2 0.5692
297 varied 1 0.4764
298 1,6-diphosphate 1 0.7536
298 1,6-diphosphate, 1 0.7536
298 10 2 0.5548
298 3716. 1 0.7536
298 a-glycerophosphate 1 0.7536
298 a-ketoglutarate, 1 0.7536
298 absence 2 0.7196
298 account 1 0.4252
298 accumulated 1 0.5793
298 acetate 4 2.2385
298 acetate, 1 0.6346
298 acid 1 0.291
298 addition 4 1.5356
298 adenine 1 0.7536
298 affec- 1 0.7536
298 aminase 1 0.7536
298 amount, 1 0.6785
298 analyses, 1 0.7536
298 cell. 1 0.5286
298 changes 1 0.2255
298 citrate 1 0.5596
298 citrate, 1 0.6346
298 citrate. 1 0.7536
298 citric 1 0.7536
298 cleotides 1 0.7536
298 close 2 0.8832
298 colytic 1 0.7536
298 com- 1 0.4477
298 con- 1 0.3909
298 concentrations 1 0.3874
298 consistent 1 0.4202
298 content 1 0.3546
298 contents 1 0.5046
298 control 2 0.5667
298 conversion 1 0.543
298 creased 1 0.4943
298 creased. 1 0.6785
298 cycle 1 0.6034
298 cytoplasm 2 0.9369
298 cytoplasm, 1 0.6034
298 de- 2 0.8404
298 decreased 4 1.3613
298 decreased, 1 0.6785
298 dehydrogenase 1 0.5793
298 dehydrogenase, 1 0.6785
298 demonstrate 1 0.4358
298 di- 1 0.6785
298 different 1 0.2666
298 dihydroxyacetone 1 0.7536
298 displaced 2 1.357
298 effect 1 0.2301
298 effects 1 0.2798
298 either 2 0.6444
298 elevated. 1 0.6785
298 enzymic 1 0.6346
298 equilibrium 1 0.5286
298 equilibrium, 1 0.7536
298 equilibrium. 3 2.2609
298 estimated 1 0.4685
298 fairly 1 0.543
298 far 2 0.97
298 fluorescence 1 0.6034
298 flux 3 2.2609
298 fructose 2 1.5073
298 glucose 3 1.1839
298 glucose. 1 0.6785
298 glutamic-oxaloacetate 1 0.7536
298 gly- 1 0.6785
298 glyceraldehyde 2 1.5073
298 glycogen 1 0.543
298 glycolysis 2 1.2069
298 glycolytic 4 2.7139
298 greatly 4 1.7907
298 heart 1 0.3496
298 heart, 1 0.5793
298 hexokinase, 1 0.7536
298 hexose 1 0.7536
298 i. 1 0.4477
298 increase 1 0.256
298 increased 3 0.7028
298 increased. 1 0.5046
298 indicate 1 0.3319
298 inhibition 4 1.5092
298 insufficient 1 0.6034
298 insulin, 1 0.543
298 insulin. 1 0.6346
298 intact 2 0.831
298 inter- 1 0.543
298 intermediate 1 0.485
298 isolated, 1 0.5793
298 kinase 1 0.6346
298 kinase. 2 1.5073
298 lac- 1 0.7536
298 lactate 1 0.6346
298 late, 1 0.7536
298 levels 4 1.1804
298 little 1 0.4025
298 ma- 1 0.6034
298 maintained 1 0.4202
298 may 1 0.1885
298 measured 1 0.3299
298 mechanisms. 1 0.6346
298 mediated 1 0.543
298 mediates 1 0.7536
298 metabolic 1 0.3598
298 metabolism 1 0.3571
298 mitochondria 1 0.5159
298 mm 2 0.97
298 monophosphates, 1 0.7536
298 nad 2 1.5073
298 nadh2 2 1.357
298 nadii2 1 0.7536
298 nadph2 1 0.6785
298 nu- 1 0.7536
298 nucleotides 1 0.5793
298 nucleotides, 1 0.7536
298 over-all 1 0.5596
298 oxaloacetate 2 1.5073
298 oxidation 1 0.6346
298 oxidized 1 0.6785
298 partmentation 1 0.7536
298 perfused 1 0.6034
298 phate 1 0.6034
298 phos- 1 0.5793
298 phosphate 2 0.7611
298 phosphate. 1 0.5793
298 phosphofructo- 1 0.7536
298 phosphofructokinase, 2 1.5073
298 phosphoglyceric 1 0.7536
298 phosphorylation 1 0.6346
298 presence 2 0.5742
298 promoted. 1 0.7536
298 pyridine 1 0.7536
298 pyru- 1 0.7536
298 pyruvate 4 2.4137
298 pyruvate, 2 1.5073
298 pyruvic 1 0.6346
298 rat 1 0.3101
298 ratio 2 0.7893
298 ratios 1 0.4943
298 reactants 1 0.7536
298 reaction 1 0.3773
298 reduced 1 0.3403
298 remained 1 0.4303
298 result 1 0.326
298 results 2 0.4316
298 shown 1 0.3241
298 similar 1 0.2821
298 situations, 1 0.6034
298 slightly 1 0.4303
298 step 1 0.5596
298 steps 2 1.1192
298 tate 1 0.7536
298 ted 1 0.5596
298 tent 1 0.7536
298 tissue 2 0.5232
298 total 3 0.8812
298 trans- 1 0.5793
298 triose- 1 0.7536
298 triphosphopyridine 1 0.6785
298 vate 1 0.7536
299 'solid' 1 0.7536
299 (24%) 1 0.6785
299 (5%) 1 0.7536
299 - 2 0.8832
299 2/39 1 0.7536
299 22/90 1 0.7536
299 244. 1 0.7536
299 320 1 0.6785
299 34 1 0.5286
299 4 2 0.5332
299 620 1 0.7536
299 absolute 1 0.5286
299 absolute. 1 0.7536
299 accurate 1 0.4611
299 air 1 0.4202
299 artefacts 1 0.7536
299 atmospheres 1 0.6785
299 atmospheric 1 0.6785
299 breathing 1 0.543
299 clin- 1 0.6785
299 compared 1 0.2924
299 complicated 1 0.5286
299 concerned 1 0.5046
299 conditions 1 0.3426
299 continuously 1 0.5793
299 damage 1 0.3839
299 determining 1 0.5793
299 disease 1 0.2708
299 due 1 0.2666
299 elec- 1 0.6346
299 electrode 1 0.6346
299 electrodes. 1 0.6785
299 hg 3 1.5477
299 human 1 0.2515
299 hyperbaric 1 0.6034
299 ical 1 0.6346
299 information 1 0.4066
299 intact 1 0.4155
299 less 1 0.2821
299 malignant 1 0.411
299 many 1 0.3038
299 mean 1 0.3625
299 meth- 1 0.7536
299 mm. 3 1.483
299 normal 3 0.608
299 obtained 1 0.2686
299 od 1 0.7536
299 oxygen 4 1.5356
299 pa- 1 0.4416
299 particularly 1 0.4155
299 patients 1 0.1812
299 po2 2 1.2069
299 po2values 1 0.7536
299 polarography 1 0.7536
299 pressure 1 0.3449
299 pressurized 1 0.7536
299 pure 1 0.485
299 recorded 1 0.4303
299 recorded. 1 0.6034
299 reduce 1 0.4764
299 registered 1 0.7536
299 research 1 0.4943
299 respectively 1 0.5159
299 results 1 0.2158
299 rises 1 0.5596
299 suggest 1 0.3426
299 tension 1 0.4542
299 tensions 1 0.6034
299 tients 1 0.485
299 tissue 2 0.5232
299 tissues 3 1.0346
299 tissues. 1 0.4943
299 trauma 1 0.5793
299 trodes 1 0.6785
299 tumour 1 0.4685
299 tumours 2 0.9528
299 value 1 0.3472
299 values 1 0.3805
299 vivo 1 0.4477
300 (v/v) 2 1.2058
300 10% 1 0.4344
300 20% 1 0.4477
300 7839.cortical 1 0.6029
300 ac 1 0.6029
300 accompanied 1 0.3362
300 acetazolamide, 1 0.6029
300 acidic 4 2.4116
300 adult 1 0.2741
300 affected 1 0.3127
300 affected, 1 0.5076
300 alkaline 2 0.8688
300 alkaline. 1 0.6029
300 also 1 0.1687
300 appear 1 0.2759
300 arachnoid 1 0.4827
300 augmented 1 0.5076
300 barrier 1 0.4634
300 barrier, 1 0.5428
300 became 1 0.3581
300 blood 1 0.1863
300 blood-brain 2 1.2058
300 cat, 2 1.0856
300 cerebral 2 0.5714
300 changed 1 0.4127
300 co2 1 0.4344
300 co2. 2 1.2058
300 complex. 1 0.4827
300 concurrently 1 0.6029
300 conditions 1 0.2741
300 controlled 1 0.3443
300 cortex 2 0.6648
300 cortical 4 1.5519
300 dc 2 1.2058
300 described 1 0.2287
300 direction 1 0.4229
300 dura. 1 0.6029
300 extracellular 1 0.4229
300 following 1 0.1998
300 hco3- 1 0.6029
300 hypoxia 1 0.388
300 i.v. 3 1.3903
300 including 1 0.3253
300 independent 1 0.3633
300 inorganic 1 0.4127
300 interpreted 1 0.4127
300 ions, 1 0.5076
300 kitten. 1 0.6029
300 kittens 1 0.6029
300 low 1 0.2639
300 measuring 1 0.4827
300 membrane. 1 0.4634
300 metabolism. 1 0.4037
300 method 1 0.2395
300 n-butanol. 1 0.6029
300 nahco3 1 0.6029
300 negativity, 1 0.6029
300 nh4+ 1 0.6029
300 nh4c1 1 0.6029
300 non-specific 1 0.4634
300 number 1 0.2307
300 oxidative 1 0.5428
300 pass. 1 0.6029
300 perhaps 1 0.3324
300 ph 4 1.3012
300 ph, 1 0.4477
300 phosphate 1 0.3044
300 potentials 1 0.5076
300 present 2 0.397
300 probably 1 0.2741
300 produce 1 0.322
300 prolonged 1 0.29
300 qualitatively, 1 0.5428
300 rabbit 1 0.3401
300 rabbits 1 0.3443
300 reduced 1 0.2723
300 related 1 0.2549
300 removal 1 0.3362
300 response 5 1.1006
300 response. 1 0.4229
300 restriction 2 0.8688
300 results 1 0.1727
300 reversibly 1 0.4827
300 salt 1 0.388
300 sodium 1 0.29
300 solution 2 0.7377
300 space, 1 0.5076
300 studied. 1 0.3401
300 substances. 1 0.5428
300 substantial 1 0.4634
300 terms 1 0.3689
300 tissues 1 0.2759
300 treatment 1 0.1779
300 ventilation. 1 0.6029
301 'conditioning' 1 0.7536
301 (cp2), 1 0.7536
301 (ohp) 1 0.6785
301 (pentobarbital, 1 0.7536
301 - 1 0.4416
301 2 1 0.2301
301 30-66 1 0.7536
301 4-dinitrophenol 1 0.7536
301 7083. 1 0.7536
301 acetazolamide 1 0.7536
301 adrenalectomy 1 0.5286
301 afforded 1 0.6346
301 also 1 0.2108
301 alterations 1 0.4155
301 anaesthetic, 1 0.7536
301 animals 1 0.3204
301 barbiturate 1 0.6785
301 biochemical 2 0.9528
301 block 1 0.543
301 brain 3 1.1517
301 caused 1 0.3299
301 cerebral 1 0.3571
301 cns 3 1.5858
301 cns-de- 1 0.7536
301 co2 1 0.543
301 cortisone, 1 0.6785
301 damage 4 1.5356
301 damage. 1 0.6785
301 decompression 1 0.5596
301 discussed 1 0.3069
301 drugs 1 0.4155
301 electroconvulsive 1 0.7536
301 ex- 1 0.4477
301 exposed 1 0.3946
301 exposures 1 0.6034
301 gauge 1 0.6785
301 given 1 0.2763
301 greatly 1 0.4477
301 guinea-pigs, 1 0.6785
301 high 2 0.5394
301 histamine 1 0.6785
301 hyper- 1 0.4477
301 hypoglycaemia, 1 0.7536
301 hypothermia 1 0.3874
301 increased 1 0.2343
301 irradiation, 1 0.5793
301 lesions 1 0.3241
301 levels. 1 0.5046
301 local 1 0.4542
301 man 1 0.3874
301 mechanisms 1 0.4542
301 methaemoglobinae- 1 0.7536
301 mia 1 0.7536
301 mice 1 0.3711
301 modified 1 0.543
301 n2o 1 0.7536
301 nh4c1, 1 0.7536
301 observations 1 0.3168
301 ohp 1 0.6346
301 ohp, 2 1.5073
301 ohp-induced 1 0.7536
301 ohp. 1 0.7536
301 oxygen 3 1.1517
301 paraldehyde, 1 0.7536
301 paralysis 2 1.1192
301 pco2, 1 0.6785
301 pharmacological 1 0.6346
301 phencyclidine) 1 0.7536
301 poisoning. 1 0.6785
301 pos- 1 0.6785
301 posure 1 0.6785
301 potentiated 1 0.6785
301 potentiation 1 0.7536
301 pressant 1 0.7536
301 pressure 3 1.0346
301 protection 1 0.485
301 rabbits, 1 0.5793
301 raised 1 0.4477
301 rates, 1 0.6785
301 rats 3 0.8731
301 relation 1 0.3472
301 respired 1 0.7536
301 results 1 0.2158
301 sequelae. 1 0.6785
301 serotonin 1 0.6785
301 shock 1 0.6034
301 show 1 0.326
301 sible 1 0.6785
301 single 1 0.3742
301 slow 1 0.4943
301 spinal 1 0.5159
301 tham, 1 0.7536
301 theories 1 0.5286
301 tissue 1 0.2616
301 treatment 1 0.2223
301 whilst 1 0.5596
301 x- 1 0.6346
302 (gas 1 0.6029
302 10% 1 0.4344
302 10, 1 0.4634
302 14, 1 0.5428
302 20 1 0.2723
302 25 1 0.3443
302 25% 1 0.4229
302 5, 1 0.4634
302 5-day-old 1 0.6029
302 8914. 1 0.6029
302 90% 1 0.4827
302 adult 2 0.5481
302 affect 1 0.3811
302 age 1 0.2494
302 aged 1 0.3633
302 animals. 2 0.6802
302 appeared 1 0.29
302 cerebral 2 0.5714
302 conditions 1 0.2741
302 consumption 5 2.1144
302 cortex 2 0.6648
302 cortex, 1 0.5076
302 cut 1 0.5428
302 days 1 0.2395
302 decreased 1 0.2723
302 determined 1 0.2741
302 development 1 0.2201
302 dia- 1 0.4827
302 diaghragm 1 0.6029
302 diaphragm 1 0.6029
302 effect 3 0.5523
302 greatest 1 0.3811
302 groups. 1 0.3581
302 however, 1 0.2183
302 hypoxia 2 0.776
302 hypoxia, 1 0.4827
302 hypoxic 1 0.4634
302 inhibitory 2 0.7909
302 later 1 0.3099
302 liver 3 0.7116
302 natal 1 0.6029
302 nitrogen) 1 0.5428
302 normal 1 0.1621
302 oxygen 5 1.5356
302 oxygen, 1 0.5076
302 phase 1 0.322
302 phragm 1 0.6029
302 post- 1 0.5428
302 rat 1 0.2481
302 rats 2 0.4656
302 rise. 1 0.5428
302 slices 4 1.931
302 started 1 0.5076
302 vitro 1 0.3099
303 2 2 0.4602
303 5407. 1 0.7536
303 79% 1 0.7536
303 85% 1 0.6785
303 abnormally 1 0.5596
303 alone, 1 0.543
303 analyze 1 0.6785
303 anoxia 1 0.6346
303 apparent 1 0.3946
303 aug- 1 0.7536
303 authors 1 0.3472
303 autonomic 1 0.6785
303 bilateral 2 0.9083
303 brain-damaged 2 1.2691
303 carbon 1 0.5046
303 centrally 1 0.7536
303 cerebral 3 1.0714
303 cilitated 1 0.7536
303 co2 2 1.086
303 combined 1 0.3874
303 compared 2 0.5847
303 dioxide 1 0.5159
303 disease 1 0.2708
303 due 1 0.2666
303 dysfunction 2 1.1586
303 entirely 1 0.485
303 eucapnia, 1 0.7536
303 fa- 1 0.6785
303 facilitated 1 0.6346
303 greater 3 0.9353
303 groups 1 0.3069
303 hg 2 1.0318
303 however, 1 0.2729
303 hypercapnia, 1 0.7536
303 hypoxia 3 1.455
303 hypoxia-hypercapnia 1 0.7536
303 hypoxia-hypercapnia. 1 0.7536
303 hypoxic 1 0.5793
303 hypoxic-hypercapnic 1 0.7536
303 imply 1 0.5286
303 influences 1 0.5793
303 interact 1 0.7536
303 interacting 1 0.7536
303 interaction 1 0.4611
303 mentation, 1 0.7536
303 mm 1 0.485
303 modifying 1 0.7536
303 normals 1 0.5793
303 normals, 1 0.5793
303 pao,50mm 1 0.7536
303 pao,90-100 1 0.7536
303 patients 2 0.3623
303 peripherally. 1 0.7536
303 pyramidal 1 0.7536
303 rather 1 0.3546
303 respiratory 2 0.7819
303 response 4 1.1006
303 response, 1 0.5596
303 response. 1 0.5286
303 responses, 1 0.6034
303 responses. 1 0.6034
303 results 1 0.2158
303 sensitivity 1 0.4542
303 showed 3 0.8059
303 similar 1 0.2821
303 since 1 0.3279
303 stimuli 1 0.543
303 subjects 1 0.3598
303 subjects. 1 0.4611
303 tilatory 1 0.7536
303 tract 1 0.4358
303 ven- 1 0.5596
303 ventilatory 2 1.5073
304 (ffa) 1 0.3448
304 2.5 1 0.3198
304 24 2 0.4468
304 25% 1 0.3021
304 3 1 0.1468
304 3917. 1 0.4306
304 accompanied 1 0.2401
304 acid 2 0.3326
304 age. 1 0.2429
304 birth 1 0.2194
304 blood 5 0.6653
304 bloods, 1 0.4306
304 con- 1 0.2234
304 constant, 1 0.331
304 cord 3 0.8844
304 correlation 2 0.4349
304 delayed 1 0.2523
304 delivery 2 0.5649
304 delivery. 1 0.3626
304 determined 1 0.1958
304 diabetic 1 0.2883
304 drop 1 0.331
304 fasting 3 0.8844
304 fatty 2 0.4312
304 ffa 4 1.3241
304 first 1 0.1579
304 following 1 0.1427
304 free 2 0.4082
304 high 1 0.1541
304 hours 2 0.4143
304 however, 1 0.156
304 infant 2 0.4859
304 infants 7 1.4391
304 length 2 0.5649
304 level 5 0.8315
304 level. 2 0.6206
304 level; 1 0.4306
304 levels 4 0.6745
304 life, 1 0.2883
304 low 1 0.1885
304 made. 1 0.2677
304 maternal 2 0.4981
304 mean 4 0.8286
304 mothers 3 0.7786
304 mothers, 1 0.3448
304 mothers. 1 0.3626
304 negative 1 0.2523
304 newborn 2 0.4697
304 obese 1 0.3877
304 observations 1 0.1811
304 observed 1 0.1468
304 occurred 1 0.1874
304 plasma 2 0.3472
304 preeclamptic 1 0.3626
304 prior 2 0.46
304 relatively 1 0.2071
304 remained 1 0.2459
304 respirations, 1 0.4306
304 rose 1 0.3021
304 significant 2 0.3023
304 simultaneous 1 0.2635
304 sugar 5 1.6552
304 thereafter, 1 0.3626
304 three 1 0.1619
304 times 2 0.4143
304 trol 1 0.3626
304 varied 1 0.2722
304 was, 1 0.331
305 (di 1 0.3768
305 + 2 0.5286
305 - 1 0.2208
305 -1.087 1 0.3768
305 0.0432 1 0.3768
305 1 1 0.1423
305 1.4 1 0.3768
305 10 1 0.1387
305 197 1 0.3392
305 243 1 0.3768
305 2933. 1 0.3768
305 = 1 0.3173
305 acid 2 0.291
305 acids 3 0.5567
305 age 1 0.1559
305 age. 1 0.2126
305 analysis 1 0.1813
305 approximately 2 0.3946
305 assessment 1 0.2523
305 basic 1 0.258
305 best 1 0.1992
305 calculated 1 0.2523
305 calculated. 1 0.3768
305 caloric 1 0.3768
305 calories 1 0.3768
305 cent 2 0.3874
305 comparable 1 0.2077
305 computer 1 0.3392
305 considered 2 0.336
305 constants 1 0.2897
305 content 1 0.1773
305 could 1 0.1354
305 curves 1 0.2342
305 data 2 0.3069
305 derived 1 0.2077
305 dienoic, 1 0.3768
305 diet 1 0.2472
305 dietary 6 1.629
305 displacement 1 0.3173
305 due 1 0.1333
305 eleven 2 0.5793
305 equation 1 0.3768
305 equations 1 0.3768
305 equations. 1 0.3768
305 essential 1 0.2208
305 estimated 1 0.2342
305 estimates 1 0.3173
305 exponential 1 0.3173
305 fatty 4 0.7546
305 food 1 0.2897
305 found 2 0.1984
305 four 3 0.5072
305 give 1 0.2055
305 greater 1 0.1559
305 indicated 1 0.1773
305 infants 6 1.0793
305 intake 2 0.5286
305 intake. 1 0.3017
305 intakes. 1 0.3768
305 linoleate 8 3.0145
305 linoleate. 1 0.3768
305 log 1 0.3768
305 logarithmic 1 0.3768
305 lower 1 0.1713
305 may 1 0.0942
305 means 1 0.167
305 methods. 1 0.2382
305 minimal 2 0.4685
305 months 2 0.3805
305 months' 3 0.9518
305 nutrient 1 0.3392
305 nutritive 1 0.3768
305 obtained 1 0.1343
305 old 3 0.6377
305 per 2 0.2937
305 polyunsaturated 1 0.3173
305 ratio 1 0.1973
305 ratios 1 0.2472
305 regression 1 0.2425
305 related 1 0.1593
305 relating 2 0.5596
305 requirement 2 0.6785
305 requirement. 1 0.3768
305 respect 1 0.2208
305 scatter 2 0.6785
305 serum 2 0.2924
305 solid 1 0.2897
305 status 1 0.2382
305 supplements 1 0.3768
305 tetra). 1 0.3768
305 tetraene 3 1.1304
305 tetraenoic 1 0.3768
305 total 2 0.2937
305 tri 1 0.3768
305 triene 3 1.1304
305 trienoic 1 0.3768
305 twelve 2 0.4764
305 two 3 0.3462
305 yielded 1 0.2382
306 (lower 1 1.0048
306 39 1 0.724
306 4th-5th 1 1.0048
306 74. 1 1.0048
306 a- 2 1.6922
306 according 1 0.5422
306 acid 1 0.388
306 acids 2 0.9897
306 addition 1 0.5119
306 allows 1 0.8046
306 analytic 1 0.9046
306 analytical 1 0.7724
306 assayed, 1 1.0048
306 authors, 1 0.9046
306 b-lipoprotein 1 1.0048
306 b-lipoproteins 1 1.0048
306 b-lipoproteins, 1 1.0048
306 b-liproproteinic 1 1.0048
306 b-proteins 2 2.0097
306 characteristics 1 0.5603
306 chemical 1 0.6056
306 cholesterol 1 0.7724
306 cholesterol, 1 0.8046
306 coefficient. 1 1.0048
306 content). 1 1.0048
306 crease 1 0.6728
306 data 1 0.4092
306 deducible 1 1.0048
306 detailed 1 0.6352
306 dyslipidemia 1 1.0048
306 especially 1 0.5165
306 esterification 1 1.0048
306 evaluation 1 0.5422
306 existence 1 0.6148
306 fatty 2 1.0062
306 fraction 1 0.5366
306 fractions 1 0.5366
306 free 1 0.4762
306 glycerides 1 1.0048
306 gradually, 1 1.0048
306 greater 1 0.4157
306 groups 1 0.4092
306 has, 1 0.8461
306 in- 1 0.4452
306 increase 1 0.3413
306 indices 1 0.7048
306 like 1 0.6466
306 lipidic 3 3.0145
306 ly 1 0.6591
306 made 2 0.7278
306 male 1 0.5119
306 method 1 0.3992
306 micellar 1 1.0048
306 month 1 0.6728
306 moreover, 1 0.6591
306 morphological 1 0.6148
306 most- 1 1.0048
306 non-esterified 1 0.8046
306 non-proportional 1 1.0048
306 nonesterified 1 0.8046
306 normal 1 0.2702
306 noted 1 0.5313
306 numerous 1 0.5969
306 obtained. 1 0.7462
306 patients, 1 0.5031
306 phosphatides 1 0.9046
306 picture 1 0.548
306 plasma 1 0.4051
306 plasma. 1 0.8046
306 pregnancy 2 1.1776
306 pregnancy, 1 0.7462
306 presenility. 1 1.0048
306 prevalent 1 0.8461
306 prevalently 1 1.0048
306 proteinic 1 1.0048
306 proven, 1 0.9046
306 quantitative 1 0.5313
306 rate 2 0.7398
306 ratios 1 0.6591
306 reduction 1 0.4948
306 regarding 1 0.6352
306 rise 1 0.4989
306 seen 1 0.4248
306 shows 1 0.554
306 simultaneous 1 0.6148
306 slow 1 0.6591
306 starting 1 0.9046
306 study 2 0.6191
306 subfractions, 1 1.0048
306 titrated, 1 1.0048
306 total 1 0.3916
306 uric 1 0.9046
306 using 1 0.4568
306 which, 1 0.724
307 (p.f.a.) 1 1.5073
307 10-15% 1 1.5073
307 100-137 1 1.5073
307 50% 1 0.9083
307 75-95 1 1.5073
307 75. 1 1.5073
307 acids 2 1.4845
307 al., 1 1.357
307 author 1 0.8832
307 behavior 1 0.8607
307 blood 1 0.4657
307 enzymatic 1 1.1586
307 et 1 1.0091
307 fatty 2 1.5092
307 full 1 1.0091
307 healthy 1 1.086
307 i.e. 1 1.1586
307 increase 1 0.5119
307 labour 2 2.7139
307 labour. 1 1.5073
307 lipoxidase 1 1.5073
307 macgee 1 1.5073
307 measured 1 0.6597
307 method 1 0.5987
307 mg.% 1 1.5073
307 mg.%, 1 1.5073
307 much, 1 1.5073
307 non-pregnant 1 1.357
307 p.f.a. 1 1.5073
307 p.f.a., 1 1.5073
307 physiological 1 0.8832
307 polyun- 1 1.5073
307 polyunsaturated 1 1.2691
307 pregnancy 1 0.8832
307 pregnancy. 1 1.1192
307 pregnant 1 0.9083
307 satured 1 1.5073
307 term 1 0.8404
307 women 1 0.8133
307 women; 1 1.357
308 3 1 0.1468
308 5196. 1 0.4306
308 a- 1 0.3626
308 acid 3 0.4989
308 acids 7 1.4845
308 addition 1 0.2194
308 altered 1 0.23
308 amine-, 1 0.4306
308 amount 1 0.2121
308 amounts 2 0.4276
308 appeared 1 0.2071
308 arachidonic 1 0.3877
308 b-position 1 0.4306
308 b-positions. 1 0.4306
308 change 1 0.1998
308 changes 1 0.1289
308 choline 1 0.3626
308 compared 1 0.1671
308 composition 1 0.2523
308 containing 1 0.2277
308 corn 1 0.4306
308 data 1 0.1754
308 deficiency 2 0.4554
308 deficiency, 1 0.3448
308 deficiency. 1 0.3021
308 deficient 2 0.5543
308 demonstrate 1 0.249
308 determined, 1 0.3877
308 diet 1 0.2825
308 diet. 1 0.3198
308 distribution 2 0.4427
308 docosatrienoic 1 0.4306
308 effects 1 0.1599
308 essential 2 0.5047
308 esterified 1 0.3448
308 ethanol- 1 0.4306
308 ex- 1 0.2558
308 fat 2 0.5269
308 fats 1 0.3877
308 fatty 6 1.2936
308 fed 1 0.2825
308 feeding 1 0.3448
308 glycerophosphatides, 1 0.4306
308 increased 1 0.1339
308 inositol-, 1 0.4306
308 large 1 0.1702
308 linoleic 1 0.3626
308 liver 2 0.3389
308 marked 1 0.1932
308 mitochondrial 2 0.6206
308 moieties 1 0.4306
308 nutritional 1 0.3626
308 oil. 1 0.3877
308 oleic 1 0.3448
308 palmitoleic 1 0.4306
308 phospholipid 1 0.3021
308 phospholipids 2 0.6896
308 phospholipids. 1 0.3626
308 rat 1 0.1772
308 rats 2 0.3326
308 reductions 1 0.4306
308 rendered 1 0.3626
308 response 1 0.1572
308 result 1 0.1863
308 resulted 1 0.2087
308 saturated 1 0.331
308 sphingomyelins 1 0.4306
308 tensive 1 0.4306
308 unique 1 0.2771
308 unsaturated 2 0.7252
308 way 1 0.2722
309 (in 1 1.1586
309 - 1 0.8832
309 2 1 0.4602
309 3204. 1 1.5073
309 5 1 0.5717
309 absence 1 0.7196
309 ana- 1 1.357
309 analysis 2 1.45
309 aneurysm 1 0.97
309 angiocardiography, 1 1.357
309 aortae 1 1.5073
309 aortic 1 0.805
309 aortopulmonary 1 1.5073
309 arteriosus 1 1.1586
309 arteriosus, 1 1.357
309 auscultatory 1 1.5073
309 base 1 1.0572
309 basis 1 0.6597
309 cardiopathies 1 1.5073
309 careful 1 0.9528
309 cases 1 0.4484
309 catheterization, 1 1.5073
309 cavities 1 1.357
309 coincidence 1 1.357
309 communication, 1 1.2691
309 concrete 1 1.2069
309 confirmation, 1 1.5073
309 course 1 0.6851
309 data 1 0.6138
309 data, 1 1.2069
309 defect, 1 1.086
309 defects 1 0.831
309 diagnosis 1 0.6202
309 diagnosis. 1 1.0091
309 differentiation 1 0.8607
309 ductus 1 1.1192
309 e. 1 1.0318
309 ecg 1 1.357
309 evaluation 1 0.8133
309 even 1 0.6597
309 f.-villaran 1 1.5073
309 features. 1 1.2691
309 hemodynamic 1 1.0091
309 hypertension, 1 1.2069
309 importance) 1 1.5073
309 indispensable. 1 1.5073
309 information 1 0.8133
309 insufficiency 1 0.8954
309 interventricular 2 2.4137
309 made 2 1.0917
309 malformations 1 0.97
309 obtained 1 0.5373
309 order 1 0.7893
309 oximetric 1 1.5073
309 patent 1 1.086
309 permits 1 1.086
309 phonocardiography, 1 1.5073
309 provided 1 0.9221
309 pulmonary 1 0.6444
309 radiology 1 1.5073
309 right 1 0.7819
309 ruptured 1 1.5073
309 sanchez 1 1.5073
309 sep- 1 1.357
309 septal 1 0.8133
309 simple. 1 1.357
309 sinus 1 1.086
309 specific 1 0.593
309 supplied 1 1.357
309 syndrome 1 0.6992
309 tal 1 1.357
309 then, 1 1.357
309 together 1 0.8607
309 tomical 1 1.357
309 truncus 1 1.5073
309 which, 1 1.086
309 with/without 1 1.5073
310 (0.894). 1 0.3349
310 (0.997) 1 0.3349
310 0.8-30.0 1 0.3349
310 10 1 0.1233
310 12-86%. 1 0.3349
310 13% 1 0.282
310 14 1 0.1847
310 18 1 0.1827
310 22% 1 0.3015
310 25-50%, 1 0.3349
310 2579. 1 0.3349
310 3.0-36.0 1 0.3349
310 4 1 0.1185
310 50-75% 1 0.3349
310 9% 1 0.3015
310 95% 1 0.282
310 <25%, 1 0.3349
310 >75%. 1 0.3349
310 angiographic 3 0.8046
310 aortic 9 1.6099
310 applicability 1 0.3015
310 applied 1 0.2019
310 artery. 1 0.2487
310 authors' 1 0.2575
310 catheterization. 1 0.282
310 clearly 1 0.2019
310 compared 1 0.1299
310 con- 1 0.1737
310 concentrations 2 0.3443
310 concluded 1 0.1533
310 confidence 1 0.3015
310 continuous 7 1.3227
310 correlation 2 0.3383
310 correspond 1 0.3015
310 correspond- 1 0.3349
310 criteria 1 0.1963
310 demonstrated 1 0.1432
310 demonstrating 1 0.2575
310 different 1 0.1185
310 direct 1 0.1576
310 down- 1 0.3349
310 downstream 1 0.3349
310 equilibrium 1 0.2349
310 equivalent 1 0.2349
310 erratic 1 0.3349
310 error 1 0.2413
310 errors 1 0.2349
310 estimate 2 0.5641
310 evaluated 1 0.1937
310 evident 1 0.2082
310 excellent 1 0.2413
310 expression 1 0.2413
310 flow 6 1.0237
310 flow, 3 0.724
310 flow. 1 0.2575
310 forward 1 0.2682
310 fraction 8 1.431
310 fusion 1 0.2487
310 grade 2 0.5364
310 gurgitant 1 0.3349
310 highly 1 0.1807
310 however, 2 0.2426
310 impaired 1 0.2293
310 in- 2 0.2968
310 indicator 3 0.8046
310 indicator, 2 0.6699
310 infusion 5 0.9448
310 infusions 2 0.4974
310 ing 1 0.1807
310 injection 3 0.4202
310 injection. 1 0.2413
310 injections 1 0.189
310 involves 1 0.2413
310 jection 1 0.282
310 l/min, 2 0.6699
310 laboratory 1 0.1937
310 larger. 1 0.3349
310 left 3 0.4538
310 limits 1 0.2575
310 magnitudes 1 0.3349
310 man 1 0.1722
310 man. 1 0.2155
310 meaningful 1 0.282
310 measured 1 0.1466
310 measurement 3 0.5669
310 measurements 3 0.6466
310 measurements, 1 0.3349
310 method 5 0.6653
310 method, 1 0.2487
310 mild 1 0.2197
310 mitral 1 0.2243
310 moderate 1 0.199
310 moderately 1 0.2413
310 multiple 1 0.1847
310 nonsimultaneity 1 0.3349
310 obtained 3 0.3582
310 patients 3 0.2415
310 patients. 1 0.1611
310 percentage 1 0.1868
310 plateaus. 1 0.3349
310 presence 1 0.1276
310 prevailed 1 0.3349
310 pulmonary 1 0.1432
310 quantifying 1 0.3349
310 ranged 1 0.2575
310 ranking 2 0.6699
310 re- 1 0.1484
310 readily 1 0.2155
310 recording 1 0.2349
310 recordings 1 0.2487
310 regurgitant 8 2.0598
310 regurgitation 9 1.9773
310 reliability, 1 0.3349
310 reproducible 1 0.3349
310 resultant 1 0.2413
310 results 1 0.0959
310 retrograde 1 0.2575
310 root 2 0.6031
310 root, 1 0.3015
310 sampling 3 0.9046
310 sampling. 1 0.3349
310 sensitivity, 1 0.282
310 severe 2 0.2968
310 severity. 2 0.6031
310 significantly 1 0.1408
310 site 1 0.1937
310 stream 1 0.2682
310 sudden 5 1.0777
310 superior 1 0.2243
310 technique 5 0.7879
310 technique. 1 0.2575
310 theoretically 1 0.3015
310 therefore, 1 0.2117
310 times 1 0.1611
310 tinuous 1 0.3349
310 total 6 0.7833
310 transseptal 1 0.3015
310 upstream 4 1.3398
310 useful 1 0.1847
310 using 2 0.3045
310 valid 1 0.282
310 validity 1 0.282
310 valvulography 1 0.3349
310 variable 1 0.2019
310 ventricle 1 0.1937
310 ventricle, 1 0.2487
310 ventricular 1 0.1457
310 yielded 1 0.2117
311 14-year- 1 0.4306
311 2950. 1 0.4306
311 abolished 1 0.2825
311 accessory 1 0.3626
311 acquired. 1 0.4306
311 aneurysm 1 0.2771
311 aneurysmal, 1 0.4306
311 anomalies, 1 0.4306
311 anomaly. 1 0.3877
311 aorta 1 0.2883
311 aortic 7 1.6099
311 aortico-left 3 1.2919
311 aortography. 1 0.4306
311 apply 1 0.3626
311 associated 1 0.1529
311 boy 1 0.2883
311 cardiovascular 1 0.2722
311 cases, 1 0.2255
311 cause 1 0.1945
311 caused 1 0.1885
311 channel 1 0.3877
311 childhood; 1 0.3877
311 clinical 1 0.1404
311 clinical, 1 0.2771
311 closure 1 0.3021
311 common 1 0.2104
311 congenital 1 0.1971
311 correct 1 0.2948
311 diagnosis 1 0.1772
311 differ 1 0.2825
311 displaced 1 0.3877
311 due 1 0.1523
311 established 1 0.2324
311 findings 1 0.1711
311 flow 1 0.2194
311 forms 1 0.2056
311 hemodynamic 2 0.5767
311 indications 1 0.2948
311 indistinguishable 1 0.331
311 intracardiac 1 0.3626
311 left 1 0.1945
311 malformation 2 0.6396
311 manifestations 1 0.2459
311 massive 2 0.6396
311 observed 1 0.1468
311 obstruction 1 0.2722
311 old 1 0.2429
311 operative 1 0.2401
311 ostium, 1 0.4306
311 outflow. 1 0.4306
311 pathologic 1 0.2635
311 portion 1 0.3021
311 posterior 1 0.2523
311 presence 1 0.1641
311 presented. 1 0.2523
311 previously 1 0.2071
311 rather 1 0.2026
311 recognized 1 0.2677
311 regurgitant 1 0.331
311 regurgitation 2 0.5649
311 regurgitation, 2 0.6621
311 replacement, 1 0.3877
311 reported 1 0.1745
311 resulted 1 0.2087
311 right 2 0.4468
311 roentgenographic, 1 0.4306
311 septum 1 0.331
311 severe 1 0.1908
311 simple 1 0.2348
311 since 1 0.1874
311 suggests 1 0.23
311 thoracic 1 0.3103
311 traversed 1 0.3877
311 treatment 1 0.1271
311 tunnel 3 1.2919
311 tunnel. 1 0.4306
311 usually 1 0.2026
311 valve 1 0.2635
311 valvular 1 0.2883
311 ventricle 2 0.4981
311 ventricular 5 0.9368
311 wall 1 0.2722
311 without 1 0.1626
312 10 1 0.2219
312 502. 1 0.6029
312 absence 1 0.2878
312 amplitude 2 0.8954
312 anacro- 1 0.6029
312 anacrotic 1 0.6029
312 aortic 5 1.6099
312 ar- 1 0.5428
312 arterial 2 0.6255
312 artery. 1 0.4477
312 bisferiens 2 1.2058
312 blood 1 0.1863
312 blood, 1 0.4127
312 braunwald 1 0.6029
312 carotid 2 0.7909
312 cases, 1 0.3157
312 certain 1 0.2655
312 change 1 0.2797
312 coincide 1 0.6029
312 condition 1 0.322
312 corresponding 1 0.3533
312 curves. 1 0.5428
312 depend 1 0.4827
312 depth 1 0.4827
312 dia- 1 0.4827
312 disease. 1 0.3188
312 displacement 3 1.5229
312 distensibility 1 0.6029
312 each. 1 0.5076
312 effect. 1 0.3955
312 ejected 1 0.6029
312 element 1 0.4634
312 found 1 0.1587
312 freedom 1 0.5076
312 gradient 1 0.4229
312 gross 1 0.4037
312 guide 1 0.5428
312 haemodynamic 1 0.5076
312 implications 1 0.388
312 indicated 1 0.2836
312 influence 1 0.2759
312 lesion. 1 0.4827
312 magnitude 1 0.3748
312 moderately 1 0.4344
312 modified 1 0.4344
312 momentum 1 0.6029
312 nature 1 0.2993
312 particularly 1 0.3324
312 patients 1 0.1449
312 peak 3 1.046
312 peaks 1 0.5076
312 percussion 2 1.2058
312 preclude 1 0.4827
312 present 1 0.1985
312 pressure 2 0.5518
312 pressure, 1 0.3955
312 proportional 1 0.4827
312 pulse 4 1.7375
312 rate 1 0.2219
312 rather 1 0.2836
312 recorded 2 0.6886
312 regurgitation 1 0.3955
312 regurgitation, 1 0.4634
312 severe 2 0.5343
312 severe, 2 0.8457
312 shape 1 0.388
312 simple 1 0.3288
312 simultaneously 1 0.3633
312 slope 1 0.4634
312 stenosis. 1 0.5428
312 stolic 1 0.6029
312 stroke 1 0.4229
312 sufficiently 1 0.5076
312 suggested 3 0.7522
312 systolic 1 0.4477
312 terial 1 0.4477
312 test 1 0.2608
312 thought 1 0.3401
312 tic 1 0.4477
312 tidal 1 0.5428
312 trough 1 0.6029
312 two 2 0.3693
312 upon 2 0.541
312 use 1 0.2383
312 valve 1 0.3689
312 valvular 1 0.4037
312 venturi 1 0.6029
312 volume 1 0.3071
312 wall, 1 0.5076
312 wave 3 1.4482
312 waves 2 0.9655
313 12 2 0.2617
313 14 1 0.1511
313 2753. 1 0.274
313 3 2 0.1868
313 4 1 0.0969
313 4-16 1 0.274
313 5 2 0.2079
313 8 1 0.1238
313 abnormal 1 0.1328
313 abnormalities 1 0.1528
313 accompanied 2 0.3056
313 adequate 1 0.1703
313 also 1 0.0767
313 alteration 1 0.1798
313 alterations 1 0.1511
313 aortic 3 0.4391
313 cardiac 2 0.2459
313 carried 1 0.1372
313 change 2 0.2542
313 changes 1 0.082
313 circulatory 1 0.1922
313 consumption, 1 0.2467
313 corrected 1 0.2307
313 depression 1 0.1922
313 detection 1 0.1703
313 determination 1 0.1677
313 diastolic 1 0.2107
313 distinct 1 0.1703
313 either 1 0.1172
313 end- 1 0.274
313 end-diastolic 7 1.6152
313 evaluations 1 0.2307
313 exercise 2 0.4615
313 exercise, 2 0.4934
313 exhibited 2 0.3353
313 fall 2 0.287
313 festation 1 0.274
313 following 2 0.1817
313 frank-starling 1 0.274
313 function 3 0.3689
313 hemodynamic 1 0.1835
313 hg 1 0.1876
313 hg. 1 0.2467
313 however, 1 0.0992
313 increase 2 0.1862
313 increased 1 0.0852
313 increases 6 0.7681
313 influence. 1 0.274
313 inotropic 1 0.2467
313 judged 1 0.1974
313 left 11 1.3613
313 less 1 0.1026
313 levels 1 0.1073
313 majority 1 0.1764
313 malformations 1 0.1764
313 mani- 1 0.2307
313 mechanism, 1 0.2307
313 meet 1 0.2194
313 mildly 1 0.2194
313 mm 2 0.3527
313 mth 1 0.2107
313 muscular 1 0.1922
313 myocardial 1 0.1922
313 normal 1 0.0737
313 normal, 1 0.2035
313 occurred 1 0.1192
313 output 2 0.3212
313 oxygen 1 0.1396
313 patients 5 0.3294
313 patients, 1 0.1372
313 patients. 1 0.1318
313 performance 1 0.1876
313 permitted 1 0.274
313 positive 1 0.1464
313 present. 1 0.1835
313 pressure 6 0.7524
313 pressure, 1 0.1798
313 pressure. 1 0.1974
313 primarily 1 0.1732
313 proposed 1 0.1798
313 reduced 1 0.1238
313 regurgitant 1 0.2107
313 relation 1 0.1263
313 relationship 1 0.1318
313 relationships 1 0.1764
313 replacement 1 0.1732
313 replacement, 1 0.2467
313 replacement. 1 0.274
313 response 1 0.1001
313 responses 2 0.3056
313 result 1 0.1185
313 simultaneous 1 0.1677
313 stenotic 1 0.2307
313 stress 1 0.1876
313 stroke 6 1.1533
313 studied 1 0.0955
313 suggested 1 0.114
313 thus, 1 0.1974
313 tricular 1 0.2307
313 valve 3 0.503
313 valve. 1 0.2467
313 variable 1 0.1652
313 ven- 1 0.2035
313 ventricle. 1 0.2307
313 ventricular 9 1.0731
313 volume 3 0.4188
313 volume, 2 0.3752
313 volume. 1 0.2107
314 2497. 1 0.7536
314 anastomosis 1 0.6785
314 angiocardiography 1 0.5596
314 appears 1 0.3241
314 artery 1 0.4303
314 associated 1 0.2676
314 atresia 1 0.4611
314 atresia-cyanosis, 1 0.7536
314 atretic 1 0.6785
314 attempts 1 0.485
314 capable 1 0.4611
314 catheterization 1 0.5046
314 cava 1 0.6346
314 cessful 1 0.6785
314 chamber 1 0.5596
314 clinical 1 0.2457
314 confirmed 1 0.4416
314 consists 1 0.4764
314 continue 1 0.5793
314 de- 1 0.4202
314 death. 1 0.6034
314 decreased 1 0.3403
314 diagnosis 1 0.3101
314 early 1 0.2763
314 electrocardiogram, 1 0.6785
314 equally 1 0.543
314 findings 1 0.2994
314 flow, 1 0.543
314 future. 1 0.7536
314 great. 1 0.7536
314 heart 1 0.3496
314 high 1 0.2697
314 hope 1 0.5286
314 hopeless 1 0.6346
314 in- 1 0.3339
314 intact 1 0.4155
314 intact, 1 0.6034
314 jection 1 0.6346
314 left 1 0.3403
314 made. 1 0.4685
314 may 1 0.1885
314 medical 1 0.4477
314 ment, 1 0.5793
314 never 1 0.4943
314 offer 1 0.485
314 past; 1 0.7536
314 pathologic 1 0.4611
314 picture 1 0.411
314 preponderance 1 0.6785
314 pressure. 1 0.543
314 prognosis 1 0.4155
314 pulmonary 4 1.2888
314 right 3 1.1728
314 risk 1 0.5046
314 selective 1 0.4477
314 septum 2 1.1586
314 similar 1 0.2821
314 small 1 0.3023
314 suc- 1 0.6785
314 success 1 0.6346
314 superior 1 0.5046
314 surgery 1 0.3742
314 thick 1 0.6346
314 treat- 1 0.4685
314 tricular 1 0.6346
314 tricuspid 1 0.5793
314 usually 1 0.3546
314 valve 1 0.4611
314 veloping 1 0.7536
314 ven- 1 0.5596
314 vena 1 0.6346
314 ventricle 1 0.4358
314 ventricle, 1 0.5596
314 ventricular 2 0.6558
314 wall 1 0.4764
315 (unlike 1 1.0048
315 1635. 1 1.0048
315 anatomical 1 0.8046
315 atria 1 0.9046
315 atrial 3 1.9399
315 atrioventricular 2 1.8093
315 atrium. 1 0.9046
315 authors 1 0.4629
315 catheter 2 1.6091
315 consists 1 0.6352
315 curve 2 1.3758
315 defect 1 0.4948
315 defect, 1 0.724
315 detailed 1 0.6352
315 diagnosis 1 0.4135
315 different 1 0.3554
315 discussing 1 0.8046
315 electrocardiogram 2 1.6922
315 electrocardiography 1 1.0048
315 endocavitary 2 2.0097
315 foramen 1 0.8046
315 identifying 1 0.8046
315 infe- 1 1.0048
315 intermediate 2 1.2933
315 intra-atrial 1 1.0048
315 intravalvular 1 1.0048
315 left 1 0.4538
315 limitations 1 0.9046
315 margin, 1 1.0048
315 may 1 0.2513
315 measurement 1 0.5669
315 method. 1 0.7048
315 methods 1 0.4538
315 new 1 0.4398
315 ostium 2 1.6922
315 passage 1 0.6591
315 pattern 2 0.9594
315 point 1 0.5811
315 possibilities 1 0.7462
315 pressure 3 1.3794
315 primum 1 0.8461
315 recording 1 0.7048
315 rests 1 0.9046
315 retraction 1 0.9046
315 right 1 0.5212
315 rior 1 0.9046
315 section 2 1.6091
315 secundum 1 0.8461
315 septal 3 1.6265
315 septum. 1 0.8046
315 septum; 1 1.0048
315 show 1 0.4346
315 shows 1 0.554
315 simultaneous 1 0.6148
315 suggest 1 0.4568
315 two 1 0.3077
315 type 1 0.4179
315 type) 1 1.0048
315 type, 1 0.6728
315 type. 1 0.6728
315 typical 1 0.6591
315 useful 1 0.554
315 withdrawal 1 0.724
315 zone 1 0.6591
316 1636. 1 0.7536
316 aneurysm 1 0.485
316 aneurysmal 1 0.7536
316 aneurysms 1 0.5596
316 aneurysms. 1 0.6785
316 angiogra- 1 0.7536
316 asymptomatic 1 0.5596
316 cases 3 0.6727
316 closure 1 0.5286
316 considered 1 0.336
316 cuptal 1 0.7536
316 defect 1 0.3711
316 diagnosis 1 0.3101
316 due 1 0.2666
316 formation 1 0.3381
316 hemodynamically 1 0.7536
316 high 1 0.2697
316 left 2 0.6807
316 limits. 1 0.6346
316 made 1 0.2729
316 membranous 1 0.5596
316 muscular 1 0.5286
316 necessary. 1 0.6785
316 normal 1 0.2027
316 one 2 0.4217
316 phy. 1 0.6785
316 portion. 1 0.7536
316 pressure. 1 0.543
316 repair 1 0.5046
316 report 1 0.3653
316 reported, 1 0.6034
316 represent 1 0.4764
316 selective 1 0.4477
316 septal 2 0.8133
316 spontaneous 1 0.4358
316 suggested 1 0.3134
316 surgical 1 0.3403
316 two 2 0.4616
316 ventricular 4 1.3116
316 ventriuclar 1 0.7536
316 weakness 1 0.7536
316 within 1 0.2798
317 1642. 1 0.6029
317 accurate 1 0.3689
317 along 1 0.4229
317 anomaly 4 1.7375
317 anomaly. 1 0.5428
317 assessment 1 0.4037
317 calls 1 0.6029
317 cardiac 3 0.8116
317 cardiographic 1 0.6029
317 case, 1 0.4477
317 catheterization 2 0.8073
317 catheters 3 1.8087
317 clinical, 1 0.388
317 con- 2 0.6255
317 concluded 1 0.2759
317 condition 1 0.322
317 confirmatory 1 0.6029
317 congenital 1 0.2759
317 creased 1 0.3955
317 definitive 1 0.4634
317 demonstrated 1 0.2578
317 diagnosis 2 0.4962
317 diagnostic 1 0.2993
317 diagnostic. 1 0.5428
317 discussed, 1 0.4827
317 ebstein's 5 3.0145
317 electro- 1 0.4827
317 electrocardiographic 1 0.4827
317 electrocardiographic, 1 0.5076
317 electrode 3 1.5229
317 evidence 1 0.221
317 examination 1 0.3044
317 experience 1 0.3099
317 explained. 1 0.4827
317 false 2 1.0856
317 features 2 0.644
317 hands, 1 0.6029
317 heart 1 0.2797
317 helpful, 1 0.5428
317 illustrated. 1 0.6029
317 in- 1 0.2671
317 increased 1 0.1874
317 intra- 1 0.4229
317 intracardiac 2 1.0153
317 investigated 1 0.3443
317 lesion 1 0.3401
317 lesion. 1 0.4827
317 made 1 0.2183
317 matched 1 0.4477
317 mechanism 1 0.2778
317 method 1 0.2395
317 nature 1 0.2993
317 negative 1 0.3533
317 patients 1 0.1449
317 positive 1 0.322
317 pre-ope- 1 0.6029
317 production 1 0.3071
317 provided 1 0.3689
317 radiological 1 0.4827
317 rather 1 0.2836
317 rative 1 0.6029
317 records 2 0.8457
317 regarded 1 0.3748
317 relied 1 0.6029
317 risk 1 0.4037
317 serious 1 0.3633
317 severity 1 0.3689
317 sidered 1 0.5428
317 skilled 1 0.5076
317 successful 1 0.4127
317 surgery 1 0.2993
317 surgical 1 0.2723
317 techniques, 1 0.5076
317 templated. 1 0.6029
317 that, 1 0.3955
317 though 1 0.3533
317 treatment 1 0.1779
317 tricuspid 2 0.9269
317 upon 1 0.2705
317 value 1 0.2778
317 valve 1 0.3689
317 valvular 1 0.4037
317 way 1 0.3811
318 3326. 1 1.5073
318 aneurysm 2 1.9399
318 believed 1 1.1192
318 case 1 0.5415
318 first 1 0.5526
318 huge 1 1.5073
318 interventricular 2 2.4137
318 membranous 2 2.2385
318 patient 2 1.1335
318 presented. 1 0.8832
318 resection. 1 1.5073
318 septum 2 2.3172
318 successful 1 1.0318
318 undergone 1 1.2069
318 unusual 1 0.9528
319 934. 1 1.0048
319 abscess. 1 1.0048
319 al 1 1.0048
319 also 1 0.2811
319 aorta 1 0.6728
319 arterial 1 0.5212
319 atrium 1 0.8461
319 bers 1 0.9046
319 blood 1 0.3105
319 case 3 1.0831
319 cava 1 0.8461
319 cham- 1 1.0048
319 clubbing 1 1.0048
319 complicated 1 0.7048
319 condition 1 0.5366
319 cyanosis 1 1.0048
319 defect. 1 0.9046
319 described. 1 0.5031
319 development 1 0.3669
319 due 1 0.3554
319 etiology 1 0.554
319 great 1 0.5738
319 gross 1 0.6728
319 heart 1 0.4661
319 hemiplegia 1 0.9046
319 ing 1 0.5422
319 inversion 1 0.9046
319 inversus, 1 0.9046
319 inversus. 1 1.0048
319 laevocardia 1 1.0048
319 levocardia, 1 1.0048
319 literature 2 1.0959
319 liver 1 0.3953
319 made. 1 0.6246
319 open- 1 0.9046
319 passage 1 0.6591
319 possible 1 0.4031
319 present 1 0.3308
319 prognosis 1 0.554
319 report 1 0.4871
319 review 2 1.108
319 right-sided 2 1.6091
319 septal 1 0.5422
319 shunt 1 0.6728
319 situs 2 1.6922
319 superior 1 0.6728
319 transposition 1 0.9046
319 vena 1 0.8461
319 veno-arteri- 1 1.0048
319 venous 1 0.5669
319 ventricular 1 0.4372
319 vessels 1 0.724
320 1831. 1 1.5073
320 aneurysm 2 1.9399
320 careful 1 0.9528
320 chest 1 1.0572
320 corrective 1 1.2069
320 defect 1 0.7423
320 diagnostic 1 0.7483
320 different 1 0.5332
320 discussed. 1 0.6444
320 evaluated 1 0.8716
320 examinations 1 1.0318
320 fallot 1 1.2069
320 follow-up 1 1.0091
320 genography. 1 1.5073
320 importance 1 0.7678
320 intercalative 1 1.5073
320 literature 1 0.8219
320 outflow 1 1.1586
320 pathogenesis 1 0.8503
320 patients 1 0.3623
320 postoperative 2 1.8167
320 pulmonic 1 1.2691
320 reported. 1 0.8716
320 reviewed 1 0.8503
320 right 2 1.5637
320 roent- 1 1.2691
320 roentgen 1 1.357
320 role 1 0.6992
320 septal 1 0.8133
320 stenosis, 1 1.1586
320 stressing 1 1.5073
320 surgery 1 0.7483
320 tests 1 0.7423
320 tetralogy 1 1.2069
320 tract 1 0.8716
320 twelve 1 0.9528
320 valvar 1 1.5073
320 ventricle 1 0.8716
320 ventricular 2 1.3116
321 (protodiastolic 1 0.4306
321 10 1 0.1585
321 1991. 1 0.4306
321 2 1 0.1315
321 5% 1 0.3103
321 50% 1 0.2595
321 across 2 0.6621
321 affected. 1 0.3448
321 age. 1 0.2429
321 always 2 0.46
321 anatomic 1 0.2883
321 and, 1 0.2234
321 anterior 1 0.2722
321 aortic 5 1.1499
321 appear 1 0.1971
321 arterial 1 0.2234
321 aspects 1 0.2429
321 basis 1 0.1885
321 blood 1 0.1331
321 bulbar 1 0.4306
321 catheterization 1 0.2883
321 causes 1 0.2429
321 characteristic 1 0.2175
321 clear. 1 0.3626
321 clinical 1 0.1404
321 coronary 1 0.2771
321 cusp 2 0.7754
321 data 1 0.1754
321 defect 3 0.6362
321 defect, 2 0.6206
321 defects 1 0.2374
321 degree 1 0.1908
321 detailed 1 0.2722
321 discussed. 1 0.1841
321 dur- 1 0.3877
321 encroach 1 0.4306
321 evidences 1 0.4306
321 exists. 1 0.4306
321 flow 1 0.2194
321 gradient 2 0.6041
321 greater 1 0.1781
321 hemody- 1 0.4306
321 high 2 0.3082
321 indicate 2 0.3793
321 infancy, 1 0.3198
321 ing 1 0.2324
321 involved, 1 0.3626
321 large 1 0.1702
321 less 2 0.3225
321 lesser 1 0.2948
321 load 1 0.3448
321 loud, 1 0.4306
321 medical 1 0.2558
321 membranous 1 0.3198
321 murmur 1 0.331
321 murmur, 1 0.4306
321 namic 1 0.4306
321 noncoronary 1 0.4306
321 noted 1 0.2277
321 ob- 1 0.2948
321 one 1 0.1205
321 outflow 2 0.6621
321 pathologic 2 0.5269
321 patients 2 0.207
321 patients, 1 0.2156
321 pressure 2 0.3941
321 pressure) 1 0.4306
321 pressure. 1 0.3103
321 principal 1 0.3448
321 prolapse, 1 0.4306
321 pulmonary 2 0.3682
321 pulse 1 0.3103
321 regurgitation 1 0.2825
321 regurgitation, 2 0.6621
321 regurgitation. 1 0.4306
321 regurgitation; 1 0.4306
321 repre- 1 0.4306
321 result 1 0.1863
321 right 3 0.6702
321 senting 1 0.4306
321 septal 6 1.3942
321 septum. 1 0.3448
321 served 1 0.2825
321 severely 2 0.5543
321 significant 1 0.1512
321 studies 1 0.1319
321 systolic 1 0.3198
321 thirty-four 1 0.4306
321 time 1 0.1517
321 tract 2 0.4981
321 tricular 1 0.3626
321 usually 2 0.4052
321 ven- 1 0.3198
321 ventricular 7 1.3116
321 whereas 2 0.4312
321 wide 1 0.2558
321 years 1 0.1958
322 15 1 0.2993
322 17% 1 0.6029
322 18 1 0.3288
322 191 1 0.6029
322 1955 1 0.5076
322 1961 1 0.5076
322 24 1 0.3127
322 2431. 1 0.5428
322 3 1 0.2055
322 30 3 0.8635
322 35% 1 0.6029
322 40 1 0.3533
322 5 1 0.2287
322 61 1 0.6029
322 8 1 0.2723
322 90 1 0.4477
322 abnormal 2 0.5845
322 age 1 0.2494
322 age. 1 0.3401
322 although 1 0.2318
322 analyzed, 1 0.5428
322 arrhythmia 1 0.6029
322 arrhythmias 5 3.0145
322 artery 1 0.3443
322 associated 2 0.4282
322 atrial 3 1.164
322 beats, 1 0.6029
322 began 2 0.8954
322 block 3 1.3032
322 block, 1 0.6029
322 block. 1 0.6029
322 blocks 1 0.4634
322 blocks, 1 0.6029
322 branch 1 0.6029
322 bundle 1 0.6029
322 cases 1 0.1794
322 cent 2 0.6198
322 children 1 0.2141
322 common 1 0.2945
322 complete 3 0.839
322 completion 1 0.5076
322 days 1 0.2395
322 deaths 3 1.3032
322 deaths; 1 0.6029
322 defect 1 0.2969
322 defects 4 1.3295
322 defects, 3 1.2686
322 degree 2 0.5343
322 determine 1 0.3401
322 developed 3 0.8222
322 ectopic 1 0.5428
322 except 1 0.3401
322 excluded. 1 0.4477
322 fatalities 2 1.2058
322 fibrillation 2 0.9655
322 fifteen 1 0.5428
322 first 1 0.221
322 flutter 2 1.2058
322 followed 1 0.2759
322 following 3 0.5995
322 four 1 0.2705
322 greater 1 0.2494
322 group. 1 0.3487
322 half 1 0.3533
322 heart 4 1.1187
322 hg 1 0.4127
322 history 1 0.3487
322 incidence 1 0.2878
322 included 1 0.3253
322 intermittent 1 0.5076
322 later. 1 0.5076
322 less 1 0.2257
322 mm. 1 0.3955
322 months 2 0.6089
322 months. 1 0.4037
322 natural 1 0.3533
322 nodal 1 0.5076
322 nodal. 1 0.6029
322 normal 1 0.1621
322 occur 1 0.2945
322 occurred 3 0.7869
322 one 2 0.3373
322 one, 1 0.4477
322 operation 2 0.6314
322 operation, 1 0.4477
322 operation. 1 0.3955
322 ostium 4 2.0306
322 oxygenator 1 0.4827
322 patients 5 0.7246
322 patients. 1 0.29
322 per 2 0.47
322 period 1 0.2287
322 period. 1 0.3633
322 persisted 1 0.4634
322 postoperative 2 0.7267
322 pressure 1 0.2759
322 primum 2 1.0153
322 prognosis 1 0.3324
322 pulmonary 1 0.2578
322 pump 1 0.4477
322 reapir 1 0.6029
322 related 1 0.2549
322 repair 2 0.8073
322 repair. 1 0.6029
322 reverted 1 0.5428
322 reviewed 1 0.3401
322 rhythm 1 0.4344
322 rhythms 2 1.0153
322 rhythms, 1 0.5428
322 second 2 0.6142
322 secundum 3 1.5229
322 septal 3 0.9759
322 serious 1 0.3633
322 seven 1 0.3443
322 sinus 1 0.4344
322 surgery 1 0.2993
322 survivors 1 0.4344
322 systolic, 1 0.6029
322 tachycardia, 1 0.6029
322 thirty-eight 1 0.6029
322 type, 1 0.4037
322 use 1 0.2383
322 variety. 1 0.6029
322 ventricular 3 0.7869
322 whose 1 0.3533
322 within 1 0.2238
322 younger 1 0.4037
322 yr. 1 0.3157
323 1021. 1 0.4306
323 5 1 0.1633
323 anatomic 2 0.5767
323 angiocardiography 1 0.3198
323 angiocardiography. 2 0.7754
323 ano- 1 0.4306
323 aortography, 1 0.3626
323 appears 1 0.1852
323 arterial 1 0.2234
323 blood 1 0.1331
323 cardiac 1 0.1932
323 cases 1 0.1281
323 catheter 1 0.3448
323 catheterization 1 0.2883
323 clarify 1 0.3448
323 combined 1 0.2213
323 considerable 1 0.2234
323 contrast 1 0.2883
323 de- 1 0.2401
323 defect 5 1.0604
323 defects 5 1.1871
323 depending 1 0.3448
323 described. 1 0.2156
323 detection 1 0.2677
323 different 1 0.1523
323 differentiate 1 0.3448
323 divided 1 0.3021
323 entered 1 0.3877
323 features 1 0.23
323 follow-up 1 0.2883
323 following 1 0.1427
323 hazardous 1 0.3877
323 history 1 0.249
323 identifiable 1 0.3877
323 in- 1 0.1908
323 indicated, 1 0.3448
323 information 1 0.2324
323 insufficiency 1 0.2558
323 j-shaped 1 0.4306
323 jection 1 0.3626
323 landmarks. 1 0.4306
323 left 5 0.9724
323 lesion. 1 0.3448
323 little, 1 0.3877
323 localization 1 0.3021
323 location 1 0.331
323 malies 1 0.4306
323 manifestations 1 0.2459
323 marked 1 0.1932
323 material 1 0.1998
323 may 2 0.2154
323 mitral 1 0.2883
323 monstrated. 1 0.4306
323 more, 1 0.3448
323 multiple 1 0.2374
323 natural 1 0.2523
323 nique 1 0.4306
323 often 1 0.2087
323 opacifies 1 0.4306
323 operated 1 0.2771
323 passing 1 0.3877
323 patients 2 0.207
323 permits 1 0.3103
323 portions 1 0.3198
323 postoperative 1 0.2595
323 preoperative 1 0.4306
323 procedure 1 0.2194
323 radiological 1 0.3448
323 rela- 1 0.3626
323 repair 2 0.5767
323 retrograde 1 0.331
323 right-sided 1 0.3448
323 selective 1 0.2558
323 septal 7 1.6265
323 septum 3 0.9931
323 septum. 3 1.0345
323 sixty-five 1 0.3877
323 studied 1 0.15
323 studies 1 0.1319
323 study 2 0.2653
323 suited 1 0.4306
323 supraval- 1 0.4306
323 surgeon 1 0.3448
323 taking 1 0.3103
323 tech- 1 0.3877
323 tion 1 0.1958
323 tip. 1 0.4306
323 types, 1 0.3626
323 under- 1 0.3877
323 upon 1 0.1932
323 used, 1 0.2771
323 value 1 0.1984
323 ventricle 2 0.4981
323 ventricular 7 1.3116
323 ventriculography, 1 0.4306
323 vular 1 0.3877
323 well 2 0.3012
323 whose 1 0.2523
324 (1) 2 0.3247
324 (2) 2 0.3247
324 (3) 2 0.3542
324 (cricetulus 1 0.3349
324 (ffa) 1 0.2682
324 (perirenal) 1 0.3349
324 (separately) 1 0.3349
324 10-fold 1 0.3349
324 4 1 0.1185
324 4105. 1 0.3349
324 8- 1 0.3349
324 9 1 0.1754
324 ac- 1 0.2155
324 acid 1 0.1293
324 acids 3 0.4948
324 active 1 0.1543
324 adipose 7 1.8773
324 age, 1 0.2197
324 alloxan-diabetic 1 0.3015
324 amount 1 0.1649
324 apparently 1 0.1827
324 appears 1 0.144
324 attributable 1 0.2293
324 body 1 0.135
324 characteristics 1 0.1868
324 chinese 9 3.0145
324 comparable 1 0.1847
324 concentra- 1 0.2413
324 concentration 1 0.1408
324 concentrations 2 0.3443
324 consistently 1 0.2155
324 diabetes 1 0.1649
324 diet, 1 0.3015
324 discussed. 1 0.1432
324 dogs, 1 0.2243
324 epididymal 3 0.9046
324 epididymal, 1 0.3349
324 fasting 1 0.2293
324 fatty 4 0.6708
324 ffa 8 2.0598
324 four-fold 1 0.3349
324 free 2 0.3175
324 glucose 4 0.7016
324 gram 1 0.282
324 great, 1 0.3349
324 greater 2 0.2771
324 greatest 1 0.2117
324 griseus) 1 0.3349
324 group 1 0.1238
324 group, 1 0.2155
324 hamster 5 1.2066
324 hamster, 1 0.3015
324 hamster. 1 0.3015
324 hamster; 1 0.3349
324 hamsters 2 0.5364
324 hamsters; 1 0.3349
324 high 1 0.1199
324 high. 1 0.282
324 higher 3 0.4321
324 however, 1 0.1213
324 in- 1 0.1484
324 increased 1 0.1041
324 incubated 1 0.2575
324 incubation 1 0.2049
324 initial 1 0.1624
324 insulin 3 0.6056
324 interval, 1 0.3349
324 leading 1 0.2082
324 less 1 0.1254
324 man; 1 0.3349
324 markedly 1 0.1789
324 mean 1 0.1611
324 metabolism 2 0.3175
324 net 1 0.2682
324 normal 1 0.0901
324 per 1 0.1305
324 possible 1 0.1344
324 produced 1 0.1364
324 rat 2 0.2757
324 rat. 2 0.5149
324 rat; 1 0.3349
324 rate 2 0.2466
324 rats, 1 0.2293
324 rats. 1 0.1754
324 reduced 1 0.1513
324 reduction 1 0.1649
324 reduction. 1 0.282
324 relation 1 0.1543
324 relatively 1 0.1611
324 release 4 0.8622
324 released, 1 0.3349
324 results 1 0.0959
324 retroperitoneal 1 0.3349
324 serum 1 0.1299
324 serum. 1 0.2413
324 sex. 1 0.3349
324 slightly 1 0.1913
324 species 1 0.1827
324 species, 1 0.2487
324 species. 1 0.2197
324 spontaneous 1 0.1937
324 sue 1 0.3349
324 sues 1 0.3349
324 sulin 1 0.3349
324 syrian 2 0.5364
324 time 1 0.118
324 times 1 0.1611
324 tions 1 0.199
324 tis- 2 0.6699
324 tissue 7 0.8139
324 tissues 1 0.1533
324 tissues, 1 0.2349
324 tive 1 0.282
324 together 1 0.1913
324 two- 1 0.282
324 uptake 1 0.2197
324 varied 1 0.2117
324 vitro 3 0.5165
324 vitro, 1 0.2487
324 was, 1 0.2575
324 weight 1 0.1576
325 (nefa) 1 1.0048
325 1 2 0.7589
325 1.7 1 0.9046
325 10-30% 1 1.0048
325 18 1 0.548
325 1st 1 0.7724
325 3.9 1 1.0048
325 30-50% 1 1.0048
325 36 1 0.7048
325 50-70% 1 1.0048
325 95. 1 1.0048
325 acid 2 0.7761
325 almost 1 0.5165
325 alter 1 0.6728
325 always 1 0.5366
325 appears 1 0.4321
325 artery 1 0.5738
325 begin 1 0.8461
325 changes 1 0.3007
325 comparable 1 0.554
325 concentration 1 0.4225
325 course 1 0.4568
325 delivery 3 1.9773
325 dosage. 1 0.8461
325 duration 1 0.5262
325 fall 2 1.0524
325 fatty 2 1.0062
325 following 1 0.3331
325 given 1 0.3684
325 hour, 1 0.9046
325 hr. 2 1.1622
325 immediately. 1 1.0048
325 induce 1 0.6728
325 induced 1 0.4272
325 labor 1 0.8461
325 labor. 2 1.8093
325 labour 1 0.9046
325 level. 1 0.724
325 levels 3 1.1804
325 lower 1 0.4568
325 maternal 1 0.5811
325 maternal/fetal 1 1.0048
325 nefa 3 2.3172
325 non-esterified 1 0.8046
325 nonesterified 1 0.8046
325 normal 2 0.5404
325 oxytocin 2 1.8093
325 pattern 1 0.4797
325 physiologic 1 0.6466
325 progressively 1 0.7462
325 provided 1 0.6148
325 rate 1 0.3699
325 ratio 1 0.5262
325 related 1 0.4248
325 rise 2 0.9978
325 rises 1 0.7462
325 series. 1 0.8046
325 serum 2 0.7797
325 significantly 1 0.4225
325 spon- 1 0.8046
325 stimulate 1 0.7048
325 taneous 1 0.8461
325 umbilical 2 1.6091
325 use 1 0.3972
325 value 1 0.4629
325 varies 1 0.724
325 vein 1 0.7462
325 within 2 0.746
326 10% 1 0.1974
326 1545. 1 0.274
326 16 1 0.1703
326 30 1 0.1308
326 500 1 0.2107
326 accelerated 1 0.1974
326 acid 2 0.2117
326 acid, 1 0.1764
326 acids 6 0.8097
326 alone. 1 0.2035
326 amounts 1 0.1361
326 anaerobic 1 0.274
326 apparatus 1 0.2107
326 application 1 0.1546
326 authors 1 0.1263
326 better 1 0.1585
326 blood 3 0.254
326 blood, 1 0.1876
326 breakdown 1 0.2467
326 brought 1 0.1798
326 cannot 1 0.1479
326 capability 1 0.2307
326 carbohydrate 1 0.1922
326 caused 3 0.3598
326 combined 1 0.1409
326 compared 1 0.1063
326 conditions. 1 0.1922
326 consisted 1 0.1628
326 continued 1 0.1585
326 cord 4 0.7504
326 could 3 0.2954
326 course 1 0.1246
326 decrease 1 0.1254
326 delivery 2 0.3595
326 depo- 1 0.274
326 determine, 1 0.274
326 different 1 0.0969
326 due 2 0.1939
326 effect 1 0.0837
326 enhanced 1 0.1703
326 especially 1 0.1409
326 established, 1 0.2467
326 exclusively. 1 0.274
326 fatty 6 0.8232
326 favorably 1 0.2194
326 fetus 1 0.1922
326 fetus, 1 0.2467
326 fetus. 2 0.4213
326 fied 1 0.2467
326 formation 1 0.123
326 found 1 0.0721
326 glucose 11 1.5786
326 glycolysis 1 0.2194
326 greater 1 0.1134
326 higher 2 0.2357
326 however, 1 0.0992
326 including 1 0.1479
326 increase 4 0.3723
326 increased 2 0.1704
326 increased. 1 0.1835
326 influenced 1 0.1703
326 infusion 7 1.0822
326 infusions 1 0.2035
326 insufficiency 1 0.1628
326 insular 1 0.274
326 insulin 6 0.9909
326 insulin, 2 0.3949
326 insulin. 1 0.2307
326 intake 1 0.1922
326 intrauterine 1 0.1974
326 investigate, 1 0.274
326 investigated 1 0.1565
326 lactic 3 0.5766
326 levels 1 0.1073
326 life. 1 0.1974
326 likewise 1 0.2194
326 lipoid 1 0.2307
326 low 1 0.1199
326 marily 1 0.274
326 metabolic 2 0.2617
326 metabolism 1 0.1299
326 metabolism. 1 0.1835
326 metabolization 1 0.274
326 min. 1 0.1922
326 ml 1 0.2194
326 mother, 1 0.2307
326 mother. 1 0.2194
326 newborns. 1 0.2467
326 order 1 0.1435
326 parameter 1 0.2107
326 parturient 3 0.7402
326 passage 2 0.3595
326 period 1 0.1039
326 place 2 0.3353
326 placenta 2 0.3949
326 possible 1 0.1099
326 pri- 1 0.2307
326 probable 1 0.1732
326 probably 1 0.1246
326 production 1 0.1396
326 products 1 0.1922
326 proof 1 0.2194
326 prove 1 0.2194
326 py- 1 0.274
326 pyruvic 1 0.2307
326 re- 1 0.1214
326 reason 2 0.3949
326 reflection 1 0.2467
326 relative 1 0.1422
326 reliably 1 0.274
326 result 1 0.1185
326 ruvic 1 0.274
326 share 1 0.2467
326 significantly 1 0.1152
326 similar 1 0.1026
326 sition 1 0.2467
326 sole 1 0.2307
326 study 1 0.0844
326 substances 1 0.1922
326 sults 1 0.2035
326 takes 1 0.2107
326 thought 1 0.1546
326 took 1 0.1974
326 u 1 0.2107
326 unesteri- 1 0.274
326 unesterified 5 1.2336
326 used 1 0.1035
326 utili- 1 0.2467
326 utilization 2 0.3844
326 values 4 0.5535
326 values, 1 0.2194
326 wanted 1 0.274
326 whether 2 0.2721
326 woman 2 0.3595
326 women; 1 0.2467
326 zation 1 0.2467
327 1, 1 0.485
327 1. 1 0.3946
327 1.3 1 0.6034
327 1.7 1 0.6785
327 1547. 1 0.7536
327 44 1 0.6034
327 acid 1 0.291
327 acids 3 1.1134
327 authors 1 0.3472
327 blood 1 0.2329
327 concentration 1 0.3168
327 contents 1 0.5046
327 cord 1 0.5159
327 cord. 1 0.7536
327 delivery 1 0.4943
327 different 1 0.2666
327 established 1 0.4066
327 fatty 4 1.5092
327 free 2 0.7143
327 glucose 4 1.5786
327 healthy 1 0.543
327 higher 1 0.3241
327 infant. 2 1.2691
327 levels 1 0.2951
327 maternal 1 0.4358
327 moment 1 0.6346
327 mother 3 1.291
327 nonesterified 1 0.6034
327 plasma 1 0.3038
327 relation 2 0.6944
327 significantly 2 0.6337
327 substances 1 0.5286
327 umbilical 1 0.6034
327 women 1 0.4066
328 3294. 1 1.0048
328 9 1 0.5262
328 acid, 1 0.6466
328 agent 1 0.5888
328 alteration 1 0.6591
328 alterations 1 0.554
328 amounts 2 0.9978
328 availability 1 0.724
328 before, 1 0.7724
328 biochemical 1 0.6352
328 carbohydrate 1 0.7048
328 catecholamines 1 1.0048
328 com- 1 0.5969
328 conclusion 1 0.6728
328 controls 1 0.6056
328 cortisone-like 1 1.0048
328 determined 1 0.4568
328 different 1 0.3554
328 effects 1 0.373
328 epi- 1 0.8461
328 epineph- 1 1.0048
328 epinephrine 3 2.4137
328 epinephrine. 1 0.9046
328 etc., 1 0.9046
328 etiologic 1 0.724
328 explained 1 0.5669
328 fatty 1 0.5031
328 glucose 1 0.5262
328 glucose, 1 0.7724
328 hormones, 1 0.9046
328 ii. 1 0.5811
328 increased 3 0.9371
328 infused 2 1.6922
328 infusion. 1 0.8046
328 infusions 1 0.7462
328 involving 1 0.6466
328 leads 1 0.5603
328 levels 1 0.3935
328 manner 1 0.6879
328 mechanism 1 0.4629
328 metabolic 1 0.4797
328 nefa 1 0.7724
328 nefa, 1 1.0048
328 nephrine 1 1.0048
328 nonesterified 1 0.8046
328 normal 2 0.5404
328 patient 1 0.3778
328 patient. 1 0.6879
328 patients 2 0.4831
328 plasma 2 0.8102
328 plicated 1 0.9046
328 preeclamptic 1 0.8461
328 pregnancies. 1 1.0048
328 pregnancy. 1 0.7462
328 pregnant 2 1.2111
328 responds 1 0.9046
328 resulting 1 0.5119
328 rine-norepinephrine 1 1.0048
328 seven 1 0.5738
328 similar 1 0.3762
328 slightly 1 0.5738
328 steroids, 1 0.8461
328 study 1 0.3096
328 thyroid, 1 1.0048
328 toxemia 1 0.9046
328 toxemic 2 2.0097
328 utilization. 1 0.8461
329 (ffa) 1 0.4827
329 12 1 0.2878
329 13 1 0.3487
329 5 1 0.2287
329 766. 1 0.5076
329 accordance 1 0.5076
329 acid 2 0.4656
329 acids 1 0.2969
329 acids, 1 0.4827
329 active 1 0.2778
329 alternative 1 0.4229
329 application 1 0.3401
329 bioassay. 1 0.6029
329 both. 1 0.5428
329 capable 2 0.7377
329 challenge, 1 0.5428
329 changes 1 0.1804
329 circulates 1 0.6029
329 com- 1 0.3581
329 concerning 1 0.3748
329 consumption 1 0.4229
329 contrainsulin 1 0.6029
329 cose 1 0.6029
329 crude 1 0.4477
329 days 1 0.2395
329 degree 1 0.2671
329 deproteination. 1 0.6029
329 described 1 0.2287
329 diabetes 1 0.2969
329 diabetogenic 1 0.5076
329 diminishes 1 0.5076
329 direct 1 0.2836
329 disappears 1 0.5076
329 elevated 1 0.388
329 elevation 1 0.4229
329 energy 1 0.4127
329 epididymal 1 0.5428
329 existing 1 0.5076
329 extraction 1 0.4344
329 extracts 1 0.3689
329 face 1 0.6029
329 facts 1 0.4344
329 fat 1 0.3689
329 fatty 4 1.2074
329 fetus. 1 0.4634
329 follows. 1 0.5076
329 found 1 0.1587
329 found. 1 0.388
329 fractions 1 0.322
329 free 4 1.1428
329 glu- 1 0.5428
329 glucose 3 0.9471
329 growth 1 0.2055
329 hibition 1 0.5428
329 hormone 1 0.2455
329 hypothesis 1 0.322
329 in- 1 0.2671
329 increased 1 0.1874
329 inducing 1 0.4344
329 inhibiting 1 0.4634
329 insulin 2 0.7267
329 late 2 0.7163
329 levels 2 0.4722
329 lipid 1 0.3689
329 lipid-mobilizing 1 0.6029
329 mater- 1 0.6029
329 maternal 5 1.7433
329 mellitus. 1 0.6029
329 men, 1 0.6029
329 metabolic 1 0.2878
329 mobilization. 1 0.5428
329 mobilizing 1 0.5428
329 nal 1 0.4827
329 nancy 1 0.6029
329 nondialyzable. 1 0.6029
329 occurring 1 0.3487
329 origin 1 0.3443
329 overt 1 0.5428
329 pad 1 0.5428
329 part 1 0.2816
329 partum. 1 0.5428
329 permits 1 0.4344
329 pituitary 2 0.6255
329 placentae 1 0.5428
329 placental 2 0.8255
329 plasma 2 0.4861
329 pose 1 0.6029
329 post 1 0.4229
329 preferential 1 0.5428
329 preg- 1 0.6029
329 pregnancy 2 0.7065
329 pregnant 2 0.7267
329 present 1 0.1985
329 probable 1 0.3811
329 procedure 1 0.3071
329 promised 1 0.6029
329 pronounced 1 0.3581
329 properties 1 0.322
329 provoke 1 0.5428
329 rat 1 0.2481
329 release 1 0.388
329 removed 1 0.3401
329 reserves, 1 0.6029
329 sera 1 0.3955
329 serum 1 0.2339
329 serve 1 0.4344
329 shunting 1 0.4127
329 stabilize 1 0.5428
329 substance 5 2.1144
329 substrate. 1 0.6029
329 time, 1 0.3487
329 uptake, 1 0.4827
329 used 1 0.2277
329 usually 1 0.2836
329 utilization 1 0.4229
329 within 1 0.2238
329 wo- 1 0.6029
329 women. 1 0.4827
329 worsen 1 0.6029
329 would 2 0.5987
329 yielded 1 0.3811
330 (tissue) 1 0.4306
330 3682. 1 0.4306
330 acids 7 1.4845
330 activity 1 0.1541
330 adult 1 0.1958
330 ample 1 0.3877
330 augmented 1 0.3626
330 birth 2 0.4387
330 birth, 1 0.331
330 birth. 1 0.3198
330 blocking 1 0.4306
330 blood 1 0.1331
330 carbohydrate 1 0.3021
330 carbohydrates 1 0.4306
330 cardiovascular 1 0.2722
330 caused 1 0.1885
330 change-over 1 0.4306
330 clearly 1 0.2595
330 com- 1 0.2558
330 concept, 1 0.3877
330 confirms 1 0.3626
330 demonstrable. 1 0.4306
330 demonstrates 1 0.3448
330 deprivation 1 0.3103
330 easily 1 0.2771
330 effect 1 0.1315
330 energy 1 0.2948
330 energy. 1 0.4306
330 ewes. 1 0.4306
330 factor 1 0.2041
330 fat 1 0.2635
330 fatty 6 1.2936
330 free 6 1.2245
330 hypoglycaemia 1 0.3877
330 important 1 0.1945
330 increased 1 0.1339
330 inhibits 1 0.2883
330 intrauterine 1 0.3103
330 lacking, 1 0.4306
330 lambs 3 1.0345
330 lambs. 1 0.3877
330 life 2 0.4554
330 main 1 0.2459
330 metabolism 1 0.2041
330 mobilization 1 0.3198
330 mobilization. 1 0.3877
330 mobilizes 1 0.4306
330 nerves 1 0.331
330 nervous 1 0.2635
330 newborn 3 0.7045
330 norepinephrine 1 0.3877
330 organism 1 0.2883
330 patible 1 0.4306
330 perinatal 1 0.3198
330 plasma 1 0.1736
330 rapid 2 0.4175
330 re- 1 0.1908
330 resulting 1 0.2194
330 rise 2 0.4276
330 rise, 1 0.3877
330 rising 1 0.3448
330 source 1 0.2883
330 source. 1 0.4306
330 special 1 0.2277
330 sponses 1 0.4306
330 study 2 0.2653
330 sudden 1 0.2771
330 sympathetic 2 0.6621
330 system 1 0.2012
330 though 1 0.2523
330 tissues. 1 0.2825
330 uses 1 0.3626
331 (efa) 1 0.6029
331 (uefa). 1 0.6029
331 10 1 0.2219
331 1163. 1 0.6029
331 20 1 0.2723
331 able 1 0.3401
331 acid 2 0.4656
331 acids 2 0.5938
331 adaptation 1 0.4634
331 administration 1 0.2655
331 also 1 0.1687
331 analysis 1 0.29
331 apparently 1 0.3288
331 attributed 1 0.4037
331 authors 1 0.2778
331 balance, 1 0.5428
331 bring 1 0.4634
331 but, 1 0.5076
331 carbohydrate 1 0.4229
331 cause 1 0.2723
331 cells, 1 0.2922
331 changes 2 0.3608
331 conditions 1 0.2741
331 conditions. 1 0.4229
331 conducted 1 0.4127
331 contrary 1 0.4229
331 crease 1 0.4037
331 creased 1 0.3955
331 decrease 1 0.2759
331 decrease, 1 0.5076
331 delivery 1 0.3955
331 delivery. 1 0.5076
331 demands 1 0.5076
331 deposition. 1 0.5428
331 different 1 0.2133
331 due 2 0.4265
331 effect 1 0.1841
331 electrolyte 1 0.4634
331 energy 1 0.4127
331 equal 1 0.3955
331 esterified 1 0.4827
331 evidence 1 0.221
331 expectations, 1 0.6029
331 explanation 1 0.4229
331 expulsive 2 1.2058
331 factors 1 0.2549
331 fat 2 0.7377
331 fatty 2 0.6037
331 fetal 2 0.6886
331 fetus 1 0.4229
331 fetus, 1 0.5428
331 find 1 0.4127
331 found 2 0.3174
331 fusion 1 0.4477
331 general, 1 0.4344
331 given 1 0.221
331 glucose 5 1.5786
331 hemodynamic 1 0.4037
331 hitherto 1 0.4827
331 however, 2 0.4367
331 hyperglycemia 2 1.0856
331 impairment 1 0.3955
331 in- 3 0.8014
331 increase 4 0.8191
331 increases 1 0.2816
331 infusion 2 0.6802
331 infusion, 1 0.6029
331 infusions 3 1.3431
331 insufficiency 1 0.3581
331 inves- 1 0.6029
331 islet 1 0.6029
331 known 1 0.2945
331 labor, 1 0.6029
331 labor. 1 0.5428
331 lactic 1 0.4229
331 leads 1 0.3362
331 levels 1 0.2361
331 life. 1 0.4344
331 likewise, 1 0.5428
331 lipoid 1 0.5076
331 lipoids 1 0.6029
331 may 1 0.1508
331 metabolic 1 0.2878
331 metabolism 1 0.2857
331 mobilization 1 0.4477
331 neither 1 0.3955
331 normally 1 0.3811
331 observe 1 0.4634
331 order 1 0.3157
331 organism. 1 0.5076
331 other, 1 0.4634
331 paradox 1 0.6029
331 parturient 3 1.6283
331 periods 1 0.3362
331 physiological 1 0.3533
331 play 1 0.3581
331 predominantly 1 0.4827
331 present 1 0.1985
331 probably 1 0.2741
331 pyruvic 1 0.5076
331 rather 1 0.2836
331 reaction 1 0.3018
331 reaction. 1 0.4477
331 received 1 0.3401
331 regularly 1 0.4344
331 respectively 1 0.4127
331 results 1 0.1727
331 retention. 1 0.5076
331 revealed 1 0.2922
331 role. 1 0.5076
331 saline 1 0.4477
331 show 1 0.2608
331 showed 1 0.2149
331 shown 1 0.2593
331 stage 2 0.5845
331 subsequent 1 0.3288
331 tigations 1 0.6029
331 uefa 1 0.6029
331 uefa- 2 1.2058
331 uefa-level 1 0.6029
331 uefa-values. 1 0.6029
331 un- 1 0.388
331 unesterified 1 0.5428
331 unusual 1 0.3811
331 usually 1 0.2836
331 values 1 0.3044
331 values, 1 0.4827
331 woman 1 0.3955
331 women 3 0.9759
332 (1) 1 0.1826
332 (2) 1 0.1826
332 (3) 1 0.1992
332 1320. 1 0.3768
332 2 2 0.2301
332 2-fold. 1 0.3768
332 3-fold 1 0.3173
332 4-fold 1 0.3392
332 acid 1 0.1455
332 acid. 1 0.2897
332 age 1 0.1559
332 altered 1 0.2012
332 although 1 0.1449
332 analyzed. 1 0.2643
332 be- 1 0.2305
332 blood 4 0.4657
332 borns 1 0.3392
332 changed, 1 0.3392
332 chromatography 1 0.2523
332 com- 1 0.2238
332 compared 1 0.1462
332 composition 2 0.4416
332 content 1 0.1773
332 creased 1 0.2472
332 decreased 1 0.1702
332 dependent 1 0.2425
332 derived 1 0.2077
332 diabetic 6 1.5137
332 diabetics 3 1.1304
332 diabetics, 1 0.3768
332 differ 1 0.2472
332 differences 2 0.3449
332 different 1 0.1333
332 except 1 0.2126
332 fat 1 0.2305
332 fatty 1 0.1887
332 fetal 2 0.4303
332 fetus 1 0.2643
332 ffa 7 2.0276
332 ffa. 1 0.3768
332 free 1 0.1786
332 gas 1 0.3017
332 gestational 2 0.7536
332 glucose 4 0.7893
332 higher 2 0.3241
332 hr 2 0.4358
332 hyperinsulinism; 1 0.3768
332 in- 1 0.167
332 indicated 1 0.1773
332 infant 5 1.0629
332 infants 3 0.5397
332 infants, 1 0.3173
332 infants. 1 0.258
332 initial 2 0.3653
332 insulin 1 0.2271
332 insulin-dependent 1 0.3768
332 interrelationships 1 0.3173
332 inverse 1 0.3173
332 latter 2 0.3909
332 levels 1 0.1476
332 life, 1 0.2523
332 maternal 1 0.2179
332 metabolic 1 0.1799
332 mother 1 0.2152
332 mother, 1 0.3173
332 mother. 1 0.3017
332 mothers 2 0.4542
332 mothers, 1 0.3017
332 new- 1 0.3173
332 newborns 1 0.3173
332 normal 8 0.8106
332 normals. 1 0.3768
332 noted 2 0.3985
332 observations 1 0.1584
332 oleic 1 0.3017
332 pattern 1 0.1799
332 patterns 1 0.2382
332 physiologic 1 0.2425
332 placental 1 0.258
332 plasma 4 0.6077
332 position. 1 0.3173
332 pregnant 1 0.2271
332 ratio 1 0.1973
332 regards 1 0.3173
332 relationship 2 0.3625
332 rise, 1 0.3392
332 saturated 1 0.2897
332 state 1 0.1937
332 sugar 1 0.2897
332 suggest 1 0.1713
332 synthesis 1 0.1871
332 time 1 0.1328
332 transfers; 1 0.3768
332 tween 1 0.2715
332 twice 1 0.2897
332 unsaturated 1 0.3173
332 values 1 0.1903
332 values; 1 0.3768
332 well 1 0.1318
332 women 1 0.2033
332 women, 1 0.2798
333 (13%) 1 0.7536
333 (22.5%), 1 0.7536
333 (30%) 1 0.7536
333 (7.5%). 1 0.7536
333 12% 1 0.7536
333 13%. 1 0.7536
333 14% 1 0.7536
333 25% 1 0.5286
333 27% 1 0.6785
333 3107. 1 0.6785
333 4 1 0.2666
333 50% 1 0.4542
333 6% 1 0.7536
333 60% 1 0.6034
333 accounted 1 0.5596
333 acid, 1 0.485
333 acids 4 1.4845
333 acids. 3 1.7379
333 analysed. 1 0.7536
333 cephalin 1 0.6346
333 cerides 1 0.7536
333 chloroform-methanol-soluble 1 0.7536
333 cholesterol 3 1.7379
333 chromatography 1 0.5046
333 chromatography, 1 0.7536
333 colamine 1 0.6785
333 component 1 0.485
333 components 1 0.4303
333 consisted 2 0.8954
333 content 2 0.7091
333 dialysis 1 0.7536
333 ed 1 0.5159
333 esters 1 0.7536
333 fatty 3 1.1319
333 form- 1 0.7536
333 free 1 0.3571
333 gas 2 1.2069
333 high 1 0.2697
333 human 2 0.5031
333 investigation 1 0.4252
333 isolated 1 0.3279
333 lecithin 1 0.6785
333 linoleic 1 0.6346
333 lipids 2 1.1192
333 lipids, 1 0.6785
333 main 1 0.4303
333 membrane 1 0.4066
333 one 1 0.2108
333 phosphatide 1 0.6346
333 phosphatides 1 0.6785
333 placenta 1 0.543
333 placentae 1 0.6785
333 polyenoic 1 0.7536
333 polyunsaturated 2 1.2691
333 quarter 1 0.6346
333 rubber 1 0.6785
333 saturated 1 0.5793
333 saturated, 1 0.7536
333 showed 1 0.2686
333 simple 2 0.8219
333 sphingomyelin 1 0.6034
333 thirds 1 0.6034
333 total 3 0.8812
333 trigly- 1 0.7536
333 triglycerides 1 0.6785
333 two 1 0.2308
333 unsaturated 1 0.6346
334 (freund's 1 1.0048
334 15 1 0.4989
334 377. 1 1.0048
334 act 1 0.6246
334 add 1 0.9046
334 adjuvant 1 0.724
334 adjuvants 2 2.0097
334 agents 1 0.5422
334 allergenicity 1 1.0048
334 alum). 1 1.0048
334 animals 1 0.4272
334 antiinfective 1 1.0048
334 appearance 1 0.4989
334 application 1 0.5669
334 augmented 1 0.8461
334 biological 1 0.5366
334 c 1 0.548
334 complete 1 0.4661
334 condition 1 0.5366
334 confirmed 1 0.5888
334 cross-sensitizations. 1 1.0048
334 diet. 1 0.7462
334 disturbances 1 0.5969
334 eczematiform 1 1.0048
334 effected 1 0.8461
334 epicutaneous 1 1.0048
334 existence 1 0.6148
334 experimental 1 0.4661
334 general 1 0.5119
334 good 1 0.5603
334 guinea-pigs 1 0.8046
334 guinea-pigs. 1 0.9046
334 involved 1 0.5119
334 lesions 1 0.4321
334 maintenance 1 0.8046
334 mechanism 1 0.4629
334 metal 1 0.6879
334 method 1 0.3992
334 necessary 1 0.5888
334 ni 1 0.7724
334 nickel 3 1.7433
334 out, 1 0.8461
334 possible 1 0.4031
334 proposed 1 0.6591
334 reason 1 0.724
334 res. 1 1.0048
334 salt 1 0.6466
334 salts 1 0.7724
334 sensitization 3 2.0183
334 sensitization, 1 1.0048
334 skin 1 0.5969
334 stimulating 1 0.7048
334 study 2 0.6191
334 sulfate 1 0.7048
334 sulfate. 1 1.0048
334 tests 1 0.4948
334 use 1 0.3972
334 vit. 1 0.8046
334 worked 1 0.9046
335 (girdles, 1 1.5073
335 (watch); 1 1.5073
335 2% 1 1.357
335 2285. 1 1.5073
335 allergologic 1 1.5073
335 clinic 1 1.2691
335 contact 1 0.8716
335 department 1 1.1586
335 dermatitis 2 2.7139
335 dermatological 1 1.5073
335 diseases 1 0.8219
335 disorder 1 0.9369
335 eruption 1 1.5073
335 follicular 1 1.5073
335 follows. 1 1.2691
335 frequent 1 0.9083
335 generally 1 0.8954
335 incubation 1 0.9221
335 keys) 1 1.5073
335 lichenoid 1 1.5073
335 long 1 0.7819
335 milan. 1 1.5073
335 nickel 1 0.8716
335 non-occupational 1 1.5073
335 observed 1 0.5138
335 often 1 0.7306
335 outpatients 1 1.5073
335 papulo-vesicular 1 1.5073
335 peculiar 1 1.2691
335 period 1 0.5717
335 prefers 1 1.5073
335 remarks 1 1.357
335 represents 1 1.0318
335 skin 1 0.8954
335 thighs 1 1.5073
335 women 1 0.8133
335 wrist 1 1.5073
336 3200. 1 0.5024
336 albumen 1 0.5024
336 allergic 1 0.3731
336 amino 1 0.3176
336 author 1 0.2944
336 behaved 1 0.423
336 binding 2 0.8046
336 bound 1 0.3439
336 bovine 1 0.2869
336 capable 1 0.3074
336 carboxyl 1 0.5024
336 complex 1 0.2905
336 concentration 1 0.2112
336 concluded 1 0.2299
336 crystalline 1 0.3731
336 dependent 1 0.3233
336 dialysis. 1 0.5024
336 equilibrium 1 0.3524
336 experiments 1 0.2226
336 free 1 0.2381
336 groups. 1 0.2985
336 hapten 1 0.5024
336 initiating 1 0.423
336 ions 1 0.3731
336 ions, 1 0.423
336 low 1 0.2199
336 nickel 6 1.7433
336 nickel-protein 1 0.5024
336 nickel. 1 0.4523
336 particular 1 0.2537
336 ph, 1 0.3731
336 primarily 1 0.3176
336 protein 3 0.6851
336 proteins 1 0.2606
336 quantity 1 0.3731
336 reaction 1 0.2515
336 reference 1 0.277
336 response. 1 0.3524
336 role 1 0.2331
336 sensitivity 1 0.3028
336 serum 1 0.1949
336 sites 1 0.3364
336 special 1 0.2657
336 stability, 1 0.4523
336 studied 1 0.175
336 studies 1 0.1539
336 technique 1 0.2364
336 unlikely 1 0.4523
336 used. 2 0.6879
336 using 1 0.2284
337 0.1% 1 1.5073
337 16 1 0.9369
337 172 1 1.5073
337 25% 1 1.0572
337 2596. 1 1.5073
337 5% 1 1.086
337 application 1 0.8503
337 clinical 1 0.4913
337 contact 1 0.8716
337 contact-type 1 1.5073
337 delayed 1 0.8832
337 demonstrated 1 0.6444
337 environment. 1 1.2691
337 experimental 1 0.6992
337 experimentally 2 2.1144
337 found 1 0.3968
337 hypersensitivity 1 1.1192
337 induced 1 0.6408
337 irritating. 1 1.5073
337 lauryl 1 1.5073
337 male 1 0.7678
337 man 1 0.7747
337 metal 1 1.0318
337 nickel 1 0.8716
337 nicl2 2 2.7139
337 occlusion 1 0.97
337 prisoners 1 1.5073
337 reactions 1 0.7363
337 repeated 1 0.8954
337 sensitivity 1 0.9083
337 sensitization 1 1.0091
337 sensitized 1 1.357
337 skin. 1 1.2691
337 sodium 1 0.725
337 solution 1 0.9221
337 subject 1 0.97
337 sulphate 1 1.2691
337 test 1 0.6519
338 1013. 1 0.7536
338 106 1 0.6785
338 39% 1 0.6785
338 allergy, 1 0.7536
338 aspects 1 0.4252
338 atopic 1 0.6785
338 cases 2 0.4484
338 causative 2 1.2069
338 cleansers, 1 0.7536
338 clinical 2 0.4913
338 contact 1 0.4358
338 contributory, 1 0.7536
338 could 2 0.5415
338 defined 1 0.5159
338 dermatitis 1 0.6785
338 dermatitis, 2 1.5073
338 diagnosis, 1 0.5046
338 discussed. 1 0.3222
338 eczema 4 2.4137
338 eczema, 2 1.5073
338 eczema. 2 1.5073
338 effect 1 0.2301
338 factor 1 0.3571
338 factors 1 0.3186
338 factors, 1 0.543
338 found. 1 0.485
338 hand 3 1.8103
338 hyperkeratotic 1 0.7536
338 identified 1 0.4416
338 idiopathic 2 1.0318
338 influence 1 0.3449
338 many 1 0.3038
338 mycotic 1 0.7536
338 nickel 1 0.4358
338 nummular 1 0.7536
338 occupational 1 0.6346
338 palms, 1 0.7536
338 partum, 1 0.6785
338 patch 1 0.6034
338 post 1 0.5286
338 probably 1 0.3426
338 prognosis 1 0.4155
338 psychiatric 1 0.485
338 psychological 1 0.4764
338 results 1 0.2158
338 reviewed. 1 0.5286
338 significant 1 0.2646
338 superimposed 1 0.6346
338 tests, 1 0.4943
338 treatment 1 0.2223
338 types 1 0.3653
338 underlying 1 0.543
338 upon 1 0.3381
338 water 1 0.3985
339 (decadron) 1 0.7536
339 5% 1 0.543
339 670. 1 0.7536
339 accelerators, 1 0.7536
339 aerosol 2 1.5073
339 afforded 1 0.6346
339 affords 2 1.2691
339 alone 1 0.4542
339 certain 1 0.3319
339 clinical 2 0.4913
339 coins. 1 0.7536
339 combination 1 0.4303
339 complete 1 0.3496
339 components 1 0.4303
339 confirmed 1 0.4416
339 contact 1 0.4358
339 degree 2 0.6678
339 dermatitis. 1 0.7536
339 detergents. 1 0.7536
339 dexamethasone 2 1.2691
339 dichromate, 1 0.7536
339 done 1 0.5046
339 due 1 0.2666
339 eczema 1 0.6034
339 ether 1 0.5596
339 fair 1 0.7536
339 film 1 0.5793
339 formaldehyde 1 0.6346
339 formaldehyde. 1 0.7536
339 housewives 1 0.7536
339 hydroquinone. 1 0.7536
339 hypersensitivity 1 0.5596
339 hypersensitivity. 1 0.7536
339 indicate 2 0.6637
339 individual 1 0.3985
339 irritants 1 0.6785
339 isopropylmyristate 1 0.7536
339 ivy 1 0.7536
339 moderate 2 0.8954
339 monobenzyl 1 0.7536
339 necessary 1 0.4416
339 nickel 4 1.7433
339 nickel-sensitive 1 0.7536
339 obtained 1 0.2686
339 oleoresin, 1 0.7536
339 paraphenylenediamine 1 0.7536
339 particular 1 0.3805
339 patch 3 1.8103
339 patients 4 0.7246
339 patients. 1 0.3625
339 poison 1 0.7536
339 potassium 1 0.5046
339 present 1 0.2481
339 presumably 1 0.4943
339 proper 1 0.5046
339 prophylactic 1 0.6785
339 prophylaxis; 1 0.7536
339 protect 2 1.1192
339 protection 4 1.9399
339 ragweed 1 0.7536
339 reference 1 0.4155
339 result 1 0.326
339 results 3 0.6474
339 rubber 1 0.6785
339 sensitivity. 2 1.357
339 soap 1 0.7536
339 solution 1 0.4611
339 spray 4 2.3172
339 steroid 1 0.4358
339 successful 1 0.5159
339 sulfate 1 0.5286
339 test 2 0.6519
339 testing 1 0.5286
339 tests 1 0.3711
339 topical 1 0.6346
339 use 3 0.8938
340 1 1 0.3795
340 20 1 0.4538
340 2078. 1 1.0048
340 5 1 0.3811
340 9 1 0.5262
340 allergic 1 0.7462
340 analysis 1 0.4833
340 attributable 1 0.6879
340 cases 1 0.299
340 chromium 2 1.6091
340 contact 3 1.7433
340 demonstrated 1 0.4296
340 detergents 3 3.0145
340 detergents, 1 1.0048
340 different 1 0.3554
340 domestic 1 0.8461
340 due 2 0.7109
340 eczema 3 2.4137
340 either 1 0.4296
340 especially 1 0.5165
340 existence 1 0.6148
340 found 1 0.2645
340 household 1 1.0048
340 likewise, 1 0.9046
340 linked 1 0.7048
340 maintained 1 0.5603
340 metallic 1 0.8461
340 metals 1 0.8461
340 metals, 1 1.0048
340 nickel 1 0.5811
340 nickel. 1 0.9046
340 p.p.m. 1 0.8046
340 patch 1 0.8046
340 pathogenesis 1 0.5669
340 pathogenically 1 1.0048
340 present 1 0.3308
340 proportion 1 0.6246
340 salts, 1 1.0048
340 samples 1 0.6352
340 sensitization 2 1.3455
340 series 1 0.4727
340 test. 1 0.6591
340 thesis 1 0.7724
340 use 1 0.3972
340 used 1 0.3795
340 varied 1 0.6352
340 washing, 1 1.0048
340 which, 1 0.724
341 (0.03 1 0.5024
341 (0.60 1 0.5024
341 (the 1 0.3731
341 1 1 0.1897
341 24 1 0.2606
341 3 1 0.1713
341 30 1 0.2399
341 4 1 0.1777
341 4010. 1 0.5024
341 60 1 0.3233
341 80 1 0.3439
341 air) 1 0.5024
341 also 1 0.1406
341 amounts 1 0.2494
341 carbonyl 2 0.8046
341 carcinogenesis. 1 0.4523
341 concentration 1 0.2112
341 either 1 0.2148
341 exposed 1 0.2631
341 exposure. 1 0.4523
341 final 1 0.3296
341 following 1 0.1665
341 found 1 0.1323
341 fraction 2 0.5366
341 fractions 3 0.805
341 greatest 1 0.3176
341 homogenates 1 0.3731
341 hours 1 0.2417
341 increased 1 0.1562
341 inhalation 2 0.7462
341 isolated 1 0.2186
341 killed 1 0.423
341 liver 4 0.7907
341 lung 3 0.6481
341 lung, 1 0.3862
341 lung. 1 0.362
341 made. 1 0.3123
341 measurements 1 0.3233
341 mg 2 0.5969
341 microsomal 2 0.9046
341 minutes 2 0.6591
341 mitochondrial 1 0.362
341 mitochondrial, 1 0.5024
341 ni(co)4/l. 1 0.5024
341 ni(co)4/l.air), 1 0.5024
341 nickel 6 1.7433
341 nickel, 1 0.4023
341 nitrogen 2 0.6591
341 nuclear 1 0.2905
341 nuclear, 1 0.5024
341 of) 1 0.5024
341 partition 1 0.5024
341 period 1 0.1906
341 ppm 2 0.7724
341 ratios 1 0.3296
341 rats 1 0.194
341 repeatedly 1 0.4523
341 rna-content 1 0.5024
341 studies 1 0.1539
341 subcellular 2 0.8046
341 supernatant 2 0.8046
341 times 1 0.2417
341 weekly 1 0.4023
341 wistar 1 0.4023
341 year. 1 0.3524
342 (n.b. 1 0.4306
342 15 1 0.2138
342 188. 1 0.4306
342 195 1 0.4306
342 24 1 0.2234
342 27 1 0.2883
342 3 1 0.1468
342 3-year 1 0.4306
342 409 1 0.4306
342 6 1 0.1801
342 adenocarcinoma 1 0.2948
342 amount 2 0.4241
342 anaplastic 1 0.3877
342 cancer 1 0.1702
342 cancer, 1 0.2722
342 capable 1 0.2635
342 carbonyl 3 1.0345
342 carbonyl. 1 0.4306
342 carcinogenesis;metastasizing 1 0.4306
342 carcinoma 1 0.2056
342 carcinoma, 1 0.3626
342 carcinoma. 1 0.2948
342 cell 1 0.1457
342 chronically 1 0.3626
342 cigarettes 1 0.3877
342 combined 1 0.2213
342 common 1 0.2104
342 comparable 1 0.2374
342 consistently 1 0.2771
342 control 1 0.1619
342 day 1 0.2138
342 developed 1 0.1958
342 entire 1 0.2825
342 exposed 2 0.451
342 exposure 1 0.2558
342 found 3 0.3401
342 included 1 0.2324
342 induced 1 0.1831
342 inducing 1 0.3103
342 inhalation 1 0.3198
342 inhaled 1 0.3877
342 initial 1 0.2087
342 lesions 2 0.3704
342 less 2 0.3225
342 lung 1 0.1852
342 mean 1 0.2071
342 metastases. 1 0.3448
342 mth. 1 0.2558
342 nickel 7 1.7433
342 per 1 0.1678
342 period 2 0.3267
342 persons 1 0.2722
342 pulmonary 4 0.7365
342 rat 1 0.1772
342 rats 4 0.6652
342 series 1 0.2026
342 smoking 1 0.4306
342 squamous 1 0.3626
342 studies 1 0.1319
342 studies, 1 0.3626
342 study. 1 0.2825
342 survived 1 0.2825
342 throughout 1 0.2459
342 tumors 1 0.2255
342 types 1 0.2087
342 weight 1 0.2026
342 wk.) 1 0.4306
342 year. 1 0.3021
343 1-month 2 1.2058
343 189. 1 0.6029
343 2 1 0.1841
343 2-month 2 1.2058
343 3-month 1 0.6029
343 added 1 0.3748
343 age, 1 0.3955
343 ages. 1 0.5428
343 aqueous 1 0.4344
343 carcinogenesis 1 0.5076
343 carcinogenic 1 0.4634
343 castrated 2 1.0856
343 castrated, 1 0.6029
343 compared 1 0.2339
343 conclusions 1 0.3811
343 could 1 0.2166
343 data 1 0.2455
343 different 1 0.2133
343 drawn 1 0.4477
343 effect 1 0.1841
343 extirpation 1 0.5428
343 female 1 0.3487
343 females 2 0.8457
343 females. 1 0.5076
343 firm 1 0.4827
343 g 1 0.4634
343 glandular 1 0.4477
343 hypophysectomized 2 0.7909
343 influence 1 0.2759
343 injected 1 0.2922
343 injection 1 0.2521
343 intact 4 1.3295
343 intact, 1 0.4827
343 intramuscular 1 0.4827
343 less 1 0.2257
343 male 1 0.3071
343 males 1 0.4127
343 males, 2 1.0856
343 marked 1 0.2705
343 mth. 1 0.3581
343 muscle 1 0.3324
343 nickel 1 0.3487
343 old 5 1.7006
343 old. 1 0.5076
343 one-month 1 0.6029
343 penicillin 1 0.4827
343 rats 2 0.4656
343 required 1 0.3288
343 response 1 0.2201
343 responsive 1 0.4477
343 responsive. 1 0.5428
343 results. 1 0.4229
343 seemed 1 0.388
343 sex 1 0.4037
343 single 1 0.2993
343 sulphide 1 0.6029
343 suspension 1 0.4344
343 would 1 0.2993
344 -1. 1 0.7536
344 0.02 1 0.6346
344 3176. 1 0.7536
344 acids 1 0.3711
344 atoms. 1 0.7536
344 center 1 0.485
344 cm 1 0.6034
344 crystal 1 0.6346
344 detected 1 0.3909
344 distorted 1 0.6346
344 divalent 1 0.6346
344 electron 2 0.7611
344 estimated 1 0.4685
344 field 1 0.4477
344 forbidden 1 0.7536
344 indicate 1 0.3319
344 intensity 1 0.5286
344 located 1 0.6346
344 manganese 4 3.0145
344 metabolism 1 0.3571
344 metal 1 0.5159
344 nominally 1 0.7536
344 octahedron 1 0.7536
344 oxygen 1 0.3839
344 paramagnetic 2 1.5073
344 parameter 1 0.5793
344 pattern 1 0.3598
344 patterns 1 0.4764
344 present 1 0.2481
344 readily 1 0.485
344 resonance 3 2.2609
344 resonances, 1 0.7536
344 ribonucleic 1 0.5286
344 rna 1 0.4155
344 rna. 1 0.6034
344 samples 1 0.4764
344 spectrum 1 0.6034
344 splitting 1 0.7536
344 state 1 0.3874
344 studies 1 0.2308
344 suggest 1 0.3426
344 trace 1 0.543
345 2-pam, 1 0.6029
345 2-pyridinealdoxime 1 0.6029
345 4790. 1 0.6029
345 acetylcholinesterase 1 0.6029
345 acetylcholinesterase, 1 0.6029
345 act 1 0.3748
345 addition, 1 0.3487
345 alignment 1 0.6029
345 catalyze 1 0.6029
345 chelate-enzyme 1 0.6029
345 chelates 5 2.7139
345 compared 1 0.2339
345 complex. 1 0.4827
345 copper 1 0.6029
345 decomposition 1 0.6029
345 dfp 1 0.6029
345 enzyme. 1 0.4477
345 however, 1 0.2183
345 improper 1 0.6029
345 inhibitors 1 0.4477
345 investigate 1 0.5076
345 metal 2 0.8255
345 nickel 1 0.3487
345 organic 1 0.3581
345 oxine 1 0.6029
345 oxygen 1 0.3071
345 part 1 0.2816
345 phosphate 2 0.6089
345 poisoned 2 1.0153
345 poor 1 0.3487
345 possible 1 0.2419
345 potential 1 0.3955
345 probably 1 0.2741
345 reactivators 2 1.2058
345 reactivators, 1 0.6029
345 sarin. 1 0.6029
345 shown 1 0.2593
345 study 1 0.1857
346 (22 1 0.3015
346 (k)0 1 0.3349
346 (na)0. 1 0.3349
346 +16mv 1 0.3349
346 +8mv 1 0.3349
346 0.1-1.0 1 0.3349
346 1.0 3 0.9046
346 2. 1 0.1754
346 3446. 1 0.3349
346 4 1 0.1185
346 50% 1 0.2019
346 action 5 0.7286
346 activity; 1 0.3349
346 addition, 1 0.1937
346 after-depolarization 1 0.3349
346 amplitude 2 0.4974
346 amplitude; 1 0.3349
346 anodal 2 0.6031
346 assuming 1 0.282
346 attempt 1 0.2049
346 c. 1 0.1771
346 c.). 1 0.3349
346 ca++ 1 0.282
346 cathodal 3 0.8461
346 change 1 0.1554
346 changes 1 0.1002
346 combined 1 0.1722
346 competition 1 0.2682
346 concluded 1 0.1533
346 constant 1 0.1827
346 could 1 0.1203
346 critical 1 0.2243
346 decline. 1 0.3349
346 decrease 2 0.3065
346 decreased 1 0.1513
346 delayed 4 0.785
346 due 1 0.1185
346 duration 1 0.1754
346 duration, 1 0.282
346 duration; 1 0.3349
346 effect 1 0.1023
346 effects 1 0.1243
346 elevated 1 0.2155
346 explain 1 0.2243
346 explained 1 0.189
346 extreme 1 0.2197
346 factor 1 0.1587
346 gradually 1 0.2117
346 inactivation 2 0.4485
346 increase 1 0.1138
346 increased 2 0.2082
346 increased. 1 0.2243
346 increases 1 0.1565
346 increasing 1 0.1963
346 influence 1 0.1533
346 influenced 1 0.2082
346 ionic 1 0.2575
346 isolated 1 0.1457
346 k 1 0.2413
346 k-depolarization 1 0.3349
346 lasting 1 0.3015
346 lengthened 1 0.3349
346 long 1 0.1737
346 long-lasting 1 0.3015
346 made 1 0.1213
346 maximum 2 0.3693
346 measured 1 0.1466
346 membrane. 1 0.2575
346 mm 4 0.8622
346 na 1 0.2117
346 na-poor 1 0.3349
346 ni++ 1 0.3349
346 nicl2 9 2.7139
346 nicl2-effect 1 0.3349
346 nicl2. 1 0.3349
346 nodal 2 0.5641
346 node 1 0.2575
346 normal 1 0.0901
346 normally 1 0.2117
346 obtained 1 0.1194
346 part 1 0.1565
346 permeability 1 0.282
346 permeability; 1 0.3349
346 phase 1 0.1789
346 plateau 4 1.2062
346 plateaus 1 0.3349
346 polarization 2 0.6699
346 polarization, 1 0.3349
346 polarization; 1 0.3349
346 potential 7 1.5379
346 potential, 1 0.3349
346 prematurely 1 0.3015
346 presence 1 0.1276
346 prolongation 2 0.5149
346 prolongs 1 0.3349
346 pulse 1 0.2413
346 pulses 2 0.6031
346 ranvier 1 0.3015
346 rate 2 0.2466
346 rectification 1 0.3015
346 reduce 1 0.2117
346 reduced 1 0.1513
346 reduction 2 0.3299
346 reduction. 1 0.282
346 relation 1 0.1543
346 repetitive 1 0.3015
346 replaced 1 0.2575
346 repolarization 1 0.3015
346 required 1 0.1827
346 responses 1 0.1868
346 ringer's 1 0.3349
346 rise 2 0.3326
346 room 1 0.2575
346 short 2 0.3874
346 shortened 1 0.282
346 similar 1 0.1254
346 sites 1 0.2243
346 slightly 2 0.3825
346 sodium 1 0.1611
346 solution 1 0.2049
346 solutions 1 0.2413
346 specific 1 0.1318
346 steady-state 1 0.3015
346 steep 1 0.3349
346 stepwise 1 0.282
346 strength. 1 0.3349
346 strong 1 0.2243
346 temperature 4 0.7155
346 tendency 1 0.2413
346 terminated 1 0.3015
346 terminates 1 0.3349
346 terms 1 0.2049
346 theory. 1 0.3349
346 threshold, 1 0.3349
346 time 1 0.118
347 (3.2 1 0.4306
347 (n-hydroxy-aaf) 1 0.4306
347 /injection), 1 0.4306
347 1 1 0.1626
347 16 2 0.5354
347 2 1 0.1315
347 2.5 2 0.6396
347 20 1 0.1945
347 2302. 1 0.4306
347 4 4 0.6093
347 4-50 1 0.4306
347 8 1 0.1945
347 account 1 0.2429
347 active 1 0.1984
347 activities 3 0.7471
347 activity 1 0.1541
347 administered 3 0.6168
347 also 1 0.1205
347 associated 1 0.1529
347 c. 1 0.2277
347 carcinogenic 3 0.9931
347 carcinogens 1 0.4306
347 cases 1 0.1281
347 cellular 1 0.2348
347 chelate 1 0.4306
347 chelates 5 1.9385
347 chelates, 1 0.4306
347 chelation 1 0.4306
347 cobaltous, 1 0.4306
347 comparable 1 0.2374
347 consideration 1 0.2825
347 constituents. 1 0.4306
347 cupric 2 0.8613
347 days. 3 0.7288
347 derivatives 2 0.6396
347 developed 1 0.1958
347 ferric, 1 0.4306
347 food 1 0.331
347 function 1 0.1932
347 given 1 0.1579
347 greater 2 0.3563
347 half-retention 4 1.7226
347 high 1 0.1541
347 higher 1 0.1852
347 hr. 2 0.4981
347 importance 1 0.2194
347 incidences 3 1.2919
347 indicate 1 0.1896
347 induced 2 0.3662
347 injection 7 1.2605
347 injections 1 0.2429
347 injections, 1 0.3877
347 injections; 1 0.4306
347 less 1 0.1612
347 locally 1 0.3626
347 longer 1 0.3021
347 lower. 1 0.4306
347 mammary 1 0.2771
347 manganous 1 0.4306
347 material 1 0.1998
347 may 1 0.1077
347 metabolites 1 0.331
347 metal 4 1.1792
347 mg. 1 0.2722
347 moderate 1 0.2558
347 must 1 0.2104
347 n-hydroxy-2-acetylaminofluorene 2 0.8613
347 n-hydroxy-aaf 5 2.1532
347 n-hydroxy-aaf, 1 0.4306
347 nickelous, 1 0.4306
347 obtained 1 0.1535
347 one-half 1 0.331
347 possible 1 0.1728
347 potassium 1 0.2883
347 prolonged 1 0.2071
347 ranged 1 0.331
347 rats 1 0.1663
347 release 1 0.2771
347 respectively. 1 0.2948
347 resulted 1 0.2087
347 retained 1 0.331
347 retention 3 0.8031
347 s. 1 0.331
347 s.c. 1 0.3448
347 salt 1 0.2771
347 sarcomas 2 0.7754
347 serious 1 0.2595
347 short 1 0.249
347 site 4 0.9961
347 site; 1 0.4306
347 sites 2 0.5767
347 slow 1 0.2825
347 spectrum 1 0.3448
347 surrounding 1 0.3021
347 time 1 0.1517
347 times 3 0.6214
347 tissue. 1 0.2771
347 tumors 3 0.6765
347 variety 1 0.2324
347 zinc 1 0.4306
348 (10 1 0.4634
348 (ap), 1 0.6029
348 (i-h), 1 0.6029
348 (russian) 1 0.4344
348 -2 1 0.5428
348 -3 1 0.5428
348 0.01% 1 0.6029
348 00mm/1. 1 0.6029
348 10 1 0.2219
348 12083. 1 0.6029
348 achieved. 1 0.6029
348 action 2 0.5246
348 along 1 0.4229
348 also 2 0.3373
348 altered 1 0.322
348 amplitude 1 0.4477
348 ap 4 2.4116
348 ascending 1 0.4634
348 binding 1 0.4827
348 cadmium 2 1.0856
348 cathodal 1 0.5076
348 caused 1 0.2639
348 cd 3 1.8087
348 concentration 1 0.2535
348 considerably 1 0.388
348 could 1 0.2166
348 critical 2 0.8073
348 cysteine 1 0.5428
348 depolarization 2 1.2058
348 depolarization, 1 0.6029
348 dissection. 1 0.6029
348 effects 1 0.2238
348 eliminated 1 0.4229
348 excess 1 0.4127
348 experimenting 1 0.6029
348 fibre 1 0.6029
348 fibres 2 1.0153
348 frog 2 1.0856
348 generation 2 1.0856
348 happened 1 0.6029
348 inactivation 3 1.211
348 increase 2 0.4095
348 increased 1 0.1874
348 influence 1 0.2759
348 influences. 1 0.6029
348 initial 2 0.5845
348 injury 1 0.4037
348 ions 5 2.2385
348 ions. 1 0.5428
348 isolated 2 0.5246
348 kcl) 1 0.6029
348 level 2 0.4656
348 m) 1 0.6029
348 made 1 0.2183
348 marked 1 0.2705
348 mechanical 1 0.4344
348 medium 1 0.322
348 membrane 2 0.6506
348 mentioned 1 0.4344
348 na 1 0.3811
348 nerve 3 1.211
348 ni 3 1.3903
348 nickel 2 0.6973
348 nodes 3 1.3903
348 permeability 2 1.0153
348 phase 1 0.322
348 phase. 1 0.4827
348 potassium 3 1.211
348 potential 1 0.3955
348 potentials 1 0.5076
348 previous 1 0.3253
348 procaine 1 0.6029
348 prolongation 1 0.4634
348 proteins, 1 0.4634
348 raised 1 0.3581
348 ranvier 1 0.5428
348 ranvier's 2 1.2058
348 rate 1 0.2219
348 reduce 1 0.3811
348 reduced 2 0.5445
348 reduction. 1 0.5076
348 repolarization 1 0.5428
348 restoration 1 0.4477
348 restored 1 0.4229
348 rise 2 0.5987
348 sh-groups 1 0.6029
348 shown 1 0.2593
348 single 2 0.5987
348 slight 1 0.3581
348 slowed 1 0.6029
348 solution, 1 0.4634
348 somewhat 1 0.4477
348 steepness 1 0.6029
348 suggestion 1 0.4477
348 that, 1 0.3955
348 weaken 2 1.2058
348 weakened 1 0.6029
348 well 1 0.2108
348 whenever 1 0.5428
349 (both 1 1.0048
349 10 1 0.3699
349 11 1 0.5366
349 12 1 0.4797
349 1287. 1 1.0048
349 able 1 0.5669
349 activity 1 0.3596
349 acute 1 0.4989
349 age 2 0.8313
349 agnostic 3 3.0145
349 alexia 2 1.8093
349 apraxia 2 1.8093
349 apraxia. 1 1.0048
349 boy 1 0.6728
349 characteristic 1 0.5074
349 child 3 1.45
349 constructing 1 1.0048
349 constructive 2 1.6922
349 copy 1 1.0048
349 copying. 1 1.0048
349 could 3 1.0831
349 determined 1 0.4568
349 determined, 1 0.9046
349 developed 1 0.4568
349 dictated). 1 1.0048
349 difficulty 1 0.6728
349 disappeared, 1 1.0048
349 disturbed 1 0.6246
349 either 1 0.4296
349 either. 1 1.0048
349 elementary, 1 1.0048
349 encephalopathy, 1 1.0048
349 etiology 1 0.554
349 even 1 0.4398
349 evolution 1 0.724
349 extreme 1 0.6591
349 features 1 0.5366
349 followed 1 0.4598
349 forms, 1 0.9046
349 freely 1 1.0048
349 fully 1 0.7462
349 functions 1 0.6246
349 geometric 1 0.9046
349 intellectual 1 0.6728
349 involution 1 1.0048
349 iq 1 0.8046
349 motor 1 0.7462
349 mth. 1 0.5969
349 normal 1 0.2702
349 normal, 1 0.7462
349 patient 1 0.3778
349 performance 1 0.6879
349 pure. 1 1.0048
349 read 2 1.5448
349 regressive 1 1.0048
349 remarkable 1 0.724
349 remarkably 1 0.8046
349 shows 1 0.554
349 speech 1 0.5262
349 spontaneously 1 0.8461
349 syndrome 2 0.9322
349 tests, 1 0.6591
349 text, 1 1.0048
349 up. 1 0.9046
349 write 1 0.9046
349 written. 1 1.0048
349 yr. 2 1.0524
350 1288. 1 1.5073
350 ability. 1 1.5073
350 actual 1 1.086
350 aphasia 1 1.1192
350 apraxia 1 1.357
350 audiometric 1 1.357
350 autotopagnosia 2 3.0145
350 became 1 0.8954
350 beginning 1 0.9528
350 binaural 1 1.5073
350 cerebral 1 0.7143
350 comprehensive 1 1.2069
350 concerned 1 1.0091
350 conduction 2 2.7139
350 constructive 1 1.2691
350 creative 1 1.5073
350 deafness 1 1.2691
350 disturbances 2 1.7907
350 disturbed 1 0.9369
350 dominant 1 1.0318
350 dyslexia 1 1.2691
350 dyslexia. 1 1.5073
350 dyspraxia 1 1.5073
350 evident 1 0.9369
350 examination 1 0.7611
350 examined 1 0.7611
350 face, 1 1.5073
350 factors 1 0.6372
350 field 1 0.8954
350 gerstmann's 1 1.2069
350 hemianopsia 1 1.2069
350 hemisphere. 1 1.357
350 left-right 1 1.5073
350 marked 1 0.6763
350 meticulously 1 1.5073
350 mild 1 0.9887
350 observed, 1 1.2691
350 parietal 2 2.2385
350 parts 1 1.0318
350 patient. 1 1.0318
350 perception 1 1.2069
350 poor. 1 1.357
350 pronounced 1 0.8954
350 regression. 1 1.5073
350 relationships, 1 1.5073
350 revealed 1 0.7306
350 right 1 0.7819
350 showed 2 1.0746
350 study 1 0.4643
350 symptom 1 1.0572
350 symptomatology 1 1.0318
350 syndrome 1 0.6992
350 syndrome, 1 1.0091
350 synthesis. 1 1.2069
350 tachistoscopy 1 1.357
350 tested 1 0.9083
350 various 1 0.5959
350 vision 1 1.2069
350 word 1 1.357
351 'spelling 1 1.0048
351 (1887) 1 1.0048
351 (1921) 1 1.0048
351 4544. 1 1.0048
351 56-year-old 1 1.0048
351 agnosia 1 0.7724
351 agnosia, 1 0.9046
351 alternative 1 0.7048
351 area 1 0.5212
351 area. 1 0.8461
351 associations 1 0.9046
351 borderland 1 1.0048
351 cannot 1 0.5422
351 cases 1 0.299
351 causative 1 0.8046
351 color 3 2.3172
351 colors 1 1.0048
351 colors. 1 1.0048
351 colour 1 0.8461
351 context. 1 0.9046
351 defect 1 0.4948
351 developed 1 0.4568
351 disorder 1 0.6246
351 dominant 1 0.6879
351 dyslexia' 1 1.0048
351 dysphasia, 1 1.0048
351 excluded. 1 0.7462
351 explained 1 0.5669
351 following 1 0.3331
351 formation 2 0.9017
351 hematoma 1 0.8461
351 hemisphere, 1 0.9046
351 impaired 2 1.3758
351 impairing 1 1.0048
351 information 1 0.5422
351 information, 1 1.0048
351 input 1 0.9046
351 interference 1 0.6728
351 interpretation, 1 1.0048
351 language 1 0.5888
351 latter 1 0.5212
351 left 1 0.4538
351 lesion 1 0.5669
351 limited 1 0.548
351 located 1 0.8461
351 man, 1 0.7462
351 may 1 0.2513
351 names 3 2.7139
351 observations 1 0.4225
351 persisted. 1 0.9046
351 picture 1 0.548
351 placed 1 0.5969
351 posterior 1 0.5888
351 posteriorly 1 1.0048
351 present 1 0.3308
351 present, 1 0.6591
351 previously 1 0.4833
351 receiving 1 0.554
351 recognition 1 0.6728
351 recollection 1 1.0048
351 recording 1 0.7048
351 reported 1 0.4072
351 resolved, 1 1.0048
351 resulting 1 0.5119
351 right-handed 1 0.9046
351 seems 1 0.5313
351 simultaneously 1 0.6056
351 sittig 1 1.0048
351 specific 1 0.3953
351 subdural 1 0.9046
351 task 1 0.7462
351 types 1 0.4871
351 use 1 0.3972
351 verbal 1 0.6728
351 views 1 1.0048
351 visual 1 0.548
351 willbrand 1 1.0048
352 652. 1 0.7536
352 amenable 1 0.6785
352 bitemporal 2 1.1192
352 chiasma. 1 0.7536
352 circle 1 0.7536
352 complete 1 0.3496
352 consequence 2 1.1586
352 constriction 1 0.6346
352 defects. 1 0.6346
352 destroyed. 1 0.6785
352 development 1 0.2752
352 direct 1 0.3546
352 disorder 1 0.4685
352 distinguished 1 0.5046
352 extent 1 0.3985
352 fibers 1 0.6034
352 field 1 0.4477
352 first 1 0.2763
352 follows 1 0.485
352 growth 1 0.2569
352 hemianopia 2 0.97
352 hence 1 0.6785
352 hypophyseal 1 0.6346
352 limited 1 0.411
352 lower 1 0.3426
352 nerve 1 0.5046
352 occurs, 1 0.7536
352 only. 1 0.543
352 operation 1 0.3946
352 pressure 2 0.6897
352 progressing 1 0.7536
352 prompt 1 0.5596
352 quadrantic 1 0.7536
352 relieving 1 0.6785
352 restoration 1 0.5596
352 restoration. 1 0.7536
352 second 1 0.3839
352 side 1 0.4252
352 stage 4 1.4612
352 stages 1 0.4155
352 start 1 0.6034
352 therefore, 1 0.4764
352 tumor 2 0.672
352 tumors. 1 0.4943
352 two 1 0.2308
352 upper 1 0.485
352 vessels. 1 0.6785
352 visual 1 0.411
353 (ocular 1 0.7536
353 (visual 1 0.7536
353 387. 1 0.7536
353 able 1 0.4252
353 agnosia) 1 0.7536
353 agnosia, 1 0.6785
353 although 1 0.2897
353 apraxia). 1 0.7536
353 apraxia, 1 0.7536
353 areas 1 0.3985
353 bilateral 3 1.3625
353 biparieto-temporal 1 0.7536
353 cases 1 0.2242
353 categorized 1 0.6785
353 causing 2 1.1192
353 cerebral 2 0.7143
353 compensated 1 0.6034
353 conjugate 2 1.2069
353 control 1 0.2834
353 defects 1 0.4155
353 described 1 0.2859
353 disturbances 3 1.3431
353 evidence 1 0.2763
353 extent 1 0.3985
353 eye 1 0.485
353 follows 1 0.485
353 frontal 1 0.5793
353 gaze. 2 1.5073
353 group 3 0.8357
353 iia 1 0.7536
353 iib 1 0.6785
353 lesions 4 1.2963
353 lesions, 1 0.543
353 lesions. 1 0.5159
353 less 1 0.2821
353 lobes. 1 0.7536
353 localization 2 1.0572
353 localization, 1 0.6346
353 localization. 1 0.6785
353 manifestations 1 0.4303
353 may 1 0.1885
353 motor 2 1.1192
353 movements 1 0.5596
353 much 1 0.3339
353 neuro-ophthalmic 1 0.7536
353 non-occipital 1 0.7536
353 object 1 0.5596
353 occipital 1 0.5159
353 ocular 1 0.5159
353 ophthalmic 1 0.6785
353 palsies 1 0.7536
353 paralysis 1 0.5596
353 patients 1 0.1812
353 persistent 1 0.5793
353 predominant 1 0.5793
353 present 2 0.4963
353 profound 1 0.5159
353 prolonged 1 0.3625
353 recognition 1 0.5046
353 resulting 1 0.3839
353 showing 1 0.4943
353 signs 1 0.4202
353 spatial 2 1.357
353 suggests 1 0.4025
353 symptoms 3 1.0714
353 twelve 1 0.4764
353 unilateral 1 0.4066
353 visual 3 1.2329
353 voluntary 1 0.7536
354 1774. 1 1.5073
354 amblyopias 1 1.5073
354 appraisal 1 1.5073
354 author 1 0.8832
354 basis 1 0.6597
354 capability 1 1.2691
354 central 1 0.8133
354 clinical 1 0.4913
354 comprehensible 1 1.5073
354 constitutes 1 1.1192
354 defects 1 0.831
354 determination 1 0.9221
354 easily 1 0.97
354 efficiency 1 1.1192
354 field, 1 1.5073
354 function 2 1.3526
354 haemianopias, 1 1.5073
354 measure 1 0.8716
354 method 1 0.5987
354 nystagmus. 1 1.5073
354 ocular 1 1.0318
354 paracentral 1 1.5073
354 question 1 1.1192
354 reading 1 1.1192
354 reading, 1 1.357
354 reading. 1 1.5073
354 recommends 1 1.5073
354 senso-motor 1 1.5073
354 speed 2 2.7139
354 spontaneous 1 0.8716
354 squint 1 1.5073
354 supplementation 1 1.5073
354 test 2 1.3038
354 tests. 1 1.0318
354 value 1 0.6944
354 visual 1 0.8219
355 1303. 1 0.3349
355 active 1 0.1543
355 affirmed 1 0.3349
355 agnosia 4 1.0299
355 agnosia. 1 0.3349
355 also 3 0.2811
355 always 1 0.1789
355 ancient 1 0.3349
355 aspects 1 0.189
355 assessment 1 0.2243
355 asthenopia. 1 0.3349
355 bay's 1 0.3349
355 case 1 0.1203
355 center 1 0.2155
355 comprehensive 1 0.2682
355 concept 1 0.2019
355 critical 1 0.2243
355 criticized. 1 0.3349
355 data. 1 0.2575
355 dealt 1 0.2682
355 decidedly 1 0.3349
355 degrees 1 0.2117
355 denies 1 0.3349
355 described 1 0.127
355 description 1 0.2197
355 discussions, 1 0.3349
355 disorder, 1 0.2682
355 disorders 1 0.1913
355 disorders, 1 0.2413
355 disturbance. 1 0.2575
355 disturbances 1 0.199
355 disturbed, 1 0.3015
355 especially 1 0.1722
355 existence 1 0.2049
355 fact 1 0.1771
355 given. 1 0.2575
355 gnostic 1 0.3015
355 higher 1 0.144
355 impressions. 1 0.3349
355 instance, 1 0.2682
355 intellectual 1 0.2243
355 interpretation 1 0.2243
355 involved. 2 0.5149
355 isolated 1 0.1457
355 leading 1 0.2082
355 led 1 0.1963
355 levels 1 0.1312
355 literature 1 0.1827
355 localized 1 0.2349
355 lower 1 0.1523
355 metamorphopsia 1 0.3349
355 modern 1 0.2487
355 mostly 1 0.2349
355 neurophysiological 1 0.282
355 normal 1 0.0901
355 often 1 0.1624
355 older 1 0.2082
355 original 1 0.1913
355 passive, 1 0.3349
355 patients 1 0.0805
355 perception 6 1.6091
355 phenomenon 1 0.1937
355 phenomenon. 1 0.3349
355 prestriate 1 0.3349
355 problem 2 0.3825
355 process, 1 0.3015
355 psychological 1 0.2117
355 pure 1 0.2155
355 rare 1 0.199
355 separate 1 0.2117
355 subjective 1 0.2682
355 theories 1 0.2349
355 various 1 0.1324
355 view, 1 0.3015
355 visual 9 1.6439
355 with. 1 0.3015
355 world 1 0.2487
356 'bends'), 1 1.0048
356 'chokes'), 1 1.0048
356 (psig). 1 1.0048
356 (the 2 1.4923
356 1,516 1 1.0048
356 100% 1 0.8046
356 2496. 1 1.0048
356 26.8 1 1.0048
356 3 1 0.3425
356 62 1 0.8046
356 ameliorated 1 1.0048
356 among 1 0.4694
356 avoided 1 0.9046
356 case 1 0.361
356 classic 1 0.7724
356 common 1 0.4909
356 compressions 1 1.0048
356 could 1 0.361
356 decompression 3 2.2385
356 decompressions 1 1.0048
356 distress 1 0.8046
356 dysbarism 1 1.0048
356 dysesthesias 1 1.0048
356 ears 1 0.9046
356 effect. 1 0.6591
356 effects 1 0.373
356 encountered 1 0.6352
356 episodes 1 0.7724
356 exposed 1 0.5262
356 exposure 1 0.5969
356 extremity 1 0.8046
356 fleeting 1 1.0048
356 forced 1 0.9046
356 gauge 1 0.9046
356 hemianopsia. 1 1.0048
356 homonymous 1 0.7462
356 hyperbaric 2 1.6091
356 ill 1 0.7724
356 inch 1 0.8046
356 increase 1 0.3413
356 inhalation 1 0.7462
356 insufflation 1 0.9046
356 may 1 0.2513
356 medical 1 0.5969
356 mild 1 0.6591
356 nostrils 1 1.0048
356 obtained 1 0.3582
356 occluded. 1 1.0048
356 occurred 1 0.4372
356 often 1 0.4871
356 oxygen 1 0.5119
356 pain 1 0.6591
356 pains 1 1.0048
356 per 1 0.3916
356 permanent 1 0.7724
356 personnel 2 1.6922
356 pounds 1 0.9046
356 pressures 1 0.6591
356 pulmonary 1 0.4296
356 rarely, 1 1.0048
356 reduction 1 0.4948
356 require 1 0.6879
356 revealed 1 0.4871
356 serious 1 0.6056
356 sickness 1 0.9046
356 sinuses 1 0.8461
356 skin 1 0.5969
356 square 1 0.8461
356 stops 1 0.8461
356 substernal 1 1.0048
356 survey 1 0.7048
356 symptom 1 0.7048
356 symptoms 3 1.4285
356 technique 1 0.4727
356 time 1 0.3541
356 transient 1 0.6879
356 treatment. 1 0.5313
356 valsalva 1 0.9046
356 without 1 0.3795
357 'visual 1 1.0048
357 (dynamic 1 1.0048
357 (static 1 1.0048
357 (with 1 0.7724
357 2, 1 0.6879
357 2996. 1 1.0048
357 2nd 1 0.724
357 able 1 0.5669
357 adults 1 0.6056
357 agnosia 2 1.5448
357 agnosic 1 1.0048
357 alexia 1 0.9046
357 alexia)'. 1 1.0048
357 angioma. 1 1.0048
357 considered 1 0.448
357 developed 1 0.4568
357 identify 1 0.9046
357 involve 1 0.724
357 left 1 0.4538
357 letter 1 1.0048
357 letters 1 1.0048
357 literal 2 2.0097
357 lobe 1 0.6879
357 lobes 1 0.8461
357 material 1 0.4661
357 method) 1 1.0048
357 method). 1 0.9046
357 nonexistent 1 1.0048
357 occipital 2 1.3758
357 one 1 0.2811
357 pathology 1 0.6728
357 patient 3 1.1335
357 poor 1 0.5811
357 predominance 1 0.8046
357 recognition 1 0.6728
357 reference 1 0.554
357 removal 1 0.5603
357 report 1 0.4871
357 right-handed 1 0.9046
357 simply 1 0.8461
357 slowly 1 0.6879
357 special 1 0.5313
357 static 1 0.9046
357 surgical 1 0.4538
357 them, 1 0.9046
357 vascular 1 0.554
357 viewed 1 0.8461
357 visual 1 0.548
358 'agnosic' 2 1.5073
358 'spatial' 1 0.7536
358 (a) 1 0.485
358 (b) 1 0.485
358 (c) 1 0.5286
358 1388. 1 0.7536
358 3 1 0.2569
358 account 1 0.4252
358 adaptation 1 0.5793
358 adaptation, 1 0.6346
358 afferences. 1 0.7536
358 affirm 1 0.7536
358 agnosia 2 1.1586
358 allow 1 0.5286
358 also 1 0.2108
358 alteration 2 0.9887
358 altered 2 0.805
358 always 2 0.805
358 among 1 0.352
358 apparent, 1 0.6785
358 aspects 2 0.8503
358 associated 1 0.2676
358 association 2 0.8133
358 attached 1 0.5596
358 attention 1 0.485
358 authors 3 1.0416
358 avoid 1 0.5596
358 basis 1 0.3299
358 behaviour 2 1.2069
358 behaviour. 1 0.6785
358 behind 1 0.6034
358 bound 1 0.5159
358 called 1 0.543
358 cannot 1 0.4066
358 capacity 1 0.411
358 carried 1 0.3773
358 cases 4 0.8969
358 categories 1 0.5596
358 centrifugal 1 0.7536
358 changes 3 0.6765
358 changes, 1 0.6034
358 chiefly, 1 0.7536
358 classical 1 0.5286
358 clinical 1 0.2457
358 clinico-pathogenetical 1 0.7536
358 closely 1 0.4303
358 complementary 2 1.2069
358 complex 1 0.4358
358 complexity 1 0.6346
358 concept 2 0.9083
358 confronted 1 0.7536
358 congruous 1 0.7536
358 connection 1 0.543
358 considerations 1 0.5159
358 convenient 1 0.6785
358 corresponding 2 0.8832
358 cortex 1 0.4155
358 cortical 2 0.97
358 darkness 1 0.7536
358 data 1 0.3069
358 deem 1 0.7536
358 deficit 1 0.7536
358 deficits 1 0.5596
358 detected 1 0.3909
358 determinant 1 0.6785
358 determine 1 0.4252
358 dichotomy 1 0.7536
358 discuss 1 0.6785
358 dissolution 1 0.7536
358 distinct 1 0.4685
358 disturbances 3 1.3431
358 divide 1 0.6346
358 due 1 0.2666
358 dynamic 1 0.6034
358 dynamics 1 0.6034
358 errors 1 0.5286
358 evaluate 1 0.5596
358 every 1 0.4202
358 explained 1 0.4252
358 exploration 2 1.2691
358 extinction, 1 0.7536
358 fact 1 0.3985
358 factors 2 0.6372
358 features 1 0.4025
358 findings, 1 0.6034
358 fit 1 0.6785
358 flicker 1 0.7536
358 fluctuation, 1 0.7536
358 function 3 1.0144
358 functional 2 0.9528
358 functionality 1 0.7536
358 functions 2 0.9369
358 functions; 1 0.7536
358 fusion, 1 0.7536
358 grounds 1 0.7536
358 half-body 1 0.7536
358 hand, 1 0.4542
358 hemianopia 1 0.485
358 homolateral 1 0.7536
358 identity. 1 0.6785
358 implied 1 0.6346
358 importance 1 0.3839
358 indispensable 1 0.7536
358 information 2 0.8133
358 innervation 1 0.7536
358 instrumentally 1 0.7536
358 interfere 1 0.5596
358 intervene 1 0.7536
358 it. 1 0.5159
358 kinesthetic 1 0.7536
358 laid 1 0.6346
358 lateral 1 0.5046
358 latest 1 0.6785
358 latter, 1 0.6785
358 less 1 0.2821
358 light 2 0.8503
358 local 1 0.4542
358 loss 1 0.3653
358 make 1 0.4477
358 may 3 0.5654
358 means. 1 0.6785
358 mechanisms, 1 0.6785
358 mechanisms; 1 0.6785
358 methods 3 1.021
358 modern 1 0.5596
358 motility 1 0.6785
358 movement, 1 0.6785
358 must 1 0.3682
358 nearly 1 0.4611
358 neurophysiological 1 0.6346
358 numerous 1 0.4477
358 objects, 1 0.7536
358 obtain 1 0.5286
358 ocular 1 0.5159
358 often 1 0.3653
358 only, 1 0.6034
358 onset 1 0.4358
358 optic 1 0.5159
358 organs 2 0.831
358 original 1 0.4303
358 particular 2 0.7611
358 pathogenetic 1 0.5793
358 pathogenetical 2 1.5073
358 pathological 1 0.4066
358 pathology 1 0.5046
358 pathology. 1 0.7536
358 perception 4 2.4137
358 perceptive 1 0.7536
358 phenomena 1 0.5286
358 phenomenology. 1 0.7536
358 physiology 1 0.5596
358 possible 2 0.6046
358 practical 1 0.485
358 present 1 0.2481
358 processes, 1 0.5596
358 proprioceptive 1 0.7536
358 proprioceptivity, 1 0.7536
358 proprioceptivity; 1 0.7536
358 psychological 1 0.4764
358 quite 1 0.4303
358 real 1 0.6346
358 receptors, 1 0.7536
358 recognition. 1 0.7536
358 recognize 1 0.5793
358 recptors 1 0.7536
358 reflected 1 0.5596
358 related 1 0.3186
358 responsible 1 0.3805
358 semeiological 3 2.2609
358 sensation 1 0.6346
358 sense 2 1.1586
358 sensorial 4 3.0145
358 show 1 0.326
358 significance 2 0.8219
358 since 1 0.3279
358 somatic 1 0.5793
358 spatialization 1 0.7536
358 sphere. 1 0.7536
358 stimuli. 1 0.6346
358 stress 1 0.5159
358 strictly 1 0.6785
358 studies 1 0.2308
358 suitability. 1 0.7536
358 suitable 2 0.97
358 survey 1 0.5286
358 symbolic 1 0.6034
358 tachistoscopy 1 0.6785
358 temporalization 1 0.7536
358 term 1 0.4202
358 therefore 1 0.4611
358 thus 1 0.3909
358 time, 1 0.4358
358 traditional 1 0.6785
358 undamaged. 1 0.7536
358 unison. 1 0.7536
358 vestibular 1 0.6785
358 vision 1 0.6034
358 visual 4 1.6439
358 well 1 0.2636
358 which, 1 0.543
359 (japanese) 1 0.6785
359 19 1 0.5046
359 2 3 0.6903
359 2568. 1 0.7536
359 3 1 0.2569
359 4 1 0.2666
359 accorded 1 0.7536
359 acuity 1 0.6785
359 analyzed. 1 0.5286
359 aneurysm. 1 0.7536
359 case 2 0.5415
359 cases 4 0.8969
359 cases, 1 0.3946
359 cases. 1 0.3946
359 caused 2 0.6597
359 central 1 0.4066
359 clinical 2 0.4913
359 cogwheel 1 0.7536
359 could 1 0.2708
359 defect 1 0.3711
359 defects 1 0.4155
359 deterioration 1 0.6346
359 died. 1 0.6785
359 etiological 1 0.5793
359 evidence 1 0.2763
359 eyeball. 1 0.7536
359 factor 1 0.3571
359 fairly 1 0.543
359 favorable 1 0.5159
359 field 2 0.8954
359 fields 1 0.6034
359 findings 1 0.2994
359 found 1 0.1984
359 frequently 1 0.3805
359 generally 1 0.4477
359 good 1 0.4202
359 hand 1 0.6034
359 hemianopia 3 1.455
359 hemianoptic 3 2.2609
359 hypertrophy 1 0.3985
359 hypophyseal 1 0.6346
359 identified 1 0.4416
359 incongruity 1 0.7536
359 lesion, 1 0.6785
359 lesion. 3 1.8103
359 lesions 1 0.3241
359 lesions. 1 0.5159
359 lobe 3 1.5477
359 macular 1 0.7536
359 mianopsia, 1 0.7536
359 movement 1 0.5793
359 nervous 1 0.4611
359 nystagmus 1 0.6034
359 observation 1 0.3946
359 observations 1 0.3168
359 observed 1 0.2569
359 occipital 3 1.5477
359 occurred 2 0.6558
359 one 3 0.6325
359 optic 1 0.5159
359 optokinetic 1 0.6785
359 parietal 1 0.5596
359 parieto-occipital 1 0.6785
359 patient 1 0.2834
359 patients 1 0.1812
359 perfect 1 0.7536
359 period 1 0.2859
359 positive 2 0.805
359 pregnancy. 1 0.5596
359 present 1 0.2481
359 prism 1 0.7536
359 prognosis 1 0.4155
359 prognosis, 1 0.6785
359 proved 1 0.4202
359 recovery 1 0.4155
359 remained 1 0.4303
359 remaining 1 0.3839
359 results 1 0.2158
359 series 1 0.3546
359 showed 1 0.2686
359 sign, 1 0.7536
359 sparing 1 0.7536
359 stationary 1 0.7536
359 subjects. 1 0.4611
359 suggest 1 0.3426
359 symptomatic 1 0.5286
359 taken 1 0.4252
359 tract 1 0.4358
359 tumor 1 0.336
359 tumors. 1 0.4943
359 vascular 2 0.831
359 visual 2 0.8219
359 vital 1 0.5596
359 wilbrand's 1 0.7536
359 years. 1 0.4764
360 1384. 1 1.5073
360 angiography 2 2.5382
360 angiography. 1 1.5073
360 artery 2 1.7214
360 authors 1 0.6944
360 beside 1 1.357
360 campimetry 2 2.7139
360 carotid 2 1.9773
360 case 1 0.5415
360 cerebral 2 1.4285
360 hemianopia 1 0.97
360 homonymous 1 1.1192
360 importance 2 1.5356
360 lateral 1 1.0091
360 posterior 2 1.7663
360 presented 1 0.5847
360 report 1 0.7306
360 stress 1 1.0318
360 thrombosis 2 2.7139
360 vertebral 2 2.7139
361 375. 1 0.7536
361 addition 1 0.3839
361 also 1 0.2108
361 although 1 0.2897
361 always 1 0.4025
361 author 1 0.4416
361 basal 1 0.4943
361 basis 1 0.3299
361 bibliographic 1 0.7536
361 binasal 3 2.0354
361 cannot 2 0.8133
361 carried 1 0.3773
361 case. 1 0.5793
361 cases 2 0.4484
361 cerebral 1 0.3571
361 certain 2 0.6637
361 clarified 1 0.7536
361 clearly 1 0.4542
361 condition 1 0.4025
361 consideration 1 0.4943
361 constitutes 1 0.5596
361 defect 2 0.7423
361 defects 1 0.4155
361 defined 1 0.5159
361 detachment, 1 0.6785
361 development 2 0.5503
361 diagnostic 1 0.3742
361 direct 1 0.3546
361 discussion 1 0.4542
361 due 1 0.2666
361 established 1 0.4066
361 etc. 1 0.6346
361 even 1 0.3299
361 event 1 0.6346
361 exact 1 0.543
361 example 1 0.6034
361 experiences 1 0.5046
361 extent, 1 0.6785
361 field 3 1.3431
361 following 1 0.2498
361 former 1 0.5159
361 found 1 0.1984
361 glaucoma 4 3.0145
361 glaucoma, 2 1.5073
361 glaucoma. 3 2.2609
361 glaucomatous 2 1.5073
361 gradual 1 0.5596
361 hemianopic 1 0.5793
361 hemianopsia 3 1.8103
361 hemianopsia, 2 1.5073
361 hemianopsias 3 2.2609
361 homonymous 2 1.1192
361 however, 1 0.2729
361 impairment 1 0.4943
361 incident. 1 0.6785
361 independent 1 0.4542
361 individual 1 0.3985
361 lesser 1 0.5159
361 likewise 1 0.6034
361 measures 1 0.4943
361 nasal 1 0.5286
361 neuritis, 1 0.7536
361 observations 1 0.3168
361 obviously 1 0.6346
361 occasionally 1 0.5046
361 occur, 1 0.7536
361 occurrence 1 0.4477
361 older 1 0.4685
361 out, 1 0.6346
361 out. 1 0.5793
361 patient 1 0.2834
361 patients, 1 0.3773
361 perimetry, 1 0.7536
361 place 1 0.4611
361 plays 1 0.5793
361 pointed 1 0.6785
361 points 1 0.5159
361 presence 1 0.2871
361 radical 1 0.5793
361 rare 1 0.4477
361 rate 1 0.2774
361 references 1 0.6346
361 relation 1 0.3472
361 repeated 1 0.4477
361 result 1 0.326
361 retinal 1 0.5596
361 role 2 0.6992
361 ruled 1 0.6346
361 simultaneous 2 0.9221
361 states 1 0.5159
361 subjected 1 0.411
361 sudden 1 0.485
361 supervenes 1 0.7536
361 symptom 1 0.5286
361 take 1 0.5159
361 taken 1 0.4252
361 therapeutic 1 0.3805
361 vessels 1 0.543
361 visual 3 1.2329
361 whether 2 0.7483
361 yet. 1 0.6785
362 1131. 1 0.6029
362 2 1 0.1841
362 7 1 0.2778
362 9 1 0.3157
362 accurate 1 0.3689
362 acute 1 0.2993
362 attention 1 0.388
362 beyond 1 0.4127
362 cases 2 0.3588
362 complete 1 0.2797
362 conjugate 3 1.4482
362 described 1 0.2287
362 diagnosis 1 0.2481
362 diagnosis. 1 0.4037
362 direction 1 0.4229
362 disorders 2 0.6886
362 dissociated 1 0.5428
362 drawn 1 0.4477
362 even 1 0.2639
362 extend 1 0.5428
362 extended 1 0.4634
362 finger, 1 0.6029
362 follow 1 0.4827
362 frontal 1 0.4634
362 functions 1 0.3748
362 hand-in-hand 1 0.6029
362 hemianopia 2 0.776
362 hemianopic 1 0.4634
362 inability 1 0.4344
362 led 1 0.3533
362 lesions 3 0.7778
362 level 1 0.2328
362 movement 1 0.4634
362 movements 1 0.4477
362 movements. 1 0.6029
362 moving 1 0.6029
362 never 1 0.3955
362 normal. 1 0.3633
362 observed 1 0.2055
362 occipital 1 0.4127
362 ocular 2 0.8255
362 oculomotor 2 1.2058
362 oedema 1 0.5428
362 optic 1 0.4127
362 paresis 5 3.0145
362 parietal 1 0.4477
362 parieto-occipital 2 1.0856
362 pathway 1 0.4827
362 patients 3 0.4348
362 persisted. 1 0.5428
362 presence 1 0.2297
362 quite 1 0.3443
362 receded 1 0.6029
362 referred 1 0.3581
362 region 1 0.4037
362 region. 2 1.0153
362 remaining 1 0.3071
362 side 1 0.3401
362 significance 1 0.3288
362 stated 1 0.6029
362 symptomatology 1 0.4127
362 topical 2 1.0153
362 type 1 0.2507
362 unobserved 1 0.6029
362 vascular 1 0.3324
362 verbally 1 0.5428
363 2333. 1 1.0048
363 6 1 0.4202
363 anomalous 3 2.5382
363 binasal 2 1.8093
363 binocular 1 1.0048
363 binocularity 1 1.0048
363 bitemporal 2 1.4923
363 complete 1 0.4661
363 concept 1 0.6056
363 contrary 1 0.7048
363 correspondence 2 1.8093
363 correspondence. 1 1.0048
363 demonstrate 1 0.5811
363 esotropes 1 1.0048
363 exotropes 1 1.0048
363 function 1 0.4509
363 hemianopia 1 0.6466
363 patients 1 0.2415
363 peripheral 1 0.5969
363 prevailing 1 0.9046
363 references. 1 1.0048
363 retina 1 0.8461
363 retinal 3 2.2385
363 suppression 1 0.6466
363 suppression. 1 1.0048
363 tested 1 0.6056
363 vision; 1 1.0048
364 1 1 0.1423
364 19 1 0.2523
364 2 4 0.4602
364 2120. 1 0.3768
364 3 1 0.1284
364 4 2 0.2666
364 5 2 0.2859
364 6-thioguanine 1 0.3768
364 action 1 0.1639
364 agents 2 0.4066
364 angiitis, 1 0.3768
364 assessment 1 0.2523
364 atopic 1 0.3392
364 attributable 1 0.258
364 autoimmune, 1 0.3392
364 benefit. 1 0.3768
364 certain 1 0.1659
364 clinical 1 0.1228
364 conventional 1 0.2715
364 debilitating 1 0.3768
364 dermatomyositis 1 0.3768
364 discussed. 1 0.1611
364 disease 1 0.1354
364 disease. 1 0.1992
364 diseases 2 0.411
364 diverse 1 0.3017
364 drug 1 0.1973
364 effectiveness 1 0.2643
364 equivocal 1 0.3768
364 erythematosus, 1 0.3173
364 evaluated 1 0.2179
364 eventual 1 0.3392
364 experienced 1 0.2798
364 hypotheses 1 0.2897
364 immunologic 1 0.2472
364 improvement 1 0.2523
364 lupus 1 0.2472
364 mechanism 1 0.1736
364 necrotizing 1 0.3768
364 neurodermatitis. 1 0.3768
364 observed 1 0.1284
364 occurred 2 0.3279
364 past 1 0.2643
364 patient 1 0.1417
364 patients 8 0.7246
364 patients. 1 0.1813
364 psoriasis 1 0.3392
364 regarding 1 0.2382
364 related 1 0.1593
364 remissions 1 0.2798
364 requires 1 0.2305
364 response 1 0.1376
364 scleroderma 1 0.3768
364 severe 1 0.167
364 significance 1 0.2055
364 significant 1 0.1323
364 study. 1 0.2472
364 syndromes. 1 0.3768
364 systemic 1 0.2101
364 therapeutic 1 0.1903
364 therapy 2 0.2979
364 thioguanine 1 0.3768
364 toxicity 1 0.2472
364 treated. 1 0.3017
364 treatment 1 0.1112
364 two 1 0.1154
364 unresponsive 1 0.3768
364 value 1 0.1736
364 years 1 0.1713
365 (japanese) 1 0.6785
365 (pn) 1 0.7536
365 (sle), 1 0.7536
365 161 1 0.7536
365 2469. 1 0.7536
365 accordingly 1 0.6785
365 affected 1 0.3909
365 also 1 0.2108
365 arises 1 0.6346
365 auto-immune 1 0.6346
365 auto-immunization 1 0.7536
365 autopsy 1 0.4943
365 become 1 0.4155
365 becomes 2 0.9083
365 cases 2 0.4484
365 collagen 2 1.2069
365 conceivable 1 0.7536
365 consider 1 0.5286
365 considered 1 0.336
365 disease 1 0.2708
365 disease, 1 0.4025
365 diseases 1 0.411
365 diseases, 1 0.6346
365 elucidation 1 0.7536
365 end 1 0.4611
365 entity. 1 0.7536
365 equal 1 0.4943
365 erythematosus 1 0.543
365 examination 1 0.3805
365 exhaustion 1 0.7536
365 fever 1 0.543
365 hidden 1 0.6785
365 hyperergic 1 0.7536
365 hypersensitivity 1 0.5596
365 important 1 0.3403
365 key 1 0.6034
365 lesions 1 0.3241
365 less 1 0.2821
365 lie 1 0.6785
365 localization 1 0.5286
365 lower, 1 0.6785
365 lupus 1 0.4943
365 manifestation 1 0.5286
365 many 1 0.3038
365 may 4 0.7539
365 moreover, 1 0.4943
365 morphological 1 0.4611
365 myco.tb 1 0.7536
365 nature 1 0.3742
365 nature, 1 0.6034
365 nephritis, 1 0.6346
365 nephrosis 1 0.7536
365 nodosa 1 0.6346
365 occurring 1 0.4358
365 one 1 0.2108
365 organs 1 0.4155
365 organs. 1 0.543
365 parasepsis, 1 0.7536
365 particular 1 0.3805
365 particularly 1 0.4155
365 phenomenon 1 0.4358
365 pn,pss,dm 1 0.7536
365 polyarteritis 1 0.6785
365 problem. 1 0.6034
365 process 1 0.3449
365 prolonged 2 0.725
365 pronounced 1 0.4477
365 rather 1 0.3546
365 reactability 1 0.7536
365 reactivity 1 0.5793
365 reference 1 0.4155
365 regarded 1 0.4685
365 renal 1 0.2924
365 results 1 0.2158
365 rheumatic 1 0.5793
365 rheumatism. 1 0.7536
365 sensitization 1 0.5046
365 sensitization. 1 0.7536
365 separate 1 0.4764
365 showing 1 0.4943
365 significant 1 0.2646
365 sle 2 1.2691
365 sle-like 2 1.5073
365 sle. 1 0.6785
365 special 1 0.3985
365 specific 2 0.593
365 stage 1 0.3653
365 state 1 0.3874
365 supposed 1 0.6034
365 symptomatology 1 0.5159
365 syndrome 2 0.6992
365 systemic 1 0.4202
365 therefore 1 0.4611
365 whether 2 0.7483
366 (leupurin) 1 1.0048
366 2 1 0.3068
366 4 1 0.3554
366 420. 1 1.0048
366 5 1 0.3811
366 6 1 0.4202
366 6-mercaptopurine 1 0.8046
366 6-mp 1 1.0048
366 accordingly 1 0.9046
366 actually 1 0.7724
366 cases 3 0.8969
366 cause 1 0.4538
366 consecutive 1 0.7048
366 considered 1 0.448
366 corticosteroid 1 0.7048
366 death. 1 0.8046
366 definite 2 1.3758
366 detectable 1 0.6352
366 effect 1 0.3068
366 elevation, 1 1.0048
366 emphasized 1 0.8046
366 general 1 0.5119
366 hopeless. 1 1.0048
366 improved 1 0.6728
366 lupus 1 0.6591
366 main 1 0.5738
366 method 1 0.3992
366 nephropathies 1 1.0048
366 nephropathy 2 1.6091
366 new 1 0.4398
366 npn 1 1.0048
366 presented 1 0.3898
366 produced 1 0.4092
366 prognosis 1 0.554
366 purinethol 1 1.0048
366 remission. 1 0.9046
366 remissions 1 0.7462
366 reported 1 0.4072
366 severe 1 0.4452
366 sle, 1 0.9046
366 therapeutic 1 0.5074
366 therapy 2 0.7945
366 total 1 0.3916
366 using 1 0.4568
367 2475. 1 1.0048
367 albumin 1 0.7048
367 associated 1 0.3568
367 auto-immune 1 0.8461
367 case 1 0.361
367 characteristics 1 0.5603
367 complement, 1 0.9046
367 complement. 1 0.9046
367 complex 1 0.5811
367 conclusion 1 0.6728
367 demonstrated 1 0.4296
367 disease 1 0.361
367 done 1 0.6728
367 erythematosus 3 2.1719
367 established 1 0.5422
367 explore 1 0.9046
367 fatal 2 1.3455
367 fibrinogen 1 0.7724
367 firmly 1 0.8046
367 glomeruli 1 0.9046
367 hemorrhage 2 1.2933
367 histologic 1 0.6728
367 human 1 0.3354
367 hypertension. 1 0.8461
367 immuno-fluorescent 1 1.0048
367 immunocytochemical 2 2.0097
367 immunological 2 1.2492
367 lesions 2 0.8642
367 lesions. 1 0.6879
367 liver 1 0.3953
367 lupus 3 1.9773
367 malignant 1 0.548
367 mechanisms 1 0.6056
367 nodosa 2 1.6922
367 observations 1 0.4225
367 operative. 1 1.0048
367 periarteritis 2 1.8093
367 possibility 1 0.5738
367 presented. 1 0.5888
367 primarily 1 0.6352
367 renal 1 0.3898
367 resembling 1 0.7724
367 serum 1 0.3898
367 studies 1 0.3077
367 techniques 1 0.548
367 type. 1 0.6728
367 vascular 2 1.108
367 y-globulin 1 0.9046
367 y-globulin, 1 1.0048
368 'relatively 1 0.3768
368 'standard' 1 0.3768
368 'very 1 0.3768
368 (anorexia, 1 0.3768
368 1 4 0.5692
368 10 3 0.4161
368 198. 1 0.3768
368 2 5 0.5753
368 2,'moderately 1 0.3768
368 3 1 0.1284
368 4-6 1 0.3392
368 7 1 0.1736
368 8 4 0.6807
368 absence 1 0.1799
368 accompanied 1 0.2101
368 additional 1 0.2012
368 adjunct 1 0.2897
368 administered 1 0.1799
368 administration 3 0.4978
368 adrenal 2 0.4477
368 alopecia 1 0.3768
368 amelioration 1 0.3392
368 and, 1 0.1955
368 apparent 1 0.1973
368 arthritis 1 0.3017
368 associated 1 0.1338
368 azathioprine 8 2.5382
368 azathioprine, 1 0.3768
368 azathioprine. 1 0.3768
368 basis 1 0.1649
368 beneficial 2 0.5286
368 cannot 1 0.2033
368 careful 1 0.2382
368 caution 1 0.3017
368 circumstances 1 0.3017
368 cirrhosis 1 0.2643
368 classified 1 0.2271
368 clinical 1 0.1228
368 colitis 3 1.1304
368 colitis, 1 0.3392
368 colitis. 1 0.3173
368 concurrent 1 0.2897
368 conjunction 1 0.2897
368 considered 1 0.168
368 controlled 1 0.2152
368 corticosteroids 1 0.2523
368 corticosteroids. 1 0.3392
368 corticotropin 1 0.3173
368 course 2 0.3426
368 definitively 1 0.3768
368 delayed 1 0.2208
368 developed 2 0.3426
368 discernible 1 0.3768
368 discomfort, 1 0.3768
368 discontinuance 1 0.3392
368 dosage 1 0.2271
368 early 1 0.1381
368 effect 1 0.1151
368 effects 3 0.4196
368 epigastric 1 0.3768
368 especially 1 0.1937
368 established 1 0.2033
368 evaluated 1 0.2179
368 exert 1 0.3173
368 experiences 1 0.2523
368 favorable 2 0.5159
368 following 1 0.1249
368 gangrenosum 1 0.3768
368 gastro-intestinal 1 0.3173
368 hematopoietic 1 0.3173
368 hepatitis. 1 0.3017
368 however, 1 0.1365
368 hypersensitivity 1 0.2798
368 immuno-suppressive 1 0.3768
368 improvement 1 0.2523
368 individuals, 1 0.2897
368 initial 1 0.1826
368 intensive 1 0.2798
368 kidneys 1 0.2101
368 leukopenia 1 0.3768
368 leukopenia. 1 0.3768
368 level 1 0.1455
368 limited. 1 0.3392
368 liver 1 0.1483
368 maintained 1 0.2101
368 may 1 0.0942
368 medication 1 0.3017
368 medication, 1 0.3392
368 medication. 1 0.3392
368 mg/kg/day. 1 0.3768
368 mild 1 0.2472
368 mild' 1 0.3768
368 moderate 1 0.2238
368 moderately 1 0.2715
368 nausea) 1 0.3768
368 note 1 0.3017
368 noted 1 0.1992
368 observations 1 0.1584
368 observations, 1 0.3392
368 observations. 1 0.3392
368 occurred 3 0.4918
368 patient, 2 0.4943
368 patients 2 0.1812
368 patients, 3 0.566
368 patients. 2 0.3625
368 patients; 1 0.2798
368 permitting 1 0.3768
368 possible 1 0.1512
368 postnecrotic 1 0.3768
368 preliminary 1 0.2152
368 prevention 1 0.258
368 probably 1 0.1713
368 prolonged 2 0.3625
368 pyoderma 1 0.3768
368 rapid 1 0.1826
368 reflected 1 0.2798
368 requiring 1 0.2715
368 respond 1 0.2305
368 response, 1 0.2798
368 series 1 0.1773
368 serum 1 0.1462
368 severe 2 0.3339
368 severe' 2 0.7536
368 skin 1 0.2238
368 small 1 0.1512
368 steroid 2 0.4358
368 steroids 1 0.258
368 supervision 1 0.3392
368 symptoms 1 0.1786
368 temporary 1 0.2715
368 tests, 1 0.2472
368 therapeutic 2 0.3805
368 therapy 3 0.4469
368 therapy. 2 0.4066
368 therefore, 1 0.2382
368 thrombocytopenia. 1 0.3768
368 toxic 1 0.2305
368 toxicity, 1 0.3392
368 trial 1 0.2798
368 ulcerative 5 1.5086
368 unchanged 1 0.2897
368 uncontrolled 1 0.3392
368 undesirable. 1 0.3768
368 upon 1 0.1691
368 use 2 0.2979
368 various 1 0.149
368 within 1 0.1399
368 wk 1 0.3173
368 woman. 1 0.3768
369 1281. 1 1.5073
369 5-fluoro-2'-deoxyuridine 1 1.357
369 5-fluorouracil 1 1.2691
369 51 1 1.5073
369 ability 1 0.7678
369 assessed 1 1.1192
369 carcinoma. 1 1.0318
369 cutaneous 2 3.0145
369 delayed 2 1.7663
369 effect 1 0.4602
369 evidence 1 0.5526
369 express 1 1.2069
369 fluoropyrimidines 1 1.5073
369 hypersensitivity 2 2.2385
369 immune 1 0.97
369 paradoxically 1 1.5073
369 parameter 1 1.1586
369 patients 1 0.3623
369 potentiate 1 1.5073
369 presented 1 0.5847
369 responsiveness. 1 1.5073
370 1 1 0.3795
370 16% 1 1.0048
370 248. 1 1.0048
370 3 1 0.3425
370 304 1 1.0048
370 36% 1 1.0048
370 5 1 0.3811
370 560 2 2.0097
370 8% 1 0.8461
370 age 1 0.4157
370 and, 1 0.5212
370 appetite 1 0.9046
370 ascites 1 0.8046
370 assessments 1 1.0048
370 attention 1 0.6466
370 calculate 1 0.8046
370 cases 1 0.299
370 cases, 1 0.5262
370 chosen 1 0.9046
370 cirrhosis 3 2.1144
370 compiled 1 1.0048
370 condition 1 0.5366
370 data 1 0.4092
370 date 1 0.7462
370 death 1 0.548
370 diagnosis 2 0.827
370 disease 1 0.361
370 eliminating 1 0.8461
370 etiology 1 0.554
370 etiology, 1 0.9046
370 extent 1 0.5313
370 figures 2 1.5448
370 general 1 0.5119
370 hemorrhage 1 0.6466
370 hepatic 1 0.5669
370 however, 1 0.3639
370 improving 1 0.9046
370 known, 1 0.9046
370 large 1 0.3972
370 life 1 0.5313
370 liver 2 0.7907
370 liver. 1 0.7048
370 made. 1 0.6246
370 majority 1 0.6466
370 many 1 0.4051
370 method 1 0.3992
370 modern 1 0.7462
370 morphology. 1 1.0048
370 paid 1 0.7724
370 particular 1 0.5074
370 pathogenesis, 1 0.8461
370 patients 1 0.2415
370 patients' 1 0.9046
370 patients, 1 0.5031
370 period 1 0.3811
370 periods 1 0.5603
370 possible 2 0.8062
370 prolong 1 0.7724
370 prophylaxis 1 0.8046
370 random, 1 1.0048
370 refer 1 0.9046
370 relieve 1 0.7724
370 reports, 1 0.9046
370 results 1 0.2878
370 selection 1 0.6879
370 sex 1 0.6728
370 show 1 0.4346
370 statistics 1 0.9046
370 studying 1 0.7724
370 stupor. 1 1.0048
370 subjects 1 0.4797
370 subjects. 1 0.6148
370 succeeded 1 0.8461
370 suffering 1 0.5969
370 survival 3 1.45
370 survived 1 0.6591
370 therapeutic 1 0.5074
370 therapy 1 0.3972
370 time 3 1.0622
370 total 1 0.3916
370 treatment 1 0.2965
370 victims. 1 1.0048
370 well 1 0.3514
370 year, 1 0.7724
370 years, 1 0.6352
370 years. 1 0.6352
371 897. 1 0.6029
371 affections. 1 0.6029
371 changes 1 0.1804
371 chronic 5 1.4391
371 complications 1 0.3533
371 concluded 1 0.2759
371 diabetic 1 0.4037
371 diagnosis 1 0.2481
371 different 1 0.2133
371 discussed 1 0.2455
371 discussed. 1 0.2578
371 discussion 1 0.3633
371 disease 3 0.6498
371 diseases 1 0.3288
371 due 1 0.2133
371 erythematosus, 1 0.5076
371 following 1 0.1998
371 function 1 0.2705
371 given 1 0.221
371 glomerulonephritis, 1 0.6029
371 important 1 0.2723
371 individually 1 0.4827
371 influence 1 0.2759
371 kidney. 1 0.3748
371 lupus 1 0.3955
371 nephropathy 1 0.4827
371 nephrotic 1 0.4634
371 normal 1 0.1621
371 paper 1 0.3253
371 polycystic 1 0.5428
371 pregnancy 3 1.0598
371 pregnancy, 1 0.4477
371 pregnancy. 1 0.4477
371 pyelonephritis, 1 0.5428
371 reciprocal 1 0.5428
371 relationships 1 0.388
371 renal 5 1.1695
371 review 3 0.9972
371 short 1 0.3487
371 subsequently, 1 0.6029
371 syndrome, 1 0.4037
372 (cmid) 1 1.0048
372 (cmv) 1 1.0048
372 4193. 1 1.0048
372 abnormalities 1 0.5603
372 acute 1 0.4989
372 agents 1 0.5422
372 all, 1 0.7724
372 appear 1 0.4598
372 cases 1 0.299
372 cause 1 0.4538
372 changes 1 0.3007
372 characteristic 1 0.5074
372 chemotherapy 1 0.6148
372 childhood 1 0.5669
372 children 2 0.7136
372 children, 1 0.5888
372 clinical 1 0.3275
372 cmid 1 1.0048
372 cough, 1 1.0048
372 culture 1 0.5031
372 cytomegalic 1 0.8046
372 cytomegalovirus 2 2.0097
372 cytopathogenic 1 0.7724
372 death 1 0.548
372 demonstrable 1 0.6728
372 demonstrated. 1 0.724
372 diarrhea, 1 0.9046
372 disease 1 0.361
372 done 1 0.6728
372 evidence 1 0.3684
372 findings 1 0.3992
372 findings. 1 0.8461
372 following 1 0.3331
372 function 1 0.4509
372 hepatosplenomegaly, 1 1.0048
372 high 1 0.3596
372 icterus. 1 0.8461
372 immunosuppressive 1 0.8046
372 including 1 0.5422
372 inclusion 1 0.6466
372 inclusions 2 1.5448
372 infections 1 0.6591
372 intranuclear 2 1.6091
372 known 1 0.4909
372 late 1 0.5969
372 leukemia 1 0.7724
372 leukemia. 1 1.0048
372 leukemic 1 0.8461
372 liver 1 0.3953
372 neither 1 0.6591
372 occurrence 1 0.5969
372 one 1 0.2811
372 onset 1 0.5811
372 pancytopenia 1 0.8461
372 patients 2 0.4831
372 patients. 1 0.4833
372 persistent 1 0.7724
372 pneumonia 1 0.6728
372 present 1 0.3308
372 presented 1 0.3898
372 properties. 1 1.0048
372 rales, 1 1.0048
372 received 1 0.5669
372 remission. 1 0.9046
372 report 1 0.4871
372 roentgenographic 1 0.9046
372 sediments 1 1.0048
372 seen 1 0.4248
372 sputa. 1 1.0048
372 symptoms. 1 0.7462
372 temperature, 1 0.7724
372 terminal 1 0.724
372 tests 1 0.4948
372 third 1 0.548
372 three 3 1.1335
372 two 2 0.6154
372 urine 2 1.0329
372 virus 1 0.5262
372 vomiting, 1 0.9046
372 week 1 0.6591
373 (sle). 1 1.0048
373 . 1 0.2262
373 10 1 0.3699
373 11 1 0.5366
373 3 1 0.3425
373 33 1 0.7724
373 4 1 0.3554
373 5 1 0.3811
373 6-mercaptopurine. 1 1.0048
373 8 1 0.4538
373 abnormal 1 0.4871
373 administration 1 0.4425
373 aged 1 0.6056
373 arteritis 2 1.6922
373 asymptomatic 1 0.7462
373 autopsied 1 1.0048
373 cases, 1 0.5262
373 cerebral 2 0.9524
373 changes 1 0.3007
373 chorea 3 3.0145
373 chorea, 1 1.0048
373 cns 1 0.7048
373 descriptions 1 0.8461
373 developed 1 0.4568
373 diffuse 1 0.6728
373 due 1 0.3554
373 erythematosus 1 0.724
373 erythematosus, 1 0.8461
373 experienced 1 0.7462
373 extensive 1 0.5669
373 found 1 0.2645
373 found. 1 0.6466
373 interval 1 0.8046
373 lesions 1 0.4321
373 lupus 2 1.3182
373 minor. 1 1.0048
373 movements 1 0.7462
373 mth, 1 1.0048
373 onset 1 0.5811
373 patients 1 0.2415
373 persisted 1 0.7724
373 previous 1 0.5422
373 quite 1 0.5738
373 short-term 1 0.7462
373 similar 1 0.3762
373 sle. 1 0.9046
373 subsided 1 0.8461
373 systemic 1 0.5603
373 woman 1 0.6591
373 yr 1 0.7462
373 yr. 1 0.5262
374 1878. 1 0.6029
374 action. 3 1.5229
374 actions 1 0.388
374 cellular 2 0.6575
374 chapters 1 0.6029
374 comparative 1 0.3689
374 drugs 1 0.3324
374 field 1 0.3581
374 following 1 0.1998
374 homotransplantation 1 0.5076
374 immunity 3 1.3032
374 immunity. 1 0.6029
374 immunologic 1 0.3955
374 immunosuppression. 1 0.6029
374 included 1 0.3253
374 interest 1 0.4037
374 manifestations 1 0.3443
374 pharmacologic 5 3.0145
374 present 1 0.1985
374 processes 1 0.3581
374 reactions 2 0.5891
374 reactivity. 1 0.5428
374 reduced 1 0.2723
374 skin 1 0.3581
374 states 1 0.4127
374 status 1 0.3811
374 susceptibilities 1 0.6029
374 susceptibility 2 0.9269
374 tests 2 0.5938
374 transplantation 1 0.3955
374 tuberculin 2 1.2058
375 (azothioprine) 1 1.5073
375 1 2 1.1384
375 12 1 0.7196
375 2 1 0.4602
375 24 1 0.7819
375 2625. 1 1.5073
375 aberrations 2 2.5382
375 abnormal 1 0.7306
375 abnormalities 1 0.8404
375 among 1 0.7041
375 aspirates 1 1.5073
375 bone 1 0.6519
375 breaks 1 1.357
375 cells 2 0.9098
375 cells. 1 0.672
375 chromatid 2 3.0145
375 chromosomal 1 1.1192
375 chromosome 1 1.0091
375 chromosome. 1 1.5073
375 chromosomes 1 1.2069
375 collagen 1 1.2069
375 counted. 1 1.5073
375 days 1 0.5987
375 diseases 1 0.8219
375 exchanges 1 1.357
375 fifty 1 1.086
375 five 1 0.797
375 following 1 0.4996
375 found 1 0.3968
375 human 1 0.5031
375 imuran 2 2.7139
375 increase 1 0.5119
375 marrow 1 0.7546
375 metaphases 1 1.357
375 mostly 1 1.0572
375 no. 1 1.357
375 nos. 1 1.5073
375 obtained 1 0.5373
375 patient 2 1.1335
375 patients 1 0.3623
375 ring 1 1.357
375 sample 1 1.1192
375 seen 1 0.6372
375 seen, 1 1.2691
375 significant. 1 1.0572
375 start 1 1.2069
375 structural 1 0.97
375 studied. 1 0.8503
375 therapy 1 0.5959
375 therapy. 1 0.8133
375 three 1 0.5667
375 treatment 1 0.4447
375 type. 1 1.0091
375 various 1 0.5959
375 women 1 0.8133
376 25 1 0.5738
376 26 1 0.6352
376 3 1 0.3425
376 30% 1 0.8046
376 301 1 1.0048
376 3645. 1 1.0048
376 69, 1 1.0048
376 90 1 0.7462
376 according 1 0.5422
376 active 2 0.9258
376 adequately 1 0.8046
376 appearances, 1 1.0048
376 attributed 1 0.6728
376 autoimmune 3 2.4137
376 biochemical 1 0.6352
376 cases 3 0.8969
376 cause 1 0.4538
376 characterized 1 0.5313
376 chronic 2 0.9594
376 cirrhosis 1 0.7048
376 cirrhosis, 1 0.9046
376 clinical 1 0.3275
376 comparison 1 0.5212
376 concept 1 0.6056
376 could 1 0.361
376 drugs. 1 0.8046
376 each. 1 0.8461
376 emerged 1 0.8461
376 end 1 0.6148
376 etiological 1 0.7724
376 factors, 1 0.724
376 groups 1 0.4092
376 hepatitis 3 2.0183
376 hepatitis, 1 0.7462
376 hepatitis. 1 0.8046
376 histological 1 0.5969
376 immunosuppressive 1 0.8046
376 individuals 1 0.6879
376 lupoid 2 1.8093
376 made 1 0.3639
376 manifestations, 1 0.8046
376 nourished 1 1.0048
376 occurring 1 0.5811
376 patients 1 0.2415
376 picture 1 0.548
376 possible 1 0.4031
376 proportion 1 0.6246
376 rate, 1 0.7048
376 reaction. 1 0.7462
376 reactions 1 0.4909
376 recognized 1 0.6246
376 relationship 1 0.4833
376 result 1 0.4346
376 results 1 0.2878
376 sle 1 0.8461
376 studied 1 0.3501
376 study 1 0.3096
376 survival 1 0.4833
376 systemic 1 0.5603
376 tests, 1 0.6591
376 uncertain. 1 0.8461
377 (mechlorethamine), 1 0.7536
377 2 1 0.2301
377 2-amino-6-((1-methyl-4-nitro-5-imidazolyl) 1 0.7536
377 5-day 1 0.7536
377 5-fluoro-2'-deoxyuridine 1 0.6785
377 5-fluorouracil, 1 0.7536
377 6-mercaptopurine 1 0.6034
377 6-mercaptopurine, 1 0.6785
377 766. 1 0.6346
377 administration. 1 0.5046
377 affect 1 0.4764
377 agents 1 0.4066
377 agents, 1 0.5596
377 agglutinin 2 1.5073
377 antigen 3 1.3431
377 antimetabolites 1 0.6346
377 appeared 2 0.725
377 before, 1 0.5793
377 beginning, 1 0.7536
377 chlormethine 1 0.7536
377 comparative 1 0.4611
377 comparison 1 0.3909
377 course 1 0.3426
377 cyclophosphamide 2 1.357
377 cytotoxic 2 1.0572
377 days 2 0.5987
377 doses, 1 0.6346
377 drug 3 1.1839
377 effects 2 0.5595
377 erythrocytes 2 1.1192
377 given 4 1.1051
377 immunization 1 0.6034
377 immunized 1 0.543
377 induction 3 1.455
377 injected 1 0.3653
377 intermediate 1 0.485
377 intraperitoneally. 1 0.7536
377 irrespective 1 0.5159
377 made 1 0.2729
377 markedly 1 0.4025
377 maximally 3 2.2609
377 methotrexate, 1 0.6785
377 middle 1 0.6034
377 one 1 0.2108
377 peak 3 1.3074
377 performed 1 0.3449
377 primary 4 1.2744
377 prior 2 0.805
377 prolong 1 0.5793
377 prolonged 2 0.725
377 purine 1 0.6785
377 rats 2 0.5821
377 response 3 0.8255
377 response. 1 0.5286
377 roboside 1 0.7536
377 selected 1 0.4416
377 several 1 0.326
377 sheep 2 1.086
377 significantly. 1 0.5793
377 stage 1 0.3653
377 stages. 1 0.6785
377 study 1 0.2322
377 suppress 3 1.6788
377 suppressed 2 1.0318
377 thio) 1 0.7536
377 three 1 0.2834
377 time 4 1.0622
377 titer 2 1.1192
377 titer, 1 0.7536
377 tolerable 1 0.7536
377 treatment. 3 1.1955
377 vinblastine 1 0.6785
378 ('azaserine') 1 0.3768
378 1,000 1 0.3173
378 100-day 1 0.3768
378 1959. 1 0.3392
378 20 1 0.1702
378 24 1 0.1955
378 50% 1 0.2271
378 50-day 1 0.3768
378 90% 1 0.3017
378 absorbed 1 0.2715
378 absorption 1 0.2342
378 account 2 0.4252
378 action 1 0.1639
378 additional 2 0.4025
378 analyses 1 0.2523
378 analysis 1 0.1813
378 analyzed. 1 0.2643
378 animals 4 0.6408
378 animals, 1 0.2271
378 animals; 1 0.3768
378 antibodies 1 0.2126
378 antigen 1 0.2238
378 apparently 1 0.2055
378 autoimmune 1 0.3017
378 azathioprine 1 0.3173
378 back 2 0.5596
378 bilaterally 1 0.3768
378 competent; 1 0.3768
378 completed 1 0.3017
378 constitutes 1 0.2798
378 continues 2 0.5793
378 current 1 0.2342
378 dammin 1 0.3768
378 days 1 0.1497
378 decrease 1 0.1724
378 diazoacetylserine 1 0.3768
378 different 1 0.1333
378 differentially 1 0.3392
378 disease 1 0.1354
378 documented 1 0.2715
378 dogs 1 0.1955
378 donor 3 0.7929
378 donors 1 0.3017
378 donors, 1 0.3768
378 dose 1 0.1799
378 double 1 0.2472
378 drug 7 1.3812
378 drug-treated 1 0.3768
378 drugs 2 0.4155
378 drugs. 1 0.3017
378 effect 1 0.1151
378 environment 1 0.2523
378 even 1 0.1649
378 explained 1 0.2126
378 female, 1 0.2798
378 fertile 1 0.3768
378 first 2 0.2763
378 following 2 0.2498
378 function; 1 0.3768
378 g. 1 0.2798
378 generalized 1 0.258
378 homografts 5 1.6962
378 homotransplantation 1 0.3173
378 homotransplants. 1 0.3768
378 host 2 0.3909
378 host. 1 0.3017
378 host; 1 0.3768
378 hosts 2 0.6346
378 immune 1 0.2425
378 immunological 1 0.2342
378 immunologically 1 0.3017
378 immunosuppressive 2 0.6034
378 increasing 1 0.2208
378 indicate 1 0.1659
378 j. 1 0.2897
378 kidney 8 1.3357
378 kidney. 1 0.2342
378 kidneys 2 0.4202
378 kidneys, 1 0.2897
378 lead 1 0.2425
378 long 4 0.7819
378 long-term 1 0.2179
378 male 1 0.1919
378 many 1 0.1519
378 mechanism 2 0.3472
378 metabolism 1 0.1786
378 multiple 1 0.2077
378 nephrectomized 1 0.2715
378 new 1 0.1649
378 non-drug 1 0.3768
378 numbers 1 0.2238
378 observations 2 0.3168
378 original 2 0.4303
378 paradoxical 1 0.3768
378 paralysis 1 0.2798
378 party, 1 0.3768
378 permanently. 1 0.3768
378 picture 1 0.2055
378 placed 1 0.2238
378 posed 1 0.3017
378 probably 1 0.1713
378 process. 1 0.2897
378 processes 1 0.2238
378 produce 1 0.2012
378 produced 1 0.1535
378 production 1 0.1919
378 prolonged 3 0.5438
378 protected 1 0.2897
378 protects 1 0.3173
378 protocol 1 0.3173
378 protocols 1 0.3392
378 questions 1 0.2798
378 recipient 1 0.2523
378 recipients; 1 0.3768
378 regarding 1 0.2382
378 regimen 1 0.3392
378 rejected 5 1.6962
378 rejecting 1 0.3768
378 rejection 1 0.2897
378 relationship 1 0.1813
378 renal 2 0.2924
378 results 1 0.1079
378 retransplantation 1 0.3768
378 retransplanted 1 0.3768
378 reveal 1 0.2523
378 second 2 0.3839
378 sensitization 1 0.2523
378 sensitized 1 0.3392
378 separate 1 0.2382
378 shortened. 1 0.3768
378 similar 1 0.1411
378 simultaneously 1 0.2271
378 skin 5 1.1192
378 sometimes 1 0.2425
378 status 1 0.2382
378 stopped 1 0.2897
378 study 1 0.1161
378 successfully 3 0.7739
378 survival 3 0.5438
378 survive; 1 0.3768
378 survives; 1 0.3768
378 surviving 4 1.1192
378 survivors 1 0.2715
378 survivors. 1 0.3392
378 test 1 0.163
378 therapy 2 0.2979
378 third 1 0.2055
378 transplanted 1 0.2715
378 treated 4 0.6202
378 two 1 0.1154
378 universally 1 0.3768
378 variation 1 0.2382
378 way 1 0.2382
378 weaned 1 0.3768
378 within 1 0.1399
379 (acetrizoates, 1 0.5024
379 3083. 1 0.5024
379 ability 1 0.2559
379 administered 1 0.2399
379 agents 6 1.6265
379 agents, 1 0.3731
379 also 1 0.1406
379 and/or 1 0.3176
379 angiography 1 0.423
379 animals. 1 0.2834
379 appear 3 0.6897
379 applications 1 0.3731
379 arterial 1 0.2606
379 authors 1 0.2315
379 bed. 1 0.4523
379 beginning 1 0.3176
379 behave 1 0.423
379 biologically. 1 0.5024
379 blood 1 0.1552
379 cardiovascular 1 0.3176
379 carried 1 0.2515
379 catheterization. 1 0.423
379 causal 1 0.4023
379 caval 1 0.5024
379 changes 1 0.1503
379 chemically 1 0.3731
379 circulation 1 0.2631
379 city 1 0.4523
379 clear 1 0.3028
379 clinical 2 0.3275
379 compound 1 0.3439
379 conclusions 1 0.3176
379 conducted 1 0.3439
379 contrast 4 1.3455
379 coronary 5 1.6166
379 culiar 1 0.5024
379 current 2 0.6246
379 degrees 2 0.6352
379 demand 1 0.4023
379 described 1 0.1906
379 diatrizoates, 1 0.5024
379 differ- 1 0.423
379 different 1 0.1777
379 distention 1 0.5024
379 divergent 1 0.4523
379 dogs, 1 0.3364
379 dominance 1 0.4023
379 effect 1 0.1534
379 electrocardiographic 1 0.4023
379 enhanced 1 0.3123
379 ent 1 0.4523
379 entirely 1 0.3233
379 established. 1 0.423
379 etc.), 1 0.5024
379 examination 1 0.2537
379 experimental 1 0.2331
379 experiments 1 0.2226
379 fact, 1 0.4023
379 familiar 1 0.4023
379 final 1 0.3296
379 find 1 0.3439
379 flow. 1 0.3862
379 following 1 0.1665
379 gans 1 0.5024
379 growing 1 0.3364
379 herein 1 0.5024
379 high-pressure 1 0.5024
379 hope 1 0.3524
379 however, 1 0.182
379 identified 1 0.2944
379 increase 1 0.1706
379 indicate 1 0.2212
379 induced 1 0.2136
379 infiltra- 1 0.5024
379 injection 1 0.2101
379 injections 1 0.2834
379 intentionally 1 0.5024
379 investigation 1 0.2834
379 investigation, 1 0.4523
379 iodine-containing 1 0.5024
379 ion 1 0.3862
379 iothalamates, 1 0.5024
379 ir- 1 0.423
379 justified 1 0.423
379 light 1 0.2834
379 limita- 1 0.5024
379 many 1 0.2026
379 massive 1 0.3731
379 media. 1 0.4023
379 method 1 0.1996
379 methods 1 0.2269
379 methylglucamine 1 0.5024
379 myocardial 6 2.1144
379 niques. 1 0.5024
379 non, 1 0.5024
379 occlusion 1 0.3233
379 occurring 1 0.2905
379 often 1 0.2435
379 one 1 0.1406
379 opacification 1 0.5024
379 or- 1 0.5024
379 particularly 1 0.277
379 pe- 1 0.4523
379 phenome- 1 0.5024
379 point 1 0.2905
379 potential 1 0.3296
379 presentation 1 0.423
379 previously 1 0.2417
379 products 1 0.3524
379 protective 1 0.423
379 radicals 1 0.5024
379 radiographic 1 0.3862
379 radiopaque 2 0.9046
379 re-emphasize 1 0.4523
379 regard 1 0.2869
379 relationship 1 0.2417
379 remains 1 0.2631
379 renewed 1 0.4523
379 reported 1 0.2036
379 reported, 1 0.4023
379 respect 1 0.2944
379 responsible 1 0.2537
379 results 2 0.2878
379 retrograde 2 0.7724
379 ritability 1 0.5024
379 salification 1 0.5024
379 salts 2 0.7724
379 seconds 1 0.4523
379 seem 1 0.274
379 selective 2 0.5969
379 shared 1 0.3862
379 significance 1 0.274
379 similar 1 0.1881
379 sodium 1 0.2417
379 standard 1 0.3439
379 stimulate 1 0.3524
379 studied 1 0.175
379 studies 2 0.3077
379 subjected 1 0.274
379 tech- 1 0.4523
379 technique 1 0.2364
379 techniques. 1 0.362
379 tested, 1 0.423
379 tests 1 0.2474
379 thereof. 1 0.5024
379 tion 1 0.2284
379 tions 1 0.2985
379 toxi- 1 0.5024
379 toxicity 5 1.6478
379 trait, 1 0.5024
379 two 1 0.1539
379 unexplained, 1 0.5024
379 unreported 1 0.423
379 use 1 0.1986
379 used 1 0.1897
379 variations 1 0.3123
379 varying 1 0.2711
379 vascular 1 0.277
379 veins 1 0.3862
379 venography 1 0.5024
379 via 1 0.3364
379 view 1 0.2944
379 well 1 0.1757
379 widely 1 0.3364
379 within 1 0.1865
379 yet 1 0.2657
380 (generally 1 0.3349
380 1 1 0.1265
380 2 1 0.1023
380 2476. 1 0.3349
380 3) 1 0.2575
380 4 1 0.1185
380 5 1 0.127
380 5.1% 1 0.3349
380 5.6% 1 0.3349
380 6.0% 1 0.3349
380 6.5% 1 0.3349
380 68 1 0.3349
380 8 1 0.1513
380 9 1 0.1754
380 approximate 1 0.3349
380 average 4 0.6011
380 behind 1 0.2682
380 biplane 1 0.3349
380 car- 1 0.2413
380 cardiac 5 0.7514
380 chambers 1 0.2575
380 change 1 0.1554
380 changes 3 0.3007
380 cineradiograms 1 0.3349
380 clips 3 1.0048
380 complications. 1 0.3015
380 con- 1 0.1737
380 considered 1 0.1493
380 consists 1 0.2117
380 continuously, 1 0.3349
380 contractility 1 0.3349
380 control 1 0.1259
380 cycle 1 0.2682
380 cycles 1 0.3349
380 cycles; 1 0.3349
380 data 1 0.1364
380 decreased 2 0.3025
380 decreased. 1 0.3015
380 decreases 1 0.2155
380 deep, 1 0.282
380 described 1 0.127
380 description 1 0.2197
380 determined 2 0.3045
380 diac 1 0.3015
380 dimen- 1 0.3349
380 dimensions 9 2.4137
380 distances 1 0.3349
380 dp/dt 1 0.3349
380 effects 4 0.4973
380 elevation 1 0.2349
380 employed 1 0.2117
380 end-diastolic 2 0.5641
380 end-sys- 1 0.3349
380 errors 1 0.2349
380 exercise 4 1.1281
380 exhibited 1 0.2049
380 expiration 1 0.3349
380 exposures, 1 0.3349
380 exter- 1 0.3349
380 found 2 0.1764
380 frame. 1 0.3349
380 heart 2 0.3107
380 heart, 1 0.2575
380 i. 1 0.199
380 ii. 1 0.1937
380 iii. 1 0.2349
380 increase 1 0.1138
380 increased, 1 0.2487
380 indicate 1 0.1475
380 individual 2 0.3542
380 inspiration 1 0.3349
380 inspiration, 1 0.3349
380 intact, 2 0.5364
380 interpreted 1 0.2293
380 lagged 1 0.3349
380 left 5 0.7563
380 light 1 0.189
380 little 1 0.1789
380 magnitude 1 0.2082
380 man. 3 0.6466
380 manoeuvre. 1 0.3349
380 mea- 1 0.282
380 measurement 1 0.189
380 method 1 0.1331
380 multiple 1 0.1847
380 muscular 3 0.7048
380 myocardial 1 0.2349
380 nal 1 0.2682
380 normal 1 0.0901
380 obtained 1 0.1194
380 occurred 2 0.2915
380 occurs 1 0.1789
380 one-half 1 0.2575
380 operations. 1 0.3349
380 opposite 1 0.282
380 patients 3 0.2415
380 patients. 1 0.1611
380 performed 1 0.1533
380 period, 1 0.2243
380 permits 1 0.2413
380 placed 1 0.199
380 plane 1 0.282
380 position 1 0.2293
380 possible 1 0.1344
380 postopera- 1 0.3349
380 precisely. 1 0.3349
380 pressure 1 0.1533
380 properly 1 0.2682
380 quite 1 0.1913
380 radiopaque 1 0.3015
380 rate 1 0.1233
380 re- 1 0.1484
380 relative 1 0.1737
380 respiration. 2 0.6031
380 respiratory 1 0.1737
380 resting 1 0.2575
380 result 1 0.1449
380 resulting 1 0.1706
380 right 6 1.0425
380 rise 1 0.1663
380 rotation 2 0.6699
380 safe 1 0.2197
380 sagittal 1 0.2682
380 salva 1 0.3349
380 serial 1 0.2049
380 silver-tantalum 1 0.3349
380 sions 1 0.2575
380 slow 1 0.2197
380 small. 1 0.3015
380 smaller 1 0.2413
380 stroke 1 0.2349
380 studied 1 0.1167
380 studies 2 0.2051
380 sulted 1 0.3349
380 supine 1 0.3349
380 sured 1 0.3349
380 surface 1 0.1807
380 suturing 1 0.3349
380 technique 1 0.1576
380 techniques 1 0.1827
380 throughout 1 0.1913
380 time 1 0.118
380 tive 1 0.282
380 tolic 1 0.3015
380 trol 1 0.282
380 unanaesthetized 1 0.3349
380 unanesthetized 1 0.3349
380 utilizing 1 0.2487
380 val- 1 0.3015
380 validation. 1 0.3349
380 ventricle 4 0.7748
380 ventricle, 1 0.2487
380 ventricle. 3 0.8461
380 ventricular 5 0.7286
380 volume. 1 0.2575
380 without 1 0.1265
381 3765. 1 1.0048
381 allow 1 0.7048
381 at- 1 1.0048
381 attempt 1 0.6148
381 authors 1 0.4629
381 blood 1 0.3105
381 change 1 0.4661
381 clinical 1 0.3275
381 coronary 2 1.2933
381 counting 1 0.7462
381 curve 1 0.6879
381 d. 1 0.6466
381 defining 1 0.9046
381 determination 1 0.6148
381 error 1 0.724
381 errors. 1 1.0048
381 evaluate 1 0.7462
381 exists, 1 1.0048
381 flow 3 1.5356
381 formula 1 0.8046
381 instrumentation 1 0.9046
381 isotope 1 0.8046
381 johnson 1 1.0048
381 large 2 0.7945
381 made 1 0.3639
381 method 1 0.3992
381 myocardial 1 0.7048
381 needed 1 0.6879
381 portion 2 1.4096
381 possible 1 0.4031
381 present 1 0.3308
381 presented 1 0.3898
381 radioactive 1 0.6246
381 rate 1 0.3699
381 rate. 1 0.724
381 ratio 1 0.5262
381 recommend 1 0.9046
381 results 1 0.2878
381 scale 1 0.8461
381 scatter, 1 1.0048
381 sevelius 1 1.0048
381 source 1 0.6728
381 surface 1 0.5422
381 technique 1 0.4727
381 tempted. 1 1.0048
381 use 2 0.7945
381 wilkinson 1 1.0048
382 1379. 1 1.5073
382 arachnoiditis 1 1.357
382 assessing 1 1.2691
382 authors 1 0.6944
382 cases 1 0.4484
382 circulation 1 0.7893
382 conclude 1 1.2691
382 csf 2 2.0183
382 detecting 1 1.2691
382 efficiency 1 1.1192
382 experience 1 0.7747
382 external 1 0.9083
382 former 1 1.0318
382 general 1 0.7678
382 hydrocephalus 1 0.7747
382 hydrocephalus. 1 1.0091
382 internal 1 0.8503
382 intraventricular 1 1.1586
382 latter 1 0.7819
382 leaks, 1 1.5073
382 may 2 0.7539
382 normal 1 0.4053
382 particularly 1 0.831
382 related. 1 1.5073
382 risa-cis- 1 1.5073
382 risa-cisternography 1 1.5073
382 risa-ventriculography 2 3.0145
382 shunts; 1 1.5073
382 study 1 0.4643
382 surgical 1 0.6807
382 technique 2 1.4182
382 ternography 1 1.5073
382 tumors 1 0.7893
382 useful 2 1.6619
382 well 2 1.0542
383 (rihsa 1 0.7536
383 113 1 0.6785
383 16 1 0.4685
383 17 1 0.4477
383 3485. 1 0.7536
383 57 1 0.6034
383 65 1 0.5159
383 90 1 0.5596
383 cardiac 3 1.0144
383 compared 2 0.5847
383 counting 1 0.5596
383 discussed. 1 0.3222
383 erythrocytes-cr51). 1 0.7536
383 exercise 1 0.6346
383 external 1 0.4542
383 including 1 0.4066
383 injection 1 0.3151
383 measured 1 0.3299
383 measurement 4 1.7006
383 methods. 1 0.4764
383 normal 1 0.2027
383 normals, 1 0.5793
383 output 3 1.3247
383 patients, 2 0.7546
383 presented 1 0.2924
383 presented. 1 0.4416
383 principle 1 0.6785
383 radiocardiography 1 0.6785
383 radioisotope-cardiography 1 0.7536
383 radioisotopes 1 0.7536
383 rest 1 0.543
383 results 3 0.6474
383 subjects 1 0.3598
383 subjects, 1 0.5046
383 subjects. 1 0.4611
383 ventricular 4 1.3116
383 volume 3 1.1517
383 volumes 1 0.5793
384 (forward) 1 0.3768
384 (retrograde) 1 0.3768
384 2 1 0.1151
384 3. 1 0.2033
384 3762. 1 0.3768
384 aberrant 3 0.8394
384 advisable. 1 0.3768
384 angio- 2 0.7536
384 angiocardiography 1 0.2798
384 angiocardiography. 1 0.3392
384 angiographic 1 0.3017
384 arteries 1 0.2897
384 artery 8 1.7214
384 artery. 1 0.2798
384 aspect 1 0.2643
384 blood 1 0.1164
384 cases 1 0.1121
384 cases, 2 0.3946
384 choice. 1 0.3173
384 clinical 1 0.1228
384 conclusively 1 0.3392
384 confirmation 1 0.3392
384 continuity 1 0.3768
384 coronary 7 1.6974
384 demonstrate 1 0.2179
384 diagnosis 1 0.1551
384 diagnosis, 1 0.2523
384 diagnosis. 1 0.2523
384 differentiation 2 0.4303
384 difficult 1 0.2425
384 electrocardiographic 1 0.3017
384 emphasis 1 0.2715
384 endocardial 2 0.6785
384 features 2 0.4025
384 fibroelas- 1 0.3768
384 fibroelastosis. 1 0.3768
384 five 1 0.1992
384 flow 1 0.1919
384 generally 1 0.2238
384 graphic 1 0.3392
384 graphy 1 0.3392
384 injection 1 0.1576
384 intravenous 1 0.2012
384 la- 1 0.3392
384 latter 1 0.1955
384 left 3 0.5105
384 left-sided 2 0.6785
384 may 2 0.1885
384 myocardiopathies 1 0.3768
384 persistently 1 0.3392
384 presented, 1 0.3017
384 problem 1 0.2152
384 procedure 1 0.1919
384 proper 2 0.5046
384 pulmonary 3 0.4833
384 selective 1 0.2238
384 sequent 1 0.3392
384 study, 2 0.485
384 sub- 1 0.2425
384 suggest 2 0.3426
384 suspected, 1 0.3392
384 teral 1 0.3768
384 thin 1 0.3017
384 tosis 1 0.3768
384 type 1 0.1567
384 usually 1 0.1773
384 ventricular 1 0.1639
384 visible, 1 0.3768
384 wall 1 0.2382
385 (1) 1 0.2087
385 (2) 1 0.2087
385 0.45 1 0.4306
385 0.65 1 0.4306
385 1.52 1 0.4306
385 1/2 1 0.3448
385 10 1 0.1585
385 100-fold 1 0.4306
385 1000 1 0.3448
385 12 1 0.2056
385 125 7 2.5382
385 13 1 0.249
385 131 1 0.3448
385 2 2 0.263
385 2% 1 0.3877
385 2.4 1 0.3877
385 2.5%. 1 0.4306
385 20 1 0.1945
385 2000 1 0.4306
385 30 1 0.2056
385 4159. 1 0.4306
385 5% 1 0.3103
385 500 1 0.331
385 70 1 0.331
385 9 1 0.2255
385 absorbed 1 0.3103
385 absorption 1 0.2677
385 adult 1 0.1958
385 advised 1 0.4306
385 all-or-none 1 0.4306
385 allowing 1 0.331
385 amount 1 0.2121
385 analyzed. 1 0.3021
385 antecubital 1 0.4306
385 area. 1 0.3626
385 arterial 5 1.1169
385 atrial 1 0.2771
385 biological 1 0.23
385 case 1 0.1547
385 clinical 1 0.1404
385 cm 1 0.3448
385 collimation 1 0.3877
385 compared 2 0.3341
385 compared. 1 0.3448
385 comparison 1 0.2234
385 compton 1 0.4306
385 count 1 0.2948
385 counts 1 0.3021
385 curve 7 2.0636
385 curve. 1 0.3877
385 curves 2 0.5354
385 decreased 1 0.1945
385 defects 2 0.4748
385 descending 2 0.7252
385 detected 1 0.2234
385 detection 3 0.8031
385 determination 1 0.2635
385 dilution 4 1.1792
385 directionality, 1 0.4306
385 dose 1 0.2056
385 due 3 0.457
385 excellent 1 0.3103
385 excess 1 0.2948
385 exposure 1 0.2558
385 external 2 0.519
385 externally 1 0.4306
385 five 1 0.2277
385 form 1 0.1874
385 graphy 1 0.3877
385 half 1 0.2523
385 half-period 1 0.4306
385 heart 4 0.7991
385 hundred 1 0.331
385 i. 2 0.5116
385 improved 1 0.2883
385 individuals, 1 0.331
385 injected 2 0.4175
385 integrated 1 0.3626
385 investigators 1 0.3626
385 iodide. 2 0.8613
385 kilos 1 0.4306
385 layer 1 0.331
385 many 1 0.1736
385 mean 1 0.2071
385 means 2 0.3816
385 mechanisms 1 0.2595
385 method 2 0.3421
385 microcuries 1 0.4306
385 minimum 1 0.331
385 mrads 1 0.4306
385 normal 1 0.1158
385 obtained 1 0.1535
385 offers 1 0.3103
385 originating 2 0.7754
385 orthoiodohippu- 1 0.4306
385 outside 1 0.331
385 part 1 0.2012
385 patients 2 0.207
385 peak 1 0.249
385 perform 1 0.3877
385 photoelectric 1 0.4306
385 photons 2 0.8613
385 pluridirectionality 1 0.4306
385 possible 1 0.1728
385 precordial 1 0.3626
385 procedure 1 0.2194
385 puncture 1 0.3877
385 pure 1 0.2771
385 pursued 1 0.4306
385 radiation 2 0.4697
385 radiocardio- 1 0.4306
385 rate 2 0.3171
385 reproducible. 1 0.4306
385 right 7 1.5637
385 right-heart 1 0.4306
385 scatter 1 0.3877
385 scintillation 1 0.3448
385 sec. 2 0.8613
385 seems 1 0.2277
385 segment 1 0.3448
385 selective 1 0.2558
385 sep- 1 0.3877
385 septal 1 0.2324
385 shape 1 0.2771
385 short 1 0.249
385 shunts 1 0.3448
385 similar 1 0.1612
385 simple 1 0.2348
385 slope 1 0.331
385 small 1 0.1728
385 soft 1 0.3626
385 tal 1 0.3877
385 tissue, 1 0.3103
385 tricle 1 0.4306
385 uc 1 0.3626
385 uni- 1 0.3877
385 use 2 0.3405
385 usefulness 1 0.3448
385 value 1 0.1984
385 vein. 1 0.3626
385 ven- 1 0.3198
385 ventricle 4 0.9961
385 ventricular 1 0.1874
385 whole-body 1 0.3103
385 yr. 1 0.2255
386 17-83 1 0.7536
386 4160. 1 0.7536
386 50 1 0.3598
386 age 1 0.3118
386 age, 1 0.4943
386 aged 1 0.4542
386 agreement 1 0.5159
386 applications 1 0.5596
386 bedside 1 0.6785
386 blood 4 0.9315
386 cardiac 2 0.6763
386 cardiovascular 1 0.4764
386 causes 1 0.4252
386 changes 1 0.2255
386 clinical 1 0.2457
386 close 2 0.8832
386 correlation 1 0.3805
386 decrease 1 0.3449
386 dependence 1 0.6346
386 described 1 0.2859
386 determinations 1 0.543
386 disorders, 1 0.543
386 easy 1 0.7536
386 found 1 0.1984
386 free 1 0.3571
386 i. 1 0.4477
386 index 1 0.4477
386 injection 1 0.3151
386 instrumentation 1 0.6785
386 interpreted 1 0.5159
386 little 1 0.4025
386 means 1 0.3339
386 method 1 0.2994
386 needed. 1 0.6346
386 normal 1 0.2027
386 obtained 1 0.2686
386 one 1 0.2108
386 output 1 0.4416
386 patients 1 0.1812
386 patients, 1 0.3773
386 pbv 2 1.5073
386 perform 1 0.6785
386 previous 1 0.4066
386 pulmonary 2 0.6444
386 quantitative 2 0.797
386 radiocardiography. 2 1.5073
386 re- 1 0.3339
386 reduction 1 0.3711
386 reports. 1 0.7536
386 results 2 0.4316
386 rihsa 1 0.7536
386 routine 1 0.543
386 showed 1 0.2686
386 significant 1 0.2646
386 simple, 1 0.6346
386 slight. 1 0.6785
386 spiratory 1 0.7536
386 statistical 1 0.485
386 studied. 1 0.4252
386 subjects 1 0.3598
386 sv, 1 0.7536
386 sv. 1 0.7536
386 technique 2 0.7091
386 thirty-nine 1 0.6785
386 trouble 1 0.6785
386 uc 1 0.6346
386 volume 3 1.1517
386 volume, 1 0.5159
386 yr., 1 0.6785
387 (rifa) 1 0.6029
387 2, 1 0.4127
387 2725. 1 0.6029
387 3 1 0.2055
387 4, 1 0.5076
387 42 1 0.4634
387 9 2 0.6314
387 absent 1 0.3955
387 acid 2 0.4656
387 acute 1 0.2993
387 approaches 1 0.5076
387 area 1 0.3127
387 areas 2 0.6376
387 ated 1 0.4827
387 biochemical 1 0.3811
387 bring 1 0.4634
387 cases 2 0.3588
387 cases. 1 0.3157
387 concentration 1 0.2535
387 corresponding 2 0.7065
387 deceased 1 0.6029
387 decreased 1 0.2723
387 definite 1 0.4127
387 definition 1 0.4827
387 demonstration 1 0.388
387 development 1 0.2201
387 diagnostic 1 0.2993
387 discrete 1 0.5428
387 electrocardiogram, 1 0.5428
387 employed 1 0.3811
387 excised 1 0.5428
387 fatal 1 0.4037
387 fatty 1 0.3018
387 heart 5 1.3983
387 incorporated 1 0.4477
387 infarcted 1 0.6029
387 infarction 2 1.0153
387 infarction, 2 1.2058
387 infarction. 2 1.2058
387 injected 1 0.2922
387 injection 1 0.2521
387 interventricular 1 0.4827
387 intravenously 1 0.4229
387 judged 1 0.4344
387 level 1 0.2328
387 life 1 0.3188
387 life; 1 0.6029
387 limits 1 0.4634
387 location 1 0.4634
387 made 2 0.4367
387 man 1 0.3099
387 man. 1 0.388
387 massive 1 0.4477
387 may 1 0.1508
387 method 1 0.2395
387 modification 1 0.4477
387 muscle 1 0.3324
387 myocardial 4 1.6915
387 necropsy 1 0.4344
387 oleic 1 0.4827
387 pa- 1 0.3533
387 permit 1 0.4827
387 photoscans 4 2.1711
387 presently 1 0.4827
387 principles 1 0.4127
387 probable 1 0.3811
387 radioactivity 3 1.3032
387 radioiodin- 1 0.6029
387 radioiodinated 1 0.5428
387 recent 1 0.3157
387 recording 1 0.4229
387 septal 1 0.3253
387 septum. 1 0.4827
387 showed 1 0.2149
387 suffered 1 0.4127
387 sufficient 1 0.3633
387 technic 1 0.4634
387 tients, 1 0.6029
387 usefulness. 1 0.6029
387 y-camera 1 0.6029
388 'seen' 1 0.5024
388 (t) 1 0.5024
388 2 1 0.1534
388 2716. 1 0.5024
388 3 1 0.1713
388 3-4 1 0.5024
388 allows 1 0.4023
388 already 1 0.362
388 an- 1 0.4523
388 angiogram 1 0.5024
388 angiogram, 1 0.5024
388 appears 1 0.216
388 application 1 0.2834
388 areas 1 0.2657
388 aspects, 1 0.4523
388 atten- 1 0.5024
388 auditory 1 0.4523
388 authors' 1 0.3862
388 axis 1 0.4523
388 based 1 0.2631
388 basis 1 0.2199
388 blood, 1 0.3439
388 c 1 0.274
388 calculation 2 1.0048
388 canal. 1 0.5024
388 car- 1 0.362
388 cardiac 3 0.6763
388 carotid 3 0.9887
388 carotid, 1 0.5024
388 cavities 2 0.9046
388 cavities, 2 1.0048
388 centered 1 0.423
388 channel. 1 0.5024
388 characteristic 1 0.2537
388 chronologic 1 0.5024
388 chronology 1 0.5024
388 circuits 1 0.5024
388 circular 1 0.5024
388 circulation 1 0.2631
388 collimator 3 1.357
388 collimator, 1 0.5024
388 conditions. 1 0.3524
388 constant 2 0.548
388 correc- 1 0.5024
388 covers 1 0.4523
388 curve 2 0.6879
388 curve. 1 0.4523
388 curves 1 0.3123
388 cycles, 1 0.4523
388 cycles. 1 0.5024
388 decrease 1 0.2299
388 demonstrated. 1 0.362
388 detail. 1 0.362
388 determining 1 0.3862
388 diac 1 0.4523
388 different 1 0.1777
388 discussed 1 0.2046
388 discussed. 1 0.2148
388 drawn 1 0.3731
388 emptying 1 0.4523
388 especially 2 0.5165
388 external 1 0.3028
388 fact 1 0.2657
388 filling. 1 0.5024
388 formula 1 0.4023
388 functions 1 0.3123
388 giogram 1 0.5024
388 heart. 1 0.5024
388 information 2 0.5422
388 interesting 1 0.362
388 interval 1 0.4023
388 irrigated 1 0.4523
388 larger 1 0.2985
388 leaves 1 0.4523
388 left 6 1.3613
388 lengthening 1 0.423
388 logical 1 0.3731
388 long 1 0.2606
388 made, 1 0.3862
388 material 2 0.4661
388 means 1 0.2226
388 measure 1 0.2905
388 measured. 1 0.5024
388 neces- 1 0.4523
388 output 2 0.5888
388 passes 1 0.423
388 pathologic 1 0.3074
388 pattern 1 0.2399
388 peak 1 0.2905
388 placed 1 0.2985
388 principal 1 0.4023
388 pulmonary 5 1.074
388 radioactive 3 0.9369
388 recirculation 1 0.5024
388 recordings 1 0.3731
388 rectification 1 0.4523
388 regards 1 0.423
388 region 1 0.3364
388 remains 1 0.2631
388 represents 1 0.3439
388 sary 1 0.5024
388 scapular 1 0.5024
388 serves 1 0.3862
388 several 1 0.2173
388 short 1 0.2905
388 shown 1 0.216
388 shunts. 1 0.423
388 simultaneously 1 0.3028
388 small 1 0.2015
388 started. 1 0.5024
388 stewart-hamilton 1 0.5024
388 successively, 1 0.5024
388 systoles, 1 0.5024
388 technique, 1 0.423
388 time 5 0.8852
388 times 1 0.2417
388 tion 2 0.4568
388 tissue 1 0.1744
388 valid 2 0.8461
388 validity 1 0.423
388 valuable 1 0.3233
388 valuable, 1 0.4523
388 various 1 0.1986
388 ventricular 1 0.2186
388 volume 1 0.2559
388 volume. 1 0.3862
388 well 1 0.1757
388 y-angiocardiography 1 0.5024
388 y-angiogram 1 0.5024
388 y-angiograms 1 0.5024
388 y-cardiogram, 2 1.0048
388 yet 1 0.2657
388 yielded 1 0.3176
389 (rihsa) 1 1.0048
389 2717. 1 1.0048
389 7 1 0.4629
389 according 1 0.5422
389 blood 2 0.621
389 capacity, 1 0.9046
389 cardiac 1 0.4509
389 circulation 1 0.5262
389 decreased 1 0.4538
389 diastolic 1 0.7724
389 diminished, 1 1.0048
389 donato's 1 1.0048
389 evacuation 1 0.9046
389 found 1 0.2645
389 hemodynamics 1 0.8461
389 inconclusive. 1 0.9046
389 investigations 1 0.6246
389 lar 1 0.7724
389 method. 1 0.7048
389 mitral 2 1.3455
389 monary 1 1.0048
389 normal 1 0.2702
389 output 1 0.5888
389 patients 1 0.2415
389 performed 1 0.4598
389 pertaining 1 0.8461
389 prolonged. 1 1.0048
389 proved 1 0.5603
389 pul- 1 1.0048
389 pulmonary 1 0.4296
389 quantitative 2 1.0626
389 radiocardiographic 1 1.0048
389 radiocardiography 1 0.9046
389 ratio 1 0.5262
389 resting 1 0.7724
389 results 1 0.2878
389 right 3 1.5637
389 six 1 0.554
389 stenosis 1 0.6352
389 stenosis, 1 0.7724
389 stroke 1 0.7048
389 studied. 1 0.5669
389 study 1 0.3096
389 subjects 1 0.4797
389 time 1 0.3541
389 value 1 0.4629
389 ventricu- 1 0.9046
389 ventricular 2 0.8744
389 volume 3 1.5356
389 well 1 0.3514
390 (asd), 1 0.4306
390 (ductus 1 0.4306
390 (pda), 1 0.4306
390 (post- 1 0.4306
390 (vsd), 1 0.4306
390 0.01-0.15 1 0.4306
390 0.5 1 0.3198
390 1 4 0.6505
390 131 3 1.0345
390 2 4 0.526
390 2-inch 1 0.4306
390 3 1 0.1468
390 3056. 1 0.4306
390 3rd 1 0.3103
390 5-15 1 0.4306
390 5-mm/sec 1 0.4306
390 analysis 1 0.2071
390 aorta 2 0.5767
390 aorta, 1 0.4306
390 aortic 7 1.6099
390 arch, 1 0.4306
390 area 1 0.2234
390 arterial 2 0.4468
390 arteriosus 1 0.331
390 artery 1 0.2459
390 artery. 1 0.3198
390 ascending 1 0.331
390 asd 1 0.4306
390 atrial 1 0.2771
390 av 2 0.8613
390 based 1 0.2255
390 baseline 1 0.3877
390 blood 1 0.1331
390 cardiopathies, 1 0.4306
390 carried 1 0.2156
390 catheterization 3 0.865
390 chambers 1 0.331
390 congenital 1 0.1971
390 constants 1 0.331
390 continuous 1 0.2429
390 coronary 2 0.5543
390 counter. 1 0.4306
390 crystal 2 0.7252
390 curves 5 1.3384
390 curves. 1 0.3877
390 defect 2 0.4241
390 descending 1 0.3626
390 described, 1 0.3448
390 detected 1 0.2234
390 developed 1 0.1958
390 different 2 0.3047
390 dilution 1 0.2948
390 direct 1 0.2026
390 dose 1 0.2056
390 downslope 1 0.4306
390 ductus 2 0.6396
390 fell 1 0.2948
390 fistula 1 0.4306
390 fistula, 1 0.4306
390 flowed 1 0.4306
390 focused 1 0.3877
390 following 1 0.1427
390 grade 1 0.3448
390 hypertension 1 0.2722
390 hypertension, 1 0.3448
390 injected 3 0.6262
390 injecting 1 0.3626
390 intercostal 1 0.4306
390 latter 1 0.2234
390 left 2 0.389
390 level 1 0.1663
390 level) 1 0.4306
390 level). 1 0.4306
390 levels 2 0.3373
390 levels. 1 0.2883
390 localization 1 0.3021
390 localizing 1 0.3626
390 margin. 1 0.4306
390 means 1 0.1908
390 mitral 2 0.5767
390 na 1 0.2722
390 nai 1 0.4306
390 near 1 0.2595
390 normal 1 0.1158
390 observed. 1 0.2595
390 obtained 3 0.4605
390 obtaining 1 0.331
390 origin 2 0.4918
390 outlet 1 0.3877
390 paper 1 0.2324
390 patent 1 0.3103
390 patients 3 0.3106
390 patients, 1 0.2156
390 pda, 1 0.4306
390 performed 1 0.1971
390 precordial 5 1.813
390 pulmonary 1 0.1841
390 pulses 1 0.3877
390 ratemeters 1 0.4306
390 recirculatory 1 0.4306
390 recorder 1 0.3877
390 records 1 0.3021
390 registration 1 0.4306
390 regurgitation 2 0.5649
390 regurgitation, 1 0.331
390 retro- 1 0.4306
390 right 1 0.2234
390 right-sided 1 0.3448
390 root, 1 0.3877
390 scintillation 1 0.3448
390 sec 2 0.7754
390 seldinger's 1 0.4306
390 septal 2 0.4647
390 seven 1 0.2459
390 shunt 1 0.2883
390 shunts 2 0.6896
390 simultaneous 1 0.2635
390 space 1 0.3198
390 speed 1 0.3877
390 sternal 1 0.3626
390 studied. 1 0.2429
390 subclavian 1 0.4306
390 swift 1 0.4306
390 systemic 1 0.2401
390 technique 3 0.6078
390 thallium-acti- 1 0.4306
390 time 1 0.1517
390 transseptal 1 0.3877
390 uc 1 0.3626
390 used 1 0.1626
390 used. 1 0.2948
390 valve 1 0.2635
390 valvulopathies. 1 0.4306
390 vated 1 0.3626
390 venous 2 0.4859
390 ventricular 1 0.1874
390 vsd. 2 0.8613
390 well 2 0.3012
390 withdrawal 1 0.3103
390 worked 1 0.3877
391 131 1 0.6034
391 1671. 1 0.7536
391 5 1 0.2859
391 99m 4 2.7139
391 aas' 1 0.7536
391 abnormally 1 0.5596
391 activity 1 0.2697
391 administered 1 0.3598
391 advantages 1 0.5286
391 associated 1 0.2676
391 authors' 1 0.5793
391 available, 1 0.6785
391 becomes 1 0.4542
391 blood 2 0.4657
391 brain 1 0.3839
391 cardiac 3 1.0144
391 cases 1 0.2242
391 comparable 1 0.4155
391 compounds 1 0.543
391 count 1 0.5159
391 decay 1 0.7536
391 delineation 1 0.7536
391 dosage. 1 0.6346
391 effusions 1 0.6346
391 eliminating 1 0.6346
391 enhanced 1 0.4685
391 following 1 0.2498
391 hands 1 0.7536
391 heart 1 0.3496
391 high 1 0.2697
391 identification 1 0.485
391 laboratory 1 0.4358
391 low 1 0.3299
391 materials. 1 0.7536
391 may 1 0.1885
391 mc 1 0.7536
391 obtained 1 0.2686
391 patient 1 0.2834
391 pericardial 1 0.5596
391 permits 1 0.543
391 pertechnetate 2 1.5073
391 pool 1 0.5793
391 pool. 2 1.5073
391 purchase 1 0.7536
391 quantities 1 0.5286
391 radiation 1 0.411
391 radio- 1 0.5596
391 rapid 1 0.3653
391 rate 1 0.2774
391 relatively 1 0.3625
391 routinely 1 0.7536
391 scanning 2 1.0091
391 scanning. 1 0.6785
391 scans, 1 0.7536
391 separated 1 0.4943
391 shelf 1 0.7536
391 since 1 0.3279
391 standard 1 0.5159
391 stomach 1 0.7536
391 surrounding 1 0.5286
391 tc 3 2.0354
391 technetium 1 0.6785
391 three 1 0.2834
391 thyroid 1 0.4416
391 use 1 0.2979
391 use. 1 0.6034
391 utilized 2 1.1586
391 vasculature 1 0.6785
392 'in 1 0.6785
392 123 1 0.7536
392 123, 1 0.7536
392 125, 1 0.7536
392 131 1 0.6034
392 132. 1 0.7536
392 2012. 1 0.7536
392 99m 4 2.7139
392 accuracy 1 0.5793
392 albumin 1 0.5286
392 allowing 1 0.5793
392 ap- 1 0.6034
392 available 1 0.411
392 becomes 1 0.4542
392 brain 1 0.3839
392 cardiac 1 0.3381
392 clinical 1 0.2457
392 collima- 1 0.7536
392 compared 1 0.2924
392 considered 1 0.336
392 counting 1 0.5596
392 discussed 1 0.3069
392 dose 1 0.3598
392 dose, 1 0.6034
392 element 1 0.5793
392 energy 1 0.5159
392 given 1 0.2763
392 high 1 0.2697
392 highest 1 0.4764
392 internal 1 0.4252
392 light-weight 1 0.7536
392 made. 1 0.4685
392 may 1 0.1885
392 mea- 1 0.6346
392 measurement 1 0.4252
392 metabolism 1 0.3571
392 near 1 0.4542
392 observation 1 0.3946
392 obtained 1 0.2686
392 optimum 1 0.7536
392 output, 1 0.6785
392 physical 1 0.4358
392 placentography 1 0.7536
392 plications 1 0.6785
392 preferable 1 0.6346
392 properties, 1 0.6785
392 radiation 2 0.8219
392 rates 1 0.4542
392 risa 1 0.6346
392 safely 1 0.6034
392 scanning 1 0.5046
392 scanning, 1 0.6346
392 scanning. 1 0.6785
392 shown 1 0.3241
392 statistical 1 0.485
392 superior 1 0.5046
392 surements 1 0.7536
392 tagged 1 0.6785
392 tc 3 2.0354
392 technetium 1 0.6785
392 thyroid 1 0.4416
392 tors 1 0.7536
392 tracer 1 0.6034
392 transients 1 0.7536
392 use 1 0.2979
392 used. 1 0.5159
392 vivo' 1 0.7536
392 y-ray 1 0.7536
393 (0.5-2.2 1 0.7536
393 - 1 0.4416
393 -an 1 0.7536
393 131-tagged 1 0.7536
393 185 1 0.7536
393 2626. 1 0.7536
393 45 1 0.5046
393 46 1 0.6346
393 48 2 0.8503
393 56 1 0.6346
393 albumin) 1 0.7536
393 allowing 1 0.5793
393 among 1 0.352
393 analyzed 1 0.5159
393 application 1 0.4252
393 arteriovenous 4 2.4137
393 becomes 1 0.4542
393 cardiac 3 1.0144
393 cardio- 1 0.7536
393 catheterization. 1 0.6346
393 central 4 1.6265
393 certain 1 0.3319
393 changes 2 0.451
393 classical 1 0.5286
393 clinical 1 0.2457
393 collimation 1 0.6785
393 concentration 1 0.3168
393 critical 1 0.5046
393 curves 3 1.4054
393 diagnosing 1 0.5596
393 diagnosis 2 0.6202
393 diagnosis, 1 0.5046
393 different 1 0.2666
393 dilution 2 1.0318
393 discrimina- 1 0.7536
393 disease, 1 0.4025
393 diseases. 1 0.5793
393 done 1 0.5046
393 especially 1 0.3874
393 exclude 1 0.6346
393 extreme 1 0.4943
393 fact 1 0.3985
393 factor 2 0.7143
393 factors, 1 0.543
393 failure 1 0.4066
393 focusing 1 0.7536
393 hand, 1 0.4542
393 important 1 0.3403
393 index 1 0.4477
393 latter 1 0.3909
393 limitations, 1 0.7536
393 limiting 1 0.5596
393 made 1 0.2729
393 material 1 0.3496
393 means. 1 0.6785
393 method 2 0.5987
393 minimal 2 0.9369
393 one 1 0.2108
393 oximetry 1 0.7536
393 patients 2 0.3623
393 possible 1 0.3023
393 preclude 1 0.6034
393 precordial 3 1.9037
393 proposed 1 0.4943
393 providing 1 0.5793
393 pure 1 0.485
393 quantities 1 0.5286
393 radioactive 1 0.4685
393 radioalbumin 1 0.7536
393 ratio 1 0.3946
393 recording 1 0.5286
393 regurgitation 1 0.4943
393 regurgitations. 1 0.7536
393 results 1 0.2158
393 sensitive 1 0.4066
393 show 1 0.326
393 shown 2 0.6481
393 shunts 2 1.2069
393 shunts, 1 0.6785
393 shunts. 3 1.9037
393 similar 1 0.2821
393 spite 1 0.5046
393 stenosis 1 0.4764
393 studied, 1 0.5596
393 study 1 0.2322
393 technique. 1 0.5793
393 thus, 1 0.543
393 tion 1 0.3426
393 together 1 0.4303
393 uc. 1 0.7536
393 used, 1 0.485
393 utilized. 1 0.7536
393 val- 1 0.6785
393 value 1 0.3472
393 valvular 2 1.0091
393 various 1 0.2979
393 vascular 1 0.4155
393 vular 1 0.6785
393 without 1 0.2846
393 zone 1 0.4943
394 2724. 1 0.4306
394 3 2 0.2936
394 8 1 0.1945
394 almost 1 0.2213
394 also 1 0.1205
394 alveolar 2 0.4697
394 approaches 1 0.3626
394 arranged 1 0.3198
394 ate. 1 0.4306
394 ated 1 0.3448
394 authors 1 0.1984
394 basal 1 0.2825
394 became 1 0.2558
394 biopsy 1 0.2771
394 bronchial 1 0.3198
394 bundles 1 0.3877
394 cancers 1 0.2883
394 carcinomas 2 0.6896
394 carcinomas. 1 0.3877
394 cell 1 0.1457
394 cell, 1 0.331
394 cells 7 0.9098
394 cells. 1 0.192
394 center 1 0.2771
394 center. 1 0.3877
394 chiefly 1 0.3103
394 confluent 1 0.4306
394 contain 1 0.2771
394 cylindrical 1 0.4306
394 cytoplasmic 1 0.2595
394 describe 1 0.331
394 desmo- 1 0.4306
394 differentiated 2 0.5767
394 disappeared 1 0.3103
394 electron 2 0.4349
394 embedded 1 0.3626
394 endoplasm 1 0.4306
394 enveloped 1 0.4306
394 epidermoid 1 0.3448
394 even 1 0.1885
394 except 1 0.2429
394 fibrils 1 0.331
394 foci 1 0.3103
394 formations 1 0.4306
394 formed 1 0.2401
394 found 1 0.1134
394 free 1 0.2041
394 glycogen 1 0.3103
394 granules 1 0.2825
394 granules, 1 0.3448
394 information. 1 0.3626
394 intermediate 1 0.2771
394 keratohyalin 1 0.4306
394 lamellar 1 0.331
394 lipid 1 0.2635
394 lung 1 0.1852
394 lung. 1 0.3103
394 made 1 0.156
394 methacryl- 1 0.4306
394 micro- 1 0.3448
394 microscope 1 0.3198
394 microscopic 1 0.2677
394 mitochondria, 1 0.3626
394 myelin 1 0.3626
394 nodes, 1 0.3103
394 nucleus, 1 0.3626
394 numerous 1 0.2558
394 observed 1 0.1468
394 often 1 0.2087
394 one 1 0.1205
394 optic 1 0.2948
394 organelles 1 0.3198
394 packed 1 0.3877
394 paper 1 0.2324
394 periphery 1 0.4306
394 picture 1 0.2348
394 primary 1 0.1821
394 resembled 1 0.3103
394 reticular 1 0.3448
394 ribosomes, 1 0.3877
394 richer 1 0.4306
394 scanty 1 0.4306
394 scopic 1 0.4306
394 seen 1 0.1821
394 slightly 1 0.2459
394 somes. 1 0.3877
394 sometimes 1 0.2771
394 specimens 1 0.2771
394 squamous 2 0.7252
394 study 2 0.2653
394 tonofibrils 2 0.7754
394 tumor 2 0.384
394 type. 1 0.2883
394 undifferenti- 1 0.4306
394 undifferentiated 1 0.3198
394 undifferentiated, 1 0.3877
394 vesicular, 1 0.4306
394 whole 1 0.2401
395 (rna) 1 0.3877
395 10 4 0.6341
395 1375. 1 0.4306
395 1965, 1 0.3877
395 2 4 0.526
395 2378. 1 0.4306
395 4 1 0.1523
395 4-10 1 0.4306
395 5 1 0.1633
395 6 2 0.3601
395 73 1 0.3626
395 80, 1 0.4306
395 abstr. 1 0.4306
395 although 1 0.1655
395 among 1 0.2012
395 another 1 0.2348
395 apparent 1 0.2255
395 articles 1 0.3877
395 basically 1 0.331
395 cancer, 1 0.2722
395 cell 3 0.4372
395 cells. 2 0.384
395 cells; 2 0.6896
395 cheek 1 0.3877
395 chromosome 2 0.5767
395 circa 1 0.4306
395 clonal 3 1.2919
395 content 1 0.2026
395 correlation 1 0.2175
395 could 1 0.1547
395 cultures 1 0.2156
395 cyto- 1 0.3626
395 cytoplasmic 1 0.2595
395 derivatives 2 0.6396
395 derived 1 0.2374
395 detail. 1 0.3103
395 differed 1 0.2948
395 differences 3 0.5912
395 different 1 0.1523
395 distinctive 1 0.3198
395 even 1 0.1885
395 examined. 1 0.2948
395 exc. 1 0.4306
395 failed 1 0.2459
395 hamster 1 0.3103
395 heterotransplant, 1 0.4306
395 heterotransplantability 2 0.8613
395 heterotransplantability. 1 0.4306
395 heterotransplantable 3 1.2919
395 heterotransplanted 1 0.4306
395 however, 1 0.156
395 ii. 1 0.249
395 inocula 4 1.5508
395 karyotypic 1 0.4306
395 kb 3 1.1631
395 laboratories 1 0.3877
395 less 1 0.1612
395 line 2 0.519
395 lines 1 0.249
395 loss 1 0.2087
395 ly 1 0.2825
395 marker. 1 0.4306
395 medica 1 0.4306
395 minor 1 0.2771
395 modal 1 0.4306
395 morphology 1 0.2635
395 neoplastic 1 0.3021
395 no. 1 0.3877
395 non-heterotransplantable 1 0.4306
395 number 2 0.3296
395 numbers 1 0.2558
395 observations 1 0.1811
395 observed 1 0.1468
395 obtained 1 0.1535
395 one 1 0.1205
395 originally 1 0.3198
395 pattern 1 0.2056
395 per 1 0.1678
395 plasmic 1 0.3877
395 possible 1 0.1728
395 pouch. 1 0.4306
395 properties 1 0.23
395 protein 1 0.1958
395 ranging 1 0.2948
395 reexamined 1 0.4306
395 remain 1 0.3103
395 respect 2 0.5047
395 ribonucleic 1 0.3021
395 see 1 0.3448
395 series 1 0.2026
395 serve 1 0.3103
395 similar 1 0.1612
395 similar, 1 0.3626
395 similarly 1 0.3448
395 studied 1 0.15
395 studied, 1 0.3198
395 sublines 7 2.4137
395 sublines. 1 0.4306
395 sufficient- 1 0.4306
395 syrian 1 0.3448
395 ten 1 0.2595
395 three 1 0.1619
395 twelve 1 0.2722
395 variability 1 0.3103
395 vitro. 1 0.2883
395 was, 1 0.331
396 10th 1 1.0048
396 1377. 1 1.0048
396 2 1 0.3068
396 93 1 0.9046
396 actino- 1 1.0048
396 animals 1 0.4272
396 ascites 1 0.8046
396 biological 1 0.5366
396 cell 1 0.3401
396 cells 3 0.9098
396 cells. 2 0.896
396 characters 1 0.9046
396 culture 3 1.5092
396 easily 1 0.6466
396 establishment 1 0.7462
396 identical 1 0.5969
396 injection 2 0.8403
396 intraperitoneal 1 0.724
396 jtc-14 2 2.0097
396 judged 1 0.724
396 kill 1 0.8461
396 line 1 0.6056
396 maintained 1 0.5603
396 malignant 1 0.548
396 mice 2 0.9897
396 mycin-induced 1 1.0048
396 original 2 1.1476
396 passage 1 0.6591
396 produced 2 0.8185
396 re-established 1 1.0048
396 sarcoma, 1 0.9046
396 strain 1 0.5313
396 subculture 1 0.9046
396 subcultured 1 0.9046
396 subcutaneous 1 0.6466
396 taken 1 0.5669
396 time 1 0.3541
396 times. 1 0.9046
396 tissue 2 0.6976
396 tumor 1 0.448
396 tumors 1 0.5262
396 vitro. 1 0.6728
396 yr. 1 0.5262
397 'commando's' 1 0.6029
397 'group' 1 0.6029
397 (strain 1 0.6029
397 1378. 1 0.6029
397 22 1 0.4127
397 aggresivity 1 0.6029
397 and, 1 0.3127
397 apart, 1 0.6029
397 arrested 1 0.5428
397 c3h 1 0.6029
397 called 1 0.4344
397 cancerous 1 0.5076
397 cells 5 0.9098
397 cells. 2 0.5376
397 cinematography 1 0.5428
397 combined 1 0.3099
397 compact 1 0.5428
397 contact 1 0.3487
397 cultivated 1 0.5076
397 cultures 1 0.3018
397 days. 1 0.3401
397 defence 1 0.5428
397 demonstrates, 1 0.6029
397 direct 1 0.2836
397 found 1 0.1587
397 group 2 0.4457
397 hand, 1 0.3633
397 homologous 1 0.4127
397 invasion 1 0.6029
397 make 1 0.3581
397 malignant 1 0.3288
397 mechanism 1 0.2778
397 meet 1 0.4827
397 mice 1 0.2969
397 micro- 1 0.4827
397 microcinematographic 1 0.6029
397 move 1 0.5076
397 movements 1 0.4477
397 myocardium 1 0.4634
397 n1 1 0.6029
397 nctc) 1 0.6029
397 newborn 1 0.3288
397 normal 4 0.6485
397 one 1 0.1687
397 other, 1 0.4634
397 rapid 1 0.2922
397 sarcomatous 1 0.5428
397 strain 1 0.3188
397 studied 1 0.2101
397 study 1 0.1857
397 tend 1 0.4344
397 tissue 1 0.2093
397 tumor 2 0.5376
397 vigorous 1 0.5428
397 vitro 1 0.3099
397 way 1 0.3811
397 wherever 1 0.6029
398 14 1 0.4155
398 22 1 0.5159
398 2413. 1 0.7536
398 appearance 1 0.3742
398 bearing 1 0.6034
398 briefly 1 0.4542
398 cell 1 0.2551
398 cells 1 0.2274
398 cells, 1 0.3653
398 cells. 1 0.336
398 culture 1 0.3773
398 cultured 1 0.4943
398 cultures 1 0.3773
398 cytoplasmatic 1 0.7536
398 derived 1 0.4155
398 discussed. 1 0.3222
398 epithelial 2 0.797
398 epithelium 1 0.4542
398 figures 1 0.5793
398 fragments 1 0.5596
398 intact 1 0.4155
398 long 1 0.3909
398 lymphocytes 2 0.8832
398 lymphocytes, 2 1.086
398 many 1 0.3038
398 mechanical 1 0.543
398 minute 1 0.5596
398 mitotic 1 0.485
398 morphological 1 0.4611
398 mouse 2 0.8404
398 mth 1 0.5793
398 mth. 1 0.4477
398 newborn 2 0.8219
398 observations 1 0.3168
398 obtained 1 0.2686
398 old 1 0.4252
398 older. 1 0.7536
398 origin 1 0.4303
398 original 1 0.4303
398 plasma 1 0.3038
398 possible 1 0.3023
398 presence 1 0.2871
398 scraping 1 0.7536
398 seen 2 0.6372
398 sheets 1 0.7536
398 started 1 0.6346
398 subcultures 1 0.7536
398 subcultures. 1 0.7536
398 term 1 0.4202
398 thymic 4 2.5382
398 transferring 1 0.7536
398 vacuoles 1 0.6346
398 vitro 1 0.3874
398 well 1 0.2636
398 within 1 0.2798
399 'plating' 2 1.0048
399 3748. 1 0.5024
399 4 3 0.5332
399 adenocarcinoma 1 0.3439
399 adenoma 1 0.362
399 air 1 0.2801
399 apparently 1 0.274
399 b. 1 0.2801
399 based 1 0.2631
399 bells 1 0.5024
399 benign 1 0.362
399 brothers 1 0.4523
399 carcinoma 1 0.2399
399 cells 1 0.1516
399 cells, 1 0.2435
399 cells. 1 0.224
399 character 1 0.3524
399 clinically 1 0.3439
399 clones 4 1.8093
399 cloning 1 0.5024
399 clues 1 0.423
399 concluded 1 0.2299
399 derived 2 0.554
399 different 3 0.5332
399 familiar 1 0.4023
399 first 1 0.1842
399 four 1 0.2254
399 grafts 1 0.423
399 henderson 1 0.5024
399 hetero- 1 0.5024
399 heterozygous 1 0.4023
399 highly 1 0.2711
399 histogenesis 1 0.4523
399 histological 1 0.2985
399 histology. 1 0.5024
399 hosts 1 0.423
399 i, 1 0.423
399 ii, 1 0.4023
399 iii, 1 0.3862
399 information 1 0.2711
399 interest, 1 0.4523
399 interesting 1 0.362
399 lastly, 1 0.423
399 lung 3 0.6481
399 male 1 0.2559
399 malignancy 1 0.4523
399 malignant 2 0.548
399 may 1 0.1257
399 metastases 1 0.3439
399 metastasis 1 0.423
399 metastasising 1 0.4523
399 morphic 1 0.5024
399 mouse 3 0.8404
399 multiple 1 0.277
399 new 1 0.2199
399 obtained. 1 0.3731
399 original 1 0.2869
399 parts 1 0.3439
399 passage, 1 0.5024
399 peculiarities 1 0.4523
399 pleo- 1 0.5024
399 pleomorphic 1 0.5024
399 point 1 0.2905
399 possible 1 0.2015
399 potential 1 0.3296
399 primary 2 0.4248
399 prognosis 1 0.277
399 provided 1 0.3074
399 reproduced 1 0.4023
399 retrospective 1 0.4523
399 rous. 1 0.5024
399 routes 1 0.423
399 select 1 0.4523
399 selective 1 0.2985
399 separate 1 0.3176
399 serial 1 0.3074
399 small 1 0.2015
399 study 1 0.1548
399 study. 1 0.3296
399 subcutaneous 1 0.3233
399 successfully 1 0.3439
399 survival 1 0.2417
399 technique 1 0.2364
399 tissues 1 0.2299
399 transplantable 3 1.2691
399 transplanted 1 0.362
399 tumour 6 1.8738
399 untreated 1 0.3731
399 valuable 1 0.3233
399 view 1 0.2944
399 zygous 1 0.5024
400 12 2 0.5757
400 12, 1 0.6029
400 12. 1 0.5428
400 16 1 0.3748
400 18 1 0.3288
400 22. 1 0.6029
400 2379. 1 0.6029
400 able 1 0.3401
400 adenovirus 4 2.0306
400 adenovirus. 1 0.6029
400 adenoviruses 1 0.6029
400 animals 1 0.2563
400 antigen, 1 0.4344
400 appears 1 0.2593
400 aspect 1 0.4229
400 authors 1 0.2778
400 bronchiolo-alveolar 1 0.6029
400 brought 1 0.3955
400 cases, 1 0.3157
400 caused 1 0.2639
400 cells 1 0.182
400 changes 1 0.1804
400 chest 1 0.4229
400 choice 1 0.388
400 consisted 1 0.3581
400 constitutes 1 0.4477
400 could 2 0.4332
400 culture 3 0.9055
400 cultured 1 0.3955
400 cultures 3 0.9055
400 cultures, 1 0.4827
400 demonstrated. 1 0.4344
400 developed 1 0.2741
400 development 1 0.2201
400 disappearance 1 0.3955
400 epithelial 3 0.9564
400 epithelium. 1 0.5076
400 examined 1 0.3044
400 fibroblasts 1 0.5076
400 fibroblasts. 1 0.5428
400 first 1 0.221
400 gave 1 0.3811
400 hamster 2 0.8688
400 hamster. 1 0.5428
400 hamsters 3 1.4482
400 histogenesis 1 0.5428
400 ical 1 0.5076
400 in-vitro 1 0.6029
400 infected 1 0.3288
400 infection 1 0.2836
400 inoculated 1 0.4344
400 known 1 0.2945
400 lung 2 0.5185
400 macrophages 1 0.4037
400 macrophages, 1 0.5076
400 made 1 0.2183
400 malignancy, 1 0.6029
400 malignant 3 0.9863
400 means 1 0.2671
400 months, 1 0.4634
400 nature, 1 0.4827
400 new-born 2 1.0856
400 normal 1 0.1621
400 one 1 0.1687
400 organotyp- 1 0.6029
400 origin. 1 0.4037
400 passages 1 0.4477
400 passages, 1 0.6029
400 presence 1 0.2297
400 presented 1 0.2339
400 progressive 1 0.3362
400 provoke 1 0.5428
400 pulmonary 2 0.5155
400 purely 1 0.4634
400 rapid 1 0.2922
400 reactions 1 0.2945
400 reimplanted 1 0.6029
400 rise 1 0.2993
400 seven 1 0.3443
400 specific 1 0.2372
400 study 1 0.1857
400 subsequent 1 0.3288
400 superinfection. 1 0.6029
400 time 1 0.2124
400 transformation 1 0.3288
400 transplant- 1 0.5428
400 tumor 1 0.2688
400 tumor. 1 0.4827
400 tumors 5 1.5786
400 tumors, 1 0.4634
400 two 1 0.1846
400 viral 1 0.3633
400 virus 1 0.3157
400 vitro, 1 0.4477
400 vivo; 1 0.6029
401 (hsl) 2 0.7536
401 (pplo) 1 0.3173
401 0.02 1 0.3173
401 125,000 1 0.3768
401 133. 1 0.3768
401 150,000; 1 0.3768
401 2 1 0.1151
401 40 1 0.2208
401 45 1 0.2523
401 50 1 0.1799
401 8 1 0.1702
401 80 1 0.258
401 ab- 1 0.3173
401 abnormal 1 0.1826
401 absent 2 0.4943
401 absorption 1 0.2342
401 active 1 0.1736
401 activity 1 0.1348
401 agar 1 0.2643
401 ammonium 1 0.3173
401 anti-hsl 1 0.3768
401 antigen 1 0.2238
401 antigen; 1 0.3768
401 antigens 2 0.4358
401 antisera 1 0.2897
401 appeared 1 0.1813
401 approximately 1 0.1973
401 associated 1 0.1338
401 best 1 0.1992
401 buffer, 1 0.3768
401 c. 1 0.1992
401 c., 2 0.6346
401 cell 4 0.5101
401 cells. 1 0.168
401 chang 2 0.7536
401 characteristic 1 0.1903
401 characterization 1 0.3173
401 chromatography 1 0.2523
401 common 2 0.3682
401 completely 1 0.2208
401 components 1 0.2152
401 concentrated 1 0.2897
401 conjunctiva, 1 0.3392
401 consist 1 0.2798
401 contained 1 0.1919
401 contamination 1 0.3392
401 culture, 1 0.3173
401 cytotoxic 1 0.2643
401 demonstrated 1 0.1611
401 demonstration, 1 0.3768
401 detected 2 0.3909
401 detroit-6. 1 0.3768
401 diploid 2 0.6346
401 electrophoresis 1 0.2798
401 eliminated 1 0.2643
401 embryo 1 0.2643
401 esophagus, 1 0.3392
401 existence 1 0.2305
401 extracts 1 0.2305
401 fluorescent 1 0.2897
401 found 1 0.0992
401 fractiona- 1 0.3768
401 fractions 1 0.2012
401 fresh 1 0.2715
401 g. 1 0.2798
401 gel 1 0.2179
401 globulin 1 0.3173
401 hela 1 0.2643
401 hela-mba, 1 0.3768
401 hela-s3, 1 0.3768
401 hela-sj 1 0.3768
401 hela-sj, 1 0.3768
401 henle's 1 0.3392
401 homogeneity 1 0.3768
401 hsl 7 2.6377
401 human 8 1.0061
401 immunoprecipitation. 1 0.3768
401 in- 1 0.167
401 inactivated 1 0.3017
401 indicated 3 0.5318
401 intestine 1 0.3017
401 j-iii. 1 0.3768
401 line 1 0.2271
401 lines 1 0.2179
401 lines, 1 0.3768
401 lines. 1 0.3017
401 liver, 1 0.258
401 material. 1 0.2715
401 microimmunodiffusion. 1 0.3768
401 minutes 3 0.7415
401 multiple 1 0.2077
401 normal 4 0.4053
401 number 1 0.1442
401 obtained 1 0.1343
401 organisms 1 0.2305
401 organs. 1 0.2715
401 partial 1 0.2101
401 particle 1 0.2897
401 pleuropneumonia-like 1 0.2897
401 po4 1 0.3392
401 preliminary 1 0.2152
401 preparations 2 0.4542
401 protein 1 0.1713
401 purest 1 0.3768
401 purification, 1 0.3768
401 purified 1 0.2382
401 rabbit 1 0.2126
401 sedimented 1 0.3768
401 sephadex 1 0.2798
401 sj-dhl, 1 0.3768
401 spectra 1 0.3768
401 stable 3 0.8145
401 still 1 0.176
401 strains 1 0.2238
401 strains, 1 0.2897
401 studies 1 0.1154
401 sulfate 1 0.2643
401 surface 1 0.2033
401 syverton's 1 0.3768
401 tion 1 0.1713
401 tissue 1 0.1308
401 tissues 1 0.1724
401 trace 1 0.2715
401 trypsin. 1 0.3173
401 two 1 0.1154
401 variety 1 0.2033
401 virtually 1 0.3173
401 weight 1 0.1773
401 wi-38 1 0.3768
401 x 1 0.2382
401 yielded 1 0.2382
402 1696. 1 1.0048
402 2 1 0.3068
402 acrobic 1 0.9046
402 adult 1 0.4568
402 also 1 0.2811
402 appreciable 1 0.7048
402 autologous 1 0.8046
402 became 1 0.5969
402 c57bl 1 0.8046
402 capacity 2 1.0959
402 carried 1 0.5031
402 cell 3 1.0202
402 change. 1 0.8461
402 chromosome 1 0.6728
402 coefficient, 1 1.0048
402 comparative 1 0.6148
402 considerably 1 0.6466
402 de- 1 0.5603
402 decreased 1 0.4538
402 derived 1 0.554
402 designated 1 0.7462
402 discussed. 1 0.4296
402 experiments 1 0.4452
402 explant 1 1.0048
402 female 1 0.5811
402 glycolysis 1 0.8046
402 inconclusive. 1 0.9046
402 isogenic 1 0.9046
402 line 3 1.8167
402 lines 2 1.1622
402 lines. 1 0.8046
402 lung 1 0.4321
402 malignant 1 0.548
402 mouse 1 0.5603
402 normal 2 0.5404
402 one 2 0.5622
402 origin, 1 0.7048
402 passages 1 0.7462
402 pg 1 0.9046
402 pg, 1 1.0048
402 proved 1 0.5603
402 provided 1 0.6148
402 pt 2 2.0097
402 pt. 1 1.0048
402 referred 1 0.5969
402 remained 1 0.5738
402 results 2 0.5755
402 scribed, 1 1.0048
402 showed 1 0.3582
402 similar 1 0.3762
402 single 1 0.4989
402 sinization 1 1.0048
402 studies 2 0.6154
402 successive 1 0.8046
402 tissue 1 0.3488
402 tryp- 1 1.0048
402 tumor-producing 1 1.0048
402 tumour-inducing 1 1.0048
402 tumour-producing 1 1.0048
402 two 1 0.3077
402 vitro 1 0.5165
402 well 1 0.3514
403 12 2 0.5757
403 1202. 1 0.6029
403 a-12, 1 0.6029
403 ability 1 0.3071
403 activity 1 0.2158
403 added 1 0.3748
403 adenovirus 2 1.0153
403 aggregated 1 0.6029
403 ance, 1 0.5428
403 appear- 1 0.5428
403 attempts 1 0.388
403 balls 1 0.6029
403 calf 1 0.4634
403 cell 1 0.204
403 cells 5 0.9098
403 cells, 2 0.5845
403 characteristics 2 0.6723
403 culture 2 0.6037
403 demonstrate 1 0.3487
403 depending 1 0.4827
403 described. 1 0.3018
403 detached 1 0.6029
403 eagle's 1 0.6029
403 either 1 0.2578
403 electron 1 0.3044
403 epithelioid 1 0.6029
403 fluids 1 0.4634
403 glass, 1 0.5428
403 grew 1 0.4037
403 growth 1 0.2055
403 hamster 3 1.3032
403 hamsters 1 0.4827
403 hamsters. 1 0.6029
403 hela 1 0.4229
403 horse 1 0.4827
403 human 3 0.6037
403 include 1 0.3581
403 induced 2 0.5126
403 inoculation 1 0.4037
403 irradiated 1 0.3487
403 lysed 1 0.6029
403 medium. 1 0.4634
403 microscopy, 1 0.4229
403 mixed 1 0.3811
403 monolayers 1 0.5076
403 negative. 1 0.5076
403 newborn 1 0.3288
403 pagated 1 0.6029
403 pro- 1 0.4127
403 rapid 1 0.2922
403 rate, 1 0.4229
403 resistance 1 0.3362
403 serially 1 0.5076
403 serum 2 0.4678
403 size, 1 0.4127
403 small 1 0.2419
403 subculture 1 0.5428
403 superinfection 1 0.6029
403 supernatant 1 0.4827
403 tissue 1 0.2093
403 transplant- 1 0.5428
403 tumor 3 0.8064
403 type 2 0.5015
403 virus 1 0.3157
403 vitro 1 0.3099
403 weanling 1 0.4634
403 whether 1 0.2993
404 (6 1 1.0048
404 (from 1 0.9046
404 (some 1 1.0048
404 142. 1 1.0048
404 20, 1 0.8046
404 3 1 0.3425
404 365 1 0.9046
404 8 1 0.4538
404 a. 1 0.6352
404 adjoining 1 1.0048
404 almost 1 0.5165
404 also 2 0.5622
404 animals 1 0.4272
404 around 1 0.6728
404 associated 1 0.3568
404 cancer 1 0.3972
404 carcinomas) 1 1.0048
404 carried 1 0.5031
404 cavity 1 0.8461
404 cell 1 0.3401
404 controlled 1 0.5738
404 cortisone 2 1.6091
404 days 1 0.3992
404 description 1 0.6591
404 detailed 1 0.6352
404 different 1 0.3554
404 examina- 1 0.9046
404 examination 1 0.5074
404 flanders, 1 1.0048
404 gave 1 0.6352
404 giant 1 0.6728
404 grafted 1 0.9046
404 heterotransplantation 1 1.0048
404 human 2 0.6707
404 it, 1 0.8046
404 kg.) 1 1.0048
404 kleisbauer 1 1.0048
404 large 1 0.3972
404 less 1 0.3762
404 lung. 1 0.724
404 massive. 1 1.0048
404 months 1 0.5074
404 necrosis 1 0.6879
404 negative 1 0.5888
404 old 1 0.5669
404 pleural 1 0.8461
404 rabbits 2 1.1476
404 radiographic 1 0.7724
404 reactions 1 0.4909
404 results 1 0.2878
404 though 1 0.5888
404 times 1 0.4833
404 tions. 1 0.9046
404 transplantation 1 0.6591
404 transplantation) 1 1.0048
404 treated 1 0.4135
404 treatment 1 0.2965
404 trials 2 1.6091
404 tumour 1 0.6246
404 tumours 3 1.9056
404 weighing 1 0.8461
405 (histiocytoma) 1 1.0048
405 1207. 1 1.0048
405 57-year-old 1 1.0048
405 abundant 1 1.0048
405 cell 2 0.6802
405 cells 1 0.3033
405 cinemato- 1 1.0048
405 culture 2 1.0062
405 finding. 1 1.0048
405 found 1 0.2645
405 granuloma 1 0.9046
405 granulomas 1 0.9046
405 graphic 1 0.9046
405 histiocytoma 1 1.0048
405 histiocytomas. 1 1.0048
405 histo- 1 1.0048
405 histopathologic, 1 1.0048
405 intensively 1 1.0048
405 lesion, 1 0.9046
405 lung 1 0.4321
405 lung. 1 0.724
405 mast 3 2.2385
405 may 1 0.2513
405 neoplastic. 1 1.0048
405 pathologically 1 0.8046
405 plasma-cell 1 1.0048
405 previously 1 0.4833
405 process 1 0.4598
405 pulmonary 1 0.4296
405 rather 1 0.4727
405 reactive 1 0.8461
405 solitary 1 0.8046
405 studied 1 0.3501
405 studies 1 0.3077
405 study 1 0.3096
405 suggested 1 0.4179
405 techniques. 1 0.724
405 time-lapse 1 0.8461
405 tissue 2 0.6976
405 unreported 1 0.8461
405 within 1 0.373
405 woman 1 0.6591
406 2773. 1 1.5073
406 3% 1 1.357
406 527 1 1.5073
406 93% 1 1.5073
406 ao-fluorochromation 1 1.5073
406 ao-fluorochromation, 1 1.5073
406 applied. 1 1.357
406 applying 1 1.5073
406 cancer 2 1.1917
406 compares 1 1.357
406 could 1 0.5415
406 cytodiag- 1 1.5073
406 cytodiagnosis 1 1.5073
406 cytology 1 1.357
406 diagnostic 1 0.7483
406 discusses 1 1.357
406 er- 1 1.5073
406 erroneously 1 1.357
406 find- 1 1.5073
406 findings 1 0.5987
406 fluorescence 1 1.2069
406 higher 2 1.2963
406 ings 1 1.5073
406 lung 1 0.6481
406 means 1 0.6678
406 method 1 0.5987
406 methods 2 1.3613
406 negative 1 0.8832
406 nostics 1 1.5073
406 paper 1 0.8133
406 positive 1 0.805
406 precision 1 1.5073
406 preparation. 1 1.2691
406 pulmonary 1 0.6444
406 rate 2 1.1097
406 reduced. 1 1.2691
406 results 1 0.4316
406 roneously 1 1.5073
406 samples 1 0.9528
406 sent 1 1.2691
406 somewhat 1 1.1192
406 test 1 0.6519
406 tissue 1 0.5232
406 total 1 0.5875
406 value 1 0.6944
407 (10.3%) 1 0.4306
407 (62%) 1 0.4306
407 24 1 0.2234
407 25%. 1 0.3877
407 2774. 1 0.4306
407 380 1 0.4306
407 39 2 0.6206
407 50% 1 0.2595
407 accounting 1 0.3877
407 accuracy 1 0.331
407 almost 1 0.2213
407 and/or 1 0.2722
407 bronchi, 1 0.4306
407 bronchial 2 0.6396
407 bronchioloalveo- 1 0.4306
407 broncho- 1 0.4306
407 bronchogenic 4 1.7226
407 cancer. 1 0.3021
407 carcinoma 7 1.4391
407 carcinoma. 2 0.5896
407 carcinomas 1 0.3448
407 carcinomas. 1 0.3877
407 cases 4 0.5125
407 cases; 1 0.3448
407 cell 1 0.1457
407 certified 1 0.4306
407 challenge 1 0.3626
407 chiefly 1 0.3103
407 clinical 2 0.2808
407 clinical, 1 0.2771
407 compatible 1 0.3626
407 conclusion 1 0.2883
407 confirmation. 1 0.4306
407 cytologic 1 0.3198
407 cytologic, 1 0.4306
407 deaths 1 0.3103
407 diagnosis 3 0.5316
407 diagnostic 2 0.4276
407 duct 1 0.2948
407 error 1 0.3103
407 exclusion 1 0.4306
407 exhibit 1 0.3877
407 extrathoracic 1 0.4306
407 features 3 0.69
407 findings 1 0.1711
407 frequency 2 0.451
407 genic 1 0.3877
407 glandular 1 0.3198
407 greatest 1 0.2722
407 growths 1 0.3877
407 histologic 3 0.865
407 identical 1 0.2558
407 inasmuch 1 0.4306
407 indistinguishable 1 0.331
407 kidney. 1 0.2677
407 lar 1 0.331
407 lesions 1 0.1852
407 lung 3 0.5555
407 lungs 1 0.2348
407 lymph 1 0.2677
407 may 3 0.3231
407 metastases 4 1.1792
407 metastatic 2 0.5543
407 morphological 1 0.2635
407 necropsy 2 0.6206
407 nodes, 1 0.3103
407 occurred 1 0.1874
407 occurs 1 0.23
407 one-third 1 0.331
407 ors 1 0.4306
407 pancreas 1 0.3103
407 phic 1 0.4306
407 pitfalls 1 0.4306
407 pleomor- 1 0.4306
407 present 1 0.1418
407 presented 1 0.1671
407 presumptive 1 0.4306
407 primary 3 0.5462
407 pulmonary 1 0.1841
407 reproduced 1 0.3448
407 resected 1 0.3626
407 responsible 1 0.2175
407 revealed 1 0.2087
407 roentgenologically 1 0.4306
407 second 1 0.2194
407 secondary 1 0.2156
407 series 1 0.2026
407 simulating 2 0.8613
407 simulation 1 0.4306
407 site 1 0.249
407 sites. 1 0.4306
407 solitary 1 0.3448
407 source 1 0.2883
407 squamous 1 0.3626
407 study 1 0.1327
407 sufficient 1 0.2595
407 tissue 1 0.1495
407 tum- 1 0.4306
407 tumors 1 0.2255
408 'residual 1 0.7536
408 'rough' 1 0.7536
408 'smooth' 1 0.7536
408 (derived 1 0.7536
408 4396. 1 0.7536
408 accumulations 1 0.6785
408 acid 3 0.8731
408 acquired 1 0.4685
408 activity. 1 0.5159
408 agents 3 1.2199
408 agents, 2 1.1192
408 alterations 1 0.4155
408 and, 2 0.7819
408 arginine 3 1.7379
408 aryl 1 0.7536
408 assumed 1 0.5159
408 autophagic 1 0.6785
408 bodies' 1 0.6785
408 bodies, 1 0.6034
408 carcinoma) 1 0.6785
408 cells 1 0.2274
408 cells, 1 0.3653
408 cells. 1 0.336
408 changes 1 0.2255
408 connections 1 0.6785
408 cultured 2 0.9887
408 cytochemical 1 0.6785
408 cytochemically 1 0.7536
408 demonstrable 1 0.5046
408 deprivation 2 1.086
408 deprivation, 1 0.6346
408 developed 1 0.3426
408 different 1 0.2666
408 doses 1 0.411
408 dye, 1 0.7536
408 effects 1 0.2798
408 either 1 0.3222
408 electron 1 0.3805
408 endoplasmic 4 2.2385
408 esterase, 1 0.7536
408 fatase 1 0.7536
408 following 1 0.2498
408 form 1 0.3279
408 formation 1 0.3381
408 glycogen. 1 0.7536
408 grown 1 0.5159
408 high 1 0.2697
408 human 1 0.2515
408 i.e., 1 0.5793
408 increase 1 0.256
408 injured 1 0.5793
408 injured, 1 0.7536
408 involved 1 0.3839
408 kb 3 2.0354
408 least 1 0.3874
408 light 1 0.4252
408 lyso- 1 0.6785
408 lysosomes 3 1.6788
408 microscopy, 1 0.5286
408 monolayers 1 0.6346
408 multivesicular 1 0.6346
408 near 1 0.4542
408 nucleolar 1 0.6785
408 number 1 0.2884
408 occasionally, 1 0.7536
408 one 1 0.2108
408 oral 1 0.4611
408 phosphatase 3 1.6788
408 possibility 1 0.4303
408 preparations, 1 0.6034
408 preparations. 1 0.5596
408 produced 2 0.6138
408 radiation 1 0.411
408 radiation, 2 1.357
408 raise 1 0.6346
408 retic- 1 0.7536
408 reticulum 3 1.7379
408 size 1 0.3946
408 somes. 1 0.6785
408 starvation 1 0.6785
408 structure 1 0.3839
408 studied 1 0.2626
408 study 1 0.2322
408 suggested 1 0.3134
408 sul- 1 0.7536
408 them. 1 0.543
408 three 3 0.8501
408 transport 1 0.4542
408 treatment 1 0.2223
408 triglyceride 1 0.6346
408 two 1 0.2308
408 ultrastructural 1 0.6346
408 ultrastructurally, 1 0.7536
408 ultraviolet 3 1.7379
408 ulum, 1 0.7536
408 vacuoles. 1 0.6346
408 variety 1 0.4066
408 varying 1 0.4066
408 viewed 1 0.6346
408 vital 1 0.5596
408 ways, 1 0.7536
408 whorls, 1 0.7536
408 x-radiation 1 0.6346
408 x-radiation. 1 0.7536
409 - 4 1.7663
409 10 1 0.2774
409 1106. 1 0.7536
409 14.8%. 1 0.7536
409 168 1 0.5793
409 2 1 0.2301
409 24.5%. 1 0.7536
409 50% 1 0.4542
409 50%. 1 0.7536
409 53 1 0.6346
409 70 1 0.5793
409 90 1 0.5596
409 arterial 1 0.3909
409 authors' 1 0.5793
409 blood 1 0.2329
409 bypass 1 0.543
409 c. 2 0.797
409 cardiac 1 0.3381
409 cardiopulmonary 1 0.5793
409 cases 3 0.6727
409 cerebrum 1 0.7536
409 changes 1 0.2255
409 circulation 1 0.3946
409 closed 1 0.5596
409 conditions 1 0.3426
409 congenital 1 0.3449
409 cooled 1 0.543
409 crista 1 0.7536
409 cyanotic 1 0.6346
409 data 1 0.3069
409 deep 1 0.5286
409 described. 1 0.3773
409 disease 1 0.2708
409 extracorporal 1 0.7536
409 fallot 1 0.6034
409 flap 1 0.6785
409 gradient 1 0.5286
409 group 1 0.2786
409 heart 2 0.6992
409 hg 1 0.5159
409 hypothermia 2 0.7747
409 hypothermia. 1 0.5793
409 hypoxic 1 0.5793
409 internal 1 0.4252
409 kept 1 0.5596
409 leads 1 0.4202
409 less 1 0.2821
409 maintained 1 0.4202
409 majority 1 0.485
409 mean 1 0.3625
409 mm. 1 0.4943
409 mortality 2 0.9083
409 neither 1 0.4943
409 operative 1 0.4202
409 organs, 1 0.5596
409 others, 1 0.5793
409 overall 1 0.4943
409 oxygenator 1 0.6034
409 patients 1 0.1812
409 perfusion 2 0.8832
409 perfusion. 1 0.6346
409 presented 1 0.2924
409 pressure 1 0.3449
409 provided 1 0.4611
409 pump 1 0.5596
409 reduced 2 0.6807
409 show 1 0.326
409 simultaneous 2 0.9221
409 supraventricularis. 1 0.7536
409 surgery 2 0.7483
409 taking 1 0.543
409 technique 2 0.7091
409 tetralogy 1 0.6034
409 tissue 1 0.2616
409 use 2 0.5959
409 volume 2 0.7678
409 vsd 1 0.7536
409 water 2 0.797
410 11% 1 0.3626
410 154% 1 0.4306
410 183% 1 0.4306
410 20 7 1.3613
410 205% 1 0.4306
410 25% 1 0.3021
410 30 1 0.2056
410 31% 1 0.4306
410 39% 1 0.3877
410 464. 1 0.4306
410 50% 1 0.2595
410 absolute 1 0.3021
410 aorta 2 0.5767
410 aortic 2 0.46
410 arch 1 0.3877
410 artery 1 0.2459
410 ascending 2 0.6621
410 blood 1 0.1331
410 c. 7 1.5939
410 cardiac 2 0.3865
410 chest 1 0.3021
410 chest. 1 0.4306
410 circumflex 1 0.4306
410 closed 1 0.3198
410 consumption 1 0.3021
410 consumption, 1 0.3877
410 cooled 1 0.3103
410 coronary 1 0.2771
410 corresponding 1 0.2523
410 decreased 3 0.5834
410 dogs 4 0.8936
410 efficiency 2 0.6396
410 experimental 1 0.1998
410 expressed 1 0.3103
410 external 2 0.519
410 flow 3 0.6581
410 hypothermia. 1 0.331
410 increased 1 0.1339
410 left 6 1.1669
410 level 6 0.9978
410 mean 1 0.2071
410 measured 1 0.1885
410 mechanical 1 0.3103
410 mothermic 1 0.4306
410 multiple 1 0.2374
410 myocardium 1 0.331
410 nor- 1 0.2771
410 normothermia, 1 0.4306
410 normothermic 6 1.9862
410 open 1 0.3021
410 oxygen 2 0.4387
410 parameters 2 0.6206
410 percentages 1 0.3448
410 performance 1 0.2948
410 peripheral 1 0.2558
410 power 2 0.6621
410 power, 1 0.3877
410 pressure 1 0.1971
410 reduced 2 0.389
410 resistance 1 0.2401
410 study 1 0.1327
410 temperature. 1 0.3448
410 total 1 0.1678
410 values 2 0.4349
410 values. 1 0.3626
410 ventricular 5 0.9368
411 (40%) 1 0.7536
411 (70%) 1 0.6785
411 10 2 0.5548
411 12 1 0.3598
411 15 2 0.7483
411 2 1 0.2301
411 200 1 0.4943
411 25 1 0.4303
411 3270. 1 0.7536
411 55 1 0.6034
411 6 1 0.3151
411 9 1 0.3946
411 acidosis 1 0.5596
411 advantages 1 0.5286
411 assured 1 0.7536
411 atrial 1 0.485
411 bypass 1 0.543
411 c 1 0.411
411 c. 1 0.3985
411 cc/kg/min 1 0.7536
411 cc/kg/min. 1 0.7536
411 chamber. 1 0.7536
411 change 1 0.3496
411 changes 1 0.2255
411 changes. 1 0.6034
411 circulation 1 0.3946
411 compared 1 0.2924
411 controlled 1 0.4303
411 death 1 0.411
411 deep 1 0.5286
411 degree, 1 0.6346
411 dogs 4 1.5637
411 due 1 0.2666
411 duration 1 0.3946
411 eleven 1 0.5793
411 even 1 0.3299
411 explained 1 0.4252
411 extracorporeal 1 0.4943
411 flow 4 1.5356
411 flow, 1 0.543
411 former 1 0.5159
411 great 1 0.4303
411 greater 1 0.3118
411 group 3 0.8357
411 group. 1 0.4358
411 groups; 1 0.6346
411 high 3 0.8091
411 hr, 1 0.7536
411 hypothermia 1 0.3874
411 hypothermia. 1 0.5793
411 hypothermic 1 0.5159
411 induced 1 0.3204
411 intermediate 1 0.485
411 left 1 0.3403
411 lived. 1 0.7536
411 low 2 0.6597
411 lung 2 0.6481
411 mainly 1 0.4943
411 maintained 2 0.8404
411 me- 1 0.5793
411 min., 1 0.7536
411 normothermia. 1 0.7536
411 normothermic 2 1.1586
411 occurred 1 0.3279
411 oxygenator 1 0.6034
411 partial 1 0.4202
411 perfused 1 0.6034
411 postperfusion 1 0.7536
411 pressure 1 0.3449
411 pulmonary 1 0.3222
411 pump 1 0.5596
411 rate 1 0.2774
411 reduced 1 0.3403
411 survived 2 0.9887
411 tabolic 1 0.7536
411 temperature 1 0.4025
411 though 1 0.4416
411 tolerance 1 0.485
411 venous 1 0.4252
411 venting 1 0.7536
412 (1) 1 0.3653
412 (2) 1 0.3653
412 (3) 1 0.3985
412 (4) 1 0.4358
412 1593. 1 0.7536
412 18 1 0.411
412 25. 1 0.6785
412 aid 1 0.543
412 also, 1 0.543
412 aneurysms 1 0.5596
412 antagonist 1 0.6785
412 antagonists; 1 0.7536
412 associated 1 0.2676
412 become 1 0.4155
412 bleeding 2 1.1192
412 body 1 0.3038
412 cases 1 0.2242
412 cause 1 0.3403
412 changes 1 0.2255
412 cir- 1 0.6346
412 circulation 2 0.7893
412 circulation. 1 0.6034
412 closed-thorax 2 1.5073
412 coagulation 1 0.5793
412 considered 1 0.336
412 control 1 0.2834
412 culation, 1 0.7536
412 deep 1 0.5286
412 defect 1 0.3711
412 determinants 1 0.6034
412 develop 1 0.4542
412 effect, 1 0.5596
412 effective 1 0.3773
412 essential 1 0.4416
412 excessive 1 0.485
412 extracorporeal 4 1.9773
412 factors 1 0.3186
412 following 1 0.2498
412 forty-three 1 0.7536
412 he- 1 0.6785
412 hemorrhagic 1 0.6034
412 hemostasis 1 0.6346
412 heparin 3 1.7379
412 hypothermia 2 0.7747
412 inhibition 1 0.3773
412 intracranial 1 0.4943
412 lead 1 0.485
412 made 1 0.2729
412 major 1 0.3625
412 may 4 0.7539
412 method 4 1.1975
412 meticulous 1 0.6785
412 microcirculation 1 0.6785
412 mimicking 1 0.7536
412 neurologic 1 0.5793
412 normal; 1 0.7536
412 occurs 1 0.4025
412 oozing 1 0.6785
412 open- 1 0.6785
412 open-thorax 1 0.7536
412 operated 1 0.485
412 parin 1 0.7536
412 pathologic 1 0.4611
412 patients 1 0.1812
412 points 1 0.5159
412 profound 1 0.5159
412 profound-hypothermia 1 0.7536
412 reaction 1 0.3773
412 respects; 1 0.7536
412 return 1 0.5596
412 several 1 0.326
412 significant 1 0.2646
412 superior 1 0.5046
412 surgery 1 0.3742
412 technics 1 0.6785
412 temperature 1 0.4025
412 tendencies 1 0.6785
412 tendency. 1 0.6785
412 thorax 1 0.6785
412 thrombin-fibrinogen 1 0.6785
412 thrombocytopenia 1 0.6785
412 use 1 0.2979
412 used 1 0.2846
413 4088. 1 1.0048
413 accompanied 1 0.5603
413 astroglia 1 1.0048
413 available 1 0.548
413 body 1 0.4051
413 brain. 1 0.7724
413 cases 1 0.299
413 cerebral 3 1.4285
413 cerebrospinal 1 0.6056
413 clinical 1 0.3275
413 damage 3 1.5356
413 dehydration 3 2.7139
413 delayed 1 0.5888
413 either 1 0.4296
413 episode 1 0.8046
413 especially 2 1.0329
413 evidence 1 0.3684
413 experimental 1 0.4661
413 failed. 1 1.0048
413 favors 1 1.0048
413 fluid 1 0.4762
413 former. 1 0.9046
413 hypothermia 2 1.0329
413 hypothermia, 1 0.7048
413 hypoxia 2 1.2933
413 hypoxia. 1 0.9046
413 immediately 1 0.6148
413 impor- 1 0.9046
413 injury 1 0.6728
413 insecure 1 1.0048
413 lowering 1 0.724
413 measures, 1 1.0048
413 nature 1 0.4989
413 oligodendroglia, 1 1.0048
413 pressure 1 0.4598
413 probably 1 0.4568
413 progressive 1 0.5603
413 proved, 1 1.0048
413 raised 1 0.5969
413 rational 2 1.6922
413 re- 1 0.4452
413 reserved 1 0.8461
413 results 2 0.5755
413 severe 1 0.4452
413 suggested 1 0.4179
413 suppress 1 0.7462
413 tant 1 0.9046
413 temperature 1 0.5366
413 treatment 2 0.5929
413 uncertain. 1 0.8461
413 use 1 0.3972
413 using 2 0.9135
413 verse 1 1.0048
414 (papaverine) 1 0.6029
414 (po2) 1 0.6029
414 15 1 0.2993
414 20 1 0.2723
414 37 1 0.4037
414 4 1 0.2133
414 40% 1 0.4344
414 7 1 0.2778
414 7828. 1 0.6029
414 acid 2 0.4656
414 acidosis 1 0.4477
414 advance 1 0.5428
414 aiding 1 0.6029
414 analysis 1 0.29
414 arteriovenous 1 0.4827
414 average 1 0.2705
414 base 1 0.4229
414 brain 5 1.5356
414 c. 2 0.6376
414 cally 1 0.5076
414 cerebral 1 0.2857
414 cooling 2 0.7267
414 cooling. 1 0.5428
414 curve 1 0.4127
414 definite 1 0.4127
414 described 1 0.2287
414 described. 1 0.3018
414 developed 1 0.2741
414 dif- 1 0.4477
414 difference 1 0.3018
414 direct 1 0.2836
414 disappearance 2 0.7909
414 discrepancy 1 0.4827
414 discussed. 3 0.7733
414 dissolved 1 0.5076
414 dogs 1 0.3127
414 dogs, 1 0.4037
414 features 1 0.322
414 ferent 1 0.6029
414 ficant 1 0.6029
414 finding 1 0.3689
414 following 1 0.1998
414 glucose 1 0.3157
414 hypothermia 1 0.3099
414 hypothermic 1 0.4127
414 indicating 1 0.388
414 ischemia 1 0.5428
414 lactic 1 0.4229
414 lowered 1 0.4477
414 markedly 1 0.322
414 may 1 0.1508
414 measured 1 0.2639
414 metabolize 1 0.5076
414 method 1 0.2395
414 methods. 1 0.3811
414 nomogram 1 0.6029
414 noted 1 0.3188
414 oxygen 2 0.6142
414 performed 1 0.2759
414 perfusate 1 0.6029
414 perfusion 1 0.3533
414 physi- 1 0.6029
414 physiology 1 0.4477
414 preference 1 0.5076
414 previously 1 0.29
414 producing 1 0.388
414 rate 4 0.8878
414 reasons 1 0.4037
414 reduced 1 0.2723
414 relieve 1 0.4634
414 represented 1 0.4827
414 safe, 1 0.5428
414 salient 1 0.6029
414 selective 3 1.0744
414 siggaard-andersen 1 0.6029
414 signi- 1 0.5428
414 significant 1 0.2116
414 substance 1 0.4229
414 suitable 1 0.388
414 survival 1 0.29
414 survived. 1 0.5076
414 technic 1 0.4634
414 technical 1 0.4344
414 technique 1 0.2836
414 tempera- 1 0.5428
414 temperature 1 0.322
414 temperatures 1 0.3811
414 temperatures. 1 0.6029
414 time 1 0.2124
414 tures, 1 0.6029
414 use 1 0.2383
414 utili- 1 0.5428
414 utilizing 1 0.4477
414 vasodilator 1 0.6029
414 vasospasm 1 0.6029
414 vitro 1 0.3099
414 zation 1 0.5428
415 28 1 0.4127
415 30-29 1 0.6029
415 32 1 0.4634
415 35-32, 1 0.6029
415 948.cardiac 1 0.6029
415 abdominal 1 0.4477
415 activity 1 0.2158
415 alters 1 0.5428
415 amounts 1 0.2993
415 appearance 1 0.2993
415 areflexia 1 0.6029
415 associated 1 0.2141
415 beating. 1 0.6029
415 below, 1 0.5428
415 bradycardia 1 0.4827
415 cavae 1 0.5428
415 changes 1 0.1804
415 circulation. 1 0.4827
415 clear 1 0.3633
415 conditions 1 0.2741
415 conduction 1 0.5428
415 continues 1 0.4634
415 contractile 1 0.5076
415 cranio-cerebral 2 1.2058
415 deepens 1 0.6029
415 degree 1 0.2671
415 deve- 1 0.6029
415 develop 1 0.3633
415 development 1 0.2201
415 diaphragm. 1 0.6029
415 direct 1 0.2836
415 energy 1 0.4127
415 especially 1 0.3099
415 even 1 0.2639
415 excitability 1 0.6029
415 excluded 1 0.4477
415 experimental 1 0.2797
415 extrasystoles 1 0.6029
415 falls, 1 0.6029
415 half 1 0.3533
415 heart 5 1.3983
415 heart, 1 0.4634
415 hemodynamic 1 0.4037
415 hypothermia 3 0.9296
415 idioventricular 1 0.6029
415 increases. 1 0.6029
415 insufficiency 1 0.3581
415 level 1 0.2328
415 ligatures 1 0.6029
415 lops, 1 0.6029
415 lue. 1 0.6029
415 mal 1 0.4037
415 marked 1 0.2705
415 may 2 0.3016
415 modified. 1 0.6029
415 mulation 1 0.6029
415 myocardium 2 0.9269
415 nor- 1 0.388
415 normal 1 0.1621
415 observed 1 0.2055
415 observed. 2 0.7267
415 onset 1 0.3487
415 opera- 1 0.4634
415 operations 3 1.1864
415 organs 1 0.3324
415 original 1 0.3443
415 patients. 1 0.29
415 power 1 0.4634
415 rare 1 0.3581
415 rarely 1 0.4229
415 rate 4 0.8878
415 rate. 1 0.4344
415 reflexogenic 1 0.6029
415 removal 1 0.3362
415 resistant. 1 0.5428
415 restored. 2 1.2058
415 rhythm 2 0.8688
415 significant 1 0.2116
415 slightly 1 0.3443
415 slows, 1 0.6029
415 solitary 1 0.4827
415 stabilization 1 0.5076
415 stage 1 0.2922
415 sti- 1 0.6029
415 stimulation 1 0.3401
415 stops 1 0.5076
415 surgical 1 0.2723
415 temperature 1 0.322
415 tion 1 0.2741
415 usually 2 0.5673
415 va- 1 0.5076
415 venae 1 0.6029
415 warming 1 0.5428
415 well-marked 1 0.6029
415 whether 1 0.2993
415 zones. 1 0.5428
416 (jorgensen 1 1.0048
416 (winterstein) 1 1.0048
416 21-25 1 1.0048
416 946. 1 1.0048
416 acid-base 1 0.8461
416 acidosis 1 0.7462
416 alkalinity 1 1.0048
416 alveolar 1 0.548
416 anesthesia, 1 0.8461
416 ar- 1 0.9046
416 arterial 1 0.5212
416 astrup) 1 1.0048
416 balance 1 0.6879
416 bicarbonate 1 0.8461
416 blood 2 0.621
416 c. 1 0.5313
416 ch 1 1.0048
416 changes 1 0.3007
416 coh/ 1 1.0048
416 completely 1 0.5888
416 concerned. 1 0.9046
416 cooling 1 0.6056
416 cooling, 1 0.8461
416 course 2 0.9135
416 decreased 1 0.4538
416 decreased, 1 0.9046
416 disappeared 1 0.724
416 dogs, 1 0.6728
416 failed 1 0.5738
416 fell, 1 1.0048
416 findings 1 0.3992
416 hypothermia. 3 2.3172
416 hypothermic 1 0.6879
416 i. 1 0.5969
416 ice 1 1.0048
416 im- 1 0.724
416 increase, 1 0.8461
416 increased, 1 0.7462
416 initial 3 1.4612
416 latory 1 1.0048
416 light 1 0.5669
416 lowering, 1 1.0048
416 made 1 0.3639
416 markedly 1 0.5366
416 mechanisms 1 0.6056
416 mersing 1 1.0048
416 metabolic 1 0.4797
416 mongrel 1 0.9046
416 normothermic 1 0.7724
416 observed 1 0.3425
416 occur. 1 0.8046
416 pattern 1 0.4797
416 pco2 1 0.8046
416 pentobarbital 1 0.8461
416 ph 1 0.5422
416 phenomenon 1 0.5811
416 progress 1 0.7048
416 pulmonary 1 0.4296
416 rapidly 1 0.5738
416 rate 1 0.3699
416 rectal 2 1.8093
416 reduced 1 0.4538
416 respiration 2 1.6922
416 respiratory 3 1.5637
416 rested 1 0.9046
416 rewarming 1 0.9046
416 slight 1 0.5969
416 spontaneous 1 0.5811
416 standard 1 0.6879
416 stimulation 1 0.5669
416 suggest 1 0.4568
416 temperature 1 0.5366
416 temperatures 1 0.6352
416 though 1 0.5888
416 transitory 1 1.0048
416 venti- 1 1.0048
416 ventilation, 1 0.8461
416 warm 1 1.0048
416 water 1 0.5313
416 water. 1 0.7462
417 896. 1 0.3349
417 aggregate. 1 0.3349
417 although 1 0.1288
417 anesthesia 1 0.282
417 be- 1 0.2049
417 behave 1 0.282
417 blood 9 0.9315
417 cells 1 0.1011
417 cellular 1 0.1827
417 concentra- 1 0.2413
417 conditions 1 0.1523
417 contraindicated 1 0.3015
417 cyclopropane, 1 0.3349
417 data 1 0.1364
417 described. 1 0.1677
417 difference 1 0.1677
417 discussed. 1 0.1432
417 ed 1 0.2293
417 essentially 1 0.2293
417 failing. 1 0.3349
417 fresh 1 0.2413
417 halothane 1 0.3015
417 hemoconcentration 1 0.3349
417 heparinized 1 0.3349
417 hypothermia, 1 0.2349
417 indicat- 1 0.3349
417 mal 1 0.2243
417 manner, 1 0.282
417 measurement 1 0.189
417 measuring 2 0.5364
417 method 1 0.1331
417 microcirculation 1 0.3015
417 modified 1 0.2413
417 nature 1 0.1663
417 newtonian 1 0.3349
417 nor- 1 0.2155
417 norepinephrine 1 0.3015
417 obtained 1 0.1194
417 plasma 2 0.2701
417 principles 1 0.2293
417 proteins 1 0.1737
417 quantity 1 0.2487
417 raise 1 0.282
417 red 1 0.199
417 reduce 1 0.2117
417 relative 1 0.1737
417 saline 1 0.2487
417 seem 2 0.3653
417 serum. 1 0.2413
417 significance 1 0.1827
417 simple 1 0.1827
417 sodium 1 0.1611
417 studies 1 0.1026
417 tend 1 0.2413
417 tendency 1 0.2413
417 thiopental 1 0.3349
417 tion. 1 0.2487
417 tween 1 0.2413
417 useful. 1 0.3349
417 varies 1 0.2413
417 viscosity 7 1.8773
417 vitro 1 0.1722
417 would 1 0.1663
418 'rewarming 2 1.0048
418 1 1 0.1897
418 37% 1 0.5024
418 4612. 1 0.5024
418 5% 1 0.362
418 75% 1 0.4023
418 abolish 1 0.423
418 abolished 1 0.3296
418 ac- 1 0.3233
418 accompa- 1 0.5024
418 accuracies 1 0.5024
418 active 1 0.2315
418 added 1 0.3123
418 addition 1 0.2559
418 advantages 1 0.3524
418 agents. 1 0.4523
418 anesthetic 1 0.423
418 anoxia 1 0.423
418 arterial 1 0.2606
418 attached 1 0.3731
418 averaging 1 0.423
418 blood 3 0.4657
418 blood. 1 0.3364
418 c. 1 0.2657
418 carotid 3 0.9887
418 cause 1 0.2269
418 cerebral 2 0.4762
418 chiefly 1 0.362
418 cir- 1 0.423
418 clinical 1 0.1638
418 co2 2 0.724
418 concerned 1 0.3364
418 considerations 1 0.3439
418 cooling 4 1.2111
418 cooling. 1 0.4523
418 counter 1 0.4523
418 cuit 1 0.5024
418 dangerous 2 0.9046
418 described 1 0.1906
418 described. 1 0.2515
418 determined 2 0.4568
418 dex 1 0.4523
418 directly 1 0.3176
418 discussed 2 0.4092
418 dogs 1 0.2606
418 due 1 0.1777
418 either 1 0.2148
418 evidence 2 0.3684
418 fall 1 0.2631
418 faster 1 0.362
418 femoral 1 0.3862
418 fixed 1 0.362
418 flow 6 1.5356
418 flows 2 0.7724
418 flows. 1 0.5024
418 fluid 1 0.2381
418 fusion 2 0.7462
418 graphs. 1 0.5024
418 halothane 1 0.4523
418 high 1 0.1798
418 humps' 1 0.5024
418 humps'. 1 0.5024
418 hypothermia 2 0.5165
418 in- 1 0.2226
418 increase 2 0.3413
418 increased 2 0.3124
418 injection 1 0.2101
418 instead 1 0.4023
418 interfering 1 0.5024
418 intrinsically 1 0.5024
418 investigation. 1 0.423
418 linked 1 0.3524
418 local 1 0.3028
418 low 2 0.4398
418 maintained 1 0.2801
418 maintenance 1 0.4023
418 manifested 1 0.3862
418 may 2 0.2513
418 mean 1 0.2417
418 mentioned 1 0.362
418 method 2 0.3992
418 methods 1 0.2269
418 minute 1 0.3731
418 nies 1 0.5024
418 occur 1 0.2454
418 output 1 0.2944
418 partial 1 0.2801
418 particularly 1 0.277
418 per 1 0.1958
418 per- 2 0.6728
418 place 1 0.3074
418 predetermined 2 0.9046
418 presented 1 0.1949
418 pressor 1 0.4023
418 pressure 4 0.9196
418 prevented 1 0.3296
418 priming 1 0.5024
418 produced 1 0.2046
418 pump 1 0.3731
418 rate. 1 0.362
418 rates 1 0.3028
418 rather 1 0.2364
418 reduction 1 0.2474
418 regional 1 0.362
418 relation 1 0.2315
418 require 1 0.3439
418 resistance. 1 0.5024
418 revolution 1 0.5024
418 rheomacro- 1 0.5024
418 scientific 1 0.5024
418 sixty 1 0.4523
418 spasm 1 0.5024
418 spasm, 1 0.5024
418 spasm. 1 0.5024
418 stroke 1 0.3524
418 subjected 1 0.274
418 suggested 2 0.4179
418 sympatholytic 1 0.5024
418 systemic 1 0.2801
418 temperatures 1 0.3176
418 thus 1 0.2606
418 tion. 1 0.3731
418 together 1 0.2869
418 total 1 0.1958
418 use 1 0.1986
418 used 2 0.3795
418 viscosity 1 0.4023
418 volume, 1 0.3439
419 3rd 1 0.724
419 4613. 1 1.0048
419 4th 1 0.7462
419 affect 1 0.6352
419 anesthesia. 1 0.9046
419 anesthetic 1 0.8461
419 anterior 1 0.6352
419 appear- 1 0.9046
419 applied 1 0.6056
419 areas 2 1.0626
419 body 2 0.8102
419 brain 1 0.5119
419 brain-stem 2 2.0097
419 cen- 1 1.0048
419 cerebral 2 0.9524
419 circulatory 2 1.4096
419 cns 1 0.7048
419 controlled 1 0.5738
419 cooling 3 1.8167
419 directly 1 0.6352
419 disappeared 1 0.724
419 distinct 1 0.6246
419 dogs. 1 0.7462
419 ed 1 0.6879
419 frontal 1 0.7724
419 heat 1 0.7724
419 heating 1 0.7724
419 hyperthermic 1 1.0048
419 hypothermia 1 0.5165
419 hypothermic 1 0.6879
419 initiation 1 0.8461
419 lar 1 0.7724
419 loss 1 0.4871
419 may 1 0.2513
419 mechanisms 1 0.6056
419 one 1 0.2811
419 panting 1 1.0048
419 panting. 1 1.0048
419 part 1 0.4694
419 pentobarbital 1 0.8461
419 perfusion 3 1.7663
419 peripheral 1 0.5969
419 produced 3 1.2277
419 purposes. 1 0.9046
419 rather 1 0.4727
419 reactions. 1 0.7724
419 related 1 0.4248
419 respiratory 2 1.0425
419 retarded 1 0.6466
419 rewarming 1 0.9046
419 selective 2 1.1938
419 shivering 2 1.6922
419 significantly 1 0.4225
419 suggested 1 0.4179
419 systems 1 0.7048
419 temperature 1 0.5366
419 temperature. 1 0.8046
419 third 1 0.548
419 trally 1 1.0048
419 unaffected 1 0.8046
419 used. 1 0.6879
419 utilized 1 0.7724
419 ventricle 1 0.5811
419 ventricu- 1 0.9046
419 ventricular 2 0.8744
420 (25 1 0.201
420 (about 1 0.1809
420 (mvo2), 1 0.201
420 100 2 0.2267
420 1139. 1 0.201
420 15 1 0.0998
420 18 3 0.3288
420 22 1 0.1376
420 25 1 0.1148
420 31 1 0.1492
420 50 2 0.1919
420 acute 1 0.0998
420 appears 1 0.0864
420 appreciably 1 0.1809
420 assayed. 1 0.201
420 bed. 1 0.1809
420 bypass 5 0.724
420 bypass. 1 0.201
420 bypassed 1 0.201
420 c. 4 0.4251
420 c.) 2 0.3384
420 capillary 1 0.1448
420 cardiovascular 1 0.127
420 caused 2 0.1759
420 causes 1 0.1134
420 changes 1 0.0601
420 changes. 1 0.1609
420 conditions, 1 0.1545
420 conducted 1 0.1376
420 constant 1 0.1096
420 constant, 1 0.1545
420 consumption 1 0.141
420 cooling 1 0.1211
420 coronary 15 1.9399
420 data 1 0.0818
420 decrease 1 0.092
420 decreasing 1 0.1609
420 direct 1 0.0945
420 dogs 1 0.1042
420 dogs, 1 0.1346
420 excessive 1 0.1293
420 experiments 2 0.1781
420 fell 1 0.1376
420 fibrillation. 1 0.1809
420 first 1 0.0737
420 flow 8 0.819
420 flow, 3 0.4344
420 flow. 3 0.4634
420 found 1 0.0529
420 fragility 1 0.201
420 heart 1 0.0932
420 hemorrhage 1 0.1293
420 hg 2 0.2752
420 hg, 3 0.5428
420 hy- 1 0.141
420 hypothermia 4 0.4132
420 hypothermia, 1 0.141
420 hypothermic 1 0.1376
420 increase 1 0.0683
420 increasing 1 0.1178
420 induction 4 0.5173
420 initially, 1 0.201
420 isolated 2 0.1749
420 later. 1 0.1692
420 leads 1 0.1121
420 less 1 0.0752
420 levels 1 0.0787
420 maintaining 1 0.1545
420 marked 1 0.0902
420 markedly 1 0.1073
420 mean 1 0.0967
420 min. 1 0.141
420 mm. 5 0.6591
420 moderate 2 0.2388
420 mvo2 1 0.201
420 mvo2. 2 0.4019
420 myocardial 2 0.2819
420 near 1 0.1211
420 normothermia 1 0.1809
420 normothermic 1 0.1545
420 optimal 1 0.1609
420 optimal. 1 0.201
420 ous 1 0.1809
420 oxygen 1 0.1024
420 partial 1 0.1121
420 percentage 1 0.1121
420 perfu- 2 0.4019
420 perfusion 4 0.471
420 pothermia 1 0.1809
420 pressure 5 0.4598
420 pro- 1 0.1376
420 probably 1 0.0914
420 produced 2 0.1637
420 pulsatile 1 0.201
420 re- 1 0.089
420 recovery 1 0.1108
420 reduc- 1 0.1809
420 reduced 3 0.2723
420 reduction 3 0.2969
420 resistance 2 0.2241
420 results 2 0.1151
420 rose 1 0.141
420 saturation 2 0.3384
420 saturation, 2 0.3619
420 series 1 0.0945
420 similar 2 0.1505
420 sion 2 0.309
420 sistance 1 0.1692
420 slightly 2 0.2295
420 temperature, 1 0.1545
420 temperatures 1 0.127
420 tion 1 0.0914
420 total 2 0.1567
420 using 3 0.2741
420 varied. 1 0.201
420 vary 1 0.1692
420 varying 1 0.1084
420 vascular 1 0.1108
420 ven- 1 0.1492
420 venous 3 0.3401
420 ventricular 1 0.0874
421 'a 1 0.5428
421 'adequate' 1 0.6029
421 12.5% 1 0.6029
421 15 1 0.2993
421 3 2 0.411
421 30 2 0.5757
421 4 1 0.2133
421 40 1 0.3533
421 8 1 0.2723
421 974. 1 0.6029
421 ability 1 0.3071
421 ani- 1 0.4634
421 animal' 1 0.6029
421 animals 3 0.7689
421 apparently 1 0.3288
421 approaching 1 0.5428
421 authors 2 0.5555
421 body 1 0.2431
421 cancer 2 0.4767
421 cancericidal 1 0.6029
421 cardiac 2 0.541
421 cavae 1 0.5428
421 clinical 1 0.1965
421 closed-chest 1 0.5428
421 cold 1 0.4127
421 conclude 1 0.5076
421 contains 1 0.3689
421 cooling 2 0.7267
421 data 1 0.2455
421 defibrillated 1 0.6029
421 determined 1 0.2741
421 dex- 1 0.6029
421 dextran. 1 0.5428
421 dogs 1 0.3127
421 drainage 2 0.9655
421 electrically, 1 0.6029
421 eleven 1 0.4634
421 enhanced 1 0.3748
421 er 1 0.5428
421 esophageal 1 0.5076
421 estimated 1 0.3748
421 evidence 1 0.221
421 ex- 1 0.3581
421 experimental 1 0.2797
421 extracorporeal 1 0.3955
421 factor 1 0.2857
421 fibrillation 1 0.4827
421 fibrillation, 1 0.6029
421 fibrillation. 1 0.5428
421 flow 5 1.5356
421 flows 1 0.4634
421 four- 1 0.6029
421 function, 1 0.4634
421 gained 1 0.4827
421 generally 1 0.3581
421 good 1 0.3362
421 gravity. 1 0.6029
421 half 1 0.3533
421 heart 1 0.2797
421 high- 1 0.6029
421 hr. 1 0.3487
421 hypo- 1 0.4344
421 hypothermia 1 0.3099
421 hypothermic 1 0.4127
421 important 1 0.2723
421 incidence 1 0.2878
421 includes 1 0.4477
421 increased 1 0.1874
421 inferior 1 0.4634
421 information 1 0.3253
421 interesting 1 0.4344
421 longer, 1 0.6029
421 low 4 1.0555
421 lower 1 0.2741
421 maintain 1 0.4477
421 maintained 1 0.3362
421 mals 1 0.5076
421 method 1 0.2395
421 min. 1 0.4229
421 minor 1 0.388
421 ml./kg./min., 1 0.6029
421 molecular 2 0.7163
421 mortality 1 0.3633
421 neurosurgery 2 1.2058
421 normothermic 1 0.4634
421 notes 1 0.5076
421 open 1 0.4229
421 output 1 0.3533
421 paper 1 0.3253
421 perfused 1 0.4827
421 perfusion 4 1.4131
421 perfusion, 1 0.4827
421 perfusions 1 0.5428
421 perfusions. 1 0.6029
421 perimental 1 0.5428
421 periods 1 0.3362
421 pre-cooling 1 0.6029
421 presented. 1 0.3533
421 quite 1 0.3443
421 rate 1 0.2219
421 rate. 2 0.8688
421 rates 3 1.09
421 re- 1 0.2671
421 receiving 1 0.3324
421 regional 1 0.4344
421 reported. 1 0.3487
421 ried 1 0.5076
421 sometimes 1 0.388
421 study 1 0.1857
421 sufficient 1 0.3633
421 superior 1 0.4037
421 surgery 1 0.2993
421 survival 2 0.58
421 survived. 2 1.0153
421 teen 1 0.6029
421 temperature. 1 0.4827
421 thermic 1 0.6029
421 thoracotomy. 1 0.5428
421 time 1 0.2124
421 tran 1 0.6029
421 transfusions 1 0.6029
421 unspecified 1 0.6029
421 use 1 0.2383
421 utilize 1 0.6029
421 va- 1 0.5076
421 variable 1 0.3633
421 venous 1 0.3401
421 ventricular 3 0.7869
421 volume 1 0.3071
421 weight 2 0.5673
421 without 2 0.4554
422 (open-chest) 1 0.7536
422 (the 1 0.5596
422 12 1 0.3598
422 2406. 1 0.7536
422 29 1 0.5159
422 30 1 0.3598
422 8 1 0.3403
422 act 1 0.4685
422 afforded 1 0.6346
422 aim 1 0.6785
422 also 1 0.2108
422 amounts 1 0.3742
422 anesthetic 1 0.6346
422 aneurysm 2 0.97
422 another 1 0.411
422 artery, 1 0.6346
422 artery. 1 0.5596
422 authors 2 0.6944
422 blood 2 0.4657
422 body 1 0.3038
422 c., 1 0.6346
422 cannot 1 0.4066
422 cannulation 1 0.7536
422 cardiac 2 0.6763
422 cases. 1 0.3946
422 cerebral 3 1.0714
422 certain 1 0.3319
422 circulation 1 0.3946
422 closed-chest 2 1.357
422 comparisons 1 0.6346
422 consists 1 0.4764
422 cooling 1 0.4542
422 defects 1 0.4155
422 describe 1 0.5793
422 developed, 1 0.6034
422 disadvantages 1 0.7536
422 drew 2 1.5073
422 due 1 0.2666
422 encountered 1 0.4764
422 even 1 0.3299
422 exceeded 1 0.6346
422 exchanger, 1 0.7536
422 extracorporeal 1 0.4943
422 give 1 0.411
422 heart 1 0.3496
422 heat 1 0.5793
422 hypothermia 4 1.5494
422 hypothermia, 1 0.5286
422 hypoxia 1 0.485
422 instructions 1 0.7536
422 intra- 1 0.5286
422 investigated 1 0.4303
422 isolated 1 0.3279
422 large 1 0.2979
422 limit 1 0.6034
422 list 1 0.6346
422 lungs 1 0.411
422 management 1 0.3985
422 mayo-gibbons 1 0.7536
422 median 1 0.6034
422 method 1 0.2994
422 method, 1 0.5596
422 methods, 1 0.6785
422 minutes 1 0.4943
422 morbidity 1 0.6785
422 needed 2 1.0318
422 offer 1 0.485
422 often 1 0.3653
422 one 1 0.2108
422 operating 1 0.6034
422 oxygenator. 1 0.7536
422 patient's 1 0.5046
422 perfusion 1 0.4416
422 perfusion, 1 0.6034
422 perfusion. 2 1.2691
422 pertaining 1 0.6346
422 problems 1 0.3909
422 production 1 0.3839
422 profound 2 1.0318
422 protection 1 0.485
422 provide 1 0.4416
422 pump-oxygenator 1 0.6785
422 pumped 1 0.7536
422 pumps 1 0.7536
422 repair 1 0.5046
422 repair; 1 0.7536
422 repaired 1 0.6034
422 requiring 1 0.543
422 returned 1 0.543
422 safe 1 0.4943
422 since 1 0.3279
422 sternotomy), 1 0.7536
422 structures 1 0.5046
422 substituting 1 0.7536
422 surface 1 0.4066
422 taken 1 0.4252
422 technic 1 0.5793
422 technic, 1 0.7536
422 technics, 1 0.7536
422 thoracotomy. 1 0.6785
422 three 1 0.2834
422 time 1 0.2656
422 two 1 0.2308
422 using 1 0.3426
422 valuable 1 0.485
422 vertical-sheet 1 0.7536
422 vital 1 0.5596
422 whole 1 0.4202
422 without 2 0.5692
423 'safe' 1 1.0048
423 (20 1 0.9046
423 10 1 0.3699
423 2.6 1 1.0048
423 28.4 1 1.0048
423 3194. 1 1.0048
423 7 1 0.4629
423 average 1 0.4509
423 averaging 1 0.8461
423 balloon 2 1.6922
423 based 1 0.5262
423 c 1 0.548
423 clinical 1 0.3275
423 comparison 1 0.5212
423 consistently, 1 1.0048
423 cooled 1 0.724
423 cooling 3 1.8167
423 cooling, 1 0.8461
423 core 1 0.7048
423 decrease 1 0.4598
423 degrees 1 0.6352
423 dog 1 0.6246
423 dogs 1 0.5212
423 efficiency 1 0.7462
423 efficient, 1 0.9046
423 eight 1 0.5738
423 far 1 0.6466
423 filled 2 1.6922
423 gastric 3 3.0145
423 hg. 1 0.9046
423 hy- 1 0.7048
423 hypothermia 1 0.5165
423 hypothermia. 2 1.5448
423 improved 1 0.6728
423 induced 1 0.4272
423 latter 1 0.5212
423 maximally, 1 1.0048
423 minutes. 1 0.8046
423 ml/kg) 1 1.0048
423 mm 1 0.6466
423 noted. 1 0.6728
423 pothermia 1 0.9046
423 pressure 1 0.4598
423 procedure 1 0.5119
423 quired 1 1.0048
423 rapid 1 0.4871
423 re- 1 0.4452
423 reports 1 0.6466
423 safely 1 0.8046
423 still 1 0.4694
423 subjected 1 0.548
423 systemic 2 1.1206
423 temperature 1 0.5366
423 three-fold 1 1.0048
423 times 1 0.4833
423 two-fold 1 1.0048
423 underwent 1 0.724
423 usual 1 0.7462
423 via 1 0.6728
423 volume 1 0.5119
423 weight 1 0.4727
424 250 1 0.4827
424 3820. 1 0.6029
424 anterior 1 0.3811
424 autoradiographic 1 0.3955
424 autoradiography 1 0.4634
424 blood 1 0.1863
424 blood. 1 0.4037
424 body 2 0.4861
424 bone 2 0.5215
424 cannot 1 0.3253
424 car- 1 0.4344
424 cell 1 0.204
424 cells 5 0.9098
424 clearance 1 0.388
424 co- 1 0.5076
424 conclusive 1 0.5076
424 counts 1 0.4229
424 data 1 0.2455
424 dog 1 0.3748
424 dogs 2 0.6255
424 dogs, 1 0.4037
424 dubious 1 0.6029
424 early 2 0.442
424 evidence 1 0.221
424 fate 1 0.4477
424 following 2 0.3997
424 found. 1 0.388
424 function 1 0.2705
424 grain 1 0.5076
424 h3-thymidine 2 0.9655
424 haemopoietic 1 0.5428
424 hematogenous 1 0.5428
424 hemopoietic 2 1.0856
424 hind 1 0.5076
424 however, 1 0.2183
424 indicate 1 0.2655
424 individual 1 0.3188
424 injected 1 0.2922
424 injection 1 0.2521
424 irradiated 2 0.6973
424 irradiation 1 0.3253
424 legs 1 0.5428
424 light 1 0.3401
424 lym- 1 0.5076
424 lymphoid 3 1.164
424 marrow 2 0.6037
424 migration, 1 0.5076
424 non-irradiated 1 0.5428
424 obtained 1 0.2149
424 out. 1 0.4634
424 phase 2 0.644
424 phoid 1 0.6029
424 ping 1 0.6029
424 plasma 1 0.2431
424 precursors 1 0.4477
424 procedure 1 0.3071
424 r 1 0.3955
424 recovery 2 0.6648
424 ried 1 0.5076
424 ruled 1 0.5076
424 serial 1 0.3689
424 stem 1 0.4827
424 strongly 1 0.388
424 studied 1 0.2101
424 studies 1 0.1846
424 time 1 0.2124
424 transformation 2 0.6575
424 transformation. 1 0.5428
424 turnover 1 0.4037
424 vein. 1 0.5076
424 whole 2 0.6723
424 x-irradiation. 1 0.5428
425 ('transitional 1 0.3768
425 (or 1 0.3173
425 (small 1 0.3768
425 - 1 0.2208
425 3927. 1 0.3768
425 ac- 1 0.2425
425 affected. 1 0.3017
425 amount 1 0.1856
425 ance 1 0.2897
425 and/or 1 0.2382
425 animals 1 0.1602
425 animals, 1 0.2271
425 animals. 1 0.2126
425 antagonistically 1 0.3768
425 arterial 1 0.1955
425 basophilic 3 0.9051
425 blood 2 0.2329
425 blood, 2 0.5159
425 blood. 2 0.5046
425 body 1 0.1519
425 causes 1 0.2126
425 cells 6 0.6823
425 cells') 1 0.3768
425 cells. 1 0.168
425 characterized 1 0.1992
425 chondrial 1 0.3768
425 ciency 1 0.3392
425 circulating 1 0.2643
425 companied 1 0.3768
425 comparisons 1 0.3173
425 considerable 1 0.1955
425 content 1 0.1773
425 cording 1 0.3768
425 cytomorphosis 1 0.3768
425 decrease 2 0.3449
425 decreased 1 0.1702
425 defi- 1 0.3017
425 delayed 1 0.2208
425 delivery 1 0.2472
425 dif- 1 0.2798
425 different 1 0.1333
425 differentiation 2 0.4303
425 disappear- 1 0.3768
425 drastic 1 0.3392
425 duct 1 0.258
425 duct, 1 0.3173
425 due 1 0.1333
425 effects 1 0.1399
425 especially 1 0.1937
425 evaluated 1 0.2179
425 exogenous 1 0.3017
425 explains 1 0.3392
425 factors 1 0.1593
425 ferentiation 1 0.3768
425 followed 1 0.1724
425 follows. 1 0.3173
425 growth 7 0.8991
425 guinea-pigs 1 0.3017
425 guinea-pigs, 1 0.3392
425 guinea-pigs. 1 0.3392
425 higher 1 0.162
425 hypotrophy 1 0.3768
425 immature 1 0.2523
425 immigrated 1 0.3768
425 importance 1 0.1919
425 incidence 2 0.3598
425 increased 8 0.9371
425 indicating 1 0.2425
425 influence 1 0.1724
425 influenced 1 0.2342
425 involuted 1 0.3768
425 judged 1 0.2715
425 large 4 0.5959
425 larger 2 0.4477
425 local 1 0.2271
425 low 1 0.1649
425 lymph 3 0.7027
425 lymph. 1 0.3768
425 lymphatic 4 1.086
425 lymphocyte 1 0.2715
425 lymphocytes 7 1.5455
425 lymphocytes) 1 0.3768
425 lymphocytes, 4 1.086
425 lymphocytes. 1 0.3173
425 main 1 0.2152
425 mature 1 0.2342
425 migratory 1 0.3768
425 mito- 1 0.3392
425 much 1 0.167
425 neonatal 2 0.4542
425 nodes 1 0.2897
425 nodes, 1 0.2715
425 normal 2 0.2027
425 normal) 1 0.3768
425 number 4 0.5768
425 occurrence 1 0.2238
425 ones. 1 0.3017
425 organ 2 0.5286
425 organs, 1 0.2798
425 organs. 1 0.2715
425 output 3 0.6624
425 parts 1 0.258
425 plasma 1 0.1519
425 populations 1 0.2798
425 postnatally 1 0.3392
425 precedes 1 0.3392
425 prevent 1 0.2523
425 probably 1 0.1713
425 produces 1 0.2382
425 promotes 2 0.6785
425 pulp. 2 0.7536
425 pyroninophilic 2 0.6785
425 racic-duct 1 0.3768
425 re- 1 0.167
425 red 2 0.4477
425 reference 1 0.2077
425 regeneration 2 0.543
425 relation 1 0.1736
425 respectively. 1 0.258
425 response 1 0.1376
425 resulting 2 0.3839
425 results 1 0.1079
425 reticular 1 0.3017
425 seen 1 0.1593
425 sham-operated 2 0.6785
425 small 6 0.907
425 special 1 0.1992
425 splenic 3 0.9518
425 streams 1 0.3768
425 studied. 1 0.2126
425 studies 2 0.2308
425 survival 1 0.1813
425 synergistically 1 0.3392
425 system 3 0.5281
425 systems 1 0.2643
425 tho- 1 0.3768
425 thoracic 1 0.2715
425 thoracic- 1 0.3768
425 thymectomized 2 0.6785
425 thymectomy 3 0.9518
425 thymic 2 0.6346
425 thymo-lympha- 1 0.3768
425 thymo-lymphatic 3 1.1304
425 thymus 4 1.086
425 thymus, 1 0.3017
425 thyroid 2 0.4416
425 thyroxin 5 1.8841
425 thyroxin-stimulated 3 1.1304
425 tic 1 0.2798
425 tissue 1 0.1308
425 tissue. 1 0.2425
425 transformation 1 0.2055
425 treated 1 0.1551
425 untreated, 1 0.3768
425 venous 3 0.6377
425 weight 1 0.1773
425 weights 1 0.2643
425 weights, 1 0.3017
425 young 1 0.1903
426 400 1 0.4827
426 750 1 0.6029
426 815. 1 0.6029
426 acute, 1 0.6029
426 applied 1 0.3633
426 became 1 0.3581
426 blood 1 0.1863
426 bone 5 1.3038
426 cell 1 0.204
426 cells. 1 0.2688
426 chronic 1 0.2878
426 concluded 1 0.2759
426 could 1 0.2166
426 coverslips 2 1.2058
426 cyte-depletion 1 0.6029
426 demonstrated 1 0.2578
426 designed 1 0.4344
426 drainage 1 0.4827
426 duct 2 0.8255
426 either 1 0.2578
426 emigrate 1 0.6029
426 emigration 3 1.6283
426 extent 1 0.3188
426 exudate 1 0.6029
426 failed 1 0.3443
426 foci 1 0.4344
426 found 1 0.1587
426 identify 1 0.5428
426 inflammation. 1 0.6029
426 injection 1 0.2521
426 injections 1 0.3401
426 irradiation 2 0.6506
426 irradiation. 1 0.4127
426 labelled 5 2.1719
426 labelling 1 0.4827
426 lesser 1 0.4127
426 lymph 1 0.3748
426 lymph, 1 0.6029
426 lympho- 1 0.4827
426 macrophages 5 2.0183
426 macrophages. 1 0.6029
426 major 1 0.29
426 marrow 4 1.2074
426 marrow, 1 0.4127
426 marrow. 1 0.4229
426 monocytes 1 0.5428
426 nodes, 1 0.4344
426 non-bacterial 1 0.6029
426 normal 1 0.1621
426 obtained 1 0.2149
426 origin 1 0.3443
426 portion 1 0.4229
426 precursors 1 0.4477
426 pro- 1 0.4127
426 proliferate. 1 0.6029
426 radioactively-labelled 1 0.6029
426 rads 2 1.0856
426 rat 1 0.2481
426 rat, 1 0.5428
426 rats 2 0.4656
426 received 1 0.3401
426 recipients 1 0.4827
426 recipients. 1 0.5428
426 reduce 1 0.3811
426 restored 1 0.4229
426 shielded 1 0.4634
426 skin 1 0.3581
426 sources 1 0.4634
426 spleen 2 0.7163
426 spleen, 1 0.4037
426 study 1 0.1857
426 subcutaneous 1 0.388
426 suppress 1 0.4477
426 suppressed 1 0.4127
426 suspensions 1 0.4634
426 syngeneic 1 0.4634
426 thoracic 2 0.8688
426 thymidine. 1 0.4827
426 thymus, 1 0.4827
426 tibial 1 0.4634
426 tissues 1 0.2759
426 transfused 1 0.4477
426 tritiated 1 0.4037
426 windows' 1 0.6029
426 x- 2 1.0153
427 1786. 1 0.3768
427 2 1 0.1151
427 2nd 1 0.2715
427 absolute 1 0.2643
427 active 1 0.1736
427 acute 2 0.3742
427 af- 1 0.3768
427 also 2 0.2108
427 although 1 0.1449
427 animals 1 0.1602
427 appears 2 0.3241
427 assuming 1 0.3173
427 atrophy 1 0.2798
427 basophilic 1 0.3017
427 basophils 1 0.3768
427 blasts 1 0.3768
427 blasts. 1 0.3768
427 body 1 0.1519
427 bone 4 0.6519
427 cells 8 0.9098
427 cells. 2 0.336
427 certain 1 0.1659
427 characteristic 1 0.1903
427 common 1 0.1841
427 compartment 2 0.6785
427 complete 2 0.3496
427 considerable 1 0.1955
427 considerably 2 0.485
427 crease 1 0.2523
427 cytes 1 0.3173
427 cytoplasm 1 0.2342
427 de- 1 0.2101
427 decline 1 0.2643
427 deeply 1 0.3392
427 demand 1 0.3017
427 depresses 1 0.3768
427 differentiate 1 0.3017
427 differentiation 1 0.2152
427 dine 1 0.3768
427 dis- 1 0.2382
427 dividing 1 0.2897
427 dna 1 0.1799
427 dna-content 1 0.3768
427 dna-synthesis 1 0.3768
427 dna-synthesizing 1 0.3392
427 dna-values 1 0.3768
427 entering 1 0.3392
427 eosinophils, 1 0.3768
427 erythron 1 0.3768
427 erythropoietic 1 0.3392
427 evidence 2 0.2763
427 exposure 1 0.2238
427 favor 1 0.3017
427 feulgen 1 0.3768
427 follow- 1 0.2897
427 form 1 0.1639
427 found 2 0.1984
427 generalized 1 0.258
427 granulocyte 1 0.3392
427 granulocytes 1 0.3768
427 granulocytes. 1 0.3768
427 greatly 1 0.2238
427 group 3 0.4179
427 guinea 2 0.5596
427 guinea-pig 1 0.2715
427 h3-thymi- 1 0.3768
427 haemorrhage 1 0.3392
427 he- 1 0.3392
427 heavy 1 0.3173
427 hemopoiesis; 1 0.3768
427 hemorrhage 2 0.485
427 hemorrhage, 1 0.3017
427 hemorrhage. 1 0.3392
427 hypoxia 4 0.97
427 hypoxic 1 0.2897
427 increased. 1 0.2523
427 ing 1 0.2033
427 involved, 1 0.3173
427 labeled 1 0.2271
427 large 1 0.149
427 larger 1 0.2238
427 later 2 0.3874
427 le- 1 0.2897
427 leucocyte 1 0.3392
427 leukon. 1 0.3768
427 levels 1 0.1476
427 loss 1 0.1826
427 lymphocytes 3 0.6624
427 lymphoid 1 0.2425
427 marked 1 0.1691
427 marked. 1 0.3768
427 marrow 8 1.5092
427 marrow, 1 0.258
427 may 2 0.1885
427 measurements 1 0.2425
427 metamyelo- 1 0.3768
427 metamyelocytes 2 0.7536
427 metamyelocytes. 1 0.3768
427 microspectrophotometric 1 0.3768
427 minimal 1 0.2342
427 mononuclear 1 0.3173
427 monophyletic 1 0.3768
427 morphologically, 1 0.3173
427 morrhage 1 0.3768
427 much 1 0.167
427 myelo- 1 0.3768
427 myelocytes 1 0.3768
427 neutrophils, 1 0.3768
427 nonsynthesizing 1 0.3768
427 normal 1 0.1013
427 notable 1 0.3768
427 number 2 0.2884
427 numbers 1 0.2238
427 one 1 0.1054
427 particularly 1 0.2077
427 pig 2 0.6034
427 populations 1 0.2798
427 procrythro- 1 0.3768
427 promyelocytes 1 0.3768
427 proportion 1 0.2342
427 range 1 0.2033
427 ratio 1 0.1973
427 reduced 1 0.1702
427 reduced. 2 0.6346
427 reduction 1 0.1856
427 related 1 0.1593
427 resting 1 0.2897
427 restrict 1 0.3392
427 sequence 1 0.2897
427 severe 3 0.5009
427 show 1 0.163
427 showed 1 0.1343
427 shows 1 0.2077
427 single 1 0.1871
427 slightly 1 0.2152
427 small 1 0.1512
427 specifically 1 0.2798
427 stages 3 0.6232
427 stem 2 0.6034
427 stem-cell 1 0.3768
427 stimulation 1 0.2126
427 studies 1 0.1154
427 supply 1 0.2798
427 synthesis 1 0.1871
427 synthesizing 1 0.3392
427 temporarily 2 0.6785
427 ter 1 0.3768
427 theory 1 0.2425
427 tinctive 1 0.3768
427 tissue. 1 0.2425
427 total 1 0.1469
427 typical 1 0.2472
427 unlimited, 1 0.3768
427 using 1 0.1713
427 values 1 0.1903
427 vels 1 0.3768
427 weight 1 0.1773
428 (c57bl 2 1.5073
428 10 2 0.5548
428 101 3 2.0354
428 101)f1 2 1.5073
428 3831. 1 0.6785
428 abilities 1 0.6346
428 ability 1 0.3839
428 additional 1 0.4025
428 advantage 1 0.6785
428 another 1 0.411
428 behavior 1 0.4303
428 bone-marrow 2 1.357
428 c57bl 3 1.8103
428 cannot 1 0.4066
428 capable 1 0.4611
428 cell 2 0.5101
428 cells 1 0.2274
428 cells. 1 0.336
428 combina- 1 0.6785
428 corre- 1 0.6785
428 determined 1 0.3426
428 differences 2 0.6897
428 discussed. 1 0.3222
428 donor 1 0.5286
428 efficient 1 0.543
428 environmental 1 0.5596
428 experiments 1 0.3339
428 explained. 1 0.6034
428 f1 3 1.8103
428 factors 1 0.3186
428 factors. 1 0.5793
428 favor 1 0.6034
428 frequently 1 0.3805
428 fully 1 0.5596
428 growth 1 0.2569
428 h-2 1 0.6785
428 hematopoietic 1 0.6346
428 hybrids 1 0.6785
428 immunological 1 0.4685
428 indicated 1 0.3546
428 injected 1 0.3653
428 irradiate 1 0.7536
428 irradiated 4 1.7433
428 lated 1 0.5793
428 less 1 0.2821
428 lethal- 1 0.7536
428 lethally 2 1.357
428 ly 1 0.4943
428 mar- 1 0.6346
428 marrow 3 1.1319
428 marrow, 1 0.5159
428 marrow. 1 0.5286
428 marrows 2 1.5073
428 mice 2 0.7423
428 mice, 1 0.5596
428 mice. 1 0.4764
428 micro- 1 0.6034
428 might 2 0.7893
428 million 2 1.2691
428 mixture 1 0.5596
428 mixtures 1 0.6034
428 nine 1 0.5159
428 one 1 0.2108
428 parental 4 2.1719
428 physiological 2 0.8832
428 recipient 1 0.5046
428 recipient. 1 0.7536
428 regresses 1 0.7536
428 regularly 1 0.543
428 relative 2 0.7819
428 relatively 2 0.725
428 repopulate 2 1.5073
428 repopulated 1 0.7536
428 repopulating 2 1.357
428 results 1 0.2158
428 retained 1 0.5793
428 rows 1 0.7536
428 selective 1 0.4477
428 shown 1 0.3241
428 solely 1 0.5596
428 strain 1 0.3985
428 suggested 1 0.3134
428 times 1 0.3625
428 tions 1 0.4477
428 type 1 0.3134
428 x 2 0.9528
428 yet 1 0.3985
429 'lymphocyte' 1 0.6029
429 'lymphocytes' 1 0.6029
429 'lymphocytes'. 1 0.6029
429 3832. 1 0.6029
429 ap- 1 0.4827
429 bone 1 0.2608
429 capacity 1 0.3288
429 cell 2 0.4081
429 cells 1 0.182
429 cells, 1 0.2922
429 columns 1 0.5428
429 constant 1 0.3288
429 efficient 1 0.4344
429 exposed 1 0.3157
429 filtered 3 1.6283
429 function 2 0.541
429 given 1 0.221
429 glass 1 0.6029
429 irradiation. 1 0.4127
429 isogenic 1 0.5428
429 lethal 1 0.5076
429 marrow 5 1.5092
429 medium 1 0.322
429 mice 1 0.2969
429 mouse 1 0.3362
429 normal 1 0.1621
429 nucleated 1 0.4634
429 number 2 0.4614
429 original 1 0.3443
429 peared 1 0.6029
429 pluripotent 1 0.6029
429 polycythemic 1 0.5428
429 present 1 0.1985
429 previously 1 0.29
429 proliferative 1 0.4344
429 recipient 1 0.4037
429 remove 1 0.6029
429 repopulating 1 0.5428
429 small 1 0.2419
429 spleen 1 0.3581
429 stem 1 0.4827
429 suspensions 1 0.4634
429 type. 1 0.4037
429 unfiltered 1 0.6029
429 wool 1 0.6029
430 (150 2 1.2058
430 -irradiation 1 0.6029
430 1/5 1 0.6029
430 150 1 0.5428
430 2 1 0.1841
430 2045. 1 0.6029
430 abortive 1 0.5428
430 animals 1 0.2563
430 approx. 1 0.4634
430 blood 1 0.1863
430 body 1 0.2431
430 bone 1 0.2608
430 cell 1 0.204
430 cells 1 0.182
430 cellular 1 0.3288
430 characterize 1 0.4827
430 coinciding 2 1.0856
430 colonization 1 0.6029
430 combined 1 0.3099
430 compared 1 0.2339
430 continued 1 0.3487
430 counts 1 0.4229
430 ded 1 0.6029
430 delayed 1 0.3533
430 depletion 1 0.3955
430 discussed. 1 0.2578
430 ed 1 0.4127
430 effect 1 0.1841
430 effective 1 0.3018
430 effects 1 0.2238
430 eliminated 1 0.4229
430 erythroid 1 0.5428
430 evidence 1 0.221
430 exposed 1 0.3157
430 fall 2 0.6314
430 ficance 1 0.6029
430 findings 1 0.2395
430 following 1 0.1998
430 gamma 1 0.6029
430 granulocytic 1 0.5428
430 granulocytopoiesis 2 1.2058
430 guinea-pig 1 0.4344
430 guineapigs 1 0.6029
430 haemopoietic 1 0.5428
430 hyperplasia. 1 0.4827
430 increase 1 0.2048
430 ing 1 0.3253
430 initial 1 0.2922
430 irradiated 4 1.3946
430 irradiation 3 0.9759
430 irradiation. 1 0.4127
430 limb 2 0.8688
430 limbs. 1 0.6029
430 lymphocytes 1 0.3533
430 marked 1 0.2705
430 marrow 5 1.5092
430 marrow. 2 0.8457
430 numbers 2 0.7163
430 observations 1 0.2535
430 overshoot 1 0.6029
430 partially 1 0.3748
430 period, 1 0.4037
430 phase 1 0.322
430 phenomena 1 0.4229
430 precursors, 1 0.6029
430 protect- 1 0.6029
430 quantitative 1 0.3188
430 r 1 0.3955
430 r) 1 0.5076
430 r). 1 0.6029
430 recovery 2 0.6648
430 response 1 0.2201
430 secondary 2 0.6037
430 shiel- 1 0.6029
430 shield- 1 0.6029
430 shielded 3 1.3903
430 shielding 1 0.6029
430 shielding. 1 0.6029
430 show 1 0.2608
430 showed 1 0.2149
430 shows 1 0.3324
430 signi- 1 0.5428
430 spleen 1 0.3581
430 splenic 1 0.5076
430 temporary 1 0.4344
430 thymus 1 0.4344
430 thymus, 1 0.4827
430 total 1 0.235
430 unilateral 1 0.3253
430 whilst 1 0.4477
430 whole- 1 0.6029
430 whole-body 2 0.8688
431 4311. 1 0.274
431 according 1 0.1479
431 adult 1 0.1246
431 blood 1 0.0847
431 blood. 1 0.1835
431 bone 6 0.7112
431 caused 1 0.1199
431 cells 11 0.9098
431 cells. 1 0.1222
431 conditions. 1 0.1922
431 cytes 1 0.2307
431 diminution 2 0.3844
431 discharged 1 0.274
431 further- 1 0.274
431 iii. 1 0.1922
431 increase 1 0.0931
431 influence 1 0.1254
431 initial 1 0.1328
431 intravenous 1 0.1464
431 lymphnode 4 1.0962
431 lympho- 2 0.4389
431 lymphocytes 1 0.1606
431 lymphocytosis 1 0.274
431 lymphoid 3 0.5291
431 marrow 5 0.686
431 marrow. 1 0.1922
431 may 1 0.0685
431 mobilize 1 0.2467
431 more, 1 0.2194
431 penia, 1 0.274
431 peripheral 4 0.6512
431 rabbits 1 0.1565
431 rabbits. 1 0.274
431 resulted 1 0.1328
431 stored 1 0.2467
431 studied. 1 0.1546
431 studies 1 0.0839
431 subsequent 1 0.1494
431 suggested 1 0.114
431 thought 1 0.1546
431 thymus 5 0.9872
431 transfused 2 0.407
431 transfusion 3 0.632
431 variety 1 0.1479
431 young 1 0.1384
432 1 1 0.2277
432 14,000 1 0.6029
432 5 3 0.686
432 5041. 1 0.6029
432 adult 1 0.2741
432 air 1 0.3362
432 altitude 1 0.5428
432 blood 1 0.1863
432 bone 2 0.5215
432 cells 1 0.182
432 chamber 1 0.4477
432 chamber, 1 0.5428
432 changes 1 0.1804
432 constant 1 0.3288
432 days, 2 0.7909
432 days. 1 0.3401
432 decompression 2 0.8954
432 despite 1 0.3811
432 differential 1 0.3811
432 erythropoiesis. 1 0.5428
432 fairly 1 0.4344
432 fall. 1 0.6029
432 feet 1 0.6029
432 finally 1 0.4127
432 fluctuations 1 0.4827
432 guinea 1 0.4477
432 however, 1 0.2183
432 hypoxia 5 1.9399
432 hypoxia, 1 0.4827
432 hypoxia. 1 0.5428
432 iii. 1 0.4229
432 increase 2 0.4095
432 kept 1 0.4477
432 level 1 0.2328
432 lymphocytes 1 0.3533
432 lymphocytes, 1 0.4344
432 made 1 0.2183
432 male 1 0.3071
432 marked 2 0.541
432 marrow 3 0.9055
432 marrow. 2 0.8457
432 nucleated 1 0.4634
432 ordinary 1 0.4477
432 period 1 0.2287
432 periods 1 0.3362
432 pigs 1 0.4827
432 placed 1 0.3581
432 primary 3 0.7646
432 quantitative 1 0.3188
432 ranging 1 0.4127
432 red 1 0.3581
432 remain 1 0.4344
432 response 1 0.2201
432 reticulocytes 1 0.6029
432 returned 1 0.4344
432 second 1 0.3071
432 secondary 4 1.2074
432 significant 1 0.2116
432 simulated 1 0.5428
432 studies 2 0.3693
432 subjected 1 0.3288
432 time, 1 0.3487
432 twenty-five 1 0.5428
432 whereas 1 0.3018
433 1044. 1 0.7536
433 50% 1 0.4542
433 almost 1 0.3874
433 appear 2 0.6897
433 body, 1 0.6034
433 bone 4 1.3038
433 cavity 1 0.6346
433 cells 1 0.2274
433 certain 1 0.3319
433 cluding 1 0.7536
433 conditions 1 0.3426
433 considerable. 1 0.7536
433 conventional 1 0.543
433 cultured 1 0.4943
433 diation. 1 0.7536
433 evidence 1 0.2763
433 experiments 1 0.3339
433 finally, 1 0.5159
433 formed 1 0.4202
433 forming 1 0.5596
433 found 2 0.3968
433 guinea-pig 2 1.086
433 host 1 0.3909
433 in- 1 0.3339
433 indicates 1 0.4943
433 investigation 1 0.4252
433 irra- 1 0.6785
433 irradiation 1 0.4066
433 irradiation, 1 0.5793
433 irradiation. 1 0.5159
433 lethal 1 0.6346
433 lymphocyte 2 1.086
433 lymphocytes 3 1.3247
433 lymphocytes. 1 0.6346
433 lymphoid 1 0.485
433 many 1 0.3038
433 marrow 4 1.5092
433 marrow. 2 1.0572
433 moreover, 1 0.4943
433 newly-formed 1 0.7536
433 numbers 1 0.4477
433 numerous 1 0.4477
433 percentages 1 0.6034
433 peritoneal 1 0.5793
433 produced 2 0.6138
433 production 2 0.7678
433 received 1 0.4252
433 recovery 1 0.4155
433 rest 1 0.543
433 shielded 1 0.5793
433 small 3 0.907
433 smears 1 0.6346
433 still 1 0.352
433 suppressed 1 0.5159
433 supra-lethal 1 0.7536
433 telophases 1 0.7536
433 tissues, 1 0.5286
433 variety 1 0.4066
433 whose 1 0.4416
434 (slightly 1 0.6029
434 10 1 0.2219
434 103. 1 0.6029
434 3 1 0.2055
434 4 1 0.2133
434 50% 1 0.3633
434 approximately 2 0.6314
434 autologous 1 0.4827
434 body 1 0.2431
434 bone 5 1.3038
434 cates 1 0.6029
434 cell 1 0.204
434 cells 4 0.7278
434 different 1 0.2133
434 entire 1 0.3955
434 experiments 1 0.2671
434 extirpation 1 0.5428
434 extremity 1 0.4827
434 faster 1 0.4344
434 fractional 1 0.5076
434 fractionation 1 0.4634
434 hour 1 0.4344
434 indi- 1 0.5076
434 indicate 1 0.2655
434 injection 1 0.2521
434 irradiation 2 0.6506
434 lymphocyte. 1 0.6029
434 marrow 4 1.2074
434 marrow). 1 0.6029
434 mice 1 0.2969
434 migrates 1 0.6029
434 mouse 3 1.0085
434 number 2 0.4614
434 numbers 1 0.3581
434 observations 1 0.2535
434 obtained 1 0.2149
434 per 1 0.235
434 post-x-irradiation 1 0.6029
434 protection 2 0.776
434 provide 1 0.3533
434 repopulation 2 1.2058
434 required 2 0.6575
434 resembles 1 0.4477
434 responsible 1 0.3044
434 shielded 2 0.9269
434 slower 1 0.4344
434 small 1 0.2419
434 spleen 5 1.7907
434 survival 1 0.29
434 survival, 1 0.6029
434 type 2 0.5015
434 x 1 0.3811
434 x-irradiation 1 0.5076
435 (leukocytes, 1 0.3015
435 + 1 0.2114
435 - 3 0.5299
435 0.5 1 0.2238
435 1-2 1 0.2538
435 1-5, 1 0.3015
435 1.0 1 0.2714
435 10 3 0.3329
435 10, 1 0.2317
435 10-15 1 0.2714
435 104. 1 0.3015
435 14 1 0.1662
435 15, 1 0.3015
435 18-22 1 0.3015
435 2 1 0.092
435 2-3 1 0.2538
435 20 1 0.1361
435 20, 1 0.2414
435 200 1 0.1977
435 21 1 0.1906
435 25 1 0.1721
435 3 1 0.1028
435 30 1 0.1439
435 4 1 0.1066
435 5 1 0.1143
435 60 1 0.194
435 600 3 0.8142
435 800-1,000 1 0.3015
435 9 2 0.3157
435 acute 1 0.1497
435 administered 1 0.1439
435 age. 1 0.1701
435 animals 1 0.1282
435 appeared 2 0.29
435 aspiration 1 0.2414
435 attained 2 0.4477
435 azure-ii-eosin. 1 0.3015
435 basophilic 2 0.4827
435 blood 4 0.3726
435 bone 8 1.0431
435 bones 1 0.2172
435 bones. 1 0.2714
435 cells 10 0.9098
435 cells. 1 0.1344
435 cm., 1 0.2714
435 coincided 1 0.2538
435 composition 1 0.1766
435 compression 1 0.2238
435 cu 1 0.3015
435 current 1 0.1874
435 days 6 0.7185
435 diminished 1 0.2018
435 distance 1 0.2317
435 distinctive 1 0.2238
435 dogs 4 0.6255
435 donor 2 0.4229
435 dosage 3 0.545
435 dosage. 1 0.2538
435 elements 1 0.2317
435 erythrocytes). 1 0.3015
435 experiments 1 0.1336
435 filters 1 0.2714
435 following 2 0.1998
435 formed 1 0.1681
435 found 3 0.2381
435 four-tube 1 0.3015
435 frequent 1 0.1817
435 given 1 0.1105
435 hyper- 1 0.1791
435 hyperbasophilic 5 1.5073
435 i.v. 1 0.2317
435 immature 1 0.2018
435 incidence 1 0.1439
435 increased 2 0.1874
435 indication 1 0.2114
435 injections 1 0.1701
435 intervals. 1 0.3015
435 irradiated 3 0.523
435 irradiation 4 0.6506
435 irradiation, 1 0.2317
435 kv, 1 0.3015
435 later; 1 0.2714
435 ma, 1 0.2538
435 machine 1 0.2538
435 made 2 0.2183
435 main 1 0.1721
435 mar- 1 0.2538
435 marrow 7 1.0565
435 marrow. 2 0.4229
435 maximum 1 0.1662
435 mm 1 0.194
435 mm.al, 1 0.3015
435 mongrel 1 0.2714
435 morphological 1 0.1844
435 mth. 1 0.1791
435 nonirradiated 1 0.2538
435 nuclear 1 0.1743
435 nucleus 1 0.2317
435 number 3 0.3461
435 obtained 1 0.1075
435 peak 1 0.1743
435 plasm 1 0.2538
435 present 1 0.0993
435 proliferation 1 0.1743
435 proto- 1 0.3015
435 puppies 1 0.2714
435 r. 2 0.4127
435 r., 2 0.6029
435 r./min. 1 0.3015
435 radia- 1 0.2714
435 rapidly. 1 0.3015
435 rate 1 0.111
435 ribs 1 0.3015
435 row, 1 0.3015
435 rum-3 1 0.3015
435 series 1 0.1418
435 sexes. 1 0.2714
435 sickness 1 0.2714
435 skeletal 1 0.2064
435 smears 1 0.2538
435 sooner 1 0.3015
435 stained 1 0.2414
435 sternum, 1 0.3015
435 study 2 0.1857
435 suspension 1 0.2172
435 target 1 0.2414
435 thereafter 2 0.4827
435 tion 1 0.137
435 transfusion 1 0.2317
435 transplantation 4 0.7909
435 transplanted 1 0.2172
435 trend 1 0.2414
435 using 1 0.137
435 various 1 0.1192
435 voltage 1 0.2714
435 x 1 0.1906
435 x-ray 1 0.1977
436 172. 1 0.3768
436 2 2 0.2301
436 250 1 0.3017
436 4 2 0.2666
436 also 1 0.1054
436 ance 1 0.2897
436 anterior 1 0.2382
436 autoradiographic 1 0.2472
436 autoradiography 1 0.2897
436 blood 3 0.3493
436 bone 3 0.4889
436 carried 1 0.1887
436 cedure 1 0.3768
436 cells 7 0.7961
436 cells, 2 0.3653
436 changed 1 0.258
436 clamping 1 0.3392
436 clear- 1 0.2897
436 clusive 1 0.3768
436 con- 1 0.1955
436 confirmed 1 0.2208
436 could 1 0.1354
436 data 1 0.1535
436 de- 1 0.2101
436 described 1 0.1429
436 dogs 3 0.5864
436 dogs, 1 0.2523
436 dogs. 1 0.2798
436 early 1 0.1381
436 evidence 1 0.1381
436 fate, 1 0.3768
436 found. 1 0.2425
436 generating 1 0.3392
436 h3-thymidine 2 0.6034
436 hemopoietic 1 0.3392
436 hind 1 0.3173
436 increased 1 0.1171
436 index 1 0.2238
436 indicate 1 0.1659
436 initially 1 0.2472
436 injected 1 0.1826
436 injection 1 0.1576
436 irradiated 8 1.7433
436 labeled 1 0.2271
436 labeling 1 0.2472
436 large 1 0.149
436 legs 1 0.3392
436 liferation 1 0.3392
436 lymphoid 8 1.9399
436 mal 1 0.2523
436 marrow 3 0.566
436 marrow. 1 0.2643
436 marrow; 1 0.3768
436 migration 1 0.2523
436 migration, 1 0.3173
436 non- 1 0.2715
436 nor- 1 0.2425
436 normal 1 0.1013
436 number 1 0.1442
436 observed. 1 0.2271
436 parenchyma 1 0.2715
436 pattern 1 0.1799
436 phase 1 0.2012
436 plasma 1 0.1519
436 population 1 0.2425
436 precursors 1 0.2798
436 pro- 2 0.5159
436 r 1 0.2472
436 re- 1 0.167
436 recovery 1 0.2077
436 relative 1 0.1955
436 results 1 0.1079
436 serial 1 0.2305
436 small 2 0.3023
436 studied 1 0.1313
436 studies 1 0.1154
436 tail. 1 0.3768
436 time 1 0.1328
436 transformation 1 0.2055
436 turnover 1 0.2523
436 vein. 1 0.3173
436 whole 1 0.2101
436 whole-body 1 0.2715
436 x-irradiation. 1 0.3392
437 175. 1 1.0048
437 activity 1 0.3596
437 activity. 1 0.6879
437 amounts 1 0.4989
437 back 1 0.7462
437 basophils, 1 1.0048
437 blood 2 0.621
437 bone 3 1.3038
437 cells 2 0.6065
437 cells, 1 0.4871
437 cells. 1 0.448
437 contain 1 0.6466
437 cytes, 1 1.0048
437 demonstrated 1 0.4296
437 dence 1 1.0048
437 elements 1 0.7724
437 en- 1 0.7724
437 eosinophil 1 1.0048
437 eral 1 0.9046
437 erythrocytes, 1 0.8046
437 estimated. 1 0.9046
437 evi- 1 0.8461
437 evidence 1 0.3684
437 extending 1 0.9046
437 formed 1 0.5603
437 histochemical 1 0.9046
437 indirect 1 0.7724
437 intracellular 1 0.6591
437 lyso- 1 0.9046
437 lysozyme 3 3.0145
437 marrow 3 1.5092
437 mast 1 0.7462
437 mature 2 1.2492
437 means 1 0.4452
437 megakaryo- 1 1.0048
437 monocytes, 1 1.0048
437 neutrophils 1 0.9046
437 periph- 1 1.0048
437 peripheral 1 0.5969
437 plasma 1 0.4051
437 platelets, 1 1.0048
437 precursors 1 0.7462
437 presented 1 0.3898
437 progranulocyte, 1 1.0048
437 rare 1 0.5969
437 reticuloendothelial 1 0.8046
437 significant 1 0.3527
437 technique, 1 0.8461
437 tissue 1 0.3488
437 trace 1 0.724
437 well 1 0.3514
437 zyme 1 1.0048
437 zyme. 1 1.0048
438 'immunologically 1 0.274
438 'thymus-type' 1 0.274
438 1770. 1 0.274
438 abundantly 1 0.2467
438 activity 2 0.1961
438 administration. 1 0.1835
438 agreement 1 0.1876
438 al. 1 0.1974
438 altered 1 0.1464
438 appa- 1 0.274
438 apparent 1 0.1435
438 appear 2 0.2508
438 assign- 1 0.274
438 basis 1 0.1199
438 bel 1 0.274
438 believed 1 0.2035
438 best 1 0.1449
438 body 1 0.1105
438 bone 1 0.1185
438 cell 6 0.5565
438 cell. 1 0.1922
438 cells 8 0.6617
438 cells, 2 0.2657
438 cells. 2 0.2444
438 centers 1 0.1922
438 change 1 0.1271
438 committed' 1 0.274
438 compatible 1 0.2307
438 consists 1 0.1732
438 containing 1 0.1449
438 cortex, 1 0.2307
438 cortex. 1 0.2467
438 could 1 0.0985
438 curvilinear 1 0.274
438 cytes 1 0.2307
438 cytokinetic 1 0.274
438 data 3 0.3348
438 depletion 1 0.1798
438 described 1 0.1039
438 difference 1 0.1372
438 different 1 0.0969
438 dilution 3 0.5628
438 dividing 4 0.8426
438 dna 11 1.4391
438 e- 1 0.274
438 employing 1 0.2307
438 enter 1 0.2107
438 entered 1 0.2467
438 entire 1 0.1798
438 equilibration 1 0.274
438 et 1 0.1835
438 evidence 1 0.1005
438 experimentally. 1 0.2467
438 explained 1 0.1546
438 feedback 1 0.2307
438 finding 1 0.1677
438 finding, 1 0.2307
438 findings 2 0.2177
438 finite 1 0.274
438 fit 1 0.2467
438 follicles. 1 0.274
438 follows 1 0.1764
438 formation 1 0.123
438 found 2 0.1443
438 ger- 1 0.274
438 grains 1 0.2467
438 h3dna 2 0.5481
438 h3tdr 3 0.8221
438 increase 1 0.0931
438 indica- 1 0.274
438 initial 2 0.2657
438 inter- 1 0.1974
438 kinetics. 1 0.2307
438 la- 1 0.2467
438 label 8 1.7554
438 labeling 2 0.3595
438 large 6 0.65
438 large, 1 0.2107
438 latter 2 0.2843
438 lead 1 0.1764
438 leads 1 0.1528
438 least 1 0.1409
438 life 1 0.1449
438 long 1 0.1422
438 loss 3 0.3985
438 lymph 3 0.511
438 lymphatic 4 0.7898
438 lympho- 1 0.2194
438 lymphocyte 1 0.1974
438 lymphocyte, 1 0.274
438 lymphocytes 3 0.4817
438 lymphocytes. 2 0.4615
438 lymphocytic 1 0.2307
438 lymphoid 1 0.1764
438 marked 2 0.2459
438 marrow 1 0.1372
438 material 1 0.1271
438 may 2 0.1371
438 mechanisms 1 0.1652
438 ment 1 0.1798
438 minal 1 0.274
438 mus 1 0.274
438 ne- 1 0.2467
438 node 1 0.2107
438 node. 1 0.274
438 nodes 1 0.2107
438 normal 1 0.0737
438 nuclear 1 0.1585
438 nucleotides 1 0.2107
438 observed 1 0.0934
438 occur 1 0.1339
438 occurs 1 0.1464
438 one, 1 0.2035
438 operative 1 0.1528
438 others. 1 0.2194
438 pattern 1 0.1308
438 patterns 1 0.1732
438 percentage 1 0.1528
438 peripheral 2 0.3256
438 phagocytosis 1 0.2467
438 pinocytosis, 1 0.2467
438 population 2 0.3527
438 population, 1 0.274
438 population. 1 0.2307
438 possibility. 1 0.274
438 precursor 1 0.2107
438 presented, 1 0.2194
438 prevails 1 0.274
438 prevents 1 0.2035
438 previous 1 0.1479
438 process 1 0.1254
438 progenitor 2 0.5481
438 proliferating 1 0.274
438 proliferative 1 0.1974
438 prolonged 1 0.1318
438 qually. 1 0.274
438 quantitation 1 0.274
438 radio- 1 0.2035
438 radioacti- 1 0.274
438 rapid 1 0.1328
438 rate 1 0.1009
438 rats 2 0.2117
438 recirculating, 1 0.274
438 regardless 1 0.2194
438 related 1 0.1159
438 relationship 1 0.1318
438 renewal 1 0.274
438 rently 1 0.274
438 retention 2 0.3407
438 sacrificed 1 0.274
438 serially 1 0.2307
438 shows 1 0.1511
438 slope 1 0.2107
438 small 10 1.0993
438 span 1 0.2467
438 spread 1 0.2035
438 stress 1 0.1876
438 studied 1 0.0955
438 subsequent 1 0.1494
438 suggesting 1 0.1677
438 suggests 1 0.1464
438 sugino 1 0.274
438 suppression 1 0.1764
438 thy- 1 0.274
438 thymic 1 0.2307
438 thymidine 2 0.3844
438 thymine 1 0.274
438 thymocytes. 1 0.274
438 thymus 6 1.1847
438 thymus, 1 0.2194
438 thymus. 3 0.7402
438 tions 1 0.1628
438 tissue, 1 0.1974
438 tissue. 1 0.1764
438 tissues 2 0.2508
438 trans- 1 0.2107
438 transfer 2 0.3527
438 tritium-labelled 1 0.274
438 two 1 0.0839
438 type, 1 0.1835
438 types 1 0.1328
438 uptake 2 0.3595
438 vertheless, 1 0.274
438 vity 1 0.2467
438 whether 1 0.1361
438 whole 2 0.3056
438 wide- 1 0.274
438 would 1 0.1361
438 x-ray, 1 0.274
439 (more 1 0.5024
439 + 1 0.3524
439 1 1 0.1897
439 1.8 1 0.4523
439 17-hydroxy-corticosteroids 1 0.5024
439 17-hydroxy-corticosteroids, 1 0.5024
439 20 1 0.2269
439 25 2 0.5738
439 3 2 0.3425
439 5 2 0.3811
439 6 1 0.2101
439 6674. 1 0.5024
439 70%, 1 0.5024
439 acid 1 0.194
439 acid-bound 1 0.5024
439 acth 3 1.2691
439 acth. 1 0.5024
439 administration 1 0.2212
439 advanced 1 0.2606
439 altered 1 0.2683
439 approximately 1 0.2631
439 average, 1 0.423
439 bound 3 1.0318
439 breast 1 0.2657
439 cancer 2 0.3972
439 carcinomas, 1 0.5024
439 corticosteroids 3 1.0091
439 corticosteroids. 1 0.4523
439 depending 1 0.4023
439 determinations 1 0.362
439 enough 1 0.3862
439 forms 1 0.2399
439 found 1 0.1323
439 free 6 1.4285
439 given 1 0.1842
439 glucuronic 2 0.9046
439 growing 1 0.3364
439 high 1 0.1798
439 hr. 2 0.5811
439 i.v. 1 0.3862
439 infusion 3 0.8503
439 infusion. 1 0.4023
439 initial 2 0.4871
439 iv 2 0.7724
439 m. 1 0.2801
439 made 1 0.182
439 mammary 1 0.3233
439 maximal 1 0.3123
439 mixed 1 0.3176
439 ml. 1 0.3364
439 others 1 0.274
439 patients 3 0.3623
439 plasma 2 0.4051
439 plasma). 1 0.5024
439 rapidly 1 0.2869
439 ratio 2 0.5262
439 ratios 1 0.3296
439 related 1 0.2124
439 seen, 1 0.423
439 seventeen 1 0.3862
439 shifts 1 0.5024
439 stage 2 0.4871
439 stimulation 1 0.2834
439 treatment 1 0.1482
439 u. 4 1.5448
439 ug./100 1 0.5024
439 value 2 0.4629
439 values 1 0.2537
440 + 1 0.4229
440 0.2% 1 0.6029
440 0.5 1 0.4477
440 0.8 1 0.6029
440 1.2 1 0.6029
440 1.3 1 0.4827
440 21% 1 0.6029
440 23% 1 0.6029
440 24 1 0.3127
440 26 1 0.3811
440 34 1 0.4229
440 4179. 1 0.6029
440 53 1 0.5076
440 62% 1 0.5076
440 active 1 0.2778
440 adrenocortical 1 0.4827
440 age 1 0.2494
440 androgen, 1 0.6029
440 arrested 1 0.5428
440 be- 1 0.3689
440 breast 3 0.9564
440 cancer 3 0.715
440 cancer, 1 0.3811
440 carcinogenic 1 0.4634
440 castration 1 0.5428
440 chemically 1 0.4477
440 confidence 1 0.5428
440 contributed 1 0.4344
440 controls 1 0.3633
440 controls, 1 0.5076
440 corticosteroid 1 0.4229
440 creted 1 0.5428
440 crine 1 0.6029
440 decreased 1 0.2723
440 derived 1 0.3324
440 dex 1 0.5428
440 endo- 1 0.5076
440 endocrine 1 0.4229
440 eq 5 3.0145
440 es- 1 0.5428
440 estradiol-17b(eq) 1 0.6029
440 estradiol-dependent 1 0.6029
440 estriol 1 0.4827
440 estriol/estrone 1 0.6029
440 estrogen, 1 0.5428
440 estrogens 1 0.5428
440 estrogens. 1 0.6029
440 ex- 1 0.3581
440 excretion 1 0.2836
440 growth 1 0.2055
440 hormo- 1 0.6029
440 imbalance 1 0.6029
440 impeded 2 1.0856
440 in- 1 0.2671
440 increase 1 0.2048
440 indicated 1 0.2836
440 induced 1 0.2563
440 level. 1 0.4344
440 major 1 0.29
440 mal, 1 0.6029
440 mammary 1 0.388
440 marked 1 0.2705
440 matching 1 0.5076
440 measured 1 0.2639
440 median 2 0.9655
440 menopause, 1 0.5428
440 metabolic 1 0.2878
440 metastases. 1 0.4827
440 nal 1 0.4827
440 noncarcinogenic 1 0.6029
440 normal. 2 0.7267
440 normaliza- 1 0.6029
440 observed 1 0.2055
440 ovarian 2 0.8954
440 pa- 1 0.3533
440 pairs 1 0.4634
440 patients 5 0.7246
440 precancerous 1 0.6029
440 prior 1 0.322
440 quotient 1 0.4827
440 ratio 1 0.3157
440 recent 1 0.3157
440 reduced 1 0.2723
440 remissions 1 0.4477
440 respectively, 1 0.4344
440 rose 1 0.4229
440 significant 1 0.2116
440 sources 1 0.4634
440 status 1 0.3811
440 sub- 1 0.388
440 subnor- 1 0.6029
440 subnormal. 1 0.6029
440 suggests 1 0.322
440 surgery 1 0.2993
440 surgery, 1 0.4634
440 test 1 0.2608
440 therapy 2 0.4767
440 therapy, 1 0.388
440 tients 1 0.388
440 tion 1 0.2741
440 toward 1 0.388
440 treatment 1 0.1779
440 trogens 1 0.6029
440 tween 1 0.4344
440 unless 1 0.4477
440 untreated 1 0.4477
440 urinary 1 0.2671
440 wilcoxon 1 0.6029
440 without 2 0.4554
440 women 1 0.3253
441 1107. 1 0.7536
441 appear 1 0.3449
441 benign 2 1.086
441 breast 4 1.5939
441 cancer 4 1.1917
441 cannot 1 0.4066
441 cantly 1 0.6785
441 control 2 0.5667
441 controls 1 0.4542
441 crete 1 0.6785
441 debilitation. 1 0.7536
441 difference 1 0.3773
441 disease 2 0.5415
441 estradiol 1 0.6034
441 estriol 4 2.4137
441 estrogen 2 1.2069
441 estrone 1 0.6785
441 estrone, 1 0.6346
441 ex- 1 0.4477
441 excreted 1 0.4685
441 excretion 3 1.0637
441 explained 1 0.4252
441 good 1 0.4202
441 group. 1 0.4358
441 groups 1 0.3069
441 groups. 1 0.4477
441 health. 1 0.7536
441 higher 2 0.6481
441 increase 1 0.256
441 levels 1 0.2951
441 lower 1 0.3426
441 pa- 1 0.4416
441 patients 2 0.3623
441 percentage 2 0.8404
441 postmenopausal 2 1.0572
441 premenopausal 2 1.2691
441 signifi- 1 0.5793
441 significant 1 0.2646
441 significantly 1 0.3168
441 tients 1 0.485
441 total 2 0.5875
441 urinary 1 0.3339
441 women 1 0.4066
442 (22 1 0.9046
442 (45 1 0.9046
442 (48 1 0.9046
442 (diethylstilbestrol), 1 1.0048
442 (six 1 1.0048
442 (testosterone), 1 1.0048
442 5323. 1 1.0048
442 advanced 2 1.0425
442 agents 1 0.5422
442 androgenic 2 2.0097
442 breast 2 1.0626
442 cancer 2 0.7945
442 complications 1 0.5888
442 contribute 1 0.7462
442 definitely 1 0.8461
442 diethylstilbestrol 1 1.0048
442 disconti- 1 1.0048
442 effects 3 1.119
442 erythropoiesis. 1 0.9046
442 estrogenic 1 0.9046
442 evaluation 1 0.5422
442 fluid 1 0.4762
442 hormonal 1 0.7462
442 hormones 2 1.4096
442 hypercalcemia 1 0.7724
442 included 1 0.5422
442 incontinence 1 1.0048
442 induced 1 0.4272
442 months) 1 0.8046
442 nausea 1 0.9046
442 necessitate 1 1.0048
442 nuance 1 1.0048
442 observa- 1 1.0048
442 patients) 1 0.9046
442 patients), 2 2.0097
442 physiologic 1 0.6466
442 postmenopausal 1 0.7048
442 propionate 1 0.7462
442 re- 1 0.4452
442 reactions 1 0.4909
442 serious 1 0.6056
442 sex 1 0.6728
442 steroid 1 0.5811
442 stimulated 1 0.6728
442 studied 1 0.3501
442 systemic 3 1.6808
442 tention. 1 1.0048
442 testosterone 1 0.724
442 therapy 1 0.3972
442 therapy. 1 0.5422
442 three 1 0.3778
442 tions 1 0.5969
442 treatment 1 0.2965
442 treatment. 1 0.5313
442 urinary 1 0.4452
442 virilization 1 1.0048
442 vomiting 1 0.9046
442 weeks 1 0.5262
442 women. 1 0.8046
443 (stage 1 0.6785
443 12 1 0.3598
443 17-hydroxycorti- 1 0.7536
443 3 1 0.2569
443 3478. 1 0.7536
443 6 1 0.3151
443 advanced 2 0.7819
443 attributed 1 0.5046
443 average 1 0.3381
443 breast 4 1.5939
443 cancer 2 0.5959
443 cancer. 2 1.0572
443 cases 3 0.6727
443 corticosteroid 1 0.5286
443 corticosteroids 1 0.5046
443 costeroids 1 0.7536
443 dehydroepiandrosterone 3 2.0354
443 dehydroepiandrosterone-phosphate. 1 0.7536
443 detectable 1 0.4764
443 diseases 1 0.411
443 effect 3 0.6903
443 findings 1 0.2994
443 found 1 0.1984
443 groups 1 0.3069
443 hr. 2 0.8716
443 ii 1 0.5046
443 infusion 1 0.4252
443 initial 1 0.3653
443 intensive 1 0.5596
443 intermediate. 1 0.7536
443 iv 1 0.5793
443 iv) 1 0.6785
443 later; 1 0.6785
443 lesions, 1 0.543
443 levels 2 0.5902
443 lowest 1 0.6034
443 mastopathy 1 0.6785
443 patients 2 0.3623
443 patients, 1 0.3773
443 plasma 2 0.6077
443 reached 1 0.4943
443 reducing 1 0.5793
443 shortened 1 0.6346
443 shortening 1 0.6785
443 stage 1 0.3653
443 stages 2 0.831
443 still 1 0.352
443 time. 1 0.5286
443 transformation 1 0.411
443 various 1 0.2979
444 17 1 0.1791
444 21 1 0.1906
444 3 1 0.1028
444 5 1 0.1143
444 5274. 1 0.3015
444 59 1 0.2414
444 6 1 0.126
444 absolute 1 0.2114
444 alone. 1 0.2238
444 also 1 0.0843
444 appetite 1 0.2714
444 appetite. 1 0.3015
444 arbi- 1 0.3015
444 assayed 1 0.2414
444 assignment 1 0.3015
444 believed, 1 0.3015
444 benign 5 1.086
444 c.e. 1 0.3015
444 cancer 6 0.715
444 cancer, 1 0.1906
444 clinical 1 0.0983
444 clinically 4 0.8255
444 compared 2 0.2339
444 days 2 0.2395
444 determine 1 0.1701
444 differences 4 0.5518
444 different. 1 0.2714
444 due 1 0.1066
444 dystrophies 1 0.3015
444 estradiol 1 0.2414
444 estradiol, 3 0.7615
444 estradiol. 1 0.3015
444 estriol 4 0.9655
444 estrogen 3 0.7241
444 estrogen-androgen 1 0.3015
444 estrone 5 1.357
444 estrone, 3 0.7615
444 estrone-androsterone 1 0.3015
444 exception 1 0.1977
444 excreted 5 0.9369
444 excretion 2 0.2836
444 exist. 1 0.3015
444 experiencing 1 0.3015
444 frac- 1 0.2414
444 fractions 2 0.322
444 group 3 0.3343
444 group. 1 0.1743
444 groups, 2 0.4037
444 higher 3 0.3889
444 hopkins 1 0.2714
444 hospitalized 2 0.4229
444 however, 1 0.1092
444 hyper- 1 0.1791
444 hypertrophy 3 0.4782
444 hypertrophy, 2 0.4344
444 imbalance. 1 0.3015
444 inanition 1 0.3015
444 internal 1 0.1701
444 less. 1 0.2538
444 levels 5 0.5902
444 loss 2 0.2922
444 lower 4 0.5481
444 patients 10 0.7246
444 percentage 1 0.1681
444 preclude 1 0.2414
444 present 1 0.0993
444 proportions 2 0.5076
444 prostatic 5 1.1586
444 ratio 2 0.3157
444 relatively 2 0.29
444 reported 1 0.1221
444 resulted 1 0.1461
444 significant 1 0.1058
444 significant. 2 0.4229
444 significantly 6 0.7604
444 subjects 3 0.4317
444 suggest 1 0.137
444 tions 1 0.1791
444 total 2 0.235
444 trary 1 0.3015
444 trophy 1 0.2538
444 urinary 3 0.4007
444 used 1 0.1138
444 variations 1 0.1874
444 well 4 0.4217
444 whether 1 0.1497
444 within 1 0.1119
445 1 1 0.2277
445 28029 1 0.6029
445 5 1 0.2287
445 activity 1 0.2158
445 breast 3 0.9564
445 cancer 1 0.2383
445 carcinoma 1 0.2878
445 carcinomas 1 0.4827
445 case 1 0.2166
445 cellularity 1 0.6029
445 contain 2 0.776
445 conversion 1 0.4344
445 detected 1 0.3127
445 due 1 0.2133
445 enzy- 1 0.6029
445 enzyme, 1 0.5428
445 enzymic 1 0.5076
445 every 1 0.3362
445 examination 1 0.3044
445 examined. 2 0.8255
445 extracts 3 1.1066
445 fibrous 1 0.4634
445 formed 1 0.3362
445 generally 1 0.3581
445 human 2 0.4024
445 ii. 1 0.3487
445 incorporation 1 0.3811
445 increase 1 0.2048
445 incubating 1 0.6029
445 instances. 1 0.5076
445 kinase 1 0.5076
445 levels 1 0.2361
445 mammary 2 0.776
445 mically 1 0.6029
445 nature 1 0.2993
445 necessarily 1 0.4127
445 normal 3 0.4864
445 observed 1 0.2055
445 obtained 1 0.2149
445 one 1 0.1687
445 oophorectomy, 1 0.6029
445 ovarian 1 0.4477
445 patients 1 0.1449
445 phosphosulfate. 1 0.6029
445 poor 1 0.3487
445 presence 1 0.2297
445 primary 1 0.2549
445 products 1 0.4229
445 revealed 1 0.2922
445 s35-adenosine-3'-phosphate-5'- 1 0.6029
445 s35-sulfate 1 0.6029
445 secondary 1 0.3018
445 showing 1 0.3955
445 shown 1 0.2593
445 specimens 1 0.388
445 specimens, 1 0.5076
445 steroid 5 1.7433
445 steroids, 1 0.5076
445 sulfate, 1 0.6029
445 sulfates. 1 0.6029
445 sulfo- 1 0.6029
445 sulfokinase 1 0.6029
445 sulfokinase(s) 1 0.6029
445 surrounding 1 0.4229
445 synthesis 1 0.2993
445 thought 1 0.3401
445 tissue 3 0.6278
445 tissue. 1 0.388
445 trace 1 0.4344
445 tumors 1 0.3157
445 undergoing 1 0.3811
445 weak 1 0.5076
445 without 1 0.2277
446 3752. 1 0.7536
446 5000 1 0.6785
446 abnormal 2 0.7306
446 abnormality 1 0.5286
446 addition, 1 0.4358
446 adrenalec- 1 0.7536
446 adrogen 1 0.7536
446 advanced 1 0.3909
446 also 1 0.2108
446 amounts 2 0.7483
446 androgen 1 0.6346
446 approximately 1 0.3946
446 breast 4 1.5939
446 cancer 2 0.5959
446 cancer, 1 0.4764
446 cancer. 1 0.5286
446 carried 1 0.3773
446 cases 2 0.4484
446 compared 1 0.2924
446 cor- 1 0.6346
446 cortisol. 1 0.7536
446 deficiency 1 0.3985
446 development 1 0.2752
446 disease. 1 0.3985
446 early 2 0.5526
446 estimations 1 0.6346
446 excrete 1 0.6346
446 excreting 1 0.6785
446 excretion 2 0.7091
446 fail 1 0.6346
446 follow-up 1 0.5046
446 found 2 0.3968
446 half 1 0.4416
446 hypophysectomy 1 0.543
446 investigated 1 0.4303
446 involving 1 0.485
446 mastectomy 1 0.6346
446 may 1 0.1885
446 measurements 2 0.97
446 metabolites 1 0.5793
446 normal 1 0.2027
446 onset 1 0.4358
446 patients 2 0.3623
446 poor 1 0.4358
446 possible 1 0.3023
446 precede 1 0.6034
446 presenting 1 0.5046
446 problem 1 0.4303
446 progno- 1 0.7536
446 rected. 1 0.7536
446 respond 1 0.4611
446 seems 1 0.3985
446 shows 1 0.4155
446 similar 1 0.2821
446 sis, 1 0.6785
446 started 1 0.6346
446 steroid 2 0.8716
446 steroids. 1 0.6785
446 subsequent 2 0.8219
446 subsequently 1 0.5046
446 tend 1 0.543
446 therefore 1 0.4611
446 tomy 1 0.7536
446 trial 2 1.1192
446 urinary 2 0.6678
446 women. 1 0.6034
447 10-15 1 0.4523
447 2365. 1 0.5024
447 again. 1 0.4523
447 age 2 0.4157
447 breast 2 0.5313
447 cancer 2 0.3972
447 constant 1 0.274
447 cycle. 1 0.423
447 decrease 1 0.2299
447 determined 1 0.2284
447 elapsed 1 0.5024
447 endocrine 1 0.3524
447 excretion 6 1.4182
447 fall 1 0.2631
447 first 1 0.1842
447 found 1 0.1323
447 group 1 0.1857
447 however, 1 0.182
447 i. 1 0.2985
447 increases 1 0.2347
447 indicate 1 0.2212
447 initial 1 0.2435
447 last 1 0.3364
447 maximum 1 0.277
447 menopause 2 0.8461
447 menopause. 2 1.0048
447 menstrual 1 0.5024
447 ment. 1 0.3731
447 new 1 0.2199
447 oestrone 1 0.423
447 oestrone, 2 0.8461
447 onward, 1 0.5024
447 patients 2 0.2415
447 patients. 1 0.2417
447 postmenopausal 1 0.3524
447 preganediol 1 0.5024
447 pregnanediol 2 0.7724
447 pregnanetriol 3 1.2691
447 rapid 1 0.2435
447 receiving 1 0.277
447 relation 2 0.4629
447 relatively 1 0.2417
447 remains 1 0.2631
447 results 1 0.1439
447 series 1 0.2364
447 since 1 0.2186
447 slow 1 0.3296
447 spontaneous 1 0.2905
447 steroid 1 0.2905
447 studied 1 0.175
447 time 1 0.177
447 treat- 1 0.3123
447 urinary 1 0.2226
447 well 1 0.1757
447 years 1 0.2284
447 yr. 1 0.2631
448 (cortisone 1 0.7536
448 10 1 0.2774
448 2366. 1 0.7536
448 3 1 0.2569
448 4 1 0.2666
448 50 1 0.3598
448 adrenalectomy 1 0.5286
448 agreement 2 1.0318
448 breast 4 1.5939
448 cancer 2 0.5959
448 cancer. 2 1.0572
448 clinical 2 0.4913
448 contribute 1 0.5596
448 corticos- 1 0.7536
448 corticosteroids 2 1.0091
448 daily 2 0.8219
448 daily, 1 0.6785
448 demonstrate 1 0.4358
448 depressed 1 0.5793
448 depressing 1 0.6785
448 determined 1 0.3426
448 diation 1 0.6785
448 different 1 0.2666
448 divided 1 0.5286
448 doses 2 0.8219
448 doses) 1 0.7536
448 easily 1 0.485
448 effect 2 0.4602
448 effective 1 0.3773
448 endocrine 1 0.5286
448 excretion 3 1.0637
448 ii. 1 0.4358
448 impression 1 0.543
448 indicate 1 0.3319
448 irra- 1 0.6785
448 irradiation 1 0.4066
448 irradiation. 1 0.5159
448 many 1 0.3038
448 may 1 0.1885
448 menopause, 1 0.6785
448 mg. 2 0.9528
448 observation 1 0.3946
448 oestrogens 1 0.6785
448 oestrone, 2 1.2691
448 ovarian 3 1.6788
448 ovariectomy, 1 0.7536
448 ovaries 1 0.6785
448 patients 2 0.3623
448 patients. 2 0.725
448 postmenopausal 2 1.0572
448 prednisone 1 0.6785
448 pregnanediol 2 1.1586
448 pregnanetriol 2 1.2691
448 production 2 0.7678
448 results 2 0.4316
448 small 1 0.3023
448 stages 1 0.4155
448 steroids 1 0.5159
448 substitution 1 0.7536
448 teroids. 1 0.7536
448 therapeutic 2 0.7611
448 tolerated 1 0.543
448 treatment. 1 0.3985
448 urinary 1 0.3339
448 value 1 0.3472
448 women 1 0.4066
448 years 1 0.3426
449 17-ketosteroid 1 0.8046
449 17-ketosteroids 3 2.3172
449 24-hr. 1 0.8461
449 33 1 0.7724
449 37 1 0.6728
449 414. 1 1.0048
449 also 1 0.2811
449 amount 1 0.4948
449 benign 1 0.724
449 biochemical 1 0.6352
449 car- 1 0.724
449 carcinoma 1 0.4797
449 cinoma 1 0.8046
449 confirmed 2 1.1776
449 contrary 1 0.7048
449 control 1 0.3778
449 diagnosis 1 0.4135
449 diagnostic 1 0.4989
449 error. 1 1.0048
449 estimated 1 0.6246
449 estimation 2 1.4923
449 experimental 1 0.4661
449 found 1 0.2645
449 great 1 0.5738
449 high 1 0.3596
449 histologically 1 0.7724
449 hyperplasia 1 0.5669
449 involves 1 0.724
449 laborious 1 1.0048
449 levels 1 0.3935
449 literature, 1 0.8046
449 method 2 0.7983
449 moreover, 1 0.6591
449 neutral 1 0.724
449 patients 2 0.4831
449 percentage 1 0.5603
449 prostate 2 1.6922
449 quite 1 0.5738
449 raised 1 0.5969
449 relatively 1 0.4833
449 reports 1 0.6466
449 results 1 0.2878
449 revealed 1 0.4871
449 samples 1 0.6352
449 subjects. 1 0.6148
449 that, 1 0.6591
449 unreliable. 1 1.0048
449 urinary 1 0.4452
449 urine. 1 0.7724
450 2820. 1 0.7536
450 67%. 1 0.7536
450 administration 1 0.3319
450 adrenal 1 0.4477
450 breast 1 0.3985
450 cancer 1 0.2979
450 corticosteroid 1 0.5286
450 corticosteroids 2 1.0091
450 cretion 1 0.6785
450 decrease 1 0.3449
450 depression 1 0.5286
450 determined. 1 0.5159
450 diminished 1 0.5046
450 doses 1 0.411
450 due 1 0.2666
450 evidently 1 0.7536
450 ex- 1 0.4477
450 excretion 4 1.4182
450 function. 1 0.6346
450 influence 1 0.3449
450 low 1 0.3299
450 observed 1 0.2569
450 oestrone 4 2.5382
450 patients 2 0.3623
450 postmenopausal 1 0.5286
450 pregnanetriol 3 1.9037
450 series 1 0.3546
450 small 1 0.3023
450 subjected 1 0.411
450 therapy 1 0.2979
450 values 1 0.3805
450 well. 1 0.5596
450 women 1 0.4066
451 (5a) 1 0.7536
451 (5b) 1 0.7536
451 1.0, 1 0.7536
451 1.3 1 0.6034
451 5062. 1 0.7536
451 5a/5b 1 0.7536
451 aetiocholanone 1 0.7536
451 affect 1 0.4764
451 affected 1 0.3909
451 america 1 0.7536
451 andosterene 1 0.7536
451 breast 2 0.797
451 britain. 1 0.7536
451 british 2 1.5073
451 cancer 2 0.5959
451 differ 1 0.4943
451 disease 1 0.2708
451 eighth 1 0.6785
451 excrete 1 0.6346
451 former 1 0.5159
451 function, 1 0.5793
451 great 1 0.4303
451 ii-deoxy-17-oxosteroids 1 0.7536
451 incidence 2 0.7196
451 japan 1 0.7536
451 japanese 2 1.357
451 latter 1 0.3909
451 living 1 0.543
451 markedly 1 0.4025
451 mean 1 0.3625
451 means 1 0.3339
451 north 1 0.7536
451 one 1 0.2108
451 ratio 2 0.7893
451 reference 1 0.4155
451 relative 1 0.3909
451 reported 1 0.3054
451 significantly. 1 0.5793
451 thyroid 2 0.8832
451 tokyo. 1 0.7536
451 urinary 1 0.3339
451 white 1 0.4685
451 women 4 1.6265
452 (17-ks) 1 0.6029
452 (17-ohcs) 1 0.5428
452 100 1 0.3401
452 17- 1 0.5076
452 17-hydrocorticosteroids 1 0.6029
452 17-hydroxycorticosteroids 1 0.5428
452 17-ketosteroids 1 0.4634
452 17-ks 1 0.6029
452 17-ohcs 1 0.5428
452 17-ohcs. 1 0.6029
452 5318. 1 0.6029
452 67 1 0.5076
452 age. 1 0.3401
452 breast 3 0.9564
452 cancer 3 0.715
452 correlation 1 0.3044
452 equivalent 1 0.4229
452 higher 2 0.5185
452 ketosteroids 1 0.6029
452 level 3 0.6985
452 mean 1 0.29
452 menopausal 1 0.5428
452 menopause 1 0.5076
452 normal 1 0.1621
452 normal. 1 0.3633
452 plasma 4 0.9723
452 significantly 2 0.5069
452 treated 1 0.2481
452 whether 1 0.2993
452 women 5 1.6265
452 young 1 0.3044
453 2 2 0.6136
453 5 1 0.3811
453 5319. 1 1.0048
453 acth 3 2.5382
453 administration. 1 0.6728
453 adreno- 1 1.0048
453 advanced 1 0.5212
453 before, 1 0.7724
453 breast 3 1.5939
453 cancer 3 1.1917
453 capacity 1 0.548
453 chromo- 1 1.0048
453 chromogens 2 2.0097
453 concluded 1 0.4598
453 consisted 1 0.5969
453 control 1 0.3778
453 cortical 1 0.6466
453 course 1 0.4568
453 day 1 0.4989
453 difference 1 0.5031
453 disease 1 0.361
453 disease. 1 0.5313
453 documented 1 0.724
453 females 1 0.7048
453 following 2 0.6662
453 found 1 0.2645
453 free 1 0.4762
453 functional 1 0.6352
453 gens 1 1.0048
453 group 2 0.7429
453 groups 2 0.8185
453 intravenous 2 1.0733
453 laboratory. 1 1.0048
453 mastectomy 1 0.8461
453 measured 2 0.8796
453 metastatic 2 1.2933
453 metho- 1 1.0048
453 methopyrapone 1 0.9046
453 normal 1 0.2702
453 normal. 1 0.6056
453 patients 3 0.7246
453 pituitary 1 0.5212
453 porter-silber 3 3.0145
453 pyrapone 1 1.0048
453 range 1 0.5422
453 rela- 1 0.8461
453 reserve 1 0.8046
453 secretion 1 0.5888
453 significant 1 0.3527
453 steroidogenesis 1 1.0048
453 study 2 0.6191
453 tively 1 0.9046
453 urinary 3 1.3357
453 within 1 0.373
453 years 1 0.4568
454 10.8. 1 0.6029
454 111 1 0.5428
454 1218 1 0.6029
454 1945-1957 1 0.6029
454 1945-1962 1 0.5428
454 1945-1962, 1 0.6029
454 1958-1962 1 0.6029
454 20-30 2 1.2058
454 2349. 1 0.6029
454 30-40 1 0.5428
454 40-60 1 0.6029
454 8.7% 1 0.6029
454 accounted 1 0.4477
454 age 4 0.9976
454 amy- 1 0.6029
454 amyloidosis 3 1.0744
454 amyloidosis. 1 0.4634
454 autopsy 2 0.7909
454 cases 1 0.1794
454 cases; 1 0.4827
454 complicated 1 0.4229
454 curve 1 0.4127
454 death 1 0.3288
454 department 2 0.9269
454 died 1 0.3533
454 difference 2 0.6037
454 examinations 1 0.4127
454 fatality 1 0.6029
454 greatest 1 0.3811
454 group, 3 1.164
454 group. 1 0.3487
454 incidence 1 0.2878
454 included 1 0.3253
454 institute, 2 1.2058
454 loidosis 1 0.6029
454 material 2 0.5593
454 men 2 0.9269
454 number 1 0.2307
454 pathology 2 0.8073
454 patients 1 0.1449
454 peak 1 0.3487
454 percentage 1 0.3362
454 postmortem 1 0.4634
454 sexes 1 0.5428
454 sis. 1 0.6029
454 tuberculo- 1 0.6029
454 tuberculosis 5 2.0636
454 two 1 0.1846
454 warsaw, 1 0.6029
454 women 1 0.3253
454 women, 1 0.4477
454 years 1 0.2741
455 (a) 1 0.388
455 (b) 1 0.388
455 (c) 1 0.4229
455 (d) 1 0.5076
455 (russian) 1 0.4344
455 (with 1 0.4634
455 30 2 0.5757
455 300 1 0.4634
455 60 1 0.388
455 766. 1 0.5076
455 absence 1 0.2878
455 active 1 0.2778
455 also 1 0.1687
455 amyloidosis 5 1.7907
455 amyloidosis. 1 0.4634
455 anaemia 1 0.4827
455 analyses 1 0.4037
455 appearance 2 0.5987
455 associated 1 0.2141
455 author 1 0.3533
455 blood 2 0.3726
455 caseous 1 0.5428
455 certain 1 0.2655
455 changes 2 0.3608
455 chronic 1 0.2878
455 cirrhotic 1 0.6029
455 clinical 1 0.1965
455 clinicians 1 0.5076
455 com- 1 0.3581
455 complete 1 0.2797
455 complicated 1 0.4229
455 complication. 1 0.6029
455 consistently 1 0.388
455 corresponding 1 0.3533
455 count 1 0.4127
455 de- 1 0.3362
455 detailed 1 0.3811
455 diagnose 1 0.6029
455 diagnosis 1 0.2481
455 disease, 1 0.322
455 early 2 0.442
455 esr 1 0.6029
455 exception 1 0.3955
455 exploring 1 0.6029
455 features 1 0.322
455 fibrocavernous 1 0.5428
455 finding 1 0.3689
455 flare-up, 1 0.6029
455 following 1 0.1998
455 forms 4 1.1513
455 formula 1 0.4827
455 generative 1 0.6029
455 haemogram 2 1.2058
455 high 1 0.2158
455 hypochromic 1 0.6029
455 increase 1 0.2048
455 inferred 1 0.5076
455 initial 1 0.2922
455 internal 2 0.6802
455 intestinal 1 0.4344
455 kidneys, 1 0.4634
455 larynx, 1 0.5428
455 left 1 0.2723
455 leucocyte 1 0.5428
455 lymph 1 0.3748
455 made 1 0.2183
455 main 1 0.3443
455 mature 1 0.3748
455 means 1 0.2671
455 neutrophil 1 0.6029
455 nodes), 1 0.6029
455 normochromic 1 0.6029
455 old 1 0.3401
455 organs 2 0.6648
455 patients 3 0.4348
455 patients, 1 0.3018
455 phase 2 0.644
455 picture 1 0.3288
455 plicated 1 0.5428
455 possibilities 1 0.4477
455 possible 2 0.4837
455 presence 1 0.2297
455 process, 1 0.5428
455 progressive 1 0.3362
455 pulmonary 2 0.5155
455 quiescence 1 0.5428
455 reason 1 0.4344
455 regression 1 0.388
455 russian 1 0.6029
455 seems 1 0.3188
455 serial 1 0.3689
455 shift 1 0.4477
455 stage. 1 0.5076
455 stages 1 0.3324
455 studied 1 0.2101
455 study 1 0.1857
455 subsidence 1 0.6029
455 tb 5 2.3172
455 tending 1 0.5428
455 thrombocytes. 1 0.6029
455 thrombocytic 1 0.6029
455 thrombocytosis 1 0.6029
455 towards 1 0.4344
455 tract 1 0.3487
455 tuberculosis 1 0.4127
455 various 1 0.2383
455 viz. 1 0.6029
455 without 1 0.2277
456 (prowse,1958) 1 1.0048
456 1319. 1 1.0048
456 account 1 0.5669
456 acts 1 0.724
456 advanced 1 0.5212
456 aetiology 1 0.8046
456 amyloid 2 1.3758
456 amyloidosis 3 1.7907
456 antibody 1 0.6148
456 antigen 1 0.5969
456 appearances 1 0.9046
456 arguments 1 0.8461
456 brief 1 0.7048
456 clinical 1 0.3275
456 common 1 0.4909
456 deposition. 1 0.9046
456 deposits. 1 0.9046
456 described; 1 0.9046
456 details 1 0.6879
456 determine 1 0.5669
456 diffuse 2 1.3455
456 disease 1 0.361
456 distribution 1 0.5165
456 duration, 1 0.8461
456 favour 1 0.9046
456 findings 1 0.3992
456 followed 1 0.4598
456 forms. 1 0.8461
456 frequency 1 0.5262
456 histological 1 0.5969
456 immunity 1 0.724
456 literature 1 0.548
456 may 1 0.2513
456 mechanism, 1 0.8461
456 nature 1 0.4989
456 necropsy 1 0.724
456 patient 1 0.3778
456 previous 1 0.5422
456 protean 1 1.0048
456 published 1 0.6728
456 rare 1 0.5969
456 report 1 0.4871
456 response 1 0.3669
456 reviewed 1 0.5669
456 site 1 0.5811
456 site, 1 1.0048
456 stimulus 1 0.6728
456 strength, 1 0.9046
456 suggested 1 0.4179
456 supplement 1 0.9046
456 tracheo-bronchial 2 2.0097
456 variant 1 0.7724
456 variations 1 0.6246
457 (corticos- 1 0.6029
457 (corticosteroid) 2 1.2058
457 (particularly 1 0.5428
457 (russian) 1 0.4344
457 (without 1 0.6029
457 1945-1962 1 0.5428
457 2091. 1 0.6029
457 414 1 0.6029
457 absent. 1 0.5076
457 account 1 0.3401
457 acid), 1 0.6029
457 adequate. 1 0.5428
457 agents 1 0.3253
457 amyloi- 1 0.5428
457 amyloidosis 5 1.7907
457 amyloidosis, 2 0.9269
457 amyloidosis. 1 0.4634
457 ascites), 1 0.6029
457 ascorbic 1 0.5428
457 azotemic 1 0.5076
457 capacity 1 0.3288
457 co- 1 0.5076
457 complicated 2 0.8457
457 condition. 1 0.4127
457 desensitizing 1 0.5428
457 deterioration 1 0.5076
457 disorders 1 0.3443
457 dosis 1 0.6029
457 earliest 1 0.4477
457 early 2 0.442
457 edema-hypotonic 2 1.2058
457 elimination 1 0.5428
457 even 1 0.2639
457 factors 1 0.2549
457 foci 1 0.4344
457 form 1 0.2623
457 functional 2 0.7622
457 genetic 1 0.3157
457 geno-peritoneum. 1 0.6029
457 hormonal 3 1.3431
457 hypoxemia 2 1.2058
457 immediate 1 0.3811
457 indicated 3 0.8509
457 indicated, 1 0.4827
457 infection 1 0.2836
457 interven- 1 0.6029
457 introduction 1 0.4344
457 joint 1 0.388
457 kidneys 2 0.6723
457 leads 1 0.3362
457 liver 2 0.4744
457 long-term 1 0.3487
457 main 2 0.6886
457 methods 1 0.2723
457 modern 1 0.4477
457 one 1 0.1687
457 oxy- 1 0.5428
457 oxygen 3 0.9213
457 patho- 1 0.5076
457 pathogenesis 1 0.3401
457 pathogenetic 1 0.4634
457 patient's 1 0.4037
457 patients 4 0.5797
457 phase 3 0.966
457 preparations, 1 0.4827
457 process 1 0.2759
457 pronounced 1 0.3581
457 protein 1 0.2741
457 proteinuric 2 1.2058
457 pulmonary 5 1.2888
457 rapid 1 0.2922
457 rational 1 0.5076
457 results 1 0.1727
457 signs 1 0.3362
457 since 2 0.5246
457 stages 1 0.3324
457 still 1 0.2816
457 studied. 1 0.3401
457 subcutaneous 1 0.388
457 surgical 1 0.2723
457 symptoms 1 0.2857
457 teroid) 1 0.6029
457 therapy 5 1.1917
457 tion 1 0.2741
457 treatment 4 0.7115
457 tuberculosis 5 2.0636
457 using 1 0.2741
457 visceral 2 0.8954
457 vitamins 1 0.6029
458 (55 1 0.3349
458 (destructive 1 0.3349
458 (proteinuria, 1 0.3349
458 (russian) 1 0.2413
458 14 1 0.1847
458 18 1 0.1827
458 2-3 1 0.282
458 22 1 0.2293
458 23 1 0.2243
458 2317. 1 0.3349
458 31 2 0.4974
458 6 1 0.1401
458 62 1 0.2682
458 73 1 0.282
458 8 1 0.1513
458 84 1 0.2682
458 86 1 0.2682
458 9 3 0.5262
458 aged 1 0.2019
458 alone. 1 0.2487
458 amyloidosis 8 1.5918
458 amyloidosis. 1 0.2575
458 applica- 1 0.3349
458 basis 2 0.2932
458 biopsies 1 0.2487
458 biopsy 3 0.6466
458 biopsy, 1 0.282
458 bioptic 2 0.6699
458 blood 2 0.207
458 case 1 0.1203
458 cases 3 0.299
458 cells. 1 0.1493
458 changes 9 0.902
458 clinical 2 0.2184
458 coincided 1 0.282
458 come, 1 0.3349
458 common 1 0.1636
458 confirmed 1 0.1963
458 contention 1 0.282
458 culosis 1 0.3349
458 cylindruria, 1 0.3349
458 detected 1 0.1737
458 developed 1 0.1523
458 diagnosed 2 0.4098
458 diagnosing 1 0.2487
458 diagnosis 2 0.2757
458 duration), 1 0.3349
458 dystrophic 5 1.6747
458 edema, 1 0.2682
458 enlargement 1 0.2293
458 epithelial 1 0.1771
458 exacerbating 1 0.3349
458 fatal 1 0.2243
458 findings 2 0.2661
458 form 1 0.1457
458 formula, 1 0.3349
458 found; 1 0.3349
458 history 1 0.1937
458 increase 1 0.1138
458 indicated 1 0.1576
458 isohyposthenuria). 1 0.3349
458 it. 1 0.2293
458 knowledge 1 0.2197
458 later 1 0.1722
458 linked 1 0.2349
458 liver 6 0.7907
458 logical 1 0.2487
458 lungs. 1 0.2575
458 marked 2 0.3006
458 may 1 0.0838
458 men 1 0.2575
458 moderate 2 0.3979
458 morphological 1 0.2049
458 needle 1 0.2575
458 occur 1 0.1636
458 out- 1 0.3349
458 patho- 1 0.282
458 patients 6 0.4831
458 patients; 1 0.2487
458 performed 1 0.1533
458 picture 1 0.1827
458 place 1 0.2049
458 post-mortem 1 0.3349
458 precede 1 0.2682
458 presence 1 0.1276
458 process 2 0.3065
458 protein 1 0.1523
458 pulmonary 2 0.2864
458 puncture 6 1.8093
458 puncture. 1 0.3349
458 purpose 1 0.2243
458 quite 1 0.1913
458 refuted 1 0.3349
458 reported. 1 0.1937
458 results 2 0.1918
458 signs 1 0.1868
458 simultaneously 1 0.2019
458 spleen, 1 0.2243
458 supported 1 0.2413
458 surmised 1 0.3349
458 suspected 1 0.2243
458 symptoms, 1 0.2413
458 taking 1 0.2413
458 tb. 1 0.2682
458 them. 1 0.2413
458 tion 1 0.1523
458 tuber- 1 0.3015
458 tuberculosis 1 0.2293
458 tuberculous 1 0.3015
458 urine 1 0.1722
458 use 1 0.1324
458 visceral 1 0.2487
458 wide 1 0.199
458 without 1 0.1265
458 women 1 0.1807
458 years' 1 0.282
458 yr.) 1 0.3349
459 (russian) 1 0.362
459 2701. 1 0.5024
459 additional 1 0.2683
459 administra- 1 0.4523
459 administration 2 0.4425
459 allergic 1 0.3731
459 along 1 0.3524
459 amyloidosis 2 0.5969
459 amyloidosis, 1 0.3862
459 amyloidosis. 3 1.1586
459 antibacterial 2 0.9046
459 ary 1 0.5024
459 automatically 1 0.5024
459 autonomic 1 0.4523
459 case. 1 0.3862
459 cases 2 0.299
459 certain 1 0.2212
459 chemo- 1 0.5024
459 chemopreparations, 1 0.5024
459 chronic 5 1.1993
459 class 1 0.4523
459 clearing 1 0.5024
459 combined 1 0.2582
459 component 1 0.3233
459 confirmed 1 0.2944
459 constitutional 1 0.3731
459 contribute 1 0.3731
459 crease 1 0.3364
459 desensitizing 2 0.9046
459 detection 1 0.3123
459 develop 1 0.3028
459 development 4 0.7337
459 diseases 1 0.274
459 drugs 2 0.554
459 dys- 1 0.5024
459 dysfunction 1 0.3862
459 early 1 0.1842
459 effective 1 0.2515
459 effects, 1 0.4023
459 effects. 1 0.4023
459 even 1 0.2199
459 factors 2 0.4248
459 fibrocavernous 4 1.8093
459 foci 2 0.724
459 fore 1 0.5024
459 frequency 1 0.2631
459 gic 1 0.5024
459 great 1 0.2869
459 helps 1 0.4523
459 high 1 0.1798
459 hypofunction 1 0.5024
459 impor- 1 0.4523
459 importance 1 0.2559
459 in- 1 0.2226
459 incidence 1 0.2399
459 individual 1 0.2657
459 infection 2 0.4727
459 kidneys 1 0.2801
459 later 1 0.2582
459 liver 1 0.1977
459 lungs, 1 0.3862
459 measures 1 0.3296
459 mildly 1 0.4023
459 patients 5 0.6038
459 preparations, 1 0.4023
459 prevent 1 0.3364
459 prevention 1 0.3439
459 prime 1 0.5024
459 processes, 1 0.3731
459 prolonged 1 0.2417
459 promote 1 0.4523
459 pronounced 1 0.2985
459 prophylaxis 1 0.4023
459 pulmon- 1 0.5024
459 pulmonary 2 0.4296
459 reac- 1 0.5024
459 reactions 4 0.9818
459 role 1 0.2331
459 showing 1 0.3296
459 side 6 1.7006
459 stimulatory 1 0.4023
459 tance 1 0.5024
459 tb 1 0.3862
459 tb, 1 0.423
459 tb. 1 0.4023
459 tends 1 0.3862
459 therapy 1 0.1986
459 therapy, 1 0.3233
459 there- 1 0.4523
459 tion 1 0.2284
459 tions 1 0.2985
459 toxic 1 0.3074
459 toxic-aller- 1 0.5024
459 toxic-allergic 2 1.0048
459 trophic 1 0.4023
459 tuberculosis 2 0.6879
459 unsystematic 1 0.5024
460 (the 1 0.7462
460 10 1 0.3699
460 100% 1 0.8046
460 17-ketosteroids 2 1.5448
460 1835. 1 1.0048
460 2 1 0.3068
460 38 1 0.6879
460 50 1 0.4797
460 600,000 1 1.0048
460 abnormal 1 0.4871
460 action 1 0.4372
460 active 1 0.4629
460 administered 1 0.4797
460 administration 1 0.4425
460 advantage 1 0.9046
460 affect 1 0.6352
460 also 1 0.2811
460 always 1 0.5366
460 ampoule 1 0.9046
460 appears 1 0.4321
460 calciferol 3 3.0145
460 calciferol) 1 1.0048
460 calciferol, 1 1.0048
460 caseous 2 1.8093
460 cases 3 0.8969
460 cases. 1 0.5262
460 cero-caseous 1 1.0048
460 combination 1 0.5738
460 condition 1 0.5366
460 confirmed 1 0.5888
460 course 1 0.4568
460 d2 1 1.0048
460 days, 1 0.6591
460 decrease 2 0.9196
460 decreased 1 0.4538
460 determination 1 0.6148
460 disease. 1 0.5313
460 drugs 1 0.554
460 drugs, 1 0.8461
460 effect 1 0.3068
460 electrolytes 1 0.8461
460 evacuation 1 0.9046
460 every 1 0.5603
460 exerts 1 0.8461
460 expected 1 0.6591
460 extensive 2 1.1337
460 form 1 0.4372
460 general 1 0.5119
460 good 1 0.5603
460 improves 1 1.0048
460 increase 2 0.6826
460 leads 2 1.1206
460 lesions. 1 0.6879
460 liquefaction 1 1.0048
460 lung 1 0.4321
460 majority 1 0.6466
460 marked 1 0.4509
460 material. 1 0.724
460 may 1 0.2513
460 metabolism 1 0.4762
460 mineralocorticoids, 1 0.9046
460 modifies 1 0.9046
460 mth. 1 0.5969
460 myc. 1 0.8461
460 nevertheless 1 0.8461
460 offers 1 0.724
460 one 1 0.2811
460 organism. 1 0.8461
460 patients 1 0.2415
460 phlogistic 1 1.0048
460 proceed 1 0.9046
460 pronounced 1 0.5969
460 proteolysis; 1 1.0048
460 proteolytic 2 1.6091
460 pulmonary 2 0.8592
460 quantitative 1 0.5313
460 radiological 1 0.8046
460 rapid 1 0.4871
460 reason, 1 1.0048
460 recovery 1 0.554
460 related 1 0.4248
460 remained 1 0.5738
460 rendered 1 0.8461
460 results 1 0.2878
460 sensitive 1 0.5422
460 shadows, 1 1.0048
460 stances. 1 1.0048
460 steroid 1 0.5811
460 steroids 2 1.3758
460 stimulates 1 0.8461
460 sub- 1 0.6466
460 substances 1 0.7048
460 tb 1 0.7724
460 tb, 1 0.8461
460 tb. 1 0.8046
460 therapeutic 1 0.5074
460 tolerated 1 0.724
460 towards 1 0.724
460 treatment 1 0.2965
460 tuberculosis 1 0.6879
460 tuberculostatic 1 1.0048
460 tuberculostic 1 1.0048
460 u. 1 0.7724
460 ul- 1 0.9046
460 urinary 2 0.8904
460 urine 1 0.5165
460 value 1 0.4629
460 vit. 1 0.8046
460 well 1 0.3514
461 1837. 1 1.5073
461 2 2 0.9204
461 amyloidosis 2 1.7907
461 amyloidosis, 1 1.1586
461 amylosis 1 1.5073
461 antibiotics, 1 1.5073
461 appeared 1 0.725
461 biological 1 0.805
461 biopsies 1 1.1192
461 case 1 0.5415
461 confirmed 1 0.8832
461 could 1 0.5415
461 course 1 0.6851
461 development 2 1.1006
461 dis- 1 0.9528
461 doubtful. 1 1.5073
461 exception 1 0.9887
461 healthy 1 1.086
461 hepatic 1 0.8503
461 highly 1 0.8133
461 improvement 1 1.0091
461 infection 1 0.7091
461 kidney 1 0.6678
461 led 1 0.8832
461 less 2 1.1286
461 liver. 1 1.0572
461 long-term 1 0.8716
461 male, 1 1.357
461 months 1 0.7611
461 mth. 1 0.8954
461 north-african 1 1.5073
461 parallel 1 0.97
461 persistence 1 1.2691
461 post-primary 1 1.5073
461 previously 1 0.725
461 primary 1 0.6372
461 prognosis 1 0.831
461 pronounced 1 0.8954
461 proteinuria, 1 1.357
461 regressed 1 1.2069
461 renal 1 0.5847
461 renders 1 1.357
461 reported 1 0.6107
461 signs 1 0.8404
461 tb 2 2.3172
461 tb, 1 1.2691
461 treatment 1 0.4447
461 ulcero-infiltrative 1 1.5073
461 visceral 1 1.1192
461 young 1 0.7611
462 (aged 1 1.0048
462 2216. 1 1.0048
462 4 1 0.3554
462 48 1 0.5669
462 62 1 0.8046
462 anaplastic 1 0.9046
462 antibodies 1 0.5669
462 antinuclear 3 3.0145
462 apparent, 1 0.9046
462 became 1 0.5969
462 carcinoma, 1 0.8461
462 case 1 0.361
462 certain 1 0.4425
462 coidosis, 1 1.0048
462 could 1 0.361
462 cussed. 1 1.0048
462 degeneration 1 0.724
462 developed 1 0.4568
462 different 1 0.3554
462 dis- 1 0.6352
462 diseases 2 1.0959
462 erythematosus 1 0.724
462 factors 2 0.8496
462 found 2 0.5291
462 gically. 1 1.0048
462 identity 1 0.7724
462 immuno-hematological 1 1.0048
462 immunohematolo- 1 1.0048
462 importance 1 0.5119
462 interpret 1 1.0048
462 investigated 1 0.5738
462 led 2 1.1776
462 led, 1 1.0048
462 leukemias, 1 1.0048
462 lupus 1 0.6591
462 lympho- 1 0.8046
462 lympho-reticular 2 2.0097
462 lymphoblastic 1 1.0048
462 lymphogranulo- 1 1.0048
462 lymphogranuloma, 1 1.0048
462 lymphosarcoma, 1 1.0048
462 ma, 1 0.8461
462 malignant 1 0.548
462 metastasizing 1 1.0048
462 methods. 1 0.6352
462 mixed 1 0.6352
462 negative. 1 0.8461
462 observation, 1 0.9046
462 one 2 0.5622
462 parotid-tumor. 1 1.0048
462 patient 3 1.1335
462 patients 2 0.4831
462 production 1 0.5119
462 proved 1 0.5603
462 relations 1 0.8046
462 report 1 0.4871
462 reticular 1 0.8046
462 sar- 1 0.9046
462 sarcoma. 1 0.9046
462 sarcomatous 1 0.9046
462 secondarily 1 1.0048
462 serological 1 0.7462
462 serologically 1 0.8046
462 serum 1 0.3898
462 system 3 1.4082
462 tests, 1 0.6591
462 tuberculosis 1 0.6879
462 tumors, 1 0.7724
462 typical 1 0.6591
462 years), 1 1.0048
463 12 1 0.2399
463 12.1% 1 0.5024
463 17 1 0.2985
463 18 1 0.274
463 4417. 1 0.5024
463 61.1% 1 0.5024
463 administration, 1 0.3862
463 adopted, 1 0.5024
463 also 1 0.1406
463 bacterial 1 0.2944
463 cases 5 0.7474
463 chronic 1 0.2399
463 components 1 0.2869
463 contrary, 1 0.423
463 cortico- 1 0.4523
463 count 1 0.3439
463 criteria 1 0.2944
463 culture 1 0.2515
463 cytology. 1 0.5024
463 determination 1 0.3074
463 diagnostic 1 0.2494
463 disease. 1 0.2657
463 diseases 1 0.274
463 disorders 1 0.2869
463 examined 1 0.2537
463 given 1 0.1842
463 glomerular 1 0.3176
463 heimer-malbin 1 0.5024
463 increase 1 0.1706
463 infectious 1 0.3862
463 information. 1 0.423
463 instances 1 0.3364
463 investigate 1 0.423
463 investigated. 1 0.3862
463 investigation 1 0.2834
463 kidney 1 0.2226
463 little 1 0.2683
463 malbin 1 0.5024
463 many 1 0.2026
463 negative 1 0.2944
463 nephropathy 1 0.4023
463 nephropathy, 1 0.5024
463 non- 1 0.362
463 normal 1 0.1351
463 normals 1 0.3862
463 osmolarity; 1 0.5024
463 patients 1 0.1208
463 peroxydase 1 0.5024
463 positive 1 0.2683
463 prednisolone 2 1.0048
463 proved 1 0.2801
463 pyelonephritis 1 0.5024
463 remaining 1 0.2559
463 renal 2 0.3898
463 sediment 3 1.5073
463 significance 1 0.274
463 stain 2 0.9046
463 staining 1 0.3364
463 stern- 1 0.5024
463 sternheimer 1 0.5024
463 steroid 1 0.2905
463 subjects, 1 0.3364
463 supplied 1 0.4523
463 technique 1 0.2364
463 test 2 0.4346
463 test, 2 0.7462
463 tubulo-interstitial 1 0.5024
463 twelve 1 0.3176
463 unequivocally 1 0.423
463 urinary 6 1.3357
463 urine 1 0.2582
463 use. 1 0.4023
463 useful 1 0.277
463 value 1 0.2315
463 various 1 0.1986
464 17 1 0.8954
464 564. 1 1.5073
464 6 1 0.6302
464 6.5 1 1.2069
464 8.5 1 1.2691
464 95 1 1.2691
464 aged 1 0.9083
464 amyloid 2 2.0636
464 amyloid. 1 1.357
464 amyloidosis 1 0.8954
464 angioma 1 1.5073
464 cases 1 0.4484
464 cm., 1 1.357
464 contained 1 0.7678
464 detailed 1 0.9528
464 finding 1 0.9221
464 hamartoma; 1 1.5073
464 incidental 1 1.5073
464 included. 1 1.357
464 left 1 0.6807
464 lobe 1 1.0318
464 lower 1 0.6851
464 lung 1 0.6481
464 lung. 1 1.086
464 mass, 1 1.357
464 may 1 0.377
464 necropsy 1 1.086
464 others 1 0.8219
464 reported 1 0.6107
464 stroma 2 2.4137
464 structure 1 0.7678
464 suggested 1 0.6268
464 summary 1 1.357
464 tumor-like 1 1.357
464 tumoral 2 3.0145
464 tumors. 1 0.9887
464 uncommon 1 1.1586
464 vessels 1 1.086
464 woman 1 0.9887
464 x 2 1.9056
465 7364. 1 0.6029
465 absence 1 0.2878
465 ac- 1 0.388
465 amyloid. 1 0.5428
465 amyloidosis 5 1.7907
465 animal 1 0.3689
465 animals 1 0.2563
465 antibodies 1 0.3401
465 antigen, 1 0.4344
465 antigen. 1 0.4477
465 around 1 0.4037
465 ascitic 1 0.6029
465 authors 2 0.5555
465 auto-immune 1 0.5076
465 basis; 1 0.6029
465 biochemical 1 0.3811
465 birth 2 0.6142
465 body 1 0.2431
465 casein 3 1.8087
465 caused 1 0.2639
465 centered 1 0.5076
465 challenged 1 0.5428
465 changes 1 0.1804
465 circulating 1 0.4229
465 circulation 1 0.3157
465 classic 1 0.4634
465 clear-cut 1 0.6029
465 control 1 0.2267
465 cytological 1 0.5428
465 demonstrated 1 0.2578
465 developed 1 0.2741
465 disappearance 1 0.3955
465 disease 1 0.2166
465 due 1 0.2133
465 either 1 0.2578
465 exclude 1 0.5076
465 experimental 2 0.5593
465 exposed 1 0.3157
465 extent. 1 0.5428
465 favor 1 0.4827
465 fluids. 2 1.2058
465 foreign 1 0.4827
465 hemagglutination 1 0.5076
465 however, 1 0.2183
465 i-labeled 1 0.6029
465 immune 2 0.776
465 immunity 1 0.4344
465 immunological 3 1.1243
465 imply 1 0.4229
465 injection 1 0.2521
465 interest 1 0.4037
465 introduction 1 0.4344
465 leading 1 0.3748
465 links 2 1.0856
465 may 2 0.3016
465 means 1 0.2671
465 measured 1 0.2639
465 mechanism 1 0.2778
465 mice 2 0.5938
465 much 1 0.2671
465 nature 1 0.2993
465 nature. 1 0.5428
465 origin 1 0.3443
465 parenteral 1 0.5428
465 passive 1 0.4127
465 pathogenesis 1 0.3401
465 perinatal 1 0.4477
465 period 1 0.2287
465 possibility, 1 0.6029
465 prevents 1 0.4477
465 process. 1 0.4634
465 proof 1 0.4827
465 protein 1 0.2741
465 protein. 1 0.4634
465 proteins 1 0.3127
465 quire 1 0.6029
465 response 1 0.2201
465 rest 1 0.4344
465 result 1 0.2608
465 results 1 0.1727
465 since 1 0.2623
465 soon 1 0.4477
465 studied 1 0.2101
465 subsequently 1 0.4037
465 suggested 1 0.2507
465 tests 1 0.2969
465 theory 1 0.388
465 tissues 1 0.2759
465 tolerance 1 0.388
465 tolerant 1 0.6029
465 treated 1 0.2481
465 upon 1 0.2705
466 'in 1 0.5428
466 'lamina 1 0.6029
466 (1) 1 0.2922
466 (2) 1 0.2922
466 (3) 1 0.3188
466 (4) 1 0.3487
466 (a) 1 0.388
466 (b) 1 0.388
466 3535. 1 0.6029
466 abnormal 1 0.2922
466 altered 1 0.322
466 amyloid 5 2.0636
466 amyloidosis 2 0.7163
466 appear 1 0.2759
466 aspect 1 0.4229
466 basal 4 1.5818
466 cannot 1 0.3253
466 capillary 2 0.8688
466 cases 1 0.1794
466 concerned 1 0.4037
466 conclusions 1 0.3811
466 densa' 1 0.6029
466 deposits, 1 0.6029
466 different 1 0.2133
466 early 2 0.442
466 electron 1 0.3044
466 endo- 1 0.5076
466 epithelial 1 0.3188
466 extrinsic 1 0.4827
466 fibrillar 2 0.9269
466 fibrils 1 0.4634
466 fibrils. 1 0.6029
466 first 1 0.221
466 follows 1 0.388
466 found 1 0.1587
466 glomeruli 1 0.5428
466 hand, 1 0.3633
466 human 1 0.2012
466 hyaline 1 0.4477
466 infiltration 1 0.4634
466 initial 1 0.2922
466 intercapillary 2 1.2058
466 later 1 0.3099
466 loops 1 0.6029
466 may 1 0.1508
466 membrane 2 0.6506
466 membrane. 2 0.9269
466 membrane; 1 0.6029
466 microscopic 1 0.3748
466 multiple 1 0.3324
466 origin, 1 0.4229
466 particularly 1 0.3324
466 peripheral 2 0.7163
466 persists, 1 0.6029
466 precipitate 1 0.5076
466 presence 1 0.2297
466 primitive 1 0.5076
466 put 1 0.5076
466 rather 1 0.2836
466 reach 1 0.4827
466 renal 1 0.2339
466 represents 1 0.4127
466 seems 1 0.3188
466 seen 1 0.2549
466 situ' 1 0.6029
466 six 1 0.3324
466 spaces 1 0.4229
466 spaces, 1 0.6029
466 stages 1 0.3324
466 stages, 1 0.5428
466 stages. 1 0.5428
466 stages; 1 0.6029
466 start. 1 0.6029
466 structure 2 0.6142
466 study 2 0.3715
466 substance 2 0.8457
466 suggests 1 0.322
466 surfaces 1 0.5076
466 thelial 1 0.6029
466 thickened 1 0.6029
466 transformation 1 0.3288
466 voluminous 1 0.6029
466 walls 1 0.5428
466 walls. 1 0.5428
467 (russian) 1 0.4344
467 30 1 0.2878
467 3544. 1 0.6029
467 75 1 0.4229
467 affection 2 1.2058
467 affections 2 1.0153
467 amyloi- 1 0.5428
467 antibacterial 1 0.5428
467 basis 1 0.2639
467 changes 2 0.3608
467 clinical 1 0.1965
467 complex 1 0.3487
467 dead 1 0.4344
467 develop 2 0.7267
467 development 1 0.2201
467 diagnosed 1 0.3689
467 died 1 0.3533
467 dosis. 1 0.6029
467 ever, 1 0.4477
467 examined. 1 0.4127
467 finally 1 0.4127
467 first 1 0.221
467 followed 1 0.2759
467 following 1 0.1998
467 found 1 0.1587
467 glomeruli, 1 0.6029
467 how- 1 0.4634
467 immune 1 0.388
467 infectious-toxic 4 2.4116
467 involving 1 0.388
467 kidneys 4 1.3447
467 lesions 2 0.5185
467 lesions. 1 0.4127
467 lungs 1 0.3288
467 lymphostasis, 1 0.6029
467 manifestations, 1 0.4827
467 may 1 0.1508
467 morphology 1 0.3689
467 nephritis, 1 0.5076
467 nephrosclerosis. 1 0.6029
467 nephrosis, 1 0.6029
467 one 1 0.1687
467 organic 1 0.3581
467 patients 2 0.2898
467 process 2 0.5518
467 produced 1 0.2455
467 prolonged 1 0.29
467 pulmonary 5 1.2888
467 rabbits 1 0.3443
467 reactions, 1 0.4827
467 recovery 1 0.3324
467 reduced 1 0.2723
467 renal 1 0.2339
467 severe 1 0.2671
467 stasis 1 0.5428
467 stroma 1 0.4827
467 tb 2 0.9269
467 tb. 2 0.9655
467 therapy 1 0.2383
467 third 1 0.3288
467 tuberculosis 1 0.4127
467 tubules. 1 0.4634
467 venous 1 0.3401
468 10 1 0.5548
468 12 1 0.7196
468 3553. 1 1.5073
468 59-year-old 1 1.5073
468 also 1 0.4217
468 aluminium 2 2.7139
468 amyloid 1 1.0318
468 amyloidosis 2 1.7907
468 basis 1 0.6597
468 branches. 1 1.2691
468 capsules. 1 1.5073
468 ceased 1 1.357
468 color 1 1.1586
468 consistency 1 1.357
468 constituted 1 1.5073
468 coronary 1 0.97
468 could 1 0.5415
468 defined, 1 1.5073
468 deposits 1 1.1586
468 diagnosis 1 0.6202
468 died 1 0.8832
468 diffuse 1 1.0091
468 disseminated 1 1.2069
468 doughy 1 1.5073
468 easily 1 0.97
468 examination 1 0.7611
468 existence 1 0.9221
468 exposure 1 0.8954
468 factor. 1 1.1586
468 factory 1 1.5073
468 findings, 1 1.2069
468 foreign-body 1 1.357
468 found 1 0.3968
468 giant-cell 1 1.5073
468 granulomas. 1 1.357
468 greyish 1 1.5073
468 histological 1 0.8954
468 infiltrates 1 1.5073
468 insufficiency, 1 1.5073
468 intraseptal 1 1.5073
468 kidney 1 0.6678
468 localization, 1 1.2691
468 lungs 1 0.8219
468 lungs. 1 1.1586
468 made 1 0.5459
468 man, 1 1.1192
468 material, 1 1.2069
468 might 1 0.7893
468 nodular 1 1.2691
468 nodules 2 2.7139
468 pathogenesis, 1 1.2691
468 periarteriolar 1 1.5073
468 plasmocytic 1 1.5073
468 postmortem 1 1.1586
468 predisposing 1 1.2691
468 previously 1 0.725
468 products 1 1.0572
468 qualities 1 1.5073
468 regard 1 0.8607
468 removed 1 0.8503
468 respiratory 1 0.7819
468 revealed 1 0.7306
468 sharply 1 1.357
468 spleen, 1 1.0091
468 staining 1 1.0091
468 suggested 1 0.6268
468 working 1 1.1586
468 yr. 2 1.5786
469 1st-set 2 2.0097
469 2 1 0.3068
469 3724. 1 1.0048
469 a. 1 0.6352
469 accelera- 1 1.0048
469 active 1 0.4629
469 aerogenes, 1 1.0048
469 albus 1 1.0048
469 altered 1 0.5366
469 antigens 1 0.5811
469 antigens. 1 0.8046
469 associated 1 0.3568
469 aureus 1 0.9046
469 b, 1 0.8046
469 b. 1 0.5603
469 bac- 1 0.9046
469 bacteria 1 0.6466
469 bacterial 1 0.5888
469 biologic 1 0.8461
469 c, 1 0.9046
469 c. 1 0.5313
469 catarrhalis, 1 1.0048
469 challenge 1 0.8461
469 cocci, 1 1.0048
469 coli, 1 1.0048
469 culosis. 1 1.0048
469 d, 1 0.8046
469 donors 1 0.8046
469 e, 1 0.9046
469 e. 1 0.6879
469 ef- 1 0.9046
469 effects 1 0.373
469 elicits 1 1.0048
469 fects 1 1.0048
469 g, 1 0.8461
469 garis, 1 1.0048
469 graft 1 0.8461
469 grafts. 1 0.9046
469 gram-negative 1 0.8461
469 group 2 0.7429
469 groups 1 0.4092
469 guinea 2 1.4923
469 h, 1 1.0048
469 h. 1 0.8046
469 heat-killed 1 1.0048
469 homograft 2 1.6922
469 homografts 2 1.8093
469 homografts. 1 1.0048
469 homologous 1 0.6879
469 human 1 0.3354
469 ii, 1 0.8046
469 ii. 1 0.5811
469 iii, 1 0.7724
469 included 1 0.5422
469 increase 1 0.3413
469 indistinguishable 1 0.7724
469 induce 1 0.6728
469 induction 2 1.2933
469 influenzae, 1 1.0048
469 l, 1 0.9046
469 lancefield 1 1.0048
469 mean 1 0.4833
469 microorganisms 2 2.0097
469 myc. 1 0.8461
469 n. 1 0.9046
469 none 1 0.6056
469 o, 1 1.0048
469 obtained 1 0.3582
469 pig. 1 0.9046
469 pigs 1 0.8046
469 pneumococcus 1 1.0048
469 pr. 1 1.0048
469 prepared 1 0.6056
469 presence 1 0.3828
469 pretreatment 1 0.724
469 randomly 1 0.8461
469 reactions 1 0.4909
469 reactivity 1 0.7724
469 recipients 2 1.6091
469 rejections 1 1.0048
469 related 1 0.4248
469 results 2 0.5755
469 rough 1 1.0048
469 s. 1 0.7724
469 selected 1 0.5888
469 sensitivity 1 0.6056
469 sensitivity. 1 0.9046
469 sensitization 2 1.3455
469 skin 3 1.7907
469 slight 1 0.5969
469 staph. 2 1.8093
469 staphylo- 1 1.0048
469 staphylococci 1 1.0048
469 state 1 0.5165
469 strain, 1 0.8046
469 strains 2 1.1938
469 streptococcal 1 1.0048
469 streptococci, 1 1.0048
469 streptococci. 1 1.0048
469 study 1 0.3096
469 subtilis, 1 0.8046
469 suggest 1 0.4568
469 suitably 1 1.0048
469 survival 1 0.4833
469 suspensions 1 0.7724
469 ted 1 0.7462
469 terial 1 0.7462
469 tested 1 0.6056
469 time 1 0.3541
469 tissue 1 0.3488
469 tissues 1 0.4598
469 transplantation 1 0.6591
469 tuber- 1 0.9046
469 types 1 0.4871
469 typhimurium, 1 1.0048
469 unrelated 1 0.7048
469 virulent 1 0.8046
469 vul- 1 1.0048
469 well 1 0.3514
469 white 1 0.6246
469 xerosis, 1 1.0048
469 xiv 1 1.0048
470 6590. 1 3.0145
470 acid 1 1.1641
470 activity 1 1.0788
470 bacillus 1 1.7214
470 bacterial 1 1.7663
470 biological 1 1.6099
470 complementary 1 2.4137
470 covalent 1 3.0145
470 cross-linked 1 3.0145
470 denaturation 1 2.5382
470 denatures 1 2.7139
470 dna 1 1.4391
470 dna. 1 2.3172
470 function 1 1.3526
470 i. 1 1.7907
470 linkage 1 2.7139
470 material 1 1.3983
470 nitrous 1 2.7139
470 polynucleotide 1 3.0145
470 reaction 1 1.5092
470 resulting 1 1.5356
470 results 1 0.8633
470 retains 1 3.0145
470 reversible 1 2.2385
470 reversibly 1 2.4137
470 strands. 1 2.7139
470 structure 1 1.5356
470 subtilis 1 1.6619
470 transformation 1 1.6439
470 transformation. 1 2.7139
471 (h25 1 0.6029
471 168 1 0.4634
471 4958. 1 0.6029
471 able 1 0.3401
471 action 2 0.5246
471 annealing 1 0.5428
471 auxotrophic 2 1.2058
471 bacillus 1 0.3443
471 bacteria 1 0.388
471 bility 1 0.5428
471 cells 2 0.3639
471 chromosome 1 0.4037
471 conditions 1 0.2741
471 denaturation 1 0.5076
471 discussed. 1 0.2578
471 dna 5 1.4391
471 dna's, 1 0.6029
471 double 3 1.1864
471 enzymes 1 0.3811
471 excluded 1 0.4477
471 experi- 1 0.6029
471 extracted 1 0.4037
471 formation 2 0.541
471 found 1 0.1587
471 genetic 1 0.3157
471 helices 1 0.6029
471 helix 1 0.6029
471 heterozygous 2 0.9655
471 his-and 1 0.6029
471 his-tryp-by 1 0.6029
471 histidine 1 0.4827
471 hybrid 1 0.4634
471 hybrids 1 0.5428
471 investigated. 1 0.4634
471 kers 1 0.6029
471 linked 1 0.4229
471 m-rna 2 1.0856
471 mar- 1 0.5076
471 means 1 0.2671
471 mechanism 1 0.2778
471 ments. 1 0.6029
471 messenger-rna 1 0.6029
471 mixture 1 0.4477
471 molecular 1 0.3581
471 molecules 2 0.8457
471 obtained 1 0.2149
471 one 1 0.1687
471 ones. 1 0.4827
471 outside 1 0.4634
471 possi- 1 0.6029
471 primer, 1 0.6029
471 prior 1 0.322
471 procedure 1 0.3071
471 prototrophic 1 0.6029
471 proved 1 0.3362
471 recipient 1 0.4037
471 replication 2 0.8954
471 rna 1 0.3324
471 rna-polymerases, 1 0.6029
471 sb25 1 0.6029
471 secondary 1 0.3018
471 serve 1 0.4344
471 single 1 0.2993
471 special 1 0.3188
471 strain 1 0.3188
471 strands 1 0.5076
471 subtilis 1 0.3324
471 synthesis 1 0.2993
471 synthesis. 2 0.9655
471 templates 1 0.5428
471 thermal 1 0.5076
471 transform 1 0.5428
471 transformation 2 0.6575
471 tryp-). 1 0.6029
471 tryptophane 1 0.6029
471 two 2 0.3693
471 using 1 0.2741
472 (an 1 0.3768
472 100 1 0.2126
472 15 1 0.1871
472 15,000 1 0.3768
472 2 1 0.1151
472 2.4 1 0.3392
472 2567. 1 0.3768
472 37 1 0.2523
472 5 1 0.1429
472 50 1 0.1799
472 9 1 0.1973
472 ac- 1 0.2425
472 accumulated 1 0.2897
472 acid, 1 0.2425
472 actinomycin 3 0.8145
472 active 1 0.1736
472 addition 5 0.9597
472 also 1 0.1054
472 amphenicof. 1 0.3768
472 appears 2 0.3241
472 applied 1 0.2271
472 approximately 2 0.3946
472 assay 1 0.2472
472 bacillus 2 0.4303
472 basis 2 0.3299
472 calculated, 1 0.3768
472 capacity 3 0.6164
472 capacity, 1 0.3392
472 carbon 1 0.2523
472 cell 4 0.5101
472 cell. 1 0.2643
472 chlor- 1 0.3768
472 compared 1 0.1462
472 contains 1 0.2305
472 convenient 1 0.3392
472 conversion 1 0.2715
472 converting 1 0.3768
472 cursor 1 0.3768
472 decays 1 0.3768
472 described 1 0.1429
472 directed 1 0.2523
472 dna-dependent 1 0.3768
472 due 1 0.1333
472 enzymatical- 1 0.3768
472 enzyme 4 0.8954
472 enzyme, 1 0.3392
472 enzyme. 1 0.2798
472 every 1 0.2101
472 existence 1 0.2305
472 experiments 1 0.167
472 exponentially 1 0.3768
472 finally, 1 0.258
472 form 2 0.3279
472 form. 1 0.2897
472 formation 2 0.3381
472 glutamate, 1 0.3768
472 growing 1 0.2523
472 half-time 2 0.7536
472 high, 1 0.3392
472 highly 1 0.2033
472 histidase 8 2.5382
472 histidase-synthesizing 2 0.7536
472 histidase. 1 0.3768
472 histidine 1 0.3017
472 inactive 1 0.258
472 induced 2 0.3204
472 inducer, 1 0.3392
472 inducer. 1 0.3392
472 induction 1 0.2425
472 inhibitor 1 0.2897
472 isolated 1 0.1639
472 ki- 1 0.3768
472 l-histidine. 1 0.3768
472 level 1 0.1455
472 loses, 1 0.3768
472 ly 1 0.2472
472 m-rna 1 0.3392
472 m-rna, 1 0.3768
472 make 1 0.2238
472 maximal 1 0.2342
472 means 1 0.167
472 messenger 1 0.3017
472 min. 4 1.0572
472 minute, 1 0.3768
472 minute. 1 0.3768
472 molecular 1 0.2238
472 molecules 4 1.0572
472 moment 1 0.3173
472 netics 1 0.3768
472 numerical 1 0.3173
472 per 3 0.4406
472 performed 1 0.1724
472 pre- 1 0.2425
472 precursor 2 0.5793
472 presence 1 0.1436
472 present 1 0.1241
472 produces 1 0.2382
472 product 1 0.2798
472 protein 1 0.1713
472 protein, 1 0.2715
472 purified 1 0.2382
472 quires 1 0.3768
472 reached 1 0.2472
472 rna 1 0.2077
472 rna. 1 0.3017
472 sensitive 1 0.2033
472 show 1 0.163
472 shown 1 0.162
472 source, 1 0.3173
472 specific 1 0.1483
472 state 1 0.1937
472 steady 1 0.2715
472 subtilis 2 0.4155
472 sufficient 1 0.2271
472 synthesis 1 0.1871
472 synthesis). 1 0.3768
472 synthesis, 1 0.2897
472 synthetic 1 0.2798
472 urocanic 1 0.3768
472 value 2 0.3472
472 values 1 0.1903
473 'cell 2 0.8613
473 2542. 1 0.4306
473 70s 1 0.4306
473 accumulating 1 0.3877
473 active 1 0.1984
473 also 2 0.2409
473 although 1 0.1655
473 apparent 1 0.2255
473 appear 2 0.3941
473 application 1 0.2429
473 area, 1 0.3448
473 arrays, 1 0.4306
473 artificially, 1 0.4306
473 ation 1 0.3877
473 author 1 0.2523
473 b 1 0.2948
473 b. 4 0.9605
473 bacillus; 1 0.4306
473 bacteria 3 0.8314
473 bacterial 3 0.757
473 basal 1 0.2825
473 base 1 0.3021
473 basically 1 0.331
473 becoming 1 0.331
473 borne 1 0.4306
473 bound 1 0.2948
473 brought 1 0.2825
473 built 1 0.4306
473 called 1 0.3103
473 capacity. 1 0.331
473 carry 1 0.3103
473 cell 2 0.2915
473 cell's 1 0.3877
473 cells 1 0.13
473 cells, 1 0.2087
473 centrioles 1 0.4306
473 chain 1 0.3877
473 chain. 1 0.4306
473 chondrioids 4 1.7226
473 chromatophore 1 0.4306
473 cies 1 0.4306
473 clarification. 1 0.4306
473 clear 1 0.2595
473 clearly 1 0.2595
473 closed 1 0.3198
473 coli 1 0.3877
473 comparison 1 0.2234
473 completely 1 0.2523
473 complexes 1 0.3448
473 composite 1 0.4306
473 conclusion 1 0.2883
473 configuration 1 0.3448
473 configuration, 1 0.4306
473 connection 2 0.6206
473 contact 1 0.249
473 contradictory 1 0.3626
473 contrary 1 0.3021
473 could 1 0.1547
473 covered 1 0.3877
473 crude 1 0.3198
473 cytoplasm 7 1.8738
473 cytoplasm, 1 0.3448
473 cytoplasm. 1 0.3877
473 cytoplasmic 1 0.2595
473 deeply 1 0.3877
473 definable 1 0.3877
473 densities, 1 0.4306
473 details 1 0.2948
473 differ 1 0.2825
473 differences 1 0.1971
473 different 1 0.1523
473 differentiated 1 0.2883
473 differentiation 1 0.2459
473 diluted, 1 0.4306
473 direct 1 0.2026
473 directions. 1 0.4306
473 disc, 1 0.4306
473 dispersion 1 0.4306
473 divergen- 1 0.4306
473 dna, 1 0.2825
473 duced 1 0.331
473 due 1 0.1523
473 e. 1 0.2948
473 electron 1 0.2175
473 en- 1 0.331
473 endoplasmic 1 0.3198
473 envelope, 1 0.4306
473 environment, 1 0.3626
473 enzyme 1 0.2558
473 er 1 0.3877
473 er, 1 0.4306
473 etc., 1 0.3877
473 even 2 0.377
473 evidence 1 0.1579
473 expand 1 0.3877
473 experiments 1 0.1908
473 extend 1 0.3877
473 extensions 2 0.8613
473 fibrillar 1 0.331
473 fibrils 3 0.9931
473 fine 4 1.2082
473 fixed 1 0.3103
473 fixing 1 0.4306
473 flagella 1 0.4306
473 function 2 0.3865
473 functional 1 0.2722
473 functions 1 0.2677
473 fundamental 2 0.6896
473 fundamentally 1 0.4306
473 gained. 1 0.4306
473 general' 1 0.4306
473 general'. 1 0.4306
473 golgi 1 0.3198
473 gram-negative 2 0.7252
473 gram-positive 1 0.3877
473 granules. 1 0.3626
473 granum 1 0.4306
473 hand, 1 0.2595
473 high-resolution 1 0.4306
473 however, 1 0.156
473 ideas 1 0.3626
473 identical 1 0.2558
473 identified 1 0.2523
473 ii. 1 0.249
473 im- 1 0.3103
473 important 1 0.1945
473 information 1 0.2324
473 interconnections 1 0.4306
473 interior 1 0.4306
473 intersected 1 0.4306
473 intracellular 1 0.2825
473 intriguing 1 0.4306
473 involved 1 0.2194
473 kinetosomes, 1 0.4306
473 known 2 0.4208
473 last 1 0.2883
473 leading 1 0.2677
473 level 1 0.1663
473 likely. 1 0.4306
473 linear 1 0.2771
473 little 1 0.23
473 lumen 1 0.3626
473 makes 1 0.3877
473 many 1 0.1736
473 may 4 0.4308
473 media, 1 0.3877
473 membrane 1 0.2324
473 membrane, 2 0.7252
473 membrane-bound 1 0.3877
473 membrane. 3 0.9931
473 membranes 1 0.2771
473 membranes, 1 0.4306
473 membranous 4 1.2791
473 messenger 1 0.3448
473 microbodies, 1 0.4306
473 micrographs 1 0.3448
473 mitochondria 1 0.2948
473 mitochondria. 2 0.7252
473 molecule. 1 0.3448
473 morphologically, 1 0.3626
473 much 3 0.5724
473 necessarily 1 0.2948
473 need 2 0.5269
473 network 1 0.3877
473 nothing 1 0.3877
473 nuclear 3 0.7471
473 nucleo- 1 0.4306
473 nucleoplasm 1 0.4306
473 nucleoplasm, 1 0.4306
473 observed 1 0.1468
473 obtained 1 0.1535
473 one 1 0.1205
473 open 1 0.3021
473 ordinary 1 0.3198
473 organelles 1 0.3198
473 organisms. 1 0.4306
473 organizational 1 0.4306
473 orientations 1 0.4306
473 p. 1 0.3198
473 particles 1 0.3103
473 parts. 1 0.4306
473 pattern 1 0.2056
473 penetrate 1 0.3877
473 peptide 1 0.3626
473 perhaps 1 0.2374
473 perhaps, 1 0.4306
473 plasm 1 0.3626
473 plasma 4 0.6945
473 point 1 0.249
473 point, 1 0.4306
473 poly- 1 0.3877
473 portant 1 0.3877
473 porter's 1 0.4306
473 possibly 1 0.2677
473 precluded 1 0.4306
473 presence 2 0.3281
473 present, 1 0.2825
473 presumably 2 0.5649
473 probable 1 0.2722
473 probably 1 0.1958
473 profiles 2 0.6896
473 prospect 1 0.3626
473 protein 1 0.1958
473 protoplasts 2 0.8613
473 protoplasts. 1 0.4306
473 rather 1 0.2026
473 re- 1 0.1908
473 recognized 1 0.2677
473 reductive 1 0.4306
473 regarding 1 0.2722
473 release 1 0.2771
473 remains 1 0.2255
473 replication 1 0.3198
473 resembles 1 0.3198
473 respiratory 2 0.4468
473 reticulum, 1 0.3877
473 reveals 2 0.7252
473 ribo- 1 0.4306
473 ribosomes 1 0.3626
473 ribosomes, 1 0.3877
473 rna 1 0.2374
473 ryter-kellenberger 1 0.4306
473 sections 2 0.5896
473 seem 1 0.2348
473 separate 1 0.2722
473 separated 1 0.2825
473 series 1 0.2026
473 similarities 1 0.3198
473 simple 1 0.2348
473 since 1 0.1874
473 single 1 0.2138
473 site 1 0.249
473 sites 1 0.2883
473 situ- 1 0.4306
473 smaller. 1 0.4306
473 somes 1 0.4306
473 special 2 0.4554
473 stained. 1 0.3877
473 stand 1 0.4306
473 state 1 0.2213
473 still 1 0.2012
473 structure 4 0.8775
473 structure. 1 0.3448
473 structures 2 0.5767
473 study 1 0.1327
473 substance, 1 0.4306
473 subtilis 2 0.4748
473 subtilis, 2 0.6896
473 suggest 1 0.1958
473 support 1 0.2374
473 surfaces. 1 0.4306
473 symposium 1 0.4306
473 synthesis 2 0.4276
473 systems. 3 1.0878
473 technic 1 0.331
473 tellurite 1 0.4306
473 tetranitro-blue 1 0.4306
473 tetrazolium 1 0.4306
473 that, 1 0.2825
473 therefore, 1 0.2722
473 thicknesses, 1 0.4306
473 thin 2 0.6896
473 this, 1 0.3626
473 thus 1 0.2234
473 tissue 1 0.1495
473 tities. 1 0.3877
473 transport 1 0.2595
473 ultrastructural 1 0.3626
473 upon 1 0.1932
473 using 1 0.1958
473 various 2 0.3405
473 vesicle 1 0.4306
473 vulgaris, 1 0.4306
473 wall 1 0.2722
473 whether 1 0.2138
473 yet 1 0.2277
474 2 1 0.1534
474 906. 1 0.5024
474 accept 1 0.4523
474 according 1 0.2711
474 activity 1 0.1798
474 also 1 0.1406
474 authors 1 0.2315
474 auxo- 1 0.5024
474 b. 1 0.2801
474 bacterial 1 0.2944
474 calculations 1 0.5024
474 carrying 1 0.5024
474 cell 1 0.17
474 cells 2 0.3033
474 characters 1 0.4523
474 chromosome 2 0.6728
474 compared. 1 0.4023
474 complementary 1 0.4023
474 consistent 1 0.2801
474 differences 1 0.2299
474 dna 6 1.4391
474 done 1 0.3364
474 donor 1 0.3524
474 double 1 0.3296
474 easily 1 0.3233
474 effect 1 0.1534
474 equal 1 0.3296
474 explained 1 0.2834
474 found 1 0.1323
474 genetic 3 0.7893
474 geny 1 0.5024
474 gous 1 0.5024
474 heterozy- 1 0.5024
474 hybrid 2 0.7724
474 in- 1 0.2226
474 incorpo- 1 0.5024
474 incorporated 1 0.3731
474 incorporation 1 0.3176
474 independent 1 0.3028
474 integration 1 0.4023
474 leading 1 0.3123
474 linked 1 0.3524
474 marker, 1 0.5024
474 markers. 2 1.0048
474 mechanism 2 0.4629
474 model 1 0.3524
474 molecular 1 0.2985
474 native 1 0.3731
474 observation 1 0.2631
474 one 1 0.1406
474 particular 1 0.2537
474 pro- 1 0.3439
474 probability 2 0.7462
474 probability. 1 0.5024
474 ration 1 0.4523
474 recipient 3 1.0091
474 recombination 2 0.7724
474 results 1 0.1439
474 segregation 1 0.5024
474 single 1 0.2494
474 strand 1 0.4523
474 strands 1 0.423
474 strands. 1 0.4523
474 subtilis 1 0.277
474 system. 1 0.3524
474 transformants. 1 0.5024
474 transformation 4 1.0959
474 transformed 1 0.3862
474 trophic 1 0.4023
474 used 1 0.1897
474 vestigated 1 0.5024
475 (dna 1 1.5073
475 1520. 1 1.5073
475 accomplished 1 1.1192
475 acids 1 0.7423
475 bacteria; 1 1.5073
475 bacterial 2 1.7663
475 bacteriophages 2 2.4137
475 biological 1 0.805
475 chanism 1 1.5073
475 components 1 0.8607
475 context. 1 1.357
475 discussed 1 0.6138
475 enzymes 1 0.9528
475 formation 1 0.6763
475 fundamental 1 1.2069
475 however, 1 0.5459
475 induced 1 0.6408
475 infected 1 0.8219
475 ism. 1 1.5073
475 itself. 1 1.357
475 may 1 0.377
475 me- 1 1.1586
475 metabol- 1 1.5073
475 multiplication 1 1.1192
475 non- 1 1.086
475 nucleic 1 0.9887
475 ordinarily 1 1.5073
475 participation 1 1.2691
475 present 1 0.4963
475 processes 1 0.8954
475 produces 1 0.9528
475 protein 1 0.6851
475 proteins; 1 1.5073
475 replication, 1 1.5073
475 reproduction 1 1.357
475 required 1 0.8219
475 requires 1 0.9221
475 rna) 1 1.5073
475 synthesis 2 1.4967
475 transcription 1 1.2691
475 translation 1 1.357
475 viral 1 0.9083
475 virus 1 0.7893
476 (l-histidine 1 1.0048
476 1361. 1 1.0048
476 absence 1 0.4797
476 actinomycin, 1 1.0048
476 active 1 0.4629
476 actually 1 0.7724
476 alternatively, 1 1.0048
476 am- 1 1.0048
476 appears 1 0.4321
476 attached 2 1.4923
476 b. 1 0.5603
476 bacillus 1 0.5738
476 become 1 0.554
476 bringing 1 1.0048
476 capacity 1 0.548
476 cells 1 0.3033
476 conver- 1 1.0048
476 des- 1 0.9046
476 dna 1 0.4797
476 effect 1 0.3068
476 engaged 1 0.9046
476 enzyme 1 0.5969
476 enzyme. 1 0.7462
476 excluded 1 0.7462
476 exerts 1 0.8461
476 forma- 1 0.8046
476 formation 1 0.4509
476 found 1 0.2645
476 fraction 1 0.5366
476 histidase 3 2.5382
476 histidase-specific 2 2.0097
476 inactive 1 0.6879
476 increase 1 0.3413
476 independent 1 0.6056
476 induced 1 0.4272
476 inducer 3 3.0145
476 inducer, 1 0.9046
476 inducer. 1 0.9046
476 induction 1 0.6466
476 inhibitor 1 0.7724
476 intracellular 1 0.6591
476 investigated. 1 0.7724
476 involve 1 0.724
476 l-histidine, 1 1.0048
476 level 1 0.388
476 lose 1 0.8461
476 lyase) 1 1.0048
476 major 1 0.4833
476 material, 1 0.8046
476 may 1 0.2513
476 mechanism 1 0.4629
476 mers, 1 1.0048
476 messenger 3 2.4137
476 monia 1 0.9046
476 mono- 1 0.9046
476 poisoned 1 0.8461
476 polymerization 1 1.0048
476 portion 1 0.7048
476 possibility 1 0.5738
476 precursor 2 1.5448
476 presence 1 0.3828
476 preventing 1 0.7724
476 pro- 1 0.6879
476 protein 1 0.4568
476 rate 1 0.3699
476 rather 1 0.4727
476 release 1 0.6466
476 results 1 0.2878
476 ribosome-bound 1 1.0048
476 ribosomes. 1 1.0048
476 rna 3 1.6619
476 rna. 1 0.8046
476 role 1 0.4661
476 show 1 0.4346
476 sion 1 0.7724
476 stabilization 1 0.8461
476 still 1 0.4694
476 stimulate 1 0.7048
476 subtilis 2 1.108
476 synthesis 2 0.9978
476 synthesis, 1 0.7724
476 synthesis. 1 0.8046
476 tein 1 1.0048
476 tion 1 0.4568
476 truction 1 1.0048
476 yet 1 0.5313
477 1362. 1 0.3768
477 16 2 0.4685
477 2-4 1 0.3392
477 4 1 0.1333
477 almost 1 0.1937
477 amounts 1 0.1871
477 attained 1 0.2798
477 autonomous 1 0.2798
477 bac- 2 0.6785
477 bacterial 1 0.2208
477 begins 1 0.3173
477 cells, 1 0.1826
477 complete 2 0.3496
477 continues 1 0.2897
477 decreases 1 0.2425
477 decreasing 1 0.3017
477 described 1 0.1429
477 detected. 1 0.3392
477 determined. 1 0.258
477 discussed. 1 0.1611
477 dna 8 1.4391
477 dna, 1 0.2472
477 dna. 1 0.2897
477 establishment 1 0.2798
477 excessive 1 0.2425
477 extraction 1 0.2715
477 fected 1 0.3173
477 findings 1 0.1497
477 fragmentation 1 0.3392
477 gradients. 1 0.3768
477 host 2 0.3909
477 host-specific 1 0.3768
477 implica- 1 0.3768
477 in- 1 0.167
477 increase 1 0.128
477 infection 1 0.1773
477 inhibition 1 0.1887
477 interaction 1 0.2305
477 larger 1 0.2238
477 leading 1 0.2342
477 lysogenic 1 0.3017
477 lysogeny 2 0.7536
477 made 2 0.2729
477 made. 1 0.2342
477 material 1 0.1748
477 method 1 0.1497
477 min, 3 0.9518
477 min. 1 0.2643
477 new 1 0.1649
477 on. 1 0.3768
477 p22 1 0.3768
477 phage 6 1.455
477 phage-specific 1 0.3768
477 possible 1 0.1512
477 prevents 1 0.2798
477 proceeds 1 0.3392
477 rate 1 0.1387
477 reached. 1 0.3392
477 recovers 1 0.3768
477 relative 1 0.1955
477 remains 1 0.1973
477 repressed 1 0.3392
477 repression 1 0.3392
477 s. 1 0.2897
477 separated 1 0.2472
477 species 1 0.2055
477 sucrose 1 0.3768
477 synthesis 5 0.9354
477 synthesized, 1 0.3768
477 teria-specific 1 0.3768
477 terial 1 0.2798
477 times 1 0.1813
477 tions 1 0.2238
477 typhimurium 1 0.3768
477 understanding 1 0.2472
477 various 1 0.149
478 1 2 0.3795
478 13.9 1 0.5024
478 37 1 0.3364
478 438. 1 0.5024
478 abolished 1 0.3296
478 acid 1 0.194
478 activation 1 0.3731
478 addition 1 0.2559
478 adsorption 1 0.4023
478 appearance 1 0.2494
478 approximately 1 0.2631
478 assumed 1 0.3439
478 bacillus 1 0.2869
478 c 1 0.274
478 cell. 2 0.7048
478 cells, 1 0.2435
478 characterizing 1 0.5024
478 concentration, 1 0.423
478 configuration 1 0.4023
478 cross-linking 1 0.5024
478 dent 1 0.4523
478 deoxyribonuclease-sensitive 1 0.5024
478 deoxyribonuclease. 2 1.0048
478 deoxyribonucleic 1 0.3524
478 dependence. 1 0.4523
478 dna 4 0.9594
478 dna, 1 0.3296
478 dna. 1 0.3862
478 energy 1 0.3439
478 entering 1 0.4523
478 entry 2 0.7724
478 evi- 1 0.423
478 exposure 1 0.2985
478 feasible 1 0.4023
478 fected 1 0.423
478 followed 1 0.2299
478 function 1 0.2254
478 genetic 2 0.5262
478 homologous 1 0.3439
478 immediate 1 0.3176
478 independent 1 0.3028
478 indicate 1 0.2212
478 instead 1 0.4023
478 inverse 1 0.423
478 investigation 1 0.2834
478 kcal. 1 0.5024
478 kinetics 1 0.4023
478 lag 6 2.4137
478 length 1 0.3296
478 make 1 0.2985
478 min 1 0.4023
478 min, 1 0.423
478 molecule 1 0.3524
478 moreover, 1 0.3296
478 period 3 0.5717
478 presence 1 0.1914
478 results 2 0.2878
478 shearing 1 0.5024
478 short 1 0.2905
478 shows 1 0.277
478 strong 1 0.3364
478 studied. 1 0.2834
478 subtilis 1 0.277
478 taken 1 0.2834
478 temperature 1 0.2683
478 terminated 2 0.9046
478 time 2 0.3541
478 trait 2 1.0048
478 transferred. 1 0.5024
478 transformants 1 0.5024
478 transformation 2 0.548
478 transforming 3 1.0318
478 unaf- 1 0.5024
478 unmarked 1 0.5024
478 washing 1 0.423
479 439. 1 0.6029
479 acid 1 0.2328
479 addition 1 0.3071
479 appearance 1 0.2993
479 b. 1 0.3362
479 bacillus 1 0.3443
479 cell 2 0.4081
479 cell. 1 0.4229
479 cells 1 0.182
479 competent 2 0.8688
479 configuration 1 0.4827
479 correlation 1 0.3044
479 culture 1 0.3018
479 deoxyribonucleic 1 0.4229
479 devoted 1 0.5428
479 discussed. 1 0.2578
479 distance 1 0.4634
479 dna 5 1.4391
479 enter 1 0.4634
479 enters 1 0.6029
479 entry 2 0.9269
479 estimated. 1 0.5428
479 event, 1 0.6029
479 evidence 1 0.221
479 fashion. 1 0.5076
479 genetic 1 0.3157
479 indicate 1 0.2655
479 indicates 1 0.3955
479 lag 2 0.9655
479 length 2 0.7909
479 lengthwise 1 0.6029
479 map 1 0.6029
479 mechanism 1 0.2778
479 nucleotide 1 0.6029
479 number 1 0.2307
479 obtained 1 0.2149
479 pairs 2 0.9269
479 part 1 0.2816
479 participate 1 0.5076
479 per 1 0.235
479 period 2 0.4574
479 preceding 1 0.4634
479 recombination 1 0.4634
479 respect 1 0.3533
479 results 2 0.3453
479 significance 1 0.3288
479 smallest 1 0.4827
479 subtilis 1 0.3324
479 subtilis. 1 0.6029
479 taken 1 0.3401
479 time, 1 0.3487
479 traits 1 0.5428
479 transforming 2 0.8255
479 transport 1 0.3633
479 unit 1 0.4229
480 (1) 1 0.1328
480 (2) 1 0.1328
480 (russian) 1 0.1974
480 2564. 1 0.274
480 achieve 1 0.1922
480 action 1 0.1192
480 activity 1 0.0981
480 annealing 1 0.2467
480 apparently 1 0.1494
480 attack 1 0.2467
480 attempts 1 0.1764
480 authors 1 0.1263
480 basis 1 0.1199
480 cell, 1 0.2107
480 cells. 1 0.1222
480 chain 2 0.4934
480 change 1 0.1271
480 chemical 4 0.6606
480 chemically 1 0.2035
480 cistrons. 1 0.274
480 closely 1 0.1565
480 code 2 0.5481
480 coding 1 0.2467
480 competent 1 0.1974
480 con- 1 0.1422
480 correct 1 0.1876
480 deletion 1 0.2307
480 deletions 1 0.274
480 described 1 0.1039
480 deteriorations, 1 0.274
480 discuss 1 0.2467
480 discussed 1 0.1116
480 dna 11 1.4391
480 dna, 2 0.3595
480 expected. 1 0.274
480 experiments 1 0.1214
480 explanation 2 0.3844
480 explanations 1 0.2307
480 exponential 1 0.2307
480 extensive 2 0.3092
480 fact. 1 0.274
480 firm 1 0.2194
480 forming 1 0.2035
480 fragmentation 1 0.2467
480 fusion 1 0.2035
480 gave 1 0.1732
480 genetic 2 0.287
480 genetically 1 0.2194
480 genome 1 0.2194
480 hno2 2 0.5481
480 hno2. 1 0.274
480 homologous 1 0.1876
480 hypothesis 1 0.1464
480 impairs 1 0.274
480 inactivated 2 0.4389
480 inactivation 7 1.2844
480 inactive 1 0.1876
480 including 1 0.1479
480 inclusion 1 0.1764
480 independently. 1 0.274
480 influence 1 0.1254
480 initial 1 0.1328
480 injured 1 0.2107
480 integration 1 0.2194
480 kinetics 1 0.2194
480 kinetics. 1 0.2307
480 large 2 0.2167
480 leads 2 0.3056
480 lesions 1 0.1178
480 light 2 0.3092
480 linked 2 0.3844
480 literature 1 0.1494
480 macromolecular 1 0.2467
480 macromolecule, 1 0.274
480 many 1 0.1105
480 markers 3 0.7402
480 may 1 0.0685
480 means 5 0.6071
480 measurements 1 0.1764
480 methods 1 0.1238
480 mistake 1 0.274
480 molecular 1 0.1628
480 molecule 2 0.3844
480 molecule. 1 0.2194
480 multiple 1 0.1511
480 one. 1 0.2107
480 part 2 0.256
480 positive 1 0.1464
480 prac- 1 0.274
480 preventing 1 0.2107
480 previously 1 0.1318
480 process 1 0.1254
480 properties 1 0.1464
480 re- 1 0.1214
480 reactivation 4 0.923
480 reading 2 0.407
480 recipient 1 0.1835
480 remarkable 1 0.1974
480 resistant 1 0.1677
480 restore 1 0.2307
480 resulting 1 0.1396
480 results. 1 0.1922
480 seems 1 0.1449
480 shown 2 0.2357
480 significantly 1 0.1152
480 simul- 1 0.2467
480 slight 1 0.1628
480 state 1 0.1409
480 structural 1 0.1764
480 studied. 1 0.1546
480 sults 1 0.2035
480 taneously, 1 0.274
480 tically 1 0.274
480 trans- 1 0.2107
480 transforming 1 0.1876
480 triplets. 1 0.274
480 two 1 0.0839
480 ultrasonic 1 0.274
480 unit 1 0.1922
480 unlinked 2 0.5481
480 uv 2 0.4934
480 vibrations 1 0.274
480 viscosity 1 0.2194
480 weight 1 0.1289
480 wrong 1 0.2467
481 10 6 0.8323
481 2565. 1 0.3768
481 acids 1 0.1856
481 activity 2 0.2697
481 authors 1 0.1736
481 b. 4 0.8404
481 bacillus 1 0.2152
481 bacterial 3 0.6624
481 bacteriophage 1 0.2798
481 bands 1 0.3017
481 cells. 1 0.168
481 characteristic 1 0.1903
481 competent 1 0.2715
481 cs2so4 2 0.7536
481 data 2 0.3069
481 denaturation 1 0.3173
481 denatures 1 0.3392
481 density 1 0.2472
481 deoxyribonucleic 1 0.2643
481 distinguishable 1 0.3392
481 dna 8 1.4391
481 dna. 3 0.869
481 effective 1 0.1887
481 experimental 1 0.1748
481 fol- 1 0.2798
481 gradient 2 0.5286
481 higher 1 0.162
481 incorporated 2 0.5596
481 indicated 1 0.1773
481 integrated 1 0.3173
481 involved 1 0.1919
481 isolated 1 0.1639
481 lower 1 0.1713
481 lowing 1 0.3173
481 phage 2 0.485
481 present 2 0.2481
481 ps 6 2.2609
481 rather 1 0.1773
481 separation 1 0.2101
481 subtilis 5 1.0387
481 temperature 1 0.2012
481 temperature. 1 0.3017
481 thermal 1 0.3173
481 transducing 2 0.6346
481 transduction. 1 0.3768
481 transformation 1 0.2055
481 transforming 3 0.7739
481 used 1 0.1423
481 viral 3 0.6812
481 without 1 0.1423
482 (h1n14) 1 0.6029
482 (h2n15) 1 0.6029
482 (h3) 1 0.6029
482 (kuvr-/kuvr+) 1 0.6029
482 (uvr-) 1 0.6029
482 2 1 0.1841
482 2529. 1 0.6029
482 3-fold 1 0.5076
482 6-8 1 0.6029
482 activity 1 0.2158
482 activity, 1 0.4344
482 agent 1 0.3533
482 alkylating 1 0.5076
482 analysis. 1 0.6029
482 b. 1 0.3362
482 bacillus 1 0.3443
482 bacteriophage 1 0.4477
482 carry 1 0.4344
482 cell 1 0.204
482 cells 5 0.9098
482 containing 1 0.3188
482 curves 1 0.3748
482 damage 5 1.5356
482 damage, 1 0.5428
482 density 1 0.3955
482 determined 2 0.5481
482 difference 1 0.3018
482 differs 1 0.4127
482 dna 4 1.1513
482 duced 2 0.9269
482 ed 1 0.4127
482 experiments. 1 0.5076
482 extractable 2 1.2058
482 fonate 1 0.6029
482 formation 1 0.2705
482 greater 1 0.2494
482 host 1 0.3127
482 in- 2 0.5343
482 inactivated 2 0.9655
482 inactivation 1 0.4037
482 increase 2 0.4095
482 incubated 1 0.4634
482 incubation 1 0.3689
482 indole+ 1 0.6029
482 induced 4 1.0252
482 irradiation 1 0.3253
482 labeled 1 0.3633
482 least 1 0.3099
482 measured 1 0.2639
482 medium 1 0.322
482 methanesul- 1 0.6029
482 methanesulfonate 1 0.6029
482 methanesulfonate. 2 1.2058
482 methyl 4 2.1711
482 molecules 1 0.4229
482 monofunctional 1 0.6029
482 mustard 1 0.5428
482 net 1 0.4827
482 new 1 0.2639
482 nitrogen 1 0.3955
482 occur. 1 0.4827
482 one 1 0.1687
482 period 1 0.2287
482 phage 3 1.164
482 phage, 1 0.4827
482 pyknometric 1 0.6029
482 ratio 1 0.3157
482 reactivation 1 0.5076
482 reco- 1 0.6029
482 recover 1 0.5428
482 recovered 1 0.3748
482 repair 3 1.211
482 sensitive, 1 0.6029
482 show- 1 0.6029
482 showed 1 0.2149
482 similar 1 0.2257
482 slopes 1 0.5076
482 spo1 1 0.6029
482 spo1. 1 0.6029
482 step 1 0.4477
482 strain 2 0.6376
482 subtilis 2 0.6648
482 survival 1 0.29
482 synthesis 1 0.2993
482 system. 1 0.4229
482 thymidine 1 0.4229
482 transformable 1 0.6029
482 transformable, 1 0.6029
482 transforming 4 1.6509
482 treated 1 0.2481
482 ultraviolet-sensitive 1 0.6029
482 unable 2 0.8954
482 uv 5 2.7139
482 uvr+ 3 1.8087
482 uvr- 1 0.6029
482 uvr-; 1 0.6029
482 ver 1 0.5076
482 virulent 1 0.4827
482 whole 4 1.3447
483 1451. 1 1.5073
483 5-hydroxymethyldeoxyuridylic 1 1.5073
483 5-hydroxymethyluracil 2 3.0145
483 90-fold 1 1.5073
483 abnormal 1 0.7306
483 account 1 0.8503
483 acid 2 1.1641
483 acid, 1 0.97
483 action, 1 1.1192
483 activity 1 0.5394
483 also 1 0.4217
483 b. 1 0.8404
483 bacillus 1 0.8607
483 bacteriophage-infected 1 1.5073
483 base. 1 1.5073
483 biosynthesis 1 1.1192
483 changes 1 0.451
483 contains 1 0.9221
483 converted 1 1.2691
483 deaminase 1 1.357
483 decreases 1 0.97
483 deoxycytidylate 1 1.5073
483 deoxynucleotide 1 1.5073
483 deoxyuridylic 2 3.0145
483 directly 1 0.9528
483 dna 1 0.7196
483 e, 1 1.357
483 enzyme 1 0.8954
483 enzyme. 1 1.1192
483 host 1 0.7819
483 hydroxymethylase 1 1.5073
483 increases 1 0.7041
483 infection. 1 0.9887
483 infects 1 1.5073
483 least 1 0.7747
483 occur 1 0.7363
483 organism 1 1.0091
483 phage 2 1.9399
483 place 1 0.9221
483 product 1 1.1192
483 rapidly 1 0.8607
483 substrate, 1 1.5073
483 subtilis 1 0.831
483 subtilis, 1 1.2069
483 synthesis 1 0.7483
483 synthetase, 1 1.357
483 thymidylate 1 1.357
483 thymine, 1 1.5073
483 uses 1 1.2691
484 50 1 0.2878
484 5574. 1 0.6029
484 acting 1 0.5076
484 anxiety 4 1.4991
484 anxiety. 1 0.6029
484 author 1 0.3533
484 become 1 0.3324
484 behavior 1 0.3443
484 boys 1 0.4477
484 cancer. 1 0.4229
484 children 5 1.0704
484 children, 1 0.3533
484 deal 1 0.4634
484 death 4 1.3151
484 depressed. 1 0.6029
484 due 1 0.2133
484 evidence 1 0.221
484 experience 2 0.6198
484 fatal 2 0.8073
484 felt 1 0.4477
484 form 1 0.2623
484 form. 1 0.4634
484 general 1 0.3071
484 girls 1 0.4634
484 hospitalized 1 0.4229
484 hypothesis 1 0.322
484 illness 2 0.9269
484 indicate 1 0.2655
484 leukemia 1 0.4634
484 likely 1 0.3533
484 older 2 0.7495
484 perceive 1 0.6029
484 postulated 1 0.4229
484 react 1 0.4634
484 reports 1 0.388
484 results 1 0.1727
484 separation 1 0.3362
484 series 1 0.2836
484 studies 1 0.1846
484 study. 1 0.3955
484 supported 1 0.4344
484 symbolic 1 0.4827
484 tended 2 0.9655
484 would 2 0.5987
484 younger 2 0.8073
485 1209. 1 0.274
485 1st 1 0.2107
485 2nd 1 0.1974
485 3 1 0.0934
485 adaptation 1 0.2107
485 adaptations. 1 0.274
485 addition 1 0.1396
485 admission 2 0.4213
485 affective 1 0.2307
485 age 1 0.1134
485 anger, 1 0.274
485 ap- 1 0.2194
485 appropriate 1 0.1798
485 area 1 0.1422
485 areas. 1 0.2194
485 aroused. 1 0.274
485 aspects 1 0.1546
485 ation 1 0.2467
485 balances 1 0.2307
485 be- 1 0.1677
485 bers 1 0.2467
485 biological 1 0.1464
485 cause 1 0.1238
485 characteristically, 1 0.274
485 collection 1 0.2194
485 commonly, 1 0.2467
485 con- 2 0.2843
485 concern 1 0.2107
485 consideration 1 0.1798
485 constellation 1 0.274
485 context 1 0.2307
485 cope 2 0.5481
485 created. 1 0.274
485 cri- 1 0.274
485 crises 1 0.274
485 crisis 2 0.407
485 crisis, 1 0.274
485 crisis. 1 0.274
485 cycle. 1 0.2307
485 data 1 0.1116
485 data. 1 0.2107
485 dealing 4 0.7898
485 decision, 1 0.274
485 dent 1 0.2467
485 determine 1 0.1546
485 developmental 3 0.5504
485 diagnostic. 1 0.2467
485 different 1 0.0969
485 dis- 1 0.1732
485 disorder 1 0.1703
485 ditional 1 0.274
485 due 1 0.0969
485 education 2 0.4389
485 education. 1 0.274
485 effects 1 0.1017
485 emerges 1 0.274
485 emotional 1 0.1528
485 emotionally 1 0.2194
485 employed 1 0.1732
485 evident 1 0.1703
485 evident, 1 0.2467
485 expectation. 1 0.274
485 external 1 0.1652
485 extrusion 1 0.274
485 faced. 1 0.274
485 factually 1 0.274
485 families 1 0.1922
485 family 11 1.8167
485 family. 2 0.4615
485 feelings 2 0.5481
485 finally, 1 0.1876
485 financial 1 0.274
485 given 1 0.1005
485 group 2 0.2026
485 guilt, 1 0.274
485 hospital 1 0.1732
485 however, 1 0.0992
485 hypo- 1 0.1974
485 ii. 1 0.1585
485 ill 2 0.4213
485 illness, 1 0.2107
485 inability 1 0.1974
485 include 1 0.1628
485 individual 1 0.1449
485 inevitable 1 0.274
485 instrument 1 0.274
485 inter- 1 0.1974
485 interaction 1 0.1677
485 intervention 1 0.2194
485 interview 2 0.5481
485 involved 1 0.1396
485 issue 1 0.274
485 leader 1 0.274
485 leads 1 0.1528
485 life 4 0.5796
485 life. 1 0.1974
485 loss 1 0.1328
485 major 1 0.1318
485 marital 1 0.274
485 maturation, 1 0.2307
485 may 2 0.1371
485 medical 1 0.1628
485 mem- 1 0.2467
485 member 1 0.2467
485 members 1 0.1835
485 mental 1 0.1546
485 mentally 1 0.1974
485 merely 1 0.2035
485 milieu 1 0.2307
485 multifactorial 1 0.274
485 mutual 1 0.2307
485 natural 1 0.1606
485 need 1 0.1677
485 observation 4 0.574
485 offers 1 0.1974
485 one 1 0.0767
485 others' 1 0.274
485 part 1 0.128
485 particular 2 0.2768
485 partner, 1 0.274
485 pathogenes. 1 0.274
485 patient 2 0.2061
485 patient's 1 0.1835
485 patient. 1 0.1876
485 personal 1 0.1922
485 phenomena, 1 0.2467
485 phenomenon 1 0.1585
485 point 1 0.1585
485 postponed 1 0.274
485 practice 1 0.2307
485 prepares 1 0.274
485 primarily, 1 0.274
485 primary 1 0.1159
485 problems 2 0.2843
485 propriate 1 0.274
485 proved 1 0.1528
485 psychopathology 1 0.2467
485 psychosocial 1 0.2467
485 rather 1 0.1289
485 relating 1 0.2035
485 resident 2 0.4615
485 reverse. 1 0.274
485 role 1 0.1271
485 ruptively 1 0.274
485 sadness, 1 0.274
485 see 1 0.2194
485 seeking 1 0.2467
485 separ- 1 0.274
485 serves 1 0.2107
485 sis 1 0.2107
485 social 1 0.1764
485 some- 1 0.274
485 specific 2 0.2156
485 stellations 1 0.274
485 stu- 1 0.2467
485 study 1 0.0844
485 style 1 0.274
485 task 2 0.407
485 task. 1 0.2307
485 tasks. 1 0.274
485 theoretical 1 0.2307
485 theory 1 0.1764
485 thesis 1 0.2107
485 time 2 0.1931
485 times 1 0.1318
485 tra- 1 0.274
485 traumatic, 1 0.274
485 unable 1 0.2035
485 understanding 1 0.1798
485 unexpected 2 0.4615
485 unique 1 0.1764
485 useful 1 0.1511
485 vicissitudes 1 0.2467
485 view 1 0.1606
485 vincing 1 0.274
485 vital. 1 0.274
485 well 1 0.0958
485 young 1 0.1384
486 (1) 1 0.4871
486 (2) 1 0.4871
486 (3) 1 0.5313
486 (4) 1 0.5811
486 265. 1 1.0048
486 absence 1 0.4797
486 adaptation 1 0.7724
486 adolescents. 1 1.0048
486 aggression 1 0.8461
486 ambition 1 1.0048
486 ambivalence 2 2.0097
486 ambivalent 1 1.0048
486 anxiety 3 1.8738
486 anxiety; 1 1.0048
486 approach 1 0.6246
486 bio-psychological 1 1.0048
486 capacity. 1 0.7724
486 cognitive 1 0.7462
486 combined 1 0.5165
486 con- 1 0.5212
486 constant, 1 0.7724
486 corporal 1 1.0048
486 determined 1 0.4568
486 ed 1 0.6879
486 ef- 1 0.9046
486 effect 1 0.3068
486 estimates 1 0.8461
486 experimental 1 0.4661
486 experimentally 1 0.7048
486 extremely 2 1.4096
486 fect 1 1.0048
486 fixation 2 1.6091
486 fixation-ambivalence 1 1.0048
486 group 1 0.3714
486 guilt 1 1.0048
486 hetero-fixated 1 1.0048
486 high 1 0.3596
486 human 1 0.3354
486 ii. 1 0.5811
486 impaired 1 0.6879
486 in- 1 0.4452
486 increase 2 0.6826
486 increases 2 0.9388
486 injury 1 0.6728
486 intense 1 0.724
486 kept 2 1.4923
486 male 1 0.5119
486 measures 1 0.6591
486 modern 1 0.7462
486 mother; 1 1.0048
486 obtain- 1 1.0048
486 one 2 0.5622
486 organizers 1 1.0048
486 personality. 1 0.9046
486 presence 1 0.3828
486 problems 1 0.5212
486 projective 1 1.0048
486 related 1 0.4248
486 seems 2 1.0626
486 separa- 1 0.8461
486 separation 1 0.5603
486 show 1 0.4346
486 shown 1 0.4321
486 society 1 0.9046
486 stant, 1 1.0048
486 studies 1 0.3077
486 subjects 2 0.9594
486 suicidal 2 1.8093
486 system 1 0.4694
486 tendencies 1 0.9046
486 tendencies, 1 1.0048
486 tense 1 1.0048
486 test 1 0.4346
486 tion 1 0.4568
486 towards 1 0.724
487 (1) 1 0.7306
487 (10) 1 1.357
487 (11) 1 1.5073
487 (12) 1 1.5073
487 (2) 1 0.7306
487 (3) 1 0.797
487 (4) 1 0.8716
487 (5) 1 0.9887
487 (6) 1 1.086
487 (7) 1 1.1586
487 (8) 1 1.5073
487 (9) 1 1.357
487 (during 1 1.5073
487 1, 1 0.97
487 12 1 0.7196
487 2, 1 1.0318
487 2837. 1 1.5073
487 3 1 0.5138
487 5 1 0.5717
487 50 1 0.7196
487 6 1 0.6302
487 8 1 0.6807
487 acting 1 1.2691
487 acute 1 0.7483
487 adjustment, 1 1.357
487 admission, 1 1.5073
487 adolescence 1 1.5073
487 alone, 1 1.086
487 associated 1 0.5352
487 bid 1 1.5073
487 case 1 0.5415
487 center 1 0.97
487 child 1 0.725
487 child- 1 1.5073
487 childhood) 1 1.5073
487 chronicity 2 3.0145
487 cial 1 1.5073
487 cited 1 1.5073
487 clear 1 0.9083
487 community, 1 1.5073
487 concentrated 1 1.1586
487 concern 1 1.1586
487 confusion 1 1.357
487 continue 1 1.1586
487 data 2 1.2277
487 depressive 1 1.357
487 derived 1 0.831
487 differences 1 0.6897
487 disorientation 1 1.357
487 dying 1 1.357
487 early 2 1.1051
487 especially 1 0.7747
487 events, 1 1.5073
487 examined 1 0.7611
487 factors 2 1.2744
487 failure 1 0.8133
487 families, 1 1.2069
487 following 1 0.4996
487 guidance 1 1.5073
487 heredity. 1 1.5073
487 history 2 1.7433
487 hood 1 1.5073
487 hospital 2 1.9056
487 hospitalized 1 1.0572
487 illness, 1 1.1586
487 indicators 1 1.357
487 intensively. 1 1.5073
487 items 1 1.357
487 kind 1 1.0572
487 later 1 0.7747
487 least 1 0.7747
487 length 1 0.9887
487 less 1 0.5643
487 life 1 0.797
487 literature 1 0.8219
487 material 1 0.6992
487 mothering 1 1.2069
487 mth., 2 2.7139
487 neither 1 0.9887
487 new 1 0.6597
487 onset 1 0.8716
487 outcome 1 1.1586
487 paration 1 1.5073
487 pathogenic 1 1.2691
487 pathology 1 1.0091
487 patients' 1 1.357
487 person, 1 1.5073
487 personality, 1 1.5073
487 persons 1 0.9528
487 phase 1 0.805
487 phrenia. 1 1.5073
487 poor 1 0.8716
487 pre-illness 1 1.5073
487 precipitating 1 1.5073
487 premor- 1 1.5073
487 previous 1 0.8133
487 prognosis 1 0.831
487 prognostic 1 1.1192
487 psychosis, 1 1.2069
487 psychotic 1 0.9887
487 reaction 1 0.7546
487 related 1 0.6372
487 release. 1 1.5073
487 remaining 1 0.7678
487 schi- 1 1.5073
487 schizo- 1 1.357
487 schizoid 2 3.0145
487 schizophrenia 2 2.2385
487 scored 1 1.357
487 se- 1 1.2691
487 seen 1 0.6372
487 sexual 1 1.1586
487 significantly 1 0.6337
487 so- 1 1.357
487 studies. 1 1.1586
487 study 1 0.4643
487 symptoms 1 0.7143
487 thought 1 0.8503
487 treatment 1 0.4447
487 vs. 1 1.357
487 zophrenic 1 1.5073
488 'normative 1 1.0048
488 4854. 1 1.0048
488 analytical 1 0.7724
488 appears 1 0.4321
488 basis 1 0.4398
488 birth 1 0.5119
488 character- 1 1.0048
488 child 3 1.45
488 children 1 0.3568
488 clinical 1 0.3275
488 communal 1 1.0048
488 conditions 1 0.4568
488 course 1 0.4568
488 crisis 1 0.7462
488 described 1 0.3811
488 development 1 0.3669
488 development. 1 0.6879
488 discussed. 1 0.4296
488 distinct, 1 0.9046
488 double 1 0.6591
488 early 1 0.3684
488 education, 1 0.9046
488 educators 1 1.0048
488 especially 1 0.5165
488 factors 1 0.4248
488 formation 3 1.3526
488 given. 1 0.7724
488 identification 1 0.6466
488 identifications 1 0.9046
488 illustrations 1 1.0048
488 in- 1 0.4452
488 infancy', 1 1.0048
488 ised 1 1.0048
488 issues 1 0.9046
488 kibbutz 3 3.0145
488 main 1 0.5738
488 material 1 0.4661
488 milieu 1 0.8461
488 mother 1 0.5738
488 need-satisfying 1 1.0048
488 object 2 1.4923
488 object-relation 3 3.0145
488 object-relations 1 1.0048
488 on, 1 0.8461
488 one. 1 0.7724
488 originally 1 0.7462
488 purpose 1 0.6728
488 rearing 1 0.9046
488 relation 1 0.4629
488 relations 1 0.8046
488 relationship 1 0.4833
488 relationships. 1 0.8461
488 relevant 1 0.724
488 represen- 1 1.0048
488 respective, 1 1.0048
488 retrospective 1 0.9046
488 seen 2 0.8496
488 separation-individuation 1 0.8461
488 stage 1 0.4871
488 stages 1 0.554
488 symbio- 1 1.0048
488 synthetised 1 1.0048
488 tations 1 1.0048
488 tensify 1 1.0048
488 tic 1 0.7462
488 transient-interchangeable 1 1.0048
488 transition 1 0.7724
488 two 2 0.6154
488 well 1 0.3514
489 4846. 1 1.5073
489 and, 1 0.7819
489 crying 2 2.5382
489 laid 1 1.2691
489 loss. 1 1.2069
489 meaning 1 1.2069
489 meanings 1 1.5073
489 multiple 1 0.831
489 particular, 1 1.357
489 response 1 0.5503
489 reviewed 1 0.8503
489 separation 1 0.8404
489 stress 1 1.0318
489 tears 1 1.357
489 type 1 0.6268
490 15 1 0.2993
490 2953. 1 0.6029
490 6 1 0.2521
490 7 1 0.2778
490 age 1 0.2494
490 amelioration 1 0.5428
490 ances 1 0.6029
490 apeutic 1 0.6029
490 appeared 1 0.29
490 attributed 1 0.4037
490 behavioral 1 0.4477
490 boys 3 1.3431
490 brief 1 0.4229
490 cal 1 0.4634
490 case 2 0.4332
490 cases 2 0.3588
490 ceased 1 0.5428
490 child 2 0.58
490 child's 2 0.7377
490 child, 1 0.4127
490 child. 1 0.4037
490 choice 1 0.388
490 cir- 1 0.5076
490 close 1 0.3533
490 closely 1 0.3443
490 considerable 1 0.3127
490 contributory 1 0.5076
490 correlated 2 0.7163
490 cumstances 1 0.6029
490 dead 1 0.4344
490 death 5 1.6439
490 delinquency 1 0.6029
490 depressive 1 0.5428
490 development 1 0.2201
490 disorder 1 0.3748
490 distinct 1 0.3748
490 disturb- 1 0.6029
490 disturbed. 1 0.6029
490 effect 1 0.1841
490 either 1 0.2578
490 especially 2 0.6198
490 etiologi- 1 0.5428
490 evidence 1 0.221
490 exception, 1 0.6029
490 factor 1 0.2857
490 factor. 1 0.4634
490 father, 1 0.6029
490 father. 2 1.2058
490 fathers 1 0.6029
490 first 1 0.221
490 func- 1 0.5428
490 future 1 0.4344
490 given 1 0.221
490 given. 1 0.4634
490 grief 3 1.8087
490 helped 1 0.5076
490 histories 1 0.4477
490 identification 1 0.388
490 illnesses 1 0.6029
490 improvement 2 0.8073
490 ing 1 0.3253
490 instance 1 0.5076
490 instances 2 0.8073
490 intervention 1 0.4827
490 involved 1 0.3071
490 large 1 0.2383
490 led 1 0.3533
490 life, 1 0.4037
490 lost 1 0.5076
490 measure 1 0.3487
490 mother 3 1.0328
490 mother's 1 0.4827
490 mother. 1 0.4827
490 mothers 1 0.3633
490 occurred 1 0.2623
490 ones 1 0.4229
490 opposed 1 0.5076
490 parent 2 0.8954
490 perpetuate 1 0.5428
490 potentially 1 0.4477
490 preoccupied 1 0.6029
490 prior 1 0.322
490 psychological 1 0.3811
490 psychoneuroses. 1 0.6029
490 psychoses, 1 0.6029
490 re- 1 0.2671
490 reach- 1 0.6029
490 reaction 2 0.6037
490 reactions 1 0.2945
490 responsible 1 0.3044
490 resulted. 1 0.5428
490 seemed 1 0.388
490 significant 1 0.2116
490 solution 1 0.3689
490 specific 1 0.2372
490 statistical 1 0.388
490 studies 1 0.1846
490 suggest 1 0.2741
490 surrounding 1 0.4229
490 symptom 1 0.4229
490 symptoms 2 0.5714
490 ther- 1 0.5076
490 therapy 1 0.2383
490 tioning. 1 0.6029
490 treatment 1 0.1779
490 unresolved 2 1.2058
490 upon 1 0.2705
490 worthwhile, 1 0.6029
490 yr. 1 0.3157
491 1848. 1 0.9046
491 1912, 1 1.0048
491 according 1 0.5422
491 always 1 0.5366
491 animals 1 0.4272
491 appear, 1 1.0048
491 appeared 1 0.4833
491 appreciation 1 1.0048
491 belief 1 0.9046
491 cance. 1 1.0048
491 change 1 0.4661
491 child's 3 1.8443
491 close 1 0.5888
491 concept 1 0.6056
491 concept, 1 0.9046
491 creatures 1 1.0048
491 cruelty 1 1.0048
491 dead 2 1.448
491 death 3 1.6439
491 death. 1 0.8046
491 decrease 1 0.4598
491 differs 1 0.6879
491 exaggerated 1 0.8461
491 far 1 0.6466
491 finds 1 0.9046
491 first 1 0.3684
491 freud, 1 1.0048
491 functions, 1 0.9046
491 interrupted 1 0.8461
491 it. 1 0.6879
491 license 1 1.0048
491 life 2 1.0626
491 like 1 0.6466
491 man's 2 2.0097
491 may 1 0.2513
491 mean 1 0.4833
491 means 1 0.4452
491 overcompensation, 1 1.0048
491 paper, 1 0.9046
491 persons 1 0.6352
491 pity 1 0.9046
491 power 2 1.5448
491 reversible 1 0.7462
491 sadism. 1 1.0048
491 separation; 1 1.0048
491 shown, 1 1.0048
491 signifi- 1 0.7724
491 sleep. 1 0.9046
491 temporary 1 0.724
491 time, 1 0.5811
491 times 1 0.4833
491 translation 1 0.9046
491 true 1 0.6728
491 unconscious 1 0.9046
491 wishes 1 1.0048
492 1 1 0.3795
492 1849. 1 1.0048
492 1st 1 0.7724
492 5th 1 1.0048
492 6th 1 0.8046
492 association 1 0.5422
492 autism 1 0.5969
492 begins. 1 1.0048
492 better 1 0.5811
492 changes 1 0.3007
492 characteristic 1 0.5074
492 characterized 1 0.5313
492 child 3 1.45
492 clinical 1 0.3275
492 cognitive 1 0.7462
492 complex 1 0.5811
492 described 1 0.3811
492 differentiation, 1 0.9046
492 dual 1 0.9046
492 emerging 1 1.0048
492 end 1 0.6148
492 extrauterine 1 1.0048
492 four 1 0.4509
492 functions. 1 0.9046
492 gradually 1 0.6352
492 illustrated 1 0.8046
492 impressive 1 0.9046
492 individuation 3 2.7139
492 infant 1 0.5669
492 interaction 1 0.6148
492 life, 1 0.6728
492 material. 1 0.724
492 mother 3 1.7214
492 mth 1 0.7724
492 mth. 1 0.5969
492 necessarily 1 0.6879
492 next 2 1.6091
492 normal 1 0.2702
492 passes 1 0.8461
492 period, 1 0.6728
492 phase 1 0.5366
492 phase, 1 0.8461
492 poor 1 0.5811
492 practicing 1 1.0048
492 preclude 1 0.8046
492 process 1 0.4598
492 relation 2 0.9258
492 separation 3 1.6808
492 stage 2 0.9741
492 stage, 1 0.7724
492 studied 1 0.3501
492 subphase 1 1.0048
492 subphase. 1 1.0048
492 subphases 2 2.0097
492 symbiotic 1 0.7724
492 this, 1 0.8461
492 throughout 1 0.5738
492 unfolding 1 1.0048
492 unity 1 1.0048
492 usually 1 0.4727
492 weeks 1 0.5262
493 2736. 1 1.5073
493 arise 1 1.2069
493 behavioral 1 1.1192
493 brings 1 1.357
493 child 1 0.725
493 children 1 0.5352
493 damage 1 0.7678
493 developing 1 0.8133
493 disturbances 1 0.8954
493 emotional 1 0.8404
493 familiar 1 1.2069
493 frightening 1 1.5073
493 hospital 1 0.9528
493 hospitalization 1 1.2069
493 manent 1 1.5073
493 may 2 0.7539
493 modify 1 1.2691
493 needs 1 1.2069
493 pa- 1 0.8832
493 painful 1 1.357
493 per- 1 1.0091
493 personality. 1 1.357
493 physical 1 0.8716
493 prevent 1 1.0091
493 probability 1 1.1192
493 procedures. 1 1.2069
493 reasons 1 1.0091
493 rents, 1 1.5073
493 result 1 0.6519
493 resultant 1 1.086
493 separation 1 0.8404
493 siblings 1 1.1192
493 steps 1 1.1192
493 stress, 1 1.357
493 subjection 1 1.357
493 surroundings, 1 1.5073
493 taken 1 0.8503
493 unless 1 1.1192
493 well 1 0.5271
494 1 1 0.3795
494 1-year-old 1 0.9046
494 2906. 1 1.0048
494 able 1 0.5669
494 age. 1 0.5669
494 anticipating 1 0.9046
494 appeared 1 0.4833
494 away 1 1.0048
494 became 1 0.5969
494 behavior. 1 0.7724
494 biologically 1 0.7462
494 cating 1 1.0048
494 cause. 1 0.7462
494 changes 1 0.3007
494 child 3 1.45
494 childhood 1 0.5669
494 children 1 0.3568
494 clinging 2 2.0097
494 crying 1 0.8461
494 determined 1 0.4568
494 duration 1 0.5262
494 early 1 0.3684
494 every 1 0.5603
494 evidence 1 0.3684
494 explaining 1 0.8461
494 frequency 1 0.5262
494 gardless 1 1.0048
494 giving 1 0.8461
494 gradual 1 0.7462
494 group 1 0.3714
494 helpful 1 0.6879
494 indi- 1 0.8461
494 long-term 1 0.5811
494 majority 1 0.6466
494 mobile 1 0.9046
494 modify 1 0.8461
494 mother 2 1.1476
494 mothers 1 0.6056
494 move 1 0.8461
494 natural 1 0.5888
494 ordinary 1 0.7462
494 pattern 1 0.4797
494 pediatrician 1 1.0048
494 phenomenon 1 0.5811
494 re- 1 0.4452
494 reaction 1 0.5031
494 reactions 1 0.4909
494 reactions. 1 0.7724
494 rearing 1 0.9046
494 recommendations 1 0.9046
494 regarded 1 0.6246
494 regressed 1 0.8046
494 response 1 0.3669
494 responses, 1 0.8046
494 separation 1 0.5603
494 separations 2 1.8093
494 separations. 1 1.0048
494 showed 1 0.3582
494 significant 1 0.3527
494 similar 1 0.3762
494 specific 1 0.3953
494 spoiled 1 1.0048
494 study 1 0.3096
494 suggests 1 0.5366
494 understand 1 0.8461
494 universality, 1 1.0048
494 yr. 1 0.5262
495 1 1 0.3795
495 2 1 0.3068
495 3 1 0.3425
495 9787. 1 1.0048
495 administered 1 0.4797
495 although 1 0.3863
495 association 1 0.5422
495 best 1 0.5313
495 changes 1 0.3007
495 conditions 1 0.4568
495 constant, 1 0.7724
495 course 1 0.4568
495 de- 1 0.5603
495 deprivation 1 0.724
495 deprivation, 1 0.8461
495 deprived 2 1.5448
495 developmental 3 2.0183
495 exam- 1 1.0048
495 experienced 1 0.7462
495 explanation 1 0.7048
495 fits 1 1.0048
495 following 1 0.3331
495 group 3 1.1143
495 group, 1 0.6466
495 group. 1 0.5811
495 groups 2 0.8185
495 home, 1 0.9046
495 immediately 1 0.6148
495 ined 1 1.0048
495 infants 2 0.9594
495 institutionalization, 1 1.0048
495 institutionalization. 1 1.0048
495 jumped 1 1.0048
495 less 1 0.3762
495 level 1 0.388
495 longitudinal 1 0.8046
495 lower 1 0.4568
495 mained 1 1.0048
495 maternal 2 1.1622
495 mechanism 1 0.4629
495 moti- 1 1.0048
495 much 1 0.4452
495 nondeprived 2 2.0097
495 obtained. 1 0.7462
495 other. 1 0.8046
495 period 2 0.7623
495 place 1 0.6148
495 program 1 0.7048
495 progressive 1 0.5603
495 quotient 1 0.8046
495 re- 1 0.4452
495 received 1 0.5669
495 regarding 1 0.6352
495 results 2 0.5755
495 retardation 1 0.6879
495 return 1 0.7462
495 scales 1 0.9046
495 scores 3 2.4137
495 separa- 1 0.8461
495 separation 1 0.5603
495 separation. 1 1.0048
495 sequent 1 0.9046
495 show 1 0.4346
495 significantly 1 0.4225
495 stimulation 1 0.5669
495 sub- 1 0.6466
495 subjected 1 0.548
495 suggested 1 0.4179
495 temporary 1 0.724
495 terioration 1 1.0048
495 terms 1 0.6148
495 testing 1 0.7048
495 theories 1 0.7048
495 tion, 1 0.8461
495 took 1 0.724
495 two 1 0.3077
495 underlying 1 0.724
495 vational 1 1.0048
496 1808. 1 1.0048
496 2 1 0.3068
496 absence. 1 0.9046
496 active 1 0.4629
496 adaptation, 1 0.8461
496 advanced 1 0.5212
496 anxiety 3 1.8738
496 attempt 1 0.6148
496 attempted 1 0.6728
496 autonomous 1 0.7462
496 autonomy 1 1.0048
496 capacity 1 0.548
496 center 1 0.6466
496 clinging, 1 1.0048
496 cognitive 1 0.7462
496 constancy, 1 1.0048
496 constancy. 1 1.0048
496 crucial 1 0.8461
496 defenses 1 0.9046
496 deny 1 1.0048
496 dependent 1 0.6466
496 designed 1 0.724
496 difficulty 1 0.6728
496 direction. 1 1.0048
496 discussed. 1 0.4296
496 distortions 1 0.9046
496 doctor-patient 1 1.0048
496 efforts 1 0.8461
496 establishing 1 0.8046
496 evidence 1 0.3684
496 factor 2 0.9524
496 help, 1 1.0048
496 implications 1 0.6466
496 include 1 0.5969
496 inordi- 1 1.0048
496 intensive 1 0.7462
496 interpersonal 1 1.0048
496 it. 1 0.6879
496 lack 2 1.1622
496 latter's 1 1.0048
496 maintain 1 0.7462
496 maintaining 1 0.7724
496 major 1 0.4833
496 many 2 0.8102
496 mastery. 1 1.0048
496 nately 1 1.0048
496 needed 1 0.6879
496 nent 1 1.0048
496 object 3 2.2385
496 objects. 1 1.0048
496 ophrenic 1 1.0048
496 others 1 0.548
496 passive 1 0.6879
496 patient's 1 0.6728
496 patients 1 0.2415
496 patients. 2 0.9667
496 perceptual 1 0.8461
496 person 1 0.7462
496 practical 1 0.6466
496 presented 1 0.3898
496 promi- 1 1.0048
496 protection, 1 1.0048
496 psychotherapy 1 0.8046
496 reasons 1 0.6728
496 recourse 1 1.0048
496 relation- 1 0.9046
496 relations 1 0.8046
496 relationships. 1 0.8461
496 representation 1 0.9046
496 reverse 1 0.9046
496 satisfactory 1 0.6591
496 schiz- 1 1.0048
496 schizophrenic 2 1.2704
496 schizophrenic's 1 1.0048
496 self-regulation 1 1.0048
496 separation 3 1.6808
496 separation, 1 0.9046
496 ship 1 0.9046
496 special 1 0.5313
496 stable 2 1.448
496 substitute 1 0.9046
496 thesis 2 1.5448
496 treatment 1 0.2965
496 unable 1 0.7462
496 upon 1 0.4509
496 vicissitudes 1 0.9046
496 victimization 1 1.0048
496 vulnerability 1 1.0048
496 without 2 0.7589
497 "separation 1 0.7536
497 25% 1 0.5286
497 455 1 0.7536
497 9101. 1 0.7536
497 adults. 1 0.5596
497 among 2 0.7041
497 apparent 1 0.3946
497 association 1 0.4066
497 cantly 1 0.6785
497 cause- 1 0.7536
497 complaints 1 0.6034
497 cornell 1 0.7536
497 data 1 0.3069
497 defined 1 0.5159
497 dis- 1 0.4764
497 effect 1 0.2301
497 experience 2 0.7747
497 experience" 1 0.7536
497 experiences 1 0.5046
497 frequency 1 0.3946
497 group 1 0.2786
497 health 1 0.5286
497 high 1 0.2697
497 higher 1 0.3241
497 history 1 0.4358
497 illness. 1 0.6785
497 index 1 0.4477
497 may 1 0.1885
497 medical 1 0.4477
497 normal 2 0.4053
497 not. 1 0.6034
497 ostensibly 1 0.7536
497 pensary 1 0.7536
497 recent 1 0.3946
497 records 1 0.5286
497 relationship 1 0.3625
497 relatively 1 0.3625
497 reported 2 0.6107
497 score 1 0.6346
497 separation 4 1.6808
497 signifi- 1 0.5793
497 ss 1 0.7536
497 study. 1 0.4943
497 suggest 1 0.3426
497 symptomatic 1 0.5286
497 terms 1 0.4611
497 understandable 1 0.7536
497 visits 1 0.7536
498 11306. 1 1.0048
498 3 1 0.3425
498 7 1 0.4629
498 among 1 0.4694
498 antecedent 1 0.9046
498 antecendent 1 1.0048
498 attempt 1 0.6148
498 attempted 2 1.3455
498 birth 1 0.5119
498 childhood 3 1.7006
498 controls. 1 0.6591
498 difference 1 0.5031
498 found 1 0.2645
498 groups 1 0.4092
498 history 1 0.5811
498 interaction 1 0.6148
498 non- 1 0.724
498 patients 1 0.2415
498 patients-at- 1 1.0048
498 period 1 0.3811
498 primarily 1 0.6352
498 psychiatric 1 0.6466
498 separation 3 1.6808
498 significant 2 0.7055
498 significantly 1 0.4225
498 suicidal 1 0.9046
498 suicide 2 2.0097
498 suicide. 1 1.0048
498 suicides 1 1.0048
498 suicides, 1 1.0048
498 suicides-there 1 1.0048
498 tempted 1 1.0048
498 urge. 1 1.0048
498 urges, 1 1.0048
498 yr. 1 0.5262
499 (1) 1 0.0635
499 (2) 1 0.0635
499 (3) 1 0.0693
499 (4) 1 0.0758
499 (5) 1 0.086
499 1463. 1 0.1311
499 accompanied 1 0.0731
499 accompany 1 0.1104
499 advancing 1 0.1311
499 affected 1 0.068
499 agar-microelectrophoresis 1 0.1311
499 age 1 0.0542
499 aging 2 0.2015
499 also 1 0.0367
499 alterations 1 0.0723
499 always 1 0.07
499 amount 2 0.1291
499 amounts 1 0.0651
499 associated 2 0.0931
499 become 1 0.0723
499 cataract 4 0.3777
499 cataract, 2 0.236
499 cataract. 3 0.3932
499 changes 4 0.1569
499 character 1 0.0919
499 character, 1 0.1311
499 clinical 1 0.0427
499 closely 1 0.0748
499 content 2 0.1233
499 crease 1 0.0878
499 de- 1 0.0731
499 decrease 2 0.1199
499 development 4 0.1914
499 different 1 0.0464
499 diminution 2 0.1839
499 disappearance 3 0.2579
499 distinct. 1 0.1311
499 electropherogram 1 0.1311
499 electropherogram. 1 0.1311
499 even 1 0.0574
499 exists 1 0.0944
499 facts 1 0.0944
499 faster 1 0.0944
499 following 1 0.0434
499 former, 1 0.1311
499 fraction 1 0.07
499 fractions 6 0.42
499 higher 1 0.0564
499 however, 1 0.0475
499 hydro- 1 0.1007
499 hydrosoluble 1 0.1311
499 important 1 0.0592
499 in- 1 0.0581
499 increase 3 0.1335
499 indicate 1 0.0577
499 insoluble 3 0.3022
499 instance, 1 0.1049
499 intensity. 1 0.1311
499 investigations 3 0.2444
499 lens 5 0.3106
499 lens. 1 0.0973
499 lenses 3 0.2444
499 lenses, 1 0.1311
499 less 1 0.0491
499 likely 1 0.0768
499 likewise 1 0.1049
499 mature 1 0.0815
499 mechanisms 1 0.079
499 medium 1 0.07
499 microelectrophoresis 1 0.1311
499 normal 2 0.0705
499 occur 1 0.064
499 ones 1 0.0919
499 opaque 1 0.1311
499 parallelism 1 0.118
499 part 2 0.1224
499 partial 1 0.0731
499 pertaining 1 0.1104
499 phase 1 0.07
499 picture 1 0.0715
499 place, 1 0.118
499 play 2 0.1557
499 point 1 0.0758
499 principal 1 0.1049
499 process 1 0.06
499 processes 3 0.2336
499 processes, 1 0.0973
499 pronounced. 1 0.1311
499 protein 23 1.3703
499 protein. 1 0.1007
499 qualitative 1 0.1007
499 quantitative 1 0.0693
499 quantity 3 0.292
499 re- 1 0.0581
499 respect, 1 0.118
499 role 1 0.0608
499 seem 2 0.1429
499 senile 6 0.7864
499 show 1 0.0567
499 similar 2 0.0981
499 slow 4 0.3439
499 soluble 10 0.7786
499 strong 1 0.0878
499 takes 1 0.1007
499 total 2 0.1022
499 transformation 2 0.1429
499 transition 1 0.1007
499 undoubtedly, 1 0.1311
499 variety, 1 0.1311
499 vealed 1 0.1311
499 velocity. 1 0.1311
499 well 3 0.1375
500 (die- 1 0.7536
500 0.005 1 0.7536
500 17 1 0.4477
500 1949. 1 0.7536
500 4, 1 0.6346
500 5, 1 0.5793
500 6, 1 0.6034
500 6.8 1 0.7536
500 7, 1 0.6034
500 8 1 0.3403
500 9 1 0.3946
500 a, 2 1.2069
500 accomplished 1 0.5596
500 analyses 1 0.5046
500 antigenic 1 0.4416
500 b 3 1.5477
500 b, 2 1.2069
500 bovine 1 0.4303
500 buffer 1 0.5793
500 buffer. 1 0.7536
500 c 1 0.411
500 c, 1 0.6785
500 cally. 1 0.7536
500 cellulose. 1 0.7536
500 changing 1 0.5596
500 chemical 1 0.4542
500 chromatogra- 1 0.7536
500 chromatography 1 0.5046
500 column 2 1.2691
500 compared 1 0.2924
500 completely 1 0.4416
500 components 1 0.4303
500 corresponded 2 1.1586
500 crystalline 2 1.1192
500 crystalline, 1 0.7536
500 crystalline. 1 0.7536
500 crystallines 1 0.7536
500 d, 1 0.6034
500 deae 1 0.6785
500 dissolved 1 0.6346
500 e 1 0.5793
500 electrophore- 1 0.7536
500 elu- 1 0.7536
500 eluting 1 0.7536
500 elution 1 0.7536
500 ethyl) 1 0.7536
500 examined 1 0.3805
500 f 1 0.7536
500 f-1-a, 1 0.7536
500 f-2-a, 1 0.7536
500 f-3, 1 0.7536
500 fraction 1 0.4025
500 fractionated 1 0.6346
500 fractions 4 1.6099
500 fractions, 1 0.6346
500 immuno- 1 0.6785
500 immunochemi- 1 0.6785
500 ionic 1 0.5793
500 lens 2 0.7143
500 lens. 1 0.5596
500 lyophilized 1 0.6785
500 mobility, 1 0.7536
500 ph 2 0.8133
500 phosphate 1 0.3805
500 phy. 1 0.6785
500 protein 1 0.3426
500 proteins 3 1.1728
500 pure 1 0.485
500 purer 1 0.6785
500 purity 1 0.6785
500 results 1 0.2158
500 separated 1 0.4943
500 showed 1 0.2686
500 soluble 2 0.8954
500 solution 1 0.4611
500 stepwise 1 0.6346
500 strength 1 0.5596
500 studies 1 0.2308
500 subjected 1 0.411
500 thylamino 1 0.7536
500 tic 1 0.5596
500 tion. 1 0.5596
501 3107. 1 0.9046
501 4 1 0.3554
501 acid 2 0.7761
501 amino 2 1.2704
501 antigenic 2 1.1776
501 arisen 1 1.0048
501 associated 1 0.3568
501 belonging 1 0.9046
501 calf 1 0.7724
501 certain 1 0.4425
501 chromatography 1 0.6728
501 columns. 1 1.0048
501 components 1 0.5738
501 compositions 1 1.0048
501 con- 1 0.5212
501 could 1 0.361
501 crystallized. 1 1.0048
501 differences 1 0.4598
501 dissimilarities. 1 1.0048
501 evolution. 1 1.0048
501 experiments 1 0.4452
501 four 1 0.4509
501 gel 1 0.5811
501 geneous 1 0.9046
501 group 1 0.3714
501 groups 1 0.4092
501 homo- 1 0.9046
501 ii. 1 0.5811
501 immunoelectrophoresis 1 0.8461
501 lens. 1 0.7462
501 main 1 0.5738
501 may 1 0.2513
501 molecular 1 0.5969
501 mutations 1 1.0048
501 n-terminal 1 0.9046
501 phosphate-cellulose 1 1.0048
501 possess 1 0.9046
501 primary 1 0.4248
501 probable 1 0.6352
501 properties 1 0.5366
501 protein 1 0.4568
501 proteins 3 1.5637
501 purification 1 0.7724
501 purified 1 0.6352
501 sequences 1 0.8046
501 showed 1 0.3582
501 similar, 1 0.8461
501 sites 1 0.6728
501 small 1 0.4031
501 structure, 1 0.8461
501 structures 1 0.6728
501 studies 1 0.3077
501 sulphoethyl-sephadex 1 1.0048
501 sulphydryl 1 1.0048
501 tained 1 0.8046
501 weights, 1 0.8046
501 y-crystallin 2 1.6091
502 (>0.2), 1 0.4306
502 2 1 0.1315
502 3105. 1 0.4306
502 7 1 0.1984
502 a-crystallin 7 2.1719
502 ability 1 0.2194
502 absence 1 0.2056
502 acid 1 0.1663
502 although 1 0.1655
502 amino 1 0.2722
502 analyses. 1 0.3877
502 apparent- 1 0.4306
502 approximately 1 0.2255
502 associate 1 0.4306
502 bination 1 0.4306
502 bonds, 1 0.4306
502 bonds. 1 0.4306
502 bound 1 0.2948
502 bovine 1 0.2459
502 chemically 1 0.3198
502 chromatography 1 0.2883
502 coefficient 1 0.3448
502 coefficients 1 0.3448
502 com- 1 0.2558
502 complete 2 0.3995
502 composition 1 0.2523
502 concentrations 1 0.2213
502 deae-cellu- 1 0.4306
502 differ. 1 0.3877
502 differences 1 0.1971
502 different 1 0.1523
502 different, 1 0.4306
502 earlier 1 0.3198
502 electrophoresis. 1 0.3877
502 electrophoretic 3 0.9062
502 even 2 0.377
502 evident 1 0.2677
502 followed 1 0.1971
502 form 1 0.1874
502 found 2 0.2267
502 fractionated 1 0.3626
502 fractions 5 1.1499
502 fugation 1 0.4306
502 gel 1 0.249
502 half 1 0.2523
502 high 6 0.9247
502 higher 1 0.1852
502 hydrophobic 1 0.3877
502 identity 1 0.331
502 identity. 1 0.3877
502 immunodiffusion 1 0.3448
502 immunoprecipitation 1 0.4306
502 investigations 1 0.2677
502 ionic 5 1.6552
502 isolated, 1 0.331
502 lens 1 0.2041
502 lose 1 0.3626
502 low 1 0.1885
502 lower 1 0.1958
502 ly 1 0.2825
502 maximal 1 0.2677
502 mobilities 2 0.7754
502 molecular 3 0.7675
502 molecule 1 0.3021
502 molecules 1 0.3021
502 moreover, 1 0.2825
502 much 2 0.3816
502 nation 1 0.4306
502 native 3 0.9593
502 never 1 0.2825
502 noncovalent 1 0.4306
502 nonspecific, 1 0.4306
502 number 2 0.3296
502 observations 1 0.1811
502 obtained 3 0.4605
502 obtained, 1 0.3626
502 obtained. 1 0.3198
502 partial 1 0.2401
502 persisted 1 0.331
502 pitin 1 0.4306
502 polyacrylamide- 1 0.4306
502 pos- 1 0.3877
502 posed 1 0.3448
502 preci- 1 0.4306
502 presence 3 0.4922
502 presence, 1 0.3877
502 purification 1 0.331
502 quantitative 1 0.2277
502 reached 1 0.2825
502 reactions 1 0.2104
502 recom- 1 0.3877
502 recombi- 1 0.4306
502 recombina- 1 0.4306
502 recovery 1 0.2374
502 related, 1 0.4306
502 removal 5 1.2006
502 sedimen- 1 0.4306
502 sedimentation 1 0.3103
502 showed 2 0.307
502 shown 1 0.1852
502 sibly 1 0.4306
502 similar 1 0.1612
502 size, 1 0.2948
502 split 1 0.4306
502 strength 1 0.3198
502 strength, 1 0.3877
502 strengths 1 0.4306
502 strengths, 1 0.4306
502 strengths. 1 0.4306
502 structure 1 0.2194
502 studied 1 0.15
502 studies 1 0.1319
502 subunits 6 2.1756
502 suggest 1 0.1958
502 tation 1 0.4306
502 techniques. 1 0.3103
502 tests, 1 0.2825
502 that, 1 0.2825
502 tion 1 0.1958
502 together 1 0.2459
502 ultracentri- 1 0.4306
502 unfractionated 1 0.4306
502 urea 6 1.8123
502 urea, 1 0.3448
502 urea-treated 1 0.3877
502 urea. 2 0.6896
502 values 1 0.2175
502 weight 1 0.2026
502 weight. 1 0.3198
502 weights. 1 0.3877
502 whereas 1 0.2156
503 1 1 0.3795
503 13.6, 1 1.0048
503 3106. 1 1.0048
503 4 2 0.7109
503 4.2 1 0.9046
503 4.9 1 1.0048
503 9.6, 1 1.0048
503 additional 1 0.5366
503 analyses. 1 0.9046
503 b-crystal- 1 1.0048
503 b-crystallin 2 1.6922
503 calf 2 1.5448
503 coefficients 1 0.8046
503 combination 1 0.5738
503 components, 1 0.8046
503 contained 1 0.5119
503 cross-linkage. 1 1.0048
503 dextran 1 0.9046
503 electrophoresis. 1 0.9046
503 fil- 1 1.0048
503 filtration 2 1.3455
503 first 1 0.3684
503 fraction 1 0.5366
503 fractionation 2 1.5448
503 fractions 3 1.6099
503 g-75 1 1.0048
503 gel 3 1.7433
503 gels 1 0.8461
503 group. 1 0.5811
503 however, 1 0.3639
503 i-iv, 1 1.0048
503 immunoelectrophoretic 1 0.9046
503 individual 1 0.5313
503 isolated 1 0.4372
503 isolation 1 0.6466
503 lens 1 0.4762
503 lenses 1 0.6246
503 lin 1 1.0048
503 low 1 0.4398
503 major 1 0.4833
503 may 1 0.2513
503 minor 1 0.6466
503 peak 1 0.5811
503 procedure 1 0.5119
503 proteins 1 0.5212
503 respectively. 1 0.6879
503 revealed 1 0.4871
503 sedimentation 2 1.448
503 sephadex 1 0.7462
503 showed 1 0.3582
503 step 1 0.7462
503 subdivided 1 0.9046
503 subsequent 1 0.548
503 tration 1 1.0048
503 ultracentrifuge, 1 0.9046
503 value 1 0.4629
503 vertical-column 1 1.0048
503 zone 1 0.6591
504 'cold 1 0.3768
504 (ccp) 1 0.3768
504 10 2 0.2774
504 17 1 0.2238
504 195. 1 0.3768
504 3-year-old 1 0.3768
504 4 1 0.1333
504 4.0, 1 0.3768
504 a-, 1 0.3768
504 ability 2 0.3839
504 ages, 1 0.3392
504 aggregation 1 0.3173
504 although 1 0.1449
504 appear 1 0.1724
504 appears 1 0.162
504 aqueous 1 0.2715
504 b- 1 0.3173
504 bonding 1 0.3768
504 c 1 0.2055
504 c. 1 0.1992
504 cataract' 1 0.3768
504 cold 2 0.5159
504 cold-precipitable 2 0.7536
504 cold. 1 0.3768
504 com- 1 0.2238
504 component, 1 0.3392
504 comprising 1 0.3392
504 concentration 2 0.3168
504 conformation 1 0.3768
504 cpp 1 0.3768
504 decreases, 1 0.3768
504 depend 1 0.3017
504 depends 1 0.3017
504 develop 1 0.2271
504 disappear, 1 0.3768
504 disc 1 0.3768
504 electrophoresis 1 0.2798
504 even 1 0.1649
504 exposed 1 0.1973
504 form 1 0.1639
504 fraction 8 1.6099
504 heterogeneous 1 0.3017
504 homogeneous 1 0.3017
504 hydrophobic 1 0.3392
504 immunodiffusion 1 0.3017
504 influence 1 0.1724
504 ionic 1 0.2897
504 isolated 1 0.1639
504 lens 1 0.1786
504 lens. 1 0.2798
504 lenses 1 0.2342
504 longer 1 0.2643
504 mammals 1 0.3173
504 may 1 0.0942
504 mixture 1 0.2798
504 molecular 1 0.2238
504 occurs 1 0.2012
504 ph 2 0.4066
504 pletely 1 0.3392
504 precipitate 2 0.6346
504 precipitates 2 0.6785
504 properties 1 0.2012
504 protein 5 0.8564
504 protein. 1 0.2897
504 rat 2 0.3101
504 rats. 1 0.1973
504 re- 1 0.167
504 reversible 1 0.2798
504 seen 1 0.1593
504 shown 1 0.162
504 soluble 1 0.2238
504 solutions 2 0.543
504 solvent. 1 0.3768
504 species 1 0.2055
504 sponsible 1 0.3768
504 strength 1 0.2798
504 subunits. 1 0.3768
504 temperatures 2 0.4764
504 ultracentrifuge, 1 0.3392
504 upon 1 0.1691
504 y-crystallin 1 0.3017
504 young 1 0.1903
505 6-phosphate 2 0.9046
505 6-week-old 1 0.5024
505 773. 1 0.5024
505 800 1 0.5024
505 activities 2 0.5811
505 activities. 1 0.423
505 activity 1 0.1798
505 animals. 2 0.5669
505 c 2 0.548
505 cells 1 0.1516
505 ceraldehydephosphate 1 0.5024
505 control 1 0.1889
505 cytochrome 2 0.9046
505 decreased 1 0.2269
505 dehydrogenase 2 0.7724
505 dehydrogenase, 6 2.7139
505 diaphorase 1 0.5024
505 diaphorase, 1 0.5024
505 effect 1 0.1534
505 enzyme 1 0.2985
505 enzymes 1 0.3176
505 epithelial 2 0.5313
505 evaluated 1 0.2905
505 exposed 1 0.2631
505 fraction 2 0.5366
505 glucose 2 0.5262
505 glutathione 2 1.0048
505 gly- 1 0.4523
505 glyceraldehydephos- 1 0.5024
505 increased 1 0.1562
505 ir- 2 0.8461
505 irradiated 1 0.2905
505 isocitrate 2 0.9046
505 lens 1 0.2381
505 lenticular 3 1.357
505 malate 2 1.0048
505 male 1 0.2559
505 mitochondrial 1 0.362
505 nadh2 2 0.9046
505 nadph2 2 0.9046
505 new 1 0.2199
505 noted 1 0.2657
505 nucleoside 2 1.0048
505 observed 1 0.1713
505 phate 1 0.4023
505 phosphorylase, 2 1.0048
505 purine 2 0.9046
505 r 1 0.3296
505 rabbits 1 0.2869
505 rabbits, 1 0.3862
505 radiated 2 1.0048
505 radiation 1 0.274
505 reductase 2 1.0048
505 reductase, 1 0.5024
505 reductase. 1 0.5024
505 soluble 1 0.2985
505 tissues 2 0.4598
505 white 1 0.3123
505 whole-head 1 0.5024
505 x-irradiation, 1 0.5024
505 young 1 0.2537
505 zealand 1 0.5024
506 465. 1 0.7536
506 7 1 0.3472
506 a-crys- 1 0.7536
506 a-crystallin 4 2.1719
506 a-crystallin, 1 0.6785
506 able 1 0.4252
506 activity. 1 0.5159
506 alloxan 3 1.7379
506 amounts 1 0.3742
506 aqueous. 1 0.7536
506 bovine 1 0.4303
506 cataract 1 0.543
506 conversion 1 0.543
506 convert 1 0.7536
506 converted 1 0.6346
506 could 1 0.2708
506 cross 1 0.6034
506 effective 1 0.3773
506 electrophoretic 1 0.5286
506 extent 1 0.3985
506 form 1 0.3279
506 form. 1 0.5793
506 glutathione, 1 0.7536
506 hcl, 1 0.6785
506 hydrogen 1 0.6785
506 injected 1 0.3653
506 insoluble 4 2.3172
506 iodoacetate. 1 0.7536
506 lens 2 0.7143
506 made 2 0.5459
506 mercaptoethanol, 1 0.7536
506 mobility 1 0.6346
506 naoh, 1 0.7536
506 ouchterlony 1 0.6785
506 peroxide, 1 0.7536
506 plate 1 0.6346
506 producing 1 0.485
506 product 1 0.5596
506 protein 1 0.3426
506 proteolytic 1 0.6034
506 rabbit 1 0.4252
506 reaction 1 0.3773
506 reagents 1 0.6785
506 reduced 1 0.3403
506 showed 1 0.2686
506 small 2 0.6046
506 soluble 2 0.8954
506 tallin 1 0.7536
506 thus 1 0.3909
506 treated 1 0.3101
506 treatment 2 0.4447
506 urea. 1 0.6034
506 vitro 1 0.3874
507 (20,000 1 1.0048
507 (s-carboxymethyl) 1 1.0048
507 1972. 1 1.0048
507 2 1 0.3068
507 3 1 0.3425
507 a-crystallin 3 2.1719
507 a-crystallin. 1 0.9046
507 absent. 1 0.8461
507 according 1 0.5422
507 acid 2 0.7761
507 agreement 1 0.6879
507 alkylated 2 2.0097
507 amino 1 0.6352
507 around 1 0.6728
507 bonds 1 0.9046
507 chromatography 1 0.6728
507 common 1 0.4909
507 composition 1 0.5888
507 conditions, 1 0.7724
507 cortex 1 0.554
507 cysteine 1 0.9046
507 cysteine, 1 1.0048
507 deae-cellulose. 1 1.0048
507 different 1 0.3554
507 dipeptide 1 1.0048
507 dipeptide. 1 1.0048
507 disulphide 1 1.0048
507 exclusively 1 0.7724
507 feature 1 0.7048
507 followed 1 0.4598
507 gives, 1 1.0048
507 group 1 0.3714
507 group/20,000g. 1 1.0048
507 hydroly- 1 1.0048
507 interpretation 1 0.6728
507 iodoacetate 1 1.0048
507 isoelectric 1 1.0048
507 isolated 1 0.4372
507 lens 1 0.4762
507 magnitude 1 0.6246
507 mainly 1 0.6591
507 method. 1 0.7048
507 molecular 1 0.5969
507 n-seryl- 1 1.0048
507 nearly 1 0.6148
507 one 2 0.5622
507 order 1 0.5262
507 ox 1 0.9046
507 partial 1 0.5603
507 peptides 3 3.0145
507 precipitation 1 0.8461
507 prepared 1 0.6056
507 presence 1 0.3828
507 probably 1 0.4568
507 protein 2 0.9135
507 radioactive 3 1.8738
507 related 1 0.4248
507 reported 1 0.4072
507 residue 1 1.0048
507 results 1 0.2878
507 sequence 1 0.7724
507 ser-cmcys. 2 2.0097
507 simplest 1 0.9046
507 sis 1 0.7724
507 structural 2 1.2933
507 studies 1 0.3077
507 sub- 2 1.2933
507 thiol 2 1.8093
507 tri- 1 1.0048
507 unit 1 0.7048
507 units 1 0.6879
507 urea. 1 0.8046
507 weight), 1 1.0048
508 'trace' 1 0.7536
508 1% 1 0.6034
508 1751. 1 0.7536
508 7 1 0.3472
508 a-crystallin 2 1.086
508 according 1 0.4066
508 acid 4 1.1641
508 aggregates 1 0.6785
508 alkaline 1 0.543
508 almost 1 0.3874
508 amino 1 0.4764
508 analytical 1 0.5793
508 authors 1 0.3472
508 bands 1 0.6034
508 block 1 0.543
508 blocks 1 0.5793
508 c870 1 0.7536
508 centrifugation 1 0.7536
508 change. 1 0.6346
508 chromatography. 1 0.6346
508 coefficient 1 0.6034
508 coiled 1 0.7536
508 compared 1 0.2924
508 concentration 3 0.9505
508 containing 1 0.3985
508 content 1 0.3546
508 could 1 0.2708
508 demonstrated. 1 0.543
508 density 1 0.4943
508 detected, 1 0.6346
508 dinitrophenyl-glutamic 1 0.7536
508 dodecyl 3 1.9037
508 either 1 0.3222
508 electron 1 0.3805
508 electrophoresis 2 1.1192
508 electrophoretic 1 0.5286
508 end-groups 1 0.7536
508 equilibrium 1 0.5286
508 extract 1 0.4764
508 filaments 1 0.6785
508 gels 1 0.6346
508 globules 1 0.7536
508 glutamic 1 0.6785
508 gradient 1 0.5286
508 hand, 1 0.4542
508 heterogeneity 1 0.6034
508 isolated 2 0.6558
508 large 1 0.2979
508 lens 1 0.3571
508 lower 1 0.3426
508 media. 1 0.6034
508 micrographs 1 0.6034
508 n-terminal 2 1.357
508 neutral 1 0.543
508 new 1 0.3299
508 number 1 0.2884
508 observed 1 0.2569
508 observed. 1 0.4542
508 obtained 1 0.2686
508 pevikon 1 0.7536
508 ph 1 0.4066
508 ph, 1 0.5596
508 polyacrylamide 1 0.6785
508 preparations 3 1.3625
508 preparative 1 0.6785
508 procedure. 1 0.6346
508 purified 4 1.9056
508 rather 1 0.3546
508 re-investigated 1 0.7536
508 result 1 0.326
508 revealed 1 0.3653
508 samples 2 0.9528
508 samples. 2 1.5073
508 sedimentation 1 0.543
508 sedimentation-diffusion 1 0.7536
508 sephadex 1 0.5596
508 showed 1 0.2686
508 similar. 1 0.6785
508 slight 1 0.4477
508 slightly 1 0.4303
508 small 1 0.3023
508 sodium 3 1.0875
508 spherical 1 0.7536
508 starch 2 1.1586
508 submitted 1 0.6785
508 substructure 1 0.7536
508 subunits 1 0.6346
508 sulphate 1 0.6346
508 sulphate. 2 1.5073
508 three 1 0.2834
508 total 1 0.2937
508 treated 1 0.3101
508 ultracentrifuge 1 0.7536
508 uniform 1 0.6785
508 urea 3 1.5858
508 urea-treated 1 0.6785
508 value 1 0.3472
508 water-soluble 1 0.6785
508 whereas 2 0.7546
508 zone 1 0.4943
508 zones 1 0.6346
509 - 1 0.3533
509 1752. 1 0.6029
509 a, 1 0.4827
509 a-crystallin, 1 0.5428
509 acetate 1 0.4477
509 achieving 1 0.6029
509 amide 1 0.6029
509 analyses 1 0.4037
509 b 2 0.8255
509 b, 1 0.4827
509 b-crystallin 1 0.5076
509 bovine 2 0.6886
509 buffer 1 0.4634
509 c 2 0.6575
509 calf 2 0.9269
509 column. 1 0.6029
509 compare 1 0.4634
509 compared 1 0.2339
509 cortical 1 0.388
509 cow 1 0.5428
509 crystallin 1 0.6029
509 d. 1 0.388
509 determined. 1 0.4127
509 distribution 1 0.3099
509 electrophoretic 1 0.4229
509 essential 1 0.3533
509 ethylenediaminetetra- 1 0.6029
509 filtration 1 0.4037
509 found 1 0.1587
509 four 2 0.541
509 fraction 4 1.2879
509 fractions 5 1.6099
509 gel 1 0.3487
509 gels 1 0.5076
509 gels. 1 0.6029
509 good 1 0.3362
509 homogenate 1 0.5076
509 immunochemical 1 0.5428
509 lens 1 0.2857
509 lens. 1 0.4477
509 lenses 4 1.4991
509 nuclear 1 0.3487
509 oxidation-sensitive 1 0.6029
509 parts 1 0.4127
509 polyacryl- 1 0.6029
509 polyacrylamide 1 0.5428
509 presence 1 0.2297
509 protein 2 0.5481
509 proteins 2 0.6255
509 se-sephadex 1 0.6029
509 separated 2 0.7909
509 separation 2 0.6723
509 soluble 3 1.0744
509 ultracentrifugal, 1 0.6029
509 used 1 0.2277
509 y-crystallin. 1 0.6029
510 1, 1 0.388
510 12.8 1 0.6029
510 1745. 1 0.6029
510 2 1 0.1841
510 4 1 0.2133
510 7 2 0.5555
510 8 1 0.2723
510 a-crystallin 3 1.3032
510 actual 1 0.4344
510 alkali 2 1.0856
510 alkali-, 1 0.6029
510 average 2 0.541
510 bovine 1 0.3443
510 coexisted 1 0.5428
510 composed 1 0.4634
510 concentration 1 0.2535
510 concluded 1 0.2759
510 conclusions 1 0.3811
510 conditions 1 0.2741
510 conditions. 2 0.8457
510 constant 1 0.3288
510 could 1 0.2166
510 data 1 0.2455
510 deaggregating 1 0.6029
510 deaggregation 2 1.2058
510 dependence. 1 0.5428
510 different 1 0.2133
510 dissociating 1 0.6029
510 distribution 1 0.3099
510 effect 1 0.1841
510 equilibrium 2 0.8457
510 evaluated 1 0.3487
510 found 2 0.3174
510 found, 1 0.4229
510 guanidine 3 1.8087
510 heterogeneity 1 0.4827
510 hydrochloride 1 0.6029
510 hydrochloride, 1 0.6029
510 hydrochloride-treated 1 0.6029
510 imply 1 0.4229
510 increasing 1 0.3533
510 independent 1 0.3633
510 indicate 2 0.531
510 indicates 1 0.3955
510 individual 1 0.3188
510 integral 1 0.6029
510 lens 2 0.5714
510 m2 1 0.6029
510 ma- 1 0.4827
510 manner 1 0.4127
510 material 2 0.5593
510 material. 2 0.8688
510 molecular 5 1.7907
510 mw 1 0.6029
510 neutral 1 0.4344
510 number 1 0.2307
510 observed. 1 0.3633
510 occurred 1 0.2623
510 one-half 1 0.4634
510 one-quarter 1 0.5428
510 performed 1 0.2759
510 ph 2 0.6506
510 ph. 1 0.6029
510 progressive 1 0.3362
510 ratio 1 0.3157
510 relation- 1 0.5428
510 respectively. 1 0.4127
510 results 1 0.1727
510 sedimentation 2 0.8688
510 ship 1 0.5428
510 since 1 0.2623
510 sized 1 0.6029
510 small 1 0.2419
510 species 3 0.9863
510 species. 1 0.3955
510 spread 1 0.4477
510 studies 2 0.3693
510 study 1 0.1857
510 succinylated 2 1.2058
510 succinylated, 1 0.6029
510 terial 1 0.4477
510 upon 1 0.2705
510 urea 2 0.8457
510 urea, 1 0.4827
510 urea-, 1 0.6029
510 value 1 0.2778
510 weight 4 1.1346
510 weights 1 0.4229
510 well 1 0.2108
511 1747. 1 0.5024
511 7 1 0.2315
511 a-crystallin. 2 0.9046
511 albuminoid 6 2.5382
511 albuminoid. 1 0.5024
511 becomes 1 0.3028
511 cause 1 0.2269
511 cellular 1 0.274
511 clear 1 0.3028
511 concentration 1 0.2112
511 connected 1 0.5024
511 constituent 1 0.4523
511 corre- 1 0.4523
511 cortex 1 0.277
511 deae-cellulose 1 0.5024
511 degree 1 0.2226
511 destroyed 1 0.3364
511 dilution 2 0.6879
511 dilution. 1 0.5024
511 disrupted. 1 0.5024
511 entails 1 0.4523
511 especially 1 0.2582
511 even 1 0.2199
511 formed 1 0.2801
511 fraction 1 0.2683
511 fractionated 1 0.423
511 fractions 2 0.5366
511 ground 1 0.5024
511 high 2 0.3596
511 insoluble 2 0.7724
511 lens 4 0.9524
511 lens, 2 0.8046
511 likely 1 0.2944
511 main 1 0.2869
511 maps 1 0.5024
511 may 1 0.1257
511 mush. 1 0.5024
511 normal 1 0.1351
511 nucleus, 1 0.423
511 order, 1 0.4523
511 ox 1 0.4523
511 peptide 1 0.423
511 perhaps 1 0.277
511 phenomenon 1 0.2905
511 precipitation 1 0.423
511 present 1 0.1654
511 problem 1 0.2869
511 proteins 1 0.2606
511 proteins. 1 0.4523
511 regarded 1 0.3123
511 similar 1 0.1881
511 sponding 1 0.4523
511 structure 1 0.2559
511 turbid 1 0.5024
511 turbidity 1 0.5024
511 undiluted 1 0.5024
511 urea; 1 0.5024
511 well 1 0.1757
512 10 1 0.1849
512 16 1 0.3123
512 2 2 0.3068
512 3 1 0.1713
512 5 1 0.1906
512 72 1 0.362
512 787. 1 0.5024
512 8 1 0.2269
512 abortive 1 0.4523
512 almost 1 0.2582
512 approximately 2 0.5262
512 ation, 1 0.5024
512 autoradiographic 1 0.3296
512 autoradiography 1 0.3862
512 beginning 2 0.6352
512 bow. 1 0.5024
512 cell 2 0.3401
512 cells 6 0.9098
512 completion 1 0.423
512 corresponds 1 0.4523
512 daughter 1 0.4523
512 days 1 0.1996
512 death 1 0.274
512 degeneration 1 0.362
512 die 1 0.3862
512 division, 1 0.4523
512 divisions. 1 0.5024
512 dna 1 0.2399
512 epithelial 1 0.2657
512 epithelium 2 0.6056
512 epithelium. 1 0.423
512 equatorial 1 0.5024
512 exposure. 1 0.4523
512 eyes 2 0.7462
512 fell 1 0.3439
512 following 1 0.1665
512 follows 1 0.3233
512 found 1 0.1323
512 g2, 1 0.5024
512 germinative 1 0.423
512 hr. 2 0.5811
512 hr.; 1 0.5024
512 hr; 1 0.5024
512 indicating 1 0.3233
512 injection 1 0.2101
512 interval 1 0.4023
512 irradi- 1 0.5024
512 irradiated 1 0.2905
512 labelled 2 0.724
512 labelling 1 0.4023
512 lens 4 0.9524
512 less 1 0.1881
512 loss 1 0.2435
512 many 1 0.2026
512 means 1 0.2226
512 migrate 1 0.4523
512 migration 1 0.3364
512 min. 1 0.3524
512 mitosis 1 0.3862
512 mitosis, 1 0.5024
512 mitosis. 1 0.4523
512 normal 3 0.4053
512 normally 1 0.3176
512 nuclei 1 0.3176
512 number 1 0.1923
512 occurred 1 0.2186
512 onset 1 0.2905
512 originally 1 0.3731
512 partitioned 1 0.4523
512 pass 1 0.3731
512 percentage 1 0.2801
512 period 1 0.1906
512 period, 1 0.3364
512 phase 1 0.2683
512 postequatorial 1 0.5024
512 preparing 1 0.423
512 proliferation 1 0.2905
512 radioactive 2 0.6246
512 rapidly 1 0.2869
512 rat 2 0.4135
512 require 1 0.3439
512 rows, 1 0.5024
512 slightly 1 0.2869
512 small 1 0.2015
512 studied 1 0.175
512 studies 1 0.1539
512 survived 1 0.3296
512 synthesis 1 0.2494
512 synthesizing 1 0.4523
512 thymidine. 1 0.4023
512 time 1 0.177
512 tracer 1 0.4023
512 tritiated 1 0.3364
512 undergo 1 0.3731
512 weeks 2 0.5262
512 would 1 0.2494
512 x-irradiated 2 0.7724
512 zero. 1 0.4523
512 zone 1 0.3296
512 zone. 1 0.5024
513 2-year 1 0.4523
513 2627. 1 0.5024
513 adjacent 1 0.362
513 adult 1 0.2284
513 annular 3 1.5073
513 anterior 1 0.3176
513 band 1 0.4523
513 cataracts. 1 0.5024
513 cell 4 0.6802
513 cells 5 0.7581
513 cells. 1 0.224
513 chicken 3 1.357
513 consisting 1 0.4023
513 cortex 1 0.277
513 de- 1 0.2801
513 developed, 1 0.4023
513 developed. 1 0.4023
513 development 1 0.1834
513 development, 1 0.3364
513 differentiated 2 0.6728
513 discussed 1 0.2046
513 division 3 1.0572
513 earliest 1 0.3731
513 entire 1 0.3296
513 epithelial 3 0.797
513 estimated 1 0.3123
513 failure 1 0.2711
513 fibers 1 0.4023
513 fibers. 1 0.4523
513 first 2 0.3684
513 germinative 2 0.8461
513 hatching 1 0.5024
513 lens 6 1.4285
513 lens. 1 0.3731
513 migrated 1 0.423
513 migration 2 0.6728
513 narrow 1 0.423
513 occurred 1 0.2186
513 occurred, 1 0.4023
513 pad 3 1.357
513 part, 1 0.423
513 period. 1 0.3028
513 posterior 1 0.2944
513 primary 1 0.2124
513 production 1 0.2559
513 radiation 1 0.274
513 relation 1 0.2315
513 shortly 1 0.423
513 side 1 0.2834
513 slow 1 0.3296
513 slowly 1 0.3439
513 stages 1 0.277
513 stopped 1 0.3862
513 surface 1 0.2711
513 thereafter, 1 0.423
513 velop 1 0.5024
513 vesicle, 1 0.5024
513 zone 1 0.3296
513 zone, 1 0.4523
514 (169 1 0.7536
514 (i.e. 1 0.7536
514 1494. 1 0.7536
514 caries 1 0.6346
514 consideration 1 0.4943
514 content 1 0.3546
514 deficiency. 1 0.5286
514 deleterious 1 0.6034
514 dental 1 0.5596
514 dietary 1 0.543
514 disease 1 0.2708
514 effect 1 0.2301
514 fact 1 0.3985
514 fish 2 1.357
514 flour 2 1.5073
514 given 1 0.2763
514 implications 1 0.485
514 important 1 0.3403
514 indicates 1 0.4943
514 kwashiorkor 1 0.7536
514 malnutrition 1 0.7536
514 malnutrition. 1 0.7536
514 man 1 0.3874
514 manifestation 1 0.5286
514 may 2 0.377
514 p.p.m. 1 0.6034
514 played 1 0.6034
514 prevention 1 0.5159
514 protein 2 0.6851
514 recommended 1 0.5046
514 relation 1 0.3472
514 research 1 0.4943
514 rich 1 0.5793
514 role 1 0.3496
514 selenium 4 1.8167
514 serious 1 0.4542
514 shown 1 0.3241
514 source 1 0.5046
514 syndromes 1 0.5286
514 teeth) 1 0.7536
514 treatment 1 0.2223
514 workers. 1 0.7536
515 (mean 1 2.7139
515 0.029 1 3.0145
515 0.039 1 3.0145
515 0.051 1 3.0145
515 0.324 1 3.0145
515 2192. 1 3.0145
515 amounts 1 1.4967
515 appreciable 1 2.1144
515 authors 1 1.3888
515 caries 1 2.5382
515 chiefly 1 2.1719
515 contains 1 1.8443
515 content 1 1.4182
515 dental 1 2.2385
515 determined 1 1.3703
515 effects 1 1.119
515 egg 1 2.4137
515 eggs 1 2.2385
515 eggs. 1 2.7139
515 element 1 2.3172
515 found 1 0.7936
515 fresh 1 2.1719
515 p.p.m. 1 2.4137
515 p.p.m.) 1 2.7139
515 se 1 2.4137
515 se; 1 2.7139
515 selenium 1 1.8167
515 study 1 0.9287
515 traces 1 3.0145
515 value 1 1.3888
515 white. 1 3.0145
515 whole 1 1.6808
515 yolk 1 2.7139
516 (17-44 1 1.0048
516 (standard 1 1.0048
516 0.003). 1 1.0048
516 0.021 1 1.0048
516 15 1 0.4989
516 1541. 1 1.0048
516 appears 1 0.4321
516 area 1 0.5212
516 capable 1 0.6148
516 caries 2 1.6922
516 children 1 0.3568
516 class 1 0.9046
516 collected 1 0.724
516 considered 1 0.448
516 content 2 0.9455
516 dental 2 1.4923
516 effect 1 0.3068
516 error 1 0.724
516 factor 1 0.4762
516 human 1 0.3354
516 increasing 1 0.5888
516 low 1 0.4398
516 mean 1 0.4833
516 milk 2 1.5448
516 mothers 1 0.6056
516 nonseleniferous, 1 1.0048
516 old) 1 1.0048
516 p.p.m. 1 0.8046
516 possible 1 0.4031
516 rats. 1 0.5262
516 selenium 3 1.8167
516 socio-economic 1 0.9046
516 susceptibility 1 0.7724
516 yr. 1 0.5262
517 1 1 0.2277
517 1577. 1 0.6029
517 a-tocopherols, 1 0.6029
517 absorption, 1 0.4827
517 across 1 0.4634
517 action 1 0.2623
517 activities 2 0.6973
517 activity 2 0.4315
517 acts 1 0.4344
517 alone 1 0.3633
517 also 1 0.1687
517 appears 1 0.2593
517 associated 1 0.2141
517 beneficial 1 0.4229
517 biological 3 0.966
517 blood 1 0.1863
517 body. 1 0.5428
517 carried 1 0.3018
517 carrier 1 0.5076
517 cell 1 0.204
517 cells 1 0.182
517 chemical 1 0.3633
517 chicks 1 0.4827
517 closely 1 0.3443
517 combination. 1 0.6029
517 compound 1 0.4127
517 d-a-tocopherol, 1 0.6029
517 d-a-tocopherol. 1 0.6029
517 destruction, 1 0.5428
517 determination 1 0.3689
517 detrimental 1 0.5076
517 dietary 2 0.8688
517 due 1 0.2133
517 dystrophy 1 0.5428
517 e 3 1.3903
517 effect 1 0.1841
517 effectiveness 1 0.4229
517 enhancing 1 0.5076
517 especially 1 0.3099
517 fact 1 0.3188
517 followed 1 0.2759
517 fraction 1 0.322
517 fractions 1 0.322
517 function 1 0.2705
517 h3-a-tocopherol 1 0.6029
517 higher 1 0.2593
517 improving 1 0.5428
517 increases 1 0.2816
517 indicated 1 0.2836
517 ineffective 1 0.4229
517 least 1 0.3099
517 levels 1 0.2361
517 levels. 1 0.4037
517 lie 1 0.5428
517 may 2 0.3016
517 membranes 1 0.388
517 mode 1 0.4344
517 muscular 1 0.4229
517 nutrients 1 0.5428
517 nutritional 1 0.5076
517 one 1 0.1687
517 part 1 0.2816
517 partially 1 0.3748
517 perhaps 2 0.6648
517 plasma 1 0.2431
517 ppm 1 0.4634
517 prevention 1 0.4127
517 proteins 1 0.3127
517 proteins. 1 0.5428
517 receiving 1 0.3324
517 relation 1 0.2778
517 retention 1 0.3748
517 retention, 1 0.4634
517 role 2 0.5593
517 se75 1 0.5428
517 selenium 5 1.8167
517 selenium-containing 1 0.6029
517 selenium75 1 0.6029
517 selenolipoprotein 1 0.6029
517 serum 4 0.9356
517 shown 1 0.2593
517 studies 1 0.1846
517 thereby 1 0.4634
517 throughout 1 0.3443
517 thus, 1 0.4344
517 tocopherols 3 1.8087
517 tracing 1 0.6029
517 transfer 1 0.388
517 tritiated 1 0.4037
517 upon 1 0.2705
517 various 1 0.2383
517 vitamin 3 1.1066
517 y-globulin. 1 0.6029
518 10 1 0.1849
518 150-200 1 0.4523
518 2 2 0.3068
518 20 1 0.2269
518 210.0%. 1 0.5024
518 290.6%, 1 0.5024
518 30 1 0.2399
518 3123. 1 0.5024
518 326.8% 1 0.5024
518 45% 1 0.5024
518 5 1 0.1906
518 acute 1 0.2494
518 ad- 1 0.3364
518 animals 1 0.2136
518 animals. 1 0.2834
518 average 1 0.2254
518 binds 1 0.5024
518 bones 1 0.362
518 comparison 1 0.2606
518 daily 1 0.274
518 days. 1 0.2834
518 death. 1 0.4023
518 deposition 1 0.362
518 doses 2 0.548
518 effect 1 0.1534
518 excretion 2 0.4727
518 experiments 1 0.2226
518 fecal 1 0.4523
518 found, 1 0.3524
518 g. 1 0.3731
518 given 1 0.1842
518 hr 1 0.2905
518 increased 1 0.1562
518 increases 2 0.4694
518 indicate 1 0.2212
518 influence 1 0.2299
518 ions 1 0.3731
518 kidneys 1 0.2801
518 level 1 0.194
518 liver 1 0.1977
518 mg/kg 3 1.2069
518 mg/kg. 1 0.4523
518 ministered 1 0.5024
518 next 1 0.4023
518 organs 1 0.277
518 organs. 1 0.362
518 os 1 0.5024
518 per 1 0.1958
518 performed 1 0.2299
518 poisoning 2 0.6879
518 protects 1 0.423
518 rats 2 0.388
518 results 1 0.1439
518 s.c. 1 0.4023
518 selenate 5 2.0114
518 shows 1 0.277
518 sodium 3 0.725
518 thallium 6 3.0145
518 treated 2 0.4135
518 urine 1 0.2582
518 weighing 1 0.423
518 wistar 1 0.4023
519 (wilson 1 0.5024
519 -2 1 0.4523
519 -3 3 1.357
519 -4 1 0.5024
519 -5 1 0.5024
519 10 6 1.1097
519 100% 2 0.8046
519 2281. 1 0.5024
519 5 1 0.1906
519 70%. 1 0.5024
519 77% 1 0.5024
519 85% 1 0.4523
519 absorption 2 0.6246
519 achieve 1 0.3524
519 action 1 0.2186
519 active 4 0.9258
519 and, 1 0.2606
519 atractyloside 4 2.0097
519 easier 1 0.5024
519 effective 2 0.5031
519 everted 1 0.5024
519 galactose. 1 0.5024
519 general 1 0.2559
519 glucose, 1 0.3862
519 ii. 1 0.2905
519 inhibit, 1 0.5024
519 inhibition 1 0.2515
519 inhibitions 2 1.0048
519 inhibitors 3 1.1192
519 intestinal 2 0.724
519 intestine 1 0.4023
519 isotonic 1 0.4023
519 jejunum 1 0.5024
519 less. 1 0.423
519 m, 2 0.9046
519 magnitude 1 0.3123
519 mepacrine 2 1.0048
519 mepacrine, 2 1.0048
519 method). 1 0.4523
519 orders 1 0.4523
519 rat 2 0.4135
519 rather 2 0.4727
519 regarded 1 0.3123
519 respectively, 1 0.362
519 sacs 1 0.4523
519 selenite 2 0.724
519 selenite, 1 0.5024
519 shown 1 0.216
519 similar 1 0.1881
519 solutions 1 0.362
519 sugars 3 1.357
519 total 1 0.1958
519 transport 4 1.2111
519 vitro 2 0.5165
519 vitro. 2 0.6728
519 vivo 1 0.2985
519 vivo, 1 0.5024
519 vivo. 1 0.4523
519 wiseman's 1 0.5024
519 within 1 0.1865
519 x 1 0.3176
520 2284. 1 0.7536
520 abdominis 1 0.7536
520 acetylcholine, 2 1.5073
520 acetylcholine-like 1 0.7536
520 acetylcholine. 1 0.7536
520 acetylselenocholine 1 0.7536
520 acetylselenocholine, 2 1.5073
520 acetylthiocholine 4 3.0145
520 acetylthiocholine. 1 0.7536
520 acetyselenocholine 1 0.7536
520 actions 1 0.485
520 activity 1 0.2697
520 addition 1 0.3839
520 air 1 0.4202
520 analogs 1 0.7536
520 analogs, 1 0.7536
520 anticholinesterase. 1 0.7536
520 apparently 1 0.411
520 approximately 1 0.3946
520 attributable 1 0.5159
520 choline 2 1.2691
520 cholineselenol; 1 0.7536
520 cholinethiol 1 0.7536
520 comparable 1 0.4155
520 comparative 1 0.4611
520 contradictory 1 0.6346
520 contrast 1 0.5046
520 diselenide, 1 0.7536
520 disulfide 1 0.7536
520 effects 2 0.5595
520 enhanced 1 0.4685
520 enzymatic 1 0.5793
520 esters, 1 0.7536
520 exert 1 0.6346
520 explaining 1 0.6346
520 frog 1 0.6785
520 guinea-pig 2 1.086
520 helpful 1 0.5159
520 high 1 0.2697
520 hydrolysis 4 2.7139
520 ii. 1 0.4358
520 ileum 2 1.5073
520 inactive 1 0.5159
520 latter 1 0.3909
520 literature 1 0.411
520 many 1 0.3038
520 neuroeffectors. 1 0.7536
520 observations 1 0.3168
520 oxidized 1 0.6785
520 parasympathetic 1 0.7536
520 parent 1 0.5596
520 pharmacological 1 0.6346
520 preparation, 1 0.7536
520 preparations. 1 0.5596
520 products 2 1.0572
520 products, 1 0.7536
520 rate 1 0.2774
520 readily 1 0.485
520 rectus 1 0.7536
520 regarding 1 0.4764
520 relatively 2 0.725
520 respectively. 1 0.5159
520 responses 1 0.4202
520 seleno 1 0.6785
520 statements 1 0.7536
520 studies 1 0.2308
520 thio 1 0.6785
520 undergo 1 0.5596
521 (hela) 1 0.7536
521 (pisum 1 0.7536
521 3604. 1 0.7536
521 4 1 0.2666
521 acid 1 0.291
521 acids 1 0.3711
521 activities 2 0.8716
521 activity 1 0.2697
521 analogues, 1 0.7536
521 cells 4 0.9098
521 comparative 1 0.4611
521 compounds 2 1.086
521 compounds. 1 0.7536
521 cytotoxic 1 0.5286
521 cytotoxicity 1 0.7536
521 derivatives 2 1.1192
521 derivatives. 1 0.6785
521 equal. 1 0.7536
521 hela 2 1.0572
521 human 1 0.2515
521 organophosphorus 1 0.7536
521 parent 1 0.5596
521 phosphoric 1 0.7536
521 pisum 1 0.7536
521 progress. 1 0.6785
521 range 1 0.4066
521 root 1 0.6785
521 root) 1 0.7536
521 seleno 2 1.357
521 selenophosphoric 1 0.7536
521 studied, 1 0.5596
521 studies 1 0.2308
521 thio 2 1.357
521 thiophosphoric 1 0.7536
521 trimethyl 1 0.7536
521 vegetable 1 0.7536
521 whereas 1 0.3773
521 wider 1 0.6785
522 (different 1 1.0048
522 (in 1 0.7724
522 2 1 0.3068
522 3640. 1 1.0048
522 action 2 0.8744
522 action, 1 0.7462
522 alloxan. 1 0.9046
522 atrophic 1 0.9046
522 attempts 1 0.6466
522 causes 1 0.5669
522 chronic 1 0.4797
522 cirrhosis, 1 0.9046
522 definite 1 0.6879
522 demonstrate 1 0.5811
522 diabetogenic 1 0.8461
522 difference 1 0.5031
522 discussed 1 0.4092
522 dogs 1 0.5212
522 drinking 1 0.724
522 due 1 0.3554
522 effects 1 0.373
522 far 1 0.6466
522 given 1 0.3684
522 groups, 1 0.6728
522 hepatic 1 0.5669
522 inconclusive 1 0.9046
522 ineffective. 1 0.9046
522 injections 1 0.5669
522 latter 1 0.5212
522 liver 1 0.3953
522 na 1 0.6352
522 pancreas 2 1.448
522 perhaps 1 0.554
522 pointed 1 0.9046
522 poisoning 2 1.3758
522 practical 1 0.6466
522 rabbits 1 0.5738
522 rats. 1 0.5262
522 reasons). 1 1.0048
522 rendering 1 1.0048
522 replace 1 1.0048
522 resemble 1 0.7724
522 results. 1 0.7048
522 se 2 1.6091
522 seems 2 1.0626
522 selenite 3 2.1719
522 sh 1 0.9046
522 sodium 1 0.4833
522 spacing 1 1.0048
522 species 1 0.548
522 technique 1 0.4727
522 thus 1 0.5212
522 type, 1 0.6728
522 used 1 0.3795
522 usually 1 0.4727
522 water) 1 1.0048
523 -selenouracil 1 1.0048
523 -selenourea 1 1.0048
523 2552. 1 1.0048
523 adrenal 1 0.5969
523 analogues 1 0.8046
523 animal's 1 1.0048
523 appeared 1 0.4833
523 compound 1 0.6879
523 could 1 0.361
523 distribution 1 0.5165
523 high 1 0.3596
523 injected 1 0.4871
523 kidney. 1 0.6246
523 labelled 1 0.724
523 liver 1 0.3953
523 lung 1 0.4321
523 lung, 1 0.7724
523 lungs 1 0.548
523 man. 1 0.6466
523 neither 1 0.6591
523 photoscanning, 1 0.9046
523 poor, 1 1.0048
523 quality 1 0.7724
523 rabbits, 1 0.7724
523 radioactivity 1 0.724
523 recommended 1 0.6728
523 scanning 1 0.6728
523 se75 3 2.7139
523 selenium 1 0.6056
523 thiouracil 1 0.9046
523 thiourea 1 1.0048
523 tissue 1 0.3488
523 trial 1 0.7462
523 visualised 1 1.0048
524 1 1 0.3795
524 1142. 1 1.0048
524 30 2 0.9594
524 5 1 0.3811
524 alterations 1 0.554
524 atrophy 1 0.7462
524 centers 1 0.7048
524 changes 2 0.6013
524 changes, 1 0.8046
524 characterize 1 0.8046
524 common. 1 0.9046
524 congestion 1 1.0048
524 consistent 1 0.5603
524 consisting 1 0.8046
524 degeneration, 1 1.0048
524 degenerative 2 1.6091
524 died 1 0.5888
524 diffuse 1 0.6728
524 early 1 0.3684
524 edema 1 0.6879
524 ewes 1 1.0048
524 fed 1 0.6591
524 fibrosis. 1 1.0048
524 focal 1 0.7462
524 found 2 0.5291
524 gastrointestinal 1 0.724
524 hemorrhages, 1 0.9046
524 insufficiency. 1 0.9046
524 interstitial 1 0.6879
524 kidneys, 1 0.7724
524 left 1 0.4538
524 levels 1 0.3935
524 liver, 1 0.6879
524 lungs 1 0.548
524 lungs. 1 0.7724
524 lymph 1 0.6246
524 lymphoid 1 0.6466
524 mth. 1 0.5969
524 myocardial 1 0.7048
524 myocardium 1 0.7724
524 necrosis 1 0.6879
524 nodes 1 0.7724
524 occasionally 1 0.6728
524 passive 1 0.6879
524 pathogenesis 2 1.1337
524 pathologic 1 0.6148
524 pathology 1 0.6728
524 processes 1 0.5969
524 pulmonary 1 0.4296
524 replacement 1 0.6352
524 resulting 1 0.5119
524 selenate 3 2.4137
524 selenium 2 1.2111
524 seventeen 1 0.7724
524 severe 1 0.4452
524 sheep 1 0.724
524 sodium 3 1.45
524 spleen 1 0.5969
524 studied 1 0.3501
524 subtoxic 1 0.9046
524 toxic 1 0.6148
524 toxicosis 3 2.5382
524 toxicosis. 1 1.0048
524 tract. 1 0.7724
524 typical 1 0.6591
524 ventricular 1 0.4372
525 (in 1 0.5793
525 1 1 0.2846
525 1143. 1 0.7536
525 5 1 0.2859
525 adult 1 0.3426
525 body 2 0.6077
525 brain. 1 0.5793
525 concentration 1 0.3168
525 consumption. 1 0.7536
525 daily 1 0.411
525 descending 1 0.6346
525 distribution 2 0.7747
525 duration 1 0.3946
525 fed 1 0.4943
525 feeding 1 0.6034
525 followed 1 0.3449
525 highest 1 0.4764
525 kidneys, 1 0.5793
525 level 1 0.291
525 liver, 1 0.5159
525 lungs, 1 0.5793
525 mth. 1 0.4477
525 muscles, 1 0.6785
525 myocardium, 1 0.6785
525 order) 1 0.7536
525 prolonged 1 0.3625
525 quantities 2 1.0572
525 selenate 3 1.8103
525 selenium 4 1.8167
525 sheep 2 1.086
525 skeletal 1 0.5159
525 sodium 3 1.0875
525 spleen, 1 0.5046
525 subtoxic 1 0.6785
525 tissue 1 0.2616
525 tissues 1 0.3449
525 toxic 2 0.9221
525 toxicosis 1 0.6346
525 type 1 0.3134
525 varied 1 0.4764
525 within 1 0.2798
526 1172. 1 1.0048
526 biosynthesis 1 0.7462
526 cause 1 0.4538
526 chick 2 1.4096
526 chondroitin 2 2.0097
526 embryo 1 0.7048
526 embryos 2 1.4923
526 experiments. 1 0.8461
526 extent 2 1.0626
526 fourteen-day-old 1 1.0048
526 greater 1 0.4157
526 incorporation 2 1.2704
526 level 1 0.388
526 levels 1 0.3935
526 low 1 0.4398
526 metabolites 1 0.7724
526 metabolites. 1 1.0048
526 observed 1 0.3425
526 rather, 1 0.9046
526 received 1 0.5669
526 reduction 2 0.9897
526 selenite 1 0.724
526 selenite-se 1 0.9046
526 selenium 1 0.6056
526 selenium. 1 1.0048
526 significant. 1 0.7048
526 significantly 1 0.4225
526 studies 1 0.3077
526 sulfate 2 1.4096
526 sulfate-s 1 1.0048
526 taurine 3 3.0145
526 tissue 1 0.3488
526 toxic 1 0.6148
526 toxicity 1 0.6591
526 treatment 1 0.2965
526 used 1 0.3795
526 vivo 1 0.5969
527 843. 1 1.5073
527 acids 1 0.7423
527 act 1 0.9369
527 analogues 1 1.2069
527 antioxidant. 1 1.5073
527 biological 1 0.805
527 causes 1 0.8503
527 cystine 1 1.5073
527 decomposition; 1 1.5073
527 hydrogen 2 2.7139
527 hydroperoxides 1 1.5073
527 may 1 0.377
527 methionine 1 1.357
527 methionine, 1 1.5073
527 much 1 0.6678
527 organic 2 1.7907
527 peroxide 2 3.0145
527 peroxides 1 1.5073
527 peroxides. 1 1.5073
527 rapidly 1 0.8607
527 react 1 1.1586
527 reactions 2 1.4727
527 reacts 1 1.357
527 results 1 0.4316
527 selenium 1 0.9083
527 seleno- 1 1.5073
527 selenocystine 2 3.0145
527 slowly 1 1.0318
527 studied. 1 0.8503
527 suggest 1 0.6851
527 sulfoamino 1 1.5073
528 2127. 1 0.3768
528 40% 1 0.2715
528 active, 1 0.2798
528 agent, 1 0.2715
528 also 1 0.1054
528 analogs. 1 0.3768
528 and/or 1 0.2382
528 animals 1 0.1602
528 animals, 1 0.2271
528 animals. 1 0.2126
528 application 1 0.2126
528 arsenic 1 0.3768
528 article, 1 0.3392
528 available 2 0.411
528 benzene, 1 0.3768
528 bibliography, 1 0.3768
528 biologically 2 0.5596
528 bound 1 0.258
528 bromobenzene, 1 0.3768
528 cadmium, 1 0.3173
528 cases 1 0.1121
528 certain 1 0.1659
528 chromium, 1 0.3173
528 cobalt, 1 0.3392
528 compendium 1 0.3768
528 considerable 2 0.3909
528 designed 1 0.2715
528 digestion, 1 0.3768
528 disease 1 0.1354
528 dogs, 1 0.2523
528 domestic 3 0.9518
528 dose. 1 0.3017
528 doses 1 0.2055
528 elemental 1 0.3392
528 evidence 1 0.1381
528 excretion 1 0.1773
528 excretion. 1 0.2798
528 exposed 1 0.1973
528 extensive 1 0.2126
528 fecal 1 0.3392
528 fluorine, 1 0.3768
528 give 1 0.2055
528 given 1 0.1381
528 however, 1 0.1365
528 inactive 1 0.258
528 increase 1 0.128
528 information 1 0.2033
528 inorganic 1 0.258
528 it. 1 0.258
528 latitude 1 0.3768
528 literature 2 0.411
528 man 1 0.1937
528 may 1 0.0942
528 misuse 1 0.3768
528 mobilize 1 0.3392
528 molybdenum, 1 0.3768
528 much 1 0.167
528 must 1 0.1841
528 napthalene 1 0.3768
528 nickel 1 0.2179
528 nutritional 1 0.3173
528 oral 1 0.2305
528 orally 1 0.2897
528 organic 1 0.2238
528 organically 1 0.3768
528 poisoning 1 0.258
528 potentially 1 0.2798
528 preparations 1 0.2271
528 preparations. 1 0.2798
528 properly 1 0.3017
528 protection 1 0.2425
528 reduction 1 0.1856
528 regarded 1 0.2342
528 relatively 1 0.1813
528 reported 1 0.1527
528 result 1 0.163
528 reveals 1 0.3173
528 ruminal 1 0.3392
528 salts 2 0.5793
528 salts. 2 0.7536
528 se 8 2.4137
528 se, 1 0.3768
528 se; 1 0.3392
528 selenium 2 0.4542
528 selenium, 1 0.3173
528 since 1 0.1639
528 single 1 0.1871
528 skin 1 0.2238
528 stimulate 1 0.2643
528 such, 1 0.3392
528 therapeutic 2 0.3805
528 though 1 0.2208
528 tissue 1 0.1308
528 topical 1 0.3173
528 toxic 1 0.2305
528 toxic. 1 0.3392
528 toxicity 3 0.7415
528 toxicity. 1 0.3392
528 treatment 1 0.1112
528 tungsten 1 0.3768
528 uranium 1 0.3768
528 use 1 0.149
528 used, 1 0.2425
528 valuable 1 0.2425
528 vanadium, 1 0.3768
528 variation 1 0.2382
528 zinc, 1 0.3768
529 (rsv-sr), 1 0.3768
529 1845. 1 0.3768
529 8000 1 0.3768
529 9 1 0.1973
529 activity 1 0.1348
529 adult 2 0.3426
529 allograft 2 0.7536
529 allografted 1 0.3768
529 allografting 1 0.3768
529 also 1 0.1054
529 antigen(s) 2 0.6785
529 antigen(s). 1 0.3768
529 antigens 1 0.2179
529 cell-free 1 0.3017
529 cells 1 0.1137
529 chicken 2 0.6785
529 clear 1 0.2271
529 coma 1 0.3768
529 common, 1 0.3392
529 containing 1 0.1992
529 could 3 0.4061
529 cut 1 0.3392
529 demon- 1 0.3017
529 demonstrable 2 0.5046
529 demonstrate 1 0.2179
529 demonstrated 1 0.1611
529 different 3 0.3999
529 extracts, 1 0.3392
529 fic 1 0.3768
529 gave 1 0.2382
529 identity 1 0.2897
529 induced 3 0.4806
529 ing 1 0.2033
529 inoculation 2 0.5046
529 isograft- 1 0.3768
529 isografting 2 0.7536
529 mice 5 0.9278
529 mors. 1 0.3768
529 mouse 2 0.4202
529 neither 1 0.2472
529 non-viral 1 0.3768
529 polyoma 2 0.6785
529 presence 1 0.1436
529 pretreatment 2 0.543
529 r 1 0.2472
529 resistance 5 1.0505
529 results 1 0.1079
529 rous 8 2.7139
529 rsv-sr 1 0.3768
529 sar- 1 0.3392
529 sarcoma 3 0.7739
529 sarcomas 1 0.3392
529 sarcomas, 1 0.3768
529 sarcomas. 2 0.7536
529 schmidt-ruppin 1 0.3768
529 sera. 1 0.3392
529 showed 1 0.1343
529 speak 1 0.3017
529 speci- 1 0.3768
529 specific 1 0.1483
529 strated 1 0.3392
529 studies 1 0.1154
529 subsequent 1 0.2055
529 suspension 1 0.2715
529 transplantation 5 1.2358
529 tu- 1 0.3173
529 tumor 2 0.336
529 tumors 3 0.592
529 tumors. 1 0.2472
529 variant 1 0.2897
529 various 1 0.149
529 viral 1 0.2271
529 virus 2 0.3946
529 virus-neutralizing 1 0.3768
529 virus. 1 0.2715
529 x-irradiated 1 0.2897
530 'tumor' 1 0.9046
530 (absolute 2 2.0097
530 (byg) 1 1.0048
530 1/50 1 1.0048
530 1/6 1 1.0048
530 10-2. 1 1.0048
530 10-3 1 1.0048
530 10-4. 1 1.0048
530 100 1 0.5669
530 1846. 1 1.0048
530 50 1 0.4797
530 acting 1 0.8461
530 anaphylactic 3 3.0145
530 antigen 3 1.7907
530 antigen. 1 0.7462
530 approximately 1 0.5262
530 bovine 1 0.5738
530 byg 2 2.0097
530 cancer 1 0.3972
530 capacity. 1 0.7724
530 carried 1 0.5031
530 challeng- 1 1.0048
530 challenge, 1 0.9046
530 concentra- 1 0.724
530 concentration 2 0.8449
530 concluded 1 0.4598
530 context 1 0.8461
530 detected 3 1.5637
530 detecting 1 0.8461
530 discriminatory 1 0.9046
530 dosage 2 1.2111
530 efficacy 1 0.8046
530 even 1 0.4398
530 formed 2 1.1206
530 found 1 0.2645
530 gated. 1 1.0048
530 high 1 0.3596
530 infrequently 1 0.8461
530 ing 1 0.5422
530 invariably 1 0.9046
530 investi- 1 1.0048
530 investigations 1 0.6246
530 mix- 1 1.0048
530 mixture, 1 1.0048
530 mock 1 1.0048
530 model 2 1.4096
530 present 2 0.6617
530 rat 2 0.827
530 readily 1 0.6466
530 sensitivity 1 0.6056
530 sensitization 1 0.6728
530 sensitizing 1 1.0048
530 serum 3 1.1695
530 serum, 1 0.7724
530 simple 1 0.548
530 study 1 0.3096
530 tests 3 1.4845
530 tion 1 0.4568
530 tissue 1 0.3488
530 tumor-antigen 1 1.0048
530 tumour 1 0.6246
530 ture 1 0.8461
530 ug.) 2 2.0097
530 used 3 1.1384
530 using 1 0.4568
530 y-globulin 1 0.9046
531 1066. 1 1.5073
531 3:4-benzpyrene 1 1.5073
531 action 1 0.6558
531 antigens 1 0.8716
531 autochthonous 1 1.357
531 believed 1 1.1192
531 cells 2 0.9098
531 duct 1 1.0318
531 effect 1 0.4602
531 efferent 1 1.5073
531 fibrosarcomata 1 1.5073
531 growth 2 1.0275
531 heterologous 1 1.1586
531 host 1 0.7819
531 immune 1 0.97
531 immunised 1 1.5073
531 immunization 1 1.2069
531 immunized 1 1.086
531 induced 1 0.6408
531 injection 1 0.6302
531 involved. 1 1.1586
531 lym- 1 1.2691
531 lymph 2 1.8738
531 lymphocytes 2 1.7663
531 lymphoid 1 0.97
531 may 1 0.377
531 medium-sized 1 1.5073
531 node 1 1.1586
531 obtained 1 0.5373
531 particular 1 0.7611
531 phocytes 1 1.357
531 piece 1 1.5073
531 primary 2 1.2744
531 pyroninophilic 1 1.357
531 rats 2 1.1641
531 react 1 1.1586
531 reaction 1 0.7546
531 responsible 1 0.7611
531 retarded 1 0.97
531 sarcomata 1 1.5073
531 sheep 2 2.1719
531 specific 2 1.186
531 specifically 1 1.1192
531 stimulate 1 1.0572
531 suggesting 1 0.9221
531 system 1 0.7041
531 treated. 1 1.2069
531 tumor 2 1.344
531 tumor- 1 1.5073
531 tumor. 1 1.2069
531 used 1 0.5692
532 22% 1 0.9046
532 2570. 1 1.0048
532 78% 1 1.0048
532 also 1 0.2811
532 alters 1 0.9046
532 another 1 0.548
532 antigenic 1 0.5888
532 antigens 1 0.5811
532 autogenous 1 0.8461
532 canine 1 0.8461
532 carcinoma 2 0.9594
532 cases. 1 0.5262
532 complete 1 0.4661
532 controls. 1 0.6591
532 cortisone-treated 1 1.0048
532 cular 1 0.9046
532 dog 1 0.6246
532 double 1 0.6591
532 effective 1 0.5031
532 followed 1 0.4598
532 foreign 1 0.8046
532 grown 1 0.6879
532 growth 2 0.685
532 host 1 0.5212
532 host. 1 0.8046
532 im- 1 0.724
532 implants 1 0.9046
532 inbred 1 0.8046
532 lesions. 1 0.6879
532 life 1 0.5313
532 lymphosarcoma 1 0.9046
532 making 1 0.7724
532 mammary 1 0.6466
532 mice 3 1.4845
532 mice. 1 0.6352
532 mole- 1 1.0048
532 neoplasm 1 0.9046
532 neoplasm, 1 0.8046
532 neoplasms 2 1.4923
532 normally 1 0.6352
532 noted 1 0.5313
532 one 1 0.2811
532 original 2 1.1476
532 plants 1 1.0048
532 preparations 1 0.6056
532 produced 1 0.4092
532 regression 2 1.2933
532 resistant 1 0.6148
532 returned 1 0.724
532 sarcoma 1 0.6879
532 scirrhous 1 1.0048
532 spans 1 1.0048
532 spontaneous 2 1.1622
532 strains 1 0.5969
532 structure 1 0.5119
532 suggested 1 0.4179
532 transplantable 2 1.6922
532 treated 3 1.2405
532 treatment 1 0.2965
532 tumours 3 1.9056
532 tumours. 1 0.9046
532 untreated 1 0.7462
532 vaccinial 1 1.0048
533 (1960), 1 0.3768
533 (20 2 0.6785
533 ) 2 0.543
533 10-7 1 0.3768
533 14s 1 0.3768
533 14s, 1 0.3768
533 17 1 0.2238
533 3.2 1 0.3768
533 40,000. 1 0.3768
533 420,000 1 0.3768
533 4s. 1 0.3768
533 744. 1 0.3768
533 ability 1 0.1919
533 acid 2 0.291
533 addition 1 0.1919
533 affected 1 0.1955
533 agglutinate 1 0.3768
533 allison 1 0.3768
533 anti- 1 0.2643
533 antigen 8 1.7907
533 antigen, 2 0.543
533 antigen. 1 0.2798
533 antiserum, 1 0.3392
533 approx. 2 0.5793
533 ascites-tumor 1 0.3768
533 ascites-tumour 1 0.3768
533 assay, 1 0.3768
533 based 1 0.1973
533 basic 1 0.258
533 block 1 0.2715
533 by-product 1 0.3768
533 capsid 2 0.7536
533 capsid- 1 0.3768
533 capsid-protein 1 0.3768
533 cell 1 0.1275
533 cell, 1 0.2897
533 cells 3 0.3412
533 cells. 3 0.504
533 cm. 1 0.3173
533 co- 1 0.3173
533 coefficient 2 0.6034
533 concentrat- 1 0.3768
533 concluded 1 0.1724
533 contain, 1 0.3768
533 contrast 1 0.2523
533 could 1 0.1354
533 cul- 1 0.3392
533 cytoplasm 1 0.2342
533 degraded 1 0.3173
533 destroyed 1 0.2523
533 detected 2 0.3909
533 determined 1 0.1713
533 developed. 1 0.3017
533 diffusion 1 0.2523
533 digestion 1 0.3017
533 ed 1 0.258
533 efficient, 1 0.3392
533 either 1 0.1611
533 ence- 1 0.3768
533 encephalomyocarditis 2 0.7536
533 erythrocytes, 1 0.3017
533 ethanolamine 1 0.3768
533 fected 1 0.3173
533 fluid 1 0.1786
533 form 1 0.1639
533 formation 1 0.1691
533 found 1 0.0992
533 gen 1 0.3173
533 hence 1 0.3392
533 however, 1 0.1365
533 hr. 1 0.2179
533 humphrey 1 0.3768
533 ii 2 0.5046
533 immunological 1 0.2342
533 increased 1 0.1171
533 infected 3 0.6164
533 infection 1 0.1773
533 intermediate 1 0.2425
533 intracellularly, 1 0.3768
533 krebs 2 0.7536
533 localized 1 0.2643
533 mammalian 1 0.258
533 mature 1 0.2342
533 may 1 0.0942
533 ment 1 0.2472
533 metabolism 1 0.1786
533 method 1 0.1497
533 molecule 1 0.2643
533 mostly 1 0.2643
533 mouse 1 0.2101
533 neutralization 1 0.3173
533 non-hemagglutinating 1 0.3768
533 nucleic 1 0.2472
533 particle 1 0.2897
533 phalomyocarditis 1 0.3768
533 polymeric 1 0.3768
533 preparations 1 0.2271
533 present 1 0.1241
533 process 1 0.1724
533 properties 1 0.2012
533 protein 7 1.199
533 purified 2 0.4764
533 represents 1 0.258
533 ribonuclease. 1 0.3768
533 ribonucleic 1 0.2643
533 sap. 1 0.3768
533 sec.-1. 1 0.3768
533 sedimentation 2 0.543
533 sheep 1 0.2715
533 similar 1 0.1411
533 similarly 1 0.3017
533 size. 1 0.2798
533 smaller 1 0.2715
533 soluble 1 0.2238
533 specific 1 0.1483
533 sq. 1 0.3768
533 studies 1 0.1154
533 syn- 1 0.3173
533 synthesized 1 0.3173
533 synthesized. 1 0.3768
533 thesis. 1 0.3768
533 time 1 0.1328
533 titer 2 0.5596
533 treat- 1 0.2342
533 treated, 1 0.3768
533 trypsin. 1 0.3173
533 ture 1 0.3173
533 viral 3 0.6812
533 virus 5 0.9866
533 virus, 2 0.6346
533 virus-in- 1 0.3768
533 virus-infected 1 0.3768
533 virus-specific 2 0.6785
533 weight 1 0.1773
533 within 1 0.1399
533 x 1 0.2382
533 yielded 1 0.2382
534 'tumor' 1 0.6785
534 1368. 1 0.7536
534 3 1 0.2569
534 3-day 1 0.7536
534 30 2 0.7196
534 adult 1 0.3426
534 age 3 0.9353
534 also 2 0.4217
534 animal. 1 0.5793
534 antibodies 1 0.4252
534 antigens 1 0.4358
534 associated 1 0.2676
534 birth 1 0.3839
534 c57bl 1 0.6034
534 capacity 1 0.411
534 cells, 1 0.3653
534 chambers 1 0.5793
534 competence 1 0.6785
534 concept 1 0.4542
534 curves 1 0.4685
534 days 3 0.8981
534 deficient 1 0.485
534 deter- 1 0.6785
534 diffusion 1 0.5046
534 discussed 1 0.3069
534 effective 1 0.3773
534 extended 1 0.5793
534 f1 1 0.6034
534 following 1 0.2498
534 found 1 0.1984
534 frequency 1 0.3946
534 glands 1 0.485
534 grafts. 1 0.6785
534 groups. 1 0.4477
534 growth 1 0.2569
534 hemagglutination-inhibition 1 0.7536
534 highly 1 0.4066
534 hybrid 1 0.5793
534 immunologic 2 0.9887
534 immunologically 1 0.6034
534 inbred 1 0.6034
534 increased 1 0.2343
534 induction 1 0.485
534 induction: 1 0.7536
534 infection 2 0.7091
534 intact 1 0.4155
534 involving 1 0.485
534 kidney, 1 0.4943
534 least 1 0.3874
534 litter 1 0.6785
534 liver 1 0.2965
534 mates. 1 0.7536
534 methods 1 0.3403
534 mice 1 0.3711
534 mice. 2 0.9528
534 millipore 1 0.7536
534 mined 1 0.7536
534 neonates 1 0.6785
534 neoplasms 2 1.1192
534 nonetheless 1 0.7536
534 periodically 1 0.6346
534 polyoma 4 2.7139
534 quite 1 0.4303
534 resist 1 0.7536
534 resistant 1 0.4611
534 restore 1 0.6346
534 restoring 1 0.7536
534 resulted 1 0.3653
534 results 1 0.2158
534 salivary 1 0.6785
534 several 1 0.326
534 similar 2 0.5643
534 spleen 1 0.4477
534 status 1 0.4764
534 stigmata 1 0.7536
534 strains 1 0.4477
534 strikingly 1 0.6785
534 susceptibility 1 0.5793
534 syngeneic 2 1.1586
534 terms 1 0.4611
534 thymectomized 3 2.0354
534 thymectomy 2 1.2691
534 thymus 2 1.086
534 tissue 1 0.2616
534 tumor 1 0.336
534 used 1 0.2846
534 usual 1 0.5596
534 virus 3 1.1839
534 virus-specific 1 0.6785
534 virus. 1 0.543
535 1848. 1 0.9046
535 250 1 0.8046
535 320 1 0.9046
535 a2- 1 1.0048
535 abnormal 2 0.9741
535 almost 1 0.5165
535 analy- 1 1.0048
535 analysis 1 0.4833
535 antigen 2 1.1938
535 antigens 3 1.7433
535 b1-globulin 1 1.0048
535 b2-globulin 1 1.0048
535 cancer 1 0.3972
535 carcinoma. 1 0.6879
535 cases 3 0.8969
535 characteristic 1 0.5074
535 classification 1 0.7724
535 controls. 1 0.6591
535 could 2 0.722
535 decreased 1 0.4538
535 demonstrated 2 0.8592
535 dif- 1 0.7462
535 differed 1 0.6879
535 disappeared 1 0.724
535 distribution 1 0.5165
535 ferentiated 1 1.0048
535 formed 1 0.5603
535 fractions. 1 1.0048
535 growth 1 0.3425
535 histopathological 1 0.8046
535 however, 1 0.3639
535 immunodiffusion 1 0.8046
535 immunoelectrophoresis 2 1.6922
535 increased 1 0.3124
535 individual 1 0.5313
535 leukemia, 1 1.0048
535 line 1 0.6056
535 lines 1 0.5811
535 lymph- 1 1.0048
535 malignant 2 1.0959
535 markedly 1 0.5366
535 method 1 0.3992
535 methods 1 0.4538
535 myeloma, 1 0.9046
535 non-tumorous 1 1.0048
535 normal 2 0.5404
535 oma 1 1.0048
535 one 1 0.2811
535 ouchterlony's 1 1.0048
535 parallel 1 0.6466
535 patients 2 0.4831
535 patients; 1 0.7462
535 patterns 1 0.6352
535 precipitin 1 0.7724
535 region 1 0.6728
535 related 1 0.4248
535 removal 1 0.5603
535 sera 3 1.9773
535 sera. 1 0.9046
535 served 1 0.6591
535 showed 1 0.3582
535 sis 1 0.7724
535 site 1 0.5811
535 surgical 1 0.4538
535 tissue. 1 0.6466
535 tumor 1 0.448
535 tumors 2 1.0524
535 tumors. 1 0.6591
535 used 1 0.3795
536 1) 1 0.2155
536 2) 1 0.2293
536 2354. 1 0.3349
536 3 1 0.1142
536 30 1 0.1599
536 4 1 0.1185
536 absorption 1 0.2082
536 adult 1 0.1523
536 another. 1 0.3349
536 antigens. 1 0.2682
536 appeared 1 0.1611
536 back-transfer 1 0.3349
536 barriers 2 0.6031
536 better 2 0.3874
536 capable 1 0.2049
536 cells. 1 0.1493
536 changes 1 0.1002
536 character 3 0.7048
536 characterized 1 0.1771
536 compared 1 0.1299
536 comparison 1 0.1737
536 concentration 3 0.4225
536 conversion 1 0.2413
536 could 1 0.1203
536 days. 1 0.189
536 derived 1 0.1847
536 detected 1 0.1737
536 determinants 1 0.2682
536 develop 1 0.2019
536 difference 2 0.3354
536 different 2 0.237
536 directed 1 0.2243
536 environment 1 0.2243
536 established, 1 0.3015
536 exposure 1 0.199
536 expressed 1 0.2413
536 expression 1 0.2413
536 f1 2 0.5364
536 fashion. 1 0.282
536 foreign 3 0.8046
536 found 1 0.0882
536 generations, 1 0.3349
536 genotype. 1 0.3015
536 genotype; 1 0.3349
536 grew 2 0.4485
536 growth 3 0.3425
536 h-2 7 2.1108
536 histocompatibility 2 0.6031
536 homograft 1 0.282
536 homozygous 2 0.5149
536 host 2 0.3475
536 hosts 2 0.5641
536 however, 1 0.1213
536 however. 1 0.3349
536 hybrids, 1 0.3349
536 hybrids. 1 0.3015
536 immunoselection 1 0.3349
536 incompa- 1 0.3349
536 incompatible 1 0.3349
536 induced 1 0.1424
536 isoantigenic 2 0.6699
536 isoantigens 1 0.3015
536 isoantisera 1 0.3349
536 line 1 0.2019
536 lines 1 0.1937
536 lower 1 0.1523
536 lowered 1 0.2487
536 made 1 0.1213
536 newborn 1 0.1827
536 nonspecific 9 2.1719
536 number 1 0.1282
536 occurred 1 0.1457
536 one 1 0.0937
536 origin 1 0.1913
536 origin. 1 0.2243
536 origin; 1 0.3349
536 original 1 0.1913
536 passage 3 0.6591
536 passages 1 0.2487
536 permanently 1 0.3015
536 pretreated 1 0.3015
536 procedures 1 0.189
536 proceed 1 0.3015
536 prolonged 1 0.1611
536 properties 1 0.1789
536 quantitative 1 0.1771
536 rate 1 0.1233
536 reaction 1 0.1677
536 recipients 1 0.2682
536 recipients. 1 0.3015
536 required 1 0.1827
536 resistant 1 0.2049
536 responsible 1 0.1691
536 result 1 0.1449
536 reversion 1 0.3349
536 reverted 1 0.3015
536 semi-isologous 1 0.3349
536 specific 1 0.1318
536 stage 1 0.1624
536 stepwise 1 0.282
536 strain 4 0.7084
536 strain- 1 0.3349
536 strain-specific 5 1.6747
536 strictly 1 0.3015
536 sublines 5 1.341
536 subsequent 1 0.1827
536 suggests 1 0.1789
536 surface 1 0.1807
536 system 1 0.1565
536 technique 1 0.1576
536 tible 1 0.3015
536 transfer 1 0.2155
536 transgressing 2 0.6699
536 tumor 1 0.1493
536 tumor, 1 0.2575
536 tumors 5 0.877
536 tumors. 1 0.2197
536 usually 1 0.1576
536 variants 1 0.3349
536 vitro. 1 0.2243
537 (y-1m) 1 0.7536
537 (y-2) 1 0.7536
537 19s 4 3.0145
537 2371. 1 0.7536
537 4s 1 0.7536
537 7s 3 2.2609
537 7s. 1 0.7536
537 active 1 0.3472
537 active, 1 0.5596
537 activity 3 0.8091
537 always 1 0.4025
537 anti- 1 0.5286
537 antibodies 1 0.4252
537 components 1 0.4303
537 contained 1 0.3839
537 detected 1 0.3909
537 dose 2 0.7196
537 enhanced 1 0.4685
537 enhancement 2 1.357
537 enhancing 1 0.6346
537 factors 1 0.3186
537 former. 1 0.6785
537 found 1 0.1984
537 fraction 3 1.2074
537 fraction, 1 0.6785
537 fraction. 1 0.7536
537 fractions 1 0.4025
537 given 2 0.5526
537 graft, 2 1.5073
537 growth 1 0.2569
537 higher 2 0.6481
537 immunoglobulin 1 0.6346
537 induced 1 0.3204
537 influenced 1 0.4685
537 interaction 1 0.4611
537 methylcholanthrene- 1 0.7536
537 methylcholanthrene-induced 1 0.6785
537 mice 1 0.3711
537 organism 1 0.5046
537 part 1 0.352
537 participation 1 0.6346
537 present 1 0.2481
537 producing 1 0.485
537 resistance 3 1.2606
537 responsible 1 0.3805
537 sera 2 0.9887
537 serum 4 1.1695
537 specific 1 0.2965
537 studied. 1 0.4252
537 syngeneic 1 0.5793
537 system 1 0.352
537 system. 1 0.5286
537 tumor 4 1.344
537 tumors 1 0.3946
537 tumours 1 0.4764
538 1 1 0.2846
538 2372. 1 0.7536
538 antigen. 1 0.5596
538 becomes 1 0.4542
538 benzpyrene 1 0.7536
538 bp 1 0.7536
538 c57bl 1 0.6034
538 containing 1 0.3985
538 contains 1 0.4611
538 content 1 0.3546
538 decreased. 1 0.6785
538 directed 1 0.5046
538 effect 1 0.2301
538 graft 1 0.6346
538 growth 1 0.2569
538 however, 1 0.2729
538 immunity 3 1.629
538 induced 1 0.3204
538 lost 1 0.6346
538 male 1 0.3839
538 mice 1 0.3711
538 resistant 1 0.4611
538 sex-antigen 4 3.0145
538 sex-antigen. 1 0.7536
538 tumor 2 0.672
538 tumor, 1 0.5793
538 tumour 1 0.4685
539 2373. 1 0.6029
539 3-5 1 0.6029
539 6th 1 0.4827
539 active 1 0.2778
539 adoptive 1 0.6029
539 analysis 1 0.29
539 cells 2 0.3639
539 demonstrated 1 0.2578
539 detected 1 0.3127
539 detection 1 0.3748
539 development 1 0.2201
539 doses 1 0.3288
539 enhancement 5 2.7139
539 factors 1 0.2549
539 found 1 0.1587
539 geneic 1 0.6029
539 growth 1 0.2055
539 immunological 2 0.7495
539 induction 1 0.388
539 influencing 1 0.4477
539 irradiated 1 0.3487
539 lymph 1 0.3748
539 means 1 0.2671
539 methylcholanthrene-induced 2 1.0856
539 mice. 2 0.7622
539 mors 1 0.6029
539 node 1 0.4634
539 passive 1 0.4127
539 phenomena. 1 0.6029
539 preimmunization 1 0.6029
539 preimmunized 1 0.6029
539 re- 1 0.2671
539 resistance 3 1.0085
539 satisfactory 1 0.3955
539 serum 1 0.2339
539 showed 1 0.2149
539 sistance 1 0.5076
539 succeeded 1 0.5076
539 suspension 1 0.4344
539 syn- 1 0.5076
539 syngeneic 1 0.4634
539 system 2 0.5633
539 system. 1 0.4229
539 threshold 1 0.5076
539 transfer 1 0.388
539 transferred 1 0.4634
539 true 1 0.4037
539 tu- 1 0.5076
539 tumor 2 0.5376
539 tumor. 1 0.4827
539 tumours 1 0.3811
539 wk. 2 1.2058
540 31 1 0.3731
540 5512. 1 0.5024
540 ab- 1 0.423
540 absorptions, 1 0.5024
540 addition, 1 0.2905
540 agar 1 0.3524
540 antigen 1 0.2985
540 antigenic 2 0.5888
540 antigens 2 0.5811
540 antigens. 2 0.8046
540 antisera 1 0.3862
540 antisera, 2 0.9046
540 attempts 1 0.3233
540 cancerous 1 0.423
540 carried 1 0.2515
540 cells. 1 0.224
540 characterize 1 0.4023
540 detectable 1 0.3176
540 different 1 0.1777
540 diffusion 1 0.3364
540 double 1 0.3296
540 extracts 1 0.3074
540 foetal 1 0.362
540 gel 1 0.2905
540 hela 1 0.3524
540 heterologous 1 0.3862
540 human 3 0.5031
540 isolate 1 0.423
540 loss 1 0.2435
540 made 1 0.182
540 malignant 1 0.274
540 means 1 0.2226
540 normal 6 0.8106
540 number 1 0.1923
540 obtained 1 0.1791
540 ouchterlony 1 0.4523
540 preliminary 1 0.2869
540 prepared 1 0.3028
540 presence 1 0.1914
540 properties 2 0.5366
540 rabbits, 1 0.3862
540 reacted 2 0.8046
540 repeated 1 0.2985
540 results 1 0.1439
540 seventy-two 1 0.4523
540 showed 1 0.1791
540 sorption 1 0.5024
540 studied 1 0.175
540 studies 1 0.1539
540 technique. 1 0.3862
540 tissue 4 0.6976
540 tissues, 3 1.0572
540 tissues. 1 0.3296
540 tumour 2 0.6246
540 tumours 3 0.9528
540 tumours. 2 0.9046
540 using 1 0.2284
541 5514. 1 0.3349
541 7 3 0.4629
541 7, 1 0.2682
541 ability 1 0.1706
541 adenovirus 4 1.1281
541 anti-sv40 1 0.3349
541 antibody 1 0.2049
541 antigen 4 0.7959
541 antigen, 1 0.2413
541 antigen. 1 0.2487
541 antiserum 1 0.2243
541 appeared 1 0.1611
541 bearing 1 0.2682
541 cell 3 0.3401
541 cells 2 0.2022
541 contained 1 0.1706
541 culture. 1 0.282
541 cultures 1 0.1677
541 cultures. 1 0.2413
541 cytopathic 1 0.2487
541 daughter 1 0.3015
541 demonstrable 1 0.2243
541 detectable 1 0.2117
541 effect 1 0.1023
541 embryo 2 0.4699
541 entirely 1 0.2155
541 exclusively 1 0.2575
541 fluorescent 1 0.2575
541 free 1 0.1587
541 genetic 1 0.1754
541 green 2 0.6031
541 hamster 1 0.2413
541 hamsters 1 0.2682
541 human 3 0.3354
541 incorporation 1 0.2117
541 induce 1 0.2243
541 induced 1 0.1424
541 inducing 1 0.2413
541 infectious 1 0.2575
541 intranuclear 1 0.2682
541 key 1 0.2682
541 kidney 1 0.1484
541 kidney, 2 0.4394
541 l.l. 2 0.6699
541 localised 1 0.3015
541 material 1 0.1554
541 measured 1 0.1466
541 mitosis. 1 0.3015
541 mon- 1 0.3349
541 monkey 2 0.4485
541 neutralized 1 0.3015
541 not. 1 0.2682
541 nuclei 1 0.2117
541 preparation 1 0.2155
541 propagated 1 0.3015
541 rabbit 1 0.189
541 serum 2 0.2599
541 staining, 1 0.3349
541 strain 2 0.3542
541 sv40 9 2.7139
541 synthesis 1 0.1663
541 tissue 1 0.1163
541 transmitted 1 0.2682
541 tumor 1 0.1493
541 tumour 6 1.2492
541 types 1 0.1624
541 viral 1 0.2019
541 virus 1 0.1754
541 virus, 1 0.282
541 within 1 0.1243
542 (to 1 0.6029
542 1/128) 1 0.6029
542 10 1 0.2219
542 264. 1 0.6029
542 95% 1 0.5076
542 absorption 1 0.3748
542 actions 1 0.388
542 adenocarcinoma 2 0.8255
542 adjacent 1 0.4344
542 agar-gel 1 0.6029
542 animals 1 0.2563
542 antibodies 5 1.7006
542 antibody 1 0.3689
542 antigens 3 1.046
542 appearing 3 1.3431
542 bled 1 0.5428
542 bodies 1 0.3689
542 cancer 1 0.2383
542 cancer-specific 5 3.0145
542 cancerous 4 2.0306
542 cancers 1 0.4037
542 cancers. 1 0.6029
542 carcinoma 3 0.8635
542 case 1 0.2166
542 cell 1 0.204
542 cells. 1 0.2688
542 certain 1 0.2655
542 change 1 0.2797
542 chronic 1 0.2878
542 colitis. 1 0.5076
542 colon 4 1.8538
542 colon, 3 1.8087
542 concentration 1 0.2535
542 could 1 0.2166
542 cross 2 0.9655
542 days 1 0.2395
542 death 1 0.3288
542 demonstrated 1 0.2578
542 dependent 1 0.388
542 destroyed 1 0.4037
542 detection 1 0.3748
542 dna 1 0.2878
542 dna- 1 0.6029
542 dna-bound 2 1.2058
542 dnase 1 0.5076
542 double-diffusion 1 0.6029
542 early 1 0.221
542 evidence 1 0.221
542 ewing's 2 1.2058
542 finding 1 0.3689
542 fluorescent 2 0.9269
542 formation 1 0.2705
542 fta 2 1.2058
542 gave 1 0.3811
542 globulins 1 0.5076
542 homogenates 1 0.4477
542 horizontal 1 0.4827
542 human 3 0.6037
542 identical 1 0.3581
542 identified 1 0.3533
542 immune 1 0.388
542 immunized. 1 0.6029
542 included 1 0.3253
542 induced 1 0.2563
542 injection. 1 0.4344
542 intranuclear 1 0.4827
542 isolation. 1 0.6029
542 last 1 0.4037
542 latent 1 0.5076
542 liver 1 0.2372
542 long-standing 1 0.5076
542 mal 1 0.4037
542 male 1 0.3071
542 maximum 1 0.3324
542 may 1 0.1508
542 metastatic 2 0.776
542 methods 1 0.2723
542 morphologically 1 0.5076
542 near 2 0.7267
542 nor- 1 0.388
542 normal 3 0.4864
542 nuclear 3 1.046
542 nuclei 1 0.3811
542 obtained 1 0.2149
542 parenchyma 1 0.4344
542 pattern 1 0.2878
542 positive 1 0.322
542 possibly 1 0.3748
542 precipitin 1 0.4634
542 prepared 1 0.3633
542 proteins 4 1.251
542 rabbits 1 0.3443
542 rather 1 0.2836
542 re- 1 0.2671
542 reacting 1 0.5076
542 reaction 1 0.3018
542 reactions 1 0.2945
542 removed 1 0.3401
542 represent 1 0.3811
542 rounded, 1 0.6029
542 salt 1 0.388
542 salt-soluble 1 0.6029
542 sarcoma 1 0.4127
542 sarcoma. 1 0.5428
542 seem 1 0.3288
542 seems 1 0.3188
542 serological 1 0.4477
542 showed 1 0.2149
542 shown 1 0.2593
542 similar 1 0.2257
542 source 1 0.4037
542 specific 2 0.4744
542 specifically 1 0.4477
542 structure. 1 0.4827
542 studied. 1 0.3401
542 study 1 0.1857
542 test. 1 0.3955
542 testing 1 0.4229
542 tissues 1 0.2759
542 tissues. 1 0.3955
542 titer 1 0.4477
542 trypsin. 1 0.5076
542 ulcerative 1 0.4827
542 upon 1 0.2705
542 used 1 0.2277
542 various 1 0.2383
543 266. 1 1.0048
543 achievement 1 0.9046
543 although 1 0.3863
543 anti- 1 0.7048
543 antigenic 1 0.5888
543 antigens 2 1.1622
543 antigens. 1 0.8046
543 application 1 0.5669
543 approach 1 0.6246
543 arise 1 0.8046
543 author 1 0.5888
543 bility 1 0.9046
543 broad 1 0.8046
543 cancer 2 0.7945
543 cancer, 1 0.6352
543 carcino- 1 1.0048
543 carcinogenesis 1 0.8461
543 carcinogenesis, 1 1.0048
543 cell 1 0.3401
543 cell: 1 1.0048
543 cells 2 0.6065
543 cellular 1 0.548
543 chemical, 1 1.0048
543 con- 1 0.5212
543 consideration 1 0.6591
543 considered 1 0.448
543 course 1 0.4568
543 current 1 0.6246
543 deletion 1 0.8461
543 deletion. 1 1.0048
543 demonstrating 1 0.7724
543 develops. 1 0.9046
543 differentiation. 1 0.9046
543 disciplines 1 0.8461
543 discover 1 0.8046
543 emphasizes, 1 1.0048
543 enzymatic 1 0.7724
543 event 1 0.8461
543 evidence 3 1.1051
543 existence 1 0.6148
543 experiments 1 0.4452
543 field 1 0.5969
543 finally 1 0.6879
543 gain 1 0.724
543 generally 1 0.5969
543 genesis 1 0.7724
543 gens, 1 0.9046
543 given 2 0.7367
543 gression 1 0.9046
543 historical 1 0.8461
543 holistic 1 1.0048
543 host 1 0.5212
543 hypothesis 1 0.5366
543 immunological 3 1.8738
543 immunology 2 2.0097
543 integra- 1 1.0048
543 intensification 1 1.0048
543 junction 1 0.8461
543 key 1 0.8046
543 limited, 1 0.9046
543 made 1 0.3639
543 malignant 1 0.548
543 methods 1 0.4538
543 might 2 1.0524
543 missing 1 1.0048
543 new 1 0.4398
543 normal 1 0.2702
543 occasional 1 0.724
543 picture. 1 0.8461
543 plea 1 0.8461
543 points 1 0.6879
543 posed: 1 1.0048
543 present 1 0.3308
543 prospect 1 0.8461
543 question 1 0.7462
543 raised 1 0.5969
543 rarity 1 0.8461
543 re- 1 0.4452
543 re-differentiation 1 1.0048
543 re-recognition. 1 1.0048
543 rejection 1 0.7724
543 resistance 1 0.5603
543 review 1 0.554
543 reviewed, 1 0.8461
543 scanty? 1 1.0048
543 showing 1 0.6591
543 specific 1 0.3953
543 spontaneous 1 0.5811
543 spontaneous, 1 1.0048
543 stratagems 1 1.0048
543 studies 1 0.3077
543 suggests 1 0.5366
543 survey 1 0.7048
543 suscepti- 1 1.0048
543 synthetic 1 0.7462
543 therapy 1 0.3972
543 tion 1 0.4568
543 tissue. 1 0.6466
543 together 1 0.5738
543 tolerance 1 0.6466
543 transform 1 0.9046
543 tumour-specific 2 2.0097
543 tumours 1 0.6352
543 view, 1 0.9046
543 viral 1 0.6056
543 yet 1 0.5313
544 : 1 1.0048
544 altered 1 0.5366
544 analogous 1 0.8046
544 arrest 2 1.448
544 arrest, 1 1.0048
544 atrophy 1 0.7462
544 bio- 1 0.8461
544 blood 3 0.9315
544 calcium 1 0.5969
544 carence 1 1.0048
544 causes 1 0.5669
544 changes 1 0.3007
544 charac- 1 1.0048
544 chemical 1 0.6056
544 chez 1 0.9046
544 cholesterol 1 0.7724
544 cholesterol. 1 1.0048
544 chondrogenesis, 1 1.0048
544 chronic 1 0.4797
544 compared 1 0.3898
544 de 1 0.6879
544 deficiency 1 0.5313
544 delay 1 0.7724
544 dense 1 0.7462
544 des 1 0.724
544 discussed 1 0.4092
544 effets 1 1.0048
544 et 1 0.6728
544 facts 1 0.724
544 fasciculae. 1 1.0048
544 following 1 0.3331
544 formation 1 0.4509
544 found 1 0.2645
544 glomerular 1 0.6352
544 growth, 1 0.6728
544 habib, 1 1.0048
544 histological 1 0.5969
544 hyperkaluria 1 1.0048
544 hypertrophy 1 0.5313
544 hypo- 1 0.724
544 hypocalciuria 1 1.0048
544 idiopathic 1 0.6879
544 increase 1 0.3413
544 increases 1 0.4694
544 infant. 1 0.8461
544 investigated 1 0.5738
544 j. 1 0.7724
544 kalaemia 1 1.0048
544 l'histologie 1 1.0048
544 la 1 0.8046
544 le 3 2.5382
544 leads 1 0.5603
544 lefebvre 1 1.0048
544 level 3 1.1641
544 lines 2 1.1622
544 lipoid 1 0.8461
544 male 1 0.5119
544 maturation, 1 0.8461
544 metaphyseal 1 1.0048
544 microradiography 1 1.0048
544 noted. 1 0.6728
544 osseous 1 0.7462
544 osteopathy 1 0.9046
544 osteoporosis. 1 1.0048
544 p. 1 0.7462
544 phosphate 2 1.0148
544 plasmatique 1 1.0048
544 potassique 1 1.0048
544 potassium 1 0.6728
544 provokes 1 0.9046
544 r. 1 0.6879
544 radiography, 1 1.0048
544 rat 2 0.827
544 reduces 1 0.8461
544 rise 1 0.4989
544 royer 1 1.0048
544 severe 1 0.4452
544 skeleton. 1 1.0048
544 squelette, 1 1.0048
544 study 1 0.3096
544 suprarenals, 1 1.0048
544 sur 1 0.8461
544 surrenales 1 1.0048
544 syndrome 1 0.4661
544 teristics 1 1.0048
544 time 1 0.3541
544 urine. 1 0.7724
544 weaning, 1 1.0048
544 weight 1 0.4727
544 zone 1 0.6591
545 "phosphatdiabetes" 1 1.0048
545 10 1 0.3699
545 adenoma 1 0.724
545 already 1 0.724
545 analysis 1 0.4833
545 based 1 0.5262
545 beim 2 2.0097
545 calcium/phosphate-metabolism. 1 1.0048
545 carried 1 0.5031
545 certainly 1 0.8461
545 clear 1 0.6056
545 clearance 3 1.9399
545 comparative 1 0.6148
545 continued 1 0.5811
545 contribution 1 0.724
545 different 1 0.3554
545 diseases 1 0.548
545 disturbances 1 0.5969
545 dosage 1 0.6056
545 etiology 1 0.554
545 examination 1 0.5074
545 examinations 1 0.6879
545 form 1 0.4372
545 function 1 0.4509
545 general 1 0.5119
545 give 1 0.548
545 high 1 0.3596
545 hyper- 1 0.5969
545 hyperparathyreoidismus 1 1.0048
545 hyperparathyroidism 1 0.724
545 improved 1 0.6728
545 increase. 1 0.9046
545 indifferent. 1 1.0048
545 kidneys 1 0.5603
545 one 1 0.2811
545 osteopathies 1 1.0048
545 parathyroid 1 0.5366
545 parathyroidism 1 1.0048
545 pathogenesis 1 0.5669
545 pathophysiology 1 0.9046
545 patient 2 0.7556
545 patients 1 0.2415
545 phosphatdiabetes 1 1.0048
545 phosphate 3 1.5222
545 phosphatelearance-untersuchungen 1 1.0048
545 points. 1 0.9046
545 postoperative 1 0.6056
545 pre- 1 0.6466
545 present. 1 0.6728
545 rary 1 1.0048
545 reabsorption 2 1.3455
545 removal 1 0.5603
545 renal 2 0.7797
545 renale 1 1.0048
545 results 1 0.2878
545 secondary 1 0.5031
545 show 1 0.4346
545 showed 2 0.7164
545 sog. 1 1.0048
545 still 1 0.4694
545 tempo- 1 1.0048
545 therapy 1 0.3972
545 two 1 0.3077
545 und 1 1.0048
545 vergleichende 1 1.0048
545 vitamin 2 1.2295
545 whose 1 0.5888
546 ashing 1 1.5073
546 calcium 2 1.7907
546 determination 2 1.8443
546 false 1 1.357
546 found 2 0.7936
546 gluconate 2 3.0145
546 gluconate. 1 1.5073
546 interfere 1 1.1192
546 interference 1 1.0091
546 intravenous 2 1.6099
546 low 1 0.6597
546 magnesium 2 2.4137
546 method 1 0.5987
546 method, 1 1.1192
546 method. 1 1.0572
546 patients 2 0.7246
546 prevented 1 0.9887
546 receiving 2 1.6619
546 results 1 0.4316
546 serum 1 0.5847
546 specimen. 1 1.5073
546 titan 2 3.0145
546 unreliability 1 1.357
546 urine 1 0.7747
546 yellow 2 2.7139
547 (bis-(4-hydroxyiminomethyl- 1 1.5073
547 (ca. 1 1.357
547 1-2 1 1.2691
547 11 1 0.805
547 20 1 0.6807
547 250 1 1.2069
547 3 1 0.5138
547 52% 1 1.5073
547 6 1 0.6302
547 87% 1 1.5073
547 absorption 2 1.8738
547 alkyl-phosphate 1 1.5073
547 amply 1 1.5073
547 ampoule 1 1.357
547 ampoules. 1 1.5073
547 anti- 1 1.0572
547 antidote, 1 1.5073
547 appears 1 0.6481
547 automatic 1 1.5073
547 autule 1 1.5073
547 blood 2 0.9315
547 body 1 0.6077
547 caused 1 0.6597
547 certain 1 0.6637
547 changed. 1 1.5073
547 concentra- 1 1.086
547 dichloride), 1 1.5073
547 dies 1 1.5073
547 dose, 1 1.2069
547 dote 1 1.5073
547 drug, 1 1.357
547 eight 1 0.8607
547 ensure 1 1.2691
547 esterase-blocking 1 1.5073
547 esterases. 1 1.5073
547 ether 1 1.1192
547 even 1 0.6597
547 excreted 1 0.9369
547 excretion 2 1.4182
547 facial 1 1.357
547 four 1 0.6763
547 given 1 0.5526
547 hours 1 0.725
547 hours, 1 1.2069
547 hours. 1 1.086
547 injected 1 0.7306
547 injection 2 1.2605
547 injections 1 0.8503
547 intramuscular 2 2.4137
547 irritation. 1 1.5073
547 level 1 0.5821
547 levels 1 0.5902
547 local 1 0.9083
547 made 2 1.0917
547 man 1 0.7747
547 maximum 1 0.831
547 men 1 1.1586
547 mg. 1 0.9528
547 mg./kg.) 1 1.5073
547 minutes. 1 1.2069
547 organic 1 0.8954
547 pass 1 1.1192
547 phosphates, 1 1.5073
547 poisoning 1 1.0318
547 pyridine-1-methyl) 1 1.5073
547 reactivation 1 1.2691
547 recorded 1 0.8607
547 regarded 1 0.9369
547 reported 1 0.6107
547 resorptive 1 1.5073
547 self-injection 1 1.5073
547 side-effects 1 1.2691
547 specific 1 0.593
547 still 1 0.7041
547 stu- 1 1.357
547 sufficient 1 0.9083
547 symptoms 1 0.7143
547 time 1 0.5311
547 tion 1 0.6851
547 tolerance, 1 1.5073
547 toxogonin 2 3.0145
547 toxogonin, 1 1.5073
547 toxogonin. 1 1.5073
547 two 1 0.4616
547 ug./ml. 1 1.5073
547 ug./ml., 1 1.5073
547 un- 1 0.97
547 urinary 1 0.6678
547 urine 1 0.7747
547 within 1 0.5595
548 (with 1 0.3862
548 accurate 1 0.3074
548 acute 1 0.2494
548 alone 1 0.3028
548 alternative 1 0.3524
548 anabolic 1 0.4523
548 atp 1 0.4523
548 balance 1 0.3439
548 balances 2 0.8461
548 balances, 1 0.5024
548 calcium 6 1.7907
548 certain 1 0.2212
548 changes 1 0.1503
548 changes, 1 0.4023
548 chromium 1 0.4023
548 compared 1 0.1949
548 complement 1 0.3439
548 condition. 1 0.3439
548 conditions. 1 0.3524
548 continuous 1 0.2834
548 d-resistant 1 0.5024
548 effective 1 0.2515
548 either 1 0.2148
548 especially 1 0.2582
548 evidence 1 0.1842
548 exception 1 0.3296
548 expected 1 0.3296
548 explored 1 0.3862
548 far 1 0.3233
548 fluoride. 1 0.5024
548 found 1 0.1323
548 high 2 0.3596
548 hormones, 1 0.4523
548 immobilization 1 0.5024
548 impossible 1 0.423
548 ineffective 1 0.3524
548 inneffective. 1 0.5024
548 intake 1 0.3524
548 intake, 1 0.4023
548 intravenous 1 0.2683
548 irrever- 1 0.5024
548 large 1 0.1986
548 marking 1 0.5024
548 may 1 0.1257
548 method 1 0.1996
548 method, 1 0.3731
548 method. 1 0.3524
548 methods 1 0.2269
548 needed 1 0.3439
548 obtain 1 0.3524
548 obtaining 1 0.3862
548 often 1 0.2435
548 osteomalacia 1 0.5024
548 osteomalacia. 2 1.0048
548 osteoporosis 3 1.5073
548 osteoporosis) 1 0.5024
548 osteoporotic 1 0.5024
548 phosphate 1 0.2537
548 positive 2 0.5366
548 possible 1 0.2015
548 producing 1 0.3233
548 prolonged 1 0.2417
548 proved 1 0.2801
548 provide 1 0.2944
548 radiological 1 0.4023
548 seems 1 0.2657
548 seen 1 0.2124
548 sesquioxide 1 0.5024
548 show 1 0.2173
548 sible 1 0.4523
548 small 2 0.4031
548 sodium 1 0.2417
548 stools 1 0.423
548 strongly 1 0.3233
548 study 1 0.1548
548 suggests 1 0.2683
548 therapies 1 0.5024
548 therefore 1 0.3074
548 treated 1 0.2067
548 two 1 0.1539
548 use 1 0.1986
548 used. 1 0.3439
548 using 1 0.2284
548 vitamin 3 0.9221
549 (1964). 1 0.6029
549 (boyce 1 0.6029
549 (proteins, 1 0.6029
549 1963). 1 0.5428
549 adding 1 0.6029
549 adsorption 1 0.4827
549 aetiology 1 0.4827
549 appropriate 1 0.3955
549 artificial 1 0.4037
549 authors 1 0.2778
549 based 1 0.3157
549 binding 2 0.9655
549 boyce 1 0.6029
549 calculi 1 0.6029
549 calculus 3 1.8087
549 calculus. 1 0.6029
549 chances 1 0.6029
549 clear 1 0.3633
549 closely 1 0.3443
549 colleagues 1 0.5428
549 colloids 1 0.6029
549 concretions 1 0.6029
549 correct 1 0.4127
549 crystal 2 1.0153
549 crystalline 1 0.4477
549 crystallization 2 1.2058
549 days 1 0.2395
549 elements. 1 0.6029
549 factor 2 0.5714
549 factors 1 0.2549
549 factors, 1 0.4344
549 form 1 0.2623
549 formation 3 0.8116
549 gill 1 0.6029
549 growth 2 0.411
549 hypothesis 2 0.644
549 immersing 1 0.6029
549 importance. 1 0.5428
549 important 2 0.5445
549 increase 1 0.2048
549 inter-relationships, 1 0.6029
549 interest 1 0.4037
549 investigations 1 0.3748
549 king, 1 0.6029
549 laboratory 1 0.3487
549 learnt 1 0.6029
549 loop 1 0.6029
549 lyon 1 0.6029
549 matrix, 1 0.6029
549 much 1 0.2671
549 muco-proteins 1 0.6029
549 non-friable 1 0.6029
549 non-specific 1 0.4634
549 normal 1 0.1621
549 nucleation 1 0.6029
549 one 1 0.1687
549 play 1 0.3581
549 poisoning. 1 0.5428
549 polysaccharides) 1 0.6029
549 postulated 1 0.4229
549 precipitates 1 0.5428
549 primarily 1 0.3811
549 primary 2 0.5098
549 probable 1 0.3811
549 process 1 0.2759
549 produced 1 0.2455
549 protein 1 0.2741
549 proteins 1 0.3127
549 rather 1 0.2836
549 recent 1 0.3157
549 relative 1 0.3127
549 remains 1 0.3157
549 resembled 1 0.4344
549 responsible 1 0.3044
549 retention 1 0.3748
549 role 1 0.2797
549 rotating 1 0.6029
549 saturated 1 0.4634
549 secondary 1 0.3018
549 several 1 0.2608
549 significance 1 0.3288
549 since 1 0.2623
549 slowly 1 0.4127
549 solutions 1 0.4344
549 specific 1 0.2372
549 still 1 0.2816
549 stone 2 1.2058
549 stone-forming 1 0.6029
549 strongly 1 0.388
549 studies 1 0.1846
549 suggested 1 0.2507
549 super- 1 0.5428
549 supersaturation, 1 0.6029
549 time 1 0.2124
549 tract. 1 0.4634
549 treatment 1 0.1779
549 upper 1 0.388
549 urinary 5 1.3357
549 urine 1 0.3099
549 various 1 0.2383
549 vermeulen, 1 0.6029
549 wire 1 0.5428
549 within 1 0.2238
549 would 1 0.2993
550 15 1 0.4989
550 action 1 0.4372
550 also 1 0.2811
550 balance 1 0.6879
550 bendrofluazide--was 1 1.0048
550 bicarbonate, 1 1.0048
550 calcium 1 0.5969
550 calcium, 1 0.8461
550 cases 1 0.299
550 causes 1 0.5669
550 cellulose 1 0.9046
550 chlorothiazide 1 0.7724
550 control 1 0.3778
550 cortisone, 1 0.9046
550 demonstrated 2 0.8592
550 derivative--namely, 1 1.0048
550 describes 1 0.6879
550 diagnosis 1 0.4135
550 dietary 1 0.724
550 different 1 0.3554
550 discussed. 1 0.4296
550 discusses 1 0.9046
550 effect, 1 0.7462
550 effect. 1 0.6591
550 effects 1 0.373
550 exclusion. 1 1.0048
550 finally, 1 0.6879
550 hypercalciuria 3 2.7139
550 hypocalciuric 1 1.0048
550 idiopathic 2 1.3758
550 made 1 0.3639
550 mode 1 0.724
550 origins 1 0.9046
550 paper 1 0.5422
550 phosphate 1 0.5074
550 phosphate, 1 0.8046
550 phosphorus 1 0.6591
550 phytate, 1 1.0048
550 presented 1 0.3898
550 renal 1 0.3898
550 restriction 1 0.724
550 shown 1 0.4321
550 similarly 1 0.8046
550 sodium 3 1.45
550 stones. 1 1.0048
550 techniques. 1 0.724
550 urinary-calcium-lowering 1 1.0048
551 (1964) 1 0.4306
551 (by 1 0.4306
551 32pi-atp 1 0.4306
551 action 1 0.1874
551 actions 1 0.2771
551 addition 1 0.2194
551 al. 1 0.3103
551 also 1 0.1205
551 amino-acid 1 0.3626
551 analysis) 1 0.4306
551 another 1 0.2348
551 apparent 1 0.2255
551 atpase, 1 0.4306
551 basic 1 0.2948
551 bioassay 1 0.3877
551 biological 1 0.23
551 biologically 1 0.3198
551 biologically, 1 0.4306
551 c1 1 0.3877
551 c2 1 0.4306
551 chemically 1 0.3198
551 completed 1 0.3448
551 date 1 0.3198
551 determine 1 0.2429
551 effects 4 0.6394
551 either 1 0.1841
551 et 1 0.2883
551 exchange 1 0.2883
551 extracts 1 0.2635
551 factor 1 0.2041
551 glands. 1 0.3448
551 hormone 4 0.7015
551 hormone, 1 0.2771
551 hormone. 1 0.2523
551 immunologically, 1 0.4306
551 important 1 0.1945
551 inert 1 0.3877
551 inhibit 1 0.2948
551 ion 1 0.331
551 isolated 1 0.1874
551 latter 1 0.2234
551 may 2 0.2154
551 measure 1 0.249
551 mechanism 1 0.1984
551 metabolism 1 0.2041
551 might 1 0.2255
551 mitochondria 1 0.2948
551 mitochondria. 1 0.3626
551 mitochondrial 3 0.9308
551 necessary 1 0.2523
551 non-hormonal 2 0.8613
551 para- 1 0.3448
551 parathyroid 7 1.6099
551 phosphate 1 0.2175
551 postulated 1 0.3021
551 precisely 1 0.4306
551 previous 1 0.2324
551 produced 1 0.1754
551 protein 3 0.5873
551 proteins 3 0.6702
551 rasmussen 1 0.4306
551 reaction. 1 0.3198
551 reflect 1 0.331
551 reports 1 0.2771
551 respiration, 1 0.3877
551 rigorous 1 0.4306
551 several 1 0.1863
551 show 1 0.1863
551 sound 1 0.3877
551 specificity 1 0.3103
551 speculation 1 0.3877
551 stimulate 1 0.3021
551 stimulates 1 0.3626
551 studies 1 0.1319
551 suggested. 1 0.3448
551 tests 2 0.4241
551 thus 1 0.2234
551 thyroid 1 0.2523
551 tools. 1 0.4306
551 transport 1 0.2595
551 transport, 1 0.4306
551 uncertain 1 0.3198
551 uniquely 1 0.4306
551 unrelated 1 0.3021
551 use 1 0.1702
551 validly 1 0.4306
551 view 1 0.2523
551 vitro 2 0.4427
551 vitro. 1 0.2883
551 vivo 1 0.2558
551 warranted 1 0.3877
551 whether 2 0.4276
551 yet 1 0.2277
552 (alkaline 1 0.6029
552 2 1 0.1841
552 acid 1 0.2328
552 acid. 2 0.9269
552 alkaline 1 0.4344
552 associated 1 0.2141
552 b. 2 0.6723
552 bladder 1 0.4827
552 cases 1 0.1794
552 caused 1 0.2639
552 cent. 1 0.4634
552 choice 1 0.388
552 condition. 1 0.4127
552 cystitis 2 1.0856
552 cystitis) 1 0.6029
552 cystitis. 1 0.6029
552 drug 1 0.3157
552 effect 1 0.1841
552 eight 1 0.3443
552 encrusted 3 1.8087
552 failed 1 0.3443
552 fails 1 0.5428
552 follow 1 0.4827
552 incidence 2 0.5757
552 increasing 1 0.3533
552 infection 1 0.2836
552 infections 1 0.3955
552 mandelamine 1 0.6029
552 mandelamine, 1 0.6029
552 may 2 0.3016
552 megavoltage 1 0.5428
552 nalidixic 3 1.8087
552 noted 1 0.3188
552 often 1 0.2922
552 patients 1 0.1449
552 per 1 0.235
552 persistent 1 0.4634
552 phosphatic 3 1.8087
552 post-radiation 1 0.6029
552 proteus 2 1.2058
552 ps. 1 0.6029
552 pyocyaneus 1 0.6029
552 relieve 1 0.4634
552 respond 1 0.3689
552 responded 1 0.4477
552 series 1 0.2836
552 series. 1 0.4827
552 side 1 0.3401
552 ten 1 0.3633
552 therapy 1 0.2383
552 tract, 1 0.4827
552 treatment 5 0.8894
552 tumour. 1 0.4827
552 urinary 1 0.2671
552 urine. 1 0.4634
552 value 1 0.2778
553 action 3 0.9837
553 addition, 1 0.4358
553 administration. 1 0.5046
553 alter 1 0.5046
553 biosynthesis 1 0.5596
553 calcification 1 0.6346
553 carried 1 0.3773
553 casts 1 0.7536
553 caused 1 0.3299
553 ceiving 1 0.6346
553 data 2 0.6138
553 de- 1 0.4202
553 deposi- 1 0.7536
553 direct 1 0.3546
553 ele- 1 0.6785
553 elevation 1 0.5286
553 ever, 1 0.5596
553 extract 1 0.4764
553 forma- 1 0.6034
553 found 1 0.1984
553 glycoprotein 4 2.5382
553 glycoprotein. 1 0.7536
553 glycoproteins 1 0.6785
553 glycoproteins. 1 0.7536
553 hepatectomized 1 0.7536
553 hepatectomy 2 1.357
553 how- 1 0.5793
553 kidney. 1 0.4685
553 liver 2 0.593
553 longer 1 0.5286
553 major 1 0.3625
553 may 1 0.1885
553 mobilizing 1 0.6785
553 parathyroid 1 0.4025
553 possible 1 0.3023
553 produced 1 0.3069
553 property 1 0.6034
553 pte 4 2.7139
553 pte-induced 1 0.7536
553 pte. 1 0.7536
553 rats 1 0.291
553 rats, 1 0.5159
553 re- 1 0.3339
553 renal 1 0.2924
553 role 1 0.3496
553 serum 2 0.5847
553 showed 1 0.2686
553 source 1 0.5046
553 stimulating 1 0.5286
553 studies 1 0.2308
553 suggest 1 0.3426
553 termine 1 0.7536
553 tion 2 0.6851
553 tubular 1 0.5046
553 vated 1 0.6346
553 well 1 0.2636
554 (psp), 1 0.5024
554 20% 1 0.3731
554 50% 1 0.3028
554 90 1 0.3731
554 accumu- 1 0.5024
554 accumulated 2 0.7724
554 acid 1 0.194
554 activity 1 0.1798
554 administered 1 0.2399
554 administration 1 0.2212
554 blood. 1 0.3364
554 bulk 1 0.423
554 cells. 1 0.224
554 circulating 1 0.3524
554 containing 1 0.2657
554 cow 2 0.9046
554 cow. 1 0.5024
554 days 1 0.1996
554 depot 1 0.4023
554 diethylstilbestrol, 1 0.5024
554 disappearance 1 0.3296
554 distribution 3 0.7747
554 effective 1 0.2515
554 excretion 2 0.4727
554 followed 1 0.2299
554 hours 1 0.2417
554 in- 1 0.2226
554 indicated 1 0.2364
554 injec- 1 0.4523
554 injection 3 0.6302
554 injection. 1 0.362
554 intramuscular 1 0.4023
554 intravenous 1 0.2683
554 jected 1 0.4523
554 labeled 1 0.3028
554 late 1 0.2985
554 lated 1 0.3862
554 liver 1 0.1977
554 material 1 0.2331
554 organ. 1 0.5024
554 organs 1 0.277
554 parenteral 1 0.4523
554 phoric 1 0.5024
554 phos- 1 0.3862
554 phosphate 2 0.5074
554 polydiethylstilbestrol 2 1.0048
554 polyester 1 0.4523
554 polymer 1 0.5024
554 preferably 1 0.5024
554 radio- 1 0.3731
554 radioactive 1 0.3123
554 radioactivity 6 2.1719
554 rats 2 0.388
554 rats, 2 0.6879
554 recovered 1 0.3123
554 removing 1 0.5024
554 reticuloendothelial 1 0.4023
554 site 2 0.5811
554 slow. 1 0.5024
554 soluble 1 0.2985
554 species. 1 0.3296
554 still 1 0.2347
554 subcutaneous 1 0.3233
554 tion. 1 0.3731
554 twenty-four 1 0.4523
554 water 1 0.2657
555 (p.t.h.) 1 0.7536
555 action 1 0.3279
555 addition, 1 0.4358
555 administration 1 0.3319
555 applied 1 0.4542
555 attempt 1 0.4611
555 conditions 1 0.3426
555 could 1 0.2708
555 de 1 0.5159
555 demonstrated 1 0.3222
555 demonstrated, 1 0.6346
555 distal 1 0.5286
555 dog 1 0.4685
555 dogs 1 0.3909
555 excretion 1 0.3546
555 experimental 1 0.3496
555 experiments 1 0.3339
555 hormone 1 0.3069
555 hormone. 1 0.4416
555 indicated 1 0.3546
555 inhibition 1 0.3773
555 inward 1 0.7536
555 locate 1 0.7536
555 m. 1 0.4202
555 mainly 1 0.4943
555 movement 1 0.5793
555 myttenaere 1 0.7536
555 p.t.h. 1 0.7536
555 p32 1 0.6034
555 parathyroid 1 0.4025
555 parathyroidectomized 1 0.6785
555 part 1 0.352
555 pattern 1 0.3598
555 performed 1 0.3449
555 phenomenon 1 0.4358
555 phosphate 2 0.7611
555 phosphate. 1 0.5793
555 phosphorus 1 0.4943
555 place 1 0.4611
555 proximal 1 0.5159
555 reabsorption 1 0.5046
555 renal 1 0.2924
555 rule 1 0.5793
555 ruling 1 0.6785
555 secretion 2 0.8832
555 significant 1 0.2646
555 site 1 0.4358
555 stop-flow 4 2.7139
555 study 1 0.2322
555 technique 2 0.7091
555 took 1 0.543
555 transtubular 1 0.7536
555 tubular 2 1.0091
555 tubule. 1 0.7536
555 tubules. 1 0.5793
555 used, 1 0.485
556 "might 1 1.5073
556 accompany. 1 1.5073
556 added 1 0.9369
556 albright 1 1.5073
556 associated 1 0.5352
556 bony 1 1.2691
556 carcinoma 2 1.4391
556 frequency. 1 1.357
556 hormone," 1 1.5073
556 hy- 1 1.0572
556 hypercalcemia 2 2.3172
556 increas- 1 1.5073
556 ing 1 0.8133
556 list 1 1.2691
556 malignant 1 0.8219
556 may 1 0.377
556 metastases 1 1.0318
556 neoplasms 1 1.1192
556 parathyroid 1 0.805
556 pelvis 2 2.7139
556 percalcemia 1 1.5073
556 producing 1 0.97
556 recorded 1 0.8607
556 renal 2 1.1695
556 since 1 0.6558
556 stupor, 1 1.5073
556 suggested 1 0.6268
556 transitional-cell 1 1.5073
556 tumors 2 1.5786
556 with- 1 1.2691
557 'sealing' 1 0.6029
557 (14.3 1 0.6029
557 (32p) 1 0.6029
557 (maximum 1 0.5076
557 1.71 1 0.6029
557 3- 2 1.2058
557 acid 1 0.2328
557 active 1 0.2778
557 activity 1 0.2158
557 ad- 1 0.4037
557 adsorption 1 0.4827
557 aluminium 3 1.6283
557 among 1 0.2816
557 and, 1 0.3127
557 anodic 1 0.6029
557 anodized 1 0.6029
557 applied 1 0.3633
557 attractive 1 0.5428
557 b-emission 1 0.6029
557 b-self-absorption 1 0.6029
557 b-therapy, 1 0.6029
557 b. 1 0.3362
557 basically 1 0.4634
557 boiling 1 0.6029
557 ca(po4), 1 0.6029
557 capacity 1 0.3288
557 capsules 1 0.5076
557 cases. 1 0.3157
557 certain 1 0.2655
557 chloride 1 0.4344
557 consists 1 0.3811
557 culties 1 0.6029
557 days) 1 0.5428
557 delicate 1 0.6029
557 desorbed, 1 0.6029
557 diffi- 1 0.6029
557 e. 1 0.4127
557 effect 1 0.1841
557 energy 1 0.4127
557 even 1 0.2639
557 expected 1 0.3955
557 fasolo, 1 0.6029
557 features 1 0.322
557 filled 1 0.5076
557 film 2 0.9269
557 forms 1 0.2878
557 found 2 0.3174
557 g. 1 0.4477
557 generally 1 0.3581
557 gold-198 1 0.6029
557 grains 2 1.0856
557 grains, 1 0.6029
557 half-life 1 0.5076
557 high, 1 0.5428
557 high-energy 1 0.6029
557 human 1 0.2012
557 implantation 1 0.5428
557 interstitial 1 0.4127
557 ions 2 0.8954
557 isotonic 1 0.4827
557 kept 1 0.4477
557 labelled 5 2.1719
557 large 1 0.2383
557 limited 1 0.3288
557 literature 1 0.3288
557 malignancies. 1 0.6029
557 malvano, 1 0.6029
557 medical 1 0.3581
557 method 1 0.2395
557 methods 1 0.2723
557 mev); 1 0.6029
557 moravek, 1 0.6029
557 moreover, 1 0.3955
557 mundinger 1 0.6029
557 new 1 0.2639
557 oxidation 1 0.5076
557 oxide 2 1.2058
557 partially 1 0.3748
557 phorus-32 1 0.6029
557 phos- 1 0.4634
557 phosphomolybdic 1 0.5428
557 phosphorus-32 1 0.6029
557 phosphorus-32. 1 0.6029
557 plastic 1 0.4634
557 po3 1 0.6029
557 po4 1 0.5428
557 preparation 2 0.776
557 preparative 1 0.5428
557 process 1 0.2759
557 produced 1 0.2455
557 proposed 1 0.3955
557 purposes 1 0.4477
557 quite 1 0.3443
557 r. 1 0.4127
557 radio-elements 1 0.6029
557 radioactive 1 0.3748
557 radionuclide 1 0.6029
557 radiophosphorus 2 1.2058
557 rames 1 0.6029
557 rather 1 0.2836
557 reported 1 0.2443
557 require 1 0.4127
557 respectively 1 0.4127
557 reversible: 1 0.6029
557 riechert 1 0.6029
557 rosa 1 0.6029
557 safe 1 0.3955
557 shows 1 0.3324
557 simple 1 0.3288
557 small 1 0.2419
557 sodium 1 0.29
557 solid 1 0.4634
557 solution, 1 0.4634
557 solution. 1 0.5428
557 sorbing 1 0.6029
557 sources, 1 0.5076
557 sources. 1 0.6029
557 suitable 1 0.388
557 technique, 1 0.5076
557 techniques 1 0.3288
557 therapeutic 1 0.3044
557 tissues 1 0.2759
557 treatment 1 0.1779
557 u. 1 0.4634
557 use 1 0.2383
557 used 1 0.2277
557 used. 1 0.4127
557 water, 1 0.4827
557 widely 1 0.4037
557 wire 1 0.5428
557 wire. 1 0.6029
557 work, 1 0.6029
557 yttrium-90 1 0.6029
557 zimmer 1 0.6029
558 (fe-din) 1 1.0048
558 1) 1 0.6466
558 2) 1 0.6879
558 achieved 1 0.6879
558 act 1 0.6246
558 administration 1 0.4425
558 although 1 0.3863
558 amounts 1 0.4989
558 animals. 1 0.5669
558 autologous 1 0.8046
558 bilateral 1 0.6056
558 buccal 1 0.9046
558 calcification 2 1.6922
558 calciphy- 1 1.0048
558 calciphylactic 2 2.0097
558 calciphylaxis. 1 1.0048
558 cardiovascular 2 1.2704
558 changes 1 0.3007
558 concluded 1 0.4598
558 control 1 0.3778
558 conversely, 1 1.0048
558 damage. 1 0.9046
558 dextrin 2 2.0097
558 effect 1 0.3068
558 effective 1 0.5031
558 elicited 1 0.7048
558 esophagus, 1 0.9046
558 experiments 1 0.4452
558 fe-din 2 2.0097
558 fe-din-induced 1 1.0048
558 ferric 2 2.0097
558 glands, 1 0.8461
558 hence, 1 1.0048
558 highly 1 0.5422
558 hormone, 1 0.6466
558 indicate 1 0.4425
558 induces 1 0.9046
558 intact 1 0.554
558 intravenous 1 0.5366
558 lactic 1 0.7048
558 may 1 0.2513
558 mediastinum 1 0.8461
558 mucosa, 1 1.0048
558 nephrectomized 2 1.448
558 nephrectomy. 2 1.2704
558 normally 1 0.6352
558 parathy- 1 0.9046
558 parathyroid 1 0.5366
558 parathyroidectomy 1 0.7724
558 preparation 1 0.6466
558 prevents 1 0.7462
558 produces 1 0.6352
558 protecting 1 0.9046
558 protects 1 0.8461
558 rat 3 1.2405
558 roidectomy 1 1.0048
558 secreted 1 0.8461
558 selective 1 0.5969
558 sensitization 2 1.3455
558 sensitizer 1 1.0048
558 system 1 0.4694
558 that: 1 1.0048
558 trachea 1 0.8461
558 upon 1 0.4509
558 uremia 1 0.9046
558 uremic 1 1.0048
559 abnormal 1 0.7306
559 adenoma 1 1.086
559 adenoma, 1 1.357
559 anterior 1 0.9528
559 approach 1 0.9369
559 case 1 0.5415
559 complete 1 0.6992
559 correction 1 1.0572
559 course 1 0.6851
559 crisis 1 1.1192
559 differentiated 1 1.0091
559 directly 1 0.9528
559 encapsulated 1 1.5073
559 exploration. 1 1.357
559 findings. 1 1.2691
559 gratifying, 1 1.5073
559 hypercalcemic 1 1.2691
559 hyperparathyroidism 1 1.086
559 laboratory 1 0.8716
559 located 1 1.2691
559 lying 1 1.357
559 mediastinal 2 2.7139
559 mediastinum, 1 1.5073
559 parathyroid 2 1.6099
559 pericardial 1 1.1192
559 postoperative 1 0.9083
559 presented. 1 0.8832
559 sac. 1 1.5073
559 sternum 1 1.357
559 surgical 1 0.6807
559 symptoms 1 0.7143
559 tumor 1 0.672
559 un- 1 0.97
559 uneventful 1 1.5073
559 usually 1 0.7091
559 well 1 0.5271
559 within 1 0.5595
559 without 1 0.5692
560 "operatively 1 1.0048
560 1) 1 0.6466
560 10 1 0.3699
560 2) 1 0.6879
560 anatomic 1 0.6728
560 be. 1 0.9046
560 best 1 0.5313
560 clinical 1 0.3275
560 could 1 0.361
560 decide 1 1.0048
560 diagnosis 3 1.2405
560 disease 1 0.361
560 documented 1 0.724
560 evaluated 1 0.5811
560 evaluation 1 0.5422
560 excretion 1 0.4727
560 experience 1 0.5165
560 fall 1 0.5262
560 favourable 1 1.0048
560 follow-up 1 0.6728
560 forty-four 1 0.9046
560 found 1 0.2645
560 gross 1 0.6728
560 hyperparathyroidism 1 0.724
560 hyperparathyroidism. 1 1.0048
560 hyperparathyroidism: 1 0.9046
560 immediate 1 0.6352
560 intervals 1 0.6246
560 long 1 0.5212
560 observations 1 0.4225
560 operative 3 1.6808
560 patients 2 0.4831
560 phosphorus 1 0.6591
560 postoperative 1 0.6056
560 primary 2 0.8496
560 proven" 1 1.0048
560 response 1 0.3669
560 significant 1 0.3527
560 specimen 1 0.724
560 substantiated 1 0.9046
560 suggested 1 0.4179
560 term 1 0.5603
560 treatment 2 0.5929
560 treatment. 1 0.5313
560 urinary 1 0.4452
560 value 1 0.4629
560 whether 1 0.4989
560 would 1 0.4989
560 years, 1 0.6352
561 (1.2-2.4 1 0.6029
561 (2.0 1 0.6029
561 (480 1 0.6029
561 (teu50). 1 0.6029
561 1, 1 0.388
561 10 1 0.2219
561 11 1 0.322
561 2- 1 0.6029
561 24 1 0.3127
561 3 1 0.2055
561 3, 1 0.4827
561 30 1 0.2878
561 4-fold 1 0.5428
561 50 2 0.5757
561 6 1 0.2521
561 94 1 0.5076
561 acid 2 0.4656
561 administration 1 0.2655
561 albino 1 0.4827
561 ascorbic 2 1.0856
561 cent 1 0.3099
561 chloride 1 0.4344
561 complexed 1 0.6029
561 control 1 0.2267
561 control, 1 0.4827
561 different 1 0.2133
561 dilution 1 0.4127
561 dose 2 0.5757
561 doses 2 0.6575
561 excreted 1 0.3748
561 female, 1 0.4477
561 function 1 0.2705
561 given 5 1.1051
561 hg/kg) 1 0.6029
561 hours 2 0.58
561 however, 1 0.2183
561 increased 1 0.1874
561 increases 1 0.2816
561 injected. 1 0.5428
561 injection 1 0.2521
561 intervals 1 0.3748
561 intraperitoneal 3 1.3032
561 limits. 1 0.5076
561 load 2 0.9655
561 markedly 1 0.322
561 measure 1 0.3487
561 mercuric 1 0.6029
561 mg 3 1.0744
561 mg/kg). 1 0.6029
561 minutes 1 0.3955
561 ml/kg, 1 0.6029
561 nb/kg 1 0.6029
561 niobium 4 2.4116
561 niobium-poisoned 1 0.6029
561 nitrate 1 0.6029
561 observed 2 0.411
561 only. 1 0.4344
561 per 1 0.235
561 prior 1 0.322
561 ranging 1 0.4127
561 rats 5 1.1641
561 renal 1 0.2339
561 resulted 1 0.2922
561 showed 1 0.2149
561 single 3 0.898
561 sodium 1 0.29
561 test 1 0.2608
561 teu50 4 2.4116
561 tripolyphosphate 1 0.6029
561 u/kg), 1 0.6029
561 uranyl 1 0.6029
561 urine 1 0.3099
561 value 2 0.5555
561 values 2 0.6089
561 water 1 0.3188
561 within 2 0.4476
562 (and 1 0.3877
562 1. 1 0.2255
562 2. 1 0.2255
562 3. 1 0.2324
562 4. 1 0.2459
562 5. 1 0.2825
562 6. 1 0.3021
562 accounted 1 0.3198
562 activity 1 0.1541
562 administration 1 0.1896
562 affect 1 0.2722
562 animals 1 0.1831
562 animals. 1 0.2429
562 associated 1 0.1529
562 balance 1 0.2948
562 bone 1 0.1863
562 bone, 2 0.6896
562 bone. 1 0.3198
562 brain, 1 0.3448
562 ca15 2 0.8613
562 ca15, 1 0.4306
562 ca45, 1 0.4306
562 calcium 1 0.2558
562 calcium, 1 0.3626
562 complex. 1 0.3448
562 considered 1 0.192
562 creased 1 0.2825
562 creased. 1 0.3877
562 data 2 0.3508
562 days 1 0.1711
562 de- 1 0.2401
562 deficiency 2 0.4554
562 deficient 1 0.2771
562 demonstrate 1 0.249
562 depletion 1 0.2825
562 destruction 1 0.3448
562 determined. 1 0.2948
562 development 1 0.1572
562 diets. 1 0.4306
562 effects 1 0.1599
562 either 1 0.1841
562 equilibrium 1 0.3021
562 exchange 7 2.0183
562 extract 2 0.5445
562 extract, 1 0.4306
562 extract. 1 0.3877
562 found. 1 0.2771
562 four 1 0.1932
562 given 1 0.1579
562 greatly 1 0.2558
562 hormone 1 0.1754
562 hours 1 0.2071
562 hypoparathyroidism, 1 0.3877
562 identical 1 0.2558
562 in- 1 0.1908
562 increased 2 0.2677
562 influence 1 0.1971
562 intestine 1 0.3448
562 intestine, 1 0.4306
562 ion 1 0.331
562 kidney 2 0.3816
562 kidney, 1 0.2825
562 liver, 1 0.2948
562 loss 1 0.2087
562 losses 1 0.3626
562 mag- 1 0.4306
562 magnesium 2 0.6896
562 magnesium, 2 0.7754
562 manifestations 1 0.2459
562 mardedly 1 0.4306
562 may 1 0.1077
562 metabolic 1 0.2056
562 mg28 1 0.4306
562 mg28, 2 0.8613
562 minerals 1 0.4306
562 minimized 1 0.3877
562 muscle 1 0.2374
562 must 1 0.2104
562 nesium 1 0.4306
562 non-osseous 2 0.8613
562 operated 1 0.2771
562 operated, 1 0.4306
562 organs. 1 0.3103
562 p32 3 1.0345
562 parathyroid 5 1.1499
562 parathyroidectomized, 1 0.4306
562 parathyroidectomy 3 0.9931
562 parathyroidectomy, 1 0.3877
562 patients 1 0.1035
562 perhaps 1 0.2374
562 phosphate 1 0.2175
562 phosphate, 1 0.3448
562 port 1 0.4306
562 potassium 1 0.2883
562 potassium) 1 0.4306
562 preferential 1 0.3877
562 presented. 1 0.2523
562 presumed. 1 0.4306
562 rat 1 0.1772
562 rates 1 0.2595
562 rats 1 0.1663
562 rats. 1 0.2255
562 receiving 1 0.2374
562 reduced 1 0.1945
562 reestablished 1 0.3877
562 response 1 0.1572
562 results 1 0.1233
562 sham 2 0.8613
562 six 1 0.2374
562 sodium 2 0.4143
562 spectrum 1 0.3448
562 studied 1 0.15
562 suggest 1 0.1958
562 target 1 0.3448
562 three 1 0.1619
562 tissues 4 0.7882
562 tissues, 1 0.3021
562 tissues. 1 0.2825
562 trans- 1 0.331
562 transport 2 0.519
562 treated 1 0.1772
562 usually 1 0.2026
562 various 1 0.1702
562 young 1 0.2175
563 acute 1 0.4989
563 alkalosis 2 2.0097
563 alkalosis. 1 1.0048
563 always 1 0.5366
563 attributable 1 0.6879
563 blood 1 0.3105
563 bolic 1 1.0048
563 carried 1 0.5031
563 cells. 1 0.448
563 centration 1 0.9046
563 co2 1 0.724
563 comparable 1 0.554
563 con- 1 0.5212
563 concentration 2 0.8449
563 concentrations 1 0.5165
563 content 1 0.4727
563 creased 1 0.6591
563 depress 1 0.8461
563 effects 1 0.373
563 evaluation 1 0.5422
563 excretion 2 0.9455
563 extracellular 1 0.7048
563 fall 2 1.0524
563 greater 1 0.4157
563 in- 1 0.4452
563 inorganic 1 0.6879
563 knowledge 1 0.6591
563 levels 1 0.3935
563 low 1 0.4398
563 man 1 0.5165
563 man. 1 0.6466
563 meta- 1 1.0048
563 metabolic 1 0.4797
563 migration 1 0.6728
563 normal 1 0.2702
563 ph 1 0.5422
563 phorus 1 1.0048
563 phos- 1 0.7724
563 phosphate 1 0.5074
563 phosphorus 2 1.3182
563 plasma 3 1.2153
563 plasma. 1 0.8046
563 red 1 0.5969
563 renal 1 0.3898
563 respiratory 2 1.0425
563 serum 1 0.3898
563 shown 1 0.4321
563 total 1 0.3916
563 urinary 1 0.4452
564 2,000 1 0.3173
564 25 1 0.2152
564 500 1 0.2897
564 abolished 1 0.2472
564 administration 3 0.4978
564 also, 1 0.2715
564 ani- 2 0.5793
564 animal. 1 0.2897
564 animals. 1 0.2126
564 biphasic 1 0.3392
564 calcium 5 1.1192
564 calcium. 1 0.3392
564 calcium; 1 0.3392
564 change 1 0.1748
564 cient 1 0.3768
564 compared 1 0.1462
564 concentra- 1 0.2715
564 content 1 0.1773
564 contrast, 1 0.2897
564 crease 1 0.2523
564 d-deficient 3 1.0177
564 d-fed 3 1.0177
564 dietary 2 0.543
564 discussed 1 0.1535
564 dose 3 0.5397
564 effect 2 0.2301
564 effects 1 0.1399
564 fall 2 0.3946
564 fol- 1 0.2798
564 followed 1 0.1724
564 groups 1 0.1535
564 hor- 1 0.3173
564 hormone 3 0.4604
564 hormone. 1 0.2208
564 immediate 1 0.2382
564 in- 1 0.167
564 increase 1 0.128
564 influence 2 0.3449
564 initial 1 0.1826
564 intact 1 0.2077
564 investigated. 1 0.2897
564 little 1 0.2012
564 lowed 1 0.3017
564 mal 1 0.2523
564 mals. 1 0.3768
564 marit 1 0.3768
564 measured 1 0.1649
564 metabolism. 1 0.2523
564 mitochondrial 1 0.2715
564 mone 1 0.3173
564 observed 1 0.1284
564 para- 1 0.3017
564 parathy- 1 0.3392
564 parathyroid 2 0.4025
564 parathyroidectomy 4 1.1586
564 phosphate 5 0.9514
564 plasma 8 1.2153
564 prevented 1 0.2472
564 rapid 1 0.1826
564 rat 2 0.3101
564 rats 1 0.1455
564 re- 1 0.167
564 relation 1 0.1736
564 relationship 1 0.1813
564 response 1 0.1376
564 responses 1 0.2101
564 restriction 1 0.2715
564 results 2 0.2158
564 rise 1 0.1871
564 rise. 1 0.3392
564 roid 1 0.3768
564 significant 1 0.1323
564 stedingk 1 0.3768
564 striking 1 0.2382
564 suffi- 1 0.3768
564 sults 1 0.2798
564 thyroid 1 0.2208
564 tions 1 0.2238
564 u 3 0.869
564 upon 4 0.6763
564 vitamin 3 0.6916
564 von 1 0.3392
565 "glucose 1 0.6029
565 (10) 1 0.5428
565 (3) 1 0.3188
565 (8)) 1 0.6029
565 (9) 1 0.5428
565 (as 1 0.4477
565 (method 1 0.6029
565 (sp) 1 0.6029
565 (table 1 0.6029
565 (up) 1 0.6029
565 2). 1 0.5428
565 accentuated 1 0.5076
565 accounted 1 0.4477
565 administration. 1 0.4037
565 also 1 0.1687
565 ance 1 0.4634
565 another 1 0.3288
565 appears 1 0.2593
565 brought 1 0.3955
565 cannot 1 0.3253
565 carried 1 0.3018
565 changes 1 0.1804
565 comparini 1 0.6029
565 conn 1 0.6029
565 considered. 1 0.5076
565 contrary, 1 0.5076
565 control 1 0.2267
565 controls 1 0.3633
565 could 1 0.2166
565 course 2 0.5481
565 days 2 0.479
565 decline 1 0.4229
565 declines 1 0.5076
565 decrease 2 0.5518
565 degree. 1 0.5428
565 differ 1 0.3955
565 different 1 0.2133
565 dis- 1 0.3811
565 entirely. 1 0.6029
565 expected 1 0.3955
565 fact 2 0.6376
565 febrile 1 0.5428
565 fever 2 0.8688
565 fever. 1 0.6029
565 five 1 0.3188
565 found 2 0.3174
565 gfr, 1 0.5428
565 glucose 5 1.5786
565 glycemic 1 0.6029
565 group 1 0.2229
565 high 1 0.2158
565 hours 2 0.58
565 however 1 0.4344
565 in- 1 0.2671
565 increase 2 0.4095
565 increased 1 0.1874
565 intravenous 1 0.322
565 it, 1 0.4827
565 jection, 1 0.6029
565 level 1 0.2328
565 licko 1 0.6029
565 literature. 1 0.5076
565 lowered 1 0.4477
565 macho 1 0.6029
565 malizia 1 0.6029
565 man 1 0.3099
565 marked 1 0.2705
565 massive 1 0.4477
565 not, 1 0.4037
565 ob- 1 0.4127
565 observed 2 0.411
565 occur) 1 0.6029
565 occurring 1 0.3487
565 opinion 1 0.4037
565 parallel 1 0.388
565 patients 1 0.1449
565 peak 1 0.3487
565 phosphorus 5 1.9773
565 place 1 0.3689
565 possibility 1 0.3443
565 purposes 1 0.4477
565 pyrogen 1 0.6029
565 pyrotherapy 2 1.2058
565 rate 3 0.6658
565 remains 1 0.3157
565 responses 1 0.3362
565 retention 1 0.3748
565 serum 4 0.9356
565 sp 1 0.4827
565 subjected 1 0.3288
565 subjects 1 0.2878
565 subjects. 1 0.3689
565 tained 1 0.4827
565 takes 1 0.4634
565 temperatures, 1 0.6029
565 test 1 0.2608
565 tests 1 0.2969
565 tests, 1 0.3955
565 tests. 1 0.4127
565 tissues 1 0.2759
565 to, 1 0.4634
565 toler- 1 0.6029
565 tolerance 2 0.776
565 too, 1 0.5428
565 transfer 1 0.388
565 urinary 2 0.5343
565 utilization 3 1.2686
565 utilization" 1 0.6029
565 whether 1 0.2993
565 without 1 0.2277
565 would 1 0.2993
566 (gfr) 1 1.0048
566 (tmp) 1 1.0048
566 considerable 1 0.5212
566 demonstrated 2 0.8592
566 direct 1 0.4727
566 dog 1 0.6246
566 dog, 1 0.8461
566 dog. 2 1.8093
566 exist 1 0.6879
566 filtration 2 1.3455
566 gfr 1 1.0048
566 glomerular 2 1.2704
566 intermittency 1 1.0048
566 man, 1 0.7462
566 maximal 2 1.2492
566 may 1 0.2513
566 normal 1 0.2702
566 occurs. 1 1.0048
566 often 1 0.4871
566 phate 1 0.8046
566 phos- 1 0.7724
566 phosphate 1 0.5074
566 plained, 1 1.0048
566 range. 1 0.8461
566 rate 3 1.1097
566 reabsorption 2 1.3455
566 relationship 3 1.45
566 remains 1 0.5262
566 renal 1 0.3898
566 suggests 1 0.5366
566 tmp 2 2.0097
566 tubular 2 1.3455
566 unex- 1 1.0048
566 variability 2 1.448
566 varied 1 0.6352
566 wide 1 0.5969
567 (range, 2 0.8613
567 1.5 1 0.331
567 13 2 0.4981
567 16.6 1 0.4306
567 20 2 0.389
567 25 1 0.2459
567 34 1 0.3021
567 45.2 1 0.4306
567 5 1 0.1633
567 6.7 1 0.3877
567 60 2 0.5543
567 70 1 0.331
567 ad- 1 0.2883
567 affected 1 0.2234
567 also 1 0.1205
567 average 1 0.1932
567 based 1 0.2255
567 be- 1 0.2635
567 blood 1 0.1331
567 ca- 1 0.4306
567 caus- 1 0.4306
567 cent 1 0.2213
567 clinical 1 0.1404
567 cocorticoid-treated 1 0.4306
567 comparable 1 0.2374
567 corticosteroids 1 0.2883
567 cortisol 2 0.7252
567 day 2 0.4276
567 described. 1 0.2156
567 dose. 1 0.3448
567 drop 1 0.331
567 duration 1 0.2255
567 equivalent 2 0.6041
567 glu- 1 0.3877
567 glucocorticoid 1 0.3626
567 glucose 1 0.2255
567 greater 1 0.1781
567 growth 4 0.5872
567 growth-hormone 2 0.6896
567 hibition 1 0.3877
567 hor- 1 0.3626
567 hormone 3 0.5262
567 hour, 1 0.3877
567 human 2 0.2875
567 hypoglycemia 1 0.3448
567 hypoglycemia, 1 0.3626
567 hypoglycemic 1 0.3877
567 hypopituitary 1 0.2948
567 in- 1 0.1908
567 ing 2 0.4647
567 inhibition 1 0.2156
567 insulin 2 0.519
567 liliter. 1 0.4306
567 long-term 1 0.249
567 marked 1 0.1932
567 mean 3 0.6214
567 measurement, 1 0.4306
567 mg. 2 0.5445
567 mil- 1 0.4306
567 milliliter 3 1.2919
567 millimicrogm. 4 1.7226
567 millimicrogm.). 2 0.8613
567 ministration. 1 0.4306
567 mone 1 0.3626
567 normal 1 0.1158
567 observed 1 0.1468
567 one 1 0.1205
567 pacity, 1 0.4306
567 patients 1 0.1035
567 per 7 1.1749
567 plasma 2 0.3472
567 produced 1 0.1754
567 radioimmunoassay 1 0.3448
567 range 1 0.2324
567 receiving 2 0.4748
567 related 1 0.1821
567 response 2 0.3145
567 response, 1 0.3198
567 resting 1 0.331
567 rise 3 0.6414
567 secretory 1 0.3021
567 short-term 1 0.3198
567 showed 3 0.4605
567 standard 2 0.5896
567 stimulation 1 0.2429
567 subjects 3 0.6168
567 subjects. 1 0.2635
567 suppression 1 0.2771
567 test 1 0.1863
567 test, 1 0.3198
567 tolerance 1 0.2771
567 total 1 0.1678
567 treatment, 1 0.2771
567 values, 1 0.3448
568 abnormalities 1 0.5603
568 accompanying 1 0.7048
568 acids, 1 0.8046
568 certain 1 0.4425
568 fasting 1 0.6879
568 fatty 1 0.5031
568 free 1 0.4762
568 glucose, 1 0.7724
568 growth 3 1.0275
568 hormone 3 1.2277
568 insulin 2 1.2111
568 insulin, 1 0.724
568 levels 2 0.787
568 metabolic 1 0.4797
568 obesity 1 1.0048
568 obesity. 1 1.0048
568 plasma 1 0.4051
568 prolonged 1 0.4833
568 responsible 1 0.5074
568 serum 1 0.3898
568 studies 1 0.3077
568 suggest 1 0.4568
569 (0.67-0.02%). 1 0.3015
569 (1.32 1 0.3015
569 (2.25 1 0.3015
569 (equivalent 2 0.6029
569 (urophysis) 1 0.3015
569 0.0225 1 0.3015
569 0.026 1 0.3015
569 0.26% 1 0.3015
569 0.6% 1 0.3015
569 10 1 0.111
569 105 1 0.3015
569 11 1 0.161
569 2 4 0.3682
569 20 2 0.2723
569 28 2 0.4127
569 28-day 1 0.3015
569 4 2 0.2133
569 40 1 0.1766
569 50 1 0.1439
569 6 2 0.2521
569 80 1 0.2064
569 ability 1 0.1536
569 abrupt 1 0.3015
569 action 1 0.1312
569 activity 1 0.1079
569 activity) 1 0.3015
569 activity), 1 0.3015
569 activity, 2 0.4344
569 adenohypophysial 1 0.3015
569 administered 1 0.1439
569 also 1 0.0843
569 alternate 1 0.2538
569 although 2 0.2318
569 appears 1 0.1296
569 arginine 1 0.2317
569 associated 1 0.107
569 average 1 0.1353
569 balanced 1 0.3015
569 beneficial 1 0.2114
569 bovine 2 0.3443
569 carp 1 0.3015
569 caudal 1 0.3015
569 causing 1 0.2238
569 comparable 1 0.1662
569 containing 2 0.3188
569 content 1 0.1418
569 daily 2 0.3288
569 day. 1 0.2414
569 days 1 0.1197
569 days, 1 0.1977
569 days. 2 0.3401
569 dilution 1 0.2064
569 dose 2 0.2878
569 doses 1 0.1644
569 duration 1 0.1579
569 effective. 1 0.2414
569 essential 1 0.1766
569 euryhaline 1 0.3015
569 every 1 0.1681
569 external 2 0.3633
569 extract 1 0.1906
569 f. 3 0.9044
569 failure 4 0.6506
569 fish 5 1.357
569 fresh 3 0.6516
569 fundulus 2 0.6029
569 gradual 1 0.2238
569 gram 6 1.5229
569 gram) 2 0.6029
569 growth 3 0.3083
569 heteroclitus 3 0.9044
569 heteroclitus, 2 0.6029
569 hormone 4 0.4911
569 human 1 0.1006
569 hypochloremia, 1 0.3015
569 hypophysectomized 3 0.5932
569 hypophysectomy, 1 0.3015
569 hypophysectomy. 1 0.2714
569 hypotonic 2 0.5428
569 ineffective. 1 0.2714
569 injections 2 0.3401
569 irrespective 1 0.2064
569 isotocin 1 0.3015
569 killifish, 1 0.3015
569 known 1 0.1473
569 maintained 3 0.5042
569 male 1 0.1536
569 mammalian 1 0.2064
569 media 1 0.2238
569 media. 1 0.2414
569 medium 1 0.161
569 milligram 2 0.6029
569 ml 1 0.2414
569 monkey 1 0.2018
569 months 1 0.1522
569 mossambica 1 0.3015
569 mu 4 1.2058
569 nacl 1 0.2238
569 neurohypophysial 2 0.5428
569 neurosecretory 1 0.3015
569 ovine 1 0.3015
569 oxytocic 1 0.2714
569 peptides, 1 0.3015
569 peptides. 1 0.3015
569 per 10 1.1749
569 period 2 0.2287
569 pituitaries 1 0.2714
569 pituitary 2 0.3127
569 preparations 2 0.3633
569 pressor 1 0.2414
569 pretreatment 1 0.2172
569 previously 1 0.145
569 produces 1 0.1906
569 prolactin 7 1.8997
569 prolactin. 1 0.2714
569 prolong 1 0.2317
569 prolonged 3 0.435
569 protect 2 0.4477
569 purified 3 0.5717
569 related 1 0.1274
569 replacement 1 0.1906
569 reported, 1 0.2414
569 resembling 1 0.2317
569 salinity 2 0.6029
569 salt 3 0.582
569 shorten 1 0.3015
569 solution 1 0.1844
569 suggests 1 0.161
569 survival 5 0.725
569 survival. 3 0.8142
569 survive 1 0.2714
569 teleostean 1 0.3015
569 test 1 0.1304
569 tested 1 0.1817
569 therapy, 1 0.194
569 tilapia 1 0.3015
569 time 1 0.1062
569 tissue 1 0.1046
569 tolerance 1 0.194
569 transfer 1 0.194
569 transfer. 1 0.3015
569 u 2 0.4634
569 ug 3 0.6952
569 vasotocin 1 0.3015
569 water 1 0.1594
569 water, 1 0.2414
569 water. 2 0.4477
569 weeks 1 0.1579
570 (15 1 0.3017
570 (hgh 1 0.3768
570 (hgh), 1 0.3392
570 (mgh) 1 0.3768
570 0.27 1 0.3768
570 1.05 1 0.3768
570 1/2-year-old 1 0.3768
570 100 1 0.2126
570 12 1 0.1799
570 2 1 0.1151
570 5-7 1 0.3768
570 7 2 0.3472
570 absent 1 0.2472
570 acceleration 2 0.6346
570 anti- 1 0.2643
570 anti-hgh 3 1.1304
570 antibodies 1 0.2126
570 antiserum 1 0.2523
570 antiserum, 1 0.3392
570 antiserum. 1 0.3173
570 binding 2 0.6034
570 body 1 0.1519
570 capacity 1 0.2055
570 clinical 1 0.1228
570 cm/month 1 0.3768
570 cm/month. 1 0.3768
570 comparable 1 0.2077
570 concentra- 1 0.2715
570 crude 1 0.2798
570 demonstrated 1 0.1611
570 despite 1 0.2382
570 differed 1 0.258
570 doses 2 0.411
570 dwarfism: 1 0.3173
570 dwarfs 1 0.3017
570 effective 3 0.566
570 extract 1 0.2382
570 fell 1 0.258
570 found 1 0.0992
570 girl 1 0.2523
570 grew 1 0.2523
570 growth 8 1.0275
570 hgh 3 0.7569
570 hgh, 1 0.3392
570 hgh-131i 1 0.3768
570 hgh. 1 0.3173
570 hibitor 1 0.3768
570 high 1 0.1348
570 hormone 4 0.6138
570 human 5 0.6288
570 immunologic 1 0.2472
570 in- 1 0.167
570 ineffective 1 0.2643
570 inhibitor 1 0.2897
570 inhibitors 1 0.2798
570 larger 1 0.2238
570 like 1 0.2425
570 long-term 1 0.2179
570 manner, 1 0.3173
570 ment. 1 0.2798
570 mg/1) 1 0.3768
570 mg/week 1 0.3768
570 mg/week), 1 0.3768
570 monkey 1 0.2523
570 months. 1 0.2523
570 observed 1 0.1284
570 occasions, 1 0.3768
570 occur. 1 0.3017
570 one 1 0.1054
570 patient. 1 0.258
570 patients 1 0.0906
570 persisted 1 0.2897
570 pituitary 2 0.3909
570 placental 1 0.258
570 rabbit 3 0.6377
570 rate 3 0.4161
570 receiving 1 0.2077
570 repeatedly 1 0.3392
570 resistance 1 0.2101
570 retreatment 1 0.3768
570 serum 3 0.4386
570 serum. 2 0.543
570 specificity 1 0.2715
570 stopping 1 0.3173
570 studies 1 0.1154
570 therapy, 1 0.2425
570 thereafter, 1 0.3173
570 thirteen 1 0.2798
570 tion 1 0.1713
570 titers 1 0.3392
570 treat- 1 0.2342
570 treated 1 0.1551
570 treatment, 1 0.2425
570 treatment. 1 0.1992
570 whereas 1 0.1887
571 14 1 0.4155
571 28 1 0.5159
571 ability 4 1.5356
571 ac- 1 0.485
571 adenohypophyses 1 0.7536
571 adenophypophysial 1 0.7536
571 adult 1 0.3426
571 alloxan 1 0.5793
571 alloxan- 1 0.7536
571 alloxan. 1 0.6785
571 amounts 2 0.7483
571 animals. 1 0.4252
571 area 1 0.3909
571 assayed 1 0.6034
571 associated 1 0.2676
571 blood 1 0.2329
571 body 1 0.3038
571 cartilage 2 1.1586
571 concluded 1 0.3449
571 contain 1 0.485
571 contained 1 0.3839
571 content 1 0.3546
571 control 1 0.2834
571 crude 1 0.5596
571 cumulation 1 0.6785
571 days 1 0.2994
571 decreased 2 0.6807
571 decrements 1 0.7536
571 depress 2 1.2691
571 determined. 1 0.5159
571 diabetes 1 0.3711
571 diabetes, 1 0.7536
571 diabetic 4 2.0183
571 diminished 1 0.5046
571 duration 1 0.3946
571 enates 1 0.7536
571 encourage 1 0.7536
571 encourages 1 0.7536
571 epiphysial 1 0.7536
571 equivalent 1 0.5286
571 ex- 1 0.4477
571 extracts 2 0.9221
571 female 1 0.4358
571 following 1 0.2498
571 gain 1 0.543
571 greater 1 0.3118
571 growth 3 0.7706
571 growth-promoting 1 0.6346
571 hematocrit 1 0.6346
571 hematocrits 1 0.7536
571 hematological 1 0.7536
571 homog- 1 0.7536
571 hormone 3 0.9208
571 hypo- 1 0.543
571 hypophysectomized 1 0.4943
571 hypophysial 2 1.5073
571 hypophysis 1 0.6346
571 immature 1 0.5046
571 increase 1 0.256
571 increasing 1 0.4416
571 indices. 1 0.7536
571 influence 2 0.6897
571 injected 1 0.3653
571 injection 1 0.3151
571 insulin 2 0.9083
571 insulin-treated 1 0.7536
571 intensity 1 0.5286
571 levels 1 0.2951
571 maintained 1 0.4202
571 male 1 0.3839
571 normal 1 0.2027
571 noted 1 0.3985
571 obtained 2 0.5373
571 pansion 1 0.7536
571 physial 1 0.7536
571 potency 1 0.6034
571 preparations 1 0.4542
571 rat 1 0.3101
571 rats 4 1.1641
571 rats. 2 0.7893
571 regimen, 1 0.7536
571 repairs 1 0.7536
571 replacement 1 0.4764
571 severity 1 0.4611
571 significant 1 0.2646
571 somatotrophin 1 0.6785
571 state 1 0.3874
571 taken 1 0.4252
571 tibial 1 0.5793
571 tissue 2 0.5232
571 varying 1 0.4066
571 weight, 1 0.5046
571 well 2 0.5271
571 width 2 1.2069
572 15 1 0.7483
572 absent. 1 1.2691
572 adenoma 1 1.086
572 amines 1 1.5073
572 catechol 1 1.5073
572 composition 1 0.8832
572 cytoma 2 3.0145
572 developed 1 0.6851
572 diagnosis 1 0.6202
572 discussed. 1 0.6444
572 eosinophilic 1 1.2069
572 etiological 1 1.1586
572 gland. 1 1.357
572 glycosuria 1 1.357
572 growth 1 0.5138
572 hormone 1 0.6138
572 hyperglycemia, 1 1.5073
572 hypersecretion 1 1.357
572 hypertension 1 0.9528
572 hypertension, 1 1.2069
572 importance 1 0.7678
572 order. 1 1.357
572 patient 1 0.5667
572 pheochromo- 2 3.0145
572 pheochromocytoma 1 1.5073
572 pituitary 1 0.7819
572 predominating 1 1.357
572 profuse 1 1.5073
572 quan- 1 1.5073
572 regarding 1 0.9528
572 relation 1 0.6944
572 relative 1 0.7819
572 seems 1 0.797
572 speculation 1 1.357
572 sweating 1 1.5073
572 symptomatology 1 1.0318
572 symptoms 2 1.4285
572 tachycardia. 1 1.5073
572 tity 1 1.5073
572 without 1 0.5692
572 years 1 0.6851
573 (hgh), 1 0.3015
573 1 2 0.253
573 1-year-old 2 0.6031
573 13 1 0.1937
573 3 3 0.3425
573 7 2 0.3086
573 activity 1 0.1199
573 association 1 0.1807
573 blood 2 0.207
573 case 1 0.1203
573 child 2 0.3222
573 compared 1 0.1299
573 day 1 0.1663
573 days, 1 0.2197
573 defects, 1 0.2349
573 deficiency 2 0.3542
573 deficiency. 1 0.2349
573 described. 1 0.1677
573 doubled 1 0.3349
573 fasting 1 0.2293
573 growth 9 1.0275
573 heretofore 1 0.3015
573 hgh 1 0.2243
573 hormone 4 0.5456
573 hormonelike 1 0.3349
573 human 1 0.1118
573 hypoglycemia, 3 0.8461
573 inch 1 0.2682
573 inches 1 0.3349
573 isolated 2 0.2915
573 leucine. 1 0.3349
573 level 1 0.1293
573 low, 1 0.3015
573 methopyrapone 1 0.3015
573 mg. 2 0.4235
573 months 1 0.1691
573 months. 1 0.2243
573 namely 1 0.2682
573 normal 1 0.0901
573 postprandial 1 0.3349
573 presented 1 0.1299
573 prevented 1 0.2197
573 previous 1 0.1807
573 probable 2 0.4235
573 produced 1 0.1364
573 protein-bound-iodine 1 0.3349
573 response 1 0.1223
573 retardation, 2 0.5364
573 reversed 1 0.2487
573 sensitivity 1 0.2019
573 serum 1 0.1299
573 since 1 0.1457
573 sugar, 1 0.3349
573 times 1 0.1611
573 tolbutamide 1 0.3015
573 treatment 1 0.0988
573 unreported 1 0.282
573 week 1 0.2197
574 actions 1 0.97
574 agents 1 0.8133
574 availability 1 1.086
574 behavior 1 0.8607
574 chemical 1 0.9083
574 concerning 1 0.9369
574 consideration 1 0.9887
574 deal 1 1.1586
574 destruction. 1 1.357
574 diabetes 1 0.7423
574 first 1 0.5526
574 flow 1 0.7678
574 helpful 1 1.0318
574 hints 1 1.5073
574 hormone 1 0.6138
574 information 1 0.8133
574 inhibition 1 0.7546
574 insulin 2 1.8167
574 insulin, 1 1.086
574 interfere 1 1.1192
574 manner 1 1.0318
574 many 1 0.6077
574 mellitus 1 1.357
574 metabolic 1 0.7196
574 might 1 0.7893
574 molecule. 1 1.2069
574 nature 1 0.7483
574 outline 1 1.2691
574 outset 1 1.5073
574 phase 1 0.805
574 precise 1 1.2069
574 present 1 0.4963
574 problems 1 0.7819
574 production, 1 1.5073
574 release 1 0.97
574 reliable 1 1.0091
574 requires 1 0.9221
574 secretion, 1 1.357
574 shall 1 1.5073
574 since 1 0.6558
574 structure 1 0.7678
574 synthesis, 1 1.1586
574 transport 1 0.9083
574 understanding 2 1.9773
574 useful 1 0.831
574 variety 1 0.8133
574 well 1 0.5271
575 (length, 1 0.7536
575 accretion 1 0.6785
575 acquisition 1 0.5286
575 actively 1 0.5596
575 advanced 1 0.3909
575 almost 1 0.3874
575 and, 1 0.3909
575 attempts 1 0.485
575 become 1 0.4155
575 cells 2 0.4549
575 define 1 0.7536
575 fertilization 1 0.7536
575 growth 4 1.0275
575 growth. 1 0.543
575 increase 1 0.256
575 indeed, 1 0.6785
575 insofar 1 0.7536
575 instances 1 0.5046
575 leads 1 0.4202
575 less 1 0.2821
575 lost. 1 0.7536
575 made 1 0.2729
575 maturity 1 0.6346
575 may 1 0.1885
575 millions 1 0.6785
575 negative 1 0.4416
575 new 1 0.3299
575 organization. 1 0.6346
575 ovum 1 0.6785
575 period 1 0.2859
575 physiological 1 0.4416
575 present 1 0.2481
575 process 1 0.3449
575 progresses 1 0.7536
575 protein 1 0.3426
575 reflected 1 0.5596
575 retardation 1 0.5159
575 review, 1 0.6785
575 sexual 1 0.5793
575 size 1 0.3946
575 standpoint 1 0.6034
575 state 1 0.3874
575 time, 1 0.4358
575 tissue 1 0.2616
575 various 1 0.2979
575 volume) 1 0.6785
575 water. 1 0.5596
575 weight, 1 0.5046
575 years 1 0.3426
576 'achondroplastic' 1 0.5024
576 (wilhelmi) 1 0.5024
576 1 1 0.1897
576 1/2 2 0.8046
576 1/4 1 0.4523
576 12 1 0.2399
576 15 1 0.2494
576 2/5 1 0.5024
576 3 6 1.0275
576 4 1 0.1777
576 5 1 0.1906
576 8 1 0.2269
576 achondroplastic 1 0.5024
576 age 1 0.2078
576 also 1 0.1406
576 another 1 0.274
576 became 1 0.2985
576 continued 1 0.2905
576 de- 1 0.2801
576 dosage 1 0.3028
576 dwarf 2 0.8461
576 dwarfism 1 0.3524
576 effect 1 0.1534
576 first 1 0.1842
576 formed 1 0.2801
576 great 1 0.2869
576 grew 2 0.6728
576 growth 5 0.8563
576 growth-promoting 1 0.423
576 hgh 1 0.3364
576 hormone 1 0.2046
576 human 1 0.1677
576 hypopi- 1 0.5024
576 hypopituitary 1 0.3439
576 inch 2 0.8046
576 inch. 2 1.0048
576 increasing 1 0.2944
576 induced 1 0.2136
576 intermittently 1 0.4523
576 least 1 0.2582
576 li 1 0.5024
576 long-term 1 0.2905
576 main- 1 0.5024
576 mg. 4 1.2704
576 month, 1 0.5024
576 month. 1 0.423
576 monthly 2 1.0048
576 old 2 0.5669
576 preparations. 1 0.3731
576 raben 1 0.4523
576 rate 2 0.3699
576 reported 1 0.2036
576 resistant. 1 0.4523
576 severely 1 0.3233
576 spurt 1 0.5024
576 subsided. 1 0.5024
576 tained. 1 0.5024
576 times 4 0.9667
576 treated 2 0.4135
576 treatment 2 0.2965
576 tuitary 1 0.4523
576 week 4 1.3182
576 year 2 0.5212
576 year. 1 0.3524
576 years. 1 0.3176
577 able 1 0.2429
577 accurate 1 0.2635
577 acro- 1 0.4306
577 acromegalic 1 0.4306
577 acromegaly 1 0.3626
577 active 1 0.1984
577 activity 1 0.1541
577 administration 1 0.1896
577 agents 1 0.2324
577 alter 1 0.2883
577 androgen 1 0.3626
577 assay 1 0.2825
577 attempt 1 0.2635
577 availability 1 0.3103
577 basal 1 0.2825
577 block 1 0.3103
577 blunt 1 0.4306
577 condition, 1 0.4306
577 determine 1 0.2429
577 diagnosis 1 0.1772
577 directly 1 0.2722
577 dosage 1 0.2595
577 early 1 0.1579
577 effectiveness. 1 0.3877
577 effects 3 0.4796
577 either 1 0.1841
577 estrogen, 1 0.3877
577 feasible 1 0.3448
577 forsham 1 0.4306
577 glucocorticoid 1 0.3626
577 growth 7 1.0275
577 h. 1 0.3448
577 hormone 6 1.0523
577 hormones 1 0.3021
577 human 1 0.1437
577 hypoglycemia. 1 0.3626
577 index 1 0.2558
577 insulin 1 0.2595
577 insulin-induced 1 0.3626
577 made 2 0.3119
577 measure 3 0.7471
577 megaly. 1 0.4306
577 normal 1 0.1158
577 patient 1 0.1619
577 patients 2 0.207
577 patterns. 1 0.3877
577 peter 1 0.3877
577 physiologic 1 0.2771
577 pituitary 1 0.2234
577 possible 2 0.3455
577 precise 1 0.3448
577 present 1 0.1418
577 problem 1 0.2459
577 provides 1 0.2722
577 purported 1 0.4306
577 response 2 0.3145
577 responsiveness 1 0.3448
577 schedules 1 0.4306
577 secretion 2 0.5047
577 sensitive 1 0.2324
577 special 1 0.2277
577 standard 1 0.2948
577 steroid 1 0.249
577 stimulus 1 0.2883
577 study 1 0.1327
577 study, 1 0.2771
577 suppress 1 0.3198
577 test 1 0.1863
577 therapeutic 1 0.2175
577 therapy. 1 0.2324
577 tolerance 1 0.2771
577 used 1 0.1626
577 various 2 0.3405
577 whether 1 0.2138
578 1 1 0.2277
578 13 1 0.3487
578 2 1 0.1841
578 accelerated 1 0.4344
578 acetic 1 0.6029
578 acetone-dried 1 0.6029
578 acetone. 1 0.6029
578 acid 1 0.2328
578 adrenal 1 0.3581
578 adverse 1 0.4634
578 alternate 1 0.5076
578 aqueous 1 0.4344
578 called 1 0.4344
578 cent 1 0.3099
578 chloride 1 0.4344
578 clinical 1 0.1965
578 cold 1 0.4127
578 complement 1 0.4127
578 corticotropin. 1 0.6029
578 days, 1 0.3955
578 dwarfs 1 0.4827
578 effects. 1 0.4827
578 extraction 1 0.4344
578 glacial 1 0.6029
578 good 1 0.3362
578 growth 5 1.0275
578 hormone 4 0.9822
578 hot 1 0.6029
578 human 2 0.4024
578 indications 1 0.4127
578 intra- 1 0.4229
578 laboratory 1 0.3487
578 mended 1 0.6029
578 mg 1 0.3581
578 muscularly 1 0.6029
578 per 1 0.235
578 physical 1 0.3487
578 pituitary 1 0.3127
578 powder 1 0.5428
578 practical 3 1.164
578 precipita- 1 0.6029
578 preparation 3 1.164
578 prepared 1 0.3633
578 rate 1 0.2219
578 recognition 1 0.4037
578 recom- 1 0.5428
578 relatively 1 0.29
578 safety, 1 0.6029
578 signs 1 0.3362
578 simplicity 1 0.5428
578 sodium 1 0.29
578 solution, 1 0.4634
578 stimulation 1 0.3401
578 subsequent 1 0.3288
578 tion 1 0.2741
578 treatment 1 0.1779
578 two 1 0.1846
578 use 1 0.2383
578 yield 1 0.4477
578 yield. 1 0.6029
579 (0.05 1 0.7536
579 (1 1 0.6785
579 abolished 1 0.4943
579 ac- 1 0.485
579 action 3 0.9837
579 adipose 2 1.2069
579 cannot 1 0.4066
579 completely 1 0.4416
579 concluded 1 0.3449
579 cortico- 1 0.6785
579 corticotropin 1 0.6346
579 cortisol 1 0.6346
579 crude, 1 0.7536
579 donor 1 0.5286
579 doses 2 0.8219
579 effect. 1 0.4943
579 endocrine 1 0.5286
579 epinephrine 4 2.4137
579 epinephrine, 1 0.7536
579 epinephrine. 2 1.357
579 extract 2 0.9528
579 factors 1 0.3186
579 full 1 0.5046
579 given. 1 0.5793
579 growth 1 0.2569
579 hormone 1 0.3069
579 hormones 1 0.5286
579 however, 1 0.2729
579 hypo- 2 1.086
579 hypophysectomized 1 0.4943
579 hypophysectomy 1 0.543
579 importance 1 0.3839
579 incubation 1 0.4611
579 influence 1 0.3449
579 injections 1 0.4252
579 large 1 0.2979
579 lipolytic 4 3.0145
579 mal 1 0.5046
579 medium) 1 0.7536
579 nor- 1 0.485
579 normal 1 0.2027
579 normal. 1 0.4542
579 partial, 1 0.7536
579 physectomized 1 0.7536
579 physectomy 1 0.7536
579 physiological 2 0.8832
579 pi- 1 0.7536
579 pituitary 1 0.3909
579 posterior 1 0.4416
579 produced 1 0.3069
579 quantitated. 1 0.7536
579 rat 1 0.3101
579 rats 2 0.5821
579 rats. 1 0.3946
579 reestablished 1 0.6785
579 relatively 1 0.3625
579 replacement 1 0.4764
579 response 2 0.5503
579 restoration 1 0.5596
579 restored 2 1.0572
579 sensitivity 1 0.4542
579 several 1 0.326
579 sterone 1 0.7536
579 thyrotropin 1 0.7536
579 tion 1 0.3426
579 tissue 2 0.5232
579 treatment 3 0.667
579 triiodothyronine 1 0.7536
579 tuitary 1 0.6785
579 ug/ml 1 0.6785
579 ug/rat/day), 1 0.7536
579 vitro 1 0.3874
579 whole 1 0.4202
579 without 1 0.2846
579 yet 1 0.3985
580 4 1 0.1333
580 acetylated 1 0.3768
580 acid 1 0.1455
580 acids 1 0.1856
580 administra- 1 0.3392
580 administration 2 0.3319
580 albumin 1 0.2643
580 altered 1 0.2012
580 animals, 1 0.2271
580 anti- 1 0.2643
580 antigenically 1 0.3017
580 appeared 1 0.1813
580 attached 1 0.2798
580 biologically 1 0.2798
580 bovine 4 0.8607
580 c-acetyl 1 0.3768
580 c-acetylation. 1 0.3768
580 comparable 1 0.2077
580 concentration 1 0.1584
580 degree 1 0.167
580 described 1 0.1429
580 dilution 1 0.258
580 fatty 2 0.3773
580 following 2 0.2498
580 free 2 0.3571
580 growth 8 1.0275
580 hormone 6 0.9208
580 hormone, 1 0.2425
580 hormone. 3 0.6624
580 hours. 1 0.2715
580 human 1 0.1258
580 hypophysec- 1 0.3768
580 immunized 1 0.2715
580 increase 1 0.128
580 increased 1 0.1171
580 injection 1 0.1576
580 intravenous 1 0.2012
580 isotope 1 0.3017
580 label 1 0.3017
580 labeled 4 0.9083
580 labeling 1 0.2472
580 least 1 0.1937
580 molecule 2 0.5286
580 neutralized 1 0.3392
580 procedure 1 0.1919
580 promoted 1 0.3392
580 rabbit 2 0.4252
580 rabbits 1 0.2152
580 rat 1 0.1551
580 rats 1 0.1455
580 remain 1 0.2715
580 response 1 0.1376
580 seen 1 0.1593
580 serum 3 0.4386
580 similar 1 0.1411
580 tion 1 0.1713
580 tomized 1 0.3768
580 unlabeled 2 0.6785
581 able 1 0.1308
581 abnormali- 1 0.2319
581 accompanied 1 0.1293
581 accompanies 1 0.2319
581 acid 1 0.0895
581 acids 3 0.3426
581 acids. 1 0.1782
581 acquired 1 0.1441
581 adipose 1 0.1857
581 administration 4 0.4084
581 also 1 0.0649
581 amino 2 0.2932
581 antibodies 1 0.1308
581 availability 1 0.1671
581 bilizes 1 0.2319
581 body 1 0.0935
581 carbohydrate 1 0.1626
581 carbohydrate, 1 0.2319
581 cartilage, 1 0.2319
581 cell 1 0.0785
581 concentration 2 0.195
581 control 1 0.0872
581 correlation 1 0.1171
581 de- 1 0.1293
581 depletion 1 0.1521
581 detected 1 0.1203
581 diabetic 1 0.1553
581 directed 1 0.1553
581 effect 3 0.2124
581 effective 1 0.1161
581 energy, 1 0.2319
581 factor 1 0.1099
581 fat 1 0.1419
581 fat, 1 0.2088
581 fatty 3 0.3483
581 fol- 1 0.1722
581 followed 2 0.2122
581 following 1 0.0769
581 free 1 0.1099
581 glands. 1 0.1857
581 glucose 2 0.2429
581 glycemia, 1 0.2319
581 glycosuria, 1 0.2319
581 growth 13 1.0275
581 hor- 1 0.1952
581 hormone 8 0.7555
581 hormone. 1 0.1359
581 hormone; 1 0.2319
581 human 1 0.0774
581 hyper- 1 0.1377
581 hypercalciuria 1 0.2088
581 hypopituitarism 1 0.1857
581 hypothalamus 1 0.2088
581 immunoassay. 1 0.2319
581 incorporation 1 0.1466
581 increases 1 0.1083
581 individuals 1 0.1587
581 influences 1 0.1782
581 inhibition 1 0.1161
581 inorganic 1 0.1587
581 instances, 1 0.1782
581 inti- 1 0.2319
581 involved 1 0.1181
581 jects 1 0.2319
581 ketosis; 1 0.2319
581 long-term 1 0.1341
581 lowed 1 0.1857
581 many 1 0.0935
581 mately 1 0.2319
581 may 1 0.058
581 me- 1 0.1782
581 mediated 1 0.1671
581 ment, 1 0.1782
581 metabolism 1 0.1099
581 metabolism. 1 0.1553
581 mineral 1 0.2319
581 mo- 1 0.2319
581 mone 1 0.1952
581 nitrogen 1 0.1521
581 normal 1 0.0624
581 order 1 0.1214
581 para- 1 0.1857
581 patient 1 0.0872
581 phosphate 1 0.1171
581 pituitary. 1 0.2319
581 plasma 1 0.0935
581 potassium, 1 0.2088
581 promotes 1 0.2088
581 promoting 1 0.2088
581 protein, 1 0.1671
581 protein. 2 0.3565
581 provide 1 0.1359
581 radio- 1 0.1722
581 release 1 0.1492
581 released 1 0.1952
581 resistance 1 0.1293
581 retained 1 0.1782
581 retention, 1 0.1782
581 secretion 1 0.1359
581 serum 2 0.1799
581 sodium, 1 0.2088
581 source 1 0.1553
581 stores 1 0.2088
581 sub- 1 0.1492
581 subjects 1 0.1107
581 substances; 1 0.2319
581 substitute 1 0.2088
581 subtle. 1 0.2319
581 synthesis. 1 0.1857
581 tabolism 1 0.2319
581 thyroid 1 0.1359
581 ties. 1 0.2319
581 tissue 1 0.0805
581 transportation 1 0.1952
581 treat- 1 0.1441
581 unavail- 1 0.2319
581 use 1 0.0917
581 usually 1 0.1091
581 velopment 1 0.2319
581 wall, 1 0.1952
582 1960. 1 1.5073
582 advances 2 2.5382
582 appearing 1 1.1192
582 biochemistry 1 1.2691
582 bone 1 0.6519
582 bone. 1 1.1192
582 bone: 1 1.2691
582 bring 1 1.1586
582 calcitonin, 1 1.5073
582 calcium 1 0.8954
582 cameron 1 1.5073
582 copp 1 1.5073
582 detail 1 1.1586
582 discussed 1 0.6138
582 dr. 1 1.1586
582 glands 1 0.97
582 here. 1 1.2691
582 hormone, 1 0.97
582 hypothetical 1 1.5073
582 important 1 0.6807
582 introductory 1 1.5073
582 investigating 1 1.5073
582 knowledge 1 0.9887
582 laboratory 1 0.8716
582 lecture 1 1.5073
582 lecture, 1 1.5073
582 literature 1 0.8219
582 mclean's 1 1.5073
582 metabolism 1 0.7143
582 need 1 0.9221
582 new 2 1.3194
582 object 1 1.1192
582 original 1 0.8607
582 outline 1 1.2691
582 parathyroid 1 0.805
582 part 1 0.7041
582 physiology 2 2.2385
582 present 1 0.4963
582 problems 1 0.7819
582 recent 1 0.7893
582 references 1 1.2691
582 repeated 1 0.8954
582 research. 1 1.357
582 since 1 0.6558
582 subjects 1 0.7196
582 summarizes 1 1.357
582 textbook 1 1.5073
582 time. 1 1.0572
582 up-to-date 1 1.5073
583 3-methyl- 1 0.6029
583 3-methylcholanthrene 1 0.6029
583 agent 1 0.3533
583 carcinogenic 1 0.4634
583 chemical 1 0.3633
583 cholanthrene 1 0.6029
583 compound 1 0.4127
583 could 1 0.2166
583 effectiveness 1 0.4229
583 exogenous 1 0.4827
583 exposed 1 0.3157
583 found 1 0.1587
583 gland 1 0.4827
583 gland. 1 0.5428
583 glands 3 1.164
583 hormones. 1 0.6029
583 hyper- 1 0.3581
583 hyperplastic 2 0.9269
583 lesions 4 1.037
583 mammary 5 1.9399
583 measure 1 0.3487
583 mice 1 0.2969
583 mouse 1 0.3362
583 plastic 1 0.4634
583 present 1 0.1985
583 probable 1 0.3811
583 production 1 0.3071
583 serve 1 0.4344
583 similar 1 0.2257
583 treated 1 0.2481
583 treatment 1 0.1779
583 tumor 1 0.2688
583 virus. 1 0.4344
584 action 1 0.2186
584 administration; 1 0.5024
584 balance 1 0.3439
584 balances 1 0.423
584 bone 2 0.4346
584 calcium 1 0.2985
584 calciuric 1 0.5024
584 change 1 0.2331
584 characteris- 1 0.4523
584 concentration 1 0.2112
584 concluded 1 0.2299
584 concomitantly 1 0.5024
584 consistently 1 0.3233
584 crease 1 0.3364
584 differs 1 0.3439
584 droxyproline 1 0.5024
584 duce 1 0.5024
584 due 1 0.1777
584 excretion 1 0.2364
584 excretion, 1 0.4523
584 exogenous 1 0.4023
584 failed 1 0.2869
584 four 1 0.2254
584 furthermore, 1 0.3731
584 growth 6 1.0275
584 hormone 3 0.6138
584 hormone, 1 0.3233
584 human 2 0.3354
584 hy- 1 0.3524
584 in- 2 0.4452
584 increase 2 0.3413
584 indicated 1 0.2364
584 infants 4 0.9594
584 infants. 2 0.6879
584 influence 1 0.2299
584 linear 1 0.3233
584 lism 1 0.5024
584 mature 1 0.3123
584 may 1 0.1257
584 metabo- 1 0.5024
584 metabolic 2 0.4797
584 nefa 1 0.3862
584 nitrogen 2 0.6591
584 normally 1 0.3176
584 observed 1 0.1713
584 observed. 2 0.6056
584 phosphorus 1 0.3296
584 possible 1 0.2015
584 premature 5 1.7197
584 reduced 1 0.2269
584 register 1 0.5024
584 response 1 0.1834
584 retention, 1 0.3862
584 rose 1 0.3524
584 serum 1 0.1949
584 sharp 1 0.4523
584 significant 1 0.1764
584 significantly. 1 0.3862
584 sth 4 1.6922
584 studies 2 0.3077
584 subjects. 1 0.3074
584 therefore 1 0.3074
584 three 1 0.1889
584 tic 1 0.3731
584 treated 2 0.4135
584 urinary 2 0.4452
585 1 1 0.1897
585 12 1 0.2399
585 2. 1 0.2631
585 abolished 1 0.3296
585 absence 2 0.4797
585 action 1 0.2186
585 activity 3 0.5394
585 addition 1 0.2559
585 ammon- 1 0.5024
585 ammonium 1 0.423
585 assay 1 0.3296
585 concentrations 1 0.2582
585 death 1 0.274
585 decreased 1 0.2269
585 effect 3 0.4602
585 effect. 1 0.3296
585 enzyme 1 0.2985
585 growth 6 1.0275
585 h 1 0.3862
585 high 1 0.1798
585 hormone 6 1.2277
585 however, 1 0.182
585 human 1 0.1677
585 hypophysectomized 1 0.3296
585 hypophysectomy 1 0.362
585 increased 1 0.1562
585 injection 1 0.2101
585 ionic 1 0.3862
585 ium 1 0.5024
585 labelling 1 0.4023
585 liver 1 0.1977
585 measured 1 0.2199
585 medium 1 0.2683
585 mentioned 1 0.362
585 mg 1 0.2985
585 normal 1 0.1351
585 nuclear 1 0.2905
585 polymerase 3 1.357
585 preparations. 1 0.3731
585 presence 1 0.1914
585 raising 1 0.362
585 rat 3 0.6202
585 rats 1 0.194
585 rats. 1 0.2631
585 results 1 0.1439
585 rna 4 1.108
585 seen 2 0.4248
585 shown 1 0.216
585 significant 1 0.1764
585 stimulating 1 0.3524
585 strength 1 0.3731
585 sulphate 1 0.423
585 sulphate; 1 0.5024
585 system 1 0.2347
585 table 1 0.423
585 vitro 1 0.2582
586 (0.5-3.0 1 0.3015
586 (dna) 1 0.3015
586 (sth) 1 0.2714
586 1-13 1 0.3015
586 14 2 0.3324
586 2 1 0.092
586 3-19 1 0.3015
586 6 1 0.126
586 acid 1 0.1164
586 also 1 0.0843
586 and/or 1 0.1906
586 another 1 0.1644
586 carried 2 0.3018
586 ceiving 1 0.2538
586 compared 1 0.1169
586 constant 1 0.1644
586 content 1 0.1418
586 control 2 0.2267
586 controls. 3 0.5932
586 daily 2 0.3288
586 day 4 0.5987
586 days 1 0.1197
586 deoxyribonucleic 1 0.2114
586 determined 2 0.2741
586 differ 1 0.1977
586 dna 2 0.2878
586 dose 2 0.2878
586 either 1 0.1289
586 elevation 1 0.2114
586 every 1 0.1681
586 evident 1 0.1874
586 gestation 1 0.2238
586 gland 1 0.2414
586 graded 2 0.5428
586 greater 1 0.1247
586 group 1 0.1114
586 groups 2 0.2455
586 growth 1 0.1028
586 hormone 2 0.2455
586 in- 1 0.1336
586 increases 1 0.1408
586 increments 2 0.5428
586 injections 1 0.1701
586 irrespective 1 0.2064
586 jections 1 0.3015
586 lactation 3 0.8142
586 lactation. 3 0.9044
586 lactators 1 0.3015
586 level 1 0.1164
586 mam- 1 0.2538
586 mammary 3 0.582
586 mary 1 0.2414
586 mg 1 0.1791
586 mg) 1 0.3015
586 milk 3 0.6952
586 occurred 1 0.1312
586 postpartum. 1 0.3015
586 pregnancy 4 0.7065
586 rats 10 1.1641
586 re- 1 0.1336
586 received 2 0.3401
586 receiving 1 0.1662
586 schedule 1 0.2414
586 served 1 0.1977
586 significant 2 0.2116
586 significantly 1 0.1267
586 somatotropin 2 0.6029
586 sth 3 0.7615
586 treated 3 0.3721
586 yield 3 0.6715
587 (1) 1 0.7306
587 (2) 1 0.7306
587 accompanying 1 1.0572
587 account 1 0.8503
587 additional 1 0.805
587 adh-growth 1 1.5073
587 adh. 1 1.5073
587 adh; 1 1.5073
587 available 1 0.8219
587 categories: 1 1.357
587 considerations, 1 1.5073
587 currently 1 1.1192
587 diabetes 2 1.4845
587 divide 1 1.2691
587 fail 1 1.2691
587 group. 1 0.8716
587 growth 2 1.0275
587 hormone 1 0.6138
587 insipidus 1 0.805
587 insipidus: 1 1.357
587 later 1 0.7747
587 least 1 0.7747
587 may 2 0.7539
587 mechanism? 1 1.5073
587 nephrogenic 1 1.0318
587 normal 1 0.4053
587 part 1 0.7041
587 patients 1 0.3623
587 presumably 2 1.9773
587 products 1 1.0572
587 reduced 1 0.6807
587 respond 1 0.9221
587 retardation 2 2.0636
587 secretion 2 1.7663
587 similar 2 1.1286
587 theory 1 0.97
587 therapeutic 1 0.7611
587 treatment 1 0.4447
587 two 1 0.4616
587 unresponsiveness 1 1.357
587 well 2 1.0542
588 & 1 0.5428
588 (1958) 1 0.6029
588 (1960). 1 0.6029
588 (gh). 1 0.6029
588 (pitressin) 1 0.6029
588 0.25 1 0.5076
588 10 1 0.2219
588 acts 1 0.4344
588 al. 1 0.4344
588 alveoli 2 0.8688
588 amount 1 0.2969
588 auto- 1 0.5428
588 autotransplanted 3 1.8087
588 body 4 0.9723
588 capacity 1 0.3288
588 capsule 1 0.4827
588 capsule, 1 0.4634
588 capsule. 1 0.5428
588 cartilage 1 0.4634
588 considerable 1 0.3127
588 controls. 1 0.3955
588 daily 1 0.3288
588 days, 1 0.3955
588 deficiency 1 0.3188
588 del 1 0.6029
588 development 2 0.4402
588 development. 1 0.4127
588 ectomized 1 0.6029
588 effect 1 0.1841
588 epiphyseal 4 2.1711
588 et 1 0.4037
588 experiments 1 0.2671
588 factor. 1 0.4634
588 favour 1 0.5428
588 further, 1 0.4634
588 gh 3 1.3903
588 gland 4 1.931
588 gland, 1 0.5428
588 glands 2 0.776
588 groups 1 0.2455
588 growth 3 0.6165
588 growth, 1 0.4037
588 hiroshige 1 0.6029
588 hormone 2 0.4911
588 however, 1 0.2183
588 hypophys- 1 0.6029
588 hypophysis 2 1.0153
588 hypophysis, 1 0.6029
588 influence 1 0.2759
588 injections 2 0.6802
588 intact 1 0.3324
588 itoh 1 0.6029
588 kidney 3 0.8014
588 length, 1 0.5076
588 mam- 1 0.5076
588 mammary 3 1.164
588 markedly 1 0.322
588 mary 1 0.4827
588 mg 1 0.3581
588 much 1 0.2671
588 observations 1 0.2535
588 pitressin 1 0.5076
588 pituitary 4 1.251
588 preparation 1 0.388
588 propionate 1 0.4477
588 purified 1 0.3811
588 rats 5 1.1641
588 rats. 1 0.3157
588 reduced 1 0.2723
588 regard 1 0.3443
588 releasing 1 0.6029
588 reported 1 0.2443
588 secreted 1 0.5076
588 secretion 2 0.7065
588 secretory 1 0.4229
588 seen 2 0.5098
588 show 1 0.2608
588 small 1 0.2419
588 special 1 0.3188
588 stimulation 1 0.3401
588 studied 1 0.2101
588 studied. 1 0.3401
588 studies 1 0.1846
588 support 1 0.3324
588 testosterone 2 0.8688
588 theory 1 0.388
588 therefore 1 0.3689
588 tibial 4 1.8538
588 tissue. 1 0.388
588 transplanted 4 1.7375
588 vasopressin 2 0.8255
588 vecchio 1 0.6029
588 view 1 0.3533
588 weight, 1 0.4037
588 width 3 1.4482
589 (hgh) 1 0.4523
589 2 1 0.1534
589 3 1 0.1713
589 5 1 0.1906
589 9 2 0.5262
589 above, 1 0.5024
589 accelerates 1 0.5024
589 active 1 0.2315
589 age. 1 0.2834
589 also 1 0.1406
589 antibodies 4 1.1337
589 antibodies. 1 0.423
589 average 3 0.6763
589 beginning 1 0.3176
589 below, 1 0.4523
589 biological 1 0.2683
589 catch-up 1 0.5024
589 caused 2 0.4398
589 certainly 1 0.423
589 children 2 0.3568
589 could 1 0.1805
589 decreasing 1 0.4023
589 deficiency. 2 0.7048
589 develop- 1 0.3862
589 development 1 0.1834
589 diagnostic 1 0.2494
589 dosage 2 0.6056
589 dwarfism 1 0.3524
589 dwarfism. 1 0.423
589 dwarfs 2 0.8046
589 dwarfs, 1 0.5024
589 effect 2 0.3068
589 endogenous 1 0.3439
589 far-reaching 1 0.5024
589 first 2 0.3684
589 five-day 1 0.5024
589 general 1 0.2559
589 gh 2 0.7724
589 great 1 0.2869
589 growth 6 1.0275
589 growth. 1 0.362
589 help 1 0.362
589 hgh 6 2.0183
589 high 2 0.3596
589 homogenous 1 0.5024
589 homologous 1 0.3439
589 hormone 4 0.8185
589 human 2 0.3354
589 hypopituitary 5 1.7197
589 importance. 1 0.4523
589 induced 1 0.2136
589 induction 1 0.3233
589 interest. 1 0.423
589 later 1 0.2582
589 least 1 0.2582
589 man 1 0.2582
589 ment 1 0.3296
589 metabolic 1 0.2399
589 metabolism 1 0.2381
589 mg./m.2 1 0.5024
589 mg./m.2/day 1 0.5024
589 might 1 0.2631
589 months 1 0.2537
589 months, 1 0.3862
589 n 2 0.9046
589 occasional 1 0.362
589 phenomenon 1 0.2905
589 physiological 1 0.2944
589 possibility 1 0.2869
589 preceding 1 0.3862
589 probably 1 0.2284
589 prolonged 1 0.2417
589 protein 1 0.2284
589 raben 1 0.4523
589 range 1 0.2711
589 rate, 1 0.3524
589 replacement 1 0.3176
589 resistance 1 0.2801
589 resistant 1 0.3074
589 response 1 0.1834
589 retain 1 0.4523
589 retention 1 0.3123
589 specific 1 0.1977
589 spite 1 0.3364
589 standardized 1 0.3862
589 suppress 1 0.3731
589 test 2 0.4346
589 test. 1 0.3296
589 therapy. 1 0.2711
589 titres 1 0.4523
589 treated 1 0.2067
589 treatment 1 0.1482
589 treatment, 1 0.3233
589 treatment. 1 0.2657
589 twice 1 0.3862
589 typical 1 0.3296
589 unexpected 1 0.423
589 used 1 0.1897
589 valuable 1 0.3233
589 weekly. 1 0.5024
589 without 2 0.3795
590 abnormal 1 0.2435
590 activity 2 0.3596
590 administration 2 0.4425
590 altered 1 0.2683
590 anabolic 1 0.4523
590 apparently 1 0.274
590 appeared 1 0.2417
590 balance 1 0.3439
590 behind 1 0.4023
590 both. 1 0.4523
590 cannot 1 0.2711
590 case 1 0.1805
590 center 1 0.3233
590 chro- 1 0.4523
590 constitution 1 0.423
590 correlation 1 0.2537
590 creased 1 0.3296
590 creatine 1 0.5024
590 creatinuria 1 0.5024
590 defect 1 0.2474
590 diminished 1 0.3364
590 discussed. 1 0.2148
590 dose 2 0.4797
590 dose. 1 0.4023
590 doses 2 0.548
590 e. 1 0.3439
590 effect 1 0.1534
590 effects 1 0.1865
590 epiphyseal 1 0.4523
590 epiphyses 1 0.4523
590 except 1 0.2834
590 excretion 2 0.4727
590 explained. 1 0.4023
590 factor 3 0.7143
590 factors 1 0.2124
590 greater 1 0.2078
590 growth 6 1.0275
590 growth, 1 0.3364
590 h. 1 0.4023
590 higher 1 0.216
590 hormone 5 1.0231
590 hormone. 1 0.2944
590 human 2 0.3354
590 hydroxyproline 1 0.4523
590 hysiological 1 0.5024
590 i.e. 1 0.3862
590 in- 1 0.2226
590 increased 2 0.3124
590 investigated 1 0.2869
590 less 1 0.1881
590 level 1 0.194
590 levels 1 0.1967
590 linear 1 0.3233
590 magnesium, 1 0.4523
590 major 1 0.2417
590 make 1 0.2985
590 mechanism 1 0.2315
590 metabolic 1 0.2399
590 might 1 0.2631
590 mosome 1 0.4523
590 normal 1 0.1351
590 normally 1 0.3176
590 obtained 1 0.1791
590 one 1 0.1406
590 parameters 1 0.362
590 patients 4 0.4831
590 physiological 1 0.2944
590 present 1 0.1654
590 presented 1 0.1949
590 processes 1 0.2985
590 range 1 0.2711
590 respect, 1 0.4523
590 respect. 1 0.5024
590 response 1 0.1834
590 responsive 1 0.3731
590 retarded 1 0.3233
590 retention 1 0.3123
590 serum 1 0.1949
590 serum. 1 0.362
590 sex 1 0.3364
590 short 2 0.5811
590 sjoberg 1 0.5024
590 stimulating 1 0.3524
590 studied 2 0.3501
590 studies. 1 0.3862
590 subjects 1 0.2399
590 suggested 1 0.2089
590 sulphation 2 1.0048
590 syndrome 2 0.4661
590 term 2 0.5603
590 three 2 0.3778
590 treatment. 1 0.2657
590 turner's 2 1.0048
590 two 2 0.3077
590 urinary 3 0.6678
590 used 1 0.1897
590 used, 1 0.3233
590 within 1 0.1865
590 would 1 0.2494
590 zones. 1 0.4523
591 (ovine 1 0.7536
591 0.5 1 0.5596
591 5.0 1 0.6785
591 activities. 1 0.6346
591 activity 1 0.2697
591 administration 1 0.3319
591 alloxan-treated 1 0.7536
591 based 1 0.3946
591 bioassay 1 0.6785
591 certain 1 0.3319
591 determination 1 0.4611
591 doses 2 0.8219
591 effect 1 0.2301
591 endocrine 1 0.5286
591 enzyme 3 1.3431
591 factors 1 0.3186
591 following 1 0.2498
591 given 1 0.2763
591 growth 4 1.0275
591 gulating 1 0.7536
591 hormone 4 1.2277
591 hypophysectomized 1 0.4943
591 hypophysectomy. 1 0.6785
591 intact 1 0.4155
591 investigated 1 0.4303
591 kidney 4 1.3357
591 large 1 0.2979
591 low 2 0.6597
591 mice 2 0.7423
591 mouse 1 0.4202
591 mouse. 1 0.6785
591 nih) 1 0.7536
591 normal. 2 0.9083
591 re- 1 0.3339
591 relatively 1 0.3625
591 restore 1 0.6346
591 role 1 0.3496
591 suggested 1 0.3134
591 total 1 0.2937
591 towards 1 0.543
591 transamidinase 3 2.2609
591 transamidinase. 1 0.7536
591 triiodothyronin 1 0.7536
591 ug/day 1 0.7536
591 values 2 0.7611
592 "mammotropic" 2 0.6699
592 (mtt.f4). 1 0.3349
592 acetate 1 0.2487
592 acetate, 2 0.5641
592 adrenals 1 0.282
592 adrenocorticotropin, 1 0.3349
592 although 1 0.1288
592 amounts 1 0.1663
592 atrophy 1 0.2487
592 bearing 2 0.5364
592 body 4 0.5401
592 cortisol 3 0.8461
592 determined 1 0.1523
592 dose 1 0.1599
592 effect 3 0.3068
592 effects 1 0.1243
592 enhanced 1 0.2082
592 enlargement 1 0.2293
592 estradiol 1 0.2682
592 estradiol, 2 0.5641
592 follicle-stimulating 1 0.3349
592 furth 1 0.3349
592 growth 4 0.4567
592 growth, 3 0.6728
592 growth. 1 0.2413
592 hormone, 2 0.4311
592 hormones 1 0.2349
592 increased 2 0.2082
592 increases 1 0.1565
592 indicated 1 0.1576
592 influence 1 0.1533
592 influencing 1 0.2487
592 inhibited 1 0.2117
592 known 1 0.1636
592 large 1 0.1324
592 levels 4 0.5246
592 luteinizing 1 0.3349
592 organ 2 0.4699
592 partially 1 0.2082
592 pituitary 2 0.3475
592 plasma 3 0.4051
592 prolactin 3 0.9046
592 prolactin, 1 0.3349
592 rats 2 0.2587
592 rats. 1 0.1754
592 reduced 1 0.1513
592 secrete 1 0.3015
592 significant 2 0.2352
592 significantly 3 0.4225
592 somatotropic 1 0.3349
592 somatotropin, 1 0.3349
592 suppressed 1 0.2293
592 thiouracil 2 0.6031
592 thymus. 1 0.3015
592 thyroid 1 0.1963
592 thyrotropin. 1 0.3349
592 thyroxine 2 0.6699
592 thyroxine, 1 0.3349
592 tumor 9 1.344
592 tumor-bearing 1 0.3349
592 used, 1 0.2155
592 weight. 1 0.2487
592 weights, 1 0.2682
592 weights. 1 0.3015
592 without 1 0.1265
593 10 1 0.1849
593 2 1 0.1534
593 5 1 0.1906
593 7 2 0.4629
593 7; 1 0.5024
593 9 1 0.2631
593 9; 1 0.5024
593 absence 1 0.2399
593 administered 1 0.2399
593 administration 1 0.2212
593 administration, 1 0.3862
593 adrenocortical 1 0.4023
593 aetiology 1 0.4023
593 also 1 0.1406
593 appearance 1 0.2494
593 blood 1 0.1552
593 change 2 0.4661
593 children 2 0.3568
593 cholesterol 1 0.3862
593 cholesterol, 1 0.4023
593 clearance 1 0.3233
593 colleagues 1 0.4523
593 confirmed 1 0.2944
593 considerable 1 0.2606
593 constant 1 0.274
593 control 1 0.1889
593 daily 1 0.274
593 days 1 0.1996
593 days. 1 0.2834
593 deficiency. 1 0.3524
593 delayed 1 0.2944
593 diagnosis 1 0.2067
593 diagnostic 1 0.2494
593 diet 1 0.3296
593 differential 1 0.3176
593 dosage 1 0.3028
593 dwarf 1 0.423
593 dwarfed 2 0.9046
593 effects 1 0.1865
593 electrophoresis, 1 0.4523
593 even 1 0.2199
593 excreted 1 0.3123
593 excretion 3 0.7091
593 fall 1 0.2631
593 fasting 1 0.3439
593 fat 2 0.6148
593 function 1 0.2254
593 growth 3 0.5138
593 hgh 6 2.0183
593 hgh, 1 0.4523
593 hgh. 1 0.423
593 high 1 0.1798
593 hormone 2 0.4092
593 hormone, 1 0.3233
593 human 2 0.3354
593 hypercholesterolaemia 1 0.5024
593 hypopituitary 3 1.0318
593 hypothyroidism. 1 0.5024
593 investigation 2 0.5669
593 levels; 1 0.5024
593 lipoprotein 1 0.4523
593 load 1 0.4023
593 maintained 1 0.2801
593 measured 1 0.2199
593 measurement 1 0.2834
593 metabolic 1 0.2399
593 mg. 1 0.3176
593 much 1 0.2226
593 negligible 1 0.4023
593 nitrogen 5 1.6478
593 non-hypopituitary 1 0.5024
593 observation 1 0.2631
593 observed 1 0.1713
593 occurs 1 0.2683
593 one 1 0.1406
593 paper 1 0.2711
593 patients 5 0.6038
593 period 2 0.3811
593 period, 1 0.3364
593 period. 2 0.6056
593 periods. 1 0.4523
593 phase 1 0.2683
593 post-hgh 2 1.0048
593 prader 1 0.5024
593 pre-b 1 0.5024
593 pre-hgh 1 0.5024
593 preliminary 1 0.2869
593 primordial 1 0.423
593 produced 1 0.2046
593 promises 1 0.5024
593 provides 1 0.3176
593 rebound 2 1.0048
593 receiving 1 0.277
593 reduction 1 0.2474
593 relevance 1 0.4523
593 retained 1 0.3862
593 retention 1 0.3123
593 returns 1 0.5024
593 serum 2 0.3898
593 short 2 0.5811
593 short-term 1 0.3731
593 show 1 0.2173
593 showed 1 0.1791
593 slowly 1 0.3439
593 state, 1 0.423
593 stature 1 0.423
593 stature. 1 0.4523
593 studied 1 0.175
593 studies 1 0.1539
593 ten 1 0.3028
593 test 1 0.2173
593 tests 1 0.2474
593 them. 1 0.362
593 thyroid 1 0.2944
593 two 1 0.1539
593 urinary 2 0.4452
593 useful 1 0.277
593 valuable 1 0.3233
593 varying 1 0.2711
593 whose 1 0.2944
593 withdrawal 4 1.448
593 withdrawal, 1 0.423
593 work 1 0.3439
594 1 1 0.2277
594 1-amino- 1 0.6029
594 1-aminocyclopentanecarboxylic 3 1.8087
594 2 1 0.1841
594 a-aminoisobutyric 1 0.6029
594 ability 1 0.3071
594 accelerated 1 0.4344
594 acid 5 1.1641
594 acid, 2 0.776
594 acid-1-c14 1 0.6029
594 acid-1-c14. 1 0.6029
594 acids. 1 0.4634
594 alter 1 0.4037
594 although 1 0.2318
594 amino 5 1.9056
594 b-estradiol 1 0.6029
594 bovine 1 0.3443
594 change 1 0.2797
594 changes 1 0.1804
594 concentrations 1 0.3099
594 conditions 1 0.2741
594 considerably 1 0.388
594 cyclopentanecarboxylic 1 0.6029
594 distribution 3 0.9296
594 elevated 2 0.776
594 entry 1 0.4634
594 examined 1 0.3044
594 found 1 0.1587
594 four 1 0.2705
594 growth 2 0.411
594 hormonal 1 0.4477
594 hormone 2 0.4911
594 hormones 2 0.8457
594 hr. 2 0.6973
594 hydrocortisone 1 0.5076
594 hypophysectomized 1 0.3955
594 immature 1 0.4037
594 increased 1 0.1874
594 kidney 1 0.2671
594 less 1 0.2257
594 level 2 0.4656
594 liver 2 0.4744
594 model 2 0.8457
594 modification 1 0.4477
594 much 1 0.2671
594 muscle 1 0.3324
594 muscle, 1 0.5076
594 new 1 0.2639
594 previously 1 0.29
594 produced 2 0.4911
594 propionate 1 0.4477
594 rat 2 0.4962
594 ratio 1 0.3157
594 rats 1 0.2328
594 serum 1 0.2339
594 significant 1 0.2116
594 significantly 1 0.2535
594 skeletal 2 0.8255
594 testosterone 1 0.4344
594 tissue 1 0.2093
594 total 1 0.235
594 uptake 1 0.3955
594 used. 1 0.4127
594 uterus. 1 0.6029
594 whereas 1 0.3018
594 within 2 0.4476
595 acids. 1 0.5793
595 action. 1 0.6346
595 actions 1 0.485
595 activity 1 0.2697
595 albumin-bound 1 0.7536
595 amount 1 0.3711
595 answer 1 0.6785
595 antagonism 1 0.6785
595 antagonist 1 0.6785
595 anterior 1 0.4764
595 ascertaining 1 0.7536
595 attractive 1 0.6785
595 blood 1 0.2329
595 certainly 1 0.6346
595 characterized 1 0.3985
595 confirmed. 1 0.6785
595 corticotropin 1 0.6346
595 determining 1 0.5793
595 diabetes-inducing 1 0.7536
595 diminishes 1 0.6346
595 directed 1 0.5046
595 earlier, 1 0.7536
595 emerged 1 0.6346
595 factors 1 0.3186
595 fats 1 0.6785
595 fatty 1 0.3773
595 free 1 0.3571
595 gland, 1 0.6785
595 glucose 1 0.3946
595 growth 3 0.7706
595 hormone 3 0.9208
595 idea 1 0.6346
595 incompletely 1 0.7536
595 increase 1 0.256
595 influence 1 0.3449
595 insulin 4 1.8167
595 insulin-antagonizing 1 0.7536
595 large 1 0.2979
595 liberated 1 0.6346
595 lobe 1 0.5159
595 may 2 0.377
595 me, 1 0.7536
595 mechanism 1 0.3472
595 mobilization 1 0.5596
595 nature 1 0.3742
595 pancreas 1 0.543
595 pituitary 1 0.3909
595 plasma 1 0.3038
595 play 1 0.4477
595 process 1 0.3449
595 promoting 1 0.6785
595 qualify, 1 0.7536
595 remains 1 0.3946
595 research 1 0.4943
595 responsible 1 0.3805
595 role 1 0.3496
595 said 1 0.6034
595 simple 1 0.411
595 still 1 0.352
595 substance 1 0.5286
595 substances 1 0.5286
595 toward 1 0.485
595 utilization 1 0.5286
595 yet 2 0.797
596 (sth) 1 0.3877
596 ability 1 0.2194
596 administered 1 0.2056
596 administered. 1 0.4306
596 also 1 0.1205
596 altering 1 0.3448
596 appearance 1 0.2138
596 associated 1 0.1529
596 bone 2 0.3725
596 bones 1 0.3103
596 caps 2 0.8613
596 cartilage 3 0.9931
596 changes 2 0.2577
596 development 1 0.1572
596 due 1 0.1523
596 estrogen 4 1.3793
596 estrogen-primed 1 0.4306
596 failed 1 0.2459
596 fibrocartilage 1 0.4306
596 fibrocartilage. 1 0.4306
596 formation 1 0.1932
596 furthermore, 1 0.3198
596 growth 2 0.2936
596 histological 2 0.5116
596 hormonally 1 0.4306
596 hormone 1 0.1754
596 hormone, 1 0.2771
596 hypophysectomized 7 1.9773
596 induced 1 0.1831
596 influence 1 0.1971
596 inhibited 1 0.2722
596 injection 1 0.1801
596 intact 4 0.9497
596 interpubic 2 0.8613
596 joint 4 1.1085
596 joints 1 0.3103
596 ligament 2 0.7754
596 ligaments 2 0.8613
596 long 2 0.4468
596 mice 5 1.0604
596 mice, 2 0.6396
596 mice. 3 0.8167
596 occurring 1 0.249
596 progesterone 1 0.3877
596 proliferate 1 0.4306
596 pubic 6 2.5839
596 relationships 1 0.2771
596 relaxin 4 1.7226
596 resorption 2 0.6896
596 responded 1 0.3198
596 restored 1 0.3021
596 resulted 1 0.2087
596 specifically 1 0.3198
596 steroids 1 0.2948
596 sth 1 0.3626
596 sth-maintained, 1 0.4306
596 studied. 1 0.2429
596 transformation 3 0.7045
596 treated 1 0.1772
596 treatment 2 0.2541
596 treatment, 1 0.2771
596 whereas 1 0.2156
596 without 1 0.1626
597 (0.1 2 0.5481
597 accelerated 1 0.1974
597 alkali-soluble 1 0.274
597 alone 1 0.1652
597 also 1 0.0767
597 ani 2 0.5481
597 bone, 1 0.2194
597 chemical 2 0.3303
597 collagen 1 0.2194
597 collagen, 1 0.274
597 composition 3 0.4817
597 content 2 0.2579
597 control 1 0.103
597 deposition 1 0.1974
597 effect 6 0.5021
597 enhance 1 0.2467
597 enhanced 1 0.1703
597 except 2 0.3092
597 given 1 0.1005
597 globular 1 0.274
597 growth 11 1.0275
597 growth-promoting 1 0.2307
597 hormone 7 0.7813
597 hypophysectomized 5 0.8988
597 increased 1 0.0852
597 keratin-clastin 1 0.274
597 levator 2 0.5481
597 male 2 0.2792
597 mg/day) 2 0.5481
597 muscle 6 0.9065
597 muscle, 1 0.2307
597 muscle. 1 0.274
597 myosin, 1 0.274
597 normal 1 0.0737
597 pelt 2 0.5481
597 pelt, 1 0.274
597 pelt. 1 0.274
597 propionate 2 0.407
597 protein 1 0.1246
597 proteins 2 0.2843
597 proteins, 1 0.2107
597 rats 2 0.2117
597 rats. 4 0.574
597 sarcoplasmic 1 0.274
597 seminal 3 0.8221
597 stimulated 2 0.367
597 studied 1 0.0955
597 studied. 1 0.1546
597 testosterone 5 0.9872
597 testosterone. 1 0.2467
597 thigh 1 0.2194
597 tissue 1 0.0951
597 tissues 3 0.3762
597 treated 1 0.1128
597 vesicles 2 0.4389
597 vesicles. 1 0.274
597 viscera 1 0.274
598 acromegaly 1 0.8461
598 advent 1 1.0048
598 although 1 0.3863
598 angiopathy, 1 1.0048
598 animals. 1 0.5669
598 argument 1 0.8461
598 association 1 0.5422
598 blindness 1 0.8046
598 classical 1 0.7048
598 control 1 0.3778
598 control. 1 0.7724
598 despite 1 0.6352
598 development 1 0.3669
598 diabetes 3 1.4845
598 diabetes. 1 0.9046
598 diabetogenic 2 1.6922
598 diet 1 0.6591
598 disturbance. 1 0.7724
598 effect 1 0.3068
598 effects 2 0.746
598 experimental 1 0.4661
598 experiments 1 0.4452
598 factor 1 0.4762
598 favorably 1 0.8046
598 first 1 0.3684
598 genetic 1 0.5262
598 glycosuria 1 0.9046
598 good 2 1.1206
598 growth 3 1.0275
598 high 1 0.3596
598 hormone 3 1.2277
598 houssay 1 1.0048
598 hyperglycemia 1 0.9046
598 hypothesis 1 0.5366
598 importance 1 0.5119
598 incidence 1 0.4797
598 influence 1 0.4598
598 insulin 2 1.2111
598 ketoacidosis 1 1.0048
598 lesions 2 0.8642
598 long 1 0.5212
598 major 3 1.45
598 man. 1 0.6466
598 may 3 0.7539
598 mellitus 2 1.8093
598 neurological 1 0.6728
598 ocular 1 0.6879
598 pathophysiology 1 0.9046
598 problem 1 0.5738
598 realized 1 0.8461
598 reflection 1 0.9046
598 remains 1 0.5262
598 replaced 1 0.7724
598 resulting 1 0.5119
598 revealed 1 0.4871
598 since 1 0.4372
598 support 1 0.554
598 time 1 0.3541
598 vascular 1 0.554
598 young 1 0.5074
599 (armour) 1 0.5024
599 accelerate 1 0.4523
599 action 1 0.2186
599 although 1 0.1931
599 ample 1 0.4523
599 birth 1 0.2559
599 combined 1 0.2582
599 complete 1 0.2331
599 contribution 1 0.362
599 decapitating 1 0.5024
599 developing 2 0.5422
599 effect 1 0.1534
599 experiments 1 0.2226
599 extent 1 0.2657
599 fetal 6 1.7214
599 fetus 3 1.0572
599 fetus. 1 0.3862
599 fetuses, 1 0.423
599 governs 1 0.5024
599 greater 1 0.2078
599 growth 4 0.685
599 growth, 1 0.3364
599 growth. 1 0.362
599 hypophysectomy 3 1.086
599 hypophyseoprivus 3 1.5073
599 hypophysis 2 0.8461
599 individual 1 0.2657
599 induced 1 0.2136
599 injected 1 0.2435
599 injections 1 0.2834
599 intact 1 0.277
599 litter, 1 0.5024
599 manner 1 0.3439
599 mother 2 0.5738
599 normal 1 0.1351
599 obscure. 1 0.423
599 observations 1 0.2112
599 occurs 1 0.2683
599 part 1 0.2347
599 pregnant 1 0.3028
599 prenatal 2 0.9046
599 present. 1 0.3364
599 presumably 1 0.3296
599 prevented 1 0.3296
599 rat 4 0.827
599 retards 3 1.5073
599 shortly 1 0.423
599 somatotrophin 4 1.8093
599 somatotrophin. 1 0.5024
599 substantially 1 0.423
599 support 1 0.277
599 time. 1 0.3524
599 utero 1 0.423
599 view 1 0.2944
599 without 1 0.1897
600 (enzymes) 1 0.3015
600 absence 2 0.2878
600 accelerated 1 0.2172
600 accurate 1 0.1844
600 acids 2 0.2969
600 act 1 0.1874
600 action 2 0.2623
600 affect 1 0.1906
600 agree 1 0.2714
600 also 1 0.0843
600 altered 1 0.161
600 amino 2 0.3811
600 animal. 1 0.2317
600 appear 1 0.1379
600 appears 1 0.1296
600 aware 1 0.2414
600 biochemist 1 0.3015
600 biosynthesis 1 0.2238
600 blood 1 0.0931
600 case 1 0.1083
600 cell; 1 0.3015
600 cells 2 0.182
600 certain 1 0.1327
600 consists 1 0.1906
600 control 1 0.1133
600 defects 1 0.1662
600 deficiency 1 0.1594
600 deficient 1 0.194
600 demand 1 0.2414
600 described. 1 0.1509
600 desires 1 0.3015
600 developing 1 0.1627
600 diabetes 2 0.2969
600 disorder 1 0.1874
600 effect 2 0.1841
600 effects 4 0.4476
600 energy 1 0.2064
600 events. 1 0.3015
600 examined 1 0.1522
600 excess 1 0.2064
600 exerts 1 0.2538
600 expression 1 0.2172
600 extracellular 1 0.2114
600 fact 2 0.3188
600 fat 1 0.1844
600 find 1 0.2064
600 formation 1 0.1353
600 formation. 1 0.2317
600 formed 1 0.1681
600 fully 1 0.2238
600 functioning 1 0.2064
600 fundamental 1 0.2414
600 future 1 0.2172
600 glucose 3 0.4736
600 glucose. 1 0.2714
600 glycogen 1 0.2172
600 growth 1 0.1028
600 high 1 0.1079
600 hormones 2 0.4229
600 immediate 2 0.3811
600 improvements, 1 0.3015
600 incidentally, 1 0.3015
600 independent 2 0.3633
600 independent. 1 0.3015
600 independently 1 0.2414
600 insulin 9 1.635
600 insulin. 2 0.5076
600 insulin; 1 0.3015
600 intracellular 2 0.3955
600 kept 1 0.2238
600 kinds 1 0.2538
600 known 1 0.1473
600 leads 1 0.1681
600 least 1 0.1549
600 level. 1 0.2172
600 likewise 1 0.2414
600 many 1 0.1215
600 may 2 0.1508
600 mean 1 0.145
600 measurements 1 0.194
600 metabolic 3 0.4317
600 metabolism 4 0.5714
600 metabolism, 2 0.6029
600 methods 1 0.1361
600 microsomal 1 0.2714
600 microsomes. 1 0.3015
600 mind. 1 0.2714
600 multiple, 1 0.3015
600 must 1 0.1473
600 need 2 0.3689
600 net 1 0.2414
600 observations 1 0.1267
600 one 2 0.1687
600 others 1 0.1644
600 outlined. 1 0.2414
600 pathological 1 0.1627
600 pathways 1 0.2538
600 patients. 1 0.145
600 periods 1 0.1681
600 phosphate 1 0.1522
600 physician 1 0.2317
600 place 2 0.3689
600 possible 1 0.1209
600 predominantly 1 0.2414
600 present 1 0.0993
600 pretreatment 1 0.2172
600 processes 1 0.1791
600 produced 1 0.1228
600 protein 10 1.3703
600 proteins 1 0.1564
600 relation 2 0.2778
600 reveal 1 0.2018
600 seemingly 1 0.3015
600 sex 1 0.2018
600 sites 1 0.2018
600 status 1 0.1906
600 stimulation 2 0.3401
600 striking 1 0.1906
600 studies 2 0.1846
600 suggested 1 0.1254
600 sustained 1 0.2317
600 synthesis 2 0.2993
600 synthesis; 1 0.3015
600 take 1 0.2064
600 things 1 0.2714
600 tissues 2 0.2759
600 tissues. 1 0.1977
600 transport 1 0.1817
600 two 1 0.0923
600 unrelated, 1 0.2714
600 urinary 1 0.1336
600 varying 1 0.1627
600 vitro, 1 0.2238
600 well 1 0.1054
600 within 2 0.2238
600 yet 1 0.1594
601 a. 1 0.3811
601 abnormalities 1 0.3362
601 acromegaly 1 0.5076
601 acute 1 0.2993
601 administration 1 0.2655
601 administration. 1 0.4037
601 also 1 0.1687
601 assay 1 0.3955
601 association 1 0.3253
601 berson, 1 0.6029
601 blood 1 0.1863
601 changes 1 0.1804
601 concentration 1 0.2535
601 demonstrate 1 0.3487
601 diabetic 1 0.4037
601 disappearance 1 0.3955
601 endogenous 1 0.4127
601 exercise, 1 0.5428
601 fasting, 1 0.5428
601 following 2 0.3997
601 found 1 0.1587
601 four 1 0.2705
601 glucose 4 1.2628
601 growth 1 0.2055
601 half 1 0.3533
601 hgh 5 2.0183
601 high 1 0.2158
601 hormone 1 0.2455
601 hours 1 0.29
601 hypoglycemia, 1 0.5076
601 hypophyseal 1 0.5076
601 influence 1 0.2759
601 interference 1 0.4037
601 intracellular 1 0.3955
601 levels 1 0.2361
601 m.d. 1 0.5076
601 markedly 1 0.322
601 method 1 0.2395
601 minutes. 1 0.4827
601 normal 1 0.1621
601 obesity, 1 0.6029
601 observed 1 0.2055
601 oral 1 0.3689
601 plasma 3 0.7292
601 prolonged 1 0.29
601 secretion 2 0.7065
601 section 1 0.4827
601 sensitive 1 0.3253
601 six 1 0.3324
601 specific 1 0.2372
601 stalk. 1 0.6029
601 stimulated 1 0.4037
601 subjects. 1 0.3689
601 suppressed 1 0.4127
601 thirty 1 0.5428
601 time 1 0.2124
601 twenty 1 0.4477
601 used 1 0.2277
601 utilization. 1 0.5076
602 "diencephalic" 1 3.0145
602 "failure-to-thrive" 1 3.0145
602 absent 1 1.9773
602 astrocytoma 1 2.7139
602 bone 1 1.3038
602 case 1 1.0831
602 characteristically 1 2.5382
602 chiasm 1 2.7139
602 childhood 1 1.7006
602 demonstrate 1 1.7433
602 demonstrated 1 1.2888
602 diencephalic 1 3.0145
602 disturbed 1 1.8738
602 emaciation 1 3.0145
602 factor 1 1.4285
602 failure 1 1.6265
602 fat. 1 3.0145
602 features 1 1.6099
602 found 1 0.7936
602 good 1 1.6808
602 growth 1 1.0275
602 growth, 1 2.0183
602 hormone 1 1.2277
602 increased 1 0.9371
602 infancy 1 2.1144
602 lipid 1 1.8443
602 may 1 0.7539
602 metabolism. 1 2.0183
602 muscular 1 2.1144
602 normal 1 0.8106
602 optic 1 2.0636
602 outline, 1 3.0145
602 overactivity, 1 3.0145
602 overalertness 1 3.0145
602 patient 1 1.1335
602 patient. 1 2.0636
602 presented 1 1.1695
602 roentgenograms 1 2.7139
602 significant 1 1.0582
602 subcutaneous 1 1.9399
602 symptoms 1 1.4285
602 syndrome 1 1.3983
602 syndrome. 1 2.3172
602 thrive: 1 3.0145
603 administration 2 0.3793
603 advocated. 1 0.3877
603 appears 2 0.3704
603 assay. 1 0.4306
603 assume 1 0.3626
603 authors 1 0.1984
603 benefit 1 0.3448
603 carefully 1 0.3103
603 children 1 0.1529
603 conclusion 1 0.2883
603 criteria 1 0.2523
603 deficiency 2 0.4554
603 deficient 1 0.2771
603 effort 1 0.3198
603 evaluated 1 0.249
603 every 1 0.2401
603 evidence 1 0.1579
603 fact 1 0.2277
603 factor 1 0.2041
603 function 1 0.1932
603 growth 7 1.0275
603 growth-hormone 4 1.3793
603 hormone 4 0.7015
603 hormone, 1 0.2771
603 human 2 0.2875
603 hypopituitarism 1 0.3448
603 hypopituitarism. 2 0.7754
603 increased 1 0.1339
603 indicate 1 0.1896
603 led 1 0.2523
603 limited 1 0.2348
603 linear 1 0.2771
603 long-term 1 0.249
603 made 1 0.156
603 main 1 0.2459
603 might 1 0.2255
603 much 1 0.1908
603 patients 3 0.3106
603 perfecting 1 0.4306
603 period 1 0.1633
603 pituitary 1 0.2234
603 questionable 1 0.3626
603 rather, 1 0.3877
603 reliable 1 0.2883
603 respond 1 0.2635
603 response 1 0.1572
603 retardation 1 0.2948
603 short 1 0.249
603 single 1 0.2138
603 stature 1 0.3626
603 stringent 1 0.3877
603 subjected 1 0.2348
603 suffering 1 0.2558
603 suggestive 1 0.3198
603 suitable 1 0.2771
603 supply 1 0.3198
603 tests 1 0.2121
603 therefore 1 0.2635
603 treated 1 0.1772
603 treatment 1 0.1271
603 treatment. 1 0.2277
603 trial 1 0.3198
603 uncover 1 0.4306
603 utilizing 1 0.3198
603 validity. 1 0.4306
603 yet 1 0.2277
604 "diagnostic 1 1.5073
604 "language 1 1.5073
604 "site 1 1.5073
604 "unknowns" 1 1.5073
604 accruing 1 1.5073
604 aphasia 2 2.2385
604 argued 2 3.0145
604 attacking 1 1.5073
604 attention 1 0.97
604 based 1 0.7893
604 care 1 0.9528
604 careful 1 0.9528
604 causal 1 1.2069
604 child. 1 1.0091
604 childhood, 1 1.357
604 children 1 0.5352
604 children: 1 1.1586
604 commonly 1 1.0572
604 complex, 1 1.086
604 comprehension 1 1.357
604 confusions 1 1.5073
604 current 2 1.8738
604 describe 1 1.1586
604 descriptions 1 1.2691
604 design 1 1.2069
604 detail, 1 1.5073
604 development 1 0.5503
604 discussed 1 0.6138
604 disorders 1 0.8607
604 etiologic 1 1.086
604 evaluating 1 1.2691
604 experimental 1 0.6992
604 explore 1 1.357
604 extensive 1 0.8503
604 extent 1 0.797
604 factors 2 1.2744
604 fairly 1 1.086
604 fruitful 1 1.5073
604 function 1 0.6763
604 functions 1 0.9369
604 generalized 1 1.0318
604 given 1 0.5526
604 group 1 0.5572
604 habits 1 1.357
604 human 1 0.5031
604 ideas 1 1.2691
604 impaired 1 1.0318
604 impairment, 1 1.5073
604 impairments 1 1.5073
604 important 1 0.6807
604 inabilities 1 1.5073
604 information 1 0.8133
604 integration 1 1.2069
604 integration. 1 1.5073
604 interferences 1 1.5073
604 labels. 1 1.5073
604 language 2 1.7663
604 language-learning. 1 1.5073
604 lesion." 1 1.5073
604 level. 1 1.086
604 may 1 0.377
604 modalities 1 1.357
604 model, 1 1.5073
604 motor 1 1.1192
604 neurophysiology 1 1.5073
604 not, 1 1.0091
604 often 1 0.7306
604 particular 1 0.7611
604 pathologic 1 0.9221
604 period 1 0.5717
604 place. 1 1.357
604 possible, 1 1.2691
604 power, 1 1.357
604 prelanguage 1 1.5073
604 premeaning 1 1.5073
604 problems 2 1.5637
604 professional 1 1.357
604 proportion 1 0.9369
604 prove 1 1.2069
604 psychosocial 1 1.357
604 questions 1 1.1192
604 reduced 1 0.6807
604 refer 1 1.357
604 reference 2 1.6619
604 reflect 1 1.1586
604 regard 1 0.8607
604 relations, 1 1.5073
604 reorganization 1 1.357
604 requires 1 0.9221
604 resolving 1 1.5073
604 scheme, 1 1.5073
604 seem 1 0.8219
604 semantic 1 1.357
604 sensation 1 1.2691
604 sensory 2 2.2385
604 sensory-integrative-motor 1 1.5073
604 simply 1 1.2691
604 special 1 0.797
604 specific 1 0.593
604 stimuli 1 1.086
604 study 1 0.4643
604 suggested 1 0.6268
604 system," 1 1.5073
604 taken 1 0.8503
604 taking 1 1.086
604 task 2 2.2385
604 teaching," 1 1.5073
604 temporal 1 1.1586
604 term 2 1.6808
604 terms 2 1.8443
604 thinking 2 2.7139
604 thoughts 1 1.5073
604 unique 1 0.97
604 use 2 1.1917
604 use, 1 1.5073
604 various 2 1.1917
604 well 1 0.5271
604 wherein 1 1.5073
604 whether 1 0.7483
604 within 1 0.5595
604 without 1 0.5692
604 working 1 1.1586
604 young 2 1.5222
605 adults. 1 0.7462
605 ages, 1 0.9046
605 along 1 0.7048
605 article 1 0.9046
605 authors, 1 0.9046
605 available 3 1.6439
605 aware 1 0.8046
605 better 1 0.5811
605 canada 1 0.9046
605 canadian 2 2.0097
605 children 2 0.7136
605 cities, 1 1.0048
605 communication 2 1.108
605 communities. 1 1.0048
605 community. 1 1.0048
605 comparison 1 0.5212
605 defective 1 0.6879
605 developing 1 0.5422
605 early 1 0.3684
605 effective 1 0.5031
605 efficient 1 0.724
605 establishment 1 0.7462
605 europe, 1 1.0048
605 every 1 0.5603
605 handicap 1 1.0048
605 handicapped 1 0.9046
605 hearing 2 1.3182
605 hearing, 1 1.0048
605 hearing-impaired 2 2.0097
605 hoped 2 1.8093
605 impaired 1 0.6879
605 impaired. 1 1.0048
605 individual, 1 0.9046
605 join 1 1.0048
605 large 1 0.3972
605 loss 1 0.4871
605 made 2 0.7278
605 medical, 1 0.9046
605 members 1 0.6728
605 mutual 1 0.8461
605 need 1 0.6148
605 needed 1 0.6879
605 non-professional, 1 1.0048
605 occur 1 0.4909
605 opinion 1 0.6728
605 paramedical 1 0.9046
605 persons 2 1.2704
605 practically, 1 1.0048
605 pressing 1 1.0048
605 problems 3 1.5637
605 problems, 1 0.9046
605 procedures 1 0.5669
605 professional 1 0.9046
605 readers 1 1.0048
605 readers, 1 0.9046
605 recognize 1 0.7724
605 rehabilitation 1 0.9046
605 rehabilitation. 1 1.0048
605 rehabilitative 2 1.6922
605 represent 2 1.2704
605 respective 1 0.8046
605 services 3 3.0145
605 services, 1 1.0048
605 social 1 0.6466
605 society 1 0.9046
605 specialists 1 1.0048
605 speech 1 0.5262
605 stages 1 0.554
605 still 1 0.4694
605 support 1 0.554
605 therapy 1 0.3972
605 today 1 0.8461
605 tremendous 1 1.0048
605 u.s.a. 1 1.0048
605 understanding 1 0.6591
605 variety 2 1.0844
605 vast 2 1.6922
605 vitally 1 0.9046
606 "remember 1 1.5073
606 adam 1 1.5073
606 animal-whose 1 1.5073
606 babies. 1 1.357
606 baby 1 1.2691
606 behavior 1 0.8607
606 consider 1 1.0572
606 days 1 0.5987
606 deuteronomist 1 1.5073
606 evolution 1 1.086
606 generations 1 1.2691
606 generations" 1 1.5073
606 genesis 1 1.1586
606 habits, 1 1.5073
606 human 1 0.5031
606 importance 1 0.7678
606 looked 1 1.2691
606 man-100,000 1 1.5073
606 many 1 0.6077
606 may 1 0.377
606 nothing 1 1.357
606 old, 1 1.357
606 ontogenesis 2 2.7139
606 paleolithic 1 1.5073
606 personification 1 1.5073
606 primitive 1 1.2691
606 reiterate 1 1.5073
606 understanding 1 0.9887
606 upon 1 0.6763
606 vast 1 1.2691
606 years 1 0.6851
607 aberrant 1 0.5596
607 child, 1 0.5159
607 children 1 0.2676
607 cleft 1 0.543
607 clinical 1 0.2457
607 congenital 1 0.3449
607 continue 1 0.5793
607 continued 1 0.4358
607 described 1 0.2859
607 first 1 0.2763
607 flap 1 0.6785
607 following 3 0.7494
607 found 1 0.1984
607 grader, 1 0.7536
607 improved 1 0.5046
607 inadequacy 1 0.6785
607 inadequacy. 1 0.6785
607 ineffective 1 0.5286
607 normal 1 0.2027
607 palates 1 0.6785
607 paper 1 0.4066
607 patient 1 0.2834
607 patients 2 0.3623
607 performed 1 0.3449
607 pharyngeal 1 0.7536
607 problems 1 0.3909
607 realized 1 0.6346
607 selected 1 0.4416
607 speech 4 1.5786
607 speech. 1 0.5596
607 surgery 2 0.7483
607 surgery. 1 0.5159
607 systematic 1 0.6346
607 therapy 3 0.8938
607 therapy. 1 0.4066
607 three 1 0.2834
607 trial. 1 0.7536
607 two 1 0.2308
607 velopharyngeal 2 1.357
607 without 1 0.2846
607 youngest 1 0.6346
608 "action 1 1.0048
608 "derailment" 1 1.0048
608 "incompleted 1 1.0048
608 "precursor 1 1.0048
608 "wrong 2 2.0097
608 (quantitatively 1 1.0048
608 action 3 1.3116
608 actions 1 0.6466
608 active 1 0.4629
608 acts 1 0.724
608 adaptive 1 0.8046
608 also 1 0.2811
608 and, 1 0.5212
608 animal 1 0.6148
608 animals, 1 0.6056
608 anticipating 1 0.9046
608 apparent 1 0.5262
608 asocial. 1 1.0048
608 asyntonic 1 1.0048
608 attention 1 0.6466
608 baby 1 0.8461
608 baby's 1 1.0048
608 become 1 0.554
608 behavior 2 1.1476
608 call 1 1.0048
608 care 2 1.2704
608 cases 1 0.299
608 caused, 1 1.0048
608 certain 1 0.4425
608 chains, 1 1.0048
608 changes 2 0.6013
608 child's 1 0.6148
608 children's 1 0.724
608 clinical 1 0.3275
608 close 1 0.5888
608 community 1 0.8461
608 completed 1 0.8046
608 completing 1 0.9046
608 completion 1 0.8461
608 connection 1 0.724
608 consequences: 1 1.0048
608 consist 2 1.4923
608 consistent 2 1.1206
608 contact 1 0.5811
608 controlled 1 0.5738
608 cumulation 2 1.8093
608 cycles". 1 1.0048
608 cycles, 1 0.9046
608 cycles," 1 1.0048
608 damage 1 0.5119
608 departure 1 1.0048
608 derailed 1 1.0048
608 derailment 2 2.0097
608 designated 1 0.7462
608 development 1 0.3669
608 development, 2 1.3455
608 dialogue 3 3.0145
608 dialogue," 1 1.0048
608 dialogue. 3 3.0145
608 direction 1 0.7048
608 discussed 1 0.4092
608 dispenses 1 1.0048
608 disturbances 1 0.5969
608 dynamics 1 0.8046
608 efforts 1 0.8461
608 elementary 1 1.0048
608 emotional 1 0.5603
608 even 1 0.4398
608 examined. 1 0.6879
608 exchanges 2 1.8093
608 experiment, 1 1.0048
608 experimental 1 0.4661
608 experiments 1 0.4452
608 explicate 1 1.0048
608 extensively 1 1.0048
608 extent 1 0.5313
608 findings 2 0.7983
608 follows 1 0.6466
608 form 1 0.4372
608 give 1 0.548
608 gradient 1 0.7048
608 growth. 1 0.724
608 has, 1 0.8461
608 him. 1 0.9046
608 however, 1 0.3639
608 human 1 0.3354
608 illustrate 1 0.9046
608 implications 1 0.6466
608 inappropriate 1 1.0048
608 increasingly 1 0.8046
608 indeed, 1 0.9046
608 individual 2 1.0626
608 individual. 1 1.0048
608 infants 1 0.4797
608 influencing 1 0.7462
608 initiated 1 0.8046
608 inquiries 1 0.9046
608 interaction 1 0.6148
608 is, 1 0.6728
608 kind 2 1.4096
608 lastly, 1 0.8461
608 link. 1 1.0048
608 links 1 0.9046
608 long-lasting 1 0.9046
608 maladaptive 1 1.0048
608 manifested 1 0.7724
608 maternal 2 1.1622
608 mechanics 1 1.0048
608 model 1 0.7048
608 mother 3 1.7214
608 mother-baby 1 1.0048
608 mothering 1 0.8046
608 mothering" 1 1.0048
608 mothering". 1 1.0048
608 mutual 1 0.8461
608 nature 1 0.4989
608 next 1 0.8046
608 normal 1 0.2702
608 norms 1 1.0048
608 of, 1 1.0048
608 one 1 0.2811
608 origin 1 0.5738
608 over-population, 1 1.0048
608 overload 1 1.0048
608 overload, 1 1.0048
608 overloading 1 1.0048
608 overloading, 1 1.0048
608 partners, 1 1.0048
608 passive 1 0.6879
608 patterns 1 0.6352
608 perhaps 1 0.554
608 physical 1 0.5811
608 physical, 1 0.9046
608 precondition 1 1.0048
608 presence 1 0.3828
608 prevents 1 0.7462
608 primal 2 2.0097
608 profound 1 0.6879
608 proposed 1 0.6591
608 proposition 1 1.0048
608 psychic 2 1.6922
608 psychic, 1 1.0048
608 psychology, 1 1.0048
608 qualitatively) 1 1.0048
608 reaction 1 0.5031
608 referred 1 0.5969
608 requires 1 0.6148
608 response 1 0.3669
608 responses 2 1.1206
608 responses. 1 0.8046
608 resulted 1 0.4871
608 results 2 0.5755
608 review 1 0.554
608 seems 1 0.5313
608 sequelae 1 0.8461
608 sequelae. 1 0.9046
608 seriated 1 1.0048
608 series 1 0.4727
608 setting, 1 1.0048
608 setting. 1 1.0048
608 show 1 0.4346
608 single 1 0.4989
608 social 3 1.9399
608 society, 1 1.0048
608 stimulating 1 0.7048
608 stimulation, 1 0.8461
608 stimulus 1 0.6728
608 stunted, 1 1.0048
608 subject 1 0.6466
608 substitute. 1 1.0048
608 suffer 1 0.9046
608 surfeit 1 1.0048
608 survival. 1 0.9046
608 systematic 1 0.8461
608 take 1 0.6879
608 time 2 0.7082
608 triggered, 1 1.0048
608 two 1 0.3077
608 varying 1 0.5422
608 vector 1 0.8461
608 vital 1 0.7462
608 well 1 0.3514
608 with, 1 0.9046
609 'a 1 0.3015
609 'it 1 0.3349
609 12 1 0.1599
609 16. 1 0.3349
609 1907 1 0.3349
609 1950s 1 0.3349
609 1955 1 0.282
609 3 1 0.1142
609 45 1 0.2243
609 added 1 0.2082
609 administered 1 0.1599
609 admitted 1 0.3015
609 aged 1 0.2019
609 ages 1 0.2413
609 ago 1 0.3349
609 aphasic 3 0.9046
609 appearance, 1 0.3015
609 authority. 1 0.3349
609 available 1 0.1827
609 bare 1 0.3349
609 became 1 0.199
609 building 1 0.3349
609 buildings 1 0.3349
609 celebrated 1 0.3349
609 cerebrally 1 0.3349
609 changed 1 0.2293
609 children 9 1.0704
609 children, 1 0.1963
609 cloakrooms, 1 0.3349
609 comfortless, 1 0.3349
609 contains 1 0.2049
609 continued, 1 0.3015
609 defective 1 0.2293
609 department 1 0.2575
609 department, 1 0.3349
609 e.f. 1 0.3349
609 educates 1 0.3349
609 education 2 0.5364
609 eight. 1 0.3015
609 emphasis 1 0.2413
609 entertainments, 1 0.3349
609 entire 1 0.2197
609 epileptic 1 0.3015
609 evenings 1 0.3349
609 experimental 1 0.1554
609 favourably'. 1 0.3349
609 finally 1 0.2293
609 first 2 0.2456
609 four 1 0.1503
609 frequently 1 0.1691
609 generally 1 0.199
609 glasgow, 1 0.3349
609 go 1 0.3015
609 golden 1 0.3015
609 gradually 1 0.2117
609 h.m.i. 1 0.3349
609 hall 1 0.3349
609 hall, 1 0.3349
609 hamilton 1 0.3349
609 handicapped 1 0.3015
609 handicaps 2 0.6699
609 headmistress. 1 0.3349
609 impossible 1 0.282
609 inspector's 1 0.3349
609 joined 1 0.3349
609 jubilee 1 0.3349
609 kelbourne 3 1.0048
609 kind 1 0.2349
609 lacking 1 0.3015
609 largely 1 0.2349
609 last 1 0.2243
609 later 1 0.1722
609 later, 1 0.2682
609 local 1 0.2019
609 maryhill 1 0.3349
609 mental 1 0.189
609 mentally 1 0.2413
609 miss 1 0.3015
609 name 1 0.3015
609 nature, 1 0.2682
609 new 2 0.2932
609 opened 1 0.3015
609 origins 1 0.3015
609 others 1 0.1827
609 palsied 1 0.3349
609 percy 1 0.3349
609 physical 2 0.3874
609 physically 1 0.3349
609 premises 1 0.3349
609 proper 1 0.2243
609 provided 1 0.2049
609 public 3 0.8046
609 pupils 1 0.3349
609 purpose'. 1 0.3349
609 range 1 0.1807
609 report 1 0.1624
609 reported 1 0.1357
609 school 3 0.7462
609 school, 2 0.6031
609 school. 3 1.0048
609 seven 1 0.1913
609 severe 1 0.1484
609 shifted 1 0.3015
609 spastic 2 0.6699
609 spastics 1 0.3349
609 spastics. 1 0.3349
609 speak 1 0.2682
609 special 1 0.1771
609 street 1 0.3349
609 three 1 0.1259
609 time. 1 0.2349
609 transferred 1 0.2575
609 two 2 0.2051
609 unheeded 1 0.3349
609 unit 1 0.2349
609 used 2 0.253
609 wars 1 0.3349
609 which, 1 0.2413
609 words 1 0.2575
609 world 1 0.2487
609 year, 1 0.2575
609 years 3 0.4568
610 acquisition 1 1.0572
610 children 1 0.5352
610 communication 1 0.831
610 consider 1 1.0572
610 deafness 2 2.5382
610 dealing 1 1.086
610 depend 1 1.2069
610 detection, 1 1.5073
610 diagnosis, 1 1.0091
610 entirely 1 0.97
610 first. 1 1.357
610 flow 1 0.7678
610 found 1 0.3968
610 involved 1 0.7678
610 knowledge 1 0.9887
610 knowledge. 1 1.5073
610 management 1 0.797
610 methods 1 0.6807
610 naturally 1 1.1192
610 patients 1 0.3623
610 practical 1 0.97
610 processes 1 0.8954
610 propose 1 1.2691
610 skill 1 1.5073
610 speech 1 0.7893
610 steps 1 1.1192
610 taken 1 0.8503
611 "supportive" 1 0.6029
611 (5 1 0.4827
611 1 1 0.2277
611 171 1 0.6029
611 1963. 1 0.6029
611 944 1 0.6029
611 adequate 1 0.3748
611 age. 1 0.3401
611 applies 1 0.6029
611 april 1 0.6029
611 assessed 1 0.4477
611 cases 2 0.3588
611 disappointing. 1 0.6029
611 figure 1 0.5076
611 follow-up 1 0.4037
611 follows 1 0.388
611 hynes 1 0.6029
611 indicated 1 0.2836
611 indication 1 0.4229
611 known 1 0.2945
611 may 1 0.1508
611 necessary 1 0.3533
611 operation 1 0.3157
611 palate 2 0.8688
611 pharyngoplastics 1 0.6029
611 pharyngoplasty 5 3.0145
611 plus), 1 0.6029
611 primary 1 0.2549
611 proved 1 0.3362
611 proves 1 0.5076
611 recent 1 0.3157
611 repair 2 0.8073
611 result 2 0.5215
611 results 1 0.1727
611 satisfactory. 1 0.6029
611 some. 1 0.6029
611 speech 3 0.9471
611 undertaken 1 0.4827
611 well 2 0.4217
611 year 1 0.3127
611 years 1 0.2741
612 "medium" 1 0.6029
612 "not 1 0.6029
612 1- 1 0.6029
612 3-step 1 0.6029
612 anything. 1 0.6029
612 arises 1 0.5076
612 behavior 1 0.3443
612 big 1 0.5428
612 children 2 0.4282
612 control 1 0.2267
612 data, 1 0.4827
612 decoding 1 0.6029
612 deficiencies 1 0.5428
612 deficiency 1 0.3188
612 discrimination 2 1.0153
612 distance 1 0.4634
612 effect 1 0.1841
612 effects 1 0.2238
612 encoding 1 0.6029
612 faster 1 0.4344
612 given 2 0.442
612 group 5 1.1143
612 groups 1 0.2455
612 groups. 1 0.3581
612 ii 2 0.8073
612 iii 1 0.4634
612 iii, 2 0.9269
612 initial 1 0.2922
612 intermediate-size 2 1.2058
612 learned 1 0.4827
612 little 1 0.322
612 motor 1 0.4477
612 one"; 1 0.6029
612 preschool 1 0.5076
612 problem 1 0.3443
612 problem, 1 0.5428
612 processes. 1 0.5428
612 response 1 0.2201
612 results, 1 0.4827
612 reward 1 0.5428
612 stimulus: 1 0.6029
612 suggest 1 0.2741
612 tests. 2 0.8255
612 three 1 0.2267
612 told 3 1.8087
612 training, 1 0.5428
612 transportation 1 0.5076
612 transposed 1 0.5428
612 transposition 1 0.5428
612 verbal 2 0.8073
612 verbalizations 1 0.6029
612 young 1 0.3044
613 "code" 1 1.5073
613 acquisition 2 2.1144
613 child 1 0.725
613 children 1 0.5352
613 constant 1 0.8219
613 creating 1 1.5073
613 different 1 0.5332
613 every 2 1.6808
613 features 1 0.805
613 features, 1 1.357
613 formal 2 2.2385
613 functions 1 0.9369
613 groups 1 0.6138
613 language 2 1.7663
613 language, 1 1.5073
613 language. 1 1.357
613 learn 2 3.0145
613 must 1 0.7363
613 situation. 1 1.2069
613 thus 1 0.7819
613 uses 1 1.2691
614 (all 1 0.8046
614 1/2 1 0.8046
614 11 1 0.5366
614 2 1 0.3068
614 5 3 1.1434
614 8 1 0.4538
614 86 1 0.8046
614 abnormal 1 0.4871
614 age 1 0.4157
614 almost 1 0.5165
614 aspects 1 0.5669
614 available 1 0.548
614 bi-modal 1 1.0048
614 birth 2 1.0237
614 birthday. 1 1.0048
614 breech 1 1.0048
614 cases 2 0.5979
614 cases); 1 1.0048
614 cases. 2 1.0524
614 cases; 2 1.6091
614 cent 2 1.0329
614 characteristics 1 0.5603
614 child. 1 0.6728
614 clinical 1 0.3275
614 complications 1 0.5888
614 data 1 0.4092
614 deliveries. 1 1.0048
614 delivery 1 0.6591
614 disorders, 1 0.724
614 distribution 1 0.5165
614 double 1 0.6591
614 eeg, 1 1.0048
614 eighteen 1 0.7724
614 evaluated 1 0.5811
614 frequent 1 0.6056
614 frequently 1 0.5074
614 generalized 1 0.6879
614 hearing 1 0.6591
614 hypotonia 1 1.0048
614 institute. 1 1.0048
614 labor 1 0.8461
614 lbs., 1 1.0048
614 less 1 0.3762
614 loss, 1 0.7724
614 mentioned 1 0.724
614 moderate. 1 1.0048
614 mongolism-some 1 1.0048
614 mongoloid 1 1.0048
614 mongoloids 1 1.0048
614 mother's 1 0.8046
614 mr. 1 1.0048
614 national 1 1.0048
614 nebraska 1 1.0048
614 one-half 2 1.5448
614 per 2 0.7833
614 pregnancy, 1 0.7462
614 prematurity. 1 0.9046
614 psychiatric 2 1.2933
614 rate 1 0.3699
614 reported 1 0.4072
614 review 1 0.554
614 sample 1 0.7462
614 second 1 0.5119
614 seen 1 0.4248
614 seven 1 0.5738
614 type 1 0.4179
614 weighed 1 0.9046
614 weight 1 0.4727
614 were: 1 0.9046
614 years 1 0.4568
615 "nonorganicity". 1 1.0048
615 "organicity" 1 1.0048
615 approach 1 0.6246
615 aspects 1 0.5669
615 begins 1 0.8461
615 birth. 1 0.7462
615 child 1 0.4833
615 children: 1 0.7724
615 compartmentalized 1 1.0048
615 considering 1 0.7724
615 criteria. 1 1.0048
615 deal 2 1.5448
615 dealt 1 0.8046
615 diagnostic 1 0.4989
615 emotional 3 1.6808
615 general 2 1.0237
615 high 1 0.3596
615 hope 1 0.7048
615 ii. 1 0.5811
615 issues 1 0.9046
615 last 1 0.6728
615 learning 3 2.3172
615 learning, 1 1.0048
615 learning. 1 0.9046
615 level 1 0.388
615 manner 1 0.6879
615 meeting 1 0.9046
615 merely 1 0.7462
615 over-all 1 0.7462
615 problem 3 1.7214
615 problems 3 1.5637
615 rather 1 0.4727
615 reading, 1 0.9046
615 relatively 1 0.4833
615 subject 1 0.6466
615 talk, 1 1.0048
615 terms 2 1.2295
615 then, 1 0.9046
615 tried 1 0.9046
615 want 1 0.9046
616 cases, 1 0.7893
616 child 2 1.45
616 children 1 0.5352
616 communication 1 0.831
616 consultation 1 1.357
616 critical. 1 1.5073
616 detection 1 0.9369
616 early 1 0.5526
616 feasible 1 1.2069
616 geared 1 1.5073
616 hearing 1 0.9887
616 infants 1 0.7196
616 management 1 0.797
616 needs. 1 1.357
616 obtained 1 0.5373
616 placed 1 0.8954
616 problem 1 0.8607
616 problems 1 0.7819
616 program 1 1.0572
616 referral 1 1.357
616 speech-language 1 1.5073
616 training 1 1.1586
617 adapt 1 1.5073
617 advances. 1 1.5073
617 become, 1 1.5073
617 best 1 0.797
617 better 1 0.8716
617 cases 1 0.4484
617 changing 1 1.1192
617 child, 1 1.0318
617 cleft 2 2.1719
617 competence 1 1.357
617 competition 1 1.2069
617 congenital 1 0.6897
617 cosmetically 1 1.5073
617 crippled 1 1.5073
617 deal 1 1.1586
617 defect 1 0.7423
617 defects 1 0.831
617 disability, 1 1.357
617 drag 1 1.5073
617 edges 1 1.5073
617 fields, 1 1.5073
617 formation 1 0.6763
617 functionally 1 1.2691
617 harsh 1 1.5073
617 hereditary 1 1.086
617 increases 1 0.7041
617 inexcusable 1 1.5073
617 ironically 1 1.5073
617 leave 1 1.5073
617 likely 1 0.8832
617 management 1 0.797
617 market 1 1.5073
617 marriage 1 1.357
617 may 1 0.377
617 merely 1 1.1192
617 number 1 0.5768
617 operative 1 0.8404
617 outside 1 1.1586
617 palate 1 1.086
617 palates, 1 1.5073
617 past 1 1.0572
617 patient 1 0.5667
617 perpetuate 1 1.357
617 place 1 0.9221
617 preliminary 1 0.8607
617 problem 1 0.8607
617 procedures 2 1.7006
617 rehabilitative 1 1.2691
617 render 1 1.5073
617 report 1 0.7306
617 show 1 0.6519
617 significant 1 0.5291
617 since 1 0.6558
617 skilled 1 1.2691
617 struggled 1 1.5073
617 surgical 1 0.6807
617 take 1 1.0318
617 techniques 1 0.8219
617 tendency. 1 1.357
617 together 1 0.8607
617 unit- 1 1.5073
617 whole 1 0.8404
617 world. 1 1.357
618 (a) 1 0.485
618 (b) 1 0.485
618 able 1 0.4252
618 acquisition 2 1.0572
618 although 1 0.2897
618 analysis, 1 0.6785
618 anthropology, 1 0.7536
618 anything 1 0.7536
618 argument 1 0.6346
618 attention 1 0.485
618 authors 1 0.3472
618 bever 1 0.7536
618 body 1 0.3038
618 briefly 1 0.4542
618 bullowa, 1 0.7536
618 cannot 2 0.8133
618 case 1 0.2708
618 chance 1 0.6034
618 children, 1 0.4416
618 complete 1 0.3496
618 contribution 1 0.543
618 data 1 0.3069
618 deal 2 1.1586
618 developing 1 0.4066
618 development 1 0.2752
618 development, 2 1.0091
618 discussion 1 0.4542
618 explicit 1 0.7536
618 fields 1 0.6034
618 framework 1 0.6346
618 functions 1 0.4685
618 future 1 0.543
618 give 1 0.411
618 good 1 0.4202
618 grammatical 1 0.6346
618 great 1 0.4303
618 greatest 1 0.4764
618 improvement 1 0.5046
618 indicating 1 0.485
618 interaction 1 0.4611
618 jones, 1 0.7536
618 language 2 0.8832
618 learned 1 0.6034
618 learned, 1 0.7536
618 let 1 0.7536
618 light 1 0.4252
618 like 1 0.485
618 linguistic 1 0.6346
618 lost 1 0.6346
618 make 1 0.4477
618 may 4 0.7539
618 method 1 0.2994
618 millenium, 1 0.7536
618 must 1 0.3682
618 nature 1 0.3742
618 necessarily 1 0.5159
618 not, 1 0.5046
618 notions. 1 0.7536
618 phonological 1 0.7536
618 pity 1 0.6785
618 present 1 0.2481
618 problem 1 0.4303
618 problem. 1 0.6034
618 progress 1 0.5286
618 promise 2 1.2691
618 psychology 1 0.6346
618 realized 1 0.6346
618 regard 1 0.4303
618 satisfactory 1 0.4943
618 shed 1 0.6785
618 since 1 0.3279
618 social 1 0.485
618 sociology, 1 0.7536
618 solution 1 0.4611
618 state 1 0.3874
618 state. 1 0.6785
618 stating 1 0.7536
618 still 1 0.352
618 suspended 1 0.6785
618 terminal 2 1.086
618 theoretical 1 0.6346
618 theory 1 0.485
618 theory, 1 0.6346
618 two 1 0.2308
618 unless 1 0.5596
618 unpredictable 1 0.6785
618 verbal 1 0.5046
618 ways: 1 0.7536
618 without 1 0.2846
618 work 2 1.0318
618 would 1 0.3742
619 analysing 1 0.6029
619 areas 1 0.3188
619 brain 1 0.3071
619 brief 1 0.4229
619 conscously 1 0.6029
619 contain 1 0.388
619 control. 1 0.4634
619 conversion 1 0.4344
619 creates 1 0.6029
619 deaf 3 1.3903
619 deaf. 1 0.6029
619 deafness 1 0.5076
619 device, 1 0.6029
619 distinction 1 0.5076
619 electronic 1 0.6029
619 essential 1 0.3533
619 expand 1 0.5428
619 features 1 0.322
619 forms. 1 0.5076
619 functors. 1 0.6029
619 glossal 1 0.6029
619 hearing 1 0.3955
619 impairment. 1 0.5428
619 including 1 0.3253
619 language 2 0.7065
619 length 1 0.3955
619 limited 1 0.3288
619 made 1 0.2183
619 monitor 1 0.6029
619 monitoring 1 0.4827
619 mostly 1 0.4229
619 new 1 0.2639
619 nouns 1 0.6029
619 number 1 0.2307
619 omissions 1 0.6029
619 oral 1 0.3689
619 output 1 0.3533
619 postulated 1 0.4229
619 production 2 0.6142
619 recent 1 0.3157
619 reduced 1 0.2723
619 relate 1 0.5076
619 report 1 0.2922
619 review 1 0.3324
619 seems 1 0.3188
619 sentence 1 0.5428
619 show 1 0.2608
619 speaking 1 0.5428
619 speech 5 1.5786
619 spoken 2 0.9655
619 studies 2 0.3693
619 syntactical 1 0.6029
619 tactile-kinaesthetic 1 0.6029
619 telegraphic 1 0.6029
619 transducer. 1 0.6029
619 undertaken, 1 0.5428
619 unique 1 0.388
619 used 1 0.2277
619 utilise 1 0.6029
619 verb 1 0.6029
619 verbs, 1 0.6029
619 visual 1 0.3288
619 visual-to-motor 1 0.6029
619 within 1 0.2238
619 words 2 0.9269
620 able 1 0.3401
620 able, 1 0.6029
620 absent 2 0.7909
620 according 1 0.3253
620 achieve 3 1.2686
620 actually 1 0.4634
620 apparently 1 0.3288
620 appeal 1 0.6029
620 assembly. 1 0.6029
620 autism 1 0.3581
620 autism. 1 0.4827
620 autism: 1 0.5428
620 autistic 5 1.6439
620 average 1 0.2705
620 become 1 0.3324
620 block 1 0.4344
620 cases 4 0.7175
620 category 1 0.5428
620 characterized 1 0.3188
620 children 2 0.4282
620 children, 1 0.3533
620 cognitive 1 0.4477
620 communicated 1 0.6029
620 composition 1 0.3533
620 comprehension 1 0.5428
620 concluded 1 0.2759
620 concrete 1 0.4827
620 conditional 1 0.6029
620 considerable 1 0.3127
620 considered 1 0.2688
620 control 1 0.2267
620 correlate 1 0.4827
620 could 3 0.6498
620 dealing 1 0.4344
620 defective 1 0.4127
620 design 1 0.4827
620 developed 2 0.5481
620 development 1 0.2201
620 disability 1 0.4634
620 discrepancy 1 0.4827
620 discriminating 1 0.6029
620 distinct 2 0.7495
620 divergencies, 1 0.6029
620 due 1 0.2133
620 dull 1 0.6029
620 early 3 0.6631
620 even 1 0.2639
620 examination 1 0.3044
620 examination, 1 0.4477
620 extreme 1 0.3955
620 failed 1 0.3443
620 far 2 0.776
620 fell 1 0.4127
620 four 4 1.0821
620 full 1 0.4037
620 functioning 1 0.4127
620 functions, 1 0.5428
620 group 4 0.8915
620 groups. 1 0.3581
620 higher 1 0.2593
620 imaginary 2 1.2058
620 impairment 1 0.3955
620 incapability 1 0.6029
620 infantile 3 0.9863
620 insufficiently 1 0.6029
620 intelligence 3 1.3431
620 investigation 1 0.3401
620 iq 1 0.4827
620 iq's 1 0.6029
620 iq, 1 0.6029
620 lack 1 0.3487
620 language 2 0.7065
620 large 2 0.4767
620 later 1 0.3099
620 less. 1 0.5076
620 level 3 0.6985
620 level. 1 0.4344
620 made 1 0.2183
620 marked 1 0.2705
620 means 3 0.8014
620 means, 1 0.5428
620 mental 2 0.6802
620 might 1 0.3157
620 much 1 0.2671
620 non-autistic 1 0.6029
620 normal 1 0.1621
620 object 1 0.4477
620 objectify 1 0.6029
620 obtained 1 0.2149
620 occupy 1 0.5428
620 only, 1 0.4827
620 or, 1 0.4827
620 particularly 1 0.3324
620 patients 1 0.1449
620 patients. 1 0.29
620 pattern, 1 0.4827
620 perceptual 1 0.5076
620 performance 2 0.8255
620 performed 1 0.2759
620 poorly 1 0.4634
620 positions 1 0.5428
620 possible. 1 0.4827
620 present 1 0.1985
620 profiles 1 0.4827
620 profiles, 1 0.6029
620 proper. 1 0.6029
620 proposed 2 0.7909
620 purely 1 0.4634
620 reach 1 0.4827
620 reduced 1 0.2723
620 reliable 1 0.4037
620 representing 1 0.4827
620 responsible 1 0.3044
620 results 1 0.1727
620 scale 3 1.5229
620 score 1 0.5076
620 scores, 1 0.6029
620 showed 2 0.4298
620 significantly 1 0.2535
620 situation. 1 0.4827
620 situations, 1 0.4827
620 situations. 1 0.5428
620 soon 1 0.4477
620 specific 1 0.2372
620 specifying 1 0.6029
620 stage 1 0.2922
620 subject's 2 1.2058
620 subtest 2 1.2058
620 subtests 3 1.8087
620 success 1 0.5076
620 suffering 1 0.3581
620 superiorly 1 0.5428
620 superiorly, 1 0.6029
620 symbolic 1 0.4827
620 symbols, 1 0.6029
620 task 1 0.4477
620 tendency 1 0.4344
620 test 3 0.7823
620 things 2 1.0856
620 thinking 1 0.5428
620 thought 1 0.3401
620 used 1 0.2277
620 value. 1 0.4827
620 variability 1 0.4344
620 variability, 1 0.6029
620 verbal 1 0.4037
620 vocabulary, 1 0.6029
620 way 1 0.3811
620 wechsler 2 1.2058
620 well, 1 0.6029
620 whole. 1 0.6029
620 within 2 0.4476
620 words 1 0.4634
620 words, 1 0.5428
621 480 1 1.5073
621 66 1 1.357
621 accomplished 1 1.1192
621 accurate 1 0.9221
621 adenoid 1 1.5073
621 audiometric 1 1.357
621 benefit 1 1.2069
621 care 1 0.9528
621 carefully 1 1.086
621 carried 1 0.7546
621 cases 2 0.8969
621 cleft 2 2.1719
621 concern 1 1.1586
621 conductive 1 1.5073
621 considerable 1 0.7819
621 despite 1 0.9528
621 documentation 1 1.357
621 done, 1 1.357
621 ear 1 1.2069
621 exact 1 1.086
621 hearing 1 0.9887
621 improvement, 1 1.5073
621 loss. 1 1.2069
621 otologic 1 1.5073
621 overall 1 0.9887
621 palate 1 1.086
621 palates 1 1.357
621 particularly 1 0.831
621 pathology 1 1.0091
621 patients 1 0.3623
621 patients. 1 0.725
621 previously 1 0.725
621 purpose 1 1.0091
621 recording 1 1.0572
621 records. 1 1.357
621 regression, 1 1.2691
621 repaired. 1 1.5073
621 results 1 0.4316
621 review 1 0.831
621 sixteen 1 1.357
621 speech 2 1.5786
621 study 1 0.4643
621 surgery 1 0.7483
621 tonsil 1 1.5073
621 virtue 1 1.5073
621 whose 1 0.8832
622 (dominant 1 1.0048
622 addition 1 0.5119
622 affected 2 1.0425
622 appears 1 0.4321
622 associated 2 0.7136
622 autosomal 1 0.724
622 cardiac 1 0.4509
622 cause. 1 0.7462
622 children 3 1.0704
622 congenital 1 0.4598
622 deaf-mutes; 1 1.0048
622 deaf-mutism 1 1.0048
622 defect 1 0.4948
622 deletion 1 0.8461
622 described 1 0.3811
622 development 1 0.3669
622 discussed. 1 0.4296
622 disease, 1 0.5366
622 dose 1 0.4797
622 eight 1 0.5738
622 either 1 0.4296
622 factor 1 0.4762
622 factors 1 0.4248
622 family 2 1.2111
622 four 2 0.9017
622 genetic 2 1.0524
622 h. 1 0.8046
622 has, 1 0.8461
622 heart 1 0.4661
622 hypertrophic 1 0.8461
622 idiopathic 1 0.6879
622 inheritance). 1 1.0048
622 karyotype 1 1.0048
622 lehan, 1 1.0048
622 likely 1 0.5888
622 m.d. 2 1.6922
622 malformations 2 1.2933
622 malformations. 1 0.7724
622 members 1 0.6728
622 mother 1 0.5738
622 mutation, 1 1.0048
622 non-sex-linked 1 1.0048
622 nongenetic 1 1.0048
622 normal 1 0.2702
622 occurring 1 0.5811
622 one 2 0.5622
622 patrick 1 1.0048
622 point 1 0.5811
622 presence 1 0.3828
622 pulmonary 2 0.8592
622 role 1 0.4661
622 several 2 0.8692
622 single 2 0.9978
622 small 1 0.4031
622 somatic 2 1.5448
622 stenosis, 1 0.7724
622 stenosis. 2 1.8093
622 subaortic 1 1.0048
622 suggested 1 0.4179
622 translocation 1 1.0048
622 transmitted 1 0.8046
622 two 1 0.3077
622 unique 1 0.6466
622 valvular 1 0.6728
623 a- 1 0.5076
623 a-deaminase 2 1.2058
623 abnormality. 1 0.5428
623 acid, 1 0.388
623 activity 5 1.0788
623 also 1 0.1687
623 apart 1 0.5076
623 autosomal 1 0.4344
623 biochemical 2 0.7622
623 blond 1 0.6029
623 blood 1 0.1863
623 blue 1 0.4827
623 born 1 0.4037
623 cases. 1 0.3157
623 characteristic 1 0.3044
623 children 4 0.8563
623 clinical 1 0.1965
623 condition 1 0.322
623 condition. 1 0.4127
623 consanguineous 1 0.5428
623 consanguinity 1 0.5428
623 deaminase 1 0.5428
623 defects, 1 0.4229
623 degree 1 0.2671
623 determination 1 0.3689
623 different 2 0.4265
623 disease: 1 0.6029
623 eeg 1 0.4344
623 elevated 1 0.388
623 exhibited 1 0.3689
623 expressed 1 0.4344
623 expression. 1 0.6029
623 eyes, 1 0.5428
623 family 1 0.3633
623 fault 1 0.6029
623 findings 1 0.2395
623 first 1 0.221
623 following 1 0.1998
623 genic 1 0.5428
623 hair, 1 0.6029
623 here. 1 0.5076
623 heterozygotes 1 0.5428
623 high 1 0.2158
623 histidase 2 1.0153
623 histidine 4 1.931
623 histidine, 1 0.5428
623 histidinemia 4 2.4116
623 histidinemia, 1 0.6029
623 however, 1 0.2183
623 hypothesis 1 0.322
623 idea 1 0.5076
623 imidazolepyruvic 1 0.6029
623 increased 1 0.1874
623 indicates 1 0.3955
623 inherited 1 0.4827
623 lends 1 0.6029
623 liver 1 0.2372
623 marriage 1 0.5428
623 mental 1 0.3401
623 normal 1 0.1621
623 not, 1 0.4037
623 observed 1 0.2055
623 oral 1 0.3689
623 parental 1 0.4344
623 peculiar 1 0.5076
623 plasma 1 0.2431
623 present. 1 0.4037
623 published 1 0.4037
623 recessive 1 0.4827
623 reduced 2 0.5445
623 reduction 1 0.2969
623 reported 2 0.4886
623 reports 1 0.388
623 represent 1 0.3811
623 results 1 0.1727
623 retardation, 1 0.4827
623 review 1 0.3324
623 rise 1 0.2993
623 second 1 0.3071
623 seem 1 0.3288
623 set 1 0.4827
623 skin 3 1.0744
623 speech 1 0.3157
623 successful. 1 0.6029
623 support 1 0.3324
623 supports 1 0.5076
623 sustained 1 0.4634
623 test. 1 0.3955
623 tests 1 0.2969
623 three 1 0.2267
623 tissues. 1 0.3955
623 tolerance 1 0.388
623 trait; 1 0.6029
623 urine 2 0.6198
623 variability 1 0.4344
623 variant 1 0.4634
624 "the 1 0.6029
624 (1950), 1 0.6029
624 (1957) 1 0.6029
624 (1961) 1 0.5428
624 act, 1 0.6029
624 analytic 1 0.5428
624 approximation 1 0.6029
624 become 1 0.3324
624 body 1 0.2431
624 borderline 2 1.0153
624 break-through 1 0.6029
624 classical 1 0.4229
624 communication 1 0.3324
624 communication, 1 0.5076
624 consist 1 0.4477
624 constantly 1 0.6029
624 contact 1 0.3487
624 currently, 1 0.6029
624 danger 1 0.5076
624 derives 1 0.6029
624 ekstein 2 1.2058
624 ella 1 0.6029
624 emphasized 1 0.4827
624 essential 1 0.3533
624 establishing 1 0.4827
624 explored 1 0.4634
624 final 1 0.3955
624 first 1 0.221
624 focused 1 0.5428
624 freeman 1 0.6029
624 given 1 0.221
624 gradually 1 0.3811
624 impetus 1 0.6029
624 initial 1 0.2922
624 insight 1 0.4827
624 interest 1 0.4037
624 interpretation 2 0.8073
624 inundated 1 0.6029
624 investigation 1 0.3401
624 itself. 1 0.5428
624 level 1 0.2328
624 libidinal 1 0.6029
624 maintaining 1 0.4634
624 material. 1 0.4344
624 meaning 1 0.4827
624 metaphor 5 3.0145
624 metaphoric 1 0.6029
624 must 1 0.2945
624 needs. 1 0.5428
624 particular 2 0.6089
624 patients 3 0.4348
624 phrases 1 0.6029
624 preliminary 1 0.3443
624 primary 1 0.2549
624 primary- 1 0.6029
624 process 1 0.2759
624 process. 1 0.4634
624 rational 1 0.5076
624 reached 1 0.3955
624 reference 1 0.3324
624 regarded 2 0.7495
624 sanity". 1 0.6029
624 schizophrenic 1 0.3811
624 secondary 1 0.3018
624 self-conscious, 1 0.6029
624 sharpe 1 0.6029
624 symbolic 1 0.4827
624 technique 3 0.8509
624 therapeutic 2 0.6089
624 treatment 1 0.1779
624 ultimately 1 0.5428
624 upon 1 0.2705
624 use 4 0.9534
624 value 2 0.5555
624 wallerstein 1 0.6029
624 within 1 0.2238
625 "lolling, 1 0.3349
625 (1931) 1 0.3349
625 4 1 0.1185
625 5 2 0.2541
625 abnormalities 1 0.1868
625 abnormality 1 0.2349
625 addition 1 0.1706
625 amaurotic 1 0.3349
625 analysis 1 0.1611
625 appears 1 0.144
625 aspect 1 0.2349
625 ataxia, 1 0.3349
625 based 1 0.1754
625 becomes 2 0.4037
625 cases 1 0.0997
625 cases, 1 0.1754
625 cerebral 3 0.4762
625 characteristic 3 0.5074
625 close 1 0.1963
625 communicative 1 0.282
625 comprehensive 1 0.2682
625 country, 1 0.3349
625 course 1 0.1523
625 described 1 0.127
625 describes 1 0.2293
625 description 1 0.2197
625 descriptions. 1 0.3349
625 deteriorate, 1 0.3349
625 developing 1 0.1807
625 diagnosed 1 0.2049
625 disabling 1 0.3015
625 disorder 4 0.8328
625 disorder. 1 0.282
625 dysarthria 1 0.3349
625 dysarthria, 1 0.3349
625 early 1 0.1228
625 eeg 1 0.2413
625 emphasized 1 0.2682
625 especially 1 0.1722
625 evident 1 0.2082
625 evolution 2 0.4827
625 finally 1 0.2293
625 form 1 0.1457
625 frequency 1 0.1754
625 handicapped. 1 0.3349
625 hesitancy 1 0.3349
625 highly 1 0.1807
625 idiocy, 1 0.3349
625 illnesses. 1 0.3349
625 impairment 1 0.2197
625 increasing 1 0.1963
625 initial 1 0.1624
625 invariably 1 0.3015
625 juvenile 4 1.3398
625 known 1 0.1636
625 lapses 1 0.3349
625 less 1 0.1254
625 lipidosis 2 0.6699
625 lipidosis. 1 0.3349
625 loss 1 0.1624
625 manifestations 1 0.1913
625 mentioned 1 0.2413
625 muscular 1 0.2349
625 mutism. 1 0.3349
625 nasality 1 0.3349
625 observed 1 0.1142
625 occasional 1 0.2413
625 often 2 0.3247
625 palsy. 1 0.3349
625 pathology 1 0.2243
625 patient 1 0.1259
625 patterns 1 0.2117
625 perseverative 1 0.3349
625 phonation 1 0.3349
625 pigmentosa 1 0.3349
625 present 1 0.1103
625 pseudobulbar 1 0.3349
625 rapidly 1 0.1913
625 recent 1 0.1754
625 repetition 1 0.282
625 report, 1 0.3349
625 resemblance 1 0.282
625 retinitis 1 0.3349
625 rigidity, 1 0.3349
625 schools 1 0.3015
625 seen 2 0.2832
625 seizures, 1 0.282
625 similar 1 0.1254
625 sjogren 1 0.3349
625 slurring, 1 0.3349
625 speech 9 1.5786
625 speech" 1 0.3349
625 stammering 1 0.3349
625 stuttering-like 1 0.3349
625 stuttering. 1 0.3349
625 syndrome. 1 0.2575
625 time 1 0.118
625 time, 1 0.1937
625 true 1 0.2243
625 upon 1 0.1503
625 vision, 1 0.282
625 visually 1 0.3015
625 well 1 0.1171
625 words. 1 0.3015
626 (.32) 1 1.0048
626 (.45) 1 1.0048
626 10 1 0.3699
626 15 1 0.4989
626 20 1 0.4538
626 20-sec. 1 1.0048
626 3 2 0.685
626 38 1 0.6879
626 4 1 0.3554
626 active 1 0.4629
626 activity 1 0.3596
626 adequate 1 0.6246
626 age 2 0.8313
626 although 1 0.3863
626 borderline 1 0.8461
626 cattell 1 1.0048
626 correlation 2 1.0148
626 correlations 1 0.724
626 cries 1 1.0048
626 crying 3 2.5382
626 crying. 1 1.0048
626 days, 1 0.6591
626 deemed 1 1.0048
626 development 1 0.3669
626 early 1 0.3684
626 frequency 1 0.5262
626 indicator 1 0.8046
626 individual 1 0.5313
626 infancy 1 0.7048
626 infant 1 0.5669
626 infants, 1 0.8461
626 intellectual 2 1.3455
626 investigation 1 0.5669
626 iq 2 1.6091
626 measured 1 0.4398
626 months, 1 0.7724
626 nonsignificant 1 1.0048
626 outburst 1 1.0048
626 period 1 0.3811
626 possible 1 0.4031
626 potential. 1 1.0048
626 prediction, 1 1.0048
626 ratings 1 0.9046
626 relation 1 0.4629
626 rosenfeld 1 1.0048
626 scores 1 0.8046
626 showed 1 0.3582
626 significant 1 0.3527
626 speech 2 1.0524
626 stanford-binet 1 1.0048
626 three 1 0.3778
626 trend 1 0.8046
626 worthy 1 1.0048
626 years 1 0.4568
626 years, 1 0.6352
626 years. 1 0.6352
627 'pouty' 1 0.5024
627 (as 1 0.3731
627 adjunct 1 0.3862
627 air 1 0.2801
627 also 1 0.1406
627 alveolar 1 0.274
627 another 1 0.274
627 anterior 1 0.3176
627 appear 2 0.4598
627 appearance. 1 0.423
627 appliance 1 0.5024
627 areas. 1 0.4023
627 articulation 1 0.423
627 associated 1 0.1784
627 assumes 1 0.5024
627 autogenous 1 0.423
627 characteristic 1 0.2537
627 cheiloplasty. 1 0.5024
627 cleft 2 0.724
627 combination, 1 0.5024
627 complex 1 0.2905
627 concern 1 0.3862
627 congenitally, 1 0.5024
627 contact 2 0.5811
627 corrective 1 0.4023
627 correctly 1 0.5024
627 current, 1 0.5024
627 deficiency 1 0.2657
627 deformities 1 0.4023
627 dental 1 0.3731
627 dentition 1 0.5024
627 designed 1 0.362
627 developed 1 0.2284
627 difficult 1 0.3233
627 direction 1 0.3524
627 displacement 1 0.423
627 either 1 0.2148
627 employed 1 0.3176
627 establish 1 0.423
627 flat 1 0.5024
627 fricatives 1 0.5024
627 implantation 1 0.4523
627 important 1 0.2269
627 improve 1 0.4023
627 include 1 0.2985
627 individually 1 0.4023
627 interference 1 0.3364
627 intraoral 1 0.5024
627 involves 1 0.362
627 labial 2 1.0048
627 lip 4 1.8093
627 lip. 2 1.0048
627 lips. 1 0.5024
627 lower 2 0.4568
627 malposition 1 0.5024
627 maxillary 2 1.0048
627 may 6 0.7539
627 missing, 1 0.5024
627 mixed 1 0.3176
627 movement 1 0.3862
627 naturally 1 0.3731
627 neglect, 1 0.5024
627 normal 2 0.2702
627 orthodontist, 1 0.5024
627 osscous 1 0.5024
627 othodontic 1 0.5024
627 palate 1 0.362
627 pathologist, 1 0.5024
627 patient 1 0.1889
627 period), 1 0.5024
627 plastic 1 0.3862
627 plosives 1 0.5024
627 premaxilla 1 0.5024
627 premaxilla. 1 0.5024
627 presents 1 0.4023
627 problems 1 0.2606
627 procedures 1 0.2834
627 procedures, 1 0.4023
627 produce 1 0.2683
627 profile 1 0.5024
627 prosthesis, 1 0.4523
627 prosthodontist. 1 0.5024
627 recently 1 0.3439
627 relation 1 0.2315
627 relationships 1 0.3233
627 repaired 1 0.4023
627 retruded 1 0.5024
627 ridge, 1 0.5024
627 rolled 1 0.5024
627 segments, 1 0.5024
627 sounds. 1 0.5024
627 speech 2 0.5262
627 structures. 1 0.4523
627 supportive 1 0.4023
627 surgeon, 1 0.5024
627 teeth 1 0.4523
627 tissue 1 0.1744
627 tongue 1 0.5024
627 upper 2 0.6466
627 usually 1 0.2364
628 'cleft 1 1.0048
628 always 1 0.5366
628 among 1 0.4694
628 and/or 1 0.6352
628 assist 1 0.9046
628 born 1 0.6728
628 cleft 2 1.448
628 commonality 1 1.0048
628 considering 1 0.7724
628 consistent 1 0.5603
628 contradictory 1 0.8461
628 contrary, 1 0.8461
628 defend 1 1.0048
628 designs 1 1.0048
628 feel 1 0.8046
628 fewest 1 1.0048
628 given 1 0.3684
628 heterogeneity 1 0.8046
628 however, 1 0.3639
628 identified 1 0.5888
628 individuals 1 0.6879
628 inherent, 1 1.0048
628 insight 1 0.8046
628 interpretation 1 0.6728
628 lip 1 0.9046
628 made 1 0.3639
628 make 1 0.5969
628 mean, 1 1.0048
628 minimize 1 1.0048
628 must 3 1.4727
628 need 1 0.6148
628 nevertheless, 1 0.8461
628 notion 1 1.0048
628 number 1 0.3845
628 observations 1 0.4225
628 one 1 0.2811
628 palate 1 0.724
628 palate. 1 1.0048
628 paper 1 0.5422
628 pertinent 1 0.8461
628 point 1 0.5811
628 population' 1 1.0048
628 population. 1 0.8461
628 possible 1 0.4031
628 possible. 1 0.8046
628 primary 1 0.4248
628 purpose. 1 1.0048
628 purposes 1 0.7462
628 recognize 2 1.5448
628 reject 1 0.8461
628 research 2 1.3182
628 results, 1 0.8046
628 smallest 1 0.8046
628 specific 1 0.3953
628 spent 1 0.8461
628 study 1 0.3096
628 study. 1 0.6591
628 subgroup 1 0.8461
628 subgroups 3 2.4137
628 technology 1 1.0048
628 tend 1 0.724
628 time 1 0.3541
628 universal 1 0.9046
628 us 1 0.6591
628 use 1 0.3972
628 various 1 0.3972
628 within 1 0.373
628 would 1 0.4989
629 70% 1 0.2714
629 80% 1 0.2238
629 a) 1 0.2714
629 abnormal 1 0.1461
629 amount 2 0.2969
629 b) 1 0.2538
629 c) 1 0.2714
629 capacity 1 0.1644
629 cineradiographic 2 0.6029
629 closure 1 0.2114
629 closure. 1 0.3015
629 coefficient 1 0.2414
629 compared 1 0.1169
629 comparison 1 0.1564
629 conclusions 1 0.1906
629 correlation 3 0.4567
629 d) 1 0.3015
629 demonstrated 1 0.1289
629 depth 2 0.4827
629 difference 4 0.6037
629 e) 1 0.3015
629 elevation 1 0.2114
629 f) 1 0.3015
629 following 1 0.0999
629 g) 1 0.2714
629 gap 2 0.5428
629 greater 1 0.1247
629 group 4 0.4457
629 group. 3 0.523
629 groups 1 0.1228
629 h) 1 0.3015
629 height 2 0.5076
629 highly 1 0.1627
629 i) 1 0.2714
629 inadequacy 7 1.8997
629 inadequacy. 1 0.2714
629 intelligibility 2 0.6029
629 j) 1 0.3015
629 judgment 2 0.6029
629 length 2 0.3955
629 made: 1 0.3015
629 means 1 0.1336
629 nasopharynx 2 0.6029
629 noncleft 2 0.6029
629 none 1 0.1817
629 normal 6 0.4864
629 normals 2 0.4634
629 nose 1 0.2714
629 obtained 1 0.1075
629 occluded 1 0.2414
629 palatal 2 0.6029
629 palate 4 0.8688
629 place 1 0.1844
629 plane. 2 0.6029
629 quality 1 0.2317
629 quality. 1 0.3015
629 readings 1 0.2317
629 significant 4 0.4233
629 significant. 2 0.4229
629 soft 4 1.0153
629 speech. 1 0.2238
629 studies 2 0.1846
629 subjects 4 0.5757
629 thickness 1 0.2414
629 took 1 0.2172
629 unoccluded. 1 0.3015
629 velopharyngeal 10 2.7139
629 vital 1 0.2238
629 voice 1 0.3015
630 ("mediational-deficiency 1 1.0048
630 ("production-deficiency 1 1.0048
630 (1) 1 0.4871
630 (2) 1 0.4871
630 2 1 0.3068
630 age 1 0.4157
630 alternative 1 0.7048
630 attempts 1 0.6466
630 childhood: 1 0.8461
630 children 1 0.3568
630 confirmed 1 0.5888
630 criteria 1 0.5888
630 deficiency 1 0.5313
630 described 1 0.3811
630 direct 1 0.4727
630 distinction 1 0.8461
630 early 1 0.3684
630 explaining 1 0.8461
630 finding 1 0.6148
630 function 1 0.4509
630 hypotheses 1 0.7724
630 hypothesis 1 0.5366
630 hypothesis"). 1 1.0048
630 hypothesis"); 1 1.0048
630 hypothesis. 1 0.8461
630 ideal 1 0.8461
630 kindergarteners 1 1.0048
630 less 1 0.3762
630 likely 1 0.5888
630 made 2 0.7278
630 made, 1 0.7724
630 mediate 1 1.0048
630 mediated 1 0.724
630 meet 1 0.8046
630 memory 1 0.9046
630 method 1 0.3992
630 names 1 0.9046
630 nonverbal 1 1.0048
630 observation 1 0.5262
630 often-reported 1 1.0048
630 older 1 0.6246
630 performance 2 1.3758
630 production-deficiency 1 1.0048
630 recall 1 1.0048
630 rehearsal 1 1.0048
630 rehearse 1 1.0048
630 response 2 0.7337
630 s's 1 0.9046
630 serial 1 0.6148
630 spontaneous 2 1.1622
630 stimulus 1 0.6728
630 study 1 0.3096
630 task 1 0.7462
630 task. 1 0.8461
630 tends 2 1.5448
630 test 1 0.4346
630 used 1 0.3795
630 verbal 3 2.0183
630 verbalizations, 1 1.0048
630 verbally 1 0.9046
631 160 1 0.6785
631 4-year-old 1 0.7536
631 act 1 0.4685
631 action 1 0.3279
631 alternatives 2 1.5073
631 among 1 0.352
631 and, 1 0.3909
631 are: 1 0.7536
631 argument 1 0.6346
631 arguments 1 0.6346
631 behavior 2 0.8607
631 central 1 0.4066
631 child 1 0.3625
631 childhood; 1 0.6785
631 children 2 0.5352
631 choice. 1 0.6346
631 codes 1 0.7536
631 cognitive 4 2.2385
631 communication 1 0.4155
631 composed 1 0.5793
631 congruent 1 0.7536
631 consideration 1 0.4943
631 constricted 1 0.7536
631 control 2 0.5667
631 cultural 2 1.2069
631 data 1 0.3069
631 deals 1 0.5793
631 depress 1 0.6346
631 deprivation 2 1.086
631 differences 1 0.3449
631 different 1 0.2666
631 early 2 0.5526
631 economic 1 0.7536
631 educational, 1 0.7536
631 effects 1 0.2798
631 examples 1 0.5596
631 experience 1 0.3874
631 family 1 0.4542
631 first, 1 0.6034
631 fostered 1 0.7536
631 four 2 0.6763
631 functioning 1 0.5159
631 general 1 0.3839
631 group 1 0.2786
631 groups 1 0.3069
631 growth 2 0.5138
631 human 1 0.2515
631 involved 1 0.3839
631 lack 1 0.4358
631 laid 1 0.6346
631 leads 1 0.4202
631 levels. 1 0.5046
631 lines 1 0.4358
631 linguistic 1 0.6346
631 maternal 1 0.4358
631 meaning 1 0.6034
631 mind? 1 0.7536
631 modes 1 0.6785
631 mother-child 1 0.6785
631 mothers 1 0.4542
631 negro 1 0.7536
631 offer 3 1.455
631 out. 1 0.5793
631 paper 1 0.4066
631 permit 1 0.6034
631 poverty 1 0.7536
631 predetermined 1 0.6785
631 presented 2 0.5847
631 processes 1 0.4477
631 quality 1 0.5793
631 question: 1 0.7536
631 range 1 0.4066
631 relations 1 0.6034
631 research 1 0.4943
631 resources 1 0.7536
631 respect 1 0.4416
631 second, 1 0.5793
631 selected 1 0.4416
631 shape 1 0.485
631 show 1 0.326
631 social 2 0.97
631 social, 1 0.7536
631 socialization 1 0.6785
631 socialized 1 0.7536
631 solutions 1 0.543
631 status 2 0.9528
631 system; 1 0.7536
631 systems 2 1.0572
631 third, 1 0.6346
631 thought 1 0.4252
631 wide 1 0.4477
632 ability 1 0.3839
632 absence 1 0.3598
632 addition, 1 0.4358
632 adequate 1 0.4685
632 agents 1 0.4066
632 antibiotics 1 0.6346
632 antiserum. 1 0.6346
632 bacteria 1 0.485
632 capable 1 0.4611
632 cause 1 0.3403
632 caution 1 0.6034
632 cell 2 0.5101
632 certain 1 0.3319
632 classifying 1 0.6785
632 commonly 1 0.5286
632 concerning 1 0.4685
632 criterion 1 0.6034
632 cultures 1 0.3773
632 cultures. 1 0.543
632 cytopathic 2 1.1192
632 effect 1 0.2301
632 effect. 1 0.4943
632 electron 1 0.3805
632 eliciting 2 1.357
632 especially 2 0.7747
632 ether, 1 0.6785
632 evidence 1 0.2763
632 exclude 1 0.6346
632 exercised 1 0.7536
632 experiments 1 0.3339
632 filterability, 1 0.7536
632 great 1 0.4303
632 growth 1 0.2569
632 haemadsorption, 1 0.7536
632 haemagglutinate 1 0.7536
632 homologous 1 0.5159
632 human 1 0.2515
632 identification. 1 0.7536
632 identity 1 0.5793
632 important 1 0.3403
632 indicates 1 0.4943
632 inhibition 2 0.7546
632 interference 1 0.5046
632 interpretation 1 0.5046
632 lack 1 0.4358
632 leukaemia 1 0.6034
632 malignancies 1 0.7536
632 microscopy, 1 0.5286
632 morphology 1 0.4611
632 moulds 1 0.7536
632 mycoplasmas 4 2.1144
632 mycoplasmas. 1 0.6346
632 myxo- 1 0.7536
632 necessity 1 0.5596
632 new 1 0.3299
632 numerous 1 0.4477
632 ordinary 1 0.5596
632 performed 1 0.3449
632 preparations 1 0.4542
632 presence 2 0.5742
632 properties, 1 0.6785
632 published 1 0.5046
632 recent 1 0.3946
632 recovery 1 0.4155
632 replication 1 0.5596
632 reports 1 0.485
632 sensitivity 1 0.4542
632 share 1 0.6785
632 since 1 0.3279
632 size, 1 0.5159
632 study 1 0.2322
632 suspected, 1 0.6785
632 testing 2 1.0572
632 tests 1 0.3711
632 thus, 1 0.543
632 transmissible 1 0.6034
632 unreliable 1 0.7536
632 used 1 0.2846
632 viral 1 0.4542
632 virus 1 0.3946
632 viruses 2 1.1192
632 viruses, 2 1.357
632 vitro, 1 0.5596
632 without 1 0.2846
633 "atypical" 1 0.3015
633 "viral." 1 0.3015
633 (45 1 0.2714
633 (ten 1 0.3015
633 1 1 0.1138
633 1, 1 0.194
633 1.5 1 0.2317
633 1000 1 0.2414
633 1000) 1 0.3015
633 1000. 1 0.3015
633 1051 1 0.3015
633 12.9 1 0.3015
633 1963, 1 0.2538
633 1964. 1 0.3015
633 31, 1 0.3015
633 72,992 1 0.3015
633 a. 1 0.1906
633 absenteeism. 1 0.3015
633 adolescents 1 0.2414
633 age 2 0.2494
633 age). 1 0.3015
633 age. 1 0.1701
633 almost 1 0.1549
633 also 1 0.0843
633 although 1 0.1159
633 annual 1 0.2714
633 attempted 1 0.2018
633 average 1 0.1353
633 basis 1 0.1319
633 blood 1 0.0931
633 came 1 0.2714
633 cases 2 0.1794
633 cause 1 0.1361
633 children 3 0.3211
633 clarke, 1 0.3015
633 clinical 1 0.0983
633 clinically 1 0.2064
633 co-operative 2 0.5428
633 common 1 0.1473
633 complaints 1 0.2414
633 correct 1 0.2064
633 cough. 1 0.3015
633 count 1 0.2064
633 december 2 0.5428
633 diagnosing 1 0.2238
633 differed 1 0.2064
633 due 3 0.3199
633 edmund 1 0.3015
633 elevated 1 0.194
633 etiology 1 0.1662
633 examination 1 0.1522
633 except 1 0.1701
633 excess 1 0.2064
633 families, 1 0.2414
633 fever, 1 0.2714
633 five 2 0.3188
633 frequent 1 0.1817
633 frequently 1 0.1522
633 grayston 1 0.3015
633 group 1 0.1114
633 group. 1 0.1743
633 half 1 0.1766
633 headache 1 0.3015
633 hospitalized 1 0.2114
633 incidence 2 0.2878
633 incidence. 1 0.3015
633 isolated 1 0.1312
633 isolation 1 0.194
633 j. 1 0.2317
633 laboratory 1 0.1743
633 larger 1 0.1791
633 m. 5 0.8404
633 maccoll, 1 0.3015
633 manifestations 1 0.1721
633 mcmahan, 1 0.3015
633 medical 2 0.3581
633 members 1 0.2018
633 membership 1 0.3015
633 much 1 0.1336
633 mycoplasma 2 0.3288
633 never 1 0.1977
633 nine 1 0.2064
633 nineteen 1 0.2538
633 obtained 1 0.1075
633 occurred 4 0.5246
633 old, 1 0.2714
633 one 2 0.1687
633 paired 1 0.3015
633 patients 1 0.0725
633 peak 1 0.1743
633 per 4 0.47
633 period 1 0.1143
633 persons 2 0.3811
633 physicians 1 0.2714
633 pneumonia 10 2.0183
633 pneumoniae 7 1.4445
633 pneumonias 3 0.9044
633 pneumonias. 1 0.3015
633 predominance 1 0.2414
633 primary 1 0.1274
633 prominent 1 0.2238
633 r. 1 0.2064
633 rate 1 0.111
633 rates 2 0.3633
633 recognized 1 0.1874
633 reported, 1 0.2414
633 reporting 1 0.2714
633 respiratory 1 0.1564
633 ruth 1 0.2714
633 school 2 0.4477
633 seasonal 1 0.2714
633 showed 1 0.1075
633 significant 1 0.1058
633 specimens 1 0.194
633 specimens, 1 0.2538
633 suffered 1 0.2064
633 swabs 1 0.3015
633 symptoms 1 0.1429
633 syndrome 1 0.1398
633 systemic 1 0.1681
633 third. 1 0.3015
633 thomas 1 0.3015
633 throat 1 0.2414
633 throughout 1 0.1721
633 total 2 0.235
633 twice 1 0.2317
633 typical 1 0.1977
633 uncommon 1 0.2317
633 upper-respiratory-tract 1 0.3015
633 usually 2 0.2836
633 whereas 1 0.1509
633 white-cell 1 0.3015
633 william 1 0.3015
633 winter. 1 0.3015
633 year, 1 0.2317
633 year. 1 0.2114
633 years 3 0.4111
634 'n' 4 3.0145
634 'n'-free 2 1.5073
634 affected 1 0.3909
634 airsacculitis 2 1.5073
634 breeding 2 1.357
634 carry 1 0.543
634 commercial 1 0.6785
634 communication 1 0.4155
634 culture. 1 0.6346
634 culturing 1 0.6785
634 describes 1 0.5159
634 difficulty 1 0.5046
634 establishment 2 1.1192
634 examined, 1 0.5596
634 flock 3 2.2609
634 flocks 1 0.7536
634 free 2 0.7143
634 frequently 1 0.3805
634 gallisepticum. 1 0.7536
634 hens 1 0.7536
634 high 1 0.2697
634 identifying 1 0.6034
634 impeded 1 0.6785
634 isolated 1 0.3279
634 known 1 0.3682
634 lack 1 0.4358
634 mycoplasma 4 1.6439
634 mycoplasma. 1 0.5596
634 nucleus 1 0.5793
634 parent 1 0.5596
634 poults 3 2.0354
634 practical 1 0.485
634 presence 1 0.2871
634 production 1 0.3839
634 proportion 1 0.4685
634 research 1 0.4943
634 selected 1 0.4416
634 serologic 1 0.543
634 serology 1 0.7536
634 small 1 0.3023
634 strain 3 1.1955
634 strains, 1 0.5793
634 test. 1 0.4943
634 toms 1 0.6785
634 turkey 3 2.0354
634 turkeys 1 0.7536
635 1 3 1.1384
635 abortion 1 0.9046
635 accompanied 1 0.5603
635 additional 1 0.5366
635 another 1 0.548
635 antibody 1 0.6148
635 blood 1 0.3105
635 blood, 1 0.6879
635 described. 1 0.5031
635 dissemination 1 0.9046
635 due 1 0.3554
635 evidence 1 0.3684
635 exhibited 1 0.6148
635 favoring 1 0.9046
635 febrile 1 0.9046
635 female 1 0.5811
635 findings 1 0.3992
635 followed 1 0.4598
635 genital 1 0.8046
635 hominis 3 2.1719
635 illness 1 0.7724
635 isolated 1 0.4372
635 m. 3 1.6808
635 m.d. 1 0.8461
635 mycoplasma 3 1.6439
635 organisms, 1 1.0048
635 particularly 1 0.554
635 pathogenicity 1 1.0048
635 patient 1 0.3778
635 ph.d., 1 1.0048
635 presence 1 0.3828
635 recovery 1 0.554
635 regarded 1 0.6246
635 response 1 0.3669
635 septicemia 1 0.8461
635 serotype. 1 1.0048
635 sheldon 1 1.0048
635 situations 1 0.8046
635 specific 1 0.3953
635 strain 1 0.5313
635 therapeutic 1 0.5074
635 tract. 1 0.7724
635 type 3 1.2537
635 upon 1 0.4509
635 viola 1 1.0048
635 well 1 0.3514
635 wolff, 1 1.0048
635 young, 1 0.9046
636 --in 1 1.0048
636 abscesses 1 1.0048
636 baby 1 0.8461
636 began 1 0.7462
636 bij 1 1.0048
636 birth. 1 0.7462
636 born 1 0.6728
636 child. 1 0.6728
636 days 1 0.3992
636 delivery, 1 0.9046
636 difficult 1 0.6466
636 door 1 1.0048
636 een 1 1.0048
636 forceps 1 1.0048
636 form 1 0.4372
636 hominis 3 2.1719
636 infectie 1 1.0048
636 infection 1 0.4727
636 mycoplasma 3 1.6439
636 neck 1 0.724
636 newborn 1 0.548
636 pasgeborene 1 1.0048
636 pus. 1 1.0048
636 recovered 1 0.6246
637 (fab) 1 0.3015
637 (hela 1 0.2714
637 (rp 1 0.3015
637 1 2 0.2277
637 2555 1 0.3015
637 abo 1 0.3015
637 absorbed 1 0.2172
637 absorption 2 0.3748
637 account 1 0.1701
637 addition, 1 0.1743
637 adsorbed 1 0.2714
637 amnion 4 0.9269
637 amnion) 1 0.3015
637 amnion, 1 0.3015
637 anti-hela 1 0.3015
637 antibodies 1 0.1701
637 antibody 1 0.1844
637 antigen 1 0.1791
637 antigens 8 1.3946
637 antisera 1 0.2317
637 blood 1 0.0931
637 cell 3 0.3061
637 cells 8 0.7278
637 cells, 3 0.4384
637 cells. 2 0.2688
637 cells: 1 0.2714
637 certain 1 0.1327
637 changes 1 0.0902
637 characterized 1 0.1594
637 common 1 0.1473
637 confirmed. 1 0.2714
637 could 1 0.1083
637 culture 1 0.1509
637 demonstrable 1 0.2018
637 detected 2 0.3127
637 detected. 1 0.2714
637 differences 1 0.1379
637 dilutions 1 0.2714
637 direct 1 0.1418
637 either 1 0.1289
637 employed. 1 0.2538
637 erythrocytes 1 0.2238
637 erythrocytes, 2 0.4827
637 erythrocytes. 1 0.3015
637 established 2 0.3253
637 fab 2 0.6029
637 finally, 1 0.2064
637 forssman 1 0.3015
637 found 3 0.2381
637 fractional 1 0.2538
637 full-term, 1 0.3015
637 gens, 1 0.2714
637 group 1 0.1114
637 hapten, 1 0.3015
637 hela 2 0.4229
637 hemagglutination, 1 0.3015
637 hemagglutination. 1 0.3015
637 hemagglutinins 1 0.3015
637 hep-2 1 0.3015
637 hep-2) 1 0.3015
637 high 1 0.1079
637 homologous 1 0.2064
637 human 10 1.0061
637 hyperimmune 1 0.3015
637 immunofluorescence 1 0.2538
637 inconsistent 1 0.3015
637 indirect 1 0.2317
637 intraspecies 1 0.3015
637 isoanti- 1 0.3015
637 lines 1 0.1743
637 lines. 1 0.2414
637 living 5 1.086
637 living, 1 0.3015
637 malignant 1 0.1644
637 methods 1 0.1361
637 methods. 1 0.1906
637 mixed-agglutination, 1 0.3015
637 mouse 1 0.1681
637 mycoplasma 1 0.1644
637 nctc 1 0.3015
637 none 1 0.1817
637 normal 1 0.0811
637 observed. 1 0.1817
637 origin 2 0.3443
637 origin, 1 0.2114
637 partially 1 0.1874
637 possessed 1 0.2538
637 possibility 1 0.1721
637 prepared 1 0.1817
637 presumed 2 0.4827
637 primary 2 0.2549
637 procedures, 1 0.2414
637 proteins 1 0.1564
637 rabbit 1 0.1701
637 reactions 1 0.1473
637 related 1 0.1274
637 removal 1 0.1681
637 responsible 1 0.1522
637 results. 1 0.2114
637 rp 1 0.2714
637 serum 2 0.2339
637 several 2 0.2608
637 sp. 1 0.2714
637 species- 1 0.2714
637 specific 1 0.1186
637 specificity 1 0.2172
637 surface 4 0.6506
637 techniques 2 0.3288
637 tests, 1 0.1977
637 titer 1 0.2238
637 two 3 0.277
637 types 1 0.1461
637 u 1 0.2317
637 uncultured 2 0.6029
637 uncultured, 1 0.3015
637 use 1 0.1192
637 used 1 0.1138
638 (100%), 1 1.0048
638 (dba/2 1 1.0048
638 also 1 0.2811
638 amyloido- 1 1.0048
638 amyloidosis 1 0.5969
638 anemia 2 1.448
638 anemia, 1 0.9046
638 antigenic 1 0.5888
638 auto- 1 0.9046
638 case 1 0.361
638 cba) 1 1.0048
638 cell 2 0.6802
638 cell-free 1 0.8046
638 cells. 1 0.448
638 characterized 1 0.5313
638 coombs-positive 1 1.0048
638 created 1 0.8046
638 dba/2 2 2.0097
638 developed, 1 0.8046
638 development 1 0.3669
638 disease 3 1.0831
638 effect 1 0.3068
638 ex- 1 0.5969
638 f1 1 0.8046
638 females 1 0.7048
638 fluid 1 0.4762
638 following 2 0.6662
638 gammaglobulinemia, 1 1.0048
638 generalized 1 0.6879
638 hemolytic 1 0.724
638 hepatic 1 0.5669
638 higher 1 0.4321
638 host 1 0.5212
638 hyper- 1 0.5969
638 immune 1 0.6466
638 incidence 1 0.4797
638 infected 1 0.548
638 infiltrations 1 1.0048
638 lesions 1 0.4321
638 leukemias 1 1.0048
638 leukemic 2 1.6922
638 loss, 1 0.7724
638 lungs. 1 0.7724
638 males 1 0.6879
638 marked 1 0.4509
638 material 1 0.4661
638 mechanism 1 0.4629
638 mediated 1 0.724
638 mice 2 0.9897
638 mice. 1 0.6352
638 milk 1 0.7724
638 much 2 0.8904
638 murine 1 1.0048
638 ous 1 0.9046
638 placenta 1 0.724
638 plasma 3 1.2153
638 proposed 1 0.6591
638 renal 1 0.3898
638 severe 1 0.4452
638 sexes. 1 0.9046
638 shorter 1 0.7724
638 sis 1 0.7724
638 splenic, 1 1.0048
638 subcellular 1 0.8046
638 supernatant 1 0.8046
638 sur- 1 0.8046
638 tissue 1 0.3488
638 tract 1 0.5811
638 transmissible 1 0.8046
638 transmission 2 1.5448
638 types 1 0.4871
638 vari- 1 0.8461
638 virus 1 0.5262
638 virus-transformed 1 1.0048
638 vival 1 1.0048
638 weight 1 0.4727
638 x 1 0.6352
639 6 3 0.9454
639 activi- 1 0.7536
639 activities 1 0.4358
639 antigen 2 0.8954
639 antigen, 1 0.543
639 biological 2 0.805
639 case 1 0.2708
639 concluded 1 0.3449
639 isolated 1 0.3279
639 kinds 1 0.6346
639 losis. 1 0.7536
639 may 1 0.1885
639 p. 4 2.2385
639 part 1 0.352
639 pasteurella 1 0.7536
639 pestis, 1 0.7536
639 pestis. 1 0.7536
639 ph 3 1.2199
639 presence 1 0.2871
639 property 1 0.6034
639 pseudotubercu- 1 0.7536
639 pseudotuberculosis 2 1.5073
639 related 1 0.3186
639 relation 1 0.3472
639 seems 1 0.3985
639 shared 1 0.5793
639 strain 1 0.3985
639 strains 3 1.3431
639 synthesize 1 0.6785
639 three 1 0.2834
639 ties 1 0.7536
639 whereas 1 0.3773
640 "prototype" 1 0.3768
640 (eaton 1 0.3392
640 1, 2 0.485
640 2, 1 0.258
640 addition, 1 0.2179
640 agar 3 0.7929
640 agent 1 0.2208
640 agent, 1 0.2715
640 agglutinin- 1 0.3768
640 although 2 0.2897
640 among 2 0.352
640 analyzed, 1 0.3392
640 antibody 1 0.2305
640 antigenic 2 0.4416
640 antigenically 1 0.3017
640 atypical 1 0.2715
640 broth 1 0.2897
640 case 1 0.1354
640 chanock 1 0.3768
640 chick 1 0.2643
640 closely 2 0.4303
640 cold 1 0.258
640 complement- 1 0.3768
640 complement-fixation 2 0.6034
640 complement-fixation, 1 0.3768
640 components 2 0.4303
640 could 3 0.4061
640 detected 1 0.1955
640 differences 1 0.1724
640 different 1 0.1333
640 diffusion 4 1.0091
640 dis- 1 0.2382
640 distinct 1 0.2342
640 distinct, 1 0.3392
640 embryo 1 0.2643
640 etiological 1 0.2897
640 evidence 1 0.1381
640 excluded. 1 0.2798
640 fermentans 1 0.3768
640 fixation 1 0.3017
640 four 3 0.5072
640 fourth 1 0.2798
640 gel 4 0.8716
640 grown 1 0.258
640 growth 1 0.1284
640 heterologous 1 0.2897
640 hominis 3 0.8145
640 human 4 0.5031
640 immunized 1 0.2715
640 infected 1 0.2055
640 infu- 1 0.3768
640 isolates 2 0.5596
640 lung 1 0.162
640 m. 8 1.6808
640 medium 1 0.2012
640 muscle 1 0.2077
640 mycoplasma 2 0.411
640 mycoplasmas 3 0.7929
640 obtained 1 0.1343
640 or, 1 0.3017
640 oro- 1 0.3768
640 pharynx 1 0.3768
640 pneumonia) 1 0.3768
640 pneumoniae 1 0.258
640 pneumoniae, 1 0.3392
640 positive 1 0.2012
640 possibility 1 0.2152
640 rabbit 2 0.4252
640 rabbits 1 0.2152
640 reactions 1 0.1841
640 recent 2 0.3946
640 recognized 1 0.2342
640 related 3 0.4779
640 relationships 2 0.485
640 resulted 1 0.1826
640 robert 1 0.3768
640 salivarium, 1 0.3768
640 salivarium. 1 0.3768
640 serological 1 0.2798
640 serum 1 0.1462
640 shared 1 0.2897
640 shown 2 0.3241
640 since 1 0.1639
640 sion 1 0.2897
640 species 2 0.411
640 species. 2 0.4943
640 studied 1 0.1313
640 supplemented 1 0.3392
640 suspension, 1 0.3768
640 technique. 1 0.2897
640 techniques. 1 0.2715
640 tests. 2 0.5159
640 three 1 0.1417
640 tinguished 1 0.3768
640 type 3 0.4701
641 absence 1 0.2399
641 application 1 0.2834
641 arginine 2 0.7724
641 avoid 1 0.3731
641 cell 6 1.0202
641 cells 1 0.1516
641 cellular 1 0.274
641 changes 2 0.3007
641 ciency 1 0.4523
641 conditions 1 0.2284
641 contaminated 1 0.5024
641 could 1 0.1805
641 created 1 0.4023
641 culture 1 0.2515
641 cultures 4 1.0062
641 cytopathogenic 2 0.7724
641 defi- 1 0.4023
641 deficiency 1 0.2657
641 depleted 1 0.5024
641 depletion 1 0.3296
641 described 1 0.1906
641 effect 1 0.1534
641 effects 2 0.373
641 either 1 0.2148
641 established 1 0.2711
641 even 1 0.2199
641 fact 1 0.2657
641 glucose 1 0.2631
641 growth 1 0.1713
641 ii. 1 0.2905
641 importance 1 0.2559
641 indicate 1 0.2212
641 lines 1 0.2905
641 longer 1 0.3524
641 malian 1 0.5024
641 mam- 1 0.423
641 mammalian 2 0.6879
641 medium 2 0.5366
641 medium. 1 0.3862
641 misinterpretation 1 0.5024
641 monolayer 2 1.0048
641 morphology 1 0.3074
641 occurrence 1 0.2985
641 omission 1 0.5024
641 omitted 1 0.4523
641 organisms 1 0.3074
641 picture 1 0.274
641 pleuropneumonia-like 1 0.3862
641 pplo 5 1.931
641 pplo-contaminated 1 0.5024
641 pplo-free 1 0.5024
641 presence 1 0.1914
641 present. 1 0.3364
641 prior 1 0.2683
641 related 1 0.2124
641 requirements. 1 0.5024
641 result 1 0.2173
641 resulted 1 0.2435
641 seen 1 0.2124
641 shown 1 0.216
641 specific, 1 0.4523
641 stressed. 1 0.3862
641 surveillance 1 0.5024
641 that, 1 0.3296
641 though 1 0.2944
641 viable 1 0.5024
641 well 1 0.1757
641 would 1 0.2494
642 (rav) 1 0.6029
642 (rsv) 1 0.6029
642 941 2 1.2058
642 941, 1 0.6029
642 agar 1 0.4229
642 agar-grown 2 1.2058
642 agent 1 0.3533
642 also 1 0.1687
642 antiserum 1 0.4037
642 artificial 1 0.4037
642 associated 1 0.2141
642 cavity. 1 0.6029
642 cell 1 0.204
642 ch19299 1 0.6029
642 ch19299, 1 0.6029
642 chick-embryo 4 2.1711
642 complement-fixation 1 0.4827
642 could 1 0.2166
642 culture-grown 1 0.6029
642 cultures 1 0.3018
642 cytopathic 2 0.8954
642 cytopathogenicity 1 0.6029
642 designated 1 0.4477
642 destruction 1 0.4827
642 diploid 2 1.0153
642 effect 1 0.1841
642 effect. 1 0.3955
642 eliminated 1 0.4229
642 fibroblasts 4 2.0306
642 fibroblasts. 1 0.5428
642 growing 1 0.4037
642 growth 2 0.411
642 however, 1 0.2183
642 human 3 0.6037
642 infected 1 0.3288
642 inhibited 2 0.7622
642 inoculation 1 0.4037
642 isolate 1 0.5076
642 isolate, 1 0.6029
642 isolated 1 0.2623
642 medium 1 0.322
642 multiplication 1 0.4477
642 mycoplasma 5 1.6439
642 mycoplasma. 3 1.3431
642 obtained 1 0.2149
642 oral 1 0.3689
642 orale 2 1.2058
642 passage 1 0.3955
642 produce 1 0.322
642 produced 1 0.2455
642 rav 1 0.6029
642 reacted 1 0.4827
642 restored 1 0.4229
642 rous 3 1.6283
642 rsv 1 0.6029
642 sarcoma 2 0.8255
642 serial 1 0.3689
642 shown 1 0.2593
642 strain 4 1.2752
642 strain, 1 0.4827
642 strongly 1 0.388
642 suppression 1 0.388
642 test 1 0.2608
642 tissue 2 0.4186
642 virus 3 0.9471
642 wi-26 1 0.6029
642 wi-26, 1 0.6029
642 wi-38, 1 0.6029
643 (pplo) 1 1.2691
643 30 1 0.7196
643 accomplished 1 1.1192
643 agreement 1 1.0318
643 air-drying 1 1.5073
643 amnion 1 1.1586
643 cell 2 1.0202
643 cells, 1 0.7306
643 cells. 1 0.672
643 complete 1 0.6992
643 con- 1 0.7819
643 cultured 1 0.9887
643 cultures 1 0.7546
643 cultures, 1 1.2069
643 de- 1 0.8404
643 demonstration 2 1.9399
643 direct 2 1.4182
643 easily 1 0.97
643 fl 1 1.357
643 follow- 1 1.1586
643 human 1 0.5031
643 hypotonic 1 1.357
643 ing 1 0.8133
643 inoculated 1 1.086
643 lines 1 0.8716
643 method 2 1.1975
643 microscopic 1 0.9369
643 observation 1 0.7893
643 orcein. 1 1.5073
643 organisms 2 1.8443
643 pernatant 1 1.5073
643 pleuropneumonia-like 2 2.3172
643 pplo 1 1.1586
643 pplo-agar 1 1.5073
643 rapid 2 1.4612
643 re- 1 0.6678
643 scribed. 1 1.5073
643 staining 1 1.0091
643 su- 1 1.357
643 sults 1 1.1192
643 suspected 1 1.0091
643 tamination 1 1.5073
643 technique 1 0.7091
643 techniques. 1 1.086
643 treatment, 1 0.97
643 using 1 0.6851
644 2 1 0.3068
644 canine 1 0.8461
644 cases. 1 0.5262
644 caused 1 0.4398
644 cell 1 0.3401
644 cells 1 0.3033
644 changes 1 0.3007
644 characteristics 2 1.1206
644 consisted 1 0.5969
644 culturally 1 0.9046
644 cultures, 1 0.8046
644 cytopathogenic 2 1.5448
644 degenerated 1 0.9046
644 disease 2 0.722
644 distinct 1 0.6246
644 dog 2 1.2492
644 fatal 2 1.3455
644 hemorrhage. 1 0.9046
644 indistinguishable 1 0.7724
644 infant 2 1.1337
644 inoculated 1 0.724
644 iso- 2 2.0097
644 isolates 1 0.7462
644 kidney 2 0.8904
644 lated 1 0.7724
644 lates 1 1.0048
644 le- 1 0.7724
644 mycoplasma 1 0.548
644 mycoplasma. 2 1.4923
644 natural 1 0.5888
644 necrosis 1 0.6879
644 organisms 3 1.8443
644 outbreaks 1 1.0048
644 pathogenic 2 1.6922
644 pathological 1 0.5422
644 possessed 1 0.8461
644 principally 1 0.8046
644 produced 1 0.4092
644 puppies 2 1.8093
644 puppies, 1 1.0048
644 recognized 1 0.6246
644 resembled 1 0.724
644 seen 1 0.4248
644 septicemic 2 1.8093
644 serologically 2 1.6091
644 sions 1 0.7724
644 species. 1 0.6591
644 spontaneously. 1 1.0048
645 3 1 0.2569
645 aberrations 1 0.6346
645 aberrations, 1 0.7536
645 although 1 0.2897
645 amnion 2 1.1586
645 appearance 1 0.3742
645 appeared 1 0.3625
645 cells. 2 0.672
645 changes 4 0.902
645 characteristic 1 0.3805
645 chromosome 4 2.0183
645 developed 1 0.3426
645 early 1 0.2763
645 fl 2 1.357
645 gradual 1 0.5596
645 human 2 0.5031
645 included 1 0.4066
645 increase 1 0.256
645 infec- 1 0.7536
645 months. 1 0.5046
645 new 1 0.3299
645 numbers, 1 0.6034
645 observed 1 0.2569
645 period 1 0.2859
645 pplo-infected 2 1.5073
645 reduction 1 0.3711
645 several 1 0.326
645 slowly, 1 0.7536
645 tion, 1 0.6346
645 varieties. 1 0.7536
646 (46 1 0.3877
646 10 1 0.1585
646 107 1 0.3877
646 132 1 0.3877
646 17 1 0.2558
646 18 1 0.2348
646 2 1 0.1315
646 37 1 0.2883
646 adults. 1 0.3198
646 agglutinins 1 0.3626
646 also 1 0.1205
646 antibody 2 0.5269
646 antigen. 1 0.3198
646 bronchitis 1 0.4306
646 cases 5 0.6406
646 cases. 1 0.2255
646 cent) 1 0.4306
646 cf 2 0.7754
646 children 1 0.1529
646 clinical 1 0.1404
646 cold 1 0.2948
646 common 1 0.2104
646 corresponding 1 0.2523
646 countries. 1 0.4306
646 demon- 1 0.3448
646 described 1 0.1633
646 evidence 1 0.1579
646 examined 1 0.2175
646 features 1 0.23
646 fluorescent 1 0.331
646 infection 3 0.6078
646 infection. 2 0.5649
646 infections 1 0.2825
646 investigations 1 0.2677
646 isolated 1 0.1874
646 m. 6 1.4407
646 milder 1 0.4306
646 mycoplasma 1 0.2348
646 occurred 1 0.1874
646 older 1 0.2677
646 patients 2 0.207
646 per 1 0.1678
646 pneumonia 2 0.5767
646 pneumoniae 7 2.0636
646 positive 1 0.23
646 re- 1 0.1908
646 respiratory 1 0.2234
646 rise 2 0.4276
646 seasons 1 0.3877
646 semble 1 0.4306
646 sera 1 0.2825
646 serologic 1 0.3103
646 serologically 1 0.3448
646 showed 1 0.1535
646 significant 1 0.1512
646 similar 1 0.1612
646 strated 1 0.3877
646 studies 1 0.1319
646 study 1 0.1327
646 sweden 1 0.3877
646 test 2 0.3725
646 test. 1 0.2825
646 thirty-five 1 0.3877
646 year 1 0.2234
646 young 1 0.2175
647 (earle) 1 0.7536
647 (maximum 1 0.6346
647 ,,l'' 1 0.7536
647 120 1 0.6346
647 2 1 0.2301
647 6 1 0.3151
647 60-64. 1 0.7536
647 amounted 1 0.6785
647 analyses 1 0.5046
647 ascertained. 1 0.7536
647 cause 1 0.3403
647 cell 3 0.7652
647 cellular 1 0.411
647 certain 1 0.3319
647 changes 1 0.2255
647 chromosomal 4 2.2385
647 chromosomes 1 0.6034
647 chromosomes) 1 0.7536
647 cleared 1 0.7536
647 clone 2 1.5073
647 constitution 1 0.6346
647 could 1 0.2708
647 cultivation-conditions 1 0.7536
647 defined 1 0.5159
647 doubling 1 0.7536
647 duration 1 0.3946
647 effect, 1 0.5596
647 examination 1 0.3805
647 factors 1 0.3186
647 feature 1 0.5286
647 features 1 0.4025
647 genetische 1 0.7536
647 hardly 1 0.7536
647 however, 1 0.2729
647 imply 1 0.5286
647 known 1 0.3682
647 l 1 0.5793
647 later 1 0.3874
647 maximal 1 0.4685
647 may 2 0.377
647 months. 1 0.5046
647 mutagenous 1 0.7536
647 new 1 0.3299
647 number 2 0.5768
647 observations, 1 0.6785
647 one 1 0.2108
647 pattern 1 0.3598
647 period 1 0.2859
647 period. 1 0.4542
647 phenomenon 1 0.4358
647 physiological 1 0.4416
647 populations 2 1.1192
647 present 1 0.2481
647 proved 1 0.4202
647 regard 1 0.4303
647 remained 1 0.4303
647 repeated 1 0.4477
647 respective 1 0.6034
647 result. 1 0.6785
647 resulted 1 0.3653
647 retained 1 0.5793
647 spon- 1 0.6034
647 spontane 1 0.7536
647 stabile 1 0.7536
647 stability 1 0.5596
647 still 1 0.352
647 strain 1 0.3985
647 studied 1 0.2626
647 subsequent 1 0.411
647 substances, 1 0.7536
647 sudden 1 0.485
647 taneous 1 0.6346
647 tested 1 0.4542
647 tests 1 0.3711
647 unchanged 1 0.5793
647 unknown 1 0.5596
647 up. 1 0.6785
647 veranderungen 1 0.7536
647 vitro 1 0.3874
647 within 1 0.2798
647 year. 1 0.5286
647 years. 1 0.4764
647 yet 1 0.3985
647 yet. 1 0.6785
647 zellstamm 1 0.7536
648 abnormalities 1 0.5603
648 adequately 1 0.8046
648 also 2 0.5622
648 blood 2 0.621
648 bone 1 0.4346
648 caution 1 0.8046
648 cell 2 0.6802
648 change 1 0.4661
648 changes 1 0.3007
648 chromosomal 1 0.7462
648 chromosome 2 1.3455
648 chromosomes, 1 1.0048
648 communication 1 0.554
648 cul- 1 0.9046
648 cultures 3 1.5092
648 damage 1 0.5119
648 described 1 0.3811
648 diploid-cell 1 1.0048
648 emphasizes 1 0.9046
648 experimental 1 0.4661
648 human 1 0.3354
648 induced 1 0.4272
648 infected 1 0.548
648 interpreting 1 0.9046
648 leukaemic 1 0.8461
648 marrow 1 0.5031
648 may 1 0.2513
648 mycoplasma 2 1.0959
648 mycoplasma. 1 0.7462
648 need 1 0.6148
648 patients. 1 0.4833
648 presence 1 0.3828
648 reported 1 0.4072
648 results 1 0.2878
648 shows 1 0.554
648 similar 1 0.3762
648 testing 1 0.7048
648 therefore 1 0.6148
648 tures. 1 1.0048
648 viruses 1 0.7462
648 without 1 0.3795
649 11 1 0.322
649 2329 1 0.6029
649 2984 1 0.6029
649 3 1 0.2055
649 400 1 0.4827
649 administered 1 0.2878
649 air 1 0.3362
649 chickens 2 1.2058
649 compared 1 0.2339
649 completely 1 0.3533
649 control 1 0.2267
649 culturing 1 0.5428
649 dead 1 0.4344
649 determine 1 0.3401
649 dipping 1 0.6029
649 drinking 1 0.4344
649 egg 5 2.4137
649 egg-dipping 1 0.6029
649 eggs 2 0.8954
649 eggs, 1 0.6029
649 eggs. 1 0.5428
649 either 1 0.2578
649 eliminate 1 0.4827
649 embryonating 1 0.6029
649 employed 1 0.3811
649 evaluation 1 0.3253
649 experimental 1 0.2797
649 gallisepticum 3 1.6283
649 greatly 1 0.3581
649 infection 2 0.5673
649 infection. 2 0.7909
649 infective 1 0.4344
649 infertile 1 0.6029
649 injected 1 0.2922
649 inoculation 1 0.4037
649 isolates 2 0.8954
649 laying 1 0.6029
649 left 1 0.2723
649 live 1 0.4127
649 m. 1 0.3362
649 mycoplasma 2 0.6575
649 necessary 1 0.3533
649 ob- 1 0.4127
649 posterior 1 0.3533
649 preventing 1 0.4634
649 produced 1 0.2455
649 purposes. 1 0.5428
649 rate 2 0.4439
649 reduced 1 0.2723
649 resulted 1 0.2922
649 sac 1 0.6029
649 satisfactory 1 0.3955
649 solution, 1 0.4634
649 subcutaneously, 1 0.6029
649 tained 1 0.4827
649 thoracic 1 0.4344
649 transmission 1 0.4634
649 trials, 1 0.6029
649 tylosin 1 0.6029
649 tylosin, 1 0.6029
649 tylosin-dipped 1 0.6029
649 water, 1 0.4827
649 well 1 0.2108
649 yolk 1 0.5428
650 (all 1 0.8046
650 114 1 0.8046
650 2 1 0.3068
650 23 3 2.0183
650 36 2 1.4096
650 41% 1 1.0048
650 42 1 0.7724
650 59 1 0.8046
650 6 1 0.4202
650 84% 1 1.0048
650 9 1 0.5262
650 abolish 1 0.8461
650 adults 1 0.6056
650 alone, 1 0.724
650 asympto- 1 1.0048
650 atypical 1 0.724
650 carrier 1 0.8461
650 case 1 0.361
650 cases 2 0.5979
650 children 1 0.3568
650 children) 1 1.0048
650 clinical 1 0.3275
650 com- 1 0.5969
650 culture 1 0.5031
650 cure 1 0.7724
650 days. 1 0.5669
650 epidemiology 1 0.9046
650 families 2 1.4096
650 families, 1 0.8046
650 families. 2 1.8093
650 family 2 1.2111
650 family-contact 1 1.0048
650 fection 1 0.9046
650 in- 1 0.4452
650 included. 1 0.9046
650 incubation 1 0.6148
650 index 2 1.1938
650 infected. 1 0.9046
650 infection 1 0.4727
650 infections, 1 0.8461
650 intervals 1 0.6246
650 isolated 1 0.4372
650 lasted 1 0.8461
650 lower-respiratory-tract 1 1.0048
650 manifestations 1 0.5738
650 matic, 1 1.0048
650 mcmahan 1 1.0048
650 median 1 0.8046
650 members 1 0.6728
650 mission 1 1.0048
650 months. 1 0.6728
650 mycoplasma 2 1.0959
650 neither 1 0.6591
650 occurred 1 0.4372
650 often 1 0.4871
650 one 1 0.2811
650 patient 1 0.3778
650 patients 1 0.2415
650 period 1 0.3811
650 pharyngitis 1 1.0048
650 pletely 1 0.9046
650 pneumonia 1 0.6728
650 pneumonia. 1 0.8461
650 pneumoniae 3 2.0636
650 probably 1 0.4568
650 ruth 1 0.9046
650 seemed 1 0.6466
650 state 1 0.5165
650 studied 1 0.3501
650 suggested 1 0.4179
650 symptoms 1 0.4762
650 symptoms, 1 0.724
650 symptoms. 1 0.7462
650 tetracycline 1 1.0048
650 three 1 0.3778
650 throat 1 0.8046
650 time 1 0.3541
650 total 1 0.3916
650 trans- 1 0.7724
650 transmission 1 0.7724
650 treatment 1 0.2965
650 unrelated 1 0.7048
650 within 1 0.373
651 (pplo) 1 0.5076
651 9 1 0.3157
651 acute 1 0.2993
651 adnexal 1 0.6029
651 antibiotic 1 0.4827
651 antibiotics. 1 0.5428
651 aspiration 1 0.4827
651 aspiration. 1 0.6029
651 case 3 0.6498
651 cases 1 0.1794
651 common 1 0.2945
651 considered 1 0.2688
651 culture 2 0.6037
651 cured 1 0.6029
651 curettage 1 0.6029
651 cycline 1 0.6029
651 dary 1 0.6029
651 described. 1 0.3018
651 diagnostic 1 0.2993
651 discharge. 1 0.6029
651 discussed. 1 0.2578
651 disease 2 0.4332
651 douglas 1 0.6029
651 due 1 0.2133
651 followed 1 0.2759
651 following 1 0.1998
651 found 1 0.1587
651 frequently 1 0.3044
651 genitalia 1 0.5428
651 grew 1 0.4037
651 growths 1 0.5428
651 healthy 1 0.4344
651 however, 1 0.2183
651 infected 1 0.3288
651 infection 1 0.2836
651 infection. 1 0.3955
651 inflam- 1 0.6029
651 inflammatory 1 0.4477
651 internal 1 0.3401
651 isolated 1 0.2623
651 like 1 0.388
651 lity 1 0.6029
651 matory 1 0.6029
651 monia 1 0.5428
651 organisms 3 1.1066
651 pelvic 2 0.9269
651 penicillin 1 0.4827
651 pleuro-pneumonalike 1 0.6029
651 pleuropneu- 1 0.6029
651 possibi- 1 0.6029
651 pouch 1 0.5428
651 pplo 5 2.3172
651 proves 1 0.5076
651 pure 2 0.776
651 pus 1 0.6029
651 pyosalpinx 1 0.6029
651 removed 1 0.3401
651 reported. 1 0.3487
651 resistant 2 0.7377
651 salpingitis 2 1.0856
651 secon- 1 0.6029
651 sensitive 1 0.3253
651 streptomycin 1 0.5428
651 tetra- 1 0.6029
651 therapy 1 0.2383
651 therapy. 1 0.3253
651 use 1 0.2383
651 vaginae 1 0.6029
651 vaginal 1 0.6029
651 women. 1 0.4827
652 (5 1 0.4023
652 (pleuro- 1 0.5024
652 (represented 1 0.5024
652 1 4 0.7589
652 2 2 0.3068
652 2, 1 0.3439
652 4 2 0.3554
652 5 1 0.1906
652 82 1 0.5024
652 adequately 1 0.4023
652 aetiology 1 0.4023
652 among 1 0.2347
652 animal 1 0.3074
652 animals, 1 0.3028
652 antigenic 1 0.2944
652 antisera 1 0.3862
652 appear 1 0.2299
652 arthritidis 2 1.0048
652 arthritidis, 1 0.5024
652 bovine 1 0.2869
652 cattle 1 0.4023
652 cattle, 1 0.4523
652 cell 2 0.3401
652 comparing 1 0.423
652 complement 1 0.3439
652 constitute 1 0.423
652 corresponded 1 0.3862
652 could 2 0.361
652 cultures 3 0.7546
652 cultures, 2 0.8046
652 demonstration 1 0.3233
652 differentiate 1 0.4023
652 differentiation 1 0.2869
652 disease 1 0.1805
652 distinct 2 0.6246
652 distinguished 2 0.6728
652 distinguished, 1 0.5024
652 eggs 2 0.7462
652 embryonated 2 0.9046
652 endogenous 1 0.3439
652 examination. 1 0.423
652 exceptions 1 0.4523
652 finding 1 0.3074
652 findings 1 0.1996
652 fixation 1 0.4023
652 goats 1 0.4523
652 goats, 2 1.0048
652 hitherto 1 0.4023
652 hominis 2 0.724
652 host-specific. 1 0.5024
652 human 2 0.3354
652 identifying 1 0.4023
652 illustrate 1 0.4523
652 illustrates 1 0.423
652 importance 1 0.2559
652 inclusion 1 0.3233
652 infections 1 0.3296
652 infective 1 0.362
652 isolated 1 0.2186
652 isolation 1 0.3233
652 laboratory 1 0.2905
652 largely 1 0.3524
652 lesions 1 0.216
652 m. 5 1.4007
652 mammalian 2 0.6879
652 man 2 0.5165
652 man, 2 0.7462
652 material 1 0.2331
652 may 1 0.1257
652 methods. 1 0.3176
652 mice, 2 0.7462
652 mixed 1 0.3176
652 mycoplasma 6 1.6439
652 mycoplasma, 1 0.4523
652 navel), 1 0.5024
652 necessity 1 0.3731
652 necessity, 1 0.5024
652 new 1 0.2199
652 one 2 0.2811
652 organism 1 0.3364
652 organisms 1 0.3074
652 organisms) 1 0.4523
652 origin 2 0.5738
652 passage 1 0.3296
652 pneumonia-like 1 0.5024
652 poultry 1 0.5024
652 poultry, 1 0.5024
652 probably 1 0.2284
652 purifying 1 0.5024
652 r38, 1 0.5024
652 rabbit 1 0.2834
652 rat. 1 0.3862
652 rather 1 0.2364
652 rats 4 0.7761
652 rats, 1 0.3439
652 recognized 2 0.6246
652 relation 1 0.2315
652 represent 1 0.3176
652 saprophytic 1 0.5024
652 saprophytic. 1 0.5024
652 serological 2 0.7462
652 serologically. 1 0.5024
652 serotype, 1 0.5024
652 serotypes 3 1.5073
652 seventeen 1 0.3862
652 sewage. 1 0.5024
652 shows 1 0.277
652 single 2 0.4989
652 sources 1 0.3862
652 species 3 0.8219
652 species. 3 0.9887
652 strain 1 0.2657
652 strain, 1 0.4023
652 strains 3 0.8954
652 strains), 1 0.5024
652 taxonomy, 1 0.5024
652 test 1 0.2173
652 tissue 1 0.1744
652 two 2 0.3077
652 type 2 0.4179
652 used 2 0.3795
652 variant 1 0.3862
652 various 1 0.1986
652 viewpoint 1 0.5024
653 0.04 1 1.5073
653 100 1 0.8503
653 administered 1 0.7196
653 agg- 1 1.5073
653 air-sac 1 1.5073
653 birds, 1 1.5073
653 bodyweight 1 1.5073
653 cent. 1 1.1586
653 chicks 2 2.4137
653 concentration 1 0.6337
653 continuously 1 1.1586
653 day-old 2 3.0145
653 days 1 0.5987
653 dose 1 0.7196
653 drinking 2 2.1719
653 eliminated 1 1.0572
653 experimental 1 0.6992
653 experimentally 1 1.0572
653 free 1 0.7143
653 gallisepticum 1 1.357
653 haemagglutination 1 1.2691
653 infected 1 0.8219
653 infection 1 0.7091
653 infection, 1 1.0572
653 inhibition 1 0.7546
653 injection 2 1.2605
653 lesions 1 0.6481
653 lutination 1 1.5073
653 m. 1 0.8404
653 medication. 1 1.357
653 mg/kg. 1 1.357
653 mycoplasmosis 1 1.5073
653 per 1 0.5875
653 poults 2 2.7139
653 react 1 1.1586
653 remained 1 0.8607
653 slide 1 1.357
653 spiramycin 2 3.0145
653 subcutaneous 2 1.9399
653 tests. 1 1.0318
653 three 1 0.5667
653 time 1 0.5311
653 treated 1 0.6202
653 treatment 1 0.4447
653 turkey 2 2.7139
653 water 2 1.5939
654 a. 1 0.3811
654 agents 1 0.3253
654 ally 1 0.6029
654 although 1 0.2318
654 biologically 1 0.4477
654 bone-marrow 2 1.0856
654 cannot 1 0.3253
654 clear. 1 0.5076
654 contained 1 0.3071
654 control 1 0.2267
654 cultures 3 0.9055
654 cultures. 1 0.4344
654 cytopathic 1 0.4477
654 d. 1 0.388
654 different 1 0.2133
654 distinguished 1 0.4037
654 effect 1 0.1841
654 electron-microscopically. 1 0.6029
654 evidence 1 0.221
654 human 2 0.4024
654 inoculated 2 0.8688
654 isolated 4 1.0492
654 leukaemia 1 0.4827
654 leukaemic 2 1.0153
654 m. 1 0.3362
654 mycoplasma, 1 0.5428
654 mycoplasmas 5 2.1144
654 mycoplasmas. 1 0.5076
654 one 1 0.1687
654 patients. 1 0.29
654 previously 1 0.29
654 pulmonis. 1 0.6029
654 readily 1 0.388
654 relationship 2 0.58
654 reported 1 0.2443
654 rodent 1 0.6029
654 seemed 1 0.388
654 serologic- 1 0.6029
654 showed 1 0.2149
654 sources 1 0.4634
654 strain 1 0.3188
654 studies 1 0.1846
654 tissue 2 0.4186
654 viruses 1 0.4477
654 woods 1 0.6029
654 yet 1 0.3188
655 114 1 0.4827
655 31 1 0.4477
655 499 1 0.6029
655 accompanying 1 0.4229
655 ankylosing 1 0.6029
655 arthritis 1 0.4827
655 arthritis, 4 2.1711
655 attempts 2 0.776
655 biopsies 1 0.4477
655 body 1 0.2431
655 colitis, 1 0.5428
655 complement-fixation 1 0.4827
655 could 1 0.2166
655 demonstrate 2 0.6973
655 disease 1 0.2166
655 disease, 1 0.322
655 disease. 1 0.3188
655 diseases. 2 0.9269
655 eight 1 0.3443
655 fluid 1 0.2857
655 fluids 1 0.4634
655 found 1 0.1587
655 genito- 1 0.6029
655 gonococcal 1 0.6029
655 gout, 1 0.6029
655 grown 1 0.4127
655 including 1 0.3253
655 isolated 1 0.2623
655 isolated. 1 0.5076
655 looked 1 0.5076
655 made 1 0.2183
655 microbiological 1 0.6029
655 negative 1 0.3533
655 negative. 1 0.5076
655 nine 1 0.4127
655 non-rheumatic 1 0.6029
655 none 1 0.3633
655 one 1 0.1687
655 organisms 1 0.3689
655 patients 5 0.7246
655 possibly 1 0.3748
655 pplo 3 1.3903
655 present 1 0.1985
655 psoriatic 1 0.6029
655 readily 1 0.388
655 reiter's 3 1.8087
655 rheumatic 2 0.9269
655 rheumatoid 1 0.4827
655 specimens 2 0.776
655 specimens, 1 0.5076
655 specimens. 1 0.5428
655 spondylitis, 1 0.6029
655 studies 1 0.1846
655 synovial 5 2.4137
655 tests 1 0.2969
655 thought 1 0.3401
655 tissue 2 0.4186
655 tissues 2 0.5518
655 traumatic 1 0.4229
655 two 2 0.3693
655 ulcerative 1 0.4827
655 urinary 1 0.2671
655 various 1 0.2383
655 viruses 2 0.8954
655 whereas 1 0.3018
655 whose 1 0.3533
656 (p.p.l.o.) 1 1.0048
656 29% 1 1.0048
656 albino 1 0.8046
656 animals 3 1.2816
656 appeared 1 0.4833
656 bacteriological 1 0.9046
656 breeder 1 1.0048
656 compared 1 0.3898
656 cultures 3 1.5092
656 ears 1 0.9046
656 examined 1 0.5074
656 examined. 1 0.6879
656 female 2 1.1622
656 genital 1 0.8046
656 genitalia 2 1.8093
656 grossly 1 0.7048
656 histologically 1 0.7724
656 identical. 1 0.9046
656 injection 1 0.4202
656 intraperitoneal 1 0.724
656 isolated 2 0.8744
656 made. 1 0.6246
656 mice 2 0.9897
656 middle 1 0.8046
656 nonproductive 1 1.0048
656 obtained 1 0.3582
656 oophoritis 1 1.0048
656 oophoritis. 1 1.0048
656 organism 2 1.3455
656 organs 1 0.554
656 ovaries 2 1.8093
656 p.p.l.o. 2 2.0097
656 pleuropneumonia-like 2 1.5448
656 produced 1 0.4092
656 purulent 1 1.0048
656 rat 1 0.4135
656 rats 2 0.7761
656 rats. 1 0.5262
656 recovery 1 0.554
656 salpingitis 2 1.8093
656 seventy-seven 2 2.0097
656 showed 1 0.3582
656 three 1 0.3778
656 two 1 0.3077
656 uterus 2 2.0097
656 young 1 0.5074
657 (crd) 1 1.5073
657 (pleuropneumonia-like 1 1.5073
657 animals 1 0.6408
657 attention 1 0.97
657 breeding 1 1.357
657 briefly 1 0.9083
657 bronchiectasis 1 1.5073
657 catarrh 1 1.5073
657 catarrh. 1 1.5073
657 catarrhal 1 1.5073
657 caused 1 0.6597
657 cesarean-derived 1 1.5073
657 characteristics 1 0.8404
657 chronic 2 1.4391
657 colonies 1 1.357
657 colonies, 1 1.5073
657 considered 1 0.672
657 control, 1 1.2069
657 crd 1 1.5073
657 cultural 1 1.2069
657 diagnosis. 1 1.0091
657 differential 1 0.9528
657 discussed 1 0.6138
657 disease 2 1.0831
657 embraces 1 1.5073
657 entities, 1 1.5073
657 enzootic 1 1.5073
657 establishment 1 1.1192
657 etiology, 1 1.357
657 experimental 1 0.6992
657 importance 1 0.7678
657 infectious 2 2.3172
657 line 1 0.9083
657 maintenance 1 1.2069
657 manifestations, 1 1.2069
657 means 1 0.6678
657 methods 1 0.6807
657 mice 2 1.4845
657 mice. 1 0.9528
657 morphologic 1 1.086
657 mycoplasmas 2 2.1144
657 namely: 1 1.5073
657 observations 1 0.6337
657 organisms 1 0.9221
657 organisms) 1 1.357
657 outlined 1 1.2069
657 paid 1 1.1586
657 particular 1 0.7611
657 pathogen-free 1 1.5073
657 pathologic 1 0.9221
657 purposes 1 1.1192
657 rats 2 1.1641
657 regard 1 0.8607
657 relation 1 0.6944
657 respiratory 2 1.5637
657 separate 1 0.9528
657 specific 1 0.593
657 standpoint 1 1.2069
657 stressed. 1 1.1586
657 swiss 1 1.2691
657 syndromes 1 1.0572
657 together 1 0.8607
657 transmission. 1 1.357
657 two 2 0.9232
657 types 1 0.7306
657 use 1 0.5959
657 virus. 1 1.086
658 (fig. 1 0.5076
658 1) 1 0.388
658 1963, 1 0.5076
658 african 2 1.2058
658 agents 4 1.3012
658 also 2 0.3373
658 altered 1 0.322
658 amnion 5 2.3172
658 animals, 1 0.3633
658 antigen 1 0.3581
658 associated 1 0.2141
658 association 1 0.3253
658 bone 1 0.2608
658 burkitt 1 0.6029
658 capacity 1 0.3288
658 caused 2 0.5278
658 cells 4 0.7278
658 changes 1 0.1804
658 characteristics 1 0.3362
658 children 2 0.4282
658 clearly 1 0.3633
658 closely 1 0.3443
658 cultivated 1 0.5076
658 cultures 2 0.6037
658 cultures. 1 0.4344
658 cytopathogenic 2 0.9269
658 cytopathogenic, 1 0.6029
658 described 1 0.2287
658 destructive 1 0.5076
658 direct 1 0.2836
658 disease, 1 0.322
658 disease. 1 0.3188
658 east 1 0.6029
658 effects 2 0.4476
658 embryonic 2 0.7622
658 encountered 1 0.3811
658 evidence 1 0.221
658 exposed 1 0.3157
658 extracts 2 0.7377
658 failed 2 0.6886
658 filtrable 1 0.6029
658 fluid 1 0.2857
658 fluids 1 0.4634
658 following 1 0.1998
658 found 1 0.1587
658 frequently 1 0.3044
658 gave 1 0.3811
658 human 2 0.4024
658 inconclusive 1 0.5428
658 induce 3 1.211
658 induction 1 0.388
658 initial 1 0.2922
658 inoculated 1 0.4344
658 inoculation 2 0.8073
658 intimate 1 0.5428
658 involved 1 0.3071
658 isolated, 1 0.4634
658 isolations 1 0.5428
658 kidney 3 0.8014
658 kind 1 0.4229
658 later 1 0.3099
658 lesions 1 0.2593
658 lesions. 1 0.4127
658 lymphomas 2 1.2058
658 malignant 1 0.3288
658 marrow 1 0.3018
658 media 1 0.4477
658 mycoplasma 1 0.3288
658 mycoplasma. 1 0.4477
658 nature 1 0.2993
658 never 1 0.3955
658 nevertheless, 1 0.5076
658 noteworthy 1 0.6029
658 observations 1 0.2535
658 others. 1 0.4827
658 peculiar 1 0.5076
658 phenomena, 1 0.5428
658 previously 1 0.29
658 primary 1 0.2549
658 protein-rich 1 0.6029
658 related 1 0.2549
658 relationship 1 0.29
658 results 1 0.1727
658 seemed 1 0.388
658 serologic 1 0.4344
658 served 1 0.3955
658 specimens 1 0.388
658 specimens. 2 1.0856
658 spindling 1 0.6029
658 subsequently 1 0.4037
658 suggested 1 0.2507
658 suggestive 1 0.4477
658 supernatant 1 0.4827
658 tests 1 0.2969
658 transmissible 1 0.4827
658 tumors 3 0.9471
658 twisting 1 0.6029
658 two 2 0.3693
658 variety 1 0.3253
659 1, 1 0.97
659 agents 1 0.8133
659 another 1 0.8219
659 biological 1 0.805
659 certain 1 0.6637
659 defined. 1 1.357
659 definitely 1 1.2691
659 disease. 1 0.797
659 distinct 1 0.9369
659 ecological 1 1.5073
659 genital-tract 1 1.5073
659 hominis 1 1.086
659 important 1 0.6807
659 infect 1 1.2691
659 known 1 0.7363
659 m. 2 1.6808
659 man 1 0.7747
659 man. 1 0.97
659 may 1 0.377
659 mycoplasma 1 0.8219
659 mycoplasmas 1 1.0572
659 one 1 0.4217
659 pathogen, 1 1.5073
659 play 1 0.8954
659 pneumoniae, 1 1.357
659 present, 1 0.9887
659 properties 1 0.805
659 respiratory- 1 1.5073
659 respiratory-tract 1 1.5073
659 role 1 0.6992
659 shown 1 0.6481
659 six 1 0.831
659 species 2 1.6439
659 species, 2 2.2385
659 tract 1 0.8716
659 type 1 0.6268
660 "virus," 1 0.6029
660 1944 1 0.6029
660 1962 1 0.5428
660 addition 1 0.3071
660 agar 1 0.4229
660 apparently 1 0.3288
660 associates 1 0.5428
660 association 1 0.3253
660 atypical 1 0.4344
660 bacteria 1 0.388
660 became 1 0.3581
660 blood 1 0.1863
660 carry 1 0.4344
660 cell-free 1 0.4827
660 cell. 1 0.4229
660 cells 1 0.182
660 cells. 1 0.2688
660 characteristics, 1 0.5428
660 chemical 1 0.3633
660 cially 1 0.6029
660 classi- 1 0.6029
660 clear- 1 0.4634
660 clinical 1 0.1965
660 colonies 1 0.5428
660 com- 1 0.3581
660 complement 1 0.4127
660 contain 1 0.388
660 contained 1 0.3071
660 contrast 1 0.4037
660 cultivated 1 0.5076
660 defined 1 0.4127
660 definite 1 0.4127
660 despite 1 0.3811
660 disease 1 0.2166
660 dna 1 0.2878
660 duced 1 0.4634
660 eaton 2 1.2058
660 enriched 1 0.5428
660 enzymes 1 0.3811
660 espe- 1 0.6029
660 essentially 1 0.4127
660 evidence 1 0.221
660 evident 1 0.3748
660 fied 1 0.5428
660 free 1 0.2857
660 full 1 0.4037
660 genus 1 0.5428
660 host 1 0.3127
660 however, 1 0.2183
660 human 2 0.4024
660 identified, 1 0.5428
660 independent 2 0.7267
660 isolated 1 0.2623
660 ject 1 0.6029
660 lacking. 1 0.6029
660 larger 1 0.3581
660 like 1 0.388
660 living 2 0.8688
660 ly 1 0.3955
660 medium 1 0.322
660 membranes 1 0.388
660 metabolism 2 0.5714
660 monia, 1 0.6029
660 mucous 1 0.6029
660 mycoplasma. 1 0.4477
660 mycoplasmatales, 1 0.6029
660 normal 1 0.1621
660 number 1 0.2307
660 order, 1 0.5428
660 organism. 1 0.5076
660 organisms 1 0.3689
660 originally 1 0.4477
660 outside 1 0.4634
660 patients 1 0.1449
660 pleuropneumonia-like 2 0.9269
660 pneu- 1 0.6029
660 pounds 1 0.5428
660 pplo 5 2.3172
660 primary 1 0.2549
660 pro- 1 0.4127
660 reality 1 0.5076
660 recently, 1 0.6029
660 recognition 1 0.4037
660 respiratory 1 0.3127
660 rna, 1 0.4827
660 separate 1 0.3811
660 serum 1 0.2339
660 several 1 0.2608
660 size, 1 0.4127
660 small 1 0.2419
660 so-called 1 0.4344
660 strains 2 0.7163
660 sub- 1 0.388
660 subjects, 1 0.4037
660 tracts. 1 0.6029
660 typical 1 0.3955
660 unique 1 0.388
660 urinary 1 0.2671
660 viruses 1 0.4477
660 yeast. 1 0.6029
661 20 1 0.2723
661 80 1 0.4127
661 aberrant, 1 0.6029
661 absent, 1 0.5428
661 accompany 1 0.5076
661 adenoma, 1 0.5428
661 adenomata 1 0.6029
661 and, 1 0.3127
661 anyone 1 0.5428
661 apposition 1 0.6029
661 area 1 0.3127
661 availing, 1 0.6029
661 believe, 1 0.6029
661 biochemical 1 0.3811
661 brown 1 0.5428
661 burden 1 0.6029
661 cannot 1 0.3253
661 careful 1 0.3811
661 carry 1 0.4344
661 cases 2 0.3588
661 cent, 2 0.9269
661 close 1 0.3533
661 colour 1 0.5076
661 completing 1 0.5428
661 correct 1 0.4127
661 damage 1 0.3071
661 development, 1 0.4037
661 diameter, 1 0.6029
661 difficult 1 0.388
661 disease 1 0.2166
661 ectopic 1 0.5428
661 embryological 1 0.6029
661 evidence 1 0.221
661 expected 1 0.3955
661 experience 1 0.3099
661 explained 1 0.3401
661 exploration 2 1.0153
661 first 1 0.221
661 functioning 1 0.4127
661 gland; 1 0.6029
661 glands 4 1.5519
661 great 1 0.3443
661 half 1 0.3533
661 inch 1 0.4827
661 incision 1 0.6029
661 indicate 1 0.2655
661 indisputable 1 0.6029
661 inspect 1 0.6029
661 it. 1 0.4127
661 kidneys. 1 0.4477
661 later, 1 0.4827
661 less 1 0.2257
661 lightly 1 0.5428
661 lobes, 1 0.6029
661 lower 1 0.2741
661 major 1 0.29
661 may 3 0.4523
661 mediasti- 1 0.6029
661 mediastinum 1 0.5076
661 must 1 0.2945
661 neck, 1 0.5428
661 normal 1 0.1621
661 num, 1 0.6029
661 numerary 1 0.6029
661 occupies 1 0.6029
661 one 3 0.506
661 operation 1 0.3157
661 organs 1 0.3324
661 outline 1 0.5076
661 pair 1 0.4634
661 parathyroid 2 0.644
661 particularly 1 0.3324
661 per 2 0.47
661 policy, 1 0.6029
661 position 1 0.4127
661 position, 1 0.6029
661 possibly 1 0.3748
661 posterior 1 0.3533
661 present. 1 0.4037
661 prevent 1 0.4037
661 problems 1 0.3127
661 proves 1 0.5076
661 rather 2 0.5673
661 relieve 1 0.4634
661 removal 1 0.3362
661 reveal 1 0.4037
661 search 1 0.5076
661 seek 1 0.5428
661 seldom 1 0.5428
661 session. 1 0.6029
661 shouldered. 1 0.6029
661 size, 1 0.4127
661 small 1 0.2419
661 sternum-splitting 1 0.6029
661 super- 1 0.5428
661 surface 1 0.3253
661 surgery. 1 0.4127
661 symptoms 1 0.2857
661 tests 1 0.2969
661 thorough 1 0.5428
661 thymus 1 0.4344
661 thyroid 2 0.7065
661 tumour 1 0.3748
661 tumour, 1 0.5428
661 tumour. 1 0.4827
661 two 1 0.1846
661 un- 1 0.388
661 undertaken, 1 0.5428
661 undertaking 1 0.6029
661 unequivocally 1 0.5076
661 usually 5 1.4182
661 vast 1 0.5076
661 weeks 1 0.3157
661 yellow 1 0.5428
662 1% 1 0.6034
662 1.1 1 0.7536
662 25 2 0.8607
662 6 1 0.3151
662 86 1 0.6034
662 age 2 0.6235
662 aged 1 0.4542
662 also 1 0.2108
662 blood 1 0.2329
662 day 2 0.7483
662 days 1 0.2994
662 dca 2 1.5073
662 drink. 1 0.7536
662 every 1 0.4202
662 evident 1 0.4685
662 experimental 1 0.3496
662 factor 1 0.3571
662 g 1 0.5793
662 given 2 0.5526
662 greater 1 0.3118
662 group. 1 0.4358
662 growth 1 0.2569
662 growth. 1 0.543
662 heart 1 0.3496
662 hormone 1 0.3069
662 hypertension 1 0.4764
662 hypertrophy 1 0.3985
662 increase 1 0.256
662 kidneys 1 0.4202
662 later 1 0.3874
662 male 2 0.7678
662 mg/100 1 0.6785
662 mortality 1 0.4542
662 nacl 1 0.5596
662 nephrectomy 1 0.4542
662 permanent 1 0.5793
662 pressure, 1 0.4943
662 rats 4 1.1641
662 rats. 1 0.3946
662 reacted 1 0.6034
662 sensibilised 1 0.7536
662 showed 1 0.2686
662 solution 1 0.4611
662 starting 1 0.6785
662 steroid 1 0.4358
662 suppression 1 0.485
662 supression 1 0.7536
662 third 1 0.411
662 type 1 0.3134
662 unilateral 1 0.4066
662 week 1 0.4943
662 weeks 1 0.3946
662 younger 2 1.0091
663 1. 1 0.5262
663 15 1 0.4989
663 20-fold 1 1.0048
663 affected 1 0.5212
663 boiled 1 1.0048
663 cells. 1 0.448
663 damaged 1 0.8046
663 days 1 0.3992
663 effect 1 0.3068
663 glycoprotein 2 1.6922
663 greater 1 0.4157
663 growth 2 0.685
663 hand, 1 0.6056
663 hyperplasia 2 1.1337
663 increase 3 1.0239
663 increased 1 0.3124
663 injury 1 0.6728
663 ischaemic 1 0.9046
663 kidney 3 1.3357
663 liberated 1 0.8461
663 little 1 0.5366
663 liver. 1 0.7048
663 necrosis 2 1.3758
663 necrosis, 1 1.0048
663 necrotic 1 1.0048
663 none. 1 1.0048
663 one 1 0.2811
663 protein 3 1.3703
663 rat 1 0.4135
663 rate 1 0.3699
663 rats 2 0.7761
663 response 3 1.1006
663 response, 1 0.7462
663 serum 2 0.7797
663 subjected 1 0.548
663 substances 1 0.7048
663 suggested 1 0.4179
663 terramycin. 1 1.0048
663 thirds 1 0.8046
663 tissue 1 0.3488
663 tissue, 1 0.724
663 treated 1 0.4135
663 tumour 2 1.2492
663 two- 1 0.8461
663 underwent 1 0.724
663 upon 1 0.4509
663 walker 1 0.8461
664 adult 1 0.2741
664 agglutinins 1 0.5076
664 anemia. 1 0.6029
664 autoimmune 5 2.4137
664 bielschow- 1 0.6029
664 bielschowsky, 1 0.6029
664 cells 1 0.182
664 coat 1 0.5428
664 col- 1 0.6029
664 colony 1 0.6029
664 color. 1 0.6029
664 comparison 1 0.3127
664 develop 1 0.3633
664 developed 1 0.2741
664 dis- 1 0.3811
664 disease 2 0.4332
664 disease. 1 0.3188
664 dr. 1 0.4634
664 dunedin 2 1.2058
664 dunedin, 1 0.6029
664 ease 1 0.5076
664 evidence 3 0.6631
664 evolved 1 0.5076
664 ficin-treated 1 0.6029
664 first 1 0.221
664 found 1 0.1587
664 group 1 0.2229
664 helyer, 1 0.6029
664 hemo- 1 0.4477
664 history 1 0.3487
664 howie 1 0.6029
664 human 1 0.2012
664 inbred 1 0.4827
664 inbreed- 1 0.6029
664 index 1 0.3581
664 ing 1 0.3253
664 life. 1 0.4344
664 lytic 1 0.4827
664 manifestations 1 0.3443
664 marianne 1 0.6029
664 mice 2 0.5938
664 mixed 1 0.3811
664 natural 1 0.3533
664 new 1 0.2639
664 nzb 2 1.2058
664 nzb/bl 2 1.2058
664 nzc, 1 0.6029
664 nzo, 1 0.6029
664 nzw, 1 0.6029
664 nzy, 1 0.6029
664 ony. 1 0.6029
664 original 1 0.3443
664 others, 1 0.4634
664 outbred 1 0.6029
664 pathological 1 0.3253
664 pattern 1 0.2878
664 presence 1 0.2297
664 red 1 0.3581
664 reported 1 0.2443
664 serological 1 0.4477
664 several 1 0.2608
664 sky 1 0.6029
664 spon- 1 0.4827
664 strain 3 0.9564
664 strains--nzb, 1 0.6029
664 taneously 1 0.5428
664 used 1 0.2277
664 zealand, 1 0.6029
665 10 1 0.2774
665 5 1 0.2859
665 area 1 0.3909
665 atrophy. 1 0.6346
665 configuration. 1 0.6785
665 diseased 2 1.5073
665 doses 1 0.411
665 enlarged. 1 0.6785
665 evidence 1 0.2763
665 expected 1 0.4943
665 intravenous 1 0.4025
665 ionizing 1 0.7536
665 irradiated 1 0.4358
665 irradiated. 1 0.7536
665 irradiation 1 0.4066
665 jected 1 0.6785
665 kidney 4 1.3357
665 kidneys 1 0.4202
665 nephrectomy. 1 0.4764
665 none 1 0.4542
665 normal 1 0.2027
665 patients 1 0.1812
665 radia- 1 0.6785
665 range 1 0.4066
665 remaining 2 0.7678
665 removed 1 0.4252
665 size 2 0.7893
665 studied 1 0.2626
665 sub- 1 0.485
665 survived 1 0.4943
665 survivors 1 0.543
665 time 1 0.2656
665 tion 1 0.3426
665 tumor 2 0.672
665 urograms 1 0.7536
665 varying 1 0.4066
665 wilms's 2 1.5073
665 within 1 0.2798
665 years 1 0.3426
666 (after 2 0.8461
666 10 1 0.1849
666 2 1 0.1534
666 23 1 0.3364
666 3-fold. 1 0.5024
666 48 3 0.8503
666 6 1 0.2101
666 60 2 0.6466
666 8 1 0.2269
666 access 1 0.5024
666 acid 3 0.5821
666 activity 2 0.3596
666 allowed 1 0.3524
666 also 1 0.1406
666 animals. 2 0.5669
666 cant. 1 0.5024
666 cellular 1 0.274
666 cent 1 0.2582
666 compensating 1 0.423
666 compensatory 1 0.2801
666 con- 1 0.2606
666 control 1 0.1889
666 cor- 1 0.423
666 cortex 4 1.108
666 day 2 0.4989
666 days 4 0.7983
666 days. 1 0.2834
666 deoxyribonucleic 3 1.0572
666 effect 1 0.1534
666 either 1 0.2148
666 enlargement 1 0.3439
666 even 1 0.2199
666 fifth 1 0.4023
666 fol- 1 0.3731
666 following 2 0.3331
666 food 2 0.7724
666 food) 1 0.5024
666 found 1 0.1323
666 found. 1 0.3233
666 fourteen 1 0.4023
666 fourth 1 0.3731
666 free 1 0.2381
666 frequency 1 0.2631
666 given 1 0.1842
666 greater 1 0.2078
666 highest 1 0.3176
666 hours 5 1.2083
666 however, 1 0.182
666 hyper- 1 0.2985
666 hyperplasia 1 0.2834
666 hyperplastic 1 0.3862
666 increase 3 0.5119
666 increased 1 0.1562
666 increases 2 0.4694
666 index 2 0.5969
666 ing 1 0.2711
666 injection 1 0.2101
666 inner 3 1.2691
666 kid- 2 1.0048
666 kidney 3 0.6678
666 kidneys 6 1.6808
666 kidneys, 1 0.3862
666 kidneys. 1 0.3731
666 labeling 1 0.3296
666 lowest 1 0.4023
666 lowing 1 0.423
666 medulla 3 1.086
666 medullary 1 0.423
666 mice 2 0.4948
666 mice. 1 0.3176
666 mitotic 4 1.2933
666 nephrectomy 3 0.9083
666 nephrectomy. 1 0.3176
666 ney 1 0.5024
666 neys 1 0.5024
666 noted 2 0.5313
666 occurred 1 0.2186
666 one 2 0.2811
666 operative 1 0.2801
666 outer 2 0.8461
666 per 1 0.1958
666 plastic 1 0.3862
666 post- 1 0.4523
666 postoperative 1 0.3028
666 prevented 1 0.3296
666 proliferation 1 0.2905
666 radioautographic 1 0.423
666 regions 1 0.4023
666 remain- 1 0.5024
666 remaining 4 1.0237
666 removal 2 0.5603
666 renal 1 0.1949
666 response 1 0.1834
666 responses 1 0.2801
666 restriction 2 0.724
666 restriction) 1 0.5024
666 returned 1 0.362
666 revealed 1 0.2435
666 second 2 0.5119
666 seen 1 0.2124
666 sham-operated 2 0.9046
666 signifi- 1 0.3862
666 significant 3 0.5291
666 significant. 1 0.3524
666 single 1 0.2494
666 starvation 1 0.4523
666 statistically 2 0.6246
666 studies 1 0.1539
666 surgery 1 0.2494
666 surviving 2 0.7462
666 synthesis 3 0.7483
666 tex 1 0.5024
666 thymidine. 1 0.4023
666 times 1 0.2417
666 tissue 1 0.1744
666 tritiated 1 0.3364
666 trol 1 0.423
666 two 1 0.1539
666 underwent 1 0.362
666 unilateral 4 1.0844
666 values. 1 0.423
666 water 4 1.0626
666 weighed 1 0.4523
666 without 1 0.1897
666 zone 1 0.3296
667 18 1 0.548
667 48 1 0.5669
667 accounted 1 0.7462
667 cell 1 0.3401
667 cellular 1 0.548
667 changed 1 0.6879
667 characterized 1 0.5313
667 compen- 1 0.9046
667 compensatory 2 1.1206
667 day, 1 0.7724
667 decline, 1 1.0048
667 dna 2 0.9594
667 early 1 0.3684
667 end 1 0.6148
667 enlargement 1 0.6879
667 enlargement. 1 1.0048
667 fifth 1 0.8046
667 first 1 0.3684
667 growth 1 0.3425
667 hour. 1 0.9046
667 hours 1 0.4833
667 hours. 1 0.724
667 hyperplasia 2 1.1337
667 hypertrophy 2 1.0626
667 increase 2 0.6826
667 kidney 2 0.8904
667 maximum 1 0.554
667 mouse, 1 0.9046
667 nephrectomy 1 0.6056
667 one-fourth 1 1.0048
667 passed 1 0.8461
667 peak 1 0.5811
667 phase 1 0.5366
667 predominant 1 0.7724
667 primary 1 0.4248
667 protein 1 0.4568
667 remaining 1 0.5119
667 remains 1 0.5262
667 renal 2 0.7797
667 response 1 0.3669
667 rises 1 0.7462
667 rna 1 0.554
667 satory 1 0.9046
667 shown 1 0.4321
667 synthesis 3 1.4967
667 thus 1 0.5212
667 un- 1 0.6466
667 unilateral 1 0.5422
667 versus 1 0.8461
667 weight. 1 0.7462
667 within 1 0.373
668 24, 1 0.5024
668 48 2 0.5669
668 72 1 0.362
668 autoradiographic 1 0.3296
668 cell 2 0.3401
668 cells 1 0.1516
668 com- 1 0.2985
668 compared 1 0.1949
668 compensatory 2 0.5603
668 concluded 1 0.2299
668 contralateral 1 0.3731
668 controls 1 0.3028
668 corresponding 1 0.2944
668 cortex 2 0.554
668 counts 3 1.0572
668 different 1 0.1777
668 division 1 0.3524
668 dna 1 0.2399
668 early 1 0.1842
668 epithelial 2 0.5313
668 experimental 1 0.2331
668 factors; 1 0.4523
668 figures 1 0.3862
668 greater 1 0.2078
668 hours 1 0.2417
668 hours. 1 0.362
668 humoral 1 0.5024
668 hydronephrosis 1 0.423
668 hyperplasia 1 0.2834
668 hyperplasia. 2 0.8046
668 increased 1 0.1562
668 interstitial 2 0.6879
668 kidney 6 1.3357
668 labeled 2 0.6056
668 left 2 0.4538
668 ligated. 1 0.5024
668 ligation 1 0.4023
668 localized 1 0.3524
668 made 1 0.182
668 male 1 0.2559
668 mechanism 1 0.2315
668 mediated 1 0.362
668 mitosis 1 0.3862
668 mitotic 1 0.3233
668 nephrectomy, 2 0.7462
668 nuclei 2 0.6352
668 number 1 0.1923
668 obstructed 3 1.5073
668 occurring 1 0.2905
668 operated 1 0.3233
668 operation. 1 0.3296
668 pensatory 1 0.5024
668 preceded 1 0.423
668 probably 1 0.2284
668 proliferation 1 0.2905
668 proliferative 1 0.362
668 rats 2 0.388
668 re- 1 0.2226
668 remaining 2 0.5119
668 renal 3 0.5847
668 responded 1 0.3731
668 response 3 0.5503
668 response. 1 0.3524
668 sham- 1 0.5024
668 showed 2 0.3582
668 side 1 0.2834
668 side, 1 0.4523
668 simul- 1 0.4523
668 slight 1 0.2985
668 sponse 1 0.3862
668 subjected 1 0.274
668 synthesis 1 0.2494
668 taneously 1 0.4523
668 thymidine 1 0.3524
668 tritiated 1 0.3364
668 tritium- 1 0.5024
668 undergoing 1 0.3176
668 ureter 1 0.5024
668 ureteral 1 0.423
668 whereas 1 0.2515
669 accuracy 1 0.4634
669 amenable 1 0.5428
669 among 1 0.2816
669 aortography, 1 0.5076
669 appropriate 1 0.3955
669 arterial 1 0.3127
669 arteriography 1 0.6029
669 artery 1 0.3443
669 atherosclerosis, 1 0.6029
669 blood 3 0.5589
669 branches. 1 0.5076
669 careful 1 0.3811
669 cases 3 0.5381
669 cause 1 0.2723
669 close 1 0.3533
669 coats 1 0.6029
669 commonly 1 0.4229
669 complex 1 0.3487
669 con- 1 0.3127
669 course 1 0.2741
669 cure. 1 0.5428
669 definitive 2 0.9269
669 diagnosis 2 0.4962
669 diagnostic 1 0.2993
669 discovered 1 0.4229
669 disease. 1 0.3188
669 elderly 1 0.5076
669 emphasized, 1 0.6029
669 establishing 1 0.4827
669 etiologic 1 0.4344
669 examination. 1 0.5076
669 factors 2 0.5098
669 first 1 0.221
669 high 1 0.2158
669 hyperplasia 1 0.3401
669 hypertension 3 1.1434
669 hypertension. 1 0.5076
669 important 1 0.2723
669 intensive 1 0.4477
669 intimal 1 0.5428
669 intravenous 1 0.322
669 involves 1 0.4344
669 mandatory 1 0.6029
669 many 3 0.7292
669 may 1 0.1508
669 means 1 0.2671
669 mechanisms. 1 0.5076
669 methods 1 0.2723
669 modern 1 0.4477
669 muscular 1 0.4229
669 obscure 1 0.5076
669 observed 1 0.2055
669 operation, 1 0.4477
669 pathogenesis 1 0.3401
669 patients 1 0.1449
669 permanent 1 0.4634
669 physical 1 0.3487
669 planning 1 0.5076
669 present 1 0.1985
669 pressure 2 0.5518
669 pressure. 1 0.4344
669 procedures 1 0.3401
669 procedures. 2 0.9655
669 provided 1 0.3689
669 readings 1 0.4634
669 reduction 1 0.2969
669 relationship 1 0.29
669 renal 5 1.1695
669 renovascular 2 1.2058
669 require 1 0.4127
669 routine 1 0.4344
669 selection 1 0.4127
669 since 2 0.5246
669 single 1 0.2993
669 sometimes 1 0.388
669 split-function 1 0.6029
669 striction 1 0.6029
669 striking 1 0.3811
669 studies 1 0.1846
669 successful 1 0.4127
669 suitable 1 0.388
669 surgery 1 0.2993
669 surgery, 1 0.4634
669 surgical 2 0.5445
669 technical 1 0.4344
669 test 1 0.2608
669 tests 1 0.2969
669 time 2 0.4249
669 urography 1 0.6029
669 usually 1 0.2836
669 variety 1 0.3253
669 whereas 1 0.3018
669 younger 1 0.4037
670 1,2-benzanthracene; 1 0.7536
670 3h-thymidine 1 0.7536
670 9,10-dimethyl-1,2-benzanthracene, 1 0.7536
670 achieved 1 0.5159
670 acth, 1 0.7536
670 administration 1 0.3319
670 aldosterone. 1 0.7536
670 autoradiographic 1 0.4943
670 cell 4 1.0202
670 cells 3 0.6823
670 chiefly 1 0.543
670 chosen 1 0.6785
670 compensatory 1 0.4202
670 contained 1 0.3839
670 cortical 1 0.485
670 decline 1 0.5286
670 delayed 1 0.4416
670 deoxycorticosterone 1 0.7536
670 dna-synthesising 1 0.7536
670 due 1 0.2666
670 early 1 0.2763
670 effect 1 0.2301
670 fewer 1 0.543
670 formation 1 0.3381
670 formation. 1 0.5793
670 forty-eight 2 1.357
670 glomerular 1 0.4764
670 growth 1 0.2569
670 hours 2 0.725
670 hydrocortisone, 1 0.7536
670 increase 2 0.5119
670 increased 1 0.2343
670 indicated 1 0.3546
670 kidney 4 1.3357
670 magnitude 1 0.4685
670 maximal 1 0.4685
670 model 1 0.5286
670 nephrectomy 1 0.4542
670 nephrectomy. 1 0.4764
670 new 4 1.3194
670 normal 1 0.2027
670 number 1 0.2884
670 numbers 1 0.4477
670 one 1 0.2108
670 one-week 1 0.7536
670 operation. 1 0.4943
670 peak 1 0.4358
670 period 1 0.2859
670 period. 1 0.4542
670 production 2 0.7678
670 progressive 1 0.4202
670 proliferation 1 0.4358
670 radiochemical 1 0.7536
670 rates 1 0.4542
670 rats 2 0.5821
670 reduced 1 0.3403
670 remaining 1 0.3839
670 removed 1 0.4252
670 renal 2 0.5847
670 response 1 0.2752
670 seventy-two 1 0.6785
670 showed 1 0.2686
670 six-week 1 0.7536
670 slow 1 0.4943
670 stimulated 1 0.5046
670 studies 1 0.2308
670 study 1 0.2322
670 substances 1 0.5286
670 thereafter. 1 0.6785
670 treatment 1 0.2223
670 tubule 1 0.543
670 tubules. 1 0.5793
670 tufts 1 0.7536
670 turnover 1 0.5046
670 two 1 0.2308
670 unilateral 2 0.8133
670 various 1 0.2979
670 weeks 1 0.3946
670 weight 1 0.3546
671 24 1 0.3127
671 activity 1 0.2158
671 adrenalectomy 2 0.8457
671 adrenalectomy. 1 0.6029
671 adrenals 1 0.5076
671 bined 1 0.6029
671 calcium 2 0.7163
671 cell 1 0.204
671 change 1 0.2797
671 changes 1 0.1804
671 com- 1 0.3581
671 combined 1 0.3099
671 corresponding 1 0.3533
671 could 1 0.2166
671 early 1 0.221
671 effects 1 0.2238
671 enlarged 1 0.5428
671 form 1 0.2623
671 glandular 1 0.4477
671 higher 1 0.2593
671 homeostasis 1 0.6029
671 hours 1 0.29
671 increased 2 0.3748
671 indications 1 0.4127
671 induce 1 0.4037
671 less 1 0.2257
671 marked 1 0.2705
671 morphological 1 0.3689
671 nephrectomized 1 0.4344
671 nephrectomy 5 1.8167
671 nuclei. 1 0.6029
671 observations 1 0.2535
671 only. 1 0.4344
671 opposite 1 0.5076
671 para- 1 0.4827
671 parathyroids 2 1.0856
671 parathyroids. 1 0.6029
671 rat 1 0.2481
671 rats 1 0.2328
671 serum 1 0.2339
671 studied 1 0.2101
671 suggest 1 0.2741
671 thyroid 1 0.3533
671 total 1 0.235
671 volume 1 0.3071
672 affected. 1 0.8046
672 ampullae 1 1.0048
672 areas 1 0.5313
672 attachment 1 0.8046
672 be- 1 0.6148
672 believe 1 0.6728
672 bile 1 0.7048
672 branches 2 2.0097
672 bud 1 1.0048
672 cal 1 0.7724
672 caused 1 0.4398
672 characterized 1 0.5313
672 collecting 3 2.4137
672 confirms 1 0.8461
672 connective 1 0.724
672 creased 1 0.6591
672 cylindri- 1 1.0048
672 cystic 1 0.7462
672 cystic. 1 1.0048
672 de- 1 0.5603
672 different 1 0.3554
672 dilatation. 1 0.9046
672 ducts 1 0.724
672 enlargement 1 0.6879
672 except 1 0.5669
672 found 1 0.2645
672 generations 1 0.8461
672 greatly 1 0.5969
672 havior 1 0.9046
672 hyperplasia 1 0.5669
672 in- 2 0.8904
672 increase 1 0.3413
672 increased. 1 0.6728
672 interstitial 2 1.3758
672 intrahepatic 1 0.8046
672 kidney 1 0.4452
672 kidneys 2 1.1206
672 length 1 0.6591
672 localized 1 0.7048
672 mal 1 0.6728
672 may 1 0.2513
672 microdissection 1 1.0048
672 minimal 1 0.6246
672 nephrons 2 2.0097
672 newborn 1 0.548
672 nor- 1 0.6466
672 normal 2 0.5404
672 normal. 2 1.2111
672 number 1 0.3845
672 numbers, 1 0.8046
672 pathogenesis 1 0.5669
672 pattern 1 0.4797
672 periods. 1 0.9046
672 poly- 1 0.9046
672 polycystic 1 0.9046
672 portions 1 0.7462
672 present 1 0.3308
672 previous 1 0.5422
672 relative 1 0.5212
672 renal 1 0.3898
672 responsible 1 0.5074
672 saccular 1 1.0048
672 scription 1 1.0048
672 secondary 1 0.5031
672 siblings 1 0.7462
672 size 1 0.5262
672 size. 1 0.7462
672 symmetrical 1 0.9046
672 tissue 1 0.3488
672 tubules 2 1.4923
672 tubules. 1 0.7724
672 uncommon 1 0.7724
672 ureteral 1 0.8461
672 variably 1 0.9046
672 variety 1 0.5422
673 add 1 0.3877
673 adenocar- 1 0.3877
673 adenoma 1 0.3103
673 adenomas 1 0.4306
673 adenomatous 1 0.3877
673 also 1 0.1205
673 apparently 1 0.2348
673 areas 1 0.2277
673 association 1 0.2324
673 ate 1 0.4306
673 autonomous 1 0.3198
673 azotemia 1 0.3877
673 chronic 1 0.2056
673 cinoma 1 0.3448
673 concurrence 2 0.8613
673 course. 1 0.4306
673 developed 1 0.1958
673 developing 1 0.2324
673 diagnosis 1 0.1772
673 dimensions 1 0.3448
673 disease 2 0.3094
673 disorders. 1 0.331
673 displayed 1 0.3448
673 due 1 0.1523
673 emphasize 1 0.3626
673 examining 1 0.3877
673 followed 1 0.1971
673 found 2 0.2267
673 four 1 0.1932
673 function. 1 0.3626
673 generalized 1 0.2948
673 glands 2 0.5543
673 glands. 1 0.3448
673 group 1 0.1592
673 hyper- 2 0.5116
673 hypercalcemia 2 0.6621
673 hyperparathyroidism 1 0.3103
673 hyperphosphatemia. 1 0.4306
673 hyperplasia 3 0.7288
673 indicate 1 0.1896
673 insufficiency. 1 0.3877
673 large 1 0.1702
673 lesions: 1 0.4306
673 long-standing 1 0.3626
673 manifesta- 1 0.3626
673 mary 1 0.3448
673 mediastinal 1 0.3877
673 moder- 1 0.4306
673 multiple 1 0.2374
673 necessity 1 0.3198
673 neoplasia 2 0.7754
673 neoplastic 1 0.3021
673 new 1 0.1885
673 nodules 1 0.3877
673 observation 1 0.2255
673 observations 1 0.1811
673 one 1 0.1205
673 one, 1 0.3198
673 other. 1 0.3448
673 pa- 1 0.2523
673 parathyroid 7 1.6099
673 patient 1 0.1619
673 patients 4 0.4141
673 plasia 2 0.7754
673 ported. 1 0.4306
673 pri- 1 0.3626
673 primary 1 0.1821
673 re- 1 0.1908
673 renal 3 0.5012
673 similar 1 0.1612
673 six 1 0.2374
673 superimposed 1 0.3626
673 surgery. 1 0.2948
673 therapy 1 0.1702
673 third 1 0.2348
673 tient 1 0.3877
673 time 1 0.1517
673 tion 1 0.1958
673 two 2 0.2638
673 well 1 0.1506
674 3h-thymidin 1 0.5024
674 3rd 1 0.362
674 48 1 0.2834
674 4th 1 0.3731
674 actual 1 0.362
674 also 1 0.1406
674 although 1 0.1931
674 amitotic 1 0.5024
674 animals 1 0.2136
674 animals, 1 0.3028
674 assumed 1 0.3439
674 assumption 1 0.4023
674 attempted 1 0.3364
674 autoradiographical 1 0.5024
674 based 1 0.2631
674 bei 1 0.5024
674 cannot 1 0.2711
674 cell 2 0.3401
674 cells 5 0.7581
674 central 1 0.2711
674 certain 2 0.4425
674 clarify 1 0.4023
674 compensatory 5 1.4007
674 concluded. 1 0.5024
674 connective 1 0.362
674 cytological, 1 0.5024
674 day 1 0.2494
674 days 1 0.1996
674 determined 1 0.2284
674 development 1 0.1834
674 distinct 1 0.3123
674 dividing 1 0.3862
674 division 1 0.3524
674 division, 1 0.4523
674 divisions 1 0.5024
674 dna-synthesizing 2 0.9046
674 early 1 0.1842
674 examinations 1 0.3439
674 experimentelle 1 0.5024
674 experiments 1 0.2226
674 extent 1 0.2657
674 follows: 1 0.4023
674 grown 1 0.3439
674 histological, 1 0.5024
674 hours 1 0.2417
674 hours, 1 0.4023
674 hypertrophy 3 0.797
674 hypertrophy. 2 0.7462
674 imagined 1 0.5024
674 increase 2 0.3413
674 increase. 1 0.4523
674 index 1 0.2985
674 indications 1 0.3439
674 indifference 1 0.5024
674 investigation 1 0.2834
674 investigations 1 0.3123
674 involved, 1 0.423
674 kidney. 2 0.6246
674 largely 1 0.3524
674 latent 1 0.423
674 localization 1 0.3524
674 major 1 0.2417
674 marked 1 0.2254
674 maximum 1 0.277
674 means 1 0.2226
674 mechanism 1 0.2315
674 mit 1 0.4523
674 mitosis 1 0.3862
674 mitotic 1 0.3233
674 must 1 0.2454
674 nach 1 0.5024
674 nephrectomy 1 0.3028
674 nephrectomy, 2 0.7462
674 nephrectomy. 1 0.3176
674 nephrektomie 1 0.5024
674 nierenvergroberung 1 0.5024
674 nuclear 1 0.2905
674 observed 2 0.3425
674 older 1 0.3123
674 one 1 0.1406
674 paper 1 0.2711
674 parallel 1 0.3233
674 parenchyma, 1 0.4523
674 part 1 0.2347
674 participate 1 0.423
674 period 1 0.1906
674 phase. 1 0.4023
674 play 1 0.2985
674 polyploid 1 0.5024
674 polyploidization 1 0.5024
674 premitotic 1 0.5024
674 process 1 0.2299
674 processes 4 1.1938
674 processes. 1 0.4523
674 proliferation 1 0.2905
674 prolonged 1 0.2417
674 provide 1 0.2944
674 questions 1 0.3731
674 rats. 1 0.2631
674 ratten 1 0.5024
674 reached 1 0.3296
674 regenerating 1 0.4523
674 regeneration 1 0.362
674 regenerative 3 1.357
674 remaining 1 0.2559
674 renal 6 1.1695
674 rest 1 0.362
674 results 2 0.2878
674 run 1 0.4523
674 section, 1 0.5024
674 sections 1 0.3439
674 simultaneous 1 0.3074
674 speak 1 0.4023
674 start 1 0.4023
674 test 2 0.4346
674 tissue 1 0.1744
674 tubule 1 0.362
674 twenty 1 0.3731
674 two 1 0.1539
674 unilateral 2 0.5422
674 unilateraler 1 0.5024
674 untersuchungen 1 0.5024
674 vessels. 1 0.4523
674 without 1 0.1897
674 young 2 0.5074
674 zone 1 0.3296
675 (i.e., 2 0.4934
675 1000 2 0.4389
675 20 1 0.1238
675 21 4 0.6929
675 4 2 0.1939
675 4-6 1 0.2467
675 5-12 1 0.274
675 50 1 0.1308
675 500 4 0.8426
675 6-14 1 0.274
675 abscopal 2 0.5481
675 amount 1 0.135
675 animals 1 0.1165
675 approximately 1 0.1435
675 area, 1 0.2194
675 basis 1 0.1199
675 bodies 1 0.1677
675 body 8 0.8839
675 calculated 1 0.1835
675 cent 1 0.1409
675 cent. 1 0.2107
675 compared 1 0.1063
675 compensatory 2 0.3056
675 concluded 1 0.1254
675 constant 1 0.1494
675 content 6 0.7736
675 controls, 1 0.2307
675 corresponding 1 0.1606
675 days 3 0.3266
675 days. 1 0.1546
675 decrease 1 0.1254
675 decreased 1 0.1238
675 degree 1 0.1214
675 determined 1 0.1246
675 difference 1 0.1372
675 dna 7 0.9158
675 due 1 0.0969
675 effect 1 0.0837
675 effect, 1 0.2035
675 effects 1 0.1017
675 elicited 1 0.1922
675 exposed 1 0.1435
675 exteriorized 1 0.274
675 following 5 0.4542
675 food 1 0.2107
675 found 1 0.0721
675 greater 1 0.1134
675 growing 1 0.1835
675 growth 3 0.2802
675 hundred 1 0.2107
675 hypertrophy 6 0.8694
675 hypertrophying 4 1.0962
675 increase 2 0.1862
675 increased 1 0.0852
675 increment 1 0.2307
675 indirect 1 0.2107
675 inhibition 1 0.1372
675 intact), 1 0.274
675 irradiation 5 0.7393
675 irradiation, 1 0.2107
675 irradiation. 1 0.1876
675 kidney 11 1.3357
675 kidney, 3 0.5393
675 kidney. 2 0.3407
675 kidneys 2 0.3056
675 lead-shielded 1 0.274
675 local 1 0.1652
675 marked 1 0.123
675 measure 1 0.1585
675 nephrectomy 1 0.1652
675 nephrectomy. 1 0.1732
675 non- 1 0.1974
675 nonirradiated 2 0.4615
675 normal 2 0.1474
675 normal, 1 0.2035
675 obtained 1 0.0977
675 occurred 1 0.1192
675 old 5 0.773
675 per 2 0.2136
675 rad 5 1.2336
675 rad, 1 0.274
675 rat 2 0.2255
675 rate 1 0.1009
675 ratio 1 0.1435
675 rats 4 0.4233
675 rats. 2 0.287
675 rays 1 0.274
675 reduction 4 0.5398
675 remaining 1 0.1396
675 restriction 1 0.1974
675 resulting 1 0.1396
675 retardation, 3 0.6583
675 secondary 1 0.1372
675 several 1 0.1185
675 shielded 1 0.2107
675 showed 2 0.1954
675 significant 2 0.1924
675 small 1 0.1099
675 sprague-dawley 1 0.2307
675 still 1 0.128
675 surface 1 0.1479
675 time 2 0.1931
675 uninephrectomy 1 0.274
675 uninephrectomy) 1 0.274
675 uninephrectomy. 2 0.5481
675 values 1 0.1384
675 week 3 0.5393
675 weeks 2 0.287
675 weight 7 0.9025
675 weight. 1 0.2035
675 white 1 0.1703
675 whole 3 0.4584
675 whole-body 1 0.1974
675 whose 1 0.1606
675 x 4 0.6929
675 x-irradiation 1 0.2307
676 .64% 1 0.5024
676 .93% 1 0.5024
676 .95% 1 0.5024
676 1.0%. 1 0.5024
676 1350 2 1.0048
676 500 1 0.3862
676 600 2 0.9046
676 abdomen 1 0.4523
676 abdominal 1 0.3731
676 alone. 1 0.3731
676 ani- 1 0.3862
676 animals 1 0.2136
676 basis 1 0.2199
676 body 4 0.8102
676 cant 1 0.5024
676 cent, 1 0.3862
676 cf-1 1 0.5024
676 changes 1 0.1503
676 compared 2 0.3898
676 controls 1 0.3028
676 decreases 1 0.3233
676 direct 1 0.2364
676 dose 1 0.2399
676 effect 1 0.1534
676 effects 1 0.1865
676 either 1 0.2148
676 enlargement 1 0.3439
676 exert 1 0.423
676 exposure 1 0.2985
676 female 1 0.2905
676 final 1 0.3296
676 following 1 0.1665
676 gain 2 0.724
676 given 2 0.3684
676 group 1 0.1857
676 groups 2 0.4092
676 half 1 0.2944
676 hours 1 0.2417
676 increase 2 0.3413
676 influences 1 0.3862
676 inhibitory 1 0.3296
676 irradiated 2 0.5811
676 irradiation 1 0.2711
676 kidney 1 0.2226
676 limits 1 0.3862
676 local 1 0.3028
676 locally 1 0.423
676 mals 1 0.423
676 mice 1 0.2474
676 mouse 1 0.2801
676 nephrectomized 1 0.362
676 nephrectomy 2 0.6056
676 nephrectomy. 1 0.3176
676 obtained 1 0.1791
676 per 1 0.1958
676 prior 1 0.2683
676 r 2 0.6591
676 r. 2 0.6879
676 radiation 1 0.274
676 ranges 1 0.423
676 ranging 1 0.3439
676 ratio 1 0.2631
676 renal 5 0.9746
676 results 1 0.1439
676 seen 1 0.2124
676 signifi- 1 0.3862
676 similar, 1 0.423
676 subjected 2 0.548
676 suggest 1 0.2284
676 three 1 0.1889
676 total 2 0.3916
676 unilateral 1 0.2711
676 value 1 0.2315
676 weanling 1 0.3862
676 weight 6 1.4182
676 weight. 1 0.3731
676 without 1 0.1897
677 basis 1 0.4398
677 carcinogenesis. 1 0.9046
677 cell 1 0.3401
677 chemical 1 0.6056
677 classified 1 0.6056
677 compound 1 0.6879
677 dimethylnitrosamine 2 2.0097
677 dimethylnitrosamine. 1 1.0048
677 dosed 1 1.0048
677 epithelial 1 0.5313
677 foci 1 0.724
677 given 1 0.3684
677 greater 1 0.4157
677 groups 1 0.4092
677 histogenesis, 1 1.0048
677 hyperplasia 2 1.1337
677 hyperplastic 1 0.7724
677 incidence 1 0.4797
677 induced 1 0.4272
677 interstitial 1 0.6879
677 kidney 1 0.4452
677 lesions 1 0.4321
677 male 1 0.5119
677 multiple 1 0.554
677 namely 1 0.8046
677 neoplasia 2 1.8093
677 neoplastic 1 0.7048
677 orally 1 0.7724
677 origin 1 0.5738
677 origin. 1 0.6728
677 rats 3 1.1641
677 recommended 1 0.6728
677 renal 3 1.1695
677 sex 1 0.6728
677 study 1 0.3096
677 tubular 1 0.6728
677 tumors. 1 0.6591
677 two 1 0.3077
677 useful 1 0.554
677 younger 1 0.6728
678 "radiation-induced 1 0.6029
678 24-hour 1 0.5076
678 ability 4 1.2285
678 acid 1 0.2328
678 administration 1 0.2655
678 age 3 0.7482
678 aging 1 0.4634
678 aging," 1 0.6029
678 cause 1 0.2723
678 cell 2 0.4081
678 cells 1 0.182
678 compen- 1 0.5428
678 compensatory 2 0.6723
678 concentrate 2 0.9655
678 concentration 1 0.2535
678 concerned 1 0.4037
678 conclusion 1 0.4037
678 cortex 2 0.6648
678 decline 1 0.4229
678 declines 1 0.5076
678 degree 1 0.2671
678 division. 2 1.2058
678 early 2 0.442
678 effect 4 0.7364
678 equally 1 0.4344
678 fast. 1 0.6029
678 female 4 1.3946
678 function 2 0.541
678 gradient 1 0.4229
678 hormone. 1 0.3533
678 hypertrophy 3 0.9564
678 hypertrophy. 1 0.4477
678 increase 1 0.2048
678 increased 1 0.1874
678 indicating 1 0.388
678 irradiated 1 0.3487
678 kidney 4 1.0685
678 kidneys 1 0.3362
678 lack 1 0.3487
678 late 1 0.3581
678 life 3 0.9564
678 long- 1 0.5428
678 long-term 2 0.6973
678 loss 2 0.5845
678 may 2 0.3016
678 measurable 1 0.5428
678 mice 2 0.5938
678 mice, 1 0.4477
678 mice. 3 1.1434
678 mouse 3 1.0085
678 mouse. 1 0.5428
678 nephrectomy 1 0.3633
678 nonirradiated 2 1.0153
678 old 3 1.0204
678 organ 1 0.4229
678 over-all 1 0.4477
678 p-aminohippuric 1 0.6029
678 process. 1 0.4634
678 processes 1 0.3581
678 pronounced 1 0.3581
678 propionate 1 0.4477
678 reduce 1 0.3811
678 reduction 2 0.5938
678 relatively 1 0.29
678 renal 3 0.7017
678 represent 1 0.3811
678 respect 2 0.7065
678 respond 1 0.3689
678 results 1 0.1727
678 role 1 0.2797
678 satory 1 0.5428
678 show 1 0.2608
678 slices 3 1.4482
678 study, 1 0.388
678 swiss 1 0.5076
678 target 1 0.4827
678 term 1 0.3362
678 testosterone 1 0.4344
678 uncertain 1 0.4477
678 undergo 1 0.4477
678 unilateral 1 0.3253
678 urine 1 0.3099
678 water 1 0.3188
678 well 1 0.2108
678 whether 1 0.2993
678 x-irradiated 1 0.4634
678 x-irradiation 5 2.5382
678 young 2 0.6089
679 adrenalecto- 1 0.7536
679 albumin 1 0.5286
679 albumin, 1 0.6785
679 aldosterone 2 1.2691
679 blood 2 0.4657
679 case 2 0.5415
679 cases. 1 0.3946
679 complex, 2 1.086
679 creased 1 0.4943
679 curative. 1 0.7536
679 depriva- 1 0.7536
679 detail. 1 0.543
679 diet 2 0.9887
679 dosteronism, 1 0.7536
679 dwarfism, 1 0.6785
679 dwarfism: 1 0.6346
679 essentials, 1 0.7536
679 fall 1 0.3946
679 features 1 0.4025
679 fell 1 0.5159
679 however, 1 0.2729
679 hyperal- 1 0.6785
679 hyperaldosteronism, 1 0.7536
679 hyperplasia 2 0.8503
679 in- 1 0.3339
679 increase 1 0.256
679 infusion 1 0.4252
679 intake. 1 0.6034
679 juxtaglo- 1 0.7536
679 juxtaglomerular 1 0.6346
679 low- 2 1.357
679 low-sodium 1 0.7536
679 lowering 1 0.543
679 mal. 1 0.7536
679 merular 1 0.7536
679 nary 1 0.7536
679 nor- 1 0.485
679 normal 2 0.4053
679 patient 2 0.5667
679 patient, 1 0.4943
679 potas- 1 0.7536
679 potassium 2 1.0091
679 pressure 1 0.3449
679 pressure, 1 0.4943
679 previously 1 0.3625
679 raised 1 0.4477
679 rapid 1 0.3653
679 rate 1 0.2774
679 rate. 1 0.543
679 re- 1 0.3339
679 report 1 0.3653
679 reported 2 0.6107
679 resembles 1 0.5596
679 response 1 0.2752
679 resul- 1 0.7536
679 rose 1 0.5286
679 secretion 2 0.8832
679 serum 3 0.8771
679 significantly 1 0.3168
679 sium 1 0.7536
679 slightly 1 0.4303
679 sodi- 1 0.7536
679 sodium 4 1.45
679 spironolactone 1 0.6346
679 sponse 1 0.5793
679 subtotal 1 0.7536
679 syndrome 1 0.3496
679 ted 1 0.5596
679 tion. 1 0.5596
679 treatment 1 0.2223
679 two 1 0.2308
679 um 1 0.7536
679 unique 1 0.485
679 uri- 1 0.7536
679 urinary 1 0.3339
679 zero 1 0.6785
679 zero. 1 0.6785
680 (known 1 0.7536
680 absence 1 0.3598
680 account 1 0.4252
680 activity 1 0.2697
680 ad- 1 0.5046
680 adrenal 3 1.3431
680 apparatus. 1 0.7536
680 associated 1 0.2676
680 biochemical 1 0.4764
680 case 2 0.5415
680 cases 1 0.2242
680 caused 1 0.3299
680 cells 3 0.6823
680 cells. 1 0.336
680 changes 1 0.2255
680 chronic 1 0.3598
680 cit) 1 0.7536
680 clinical 1 0.2457
680 compartment 1 0.6785
680 compensatory 1 0.4202
680 cortex 2 0.831
680 could 1 0.2708
680 defect 1 0.3711
680 defi- 1 0.6034
680 different 1 0.2666
680 enzyme 1 0.4477
680 erulosa 1 0.7536
680 examination 2 0.7611
680 excessive 1 0.485
680 exhibiting 1 0.6785
680 form 1 0.3279
680 forms 1 0.3598
680 genetic 1 0.3946
680 glom- 1 0.7536
680 glomerular 2 0.9528
680 glomerulosa 1 0.6346
680 glomerulosa. 2 1.5073
680 hyper- 1 0.4477
680 hyperplasia 1 0.4252
680 hyperplasia: 1 0.7536
680 hypertension 1 0.4764
680 hypertensive 3 1.8103
680 hypertrophy 4 1.5939
680 hypothesized 1 0.7536
680 intravascular 1 0.6346
680 intrinsic 1 0.5286
680 involve 1 0.543
680 juxta- 2 1.5073
680 juxtaglomerular 3 1.9037
680 kidney 1 0.3339
680 kidneys 1 0.4202
680 led 1 0.4416
680 losing 1 0.7536
680 loss 1 0.3653
680 loss. 1 0.6034
680 observations 1 0.3168
680 one 1 0.2108
680 overproduc- 1 0.7536
680 pathological 1 0.4066
680 presented 1 0.2924
680 renal 1 0.2924
680 resultant 1 0.543
680 revealed 1 0.3653
680 showed 2 0.5373
680 sodium 3 1.0875
680 sodium-losing 1 0.7536
680 sodium-retaining 1 0.6785
680 state 1 0.3874
680 steroids 1 0.5159
680 stimula- 1 0.7536
680 tion 2 0.6851
680 trophy 1 0.6346
680 two 1 0.2308
680 type 1 0.3134
680 type. 1 0.5046
680 virilizing 2 1.5073
680 without 1 0.2846
680 zona 4 2.4137
681 12 1 0.1799
681 3 3 0.3853
681 4 1 0.1333
681 6 1 0.1576
681 7 1 0.1736
681 accompanied 1 0.2101
681 adult 1 0.1713
681 agar 1 0.2643
681 anaemia 2 0.6034
681 animal. 1 0.2897
681 animals 1 0.1602
681 animals. 1 0.2126
681 attack 1 0.3392
681 attempted 1 0.2523
681 blood 3 0.3493
681 blood. 1 0.2523
681 caused 1 0.1649
681 cells 1 0.1137
681 changes 1 0.1127
681 characteristic 1 0.1903
681 circulating 1 0.2643
681 concurrent 1 0.2897
681 control 1 0.1417
681 controlled 1 0.2152
681 convoluted 1 0.3173
681 corpuscles 1 0.3768
681 cortex. 1 0.3392
681 culture 1 0.1887
681 days. 1 0.2126
681 deposition 1 0.2715
681 detectable 1 0.2382
681 developed 2 0.3426
681 difference 1 0.1887
681 disappearance 1 0.2472
681 eight 1 0.2152
681 eperythrozoon 3 1.1304
681 experiment 1 0.2523
681 failed 2 0.4303
681 fever 1 0.2715
681 following 1 0.1249
681 gain 2 0.543
681 ground-up 1 0.3768
681 haemosiderin 1 0.3768
681 histopathological 1 0.3017
681 hoggs 1 0.3768
681 hyperplasia 1 0.2126
681 icterus. 1 0.3173
681 incubation 1 0.2305
681 infected 6 1.2329
681 infection 3 0.5318
681 infection, 1 0.2643
681 inoculation 3 0.7569
681 intravenous 2 0.4025
681 keds 1 0.3768
681 kidney 2 0.3339
681 lambs 2 0.6034
681 lasted 1 0.3173
681 led 1 0.2208
681 less 1 0.1411
681 lice 2 0.7536
681 lymphoid 1 0.2425
681 malphigian 1 0.3768
681 may 1 0.0942
681 mice. 1 0.2382
681 monolayers 1 0.3173
681 occasionally 1 0.2523
681 old 1 0.2126
681 organism 1 0.2523
681 parasi- 1 0.3768
681 parasitaemia 2 0.7536
681 period 1 0.1429
681 phenomenon 1 0.2179
681 produced 1 0.1535
681 profound 1 0.258
681 proximal 1 0.258
681 pyrexia. 1 0.3768
681 recipient 1 0.2523
681 severe 1 0.167
681 sheep 8 2.1719
681 sheep, 1 0.3768
681 significant 1 0.1323
681 smallest 1 0.3017
681 spleen 1 0.2238
681 stage 1 0.1826
681 studies 1 0.1154
681 suggested 1 0.1567
681 symptoms 2 0.3571
681 taemic 1 0.3768
681 ten 1 0.2271
681 tick-borne 1 0.3768
681 transference 1 0.3392
681 transmission 1 0.2897
681 transmit 1 0.3392
681 tubules 1 0.2798
681 two 1 0.1154
681 uninfected 1 0.3768
681 unsuccessful 1 0.3768
681 varied 1 0.2382
681 week 1 0.2472
681 weeks 1 0.1973
681 weeks. 1 0.3017
681 weight 1 0.1773
681 weight. 1 0.2798
681 within 1 0.1399
682 11 2 1.0733
682 4 1 0.3554
682 48 1 0.5669
682 administered 1 0.4797
682 adult 2 0.9135
682 adults. 1 0.7462
682 age 3 1.247
682 autoradiography. 1 0.9046
682 cells 3 0.9098
682 cellular 1 0.548
682 centages 2 2.0097
682 control 3 1.1335
682 controls 1 0.6056
682 cortex 3 1.6619
682 destined 1 1.0048
682 differ 1 0.6591
682 differences 1 0.4598
682 especially 1 0.5165
682 ex- 1 0.5969
682 exclusively 1 0.7724
682 found 1 0.2645
682 frequent 1 0.6056
682 greater 1 0.4157
682 greatly 1 0.5969
682 groups. 2 1.1938
682 hours 2 0.9667
682 hyperplastic 1 0.7724
682 increase 1 0.3413
682 increases 1 0.4694
682 kidneys 3 1.6808
682 labeled 2 1.2111
682 levels 1 0.3935
682 means 1 0.4452
682 medulla 3 2.1719
682 medulla, 1 0.8461
682 ne- 1 0.9046
682 nucleoprotein 1 1.0048
682 per- 2 1.3455
682 percentage 1 0.5603
682 perimental 1 0.9046
682 phrectomy 1 1.0048
682 prior 1 0.5366
682 proliferation 1 0.5811
682 pronounced 1 0.5969
682 rare 1 0.5969
682 rat 1 0.4135
682 rats 3 1.1641
682 rats. 1 0.5262
682 regions 1 0.8046
682 remaining 2 1.0237
682 response 1 0.3669
682 sacrifice. 1 1.0048
682 significant 1 0.3527
682 sis, 1 0.9046
682 studied 1 0.3501
682 synthe- 1 1.0048
682 three 1 0.3778
682 times 1 0.4833
682 tissues, 1 0.7048
682 tritiated-thymidine, 1 1.0048
682 tubular 1 0.6728
682 two 1 0.3077
682 unilateral 1 0.5422
682 weanling 2 1.5448
682 young 2 1.0148
683 (june 1 0.3768
683 - 1 0.2208
683 4.0 1 0.3768
683 acid 1 0.1455
683 acid-stannous 1 0.3768
683 active. 1 0.3392
683 also 1 0.1054
683 apical 1 0.3173
683 baker's 1 0.3768
683 breeds 1 0.3768
683 cells 1 0.1137
683 chloride, 1 0.3392
683 choline 1 0.3173
683 collecting 1 0.3017
683 communication 1 0.2077
683 completely 1 0.2208
683 composi- 1 0.3768
683 containing 1 0.1992
683 cycle 1 0.3017
683 describes 1 0.258
683 developed 1 0.1713
683 development 2 0.2752
683 estimation 1 0.2798
683 feature 1 0.2643
683 females 1 0.2643
683 females. 1 0.3173
683 flaviviridis 3 1.1304
683 following 1 0.1249
683 forming 1 0.2798
683 granular 1 0.2897
683 hae- 1 0.3768
683 hemidactylus 3 1.1304
683 house 3 1.0177
683 hyper- 1 0.2238
683 hypertrophied 1 0.3392
683 indian 3 1.0177
683 indicating 1 0.2425
683 injection 1 0.1576
683 isolation 1 0.2425
683 july). 1 0.3768
683 kidney 2 0.3339
683 lizard, 4 1.5073
683 lizards 1 0.3768
683 loaded 1 0.3768
683 male 1 0.1919
683 males 2 0.5159
683 matein 1 0.3768
683 mature 1 0.2342
683 maximum 1 0.2077
683 may 1 0.0942
683 ment. 1 0.2798
683 mg 1 0.2238
683 occurs 1 0.2012
683 october 1 0.3392
683 onally. 1 0.3768
683 period 1 0.1429
683 phospholipids 3 0.9051
683 phospholipids. 1 0.3173
683 phosphomolybdic 1 0.3392
683 portions 1 0.2798
683 preliminary 1 0.2152
683 presence 1 0.1436
683 present 1 0.1241
683 propionate 1 0.2798
683 quantitative 1 0.1992
683 quiescence 2 0.6785
683 regressed 2 0.6034
683 ruppell 1 0.3768
683 ruppell. 1 0.3768
683 seas- 1 0.3768
683 season 1 0.3392
683 secondary 1 0.1887
683 secretions 1 0.3768
683 seg- 1 0.3392
683 segment 6 1.8103
683 segment, 1 0.3768
683 sex- 1 0.3768
683 sexual 8 2.3172
683 sexually 1 0.3768
683 snakes, 1 0.3768
683 spermatogenically 1 0.3768
683 stained 1 0.3017
683 stimulated 1 0.2523
683 synchronous 1 0.3392
683 tertiary 1 0.3768
683 testes 1 0.3768
683 testicular 1 0.3392
683 testosterone 1 0.2715
683 tion 1 0.1713
683 trophy 1 0.3173
683 tubules 1 0.2798
683 two 1 0.1154
683 ual 1 0.3768
683 unique 1 0.2425
683 unknown. 1 0.3017
683 weeks 1 0.1973
683 year, 1 0.2897
683 year; 1 0.3768
684 (on 1 0.8046
684 59fe 2 2.0097
684 count 2 1.3758
684 count, 1 1.0048
684 determination, 1 1.0048
684 different 1 0.3554
684 effect 3 0.9204
684 erythrocyte 1 0.7462
684 erythropoiesis 1 0.8461
684 erythropoietic 1 0.9046
684 globin 1 0.9046
684 haemo- 1 0.7724
684 hepatectomy 2 1.8093
684 hyper- 1 0.5969
684 hypertrophic 1 0.8461
684 increased 1 0.3124
684 kidney 2 0.8904
684 liver 3 1.186
684 means 1 0.4452
684 nephrectomy 1 0.6056
684 nephrectomy. 1 0.6352
684 normal 1 0.2702
684 partial 2 1.1206
684 rat 1 0.4135
684 rats 1 0.388
684 regenerated 2 2.0097
684 renal 1 0.3898
684 respectively 1 0.6879
684 reticulocyte 2 2.0097
684 seen 1 0.4248
684 sera 1 0.6591
684 significantly 1 0.4225
684 stimulating 1 0.7048
684 strongly 1 0.6466
684 studied 1 0.3501
684 suspensions) 1 1.0048
684 tissue 3 1.0464
684 tissue. 1 0.6466
684 treatment 2 0.5929
684 trophic 1 0.8046
684 undergone 1 0.8046
684 unilateral 2 1.0844
684 utilization 1 0.7048
684 utilization. 1 0.8461
685 abnormalities. 1 1.2691
685 associated 2 1.0704
685 asymmetry 1 1.2069
685 atrophy 1 1.1192
685 be- 1 0.9221
685 beyond 1 1.0318
685 body 2 1.2153
685 cause 1 0.6807
685 condition 1 0.805
685 congenital 2 1.3794
685 cryptorchidism, 1 1.5073
685 distinguished 1 1.0091
685 ex- 1 0.8954
685 frequently 1 0.7611
685 growth 1 0.5138
685 half 1 0.8832
685 hemiatrophy 1 1.5073
685 hemihypertrophy 2 3.0145
685 hemihypertrophy, 1 1.5073
685 hypertrophy 1 0.797
685 hypospadias, 1 1.5073
685 incidence 1 0.7196
685 include 1 0.8954
685 increased 1 0.4686
685 kidney 1 0.6678
685 lesions. 1 1.0318
685 medullary 1 1.2691
685 neurological 1 1.0091
685 occurred, 1 1.2069
685 one 2 0.8433
685 over- 1 1.5073
685 pected 1 1.357
685 range. 1 1.2691
685 rare, 1 1.357
685 renal 1 0.5847
685 several 1 0.6519
685 side 1 0.8503
685 sponge 1 1.5073
685 though 1 0.8832
685 tract, 1 1.2069
685 tumour. 1 1.2069
685 unilateral 1 0.8133
685 urogenital 1 1.5073
685 usually 1 0.7091
685 wilms' 1 1.5073
685 withering 1 1.5073
686 10% 1 0.3103
686 1st 1 0.331
686 2 1 0.1315
686 4 2 0.3047
686 accompanied 1 0.2401
686 affected 1 0.2234
686 almost 1 0.2213
686 also 2 0.2409
686 animals 1 0.1831
686 approximately 1 0.2255
686 aspects 1 0.2429
686 average, 1 0.3626
686 changes 1 0.1289
686 chemical 1 0.2595
686 compensatory 1 0.2401
686 composition 1 0.2523
686 containing 1 0.2277
686 content 2 0.4052
686 contents 1 0.2883
686 days 2 0.3421
686 diet 2 0.5649
686 diet, 1 0.3877
686 diet. 1 0.3198
686 dna 2 0.4112
686 dna, 1 0.2825
686 dramatic 1 0.3448
686 dry 1 0.3198
686 effect 1 0.1315
686 fed 2 0.5649
686 feeding 1 0.3448
686 follows 1 0.2771
686 found 1 0.1134
686 greater 2 0.3563
686 heavier 1 0.3877
686 high-protein 3 1.2919
686 higher 2 0.3704
686 hypertrophy 1 0.2277
686 identical 1 0.2558
686 increase 3 0.4388
686 increases 1 0.2012
686 intake. 1 0.3448
686 investigated 1 0.2459
686 is, 1 0.2883
686 kidney 7 1.3357
686 kidneys 1 0.2401
686 left 1 0.1945
686 less 1 0.1612
686 lipid 1 0.2635
686 low-protein 1 0.4306
686 magnitude 1 0.2677
686 moreover, 1 0.2825
686 much 2 0.3816
686 nephrectomy 3 0.7786
686 nephrectomy. 2 0.5445
686 normal 1 0.1158
686 operation. 1 0.2825
686 phosphorus 1 0.2825
686 protein, 1 0.3103
686 protein/dna 1 0.4306
686 protein/dna. 1 0.4306
686 ratio 2 0.451
686 ratio. 1 0.3877
686 ratios 2 0.5649
686 rats 2 0.3326
686 rats. 1 0.2255
686 remaining 3 0.6581
686 renal 1 0.1671
686 resulting 1 0.2194
686 right 1 0.2234
686 rise 1 0.2138
686 rna, 1 0.3448
686 rna. 1 0.3448
686 rna/dna 5 2.1532
686 significantly 1 0.1811
686 size 1 0.2255
686 slower 1 0.3103
686 steadily 1 0.4306
686 surviving 1 0.3198
686 total 3 0.5035
686 unilateral 5 1.1618
686 urea, 1 0.3448
686 weight 2 0.4052
686 wet 1 0.331
687 1 1 0.2277
687 2 1 0.1841
687 3 1 0.2055
687 action 1 0.2623
687 amount 1 0.2969
687 antidiuretic 2 0.7909
687 balance 1 0.4127
687 began 1 0.4477
687 believed 1 0.4477
687 betes 1 0.6029
687 body 1 0.2431
687 brought 1 0.3955
687 case 1 0.2166
687 case, 1 0.4477
687 changes 1 0.1804
687 chlorothiazide 1 0.4634
687 con- 1 0.3127
687 convoluted 2 1.0153
687 creases 1 0.6029
687 daily 2 0.6575
687 day 2 0.5987
687 days 1 0.2395
687 decreased 3 0.8168
687 decreases. 1 0.6029
687 deficient 1 0.388
687 depletion 1 0.3955
687 despite 1 0.3811
687 dia- 1 0.4827
687 diabetes 2 0.5938
687 discontinua- 1 0.6029
687 distal 1 0.4229
687 dium 1 0.6029
687 drug. 2 1.0856
687 ed. 1 0.6029
687 electro- 1 0.4827
687 excre- 1 0.5428
687 fall 1 0.3157
687 falls. 1 0.6029
687 filtrate 1 0.4827
687 final 1 0.3955
687 first 1 0.221
687 fixed 1 0.4344
687 glomerular 1 0.3811
687 hydro- 1 0.4634
687 hydrochlorothia- 1 0.5428
687 hydrochlorothiazide 2 1.0153
687 in- 1 0.2671
687 increased 2 0.3748
687 insipidus 3 0.966
687 intake 3 1.2686
687 intake, 1 0.4827
687 kidney 1 0.2671
687 level 1 0.2328
687 limited. 1 0.5428
687 low 1 0.2639
687 ly 1 0.3955
687 lyte 1 0.6029
687 markedly 2 0.644
687 mechanism 1 0.2778
687 output 1 0.3533
687 patients 1 0.1449
687 per- 1 0.4037
687 pretreatment 1 0.4344
687 proximal 1 0.4127
687 reabsorption 1 0.4037
687 reaching 1 0.4344
687 related 1 0.2549
687 restored 1 0.4229
687 returned 1 0.4344
687 second 1 0.3071
687 sisted 1 0.6029
687 so- 1 0.5428
687 sodium 5 1.45
687 sodium. 1 0.6029
687 state 1 0.3099
687 strict- 1 0.6029
687 studi- 1 0.6029
687 therapy 2 0.4767
687 thus 1 0.3127
687 tinued 1 0.6029
687 tion 2 0.5481
687 treatment 2 0.3558
687 treatment, 1 0.388
687 tubules 2 0.8954
687 urinary 4 1.0685
687 use 1 0.2383
687 vasopressin- 1 0.6029
687 volume 3 0.9213
687 water 2 0.6376
687 zide 1 0.5076
688 & 4 2.7139
688 (1959), 1 0.7536
688 (earley 1 0.7536
688 (robson 1 0.7536
688 1962), 1 0.6785
688 1962, 2 1.2069
688 1963). 1 0.6785
688 7 1 0.3472
688 abatement 1 0.7536
688 action 3 0.9837
688 actions 1 0.485
688 administration 1 0.3319
688 analogues 1 0.6034
688 antidiuretic 1 0.4943
688 basis 1 0.3299
688 carter 1 0.7536
688 central 1 0.4066
688 chlorothiazide 1 0.5793
688 chronic 1 0.3598
688 conducted 1 0.5159
688 confirmed 1 0.4416
688 contended 1 0.7536
688 crawford 1 0.7536
688 curious 1 0.6785
688 decreasing 1 0.6034
688 described 1 0.2859
688 detailed 1 0.4764
688 diabetes 3 1.1134
688 disease, 1 0.4025
688 diuretic 1 0.5596
688 diuretics 1 0.6346
688 drugs 2 0.831
688 effect 1 0.2301
688 enon 1 0.7536
688 entirely 1 0.485
688 explain 1 0.5046
688 first 1 0.2763
688 forms 1 0.3598
688 goodman 1 0.7536
688 group 1 0.2786
688 in-patient 1 0.7536
688 increase 1 0.256
688 insipidus 2 0.805
688 insipidus. 1 0.485
688 investigators 1 0.6346
688 kennedy 1 0.7536
688 lambie 1 0.7536
688 may 1 0.1885
688 mechanism 1 0.3472
688 nephrogenic 1 0.5159
688 number 1 0.2884
688 obscure. 1 0.6346
688 oral 1 0.4611
688 orloff 1 0.7536
688 osmolality. 1 0.6785
688 others 1 0.411
688 past 1 0.5286
688 patients 1 0.1812
688 phenom- 1 0.7536
688 pituitary 2 0.7819
688 polyuria 1 0.5793
688 precise 1 0.6034
688 reduction 1 0.3711
688 remains 1 0.3946
688 renal 1 0.2924
688 results 1 0.2158
688 secondary 1 0.3773
688 series 1 0.3546
688 since 1 0.3279
688 skadhauge 1 0.7536
688 sought 1 0.6785
688 striking 1 0.4764
688 studies 1 0.2308
688 thiazide 2 1.1192
688 thiazides 1 0.6785
688 thirst 1 0.6346
688 though 1 0.4416
688 two 1 0.2308
688 urinary 2 0.6678
688 various 1 0.2979
688 volume 1 0.3839
688 whilst 1 0.5596
688 widely 1 0.5046
688 years, 1 0.4764
689 21 1 0.4764
689 28-39%. 1 0.7536
689 4 1 0.2666
689 7 1 0.3472
689 7-128%. 1 0.7536
689 8 1 0.3403
689 action, 1 0.5596
689 also 1 0.2108
689 ance, 1 0.6785
689 antidiuresis 4 2.3172
689 average 1 0.3381
689 certain 1 0.3319
689 chloride 1 0.543
689 chloride, 1 0.6785
689 clear- 1 0.5793
689 clearance 1 0.485
689 concluded 1 0.3449
689 corrected 1 0.6346
689 creatinine 2 1.2069
689 cretion 1 0.6785
689 day 2 0.7483
689 day. 1 0.6034
689 decrease 1 0.3449
689 decreased 1 0.3403
689 degree 1 0.3339
689 deprivation 1 0.543
689 diabetes 2 0.7423
689 direct 1 0.3546
689 diuresis 3 1.8103
689 duced 1 0.5793
689 due 1 0.2666
689 electrolyte 1 0.5793
689 even 2 0.6597
689 ex- 1 0.4477
689 extent 1 0.3985
689 extra 1 0.6346
689 feeling; 1 0.7536
689 filtration 1 0.5046
689 first 2 0.5526
689 found 2 0.3968
689 fourth 1 0.5596
689 full 1 0.5046
689 glomerular 1 0.4764
689 increased 1 0.2343
689 initiated 1 0.6034
689 insipidus 1 0.4025
689 insipidus. 1 0.485
689 investigations 1 0.4685
689 involving 1 0.485
689 least 1 0.3874
689 mainly 1 0.4943
689 ment. 1 0.5596
689 meq/i 1 0.7536
689 meq/i, 1 0.7536
689 minimal 1 0.4685
689 mosm/kg, 1 0.7536
689 natriuresis 1 0.7536
689 observed. 1 0.4542
689 one 2 0.4217
689 operating 1 0.6034
689 osmolality 3 1.7379
689 pa- 1 0.4416
689 patient. 1 0.5159
689 patients 2 0.3623
689 plasma 3 0.9115
689 pronounced 1 0.4477
689 rate. 1 0.543
689 re- 1 0.3339
689 reduc- 1 0.6785
689 reduced 2 0.6807
689 renal 1 0.2924
689 secondary 1 0.3773
689 seems 1 0.3985
689 serum 2 0.5847
689 significantly. 1 0.5793
689 sodium 1 0.3625
689 sodium, 1 0.6785
689 studied 1 0.2626
689 test 1 0.326
689 thiazide 2 1.1192
689 thiazide, 1 0.7536
689 thiazide-induced 1 0.7536
689 third 1 0.411
689 thirst- 1 0.7536
689 thirst-feeling 1 0.7536
689 tient 1 0.6785
689 tion 1 0.3426
689 together 1 0.4303
689 treat- 1 0.4685
689 treatment 2 0.4447
689 treatment. 1 0.3985
689 urine 1 0.3874
689 water 1 0.3985
690 antidiuretic 1 0.4943
690 application. 1 0.6785
690 body 1 0.3038
690 contributory 1 0.6346
690 deficit. 1 0.7536
690 depletion 1 0.4943
690 depletion. 1 0.7536
690 diabetes 2 0.7423
690 effect 1 0.2301
690 fall 1 0.3946
690 hazard 1 0.6785
690 hormone 1 0.3069
690 important 1 0.3403
690 indicated 1 0.3546
690 induced 1 0.3204
690 insipidus 2 0.805
690 insufficiency 1 0.4477
690 intolerant 1 0.7536
690 major 1 0.3625
690 may 1 0.1885
690 ment. 1 0.5596
690 nephrogenic 1 0.5159
690 osmolality 1 0.5793
690 patients 1 0.1812
690 potassium 1 0.5046
690 reducing 1 0.5793
690 replace- 1 0.7536
690 result 1 0.326
690 salt 1 0.485
690 self-limiting 1 0.6785
690 serum 1 0.2924
690 sodium 2 0.725
690 therapeutic 1 0.3805
690 thiazides 4 2.7139
690 thirst. 1 0.7536
690 thus 1 0.3909
690 treatment 1 0.2223
690 type 1 0.3134
690 use 1 0.2979
690 vasopressin 1 0.5159
690 water 1 0.3985
691 "escape" 1 1.5073
691 able 1 0.8503
691 achieve 1 1.0572
691 action 2 1.3116
691 adequate 1 0.9369
691 age. 1 0.8503
691 alone 1 0.9083
691 analogues 1 1.2069
691 anti- 1 1.0572
691 antidiuretic 2 1.9773
691 asso- 1 1.357
691 beneficial 1 1.0572
691 chloro- 1 1.5073
691 chlorothiazide 2 2.3172
691 ciated 1 1.5073
691 commonly 1 1.0572
691 de- 1 0.8404
691 degree 1 0.6678
691 dehydrated 1 1.357
691 diabetes 1 0.7423
691 diet 1 0.9887
691 diuretic 1 1.1192
691 dramatic 1 1.2069
691 drug 2 1.5786
691 effects 1 0.5595
691 establishing 1 1.2069
691 exact 1 1.086
691 fluid 2 1.4285
691 follow- 1 1.1586
691 found 1 0.3968
691 however, 1 0.5459
691 hydra- 1 1.5073
691 hydration. 1 1.5073
691 increased 1 0.4686
691 infants 2 1.4391
691 ing 1 0.8133
691 initial 2 1.4612
691 insipidus 1 0.805
691 intake 1 1.0572
691 intake. 1 1.2069
691 known. 1 1.2069
691 less 1 0.5643
691 maintain 1 1.1192
691 maintaining 1 1.1586
691 mechanism 1 0.6944
691 ment, 1 1.1586
691 months 1 0.7611
691 must 1 0.7363
691 ndi 1 1.5073
691 ndi, 1 1.5073
691 nephrogenic 1 1.0318
691 occurred. 1 1.357
691 optimal 1 1.2069
691 patients 1 0.3623
691 patients; 1 1.1192
691 po- 1 1.5073
691 prior 1 0.805
691 prolonged 1 0.725
691 remembered, 1 1.5073
691 resistance 1 0.8404
691 response 2 1.1006
691 response, 2 2.2385
691 seems 1 0.797
691 showed 1 0.5373
691 six 2 1.6619
691 spite 1 1.0091
691 studied 1 0.5251
691 sufficient 1 0.9083
691 tentially 1 1.5073
691 therapeutic 1 0.7611
691 thiazide 1 1.1192
691 tion 1 0.6851
691 toxic. 1 1.357
691 treat- 1 0.9369
691 treatment. 1 0.797
691 trial 1 1.1192
691 two 1 0.4616
691 unable 1 1.1192
691 unpredictability 1 1.5073
691 value 1 0.6944
691 vari- 1 1.2691
691 warranted 1 1.357
692 (case 2 1.357
692 (ecv) 1 0.7536
692 (tbw). 1 0.7536
692 1) 1 0.485
692 2) 1 0.5159
692 absence 1 0.3598
692 aldosterone 1 0.6346
692 atro- 1 0.7536
692 body 2 0.6077
692 capacity 1 0.411
692 cerebral 1 0.3571
692 combination 1 0.4303
692 combined 1 0.3874
692 concentration 1 0.3168
692 considerable 1 0.3909
692 continuously 1 0.5793
692 could 1 0.2708
692 deprivation 1 0.543
692 development 1 0.2752
692 diabetes 3 1.1134
692 diet 1 0.4943
692 diuresis 1 0.6034
692 drug 1 0.3946
692 ecv 1 0.7536
692 electrolyte 1 0.5793
692 electrolytemia 1 0.7536
692 even 1 0.3299
692 excretion. 1 0.5596
692 extracellular 1 0.5286
692 fever 1 0.543
692 first 1 0.2763
692 fluid 4 1.4285
692 fol- 1 0.5596
692 following 1 0.2498
692 found 1 0.1984
692 found. 1 0.485
692 given 1 0.2763
692 height 1 0.6346
692 higher 1 0.3241
692 house 1 0.6785
692 hydronephrosis, 1 0.7536
692 hypernatriemia 1 0.7536
692 hypertonic. 1 0.7536
692 increase 2 0.5119
692 infants 2 0.7196
692 insipidus 2 0.805
692 insipidus. 1 0.485
692 low 1 0.3299
692 low- 1 0.6785
692 lowed 1 0.6034
692 lower 1 0.3426
692 maintain 1 0.5596
692 may 2 0.377
692 metabolism 1 0.3571
692 nephrogenic 3 1.5477
692 normal 3 0.608
692 noted, 1 0.6785
692 ordinary 1 0.5596
692 patient 2 0.5667
692 patients 2 0.3623
692 phy 1 0.7536
692 place 1 0.4611
692 polydipsia 1 0.7536
692 polyuria. 1 0.7536
692 present 1 0.2481
692 psychic 1 0.6346
692 reduction 1 0.3711
692 revealed 1 0.3653
692 rightsided 1 0.7536
692 se- 1 0.6346
692 side. 1 0.6346
692 spirolactone. 1 0.7536
692 tbw 1 0.7536
692 test 1 0.326
692 therapy 1 0.2979
692 thiazide 1 0.5596
692 thiazide. 1 0.7536
692 took 1 0.543
692 total 1 0.2937
692 treated 1 0.3101
692 treatment 1 0.2223
692 treatment. 1 0.3985
692 two 1 0.2308
692 unexplained 1 0.6785
692 untreated 1 0.5596
692 urinary 1 0.3339
692 urine 1 0.3874
692 vere 1 0.7536
692 volume 1 0.3839
692 volumes 1 0.5793
692 vomiting 1 0.6785
692 water 1 0.3985
692 without 2 0.5692
693 adjuncts 1 1.0048
693 advantage, 1 1.0048
693 age 1 0.4157
693 agents 1 0.5422
693 although 1 0.3863
693 application. 1 0.9046
693 approach 1 0.6246
693 chronic 1 0.4797
693 clinical 3 0.9826
693 cology 1 1.0048
693 comments 1 0.8461
693 coupled 1 0.9046
693 development 1 0.3669
693 discussion 1 0.6056
693 disease, 1 0.5366
693 diuretics 2 1.6922
693 drugs 1 0.554
693 edematous 1 0.9046
693 failure, 1 0.7724
693 given 1 0.3684
693 heart 1 0.4661
693 hyper- 1 0.5969
693 indications. 1 0.9046
693 lack 1 0.5811
693 limited 1 0.548
693 looked 1 0.8461
693 management 2 1.0626
693 mit 1 0.9046
693 new 1 0.4398
693 notes 1 0.8461
693 number 1 0.3845
693 oral 1 0.6148
693 orally 1 0.7724
693 par- 1 0.8046
693 patients 1 0.2415
693 pediatric 2 1.6922
693 pediatrics 1 1.0048
693 per- 1 0.6728
693 pharma- 1 1.0048
693 potent 1 0.7462
693 practice 1 0.8461
693 range 1 0.5422
693 receiving 1 0.554
693 recent 1 0.5262
693 refractory 1 1.0048
693 relative 1 0.5212
693 relatively 1 0.4833
693 renal 1 0.3898
693 require 1 0.6879
693 reviews 1 0.8046
693 significant 1 0.3527
693 small, 1 0.9046
693 states. 1 0.8461
693 tension. 1 0.8461
693 ticularly 1 1.0048
693 toxicity. 1 0.9046
693 upon 1 0.4509
693 usefulness 1 0.8046
693 valuable 1 0.6466
693 years, 1 0.6352
694 (in 2 0.5793
694 (leisurely 1 0.3768
694 0.14 1 0.3768
694 13 2 0.4358
694 150 1 0.3392
694 2 4 0.4602
694 30 2 0.3598
694 300 1 0.2897
694 4 1 0.1333
694 5 1 0.1429
694 6 1 0.1576
694 abnormal 1 0.1826
694 abolished 1 0.2472
694 absence 1 0.1799
694 ad- 1 0.2523
694 adh 3 1.1304
694 administration 1 0.1659
694 adrenal 2 0.4477
694 al- 1 0.2897
694 aldosterone 1 0.3173
694 aldosterone, 1 0.3768
694 alone. 1 0.2798
694 amount 1 0.1856
694 amphetamine 1 0.3768
694 ance 1 0.2897
694 antidiuresis 3 0.869
694 assuming 1 0.3173
694 bent, 1 0.3768
694 cause 1 0.1702
694 cent 1 0.1937
694 changed 1 0.258
694 changes 1 0.1127
694 chloride 1 0.2715
694 circulating 1 0.2643
694 clear- 1 0.2897
694 compared 1 0.1462
694 completely 1 0.2208
694 creatinine 2 0.6034
694 creted 1 0.3392
694 currence 1 0.3768
694 d- 1 0.3768
694 delayed 1 0.2208
694 diabetes 2 0.3711
694 dosterone 1 0.3768
694 dosteronism. 1 0.3768
694 drank 1 0.3768
694 drug 1 0.1973
694 duced 1 0.2897
694 edema 3 0.7739
694 edema, 1 0.3017
694 edema. 1 0.3173
694 edematous 2 0.6785
694 effects 1 0.1399
694 either 1 0.1611
694 equal 1 0.2472
694 ethanol 1 0.3768
694 ethanol. 1 0.3768
694 every 1 0.2101
694 ex- 1 0.2238
694 excessive 1 0.2425
694 excre- 1 0.3392
694 excretion 6 1.0637
694 fall 2 0.3946
694 fell 1 0.258
694 first 2 0.2763
694 flow 1 0.1919
694 found 1 0.0992
694 free 1 0.1786
694 group 1 0.1393
694 groups 2 0.3069
694 half 2 0.4416
694 half- 1 0.3768
694 hour 3 0.8145
694 hour. 1 0.3392
694 hourly 1 0.3768
694 hours 2 0.3625
694 hours) 1 0.3768
694 hours, 1 0.3017
694 however, 1 0.1365
694 hydrocortisone 1 0.3173
694 hyperal- 1 0.3392
694 idiopathic 4 1.0318
694 increase 1 0.128
694 increased 2 0.2343
694 indicate 1 0.1659
694 insipidus 1 0.2012
694 insipidus) 1 0.3768
694 insufficiency 1 0.2238
694 insufficiency) 1 0.3768
694 lack 2 0.4358
694 last 1 0.2523
694 lower 2 0.3426
694 magni- 1 0.3768
694 magnitude 1 0.2342
694 min- 1 0.3768
694 ministration 1 0.3392
694 minutes. 1 0.3017
694 ml. 1 0.2523
694 na 2 0.4764
694 normal 6 0.608
694 oc- 1 0.3392
694 occur 1 0.1841
694 orthostatic 1 0.3768
694 overcome 1 0.2897
694 pa- 1 0.2208
694 patients 7 0.634
694 per 1 0.1469
694 performed 1 0.1724
694 period 1 0.1429
694 period. 1 0.2271
694 postural 1 0.3392
694 posture 3 1.1304
694 posture, 1 0.3392
694 posture. 1 0.3768
694 preceding 1 0.2897
694 prevent 1 0.2523
694 probably 3 0.5138
694 progressively 1 0.2798
694 re- 2 0.3339
694 recum- 1 0.3768
694 recumbency 3 1.1304
694 recumbent 1 0.3768
694 reduced 1 0.1702
694 reduction 1 0.1856
694 release 1 0.2425
694 release, 1 0.3768
694 renal 1 0.1462
694 responsible 1 0.1903
694 results 3 0.3237
694 retention 1 0.2342
694 role 1 0.1748
694 show 1 0.163
694 significant 2 0.2646
694 significantly 3 0.4753
694 similar 1 0.1411
694 since 1 0.1639
694 slightly 1 0.2152
694 sodium 7 1.2688
694 solution 1 0.2305
694 spironolactone 1 0.3173
694 studied 1 0.1313
694 studies 1 0.1154
694 subjects 5 0.8995
694 subjects. 1 0.2305
694 tention 1 0.3768
694 therapy. 1 0.2033
694 thereafter. 1 0.3392
694 tients 1 0.2425
694 tion 1 0.1713
694 treated 2 0.3101
694 tude 1 0.3768
694 un- 1 0.2425
694 upright 8 3.0145
694 upright. 1 0.3768
694 urine 3 0.581
694 utes 1 0.3768
694 vasopressin 1 0.258
694 volume 1 0.1919
694 volume, 1 0.258
694 walking 3 1.1304
694 water 1 0.1992
695 60 1 0.388
695 achieve 1 0.4229
695 acid 5 1.1641
695 acid, 1 0.388
695 action 1 0.2623
695 administration 1 0.2655
695 agent, 1 0.4344
695 agents 1 0.3253
695 allowing 1 0.4634
695 antidiuretic 2 0.7909
695 attempt 1 0.3689
695 chlo- 1 0.6029
695 clearance 2 0.776
695 creased 1 0.3955
695 daily 1 0.3288
695 de- 1 0.3362
695 decreased 4 1.0891
695 diabetes 3 0.8907
695 diet. 1 0.4477
695 discussed. 1 0.2578
695 diuretic 1 0.4477
695 effect 1 0.1841
695 ethacrynic 5 3.0145
695 excretion, 1 0.5428
695 free 2 0.5714
695 function, 1 0.4634
695 gfr. 1 0.6029
695 insipidus 3 0.966
695 instituted 1 0.6029
695 intake 1 0.4229
695 intravenous 1 0.322
695 liberal 1 0.6029
695 limited 1 0.3288
695 meq. 1 0.6029
695 metabolism 1 0.2857
695 mode 1 0.4344
695 nephrogenic 3 1.2382
695 oral 1 0.3689
695 patients 1 0.1449
695 ported 1 0.5428
695 potassium 1 0.4037
695 potent 1 0.4477
695 prolonged 1 0.29
695 promoted 1 0.5428
695 re- 2 0.5343
695 renal 1 0.2339
695 response 1 0.2201
695 result 1 0.2608
695 resulted 1 0.2922
695 ride 1 0.6029
695 rpf 1 0.6029
695 saluretic 1 0.6029
695 significant 2 0.4233
695 sodium 2 0.58
695 sponse 1 0.4634
695 study 1 0.1857
695 treatment 1 0.1779
695 uric 1 0.5428
695 urine 2 0.6198
695 use 3 0.715
695 volume 1 0.3071
695 volume, 1 0.4127
695 water 1 0.3188
695 water. 1 0.4477
696 (pituitary 1 0.6029
696 activity 1 0.2158
696 alter 1 0.4037
696 altering 1 0.4827
696 biological 1 0.322
696 case 1 0.2166
696 cent 1 0.3099
696 conve- 1 0.6029
696 convenience, 1 0.6029
696 diabetes 5 1.4845
696 economy, 1 0.6029
696 effective, 1 0.6029
696 efficient 1 0.4344
696 evaluating 1 0.5076
696 expected, 1 0.6029
696 extrapituitary 1 0.6029
696 factors 1 0.2549
696 function 3 0.8116
696 health 1 0.4229
696 however, 1 0.2183
696 important 1 0.2723
696 ineffective 1 0.4229
696 insipidus 3 0.966
696 insipidus, 1 0.4827
696 insipidus. 1 0.388
696 introduce 1 0.6029
696 is, 1 0.4037
696 kidney 1 0.2671
696 kidney. 1 0.3748
696 life 1 0.3188
696 lysyl-8-vasopressin 1 0.6029
696 maximum 1 0.3324
696 may 1 0.1508
696 nasal 1 0.4229
696 nience, 1 0.6029
696 normal 1 0.1621
696 note 1 0.4827
696 offers 1 0.4344
696 patient 1 0.2267
696 per 1 0.235
696 pituitary 1 0.3127
696 problem. 1 0.4827
696 produced 1 0.2455
696 purpose 1 0.4037
696 reabsorption 1 0.4037
696 reactions. 1 0.4634
696 responsive 1 0.4477
696 secondary 1 0.3018
696 society. 1 0.6029
696 span, 1 0.5428
696 spray 1 0.4634
696 ten 1 0.3633
696 tests. 1 0.4127
696 therapy 2 0.4767
696 treatment 2 0.3558
696 unresponsive) 1 0.6029
696 untoward 1 0.6029
697 1 1 0.2846
697 100-150 1 0.7536
697 12 1 0.3598
697 2-4 1 0.6785
697 200 1 0.4943
697 50% 1 0.4542
697 8 1 0.3403
697 act 1 0.4685
697 action 1 0.3279
697 alleviated. 1 0.7536
697 also 1 0.2108
697 altered 1 0.4025
697 alternative 1 0.5286
697 antidiuretic 2 0.9887
697 blood 3 0.6986
697 briefly 1 0.4542
697 brought 1 0.4943
697 cases 1 0.2242
697 ch'iuan-lu 1 0.7536
697 changed 1 0.5159
697 compared 1 0.2924
697 consequence 1 0.5793
697 continued 1 0.4358
697 contraction 1 0.6346
697 could 1 0.2708
697 daily 1 0.411
697 daily, 1 0.6785
697 day. 2 1.2069
697 decrease 1 0.3449
697 decreases 1 0.485
697 depletion, 1 0.6785
697 destroyed 1 0.5046
697 diabetes 2 0.7423
697 diet. 1 0.5596
697 dietary 1 0.543
697 diminished 1 0.5046
697 discussed. 1 0.3222
697 dose 1 0.3598
697 drip 1 0.7536
697 drug 2 0.7893
697 drug, 1 0.6785
697 ecg 1 0.6785
697 effect 3 0.6903
697 effect. 1 0.4943
697 effects 1 0.2798
697 electrocardiogram 1 0.6346
697 electrolytes, 1 0.6034
697 encountered 1 0.4764
697 essentially 1 0.5159
697 even 2 0.6597
697 excessive 1 0.485
697 extracel- 1 0.7536
697 failure 1 0.4066
697 fifth 1 0.6034
697 filtrate, 1 0.6785
697 fixed 1 0.543
697 fluid 1 0.3571
697 fourth 1 0.5596
697 fre- 2 1.2691
697 given 1 0.2763
697 glomerular 1 0.4764
697 gm 1 0.6785
697 hours 1 0.3625
697 hydrochlorothia- 1 0.6785
697 hydrochlorothiazide 1 0.6346
697 hyper- 1 0.4477
697 hypertonic 1 0.7536
697 improved 1 0.5046
697 indications 1 0.5159
697 ingestion 1 0.6346
697 initial 1 0.3653
697 insipidus 2 0.805
697 intermittent 1 0.6346
697 intravenous 1 0.4025
697 ion 1 0.5793
697 kaluretic 1 0.7536
697 low 1 0.3299
697 lular 1 0.7536
697 maximal 1 0.4685
697 mechanism 1 0.3472
697 mechanism, 1 0.6346
697 medication 1 0.6034
697 ment. 1 0.5596
697 meq 1 0.7536
697 mg 1 0.4477
697 might 1 0.3946
697 month. 1 0.6346
697 noted 1 0.3985
697 obtained 1 0.2686
697 owing 1 0.5046
697 patients. 1 0.3625
697 physical 1 0.4358
697 plasma 2 0.6077
697 possibly 1 0.4685
697 potassium 1 0.5046
697 pre- 1 0.485
697 pres- 1 0.5793
697 pressure, 1 0.4943
697 pretreatment 1 0.543
697 quently 2 1.357
697 re- 1 0.3339
697 regimen. 1 0.7536
697 renal 1 0.2924
697 saline 2 1.1192
697 salt 4 1.9399
697 satisfactory 1 0.4943
697 secondary 1 0.3773
697 side 1 0.4252
697 signs, 1 0.7536
697 sodium 1 0.3625
697 studied 1 0.2626
697 sults 1 0.5596
697 sure 1 0.6785
697 symptoms, 1 0.543
697 syndrome 1 0.3496
697 table 1 0.6346
697 test 2 0.6519
697 therapeutic 2 0.7611
697 therapy 2 0.5959
697 thirst 1 0.6346
697 timely 1 0.6785
697 tonic 1 0.7536
697 treat- 1 0.4685
697 treatment. 1 0.3985
697 un- 1 0.485
697 urinary 4 1.3357
697 use 1 0.2979
697 value. 1 0.6034
697 vented 1 0.7536
697 volume 3 1.1517
697 volume, 2 1.0318
697 volumes 1 0.5793
697 zide 1 0.6346
698 (kennedy 1 0.5024
698 1963) 1 0.4523
698 accompanied 2 0.5603
698 also 1 0.1406
698 although 2 0.3863
698 antidiuretic 1 0.3296
698 change 1 0.2331
698 clearance 2 0.6466
698 concentration 2 0.4225
698 diabetes 3 0.7423
698 diet. 1 0.3731
698 dilution; 1 0.5024
698 direct 1 0.2364
698 drink 1 0.5024
698 drug 1 0.2631
698 effect 2 0.3068
698 fall 1 0.2631
698 fell. 2 1.0048
698 free 2 0.4762
698 given 1 0.1842
698 high 3 0.5394
698 hill, 1 0.5024
698 hydrochlorothiazide 3 1.2691
698 hydrochlorothiazide, 2 1.0048
698 hypo- 1 0.362
698 hypothalamic 1 0.423
698 increased 2 0.3124
698 insipidus 2 0.5366
698 insipidus, 1 0.4023
698 intake 3 1.0572
698 intake, 1 0.4023
698 interfere 1 0.3731
698 less 2 0.3762
698 may 1 0.1257
698 moreover 1 0.5024
698 normal 2 0.2702
698 obese 1 0.4523
698 osmolality 2 0.7724
698 osmolality. 1 0.4523
698 otherwise 1 0.3731
698 patients 1 0.1208
698 plasma 6 1.2153
698 polyuria 1 0.3862
698 potassium 1 0.3364
698 prevented 1 0.3296
698 previously 1 0.2417
698 purely 1 0.3862
698 rat 1 0.2067
698 rats 4 0.7761
698 reduced 2 0.4538
698 reduction 3 0.7423
698 renal, 1 0.4523
698 response 1 0.1834
698 result 1 0.2173
698 self-evident 1 0.5024
698 shown 1 0.216
698 sodium 2 0.4833
698 still 1 0.2347
698 thalamic 1 0.5024
698 thirst 1 0.423
698 thirsty, 1 0.5024
698 turnover 1 0.3364
698 urine 3 0.7747
698 vasopressin, 1 0.5024
698 volume 2 0.5119
698 volume. 1 0.3862
698 water 4 1.0626
698 whereas 1 0.2515
698 yet 1 0.2657
699 "free 1 0.6029
699 (giving 1 0.6029
699 (preventing 1 0.6029
699 accounting 1 0.5428
699 action 1 0.2623
699 ad- 1 0.4037
699 addition, 1 0.3487
699 administration. 1 0.4037
699 adrenalectomized 1 0.4827
699 adrenalectomy 1 0.4229
699 altered 2 0.644
699 although 1 0.2318
699 anti- 1 0.4229
699 antidiuresis 1 0.4634
699 antidiuretic 4 1.5818
699 antidiuretic. 1 0.6029
699 associated 1 0.2141
699 believed 1 0.4477
699 best 1 0.3188
699 body 1 0.2431
699 centration 1 0.5428
699 change 1 0.2797
699 changes 1 0.1804
699 chlorothia- 1 0.6029
699 chlorothiazide 5 2.3172
699 chlorothiazide-induced 1 0.6029
699 clearance. 1 0.5428
699 clearly 1 0.3633
699 con- 2 0.6255
699 concentration). 1 0.6029
699 coupled 1 0.5428
699 de- 1 0.3362
699 decrease 3 0.8276
699 decreased 1 0.2723
699 dependent 1 0.388
699 diabetes 5 1.4845
699 diazoxide 1 0.6029
699 distal 3 1.2686
699 diuretic 1 0.4477
699 dogs 2 0.6255
699 dogs. 2 0.8954
699 essential 1 0.3533
699 explained 1 0.3401
699 extracellular 1 0.4229
699 filtrate 1 0.4827
699 final 1 0.3955
699 fined, 1 0.6029
699 fluid 1 0.2857
699 fore, 1 0.6029
699 found 1 0.1587
699 function 1 0.2705
699 gfr, 1 0.5428
699 in- 1 0.2671
699 increase 2 0.4095
699 ing 1 0.3253
699 inhibition 1 0.3018
699 insipidus 3 0.966
699 insipidus. 1 0.388
699 investigated 1 0.3443
699 lating 1 0.6029
699 mally 1 0.5428
699 mechanism 1 0.2778
699 mercuhydrin 1 0.6029
699 mineralocorticoids 1 0.6029
699 ministration 1 0.5428
699 nephron 1 0.5076
699 nor- 1 0.388
699 one 1 0.1687
699 plasma 1 0.2431
699 possible 1 0.2419
699 postu- 1 0.6029
699 presence 1 0.2297
699 produce 1 0.322
699 properties 1 0.322
699 re- 1 0.2671
699 reabsorption 2 0.8073
699 reaching 1 0.4344
699 response 3 0.6604
699 role 1 0.2797
699 rpf, 1 0.6029
699 saluresis. 1 0.6029
699 seems 1 0.3188
699 seen, 1 0.5076
699 selective 1 0.3581
699 sipidus 1 0.6029
699 sistent 1 0.6029
699 sodium-retain- 1 0.6029
699 sodium-retaining 1 0.5428
699 solute 2 1.2058
699 spironolactone 1 0.5076
699 steroids 2 0.8255
699 therapy 1 0.2383
699 therapy. 1 0.3253
699 there- 1 0.5428
699 tmpah, 1 0.6029
699 total 1 0.235
699 tubule 2 0.8688
699 urinary 1 0.2671
699 urine 4 1.2395
699 volume 1 0.3071
699 volume) 1 0.5428
699 volume, 1 0.4127
699 water" 1 0.6029
699 water. 1 0.4477
699 zide 1 0.5076
700 (carlisle 1 0.4306
700 0.7. 1 0.4306
700 1st 1 0.331
700 2 1 0.1315
700 240 1 0.4306
700 2nd 1 0.3103
700 40 1 0.2523
700 475ug/g. 1 0.4306
700 5 1 0.1633
700 9 1 0.2255
700 90sr 2 0.8613
700 90sr. 1 0.4306
700 account 1 0.2429
700 adult 5 0.9788
700 adults 1 0.2595
700 age 3 0.5344
700 analysis 1 0.2071
700 anatomically 1 0.3626
700 apart 1 0.3626
700 area 1 0.2234
700 area, 1 0.3448
700 babies 2 0.6896
700 birth 1 0.2194
700 bone 2 0.3725
700 bone. 1 0.3198
700 bone: 1 0.3626
700 bones 2 0.6206
700 britain 1 0.4306
700 broad 1 0.3448
700 ca 1 0.3021
700 carlisle. 1 0.4306
700 change 4 0.7991
700 changes 1 0.1289
700 children 2 0.3058
700 close 1 0.2523
700 compared, 1 0.3877
700 concentration 1 0.1811
700 concluded 1 0.1971
700 congenital 1 0.1971
700 correlated 1 0.2558
700 correlation 2 0.4349
700 data 1 0.1754
700 deductions 1 0.4306
700 defects. 1 0.3626
700 demonstrably 1 0.4306
700 derived 1 0.2374
700 detailed 1 0.2722
700 differences 2 0.3941
700 different 2 0.3047
700 different: 1 0.4306
700 discrimination 1 0.3626
700 dying 1 0.3877
700 end 1 0.2635
700 england 3 1.2919
700 estimate 1 0.3626
700 even 1 0.1885
700 except 1 0.2429
700 exception 1 0.2825
700 extreme 1 0.2825
700 first 1 0.1579
700 found 1 0.1134
700 geographical 2 0.8613
700 great 1 0.2459
700 gross 1 0.2883
700 higher 2 0.3704
700 human 3 0.4312
700 inverse 1 0.3626
700 kingdom 2 0.8613
700 level 4 0.6652
700 level: 1 0.4306
700 levels 5 0.8432
700 levels. 1 0.2883
700 life: 1 0.4306
700 london 2 0.8613
700 made 1 0.156
700 making 1 0.331
700 may 1 0.1077
700 mean 1 0.2071
700 miles 1 0.4306
700 months 1 0.2175
700 need 1 0.2635
700 normal 1 0.1158
700 occurred 1 0.1874
700 old 1 0.2429
700 one 2 0.2409
700 only. 1 0.3103
700 particular 1 0.2175
700 parts 1 0.2948
700 pattern 1 0.2056
700 perinatal 4 1.2791
700 physiological 1 0.2523
700 placental 1 0.2948
700 progressive 1 0.2401
700 published 1 0.2883
700 quite 1 0.2459
700 ranged 1 0.331
700 ratio 1 0.2255
700 ratio, 1 0.3877
700 re-assessment 1 0.4306
700 reached. 1 0.3877
700 rest 1 0.3103
700 results 1 0.1233
700 rise 1 0.2138
700 salt 1 0.2771
700 seasonal 1 0.3877
700 seemed 1 0.2771
700 shortly 1 0.3626
700 showed 1 0.1535
700 so. 1 0.4306
700 somewhat 2 0.6396
700 south-east 3 1.2919
700 sr 7 2.7139
700 sr. 1 0.4306
700 stable 7 2.1719
700 striking 1 0.2722
700 strontium 1 0.4306
700 strontium-90 1 0.4306
700 suggested 1 0.1791
700 summer 1 0.4306
700 taken 1 0.2429
700 time 1 0.1517
700 turnover 1 0.2883
700 united 2 0.7252
700 v. 1 0.3626
700 values 1 0.2175
700 westmorland). 1 0.4306
700 winter 1 0.4306
700 workers 1 0.3103
700 year 2 0.4468
700 years 1 0.1958
701 aneurysm 1 0.6466
701 aspects 1 0.5669
701 association 1 0.5422
701 blood 1 0.3105
701 brain 1 0.5119
701 brain, 1 0.8046
701 categories: 1 0.9046
701 central 3 1.6265
701 children 2 0.7136
701 commoner 1 1.0048
701 conditions 1 0.4568
701 congenital 1 0.4598
701 degenerative 1 0.8046
701 deposition 2 1.448
701 discussed 2 0.8185
701 discussed. 1 0.4296
701 disease 1 0.361
701 diseases 3 1.6439
701 draining 1 1.0048
701 either 1 0.4296
701 fall 1 0.5262
701 fibrin 3 2.5382
701 first, 1 0.8046
701 general 1 0.5119
701 great 1 0.5738
701 haemorrhage, 1 0.8461
701 here; 1 1.0048
701 hydrocephalus 1 0.5165
701 incidents 1 0.8461
701 infiltration. 1 1.0048
701 large 1 0.3972
701 length, 1 0.8461
701 lesions, 1 0.724
701 main 1 0.5738
701 membranes 1 0.6466
701 metabolic 1 0.4797
701 much 1 0.4452
701 nervous 3 1.8443
701 omitted. 1 1.0048
701 overlying 1 0.9046
701 particular 1 0.5074
701 presence 1 0.3828
701 rare 1 0.5969
701 rarely 1 0.7048
701 reference 1 0.554
701 related 2 0.8496
701 relating 1 0.7462
701 reported 1 0.4072
701 second, 1 0.7724
701 small 1 0.4031
701 superficial 1 0.7462
701 system 3 1.4082
701 thrombosis 3 2.7139
701 thrombotic 1 1.0048
701 two 1 0.3077
701 vascular 1 0.554
701 vasculitis 1 1.0048
701 veins 1 0.7724
701 ventricles 1 0.8046
701 vessels 1 0.724
702 9-year-old 1 1.0048
702 achieved 1 0.6879
702 air 1 0.5603
702 apparent. 1 0.9046
702 aqueductal 1 0.9046
702 astrocytoma 1 0.9046
702 astrocytoma, 1 1.0048
702 became 1 0.5969
702 case 1 0.361
702 cerebellar 2 1.6091
702 compared. 1 0.8046
702 cystic 1 0.7462
702 demonstrating 1 0.7724
702 diminution 1 0.7048
702 due 2 0.7109
702 four 3 1.3526
702 girl 1 0.6728
702 hydrocephalus 1 0.5165
702 increased 1 0.3124
702 intracranial 1 0.6591
702 mass 1 0.7462
702 means 1 0.4452
702 neoplasm, 1 0.8046
702 obstruction, 1 0.9046
702 palliation 1 0.6352
702 period 1 0.3811
702 placement 1 0.8461
702 presented 1 0.3898
702 pressure, 1 0.6591
702 presumed 1 0.8046
702 prolonged 1 0.4833
702 removed. 1 1.0048
702 resected 1 0.8461
702 shunt 2 1.3455
702 shunt, 1 0.8046
702 shunt. 1 0.7724
702 signs 2 1.1206
702 size 1 0.5262
702 studies 1 0.3077
702 subsequently 1 0.6728
702 totally 1 0.7048
702 treated 1 0.4135
702 unrecognized 1 0.8461
702 ventricular 1 0.4372
702 ventriculoatrial 2 2.0097
702 within 1 0.373
702 year 1 0.5212
702 years 2 0.9135
703 authority 1 2.7139
703 begun 1 2.5382
703 clearly 1 1.8167
703 clinical 1 0.9826
703 delineated 1 3.0145
703 discussion 1 1.8167
703 drawbacks, 1 3.0145
703 field. 1 2.5382
703 formerly 1 3.0145
703 forms 1 1.4391
703 hopeless 1 2.5382
703 hydrocephalus 1 1.5494
703 hydrocephalus, 1 2.1144
703 indications 1 2.0636
703 leading 1 1.8738
703 new 1 1.3194
703 one, 1 2.2385
703 problem 1 1.7214
703 recent 1 1.5786
703 research. 1 2.7139
703 treatment, 1 1.9399
703 years 1 1.3703
703 yield 1 2.2385
704 3-day-old 1 1.5073
704 case 2 1.0831
704 cephalus 1 1.2691
704 foramen 2 2.4137
704 gliomatosis 1 1.5073
704 hydro- 1 1.1586
704 hydrocephalus 1 0.7747
704 infant 1 0.8503
704 monro 2 2.7139
704 obstructive 1 1.0091
704 occlusion 2 1.9399
704 one 2 0.8433
704 reported. 1 0.8716
704 secondary 2 1.5092
704 unilateral 2 1.6265
704 unique 1 0.97
705 6 1 0.4202
705 9 1 0.5262
705 additional 1 0.5366
705 age 1 0.4157
705 aneurysm 3 1.9399
705 aneurysms 1 0.7462
705 calcification 3 2.5382
705 case 1 0.361
705 cases 1 0.299
705 communication 1 0.554
705 congenital 1 0.4598
705 describes 1 0.6879
705 discovered 1 0.7048
705 galen 2 2.0097
705 genograms 1 1.0048
705 heretofore 1 0.9046
705 number. 1 1.0048
705 ously. 1 1.0048
705 patient 1 0.3778
705 plain 1 0.8461
705 present 1 0.3308
705 previ- 1 1.0048
705 reported 1 0.4072
705 reported. 1 0.5811
705 roent- 1 0.8461
705 skull 1 0.9046
705 thirty-one 1 1.0048
705 vein 2 1.4923
705 visible 1 0.8461
705 wall 1 0.6352
705 within 2 0.746
705 years, 1 0.6352
705 youngest 1 0.8461
706 14.3 1 1.0048
706 48 1 0.5669
706 5-year 1 0.7724
706 75 1 0.7048
706 appears 1 0.4321
706 arrest 1 0.724
706 atrioventricular 1 0.9046
706 carefully 1 0.724
706 cause 1 0.4538
706 cent 2 1.0329
706 choice 1 0.6466
706 comparable 1 0.554
706 complica- 1 1.0048
706 complications 1 0.5888
706 date 1 0.7462
706 death 1 0.548
706 discussed 1 0.4092
706 drocephalic 1 0.9046
706 drocephalus. 1 1.0048
706 estab- 1 1.0048
706 experience 1 0.5165
706 fection 1 0.9046
706 followed 1 0.4598
706 function 1 0.4509
706 hy- 2 1.4096
706 hydrocephalic 1 0.724
706 hydrocephalus 1 0.5165
706 in- 1 0.4452
706 infantile 1 0.548
706 infection. 1 0.6591
706 introduction 1 0.724
706 lished. 1 1.0048
706 major 1 0.4833
706 ment 1 0.6591
706 meticulous 1 0.9046
706 neces- 1 0.9046
706 nonfunctioning. 1 1.0048
706 ob- 1 0.6879
706 occur 1 0.4909
706 overall 1 0.6591
706 pa- 1 0.5888
706 patients 3 0.7246
706 per 2 0.7833
706 period 1 0.3811
706 present 1 0.3308
706 presented. 1 0.5888
706 procedure, 1 0.8461
706 process 1 0.4598
706 promptly. 1 0.9046
706 rate 2 0.7398
706 recognized 1 0.6246
706 results 1 0.2878
706 review 1 0.554
706 revisions 1 1.0048
706 satisfactory 1 0.6591
706 series. 1 0.8046
706 servation 1 0.9046
706 severe 1 0.4452
706 shunt 2 1.3455
706 shunt, 1 0.8046
706 shunts 2 1.6091
706 sitated 1 1.0048
706 spontaneous 1 0.5811
706 supports 1 0.8461
706 survival 1 0.4833
706 tients 1 0.6466
706 tions 1 0.5969
706 treat- 1 0.6246
706 treated 2 0.827
706 venous 1 0.5669
706 ventriculo- 1 0.9046
706 ventriculo-venous 2 2.0097
707 accepting 1 1.5073
707 affected 2 1.5637
707 anencephalus 1 1.5073
707 aunts, 1 1.5073
707 bifida 1 1.2691
707 c.n.s. 1 1.5073
707 cases 2 0.8969
707 central 1 0.8133
707 children 1 0.5352
707 congenital 1 0.6897
707 cousins 1 1.5073
707 dependent, 1 1.5073
707 determined. 1 1.0318
707 dr. 1 1.1586
707 due 1 0.5332
707 embryo 1 1.0572
707 environment 1 1.0091
707 environmental 1 1.1192
707 explained 1 0.8503
707 extent 1 0.797
707 fact 1 0.797
707 factor 1 0.7143
707 factors. 1 1.1586
707 found 1 0.3968
707 frequently 1 0.7611
707 genetic 1 0.7893
707 genetical 1 1.5073
707 higher 1 0.6481
707 history 1 0.8716
707 hypothesis 1 0.805
707 incidence 1 0.7196
707 index 1 0.8954
707 interesting 1 1.086
707 intra- 1 1.0572
707 least, 1 1.2691
707 malformations 2 1.9399
707 malformations. 1 1.1586
707 maternal 2 1.7433
707 merely 1 1.1192
707 modifies 1 1.357
707 mother. 1 1.2069
707 mothers 1 0.9083
707 nature 1 0.7483
707 nervous 1 0.9221
707 obtained 1 0.5373
707 one 1 0.4217
707 opens 1 1.5073
707 paternal 1 1.5073
707 possibilities, 1 1.5073
707 predisposes 1 1.5073
707 proportion 1 0.9369
707 relatives 2 3.0145
707 satisfied 1 1.5073
707 seems 1 0.797
707 simple 1 0.8219
707 small 1 0.6046
707 spina 1 1.2691
707 suggested 1 0.6268
707 system 1 0.7041
707 terms 1 0.9221
707 thus 1 0.7819
707 uncles, 1 1.5073
707 uterine 1 1.357
707 were. 1 1.5073
707 williamson 1 1.5073
707 would 1 0.7483
707 yet 1 0.797
708 0.15 1 0.3349
708 0.25 1 0.282
708 48 1 0.189
708 50 1 0.1599
708 63 1 0.3015
708 63, 1 0.3349
708 75 1 0.2349
708 abdominal 1 0.2487
708 absorption. 1 0.3349
708 administration 1 0.1475
708 almost 1 0.1722
708 averaged 2 0.5364
708 be- 1 0.2049
708 blockade 1 0.3349
708 cases 2 0.1993
708 cerebral 2 0.3175
708 cerebrospinal 1 0.2019
708 cistern 1 0.3349
708 cisterna 1 0.2682
708 compression. 1 0.3349
708 contralateral 1 0.2487
708 crease 1 0.2243
708 csf 7 1.5698
708 decreased 1 0.1513
708 degree 1 0.1484
708 diate 1 0.3349
708 dilatation 1 0.2349
708 directional, 1 0.3349
708 dogs 1 0.1737
708 dogs. 1 0.2487
708 dogs; 1 0.3349
708 either 1 0.1432
708 experimental 2 0.3107
708 fall 1 0.1754
708 fell 1 0.2293
708 flow 9 1.5356
708 fluid 1 0.1587
708 following 1 0.111
708 former 1 0.2293
708 gained 1 0.2682
708 higher. 1 0.282
708 hour 2 0.4827
708 hy- 1 0.2349
708 hydrocephalic 1 0.2413
708 in- 1 0.1484
708 increase 1 0.1138
708 increasing 1 0.1963
708 induced 1 0.1424
708 injected 1 0.1624
708 interme- 1 0.3349
708 intravenous 1 0.1789
708 intraventricular 1 0.2575
708 jugular 1 0.2487
708 kaolin 1 0.3349
708 larger 1 0.199
708 lateral 2 0.4485
708 latter 1 0.1737
708 limit 1 0.2682
708 low 1 0.1466
708 lumbar 1 0.2575
708 lyco- 1 0.3349
708 magna 1 0.282
708 mixed 1 0.2117
708 ml. 2 0.4485
708 mm. 1 0.2197
708 observed. 1 0.2019
708 original 1 0.1913
708 parallel 2 0.4311
708 per 2 0.2611
708 performed 1 0.1533
708 pertonic 1 0.3349
708 podium 1 0.3349
708 pres- 1 0.2575
708 pressure 5 0.7663
708 probably 1 0.1523
708 produced 1 0.1364
708 raised. 1 0.3349
708 rate 4 0.4932
708 re- 1 0.1484
708 recovered. 1 0.2682
708 reflux 1 0.3015
708 results 1 0.0959
708 seems 1 0.1771
708 shunting 1 0.2293
708 shunting, 1 0.3349
708 shunting. 1 0.3349
708 solutions, 1 0.3349
708 space 2 0.4974
708 space. 1 0.2682
708 steady 1 0.2413
708 stopped. 1 0.3349
708 studies 1 0.1026
708 subarachnoid 2 0.5364
708 successfully 1 0.2293
708 sure 1 0.3015
708 suspension 1 0.2413
708 toward 1 0.2155
708 transient 1 0.2293
708 tween 1 0.2413
708 uni- 1 0.3015
708 unilateral 1 0.1807
708 upper 1 0.2155
708 value 1 0.1543
708 ventricle 3 0.5811
708 ventricular 1 0.1457
708 water 1 0.1771
709 "dandy-walker 1 1.0048
709 (1944), 1 1.0048
709 1 1 0.3795
709 1914, 1 1.0048
709 1954 1 1.0048
709 59 1 0.8046
709 adult 1 0.4568
709 aged 1 0.6056
709 also. 1 1.0048
709 always 1 0.5366
709 anomaly 1 0.724
709 associated 1 0.3568
709 atresia 3 1.8443
709 benda 1 1.0048
709 best 1 0.5313
709 blackfen 1 1.0048
709 case 1 0.361
709 cases 2 0.5979
709 cerebellar 2 1.6091
709 childhood 1 0.5669
709 concluded 1 0.4598
709 condition 1 0.5366
709 condition. 1 0.6879
709 congenital 1 0.4598
709 consequent 1 0.8461
709 dandy 1 0.9046
709 dandy-walker 2 2.0097
709 description 1 0.6591
709 dilated 1 1.0048
709 dilated. 1 1.0048
709 discovered 1 0.7048
709 early 1 0.3684
709 entity 1 0.8046
709 figure 1 0.8461
709 first 1 0.3684
709 foramen 2 1.6091
709 foramina 1 0.8046
709 fourth 1 0.7462
709 grossly 1 0.7048
709 illustrates 1 0.8461
709 infancy, 1 0.7462
709 lateral 1 0.6728
709 lesions 1 0.4321
709 life. 1 0.724
709 luschka 1 0.9046
709 magendie, 1 1.0048
709 magendie. 1 0.9046
709 malformation 1 0.7462
709 many 1 0.4051
709 morbid 1 1.0048
709 nearly 1 0.6148
709 oldest 1 0.8461
709 others 1 0.548
709 patient 1 0.3778
709 present 1 0.3308
709 proposed 1 0.6591
709 published 1 0.6728
709 recognized 1 0.6246
709 recorded 1 0.5738
709 specific 1 0.3953
709 specimen 1 0.724
709 syndrome 2 0.9322
709 syndrome". 1 1.0048
709 taggart 1 1.0048
709 term 1 0.5603
709 third 1 0.548
709 upon 1 0.4509
709 usually 1 0.4727
709 ventricle 1 0.5811
709 ventricles 1 0.8046
709 vermis. 1 1.0048
709 walker 1 0.8461
709 years. 1 0.6352
710 1940-1941 1 1.5073
710 1940-41 1 1.5073
710 believing 1 1.5073
710 cause. 1 1.1192
710 congenital 2 1.3794
710 continuously; 1 1.5073
710 defined 1 1.0318
710 described; 1 1.357
710 detected 1 0.7819
710 epidemic 1 1.357
710 epidemics 2 2.7139
710 find 1 1.0318
710 genuine 1 1.5073
710 given 1 0.5526
710 hydrocephalus 2 1.5494
710 incidence 2 1.4391
710 indeed. 1 1.5073
710 large 1 0.5959
710 late 1 0.8954
710 malformations 2 1.9399
710 must 1 0.7363
710 peak 1 0.8716
710 phenomenon, 1 1.5073
710 population 2 1.9399
710 probable 1 0.9528
710 promptly 1 1.357
710 reasons 1 1.0091
710 studied 2 1.0503
710 though 1 0.8832
711 abnormal 2 0.4175
711 abnormality 1 0.3021
711 abnormally 1 0.3198
711 ac- 1 0.2771
711 achondroplasia. 1 0.4306
711 addition, 2 0.4981
711 age. 1 0.2429
711 ages 1 0.3103
711 aid 1 0.3103
711 air 1 0.2401
711 al- 1 0.331
711 also 1 0.1205
711 analysis 1 0.2071
711 anchor 1 0.4306
711 and, 1 0.2234
711 apart 1 0.3626
711 apparently 1 0.2348
711 appearance 1 0.2138
711 arachnoid 1 0.3448
711 areas 1 0.2277
711 base 3 0.9062
711 bone 2 0.3725
711 bone: 1 0.3626
711 bones 2 0.6206
711 brain 3 0.6581
711 brain. 1 0.331
711 cal- 2 0.8613
711 calvaria 4 1.4504
711 calvarial 4 1.7226
711 cap- 1 0.4306
711 capsule, 1 0.331
711 capsule. 1 0.3877
711 car- 1 0.3103
711 cartilage. 1 0.4306
711 cerebral 3 0.6122
711 changes 2 0.2577
711 chondrocranium 1 0.4306
711 closely 1 0.2459
711 closure 1 0.3021
711 components. 2 0.8613
711 composed 1 0.331
711 consequently, 2 0.8613
711 considering 1 0.331
711 correlation 1 0.2175
711 counts 1 0.3021
711 cranial 3 1.0345
711 craniology: 1 0.4306
711 de- 1 0.2401
711 demands 1 0.3626
711 deposition 1 0.3103
711 determined 1 0.1958
711 diploe 3 1.2919
711 directly 3 0.8167
711 distinctly 1 0.4306
711 disturb 1 0.4306
711 division 1 0.3021
711 due 1 0.1523
711 dura 2 0.8613
711 dural 1 0.3877
711 epiphyses 1 0.3877
711 expanding 1 0.3877
711 explained 1 0.2429
711 extrinsic 1 0.3448
711 facial 2 0.7754
711 facilitated 1 0.3626
711 fair. 1 0.4306
711 fiber 1 0.3877
711 fication 1 0.4306
711 final 1 0.2825
711 flects 1 0.4306
711 form 7 1.3116
711 form, 1 0.3448
711 form. 1 0.331
711 formity 1 0.4306
711 forms 1 0.2056
711 function 2 0.3865
711 functional 3 0.8167
711 functionally 1 0.3626
711 general 1 0.2194
711 given 1 0.1579
711 grams 1 0.4306
711 grow- 1 0.4306
711 growth 3 0.4404
711 growth. 1 0.3103
711 hematopoiesis; 1 0.4306
711 however, 2 0.3119
711 increased 1 0.1339
711 inferred 1 0.3626
711 ing 1 0.2324
711 innate 1 0.3448
711 inner 3 1.0878
711 intelligence 1 0.3198
711 interpreting 1 0.3877
711 intimately 1 0.4306
711 intrinsic 1 0.3021
711 it. 1 0.2948
711 large. 1 0.4306
711 lightweight 1 0.4306
711 lowing 1 0.3626
711 major 1 0.2071
711 mammals 1 0.3626
711 many 1 0.1736
711 margins. 1 0.4306
711 mass 2 0.6396
711 mass, 1 0.3877
711 mass. 1 0.3877
711 mater 2 0.8613
711 mater. 1 0.4306
711 may 3 0.3231
711 mediated 1 0.3103
711 membrane 1 0.2324
711 motion 1 0.4306
711 muscles 2 0.7252
711 neu- 1 0.4306
711 neural 5 1.813
711 number 1 0.1648
711 occur 2 0.4208
711 op- 1 0.4306
711 oppose 1 0.4306
711 osseous 1 0.3198
711 ossi- 1 0.4306
711 outer 2 0.7252
711 particularly 1 0.2374
711 passively 1 0.3877
711 pig, 1 0.3626
711 plain 1 0.3626
711 por- 1 0.4306
711 portions 1 0.3198
711 posite 1 0.4306
711 possibly 1 0.2677
711 potential: 1 0.4306
711 precedes 1 0.3877
711 preformed 1 0.4306
711 premature 1 0.2948
711 presence 1 0.1641
711 primi- 1 0.4306
711 principal 1 0.3448
711 protect 1 0.3198
711 purposes, 1 0.4306
711 ral 1 0.4306
711 re- 1 0.1908
711 reason 1 0.3103
711 recognition 1 0.2883
711 reflect 1 0.331
711 reflects 1 0.3448
711 related 2 0.3641
711 relative 1 0.2234
711 removal 1 0.2401
711 represents 1 0.2948
711 ried 1 0.3626
711 rigid 1 0.3877
711 roentgeno- 1 0.3877
711 roentgenograms 1 0.3877
711 roentgenologist's 1 0.4306
711 scalp 1 0.4306
711 secondary 1 0.2156
711 separa- 1 0.3626
711 separate 1 0.2722
711 separation 1 0.2401
711 serves 2 0.6621
711 shape 1 0.2771
711 sinuses 1 0.3626
711 site 1 0.249
711 size 2 0.451
711 size, 1 0.2948
711 skeleton 2 0.8613
711 skull 7 2.7139
711 skull. 2 0.8613
711 small 1 0.1728
711 small. 1 0.3877
711 somatic 2 0.6621
711 specific 1 0.1694
711 su- 1 0.3877
711 sule 1 0.4306
711 suture 2 0.7754
711 sutures 1 0.4306
711 sutures, 1 0.4306
711 sutures. 1 0.4306
711 table 3 1.0878
711 table, 1 0.4306
711 table. 1 0.4306
711 tables. 1 0.4306
711 tend 1 0.3103
711 terms 1 0.2635
711 them. 1 0.3103
711 thick-skulled 1 0.4306
711 three 1 0.1619
711 tion 2 0.3915
711 tive 1 0.3626
711 tracts 1 0.3877
711 tures 1 0.4306
711 two 1 0.1319
711 underlie 1 0.4306
711 unusual 1 0.2722
711 usually, 1 0.4306
711 valuable, 1 0.3877
711 varia 1 0.4306
711 varial 1 0.4306
711 volume 1 0.2194
711 well. 1 0.3198
711 within 2 0.3197
711 yet 1 0.2277
712 /min. 1 0.3015
712 /min./cm.2 1 0.3015
712 0.011 1 0.3015
712 0.016 1 0.3015
712 0.20 1 0.3015
712 0.24 1 0.3015
712 0.3x10-3 1 0.3015
712 4th 1 0.2238
712 ability 1 0.1536
712 absorb 1 0.3015
712 absorption 4 0.7495
712 absorption, 1 0.2414
712 accuracy 1 0.2317
712 adjust 1 0.2714
712 always 1 0.161
712 animals 1 0.1282
712 applied 1 0.1817
712 arachnoid 1 0.2414
712 beat 1 0.3015
712 became 1 0.1791
712 brospinal 1 0.3015
712 calculate 1 0.2414
712 calculated 1 0.2018
712 cere- 1 0.3015
712 cerebral 1 0.1429
712 cerebrospinal 10 1.8167
712 changes 2 0.1804
712 changing 1 0.2238
712 choroid 1 0.2238
712 chronic 1 0.1439
712 clinical 1 0.0983
712 concerns 1 0.2538
712 considered 1 0.1344
712 constant 1 0.1644
712 constant, 1 0.2317
712 constantly. 1 0.3015
712 contents 2 0.4037
712 could 1 0.1083
712 craniospinal 1 0.3015
712 crea- 1 0.3015
712 data 2 0.2455
712 decrease 1 0.1379
712 development 1 0.1101
712 different 1 0.1066
712 diffusion 1 0.2018
712 diffusive 1 0.3015
712 distinguished 1 0.2018
712 dog 1 0.1874
712 dog. 1 0.2714
712 dogs 1 0.1564
712 enlargement 1 0.2064
712 ependyma 1 0.3015
712 ependymal 1 0.3015
712 fact, 1 0.2414
712 flattened 1 0.2414
712 flow 1 0.1536
712 fluid 9 1.2857
712 fluid/min. 2 0.6029
712 fluid/min./gm. 1 0.3015
712 forma- 1 0.2414
712 formation 3 0.4058
712 formation, 1 0.2714
712 found 2 0.1587
712 fusion. 1 0.3015
712 higher 1 0.1296
712 hydrocephalic 3 0.6516
712 hydrocephalus 1 0.1549
712 hydrocephalus. 1 0.2018
712 hydrocephalus: 1 0.3015
712 hydrostatic 1 0.2714
712 increased 1 0.0937
712 independent 1 0.1817
712 intracranial 1 0.1977
712 intraventricular 2 0.4634
712 lateral 1 0.2018
712 mean 1 0.145
712 measured 1 0.1319
712 ml. 5 1.0091
712 much 1 0.1336
712 normal 5 0.4053
712 occur 1 0.1473
712 occurred 1 0.1312
712 per- 1 0.2018
712 permeabilities 1 0.3015
712 place 1 0.1844
712 plexus, 1 0.2714
712 pore 1 0.2714
712 pressure 1 0.1379
712 pressure, 1 0.1977
712 problem 1 0.1721
712 produced 1 0.1228
712 progressively 1 0.2238
712 pulse. 1 0.3015
712 radius 1 0.3015
712 rapid 1 0.1461
712 re- 2 0.2671
712 reason 1 0.2172
712 resistance 2 0.3362
712 significantly 1 0.1267
712 sistance 1 0.2538
712 small 1 0.1209
712 space. 1 0.2414
712 spaces. 1 0.2714
712 steady-state 1 0.2714
712 stricted 1 0.3015
712 studies 1 0.0923
712 sub- 1 0.194
712 subarachnoid 1 0.2414
712 sufficient 1 0.1817
712 suggest 1 0.137
712 surface. 1 0.2414
712 take 1 0.2064
712 test. 1 0.1977
712 theory 1 0.194
712 tinine 1 0.3015
712 tion 1 0.137
712 unaffected 1 0.2414
712 urea, 1 0.2414
712 using 2 0.2741
712 ventricle 2 0.3487
712 ventricle. 2 0.5076
712 ventricles 2 0.4827
712 ventricles, 1 0.2714
712 ventricular 3 0.3935
712 volume 1 0.1536
712 well 1 0.1054
712 when, 1 0.3015
712 within 3 0.3357
713 "non 1 0.7536
713 (csfp) 1 0.7536
713 (ssvp) 1 0.7536
713 (tvp) 1 0.7536
713 1:1 1 0.7536
713 ab- 1 0.6346
713 acute 1 0.3742
713 anterior 1 0.4764
713 cause 1 0.3403
713 cerebro- 1 0.6346
713 changes 2 0.451
713 correlation 1 0.3805
713 could 1 0.2708
713 csfp 2 1.5073
713 csfp. 1 0.7536
713 csfp>ssvp>tvp. 1 0.7536
713 decrease 1 0.3449
713 demonstrated 1 0.3222
713 dog 1 0.4685
713 dog, 1 0.6346
713 dogs 1 0.3909
713 dural 1 0.6785
713 elevation 1 0.5286
713 ex- 1 0.4477
713 fashion. 1 0.6346
713 fluid 3 1.0714
713 follows: 1 0.6034
713 hand, 1 0.4542
713 hydrocephalic 2 1.086
713 mean 1 0.3625
713 measurement 1 0.4252
713 mechanism 1 0.3472
713 meet 1 0.6034
713 normal 2 0.4053
713 occlusion 1 0.485
713 partial 1 0.4202
713 pected 1 0.6785
713 poor 1 0.4358
713 poste- 1 0.7536
713 postulated 1 0.5286
713 pres- 1 0.5793
713 pressure 4 1.3794
713 pressures 1 0.4943
713 related 2 0.6372
713 relationship 1 0.3625
713 rior 1 0.6785
713 rises 1 0.5596
713 sagittal 1 0.6034
713 shown 1 0.3241
713 simultaneous 1 0.4611
713 sinus 2 1.086
713 sinus. 1 0.7536
713 sorption. 1 0.7536
713 spinal 1 0.5159
713 ssvp 3 2.2609
713 statistical 1 0.485
713 sures 1 0.6785
713 tvp 1 0.7536
713 venous 1 0.4252
713 venting" 1 0.7536
714 17-month-old 1 1.5073
714 ac- 1 0.97
714 although 1 0.5794
714 case 2 1.0831
714 complished 1 1.5073
714 craniotomy 1 1.357
714 days 1 0.5987
714 erect 1 1.5073
714 feet. 1 1.5073
714 female, 1 1.1192
714 five 1 0.797
714 four 1 0.6763
714 head 1 0.9887
714 holding 1 1.5073
714 hospital 1 0.9528
714 incident. 1 1.357
714 intraventricular 2 2.3172
714 kept 1 1.1192
714 lateral 1 1.0091
714 left 2 1.3613
714 literature 1 0.8219
714 observation 1 0.7893
714 papilloma 2 2.7139
714 patient, 1 0.9887
714 performed 1 0.6897
714 perhaps 1 0.831
714 portant 1 1.357
714 postoperatively 1 1.357
714 relatively 1 0.725
714 removal 1 0.8404
714 reported 1 0.6107
714 reported. 1 0.8716
714 reviewed. 1 1.0572
714 right 1 0.7819
714 satisfactorily 1 1.357
714 sustaining 1 1.5073
714 tilted 1 1.5073
714 time 1 0.5311
714 tumor 1 0.672
714 unim- 1 1.5073
714 unsupported 1 1.5073
714 unusual 1 0.9528
714 ventricle 1 0.8716
714 weight 1 0.7091
714 without 1 0.5692
715 "arrest" 1 0.5024
715 "bubble" 1 0.5024
715 (113 1 0.5024
715 (based 1 0.5024
715 (i.q. 2 1.0048
715 1 1 0.1897
715 10 1 0.1849
715 113 1 0.4523
715 120 1 0.423
715 16.7 1 0.5024
715 22.2 1 0.5024
715 27.6 1 0.5024
715 33.8 1 0.5024
715 48 1 0.2834
715 5-year 1 0.3862
715 5.5 1 0.4523
715 61.8 1 0.5024
715 65 1 0.3439
715 75 1 0.3524
715 75): 1 0.5024
715 ability 1 0.2559
715 abnormal, 1 0.5024
715 advantages 1 0.3524
715 apparently 2 0.548
715 appropriate 1 0.3296
715 associated 3 0.5352
715 ated 1 0.4023
715 atrium. 1 0.4523
715 attempts 1 0.3233
715 basic 3 1.0318
715 basis 1 0.2199
715 better): 1 0.5024
715 birth 1 0.2559
715 blood 1 0.1552
715 breakage 1 0.4523
715 capacity 1 0.274
715 cardiac 1 0.2254
715 carried 1 0.2515
715 cases) 1 0.423
715 cases. 1 0.2631
715 cause 1 0.2269
715 causing 1 0.3731
715 cent 3 0.7747
715 cent. 1 0.3862
715 cent; 2 1.0048
715 centers 1 0.3524
715 cerebral 3 0.7143
715 cerebro- 1 0.423
715 cerebrospinal 1 0.3028
715 children 5 0.892
715 clearance 1 0.3233
715 comparative 1 0.3074
715 compared 1 0.1949
715 compensated 1 0.4023
715 competent 1 0.362
715 conclusions 1 0.3176
715 cor- 1 0.423
715 correlate 1 0.4023
715 correlation 1 0.2537
715 correlations 1 0.362
715 could 1 0.1805
715 data 1 0.2046
715 death 1 0.274
715 decreases 1 0.3233
715 demonstrate 1 0.2905
715 demonstrated 1 0.2148
715 depth. 1 0.5024
715 determine 1 0.2834
715 disciplines 1 0.423
715 done 2 0.6728
715 dramatic 1 0.4023
715 drocephalic 1 0.4523
715 ducing 1 0.5024
715 duration 1 0.2631
715 early 3 0.5526
715 end 1 0.3074
715 etiologies 1 0.5024
715 etiology 2 0.554
715 evalua- 1 0.5024
715 evaluation. 1 0.5024
715 examinations, 1 0.5024
715 factors 2 0.4248
715 factors, 1 0.362
715 favoring 1 0.4523
715 five-year 1 0.4523
715 fluid 3 0.7143
715 follow- 2 0.7724
715 functioning 1 0.3439
715 give 1 0.274
715 gives 1 0.362
715 goal. 1 0.5024
715 group 1 0.1857
715 group, 2 0.6466
715 groups 1 0.2046
715 growth 1 0.1713
715 hav- 1 0.5024
715 hy- 1 0.3524
715 hydrocepha- 1 0.5024
715 hydrocephalic 1 0.362
715 hydrocephalus 2 0.5165
715 hydrocephalus, 1 0.3524
715 hydrocephalus-pro- 1 0.5024
715 hydrocephalus; 1 0.5024
715 imply 1 0.3524
715 in- 2 0.4452
715 including 1 0.2711
715 increase 1 0.1706
715 increased 1 0.1562
715 increases 1 0.2347
715 infection. 1 0.3296
715 inflammatory 1 0.3731
715 ing 2 0.5422
715 instances. 1 0.423
715 intellectual 2 0.6728
715 intelligence, 1 0.4523
715 invaluable 1 0.4523
715 irrespective 2 0.6879
715 ity 1 0.5024
715 justified: 1 0.5024
715 large 1 0.1986
715 late 1 0.2985
715 less 1 0.1881
715 life-long 1 0.5024
715 life-table 1 0.5024
715 logical 1 0.3731
715 lus 1 0.5024
715 major 1 0.2417
715 malfunctioning 1 0.5024
715 manner 1 0.3439
715 mantle 1 0.5024
715 mantle, 1 0.5024
715 mantle; 1 0.5024
715 many 1 0.2026
715 mechanical 1 0.362
715 medical 1 0.2985
715 might 1 0.2631
715 morbid- 1 0.5024
715 morbidity 1 0.4523
715 morbidity, 1 0.4523
715 mortality, 1 0.4523
715 necessity 1 0.3731
715 noncompetitive 1 0.4523
715 number 2 0.3845
715 numbers 1 0.2985
715 numerous 1 0.2985
715 obstruction 1 0.3176
715 obstructions 1 0.5024
715 occlusions 1 0.4523
715 on, 1 0.423
715 oper- 1 0.5024
715 opera- 1 0.3862
715 operated 1 0.3233
715 operation 1 0.2631
715 operations 1 0.3296
715 operative 2 0.5603
715 over; 1 0.5024
715 patient 2 0.3778
715 patients 1 0.1208
715 per 6 1.1749
715 periodic 2 0.724
715 periodically 1 0.423
715 possible 1 0.2015
715 pres- 1 0.3862
715 pressure. 1 0.362
715 pressures 1 0.3296
715 prevention 1 0.3439
715 procedure 1 0.2559
715 process 2 0.4598
715 program 3 1.0572
715 projected 1 0.5024
715 prolonged 1 0.2417
715 prompt 1 0.3731
715 proved 1 0.2801
715 psycho- 1 0.5024
715 re-establishment 1 0.5024
715 recognition 1 0.3364
715 recovery 1 0.277
715 related 3 0.6372
715 removal 1 0.2801
715 require 1 0.3439
715 required 1 0.274
715 retraction 1 0.4523
715 risa, 1 0.5024
715 seemed 1 0.3233
715 septicemia 1 0.423
715 septicemia. 1 0.5024
715 show 1 0.2173
715 showed: 1 0.5024
715 shunt 3 1.0091
715 shunt. 1 0.3862
715 shunted 1 0.5024
715 shunting 6 2.0636
715 shunts. 1 0.423
715 significant 1 0.1764
715 similar 1 0.1881
715 single 1 0.2494
715 spinal 2 0.6879
715 spite 1 0.3364
715 stream. 1 0.5024
715 studied 1 0.175
715 studies 2 0.3077
715 study 3 0.4643
715 sures 1 0.4523
715 survival: 1 0.5024
715 symptoms, 1 0.362
715 testings, 1 0.5024
715 this. 1 0.5024
715 this; 1 0.5024
715 thorough 1 0.4523
715 tions 1 0.2985
715 tions, 1 0.4523
715 tracranial 1 0.5024
715 type 1 0.2089
715 ultimate 1 0.4523
715 usually 1 0.2364
715 ventricular 1 0.2186
715 ventriculo-atrial 1 0.423
715 ventriculograms, 1 0.5024
715 versely 1 0.5024
715 vs. 2 0.9046
715 width 3 1.2069
715 without 1 0.1897
715 years) 1 0.5024
716 abnormal 1 0.3653
716 adopt 1 0.7536
716 amount 1 0.3711
716 anomalies. 1 0.7536
716 arachnoiditis 1 0.6785
716 atrial 1 0.485
716 authors 1 0.3472
716 availed 1 0.7536
716 cannot 1 0.4066
716 cause 1 0.3403
716 cause. 1 0.5596
716 cerebrospi- 1 0.7536
716 characterized 1 0.3985
716 choice 1 0.485
716 choroidoplex- 1 0.7536
716 common 1 0.3682
716 concept 1 0.4542
716 condition 1 0.4025
716 congenital 1 0.3449
716 conservative 1 0.6346
716 day 1 0.3742
716 definition 1 0.6034
716 ectomy, 1 0.7536
716 either 1 0.3222
716 enlarge- 1 0.7536
716 excessive 1 0.485
716 fluid 1 0.3571
716 fol- 1 0.5596
716 halter 1 0.7536
716 head. 1 0.7536
716 hydrocephalus 4 1.5494
716 ideal 1 0.6346
716 like, 1 0.7536
716 loose. 1 0.7536
716 lowed 1 0.6034
716 medical 1 0.4477
716 ment 1 0.4943
716 nal 1 0.6034
716 neoplasm 1 0.6785
716 noid-ureteral, 1 0.7536
716 older 1 0.4685
716 others. 1 0.6034
716 placement 1 0.6346
716 present 1 0.2481
716 procedure 1 0.3839
716 procedures, 1 0.6034
716 pudenz 1 0.7536
716 rare 1 0.4477
716 rather 1 0.3546
716 shunt, 1 0.6034
716 shunting 1 0.5159
716 subarach- 1 0.7536
716 support 1 0.4155
716 surgical 2 0.6807
716 tapping 1 0.7536
716 thecal-fimbia, 1 0.7536
716 using 1 0.3426
716 valves 1 0.6346
716 valves. 1 0.7536
716 ventricular 1 0.3279
716 ventriculo- 1 0.6785
716 ventriculo-peritoneal, 1 0.7536
716 waiting 1 0.7536
716 without 1 0.2846
716 would 1 0.3742
717 2 1 0.4602
717 adult 1 0.6851
717 advanced 1 0.7819
717 cases. 1 0.7893
717 condition 1 0.805
717 data 1 0.6138
717 development 1 0.5503
717 diagnosis 1 0.6202
717 dilatation 1 1.0572
717 discus- 1 1.5073
717 eight 1 0.8607
717 following 1 0.4996
717 hem- 1 1.5073
717 hemorrhage 1 0.97
717 hydrocephalus 2 1.5494
717 mechanisms 1 0.9083
717 number 1 0.5768
717 orrhage 1 1.5073
717 pathological 1 0.8133
717 patients 1 0.3623
717 possible 1 0.6046
717 presented 2 1.1695
717 recognition 1 1.0091
717 secondary 1 0.7546
717 sion 1 1.1586
717 spontaneous 2 1.7433
717 subarachnoid 2 2.4137
717 treatment 1 0.4447
717 treatment. 1 0.797
717 ventricular 1 0.6558
718 (especially 1 0.9046
718 (for 1 1.0048
718 1940 1 1.0048
718 1941 1 1.0048
718 1960 1 0.9046
718 1961, 1 0.8461
718 also 1 0.2811
718 anomalies 1 0.6591
718 ardized 1 1.0048
718 australia 1 1.0048
718 basic 1 0.6879
718 basis 1 0.4398
718 better 1 0.5811
718 century, 1 1.0048
718 city) 1 1.0048
718 classifying 1 0.9046
718 clearly 1 0.6056
718 clinical 1 0.3275
718 clinicians, 1 1.0048
718 community 2 1.6922
718 congenital 3 1.3794
718 considerations 1 0.6879
718 constructed 1 0.8461
718 data 1 0.4092
718 deformity 1 0.8461
718 demic 1 1.0048
718 demonstrated 1 0.4296
718 distributions 1 0.9046
718 elsewhere 1 1.0048
718 embryopathies 1 1.0048
718 endeavor 1 1.0048
718 epidemic 1 0.9046
718 epidemiology 1 0.9046
718 europe 1 1.0048
718 events 1 0.7462
718 example, 1 0.9046
718 group 1 0.3714
718 health 1 0.7048
718 hospital) 1 1.0048
718 importance 1 0.5119
718 ing 1 0.5422
718 joint 1 0.6466
718 lance 1 1.0048
718 levels. 1 0.6728
718 malformations 2 1.2933
718 malformations. 3 2.3172
718 medical 1 0.5969
718 methodical 1 1.0048
718 methods 1 0.4538
718 monitoring 1 0.8046
718 need 1 0.6148
718 new, 1 0.9046
718 new. 1 1.0048
718 occurrence 1 0.5969
718 or, 1 0.8046
718 pan- 1 1.0048
718 part 1 0.4694
718 person 1 0.7462
718 place, 1 0.9046
718 post-rubella 1 1.0048
718 prevention, 1 1.0048
718 primary 1 0.4248
718 principle 1 0.9046
718 programs 2 1.8093
718 public 1 0.8046
718 reconstruct 1 1.0048
718 record 1 0.8461
718 report- 1 1.0048
718 reporting 1 0.9046
718 scien- 1 1.0048
718 scientifically 1 1.0048
718 service 1 0.9046
718 significant 1 0.3527
718 stand- 1 1.0048
718 statistics 1 0.9046
718 still, 1 1.0048
718 surveil- 1 1.0048
718 system 1 0.4694
718 thalidomide 1 1.0048
718 time, 1 0.5811
718 tists 1 1.0048
718 two 1 0.3077
718 use 1 0.3972
718 utilizing 1 0.7462
718 vital 1 0.7462
718 workers 1 0.724
719 (8%) 1 0.5024
719 1 1 0.1897
719 1,256 1 0.5024
719 118 1 0.5024
719 12 1 0.2399
719 22, 1 0.5024
719 24.1%. 1 0.5024
719 25 1 0.2869
719 306 1 0.5024
719 54, 1 0.5024
719 6.8% 1 0.5024
719 722 1 0.5024
719 85 1 0.4523
719 9. 1 0.4523
719 affected. 1 0.4023
719 among 1 0.2347
719 anencephaly 1 0.5024
719 bifida 4 1.6922
719 born 3 1.0091
719 case 1 0.1805
719 case. 1 0.3862
719 cases 5 0.7474
719 central 2 0.5422
719 children 1 0.1784
719 complete 1 0.2331
719 condition. 1 0.3439
719 curred 1 0.5024
719 cystica 4 1.8093
719 families 1 0.3524
719 family 6 1.8167
719 five 1 0.2657
719 follow-up 1 0.3364
719 generations. 1 0.4523
719 genetic 1 0.2631
719 gical 1 0.4523
719 gross 2 0.6728
719 histories 1 0.3731
719 history 1 0.2905
719 hydrocephalus 1 0.2582
719 including 1 0.2711
719 increase 1 0.1706
719 increasing 1 0.2944
719 index 3 0.8954
719 infants 1 0.2399
719 inherited 1 0.4023
719 inquiries 1 0.4523
719 intensive 1 0.3731
719 known 1 0.2454
719 made 1 0.182
719 malfor- 1 0.5024
719 malformation 1 0.3731
719 mation 1 0.5024
719 members 1 0.3364
719 might 1 0.2631
719 more, 1 0.4023
719 mul- 1 0.5024
719 multiple 1 0.277
719 nervous 2 0.6148
719 ob- 1 0.3439
719 oc- 1 0.4523
719 occurred 2 0.4372
719 pedigree, 1 0.5024
719 point 1 0.2905
719 possible 1 0.2015
719 progressive 1 0.2801
719 prospective 1 0.4523
719 recessively 1 0.4523
719 referred 1 0.2985
719 selected 1 0.2944
719 siblings 2 0.7462
719 siblings. 1 0.4523
719 sibships 1 0.5024
719 size. 1 0.3731
719 spina 4 1.6922
719 studied. 1 0.2834
719 sur- 1 0.4023
719 system 1 0.2347
719 system: 1 0.5024
719 tain 1 0.5024
719 three 1 0.1889
719 tiple 1 0.5024
719 treatment 1 0.1482
719 uncomplicated 1 0.4523
719 view. 1 0.5024
719 way 1 0.3176
720 "multiple" 1 0.7536
720 "old" 1 0.7536
720 3 1 0.2569
720 65 1 0.5159
720 addition, 1 0.4358
720 alterations. 1 0.7536
720 apparatus 2 1.1586
720 attributed 1 0.5046
720 changes 1 0.2255
720 compared 1 0.2924
720 complicating 1 0.5793
720 control 1 0.2834
720 cor 1 0.6785
720 cular 1 0.6785
720 described 1 0.2859
720 diagnosis 1 0.3101
720 died 1 0.4416
720 difference 1 0.3773
720 drocephalus 1 0.7536
720 following 1 0.2498
720 found 1 0.1984
720 grounds. 1 0.7536
720 group 1 0.2786
720 high 1 0.2697
720 histologic 2 1.0091
720 hy- 1 0.5286
720 hydrocephalus 1 0.3874
720 hypdrocephalus. 1 0.7536
720 hypertension 2 0.9528
720 incidence 2 0.7196
720 intervals 1 0.4685
720 lesions 2 0.6481
720 lung 1 0.3241
720 material 1 0.3496
720 noted 1 0.3985
720 obtained 1 0.2686
720 operative 1 0.4202
720 patient 1 0.2834
720 patients 1 0.1812
720 placement 2 1.2691
720 postmortem 1 0.5793
720 procedure. 1 0.6346
720 pulmonale 1 0.7536
720 pulmonary 4 1.2888
720 purely 1 0.5793
720 regard 1 0.4303
720 reviewed 1 0.4252
720 sections 1 0.5159
720 shunting 3 1.5477
720 subjects. 1 0.4611
720 suggest 1 0.3426
720 tissue 1 0.2616
720 treatment 1 0.2223
720 various 1 0.2979
720 vas- 1 0.7536
720 vascular 2 0.831
720 ventriculovascular 3 2.2609
720 widespread 1 0.6785
720 years 1 0.3426
721 1 1 0.2277
721 1% 1 0.4827
721 16 1 0.3748
721 17-day-old 1 0.6029
721 18 1 0.3288
721 20 1 0.2723
721 20, 1 0.4827
721 31 1 0.4477
721 33 1 0.4634
721 6, 1 0.4827
721 7, 1 0.4827
721 8 1 0.2723
721 age. 1 0.3401
721 albino 2 0.9655
721 also 1 0.1687
721 animals. 1 0.3401
721 antenatal 1 0.6029
721 aqueduct 1 0.4827
721 aqueductal 3 1.6283
721 aqueducts 1 0.6029
721 bell 1 0.6029
721 bell, 1 0.6029
721 blue 4 1.931
721 blue. 1 0.6029
721 chroma-gesellschaft 2 1.2058
721 cm3 1 0.6029
721 coleman 2 1.2058
721 collected 1 0.4344
721 concluded 1 0.2759
721 conclusively 1 0.5428
721 days 3 0.7185
721 decalcified 1 0.6029
721 decrease 1 0.2759
721 defect 2 0.5938
721 demonstrated 1 0.2578
721 dose 1 0.2878
721 doses. 1 0.6029
721 dye 1 0.6029
721 dyes 1 0.6029
721 effect 1 0.1841
721 embedded 1 0.5076
721 etiology 1 0.3324
721 evident. 1 0.6029
721 examined, 1 0.4477
721 excised 1 0.5428
721 extremely 1 0.4229
721 fetuses 3 1.3032
721 fetuses, 1 0.5076
721 fixed, 1 0.6029
721 frequent 1 0.3633
721 gestation. 1 0.5076
721 highly 1 0.3253
721 hydrocephalic. 1 0.6029
721 hydrocephalics 1 0.6029
721 hydrocephalus 3 0.9296
721 hydrocephalus. 1 0.4037
721 increase 1 0.2048
721 increasing 1 0.3533
721 induced 1 0.2563
721 injected 2 0.5845
721 litter 1 0.5428
721 matheson, 2 1.2058
721 necessary, 1 0.6029
721 neural 1 0.5076
721 newborn 2 0.6575
721 observed 1 0.2055
721 occluded 2 0.9655
721 occlusion 2 0.776
721 occlusion. 1 0.6029
721 paraffin, 1 0.6029
721 predisposing 1 0.5076
721 present 1 0.1985
721 purified 2 0.7622
721 rat 1 0.2481
721 rats 2 0.4656
721 reproductive 1 0.5428
721 sample 1 0.4477
721 sample. 1 0.5076
721 sectioned 2 1.2058
721 sections 1 0.4127
721 serial 1 0.3689
721 serially 1 0.5076
721 showed 1 0.2149
721 similarly. 1 0.6029
721 sixteen-day-old 1 0.6029
721 size. 1 0.4477
721 solution 1 0.3689
721 stained. 1 0.5428
721 stenosis 3 1.1434
721 stenotic 1 0.5076
721 strain 2 0.6376
721 sylvius 1 0.6029
721 tenotic 1 0.6029
721 teratogenic 1 0.6029
721 teratogenic. 1 0.6029
721 teratogenicity 1 0.6029
721 three 1 0.2267
721 treated 2 0.4962
721 trypan 5 3.0145
721 types 1 0.2922
721 used: 1 0.6029
721 wistar 1 0.4827
721 without 1 0.2277
721 yield 1 0.4477
721 young 2 0.6089
722 additional 1 0.5366
722 aqueduct 1 0.8046
722 attributed 1 0.6728
722 autopsy 1 0.6591
722 bilateral 2 1.2111
722 bone. 1 0.7462
722 brane. 1 1.0048
722 case 2 0.722
722 cephalus 1 0.8461
722 children, 1 0.5888
722 choroid 3 2.2385
722 choroidal 1 0.9046
722 conceivably 1 1.0048
722 considering 1 0.7724
722 cure. 1 0.9046
722 cytomegalic 1 0.8046
722 delicate, 1 1.0048
722 diagnosis 2 0.827
722 differential 1 0.6352
722 disease 1 0.361
722 due 1 0.3554
722 early 1 0.3684
722 either 1 0.4296
722 encountered 1 0.6352
722 evident 1 0.6246
722 examination, 1 0.7462
722 existing 1 0.8461
722 factors; 1 0.9046
722 feature 1 0.7048
722 five-and-a-half-year 1 1.0048
722 girl 1 0.6728
722 haversian 1 1.0048
722 here, 1 0.8461
722 hydro- 1 0.7724
722 hydrocephalic 1 0.724
722 hydrocephalus 2 1.0329
722 hypersecretion 1 0.9046
722 inclusion 1 0.6466
722 interesting 1 0.724
722 itself, 1 0.8461
722 level 1 0.388
722 life, 1 0.6728
722 ma, 1 0.8461
722 made 1 0.3639
722 mem- 1 0.9046
722 ment 1 0.6591
722 might 1 0.5262
722 mortem 1 0.9046
722 obstruction 1 0.6352
722 old 1 0.5669
722 papillo- 1 1.0048
722 papilloma 3 2.7139
722 plea 1 0.8461
722 plexus 3 2.5382
722 post 1 0.7048
722 pre- 1 0.6466
722 presence, 1 0.9046
722 rare 1 0.5969
722 regularly 1 0.724
722 result 1 0.4346
722 sented. 1 1.0048
722 suspected 1 0.6728
722 sylvian 1 1.0048
722 tense, 1 1.0048
722 total 1 0.3916
722 toxoplasmosis. 1 1.0048
722 translucent 1 1.0048
722 treat- 1 0.6246
722 tumor 2 0.896
722 two 1 0.3077
722 uncommon 1 0.7724
722 well-formed 1 1.0048
722 within 1 0.373
723 accurate 2 1.2295
723 aid 1 0.724
723 available 1 0.548
723 cerebrospinal 1 0.6056
723 charts 1 0.9046
723 condition 1 0.5366
723 constitute 1 0.8461
723 continues 1 0.7724
723 correction 1 0.7048
723 damage 1 0.5119
723 definitive 1 0.7724
723 detected, 1 0.8461
723 detection 2 1.2492
723 determine 1 0.5669
723 determining 1 0.7724
723 develop 1 0.6056
723 deviation 1 0.7724
723 diagnosis 2 0.827
723 earliest 1 0.7462
723 early 3 1.1051
723 easiest 1 0.9046
723 effective. 1 0.8046
723 enlarging. 1 1.0048
723 evaluating 1 0.8461
723 excessive 1 0.6466
723 fairly 1 0.724
723 fluid 1 0.4762
723 full-term 1 0.9046
723 head 3 1.9773
723 help 1 0.724
723 however, 1 0.3639
723 hydrocephalus 3 1.5494
723 hydrocephalus. 1 0.6728
723 imperative 1 1.0048
723 improved 1 0.6728
723 infant's 1 0.9046
723 infants 1 0.4797
723 insertion 1 0.9046
723 intellectual 1 0.6728
723 irreversible 1 1.0048
723 likely 1 0.5888
723 may 1 0.2513
723 means 1 0.4452
723 measurements 1 0.6466
723 method 1 0.3992
723 methods 1 0.4538
723 neurosurgeon 1 1.0048
723 normal 1 0.2702
723 normal. 1 0.6056
723 offer 1 0.6466
723 operative 1 0.5603
723 physician 1 0.7724
723 plan. 1 1.0048
723 premature 1 0.6879
723 prevent 1 0.6728
723 procedure 2 1.0237
723 serial 1 0.6148
723 shunting 1 0.6879
723 size 1 0.5262
723 spitz-holter 1 1.0048
723 steps 1 0.7462
723 transillumination 1 1.0048
723 treatment 2 0.5929
723 unchecked. 1 1.0048
723 used 1 0.3795
723 valve. 1 0.9046
723 whether 1 0.4989
723 widely 1 0.6728
724 air 1 0.8404
724 arachnoiditis. 1 1.5073
724 basic 1 1.0318
724 case 1 0.5415
724 cause 1 0.6807
724 cerebrospinal-fluid 1 1.5073
724 closed 1 1.1192
724 condition 1 0.805
724 dis- 1 0.9528
724 extracerebral 1 1.5073
724 fossa 2 2.7139
724 give 1 0.8219
724 hematoma 2 2.5382
724 hemorrhage 1 0.97
724 hydrocephalus 2 1.5494
724 infant, 1 1.5073
724 infantile 1 0.8219
724 information 1 0.8133
724 intracerebral 1 1.5073
724 intracranial 2 1.9773
724 lumbar 1 1.1586
724 moval 1 1.5073
724 necessitated 1 1.5073
724 normalized 1 1.5073
724 occluded 1 1.2069
724 ones 1 1.0572
724 passage 1 0.9887
724 pathways 1 1.2691
724 perinatal 1 1.1192
724 period. 1 0.9083
724 permanent 1 1.1586
724 posterior 2 1.7663
724 presented 1 0.5847
724 pressure. 1 1.086
724 raised 1 0.8954
724 re- 1 0.6678
724 relief 1 1.2069
724 shunt. 1 1.1586
724 stage 1 0.7306
724 still 1 0.7041
724 study 1 0.4643
724 surgical 1 0.6807
724 ventriculo-atrial 1 1.2691
724 whereas 1 0.7546
725 4-5 1 0.9046
725 amounts 1 0.4989
725 aqueduct 1 0.8046
725 aqueduct. 1 1.0048
725 c.s.f. 1 0.9046
725 cases 2 0.5979
725 cephalus 2 1.6922
725 communicating 2 1.8093
725 cumulative 1 0.8461
725 determined 1 0.4568
725 dif- 1 0.7462
725 diodrast 1 1.0048
725 easily 1 0.6466
725 effects. 1 0.8046
725 excretion 3 1.4182
725 expansive 1 1.0048
725 fers 1 1.0048
725 first 1 0.3684
725 hours 1 0.4833
725 hydro- 2 1.5448
725 hydrocephalus 1 0.5165
725 i131-diodrast 2 2.0097
725 infantile 1 0.548
725 injected 1 0.4871
725 injecting 1 0.8461
725 injection. 1 0.724
725 intra- 1 0.7048
725 intraventricularly 1 1.0048
725 investigated 1 0.5738
725 investigation 1 0.5669
725 nine 1 0.6879
725 performed 1 0.4598
725 produced 1 0.4092
725 rapid 1 0.4871
725 side 1 0.5669
725 small 1 0.4031
725 stenosis 2 1.2704
725 tracer 1 0.8046
725 urinary 2 0.8904
725 ventricularly. 1 1.0048
726 1,750 1 0.7536
726 25 2 0.8607
726 acute 2 0.7483
726 adults, 1 0.6346
726 ana- 1 0.6785
726 apparent 1 0.3946
726 autopsies. 1 0.7536
726 autopsy. 1 0.7536
726 bacterial 1 0.4416
726 brain 1 0.3839
726 cases, 1 0.3946
726 categories 1 0.5596
726 causative 1 0.6034
726 cause 1 0.3403
726 causes 1 0.4252
726 central 4 1.6265
726 ceration 1 0.7536
726 cerebrovascular 1 0.6346
726 children, 1 0.4416
726 commonest 2 1.2691
726 could 1 0.2708
726 crease 1 0.5046
726 development 1 0.2752
726 devised 1 0.5793
726 drug 1 0.3946
726 drugs 1 0.4155
726 due 2 0.5332
726 etc. 1 0.6346
726 experience 1 0.3874
726 found 2 0.3968
726 freezing 1 0.6785
726 gastroin- 1 0.7536
726 gastrointestinal 2 1.086
726 general 1 0.3839
726 hydrocephalus, 1 0.5286
726 iatrogenic 1 0.6785
726 in- 1 0.3339
726 incidence 2 0.7196
726 including 1 0.4066
726 increased 1 0.2343
726 instances 1 0.5046
726 le- 1 0.5793
726 lesions 3 0.9722
726 lesions. 1 0.5159
726 local 1 0.4542
726 malacias. 1 0.7536
726 measures 1 0.4943
726 meningitis. 1 0.7536
726 mor, 1 0.7536
726 mortality. 1 0.6785
726 needed. 1 0.6346
726 nervous 4 1.8443
726 new 1 0.3299
726 offers 1 0.543
726 pathogenesis 1 0.4252
726 peptic 1 0.7536
726 poliomyelitis, 1 0.6346
726 presented. 1 0.4416
726 promise 1 0.6346
726 real 1 0.6346
726 recent 1 0.3946
726 recently 1 0.5159
726 recognized: 1 0.7536
726 reduction 1 0.3711
726 reflects 1 0.6034
726 responsible 1 0.3805
726 severe 1 0.3339
726 single 1 0.3742
726 sions 1 0.5793
726 surgical 2 0.6807
726 sys- 1 0.6785
726 system 2 0.7041
726 techniques 1 0.411
726 tem 1 0.7536
726 testinal 1 0.7536
726 theories 1 0.5286
726 therapy 1 0.2979
726 therapy. 1 0.4066
726 tomical 1 0.6785
726 tu- 1 0.6346
726 two 1 0.2308
726 ul- 1 0.6785
726 ulceration 4 3.0145
726 upper 1 0.485
726 variety 1 0.4066
727 appear 1 0.3449
727 are, 1 0.6785
727 avian 1 0.6785
727 calmettei 1 0.7536
727 certain 1 0.3319
727 ceylon 2 1.5073
727 ceylon. 1 0.7536
727 crassipes 3 2.2609
727 crassipes. 1 0.7536
727 crithidial 1 0.7536
727 differs 1 0.5159
727 engorged 1 0.7536
727 fact 1 0.3985
727 filarioids, 1 0.7536
727 first 1 0.2763
727 forms 1 0.3598
727 fowl 1 0.7536
727 fowls 3 2.2609
727 fowls. 1 0.7536
727 gallinaceum 2 1.5073
727 gallinarum 1 0.7536
727 host 1 0.3909
727 hosts. 1 0.6785
727 however, 1 0.2729
727 lophurae 3 2.2609
727 m. 3 1.2606
727 mansonia 1 0.6346
727 may, 1 0.7536
727 midgut 1 0.7536
727 mosquito 1 0.7536
727 natural 3 1.3247
727 observations 1 0.3168
727 one 1 0.2108
727 p. 4 2.2385
727 part 1 0.352
727 plasmodia 2 1.5073
727 plasmodium 2 1.357
727 possibly 1 0.4685
727 previously 1 0.3625
727 prove 1 0.6034
727 record 1 0.6346
727 related 1 0.3186
727 reported 1 0.3054
727 seen 1 0.3186
727 species 1 0.411
727 t. 1 0.7536
727 therefore, 1 0.4764
727 trypanosoma 1 0.7536
727 trypanosome 2 1.5073
727 vector 3 1.9037
727 vertebrate 1 0.6785
727 well. 1 0.5596
727 whether 1 0.3742
727 wild-caught 1 0.7536
727 world. 1 0.6785
727 would 1 0.3742
728 3.3-5.0 1 0.6029
728 9.3-13.3 1 0.6029
728 adult 1 0.2741
728 appearance 1 0.2993
728 bancrofti 2 0.9655
728 blood 3 0.5589
728 body 2 0.4861
728 brugia 1 0.5076
728 cats, 1 0.5428
728 cephalic-space 1 0.6029
728 citrate 1 0.4477
728 clinical 1 0.1965
728 confined 1 0.5428
728 daily 1 0.3288
728 damaged 1 0.4827
728 days. 1 0.3401
728 described 1 0.2287
728 diethylcarbamazine 1 0.5076
728 differs 1 0.4127
728 distributed 1 0.5076
728 dogs 1 0.3127
728 doses 1 0.3288
728 elephantiasis 1 0.5428
728 failure 1 0.3253
728 female 1 0.3487
728 filariasis 3 1.2382
728 films: 1 0.6029
728 found 3 0.4762
728 fragments 1 0.4477
728 general 1 0.3071
728 giemsa. 1 0.5428
728 infection 1 0.2836
728 investigation 1 0.3401
728 kgm. 2 1.0856
728 knee. 1 0.6029
728 length, 1 0.5076
728 lesions 1 0.2593
728 limbs 1 0.5428
728 low. 1 0.6029
728 lower 1 0.2741
728 malayi 1 0.5076
728 man 1 0.3099
728 mgm. 2 1.0856
728 microfilaria 4 1.931
728 microfilaria, 1 0.6029
728 microfilariae 1 0.3748
728 mild; 1 0.6029
728 monkeys. 1 0.4827
728 new 2 0.5278
728 nocturnally 1 0.6029
728 nuclei 1 0.3811
728 observations 1 0.2535
728 oedema 1 0.5428
728 one 1 0.1687
728 other, 1 0.4634
728 over-all 1 0.4477
728 per 2 0.47
728 periodic. 1 0.6029
728 peripheral 1 0.3581
728 portuguese 2 1.2058
728 possession 1 0.6029
728 probably 1 0.2741
728 rapidly 1 0.3443
728 rates 1 0.3633
728 ratio, 1 0.5428
728 reaction 1 0.3018
728 recovered. 1 0.4827
728 referred 1 0.3581
728 removed 1 0.3401
728 resembles 1 0.4477
728 results 1 0.1727
728 seven 1 0.3443
728 sheath 1 0.6029
728 showed 1 0.2149
728 species. 1 0.3955
728 stain 1 0.5428
728 staining 1 0.4037
728 still 1 0.2816
728 surveys 1 0.6029
728 terminal 1 0.4344
728 territory 1 0.6029
728 thread, 1 0.6029
728 timor 5 3.0145
728 timor, 1 0.6029
728 timor. 1 0.6029
728 treatment 1 0.1779
728 two 2 0.3693
728 types 1 0.2922
728 unknown. 1 0.4827
728 usually 1 0.2836
728 vectors 1 0.5428
728 w. 1 0.4827
728 weight 2 0.5673
728 widely 1 0.4037
728 worms 1 0.4477
728 wuchereria 1 0.4827
729 (31%) 1 1.0048
729 (filarioidea: 1 1.0048
729 (mc- 1 1.0048
729 (mccoy,1936) 1 1.0048
729 1935, 1 1.0048
729 1936) 1 1.0048
729 1936, 1 1.0048
729 29 1 0.6879
729 42 1 0.7724
729 93 1 0.9046
729 99 1 1.0048
729 additional 1 0.5366
729 adult 2 0.9135
729 albifrons 1 1.0048
729 animals, 1 0.6056
729 apella 1 1.0048
729 areas 1 0.5313
729 blood 1 0.3105
729 c. 2 1.0626
729 capucinus 1 1.0048
729 cebus 1 1.0048
729 colombia, 1 1.0048
729 colombia. 1 1.0048
729 colombian 1 1.0048
729 comb. 2 2.0097
729 complex, 1 0.724
729 connective 1 0.724
729 coy, 1 1.0048
729 described 1 0.3811
729 description 1 0.6591
729 detail. 1 0.724
729 dipetalonema 2 1.6922
729 esophageal 1 0.8461
729 faust, 1 1.0048
729 female, 1 0.7462
729 found 1 0.2645
729 identified 1 0.5888
729 infected 1 0.548
729 male 1 0.5119
729 marmosetae 1 1.0048
729 mccoy, 1 1.0048
729 microfilaria 1 0.8046
729 n. 2 1.8093
729 northern 1 1.0048
729 obtusa 3 3.0145
729 onchocercidae) 1 1.0048
729 peri- 1 0.8461
729 primates, 1 0.9046
729 recovered 1 0.6246
729 resembles 1 0.7462
729 right 1 0.5212
729 saimiri 1 1.0048
729 sciurea 1 1.0048
729 simple. 1 0.9046
729 smaller 1 0.724
729 spicule 1 1.0048
729 tetrapetalonema 1 1.0048
729 tissue 1 0.3488
730 active 2 0.6944
730 alive 1 0.6034
730 alone, 1 0.543
730 although 1 0.2897
730 an- 1 0.6785
730 angle 1 0.7536
730 anterior 4 1.9056
730 aspects 1 0.4252
730 attempt 1 0.4611
730 basis 1 0.3299
730 be- 1 0.4611
730 body, 1 0.6034
730 cally 1 0.6346
730 cells 1 0.2274
730 cercal 1 0.7536
730 chamber 3 1.6788
730 chamber, 1 0.6785
730 chimpanzee 2 1.5073
730 chimpanzee. 1 0.7536
730 chorioretinal 1 0.7536
730 choroid 1 0.5596
730 choroiditis. 1 0.7536
730 ciliary 1 0.6785
730 clini- 1 0.7536
730 com- 1 0.4477
730 conditions 1 0.3426
730 contributed 1 0.543
730 could 3 0.8123
730 dead 1 0.543
730 debris 1 0.7536
730 degeneration 1 0.543
730 demonstrated 2 0.6444
730 derived 1 0.4155
730 died 1 0.4416
730 discussed 1 0.3069
730 docyclitis 1 0.7536
730 effects 2 0.5595
730 experimental 1 0.3496
730 experimentation. 1 0.7536
730 extensive 1 0.4252
730 extracts, 1 0.6785
730 eye 1 0.485
730 eye, 1 0.7536
730 eye. 1 0.7536
730 eyes 1 0.5596
730 filariae. 1 0.7536
730 first 2 0.5526
730 giant 1 0.5046
730 gle 1 0.7536
730 histologic 1 0.5046
730 human 2 0.5031
730 incipient 1 0.7536
730 infiltration 1 0.5793
730 inflammation 1 0.7536
730 injec- 1 0.6785
730 injected 1 0.3653
730 injection 1 0.3151
730 intraocular 1 0.6785
730 intravenous 1 0.4025
730 iri- 1 0.7536
730 iris, 1 0.6785
730 lesion 1 0.4252
730 lesions 2 0.6481
730 limbal 1 0.7536
730 live 2 1.0318
730 made 1 0.2729
730 may 1 0.1885
730 meshwork 1 0.7536
730 micro- 1 0.6034
730 microfilariae 3 1.4054
730 microfilariae, 2 1.357
730 o. 1 0.7536
730 ocular 1 0.5159
730 oncho- 1 0.7536
730 onchocercal 2 1.5073
730 onchocerciasis 1 0.7536
730 onchocercomas, 1 0.7536
730 onset 1 0.4358
730 pannus, 1 0.7536
730 parison, 1 0.7536
730 pathogenesis 1 0.4252
730 penetrate 1 0.6785
730 posterior 1 0.4416
730 present 1 0.2481
730 produce 1 0.4025
730 quiescent. 1 0.7536
730 reproduced. 1 0.7536
730 sections, 1 0.7536
730 segment 1 0.6034
730 sensitization 1 0.5046
730 short 1 0.4358
730 subconjunctival 1 0.7536
730 subcutaneous 1 0.485
730 therefore, 1 0.4764
730 time. 2 1.0572
730 tions 1 0.4477
730 trabecular 1 0.7536
730 tween 1 0.543
730 various 1 0.2979
730 vitreous. 1 0.7536
730 volvulus 1 0.6785
730 within 3 0.8393
730 without 1 0.2846
730 worm 1 0.6346
731 1959. 1 0.9046
731 356 1 1.0048
731 also 1 0.2811
731 b. 2 1.1206
731 bonneae 1 1.0048
731 brugia 1 0.8461
731 brugla. 1 1.0048
731 d. 1 0.6466
731 dirofilaria 2 1.4923
731 examined, 1 0.7462
731 forest. 1 1.0048
731 forests. 1 1.0048
731 found 3 0.7936
731 gested 1 0.9046
731 high 2 0.7192
731 infected 3 1.6439
731 infection 2 0.9455
731 island 1 0.8461
731 larvae 1 0.9046
731 living 2 1.448
731 macaca 1 0.9046
731 macaques 1 1.0048
731 magnilarvatum 2 2.0097
731 magnilarvatum. 1 1.0048
731 malayi 2 1.6922
731 mansonia 1 0.8461
731 may 2 0.5026
731 microfilarial 1 0.8046
731 monkeys 2 1.4096
731 naturally 1 0.7462
731 observations 1 0.4225
731 observed 1 0.3425
731 occurence 1 1.0048
731 one 1 0.2811
731 palawan, 2 2.0097
731 people 2 1.6091
731 periodic 1 0.724
731 periodicity. 1 0.8461
731 philippine 2 2.0097
731 philippinensis 1 1.0048
731 price 1 1.0048
731 price, 1 1.0048
731 rates 2 1.2111
731 reservoirs 2 2.0097
731 serve 2 1.448
731 showed 1 0.3582
731 small 2 0.8062
731 sp. 1 0.9046
731 species 3 1.6439
731 stage 1 0.4871
731 sub- 1 0.6466
731 sub-periodic 2 2.0097
731 sug- 1 0.8461
731 suggest 1 0.4568
731 third 1 0.548
731 three 1 0.3778
731 type 1 0.4179
731 villages 2 2.0097
732 (gorilla 1 0.3768
732 (one 1 0.3768
732 (two 1 0.3768
732 20 2 0.3403
732 4 1 0.1333
732 6 1 0.1576
732 abnormal 1 0.1826
732 accidental 1 0.3768
732 adolescents 1 0.3017
732 africa 1 0.3768
732 also 1 0.1054
732 autoinfection 1 0.3768
732 autopsies 1 0.3768
732 autopsy 1 0.2472
732 balantidiasis 1 0.3768
732 become 1 0.2077
732 belonging 1 0.3392
732 beringei 1 0.3768
732 beringei) 1 0.3768
732 binucleata, 1 0.3768
732 binucleata. 1 0.3768
732 blood 2 0.2329
732 blood. 1 0.2523
732 capture. 1 0.3768
732 caused 1 0.1649
732 cercum, 1 0.3768
732 chimpan- 1 0.3768
732 chimpanzee, 1 0.3768
732 chimpanzees 1 0.3768
732 chimpanzees. 1 0.3768
732 close 1 0.2208
732 common 1 0.1841
732 commonly 1 0.2643
732 communications 1 0.3392
732 congo 4 1.5073
732 consecutive 1 0.2643
732 considered 1 0.168
732 consistently 1 0.2425
732 contact 1 0.2179
732 d. 7 1.6974
732 death 1 0.2055
732 degenera- 1 0.3768
732 dermal 1 0.3392
732 described 2 0.2859
732 described: 1 0.3768
732 detailed 1 0.2382
732 developed 1 0.1713
732 diarrhoea 1 0.3768
732 different 1 0.1333
732 dipetalonema 2 0.6346
732 discovered 3 0.7929
732 eastern 4 1.5073
732 eggs 1 0.2798
732 eleven 1 0.2897
732 else 1 0.3392
732 examined 1 0.1903
732 examined, 1 0.2798
732 examined. 1 0.258
732 existence 1 0.2305
732 far 1 0.2425
732 fatty 1 0.1887
732 females), 2 0.7536
732 fifty 1 0.2715
732 filarial 3 0.9051
732 first 1 0.1381
732 found 4 0.3968
732 four 2 0.3381
732 full-grown 1 0.3768
732 genus 1 0.3392
732 gorilla 6 2.2609
732 gorilla, 1 0.3768
732 gorilla. 1 0.3768
732 gorillae 2 0.7536
732 gorillae, 1 0.3768
732 gorillae. 1 0.3768
732 gorillas 8 3.0145
732 gorillas. 1 0.3768
732 host 1 0.1955
732 however 1 0.2715
732 identified 1 0.2208
732 including 1 0.2033
732 infection 1 0.1773
732 intensive 1 0.2798
732 intestinal 1 0.2715
732 kivu 1 0.3768
732 known 2 0.3682
732 later 1 0.1937
732 layers 1 0.3768
732 leopoldi, 2 0.7536
732 liminary 1 0.3768
732 liver. 1 0.2643
732 loa 4 1.357
732 male 1 0.1919
732 males 1 0.258
732 man 2 0.3874
732 man. 1 0.2425
732 many 1 0.1519
732 mentioning 1 0.3768
732 microfilaria 2 0.6034
732 microfilariae 2 0.4685
732 might 2 0.3946
732 months. 1 0.2523
732 mountain 1 0.3173
732 n.subsp. 1 0.3768
732 namely 2 0.6034
732 never 1 0.2472
732 nine 1 0.258
732 oesophagostomum 2 0.7536
732 oligotrichida 1 0.3768
732 onchocerca 3 1.1304
732 one 2 0.2108
732 original 1 0.2152
732 others 1 0.2055
732 parasites 4 1.2691
732 performed. 1 0.3173
732 picture 1 0.2055
732 plasmodium 1 0.3392
732 pre- 1 0.2425
732 present 1 0.1241
732 previously 2 0.3625
732 primates, 1 0.3392
732 protozoa 1 0.3768
732 province. 1 0.3768
732 published 1 0.2523
732 reservoir 1 0.3173
732 resulting 1 0.1919
732 revealed 1 0.1826
732 seven 1 0.2152
732 several 2 0.326
732 severe 1 0.167
732 six 1 0.2077
732 skin. 2 0.6346
732 species 1 0.2055
732 species, 1 0.2798
732 stephanostomum 2 0.7536
732 stools 1 0.3173
732 strepto- 1 0.3768
732 streptocercum 1 0.3768
732 streptocercum, 1 0.3768
732 study 1 0.1161
732 survey 1 0.2643
732 ten 1 0.2271
732 three 3 0.425
732 tion 1 0.1713
732 tract. 1 0.2897
732 troglodytella 1 0.3768
732 two 3 0.3462
732 undertaken 1 0.3017
732 vanhoofi 1 0.3768
732 vanhoofi, 1 0.3768
732 vectors 1 0.3392
732 volvulus 2 0.6785
732 volvulus. 1 0.3768
732 weeks 1 0.1973
732 west 1 0.3768
732 worms 1 0.2798
732 young 3 0.5708
732 zee, 1 0.3768
733 (86.8 1 0.274
733 (95.5 1 0.274
733 (all 1 0.2194
733 (each 1 0.274
733 0.12. 1 0.274
733 0.48 1 0.274
733 0.6 1 0.274
733 1,023). 1 0.274
733 2.2 2 0.5481
733 20 2 0.2475
733 21.1 2 0.5481
733 25 1 0.1565
733 26.1 1 0.274
733 4,136 1 0.274
733 4,557 1 0.274
733 4.8 1 0.2467
733 5 1 0.1039
733 5.3 1 0.274
733 52 1 0.2107
733 568 1 0.274
733 8.5 1 0.2307
733 8.6 1 0.274
733 977 1 0.274
733 98 1 0.274
733 administered 1 0.1308
733 also 1 0.0767
733 another; 1 0.274
733 b. 3 0.4584
733 bangkok 1 0.2467
733 blood 4 0.3387
733 body 1 0.1105
733 brugia 1 0.2307
733 c.mm. 1 0.274
733 c.mm.) 1 0.274
733 carried 1 0.1372
733 case 1 0.0985
733 cats, 1 0.2467
733 caught 1 0.274
733 caught. 1 0.274
733 cent. 8 1.6853
733 cent., 1 0.274
733 cessation 1 0.2307
733 citrate 1 0.2035
733 considerable 1 0.1422
733 control 1 0.103
733 ddt 1 0.274
733 decline 1 0.1922
733 decreased 1 0.1238
733 density 1 0.1798
733 diethylcarbamazine 1 0.2307
733 dissected 1 0.274
733 dissections, 1 0.274
733 district 1 0.274
733 dogs 1 0.1422
733 dose 1 0.1308
733 drug 1 0.1435
733 drug. 1 0.2467
733 eight 1 0.1565
733 eighty-eight 1 0.274
733 elephantiasis 1 0.2467
733 established 1 0.1479
733 every 1 0.1528
733 examinations 1 0.1876
733 examined 1 0.1384
733 examined, 1 0.2035
733 examined. 1 0.1876
733 field 1 0.1628
733 filariasis 3 0.5628
733 films 3 0.8221
733 found 6 0.4329
733 giemsa. 1 0.2467
733 harboured 1 0.274
733 houses 1 0.274
733 hundred 1 0.2107
733 identified. 1 0.274
733 ii 1 0.1835
733 iii 1 0.2107
733 infection 2 0.2579
733 initial 1 0.1328
733 investigation. 1 0.2307
733 kanjanadit 1 0.274
733 kgm. 1 0.2467
733 larvae 3 0.7402
733 last 1 0.1835
733 m. 2 0.3056
733 malayi 3 0.6922
733 malayi). 1 0.274
733 mansonia 2 0.4615
733 many 1 0.1105
733 markedly 1 0.1464
733 mass 1 0.2035
733 mean 1 0.1318
733 medicine, 1 0.274
733 mgm. 1 0.2467
733 microfilaria-carriers 1 0.274
733 microfilaria-carriers. 1 0.274
733 microfilariae 1 0.1703
733 microfilarial 2 0.4389
733 monkeys 1 0.1922
733 month 2 0.367
733 mosquitoes 4 1.0962
733 nearly 1 0.1677
733 nocturnal. 1 0.274
733 numbers 1 0.1628
733 observed 1 0.0934
733 one 5 0.3833
733 people 1 0.2194
733 per 11 1.1749
733 percentage 1 0.1528
733 periodicity 1 0.1974
733 person 1 0.2035
733 persons 2 0.3465
733 persons; 1 0.274
733 phase 1 0.1464
733 pilot 1 0.2194
733 population 1 0.1764
733 population). 1 0.274
733 population. 1 0.2307
733 possible, 1 0.2307
733 prepared 1 0.1652
733 project 1 0.2467
733 proportion 1 0.1703
733 province, 1 0.2467
733 rate 2 0.2018
733 received 1 0.1546
733 recovered. 1 0.2194
733 repeated 1 0.1628
733 respectively, 1 0.1974
733 resulted 1 0.1328
733 salt 1 0.1764
733 school 1 0.2035
733 side-effects 1 0.2307
733 six 1 0.1511
733 slight 1 0.1628
733 south 1 0.274
733 spp. 1 0.274
733 spraying 1 0.2467
733 stage 2 0.2657
733 stained 1 0.2194
733 station 1 0.274
733 studied 1 0.0955
733 studies 1 0.0839
733 surat-thani 1 0.274
733 survey, 1 0.274
733 thailand 1 0.274
733 thailand, 1 0.274
733 therapy. 1 0.1479
733 thick 1 0.2307
733 total 1 0.1068
733 tropical 1 0.274
733 two 2 0.1678
733 uniformis 2 0.5481
733 village 1 0.274
733 villagers 1 0.274
733 weekly 1 0.2194
733 weeks. 1 0.2194
733 weight 1 0.1289
733 year 2 0.2843
734 (bombe 1 0.7536
734 (duke 1 0.7536
734 (mandrillus 1 0.7536
734 1958). 1 0.7536
734 abundantly 1 0.6785
734 according 1 0.4066
734 adult 1 0.3426
734 also 1 0.2108
734 among 1 0.352
734 anthropophilic 1 0.7536
734 apparently 1 0.411
734 c. 3 1.1955
734 cameroons 1 0.7536
734 canopy-dwelling 1 0.7536
734 centurionis. 1 0.7536
734 characteristics 1 0.4202
734 characterized 1 0.3985
734 chrysops 1 0.7536
734 complex 1 0.4358
734 contrasting 1 0.6785
734 crepuscular 1 0.7536
734 cross-mating 1 0.7536
734 day-biting 1 0.7536
734 decided 1 0.6034
734 describes 1 0.5159
734 dimidiata 1 0.7536
734 diurnal 1 0.7536
734 diurnally 1 0.7536
734 done, 1 0.6785
734 drill 1 0.7536
734 drill, 1 0.7536
734 drills, 1 0.7536
734 evolving 1 0.7536
734 exist 1 0.5159
734 experimentally 1 0.5286
734 form). 1 0.7536
734 found 1 0.1984
734 host 1 0.3909
734 host-vector 1 0.7536
734 human 2 0.5031
734 hybrid 1 0.5793
734 hybridization 1 0.7536
734 hybrids. 1 0.6785
734 interbreeding, 1 0.7536
734 iv.--experimental 1 0.7536
734 langi 1 0.7536
734 large 1 0.2979
734 leucophaeus), 1 0.7536
734 loa 1 0.6785
734 loa, 1 0.7536
734 loiasis 1 0.7536
734 maintain 1 0.5596
734 maintained 1 0.4202
734 mendelian 1 0.7536
734 methods 1 0.3403
734 microfilariae 3 1.4054
734 monkey 1 0.5046
734 monkeys. 1 0.6034
734 natural 2 0.8832
734 nocturnal 1 0.6346
734 paper 1 0.4066
734 parasite 2 1.2691
734 parasites 1 0.6346
734 parasites, 1 0.7536
734 pattern 1 0.3598
734 periodic 1 0.543
734 periodicity 2 1.086
734 periodicity. 2 1.2691
734 population 1 0.485
734 present 1 0.2481
734 produce 1 0.4025
734 rain-forest 1 0.7536
734 records 1 0.5286
734 regards 1 0.6346
734 segregate 1 0.7536
734 silacea 1 0.7536
734 simian 2 1.1586
734 simple 1 0.411
734 size 2 0.7893
734 size. 1 0.5596
734 small 1 0.3023
734 somatic 3 1.7379
734 strains 4 1.7907
734 studies 1 0.2308
734 suggests 1 0.4025
734 that, 1 0.4943
734 transmitted 3 1.8103
734 try 1 0.6346
734 two 3 0.6924
734 wijers, 1 0.7536
734 worms 1 0.5596
735 1c 1 1.0048
735 24 1 0.5212
735 38 1 0.6879
735 4 1 0.3554
735 animal-derived 1 1.0048
735 anopheles 2 1.8093
735 bandrode 1 1.0048
735 blood 1 0.3105
735 capable 1 0.6148
735 containing 1 0.5313
735 developing 1 0.5422
735 development 1 0.3669
735 dirofilaria 2 1.4923
735 exposure 1 0.5969
735 fed 1 0.6591
735 freezing 1 0.9046
735 frozen 1 1.0048
735 head 1 0.6591
735 hr 1 0.5811
735 immitis 2 1.5448
735 infective 1 0.724
735 labium 1 1.0048
735 laboratory-reared 1 1.0048
735 larval 1 0.9046
735 maculatus 1 1.0048
735 membrane 1 0.5422
735 microfilariae 3 1.8738
735 migrating 1 0.8461
735 months, 1 0.7724
735 mosquito. 1 1.0048
735 periods 1 0.5603
735 quadri- 1 1.0048
735 quadrimaculatus. 1 1.0048
735 ranging 1 0.6879
735 samples 1 0.6352
735 stage 1 0.4871
735 stored 1 0.9046
735 temperature 1 0.5366
735 thawed 1 1.0048
735 third 1 0.548
736 24 1 0.2606
736 accumulation 2 0.7048
736 advances 2 0.8461
736 apparently 2 0.548
736 arterioles. 1 0.5024
736 best 1 0.2657
736 biological 1 0.2683
736 blood 1 0.1552
736 body 1 0.2026
736 capillaries 1 0.4023
736 chloroquine 1 0.5024
736 cinematography. 1 0.5024
736 circadian 2 0.8046
736 compound 1 0.3439
736 concerning 1 0.3123
736 considered 1 0.224
736 containing 1 0.2657
736 continued 1 0.2905
736 control 1 0.1889
736 cooking 1 0.5024
736 cyclical 1 0.5024
736 diethylcarbamazine--e.g. 1 0.5024
736 disappearance 1 0.3296
736 done 1 0.3364
736 due 1 0.1777
736 edesonfilaria 1 0.423
736 effective 1 0.2515
736 entrained 1 0.4523
736 especially 1 0.2582
736 every 1 0.2801
736 experiments 1 0.2226
736 facilitate 1 0.5024
736 filariasis 4 1.3758
736 furthermore, 1 0.3731
736 given 1 0.1842
736 host 1 0.2606
736 host. 1 0.4023
736 hours. 1 0.362
736 incorporation 1 0.3176
736 investigations 1 0.3123
736 judging 1 0.4523
736 knowledge 1 0.3296
736 large 1 0.1986
736 lungs 1 0.274
736 lungs, 1 0.3862
736 malaria. 1 0.5024
736 malayensis, 1 0.4523
736 means 1 0.2226
736 mechanical 1 0.362
736 methods 1 0.2269
736 microfilariae 6 1.8738
736 migrate 1 0.4523
736 monkeys 1 0.3524
736 movements 1 0.3731
736 network 1 0.4523
736 occurs 1 0.2683
736 order 1 0.2631
736 past 1 0.3524
736 people 1 0.4023
736 perhaps 1 0.277
736 periodicity 2 0.724
736 peripheral 1 0.2985
736 populations, 1 0.5024
736 pre-capillary 1 0.5024
736 protect 1 0.3731
736 pulmonary 1 0.2148
736 retention, 1 0.3862
736 review 1 0.277
736 rhythm 2 0.724
736 rhythm. 1 0.4523
736 rhythmic 1 0.4523
736 round 2 1.0048
736 salt, 1 0.5024
736 schools. 1 0.5024
736 seems 1 0.2657
736 steps 1 0.3731
736 stimuli 2 0.724
736 studied 1 0.175
736 synchronized 1 0.5024
736 systematic 1 0.423
736 taken 1 0.2834
736 temperature 1 0.2683
736 ten 1 0.3028
736 treatment 1 0.1482
736 understand 1 0.423
736 urged 1 0.5024
736 variation 1 0.3176
736 years. 1 0.3176
736 young 1 0.2537
737 (dissanaike 1 1.0048
737 1963); 1 1.0048
737 animals. 1 0.5669
737 attempts 2 1.2933
737 bancrofti 3 2.4137
737 cats 3 2.7139
737 describes 1 0.6879
737 details 1 0.6879
737 development 1 0.3669
737 development. 1 0.6879
737 domestic 1 0.8461
737 experimental 2 0.9322
737 finding 1 0.6148
737 gives 1 0.724
737 infective 1 0.724
737 larva 1 1.0048
737 larva. 1 1.0048
737 larval 1 0.9046
737 monkey 2 1.3455
737 niles, 1 1.0048
737 note 1 0.8046
737 one 1 0.2811
737 paper 1 0.5422
737 periodic 1 0.724
737 preliminary 1 0.5738
737 present 1 0.3308
737 records 1 0.7048
737 recovered 1 0.6246
737 reported 1 0.4072
737 toque 2 2.0097
737 transmit 2 1.8093
737 undergone 1 0.8046
737 w. 1 0.8046
737 wuchereria 2 1.6091
738 "effective 1 0.7536
738 (but 1 0.7536
738 almost 1 0.3874
738 artificial 2 1.0091
738 blood 2 0.4657
738 body 4 1.2153
738 caused 2 0.6597
738 circadian 4 2.4137
738 contained 1 0.3839
738 count 1 0.5159
738 cycle 1 0.6034
738 cycle. 1 0.6346
738 daytime 1 0.7536
738 e. 1 0.5159
738 edesonfilaria 1 0.6346
738 entrained 1 0.6785
738 fall 1 0.3946
738 followed 1 0.3449
738 forward 1 0.6034
738 hypothesis 1 0.4025
738 i.e. 1 0.5793
738 inversion 2 1.357
738 lowering 1 0.543
738 malayensis 1 0.6785
738 malayensis, 1 0.6785
738 microfilaria 1 0.6034
738 microfilariae 4 1.8738
738 microfilariae. 1 0.6034
738 microfilarial 2 1.2069
738 monkeys 2 1.0572
738 night 1 0.6346
738 nocturnal 1 0.6346
738 normal 1 0.2027
738 periodicity 1 0.543
738 periodicity. 1 0.6346
738 probably 1 0.3426
738 provides 1 0.4764
738 put 1 0.6346
738 raising 1 0.543
738 relation 1 0.3472
738 respond. 1 0.7536
738 rhythm 3 1.629
738 rhythm. 1 0.6785
738 rise; 1 0.7536
738 species) 1 0.7536
738 stimuli" 1 0.7536
738 temperature 4 1.6099
738 temperature, 1 0.5793
738 thus 1 0.3909
738 used 1 0.2846
738 whose 1 0.4416
738 x. 1 0.7536
738 zero, 1 0.7536
739 (edesonfilaria) 1 0.7536
739 (yeh, 1 0.7536
739 1960) 1 0.7536
739 analyse 1 0.7536
739 another 1 0.411
739 attempt 1 0.4611
739 circadian 3 1.8103
739 different 1 0.2666
739 edesonfilaria 1 0.6346
739 experiments 2 0.6678
739 host 2 0.7819
739 importance 1 0.3839
739 inherent 1 0.7536
739 ix. 1 0.7536
739 known 1 0.3682
739 macaca 1 0.6785
739 malayensis 1 0.6785
739 microfilariae 4 1.8738
739 migrations. 1 0.7536
739 monkey 1 0.5046
739 monkeys 1 0.5286
739 one 1 0.2108
739 paper 1 0.4066
739 performed 1 0.3449
739 periodic 1 0.543
739 periodicity 1 0.543
739 phase 3 1.2074
739 present 1 0.2481
739 production 1 0.3839
739 relative 1 0.3909
739 reports 1 0.485
739 rhythm 2 1.086
739 rhythm, 1 0.6346
739 rhythms 1 0.6346
739 thailand. 1 0.7536
739 transfused 1 0.5596
739 transfusion 1 0.5793
739 well 1 0.2636
740 "guarded" 1 0.5024
740 "hepatic" 1 0.5024
740 "pessimistic" 1 0.5024
740 (100 1 0.5024
740 (as 1 0.3731
740 1/4 1 0.4523
740 10 1 0.1849
740 11 2 0.5366
740 1965) 1 0.5024
740 8 1 0.2269
740 86 2 0.8046
740 able 1 0.2834
740 age 1 0.2078
740 although 1 0.1931
740 among 1 0.2347
740 artificial 2 0.6728
740 atresia 3 0.9221
740 atresia. 2 0.7048
740 avoid 1 0.3731
740 babies 1 0.4023
740 babies. 1 0.4523
740 bile 3 1.0572
740 biliary 6 1.7907
740 correlations 1 0.362
740 ducts 2 0.724
740 ducts, 1 0.4523
740 ductule 1 0.5024
740 exists 1 0.362
740 extrahepatic 1 0.3364
740 factors 1 0.2124
740 fibrosis, 1 0.3862
740 found 1 0.1323
740 gallbladder 4 2.0097
740 good 1 0.2801
740 hepatic 2 0.5669
740 identified 1 0.2944
740 identified, 1 0.4523
740 infants 3 0.7196
740 infants. 1 0.3439
740 long-term 2 0.5811
740 maximal 1 0.3123
740 may 2 0.2513
740 minimal 1 0.3123
740 months) 1 0.4023
740 morphology 1 0.3074
740 nosis 1 0.4523
740 noted. 1 0.3364
740 observation 1 0.2631
740 occurrence 1 0.2985
740 october 1 0.4523
740 opportunity 1 0.423
740 overcome 1 0.3862
740 pattern 1 0.2399
740 pedicle. 1 0.5024
740 presence 2 0.3828
740 present 1 0.1654
740 prog- 1 0.5024
740 prognosis 1 0.277
740 prognostic 1 0.3731
740 proliferations 1 0.5024
740 prolonged 1 0.2417
740 provide 1 0.2944
740 rather 1 0.2364
740 significance 1 0.274
740 specific 1 0.1977
740 suggestive 1 0.3731
740 suggests 1 0.2683
740 surgeon 1 0.4023
740 survival 1 0.2417
740 survivals 1 0.4523
740 survivors 1 0.362
740 suspected 1 0.3364
740 tract 1 0.2905
740 tragic 1 0.5024
740 trauma 1 0.3862
740 use 2 0.3972
740 years 1 0.2284
740 yet 1 0.2657
741 (29.6%). 1 0.5024
741 18 1 0.274
741 27 1 0.3364
741 8% 1 0.423
741 additional 1 0.2683
741 advanced 1 0.2606
741 alive 1 0.4023
741 angeles 1 0.5024
741 atresia 4 1.2295
741 biliary 6 1.7907
741 cali- 1 0.5024
741 cirrhosis 1 0.3524
741 concepts 1 0.3731
741 congenital 2 0.4598
741 corrective 1 0.4023
741 cure 1 0.3862
741 current 2 0.6246
741 decompression 2 0.7462
741 described 1 0.1906
741 develops. 1 0.4523
741 diagnosis 1 0.2067
741 early 1 0.1842
741 eight 1 0.2869
741 enteric 1 0.4523
741 extrahepatic 1 0.3364
741 figures 1 0.3862
741 five 1 0.2657
741 fornia, 1 0.5024
741 gery 1 0.5024
741 hepatic 1 0.2834
741 higher 1 0.216
741 im- 1 0.362
741 los 1 0.4523
741 lymphaticojejunostomy. 1 0.5024
741 management 2 0.5313
741 may 1 0.1257
741 means 1 0.2226
741 order 1 0.2631
741 patients 1 0.1208
741 patients, 1 0.2515
741 perative 1 0.4523
741 performed 2 0.4598
741 presently 1 0.4023
741 previously 1 0.2417
741 rate 1 0.1849
741 recently. 1 0.5024
741 reported. 1 0.2905
741 reviewed. 1 0.3524
741 sur- 1 0.4023
741 underwent 1 0.362
741 university 1 0.423
742 1/2 2 2.4137
742 1960 2 2.7139
742 2 1 0.4602
742 8 1 0.6807
742 age 1 0.6235
742 age, 1 0.9887
742 almost 1 0.7747
742 always 1 0.805
742 and, 1 0.7819
742 atresia 2 1.8443
742 attained 1 1.1192
742 becomes 1 0.9083
742 bile 1 1.0572
742 biliary 1 0.8954
742 congenital 2 1.3794
742 course 2 1.3703
742 developing 1 0.8133
742 ducts 1 1.086
742 exception 1 0.9887
742 extra- 1 1.5073
742 extrahepatic 1 1.0091
742 fatal, 1 1.5073
742 free 2 1.4285
742 good 2 1.6808
742 health 1 1.0572
742 health, 1 1.5073
742 hepatic 1 0.8503
742 history 1 0.8716
742 infant 1 0.8503
742 interest. 2 2.5382
742 jaundice, 1 1.2691
742 jaundice. 1 1.1586
742 mally 1 1.357
742 nor- 1 0.97
742 one 1 0.4217
742 opera- 2 2.3172
742 remarkable 1 1.086
742 reported 1 0.6107
742 since 2 1.3116
742 still 1 0.7041
742 three 1 0.5667
742 tions, 2 2.7139
742 tract 1 0.8716
742 two 1 0.4616
742 years 2 1.3703
743 "hallervorden-spatz 1 0.6029
743 8 1 0.2723
743 aging 1 0.4634
743 also 1 0.1687
743 astrocytic 1 0.6029
743 atresia 2 0.7377
743 atresia. 1 0.4229
743 axonal 2 1.2058
743 bears 1 0.6029
743 biliary 3 1.0744
743 cells 1 0.182
743 central 1 0.3253
743 change 1 0.2797
743 changes 1 0.1804
743 characteristic 1 0.3044
743 conditions 1 0.2741
743 congenital 3 0.8276
743 cuneate 1 0.6029
743 deficiency. 1 0.4229
743 degree 1 0.2671
743 described 1 0.2287
743 disease". 1 0.6029
743 diseases, 1 0.5076
743 diverse 1 0.4827
743 dystrophy 5 2.7139
743 dystrophy, 1 0.6029
743 e 1 0.4634
743 e-deficient 1 0.5428
743 encountered 1 0.3811
743 experimental 1 0.2797
743 forms 1 0.2878
743 gracile, 1 0.6029
743 group 1 0.2229
743 heredo-degenerative 1 0.6029
743 include 1 0.3581
743 investigation 1 0.3401
743 loss 1 0.2922
743 mainly 1 0.3955
743 manifestation 1 0.4229
743 medulla, 1 0.5076
743 metabolic 1 0.2878
743 mild 1 0.3955
743 mucoviscidosis 1 0.6029
743 nerve 2 0.8073
743 nervous 1 0.3689
743 neuroaxonal 5 3.0145
743 nuclei 1 0.3811
743 parts 1 0.4127
743 pathological 1 0.3253
743 patients 5 0.7246
743 possible 1 0.2419
743 prolonged 2 0.58
743 rarely 1 0.4229
743 rats. 1 0.3157
743 reaction, 1 0.5076
743 relationship 1 0.29
743 remarkably 1 0.4827
743 resemblance 1 0.5076
743 seen 1 0.2549
743 similar 2 0.4514
743 similarity 1 0.4634
743 strongly 1 0.388
743 suggested 1 0.2507
743 system. 1 0.4229
743 them. 1 0.4344
743 trigeminal 1 0.6029
743 variable 1 0.3633
743 various 1 0.2383
743 vitamin 2 0.7377
743 warrants 1 0.6029
744 10 1 0.3699
744 14 1 0.554
744 35 1 0.7724
744 5 1 0.3811
744 although 1 0.3863
744 atresia 2 1.2295
744 atresia: 1 1.0048
744 authors 1 0.4629
744 babies, 1 1.0048
744 baby, 1 1.0048
744 biliary 3 1.7907
744 biopsy 1 0.6466
744 biopsy, 1 0.8461
744 cases 1 0.299
744 cases, 1 0.5262
744 claimed 1 1.0048
744 comments 1 0.8461
744 concluded 1 0.4598
744 confirmation 1 0.9046
744 correctable 1 0.8461
744 cures. 1 1.0048
744 detected 1 0.5212
744 diagnosis 1 0.4135
744 discovered 1 0.7048
744 discussed 1 0.4092
744 discussed. 1 0.4296
744 encountered. 1 0.9046
744 extrahepatic 2 1.3455
744 findings 1 0.3992
744 forms 1 0.4797
744 frequency 2 1.0524
744 including 1 0.5422
744 infants 1 0.4797
744 known. 1 0.8046
744 laparotomy 1 1.0048
744 lesion 1 0.5669
744 lesions 1 0.4321
744 literature 1 0.548
744 liver 2 0.7907
744 many 1 0.4051
744 necropsies 1 1.0048
744 necropsy 1 0.724
744 neglected 1 1.0048
744 one 1 0.2811
744 operable 3 3.0145
744 operative 1 0.5603
744 performed. 1 0.8461
744 period, 1 0.6728
744 potentially 3 2.2385
744 really 1 0.9046
744 revealed 1 0.4871
744 review 1 0.554
744 subjected 1 0.548
744 surgery 1 0.4989
744 surgical 1 0.4538
744 twenty-eight 1 0.9046
744 year 1 0.5212
745 3 1 0.2569
745 administered 1 0.3598
745 albumin. 1 0.7536
745 assumed 1 0.5159
745 atresia 1 0.4611
745 atresia. 2 1.0572
745 bili- 2 1.5073
745 biliary 3 1.3431
745 bilirubin 4 2.0183
745 breakdown, 1 0.6785
745 c14-labeled 1 0.7536
745 calculated 1 0.5046
745 cells. 1 0.336
745 cent 1 0.3874
745 children 3 0.8028
745 confirmed 1 0.4416
745 cr51-tagged 1 0.7536
745 daily 2 0.8219
745 days 1 0.2994
745 distribution 2 0.7747
745 due 1 0.2666
745 excretion 1 0.3546
745 extravascular 1 0.7536
745 form 1 0.3279
745 forms 1 0.3598
745 found 1 0.1984
745 fourteen 1 0.6034
745 g. 1 0.5596
745 greater 1 0.3118
745 half-life 1 0.6346
745 hemoglobin 1 0.5793
745 increased 1 0.2343
745 injected 1 0.3653
745 intra- 1 0.5286
745 intravenously 1 0.5286
745 isotope 1 0.6034
745 jaundice, 1 0.6346
745 judson 1 0.7536
745 label 1 0.6034
745 may 1 0.1885
745 metabolism 1 0.3571
745 normal 1 0.2027
745 not, 1 0.5046
745 observed 1 0.2569
745 per 1 0.2937
745 period 1 0.2859
745 principally 2 1.2069
745 production 1 0.3839
745 prognostic 1 0.5596
745 radioactive 2 0.9369
745 radioisotope 1 0.5596
745 randolph 1 0.7536
745 recovered 1 0.4685
745 red 1 0.4477
745 rubin. 2 1.5073
745 serum 1 0.2924
745 several 1 0.326
745 sixty 1 0.6785
745 studies 1 0.2308
745 survival 1 0.3625
745 ten 1 0.4542
745 times 1 0.3625
745 turnover 1 0.5046
745 urine 1 0.3874
745 urine. 1 0.5793
745 useful 1 0.4155
745 value 1 0.3472
745 venously 1 0.7536
746 (1,2), 1 0.7536
746 (3,4). 1 0.7536
746 (fig.1). 1 0.7536
746 (g6p 1 0.7536
746 (gk) 1 0.7536
746 (hk) 1 0.7536
746 activity 3 0.8091
746 adult 2 0.6851
746 adulthood 1 0.7536
746 alloxan 1 0.5793
746 although 1 0.2897
746 and, 1 0.3909
746 animals 1 0.3204
746 approaching 1 0.6785
746 central 1 0.4066
746 changes 1 0.2255
746 decreases 1 0.485
746 dehydrogenase 1 0.5793
746 development 1 0.2752
746 development. 1 0.5159
746 dh) 1 0.7536
746 diabetic 1 0.5046
746 embryonal 3 2.2609
746 embryonic 2 0.9528
746 enzyme 1 0.4477
746 fraction 2 0.805
746 gk 1 0.7536
746 glucokinase 1 0.7536
746 glucose-6-phosphate 1 0.6785
746 gradually 1 0.4764
746 half 1 0.4416
746 hexokinase 1 0.7536
746 higher 1 0.3241
746 incretion 1 0.7536
746 induce 1 0.5046
746 insulin, 1 0.543
746 known 1 0.3682
746 lacks 1 0.7536
746 liver 4 1.186
746 mammalian 1 0.5159
746 mitochondria 1 0.5159
746 much 1 0.3339
746 non-specific 1 0.5793
746 occurs 1 0.4025
746 particularly, 1 0.6785
746 period, 1 0.5046
746 postnatally 1 0.6785
746 prenatal 1 0.6785
746 quite 1 0.4303
746 rabbit; 1 0.7536
746 regulation 1 0.5596
746 second 1 0.3839
746 similar 1 0.2821
746 soluble 2 0.8954
746 specific 1 0.2965
746 subject 1 0.485
746 synthesis 2 0.7483
746 tissues 1 0.3449
746 values 1 0.3805
747 accordingly, 1 0.6785
747 acid 1 0.291
747 activity 1 0.2697
747 activity. 1 0.5159
747 adult 1 0.3426
747 alterations 1 0.4155
747 although 1 0.2897
747 amphibian1-5 1 0.7536
747 associated 1 0.2676
747 avian6,7 1 0.7536
747 biosynthesis 1 0.5596
747 certain 1 0.3319
747 changes 1 0.2255
747 concerns 1 0.6346
747 considerable 1 0.3909
747 construction 1 0.7536
747 derepression 1 0.7536
747 development 4 1.1006
747 differentiation. 1 0.6785
747 effort 1 0.5596
747 embryonic 2 0.9528
747 enzyme. 1 0.5596
747 enzymes 1 0.4764
747 events 1 0.5596
747 exists 1 0.543
747 expended 1 0.7536
747 finished 1 0.7536
747 fluctuations 1 0.6034
747 genome 1 0.6034
747 hepatic 2 0.8503
747 information 1 0.4066
747 investigation 1 0.4252
747 involvement 1 0.4943
747 literature 1 0.411
747 liver 2 0.593
747 liver. 1 0.5286
747 mammalian 2 1.0318
747 many 1 0.3038
747 marked 1 0.3381
747 may 1 0.1885
747 metabolism 1 0.3571
747 molecule 1 0.5286
747 nuclear 1 0.4358
747 nuclei 1 0.4764
747 occur 1 0.3682
747 paucity 1 0.7536
747 prompted 1 0.6346
747 properties 1 0.4025
747 protein 1 0.3426
747 qualitative 1 0.5793
747 quantitative 1 0.3985
747 rat 1 0.3101
747 regard 1 0.4303
747 related 1 0.3186
747 report 1 0.3653
747 repression 1 0.6785
747 ribonuclease 2 1.5073
747 ribonucleic 1 0.5286
747 rna 2 0.831
747 sea 1 0.7536
747 specialized 1 0.7536
747 stage. 1 0.6346
747 study 1 0.2322
747 subcellular 1 0.6034
747 systems, 1 0.7536
747 transcription 1 0.6346
747 undergoes 1 0.7536
747 undertaken. 1 0.7536
747 urchin8-11, 1 0.7536
747 well 1 0.2636
748 24 1 0.3909
748 absorption, 1 0.6034
748 acquired 1 0.4685
748 addition 1 0.3839
748 adult 3 1.0277
748 after. 1 0.7536
748 allow 1 0.5286
748 apical 1 0.6346
748 apocrine 1 0.7536
748 associated 1 0.2676
748 band. 1 0.7536
748 basal 1 0.4943
748 believed 1 0.5596
748 birth 3 1.1517
748 bladder 2 1.2069
748 bullae. 1 0.7536
748 cell 4 1.0202
748 cell. 1 0.5286
748 cells 2 0.4549
748 cells. 1 0.336
748 changes 1 0.2255
748 characteristics 1 0.4202
748 characteristics; 1 0.7536
748 chondria 1 0.7536
748 circulation. 1 0.6034
748 common 1 0.3682
748 concentrated 1 0.5793
748 consists 1 0.4764
748 continuous 1 0.4252
748 cytosis 1 0.7536
748 damage 1 0.3839
748 dark 1 0.6785
748 days 1 0.2994
748 dehydrated 1 0.6785
748 dense 1 0.5596
748 developing 1 0.4066
748 display 2 1.2069
748 distributed. 1 0.7536
748 elaboration 1 0.6785
748 electron 1 0.3805
748 epithelial 4 1.5939
748 epithelium 2 0.9083
748 features 1 0.4025
748 first 1 0.2763
748 foetal 1 0.543
748 function 1 0.3381
748 functional 2 0.9528
748 gall 2 1.5073
748 granules 1 0.4943
748 immediately 1 0.4611
748 infiltration 1 0.5793
748 infrequent 1 0.6785
748 intercellular 1 0.6034
748 lack 1 0.4358
748 large 1 0.2979
748 lateral 1 0.5046
748 limited 1 0.411
748 lysosomes 1 0.5596
748 may 1 0.1885
748 membrane 1 0.4066
748 microscopic 1 0.4685
748 microvilli, 1 0.7536
748 mito- 1 0.6785
748 mitochondria 1 0.5159
748 notably 1 0.6346
748 occurs 2 0.805
748 others 1 0.411
748 outlines, 1 0.7536
748 pale 1 0.7536
748 passage 1 0.4943
748 pino- 1 0.7536
748 pinocytosis, 1 0.6785
748 pinocytosis. 1 0.7536
748 rabbit 2 0.8503
748 resorption 1 0.6034
748 rod-shaped 1 0.7536
748 second 1 0.3839
748 shows 1 0.4155
748 smooth 1 0.6346
748 spaces. 1 0.6785
748 study 1 0.2322
748 subapical 1 0.7536
748 subsides. 1 0.7536
748 two 1 0.2308
748 type 2 0.6268
748 types 1 0.3653
748 uniformly 1 0.7536
748 unknown 1 0.5596
748 vigorous 1 0.6785
748 water 2 0.797
748 white 1 0.4685
749 anatomic 1 0.6728
749 anomalies 3 1.9773
749 appearance 1 0.4989
749 characteris- 1 0.9046
749 clinical 1 0.3275
749 congenital 1 0.4598
749 cystic 2 1.4923
749 described 1 0.3811
749 development 1 0.3669
749 differ- 1 0.8461
749 discussed. 1 0.4296
749 duct 1 0.6879
749 duct, 1 0.8461
749 embryonic 1 0.6352
749 ent 1 0.9046
749 four 1 0.4509
749 phineas 1 1.0048
749 rabinovitch 1 1.0048
749 reported. 1 0.5811
749 significance 1 0.548
749 surgical 1 0.4538
749 tic 1 0.7462
749 types, 1 0.8461
750 "single 1 0.7536
750 (i.e., 1 0.6785
750 abnormalities, 1 0.7536
750 abnormality 1 0.5286
750 affected 1 0.3909
750 anomaly, 1 0.7536
750 apparently 1 0.411
750 appear 1 0.3449
750 bio- 1 0.6346
750 capabilities 1 0.7536
750 caused 2 0.6597
750 cell 1 0.2551
750 cells 1 0.2274
750 chemical 1 0.4542
750 chromosomal) 1 0.7536
750 clinical, 1 0.485
750 conventional 1 0.543
750 defined 1 0.5159
750 deletion, 1 0.7536
750 delian 1 0.7536
750 demonstrated 1 0.3222
750 described. 1 0.3773
750 determined 1 0.3426
750 disease 1 0.2708
750 diseases 4 1.6439
750 disorders 1 0.4303
750 diverse 1 0.6034
750 families 1 0.5286
750 gene 2 1.2069
750 gene" 1 0.7536
750 genetic 1 0.3946
750 genetically 1 0.6034
750 hereditary 2 1.086
750 involvement 1 0.4943
750 lesions 1 0.3241
750 liver 3 0.8895
750 liver, 1 0.5159
750 major 1 0.3625
750 many 1 0.3038
750 mechanisms. 1 0.6346
750 men- 1 0.7536
750 metabolic 2 0.7196
750 methods. 1 0.4764
750 misinformation 1 0.7536
750 mutation 1 0.5793
750 nondisjunction, 1 0.7536
750 paper 1 0.4066
750 parenchymal 1 0.6785
750 pathological, 1 0.7536
750 perhaps 1 0.4155
750 produced 1 0.3069
750 quantitative 1 0.3985
750 receive 1 0.6034
750 relatively 1 0.3625
750 repetitive 1 0.6785
750 result 1 0.326
750 result, 1 0.7536
750 several 1 0.326
750 stromal, 1 0.7536
750 surprising 1 0.7536
750 surveyed 1 0.6346
750 translocation, 1 0.7536
750 transmitted 1 0.6034
750 types 1 0.3653
750 unknown, 1 0.7536
750 various 1 0.2979
750 whether 2 0.7483
751 accessory 2 1.6922
751 acid 3 1.1641
751 activity 3 1.0788
751 adenocar- 1 0.9046
751 adult 1 0.4568
751 amphibia 1 1.0048
751 cancer 1 0.3972
751 catabolic 1 1.0048
751 cathepsin 1 1.0048
751 catheptic 2 2.0097
751 cinoma 1 0.8046
751 considerable 1 0.5212
751 content 1 0.4727
751 correlation 1 0.5074
751 correlations 1 0.724
751 deduced. 1 1.0048
751 determined 1 0.4568
751 development 1 0.3669
751 differences 2 0.9196
751 dissociation, 1 0.9046
751 distribution 1 0.5165
751 effect 1 0.3068
751 enzyme 2 1.1938
751 enzymes 1 0.6352
751 enzymes. 1 1.0048
751 features 1 0.5366
751 formation 1 0.4509
751 found 2 0.5291
751 found, 1 0.7048
751 further, 1 0.7724
751 heterogeneous 1 0.8046
751 host 1 0.5212
751 implant 1 1.0048
751 implant-induced 1 1.0048
751 inducibility, 1 1.0048
751 initiation 1 0.8461
751 kidneys 1 0.5603
751 limb 2 1.448
751 livers 1 0.8461
751 lysosomes 1 0.7462
751 organ-specific 1 0.9046
751 phenomenon 1 0.5811
751 phosphatase 2 1.4923
751 pipiens 1 0.9046
751 pipiens. 1 1.0048
751 population 1 0.6466
751 positive 2 1.0733
751 rana 2 2.0097
751 relation 1 0.4629
751 renal 1 0.3898
751 resistance 1 0.5603
751 respect 1 0.5888
751 species- 1 0.9046
751 specific 1 0.3953
751 stability 1 0.7462
751 tissue 1 0.3488
751 triton 1 1.0048
751 triturus 1 0.8461
751 two 1 0.3077
751 urodeles. 1 1.0048
751 viridescens. 1 1.0048
751 virus-induced 1 1.0048
751 well 1 0.3514
751 x-100 1 1.0048
752 "direct" 1 1.0048
752 (conjugated) 1 1.0048
752 (fig. 2 1.6922
752 1) 1 0.6466
752 2) 1 0.6879
752 acterization 1 1.0048
752 below. 1 1.0048
752 biliru- 1 1.0048
752 bilirubin 2 1.3455
752 billing. 1 1.0048
752 bin 1 1.0048
752 char- 1 0.8461
752 clear 1 0.6056
752 concepts 1 0.7462
752 conjugation 1 0.9046
752 considerable 1 0.5212
752 current 1 0.6246
752 described 1 0.3811
752 dia- 1 0.8046
752 diagrammatic 1 1.0048
752 discussion 1 0.6056
752 established 1 0.5422
752 ester 1 1.0048
752 etiology 1 0.554
752 excellent 1 0.724
752 follow. 1 1.0048
752 furnish 1 0.8461
752 glucuronide. 1 1.0048
752 gram 1 0.8461
752 hepatic 1 0.5669
752 interesting 1 0.724
752 involved 1 0.5119
752 jaundice 3 1.8167
752 knowledge 1 0.6591
752 made 1 0.3639
752 may 1 0.2513
752 mecha- 1 1.0048
752 metabolic 1 0.4797
752 metabolism 2 0.9524
752 mind. 1 0.9046
752 neonatology 1 1.0048
752 nisms 1 1.0048
752 number 1 0.3845
752 occur 1 0.4909
752 pathway 1 0.8046
752 physiologic 1 0.6466
752 picture 1 0.548
752 point 1 0.5811
752 possible 1 0.4031
752 progress 1 0.7048
752 re-examine 1 1.0048
752 reasons, 1 1.0048
752 reference 1 0.554
752 representations 1 1.0048
752 reproduced 1 0.8046
752 reviews 1 0.8046
752 serve 1 0.724
752 sherlock 1 1.0048
752 sherlock's 1 1.0048
752 since 1 0.4372
752 subject 1 0.6466
752 well 1 0.3514
753 (1) 1 0.3653
753 (2) 1 0.3653
753 (3) 1 0.3985
753 (g-6-pd) 1 0.7536
753 admission 1 0.5793
753 affected 1 0.3909
753 agents 1 0.4066
753 areas 1 0.3985
753 assess 1 0.6346
753 bilirubin 1 0.5046
753 bilirubinemia. 1 0.7536
753 bloods 1 0.7536
753 canada 1 0.6785
753 canada, 1 0.6785
753 cause 2 0.6807
753 cell 2 0.5101
753 certain 1 0.3319
753 chinese, 1 0.7536
753 ciency. 1 0.7536
753 confirmed 1 0.4416
753 cord 1 0.5159
753 defi- 1 0.6034
753 deficiency 1 0.3985
753 deficiency--a 1 0.7536
753 deficient 1 0.485
753 dehydrogenase 2 1.1586
753 detec- 1 0.7536
753 diag- 1 0.7536
753 due 1 0.2666
753 ethnic 3 2.2609
753 evident 1 0.4685
753 exchange 1 0.5046
753 fatal 1 0.5046
753 five, 1 0.7536
753 follow- 1 0.5793
753 four 1 0.3381
753 full-term 1 0.6785
753 g-6-pd 2 1.5073
753 glucose-6- 1 0.7536
753 glucose-6-phosphate 1 0.6785
753 greek 1 0.7536
753 groups 1 0.3069
753 groups. 1 0.4477
753 groups: 1 0.6034
753 hemo- 1 0.5596
753 hemolysis 1 0.6785
753 hemolytic 1 0.543
753 high-risk 1 0.7536
753 home. 1 0.6785
753 hospital 1 0.4764
753 hyper- 1 0.4477
753 infants 4 1.4391
753 ing 1 0.4066
753 inhalation 1 0.5596
753 italian 1 0.7536
753 jaundice 3 1.3625
753 k 1 0.543
753 kernicterus 2 1.5073
753 levels 1 0.2951
753 lytic 1 0.6034
753 male 2 0.7678
753 measures 1 0.4943
753 methemoglobin 1 0.6785
753 mothball 1 0.7536
753 naphthalene, 1 0.7536
753 need 1 0.4611
753 neonatal 1 0.4542
753 newborns 2 1.2691
753 newly 1 0.5046
753 nosis 1 0.6785
753 ob- 1 0.5159
753 origin 1 0.4303
753 phosphate 1 0.3805
753 potentially 1 0.5596
753 precipi- 1 0.7536
753 preparations, 1 0.6034
753 presented 1 0.2924
753 prevail, 1 0.7536
753 protection 1 0.485
753 recognized 1 0.4685
753 recommended: 1 0.7536
753 red 2 0.8954
753 reduction 1 0.3711
753 screening 1 0.6346
753 serum 1 0.2924
753 servation 1 0.6785
753 seven 1 0.4303
753 severe 1 0.3339
753 similar 1 0.2821
753 six 1 0.4155
753 sulfonamides; 1 0.7536
753 suspected 1 0.5046
753 tated 1 0.7536
753 test. 1 0.4943
753 these. 1 0.7536
753 tion 1 0.3426
753 toronto, 1 0.7536
753 transfusion 1 0.5793
753 upon 1 0.3381
753 vapours 1 0.7536
753 vitamin 1 0.4611
754 17-18 3 2.2609
754 absence 1 0.3598
754 addition 1 0.3839
754 agenesis 1 0.6785
754 among 1 0.352
754 amputation 1 0.5793
754 aplasia 1 0.7536
754 atresia 1 0.4611
754 atresia. 1 0.5286
754 biliary 2 0.8954
754 bones 1 0.543
754 case 1 0.2708
754 cases 1 0.2242
754 characteristics 1 0.4202
754 classical 1 0.5286
754 congenital 4 1.3794
754 described. 1 0.3773
754 docu- 1 0.7536
754 extrahepatic 2 1.0091
754 findings 1 0.2994
754 foot 1 0.7536
754 foot, 1 0.7536
754 forearm 1 0.6785
754 hand, 1 0.4542
754 left 2 0.6807
754 mented 1 0.7536
754 phenotypic 1 0.7536
754 recently 2 1.0318
754 studied 1 0.2626
754 symptoms. 1 0.5596
754 syndrome 4 1.3983
754 trisomy 3 2.2609
754 various 1 0.2979
754 well 1 0.2636
755 (adult) 2 1.2058
755 (embryonic) 2 1.2058
755 blastoderm 1 0.6029
755 blastoderms 1 0.6029
755 brain 1 0.3071
755 brain, 1 0.4827
755 cases, 1 0.3157
755 caused 1 0.2639
755 chick 1 0.4229
755 chorio-allantoic 1 0.6029
755 cle 1 0.6029
755 controls 1 0.3633
755 culture 1 0.3018
755 cultured 1 0.3955
755 cysts 2 0.9655
755 days 1 0.2395
755 days. 1 0.3401
755 dermal 1 0.5428
755 dermis. 1 0.6029
755 development 1 0.2201
755 devoid 1 0.5428
755 differentiation 1 0.3443
755 discussed 1 0.2455
755 early 1 0.221
755 eight 1 0.3443
755 enhanced 1 0.3748
755 enriched 1 0.5428
755 entodermal 1 0.6029
755 epi- 3 1.5229
755 epidermal 1 0.6029
755 epidermis 2 1.2058
755 explanted 1 0.5428
755 feather 1 0.6029
755 fibrillar 2 0.9269
755 formation 1 0.2705
755 formation. 1 0.4634
755 fragments 2 0.8954
755 giant 1 0.4037
755 grafted 1 0.5428
755 head 1 0.3955
755 heart 1 0.2797
755 hyper- 1 0.3581
755 ible 1 0.6029
755 ii. 1 0.3487
755 keratini- 1 0.6029
755 keratinized 2 1.2058
755 liver 1 0.2372
755 medium 2 0.644
755 membrane 1 0.3253
755 modifications. 1 0.6029
755 mus- 1 0.6029
755 nine 1 0.4127
755 organization. 1 0.5076
755 pancreatic 1 0.6029
755 papillary 2 1.0856
755 papillomatous 1 0.6029
755 plasia 1 0.5428
755 plemented 1 0.6029
755 posterior 1 0.3533
755 process 1 0.2759
755 produced 1 0.2455
755 projections. 1 0.5428
755 protein-deficient 2 1.2058
755 proteins 1 0.3127
755 relationships 1 0.388
755 results 1 0.1727
755 rna 5 1.6619
755 rna's, 1 0.6029
755 skin. 1 0.5076
755 small, 1 0.5428
755 sup- 1 0.5428
755 terms 1 0.3689
755 thelium. 1 0.6029
755 tissue 1 0.2093
755 two 1 0.1846
755 unkeratinized 1 0.6029
755 various 1 0.2383
755 vis- 1 0.6029
755 vitro 1 0.3099
755 with, 1 0.5428
755 zation, 1 0.6029
756 'conditioned' 1 0.3768
756 1-2 2 0.6346
756 37 1 0.2523
756 absence. 1 0.3392
756 adhesion 1 0.3768
756 adhesion. 1 0.3768
756 adhesiveness 1 0.3768
756 aggregation 8 2.5382
756 agree 1 0.3392
756 antibodies, 1 0.3768
756 antiserum 1 0.2523
756 assessing 1 0.3173
756 bud, 1 0.3768
756 c. 2 0.3985
756 c., 1 0.3173
756 cell 2 0.2551
756 cells 1 0.1137
756 cells, 1 0.1826
756 cells. 1 0.168
756 cellular 1 0.2055
756 chick 1 0.2643
756 closely 1 0.2152
756 confirmed 1 0.2208
756 contact 1 0.2179
756 contains 1 0.2305
756 described 1 0.1429
756 destroyed 1 0.2523
756 direct 1 0.1773
756 elucidate 1 0.3392
756 embryonic 1 0.2382
756 evaluated; 1 0.3768
756 factor 1 0.1786
756 flocculation 1 0.3392
756 forming 1 0.2798
756 found 1 0.0992
756 heart 1 0.1748
756 inhibited 1 0.2382
756 inhibition 2 0.3773
756 inhibitory 1 0.2472
756 inhibits 1 0.2523
756 investigated 1 0.2152
756 involved 1 0.1919
756 kinetics 2 0.6034
756 kinetics, 1 0.3392
756 kinetics. 1 0.3173
756 lack 2 0.4358
756 limb 1 0.2715
756 liver 1 0.1483
756 measured 1 0.1649
756 measurement 1 0.2126
756 measurements 1 0.2425
756 mechanism 1 0.1736
756 metabolism. 1 0.2523
756 method 2 0.2994
756 new 1 0.1649
756 order 1 0.1973
756 power 1 0.2897
756 pre-treated 1 0.3768
756 presence 3 0.4307
756 probability 1 0.2798
756 protein 1 0.1713
756 provides 1 0.2382
756 pure 1 0.2425
756 quail 1 0.3768
756 quantitative 1 0.1992
756 serum 6 0.8771
756 shaker 1 0.3768
756 similar 1 0.1411
756 suggest 1 0.1713
756 system 1 0.176
756 technique 1 0.1773
756 terms 1 0.2305
756 two 1 0.1154
756 using 1 0.1713
757 (109 1 1.0048
757 (69 1 1.0048
757 200 1 0.6591
757 30 1 0.4797
757 among 1 0.4694
757 analysis 1 0.4833
757 appear 1 0.4598
757 cases) 1 0.8461
757 cases). 1 0.8461
757 clearly 1 0.6056
757 clinical, 1 0.6466
757 comparative 1 0.6148
757 data 1 0.4092
757 data. 1 0.7724
757 de 1 0.6879
757 dehors 1 1.0048
757 diagnosis 1 0.4135
757 difficulties 1 0.7462
757 du 1 0.8461
757 en 1 0.9046
757 evolutive 1 0.9046
757 foeto-maternal 1 1.0048
757 foeto-maternelle 1 1.0048
757 frequently 1 0.5074
757 groups 2 0.8185
757 haemo- 1 0.7724
757 haemolytic 1 1.0048
757 hepatitis 1 0.6728
757 histological 1 0.5969
757 icteres 1 1.0048
757 icteri 2 2.0097
757 icteri. 1 1.0048
757 important 1 0.4538
757 incompatibility, 1 1.0048
757 l'incompatibilite 1 1.0048
757 latter, 1 0.9046
757 les 1 0.7724
757 linked 1 0.7048
757 lytic 1 0.8046
757 malformative 1 0.9046
757 neonatal 3 1.8167
757 non 1 1.0048
757 nouveau-ne 1 1.0048
757 pulled 1 1.0048
757 rencountered 1 1.0048
757 statistical 2 1.2933
757 study 1 0.3096
757 two 2 0.6154
758 (12, 2 1.0048
758 (13, 1 0.5024
758 (16,27). 1 0.5024
758 (2, 1 0.5024
758 (24,25). 1 0.5024
758 (3,27). 1 0.5024
758 (3,27,71), 1 0.5024
758 (31-33). 1 0.5024
758 (68-70). 1 0.5024
758 14, 1 0.4523
758 15). 1 0.5024
758 16, 1 0.5024
758 19, 2 0.9046
758 20) 1 0.4523
758 20, 1 0.4023
758 23, 1 0.5024
758 25, 1 0.4523
758 26). 1 0.5024
758 3 1 0.1713
758 3, 1 0.4023
758 34). 1 0.5024
758 absence 3 0.7196
758 agammaglobulinemia 1 0.5024
758 agar 1 0.3524
758 almost 1 0.2582
758 amount 1 0.2474
758 amounts 2 0.4989
758 analysis 1 0.2417
758 antibodies 1 0.2834
758 antigenic 1 0.2944
758 any, 1 0.4523
758 appear 1 0.2299
758 appears 1 0.216
758 appreciable 1 0.3524
758 associated 1 0.1784
758 best 1 0.2657
758 birth 2 0.5119
758 blood 2 0.3105
758 bone 1 0.2173
758 catabolism 1 0.5024
758 cells 3 0.4549
758 complete 1 0.2331
758 completely 1 0.2944
758 conditions 1 0.2284
758 congenital 1 0.2299
758 considered 1 0.224
758 contains 1 0.3074
758 cord 1 0.3439
758 decreases 1 0.3233
758 detected 1 0.2606
758 development 1 0.1834
758 diffusion 1 0.3364
758 directly 1 0.3176
758 double 1 0.3296
758 engaged 1 0.4523
758 evidence 1 0.1842
758 excluded. 1 0.3731
758 explained 1 0.2834
758 favor 1 0.4023
758 fetal 1 0.2869
758 fetus 6 2.1144
758 first 1 0.1842
758 formation 4 0.9017
758 found 1 0.1323
758 generally 1 0.2985
758 gestation 1 0.3731
758 globulins; 1 0.5024
758 gm 1 0.4523
758 gradually 1 0.3176
758 groups 1 0.2046
758 however, 2 0.3639
758 human 4 0.6707
758 identical 1 0.2985
758 iga 2 0.9046
758 igg 3 1.5073
758 igg, 2 1.0048
758 igm 2 1.0048
758 igm, 1 0.5024
758 immature 1 0.3364
758 immuno- 1 0.4523
758 immunochemical 1 0.4523
758 immunoelectrophoretic 1 0.4523
758 immunoglobulin 1 0.423
758 immunoglobulins 2 0.9046
758 immunological 1 0.3123
758 inadequate 1 0.5024
758 indicate 1 0.2212
758 infant 1 0.2834
758 infants 1 0.2399
758 intrauterine 1 0.362
758 itself, 1 0.423
758 large 1 0.1986
758 level 2 0.388
758 little, 1 0.4523
758 lymphoid 1 0.3233
758 maintain 1 0.3731
758 marrow 1 0.2515
758 maternal 2 0.5811
758 maternally-transferred 1 0.5024
758 mature 1 0.3123
758 may 1 0.1257
758 minute 1 0.3731
758 molecules 1 0.3524
758 month 1 0.3364
758 months 1 0.2537
758 mother 1 0.2869
758 mothers 1 0.3028
758 neonate 1 0.4523
758 neonates 1 0.4523
758 newborn 4 1.0959
758 newborn. 1 0.423
758 normal 2 0.2702
758 observation 1 0.2631
758 opinion 1 0.3364
758 origin. 1 0.3364
758 original 1 0.2869
758 originate 1 0.3862
758 pass 1 0.3731
758 passage 2 0.6591
758 pathological 1 0.2711
758 placenta, 1 0.4523
758 plasma 2 0.4051
758 present 1 0.1654
758 process 1 0.2299
758 quantitative 1 0.2657
758 readily 1 0.3233
758 reported 1 0.2036
758 respond 1 0.3074
758 said 1 0.4023
758 selective 1 0.2985
758 sensitive 1 0.2711
758 serum 4 0.7797
758 shown 1 0.216
758 since 1 0.2186
758 sixth 1 0.5024
758 still 1 0.2347
758 stimulus 1 0.3364
758 studies 1 0.1539
758 syphilis 1 0.5024
758 techniques 1 0.274
758 techniques, 1 0.423
758 test 1 0.2173
758 tissues 1 0.2299
758 toxoplasmosis 1 0.4523
758 trace 1 0.362
758 transfer 2 0.6466
758 transferred, 1 0.5024
758 transplacental 2 1.0048
758 ultracentrifugation 1 0.5024
758 weeks 1 0.2631
758 well 1 0.1757
758 whereas 1 0.2515
759 attention 1 0.97
759 brief 1 1.0572
759 careful 1 0.9528
759 case 1 0.5415
759 cases 1 0.4484
759 certain 1 0.6637
759 congenital 1 0.6897
759 congenitale 1 1.5073
759 consider 1 1.0572
759 degree 1 0.6678
759 disease 1 0.5415
759 even 1 0.6597
759 familial 1 0.9887
759 frequent 1 0.9083
759 galac- 1 1.5073
759 galactosemia 1 1.5073
759 galactosemia, 1 1.5073
759 galactosemie 1 1.5073
759 gives 1 1.086
759 incidence 1 0.7196
759 many 1 0.6077
759 much 1 0.6678
759 must 2 1.4727
759 observation 1 0.7893
759 opportunity 1 1.2691
759 particular 1 0.7611
759 pediatrician. 1 1.5073
759 point 1 0.8716
759 prognosis, 1 1.357
759 receive 1 1.2069
759 reserved 1 1.2691
759 review 1 0.831
759 severe 1 0.6678
759 slight 1 0.8954
759 subject. 1 1.2691
759 suppose, 1 1.5073
759 tosemia 1 1.5073
759 view 1 0.8832
760 accordingly, 1 0.4523
760 approximately 1 0.2631
760 birth 1 0.2559
760 birth. 1 0.3731
760 blood 4 0.621
760 branches. 1 0.423
760 cava 1 0.423
760 changes 1 0.1503
760 circulation 1 0.2631
760 constant. 1 0.5024
760 contrast, 1 0.3862
760 deprived 1 0.3862
760 development 1 0.1834
760 digestive 1 0.423
760 directly 1 0.3176
760 exposed 1 0.2631
760 falls 1 0.5024
760 flow 1 0.2559
760 flow. 1 0.3862
760 flows 1 0.3862
760 foetal 1 0.362
760 gradient 1 0.3524
760 higher. 1 0.423
760 however 1 0.362
760 immediately 1 0.3074
760 inactive 1 0.3439
760 inferior 1 0.3862
760 large 1 0.1986
760 liver 1 0.1977
760 main 1 0.2869
760 narrow 1 0.423
760 one-quarter 1 0.4523
760 oxygenated 1 0.5024
760 perhaps 1 0.277
760 portal 5 2.1152
760 portion 1 0.3524
760 postnatal 1 0.4023
760 pressure 5 1.1495
760 probably 1 0.2284
760 recess 1 0.5024
760 remains 1 0.2631
760 small 1 0.2015
760 somewhat 1 0.3731
760 substantial 1 0.3862
760 though 1 0.2944
760 tract, 1 0.4023
760 trunk 1 0.5024
760 umbilical 6 2.4137
760 vein 2 0.7462
760 veins 1 0.3862
760 vena 1 0.423
760 venous 2 0.5669
760 wide 1 0.2985
761 ac- 1 0.6466
761 activity 1 0.3596
761 another 1 0.548
761 born 1 0.6728
761 cause 1 0.4538
761 clusion 1 0.9046
761 congenital 2 0.9196
761 cytomegalic 2 1.6091
761 date. 1 0.9046
761 described. 1 0.5031
761 disease 2 0.722
761 due 1 0.3554
761 enzymatic 1 0.7724
761 evolved 1 0.8461
761 found 1 0.2645
761 hepatic 1 0.5669
761 in- 1 0.4452
761 inclusion 1 0.6466
761 infant 2 1.1337
761 infants 1 0.4797
761 involvement 1 0.6591
761 jaundice 2 1.2111
761 neonatal 2 1.2111
761 new- 1 0.8461
761 newborn 1 0.548
761 pattern 3 1.4391
761 serum 2 0.7797
761 studied 1 0.3501
761 tivity 1 0.9046
761 toxoplasmosis 2 1.8093
761 transaminase 2 1.8093
761 unlike 1 0.8461
762 1 1 0.3795
762 15 1 0.4989
762 180 1 1.0048
762 20 2 0.9076
762 3 1 0.3425
762 30 1 0.4797
762 60% 1 0.8046
762 activities 3 1.7433
762 activity 2 0.7192
762 age 1 0.4157
762 alter 1 0.6728
762 altered. 1 0.9046
762 birth 2 1.0237
762 ceiving 1 0.8461
762 controls. 1 0.6591
762 day 2 0.9978
762 days 3 1.1975
762 dehydrogenases 1 1.0048
762 development 3 1.1006
762 enzyme 3 1.7907
762 enzymes 1 0.6352
762 finding 1 0.6148
762 gestation 1 0.7462
762 gestation, 1 0.9046
762 gestation. 1 0.8461
762 glucose-6-phosphatase 1 1.0048
762 glycerophosphate 1 1.0048
762 impaired 1 0.6879
762 increases 1 0.4694
762 irradiation 2 1.0844
762 lactic 1 0.7048
762 later 1 0.5165
762 liver 2 0.7907
762 may 1 0.2513
762 observed 1 0.3425
762 perinatal 1 0.7462
762 period. 1 0.6056
762 rads 1 0.9046
762 rat 1 0.4135
762 rats 1 0.388
762 re- 1 0.4452
762 studied 1 0.3501
762 subsequent 1 0.548
762 suggests 1 0.5366
762 three 1 0.3778
762 utero 2 1.6922
762 x-rays 1 0.9046
763 (cytological 1 1.0048
763 acids, 1 0.8046
763 adults 1 0.6056
763 adults. 1 0.7462
763 alterations 1 0.554
763 apparatus 2 1.5448
763 cells 2 0.6065
763 changes 2 0.6013
763 compared. 1 0.8046
763 contents 3 2.0183
763 cytochemical 1 0.9046
763 cytoplasm 1 0.6246
763 data 1 0.4092
763 developing 1 0.5422
763 developmental 1 0.6728
763 dna, 1 0.6591
763 embryo 1 0.7048
763 embryo) 1 1.0048
763 embryonic 1 0.6352
763 embryos 1 0.7462
763 essential 1 0.5888
763 form 1 0.4372
763 found 1 0.2645
763 golgi 2 1.4923
763 granules 1 0.6591
763 hepatic 2 1.1337
763 human 3 1.0061
763 increased: 1 1.0048
763 iron 2 1.6922
763 lipids 2 1.4923
763 localisations 1 1.0048
763 mitochondria 2 1.3758
763 noted. 1 0.6728
763 nucleic 1 0.6591
763 obtained 1 0.3582
763 period 1 0.3811
763 place. 1 0.9046
763 polysaccharides 1 1.0048
763 polysaccharides, 1 1.0048
763 process 1 0.4598
763 proteins, 2 1.5448
763 revealed 1 0.4871
763 rna 1 0.554
763 salts 1 0.7724
763 studied; 1 1.0048
763 study 1 0.3096
763 taking 1 0.724
763 throughout 1 0.5738
763 well 1 0.3514
764 (4.6%) 1 1.0048
764 100 1 0.5669
764 16 1 0.6246
764 29 1 0.6879
764 34% 1 1.0048
764 634 1 1.0048
764 9.1% 1 1.0048
764 absence 1 0.4797
764 activity--in 1 1.0048
764 area 1 0.5212
764 born 1 0.6728
764 combined 1 0.5165
764 deficiency 2 1.0626
764 deficiency. 1 0.7048
764 deficient 1 0.6466
764 deficient. 1 1.0048
764 enzyme 1 0.5969
764 especially 1 0.5165
764 factor 2 0.9524
764 first 1 0.3684
764 found 1 0.2645
764 g.-6-p.d. 3 3.0145
764 g.-6-p.d.- 1 1.0048
764 g.-6-p.d.-deficient 1 1.0048
764 g.-6-p.d.-normal 1 1.0048
764 glucose-6-phosphate-dehydrogenase 1 1.0048
764 group. 1 0.5811
764 half 1 0.5888
764 high 1 0.3596
764 hyperbilirubinaemia 1 1.0048
764 incidence 3 1.4391
764 incompatibility 1 1.0048
764 increases 1 0.4694
764 infants 2 0.9594
764 island 1 0.8461
764 jaundice 3 1.8167
764 jaundice, 1 0.8461
764 lesbos 2 2.0097
764 male 1 0.5119
764 males 1 0.6879
764 mg. 1 0.6352
764 ml. 1 0.6728
764 neonatal 3 1.8167
764 newborn 2 1.0959
764 normal 1 0.2702
764 observed 1 0.3425
764 one 1 0.2811
764 per 1 0.3916
764 population 1 0.6466
764 postulated 1 0.7048
764 prematurity. 1 0.9046
764 reported 1 0.4072
764 risk 1 0.6728
764 second 1 0.5119
764 severe 2 0.8904
764 studied. 1 0.5669
764 tested, 1 0.8461
764 time 1 0.3541
764 year 1 0.5212
765 acti- 1 1.357
765 b-glucuronidase 2 3.0145
765 bile 2 2.1144
765 bilirubin 1 1.0091
765 biliverdin 1 1.5073
765 chick 2 2.1144
765 chick-embryo 1 1.357
765 chicks 1 1.2069
765 con- 1 0.7819
765 devel- 1 1.5073
765 embryos 1 1.1192
765 function 1 0.6763
765 liver 1 0.593
765 must 1 0.7363
765 occur- 1 1.5073
765 oping 1 1.5073
765 possibility 1 0.8607
765 reason 1 1.086
765 rence 1 1.5073
765 search 1 1.2691
765 serious 1 0.9083
765 sideration. 1 1.5073
765 studies 1 0.4616
765 taken 1 0.8503
765 unconjugated 1 1.357
765 vity 1 1.357
766 causes 1 0.8503
766 discussed. 1 0.6444
766 empha- 1 1.5073
766 encountered 1 0.9528
766 infancy 2 2.1144
766 infant. 1 1.2691
766 jaundice 2 1.8167
766 neonate 1 1.357
766 sis 1 1.1586
766 solely 1 1.1192
766 syndromes 1 1.0572
766 usually 1 0.7091
767 18th 1 1.357
767 absence 2 1.4391
767 anomalies 1 0.9887
767 anomaly 1 1.086
767 basis 1 0.6597
767 biliary 1 0.8954
767 case 2 1.0831
767 congenital 1 0.6897
767 cystic 2 2.2385
767 described, 1 1.2069
767 discussed. 1 0.6444
767 duct 2 2.0636
767 early 1 0.5526
767 embryogenetic 1 1.5073
767 extrahepatic 1 1.0091
767 literature. 1 1.2691
767 management 1 0.797
767 methods 1 0.6807
767 operative 1 0.8404
767 recognition 1 1.0091
767 reported 1 0.6107
767 suggested. 1 1.2069
767 surgical 1 0.6807
767 tree 1 1.2691
768 anomalies 1 0.4943
768 association 1 0.4066
768 atresia 2 0.9221
768 biliary 3 1.3431
768 clinically 1 0.5159
768 condition. 1 0.5159
768 congenital 2 0.6897
768 correlated 1 0.4477
768 described. 1 0.3773
768 discussed 1 0.3069
768 drome 1 0.7536
768 etiology. 1 0.5793
768 except 1 0.4252
768 extrahepatic 2 1.0091
768 facts 1 0.543
768 familial 4 1.9773
768 family 1 0.4542
768 fifth 1 0.6034
768 formation 1 0.3381
768 in- 1 0.3339
768 incidence 1 0.3598
768 known. 1 0.6034
768 males 1 0.5159
768 must 1 0.3682
768 nature 1 0.3742
768 new 1 0.3299
768 nonfamilial 1 0.7536
768 pathologically 1 0.6034
768 possible 1 0.3023
768 predominance 1 0.6034
768 relation 1 0.3472
768 sex 1 0.5046
768 similar 1 0.2821
768 syn- 1 0.6346
768 uncovered 1 0.7536
769 (via 1 0.6029
769 according 1 0.3253
769 adenites, 1 0.6029
769 adenolymphoceles, 1 0.6029
769 affe- 1 0.6029
769 african; 1 0.6029
769 allow 1 0.4229
769 already 1 0.4344
769 also 1 0.1687
769 altera- 1 0.5428
769 alterations 2 0.6648
769 always 1 0.322
769 anastomoses 2 1.2058
769 aspects 1 0.3401
769 assume 1 0.5076
769 asymptomatic 1 0.4477
769 author 1 0.3533
769 caliber, 1 0.6029
769 causes 1 0.3401
769 causing 1 0.4477
769 changes 1 0.1804
769 chiefly 1 0.4344
769 circula- 1 0.6029
769 circulation 1 0.3157
769 circulatory 1 0.4229
769 clear 1 0.3633
769 coincident 1 0.6029
769 collateral 1 0.5076
769 considerable 1 0.3127
769 da 1 0.6029
769 decrease 2 0.5518
769 dences 1 0.6029
769 deviate 1 0.6029
769 different 1 0.2133
769 dilatation 1 0.4229
769 dilatations, 1 0.6029
769 discreet 1 0.6029
769 disease's 1 0.6029
769 ducts, 1 0.5428
769 due 2 0.4265
769 duration 1 0.3157
769 estudo 1 0.6029
769 even 1 0.2639
769 evi- 1 0.5076
769 examina- 1 0.5428
769 extensive 1 0.3401
769 factors: 1 0.6029
769 fibrosis 1 0.4827
769 filariase 1 0.6029
769 filariasis. 1 0.4344
769 first 1 0.221
769 flow 1 0.3071
769 flow, 1 0.4344
769 formation 1 0.2705
769 frequent 1 0.3633
769 ganglial 4 2.4116
769 glands, 1 0.5076
769 higher 1 0.2593
769 hypertrophy 2 0.6376
769 i.e., 1 0.4634
769 includes 1 0.4477
769 increase 1 0.2048
769 indi- 1 0.5076
769 influenced 1 0.3748
769 inguinal 1 0.5428
769 insufficiency 1 0.3581
769 intense 1 0.4344
769 leading 1 0.3748
769 level 1 0.2328
769 linfangiografia 1 0.6029
769 linfatica 1 0.6029
769 lym- 1 0.5076
769 lymph 3 1.1243
769 lymphangiogram 1 0.6029
769 lymphangiographic 3 1.8087
769 lymphangiography 1 0.6029
769 lymphangites, 1 0.6029
769 lymphatic 5 2.1719
769 lymphatics, 1 0.6029
769 lymphatics. 1 0.6029
769 lymphedemas, 1 0.6029
769 marked 2 0.541
769 may 1 0.1508
769 mentary 1 0.6029
769 normal 1 0.1621
769 noticed 1 0.5076
769 numerical 1 0.5076
769 observation 1 0.3157
769 observed. 1 0.3633
769 obstruction 2 0.7622
769 occa- 1 0.6029
769 one 1 0.1687
769 paper 1 0.3253
769 part 2 0.5633
769 pathogeny 1 0.6029
769 period 1 0.2287
769 permeability. 1 0.6029
769 phangitis, 1 0.6029
769 pre-sacral 1 0.6029
769 present 1 0.1985
769 presented 1 0.2339
769 primitive-iliac 1 0.6029
769 rate 1 0.2219
769 reflux 1 0.5428
769 relationship 1 0.29
769 rent 1 0.6029
769 results 1 0.1727
769 retention. 1 0.5076
769 risa 1 0.5076
769 risa's 1 0.6029
769 risa) 1 0.6029
769 sclerosis, 1 0.6029
769 sclerosis. 1 0.6029
769 second 1 0.3071
769 seg- 1 0.5428
769 several 1 0.2608
769 shows 2 0.6648
769 sional 1 0.6029
769 slight 1 0.3581
769 spite 1 0.4037
769 stage, 2 0.9269
769 stages 2 0.6648
769 stasis. 1 0.6029
769 study 1 0.1857
769 symptomatic 1 0.4229
769 symptoms 1 0.2857
769 three 1 0.2267
769 thus 1 0.3127
769 tion 2 0.5481
769 tions 1 0.3581
769 together 1 0.3443
769 trouble 1 0.5428
769 troubles 1 0.6029
769 trunks, 1 0.6029
769 trunks. 1 0.6029
769 us 1 0.3955
769 varicosities 1 0.6029
769 vary 1 0.5076
769 vidual. 1 0.6029
769 visualization 1 0.6029
769 white 1 0.3748
770 1962, 1 1.2069
770 20 1 0.6807
770 300 1 1.1586
770 5-fluorodeoxyuridine 1 1.5073
770 ability 1 0.7678
770 accumulation 1 1.0572
770 adequate 1 0.9369
770 adjuvant 2 2.1719
770 adverse 1 1.1586
770 analysis 1 0.725
770 approach 1 0.9369
770 assessment 1 1.0091
770 avail- 1 1.5073
770 begun 1 1.2691
770 bowel 1 1.1586
770 bowel. 1 1.5073
770 cancer 2 1.1917
770 carcinoma 1 0.7196
770 cases 2 0.8969
770 cent 1 0.7747
770 chemotherapy 1 0.9221
770 colon 1 1.1586
770 completeness 1 1.5073
770 continuous 1 0.8503
770 cooperative 1 1.2691
770 curative 1 1.2691
770 demon- 1 1.2069
770 demonstrated 1 0.6444
770 drug 1 0.7893
770 effects, 1 1.2069
770 excisional 1 1.5073
770 five 1 0.797
770 group 2 1.1143
770 hoped 1 1.357
770 improved. 1 1.5073
770 january, 1 1.5073
770 known 1 0.7363
770 large 2 1.1917
770 may 2 0.7539
770 new 1 0.6597
770 objective 1 0.9887
770 per 1 0.5875
770 produce 1 0.805
770 provide 1 0.8832
770 quick 1 1.5073
770 rate 1 0.5548
770 rela- 1 1.2691
770 remissions 1 1.1192
770 reporting, 1 1.5073
770 resections 1 1.357
770 statistical 1 0.97
770 strate 1 1.5073
770 study 2 0.9287
770 surgery 1 0.7483
770 survival 1 0.725
770 that, 1 0.9887
770 tively 1 1.357
770 treatment 1 0.4447
770 unresectable 1 1.5073
770 use 1 0.5959
770 warn 1 1.5073
770 year 2 1.5637
771 136 1 0.7536
771 37 1 0.5046
771 45 1 0.5046
771 5-fluoro-2'-deoxyuridine, 1 0.7536
771 administration 1 0.3319
771 advanced 1 0.3909
771 antidote 1 0.6785
771 antimetabolite 1 0.7536
771 arterial 2 0.7819
771 artery 2 0.8607
771 cancer 1 0.2979
771 cancers 1 0.5046
771 catheter 1 0.6034
771 chemotherapy 1 0.4611
771 chemotherapy. 1 0.5793
771 citrovorum 1 0.7536
771 commonly, 1 0.6785
771 concentration 1 0.3168
771 continuously 1 0.5793
771 conventional 1 0.543
771 course 1 0.3426
771 current 1 0.4685
771 days 1 0.2994
771 days. 1 0.4252
771 drug 2 0.7893
771 either 1 0.3222
771 experience 1 0.3874
771 fac- 1 0.7536
771 far 1 0.485
771 fluorinated 2 1.357
771 followed 1 0.3449
771 gen 1 0.6346
771 hepatic 1 0.4252
771 high 1 0.2697
771 infusion 4 1.7006
771 injected 1 0.3653
771 liver 1 0.2965
771 metastases. 1 0.6034
771 methotrexate 2 1.1586
771 months 1 0.3805
771 patients 3 0.5435
771 patients. 1 0.3625
771 plastic 1 0.5793
771 pre- 1 0.485
771 preferentially 1 0.7536
771 preferred 1 0.6785
771 prolonged 2 0.725
771 provide 1 0.4416
771 pyrimidine, 2 1.5073
771 received 1 0.4252
771 regional 1 0.543
771 reported 1 0.3054
771 roent- 1 0.6346
771 sented 1 0.6785
771 small 1 0.3023
771 solution, 1 0.5793
771 suitable 1 0.485
771 surgical 1 0.3403
771 systemic 1 0.4202
771 therapy 1 0.2979
771 therapy. 1 0.4066
771 tor 1 0.7536
771 treated 1 0.3101
771 treatment. 1 0.3985
771 un- 1 0.485
771 unobstructed 1 0.7536
771 used 1 0.2846
771 variety 1 0.4066
771 weeks. 1 0.6034
772 advanced, 1 1.5073
772 available 1 0.8219
772 cancer 2 1.1917
772 cases 1 0.4484
772 difficult 1 0.97
772 effective 1 0.7546
772 hopeless 1 1.2691
772 hypopharyngeal 1 1.5073
772 hypopharynx 1 1.5073
772 incurable 1 1.0572
772 ing 1 0.8133
772 insert- 1 1.5073
772 instance, 1 1.2069
772 montgomery 1 1.5073
772 otherwise 1 1.1192
772 palliate 1 1.5073
772 palliation 1 0.9528
772 presented. 1 0.8832
772 procedure 1 0.7678
772 prothesis 1 1.5073
772 served 1 0.9887
772 simple 1 0.8219
772 situation. 1 1.2069
772 three 1 0.5667
772 tube 1 1.2069
773 2 1 0.2301
773 3 1 0.2569
773 account 1 0.4252
773 ad- 1 0.5046
773 adjuvant 4 2.1719
773 administered 1 0.3598
773 antimitotics, 1 0.7536
773 authors 1 0.3472
773 blood-borne 1 0.7536
773 can- 1 0.7536
773 cancer 2 0.5959
773 cases 1 0.2242
773 cer 1 0.7536
773 chemotherapy 3 1.3832
773 derivatives. 1 0.6785
773 development 2 0.5503
773 dically 1 0.7536
773 dosage 3 1.3625
773 dose 3 1.0793
773 fixed: 1 0.7536
773 given 1 0.2763
773 inoperable 1 0.6785
773 juvant 1 0.7536
773 levels 1 0.2951
773 maximum 3 1.2465
773 measure 1 0.4358
773 metastases. 1 0.6034
773 non-ra- 1 0.7536
773 operated 1 0.485
773 oral 1 0.4611
773 pa- 2 0.8832
773 palliative 3 1.5137
773 patients. 1 0.3625
773 podophyllin 1 0.7536
773 purposes 1 0.5596
773 purposes: 1 0.7536
773 radical 1 0.5793
773 reduce 1 0.4764
773 renteral 1 0.7536
773 risk 1 0.5046
773 schedule 2 1.2069
773 sp-g, 1 0.7536
773 sp-i 1 0.7536
773 surgery 1 0.3742
773 surgical 2 0.6807
773 therapy. 3 1.2199
773 tients. 1 0.6785
773 tolerated 3 1.629
773 treatment 2 0.4447
773 two 1 0.2308
773 used 1 0.2846
774 apy; 1 1.0048
774 believe 1 0.6728
774 bene- 1 1.0048
774 briefly 1 0.6056
774 cancer 3 1.1917
774 choice 1 0.6466
774 comparative 1 0.6148
774 conclusions 1 0.6352
774 course 2 0.9135
774 effected 1 0.8461
774 effort 1 0.7462
774 feasible. 1 1.0048
774 ferences 1 1.0048
774 ficially 1 1.0048
774 form 1 0.4372
774 forms 1 0.4797
774 however 1 0.724
774 improve 1 0.8046
774 in- 1 0.4452
774 incurable 1 0.7048
774 justified 1 0.8461
774 lung 3 1.2963
774 number 1 0.3845
774 palliation 2 1.2704
774 palliative 1 0.6728
774 patient 1 0.3778
774 patients 1 0.2415
774 preference 1 0.8461
774 presented. 1 0.5888
774 primary 1 0.4248
774 regarding 1 0.6352
774 removal 1 0.5603
774 resecting 1 1.0048
774 results 1 0.2878
774 small 1 0.4031
774 study 1 0.3096
774 surgical 1 0.4538
774 technically 1 0.9046
774 terminal 2 1.448
774 ther- 1 0.8461
774 therapy 1 0.3972
774 tumor 1 0.448
774 whenever 1 0.9046
775 (40 1 0.6029
775 (provera) 1 0.6029
775 20 1 0.2723
775 8 1 0.2723
775 acetate 1 0.4477
775 adenocarcinoma 3 1.2382
775 administration 1 0.2655
775 advanced 3 0.9382
775 apparently 1 0.3288
775 basis 2 0.5278
775 biopsies 1 0.4477
775 cases. 1 0.3157
775 cent). 1 0.6029
775 changes 2 0.3608
775 complete 1 0.2797
775 criteria 1 0.3533
775 degree 1 0.2671
775 differentiation 1 0.3443
775 discussed. 1 0.2578
775 documentation 1 0.5428
775 documented 1 0.4344
775 droxyprogesterone 1 0.6029
775 effect 1 0.1841
775 effects 1 0.2238
775 endometrial 3 1.8087
775 evaluation 1 0.3253
775 excretion 1 0.2836
775 experience, 1 0.4827
775 histologic 1 0.4037
775 histologic, 1 0.6029
775 hormone 2 0.4911
775 i.e., 1 0.4634
775 index 1 0.3581
775 justified. 1 0.5428
775 lated 1 0.4634
775 le- 1 0.4634
775 logic 1 0.6029
775 management 1 0.3188
775 mary 1 0.4827
775 me- 1 0.4634
775 means, 1 0.5428
775 medroxyprogester- 1 0.6029
775 medroxyprogesterone 2 1.2058
775 ment 1 0.3955
775 neoplasm, 1 0.4827
775 objective 1 0.3955
775 one 1 0.1687
775 only, 1 0.4827
775 palliation 1 0.3811
775 palpable, 1 0.6029
775 partial 1 0.3362
775 patients 5 0.7246
775 patients. 1 0.29
775 per 1 0.235
775 potent 1 0.4477
775 presented. 1 0.3533
775 pri- 1 0.5076
775 produces 1 0.3811
775 progestin 3 1.8087
775 provides 1 0.3811
775 rates 1 0.3633
775 re- 1 0.2671
775 remission 1 0.4634
775 response 1 0.2201
775 responsive. 1 0.5428
775 revealed 1 0.2922
775 roentgeno- 1 0.5428
775 sched- 1 0.6029
775 seems 1 0.3188
775 selection 1 0.4127
775 serial 2 0.7377
775 several 1 0.2608
775 significant 1 0.2116
775 sions 1 0.4634
775 suscep- 1 0.6029
775 therapy 4 0.9534
775 tible 1 0.5428
775 treat- 1 0.3748
775 treatment 1 0.1779
775 tumor 1 0.2688
775 ule 1 0.6029
775 upon 1 0.2705
775 urinary 1 0.2671
775 visual, 1 0.5076
775 well-differentiated 1 0.6029
776 20 1 0.1945
776 5 1 0.1633
776 advanced 2 0.4468
776 agent 2 0.5047
776 agents 1 0.2324
776 also 1 0.1205
776 ameliorating 1 0.4306
776 ap- 1 0.3448
776 apparent 1 0.2255
776 apparent. 1 0.3877
776 apparently 1 0.2348
776 apy 1 0.3626
776 areas 1 0.2277
776 associated 1 0.1529
776 be- 1 0.2635
776 become 1 0.2374
776 becoming 1 0.331
776 breast 2 0.4554
776 cancer 7 1.1917
776 cancer, 1 0.2722
776 cannot 1 0.2324
776 care 1 0.2722
776 cases 1 0.1281
776 cell 1 0.1457
776 cent 1 0.2213
776 chemother- 1 0.3626
776 chemotherapeutic 1 0.331
776 chemotherapy 4 1.0539
776 choice 2 0.5543
776 come 1 0.3877
776 creasingly 1 0.4306
776 curative 1 0.3626
776 cured. 1 0.4306
776 decisions 1 0.4306
776 deliver- 1 0.4306
776 difficult. 1 0.3626
776 difficulty 1 0.2883
776 dis- 1 0.2722
776 disease. 1 0.2277
776 dose 1 0.2056
776 effective 1 0.2156
776 employed, 1 0.3877
776 established. 1 0.3626
776 even 1 0.1885
776 evident, 1 0.3877
776 experience 1 0.2213
776 extra 1 0.3626
776 fact 1 0.2277
776 far 1 0.2771
776 hormone 1 0.1754
776 however, 1 0.156
776 in- 1 0.1908
776 increases, 1 0.3877
776 increasingly 1 0.3448
776 ing 1 0.2324
776 involved 1 0.2194
776 limit 1 0.3448
776 live 1 0.2948
776 majority 1 0.2771
776 many 1 0.1736
776 may 2 0.2154
776 occasional 1 0.3103
776 oncolytic 2 0.7754
776 one. 1 0.331
776 patient 2 0.3238
776 patient's 1 0.2883
776 patients 2 0.207
776 pears 1 0.4306
776 per 1 0.1678
776 physician 1 0.331
776 positive 1 0.23
776 procedure 1 0.2194
776 program 1 0.3021
776 prolonging 1 0.4306
776 providing 1 0.331
776 puzzling 1 0.4306
776 re- 1 0.1908
776 referred 1 0.2558
776 regarded 1 0.2677
776 responsive 1 0.3198
776 results 1 0.1233
776 similar 1 0.1612
776 sponse 1 0.331
776 stages 1 0.2374
776 survival 1 0.2071
776 symptoms 1 0.2041
776 therapy, 1 0.2771
776 though 1 0.2523
776 time, 1 0.249
776 tool 1 0.3448
776 treatment 2 0.2541
776 treatment. 1 0.2277
776 tressing 1 0.4306
776 tumor 1 0.192
776 type 1 0.1791
776 un- 1 0.2771
776 unless 1 0.3198
776 useful 1 0.2374
776 usefulness 1 0.3448
776 usually 1 0.2026
776 value 1 0.1984
776 variability 1 0.3103
776 well 1 0.1506
776 years 1 0.1958
777 (5-fu) 1 0.7536
777 5-fluorouracil 2 1.2691
777 abreast 1 0.7536
777 act 1 0.4685
777 actions 1 0.485
777 actually 1 0.5793
777 ad- 2 1.0091
777 added 1 0.4685
777 adenocarcinoma 1 0.5159
777 also 1 0.2108
777 antibiotics 1 0.6346
777 apy 1 0.6346
777 armamentarium 1 0.7536
777 bacteria. 1 0.6785
777 become 1 0.4155
777 becoming 1 0.5793
777 begin 1 0.6346
777 breast 1 0.3985
777 cancer 1 0.2979
777 cancer, 1 0.4764
777 cancerocidal 1 0.7536
777 cancers 1 0.5046
777 chemical 1 0.4542
777 chemother- 1 0.6346
777 chemotherapy 2 0.9221
777 chemotherapy. 1 0.5793
777 clin- 1 0.6785
777 clinical 1 0.2457
777 colon 1 0.5793
777 devised 1 0.5793
777 drugs 1 0.4155
777 drugs. 1 0.6034
777 established 1 0.4066
777 experience 1 0.3874
777 extensive 1 0.4252
777 familiar 1 0.6034
777 field 1 0.4477
777 firmly 1 0.6034
777 five 1 0.3985
777 helpful 1 0.5159
777 ical 1 0.6346
777 important 1 0.3403
777 incurable 1 0.5286
777 interested 1 0.6785
777 junct 1 0.7536
777 keep 1 0.7536
777 metastatic 1 0.485
777 mode 1 0.543
777 months. 1 0.5046
777 palliation 4 1.9056
777 patients 2 0.3623
777 perhaps 1 0.4155
777 primary 2 0.6372
777 probable 1 0.4764
777 produced 1 0.3069
777 reason 1 0.543
777 receiving 1 0.4155
777 recent 1 0.3946
777 significant 1 0.2646
777 six 1 0.4155
777 solid 2 1.1586
777 someday 1 0.7536
777 surgeons 2 1.357
777 technics 2 1.357
777 therapeutic 1 0.3805
777 third 1 0.411
777 tool. 1 0.7536
777 treatment 3 0.667
777 try 1 0.6346
777 tumors 1 0.3946
777 tumors. 1 0.4943
777 use 2 0.5959
777 vances 1 0.7536
777 various 1 0.2979
777 within 1 0.2798
777 years 1 0.3426
778 carcinoma 1 0.7196
778 chemotherapy 1 0.9221
778 couraging. 1 1.5073
778 degree 1 0.6678
778 en- 1 1.1586
778 isolation 1 0.97
778 method 1 0.5987
778 near 1 0.9083
778 palliation 1 0.9528
778 pelvic 1 1.1586
778 pelvis 1 1.357
778 perfusion 1 0.8832
778 perfusion. 1 1.2691
778 presented. 1 0.8832
778 rectum 1 1.357
778 regional 1 1.086
778 stage 1 0.7306
778 subjects 1 0.7196
778 survival 1 0.725
778 terminal 1 1.086
778 time 2 1.0622
779 acteristics 1 1.5073
779 best 1 0.797
779 cancer 1 0.5959
779 carcinoma 1 0.7196
779 cases 1 0.4484
779 char- 1 1.2691
779 clusion, 1 1.5073
779 compared 1 0.5847
779 complaints 1 1.2069
779 con- 1 0.7819
779 consisting 1 1.2069
779 cure 1 1.1586
779 diagnosis, 1 1.0091
779 discussed. 1 0.6444
779 disease 1 0.5415
779 disease, 1 0.805
779 equal 1 0.9887
779 esophagus 2 2.5382
779 extremely 1 1.0572
779 fifty-seven 1 1.5073
779 gave 1 0.9528
779 groups 2 1.2277
779 longer 1 1.0572
779 ment, 1 1.1586
779 methods 1 0.6807
779 occurring 1 0.8716
779 one 1 0.4217
779 opinion 1 1.0091
779 others, 1 1.1586
779 pa- 1 0.8832
779 palliation 1 0.9528
779 patient 1 0.5667
779 patients 1 0.3623
779 period 1 0.5717
779 poor. 1 1.357
779 presented. 1 0.8832
779 presenting 1 1.0091
779 resection 2 2.2385
779 results 1 0.4316
779 suitable 1 0.97
779 supported 1 1.086
779 sur- 1 1.2069
779 surgical 2 1.3613
779 survey 1 1.0572
779 therapy 1 0.5959
779 three 2 1.1335
779 tients. 1 1.357
779 treat- 1 0.9369
779 treatment 1 0.4447
779 treatment, 1 0.97
779 twenty 1 1.1192
779 two 1 0.4616
779 used 1 0.5692
779 vived 1 1.5073
779 x-ray 2 1.9773
779 year 1 0.7819
779 years. 1 0.9528
780 (broders'). 1 0.7536
780 (whitmore 1 0.7536
780 121 1 0.6785
780 15 1 0.3742
780 1959 1 0.7536
780 1962, 1 0.6034
780 2 2 0.4602
780 202 1 0.7536
780 28 2 1.0318
780 3 2 0.5138
780 30 1 0.3598
780 32 1 0.5793
780 4 1 0.2666
780 49 1 0.6346
780 5000 1 0.6785
780 alive. 1 0.7536
780 alive; 1 0.7536
780 b2, 1 0.7536
780 believe 1 0.5046
780 better 1 0.4358
780 bladder 2 1.2069
780 bladder. 2 1.5073
780 bladder: 1 0.7536
780 c 1 0.411
780 cal 1 0.5793
780 carcinoma 3 1.0793
780 cases. 1 0.3946
780 cobalt 1 0.6785
780 cobalt-60 1 0.7536
780 com- 1 0.4477
780 considered 1 0.336
780 cystectomy 3 2.0354
780 disease 1 0.2708
780 done 1 0.5046
780 doses 1 0.411
780 excess 1 0.5159
780 excessive. 1 0.7536
780 followed 1 0.3449
780 four 1 0.3381
780 function 1 0.3381
780 grades 1 0.6034
780 indications. 1 0.6785
780 infiltrative 1 0.7536
780 initial 1 0.3653
780 lymph 1 0.4685
780 majority 1 0.485
780 marshall) 1 0.7536
780 nodes. 1 0.7536
780 none 1 0.4542
780 pa- 2 0.8832
780 patients 4 0.7246
780 performed 1 0.3449
780 plications 1 0.6785
780 pre- 1 0.485
780 presented 1 0.2924
780 preserved 1 0.6346
780 quoted 1 0.6785
780 rad 1 0.6785
780 radi- 1 0.7536
780 radical 2 1.1586
780 radiotherapy 3 1.5858
780 received 2 0.8503
780 reserve 1 0.6034
780 residual 1 0.5596
780 sented 1 0.6785
780 showed 1 0.2686
780 sixteen 1 0.6785
780 specific 1 0.2965
780 stage 1 0.3653
780 survivals 1 0.6785
780 survived 1 0.4943
780 survivors 1 0.543
780 survivors. 1 0.6785
780 therapy 2 0.5959
780 tients 2 0.97
780 treatment 1 0.2223
780 treatment, 1 0.485
780 tumor 1 0.336
780 tumors 2 0.7893
780 useful 1 0.4155
780 weeks. 1 0.6034
780 years 2 0.6851
781 (1) 1 0.4871
781 (2) 1 0.4871
781 (3) 1 0.5313
781 (4) 1 0.5811
781 acterized 1 1.0048
781 anemia 1 0.724
781 asymptomatic 2 1.4923
781 attitude 1 0.8046
781 car- 1 0.724
781 carcinomatosis, 1 1.0048
781 cases 2 0.5979
781 char- 1 0.8461
781 cinomas 1 1.0048
781 clinical 1 0.3275
781 clinician 1 0.9046
781 colon 2 1.5448
781 complete 1 0.4661
781 crete 1 0.9046
781 cure 1 0.7724
781 diffuse 1 0.6728
781 dis- 1 0.6352
781 discover 1 0.8046
781 discussed 1 0.4092
781 disease 1 0.361
781 distant 1 1.0048
781 emotional 1 0.5603
781 emphasis 1 0.724
781 en- 1 0.7724
781 encouraging, 1 0.9046
781 enu- 1 1.0048
781 essential 1 0.5888
781 extensive 1 0.5669
781 familial 1 0.6591
781 following 1 0.3331
781 forms 1 0.4797
781 grossly 1 0.7048
781 im- 1 0.724
781 incurable 1 0.7048
781 lesions 1 0.4321
781 local 1 0.6056
781 looks 1 1.0048
781 malignant 2 1.0959
781 may 3 0.7539
781 merated: 1 1.0048
781 metastasis, 1 0.9046
781 mildly 1 0.8046
781 multicentric 1 1.0048
781 necessary. 1 0.9046
781 obtained 1 0.3582
781 origin. 1 0.6728
781 paid 1 0.7724
781 palliative 1 0.6728
781 paper 1 0.5422
781 part 1 0.4694
781 patients. 1 0.4833
781 perative 1 0.9046
781 phase 3 1.6099
781 polyposis 2 2.0097
781 polyposis. 2 2.0097
781 possibly 1 0.6246
781 practice 1 0.8461
781 pre- 1 0.6466
781 premalignant 1 1.0048
781 present 1 0.3308
781 primary 1 0.4248
781 private 1 1.0048
781 problems 1 0.5212
781 recurrences 1 0.8461
781 resection 2 1.4923
781 results 1 0.2878
781 rewarding. 1 1.0048
781 second 1 0.5119
781 secure 1 1.0048
781 seen 1 0.4248
781 situ. 1 0.9046
781 special 1 0.5313
781 stage 1 0.4871
781 state. 1 0.9046
781 subsequent 1 0.548
781 surgeon 2 1.6091
781 surgery 1 0.4989
781 sympathetic 1 0.7724
781 third 1 0.548
781 tities. 1 0.9046
781 treat 1 1.0048
781 variety 1 0.5422
781 whether 1 0.4989
781 worthwhile 1 0.9046
782 (cns) 1 1.0048
782 13 1 0.5811
782 62% 1 0.8461
782 able 1 0.5669
782 all, 1 0.7724
782 also 1 0.2811
782 although 1 0.3863
782 apy 1 0.8461
782 associated 1 0.3568
782 believe 1 0.6728
782 blood 1 0.3105
782 cases 1 0.299
782 central 1 0.5422
782 chemother- 1 0.8461
782 chemotherapy 1 0.6148
782 chemotherapy. 1 0.7724
782 cns 3 2.1144
782 con- 1 0.5212
782 data. 1 0.7724
782 demonstrable 1 0.6728
782 different 1 0.3554
782 disease, 1 0.5366
782 disorders. 1 0.7724
782 eight. 1 0.9046
782 etic 1 1.0048
782 even 1 0.4398
782 evidence 1 0.3684
782 exactly, 1 1.0048
782 feel 1 0.8046
782 hematopoi- 1 1.0048
782 however, 1 0.3639
782 indicated, 1 0.8046
782 latter 1 0.5212
782 lesions 2 0.8642
782 lesions, 1 0.724
782 measure 1 0.5811
782 metastases 1 0.6879
782 metastatic 2 1.2933
782 nervous 1 0.6148
782 number 1 0.3845
782 ob- 1 0.6879
782 pa- 1 0.5888
782 paralysis 1 0.7462
782 patient 1 0.3778
782 patients 1 0.2415
782 poorly, 1 1.0048
782 ported 1 0.9046
782 present. 1 0.6728
782 rate 1 0.3699
782 recently 1 0.6879
782 regressed. 1 1.0048
782 regression 1 0.6466
782 remission 1 0.7724
782 remissions 1 0.7462
782 reported 1 0.4072
782 respond 1 0.6148
782 resulted 1 0.4871
782 results 1 0.2878
782 seizures, 1 0.8461
782 sidered 1 0.9046
782 significant 1 0.3527
782 significant. 1 0.7048
782 solid 2 1.5448
782 studied, 1 0.7462
782 suggest 1 0.4568
782 sup- 1 0.9046
782 supply 1 0.7462
782 symptomatology 1 0.6879
782 system 1 0.4694
782 systemic 3 1.6808
782 tained 1 0.8046
782 therapy. 1 0.5422
782 tients 1 0.6466
782 tumors 3 1.5786
782 type 1 0.4179
782 variables 1 0.7462
783 40 1 0.4416
783 44 1 0.6034
783 5-fluorouracil 4 2.5382
783 50 1 0.3598
783 a. 1 0.4764
783 achieved 1 0.5159
783 additive 1 0.7536
783 advanced 2 0.7819
783 associated 1 0.2676
783 body 1 0.3038
783 cancer: 1 0.7536
783 carcinoma. 1 0.5159
783 colby, 1 0.7536
783 combination 1 0.4303
783 combined 2 0.7747
783 controlled 1 0.4303
783 dose 1 0.3598
783 doses 1 0.411
783 employed 1 0.4764
783 excessive 1 0.485
783 found 1 0.1984
783 gastrointestinal 2 1.086
783 given 1 0.2763
783 holbrook 1 0.7536
783 injection 1 0.3151
783 intravenous 1 0.4025
783 justify 1 0.6785
783 kilogram 1 0.7536
783 larger 1 0.4477
783 malcolm 1 0.7536
783 manage- 1 0.7536
783 margaret 1 0.7536
783 may 1 0.1885
783 ment 1 0.4943
783 mg. 1 0.4764
783 mortality. 1 0.6785
783 number 1 0.2884
783 objective 1 0.4943
783 onset 1 0.4358
783 pa- 1 0.4416
783 palliation 1 0.4764
783 palliative 2 1.0091
783 patients 1 0.1812
783 per 1 0.2937
783 pilot 1 0.6034
783 possible 1 0.3023
783 radiation 4 1.6439
783 rapid 1 0.3653
783 relatively 1 0.3625
783 role 1 0.3496
783 safe 1 0.4943
783 study 2 0.4643
783 subjective 1 0.6034
783 sufficient 1 0.4542
783 supervoltage 2 1.357
783 synergistic 1 0.6346
783 therapy 3 0.8938
783 therapy. 1 0.4066
783 tients 1 0.485
783 tolerable. 1 0.7536
783 total 1 0.2937
783 toxicity 1 0.4943
783 treatment 1 0.2223
783 weight 1 0.3546
783 y. 1 0.7536
784 80% 1 0.5596
784 adenocarcinoma, 1 0.7536
784 almost 1 0.3874
784 available 1 0.411
784 beyond 1 0.5159
784 cancer 4 1.1917
784 cancers 2 1.0091
784 cancers, 1 0.6785
784 carcinoma 3 1.0793
784 cell 1 0.2551
784 cervix 1 0.7536
784 cervix, 1 0.7536
784 comfort 1 0.7536
784 comfortable 1 0.6785
784 considered 1 0.336
784 curable 1 0.6346
784 curable. 1 0.6785
784 cure 2 1.1586
784 date 1 0.5596
784 degree. 1 0.6785
784 diagnosis 1 0.3101
784 disease; 1 0.7536
784 effective 1 0.3773
784 ence; 1 0.7536
784 epithelial 1 0.3985
784 estimated 1 0.4685
784 exist- 1 0.7536
784 exquisite 1 0.7536
784 favorable 1 0.5159
784 first 2 0.5526
784 foremost, 1 0.7536
784 found 1 0.1984
784 glandular 1 0.5596
784 grows, 1 0.7536
784 highly 1 0.4066
784 however, 1 0.2729
784 in- 1 0.3339
784 irradiation 1 0.4066
784 larynx, 2 1.357
784 less 1 0.2821
784 like 1 0.485
784 lung 3 0.9722
784 lung, 2 1.1586
784 lymphomas. 1 0.7536
784 made, 1 0.5793
784 magnitude 1 0.4685
784 making 2 1.1586
784 management 1 0.3985
784 may 1 0.1885
784 means 2 0.6678
784 moderately 1 0.543
784 modest 1 0.6785
784 more, 1 0.6034
784 much 1 0.3339
784 not, 1 0.5046
784 oat- 1 0.7536
784 often 3 1.0959
784 order 1 0.3946
784 origin, 2 1.0572
784 palliation 1 0.4764
784 presently 1 0.6034
784 principally 1 0.6034
784 prolong 1 0.5793
784 provide 1 0.4416
784 purpose 1 0.5046
784 quite 2 0.8607
784 radiation 1 0.411
784 radiation. 1 0.6785
784 radiocurable 1 0.7536
784 radiosensitive 1 0.7536
784 radiotherapy 2 1.0572
784 ratio. 1 0.6785
784 re- 1 0.3339
784 reasons 1 0.5046
784 relief 1 0.6034
784 resis- 1 0.7536
784 response 1 0.2752
784 second, 2 1.1586
784 sensitivity, 1 0.6346
784 should, 1 0.6785
784 site 1 0.4358
784 skin, 2 1.357
784 so-called 1 0.543
784 sometimes 1 0.485
784 sponding 1 0.6785
784 spread 1 0.5596
784 squamous-cell 2 1.5073
784 substrate 1 0.6346
784 suffering 1 0.4477
784 surround 1 0.7536
784 susceptibility 1 0.5793
784 symptomatic 1 0.5286
784 tant. 1 0.7536
784 theory, 1 0.6346
784 therapeutic 1 0.3805
784 third, 1 0.6346
784 thus 2 0.7819
784 time 1 0.2656
784 tissues 1 0.3449
784 tolerates 1 0.6785
784 true. 1 0.7536
784 tunately, 1 0.7536
784 two: 1 0.7536
784 un- 1 0.485
784 undifferentiated, 1 0.6785
784 unfor- 1 0.7536
784 unlikely. 1 0.7536
784 useful 1 0.4155
784 vary 1 0.6346
784 well 1 0.2636
784 widely 1 0.5046
785 (33.8%) 1 1.5073
785 1/2-year 1 1.5073
785 23.9 1 1.5073
785 7 1 0.6944
785 71 1 1.5073
785 ably 1 1.357
785 action, 1 1.1192
785 administered 1 0.7196
785 agents, 1 1.1192
785 alkylating-agent-cortico- 1 1.5073
785 and/or 1 0.9528
785 average 1 0.6763
785 breast 2 1.5939
785 cancer 1 0.5959
785 carcinoma 1 0.7196
785 chlorambucil 1 1.357
785 chlorambucil-prednisolone 1 1.5073
785 choice. 1 1.2691
785 combined 1 0.7747
785 disagreeable 1 1.5073
785 disseminated 2 2.4137
785 drugs 1 0.831
785 duration 1 0.7893
785 effects. 1 1.2069
785 endocrine-ablation 1 1.5073
785 endogenous 1 1.0318
785 er; 1 1.5073
785 eradication 1 1.5073
785 estrogen. 1 1.5073
785 ie. 1 1.5073
785 long- 1 1.357
785 mechanism 1 0.6944
785 modalities 1 1.357
785 months' 1 1.2691
785 months. 1 1.0091
785 nisolone 1 1.5073
785 objective 1 0.9887
785 obtained 1 0.5373
785 orally, 1 1.5073
785 patients 2 0.7246
785 period, 1 1.0091
785 pred- 1 1.5073
785 presum- 1 1.5073
785 produced 1 0.6138
785 regression 1 0.97
785 results 1 0.4316
785 serious 1 0.9083
785 sex-steroid 1 1.5073
785 similar 2 1.1286
785 sion 1 1.1586
785 six 1 0.831
785 statistically 1 0.9369
785 steroid 1 0.8716
785 suppres- 1 1.5073
785 survival 1 0.725
785 therapy 2 1.1917
785 therapy, 1 0.97
785 therapy. 1 0.8133
785 three 1 0.5667
785 time 1 0.5311
785 toxic 1 0.9221
785 treated 1 0.6202
785 twen- 1 1.5073
785 ty-four 1 1.5073
786 5-year 1 1.1586
786 addition, 1 0.8716
786 advances 1 1.2691
786 beyond 1 1.0318
786 cancer 1 0.5959
786 carcinoma 1 0.7196
786 combining 1 1.2691
786 danger 1 1.2691
786 destroyed. 1 1.357
786 diminished. 1 1.357
786 disseminating 1 1.357
786 encased 1 1.5073
786 encouraging, 1 1.357
786 esopha- 1 1.5073
786 esophagus 2 2.5382
786 excision, 1 1.5073
786 fibrosis 1 1.2069
786 fibrous 1 1.1586
786 firmly 1 1.2069
786 gests 1 1.5073
786 gives 1 1.086
786 gus 1 1.5073
786 however, 1 0.5459
786 impression 1 1.086
786 improve 1 1.2069
786 irradiated 1 0.8716
786 limits 1 1.1586
786 locally, 1 1.5073
786 may 1 0.377
786 noticeably 1 1.357
786 observe 1 1.1586
786 operation 1 0.7893
786 previously 1 0.725
786 radiation 1 0.8219
786 rate 1 0.5548
786 recent 1 0.7893
786 remains 1 0.7893
786 resection 1 1.1192
786 seen. 1 1.5073
786 spread 1 1.1192
786 sug- 1 1.2691
786 supervoltage 1 1.357
786 surgery 1 0.7483
786 surgical 1 0.6807
786 survival 1 0.725
786 therapy 1 0.5959
786 time 2 1.0622
786 tissue, 1 1.086
786 treatment 1 0.4447
786 tumor 2 1.344
786 whether 1 0.7483
787 advanced 2 1.5637
787 application 1 0.8503
787 author. 1 1.5073
787 available 1 0.8219
787 bronchial 2 2.2385
787 carcinoma 2 1.4391
787 clinical 1 0.4913
787 controlled 1 0.8607
787 course 1 0.6851
787 cyclophospha- 1 1.5073
787 cyclophosphamide 1 1.357
787 cyclophosphamide. 1 1.5073
787 details 1 1.0318
787 drug 1 0.7893
787 effect 1 0.4602
787 forty 1 1.5073
787 full 1 1.0091
787 intravenous 1 0.805
787 maintenance 1 1.2069
787 management 1 0.797
787 may 1 0.377
787 mide 1 1.5073
787 noted. 1 1.0091
787 oat-cell 1 1.5073
787 occur 1 0.7363
787 oral 1 0.9221
787 paper 1 0.8133
787 patient 1 0.5667
787 patients 2 0.7246
787 referred 1 0.8954
787 relapses 1 1.5073
787 reviewed. 1 1.0572
787 selective 1 0.8954
787 statistical 1 0.97
787 suffering 1 0.8954
787 suggested 1 0.6268
787 therapy 1 0.5959
787 treated 1 0.6202
787 tumours 1 0.9528
787 type 1 0.6268
788 ably 1 0.6785
788 agement 1 0.7536
788 also 1 0.2108
788 appear 1 0.3449
788 arise 1 0.6034
788 car- 2 1.086
788 carcinoma 1 0.3598
788 care 1 0.4764
788 cinoma 1 0.6034
788 cinoma. 1 0.7536
788 dealing 1 0.543
788 debilitated 1 0.7536
788 doscopic 1 0.7536
788 en- 1 0.5793
788 endoscopically 1 0.7536
788 esophageal 4 2.5382
788 experience 1 0.3874
788 handling 1 0.6785
788 helpful 1 0.5159
788 incurable 1 0.5286
788 inserted 1 0.7536
788 insertion 1 0.6785
788 intraluminal 1 0.6785
788 lems 1 0.6785
788 man- 1 0.6785
788 may 1 0.1885
788 method 1 0.2994
788 obstruction 2 0.9528
788 opera- 1 0.5793
788 particular 1 0.3805
788 patients 3 0.5435
788 preparing 1 0.6346
788 prob- 1 0.6785
788 problems 1 0.3909
788 provides 1 0.4764
788 radiation 1 0.411
788 reason- 1 0.7536
788 regurgitation 1 0.4943
788 relatively 1 0.3625
788 rigors 1 0.7536
788 safe 1 0.4943
788 severely 1 0.485
788 simple 1 0.411
788 suggests 1 0.4025
788 therapy. 1 0.4066
788 tion 1 0.3426
788 tube 1 0.6034
788 tubes 2 1.357
788 tumors, 1 0.5793
788 use 2 0.5959
788 withstand 1 0.6785
788 would 1 0.3742
789 "incurable" 1 0.7536
789 accomplishment, 1 0.7536
789 allowed 1 0.5286
789 application 1 0.4252
789 atti- 1 0.7536
789 avoids 1 0.7536
789 backgrounds 1 0.7536
789 benefit, 1 0.7536
789 cancer 1 0.2979
789 cancer. 1 0.5286
789 care 1 0.4764
789 care, 1 0.7536
789 claims 1 0.7536
789 condemnation 1 0.7536
789 contraindications 2 1.5073
789 delay 1 0.5793
789 demonstration 1 0.485
789 directed 1 0.5046
789 dominant 1 0.5159
789 effort, 1 0.7536
789 equally 1 0.543
789 experience 1 0.3874
789 forces 1 0.5793
789 futility 1 0.7536
789 good 1 0.4202
789 indications 2 1.0318
789 influenced 1 0.4685
789 lack 1 0.4358
789 led 1 0.4416
789 lessen 1 0.7536
789 like 1 0.485
789 little 1 0.4025
789 loss 1 0.3653
789 maximal 1 0.4685
789 may 1 0.1885
789 method 1 0.2994
789 methods 1 0.3403
789 modality. 1 0.7536
789 money 1 0.7536
789 morbidity, 1 0.6785
789 must 2 0.7363
789 obtain 1 0.5286
789 palliative 1 0.5046
789 patient 2 0.5667
789 patient's 1 0.5046
789 per- 1 0.5046
789 physician 1 0.5793
789 physicians 1 0.6785
789 premature 1 0.5159
789 prevalent 1 0.6346
789 prone 1 0.6785
789 publicized 1 0.7536
789 radiation 4 1.6439
789 radiologist. 1 0.7536
789 rather 1 0.3546
789 realistically 1 0.7536
789 recent 1 0.3946
789 remain 1 0.543
789 responsibility 1 0.6785
789 resultant 1 0.543
789 scene. 1 0.7536
789 seeking 1 0.6785
789 still 1 0.352
789 stringent 1 0.6785
789 suasions. 1 0.7536
789 suitable 1 0.485
789 surgery 1 0.3742
789 therapeutic 3 1.1416
789 therapy 4 1.1917
789 time, 1 0.4358
789 treatment 1 0.2223
789 treatment. 1 0.3985
789 tudes 1 0.7536
789 unfortunate 1 0.7536
789 unjustified 2 1.5073
789 unnecessary 1 0.7536
789 useful 1 0.4155
789 user, 1 0.7536
789 various 1 0.2979
789 waste 1 0.7536
789 welfare. 1 0.7536
789 widely 1 0.5046
790 100 1 0.5669
790 29%. 1 1.0048
790 5 1 0.3811
790 carcinoma 2 0.9594
790 cases 3 0.8969
790 crude 1 0.7462
790 difference 1 0.5031
790 ear 2 1.6091
790 increases 1 0.4694
790 large 1 0.3972
790 mastoidectomy 1 1.0048
790 megavoltage 1 0.9046
790 middle 2 1.6091
790 not. 1 0.8046
790 number 1 0.3845
790 preliminary 1 0.5738
790 probably 1 0.4568
790 radiotherapy 1 0.7048
790 rate 1 0.3699
790 rate. 1 0.724
790 relatively 1 0.4833
790 reported. 1 0.5811
790 results 1 0.2878
790 survival 3 1.45
790 use 1 0.3972
790 x-rays 1 0.9046
790 year 1 0.5212
791 64 1 0.8461
791 80% 1 0.7462
791 advanced 2 1.0425
791 analyzed. 1 0.7048
791 appears 1 0.4321
791 attempt 1 0.6148
791 bucil, 1 1.0048
791 carcinoma 2 0.9594
791 carcinoma. 1 0.6879
791 cases 1 0.299
791 cation, 1 1.0048
791 chloram- 1 1.0048
791 chlorambucil 2 1.8093
791 chlorambucil, 1 1.0048
791 compare 1 0.7724
791 diation 1 0.9046
791 different 1 0.3554
791 discussed. 1 0.4296
791 dosage 1 0.6056
791 efficacious 1 1.0048
791 effusion 1 0.7724
791 end 1 0.6148
791 favorably 1 0.8046
791 irradiation 1 0.5422
791 liation 1 1.0048
791 made 1 0.3639
791 management 1 0.5313
791 may 1 0.2513
791 medi- 1 1.0048
791 oral 1 0.6148
791 outpatient 1 1.0048
791 ovarian 3 2.2385
791 pal- 1 0.9046
791 palliation 1 0.6352
791 peritoneal 1 0.7724
791 pleural 1 0.8461
791 points. 1 0.9046
791 possibility 1 0.5738
791 ra- 1 1.0048
791 radiation 1 0.548
791 respond 1 0.6148
791 salvage 1 1.0048
791 schedule 1 0.8046
791 sustained 2 1.5448
791 therapy. 1 0.5422
791 time 1 0.3541
791 time. 1 0.7048
791 used 1 0.3795
791 using 2 0.9135
791 value 2 0.9258
792 basis 1 0.4398
792 bedside 1 0.9046
792 cancer 3 1.1917
792 care 1 0.6352
792 changed 1 0.6879
792 chronic 1 0.4797
792 clear 1 0.6056
792 clinician 1 0.9046
792 clues 3 2.5382
792 communication 2 1.108
792 consider 1 0.7048
792 days 1 0.3992
792 dealing 2 1.448
792 different 1 0.3554
792 disease. 1 0.5313
792 diseases. 1 0.7724
792 doctor 1 1.0048
792 effective. 1 0.8046
792 gifted 1 1.0048
792 help 1 0.724
792 instinctively 1 1.0048
792 knew 1 0.9046
792 made 1 0.3639
792 making 1 0.7724
792 manifest 1 0.7462
792 ministrations. 1 1.0048
792 paramedical 1 0.9046
792 past 1 0.7048
792 patient 1 0.3778
792 patients 1 0.2415
792 pattern 1 0.4797
792 patterns 1 0.6352
792 perhaps 1 0.554
792 personnel 1 0.8461
792 relentless 1 1.0048
792 social 1 0.6466
792 stages 1 0.554
792 thanks 1 1.0048
792 total 1 0.3916
792 us 1 0.6591
792 wise 1 1.0048
792 worker 1 0.9046
793 13 1 0.8716
793 2 1 0.4602
793 also 1 0.4217
793 author's 1 1.357
793 cancer 2 1.1917
793 complications 1 0.8832
793 control 1 0.5667
793 cystitis 1 1.357
793 disease. 1 0.797
793 early 1 0.5526
793 extended 1 1.1586
793 extensive 2 1.7006
793 hemorrhagic 1 1.2069
793 immediate 1 0.9528
793 implants 2 2.7139
793 late 1 0.8954
793 nonexistent. 1 1.5073
793 otherwise 1 1.1192
793 patients. 1 0.725
793 practically 1 1.2691
793 radioactive 2 1.8738
793 radon 1 1.5073
793 rare, 1 1.357
793 reactions 1 0.7363
793 recurrent 2 2.3172
793 result 1 0.6519
793 seed 2 3.0145
793 serious 1 0.9083
793 severe 1 0.6678
793 untreatable 1 1.5073
793 vaginal-pelvic 2 3.0145
793 volume 2 1.5356
794 again. 1 0.9046
794 always 1 0.5366
794 aware 1 0.8046
794 brown's 1 1.0048
794 cancer 1 0.3972
794 carcinoma. 1 0.6879
794 course, 1 0.8461
794 deceive 1 1.0048
794 deteriorating 1 1.0048
794 difficult 1 0.6466
794 herself, 1 1.0048
794 home 1 0.8461
794 hope 1 0.7048
794 illness, 1 0.7724
794 ing 1 0.5422
794 it. 1 0.6879
794 knew 1 0.9046
794 life 1 0.5313
794 life, 1 0.6728
794 living 1 0.724
794 mrs. 1 0.9046
794 new 1 0.4398
794 nurse 1 0.9046
794 nursed 1 1.0048
794 part 1 0.4694
794 perhaps 1 0.554
794 process 1 0.4598
794 say- 1 1.0048
794 something 1 1.0048
794 terminal 1 0.724
794 times, 1 0.7724
794 treatment 1 0.2965
794 try 1 0.8461
794 turn 1 0.9046
794 up, 1 1.0048
794 way 1 0.6352
794 working 1 0.7724
794 worth 1 0.9046
794 would 3 1.4967
795 109 1 0.7536
795 25 1 0.4303
795 3 1 0.2569
795 84 1 0.6034
795 administered 1 0.3598
795 advanced 1 0.3909
795 alone 2 0.9083
795 analyzed. 1 0.5286
795 apy, 1 0.7536
795 assessed 1 0.5596
795 biological 1 0.4025
795 breast 3 1.1955
795 breast, 1 0.7536
795 brought 1 0.4943
795 cancer 2 0.5959
795 carcinoma, 1 0.6346
795 cases, 1 0.3946
795 cases. 1 0.3946
795 closely 1 0.4303
795 considered 1 0.336
795 consisted 1 0.4477
795 continuous 1 0.4252
795 control 1 0.2834
795 corded 1 0.7536
795 course 1 0.3426
795 days 1 0.2994
795 deep, 1 0.6346
795 degree 1 0.3339
795 determine 1 0.4252
795 doses, 1 0.6346
795 drainage. 1 0.7536
795 effects 2 0.5595
795 efficacy 1 0.6034
795 entire 1 0.4943
795 essentially 1 0.5159
795 five 1 0.3985
795 five-year 1 0.6785
795 gression 1 0.6785
795 healing 1 0.5793
795 highest 1 0.4764
795 hundred 1 0.5793
795 immediate 1 0.4764
795 incidence 1 0.3598
795 initial 1 0.3653
795 initially 1 0.4943
795 inoperable. 1 0.7536
795 integrated 1 0.6346
795 intent 1 0.7536
795 involved. 1 0.5793
795 involving 1 0.485
795 irradiation 4 1.6265
795 late 1 0.4477
795 levels 1 0.2951
795 lymphatic 1 0.543
795 manifestations 1 0.4303
795 mastectomy 1 0.6346
795 maximum 1 0.4155
795 method 1 0.2994
795 mostly 1 0.5286
795 must 1 0.3682
795 neoplastic 1 0.5286
795 nodes, 1 0.543
795 one 1 0.2108
795 palpable 1 0.7536
795 patients 1 0.1812
795 patients, 1 0.3773
795 performed 1 0.3449
795 period 1 0.2859
795 phases. 1 0.7536
795 plan 1 0.7536
795 postirradiation 1 0.7536
795 primarily 2 0.9528
795 primary 1 0.3186
795 protracted 1 0.6785
795 radiation 2 0.8219
795 re- 2 0.6678
795 recurrence 1 0.5596
795 remained 1 0.4303
795 remarkable. 1 0.7536
795 required 1 0.411
795 results 1 0.2158
795 seventy- 1 0.7536
795 single 1 0.3742
795 sole 1 0.6346
795 stages, 1 0.6785
795 structures 1 0.5046
795 superficial 1 0.5596
795 ther- 1 0.6346
795 tissue 1 0.2616
795 tolerance 1 0.485
795 treated 2 0.6202
795 treatment 2 0.4447
795 treatment. 1 0.3985
795 tumor 1 0.336
795 ulcerated 1 0.7536
795 within 1 0.2798
795 x 1 0.4764
796 ablation, 1 1.5073
796 ad- 1 1.0091
796 analgesics, 1 1.357
796 application 1 0.8503
796 ataractic 1 1.5073
796 axilla, 1 1.5073
796 beyond 1 1.0318
796 breast 2 1.5939
796 cancer 2 1.1917
796 chemotherapy. 1 1.1586
796 comfortable 1 1.357
796 conjunction 1 1.1586
796 day 1 0.7483
796 disability 1 1.1586
796 disease 1 0.5415
796 disseminated 1 1.2069
796 drugs, 1 1.2691
796 frequently 1 0.7611
796 given 1 0.5526
796 greatly 1 0.8954
796 growth 1 0.5138
796 helped 1 1.2691
796 hormone 1 0.6138
796 however 1 1.086
796 incurable 1 1.0572
796 irradiation, 1 1.1586
796 life. 1 1.086
796 mammary 1 0.97
796 management 1 0.797
796 may 1 0.377
796 measures 1 0.9887
796 methods. 1 0.9528
796 ministration, 1 1.5073
796 pain 1 0.9887
796 patient 1 0.5667
796 period 1 0.5717
796 present 1 0.4963
796 prolong 1 1.1586
796 reduce 1 0.9528
796 retarded 1 0.97
796 sedatives, 1 1.5073
796 skillful 1 1.5073
796 spread 1 1.1192
796 surgical 1 0.6807
796 sympathetic 1 1.1586
796 tissues 1 0.6897
796 tumor 1 0.672
796 useful 1 0.831
797 (1963) 1 0.7536
797 (barrett, 1 0.7536
797 (brady 1 0.7536
797 (e.g. 1 0.7536
797 (flanagan 1 0.7536
797 (lindsley, 1 0.7536
797 (mowrer 1 0.7536
797 (neale, 1 0.7536
797 (rachman, 1 0.7536
797 18 1 0.411
797 1938; 1 0.7536
797 1956; 1 0.7536
797 1958) 1 0.7536
797 1960, 1 0.7536
797 1961), 2 1.5073
797 1961, 1 0.6346
797 1962) 1 0.7536
797 1962), 1 0.6785
797 1963; 1 0.7536
797 1963a, 1 0.7536
797 1965). 1 0.7536
797 6 1 0.3151
797 8-yr-old 1 0.7536
797 9-yr-old 1 0.7536
797 al., 1 0.6785
797 and, 1 0.3909
797 attention) 1 0.7536
797 autism. 1 0.6034
797 autistic 1 0.411
797 b) 1 0.6346
797 be- 1 0.4611
797 blindness 1 0.6034
797 book 1 0.6785
797 bowel 1 0.5793
797 boy 2 1.0091
797 boy's 1 0.7536
797 boy, 1 0.6346
797 candy, 1 0.7536
797 case 3 0.8123
797 child 1 0.3625
797 children 1 0.2676
797 clean 1 0.7536
797 comment. 1 0.7536
797 complete 1 0.3496
797 conditioning 2 1.2691
797 diagnosed 1 0.4611
797 disabilities 1 0.6785
797 eight-year-old 1 0.7536
797 encopresis 1 0.7536
797 encopresis, 1 0.7536
797 encopretic 1 0.7536
797 enuresis 1 0.7536
797 et. 1 0.7536
797 event 1 0.6346
797 four 1 0.3381
797 given 1 0.2763
797 going 1 0.6785
797 habits. 1 0.7536
797 havioral 1 0.7536
797 here. 1 0.6346
797 history 1 0.4358
797 hysterical 1 0.7536
797 inadvertently 1 0.7536
797 including 1 0.4066
797 infantile 1 0.411
797 instances, 1 0.5793
797 lind, 1 0.7536
797 lovibond, 1 0.7536
797 madsen, 1 0.7536
797 month 1 0.5046
797 months 1 0.3805
797 mowrer, 1 0.7536
797 neale 3 2.2609
797 negative 1 0.4416
797 number 1 0.2884
797 one 1 0.2108
797 operant 2 1.357
797 pair 1 0.5793
797 pants 1 0.7536
797 positive 1 0.4025
797 praise 1 0.7536
797 presence. 1 0.7536
797 problems 1 0.3909
797 procedures 1 0.4252
797 psychiatrist/neurologist 1 0.7536
797 psychotic 1 0.4943
797 punished; 1 0.7536
797 rapid 1 0.3653
797 reading 1 0.5596
797 recording 1 0.5286
797 reinforcement 1 0.7536
797 relapse 1 0.6785
797 report 1 0.3653
797 reported 1 0.3054
797 reports 1 0.485
797 response 1 0.2752
797 rewarded 2 1.357
797 similar 1 0.2821
797 small 1 0.3023
797 soiling 1 0.7536
797 special 1 0.3985
797 stuttering 1 0.7536
797 successfully 2 1.0318
797 symptoms 1 0.3571
797 techniques 1 0.411
797 techniques. 1 0.543
797 therapy: 1 0.6785
797 three 1 0.2834
797 tics 1 0.7536
797 toilet 4 3.0145
797 train 1 0.7536
797 training 3 1.7379
797 treated 1 0.3101
797 treatment 2 0.4447
797 used 4 1.1384
797 using 1 0.3426
797 variety 1 0.4066
797 wide 1 0.4477
797 without 1 0.2846
797 would 1 0.3742
798 "social 1 0.6029
798 11 1 0.322
798 28 2 0.8255
798 50 1 0.2878
798 69 1 0.4827
798 able 1 0.3401
798 absence 1 0.2878
798 adequate 1 0.3748
798 adjustment 2 1.0153
798 adjustment. 1 0.6029
798 also 1 0.1687
798 answer 1 0.5428
798 appeared 1 0.29
798 applied 1 0.3633
798 associated 1 0.2141
798 autism 2 0.7163
798 autism, 1 0.5428
798 autism. 1 0.4827
798 be- 1 0.3689
798 characteristic 1 0.3044
798 check 1 0.6029
798 children 1 0.2141
798 classified 1 0.3633
798 community 1 0.5076
798 concerned 1 0.4037
798 concluded 1 0.2759
798 conjunction 1 0.4634
798 contained 1 0.3071
798 control, 1 0.4827
798 deter- 1 0.5428
798 dif- 1 0.4477
798 different 1 0.2133
798 direct 1 0.2836
798 distinguished 1 0.4037
798 dur- 1 0.5428
798 early 4 0.8841
798 ego 1 0.4344
798 except 1 0.3401
798 existed 1 0.6029
798 features 1 0.322
798 ferentiating 1 0.6029
798 finding 1 0.3689
798 first 1 0.221
798 former 1 0.4127
798 found 2 0.3174
798 frequently 1 0.3044
798 gories 1 0.6029
798 group. 1 0.3487
798 groups. 1 0.3581
798 heading 1 0.6029
798 high 1 0.2158
798 hospital 1 0.3811
798 hospital. 1 0.5076
798 hospitalized 2 0.8457
798 impairment 1 0.3955
798 incidence 1 0.2878
798 indicated 1 0.2836
798 infantile 4 1.3151
798 ing 1 0.3253
798 interviewed 1 0.6029
798 items 1 0.5428
798 items. 1 0.6029
798 later 1 0.3099
798 lems 1 0.5428
798 life 1 0.3188
798 list. 1 0.6029
798 ly 1 0.3955
798 make 1 0.3581
798 mental 2 0.6802
798 mine 1 0.6029
798 mothers 3 1.09
798 normals, 2 0.9269
798 number 1 0.2307
798 occurrence 1 0.3581
798 occurring 1 0.3487
798 often 2 0.5845
798 one 1 0.1687
798 outside 1 0.4634
798 overall 1 0.3955
798 patient. 1 0.4127
798 patients 4 0.5797
798 presence 2 0.4594
798 presenting 1 0.4037
798 prob- 1 0.5428
798 proportion 1 0.3748
798 provide 1 0.3533
798 psychia- 1 0.6029
798 psychiatric 1 0.388
798 ques- 1 0.6029
798 questioned 1 0.5076
798 regard 1 0.3443
798 relationship 2 0.58
798 reported 3 0.7329
798 reportedly 1 0.6029
798 represent 1 0.3811
798 residing 1 0.5428
798 results 1 0.1727
798 retrospective- 1 0.6029
798 s's 1 0.5428
798 school 1 0.4477
798 sensitive 1 0.3253
798 several 1 0.2608
798 severe 1 0.2671
798 significant 2 0.4233
798 significantly 1 0.2535
798 signs 3 1.0085
798 status 1 0.3811
798 students 1 0.4827
798 study 2 0.3715
798 subcate- 1 0.6029
798 subsequent 2 0.6575
798 subsequently 1 0.4037
798 symptoms 5 1.4285
798 symptoms. 1 0.4477
798 tion 1 0.2741
798 tric 1 0.6029
798 tween 1 0.4344
798 two 1 0.1846
798 unmarried 1 0.5428
798 well 1 0.2108
798 withdrawal" 1 0.6029
798 years 1 0.2741
798 young 1 0.3044
799 10 1 0.1585
799 13 1 0.249
799 13% 1 0.3626
799 149 2 0.8613
799 19% 1 0.4306
799 33% 1 0.3877
799 37 1 0.2883
799 4 1 0.1523
799 44 1 0.3448
799 51% 2 0.8613
799 58 2 0.7252
799 91 1 0.3877
799 abnormal 1 0.2087
799 abnormalities 5 1.2006
799 abnormalities. 1 0.3626
799 ac- 1 0.2771
799 acting-out 2 0.8613
799 alone 1 0.2595
799 although 1 0.1655
799 among 1 0.2012
799 amount 1 0.2121
799 anxiety 1 0.2677
799 au- 1 0.3877
799 autistic 1 0.2348
799 autistic-symbiotic 1 0.4306
799 behavior 2 0.4918
799 best 1 0.2277
799 body 1 0.1736
799 cannot 1 0.2324
799 cative 1 0.4306
799 cepted 1 0.4306
799 cerebral 1 0.2041
799 chem- 1 0.4306
799 chiatric 1 0.4306
799 childhood 2 0.4859
799 children 5 0.7646
799 children, 1 0.2523
799 children. 2 0.4918
799 children: 1 0.331
799 chronic 2 0.4112
799 clinical 2 0.2808
799 com- 1 0.2558
799 communi- 1 0.4306
799 comparison 1 0.2234
799 complex, 1 0.3103
799 complexes 1 0.3448
799 concomitant 1 0.331
799 conditions 1 0.1958
799 decided 1 0.3448
799 demonstrated 1 0.1841
799 determined 1 0.1958
799 diagnoses 1 0.3877
799 diagnosis. 1 0.2883
799 different 1 0.1523
799 disorder 1 0.2677
799 disorders. 1 0.331
799 disorders; 1 0.4306
799 distrubed 1 0.4306
799 disturbed 1 0.2677
799 done 1 0.2883
799 double-blind 1 0.3877
799 dysfunction 1 0.331
799 early 1 0.1579
799 eeg 7 2.1719
799 eeg's 2 0.7754
799 effect 1 0.1315
799 either 1 0.1841
799 electrical 1 0.3877
799 entiated 1 0.4306
799 even 1 0.1885
799 except 1 0.2429
799 factor 1 0.2041
799 final 1 0.2825
799 focal 2 0.6396
799 frequent 2 0.519
799 group, 1 0.2771
799 groups 1 0.1754
799 higher 1 0.1852
799 higher. 1 0.3626
799 identical 1 0.2558
799 ilar 1 0.4306
799 im- 1 0.3103
799 incidence 3 0.6168
799 included 1 0.2324
799 increasing 1 0.2523
799 independent 2 0.519
799 ir- 1 0.3626
799 istry 1 0.4306
799 knowledge 2 0.5649
799 made 1 0.156
799 might 1 0.2255
799 neuroses; 1 0.4306
799 neurotics, 1 0.4306
799 never- 1 0.4306
799 non-psychotic 2 0.8613
799 none 1 0.2595
799 normal 3 0.3474
799 obtained 1 0.1535
799 often 1 0.2087
799 order 1 0.2255
799 organic 1 0.2558
799 oxysmal 1 0.4306
799 par- 1 0.3448
799 paroxysmal 2 0.8613
799 patients 1 0.1035
799 patients, 1 0.2156
799 patients. 2 0.4143
799 performing, 1 0.4306
799 placed 1 0.2558
799 ple, 1 0.4306
799 plexes, 1 0.4306
799 plied 1 0.4306
799 primary 1 0.1821
799 prolonged 1 0.2071
799 promazine 2 0.8613
799 psy- 1 0.4306
799 psychiatric 1 0.2771
799 psychiatrically 4 1.7226
799 psychosis. 1 0.3198
799 qualitatively 1 0.3626
799 quantitatively 1 0.4306
799 random 1 0.3626
799 read 1 0.331
799 readings 1 0.331
799 records. 1 0.3877
799 regular 1 0.3198
799 remaining 1 0.2194
799 sam- 1 0.4306
799 schizophrenia: 1 0.4306
799 schizophrenia; 1 0.4306
799 schizophrenics 1 0.3877
799 secondary 1 0.2156
799 sedation 2 0.8613
799 seen 1 0.1821
799 seizure 1 0.4306
799 seizures, 1 0.3626
799 severe, 1 0.3021
799 significantly 1 0.1811
799 sim- 1 0.4306
799 similar 1 0.1612
799 sleep. 1 0.3877
799 slowing, 1 0.4306
799 speech 1 0.2255
799 spike 1 0.4306
799 spikes 2 0.8613
799 spikes, 1 0.4306
799 spikes. 2 0.8613
799 statistically 1 0.2677
799 study 2 0.2653
799 study, 1 0.2771
799 symbiotic 1 0.331
799 theless, 1 0.4306
799 time 1 0.1517
799 time. 1 0.3021
799 tistic-symbiotic 1 0.4306
799 tracings 1 0.4306
799 transition 1 0.331
799 undiffer- 1 0.4306
799 undifferentiated 1 0.3198
799 wake 1 0.4306
799 wave 1 0.3448
799 waves 1 0.3448
799 waves, 1 0.3877
799 whether 1 0.2138
799 without 2 0.3253
800 abysmal 1 1.0048
800 accuracy. 1 1.0048
800 also 1 0.2811
800 alternated 1 1.0048
800 alternation 1 1.0048
800 attacks. 1 1.0048
800 autistic 2 1.0959
800 beset 1 1.0048
800 biotic 1 1.0048
800 breast-feeding 1 1.0048
800 budding 1 1.0048
800 case, 3 2.2385
800 child 3 1.45
800 closeness 1 1.0048
800 conclusion, 1 1.0048
800 constitutional 1 0.7462
800 constitutionally 1 1.0048
800 contact 1 0.5811
800 contrast, 1 0.7724
800 contrasting 1 0.9046
800 core 1 0.7048
800 could 1 0.361
800 created 1 0.8046
800 de-animation 1 1.0048
800 degree 1 0.4452
800 described 1 0.3811
800 destructiveness 1 1.0048
800 dis- 2 1.2704
800 distortions 1 0.9046
800 drove 1 1.0048
800 early 1 0.3684
800 ego, 1 0.8461
800 emotional 1 0.5603
800 evaluated 1 0.5811
800 ever-presence 1 1.0048
800 experience 1 0.5165
800 experiences 1 0.6728
800 extreme 1 0.6591
800 factors 1 0.4248
800 first 1 0.3684
800 gratification-frustration 1 1.0048
800 heart 1 0.4661
800 human 1 0.3354
800 impossible 1 0.8461
800 individuation 1 0.9046
800 infant 1 0.5669
800 infantile 1 0.548
800 instances, 1 0.7724
800 instrusion 1 1.0048
800 interference 1 0.6728
800 lay 1 1.0048
800 made 2 0.7278
800 marked 1 0.4509
800 may 1 0.2513
800 mother's 2 1.6091
800 mother, 1 0.8461
800 must 1 0.4909
800 normal 2 0.5404
800 not, 1 0.6728
800 one 2 0.5622
800 pace; 1 1.0048
800 panic. 1 1.0048
800 particularly 1 0.554
800 perhaps 1 0.554
800 period 1 0.3811
800 phase. 1 0.8046
800 physical 1 0.5811
800 predispositionally 1 1.0048
800 primarily 1 0.6352
800 process 1 0.4598
800 psychosis 2 1.5448
800 psychosis. 1 0.7462
800 psychotic 1 0.6591
800 purely 1 0.7724
800 rage 1 1.0048
800 reality. 1 1.0048
800 roots. 1 1.0048
800 second 1 0.5119
800 see 1 0.8046
800 separation-individuation 1 0.8461
800 sequences 1 0.8046
800 severe 1 0.4452
800 situations, 1 0.8046
800 sought 1 0.9046
800 state 1 0.5165
800 structuralization 1 1.0048
800 sym- 1 1.0048
800 symbiosis 1 0.9046
800 symbiotic 1 0.7724
800 syndromes 1 0.7048
800 tortions 1 1.0048
800 turbance 1 1.0048
800 unavailability 1 1.0048
800 unendurable 1 1.0048
800 unpredictable 1 0.9046
800 upon 1 0.4509
800 vulnerable. 1 1.0048
800 warding 1 1.0048
800 was, 1 0.7724
800 wish 1 1.0048
800 world 1 0.7462
801 "autistic 1 1.5073
801 10 1 0.5548
801 5 1 0.5717
801 acta 1 1.5073
801 appear 1 0.6897
801 arn. 1 1.5073
801 author 1 0.8832
801 autopathy:follow-up 1 1.5073
801 brief 1 1.0572
801 cases 2 0.8969
801 cases. 1 0.7893
801 conform 1 1.5073
801 contribution 1 1.086
801 d. 1 0.97
801 description. 1 1.357
801 eventual 1 1.357
801 fact 1 0.797
801 followed 1 0.6897
801 give 1 0.8219
801 idea 1 1.2691
801 krevelen 1 1.5073
801 least 1 0.7747
801 lies 1 1.2691
801 may 1 0.377
801 paedopsychiatrica 1 1.5073
801 papers 1 1.2691
801 present 1 0.4963
801 psychopathy", 1 1.5073
801 publication 1 1.5073
801 recently 1 1.0318
801 results 1 0.4316
801 stimulated 1 1.0091
801 subject 1 0.97
801 two 1 0.4616
801 type 1 0.6268
801 value 1 0.6944
801 van 1 1.5073
801 years, 1 0.9528
802 (hermelin 1 0.7536
802 1964) 1 0.6785
802 addition 1 0.3839
802 affected 1 0.3909
802 also 1 0.2108
802 autistic 2 0.8219
802 autistic, 1 0.7536
802 bimodal, 1 0.7536
802 children 4 1.0704
802 combina- 1 0.6785
802 command 1 0.7536
802 conditions 1 0.3426
802 control 1 0.2834
802 controls 1 0.4542
802 determined. 1 0.5159
802 dominance 2 1.2069
802 experiment 2 1.0091
802 found 1 0.1984
802 frequently 2 0.7611
802 groups 1 0.3069
802 groups. 1 0.4477
802 high 1 0.2697
802 however, 1 0.2729
802 imbecile 4 3.0145
802 independent 1 0.4542
802 intensities 1 0.7536
802 intensity 2 1.0572
802 irrespective 1 0.5159
802 level 1 0.291
802 light 3 1.2755
802 made, 1 0.5793
802 modality, 1 0.7536
802 mongol, 1 0.7536
802 nonmongol 2 1.5073
802 not. 1 0.6034
802 o'connor, 1 0.7536
802 present 1 0.2481
802 presented 1 0.2924
802 previous 1 0.4066
802 relative 1 0.3909
802 remained 1 0.4303
802 responded 2 1.1192
802 responses, 1 0.6034
802 results 1 0.2158
802 rewarded. 1 0.7536
802 role 1 0.3496
802 sensory 1 0.5596
802 showed 1 0.2686
802 significantly 1 0.3168
802 simultaneous 1 0.4611
802 simultaneously 1 0.4542
802 sound 1 0.6785
802 sound, 1 0.7536
802 stim- 1 0.7536
802 stimulation. 1 0.6785
802 stimuli 1 0.543
802 stimulus 1 0.5046
802 stimulus, 1 0.6785
802 tendency 1 0.543
802 tested. 1 0.7536
802 tions. 1 0.6785
802 two 1 0.2308
802 ulus 1 0.7536
802 various 1 0.2979
802 verbal 2 1.0091
802 visual 1 0.411
803 5-year-old 1 0.9046
803 age. 1 0.5669
803 amount 1 0.4948
803 autistic 3 1.6439
803 children 1 0.3568
803 chin 1 1.0048
803 dreaming 2 2.0097
803 electroencephalogram, 1 1.0048
803 eye 1 0.6466
803 heart 1 0.4661
803 identical 1 0.5969
803 movement, 1 0.9046
803 muscle 1 0.554
803 night 1 0.8461
803 normal 1 0.2702
803 observed 1 0.3425
803 one 1 0.2811
803 patterning 1 1.0048
803 potential 1 0.6591
803 rate, 1 0.7048
803 recorded. 1 0.8046
803 reported 1 0.4072
803 session 1 0.9046
803 showed 1 0.3582
803 similar 1 0.3762
803 sleep 3 2.7139
803 spontaneous 1 0.5811
803 twins 3 2.4137
804 acquisition 1 0.5286
804 also 2 0.4217
804 although 2 0.5794
804 appears 1 0.3241
804 autism 3 1.3431
804 autism. 2 1.2069
804 available 1 0.411
804 blood 1 0.2329
804 case 1 0.2708
804 cases 1 0.2242
804 childhood 1 0.4252
804 cific 1 0.7536
804 consistent 1 0.4202
804 data, 1 0.6034
804 demon- 1 0.6034
804 determinants. 1 0.7536
804 develop- 1 0.5793
804 development 1 0.2752
804 different. 1 0.6785
804 discordant 3 2.2609
804 documented 1 0.543
804 early 2 0.5526
804 emotional 1 0.4202
804 etiology 1 0.4155
804 evidence 1 0.2763
804 factors 4 1.2744
804 fest 1 0.7536
804 findings 1 0.2994
804 genetic 3 1.1839
804 guage 1 0.7536
804 hereditary 1 0.543
804 heterozygous 1 0.6034
804 homozygous 1 0.5793
804 hypothesis 1 0.4025
804 impaired 1 0.5159
804 infantile 3 1.2329
804 kanner's 1 0.6785
804 lan- 1 0.7536
804 literature 1 0.411
804 mani- 1 0.6346
804 may 2 0.377
804 ment 1 0.4943
804 needed. 1 0.6346
804 obscure, 1 0.7536
804 offer 1 0.485
804 one. 1 0.5793
804 organic 1 0.4477
804 out, 1 0.6346
804 pair 1 0.5793
804 part, 1 0.6346
804 physical 1 0.4358
804 play 1 0.4477
804 presented 1 0.2924
804 probably 1 0.3426
804 properly 1 0.6034
804 relevant 2 1.086
804 remains 1 0.3946
804 reported 2 0.6107
804 reversible 1 0.5596
804 reviewed. 1 0.5286
804 role 1 0.3496
804 ruled 1 0.6346
804 second 2 0.7678
804 set 2 1.2069
804 sibling 1 0.7536
804 spe- 1 0.6785
804 strated. 1 0.7536
804 studies 2 0.4616
804 suggests 1 0.4025
804 syndrome 1 0.3496
804 that, 1 0.4943
804 twin 2 1.5073
804 twins 4 2.4137
804 twins' 1 0.7536
804 typing 1 0.6785
804 view 1 0.4416
805 (and 1 0.6785
805 (regardless 1 0.7536
805 abate 1 0.7536
805 action 1 0.3279
805 actual 1 0.543
805 acute 1 0.3742
805 adventi- 1 0.7536
805 and, 1 0.3909
805 attitude, 1 0.7536
805 autism 1 0.4477
805 autistic 4 1.6439
805 available; 1 0.7536
805 behavior, 1 0.6034
805 believe 1 0.5046
805 cal 1 0.5793
805 cata- 1 0.7536
805 child 2 0.725
805 child's 4 1.8443
805 children 1 0.2676
805 choice 1 0.485
805 circumstances, 2 1.5073
805 consequent 1 0.6346
805 considered 1 0.336
805 constitute 1 0.6346
805 core 1 0.5286
805 counter 1 0.6785
805 counterrejection 1 0.7536
805 counterwithdrawal. 1 0.7536
805 cumulative 1 0.6346
805 de- 1 0.4202
805 defensive 1 0.6785
805 degrees 1 0.4764
805 develop- 1 0.5793
805 developing, 1 0.7536
805 development. 1 0.5159
805 developmental 1 0.5046
805 directed 1 0.5046
805 disruption 1 0.7536
805 drawal, 1 0.7536
805 effort 1 0.5596
805 ego 1 0.543
805 etiologi- 1 0.6785
805 evaluation 1 0.4066
805 even 1 0.3299
805 every 1 0.4202
805 exist 1 0.5159
805 families 1 0.5286
805 family 1 0.4542
805 family) 1 0.7536
805 felt 1 0.5596
805 formal 2 1.1192
805 fortunately 1 0.7536
805 gradually 1 0.4764
805 immature 1 0.5046
805 infantile 1 0.411
805 intervention 1 0.6034
805 limation 1 0.7536
805 little 1 0.4025
805 lusional 1 0.7536
805 magical 1 0.7536
805 make 1 0.4477
805 malignant 1 0.411
805 many 1 0.3038
805 may 2 0.377
805 mental 1 0.4252
805 modify 1 0.6346
805 mother 4 1.7214
805 necessary 1 0.4416
805 object 1 0.5596
805 object. 2 1.5073
805 objects 1 0.5793
805 obsessional 1 0.7536
805 organism 2 1.0091
805 others. 1 0.6034
805 overwhelming 1 0.7536
805 paranoid 4 3.0145
805 part 1 0.352
805 pathological 1 0.4066
805 physiological 1 0.4416
805 planning 1 0.6346
805 possibility 1 0.4303
805 primary 3 0.9558
805 primitive 2 1.2691
805 processes, 1 0.5596
805 psychopathology 1 0.6785
805 range 1 0.4066
805 ranging 1 0.5159
805 re- 1 0.3339
805 reaction 3 1.1319
805 reaction. 1 0.5596
805 reactions 1 0.3682
805 rejection 1 0.5793
805 relationships 2 0.97
805 respond 2 0.9221
805 responds 1 0.6785
805 severe 1 0.3339
805 shows 1 0.4155
805 simple 1 0.411
805 since 1 0.3279
805 skills, 1 0.7536
805 speech, 1 0.5793
805 stage 1 0.3653
805 stage, 1 0.5793
805 still 2 0.7041
805 stress 1 0.5159
805 stress. 1 0.7536
805 strophic 1 0.7536
805 sub- 1 0.485
805 symptoms 1 0.3571
805 tends 1 0.5793
805 therapeutic 1 0.3805
805 though 1 0.4416
805 thought 1 0.4252
805 tious 1 0.7536
805 traumata 1 0.7536
805 treatment 1 0.2223
805 treatment. 1 0.3985
805 un- 1 0.485
805 undifferentiated 1 0.5596
805 variables) 1 0.7536
805 varying 1 0.4066
805 vulnerable 1 0.6785
805 wide 1 0.4477
805 with- 1 0.6346
805 without 1 0.2846
805 yet, 1 0.7536
806 20 1 0.4538
806 accessible 1 0.9046
806 all, 1 0.7724
806 always 1 0.5366
806 american 1 1.0048
806 annual 1 0.9046
806 association, 1 0.9046
806 attend 1 1.0048
806 attending 1 0.8461
806 back 1 0.7462
806 be. 1 0.9046
806 behavior 1 0.5738
806 believe 2 1.3455
806 best, 1 1.0048
806 bright 1 1.0048
806 brought 1 0.6591
806 charts, 1 1.0048
806 chronic 1 0.4797
806 chronically 1 0.8461
806 clinical 1 0.3275
806 complete 1 0.4661
806 convulsions 1 1.0048
806 could 1 0.361
806 course 1 0.4568
806 current 1 0.6246
806 deteriorated 1 1.0048
806 determined 1 0.4568
806 drug 1 0.5262
806 evaluation? 1 1.0048
806 fantasies 1 1.0048
806 fifty-second 1 1.0048
806 form 1 0.4372
806 given 2 0.7367
806 graphs, 1 1.0048
806 group 1 0.3714
806 helpful 1 0.6879
806 home 1 0.8461
806 hospital 1 0.6352
806 hospitalized 1 0.7048
806 hospitalized, 1 1.0048
806 hospitals 1 1.0048
806 however, 1 0.3639
806 im- 1 0.724
806 inaccessible 1 1.0048
806 indefinitely. 1 1.0048
806 individual 1 0.5313
806 judge 1 1.0048
806 least 1 0.5165
806 level 1 0.388
806 live 1 0.6879
806 living 1 0.724
806 ma- 1 0.8046
806 making 1 0.7724
806 many 3 1.2153
806 margin 1 0.8461
806 may 1 0.2513
806 meaningful 1 0.8461
806 meeting 1 0.9046
806 ment 1 0.6591
806 metrazol-induced 1 1.0048
806 mother 1 0.5738
806 never 1 0.6591
806 one 1 0.2811
806 others 1 0.548
806 patient 1 0.3778
806 patients 2 0.4831
806 physiological 1 0.5888
806 program 1 0.7048
806 program, 1 1.0048
806 proving. 1 1.0048
806 pseudoneurotic 1 1.0048
806 psychopathological 1 1.0048
806 psychosis, 1 0.8046
806 puberty 1 0.9046
806 public 1 0.8046
806 raising 1 0.724
806 range 1 0.5422
806 regressed, 1 1.0048
806 results 1 0.2878
806 schizophrenia 1 0.7462
806 schizophrenic 1 0.6352
806 schizophrenic? 1 1.0048
806 schizophrenogenic? 1 1.0048
806 schools 1 0.9046
806 several 1 0.4346
806 shows 1 0.554
806 since, 1 1.0048
806 sinner 2 2.0097
806 sinner, 1 1.0048
806 sinner; 1 1.0048
806 speaker 1 1.0048
806 state 1 0.5165
806 statistical 1 0.6466
806 still 1 0.4694
806 sufficiently 1 0.8461
806 ten 1 0.6056
806 terial 1 0.7462
806 therapeutic 1 0.5074
806 therapy 2 0.7945
806 thus 1 0.5212
806 time 1 0.3541
806 tolerance 1 0.6466
806 total 1 0.3916
806 treat- 1 0.6246
806 twenty-five 1 0.9046
806 view 1 0.5888
806 wealth 1 1.0048
806 whose 1 0.5888
806 without 1 0.3795
806 year 1 0.5212
806 years, 1 0.6352
806 years. 1 0.6352
807 "group 1 0.7536
807 approach 1 0.4685
807 autism 1 0.4477
807 children 3 0.8028
807 collateral 1 0.6346
807 constitutes 1 0.5596
807 defense 2 1.5073
807 ego," 1 0.7536
807 first 1 0.2763
807 forms 1 0.3598
807 group 4 1.1143
807 loss 1 0.3653
807 new 1 0.3299
807 occur. 1 0.6034
807 one 1 0.2108
807 parents: 1 0.7536
807 partner. 1 0.7536
807 penetrates 1 0.7536
807 pole 1 0.7536
807 preliminary 1 0.4303
807 preschool 1 0.6346
807 preschool-aged 1 0.7536
807 psychotherapy 1 0.6034
807 psychotic 2 0.9887
807 report 1 0.3653
807 reported. 1 0.4358
807 separation-individuation 1 0.6346
807 symbiosis 1 0.6785
807 symbiotic 1 0.5793
807 therapeutic 1 0.3805
807 therapy 1 0.2979
807 treatment 1 0.2223
807 two 1 0.2308
807 years 1 0.3426
808 "autism" 1 1.5073
808 "autism", 1 1.5073
808 "autistic" 1 1.5073
808 autistic 1 0.8219
808 background 1 1.1192
808 briefly 1 0.9083
808 child 2 1.45
808 childhood. 1 1.357
808 childhood: 1 1.2691
808 clinical 1 0.4913
808 considerations 2 2.0636
808 definition 1 1.2069
808 designated. 1 1.5073
808 diagnosis 1 0.6202
808 diagnostic 1 0.7483
808 differential 2 1.9056
808 disturbances 1 0.8954
808 early 2 1.1051
808 emotional 1 0.8404
808 etiological-diagnostic 1 1.5073
808 experiences 1 1.0091
808 field. 1 1.2691
808 formidable 1 1.5073
808 frequently 1 0.7611
808 given 1 0.5526
808 historical 1 1.2691
808 however, 1 0.5459
808 implications, 1 1.5073
808 label 1 1.2069
808 paper 1 0.8133
808 presents 1 1.2069
808 problems 1 0.7819
808 psychiatric 1 0.97
808 purpose 1 1.0091
808 ramifications, 1 1.5073
808 reactions 1 0.7363
808 recent 1 0.7893
808 regard 1 0.8607
808 review 1 0.831
808 severe 1 0.6678
808 specific 1 0.593
808 term 2 1.6808
808 term, 1 1.2691
808 today 1 1.2691
808 treatment 1 0.4447
808 used 1 0.5692
809 (memorial 1 0.6029
809 1959). 1 0.6029
809 able 1 0.3401
809 affective 1 0.5076
809 also 1 0.1687
809 ance 1 0.4634
809 another 1 0.3288
809 anyone 1 0.5428
809 appear 1 0.2759
809 appears 1 0.2593
809 approach 1 0.3748
809 area 1 0.3127
809 autism: 1 0.5428
809 autistic 1 0.3288
809 autoerotic 2 1.2058
809 awareness 1 0.5428
809 behavior, 1 0.4827
809 behavior. 1 0.4634
809 biting 1 0.6029
809 bodies, 1 0.4827
809 body 2 0.4861
809 body, 1 0.4827
809 body; 1 0.6029
809 center 1 0.388
809 change 1 0.2797
809 child 2 0.58
809 child's 2 0.7377
809 child, 1 0.4127
809 children 2 0.4282
809 clinic 1 0.5076
809 clinic, 1 0.6029
809 communicate 1 0.6029
809 concurrent 1 0.4634
809 contact. 1 0.5428
809 developed 1 0.2741
809 display 5 2.4137
809 distress. 1 0.5428
809 dragging 1 0.6029
809 early 1 0.221
809 example, 1 0.5428
809 expression 1 0.4344
809 external 1 0.3633
809 family 1 0.3633
809 first 1 0.221
809 genital 1 0.4827
809 give 1 0.3288
809 growing 1 0.4037
809 growth 1 0.2055
809 guid- 1 0.6029
809 guideposts 1 0.6029
809 heads 1 0.6029
809 hitting 1 0.6029
809 human 1 0.2012
809 impression 1 0.4344
809 increased 1 0.1874
809 indicate 1 0.2655
809 infantile 1 0.3288
809 inflict 1 0.6029
809 injured 1 0.4634
809 injury 1 0.4037
809 insensitive 1 0.6029
809 integrate 1 0.6029
809 internal 1 0.3401
809 known 1 0.2945
809 later, 1 0.4827
809 leg 1 0.5428
809 little 2 0.644
809 made 1 0.2183
809 manifested 1 0.4634
809 noted 1 0.3188
809 objects 1 0.4634
809 observing 1 0.5428
809 one 3 0.506
809 others, 1 0.4634
809 outward 1 0.6029
809 pain 1 0.3955
809 pain, 1 0.6029
809 pain. 1 0.5428
809 part 1 0.2816
809 period 1 0.2287
809 pleasure 1 0.6029
809 point 1 0.3487
809 polio 1 0.6029
809 preliminary 1 0.3443
809 quite 3 1.0328
809 readily. 1 0.6029
809 residence 1 0.5428
809 residential 1 0.5428
809 respond 1 0.3689
809 seemed 1 0.388
809 source, 1 0.5076
809 sources, 1 0.5076
809 stay 1 0.6029
809 stimulation, 1 0.5076
809 stimuli, 1 0.6029
809 themselves, 1 0.6029
809 therapist 1 0.6029
809 therapy, 1 0.388
809 ticklish, 1 0.6029
809 toward 1 0.388
809 treatment 1 0.1779
809 unable 1 0.4477
809 unaware 2 1.2058
809 us 1 0.3955
809 well 1 0.2108
809 working 1 0.4634
809 would 1 0.2993
810 (autistic) 1 0.7536
810 abnormalities 1 0.4202
810 accompanied 1 0.4202
810 analysed 1 0.6785
810 analysis 1 0.3625
810 appropriate 1 0.4943
810 assessment 1 0.5046
810 available 1 0.411
810 behavioural 1 0.6785
810 changing 1 0.5596
810 children 4 1.0704
810 children. 1 0.4303
810 clinical 1 0.2457
810 compared 1 0.2924
810 context, 1 0.7536
810 correlated 1 0.4477
810 cues. 1 0.7536
810 curiosity 1 0.7536
810 data 1 0.3069
810 detailed 1 0.4764
810 development 1 0.2752
810 developmental 1 0.5046
810 earlier 1 0.5596
810 environmental 2 1.1192
810 expressions 1 0.7536
810 fourteen 2 1.2069
810 grossly 1 0.5286
810 highly 1 0.4066
810 histories 1 0.5596
810 history 1 0.4358
810 illness. 1 0.6785
810 lack 1 0.4358
810 language 4 1.7663
810 level 1 0.291
810 means 1 0.3339
810 measures 1 0.4943
810 normal 2 0.4053
810 observation 1 0.3946
810 observations. 1 0.6785
810 overall 1 0.4943
810 previous 2 0.8133
810 protocols 1 0.6785
810 recorded 1 0.4303
810 repetition 1 0.6346
810 responsiveness 1 0.6034
810 retarded 1 0.485
810 schizophrenic 3 1.4292
810 severity 1 0.4611
810 stereotyped 1 0.6785
810 striking 1 0.4764
810 studied 2 0.5251
810 utterances 1 0.7536
811 'cut-off' 1 0.2512
811 'flat' 1 0.2512
811 (early 1 0.2512
811 10 2 0.1849
811 3 1 0.0856
811 6 1 0.105
811 a. 2 0.3176
811 acti- 1 0.2262
811 active 1 0.1157
811 activities 1 0.1453
811 activity 2 0.1798
811 activity. 1 0.172
811 acutely 1 0.2512
811 adult. 1 0.2262
811 adult; 1 0.2262
811 advanced 1 0.1303
811 age 1 0.1039
811 age. 1 0.1417
811 alpha 1 0.2512
811 also 2 0.1406
811 analysis 1 0.1208
811 another 1 0.137
811 arousal. 1 0.2512
811 autism). 1 0.2512
811 autistic 7 0.9589
811 b 1 0.172
811 b. 1 0.1401
811 behaviour 1 0.2011
811 behaviour. 1 0.2262
811 behavioural 2 0.4523
811 biographies 1 0.2512
811 block-play 1 0.2512
811 blocks 3 0.5793
811 c. 1 0.1328
811 carried 1 0.1258
811 carry 1 0.181
811 changes 2 0.1503
811 characteristically 1 0.2115
811 characterized 1 0.1328
811 child, 1 0.172
811 children 12 1.0704
811 children, 2 0.2944
811 chronically 1 0.2115
811 clear 1 0.1514
811 clearly 1 0.1514
811 compared 1 0.0975
811 complexity: 1 0.2512
811 constructive 1 0.2115
811 contact 1 0.1453
811 containing 1 0.1328
811 contrast 1 0.1682
811 d. 1 0.1617
811 diagnosed 1 0.1537
811 differentiated 1 0.1682
811 discussed 1 0.1023
811 duration 1 0.1315
811 eeg 3 0.543
811 eegs 2 0.5024
811 eight 1 0.1434
811 electro- 1 0.2011
811 electroencephalographic 1 0.2115
811 empty 1 0.2512
811 encephalographic 1 0.2512
811 environment 2 0.3364
811 environment, 1 0.2115
811 environments 2 0.5024
811 environments. 2 0.5024
811 established 1 0.1355
811 except 1 0.1417
811 findings 1 0.0998
811 fixations 1 0.2512
811 four 1 0.1127
811 free-field 1 0.2512
811 gesturing, 1 0.2512
811 given 1 0.0921
811 gressively 1 0.2512
811 group 1 0.0929
811 high 1 0.0899
811 higher 1 0.108
811 hypothesis 1 0.1342
811 hypothesis. 1 0.2115
811 including 1 0.1355
811 infantile 1 0.137
811 irregular 3 0.5596
811 kanner's 1 0.2262
811 laboratory 1 0.1453
811 lacked 1 0.2512
811 latter 1 0.1303
811 less 1 0.094
811 little 1 0.1342
811 locomotion, 1 0.2512
811 logical 1 0.1865
811 low 1 0.11
811 made 1 0.091
811 manipulation 1 0.2262
811 manipulatory 1 0.2512
811 materials 1 0.1762
811 means 1 0.1113
811 minute 1 0.1865
811 non-stereotypy 1 0.2512
811 normal 2 0.1351
811 normals, 3 0.5793
811 not, 1 0.1682
811 objects 1 0.1931
811 observations 1 0.1056
811 observed 1 0.0856
811 one 1 0.0703
811 passive 1 0.172
811 periods 1 0.1401
811 physio- 1 0.2512
811 play 2 0.2985
811 plus 2 0.423
811 points 1 0.172
811 possible 1 0.1008
811 presence 1 0.0957
811 present 1 0.0827
811 present; 1 0.2512
811 pro- 1 0.172
811 record 1 0.2115
811 records 2 0.3524
811 relatively 1 0.1208
811 respect 1 0.1472
811 responsive 1 0.1865
811 rhythmic, 1 0.2512
811 rhythms; 1 0.2512
811 room 1 0.1931
811 room; 1 0.2512
811 short 1 0.1453
811 shorter 1 0.1931
811 showed 8 0.7164
811 significantly 1 0.1056
811 similar 2 0.1881
811 simultaneous 1 0.1537
811 social 2 0.3233
811 spent 2 0.423
811 state 1 0.1291
811 stereotyped 1 0.2262
811 stereotypies 1 0.2512
811 stereotypy 1 0.2512
811 stereotypy. 1 0.2512
811 stimulus. 1 0.2512
811 structure 1 0.128
811 studies 1 0.0769
811 study 2 0.1548
811 sub-group 2 0.5024
811 sub-group. 1 0.2512
811 subdivided 1 0.2262
811 suffering 1 0.1492
811 syndrome 1 0.1165
811 telemetred 1 0.2512
811 telemetry. 1 0.2512
811 theta 1 0.2512
811 though 1 0.1472
811 three 1 0.0945
811 time 2 0.177
811 toy 1 0.2512
811 two 2 0.1539
811 unstable 1 0.2262
811 variability 1 0.181
811 varying 1 0.1355
811 virtually 1 0.2115
811 visual 1 0.137
811 vities 1 0.2512
811 voltage 2 0.4523
811 waking 1 0.2512
811 whereas 1 0.1258
811 whole 1 0.1401
811 without 1 0.0949
811 wooden 1 0.2512
811 workers 1 0.181
811 years, 1 0.1588
812 ability 1 0.3839
812 abnormalities 1 0.4202
812 absence 1 0.3598
812 admitting 1 0.7536
812 adolescent 1 0.7536
812 adult. 1 0.6785
812 adults 1 0.4542
812 age 1 0.3118
812 another 2 0.8219
812 anxiety 4 1.8738
812 apparent 1 0.3946
812 approval 1 0.7536
812 associated 1 0.2676
812 attempts 1 0.485
812 autism 2 0.8954
812 autistic 3 1.2329
812 capacity 1 0.411
812 care 1 0.4764
812 categorized 2 1.357
812 category 1 0.6785
812 cause 2 0.6807
812 child 3 1.0875
812 child's 1 0.4611
812 child, 1 0.5159
812 children 2 0.5352
812 closely 1 0.4303
812 conceives 1 0.7536
812 concept 1 0.4542
812 concerned. 1 0.6785
812 condition 2 0.805
812 congenital 1 0.3449
812 considered 2 0.672
812 contact. 1 0.6785
812 contacts 2 1.357
812 degrees 1 0.4764
812 demonstrate 1 0.4358
812 detachment 1 0.6785
812 deterred 1 0.7536
812 develop 1 0.4542
812 developing 1 0.4066
812 development 1 0.2752
812 disorder. 1 0.6346
812 disturbance 1 0.543
812 es- 1 0.6785
812 established 1 0.4066
812 esteem 1 0.7536
812 extreme 1 0.4943
812 five 1 0.3985
812 forces 1 0.5793
812 forerunner 1 0.7536
812 gained 1 0.6034
812 him. 1 0.6785
812 human 1 0.2515
812 illness, 1 0.5793
812 infantile 1 0.411
812 initial 1 0.3653
812 innate 1 0.6034
812 institutions. 1 0.7536
812 intrauterine 1 0.543
812 love, 1 0.7536
812 major 1 0.3625
812 manifestations 1 0.4303
812 may 2 0.377
812 meaningful 1 0.6346
812 mental 3 1.2755
812 need 1 0.4611
812 normal. 1 0.4542
812 occurrance 1 0.7536
812 one 1 0.2108
812 overt 1 0.6785
812 patients 1 0.1812
812 pattern 1 0.3598
812 people. 1 0.7536
812 period. 1 0.4542
812 persistent 1 0.5793
812 persists 1 0.6785
812 phrenia, 1 0.7536
812 placed 1 0.4477
812 problem 1 0.4303
812 psychologists 1 0.7536
812 range 1 0.4066
812 reality 1 0.6346
812 reported 1 0.3054
812 responsibility 1 0.6785
812 result. 1 0.6785
812 resulting 1 0.3839
812 retardation. 1 0.7536
812 retreating 1 0.7536
812 satisfied, 1 0.7536
812 schizo- 1 0.6785
812 schizophrenic 1 0.4764
812 school 2 1.1192
812 school-nurse 1 0.7536
812 security 1 0.6785
812 self-realization 1 0.7536
812 sense 1 0.5793
812 sential 1 0.7536
812 serious 1 0.4542
812 severity 1 0.4611
812 social 1 0.485
812 state 1 0.3874
812 symptoms 1 0.3571
812 teacher 1 0.6034
812 thought 1 0.4252
812 thwarted, 1 0.7536
812 varying 1 0.4066
812 withdrawal 1 0.543
812 years. 1 0.4764
812 yet 1 0.3985
813 25%, 1 1.0048
813 58%, 1 1.0048
813 70% 1 0.9046
813 abnormalities 2 1.1206
813 autism 3 1.7907
813 autistic 1 0.548
813 behavioral 1 0.7462
813 brain 2 1.0237
813 careful 1 0.6352
813 cases. 1 0.5262
813 chil- 1 0.9046
813 child 1 0.4833
813 child. 1 0.6728
813 close 1 0.5888
813 clues 1 0.8461
813 coincidence 1 0.9046
813 coldness, 1 1.0048
813 compulsion 1 1.0048
813 conditions 1 0.4568
813 damage 2 1.0237
813 deficiency, 1 0.8046
813 deficits 1 0.7462
813 diagnosis. 1 0.6728
813 disclose 1 1.0048
813 disorder, 1 0.8046
813 displays 1 1.0048
813 dren. 1 1.0048
813 eeg 2 1.448
813 ego, 1 0.8461
813 emotional 1 0.5603
813 ents 1 1.0048
813 environmental 1 0.7462
813 epilepsy, 1 1.0048
813 eral 1 0.9046
813 etc. 1 0.8461
813 etiology 1 0.554
813 fa- 1 0.9046
813 factors 2 0.8496
813 found 1 0.2645
813 frequently 1 0.5074
813 give 1 0.548
813 his- 1 1.0048
813 important 2 0.9076
813 inattention, 1 1.0048
813 incidence 1 0.4797
813 incomplete 1 0.8461
813 incriminated. 1 1.0048
813 infant 1 0.5669
813 instances. 1 0.8461
813 intelligence 1 0.7462
813 lack 1 0.5811
813 low; 1 1.0048
813 many 2 0.8102
813 mental 1 0.5669
813 milial 1 1.0048
813 minor 1 0.6466
813 mistaken 1 1.0048
813 neurological 2 1.3455
813 observation 1 0.5262
813 obviously 1 0.8461
813 occurred 1 0.4372
813 often 1 0.4871
813 organic 1 0.5969
813 par- 1 0.8046
813 pattern 1 0.4797
813 prominent 1 0.7462
813 psychoses 1 1.0048
813 psychotic 1 0.6591
813 quite 1 0.5738
813 rejection, 1 1.0048
813 role 1 0.4661
813 sameness, 1 1.0048
813 scored 1 0.9046
813 seem 1 0.548
813 seizures 1 1.0048
813 separation, 1 0.9046
813 series 1 0.4727
813 sev- 1 1.0048
813 siblings. 1 0.9046
813 significant. 1 0.7048
813 situations. 1 0.9046
813 speech 1 0.5262
813 symp- 1 1.0048
813 symptom 1 0.7048
813 toms 1 0.9046
813 tory 1 1.0048
813 toward 1 0.6466
813 types 1 0.4871
813 uncertain. 1 0.8461
813 under- 1 0.9046
813 various 1 0.3972
813 withdrawal, 1 0.8461
814 accompanying 1 0.7048
814 additional 1 0.5366
814 also 1 0.2811
814 anxieties 1 0.9046
814 article, 1 0.9046
814 attended. 1 1.0048
814 autistic 1 0.548
814 behavior. 1 0.7724
814 behavior; 1 1.0048
814 center 1 0.6466
814 child 1 0.4833
814 children. 1 0.5738
814 communica- 1 1.0048
814 con- 1 0.5212
814 conducted 1 0.6879
814 conflicts 1 1.0048
814 darkroom 1 1.0048
814 darkroom, 1 1.0048
814 developed 1 0.4568
814 difficulties 1 0.7462
814 disturbed 1 0.6246
814 disturbed, 1 0.9046
814 exhibited 1 0.6148
814 florida, 1 1.0048
814 gainesville, 1 1.0048
814 gressive-transcendential 1 1.0048
814 illustration 1 1.0048
814 jectured 1 1.0048
814 level 1 0.388
814 light 1 0.5669
814 night 1 0.8461
814 playroom, 1 1.0048
814 produce 1 0.5366
814 projector 1 1.0048
814 psychotic 1 0.6591
814 re- 1 0.4452
814 reaction 1 0.5031
814 reactions. 1 0.7724
814 readily 1 0.6466
814 reveal 1 0.6728
814 severely 1 0.6466
814 shadow 2 2.0097
814 shadows 1 1.0048
814 silhouettes 1 1.0048
814 simulated 1 0.9046
814 situation. 1 0.8046
814 socializing. 1 1.0048
814 static 1 0.9046
814 stimuli. 1 0.8461
814 subject 1 0.6466
814 subjects 2 0.9594
814 sunland 1 1.0048
814 therapy 3 1.1917
814 tion 1 0.4568
814 training 1 0.7724
814 transcended 1 1.0048
814 twelve 1 0.6352
814 used 2 0.7589
814 usual 1 0.7462
814 vocalizing 1 1.0048
814 would 1 0.4989
815 autistic 2 1.0959
815 basis 1 0.4398
815 child 1 0.4833
815 children 1 0.3568
815 children. 1 0.5738
815 communication 1 0.554
815 considered 1 0.448
815 determine 1 0.5669
815 developing 1 0.5422
815 development 1 0.3669
815 effect 1 0.3068
815 functioning 2 1.3758
815 group 1 0.3714
815 inclusion 1 0.6466
815 language 3 1.7663
815 lessening 1 1.0048
815 level 2 0.7761
815 non-verbal, 1 1.0048
815 preliminary 1 0.5738
815 program 1 0.7048
815 re- 1 0.4452
815 relatedness 1 1.0048
815 reported. 1 0.5811
815 retarded 2 1.2933
815 speech 2 1.0524
815 study 1 0.3096
815 study, 1 0.6466
815 suggested 1 0.4179
815 sults 1 0.7462
815 techniques 1 0.548
815 therapy 2 0.7945
815 training 1 0.7724
815 treatment 2 0.5929
815 un- 1 0.6466
816 (eeg) 1 1.5073
816 adequate 1 0.9369
816 also, 1 1.086
816 although 1 0.5794
816 analysis 1 0.725
816 association 1 0.8133
816 auditory, 1 1.357
816 baffling 1 1.5073
816 brain 2 1.5356
816 brain. 1 1.1586
816 chal- 1 1.5073
816 complexity 1 1.2691
816 concepts 1 1.1192
816 constant 1 0.8219
816 construct 1 1.5073
816 continuous 1 0.8503
816 convergence 1 1.5073
816 cortex 1 0.831
816 crucial 1 1.2691
816 design 1 1.2069
816 difficulties, 1 1.5073
816 difficulty 1 1.0091
816 dimensional 1 1.5073
816 display 1 1.2069
816 electrical 2 2.7139
816 electro-encephalographic 1 1.5073
816 elusive, 1 1.5073
816 entirely 1 0.97
816 equipment 1 1.5073
816 essential 1 0.8832
816 experimenters 1 1.5073
816 experiments 1 0.6678
816 facing 1 1.357
816 fluctuate 1 1.357
816 form 1 0.6558
816 given 1 0.5526
816 human 2 1.0061
816 imagine 1 1.5073
816 incentive 1 1.5073
816 information 1 0.8133
816 integration 1 1.2069
816 interaction 1 0.9221
816 intriguing, 1 1.5073
816 intrinsic 1 1.0572
816 lenging 1 1.5073
816 less 1 0.5643
816 likely 1 0.8832
816 limited 1 0.8219
816 manner, 1 1.2691
816 mechanisms; 1 1.357
816 mental 1 0.8503
816 method 1 0.5987
816 much 1 0.6678
816 neurophysiologists 1 1.5073
816 nonspecific 1 1.086
816 obtained 1 0.5373
816 often 1 0.7306
816 overcome. 1 1.5073
816 per- 1 1.0091
816 perhaps 1 0.831
816 phenomenon 1 0.8716
816 physiological 1 0.8832
816 presents 1 1.2069
816 problems 1 0.7819
816 processes 1 0.8954
816 properties 1 0.805
816 prospect 1 1.2691
816 psychological 1 0.9528
816 quite 1 0.8607
816 receding 1 1.5073
816 recently 1 1.0318
816 regular 1 1.1192
816 relation 1 0.6944
816 remarkably 1 1.2069
816 respect 1 0.8832
816 responses 2 1.6808
816 results. 1 1.0572
816 rhythms 1 1.2691
816 rhythms, 1 1.357
816 satisfactory 1 0.9887
816 seemed 1 0.97
816 serious 1 0.9083
816 space 1 1.1192
816 still 1 0.7041
816 sufficient. 1 1.357
816 tactile 1 1.357
816 techniques 1 0.8219
816 that, 1 0.9887
816 three 1 0.5667
816 time 1 0.5311
816 time, 1 0.8716
816 today. 1 1.5073
816 uncertainty 1 1.5073
816 understanding 1 0.9887
816 undoubtedly 1 1.2691
816 unifying 1 1.5073
816 variations 1 0.9369
816 visual, 1 1.2691
816 way 1 0.9528
816 whether 1 0.7483
816 within 1 0.5595
816 would 1 0.7483
816 yet 1 0.797
817 "au- 1 1.0048
817 "we 1 1.0048
817 (8 1 1.0048
817 11 1 0.5366
817 1943, 1 1.0048
817 1944, 1 1.0048
817 3 1 0.3425
817 accentuating 1 1.0048
817 accessibility. 1 1.0048
817 affective 3 2.5382
817 alone- 1 1.0048
817 anx- 1 1.0048
817 appropriate 1 0.6591
817 assume 1 0.8461
817 assumption 1 0.8046
817 atric 1 1.0048
817 au- 1 0.9046
817 autism 1 0.5969
817 autism, 1 0.9046
817 be- 1 0.6148
817 beginning 1 0.6352
817 biologi- 1 1.0048
817 boys 1 0.7462
817 cally 1 0.8461
817 caps. 1 1.0048
817 chil- 1 0.9046
817 children 3 1.0704
817 children's 2 1.448
817 combination 1 0.5738
817 come 2 1.8093
817 common 1 0.4909
817 components 1 0.5738
817 con- 1 0.5212
817 concluded 1 0.4598
817 concrete 1 0.8046
817 considered 1 0.448
817 constitutional 1 0.7462
817 contact 1 0.5811
817 contact." 1 1.0048
817 correct, 1 1.0048
817 criteria 1 0.5888
817 decided 1 0.8046
817 designa- 1 1.0048
817 desire 1 1.0048
817 diffuse 1 0.6728
817 discussion 1 0.6056
817 disturbances 2 1.1938
817 dren 1 1.0048
817 early 1 0.3684
817 emotional 1 0.5603
817 entitled 1 1.0048
817 examples 1 0.7462
817 extreme 1 0.6591
817 first 1 0.3684
817 form 1 0.4372
817 furnish 1 0.8461
817 girls) 1 1.0048
817 groping, 1 1.0048
817 handi- 1 1.0048
817 havior 1 0.9046
817 help 1 0.724
817 hopkins 1 0.9046
817 hospital 1 0.6352
817 inability 1 0.724
817 inborn 1 0.8046
817 infantile 2 1.0959
817 innate 2 1.6091
817 intellectual 1 0.6728
817 iously 1 1.0048
817 johns 1 1.0048
817 life 1 0.5313
817 limited 1 0.548
817 manifesta- 1 0.8461
817 may 1 0.2513
817 much 1 0.4452
817 must 1 0.4909
817 ness 1 1.0048
817 notions 1 1.0048
817 observations 1 0.4225
817 obsessive 1 1.0048
817 paper 1 0.5422
817 pattern 1 0.4797
817 people, 1 1.0048
817 physical 1 0.5811
817 preservation 1 0.9046
817 previously 1 0.4833
817 provided 1 0.6148
817 psychi- 1 1.0048
817 published 1 0.6728
817 pure-culture 1 1.0048
817 reactivity. 1 0.9046
817 regarding 1 0.6352
817 reported 1 0.4072
817 sameness. 1 1.0048
817 saying: 1 1.0048
817 schizophrenias 1 1.0048
817 search 1 0.8461
817 seem 1 0.548
817 service 1 0.9046
817 still 1 0.4694
817 striking 1 0.6352
817 study 1 0.3096
817 symptoms 1 0.4762
817 tact," 1 1.0048
817 term 1 0.5603
817 thus 1 0.5212
817 time 1 0.3541
817 tion, 1 0.8461
817 tions 1 0.5969
817 tistic 2 2.0097
817 uniqueness. 1 1.0048
817 usual, 1 1.0048
817 viewed 1 0.8461
817 world 2 1.4923
818 article. 1 1.5073
818 autism 1 0.8954
818 autistic 1 0.8219
818 back 1 1.1192
818 causes 1 0.8503
818 child 1 0.725
818 childhood 1 0.8503
818 children 1 0.5352
818 described 1 0.5717
818 early 1 0.5526
818 form 1 0.6558
818 leading 1 0.9369
818 life 1 0.797
818 mal 1 1.0091
818 mother 1 0.8607
818 nor- 1 0.97
818 original 1 0.8607
818 part 1 0.7041
818 reject 1 1.2691
818 relationships. 1 1.2691
818 schizophrenia. 1 1.2069
818 separation 1 0.8404
818 shock 1 1.2069
818 situation 1 1.2069
818 sudden 1 0.97
818 traumatic 2 2.1144
818 treatment 1 0.4447
818 world 1 1.1192
819 applied 1 0.9083
819 autism 1 0.8954
819 autistic 1 0.8219
819 case 1 0.5415
819 child 1 0.725
819 de 2 2.0636
819 described. 1 0.7546
819 early 1 0.5526
819 gilles 2 3.0145
819 infantile 1 0.8219
819 la 2 2.4137
819 outlined. 1 1.2069
819 presenting 1 1.0091
819 syndrome 2 1.3983
819 tourette 2 3.0145
819 treatment 1 0.4447
820 acting, 1 1.5073
820 activity. 1 1.0318
820 actors 1 1.5073
820 adaptable 1 1.5073
820 attain 1 1.5073
820 be: 1 1.5073
820 becomes 1 0.9083
820 child 2 1.45
820 children 2 1.0704
820 children's 1 1.086
820 children. 1 0.8607
820 comes 1 1.5073
820 competition 1 1.2069
820 deed, 1 1.5073
820 degree 1 0.6678
820 difficult 1 0.97
820 disturbed 1 0.9369
820 dramatic 1 1.2069
820 especially 1 0.7747
820 ever, 1 1.1192
820 evokes 1 1.5073
820 fireman, 1 1.5073
820 form 1 0.6558
820 group 1 0.5572
820 horse, 1 1.5073
820 how- 1 1.1586
820 ill 1 1.1586
820 in- 1 0.6678
820 indian, 1 1.5073
820 intense 1 1.086
820 involvement 1 0.9887
820 is, 1 1.0091
820 make-believe 1 1.5073
820 many 1 0.6077
820 ment 1 0.9887
820 mentally 1 1.086
820 minimal: 1 1.5073
820 much 1 0.6678
820 natural 1 0.8832
820 naturally. 1 1.5073
820 observers. 1 1.5073
820 offers 1 1.086
820 participate 1 1.2691
820 person 1 1.1192
820 play 1 0.8954
820 pretends 1 1.5073
820 psychodrama 2 3.0145
820 restriction 1 1.086
820 situa- 1 1.5073
820 spontaneity 1 1.5073
820 therapies, 1 1.5073
820 thing 1 1.5073
820 tiger. 1 1.5073
820 tions 1 0.8954
820 treat- 1 0.9369
821 abilities 1 0.3626
821 all. 1 0.4306
821 areas 1 0.2277
821 articulation, 1 0.3877
821 autistic-schizophrenic 1 0.4306
821 autistic-schizophrenic, 1 0.4306
821 be- 1 0.2635
821 behaviour 1 0.3448
821 bizarre 1 0.3626
821 brain-damaged 1 0.3626
821 categories 1 0.3198
821 children 6 0.9175
821 communicative 1 0.3626
821 develop- 1 0.331
821 disorder, 1 0.3448
821 disorders 2 0.4918
821 disturbance. 1 0.331
821 disturbed 2 0.5354
821 divided 1 0.3021
821 emotionally 1 0.3448
821 fluency. 1 0.4306
821 forms 1 0.2056
821 frequent 1 0.2595
821 group, 1 0.2771
821 haviour 1 0.4306
821 language 7 1.7663
821 ment, 1 0.331
821 minimally 1 0.4306
821 nature. 1 0.3877
821 neurotic, 1 0.4306
821 non- 1 0.3103
821 normal 1 0.1158
821 predominantly 1 0.3448
821 primary 2 0.3641
821 problems 2 0.4468
821 problems. 1 0.4306
821 psychiatric 1 0.2771
821 rate 1 0.1585
821 relate 1 0.3626
821 severe 2 0.3816
821 severely 1 0.2771
821 similar 1 0.1612
821 speech 6 1.353
821 two 1 0.1319
821 type 1 0.1791
821 use 1 0.1702
821 used 1 0.1626
822 (part 1 0.7536
822 abnormalities 1 0.4202
822 age, 1 0.4943
822 allow 2 1.0572
822 autism 1 0.4477
822 autistic 2 0.8219
822 average 1 0.3381
822 cessful 1 0.6785
822 chance 1 0.6034
822 characteristic 1 0.3805
822 childhood 1 0.4252
822 children 1 0.2676
822 con- 1 0.3909
822 criteria 1 0.4416
822 diagnosis 1 0.3101
822 differences 1 0.3449
822 dis- 1 0.4764
822 distinct 1 0.4685
822 duration, 1 0.6346
822 early 1 0.2763
822 enough 1 0.5793
822 factors. 1 0.5793
822 family 1 0.4542
822 firm 1 0.6034
822 following 1 0.2498
822 func- 1 0.6785
822 geneous 1 0.6785
822 group 4 1.1143
822 group. 1 0.4358
822 homo- 1 0.6785
822 i--description 1 0.7536
822 infantile 1 0.411
822 intact 1 0.4155
822 intellectual 1 0.5046
822 larger 1 0.4477
822 lected 1 0.7536
822 limiting 1 0.5596
822 ly 1 0.4943
822 metropolitan 1 0.6785
822 months' 1 0.6346
822 near 1 0.4542
822 noted 1 0.3985
822 observation 2 0.7893
822 opposed 1 0.6346
822 period 1 0.2859
822 presence 1 0.2871
822 present. 1 0.5046
822 program. 1 0.7536
822 rather 1 0.3546
822 reasonable 1 0.6034
822 sample) 1 0.7536
822 schizophrenia 2 1.1192
822 schizophrenic 1 0.4764
822 se- 1 0.6346
822 selected 1 0.4416
822 siderations 1 0.7536
822 speech 1 0.3946
822 statistical 1 0.485
822 study 1 0.2322
822 suc- 1 0.6785
822 three 1 0.2834
822 tinguishing 1 0.7536
822 tioning, 1 0.7536
822 toronto 1 0.7536
822 treatment 3 0.667
822 twelve 1 0.4764
822 undoubted- 1 0.7536
822 valid. 1 0.7536
822 would 1 0.3742
822 younger 1 0.5046
823 alagille 1 1.0048
823 analagous 1 1.0048
823 calcaneum 1 1.0048
823 case 2 0.722
823 cyst 2 1.5448
823 demonstrated 1 0.4296
823 des 1 0.724
823 described 2 0.7623
823 diagnosis 1 0.4135
823 discussion 1 0.6056
823 doctors 1 1.0048
823 dr. 3 2.3172
823 erroneous 1 0.8461
823 favre-gilly 1 0.9046
823 favre-gilly; 1 1.0048
823 haemophilic 1 0.7724
823 hemophiles 1 0.8461
823 josso 1 1.0048
823 kugler 1 1.0048
823 les 1 0.7724
823 made. 1 0.6246
823 maxilla 1 1.0048
823 one 1 0.2811
823 osseuses 1 1.0048
823 osteosarcoma 1 1.0048
823 perineum; 1 1.0048
823 pseudo-tumeurs 1 1.0048
823 pseudo-tumour 1 1.0048
823 queneau 1 0.9046
823 referred 1 0.5969
823 seen 1 0.4248
823 sur 1 0.8461
823 trillat 1 1.0048
823 x-rays; 1 1.0048
824 characteristic 1 0.5074
824 correlation 1 0.5074
824 effect 1 0.3068
824 effusion 2 1.5448
824 effusions 1 0.8461
824 held 1 0.9046
824 here, 1 0.8461
824 hydrostatic 1 0.9046
824 increases 1 0.4694
824 indicate 1 0.4425
824 intra-articular 2 1.8093
824 joint 2 1.2933
824 joint's 1 1.0048
824 joints 2 1.448
824 known 1 0.4909
824 made 1 0.3639
824 movement 1 0.7724
824 pain. 2 1.8093
824 position 1 0.6879
824 position. 1 0.8461
824 positions 1 0.9046
824 possible 1 0.4031
824 pressure 3 1.3794
824 relationship 1 0.4833
824 reported 1 0.4072
824 results 1 0.2878
824 spontaneously 1 0.8461
824 study 1 0.3096
824 symptomatic 1 0.7048
825 (fig. 2 1.6922
825 1). 1 0.9046
825 1962 1 0.9046
825 2). 1 0.9046
825 appearance 1 0.4989
825 aware 1 0.8046
825 before. 1 1.0048
825 blood 2 0.621
825 bone, 1 0.8046
825 boy 1 0.6728
825 colour 1 0.8461
825 consistent, 1 1.0048
825 cyst 2 1.5448
825 cystic 1 0.7462
825 department 1 0.7724
825 destruction 2 1.6091
825 diagnosis 1 0.4135
825 dorsum 1 1.0048
825 dusky 1 1.0048
825 examination, 1 0.7462
825 expanding 1 0.9046
825 first 1 0.3684
825 foot. 1 1.0048
825 forefoot, 1 1.0048
825 haemophiliac, 1 1.0048
825 haemophilic 2 1.5448
825 hospital 1 0.6352
825 increase 1 0.3413
825 known 1 0.4909
825 left 1 0.4538
825 lesion 1 0.5669
825 made. 1 0.6246
825 may 1 0.2513
825 metatarsal 1 1.0048
825 mongol 1 1.0048
825 months 1 0.5074
825 noticed 1 0.8461
825 occupy 1 0.9046
825 orthopaedic 1 0.9046
825 parents 1 0.724
825 proximal 1 0.6879
825 radiographs 1 0.9046
825 red 1 0.5969
825 seen 2 0.8496
825 showed 1 0.3582
825 since 1 0.4372
825 size 1 0.5262
825 skin 1 0.5969
825 southmead 1 1.0048
825 steady 1 0.724
825 stretched 1 1.0048
825 swelling 3 2.5382
825 ten, 1 1.0048
825 third 1 0.548
825 thought 1 0.5669
825 two 1 0.3077
825 two-thirds 1 0.8461
825 within 1 0.373
826 account. 1 0.6029
826 amount 1 0.2969
826 anaesthesia, 1 0.6029
826 antihaemophilic 1 0.6029
826 arthropathy 1 0.4827
826 avoided. 1 0.6029
826 best 1 0.3188
826 chronic 1 0.2878
826 concluded 1 0.2759
826 continuous 1 0.3401
826 contractures 1 0.5428
826 deformities 1 0.4827
826 deformity 3 1.5229
826 discussed 1 0.2455
826 discussing 1 0.4827
826 early 1 0.221
826 eighteen 1 0.4634
826 entirely 1 0.388
826 evidence 1 0.221
826 factor 1 0.2857
826 followed 1 0.2759
826 form 1 0.2623
826 forms 2 0.5757
826 general 1 0.3071
826 haemarthroses 1 0.5428
826 haemophilia 3 1.3431
826 haemophilia. 1 0.5428
826 haemorrhage. 1 0.6029
826 haemorrhagic 1 0.6029
826 histories 1 0.4477
826 immobilisation 1 0.6029
826 important 1 0.2723
826 include 1 0.3581
826 indicated. 1 0.5076
826 initially 1 0.3955
826 intravenous 2 0.644
826 joint 4 1.5519
826 less 1 0.2257
826 main 1 0.3443
826 manipulation 1 0.5428
826 often 1 0.2922
826 open 1 0.4229
826 operation, 1 0.4477
826 orthopaedic 1 0.5428
826 painless 1 0.6029
826 patients 2 0.2898
826 period 1 0.2287
826 physiotherapy. 1 0.6029
826 physiotherapy; 1 0.6029
826 plays 1 0.4634
826 presented 1 0.2339
826 prevention 2 0.8255
826 preventive 1 0.6029
826 prolonged 1 0.29
826 provide 1 0.3533
826 required 1 0.3288
826 reviewed 1 0.3401
826 role 1 0.2797
826 seven 1 0.3443
826 severe 1 0.2671
826 splintage 2 1.2058
826 taken 1 0.3401
826 therapy 2 0.4767
826 thirteen 1 0.4477
826 threat 1 0.6029
826 traction, 1 0.6029
826 treatment 5 0.8894
826 years. 1 0.3811
827 aa. 1 3.0145
827 affection. 1 3.0145
827 anatomic 1 2.0183
827 case 1 1.0831
827 clinical 1 0.9826
827 curative 1 2.5382
827 dwell 1 3.0145
827 emofilia 1 3.0145
827 examine 1 2.5382
827 extrarticular 1 3.0145
827 hemophilia. 1 2.2385
827 illness 1 2.3172
827 important 1 1.3613
827 known 1 1.4727
827 less 1 1.1286
827 literature 1 1.6439
827 material 1 1.3983
827 medico-surgical 1 3.0145
827 one 1 0.8433
827 osteopathy 1 2.7139
827 osteopatia 1 3.0145
827 peculiarities 1 2.7139
827 personal 1 2.1144
827 picture 1 1.6439
827 present 1 0.9925
827 problems 1 1.5637
827 remark 1 3.0145
827 upon 1 1.3526
828 accord 1 1.5073
828 al. 1 1.086
828 analgesics. 1 1.5073
828 attempted 1 1.0091
828 cases 1 0.4484
828 clinically 1 1.0318
828 corticoids 1 1.5073
828 dans 1 1.2691
828 de 1 1.0318
828 des 1 1.086
828 douleur 1 1.5073
828 either 1 0.6444
828 else 1 1.357
828 et 1 1.0091
828 explanation 1 1.0572
828 fifty 1 1.086
828 following 1 0.4996
828 give 1 0.8219
828 hemarthroses 1 1.2069
828 hemarthrosis 1 1.2691
828 hemophiliac 1 1.1192
828 hemophilic 1 1.1192
828 hemophiliques 1 1.5073
828 hours. 1 1.086
828 immobilization, 1 1.5073
828 la 2 2.4137
828 le 1 1.2691
828 marx 1 1.5073
828 minima 1 1.5073
828 pain 1 0.9887
828 pathogenic 1 1.2691
828 perfusion 1 0.8832
828 physio-pathologic 1 1.5073
828 placebo 1 1.5073
828 plasma 2 1.2153
828 plasmatherapie 1 1.5073
828 quantity 1 1.1192
828 r. 1 1.0318
828 seem 1 0.8219
828 similar 1 0.5643
828 small 1 0.6046
828 stop 1 1.2691
828 studies 1 0.4616
828 sufficient 1 0.9083
828 traitement 1 1.5073
828 treated 1 0.6202
828 were, 1 1.2691
828 would 1 0.7483
829 20 1 0.4538
829 achieve 1 0.7048
829 acute 1 0.4989
829 afterwards. 1 1.0048
829 always 1 0.5366
829 analgesique 1 1.0048
829 body 1 0.4051
829 capsule, 1 0.7724
829 cases 2 0.5979
829 de 1 0.6879
829 des 2 1.448
829 distension 1 0.9046
829 du 1 0.8461
829 effet 1 1.0048
829 evolutive 1 0.9046
829 fresh 1 0.724
829 genou 1 0.9046
829 hemarthroses 1 0.8046
829 hemarthrosis 1 0.8461
829 hemarthrosis; 1 1.0048
829 hemophiles 1 0.8461
829 hemostasis, 1 0.9046
829 immediat 1 1.0048
829 immediately 1 0.6148
829 important 1 0.4538
829 injection 1 0.4202
829 injection, 1 0.7462
829 injections 1 0.5669
829 kg 1 0.8461
829 knee 1 0.7462
829 lyophilized 1 0.9046
829 ml 1 0.8046
829 pain 1 0.6591
829 per 1 0.3916
829 period. 1 0.6056
829 permanent 1 0.7724
829 plasma 3 1.2153
829 pour 1 1.0048
829 proposed 1 0.6591
829 recent 1 0.5262
829 recentes 1 1.0048
829 reduce 1 0.6352
829 single 1 0.4989
829 subsides 1 1.0048
829 treatment 1 0.2965
829 weight 1 0.4727
830 (1) 1 0.4871
830 (2) 1 0.4871
830 (3) 1 0.5313
830 advance 1 0.9046
830 agement: 1 1.0048
830 antihemophilic 1 0.9046
830 available 1 0.548
830 cautery 1 1.0048
830 country 1 0.9046
830 disarticulation 2 1.8093
830 electro- 1 0.8046
830 entire 1 0.6591
830 factor 1 0.4762
830 femur 1 0.8046
830 fibrinogen 1 0.7724
830 following 1 0.3331
830 hemophilia 1 0.7048
830 hemophilia. 1 0.7462
830 hemophiliac 3 2.2385
830 hemotologic 1 1.0048
830 highly 1 0.5422
830 hip 2 1.6922
830 infected 2 1.0959
830 initially. 1 1.0048
830 involving 1 0.6466
830 left 1 0.4538
830 lifesaving. 1 1.0048
830 man- 1 0.9046
830 open 1 0.7048
830 osteomyelitis 1 1.0048
830 pa- 1 0.5888
830 patient 2 0.7556
830 patient. 1 0.6879
830 performed 1 0.4598
830 potent 1 0.7462
830 prepa- 1 1.0048
830 ration 1 0.9046
830 right 1 0.5212
830 safe 1 0.6591
830 severe 1 0.4452
830 significant 1 0.3527
830 suggestions 1 0.9046
830 surgical 1 0.4538
830 tients 1 0.6466
830 treatment 1 0.2965
830 used 1 0.3795
830 wound 1 0.7724
830 wounds 1 1.0048
831 (1956). 1 0.6029
831 (a 1 0.4827
831 (grades 1 0.6029
831 (walk, 1 0.6029
831 116 1 0.5428
831 127 1 0.6029
831 2, 1 0.4127
831 21 1 0.3811
831 24 1 0.3127
831 242 1 0.6029
831 3 1 0.2055
831 308 1 0.6029
831 38 1 0.4127
831 4) 1 0.4827
831 57 1 0.4827
831 65 1 0.4127
831 7 1 0.2778
831 95 1 0.5076
831 ability 1 0.3071
831 abnormal 1 0.2922
831 according 1 0.3253
831 addition 1 0.3071
831 also 1 0.1687
831 arthropathy 2 0.9655
831 b 1 0.4127
831 b) 1 0.5076
831 classified 1 0.3633
831 clinical 3 0.5896
831 comprised 1 0.4827
831 consisted 1 0.3581
831 cotler 1 0.6029
831 degree 1 0.2671
831 depalma 1 0.6029
831 disability 1 0.4634
831 dress, 1 0.6029
831 eat, 1 0.6029
831 evaluation 2 0.6506
831 examination 2 0.6089
831 examination. 1 0.5076
831 extra-articular 1 0.6029
831 found 1 0.1587
831 general 1 0.3071
831 haemophilia 3 1.3431
831 haemophilia, 5 3.0145
831 haemophilia. 1 0.5428
831 haemophiliacs 1 0.6029
831 help. 1 0.5428
831 incidence, 1 0.5428
831 included 1 0.3253
831 information 1 0.3253
831 investigation 1 0.3401
831 joints 2 0.8688
831 known 1 0.2945
831 largely 1 0.4229
831 latter 1 0.3127
831 made 1 0.2183
831 major 1 0.29
831 manage 1 0.6029
831 manifesta- 1 0.5076
831 manifestations 1 0.3443
831 material 1 0.2797
831 mild 2 0.7909
831 moderate 2 0.7163
831 musculo-skeletal 1 0.6029
831 obtained 1 0.2149
831 only. 1 0.4344
831 patients 4 0.5797
831 practically 1 0.5076
831 prophylaxis 1 0.4827
831 questionnaire 1 0.5428
831 regard 1 0.3443
831 roentgen 1 0.5428
831 severe 2 0.5343
831 sweden 1 0.5428
831 sweden. 1 0.6029
831 tions 1 0.3581
831 toilet) 1 0.6029
831 treatment 1 0.1779
831 vii. 1 0.6029
831 with- 1 0.5076
832 10 1 0.5548
832 100 1 0.8503
832 175 1 1.5073
832 22 1 1.0318
832 25 1 0.8607
832 7 1 0.6944
832 annum 1 1.5073
832 arthropathies. 1 1.5073
832 authors 1 0.6944
832 average 1 0.6763
832 beneficial 1 1.0572
832 cases, 1 0.7893
832 chez 1 1.357
832 children 1 0.5352
832 considerably 1 0.97
832 dans 1 1.2691
832 days 2 1.1975
832 de 1 1.0318
832 delivered 1 1.2069
832 dose 1 0.7196
832 du 1 1.2691
832 due 1 0.5332
832 effect 1 0.4602
832 following 2 0.9992
832 genou 1 1.357
832 growth 1 0.5138
832 haemarthrosis 2 3.0145
832 haemo- 1 1.1586
832 harmful 1 1.5073
832 hemarthroses 1 1.2069
832 infirmary 1 1.5073
832 interet 1 1.5073
832 irradiation 1 0.8133
832 justify 1 1.357
832 knee 1 1.1192
832 knees 1 1.357
832 l'hemophile 1 1.5073
832 la 1 1.2069
832 les 1 1.1586
832 method. 1 1.0572
832 number 2 1.1536
832 one 1 0.4217
832 onsets 1 1.5073
832 onsets; 1 1.5073
832 patients 1 0.3623
832 patients; 1 1.1192
832 per 1 0.5875
832 philiac 1 1.357
832 presenting 1 1.0091
832 r 1 0.9887
832 radio- 1 1.1192
832 radiotherapie 1 1.5073
832 radiotherapy 1 1.0572
832 recidivantes 1 1.5073
832 recurring 1 1.357
832 reducing 1 1.1586
832 repeated 1 0.8954
832 result: 1 1.5073
832 results 1 0.4316
832 showed 1 0.5373
832 significant 1 0.5291
832 stays 1 1.5073
832 therapeutic 1 0.7611
832 therapy 1 0.5959
832 think 1 1.2691
832 third 1 0.8219
832 thirds 1 1.2069
832 times, 1 1.1586
832 totally 1 1.0572
832 two 1 0.4616
832 year 1 0.7819
832 year. 2 2.1144
833 according 1 0.1479
833 acts 1 0.1974
833 also 1 0.0767
833 anatomical 1 0.2194
833 answered. 1 0.274
833 anterior 1 0.1732
833 appearance 2 0.2721
833 arthropathies 1 0.2467
833 asks 1 0.274
833 brinkhous, 1 0.274
833 but, 1 0.2307
833 cartilage 1 0.2107
833 caused 1 0.1199
833 cerning 1 0.274
833 children 1 0.0973
833 children, 1 0.1606
833 children. 1 0.1565
833 coeur 2 0.5481
833 con- 1 0.1422
833 condyles 1 0.2467
833 could 1 0.0985
833 dans 1 0.2307
833 data 1 0.1116
833 de 1 0.1876
833 decalcification 1 0.274
833 decalcification, 1 0.274
833 decalcification. 1 0.274
833 densification 1 0.2467
833 des 1 0.1974
833 discussion 1 0.1652
833 donnees 1 0.274
833 dr. 11 2.3172
833 due 1 0.0969
833 early 1 0.1005
833 favre-gilly 3 0.7402
833 fibrillary 1 0.274
833 frequently 1 0.1384
833 fringed 1 0.274
833 genoux 1 0.2467
833 geodes 1 0.274
833 haemo- 1 0.2107
833 haemophiliac 2 0.4389
833 haemorrhages 1 0.2467
833 haemosideraemia; 1 0.274
833 homogeneous 1 0.2194
833 impression 1 0.1974
833 infiltration 1 0.2107
833 insufficient 1 0.2194
833 intra- 1 0.1922
833 izarn 1 0.274
833 izarn. 1 0.274
833 joint 1 0.1764
833 le 2 0.4615
833 les 2 0.4213
833 logical 1 0.2035
833 marchal 1 0.274
833 membranes 1 0.1764
833 moderator. 1 0.274
833 mourgues 1 0.274
833 necroses; 1 0.274
833 normal 2 0.1474
833 occur 1 0.1339
833 older 1 0.1703
833 ones. 1 0.2194
833 opinion 2 0.367
833 osseous 1 0.2035
833 patho- 1 0.2307
833 pathological 1 0.1479
833 philiac 1 0.2467
833 professor 1 0.274
833 queneau 2 0.4934
833 queneau, 1 0.274
833 question 1 0.2035
833 radiologiques 1 0.274
833 really 1 0.2467
833 represents 1 0.1876
833 result 1 0.1185
833 scalariform 1 0.274
833 seems 2 0.2898
833 significance; 1 0.274
833 stage 2 0.2657
833 subjects 2 0.2617
833 sur 1 0.2307
833 synovial 1 0.2194
833 think 1 0.2307
833 thought 1 0.1546
833 traits 1 0.2467
833 ultimate 1 0.2467
833 whereas 1 0.1372
833 wonders 1 0.274
833 young 1 0.1384
834 (28 1 0.9046
834 (78 1 0.9046
834 (geodes, 1 1.0048
834 (inter- 1 1.0048
834 100 2 1.1337
834 15 2 0.9978
834 25 1 0.5738
834 29 1 0.6879
834 30 1 0.4797
834 52 1 0.7724
834 6 1 0.4202
834 64 1 0.8461
834 7 2 0.9258
834 abnormal 1 0.4871
834 affected 1 0.5212
834 aged 1 0.6056
834 alterations 1 0.554
834 always 1 0.5366
834 ans 1 1.0048
834 articular 1 0.8461
834 aspects 1 0.5669
834 atrophy 1 0.7462
834 bilateral 1 0.6056
834 bio- 1 0.8461
834 broadening 1 1.0048
834 condyles 1 0.9046
834 corresponded 2 1.5448
834 crushing 1 1.0048
834 de 2 1.3758
834 decalcification). 1 1.0048
834 deformations 1 1.0048
834 densification 1 0.9046
834 deposits. 1 0.9046
834 des 1 0.724
834 diaphysis 1 1.0048
834 disk, 1 1.0048
834 disturbance. 1 0.7724
834 early 1 0.3684
834 encountered. 1 0.9046
834 erosion 1 1.0048
834 erosions 1 1.0048
834 especially 1 0.5165
834 etude 1 1.0048
834 examination 1 0.5074
834 exist, 1 1.0048
834 explains 1 0.9046
834 femur 1 0.8046
834 femur. 1 1.0048
834 findings 1 0.3992
834 fracture 1 1.0048
834 fre- 1 0.8461
834 frequency 1 0.5262
834 genoux 1 0.9046
834 genu 1 1.0048
834 haemarthrosis, 1 1.0048
834 haemarthrosis. 1 1.0048
834 haemophiliac 1 0.8046
834 hemophiles 1 0.8461
834 homogeneous 1 0.8046
834 hypertrophy 1 0.5313
834 intensity 1 0.7048
834 intercondylian 1 1.0048
834 interlinear 1 1.0048
834 internal 1 0.5669
834 intra-articular 1 0.9046
834 iron 1 0.8461
834 knee 2 1.4923
834 knee-caps, 1 1.0048
834 knees 1 0.9046
834 knees) 1 1.0048
834 knees). 1 1.0048
834 knees, 1 1.0048
834 knees. 1 1.0048
834 linear 1 0.6466
834 logical 3 2.2385
834 major 2 0.9667
834 matically 1 1.0048
834 membrane 1 0.5422
834 ob- 1 0.6879
834 observe 1 0.7724
834 observed 1 0.3425
834 occur 1 0.4909
834 one 2 0.5622
834 opacification, 1 1.0048
834 osseous 1 0.7462
834 others 1 0.548
834 performed 1 0.4598
834 pinch 1 1.0048
834 pinch, 1 1.0048
834 posterior 1 0.5888
834 present 1 0.3308
834 quent 1 1.0048
834 radio- 2 1.4923
834 radiographic 1 0.7724
834 radiographique 1 1.0048
834 recent 1 0.5262
834 relation 1 0.4629
834 seem 1 0.548
834 sequelae 1 0.8461
834 served 1 0.6591
834 severity 1 0.6148
834 space, 1 0.8461
834 subjects 1 0.4797
834 subluxation 1 1.0048
834 surfaces 1 0.8461
834 surfaces), 1 1.0048
834 synovial 1 0.8046
834 syste- 1 1.0048
834 tardier 1 1.0048
834 tibia 1 1.0048
834 tibial 1 0.7724
834 uninjured. 1 1.0048
834 valgum 1 1.0048
834 years, 1 0.6352
835 (1) 1 0.3653
835 (2) 1 0.3653
835 and/or 1 0.4764
835 blood 1 0.2329
835 con- 1 0.3909
835 connection 2 1.086
835 disorders 2 0.8607
835 ear 3 1.8103
835 ear, 1 0.7536
835 include 1 0.4477
835 involve 1 0.543
835 lesions 2 0.6481
835 nose, 4 3.0145
835 organs 1 0.4155
835 part 1 0.352
835 primarily 1 0.4764
835 producing 1 0.485
835 separately. 1 0.7536
835 sider 1 0.7536
835 signs 1 0.4202
835 symptomatology 1 0.5159
835 symptoms 1 0.3571
835 throat 4 2.4137
835 vascular 1 0.4155
835 well. 1 0.5596
836 1881. 1 0.7536
836 affected 1 0.3909
836 affected, 1 0.6346
836 also 1 0.2108
836 arterial 2 0.7819
836 basically 1 0.5793
836 blood 2 0.4657
836 cases, 1 0.3946
836 causes 1 0.4252
836 commonest 1 0.6346
836 complete 1 0.3496
836 condition 2 0.805
836 consists 1 0.4764
836 contracts, 1 0.7536
836 contracture. 2 1.5073
836 damaged 1 0.6034
836 deprived 1 0.5793
836 described 1 0.2859
836 die 1 0.5793
836 entire 1 0.4943
836 events 1 0.5596
836 fibrosis, 1 0.5793
836 fibrous 3 1.7379
836 fingers 2 1.357
836 flexion 1 0.6785
836 flexor 4 3.0145
836 following 1 0.2498
836 forearm 1 0.6785
836 forearm. 1 0.7536
836 fortunately--mainly 1 0.7536
836 frank 1 0.6785
836 gangrene; 1 0.7536
836 give 1 0.411
836 given 1 0.2763
836 group 1 0.2786
836 held 1 0.6785
836 hours 1 0.3625
836 improved 1 0.5046
836 injury 1 0.5046
836 ischaemia 2 1.5073
836 ischaemic 2 1.357
836 like 1 0.485
836 limb 2 1.086
836 main 1 0.4303
836 mass 1 0.5596
836 may 2 0.377
836 methods 1 0.3403
836 muscle 1 0.4155
836 muscles 4 2.5382
836 muscles, 1 0.6785
836 muscles. 2 1.5073
836 name 1 0.6785
836 nerves 1 0.5793
836 occlusion 3 1.455
836 originally 1 0.5596
836 overall 1 0.4943
836 owing 1 0.5046
836 paralysed 1 0.6785
836 partial 1 0.4202
836 periods 1 0.4202
836 picture 1 0.411
836 prevention. 1 0.7536
836 producing 1 0.485
836 rare 1 0.4477
836 replaced 2 1.1586
836 replacement 1 0.4764
836 rise 1 0.3742
836 scars, 1 0.7536
836 sequence 1 0.5793
836 sequently 1 0.7536
836 several 1 0.326
836 severe 1 0.3339
836 shortening 1 0.6785
836 shorter 1 0.5793
836 sometimes 1 0.485
836 sub- 1 0.485
836 supply 1 0.5596
836 supply, 1 0.7536
836 thin 1 0.6034
836 tissue 2 0.5232
836 tissue. 1 0.485
836 toes 1 0.7536
836 total 2 0.5875
836 totally 1 0.5286
836 usually 1 0.3546
836 volkmann 1 0.7536
836 volkmann's 3 2.2609
836 wasted, 1 0.7536
836 well. 1 0.5596
837 - 2 1.1776
837 affections 2 1.6922
837 ago. 1 1.0048
837 also 1 0.2811
837 among 1 0.4694
837 area 1 0.5212
837 arthropathies 1 0.9046
837 arthrosis 1 1.0048
837 arthrotic 1 1.0048
837 belong 1 0.9046
837 bouchard-nodes 1 1.0048
837 calculate 1 0.8046
837 changes 1 0.3007
837 chronic 1 0.4797
837 conditions, 1 0.7724
837 coste 1 1.0048
837 days 1 0.3992
837 dedicated 1 1.0048
837 degenerative 3 2.4137
837 der 1 1.0048
837 described 1 0.3811
837 diagnosis. 1 0.6728
837 differential 1 0.6352
837 differentiation 1 0.5738
837 digital 1 1.0048
837 discussed. 1 0.4296
837 diseases 1 0.548
837 diseases. 1 0.7724
837 disorders 1 0.5738
837 enumerated, 1 1.0048
837 fingers 1 0.9046
837 forced 1 0.9046
837 forestier 1 1.0048
837 get 1 0.9046
837 gical 1 0.9046
837 gout 2 2.0097
837 heberden-nodes, 1 1.0048
837 hemo- 1 0.7462
837 important 1 0.4538
837 inflammatory 1 0.7462
837 inter- 1 0.724
837 joints 2 1.448
837 joints, 2 2.0097
837 klinik 1 1.0048
837 lffb 1 1.0048
837 mentioned. 1 0.9046
837 metabolic 1 0.4797
837 mixed 1 0.6352
837 occurs 1 0.5366
837 often 2 0.9741
837 one 1 0.2811
837 philia, 1 0.9046
837 polyarthrosen 1 1.0048
837 polyarthrosis 1 1.0048
837 polyarticular 1 1.0048
837 psoriasis 1 0.9046
837 rare 1 0.5969
837 reactions 1 0.4909
837 red 1 0.5969
837 refer- 1 1.0048
837 referred 1 0.5969
837 serolo- 1 1.0048
837 significance 1 0.548
837 subjects 1 0.4797
837 symptoms 1 0.4762
837 them. 1 0.724
837 thoroughly 1 1.0048
837 to, 1 0.7724
837 wider 1 0.9046
837 wrote 1 1.0048
837 years 1 0.4568
838 (fibrinogen/ahg) 1 1.5073
838 ability 1 0.7678
838 accordance 1 1.2691
838 amputation 1 1.1586
838 amputation, 1 1.357
838 clot 1 1.357
838 cohn 1 1.5073
838 ensure 1 1.2691
838 firm 1 1.2069
838 form 1 0.6558
838 fraction 1 0.805
838 hemo- 1 1.1192
838 hemophiliac 1 1.1192
838 hemostasis. 1 1.5073
838 human 1 0.5031
838 including 2 1.6265
838 knee, 1 1.5073
838 major 1 0.725
838 measured 1 0.6597
838 normal 2 0.8106
838 patient's 1 1.0091
838 patient, 1 0.9887
838 philia 1 1.2691
838 prescribed 1 1.5073
838 procedures 1 0.8503
838 procedures, 1 1.2069
838 reported. 1 0.8716
838 serial 1 0.9221
838 studies 1 0.4616
838 surgical 2 1.3613
838 thrombelastograph. 1 1.5073
838 time 1 0.5311
838 treatment 1 0.4447
838 used 1 0.5692
838 various 1 0.5959
838 within 1 0.5595
839 actual 1 0.724
839 affected 1 0.5212
839 arteries, 1 0.9046
839 becomes 1 0.6056
839 bleeding 1 0.7462
839 bleeding. 1 0.8461
839 children 2 0.7136
839 christmas 1 1.0048
839 chronic 1 0.4797
839 con- 1 0.5212
839 contractures 1 0.9046
839 crippling 2 2.0097
839 crippling. 1 1.0048
839 cumulative 1 0.8461
839 cyst 1 0.7724
839 damage 1 0.5119
839 deep 1 0.7048
839 destruction 1 0.8046
839 develop 1 0.6056
839 disease 1 0.361
839 episode 1 0.8046
839 episodes 1 0.7724
839 failure 1 0.5422
839 formation. 1 0.7724
839 haemarthroses 1 0.9046
839 haematoma 1 0.9046
839 haematomata 1 1.0048
839 haemo- 1 0.7724
839 haemophilic 1 0.7724
839 haemorrhages 1 0.9046
839 healing 1 0.7724
839 immobility 1 1.0048
839 important 1 0.4538
839 increasingly 1 0.8046
839 injuries. 1 1.0048
839 joint 2 1.2933
839 joints 1 0.724
839 leading 1 0.6246
839 leads 1 0.5603
839 liable 1 1.0048
839 muscle 3 1.6619
839 muscles 1 0.8461
839 nerves 1 0.7724
839 original 1 0.5738
839 philia 1 0.8461
839 pressure 1 0.4598
839 prevention 1 0.6879
839 produce 2 1.0733
839 produces 1 0.6352
839 recovery 1 0.554
839 recurrent; 1 1.0048
839 renewed 1 0.9046
839 repeated 1 0.5969
839 resolution 1 1.0048
839 severely 1 0.6466
839 suffer 1 0.9046
839 surface 1 0.5422
839 tend 1 0.724
839 thus 1 0.5212
839 tissue, 1 0.724
839 trivial 1 0.9046
839 valescence 1 1.0048
839 weakness. 1 1.0048
840 becoming 1 1.1586
840 constitutional 1 1.1192
840 defective 1 1.0318
840 defects 1 0.831
840 detail 1 1.1586
840 encountered 1 0.9528
840 est 1 1.5073
840 haemostasis 1 1.357
840 haemostatic 1 1.5073
840 inter- 1 1.086
840 nose 2 2.7139
840 patients 2 0.7246
840 possible 1 0.6046
840 problems 1 0.7819
840 successful 1 1.0318
840 surgery 2 1.4967
840 surgery. 1 1.0318
840 throat 2 2.4137
841 (47.7%). 1 0.3768
841 (78.8%) 1 0.3768
841 (especially 1 0.3392
841 (knee, 1 0.3768
841 (weight 1 0.3768
841 14 3 0.6232
841 14th 1 0.3392
841 16.6%. 1 0.3768
841 21 1 0.2382
841 49 1 0.3173
841 5 1 0.1429
841 54 1 0.3392
841 66.6% 1 0.3768
841 6th 1 0.3017
841 9.3% 1 0.3768
841 a, 1 0.3017
841 according 1 0.2033
841 accordingly. 1 0.3768
841 acute 1 0.1871
841 affected 3 0.5864
841 age 3 0.4676
841 age. 1 0.2126
841 also 1 0.1054
841 although 1 0.1449
841 ankle) 1 0.3768
841 antalovska 1 0.3768
841 arthritis, 2 0.6785
841 arthropathy 2 0.6034
841 articular 5 1.5864
841 authors 1 0.1736
841 b. 2 0.4202
841 bearing 1 0.3017
841 began 1 0.2798
841 bleeding 7 1.9587
841 bleeding. 1 0.3173
841 bleedings 1 0.3392
841 body 1 0.1519
841 c-reactive 1 0.3768
841 carried 1 0.1887
841 cases 8 0.8969
841 changes 4 0.451
841 children 1 0.1338
841 classified 1 0.2271
841 clinical 1 0.1228
841 close 1 0.2208
841 coagulation 1 0.2897
841 complexity 1 0.3173
841 complicating 1 0.2897
841 con- 1 0.1955
841 condition 1 0.2012
841 cooperation 1 0.3392
841 criteria 1 0.2208
841 decisive 1 0.3768
841 dependent 1 0.2425
841 diagnosed 1 0.2305
841 differences 1 0.1724
841 diseases 1 0.2055
841 disorder 1 0.2342
841 elbow, 1 0.3768
841 erythrocyte 1 0.2798
841 especially 1 0.1937
841 even 1 0.1649
841 experience 1 0.1937
841 extinguished. 1 0.3768
841 fact 1 0.1992
841 factor, 1 0.3768
841 factors 1 0.1593
841 fate 1 0.2798
841 fever, 1 0.3392
841 findings 2 0.2994
841 first 2 0.2763
841 following 1 0.1249
841 frequent 2 0.4542
841 function 1 0.1691
841 functional 1 0.2382
841 group 3 0.4179
841 groups: 1 0.3017
841 halves 1 0.3768
841 hematologist 1 0.3768
841 hemo- 2 0.5596
841 hemophilia 3 0.7929
841 hemophilic 4 1.1192
841 importance 1 0.1919
841 improvement 1 0.2523
841 individual 1 0.1992
841 irreparable 1 0.3768
841 jaromir 1 0.3768
841 joint 4 0.97
841 joint, 3 1.1304
841 joints 8 2.1719
841 laboratory 1 0.2179
841 large 1 0.149
841 latex 1 0.3768
841 limited 1 0.2055
841 localization 1 0.2643
841 localization, 1 0.3173
841 mainly 1 0.2472
841 manifestation 1 0.2643
841 manifestations 2 0.4303
841 matoid 1 0.3768
841 may 2 0.1885
841 mecoprotein 1 0.3768
841 monoarticular 1 0.3768
841 normal 1 0.1013
841 number 1 0.1442
841 observed 1 0.1284
841 occurred 2 0.3279
841 occurrence 1 0.2238
841 often 1 0.1826
841 one 1 0.1054
841 orthopedist 1 0.3768
841 out: 1 0.3768
841 owing 1 0.2523
841 patients 2 0.1812
841 patients. 2 0.3625
841 patients; 1 0.2798
841 philia 1 0.3173
841 philia, 1 0.3392
841 point 1 0.2179
841 practically 1 0.3173
841 preceded. 1 0.3768
841 present 1 0.1241
841 preserved, 1 0.3768
841 priborsky, 1 0.3768
841 progressive 1 0.2101
841 protein, 1 0.2715
841 reaction, 1 0.3173
841 remains 1 0.1973
841 repeated 1 0.2238
841 report 1 0.1826
841 rheu- 1 0.3768
841 rheumatic 1 0.2897
841 rheumatologist 1 0.3768
841 second 1 0.1919
841 sedimentation 1 0.2715
841 serious. 1 0.3768
841 seriousness 2 0.6785
841 several 1 0.163
841 simultaneously. 1 0.3768
841 spite 1 0.2523
841 suffering 1 0.2238
841 test 1 0.163
841 test. 1 0.2472
841 tests 1 0.1856
841 therapy 1 0.149
841 third 1 0.2055
841 three 1 0.1417
841 treated 1 0.1551
841 treatment) 1 0.3768
841 tribute 1 0.3768
841 troublesome 1 0.3768
841 tuberculous 1 0.3392
841 tyrosine 1 0.3768
841 uniformly. 1 0.3768
841 unless 1 0.2798
841 usually 1 0.1773
841 view) 1 0.3768
841 well. 1 0.2798
841 weltmann's 1 0.3768
841 wrongly 1 0.3768
841 x-ray 1 0.2472
841 year 1 0.1955
841 years 2 0.3426
841 years. 1 0.2382
841 zora 1 0.3768
842 10 1 0.5548
842 27 1 1.0091
842 8 1 0.6807
842 chronic 1 0.7196
842 deformities 1 1.2069
842 deformity 1 1.2691
842 deformity. 1 1.5073
842 deformtiy 1 1.5073
842 development 1 0.5503
842 different 1 0.5332
842 established 1 0.8133
842 experience 1 0.7747
842 haemophilia 1 1.1192
842 haemorrhage, 1 1.2691
842 joint 2 1.9399
842 last 1 1.0091
842 patients, 2 1.5092
842 prevent 1 1.0091
842 preventing 1 1.1586
842 prevention 1 1.0318
842 require 1 1.0318
842 shown 1 0.6481
842 treating 1 1.5073
842 treatment 2 0.8894
842 two 1 0.4616
842 types 1 0.7306
842 years, 1 0.9528
842 younger 1 1.0091
843 adjacent 1 0.543
843 always 1 0.4025
843 amputation 1 0.5793
843 associated 1 0.2676
843 available 1 0.411
843 bone. 1 0.5596
843 case 1 0.2708
843 conclusion 1 0.5046
843 confined 1 0.6785
843 cyst 1 0.5793
843 cysts 1 0.6034
843 described. 1 0.3773
843 effect 1 0.2301
843 evidence 1 0.2763
843 examination 1 0.3805
843 haematoma 2 1.357
843 haemophiliac 1 0.6034
843 haemophilic 4 2.3172
843 haemorrhage, 1 0.6346
843 histology 1 0.6346
843 history 1 0.4358
843 hypothesis 1 0.4025
843 large 1 0.2979
843 led 1 0.4416
843 limb 1 0.543
843 little 1 0.4025
843 muscle 1 0.4155
843 origin. 1 0.5046
843 presented 1 0.2924
843 pseudotumour 1 0.7536
843 pseudotumours 1 0.6785
843 radiographs 1 0.6785
843 subperiosteal 3 2.2609
843 support 1 0.4155
843 thigh 1 0.6034
843 treated 1 0.3101
844 actinomycin 2 2.1719
844 altering 1 1.2069
844 bone, 1 1.2069
844 ca 2 2.1144
844 effect 1 0.4602
844 effects 1 0.5595
844 excretion 1 0.7091
844 hormone 2 1.2277
844 inhibits 1 1.0091
844 measured 1 0.6597
844 mobilization, 1 1.5073
844 parathyroid 2 1.6099
844 phosphate 1 0.7611
844 rats. 1 0.7893
844 renal 1 0.5847
844 response 1 0.5503
844 upon 2 1.3526
844 without 1 0.5692
845 24-hour 1 0.5076
845 activities 1 0.3487
845 activity 3 0.6473
845 aspects 1 0.3401
845 brain 4 1.2285
845 changes 2 0.3608
845 circadian 5 2.4137
845 concentration 1 0.2535
845 consequence 2 0.9269
845 consideration 1 0.3955
845 content 3 0.8509
845 content. 1 0.5428
845 corticosterone. 1 0.6029
845 course 1 0.2741
845 data 1 0.2455
845 demonstrated. 1 0.4344
845 distribution 1 0.3099
845 disturbance 1 0.4344
845 effect 1 0.1841
845 explanation 1 0.4229
845 extent 1 0.3188
845 following 1 0.1998
845 fractions 1 0.322
845 incident 1 0.6029
845 incorporation 1 0.3811
845 indicative 1 0.4634
845 injection 2 0.5042
845 inorganic 5 2.0636
845 intermediary 1 0.6029
845 intraperitoneal 1 0.4344
845 kinetic 1 0.5076
845 liver 5 1.186
845 marked 1 0.2705
845 mathematical 1 0.6029
845 metabolism 1 0.2857
845 metabolism. 1 0.4037
845 mice 2 0.5938
845 model 1 0.4229
845 mouse 2 0.6723
845 observed 1 0.2055
845 observed. 1 0.3633
845 orthophosphate 1 0.6029
845 p32 4 1.931
845 p32-labeled 1 0.6029
845 performed 1 0.2759
845 periodic 2 0.8688
845 periodicity 4 1.7375
845 phosphate 4 1.2178
845 phosphate, 2 0.9655
845 phospholipid 3 1.2686
845 phospholipids 1 0.4827
845 phospholipids. 1 0.5076
845 phosphorus 3 1.1864
845 plasma 4 0.9723
845 postinjection 1 0.6029
845 probably 1 0.2741
845 rate 1 0.2219
845 relative 3 0.9382
845 results 1 0.1727
845 rhythm 1 0.4344
845 scale. 1 0.6029
845 segments 1 0.6029
845 selected 1 0.3533
845 significant 1 0.2116
845 similar 1 0.2257
845 specific 4 0.9488
845 studies 2 0.3693
845 suggest 2 0.5481
845 suggests 1 0.322
845 time 2 0.4249
845 total 1 0.235
845 two 1 0.1846
845 variation 3 1.1434
845 within-day 2 1.2058
846 amino-acids 2 2.7139
846 certain 2 1.3275
846 clearly 1 0.9083
846 closely 1 0.8607
846 compunds 1 1.5073
846 differentiation 1 0.8607
846 highly 1 0.8133
846 inhibition 2 1.5092
846 isomer 1 1.5073
846 l 1 1.1586
846 one 1 0.4217
846 phosphate 2 1.5222
846 possible. 1 1.2069
846 reabsorption 2 2.0183
846 related 1 0.6372
846 specific 1 0.593
846 specificity 1 1.086
846 tubular 2 2.0183
847 absence 1 0.2399
847 across 1 0.3862
847 action 1 0.2186
847 activity 1 0.1798
847 administration 1 0.2212
847 analysis 1 0.2417
847 appearance 1 0.2494
847 appeared 1 0.2417
847 caused 1 0.2199
847 clearance 1 0.3233
847 collections 1 0.423
847 despite 1 0.3176
847 dog 1 0.3123
847 dogs. 1 0.3731
847 effect 1 0.1534
847 evidence 1 0.1842
847 excess 1 0.3439
847 excretion 2 0.4727
847 excretion. 1 0.3731
847 filtered 2 0.9046
847 filtrate. 1 0.5024
847 flow 1 0.2559
847 hormone 6 1.2277
847 hormone. 1 0.2944
847 increase 1 0.1706
847 increased 1 0.1562
847 increasing 1 0.2944
847 indicated 1 0.2364
847 inhibiting 1 0.3862
847 injected 1 0.2435
847 intact 1 0.277
847 investigated 1 0.2869
847 load. 1 0.5024
847 localization 1 0.3524
847 mechanism 1 0.2315
847 mechanism. 1 0.5024
847 mediated 1 0.362
847 nephron 1 0.423
847 new 1 0.2199
847 one 1 0.1406
847 p32 2 0.8046
847 parathyroid 5 1.3416
847 phosphate 4 1.0148
847 phosphaturic 2 1.0048
847 presence 1 0.1914
847 process 1 0.2299
847 proximal 1 0.3439
847 rate 1 0.1849
847 reabsorbed 1 0.4523
847 reabsorptive 1 0.5024
847 renal 2 0.3898
847 secretory 1 0.3524
847 seven 1 0.2869
847 showed 1 0.1791
847 significant 3 0.5291
847 simultaneously 1 0.3028
847 site 1 0.2905
847 stop-flow 3 1.357
847 stopped 1 0.3862
847 techniques 1 0.274
847 thyroparathyroidectomized 1 0.5024
847 transport 1 0.3028
847 tubular 1 0.3364
847 tubule 1 0.362
847 tubule, 1 0.5024
847 without 1 0.1897
848 acute 1 0.2494
848 alterations 2 0.554
848 antibodies 1 0.2834
848 appears 1 0.216
848 assumption, 1 0.5024
848 body 1 0.2026
848 caused 1 0.2199
848 changes 4 0.6013
848 circulation 1 0.2631
848 communication 1 0.277
848 concentration 2 0.4225
848 concentration, 1 0.423
848 contributory 1 0.423
848 control 1 0.1889
848 degradation 1 0.4023
848 developed 1 0.2284
848 evidence 1 0.1842
848 except 1 0.2834
848 excretion. 1 0.3731
848 fluctuations 1 0.4023
848 fluids 1 0.3862
848 following 1 0.1665
848 gh. 1 0.4523
848 growth 1 0.1713
848 hgh 6 2.0183
848 hgh. 1 0.423
848 hormonal 1 0.3731
848 hormone 2 0.4092
848 however, 2 0.3639
848 implied 1 0.423
848 important 1 0.2269
848 investigations 1 0.3123
848 measurement 1 0.2834
848 might 1 0.2631
848 occur 1 0.2454
848 often 1 0.2435
848 patients 1 0.1208
848 plasma 4 0.8102
848 play 1 0.2985
848 present 1 0.1654
848 presentation, 1 0.5024
848 radioimmunoassay 1 0.4023
848 rapid 1 0.2435
848 rate 3 0.5548
848 reasonable 1 0.4023
848 regulation 1 0.3731
848 removal 2 0.5603
848 responsible 1 0.2537
848 role. 1 0.423
848 secretion 2 0.5888
848 secretory 1 0.3524
848 since 1 0.2186
848 slower 1 0.362
848 solely 1 0.3731
848 summarize 1 0.5024
848 throughout 1 0.2869
848 treatment 1 0.1482
848 using 1 0.2284
849 arousal 1 0.5024
849 autism 3 0.8954
849 autistic 1 0.274
849 available 2 0.548
849 certain 1 0.2212
849 child 1 0.2417
849 communication 1 0.277
849 compared 1 0.1949
849 consistent 1 0.2801
849 constitutional 1 0.3731
849 deficiency 1 0.2657
849 deprivation 1 0.362
849 deprivation. 1 0.5024
849 developing 1 0.2711
849 development, 1 0.3364
849 deviation 1 0.3862
849 deviations 1 0.4523
849 diagnosis 1 0.2067
849 directions 1 0.4523
849 distance 1 0.3862
849 dominance. 1 0.5024
849 early 5 0.9209
849 examined 1 0.2537
849 framework 1 0.423
849 function 1 0.2254
849 functions 1 0.3123
849 hierarchies 1 0.5024
849 including 1 0.2711
849 indicated. 1 0.423
849 infantile 3 0.8219
849 information 1 0.2711
849 inhibiting 1 0.3862
849 interaction 1 0.3074
849 involves 1 0.362
849 mothering 1 0.4023
849 near 2 0.6056
849 near-distance 1 0.5024
849 normal 1 0.1351
849 processes 1 0.2985
849 receptor 6 2.7139
849 results 1 0.1439
849 reticular 1 0.4023
849 sensory 3 1.1192
849 stimulation 1 0.2834
849 study 1 0.1548
849 suggested 1 0.2089
849 syndrome 1 0.2331
849 systems. 1 0.423
849 tending 1 0.4523
849 treatment 2 0.2965
849 understimulation. 1 0.5024
849 usage. 1 0.5024
849 via 1 0.3364
849 view 1 0.2944
849 young 1 0.2537
850 changes 1 0.1503
850 close 1 0.2944
850 compared 1 0.1949
850 comparing 1 0.423
850 compensatory 2 0.5603
850 control 4 0.7556
850 correlation 1 0.2537
850 data 1 0.2046
850 degree 2 0.4452
850 duration 1 0.2631
850 effect 1 0.1534
850 either 1 0.2148
850 following 2 0.3331
850 growth 2 0.3425
850 hydronephrosis 2 0.8461
850 hyperplasia 1 0.2834
850 hypertrophy 2 0.5313
850 hypertrophy. 1 0.3731
850 i. 1 0.2985
850 indicating 1 0.3233
850 interpreted 1 0.3439
850 kidney 6 1.3357
850 kidney. 1 0.3123
850 latter. 1 0.5024
850 ligation 3 1.2069
850 ligation, 1 0.5024
850 nephrectomy. 1 0.3176
850 observations 1 0.2112
850 observed 1 0.1713
850 one 1 0.1406
850 operated 2 0.6466
850 operation 1 0.2631
850 presented 1 0.1949
850 progressive 1 0.2801
850 pronounced 1 0.2985
850 rate 1 0.1849
850 rats 1 0.194
850 regulating 1 0.5024
850 related 1 0.2124
850 relative 1 0.2606
850 removal 1 0.2801
850 renal 2 0.3898
850 response 1 0.1834
850 resulting 1 0.2559
850 showed 1 0.1791
850 side 2 0.5669
850 side. 1 0.423
850 size. 1 0.3731
850 slower 1 0.362
850 strikingly 1 0.4523
850 studies 1 0.1539
850 system 1 0.2347
850 transection 3 1.5073
850 transection, 1 0.5024
850 unilateral 2 0.5422
850 unoperated 1 0.4523
850 ureteral 4 1.6922
850 way 1 0.3176
851 (100%) 1 0.3349
851 (30%). 1 0.3349
851 (60%), 1 0.3349
851 (70%) 1 0.3015
851 14 2 0.3693
851 2 1 0.1023
851 24 3 0.5212
851 25%. 1 0.3015
851 35 1 0.2575
851 4 2 0.237
851 40% 1 0.2413
851 7 2 0.3086
851 accompanied 1 0.1868
851 accumulation 1 0.2349
851 acid 8 1.0348
851 acid, 1 0.2155
851 administration 1 0.1475
851 almost 2 0.3443
851 alone. 1 0.2487
851 attempt 1 0.2049
851 body 1 0.135
851 cells 1 0.1011
851 changes 2 0.2004
851 combined, 1 0.3015
851 compared 2 0.2599
851 content 7 1.1031
851 corresponding 1 0.1963
851 cortex 1 0.1847
851 days 2 0.2661
851 days, 2 0.4394
851 days. 3 0.5669
851 declined, 1 0.3349
851 differences 1 0.1533
851 differences. 1 0.3349
851 dna 8 1.2792
851 dry 3 0.7462
851 early 1 0.1228
851 either 2 0.2864
851 exaggerated 1 0.282
851 experimentally 1 0.2349
851 first 2 0.2456
851 folic 8 2.4124
851 followed 2 0.3065
851 found 3 0.2645
851 greater 1 0.1386
851 greatly 1 0.199
851 growth 1 0.1142
851 high 1 0.1199
851 higher 1 0.144
851 hr 3 0.5811
851 hypertrophy 1 0.1771
851 increase 5 0.5688
851 increased 3 0.3124
851 increases 3 0.4694
851 indices 1 0.2349
851 induced 1 0.1424
851 injection 2 0.2801
851 injection, 2 0.4974
851 injection. 2 0.4827
851 inner 1 0.282
851 kidney 7 1.0388
851 kidney, 2 0.4394
851 labeling 1 0.2197
851 large 3 0.3972
851 later 2 0.3443
851 latter 1 0.1737
851 level 2 0.2587
851 lower, 1 0.3015
851 marked 1 0.1503
851 medulla 1 0.2413
851 medulla. 1 0.3015
851 much 2 0.2968
851 nature 1 0.1663
851 nephrectomy 6 1.2111
851 nephrectomy, 1 0.2487
851 nephrectomy. 2 0.4235
851 newly 1 0.2243
851 normal 5 0.4503
851 nucleic 1 0.2197
851 occur 1 0.1636
851 outer 1 0.282
851 parameter 1 0.2575
851 parameters 1 0.2413
851 rat 1 0.1378
851 rate 4 0.4932
851 reached 1 0.2197
851 reaching 1 0.2413
851 relative 1 0.1737
851 remaining 1 0.1706
851 renal 1 0.1299
851 response 1 0.1223
851 responses 1 0.1868
851 resulted 1 0.1624
851 returning 3 1.0048
851 rna 3 0.554
851 significant 1 0.1176
851 similar 1 0.1254
851 small 1 0.1344
851 smaller 1 0.2413
851 steady 1 0.2413
851 studies 1 0.1026
851 study 1 0.1032
851 synthesis 4 0.6652
851 synthesized 1 0.282
851 than, 1 0.3349
851 thereafter 1 0.2682
851 though 1 0.1963
851 three 1 0.1259
851 time 1 0.118
851 times 1 0.1611
851 to, 1 0.2575
851 treatment 2 0.1976
851 treatments 1 0.3349
851 unilateral 9 1.6265
851 water 1 0.1771
851 weight 4 0.6303
851 weight, 3 0.6728
851 wet 3 0.7724
851 whereas 1 0.1677
851 zones 1 0.282
852 abolished 1 0.6591
852 adrenal 2 1.1938
852 adrenalectomy 1 0.7048
852 adrenals 1 0.8461
852 also 1 0.2811
852 animals 1 0.4272
852 bilateral 1 0.6056
852 caused 1 0.4398
852 cell 1 0.3401
852 compensatory 2 1.1206
852 cortex 1 0.554
852 division 1 0.7048
852 doca. 1 1.0048
852 drinking 2 1.448
852 experiments 1 0.4452
852 follows 1 0.6466
852 fresh 1 0.724
852 hydronephrosis. 1 0.9046
852 hyperplasia 3 1.7006
852 important 1 0.4538
852 increased 1 0.3124
852 injected 1 0.4871
852 kidneys. 1 0.7462
852 maintained 1 0.5603
852 may 1 0.2513
852 mineralocorticoids, 1 0.9046
852 nephrectomy 1 0.6056
852 normally 1 0.6352
852 proliferation 1 0.5811
852 promote 1 0.9046
852 provided 1 0.6148
852 rats 1 0.388
852 relationships 1 0.6466
852 renal 3 1.1695
852 restored 1 0.7048
852 retention 1 0.6246
852 role 1 0.4661
852 saline 1 0.7462
852 secrete 1 0.9046
852 sodium 1 0.4833
852 stimulate 1 0.7048
852 suggest 1 0.4568
852 thereby 1 0.7724
852 unilateral 2 1.0844
852 water 1 0.5313
852 water, 1 0.8046
853 'neonatal 5 3.0145
853 4 1 0.2133
853 50 1 0.2878
853 58 1 0.5076
853 7 1 0.2778
853 age, 1 0.3955
853 analysed 1 0.5428
853 another 1 0.3288
853 apparent 1 0.3157
853 atresia 1 0.3689
853 atresia, 2 0.9655
853 autosomal 1 0.4344
853 biliary 3 1.0744
853 birth 2 0.6142
853 children 1 0.2141
853 clinical 1 0.1965
853 concerning 1 0.3748
853 consanguineous 1 0.5428
853 criteria, 1 0.6029
853 data. 1 0.4634
853 decrease, 1 0.5076
853 development. 1 0.4127
853 diagnosis 1 0.2481
853 diagnostic 1 0.2993
853 disease. 1 0.3188
853 disturbance 1 0.4344
853 disturbed 1 0.3748
853 evidence 2 0.442
853 excess 1 0.4127
853 extrahepatic 2 0.8073
853 failure 1 0.3253
853 familial 1 0.3955
853 familial, 1 0.6029
853 females 1 0.4229
853 foetal 1 0.4344
853 foetus. 1 0.6029
853 form, 1 0.4827
853 form. 1 0.4634
853 function 1 0.2705
853 gene 1 0.4827
853 genetic 1 0.3157
853 genotype 1 0.6029
853 genotype. 1 0.5428
853 hepatitis' 4 2.1711
853 hepatitis', 1 0.6029
853 history, 1 0.6029
853 homozygous 1 0.4634
853 infants 1 0.2878
853 influence 1 0.2759
853 intrahepatic 1 0.4827
853 jaundice 1 0.3633
853 liver 1 0.2372
853 made. 1 0.3748
853 males 1 0.4127
853 manifest 1 0.4477
853 manifestation 2 0.8457
853 marked 1 0.2705
853 maternal 1 0.3487
853 may 3 0.4523
853 mild 1 0.3955
853 mutant 1 0.4344
853 natural 1 0.3533
853 neonatal 1 0.3633
853 obstructive 1 0.4037
853 one 1 0.1687
853 order 1 0.3157
853 parents, 1 0.5428
853 pathological 1 0.3253
853 perhaps 1 0.3324
853 sequence 1 0.4634
853 severe 1 0.2671
853 shows 1 0.3324
853 so, 1 0.5428
853 study 1 0.1857
853 suggesting 1 0.3689
853 tendency, 1 0.6029
853 weight 1 0.2836
854 (750 1 1.0048
854 (at 1 0.9046
854 (pte) 1 1.0048
854 ++ 1 1.0048
854 -keto 1 1.0048
854 14 1 0.554
854 200 1 0.6591
854 4 1 0.3554
854 absent, 1 0.9046
854 acids 1 0.4948
854 action 1 0.4372
854 active 1 0.4629
854 activity 1 0.3596
854 administered 1 0.4797
854 alteration. 1 1.0048
854 altered 1 0.5366
854 animal. 1 0.7724
854 animals 2 0.8544
854 ca 1 0.7048
854 ca++ 1 0.8461
854 cacl 1 1.0048
854 changes 1 0.3007
854 citrate, 2 1.6922
854 co 1 0.724
854 consequence 1 0.7724
854 consumption 1 0.7048
854 control 3 1.1335
854 could 3 1.0831
854 data 1 0.4092
854 decline 1 0.7048
854 derived 1 0.554
854 detected 1 0.5212
854 due, 1 1.0048
854 duplicated 1 0.9046
854 early 1 0.3684
854 effect 2 0.6136
854 elicited 1 0.7048
854 extract 1 0.6352
854 extract-induced 1 1.0048
854 fumarate-c 1 1.0048
854 general 1 0.5119
854 glutarate-c, 1 1.0048
854 greater 1 0.4157
854 hormone 1 0.4092
854 hr 1 0.5811
854 hr). 1 1.0048
854 increased 1 0.3124
854 incubation 1 0.6148
854 inhibition 2 1.0062
854 injection 2 0.8403
854 lactate. 1 1.0048
854 least, 1 0.8461
854 less 1 0.3762
854 little 1 0.5366
854 liver 1 0.3953
854 liver. 1 0.7048
854 markedly 1 0.5366
854 medium, 1 0.8046
854 metabolic 1 0.4797
854 metabolism 2 0.9524
854 minces 2 2.0097
854 minces. 1 1.0048
854 one 1 0.2811
854 organic 1 0.5969
854 oxidation 2 1.6922
854 oxidation. 1 1.0048
854 parathyroid 3 1.6099
854 part 1 0.4694
854 partially 1 0.6246
854 present 1 0.3308
854 produced 1 0.4092
854 pte 3 2.7139
854 purified 1 0.6352
854 rabbit 1 0.5669
854 rapid 1 0.4871
854 separate 1 0.6352
854 stimulation 2 1.1337
854 succinate 1 1.0048
854 succinate-c, 1 1.0048
854 suggest 1 0.4568
854 tissue 1 0.3488
854 tissue. 1 0.6466
854 tissues. 1 0.6591
854 total 1 0.3916
854 treated 2 0.827
854 treatment 1 0.2965
854 u 1 0.7724
854 u/kg) 1 1.0048
854 unrelated 1 0.7048
854 vitro 1 0.5165
854 vivo 1 0.5969
855 (fe 1 0.9046
855 0.25 1 0.8461
855 10 1 0.3699
855 2 1 0.3068
855 abolish 1 0.8461
855 actinomycin 3 2.1719
855 actinomycin. 1 1.0048
855 acts 1 0.724
855 adequate 1 0.6246
855 adequate. 1 0.9046
855 amounts 1 0.4989
855 appearance 1 0.4989
855 b6d2f 1 1.0048
855 cells 1 0.3033
855 curves 1 0.6246
855 developing 1 0.5422
855 dose 1 0.4797
855 doses, 1 0.8461
855 early 2 0.7367
855 effect 1 0.3068
855 enough 1 0.7724
855 erythrocyte 1 0.7462
855 erythropoiesis 3 2.5382
855 erythropoiesis; 1 1.0048
855 erythropoietin 3 2.7139
855 erythropoietin. 1 1.0048
855 even 1 0.4398
855 female 1 0.5811
855 hypothesis 1 0.5366
855 hypoxic 1 0.7724
855 longer 1 0.7048
855 mice 2 0.9897
855 mice. 2 1.2704
855 new 1 0.4398
855 normal 1 0.2702
855 plasma 1 0.4051
855 polycythemic 1 0.9046
855 prevent 2 1.3455
855 production 1 0.5119
855 rapid 1 0.4871
855 recovery 1 0.554
855 recovery, 1 1.0048
855 repeated 1 0.5969
855 sensitive 1 0.5422
855 short 1 0.5811
855 single 1 0.4989
855 stage 2 0.9741
855 stimulatory 1 0.8046
855 support 1 0.554
855 suppress 1 0.7462
855 suppression 1 0.6466
855 time 2 0.7082
855 units 1 0.6879
855 uptake). 1 1.0048
855 versus 1 0.8461
856 (light) 1 0.3768
856 30 2 0.3598
856 actively 2 0.5596
856 amount 1 0.1856
856 atrophic 5 1.6962
856 became 1 0.2238
856 cell 2 0.2551
856 cells 6 0.6823
856 cells, 1 0.1826
856 cells. 2 0.336
856 characterized 1 0.1992
856 chief 8 2.7139
856 comparatively 1 0.3768
856 compared 2 0.2924
856 complexes. 1 0.3768
856 concerned 1 0.2523
856 containing 1 0.1992
856 contrast 1 0.2523
856 controls. 3 0.7415
856 cows 6 2.0354
856 cytoplasm, 1 0.3017
856 cytoplasmic 1 0.2271
856 d-fed 1 0.3392
856 d-fed, 1 0.3768
856 d. 1 0.2425
856 daily 1 0.2055
856 dark 2 0.6785
856 days 1 0.1497
856 density, 1 0.3173
856 developed. 1 0.3017
856 diminution 1 0.2643
856 dominated 1 0.3768
856 electron 2 0.3805
856 electron-transparent, 1 0.3768
856 ergastoplasm 1 0.3768
856 fed 1 0.2472
856 feeding 2 0.6034
856 fewer 1 0.2715
856 following 1 0.1249
856 glands 5 1.2125
856 glycogen 1 0.2715
856 golgi 1 0.2798
856 granules, 1 0.3017
856 granules. 1 0.3173
856 high 1 0.1348
856 highly 1 0.2033
856 histochemistry 1 0.3392
856 histopathology, 1 0.3768
856 inactive 4 1.0318
856 increased 1 0.1171
856 increased. 1 0.2523
856 intercellular 1 0.3017
856 intermediate 2 0.485
856 irregular 1 0.2798
856 larger 1 0.2238
856 level 1 0.1455
856 light 1 0.2126
856 markedly 1 0.2012
856 membranes. 1 0.3392
856 microscopy 1 0.2425
856 million 1 0.3173
856 nonpregnant 4 1.5073
856 nucleus 1 0.2897
856 number 1 0.1442
856 numerous 1 0.2238
856 observed 1 0.1284
856 occasionally 1 0.2523
856 organelles 1 0.2798
856 packaging 1 0.3768
856 parathyroid 5 1.0062
856 parathyroids 1 0.3392
856 parenchyma 1 0.2715
856 percentage 1 0.2101
856 poorly 1 0.2897
856 predominated. 1 0.3768
856 predominating 1 0.3392
856 pregnant 5 1.1354
856 present 1 0.1241
856 processes, 1 0.2798
856 protein 1 0.1713
856 reduced 1 0.1702
856 regular 1 0.2798
856 relatively 1 0.1813
856 secreting 2 0.6785
856 secretory 3 0.7929
856 severely 1 0.2425
856 shape 1 0.2425
856 shape, 1 0.3392
856 shrunken 1 0.3768
856 spaces 1 0.2643
856 straight 1 0.3392
856 studied 1 0.1313
856 synthesis 1 0.1871
856 traversed 1 0.3392
856 type 1 0.1567
856 ultrastructure, 1 0.3768
856 units 2 0.5159
856 untreated 4 1.1192
856 vit 4 1.357
856 vitamin 1 0.2305
856 widened 1 0.3768
857 acid 4 1.1641
857 activity 2 0.5394
857 animals 1 0.3204
857 appropriate 1 0.4943
857 bone 2 0.6519
857 bone. 1 0.5596
857 calvaria 1 0.6346
857 combination 1 0.4303
857 compared 1 0.2924
857 controls. 1 0.4943
857 diaphysis. 1 0.7536
857 discussed. 1 0.3222
857 effect 1 0.2301
857 enhanced 1 0.4685
857 extract 1 0.4764
857 facts 1 0.543
857 found 1 0.1984
857 heparin 3 1.7379
857 heparin, 1 0.7536
857 injected. 1 0.6785
857 interval 1 0.6034
857 lysosomes 1 0.5596
857 metaphysis 1 0.6785
857 might 1 0.3946
857 osteoclasts 1 0.7536
857 parathyroid 1 0.4025
857 phosphatase 4 2.2385
857 possible 1 0.3023
857 presence 1 0.2871
857 pte, 1 0.7536
857 pte-stimulated 1 0.7536
857 rats, 1 0.5159
857 relation 1 0.3472
857 stimulate 1 0.5286
857 test 1 0.326
857 theory 1 0.485
857 time 1 0.2656
857 treated 1 0.3101
857 young 1 0.3805
858 (thyrocalcitionin) 1 0.7536
858 12 1 0.3598
858 actinomycin 1 0.543
858 action 1 0.3279
858 active 1 0.3472
858 acts 1 0.543
858 administration 1 0.3319
858 bone 1 0.326
858 calcium 3 1.3431
858 calcium. 1 0.6785
858 cardiac 1 0.3381
858 change 1 0.3496
858 combination 1 0.4303
858 concluded 1 0.3449
858 d, 1 0.6034
858 d. 1 0.485
858 deficiency, 1 0.6034
858 deficiency. 1 0.5286
858 described. 1 0.3773
858 dog, 1 0.6346
858 effective 2 0.7546
858 effects 1 0.2798
858 extracted 1 0.5046
858 filtration 1 0.5046
858 fractionation 1 0.5793
858 gel 1 0.4358
858 goat, 1 0.7536
858 hormone 4 1.2277
858 hr 1 0.4358
858 important 1 0.3403
858 infusion 1 0.4252
858 injection 1 0.3151
858 isolation 2 0.97
858 lowering 1 0.543
858 lowers 1 0.7536
858 magnesium 1 0.6034
858 material 1 0.3496
858 microgram 1 0.7536
858 monkey. 1 0.7536
858 muscle 1 0.4155
858 nephrectomy, 1 0.5596
858 new 1 0.3299
858 normal 1 0.2027
858 one 1 0.2108
858 overdosage 1 0.7536
858 ox, 1 0.7536
858 parathyroidectomy, 1 0.6785
858 phosphate. 1 0.5793
858 physiology. 1 0.7536
858 pig 1 0.6034
858 pig, 1 0.6346
858 plasma 1 0.3038
858 plays 1 0.5793
858 polypeptide 1 0.6785
858 prevented 1 0.4943
858 prior 1 0.4025
858 probably 1 0.3426
858 pure 1 0.485
858 rat, 1 0.6785
858 rat. 2 1.1586
858 remains 1 0.3946
858 role 1 0.3496
858 salt 1 0.485
858 secretes 1 0.7536
858 single 1 0.3742
858 soft 1 0.6346
858 study 1 0.2322
858 thyrocalcitonin 2 1.5073
858 thyroid 4 1.7663
858 tissue 1 0.2616
858 vitamin 2 0.9221
859 (amd), 1 0.3768
859 4 1 0.1333
859 actinomycin 2 0.543
859 action 2 0.3279
859 acute 1 0.1871
859 added 1 0.2342
859 addition, 1 0.2179
859 administered 3 0.5397
859 administration 1 0.1659
859 although 2 0.2897
859 amd 8 3.0145
859 amd, 1 0.3768
859 animals 5 0.801
859 animals, 1 0.2271
859 animals. 1 0.2126
859 antibiotic 1 0.3017
859 bone 2 0.326
859 ca 7 1.8501
859 ca, 1 0.2897
859 change 1 0.1748
859 changes 3 0.3382
859 component 2 0.485
859 concluded 1 0.1724
859 consistently 1 0.2425
859 continuous 1 0.2126
859 directly 1 0.2382
859 distal 1 0.2643
859 dna-directed 1 0.3768
859 drop 1 0.2897
859 effect 2 0.2301
859 endogenous 1 0.258
859 enzymes 1 0.2382
859 examined. 1 0.258
859 excretion 2 0.3546
859 expected 2 0.4943
859 femora 1 0.3768
859 femur 1 0.3017
859 hormone 1 0.1535
859 however, 1 0.1365
859 hr. 1 0.2179
859 increase 1 0.128
859 increased 1 0.1171
859 increased. 1 0.2523
859 incubation 3 0.6916
859 inhibit 1 0.258
859 injected 1 0.1826
859 injections 1 0.2126
859 intact 4 0.831
859 kidney, 1 0.2472
859 kidney. 1 0.2342
859 known 1 0.1841
859 lavage 2 0.7536
859 lavaged 1 0.3768
859 levels 1 0.1476
859 lower 1 0.1713
859 lowered 1 0.2798
859 m-rna. 1 0.3768
859 media 1 0.2798
859 medium 1 0.2012
859 metaphysis 1 0.3392
859 mg 1 0.2238
859 mobilization 1 0.2798
859 necessarily 1 0.258
859 numbers 1 0.2238
859 osteoclast 1 0.3768
859 p 2 0.5596
859 p, 1 0.3173
859 parathyroid 1 0.2012
859 parathyroid-induced 2 0.7536
859 parathyroidectomized 4 1.357
859 parathyroidectomy 1 0.2897
859 peritoneal 3 0.869
859 phosphate 1 0.1903
859 pretreated 1 0.3392
859 pretreatment 1 0.2715
859 prevented 1 0.2472
859 production 2 0.3839
859 rats 1 0.1455
859 rats. 1 0.1973
859 recently 1 0.258
859 related 1 0.1593
859 removed 1 0.2126
859 renal 1 0.1462
859 requires 1 0.2305
859 responsible 1 0.1903
859 resulted 2 0.3653
859 rinse 1 0.3768
859 rinse. 2 0.7536
859 rna 1 0.2077
859 serum 1 0.1462
859 significantly 2 0.3168
859 still 1 0.176
859 study 1 0.1161
859 subcutaneous 1 0.2425
859 subjected 1 0.2055
859 subsequent 1 0.2055
859 synthesis, 1 0.2897
859 transfer 2 0.485
859 treated 1 0.1551
859 ultimately 1 0.3392
859 urine 1 0.1937
859 used 1 0.1423
859 vitro 1 0.1937
859 vitro. 1 0.2523
859 vivo 1 0.2238
859 well 1 0.1318
860 (pth) 1 1.0048
860 /ml. 1 1.0048
860 0.004 1 1.0048
860 a. 2 1.2704
860 act 1 0.6246
860 actinomycin 3 2.1719
860 agents 1 0.5422
860 bone 3 1.3038
860 cell 1 0.3401
860 competitively. 1 1.0048
860 control 1 0.3778
860 cultures 1 0.5031
860 d, 1 0.8046
860 dose 2 0.9594
860 effects 1 0.373
860 embryonic 1 0.6352
860 findings 1 0.3992
860 hormone 1 0.4092
860 horome 1 1.0048
860 increasing 1 0.5888
860 induced 1 0.4272
860 inhibited 1 0.6352
860 inhibition 2 1.0062
860 inhibits 1 0.6728
860 overcome 1 0.7724
860 parathyroid 2 1.0733
860 partially 1 0.6246
860 prevents 1 0.7462
860 proliferation 1 0.5811
860 pth 1 1.0048
860 pth. 1 1.0048
860 rat 1 0.4135
860 resorption 2 1.6091
860 stimulation 1 0.5669
860 suggest 1 0.4568
860 vit. 1 0.8046
860 vitamin 1 0.6148
861 (457-464). 1 0.6029
861 1 1 0.2277
861 1965, 1 0.5428
861 2 1 0.1841
861 25/4 1 0.6029
861 action 1 0.2623
861 activity 1 0.2158
861 administration 4 1.062
861 adrenal 2 0.7163
861 antagonism 1 0.5428
861 antagonistic 1 0.5428
861 associated 1 0.2141
861 balance 1 0.4127
861 biochemical 1 0.3811
861 bone 1 0.2608
861 ca, 2 0.9269
861 citrate 1 0.4477
861 clin. 1 0.6029
861 concentrations, 1 0.5428
861 concluded 1 0.2759
861 cortical 2 0.776
861 decreased 2 0.5445
861 degradation 1 0.4827
861 done 1 0.4037
861 effect 1 0.1841
861 endocr. 1 0.6029
861 excretion 1 0.2836
861 expressed 1 0.4344
861 extract 2 0.7622
861 extract. 1 0.5428
861 glycoprotein 1 0.5076
861 hormone. 1 0.3533
861 hydrocortisone 1 0.5076
861 hypoparathyroidism 1 0.5428
861 inactivation 1 0.4037
861 increased 1 0.1874
861 j. 1 0.4634
861 kidney, 1 0.3955
861 man. 1 0.388
861 metabolic 1 0.2878
861 parathyroid 5 1.6099
861 patient 1 0.2267
861 patients 1 0.1449
861 phosphate 1 0.3044
861 phosphate. 1 0.4634
861 prednisone 2 1.0856
861 prednisone. 1 0.6029
861 probably 1 0.2741
861 received 1 0.3401
861 reduce 1 0.3811
861 result 1 0.2608
861 retention, 1 0.4634
861 secretion 1 0.3533
861 serum 2 0.4678
861 sites 1 0.4037
861 steroids 3 1.2382
861 studies 1 0.1846
861 uninfluenced 1 0.6029
861 urinary 1 0.2671
861 urine 1 0.3099
862 10 1 0.0925
862 10-40% 1 0.2512
862 2 2 0.1534
862 20% 1 0.1865
862 25% 1 0.1762
862 3 1 0.0856
862 30% 1 0.2011
862 4 1 0.0889
862 40% 1 0.181
862 75% 1 0.2011
862 9% 1 0.2262
862 abnormal 1 0.1218
862 accumulation 2 0.3524
862 acidsoluble 1 0.2512
862 activity, 1 0.181
862 acute 3 0.3742
862 addition 1 0.128
862 also 1 0.0703
862 altered 2 0.2683
862 although 1 0.0966
862 appear 1 0.115
862 appreciably 1 0.2262
862 bidirectional 1 0.2512
862 bone 1 0.1087
862 c1 2 0.4523
862 ca 12 2.1144
862 ca, 1 0.1931
862 cation 1 0.2011
862 cell 10 0.8502
862 comparable 1 0.1385
862 compatible 1 0.2115
862 concentration 2 0.2112
862 concentrations 8 1.0329
862 control 2 0.1889
862 data 1 0.1023
862 decrease 1 0.115
862 decreased 5 0.5672
862 dependent 1 0.1617
862 directly 1 0.1588
862 distribution 2 0.2582
862 dogs 1 0.1303
862 dogs. 2 0.3731
862 due 1 0.0889
862 effects 4 0.373
862 efflux 1 0.2512
862 electrolytes 1 0.2115
862 electrolytes, 1 0.2011
862 evidence 1 0.0921
862 except 1 0.1417
862 exchange 4 0.6728
862 exchangeability 2 0.5024
862 experimental 2 0.2331
862 extracellular 2 0.3524
862 following 1 0.0833
862 fractional 3 0.6346
862 gradient. 1 0.2512
862 greater 1 0.1039
862 hyper- 2 0.2985
862 hypercalcemia 4 0.7724
862 hypercalcemic 1 0.2115
862 hyperparathyroidism 1 0.181
862 hyperparathyroidism, 1 0.2512
862 hypoparathyroidism 1 0.2262
862 hypoparathyroidism, 1 0.2262
862 hypoparathyroidism. 1 0.2262
862 hypotheses 1 0.1931
862 increase 1 0.0853
862 increased. 3 0.5046
862 increases 1 0.1173
862 increment 1 0.2115
862 influx 2 0.4523
862 inhibits 1 0.1682
862 inorganic 2 0.3439
862 intrinsic 1 0.1762
862 ions. 1 0.2262
862 k. 1 0.2115
862 less 1 0.094
862 lesser 1 0.172
862 ligation 1 0.2011
862 ligation. 1 0.2512
862 mg 8 1.1938
862 mg. 1 0.1588
862 muscle 1 0.1385
862 myocardium, 1 0.2262
862 na 3 0.4764
862 observed: 1 0.2512
862 occurred 2 0.2186
862 occurs 1 0.1342
862 opposes 1 0.2512
862 others 1 0.137
862 p 3 0.5596
862 p, 1 0.2115
862 parathormone 2 0.5024
862 parathyroid 1 0.1342
862 pedicle 2 0.5024
862 plasma 4 0.4051
862 present 1 0.0827
862 presented 1 0.0975
862 previously 1 0.1208
862 raising 1 0.181
862 rapid 1 0.1218
862 rate 3 0.2774
862 renal 2 0.1949
862 reported 1 0.1018
862 severity 1 0.1537
862 significant 1 0.0882
862 significantly 1 0.1056
862 skeletal 1 0.172
862 stimulates 2 0.423
862 studied 1 0.0875
862 tissue 7 0.6104
862 tissues 2 0.2299
862 tissues. 2 0.3296
862 transport 2 0.3028
862 transport. 1 0.2512
862 types 1 0.1218
862 unaltered 1 0.2262
862 unaltered. 1 0.2262
862 univalent 1 0.2512
862 upon 1 0.1127
862 usually 1 0.1182
862 well 1 0.0879
863 12 1 0.3598
863 200 1 0.4943
863 24 1 0.3909
863 6 1 0.3151
863 activity 1 0.2697
863 adenosine 2 1.357
863 administered 2 0.7196
863 alteration 1 0.4943
863 apparent 1 0.3946
863 become 1 0.4155
863 ca 1 0.5286
863 ca++ 1 0.6346
863 changes 1 0.2255
863 citrate 1 0.5596
863 citrate, 1 0.6346
863 close 1 0.4416
863 combination 1 0.4303
863 compared 1 0.2924
863 concentrations 1 0.3874
863 concluded 1 0.3449
863 conditions 1 0.3426
863 control 3 0.8501
863 control, 1 0.6034
863 cortex 1 0.4155
863 could 2 0.5415
863 decreased 1 0.3403
863 diminished 1 0.5046
863 diphospho- 1 0.7536
863 duplicated 1 0.6785
863 effect 1 0.2301
863 effects 2 0.5595
863 elevated 1 0.485
863 elevating 1 0.7536
863 elicited 1 0.5286
863 evidenced 1 0.5793
863 exchange 1 0.5046
863 frequently 1 0.3805
863 fumarate, 1 0.7536
863 hormone 4 1.2277
863 hormone. 1 0.4416
863 hr. 2 0.8716
863 hr., 1 0.5793
863 identical 1 0.4477
863 including 1 0.4066
863 increased 1 0.2343
863 inhibition 1 0.3773
863 injection, 1 0.5596
863 isocitrate 1 0.6785
863 isocitrate. 1 0.7536
863 ketoglutarate, 1 0.7536
863 kidney 3 1.0017
863 level 1 0.291
863 levels 1 0.2951
863 little 1 0.4025
863 liver 1 0.2965
863 maintaining 1 0.5793
863 malate, 1 0.7536
863 metabolic 1 0.3598
863 mitochondria 3 1.5477
863 mitochondria, 1 0.6346
863 mitochondria. 1 0.6346
863 multiple 1 0.4155
863 nature 1 0.3742
863 normal 2 0.4053
863 nucleotides 1 0.5793
863 otherwise 1 0.5596
863 p:o 1 0.7536
863 parathyroid 3 1.2074
863 parathyroid-treated 1 0.7536
863 phosphate 1 0.3805
863 phosphorylation 1 0.6346
863 plus 1 0.6346
863 potency 1 0.6034
863 preparations. 1 0.5596
863 produced 2 0.6138
863 pyruvate 1 0.6034
863 rabbits 2 0.8607
863 raising 1 0.543
863 rate 1 0.2774
863 rate, 1 0.5286
863 ratio 1 0.3946
863 reaction 1 0.3773
863 related 1 0.3186
863 remaining 1 0.3839
863 respiration 2 1.2691
863 respiratory 3 1.1728
863 series 1 0.3546
863 serum 1 0.2924
863 substrates 2 1.5073
863 substrates. 1 0.7536
863 succinate, 1 0.7536
863 triphosphatase 1 0.7536
863 triphosphate-inorganic 1 0.7536
863 triphosphopyridine 1 0.6785
863 twice 1 0.5793
863 unaffected. 1 0.7536
863 undiminished 1 0.6785
863 units 1 0.5159
863 usp 1 0.7536
863 vivo 1 0.4477
863 vivo. 1 0.6785
864 (up:uc 1 0.5024
864 (up:uo 1 0.5024
864 10 4 0.7398
864 10) 2 1.0048
864 10, 1 0.3862
864 2 1 0.1534
864 3 1 0.1713
864 30 1 0.2399
864 30- 1 0.5024
864 4 1 0.1777
864 45-minute 1 0.5024
864 50 1 0.2399
864 6 1 0.2101
864 also 1 0.1406
864 both, 1 0.5024
864 calcium 2 0.5969
864 clearance 1 0.3233
864 clinical 1 0.1638
864 concentration 2 0.4225
864 creatinine 1 0.4023
864 decrease 2 0.4598
864 decreased 1 0.2269
864 determining 1 0.3862
864 disodium 2 1.0048
864 edta 1 0.4023
864 edta. 1 0.5024
864 excretion 1 0.2364
864 followed 1 0.2299
864 function 1 0.2254
864 group 1 0.1857
864 group. 1 0.2905
864 groups. 2 0.5969
864 hr 1 0.2905
864 hypocalcemia 1 0.423
864 hypoparathyroid 3 1.5073
864 hypoparathyroidism. 1 0.4523
864 hypophosphatemia 1 0.5024
864 increase 1 0.1706
864 increased 1 0.1562
864 individuals, 1 0.3862
864 infusion 3 0.8503
864 interval. 1 0.5024
864 intravenous 1 0.2683
864 marked 1 0.2254
864 marked, 1 0.5024
864 measure 1 0.2905
864 mg/kg 1 0.4023
864 min 1 0.4023
864 normal 4 0.5404
864 osmolality 1 0.3862
864 parathyroid 1 0.2683
864 phosphate 3 0.7611
864 phosphate: 2 1.0048
864 pre-infusion 1 0.5024
864 rate 1 0.1849
864 ratios 2 0.6591
864 reflected 1 0.3731
864 return 1 0.3731
864 serum 3 0.5847
864 showed 1 0.1791
864 simple 1 0.274
864 subjects 1 0.2399
864 subjects. 1 0.3074
864 sudden 1 0.3233
864 suddenly 1 0.5024
864 suggested 1 0.2089
864 transient 1 0.3439
864 up:uc 1 0.5024
864 up:uo 1 0.5024
864 urine 4 1.0329
864 values 1 0.2537
864 x 6 1.9056
865 134 2 0.4019
865 2 1 0.0614
865 accompanying 1 0.141
865 according 1 0.1084
865 acquired 1 0.1249
865 action 1 0.0874
865 adequate 1 0.1249
865 advanced 1 0.1042
865 allocating 1 0.201
865 also 2 0.1124
865 among 1 0.0939
865 analogy 1 0.1692
865 analyzed 1 0.1376
865 associated 1 0.0714
865 available 2 0.2192
865 azotaemic 1 0.201
865 azotemic 3 0.5076
865 belief, 1 0.201
865 bicarbonate 1 0.1692
865 biochemistry 1 0.1692
865 blood-urea-nitrogen 1 0.201
865 bones. 2 0.3619
865 calcemic 1 0.201
865 calcification. 1 0.201
865 calcium 7 0.8357
865 calcium, 1 0.1692
865 case 1 0.0722
865 cases 6 0.3588
865 cases, 1 0.1052
865 chronic 4 0.3838
865 collection 1 0.1609
865 compared 1 0.078
865 concerning 1 0.1249
865 contrary 1 0.141
865 correlated 1 0.1194
865 correlation 1 0.1015
865 could 1 0.0722
865 d. 1 0.1293
865 data 3 0.2455
865 defect 2 0.1979
865 defective 2 0.2752
865 deficiency, 1 0.1609
865 degree 1 0.089
865 development 2 0.1467
865 differences 1 0.092
865 directly. 1 0.201
865 disease. 1 0.1063
865 disturbances 1 0.1194
865 duration 1 0.1052
865 effective 1 0.1006
865 effectively 1 0.1809
865 effects 2 0.1492
865 either 3 0.2578
865 entails 1 0.1809
865 evidence 1 0.0737
865 failure 2 0.2169
865 failure, 1 0.1545
865 failure. 2 0.3384
865 fibrosa 2 0.4019
865 fibrosa, 1 0.201
865 form 1 0.0874
865 found 2 0.1058
865 function 4 0.3607
865 general 1 0.1024
865 generalized 3 0.4127
865 glands 2 0.2587
865 greater 1 0.0831
865 group 5 0.3714
865 healing 1 0.1545
865 higher 2 0.1728
865 history 1 0.1162
865 hormone 1 0.0818
865 hormone. 1 0.1178
865 hyperparathyroidism 1 0.1448
865 hypertrophy 1 0.1063
865 hypocalcemia 1 0.1692
865 hypocalcemic, 1 0.201
865 imply 1 0.141
865 increased 2 0.1249
865 independently 1 0.1609
865 indicate 1 0.0885
865 information 1 0.1084
865 interpreted 1 0.1376
865 irrespective 1 0.1376
865 known 1 0.0982
865 lesions 2 0.1728
865 level 1 0.0776
865 levels 3 0.2361
865 levels. 1 0.1346
865 liability 1 0.201
865 likely 1 0.1178
865 made 2 0.1456
865 mean 1 0.0967
865 measurements 1 0.1293
865 metabolic 1 0.0959
865 metastatic 1 0.1293
865 mineralization 3 0.6029
865 mineralization. 1 0.201
865 natural 1 0.1178
865 normal 3 0.1621
865 normal. 1 0.1211
865 normocalcemic, 1 0.201
865 one 1 0.0562
865 osteitis 3 0.6029
865 osteodystrophy 1 0.1809
865 osteodystrophy, 2 0.3619
865 osteodystrophy. 2 0.3619
865 osteomalacia, 1 0.201
865 overcome 1 0.1545
865 parathyroid 8 0.8586
865 parathyroidectomy 1 0.1545
865 pathological 2 0.2169
865 patients 4 0.1932
865 personal 1 0.141
865 phosphate 3 0.3044
865 phosphate, 1 0.1609
865 phosphate. 2 0.309
865 plasma 15 1.2153
865 plasma-calcium 2 0.4019
865 present 2 0.1323
865 primary 1 0.085
865 production 1 0.1024
865 proteins 1 0.1042
865 prove 1 0.1609
865 published 1 0.1346
865 reciprocally 1 0.201
865 recorded 1 0.1148
865 related 2 0.1699
865 relation 1 0.0926
865 relative 1 0.1042
865 renal 8 0.6237
865 representative 1 0.1809
865 resistance 2 0.2241
865 response 1 0.0734
865 results 2 0.1151
865 rickets 1 0.201
865 sample. 1 0.1692
865 secondary 1 0.1006
865 seems 1 0.1063
865 series 1 0.0945
865 significant 1 0.0705
865 significantly 1 0.0845
865 simple 1 0.1096
865 since 1 0.0874
865 size 1 0.1052
865 skeletal 1 0.1376
865 state 1 0.1033
865 states 1 0.1376
865 statistical 1 0.1293
865 statistically 3 0.3748
865 sub-group; 1 0.201
865 sub-groups, 1 0.201
865 sub-normal. 1 0.201
865 sub-total 1 0.201
865 sufficient 1 0.1211
865 suggest 1 0.0914
865 suggested 1 0.0836
865 survey 2 0.2819
865 tissues, 1 0.141
865 type 1 0.0836
865 unresponsiveness 1 0.1809
865 varies 1 0.1448
865 various 1 0.0794
865 vitamin 3 0.3689
865 weights 1 0.141
865 whole 1 0.1121
866 2, 1 0.4127
866 albright's 3 1.8087
866 antigenically 1 0.4827
866 atypical 1 0.4344
866 autosomal 1 0.4344
866 biopsy 1 0.388
866 bone 3 0.7823
866 case 1 0.2166
866 cellular 1 0.3288
866 consistent 1 0.3362
866 course 1 0.2741
866 defects 1 0.3324
866 different 1 0.2133
866 discussed. 1 0.2578
866 dominant 1 0.4127
866 each. 1 0.5076
866 emphasized. 1 0.5076
866 established 1 0.3253
866 explain 1 0.4037
866 extract 1 0.3811
866 families 1 0.4229
866 family 1 0.3633
866 family, 1 0.6029
866 forms 2 0.5757
866 found 1 0.1587
866 hereditary 3 1.3032
866 hormone 3 0.7366
866 hypocalcemia 1 0.5076
866 immunologic 1 0.3955
866 importance 1 0.3071
866 indicated 1 0.2836
866 inheritance. 1 0.6029
866 intramuscular 1 0.4827
866 kindred 1 0.6029
866 labeled 1 0.3633
866 low 1 0.2639
866 may 1 0.1508
866 members 1 0.4037
866 microscopically. 1 0.6029
866 mode 1 0.4344
866 new 1 0.2639
866 observations 1 0.2535
866 osteodystrophy 1 0.5428
866 osteodystrophy, 1 0.5428
866 osteodystrophy. 1 0.5428
866 parathyroid 5 1.6099
866 pathogenesis 1 0.3401
866 pattern 1 0.2878
866 presence 1 0.2297
866 presented. 1 0.3533
866 proof 1 0.4827
866 propositus 1 0.6029
866 propositus. 1 0.6029
866 rates 1 0.3633
866 remodeling 1 0.5428
866 remodeling. 1 0.6029
866 report 1 0.2922
866 reported 1 0.2443
866 representing 1 0.4827
866 resistance 1 0.3362
866 resistant 1 0.3689
866 rib, 1 0.6029
866 sex-linked 1 0.5428
866 shared 1 0.4634
866 similar 2 0.4514
866 single 1 0.2993
866 specimens 1 0.388
866 studied 1 0.2101
866 studies 2 0.3693
866 substance 1 0.4229
866 tetracycline, 1 0.5428
866 tissue 1 0.2093
866 turnover 1 0.4037
866 two 1 0.1846
866 vivo 1 0.3581
867 acute 2 0.9978
867 additional 1 0.5366
867 aids 1 0.9046
867 antecedent 1 0.9046
867 better 1 0.5811
867 case 1 0.361
867 cases 1 0.299
867 cases. 1 0.5262
867 character 1 0.7048
867 clinical 2 0.6551
867 control 1 0.3778
867 crisis 2 1.4923
867 described 1 0.3811
867 despite 1 0.6352
867 diagnosis 1 0.4135
867 diagnosis, 1 0.6728
867 differential 1 0.6352
867 difficult 1 0.6466
867 discussed. 1 0.4296
867 distinctive 1 0.7462
867 duodenal 1 1.0048
867 early 1 0.3684
867 effective 2 1.0062
867 emergency. 2 2.0097
867 emphasizing 1 0.9046
867 especially 1 0.5165
867 features 1 0.5366
867 forms 1 0.4797
867 frequent 1 0.6056
867 gastrointestinal 1 0.724
867 history 1 0.5811
867 hypercalcemia 1 0.7724
867 hypercalcemic 1 0.8461
867 hyperparathyroidism 1 0.724
867 hyperparathyroidism: 1 0.9046
867 identification 1 0.6466
867 known 1 0.4909
867 known. 1 0.8046
867 manifestations, 2 1.6091
867 occurrence 2 1.1938
867 often 1 0.4871
867 pancreatitis 1 1.0048
867 pattern 1 0.4797
867 polymorphous 1 1.0048
867 precede 1 0.8046
867 present 1 0.3308
867 previously 1 0.4833
867 prospects 1 0.9046
867 recognizable 1 1.0048
867 recurring 1 0.9046
867 removal 1 0.5603
867 renal 1 0.3898
867 reported 1 0.4072
867 reported. 1 0.5811
867 reviewed 1 0.5669
867 skeletal 1 0.6879
867 surgical 3 1.3613
867 symptoms, 1 0.724
867 symptoms. 1 0.7462
867 syndrome 2 0.9322
867 time, 1 0.5811
867 total 1 0.3916
867 treatment. 1 0.5313
867 tumor 2 0.896
867 ulcer 1 1.0048
867 variability 1 0.724
867 variable 1 0.6056
867 well 1 0.3514
868 1-tyrosine 1 0.4306
868 18 1 0.2348
868 3 1 0.1468
868 across 3 0.9931
868 actinomycin 5 1.5514
868 action 1 0.1874
868 action. 1 0.3626
868 actions 1 0.2771
868 blocks 1 0.331
868 c. 1 0.2277
868 ca 6 1.8123
868 calcium 1 0.2558
868 concentrations 1 0.2213
868 concentrative 1 0.4306
868 conditions 1 0.1958
868 d-deficient 1 0.3877
868 d-treated 1 0.4306
868 d. 1 0.2771
868 deficient 1 0.2771
868 direct 1 0.2026
868 effect 2 0.263
868 fasted 1 0.4306
868 hr 2 0.4981
868 increasing 1 0.2523
868 influence 1 0.1971
868 inhibition 1 0.2156
868 inhibitory 1 0.2825
868 inhibits 1 0.2883
868 injection 2 0.3601
868 interaction 1 0.2635
868 intestinal 3 0.9308
868 less 1 0.1612
868 marked 1 0.1932
868 mucosal 1 0.3877
868 present 1 0.1418
868 raising 1 0.3103
868 rather 1 0.2026
868 rats 1 0.1663
868 rats. 1 0.2255
868 s. 1 0.331
868 serum 1 0.1671
868 stimulatory 1 0.3448
868 suggests 1 0.23
868 surface 1 0.2324
868 system, 1 0.3626
868 system. 1 0.3021
868 transport 7 1.8167
868 vit 5 1.9385
868 vitamin 1 0.2635
868 vitro 1 0.2213
868 vitro. 1 0.2883
868 wall 2 0.5445
868 well 1 0.1506
868 within 1 0.1599
869 2.5 1 0.5596
869 3-fold 1 0.6346
869 children 1 0.2676
869 corticosteroid-induced 1 0.7536
869 corticosteroids 1 0.5046
869 decreased 1 0.3403
869 doses 1 0.411
869 dwarfism: 1 0.6346
869 excretion 3 1.0637
869 growing 1 0.5046
869 growth 4 1.0275
869 hormone. 2 0.8832
869 human 2 0.5031
869 hydroxyproline 3 2.0354
869 increased 2 0.4686
869 initially 1 0.4943
869 large 1 0.2979
869 level. 1 0.543
869 low 1 0.3299
869 normal 1 0.2027
869 promptly. 1 0.6785
869 rate 3 0.8323
869 receiving 1 0.4155
869 retarded 1 0.485
869 stopped, 1 0.7536
869 studies 1 0.2308
869 treated 1 0.3101
869 treatment 2 0.4447
869 two 1 0.2308
869 urinary 1 0.3339
869 years 1 0.3426
870 (hgh) 1 0.9046
870 (hpl) 2 2.0097
870 200 2 1.3182
870 addition, 1 0.5811
870 augment 1 1.0048
870 balance 1 0.6879
870 based 1 0.5262
870 comparison 1 0.5212
870 conclusions 1 0.6352
870 day 1 0.4989
870 dose 2 0.9594
870 effect 1 0.3068
870 given 1 0.3684
870 growth 2 0.685
870 hormone 2 0.8185
870 human 2 0.6707
870 hypopituitary 2 1.3758
870 induce 1 0.6728
870 lactogen 3 3.0145
870 level 1 0.388
870 mg./ 1 1.0048
870 mg./day. 1 1.0048
870 nitrogen 2 1.3182
870 patients. 1 0.4833
870 placental 2 1.3758
870 positive 1 0.5366
870 reported 1 0.4072
870 retaining 1 1.0048
870 studies 1 0.3077
870 subjects. 1 0.6148
870 two 1 0.3077
871 (4 1 1.5073
871 acromegaly. 1 1.5073
871 administration. 1 1.0091
871 appropriate 1 0.9887
871 brain 2 1.5356
871 carefully 1 1.086
871 cases 1 0.4484
871 cause 1 0.6807
871 cerebral 1 0.7143
871 considered 1 0.672
871 courses 1 1.357
871 develop 1 0.9083
871 dosimetry 1 1.5073
871 due 1 0.5332
871 error 1 1.086
871 exceeded. 1 1.5073
871 fatal. 1 1.5073
871 latent 1 1.2691
871 lesions 1 0.6481
871 months 1 0.7611
871 multiple 1 0.831
871 necrosis 2 2.0636
871 often 1 0.7306
871 particulary 1 1.357
871 period 1 0.5717
871 pituitary 2 1.5637
871 preferable 1 1.2691
871 progressive 1 0.8404
871 radiation 2 1.6439
871 radiation. 1 1.357
871 rapid 1 0.7306
871 repeated 1 0.8954
871 reported), 1 1.5073
871 schedule 1 1.2069
871 surgery 1 0.7483
871 therapy 1 0.5959
871 treatment 2 0.8894
871 tumors 1 0.7893
872 ('catch-up' 1 0.5024
872 10 1 0.1849
872 41 1 0.5024
872 6 2 0.4202
872 acceleration 1 0.423
872 accompanied 1 0.2801
872 administration. 2 0.6728
872 age 1 0.2078
872 age. 1 0.2834
872 also 1 0.1406
872 and, 1 0.2606
872 asphyxia, 1 0.5024
872 attempt 1 0.3074
872 average 1 0.2254
872 become 1 0.277
872 birth 1 0.2559
872 birth, 1 0.3862
872 briefly. 1 0.5024
872 cases 1 0.1495
872 cases, 1 0.2631
872 cause. 1 0.3731
872 cm. 1 0.423
872 cm./year, 1 0.5024
872 concerning 1 0.3123
872 consider 1 0.3524
872 considered 1 0.224
872 continued 1 0.2905
872 could 1 0.1805
872 degree 2 0.4452
872 delay 1 0.3862
872 detailed 1 0.3176
872 diagnostic 1 0.2494
872 discussed 1 0.2046
872 disproportionate 1 0.4523
872 due 1 0.1777
872 dwarfism, 1 0.4523
872 dwarfism. 1 0.423
872 dwarfs 1 0.4023
872 evidence 1 0.1842
872 exception 1 0.3296
872 experiences 1 0.3364
872 far 1 0.3233
872 first 2 0.3684
872 four 3 0.6763
872 gonadotrophic 1 0.5024
872 growth 3 0.5138
872 growth). 1 0.5024
872 growth, 1 0.3364
872 height 1 0.423
872 height. 1 0.5024
872 hereditary 1 0.362
872 hgh 3 1.0091
872 hormones 1 0.3524
872 human 1 0.1677
872 hypopituitarism 1 0.4023
872 hypopituitary 1 0.3439
872 hypothyroidism, 1 0.5024
872 important 1 0.2269
872 increased 1 0.1562
872 increment 1 0.423
872 information 1 0.2711
872 insulin 1 0.3028
872 life 1 0.2657
872 marked 1 0.2254
872 maturated 1 0.5024
872 maturation 2 0.8046
872 maturation, 1 0.423
872 metopyrone 1 0.5024
872 moderately 1 0.362
872 months 1 0.2537
872 neonatal 1 0.3028
872 none 2 0.6056
872 normal 3 0.4053
872 obtained. 2 0.7462
872 oldest 1 0.423
872 one 1 0.1406
872 passed 1 0.423
872 patient 1 0.1889
872 patients 6 0.7246
872 patients. 1 0.2417
872 periods 1 0.2801
872 pituitary 2 0.5212
872 poor 1 0.2905
872 possibility 1 0.2869
872 possible 1 0.2015
872 possibly 1 0.3123
872 produce 1 0.2683
872 pronounced 1 0.2985
872 puberty 1 0.4523
872 rate 1 0.1849
872 rather 1 0.2364
872 reached 1 0.3296
872 reported. 1 0.2905
872 resistant 1 0.3074
872 responded 1 0.3731
872 response 1 0.1834
872 retardation 2 0.6879
872 rule 1 0.3862
872 secondary 1 0.2515
872 sensitivity, 1 0.423
872 severe 1 0.2226
872 severe, 1 0.3524
872 sexual 1 0.3862
872 sexually. 1 0.5024
872 signs 1 0.2801
872 six 1 0.277
872 skeletal 2 0.6879
872 stated. 1 0.5024
872 therapy. 1 0.2711
872 traumatic 1 0.3524
872 treatment 3 0.4447
872 twelve 2 0.6352
872 type, 1 0.3364
872 unknown 1 0.3731
872 using 1 0.2284
872 varying 1 0.2711
872 well 1 0.1757
872 whether 1 0.2494
872 year 3 0.7819
872 yet 1 0.2657
873 10 2 0.4439
873 14 1 0.3324
873 17 1 0.3581
873 20 1 0.2723
873 3 1 0.2055
873 boy 1 0.4037
873 case 1 0.2166
873 cases 1 0.1794
873 cm. 1 0.5076
873 constitutional 1 0.4477
873 curve 1 0.4127
873 discussed: 1 0.5428
873 dwarf 1 0.5076
873 dwarfism 1 0.4229
873 female 1 0.3487
873 following 1 0.1998
873 girl 1 0.4037
873 grew 1 0.4037
873 growth 5 1.0275
873 growth, 1 0.4037
873 hormone 1 0.2455
873 hormone. 1 0.3533
873 human 2 0.4024
873 hypopituitary 1 0.4127
873 increased; 1 0.6029
873 mth.; 1 0.5428
873 primordial 1 0.5076
873 rate 1 0.2219
873 results 1 0.1727
873 retarded 2 0.776
873 treatment 2 0.3558
873 treatment. 1 0.3188
873 unaffected 1 0.4827
873 yr. 2 0.6314
873 yr., 1 0.5428
874 abnormal 1 0.2922
874 abnormally 1 0.4477
874 active 1 0.2778
874 clinical 1 0.1965
874 concentration 1 0.2535
874 concentrations 1 0.3099
874 deficiency 1 0.3188
874 description 1 0.3955
874 dwarfism 1 0.4229
874 endogenous 1 0.4127
874 error 1 0.4344
874 exogenous 1 0.4827
874 genetic 1 0.3157
874 given 1 0.221
874 growth 5 1.0275
874 high 2 0.4315
874 hormone 4 0.9822
874 hormone. 1 0.3533
874 hypoglycemia 1 0.4827
874 immunoreactive 1 0.6029
874 inborn 1 0.4827
874 laboratory 1 0.3487
874 metabolism?. 1 0.6029
874 molecule 1 0.4229
874 new 1 0.2639
874 patients, 1 0.3018
874 pituitary 1 0.3127
874 postulated. 1 0.6029
874 secretion 1 0.3533
874 serum 2 0.4678
874 siblings 1 0.4477
874 signs 1 0.3362
874 since 1 0.2623
874 three 1 0.2267
875 associated 1 0.5352
875 ateliosis, 1 1.5073
875 autosomal 1 1.086
875 birth 1 0.7678
875 body 1 0.6077
875 defect. 1 1.357
875 deficiencies 1 1.357
875 deficiency 2 1.5939
875 development, 1 1.0091
875 dwarfism 1 1.0572
875 form 1 0.6558
875 growth 1 0.5138
875 growth-hormone 1 1.2069
875 hormone 1 0.6138
875 human 1 0.5031
875 inherited 2 2.4137
875 isolated, 1 1.1586
875 lactation 1 1.357
875 man: 1 1.5073
875 midgets 1 1.5073
875 normal 1 0.4053
875 observed 1 0.5138
875 pituitary 1 0.7819
875 postpartum 1 1.357
875 proportions, 1 1.357
875 recessive 1 1.2069
875 recessively 1 1.357
875 sexual 2 2.3172
875 syndrome. 1 1.1586
875 trait. 1 1.5073
875 weight, 1 1.0091
876 (raben) 1 0.3768
876 (raben). 1 0.3768
876 11 1 0.2012
876 13 1 0.2179
876 2 1 0.1151
876 3 1 0.1284
876 achieved 1 0.258
876 activation 1 0.2798
876 adolescents 1 0.3017
876 adrenal 1 0.2238
876 adverse 1 0.2897
876 age, 1 0.2472
876 agent 1 0.2208
876 bone 1 0.163
876 cases 1 0.1121
876 cases. 1 0.1973
876 children 2 0.2676
876 clinically 1 0.258
876 conditions. 1 0.2643
876 continued 1 0.2179
876 demands 1 0.3173
876 discussed. 1 0.1611
876 documented 1 0.2715
876 dose 1 0.1799
876 due 1 0.1333
876 dwarf. 1 0.3768
876 evaluated 1 0.2179
876 evaluation 1 0.2033
876 experience 1 0.1937
876 failure, 1 0.2897
876 fulfils 1 0.3768
876 gonadal 1 0.3768
876 growth 8 1.0275
876 hormone 3 0.4604
876 human 3 0.3773
876 hypopituitary 2 0.5159
876 improvement 1 0.2523
876 increase 1 0.128
876 increases 1 0.176
876 invaluable 1 0.3392
876 limited 1 0.2055
876 linear 1 0.2425
876 longitudinal 1 0.3017
876 material 1 0.1748
876 mg 1 0.2238
876 noted 1 0.1992
876 noted; 1 0.3392
876 observed. 1 0.2271
876 owing 1 0.2523
876 panacea 1 0.3768
876 patients. 1 0.1813
876 pituitary 2 0.3909
876 point 1 0.2179
876 probably 1 0.1713
876 protocol 1 0.3173
876 rate 2 0.2774
876 reactions 1 0.1841
876 recommended 1 0.2523
876 replacement 1 0.2382
876 response 1 0.1376
876 role 1 0.1748
876 scrutiny. 1 0.3768
876 short 4 0.8716
876 significant 2 0.2646
876 stature 2 0.6346
876 stature, 1 0.3768
876 stature. 1 0.3392
876 stimulated, 1 0.3768
876 study 1 0.1161
876 supply 1 0.2798
876 therapeutic 2 0.3805
876 therapy 1 0.149
876 thirty-five 1 0.3392
876 though 2 0.4416
876 thyroidal, 1 0.3768
876 times 1 0.1813
876 treatment 3 0.3335
876 undue 1 0.3392
876 unique 1 0.2425
876 used 1 0.1423
876 weekly 1 0.3017
876 whose 1 0.2208
876 without 1 0.1423
877 13 1 0.5811
877 13. 1 1.0048
877 18 1 0.548
877 8 2 0.9076
877 acth 1 0.8461
877 activity 1 0.3596
877 adenomatous 1 0.9046
877 administration 1 0.4425
877 adrenal 1 0.5969
877 adrenocortical 1 0.8046
877 autonomously 1 1.0048
877 began 2 1.4923
877 bilateral 3 1.8167
877 case 2 0.722
877 clinical 1 0.3275
877 continuous 1 0.5669
877 controlled 1 0.5738
877 cushing's 2 2.0097
877 day 1 0.4989
877 decrease 1 0.4598
877 development 1 0.3669
877 dexamethasone 1 0.8461
877 disease 2 0.722
877 duration 2 1.0524
877 duration. 1 1.0048
877 dwarfism 1 0.7048
877 eighteen 1 0.7724
877 evidence 2 0.7367
877 evolved 1 0.8461
877 excretion. 1 0.7462
877 explanation 1 0.7048
877 failed 1 0.5738
877 first 1 0.3684
877 found 1 0.2645
877 functioning 1 0.6879
877 gh 1 0.7724
877 grade 1 0.8046
877 growth 1 0.3425
877 however, 1 0.3639
877 hyperplasia 2 1.1337
877 hyperplasia. 1 0.8046
877 increased 1 0.3124
877 indicate 1 0.4425
877 levels 1 0.3935
877 long 1 0.5212
877 low 1 0.4398
877 mg 1 0.5969
877 next 1 0.8046
877 nodular 2 1.6922
877 old 1 0.5669
877 one 1 0.2811
877 partially 1 0.6246
877 patient 1 0.3778
877 patient's 1 0.6728
877 patient. 1 0.6879
877 per 1 0.3916
877 period 1 0.3811
877 pituitary 2 1.0425
877 presented 1 0.3898
877 presented. 1 0.5888
877 primary 1 0.4248
877 probable 1 0.6352
877 process 1 0.4598
877 provides 1 0.6352
877 radiation 1 0.548
877 reasonable 1 0.8046
877 secretion 2 1.1776
877 steroid 2 1.1622
877 suggested 1 0.4179
877 suppression 1 0.6466
877 surgery. 1 0.6879
877 syndrome 2 0.9322
877 urinary 1 0.4452
877 years 1 0.4568
877 years' 2 1.6922
877 years. 1 0.6352
878 (accidentally 1 0.3349
878 25 1 0.1913
878 adrenocorticotropic 1 0.3349
878 adults 1 0.2019
878 adults. 1 0.2487
878 antibodies. 1 0.282
878 antithyroid 1 0.3349
878 asymptomatic 1 0.2487
878 capacity. 1 0.2575
878 characteristic 1 0.1691
878 defects 1 0.1847
878 deficiency 2 0.3542
878 demonstrated 1 0.1432
878 demonstrates 1 0.2682
878 diagnosis 1 0.1378
878 direct 1 0.1576
878 discovered) 1 0.3349
878 elevated 1 0.2155
878 endocrine 1 0.2349
878 enlargement 2 0.4586
878 etiology 1 0.1847
878 evaluated 1 0.1937
878 evaluation, 1 0.2682
878 evidence 1 0.1228
878 exhibited 1 0.2049
878 failure 1 0.1807
878 first 1 0.1228
878 frequency 1 0.1754
878 function 3 0.4509
878 functions. 1 0.3015
878 gonadotropin, 1 0.3349
878 growth 9 1.0275
878 high 1 0.1199
878 hormonal 1 0.2487
878 hormone 9 1.2277
878 hormone, 2 0.4311
878 hormone. 1 0.1963
878 hypoglycemia 2 0.5364
878 hypoglycemia. 1 0.282
878 hypopituitarism 1 0.2682
878 hypopituitarism. 2 0.6031
878 hypopituitarism: 1 0.3349
878 hypopituitary 1 0.2293
878 indicated 1 0.1576
878 insulin-induced 1 0.282
878 intrinsic 1 0.2349
878 isolated 1 0.1457
878 levels 1 0.1312
878 liters 1 0.3349
878 loss 2 0.3247
878 loss, 1 0.2575
878 may 1 0.0838
878 measured 1 0.1466
878 normal 1 0.0901
878 one 2 0.1874
878 order 1 0.1754
878 particular 1 0.1691
878 patient 1 0.1259
878 patients 2 0.161
878 pattern 1 0.1599
878 pituitary 2 0.3475
878 plasma 1 0.135
878 prevalence 1 0.2682
878 radioimmunoassay 2 0.5364
878 remarkably 1 0.2682
878 represents 1 0.2293
878 reserve. 1 0.3349
878 response 2 0.2446
878 rise 1 0.1663
878 samples 1 0.2117
878 secretion, 2 0.6031
878 secretory 2 0.4699
878 sella 2 0.6699
878 sensitive 1 0.1807
878 series 2 0.3152
878 significant 1 0.1176
878 standardized 1 0.2575
878 stimulating 1 0.2349
878 study 2 0.2064
878 suggests 1 0.1789
878 taken 1 0.189
878 test 1 0.1449
878 tests 1 0.1649
878 thyroid 2 0.3925
878 turcica 1 0.3349
878 turcica. 1 0.3349
878 two 1 0.1026
878 was: 1 0.3349
878 well 1 0.1171
879 (normal 1 1.0048
879 1 2 0.7589
879 1-3), 1 1.0048
879 3-6 1 1.0048
879 30-40 1 0.9046
879 7-year-old 1 1.0048
879 adrenal, 1 1.0048
879 adrenaline 1 0.9046
879 age 1 0.4157
879 age. 1 0.5669
879 alterations 2 1.108
879 appropriate. 1 1.0048
879 associated 1 0.3568
879 authors 1 0.4629
879 blood 1 0.3105
879 bone 1 0.4346
879 boy 1 0.6728
879 carbohydrate 2 1.4096
879 concluded 1 0.4598
879 deficiency 2 1.0626
879 demonstrated 1 0.4296
879 dwarfed 1 0.9046
879 dwarfism 2 1.4096
879 episodes 1 0.7724
879 fasting 2 1.3758
879 function 1 0.4509
879 g./ml. 1 1.0048
879 gh 3 2.3172
879 glucagon 1 1.0048
879 glucose 1 0.5262
879 glycogenolysis 1 1.0048
879 growth 1 0.3425
879 hepatic, 1 1.0048
879 hgh 1 0.6728
879 history 1 0.5811
879 hormone. 1 0.5888
879 hr. 1 0.5811
879 hypoglycemia 2 1.6091
879 hypoglycemia. 1 0.8461
879 hypoglycemic 2 1.8093
879 insulin 1 0.6056
879 insulin-induced 1 0.8461
879 isolated 2 0.8744
879 l-leucine 1 0.9046
879 less 1 0.3762
879 levels 2 0.787
879 low 1 0.4398
879 metabolism. 2 1.3455
879 mg./100 1 1.0048
879 ml. 1 0.6728
879 normal. 1 0.6056
879 patient 1 0.3778
879 plasma 1 0.4051
879 recurrent 1 0.7724
879 response 1 0.3669
879 resulted 1 0.4871
879 retarded 1 0.6466
879 reversed 1 0.7462
879 rise 2 0.9978
879 seen 1 0.4248
879 sensitive 1 0.5422
879 sensitivity 1 0.6056
879 severe, 1 0.7048
879 showed 1 0.3582
879 similarly, 1 0.9046
879 since 1 0.4372
879 studied 1 0.3501
879 suffered 1 0.6879
879 sugars 1 0.9046
879 test. 1 0.6591
879 thyroid 1 0.5888
879 tolerance 1 0.6466
879 treatment 1 0.2965
879 unresponsiveness. 1 1.0048
880 -ketoglutaric 2 1.2058
880 1 1 0.2277
880 12 1 0.2878
880 2 1 0.1841
880 24 1 0.3127
880 4 1 0.2133
880 5 1 0.2287
880 7 1 0.2778
880 absorption, 1 0.4827
880 acceleration 1 0.5076
880 accompanied 1 0.3362
880 accompanying 1 0.4229
880 acid 1 0.2328
880 acid. 1 0.4634
880 action 1 0.2623
880 administration, 1 0.4634
880 alter 1 0.4037
880 alter. 1 0.6029
880 alteration 1 0.3955
880 altered, 1 0.6029
880 amino-acid 1 0.5076
880 biphasic 1 0.5428
880 blood 5 0.9315
880 calcium 2 0.7163
880 calcium; 1 0.5428
880 catabolism: 1 0.6029
880 change 1 0.2797
880 citrate 5 2.2385
880 compartment, 1 0.6029
880 complex, 1 0.4344
880 components, 1 0.4827
880 concentration 2 0.5069
880 concentrations 2 0.6198
880 concentrations. 1 0.6029
880 correlating 1 0.6029
880 daily 1 0.3288
880 days 1 0.2395
880 despite 1 0.3811
880 doses 1 0.3288
880 dwarfism. 2 1.0153
880 effect 1 0.1841
880 effects 2 0.4476
880 electrolyte 1 0.4634
880 excretion 1 0.2836
880 excretion; 1 0.6029
880 expansion 2 1.2058
880 extracellular 2 0.8457
880 fasting 3 1.2382
880 fasting, 1 0.5428
880 fasting. 1 0.6029
880 fat 2 0.7377
880 follows: 1 0.4827
880 formation. 1 0.4634
880 found 1 0.1587
880 gain 1 0.4344
880 given 1 0.221
880 glucose 1 0.3157
880 glycaemia 1 0.6029
880 growth 3 0.6165
880 hormone 4 0.9822
880 hormone, 1 0.388
880 hormone. 1 0.3533
880 hours 3 0.87
880 human 2 0.4024
880 hypercalciuria, 1 0.6029
880 hyperglycaemia. 1 0.6029
880 hypoglycaemia 1 0.5428
880 hypothalamo-pituitary 1 0.6029
880 i. 1 0.3581
880 i.m. 1 0.5076
880 increase 2 0.4095
880 increased 3 0.5623
880 injection 2 0.5042
880 injection. 1 0.4344
880 injections, 1 0.5428
880 insulin 1 0.3633
880 intermediate 1 0.388
880 intestinal 2 0.8688
880 intracellular 2 0.7909
880 isolated 1 0.2623
880 isotonic 1 0.4827
880 levels 1 0.2361
880 levels. 1 0.4037
880 lipid 1 0.3689
880 load 1 0.4827
880 low 1 0.2639
880 marked 1 0.2705
880 metabolic 2 0.5757
880 metabolism 1 0.2857
880 metabolism. 1 0.4037
880 method, 1 0.4477
880 mg. 1 0.3811
880 mobilisation 2 1.2058
880 nefa 2 0.9269
880 nitrogen 2 0.7909
880 one 1 0.1687
880 oral 1 0.3689
880 partly 1 0.4634
880 patients 1 0.1449
880 period 1 0.2287
880 periods 1 0.3362
880 phosphate 1 0.3044
880 phosphate; 1 0.6029
880 phosphorus, 1 0.6029
880 pituitary-hypothalamic 1 0.6029
880 plasma 5 1.2153
880 progressive 1 0.3362
880 proportions 1 0.5076
880 protoplasm 1 0.6029
880 raben's 1 0.6029
880 reduction 1 0.2969
880 required 1 0.3288
880 reserves. 1 0.6029
880 retention 5 1.8738
880 reversed 1 0.4477
880 reversible 1 0.4477
880 rise 1 0.2993
880 sometimes 1 0.388
880 space, 1 0.5076
880 state, 1 0.5076
880 stopping 2 1.0153
880 stores 1 0.5428
880 sugar 2 0.9269
880 test 1 0.2608
880 tests 1 0.2969
880 tolbutamide 1 0.5428
880 treatment, 2 0.776
880 treatment. 1 0.3188
880 urea. 1 0.4827
880 urinary 2 0.5343
880 variable 1 0.3633
880 various 1 0.2383
880 weight 1 0.2836
880 well 1 0.2108
880 without 1 0.2277
881 'growth 2 0.6699
881 (cgp) 1 0.3349
881 (sem 3 1.0048
881 (sem0.39) 1 0.3349
881 0.003), 1 0.3349
881 0.019 1 0.3349
881 0.52) 1 0.3349
881 0.57 1 0.3349
881 1076 1 0.3349
881 29 1 0.2293
881 300-fold 1 0.3349
881 33.5 1 0.3349
881 4.6). 1 0.3349
881 5.6 1 0.3349
881 5.9 1 0.3015
881 actions 1 0.2155
881 almost 1 0.1722
881 appreciable 1 0.2349
881 attributable 1 0.2293
881 blood 2 0.207
881 cgp 4 1.3398
881 cgp/hgh 1 0.3349
881 changes 1 0.1002
881 chorionic 2 0.6699
881 circulation. 1 0.2682
881 circulations. 1 0.3349
881 concentration 3 0.4225
881 consistent 1 0.1868
881 contrariwise, 1 0.3349
881 contrast 1 0.2243
881 data 1 0.1364
881 difference. 1 0.3015
881 effects 1 0.1243
881 exchange 1 0.2243
881 exclusively 1 0.2575
881 exerting 1 0.3349
881 fetal 2 0.3825
881 fetus 1 0.2349
881 fetus. 1 0.2575
881 fetuses 1 0.2413
881 findings 1 0.1331
881 further, 1 0.2575
881 g/ml 4 1.3398
881 growth 2 0.2283
881 hgh 3 0.6728
881 hormone 2 0.2728
881 hormone-like 1 0.3349
881 hormone-prolactin' 2 0.6699
881 hypothesis 1 0.1789
881 important 1 0.1513
881 indirectly 1 0.3349
881 level 1 0.1293
881 manner 1 0.2293
881 maternal 6 1.1622
881 mean 3 0.4833
881 measured 1 0.1466
881 metabolic 2 0.3198
881 mother 2 0.3825
881 observed 1 0.1142
881 obtained 1 0.1194
881 occurs 1 0.1789
881 pituitary 2 0.3475
881 placenta, 1 0.3015
881 possibly 1 0.2082
881 pregnancy 2 0.3925
881 pregnant 1 0.2019
881 procedures. 1 0.2682
881 radioimmunoassay 1 0.2682
881 ratio 1 0.1754
881 secreted 1 0.282
881 sensitive 1 0.1807
881 serum 9 1.1695
881 serum. 1 0.2413
881 simultaneously 1 0.2019
881 strongly 1 0.2155
881 suggest 1 0.1523
881 support 1 0.1847
881 syncytiotrophoblast 1 0.3349
881 term 1 0.1868
881 term. 1 0.3015
881 umbilical 3 0.8046
881 unidirectional 1 0.3349
881 unlikely 1 0.3015
881 utilizing 1 0.2487
881 venous 5 0.9448
881 view 1 0.1963
881 whereas 1 0.1677
881 women 1 0.1807
882 72 1 0.4344
882 abdominal 2 0.8954
882 assimilation 1 0.5428
882 blood-glucose 1 0.6029
882 corticotrophin 1 0.6029
882 effect 2 0.3682
882 extent 1 0.3188
882 fasting 2 0.8255
882 followed 1 0.2759
882 glucose 4 1.2628
882 greater 1 0.2494
882 growth 2 0.411
882 growth-hormone 1 0.4827
882 high 1 0.2158
882 higher 1 0.2593
882 hormone 1 0.2455
882 hormone, 1 0.388
882 hours 1 0.29
882 hydrocortisone. 1 0.6029
882 immediate 1 0.3811
882 increases 1 0.2816
882 infusion 1 0.3401
882 insulin, 1 0.4344
882 intravenous 2 0.644
882 least 1 0.3099
882 levels 5 1.1804
882 levels. 1 0.4037
882 moderate 1 0.3581
882 much 1 0.2671
882 operation 1 0.3157
882 operation, 1 0.4477
882 operation. 1 0.3955
882 operations 1 0.3955
882 period. 1 0.3633
882 persists 1 0.5428
882 plasma-hydrocortisone 1 0.6029
882 plasma-insulin 1 0.6029
882 postoperative 1 0.3633
882 produces 1 0.3811
882 raised 1 0.3581
882 reduced 1 0.2723
882 reduces 1 0.5076
882 serum 1 0.2339
882 serum-insulin 2 1.2058
882 severity 1 0.3689
882 surgery. 1 0.4127
882 tolerance 2 0.776
883 12.0 1 0.4306
883 150-200 1 0.3877
883 17.3, 1 0.4306
883 54.9 1 0.4306
883 94.2 1 0.4306
883 anesthesia, 1 0.3626
883 anesthesia. 1 0.3877
883 assay 2 0.5649
883 brief 1 0.3021
883 concentration 2 0.3621
883 conditions 1 0.1958
883 depressed 1 0.331
883 described 1 0.1633
883 detail. 1 0.3103
883 detect 1 0.3877
883 detectable 1 0.2722
883 determine 1 0.2429
883 determined 2 0.3915
883 elevated 1 0.2771
883 ether 1 0.3198
883 evidence 2 0.3157
883 experimental 1 0.1998
883 experiments 1 0.1908
883 extrasellar 1 0.4306
883 factors 1 0.1821
883 failed 1 0.2459
883 fall 1 0.2255
883 fasting 1 0.2948
883 female, 1 0.3198
883 females 1 0.3021
883 females, 1 0.3877
883 findings 1 0.1711
883 g, 1 0.3626
883 g/ml. 1 0.4306
883 gh 7 2.3172
883 gh. 1 0.3877
883 growth 1 0.1468
883 hormone 1 0.1754
883 hosts. 1 0.3877
883 hypophysectomized 1 0.2825
883 hypophysectomy 2 0.6206
883 influence 1 0.1971
883 intraocular 1 0.3877
883 involved 1 0.2194
883 lactating 1 0.4306
883 lactation, 1 0.4306
883 led 1 0.2523
883 levels 5 0.8432
883 male, 1 0.3877
883 males, 1 0.3877
883 mean 1 0.2071
883 method 1 0.1711
883 nervous 1 0.2635
883 normal 1 0.1158
883 periods 1 0.2401
883 pituitary 3 0.6702
883 plasma 2 0.3472
883 pregnancy, 1 0.3198
883 pregnant 1 0.2595
883 prolactin. 1 0.3877
883 providing 1 0.331
883 radioimmunoassay: 1 0.4306
883 raise 1 0.3626
883 range 1 0.2324
883 rat 1 0.1772
883 rats 3 0.4989
883 rats. 1 0.2255
883 regulate 1 0.4306
883 regulation 1 0.3198
883 results 1 0.1233
883 secretion 1 0.2523
883 secretion. 1 0.4306
883 several 1 0.1863
883 sex, 1 0.3626
883 species. 1 0.2825
883 sprague-dawley 1 0.3626
883 studied, 1 0.3198
883 system 1 0.2012
883 thereby 1 0.331
883 transplantation 1 0.2825
883 transplants 1 0.3877
883 transplants. 1 0.4306
883 used 1 0.1626
883 validate 1 0.4306
883 weighing 1 0.3626
884 'alalies' 1 0.6029
884 (russian). 1 0.6029
884 absence 1 0.2878
884 adjacent 1 0.4344
884 affections 1 0.5076
884 alalies 5 3.0145
884 alaly 3 1.8087
884 alaly, 1 0.6029
884 alimentary 1 0.6029
884 amnesia. 1 0.6029
884 anterior, 1 0.6029
884 applied 1 0.3633
884 associated 1 0.2141
884 causes 1 0.3401
884 centers 1 0.4229
884 cerebral 4 1.1428
884 character 1 0.4229
884 children 1 0.2141
884 children, 1 0.3533
884 clinical 2 0.3931
884 combined 1 0.3099
884 complex. 1 0.4827
884 condition. 1 0.4127
884 cortex 1 0.3324
884 defective 1 0.4127
884 degrees 1 0.3811
884 demonstrated 1 0.2578
884 depends 1 0.4827
884 development 4 0.8805
884 disorders 3 1.0328
884 disorders. 1 0.4634
884 distinguish 1 0.6029
884 dominant 1 0.4127
884 drugs 1 0.3324
884 early 1 0.221
884 excitation 1 0.6029
884 explain 1 0.4037
884 features 1 0.322
884 formations. 1 0.6029
884 forms 1 0.2878
884 forms: 1 0.6029
884 frontal, 1 0.6029
884 functional 1 0.3811
884 gives 1 0.4344
884 good 1 0.3362
884 hemisphere. 1 0.5428
884 hemispheres 1 0.5428
884 hemorrhage, 1 0.4827
884 indicating 1 0.388
884 indication 1 0.4229
884 inflammatory 1 0.4477
884 inhibition 1 0.3018
884 insufficient 1 0.4827
884 involvement 1 0.3955
884 lesion 1 0.3401
884 local 1 0.3633
884 logopedic 1 0.6029
884 measures 1 0.3955
884 metabolic 1 0.2878
884 motor, 2 1.2058
884 multiple: 1 0.6029
884 nature 1 0.2993
884 neurological 1 0.4037
884 neurotic 1 0.6029
884 often 3 0.8767
884 organic 1 0.3581
884 parietal 1 0.4477
884 pathological 1 0.3253
884 patients 1 0.1449
884 pedagogic 1 0.6029
884 perinatal 1 0.4477
884 possible 1 0.2419
884 presence 1 0.2297
884 process 1 0.2759
884 processes 1 0.3581
884 processes, 1 0.4477
884 reactions, 1 0.4827
884 region 1 0.4037
884 regions 1 0.4827
884 resulting 3 0.9213
884 results. 1 0.4229
884 right 1 0.3127
884 semantic 1 0.5428
884 sensory, 1 0.6029
884 several 1 0.2608
884 severity. 1 0.5428
884 show 2 0.5215
884 side, 1 0.5428
884 signs 3 1.0085
884 speech 2 0.6314
884 speech, 1 0.4634
884 speech. 1 0.4477
884 states 1 0.4127
884 study 1 0.1857
884 subcortical 1 0.6029
884 suffering 1 0.3581
884 symptoms 1 0.2857
884 temporal 1 0.4634
884 term 1 0.3362
884 trauma, 1 0.6029
884 treatment 1 0.1779
884 trophic 1 0.4827
884 various 2 0.4767
884 varying 1 0.3253
884 would 1 0.2993
885 (later 1 1.5073
885 10 1 0.5548
885 4 1 0.5332
885 5 1 0.5717
885 6 2 1.2605
885 abnormal 1 0.7306
885 acquired 2 1.8738
885 age 1 0.6235
885 aphasia 1 1.1192
885 aphasia-both 1 1.5073
885 appeared 1 0.725
885 attacks-which 1 1.5073
885 boys. 1 1.5073
885 children, 1 0.8832
885 children. 1 0.8607
885 comprehend 1 1.5073
885 csf 1 1.0091
885 degree 1 0.6678
885 described 1 0.5717
885 disorder 1 0.9369
885 eeg's 1 1.357
885 epileptiform 1 1.5073
885 examination 1 0.7611
885 executive 2 3.0145
885 failure 1 0.8133
885 finally 1 1.0318
885 followed 1 0.6897
885 form 2 1.3116
885 girls 1 1.1586
885 hearing 1 0.9887
885 impairment 1 0.9887
885 imparied. 1 1.5073
885 improving), 1 1.5073
885 intelligence 1 1.1192
885 language 1 0.8832
885 leads. 1 1.5073
885 loss 2 1.4612
885 mainly 1 0.9887
885 non-verbal 1 1.2691
885 normal 1 0.4053
885 occurred 1 0.6558
885 occurring 1 0.8716
885 one 1 0.4217
885 onset 1 0.8716
885 peg 1 1.5073
885 receptive 1 1.357
885 repeated-but 1 1.5073
885 results. 1 1.0572
885 self-limiting 1 1.357
885 speech. 1 1.1192
885 spoken 1 1.2069
885 temporal 1 1.1586
885 throughout 1 0.8607
885 unusual 2 1.9056
885 yielded 1 0.9528
885 yr. 1 0.7893
886 3-yr. 1 1.5073
886 40% 1 1.086
886 ages. 1 1.357
886 amount 1 0.7423
886 analytical 1 1.1586
886 appropriateness 1 1.5073
886 child's 1 0.9221
886 childhood 1 0.8503
886 children 1 0.5352
886 chronological 1 1.357
886 clinical 2 0.9826
886 conditions. 1 1.0572
886 controlled 1 0.8607
886 conversation 1 1.5073
886 delayed, 1 1.5073
886 deviation 1 1.1586
886 early 1 0.5526
886 echo 2 3.0145
886 echo: 1 1.5073
886 echoed, 1 1.5073
886 echolalia 2 2.7139
886 echolalic 2 3.0145
886 experimental 2 1.3983
886 findings 1 0.5987
886 group 2 1.1143
886 group. 1 0.8716
886 include 1 0.8954
886 investigation. 1 1.2691
886 linguistic 1 1.2691
886 mean 1 0.725
886 mental 1 0.8503
886 nature 1 0.7483
886 neuropathologic 1 1.5073
886 non-echo 1 1.5073
886 non-echo:silence 1 1.5073
886 non-echoed 1 1.5073
886 olds 1 1.5073
886 pathological 1 0.8133
886 pattern 1 0.7196
886 pattern, 1 1.2069
886 patterns. 1 1.357
886 percentages 1 1.2069
886 pitch-loudness-time 1 1.5073
886 preliminary 1 0.8607
886 procedures 1 0.8503
886 proportion 1 0.9369
886 psychotic 1 0.9887
886 quality 1 1.1586
886 quantitative 1 0.797
886 rationale 1 1.5073
886 referrals 1 1.5073
886 reported 1 0.6107
886 representing 2 2.4137
886 results 1 0.4316
886 samples 1 0.9528
886 selected 1 0.8832
886 silence, 1 1.5073
886 similar 1 0.5643
886 speech 1 0.7893
886 speech, 1 1.1586
886 stimulus 2 2.0183
886 stimulus, 1 1.357
886 study 1 0.4643
886 subjects 1 0.7196
886 tape-recorded 1 1.5073
886 together 1 0.8607
886 triggering 1 1.5073
886 variables 1 1.1192
886 variations, 1 1.5073
886 variety 1 0.8133
886 yielded 1 0.9528
886 young 1 0.7611
887 areas 1 0.3188
887 attempted 1 0.4037
887 breakdown 1 0.5428
887 children's 1 0.4344
887 correlate 1 0.4827
887 corroborate 1 0.6029
887 demonstrate 1 0.3487
887 development 2 0.4402
887 development. 1 0.4127
887 direct 1 0.2836
887 disorders 1 0.3443
887 emotional 1 0.3362
887 general 1 0.3071
887 ideas 1 0.5076
887 indicators 1 0.5428
887 intellectual, 1 0.6029
887 intelligence. 1 0.6029
887 lag 1 0.4827
887 landmark 1 0.6029
887 language 2 0.7065
887 may 3 0.4523
887 mouth. 1 0.6029
887 must 1 0.2945
887 observations 1 0.2535
887 originate 1 0.4634
887 physical, 1 0.5428
887 point 1 0.3487
887 precede 1 0.4827
887 progress. 1 0.5428
887 seldom 1 0.5428
887 serve 1 0.4344
887 speech 5 1.5786
887 speech, 1 0.4634
887 suspect 1 0.6029
887 them. 1 0.4344
887 valuable 1 0.388
887 way 1 0.3811
888 (1) 1 0.2435
888 (2) 1 0.2435
888 achieved 1 0.3439
888 acquiring 1 0.5024
888 appear 1 0.2299
888 applicability 1 0.4523
888 behavior 3 0.8607
888 behavior. 1 0.3862
888 book 1 0.4523
888 child 3 0.725
888 child's 1 0.3074
888 child. 1 0.3364
888 children 2 0.3568
888 children. 1 0.2869
888 classroom 1 0.5024
888 clear 1 0.3028
888 conceive 1 0.5024
888 concepts. 1 0.5024
888 constant 1 0.274
888 constructed 2 0.8461
888 correctness 1 0.5024
888 correlated 1 0.2985
888 deaf 5 1.931
888 desirable 1 0.423
888 discover 1 0.4023
888 education 1 0.4023
888 efficiency 1 0.3731
888 extra 1 0.423
888 feedback 1 0.423
888 film 1 0.3862
888 form, 1 0.4023
888 generally 1 0.2985
888 guided 1 0.5024
888 guiding 1 0.5024
888 help 3 1.086
888 help. 1 0.4523
888 helping 1 0.423
888 highly 1 0.2711
888 hours 1 0.2417
888 includes 1 0.3731
888 individualistic 1 0.5024
888 individualized 2 1.0048
888 instruction 1 0.5024
888 instruction. 1 0.4523
888 insure 1 0.5024
888 kind 1 0.3524
888 language 6 1.7663
888 learned 2 0.8046
888 learning 1 0.3862
888 machine 1 0.423
888 mainly 1 0.3296
888 materials 1 0.3524
888 maximum 1 0.277
888 may 1 0.1257
888 medium. 1 0.3862
888 methods. 1 0.3176
888 needs 1 0.4023
888 offer 1 0.3233
888 older 1 0.3123
888 operates 1 0.5024
888 order 1 0.2631
888 over-learning 1 0.5024
888 parents' 1 0.5024
888 practice. 1 0.5024
888 principles 1 0.3439
888 probability 1 0.3731
888 proceeds 1 0.4523
888 process 3 0.6897
888 program 2 0.7048
888 programed 2 1.0048
888 programs 2 0.9046
888 progress 1 0.3524
888 provide 1 0.2944
888 requires 1 0.3074
888 responses. 1 0.4023
888 role 2 0.4661
888 seems 1 0.2657
888 self-tutoring 1 0.5024
888 shape 1 0.3233
888 socializing 1 0.5024
888 step 2 0.7462
888 strip, 1 0.5024
888 structure 1 0.2559
888 success 1 0.423
888 symbols. 1 0.5024
888 teacher 1 0.4023
888 teacher's 1 0.5024
888 teaching 2 1.0048
888 thousands 1 0.5024
888 toward 1 0.3233
888 traditional 1 0.4523
888 use 2 0.3972
888 user 1 0.5024
888 verbal 3 1.0091
888 visual 1 0.274
888 well 1 0.1757
888 young 1 0.2537
888 younger 1 0.3364
889 affecting 1 1.2691
889 attitudes 1 1.357
889 child 1 0.725
889 considered. 1 1.2691
889 deaf 1 1.1586
889 differences 1 0.6897
889 effects 1 0.5595
889 emotional 1 0.8404
889 emphasis 1 1.086
889 experience. 1 1.357
889 extrinsic 1 1.2069
889 factors 1 0.6372
889 home 1 1.2691
889 impact 1 1.2691
889 individual 1 0.797
889 intrinsic 1 1.0572
889 language 2 1.7663
889 learning 1 1.1586
889 learning. 1 1.357
889 matrix 1 1.357
889 parental 1 1.086
889 particular 1 0.7611
889 placed 1 0.8954
889 prelingually 1 1.5073
889 provision 1 1.5073
889 restriction 1 1.086
889 stability 1 1.1192
890 1955 1 0.8461
890 1956 1 1.0048
890 2,500 1 1.0048
890 5 1 0.3811
890 5.8 1 0.9046
890 55 1 0.8046
890 age 1 0.4157
890 articulation 1 0.8461
890 articulation, 1 0.9046
890 auditory 2 1.8093
890 birth 1 0.5119
890 born 3 2.0183
890 categories. 1 1.0048
890 children 3 1.0704
890 children's 1 0.724
890 compared 1 0.3898
890 comprehension, 1 1.0048
890 controls. 1 0.6591
890 definitions 1 1.0048
890 discrimination, 1 1.0048
890 disintegration, 1 1.0048
890 elaboration, 1 1.0048
890 errors, 1 1.0048
890 fifty-one 1 0.9046
890 finding, 1 0.8461
890 grammatical 1 0.8461
890 grams. 1 1.0048
890 groups 1 0.4092
890 inferior 1 0.7724
890 language 2 1.1776
890 length 1 0.6591
890 longest 1 0.9046
890 mean 2 0.9667
890 memory 1 0.9046
890 normally 1 0.6352
890 number 1 0.3845
890 oral 1 0.6148
890 patterns, 1 0.9046
890 performance 2 1.3758
890 premature 3 2.0636
890 recognition, 1 1.0048
890 resistance 1 0.5603
890 sentence 1 0.9046
890 sentences, 1 1.0048
890 span, 1 0.9046
890 story 1 1.0048
890 subjects 1 0.4797
890 tapped 1 1.0048
890 telling, 1 1.0048
890 term. 1 0.9046
890 tested 1 0.6056
890 used, 1 0.6466
890 weights 1 0.7048
890 word 2 1.8093
890 words 1 0.7724
891 accept 1 0.4523
891 advice 1 0.4523
891 advising 1 0.5024
891 again, 1 0.5024
891 allay 1 0.5024
891 anxiety 1 0.3123
891 articulation 1 0.423
891 assist 1 0.4523
891 attentive 1 0.5024
891 can, 1 0.5024
891 cause 1 0.2269
891 cause. 1 0.3731
891 center 1 0.3233
891 child 5 1.2083
891 child's 1 0.3074
891 child, 1 0.3439
891 child-raising 1 0.5024
891 child. 2 0.6728
891 childhood. 1 0.4523
891 children 1 0.1784
891 chronic 1 0.2399
891 cleft 1 0.362
891 communication 3 0.831
891 communicative 1 0.423
891 concern 1 0.3862
891 condition 1 0.2683
891 contribution 1 0.362
891 correction 1 0.3524
891 damaging 1 0.5024
891 defective 1 0.3439
891 defects, 1 0.3524
891 delayed 2 0.5888
891 denied. 1 0.5024
891 development 1 0.1834
891 development, 1 0.3364
891 deviations 1 0.4523
891 diagnostic 1 0.2494
891 discussed: 1 0.4523
891 disorder. 1 0.423
891 disorders 2 0.5738
891 disorders, 1 0.362
891 disorders. 1 0.3862
891 ear 1 0.4023
891 eliminated. 1 0.5024
891 emotional 1 0.2801
891 environment 1 0.3364
891 even 1 0.2199
891 existence 1 0.3074
891 explored 1 0.3862
891 exposed 1 0.2631
891 facing 1 0.4523
891 fact 1 0.2657
891 factors, 1 0.362
891 fears. 1 0.5024
891 following 1 0.1665
891 foster 1 0.5024
891 frequently 1 0.2537
891 functional 1 0.3176
891 general. 1 0.5024
891 great 1 0.2869
891 handling 1 0.4523
891 harmful. 1 0.5024
891 health 6 2.1144
891 healthy 1 0.362
891 hearing 1 0.3296
891 help 2 0.724
891 helping 1 0.423
891 home. 1 0.4523
891 ineffective; 1 0.5024
891 intermingling 1 0.5024
891 it, 1 0.4023
891 listens 1 0.5024
891 loss, 1 0.3862
891 make 1 0.2985
891 manner 1 0.3439
891 many 1 0.2026
891 may 3 0.377
891 nature 1 0.2494
891 neurological 1 0.3364
891 normal 1 0.1351
891 nurse 1 0.4523
891 offer 1 0.3233
891 overabundance 1 0.5024
891 painful 1 0.4523
891 palate, 1 0.4523
891 parents 5 1.8099
891 parents, 2 0.9046
891 particular 1 0.2537
891 physician 1 0.3862
891 physiological 1 0.2944
891 position 1 0.3439
891 possibly 1 0.3123
891 practices 2 1.0048
891 presenting 1 0.3364
891 problem 2 0.5738
891 problem, 1 0.4523
891 problems 1 0.2606
891 process 1 0.2299
891 psychological, 1 0.5024
891 public 6 2.4137
891 rarely 1 0.3524
891 reading 2 0.7462
891 referred 1 0.2985
891 reflecting 1 0.423
891 residing 1 0.4523
891 result 1 0.2173
891 role. 1 0.423
891 school, 1 0.4523
891 sensed 1 0.5024
891 serious 1 0.3028
891 simply 1 0.423
891 single 1 0.2494
891 specific 1 0.1977
891 speech 5 1.3155
891 still 1 0.2347
891 stuttering, 1 0.5024
891 sympathetic 1 0.3862
891 teacher 1 0.4023
891 teachers. 1 0.5024
891 thus 1 0.2606
891 treatment 1 0.1482
891 underlying 1 0.362
891 unfortunately 1 0.5024
891 valuable 1 0.3233
891 vitiate 1 0.5024
891 well-intentioned 1 0.5024
891 within 1 0.1865
891 worker 4 1.8093
891 worker's 1 0.5024
892 assessment 1 1.0091
892 briefly 1 0.9083
892 causation, 1 1.5073
892 children 1 0.5352
892 children. 1 0.8607
892 communication 2 1.6619
892 development 1 0.5503
892 developmental 1 1.0091
892 diagnosis, 1 1.0091
892 differential 1 0.9528
892 discussed. 1 0.6444
892 disorders 2 1.7214
892 individual 1 0.797
892 language 1 0.8832
892 management 1 0.797
892 normal 1 0.4053
892 outlined. 1 1.2069
892 spoken 1 1.2069
892 young 2 1.5222
893 (1) 1 0.2922
893 (2) 1 0.2922
893 (3) 1 0.3188
893 (vascular 1 0.6029
893 10 1 0.2219
893 11 1 0.322
893 13 1 0.3487
893 2 2 0.3682
893 21 1 0.3811
893 3 1 0.2055
893 5 1 0.2287
893 acquired 1 0.3748
893 adult; 1 0.5428
893 aneurysm 1 0.388
893 angioma); 1 0.6029
893 aphasia 3 1.3431
893 artery 1 0.3443
893 astrocytoma; 1 0.6029
893 boys 1 0.4477
893 carried 1 0.3018
893 cases 5 0.8969
893 cases, 1 0.3157
893 cerebral 3 0.8571
893 children. 2 0.6886
893 compared 1 0.2339
893 concerns 1 0.5076
893 conclusions 1 0.3811
893 contusion; 1 0.6029
893 course 1 0.2741
893 damage 1 0.3071
893 diagnosis 1 0.2481
893 disorder; 1 0.6029
893 fall 1 0.3157
893 followed 1 0.2759
893 future 1 0.4344
893 general 1 0.3071
893 girls 1 0.4634
893 headings: 1 0.6029
893 hematoma 1 0.5076
893 intellectual 1 0.4037
893 intracranial 1 0.3955
893 left 1 0.2723
893 level 1 0.2328
893 made. 1 0.3748
893 malformation, 1 0.5076
893 middle 1 0.4827
893 nontraumatic 1 0.6029
893 occlusion 1 0.388
893 occurred; 1 0.6029
893 operation 1 0.3157
893 out. 1 0.4634
893 performance 1 0.4127
893 period 1 0.2287
893 precise 1 0.4827
893 prospects 1 0.5428
893 rehabilitation 1 0.5428
893 remaining 1 0.3071
893 report 1 0.2922
893 resulted 1 0.2922
893 several 1 0.2608
893 studied 1 0.2101
893 symptomatology 1 0.4127
893 traumatic 1 0.4229
893 years 1 0.2741
894 181 1 0.7536
894 30 1 0.3598
894 72 1 0.543
894 abnormality 1 0.5286
894 additional 1 0.4025
894 also 1 0.2108
894 arising 1 0.5793
894 cases 2 0.4484
894 causes 1 0.4252
894 chance 1 0.6034
894 child 2 0.725
894 child, 1 0.5159
894 children 3 0.8028
894 cleft 3 1.629
894 conditions 1 0.3426
894 db. 1 0.7536
894 decrease 1 0.3449
894 delayed 1 0.4416
894 develop 1 0.4542
894 development 4 1.1006
894 develops 1 0.6785
894 diagnostic 1 0.3742
894 difficult. 1 0.6346
894 discussed. 1 0.3222
894 disturbances 1 0.4477
894 emphasized. 1 0.6346
894 exceeding 1 0.6785
894 external 1 0.4542
894 factors. 1 0.5793
894 favorable 1 0.5159
894 given 1 0.2763
894 hampered 1 0.6785
894 hearing 2 0.9887
894 included-out 1 0.7536
894 influence 1 0.3449
894 injured 1 0.5793
894 injury 1 0.5046
894 injury. 1 0.7536
894 internal 1 0.4252
894 investigation 1 0.4252
894 make 1 0.4477
894 may 2 0.377
894 necessity 1 0.5596
894 need 1 0.4611
894 palate 1 0.543
894 palate, 2 1.357
894 parallelly 1 0.7536
894 pass 1 0.5596
894 phases 1 0.6785
894 possibilities 1 0.5596
894 psychophysical 1 0.7536
894 remaining 1 0.3839
894 sense 2 1.1586
894 simultaneously 1 0.4542
894 speech 4 1.5786
894 speech. 1 0.5596
894 team 1 0.6346
894 testing 1 0.5286
894 treatment 2 0.4447
894 unnoticed, 1 0.7536
894 various 1 0.2979
894 without 1 0.2846
895 'high 1 0.5024
895 'higher 1 0.5024
895 'lower 1 0.5024
895 (transfer 1 0.5024
895 1). 1 0.4523
895 1, 2 0.6466
895 27 2 0.6728
895 3 1 0.1713
895 analysis 1 0.2417
895 attention, 1 0.5024
895 children 1 0.1784
895 classified 1 0.3028
895 comparable 1 0.277
895 concept 4 1.2111
895 conceptual 1 0.4523
895 control. 1 0.3862
895 criterion 1 0.4023
895 culturally 1 0.4523
895 data 1 0.2046
895 differences 1 0.2299
895 disadvantaged 1 0.5024
895 discrimination 1 0.423
895 divided 1 0.3524
895 effect 1 0.1534
895 effects 1 0.1865
895 experiment 1 0.3364
895 function 1 0.2254
895 future 1 0.362
895 group 2 0.3714
895 groups 1 0.2046
895 groups: 1 0.4023
895 indicates 1 0.3296
895 influence 2 0.4598
895 intelligence, 1 0.4523
895 investigate 1 0.423
895 label, 1 0.5024
895 learning 6 2.3172
895 mentally 1 0.362
895 new, 1 0.4523
895 normal 1 0.1351
895 performance 2 0.6879
895 performance. 1 0.5024
895 positive 2 0.5366
895 presented 2 0.3898
895 pretraining 5 2.5121
895 pretraining. 1 0.5024
895 purpose 1 0.3364
895 randomly 1 0.423
895 reaching 1 0.362
895 research 1 0.3296
895 retarded 2 0.6466
895 revealed 1 0.2435
895 risk 1 0.3364
895 risk' 3 1.5073
895 second, 1 0.3862
895 shown 1 0.216
895 significant 1 0.1764
895 significantly 1 0.2112
895 stimuli 1 0.362
895 stimulus 1 0.3364
895 subjects 5 1.1993
895 subjects. 1 0.3074
895 subsequent 1 0.274
895 task 4 1.4923
895 task. 1 0.423
895 tasks 1 0.5024
895 time. 1 0.3524
895 transfer 2 0.6466
895 types 1 0.2435
895 used 1 0.1897
895 verbal 3 1.0091
896 are, 1 0.9046
896 author 1 0.5888
896 child's 1 0.6148
896 children. 1 0.5738
896 classroom. 1 1.0048
896 concept 2 1.2111
896 concepts 2 1.4923
896 conceptual 1 0.9046
896 contributions 1 0.8046
896 deaf 1 0.7724
896 describes 1 0.6879
896 development 3 1.1006
896 educationally, 1 1.0048
896 errors 1 0.7048
896 example 1 0.8046
896 factors 1 0.4248
896 included 1 0.5422
896 instruction. 1 0.9046
896 language 2 1.1776
896 may 2 0.5026
896 occur 1 0.4909
896 presented, 1 0.8046
896 psychologically, 1 1.0048
896 related 1 0.4248
896 review 1 0.554
896 stressed. 1 0.7724
896 to, 1 0.7724
897 adults 1 0.6056
897 aid 1 0.724
897 authors 1 0.4629
897 certain 1 0.4425
897 characteristics 1 0.5603
897 childhood 3 1.7006
897 children 1 0.3568
897 contemporary 1 1.0048
897 conversational 1 1.0048
897 diagnostic 1 0.4989
897 disorders 1 0.5738
897 distributions 1 0.9046
897 ego 1 0.724
897 fairly 1 0.724
897 formal 1 0.7462
897 found 2 0.5291
897 frequency 1 0.5262
897 functioning 1 0.6879
897 grammatical 1 0.8461
897 hypothesis 1 0.5366
897 idiosyncratic 1 1.0048
897 interpretations 1 1.0048
897 many 1 0.4051
897 might 1 0.5262
897 noted 1 0.5313
897 phenomena 1 0.7048
897 psychoanalytical 1 1.0048
897 psychological 1 0.6352
897 psychosis. 3 2.2385
897 relationship 1 0.4833
897 seen 1 0.4248
897 specific 1 0.3953
897 speech 2 1.0524
897 spontaneous 1 0.5811
897 stable. 1 1.0048
897 support 1 0.554
897 tested 1 0.6056
897 this, 1 0.8461
897 units 1 0.6879
897 use 1 0.3972
897 various 1 0.3972
897 well 1 0.3514
898 1 1 0.2277
898 10-12 1 0.6029
898 accompaniment 1 0.6029
898 acquisition 1 0.4229
898 acquistion 1 0.6029
898 and/or 1 0.3811
898 areas 1 0.3188
898 basis 1 0.2639
898 brain. 1 0.4634
898 cerebral 4 1.1428
898 children. 1 0.3443
898 consistently 1 0.388
898 control 1 0.2267
898 counterparts 1 0.6029
898 deaf 2 0.9269
898 dominance 1 0.4827
898 dominance, 1 0.6029
898 earned 1 0.6029
898 education 1 0.4827
898 examining 1 0.5428
898 eye 1 0.388
898 facilitated, 1 0.6029
898 finding 1 0.3689
898 formal 1 0.4477
898 found 1 0.1587
898 grades 1 0.4827
898 hand 1 0.4827
898 hand, 1 0.3633
898 hearing 1 0.3955
898 hemisphere 1 0.5076
898 hemisphere, 1 0.5428
898 higher 1 0.2593
898 hypothesis 1 0.322
898 indexed 1 0.6029
898 individuals 1 0.4127
898 interference 1 0.4037
898 learning 1 0.4634
898 left 2 0.5445
898 less 1 0.2257
898 likely 1 0.3533
898 localized 1 0.4229
898 loss. 1 0.4827
898 matched 1 0.4477
898 mechanisms 1 0.3633
898 period 1 0.2287
898 positive 1 0.322
898 prediction 1 0.4477
898 preference, 1 0.6029
898 primarily 1 0.3811
898 prone 1 0.5428
898 relevant 1 0.4344
898 right-handed-left-sighting 1 0.6029
898 right-handed-mixed-sighting 1 0.6029
898 right-handed-right-sighting 1 0.6029
898 sighting 1 0.6029
898 simplified, 1 0.6029
898 speech 5 1.5786
898 speech, 1 0.4634
898 students 1 0.4827
898 supports 1 0.5076
898 whose 1 0.3533
898 year 1 0.3127
899 ability 1 0.3839
899 accessory 1 0.6346
899 alkaline 2 1.086
899 antibodies 1 0.4252
899 antibody 2 0.9221
899 antiserum. 2 1.2691
899 arginine 1 0.5793
899 based 1 0.3946
899 color 1 0.5793
899 convalescent 1 0.6785
899 described. 1 0.3773
899 effect 1 0.2301
899 factor(s) 1 0.7536
899 growth 1 0.2569
899 guinea 1 0.5596
899 human 3 0.7546
899 immune 1 0.485
899 inhibited 1 0.4764
899 inhibiting 1 0.5793
899 inhibition 1 0.3773
899 inhibitory 1 0.4943
899 labile 1 0.7536
899 measurement 3 1.2755
899 medium. 1 0.5793
899 metabolic 1 0.3598
899 metabolize 1 0.6346
899 mycoplasma 2 0.8219
899 mycoplasmas 1 0.5286
899 non-acid 1 0.7536
899 non-acid-forming 1 0.7536
899 organisms 1 0.4611
899 ph 1 0.4066
899 pig 1 0.6034
899 potentiates 1 0.7536
899 present 1 0.2481
899 producing 1 0.485
899 rabbit 1 0.4252
899 resultant 1 0.543
899 sensitive 1 0.4066
899 serum 1 0.2924
899 serum. 1 0.543
899 shift 2 1.1192
899 species 1 0.411
899 species. 1 0.4943
899 specific 2 0.593
899 test 4 1.3038
899 unheated 1 0.7536
899 upon 1 0.3381
900 although 1 0.3863
900 and, 1 0.5212
900 animal 1 0.6148
900 antibodies 1 0.5669
900 antibody 2 1.2295
900 antibody. 1 0.9046
900 cell 1 0.3401
900 cells 1 0.3033
900 demonstration 1 0.6466
900 described. 1 0.5031
900 devised. 1 1.0048
900 diagnostic 1 0.4989
900 diluent. 1 1.0048
900 direct, 1 1.0048
900 employed 1 0.6352
900 employed, 1 0.9046
900 epidemiologic 2 1.8093
900 erythrocytes 1 0.7462
900 fetus. 1 0.7724
900 generally 1 0.5969
900 heat 1 0.7724
900 hemagglutination 2 1.6922
900 hemagglutinin 1 0.9046
900 horse 1 0.8046
900 human 2 0.6707
900 i. 1 0.5969
900 identification 1 0.6466
900 inactivation 1 0.6728
900 inhibited 1 0.6352
900 inhibition 1 0.5031
900 isolates. 1 1.0048
900 limited, 1 0.9046
900 live 1 0.6879
900 m. 3 1.6808
900 many 1 0.4051
900 may 1 0.2513
900 method 1 0.3992
900 micro 1 1.0048
900 monkey 1 0.6728
900 natural 1 0.5888
900 new 2 0.8796
900 origin. 1 0.6728
900 passively 1 0.9046
900 persist 1 0.8461
900 pneumoniae 1 0.6879
900 pneumoniae. 2 1.6922
900 presence 1 0.3828
900 present, 1 0.6591
900 rabbit 1 0.5669
900 rapid 1 0.4871
900 reaction 1 0.5031
900 red 1 0.5969
900 required, 1 1.0048
900 requires 1 0.6148
900 reverse, 1 1.0048
900 sera 1 0.6591
900 serologic 2 1.448
900 serum 1 0.3898
900 specific 2 0.7907
900 studies 2 0.6154
900 test 1 0.4346
900 transferred 1 0.7724
900 used. 1 0.6879
900 useful 1 0.554
900 utilized 1 0.7724
900 variation 1 0.6352
900 vervet 1 1.0048
900 whether 1 0.4989
900 years 1 0.4568
901 'normal' 1 0.7536
901 (53%) 1 0.7536
901 10 1 0.2774
901 124 1 0.6785
901 15 2 0.7483
901 169 1 0.7536
901 26% 1 0.7536
901 3 1 0.2569
901 6 1 0.3151
901 63% 1 0.7536
901 65 1 0.5159
901 67 1 0.6346
901 68% 1 0.7536
901 7 1 0.3472
901 76 1 0.6785
901 90%. 1 0.7536
901 acquired 3 1.4054
901 age 2 0.6235
901 among 1 0.352
901 antibodies 4 1.7006
901 antibodies. 4 2.5382
901 antibody 1 0.4611
901 approximately 1 0.3946
901 attending 1 0.6346
901 barrow 1 0.7536
901 beginning 1 0.4764
901 children 2 0.5352
901 civilian 1 0.6785
901 clinic 1 0.6346
901 companies 1 0.7536
901 cottage 1 0.7536
901 could 1 0.2708
901 demonstrated 1 0.3222
901 determined 1 0.3426
901 divergent 1 0.6785
901 elderly 1 0.6346
901 epidemics 1 0.6785
901 epidemiologic 1 0.6785
901 families, 1 0.6034
901 fever 1 0.543
901 following 1 0.2498
901 group 1 0.2786
901 home, 1 0.6785
901 ii. 1 0.4358
901 infection 1 0.3546
901 infection, 1 0.5286
901 infections 1 0.4943
901 infrequently 1 0.6346
901 latter 1 0.3909
901 least 1 0.3874
901 m. 3 1.2606
901 mates 1 0.7536
901 means 1 0.3339
901 members 1 0.5046
901 naval 1 0.7536
901 new 1 0.3299
901 none 1 0.4542
901 one 3 0.6325
901 other. 1 0.6034
901 patterns, 1 0.6785
901 persist 1 0.6346
901 persons 1 0.4764
901 persons, 1 0.7536
901 pneumoniae 2 1.0318
901 pneumoniae. 1 0.6346
901 point 1 0.4358
901 population 2 0.97
901 populations 1 0.5596
901 populations. 2 1.5073
901 positive 1 0.4025
901 positive. 1 0.6785
901 prevalence 2 1.2069
901 produce 1 0.4025
901 prophylaxis 1 0.6034
901 proportion 1 0.4685
901 rate 1 0.2774
901 rates 1 0.4542
901 rather 1 0.3546
901 recruits 1 0.7536
901 remained 1 0.4303
901 residents, 1 0.7536
901 rheumatic 1 0.5793
901 seem 1 0.411
901 serologic 2 1.086
901 several 1 0.326
901 similar 2 0.5643
901 sporadic 1 0.7536
901 studies 1 0.2308
901 test. 1 0.4943
901 titer 1 0.5596
901 training, 1 0.6785
901 two 1 0.2308
901 undiminished 1 0.6785
901 uninfected. 1 0.7536
901 year. 1 0.5286
901 yr. 1 0.3946
902 'eclipse' 1 0.4306
902 (between 1 0.3877
902 1,000 1 0.3626
902 10 2 0.3171
902 10% 1 0.3103
902 10.0, 1 0.4306
902 16th 1 0.4306
902 200 1 0.2825
902 24 1 0.2234
902 3 1 0.1468
902 36 1 0.3021
902 40 1 0.2523
902 6.0, 1 0.4306
902 6th 1 0.3448
902 7.0, 1 0.4306
902 8.0, 1 0.4306
902 9.0, 1 0.4306
902 agama 1 0.4306
902 also 1 0.1205
902 bacteria. 1 0.3877
902 broth 1 0.331
902 c 1 0.2348
902 clinical 1 0.1404
902 close 1 0.2523
902 colony-forming 1 0.4306
902 complement-mediated 1 0.4306
902 containing 1 0.2277
902 could 1 0.1547
902 counts. 1 0.4306
902 cultures 2 0.4312
902 daily 1 0.2348
902 data 2 0.3508
902 day 1 0.2138
902 day, 1 0.331
902 days 1 0.1711
902 delayed 2 0.5047
902 detected 2 0.4468
902 effect. 1 0.2825
902 events 1 0.3198
902 explained. 1 0.3448
902 followed 1 0.1971
902 found 1 0.1134
902 g 1 0.331
902 greatest 1 0.2722
902 growth 7 1.0275
902 horse 3 1.0345
902 hr 1 0.249
902 illustrates 1 0.3626
902 incubation 4 1.0539
902 incubation, 1 0.4306
902 incubation. 1 0.3877
902 inhibition 3 0.6468
902 inhibitors 1 0.3198
902 inhibitory 1 0.2825
902 isolated 1 0.1874
902 late 1 0.2558
902 levels 1 0.1686
902 liquid 1 0.3626
902 little 1 0.23
902 m. 3 0.7204
902 material 1 0.1998
902 maximal 3 0.8031
902 may 1 0.1077
902 media 1 0.3198
902 media. 1 0.3448
902 medium, 1 0.3448
902 mycoplasma 2 0.4697
902 mycoplasmas 1 0.3021
902 neurolyticum 4 1.7226
902 observed. 1 0.2595
902 obtained 1 0.1535
902 occur 1 0.2104
902 order. 1 0.3877
902 penicillin 1 0.3448
902 period 2 0.3267
902 ph 2 0.4647
902 phenomenon 1 0.249
902 plate 1 0.3626
902 presence 1 0.1641
902 present, 1 0.2825
902 present. 1 0.2883
902 presented 1 0.1671
902 prolonged 1 0.2071
902 recrudescence 1 0.4306
902 reduced 1 0.1945
902 relationship 1 0.2071
902 reversed 1 0.3198
902 serum 1 0.1671
902 serum, 1 0.331
902 serum. 1 0.3103
902 showed 1 0.1535
902 species 1 0.2348
902 spontaneously 1 0.3626
902 stability 2 0.6396
902 studies 1 0.1319
902 suggest 1 0.1958
902 survival 3 0.6214
902 temperature 1 0.23
902 temporary 1 0.3103
902 undetectable 1 0.4306
902 units/ml 2 0.8613
902 units/ml) 1 0.4306
902 units/ml. 1 0.4306
902 used 1 0.1626
902 viability 1 0.4306
902 whole 1 0.2401
903 (budr) 1 0.1256
903 (hela 1 0.1131
903 10, 1 0.0966
903 100 1 0.0709
903 15,25,50, 1 0.1256
903 2-5% 1 0.1256
903 35-45% 1 0.1256
903 43% 1 0.1256
903 5 1 0.0476
903 6 1 0.0525
903 8%, 1 0.1256
903 activities 2 0.1453
903 activities. 1 0.1058
903 activity 4 0.1798
903 activity, 1 0.0905
903 activity. 2 0.172
903 also 1 0.0351
903 amounts 1 0.0624
903 approx. 1 0.0966
903 assay 1 0.0824
903 bromodeoxyuridine 2 0.2512
903 bromodeoxyuridine-h 1 0.1256
903 bu-10 1 0.1256
903 bu-10, 1 0.1256
903 bu-100 9 1.1304
903 bu-100) 1 0.1256
903 bu-15 1 0.1256
903 bu-15, 1 0.1256
903 bu-25, 2 0.2512
903 bu-50, 2 0.2512
903 budr 1 0.1256
903 budr, 2 0.2512
903 cell 4 0.17
903 cells 8 0.3033
903 cells. 4 0.224
903 competing 1 0.1256
903 contained 1 0.064
903 deficiency 1 0.0664
903 deficient 2 0.1617
903 deoxyuridine-h, 1 0.1256
903 displayed 2 0.2011
903 due 1 0.0444
903 enzymes 1 0.0794
903 equivalent 1 0.0881
903 exhibit 1 0.1131
903 exhibited 1 0.0768
903 extracts 5 0.3842
903 extracts. 1 0.1256
903 feedback 1 0.1058
903 fewer 1 0.0905
903 following 2 0.0833
903 growth 1 0.0428
903 heavily 1 0.1058
903 hela 24 2.1144
903 high 2 0.0899
903 however, 1 0.0455
903 hr 1 0.0726
903 increased 1 0.039
903 incubated 1 0.0966
903 induced 1 0.0534
903 infection 1 0.0591
903 inhibition 2 0.1258
903 inhibitors 1 0.0933
903 interference 1 0.0841
903 isolated. 1 0.1058
903 kinase 9 0.9518
903 kinase, 1 0.1256
903 labeled 2 0.1514
903 labeled. 1 0.1256
903 lacking 1 0.1131
903 levels 2 0.0984
903 lightly 1 0.1131
903 lines 1 0.0726
903 media 1 0.0933
903 mg/ml 1 0.1256
903 mixtures 1 0.1006
903 moreover, 1 0.0824
903 mutant 1 0.0905
903 negative 1 0.0736
903 normal 1 0.0338
903 nuclei 3 0.2382
903 parental 2 0.181
903 passages 1 0.0933
903 phosphorylating 1 0.1256
903 prepared, 1 0.1256
903 presence 1 0.0479
903 proliferated 1 0.1256
903 radioactivity. 1 0.1256
903 radioautographic 1 0.1058
903 resistant 3 0.2305
903 respectively, 2 0.181
903 respectively. 1 0.086
903 s3 6 0.7536
903 shown 1 0.054
903 studies 1 0.0385
903 sublines 1 0.1006
903 sum 1 0.1256
903 synthetase, 1 0.1131
903 thymidilate 1 0.1256
903 thymidine 8 0.7048
903 thymidine-h, 2 0.2512
903 thymidylate 1 0.1131
903 uridine 1 0.1131
903 vaccinia 1 0.1131
903 virus, 1 0.1058
903 weekly 1 0.1006
903 yielding 1 0.1256
904 'campo' 1 1.0048
904 'campo', 1 1.0048
904 2 1 0.3068
904 2. 1 0.5262
904 27 1 0.6728
904 arthritidis. 1 1.0048
904 classification 1 0.7724
904 classified 1 0.6056
904 hitherto 1 0.8046
904 hominis 1 0.724
904 hominis, 1 1.0048
904 identified 1 0.5888
904 like 1 0.6466
904 myc. 2 1.6922
904 mycoplasma 2 1.0959
904 note 1 0.8046
904 pg 1 0.9046
904 similar 1 0.3762
904 status 1 0.6352
904 strain 1 0.5313
904 strains 3 1.7907
904 taxonomic 1 1.0048
904 type 2 0.8358
904 withdrawn. 1 1.0048
905 (18%, 1 0.3349
905 (9.8%) 1 0.3349
905 (a) 1 0.2155
905 (b) 1 0.2155
905 (c) 1 0.2349
905 (d) 1 0.282
905 (e) 1 0.3015
905 (f) 1 0.3349
905 (g) 1 0.3349
905 (h) 1 0.3015
905 (uninfected 1 0.3349
905 17 1 0.199
905 18%; 1 0.3349
905 2,000 1 0.282
905 29%, 1 0.3349
905 3 1 0.1142
905 5.2%). 1 0.3349
905 68%,). 1 0.3349
905 7 1 0.1543
905 9 1 0.1754
905 9.8%. 1 0.3349
905 abnormalities 1 0.1868
905 abortion 1 0.3015
905 abortion-derived 1 0.3349
905 abortions 1 0.3015
905 abortus 1 0.3349
905 although 3 0.3863
905 among 1 0.1565
905 apparatus 1 0.2575
905 appears 1 0.144
905 associated 1 0.1189
905 average 2 0.3006
905 break 1 0.3349
905 breakage 4 1.2062
905 breaks 1 0.3015
905 capacities. 1 0.3349
905 cell 5 0.5668
905 cells 3 0.3033
905 cells: 1 0.3015
905 changes 2 0.2004
905 chromosomal 1 0.2487
905 chromosome 5 1.1213
905 chromosomes 2 0.5364
905 chromosomes. 1 0.3015
905 chronic 1 0.1599
905 combined 1 0.1722
905 complete. 1 0.3349
905 continued 1 0.1937
905 correlation 1 0.1691
905 could 1 0.1203
905 cultivated, 1 0.3349
905 cultivation, 1 0.3349
905 cultured 1 0.2197
905 cytologic 1 0.2487
905 cytopathic 1 0.2487
905 damage 2 0.3412
905 demonstrated, 1 0.282
905 determine 1 0.189
905 dissemination 1 0.3015
905 early 1 0.1228
905 effect 1 0.1023
905 effects 4 0.4973
905 elevation 2 0.4699
905 elevations 1 0.282
905 embryonic 2 0.4235
905 established 1 0.1807
905 exception 1 0.2197
905 experimentally 1 0.2349
905 experimentally. 1 0.3015
905 fetal 1 0.1913
905 fetuses 2 0.4827
905 fibroblast 1 0.3015
905 fibroblasts 1 0.282
905 follows: 1 0.2682
905 four 1 0.1503
905 frequency 4 0.7016
905 general 2 0.3412
905 genetic 1 0.1754
905 greater 1 0.1386
905 growth 3 0.3425
905 high 1 0.1199
905 however, 1 0.1213
905 human 2 0.2236
905 implications 1 0.2155
905 increased 1 0.1041
905 increases 1 0.1565
905 indicated 1 0.1576
905 induced 1 0.1424
905 infected 5 0.9133
905 infection 4 0.6303
905 initiated 1 0.2682
905 instances 1 0.2243
905 likely 1 0.1963
905 limited 1 0.1827
905 lung 1 0.144
905 many 1 0.135
905 marked 1 0.1503
905 material 2 0.3107
905 may 2 0.1675
905 metaphase 1 0.282
905 metaphases, 1 0.3349
905 months 1 0.1691
905 mothers 1 0.2019
905 mothers. 2 0.5641
905 naturally 1 0.2487
905 neither 1 0.2197
905 newborns 1 0.282
905 non-disjunctional 1 0.3349
905 non-rubella 1 0.3349
905 normal 1 0.0901
905 noted 1 0.1771
905 noted. 1 0.2243
905 observations 1 0.1408
905 observed 1 0.1142
905 obtained 3 0.3582
905 obvious 1 0.3015
905 occurred 1 0.1457
905 one 1 0.0937
905 organs 1 0.1847
905 pathology 1 0.2243
905 possible 1 0.1344
905 pregnancy. 1 0.2487
905 produces 1 0.2117
905 properties 1 0.1789
905 question. 1 0.3349
905 rather 1 0.1576
905 readily 1 0.2155
905 rearrangements 1 0.3349
905 restricted 2 0.5641
905 result 1 0.1449
905 results 1 0.0959
905 rubella 5 1.6747
905 rubella-abortion 1 0.3349
905 rubella-infected 2 0.6699
905 seen 1 0.1416
905 set 2 0.5364
905 shed 1 0.3015
905 shedding 2 0.6699
905 showed 1 0.1194
905 significant 1 0.1176
905 similar 1 0.1254
905 similarly, 1 0.3015
905 slight 1 0.199
905 slight, 1 0.3349
905 spontaneous 1 0.1937
905 sporadic. 1 0.3349
905 strains 9 1.7907
905 strains, 1 0.2575
905 studies 3 0.3077
905 study 1 0.1032
905 therapeutic 2 0.3383
905 throughout 1 0.1913
905 tissue 1 0.1163
905 types 3 0.4871
905 undertaken 1 0.2682
905 upon 3 0.4509
905 utero 1 0.282
905 values. 1 0.282
905 virus 7 1.2278
905 virus. 1 0.2413
905 vitro 6 1.0329
905 vitro. 1 0.2243
905 vitro; 1 0.3349
905 vivo 1 0.199
905 whether 1 0.1663
905 wide 1 0.199
905 yielded 1 0.2117
906 'trilamellar' 1 0.7536
906 allowed 1 0.5286
906 appearance 1 0.3742
906 area 1 0.3909
906 areas 1 0.3985
906 aureus 1 0.6785
906 bacterial 2 0.8832
906 bodies 1 0.4611
906 bound 1 0.5159
906 cell 1 0.2551
906 cells 1 0.2274
906 cells. 1 0.336
906 compact, 1 0.7536
906 comparable 1 0.4155
906 comparison 1 0.3909
906 correlated 1 0.4477
906 could 1 0.2708
906 cytoplasmic 1 0.4542
906 described 1 0.2859
906 diffuse 1 0.5046
906 division 1 0.5286
906 electron 2 0.7611
906 evidence 1 0.2763
906 fibrillar 1 0.5793
906 fine 1 0.5286
906 form 2 0.6558
906 formation 1 0.3381
906 forms 2 0.7196
906 fragments 1 0.5596
906 indicated 1 0.3546
906 involved 1 0.3839
906 l 4 2.3172
906 l-forms. 1 0.7536
906 lack 1 0.4358
906 large 1 0.2979
906 many 1 0.3038
906 membrane 1 0.4066
906 micrographs. 1 0.7536
906 microscopy. 1 0.6785
906 mycoplasma 1 0.411
906 nuclear 2 0.8716
906 obtained 1 0.2686
906 particular 1 0.3805
906 pinching 1 0.7536
906 possibly 1 0.4685
906 present 1 0.2481
906 process. 1 0.5793
906 processed 1 0.7536
906 reproductive 1 0.6785
906 rigid 1 0.6785
906 sections 1 0.5159
906 seen 1 0.3186
906 septa 1 0.7536
906 size 1 0.3946
906 sizes 1 0.6785
906 small 1 0.3023
906 species. 1 0.4943
906 staph. 1 0.6785
906 staphylococcal 2 1.5073
906 staphylococccal 1 0.7536
906 structural 2 0.97
906 structure 1 0.3839
906 technique 1 0.3546
906 typical 1 0.4943
906 ultrathin 1 0.6785
906 unit. 1 0.7536
906 units 4 2.0636
906 wall 1 0.4764
906 within 1 0.2798
907 (adjuvant 1 0.7536
907 (eaton 1 0.6785
907 1,2,3 1 0.7536
907 2 1 0.2301
907 3 1 0.2569
907 4 1 0.2666
907 65 1 0.5159
907 65) 1 0.7536
907 90% 1 0.6034
907 acceptable 1 0.7536
907 adjuvant 1 0.543
907 adjuvant. 1 0.7536
907 adults 1 0.4542
907 agent) 1 0.7536
907 although 1 0.2897
907 alum 4 3.0145
907 always 1 0.4025
907 animals 1 0.3204
907 antibody 4 1.8443
907 antibody. 2 1.357
907 antigenic 1 0.4416
907 appeared 1 0.3625
907 aqueous 2 1.086
907 artificial 1 0.5046
907 best 1 0.3985
907 better 2 0.8716
907 bleeding 1 0.5596
907 cf 1 0.6785
907 children 2 0.5352
907 clinical 1 0.2457
907 concentrated 1 0.5793
907 concentrations 1 0.3874
907 consequence 1 0.5793
907 degree 1 0.3339
907 demonstrating 1 0.5793
907 detectable 2 0.9528
907 different 1 0.2666
907 disease, 1 0.4025
907 doses 1 0.411
907 effect. 1 0.4943
907 effectiveness 1 0.5286
907 emulsified 1 0.7536
907 findings, 1 0.6034
907 following 1 0.2498
907 formalin-killed 1 0.7536
907 formulation 1 0.7536
907 gave 1 0.4764
907 give 1 0.411
907 hamsters, 1 0.6785
907 high 1 0.2697
907 highly 1 0.4066
907 ii. 1 0.4358
907 included 1 0.4066
907 incorporated 1 0.5596
907 indicate 1 0.3319
907 induce 1 0.5046
907 infection 1 0.3546
907 initially 2 0.9887
907 institutionalized 1 0.7536
907 local 1 0.4542
907 m. 1 0.4202
907 man, 1 0.5596
907 man. 1 0.485
907 maximal 1 0.4685
907 measured 1 0.3299
907 medium. 1 0.5793
907 mentioned. 1 0.6785
907 monkeys, 1 0.7536
907 mycoplasma 2 0.8219
907 natural 1 0.4416
907 necessary 1 0.4416
907 neutralizing 2 1.2691
907 noted 1 0.3985
907 oil 1 0.7536
907 optimal 1 0.6034
907 peanut 1 0.7536
907 persons 4 1.9056
907 pneumoniae 2 1.0318
907 pre-existing 1 0.6346
907 preparation. 1 0.6346
907 preparations 1 0.4542
907 prepared 1 0.4542
907 preschool 1 0.6346
907 propagated 1 0.6785
907 protecting 1 0.6785
907 purified 1 0.4764
907 reaction 1 0.3773
907 recent 1 0.3946
907 respiratory 1 0.3909
907 responses 2 0.8404
907 results 1 0.2158
907 serum 1 0.2924
907 serum-free 1 0.7536
907 sometimes 1 0.485
907 stimulating 1 0.5286
907 systemic 1 0.4202
907 thus 1 0.3909
907 times 1 0.3625
907 two 1 0.2308
907 unpublished 1 0.6785
907 use 1 0.2979
907 vaccinated. 1 0.7536
907 vaccinations. 1 0.7536
907 vaccine 4 3.0145
907 vaccines 4 3.0145
907 vaccines. 2 1.5073
907 virus 1 0.3946
907 vulnerable 1 0.6785
907 without 2 0.5692
907 would 1 0.3742
908 (cf) 1 0.3768
908 (tri) 1 0.3768
908 13% 1 0.3173
908 15 1 0.1871
908 197 1 0.3392
908 2 2 0.2301
908 20% 1 0.2798
908 254 1 0.3768
908 30 1 0.1799
908 33% 1 0.3392
908 50% 2 0.4542
908 56% 1 0.3768
908 8% 1 0.3173
908 accounted 1 0.2798
908 acute 1 0.1871
908 adults 1 0.2271
908 age. 1 0.2126
908 agglutinins 1 0.3173
908 also, 1 0.2715
908 antibodies 1 0.2126
908 attempted 1 0.2523
908 atypical 1 0.2715
908 bronchial 1 0.2798
908 cases 1 0.1121
908 cases. 1 0.1973
908 chronic 1 0.1799
908 civilian 1 0.3392
908 cold 1 0.258
908 complement-fixation 1 0.3017
908 constant 1 0.2055
908 developed 1 0.1713
908 diagnosis. 2 0.5046
908 differences 1 0.1724
908 different 2 0.2666
908 discriminatory 1 0.3392
908 disease. 1 0.1992
908 diseases 1 0.2055
908 especially 1 0.1937
908 etiologic 1 0.2715
908 etiologically 1 0.3768
908 evidence 1 0.1381
908 fall 1 0.1973
908 frequency 1 0.1973
908 frequently 1 0.1903
908 greatest 1 0.2382
908 growth 1 0.1284
908 highest 1 0.2382
908 hospitalized 1 0.2643
908 incidence 1 0.1799
908 indicate 1 0.1659
908 infection 2 0.3546
908 infection, 1 0.2643
908 infection. 1 0.2472
908 infections. 1 0.3392
908 inhibition 1 0.1887
908 isolated. 1 0.3173
908 isolates 1 0.2798
908 isolation 4 0.97
908 lobar 1 0.3768
908 m. 8 1.6808
908 males 1 0.258
908 many 1 0.1519
908 maximum 1 0.2077
908 may 1 0.0942
908 measure 1 0.2179
908 minimum 1 0.2897
908 mycoplasma 2 0.411
908 nonlobar 1 0.3768
908 nonpathogenic 1 0.3768
908 obtained 1 0.1343
908 occurred 1 0.1639
908 occurrence 1 0.2238
908 one 1 0.1054
908 organisms 1 0.2305
908 patients 5 0.4529
908 persons 1 0.2382
908 pharyngis 1 0.3768
908 pneumonia 3 0.7569
908 pneumonia, 2 0.6785
908 pneumonia. 2 0.6346
908 pneumoniae 6 1.5477
908 pneumoniae. 1 0.3173
908 poorly 1 0.2897
908 prevalence 1 0.3017
908 rapid 1 0.1826
908 rare 1 0.2238
908 received 1 0.2126
908 related 1 0.1593
908 relative 1 0.1955
908 requires 1 0.2305
908 respiratory 3 0.5864
908 role 1 0.1748
908 salivarium 1 0.3768
908 season 1 0.3392
908 seasons 1 0.3392
908 sensitive 1 0.2033
908 serologic 2 0.543
908 serum 1 0.1462
908 significant 1 0.1323
908 significantly 1 0.1584
908 specific. 1 0.3768
908 spring. 1 0.3768
908 sputum 1 0.3392
908 statistically 1 0.2342
908 strains 1 0.2238
908 studied. 1 0.2126
908 syndrome 1 0.1748
908 test 1 0.163
908 tests 1 0.1856
908 tests, 1 0.2472
908 tetracycline, 1 0.3392
908 tetracycline. 1 0.3768
908 treated 1 0.1551
908 underestimates 1 0.3768
908 upper 1 0.2425
908 useful 1 0.2077
908 various 1 0.149
908 weeks:therefore, 1 0.3768
908 yr. 1 0.1973
909 ability 2 0.6142
909 added 1 0.3748
909 ammonia 2 1.0856
909 ammonia, 1 0.6029
909 antibody 3 1.1066
909 antiserum 2 0.8073
909 based 1 0.3157
909 change 1 0.2797
909 color 1 0.4634
909 concomitant 1 0.4634
909 demonstrated 1 0.2578
909 developed, 1 0.4827
909 distinct 1 0.3748
909 human 1 0.2012
909 indicator 1 0.4827
909 inhibit 1 0.4127
909 inhibition 2 0.6037
909 large-colony 1 0.6029
909 measurement 2 0.6802
909 medium 1 0.322
909 metabolic 2 0.5757
909 metabolize 1 0.5076
909 mycoplasma 2 0.6575
909 mycoplasmas 2 0.8457
909 mycoplasmas. 2 1.0153
909 organism 1 0.4037
909 ph 1 0.3253
909 phenol 1 0.5428
909 prepared. 1 0.6029
909 production 1 0.3071
909 production. 2 1.2058
909 recognized 1 0.3748
909 red 1 0.3581
909 resulting 1 0.3071
909 sera 1 0.3955
909 serologically 1 0.4827
909 served 1 0.3955
909 shown 1 0.2593
909 specific 1 0.2372
909 specific, 1 0.5428
909 strain 1 0.3188
909 t-960 2 1.2058
909 t-strain 5 3.0145
909 technique 1 0.2836
909 technique. 1 0.4634
909 test 1 0.2608
909 upon 1 0.2705
909 urea 1 0.4229
910 (hek) 1 0.7536
910 1 1 0.2846
910 1, 1 0.485
910 action 2 0.6558
910 agent, 1 0.543
910 assay 1 0.4943
910 capable 1 0.4611
910 cell 1 0.2551
910 cells 2 0.4549
910 cells, 1 0.3653
910 cells. 2 0.672
910 culture 1 0.3773
910 cultures 1 0.3773
910 cultures. 1 0.543
910 detectable 1 0.4764
910 diminished. 1 0.6785
910 effect 1 0.2301
910 embryonic 1 0.4764
910 employed. 1 0.6346
910 f12 1 0.7536
910 hek 1 0.7536
910 hominis 2 1.086
910 human 1 0.2515
910 impair 1 0.6785
910 induction 1 0.485
910 infection 2 0.7091
910 influence 1 0.3449
910 inoculation 1 0.5046
910 interferon 4 3.0145
910 interferon, 2 1.5073
910 kidney 1 0.3339
910 l 2 1.1586
910 levels 1 0.2951
910 m. 3 1.2606
910 multiplication 1 0.5596
910 mycoplasma 4 1.6439
910 negroni 1 0.7536
910 none 1 0.4542
910 noticeably 1 0.6785
910 pneumoniae 1 0.5159
910 produced 1 0.3069
910 production 2 0.7678
910 remained 1 0.4303
910 replication 1 0.5596
910 responsiveness 1 0.6034
910 sensitivity 1 0.4542
910 stomatitis 1 0.7536
910 strains 1 0.4477
910 studied 1 0.2626
910 systems 1 0.5286
910 unaltered. 1 0.6785
910 used 1 0.2846
910 vesicular 1 0.6785
910 virus 2 0.7893
911 agent 1 0.4416
911 cell 1 0.2551
911 characterization 2 1.2691
911 cpe. 1 0.7536
911 cultures. 1 0.543
911 developed 1 0.3426
911 dktc 1 0.7536
911 dog 1 0.4685
911 group. 1 0.4358
911 herpes 1 0.7536
911 herpes-like 1 0.7536
911 indicated 1 0.3546
911 kidney 1 0.3339
911 member 1 0.6785
911 new 1 0.3299
911 primary 1 0.3186
911 recovered 1 0.4685
911 recovery 1 0.4155
911 serological 1 0.5596
911 spontaneous 1 0.4358
911 studies 1 0.2308
911 transmissible 1 0.6034
911 virus 4 1.5786
912 10 1 0.3699
912 11 1 0.5366
912 7 2 0.9258
912 8 1 0.4538
912 additional 1 0.5366
912 adults 1 0.6056
912 arthritis 2 1.6091
912 arthritis. 1 1.0048
912 assays 1 0.9046
912 c' 2 2.0097
912 cases 3 0.8969
912 cells, 1 0.4871
912 changes 1 0.3007
912 children 1 0.3568
912 clinical 1 0.3275
912 collections 1 0.8461
912 complement 1 0.6879
912 complement. 1 0.9046
912 connective 1 0.724
912 correlation 1 0.5074
912 cytoplasm 1 0.6246
912 demonstrated 1 0.4296
912 diffusely 1 0.9046
912 discrete 1 0.9046
912 disease 1 0.361
912 examined 1 0.5074
912 findings 1 0.3992
912 fluid 1 0.4762
912 forms 1 0.4797
912 found 2 0.5291
912 four 1 0.4509
912 immunoglobulin 1 0.8461
912 immunoglobulins 2 1.8093
912 immunopathologic 1 1.0048
912 joint 2 1.2933
912 larger, 1 0.9046
912 localization 3 2.1144
912 made. 1 0.6246
912 patients 1 0.2415
912 present 1 0.3308
912 remaining 1 0.5119
912 results 1 0.2878
912 rheumatoid 3 2.4137
912 staining 1 0.6728
912 stroma; 1 1.0048
912 synovial 2 1.6091
912 synovium. 2 2.0097
912 three 1 0.3778
912 throughout 1 0.5738
912 tissue 2 0.6976
912 weakly 1 0.9046
912 within 2 0.746
913 'elementary 1 0.4306
913 (growth). 1 0.4306
913 (pplo 1 0.4306
913 0.5 1 0.3198
913 1 1 0.1626
913 100m 1 0.4306
913 880) 1 0.4306
913 880, 1 0.4306
913 although 1 0.1655
913 antibiotics. 1 0.3877
913 area 1 0.2234
913 area. 1 0.3626
913 artificial 1 0.2883
913 associated 1 0.1529
913 attach 1 0.4306
913 attached 1 0.3198
913 bodies' 1 0.3877
913 broth 1 0.331
913 cell 5 0.7287
913 cells 1 0.13
913 characteristics 1 0.2401
913 closely 1 0.2459
913 common 1 0.2104
913 conditions 1 0.1958
913 considerable 1 0.2234
913 consistent 1 0.2401
913 contained 1 0.2194
913 culture 2 0.4312
913 culture. 1 0.3626
913 cultures 1 0.2156
913 cultures. 1 0.3103
913 cytoplasm 1 0.2677
913 cytoplasmic 1 0.2595
913 described 1 0.1633
913 details 1 0.2948
913 diameter 2 0.7754
913 differences 1 0.1971
913 difficulty 1 0.2883
913 dna. 1 0.331
913 either 1 0.1841
913 electron 1 0.2175
913 electron-dense. 1 0.4306
913 eradicating 1 0.4306
913 exhibited 1 0.2635
913 explain 1 0.2883
913 fewer 1 0.3103
913 fibrillar 1 0.331
913 filamentous 1 0.3877
913 flattened 1 0.3448
913 form 1 0.1874
913 forms 2 0.4112
913 forms, 1 0.3877
913 glass, 1 0.3877
913 granules 1 0.2825
913 grew 1 0.2883
913 growth 1 0.1468
913 including 2 0.4647
913 indented 1 0.4306
913 infected 1 0.2348
913 internal 1 0.2429
913 intracellular 1 0.2825
913 isolated 1 0.1874
913 leukemic 1 0.3626
913 lines 2 0.4981
913 lines. 1 0.3448
913 may 3 0.3231
913 mechanisms 1 0.2595
913 medium 1 0.23
913 membrane-lined 1 0.4306
913 microscopic 1 0.2677
913 monolayer, 1 0.4306
913 mycoplasma 7 1.6439
913 nuclear 2 0.4981
913 observed 1 0.1468
913 occasionally 1 0.2883
913 organism 1 0.2883
913 organisms 1 0.2635
913 partly 1 0.331
913 patient, 1 0.2825
913 pleomorphism 1 0.4306
913 previously 1 0.2071
913 probably 1 0.1958
913 projections. 1 0.3877
913 protected 1 0.331
913 related 1 0.1821
913 reproduction 1 0.3877
913 ribosome-like 1 0.4306
913 seen 1 0.1821
913 several 2 0.3725
913 shape, 1 0.3877
913 similar 1 0.1612
913 size, 1 0.2948
913 strain 4 0.9108
913 strain. 1 0.3877
913 strains, 1 0.331
913 strands, 1 0.4306
913 structure 1 0.2194
913 structure, 1 0.3626
913 studied 1 0.15
913 studies 1 0.1319
913 suggestion 1 0.3198
913 surface 1 0.2324
913 surface. 1 0.3448
913 tissue 2 0.299
913 ultrastructure 1 0.3626
913 used 1 0.1626
913 vacuole 1 0.3877
913 vacuoles. 1 0.3626
913 various 2 0.3405
913 would 1 0.2138
914 2 2 0.6136
914 affects 1 1.0048
914 also 1 0.2811
914 aspects 1 0.5669
914 assets 1 1.0048
914 based 1 0.5262
914 children 3 1.0704
914 children, 1 0.5888
914 comparison 1 0.5212
914 control 1 0.3778
914 controlled 1 0.5738
914 critical 1 0.6728
914 defect 1 0.4948
914 determines 1 0.9046
914 development 1 0.3669
914 developmental 1 0.6728
914 different 2 0.7109
914 disordered 1 1.0048
914 double-blind 1 0.9046
914 drug 2 1.0524
914 evident 1 0.6246
914 factors. 1 0.7724
914 group 1 0.3714
914 groups 2 0.8185
914 guarantee 1 0.9046
914 handicaps. 1 1.0048
914 illness, 1 0.7724
914 immediate 1 0.6352
914 impairment. 1 0.9046
914 initial 1 0.4871
914 language 1 0.5888
914 long-term 2 1.1622
914 major 2 0.9667
914 matched 1 0.7462
914 matched, 1 1.0048
914 matching 1 0.8461
914 may 1 0.2513
914 misleading 1 0.9046
914 must 1 0.4909
914 nonpharmacologic 1 1.0048
914 outcome 1 0.7724
914 patterns 1 0.6352
914 pharmacological 1 0.8461
914 predicted 1 0.7724
914 profiles 1 0.8046
914 prognosis 1 0.554
914 prognostic 1 0.7462
914 regimes 1 0.9046
914 related 1 0.4248
914 response 3 1.1006
914 responsiveness 2 1.6091
914 schizophrenic 3 1.9056
914 severity 2 1.2295
914 since 1 0.4372
914 speech 1 0.5262
914 study 2 0.6191
914 study, 1 0.6466
914 study; 1 1.0048
914 subgroups 1 0.8046
914 technique 1 0.4727
914 therapy: 1 0.9046
914 thus 1 0.5212
914 treatment 3 0.8894
914 treatment. 1 0.5313
914 treatments. 1 1.0048
914 trifluoperazine. 1 1.0048
914 type 1 0.4179
914 types 1 0.4871
914 use 1 0.3972
914 well 1 0.3514
914 well-controlled 1 1.0048
914 within 1 0.373
914 without, 1 1.0048
914 young 1 0.5074
915 'early 1 1.0048
915 6 1 0.4202
915 admitted, 1 1.0048
915 analysis 1 0.4833
915 autistic 1 0.548
915 boy, 1 0.8461
915 briefly 1 0.6056
915 care 1 0.6352
915 case 1 0.361
915 child 3 1.45
915 childhood 2 1.1337
915 children. 2 1.1476
915 choice 1 0.6466
915 clearly 1 0.6056
915 clinical 1 0.3275
915 communication, 1 0.8461
915 data 1 0.4092
915 deals 1 0.7724
915 description 1 0.6591
915 diagnosed, 1 0.9046
915 discussion 1 0.6056
915 disposal 1 1.0048
915 disturbed 1 0.6246
915 ego 1 0.724
915 emotionally 1 0.8046
915 existence 1 0.6148
915 express 1 0.8046
915 first 1 0.3684
915 focuses 1 1.0048
915 formation 1 0.4509
915 fragile 1 1.0048
915 framework 1 0.8461
915 gestures. 1 1.0048
915 hospital. 2 1.6922
915 ill 1 0.7724
915 importance 2 1.0237
915 important 1 0.4538
915 language. 1 0.9046
915 lay-out 1 1.0048
915 long 1 0.5212
915 long-term 1 0.5811
915 material 1 0.4661
915 mental 1 0.5669
915 mentally 1 0.724
915 method 1 0.3992
915 milieu 1 0.8461
915 nevertheless, 1 0.8461
915 new 1 0.4398
915 non-verbal 1 0.8461
915 object-relationship 1 1.0048
915 obtained 1 0.3582
915 old 1 0.5669
915 one 1 0.2811
915 part 1 0.4694
915 particularly 1 0.554
915 patients 1 0.2415
915 phase 1 0.5366
915 play 1 0.5969
915 preceding 1 0.7724
915 precious 1 1.0048
915 premature 1 0.6879
915 presented 1 0.3898
915 psychiatric 1 0.6466
915 psychoses. 1 1.0048
915 psychosis, 2 1.6091
915 psychotherapy 1 0.8046
915 psychotic 2 1.3182
915 quality 1 0.7724
915 rich 1 0.7724
915 sensitivities' 1 1.0048
915 severe 1 0.4452
915 structure 1 0.5119
915 term 1 0.5603
915 therapeutic 1 0.5074
915 treatment 3 0.8894
915 type. 1 0.6728
915 underlining 1 1.0048
915 unit 1 0.7048
915 unusual 1 0.6352
915 unusually 1 0.9046
915 well-known 1 0.9046
915 within 1 0.373
915 yr. 1 0.5262
916 account 1 0.8503
916 autism 1 0.8954
916 case 2 1.0831
916 comments 1 1.2691
916 dangerous 1 1.357
916 defence 1 1.357
916 depended 1 1.357
916 environment. 1 1.2691
916 given 1 0.5526
916 improvement 1 1.0091
916 infantile 2 1.6439
916 much 1 0.6678
916 mutism 1 1.5073
916 psychosis. 1 1.1192
916 psychotherapy. 1 1.357
916 spectacular 1 1.5073
916 symptomatology 1 1.0318
916 threatening 1 1.2691
916 true 1 1.0091
916 unusual 1 0.9528
916 upon 1 0.6763
916 withdrawing 1 1.5073
917 'nosological 1 1.0048
917 'pre-scientific' 1 1.0048
917 'psychiatric 1 1.0048
917 'right' 1 1.0048
917 (as, 1 1.0048
917 (schizophrenia, 1 1.0048
917 analyze 1 0.9046
917 arbitrary 1 0.9046
917 asperger) 1 1.0048
917 assigned 1 1.0048
917 autism 3 1.7907
917 case 1 0.361
917 claim 1 1.0048
917 classifications 1 1.0048
917 clinical 1 0.3275
917 concentrate 1 0.8046
917 concept 1 0.6056
917 conditions 1 0.4568
917 controversial, 1 1.0048
917 different 1 0.3554
917 discovered. 1 0.9046
917 discussing 1 0.8046
917 distinctions 1 0.9046
917 divided 1 0.7048
917 early 2 0.7367
917 entities'. 1 1.0048
917 etiology 2 1.108
917 individual 1 0.5313
917 infantile 3 1.6439
917 instance, 1 0.8046
917 instead 1 0.8046
917 kanner 1 1.0048
917 literature 1 0.548
917 long 1 0.5212
917 mental 2 1.1337
917 neurosis). 1 1.0048
917 nosology. 1 1.0048
917 particular 1 0.5074
917 problems 1 0.5212
917 promising 1 0.8461
917 psychiatric 2 1.2933
917 psychiatry 1 1.0048
917 psychopathy, 1 1.0048
917 schizophrenia, 2 1.6922
917 school' 1 1.0048
917 seems 1 0.5313
917 several 1 0.4346
917 since 1 0.4372
917 situation 1 0.8046
917 subgroup 2 1.6922
917 subgroups 1 0.8046
917 symptomatology 1 0.6879
917 syndrome 1 0.4661
917 thought 1 0.5669
917 too, 1 0.9046
917 unknown. 1 0.8046
917 yet 1 0.5313
918 (1) 2 0.9741
918 (2) 2 0.9741
918 (3) 2 1.0626
918 (4) 1 0.5811
918 (5) 1 0.6591
918 (6) 1 0.724
918 (7) 1 0.7724
918 2 1 0.3068
918 2.8:1. 1 1.0048
918 3 3 1.0275
918 age 1 0.4157
918 among 3 1.4082
918 autism 1 0.5969
918 autistic 3 1.6439
918 basis 1 0.4398
918 better 1 0.5811
918 birth 1 0.5119
918 broken 2 2.0097
918 child. 1 0.6728
918 childhood 1 0.5669
918 children 3 1.0704
918 children, 1 0.5888
918 chronic 3 1.4391
918 compared 1 0.3898
918 data 1 0.4092
918 demographic 1 1.0048
918 diagnosed 1 0.6148
918 diagnoses 1 0.9046
918 diagnosis 1 0.4135
918 different 1 0.3554
918 disturbance. 1 0.7724
918 disturbed 3 1.8738
918 divided 1 0.7048
918 early 1 0.3684
918 educated 1 1.0048
918 educational 1 0.8461
918 emotional 1 0.5603
918 emotionally 1 0.8046
918 employed 1 0.6352
918 families 2 1.4096
918 father; 1 1.0048
918 following 1 0.3331
918 forms 1 0.4797
918 general, 1 0.724
918 group 1 0.3714
918 group, 1 0.6466
918 group; 1 1.0048
918 groups 3 1.2277
918 groups. 1 0.5969
918 groups; 1 0.8461
918 highly 1 0.5422
918 homes 1 1.0048
918 homes; 1 1.0048
918 indicated 1 0.4727
918 level 2 0.7761
918 male-female 2 2.0097
918 many 1 0.4051
918 measures: 1 1.0048
918 nonschizophrenic 1 1.0048
918 occupational 1 0.8461
918 occupations 1 1.0048
918 of: 1 1.0048
918 ordinal 3 3.0145
918 otherwise 1 0.7462
918 parents 3 2.1719
918 parents; 1 1.0048
918 patient 1 0.3778
918 position 2 1.3758
918 position. 1 0.8461
918 prevalence 1 0.8046
918 prevalent 1 0.8461
918 rated 1 1.0048
918 ratio 2 1.0524
918 results 1 0.2878
918 revealed 1 0.4871
918 schizophrenia, 1 0.8461
918 schizophrenia. 2 1.6091
918 schizophrenic 1 0.6352
918 sex; 1 1.0048
918 show 1 0.4346
918 siblings 1 0.7462
918 siblings; 1 1.0048
918 significantly 1 0.4225
918 similarities 1 0.7462
918 specifically, 1 1.0048
918 statistically 1 0.6246
918 subjects. 1 0.6148
918 symbiosis, 1 1.0048
918 symbiotic 1 0.7724
918 trend 1 0.8046
918 undifferentiated 3 2.2385
919 'psychosis' 1 1.0048
919 'schizophrenic 1 1.0048
919 (1) 1 0.4871
919 (2) 1 0.4871
919 (3) 1 0.5313
919 (4) 1 0.5811
919 (5) 1 0.6591
919 (6) 1 0.724
919 1961 1 0.8461
919 associates 1 0.9046
919 available, 1 0.9046
919 best 1 0.5313
919 called 1 0.724
919 childhood 3 1.7006
919 childhood'. 1 1.0048
919 classification 1 0.7724
919 creak 1 1.0048
919 criteria 1 0.5888
919 deprivation, 1 0.8461
919 description 1 0.6591
919 diagnostic 1 0.4989
919 discussed. 1 0.4296
919 forward 1 0.8046
919 generic 1 1.0048
919 given 1 0.3684
919 grouped 1 1.0048
919 into: 1 1.0048
919 manic-depressive 1 1.0048
919 mental 1 0.5669
919 neurosis, 1 1.0048
919 organic 1 0.5969
919 presented 1 0.3898
919 psychosis, 2 1.6091
919 psychosis. 2 1.4923
919 psychotic 1 0.6591
919 put 1 0.8461
919 reactions 1 0.4909
919 schizophrenia, 1 0.8461
919 sensory 1 0.7462
919 states 1 0.6879
919 subnormality 1 1.0048
919 suggested 1 0.4179
919 syndrome 1 0.4661
919 term 1 0.5603
920 32 1 0.7724
920 among 1 0.4694
920 aspects 1 0.5669
920 autism 1 0.5969
920 basis 1 0.4398
920 better 1 0.5811
920 brain 1 0.5119
920 caution 1 0.8046
920 childhood 1 0.5669
920 childhood: 1 0.8461
920 children 1 0.3568
920 children. 1 0.5738
920 chronic 1 0.4797
920 classification 1 0.7724
920 clinical 1 0.3275
920 clinicians 1 0.8461
920 comparisons 1 0.8461
920 comprehensive 1 0.8046
920 consideration 1 0.6591
920 considerations 1 0.6879
920 developed 1 0.4568
920 diagnosis 2 0.827
920 diagnostic 1 0.4989
920 differential 1 0.6352
920 disorders 1 0.5738
920 early 2 0.7367
920 emotional 1 0.5603
920 emphasis 1 0.724
920 especially 1 0.5165
920 etiology. 1 0.7724
920 evaluations 1 0.8461
920 experiences 1 0.6728
920 field. 1 0.8461
920 findings, 1 0.8046
920 group 1 0.3714
920 groups 1 0.4092
920 guidelines 1 1.0048
920 incomplete 1 0.8461
920 individual 1 0.5313
920 infancy 1 0.7048
920 infantile 1 0.548
920 information. 1 0.8461
920 initially 1 0.6591
920 interpretation 1 0.6728
920 made 1 0.3639
920 many 1 0.4051
920 mental 1 0.5669
920 mentally 1 0.724
920 must 1 0.4909
920 need 1 0.6148
920 offer 1 0.6466
920 picture 1 0.548
920 pieces 1 0.8461
920 pilot 1 0.8046
920 placed 1 0.5969
920 possible 1 0.4031
920 presented 1 0.3898
920 primary 1 0.4248
920 prognosis. 1 0.9046
920 prognostic 1 0.7462
920 project. 1 1.0048
920 psychological 1 0.6352
920 psychosis 2 1.5448
920 psychotic 3 1.9773
920 questions 1 0.7462
920 raised 1 0.5969
920 reactions 2 0.9818
920 regard 1 0.5738
920 regarding 1 0.6352
920 resulting 2 1.0237
920 results 1 0.2878
920 retardation 1 0.6879
920 retarded. 1 1.0048
920 stressed. 1 0.7724
920 study 1 0.3096
920 suggested 1 0.4179
920 superimposed 1 0.8461
920 syndrome 2 0.9322
920 synthesis 1 0.4989
920 team 1 0.8461
920 test 1 0.4346
920 thought 1 0.5669
920 total 1 0.3916
920 treatment 1 0.2965
920 unitary 1 1.0048
920 valid 1 0.8461
920 working 1 0.7724
921 50 1 0.4797
921 adjunct 1 0.7724
921 administered 1 0.4797
921 affect. 1 1.0048
921 angus 1 1.0048
921 appearance 1 0.4989
921 appearance. 1 0.8461
921 appears 1 0.4321
921 areas 2 1.0626
921 autistic 3 1.6439
921 behavior 3 1.7214
921 behavior, 1 0.8046
921 behavior. 1 0.7724
921 behavioral 1 0.7462
921 behaviors 2 1.8093
921 changes 1 0.3007
921 changes. 1 0.8046
921 children 1 0.3568
921 closely 1 0.5738
921 consistent 1 0.5603
921 contact, 1 1.0048
921 control 1 0.3778
921 decrease 1 0.4598
921 demonstrated 1 0.4296
921 diverse 1 0.8046
921 drug 1 0.5262
921 effect 1 0.3068
921 esterline 1 1.0048
921 eye-to-face 1 1.0048
921 face-to-face, 1 1.0048
921 following 1 0.3331
921 hand-holding 1 1.0048
921 identical 1 0.5969
921 increase 2 0.6826
921 interaction 1 0.6148
921 isolation 1 0.6466
921 laughter 1 1.0048
921 lsd 1 1.0048
921 lsd-25 2 2.0097
921 lsd-25. 1 1.0048
921 made 2 0.7278
921 male 1 0.5119
921 measured 1 0.4398
921 modification 1 0.7462
921 multiple 1 0.554
921 observations 1 0.4225
921 observed 1 0.3425
921 offer 1 0.6466
921 pair 1 0.7724
921 pat-a-cake, 1 1.0048
921 peek-a-boo, 1 1.0048
921 pen 1 1.0048
921 percent 1 0.6728
921 periodically 1 0.8461
921 placed 1 0.5969
921 plotted 1 0.9046
921 positive 1 0.5366
921 process 1 0.4598
921 psychotherapy 1 0.8046
921 psychotherapy. 1 0.9046
921 recorded 1 0.5738
921 recorder. 1 1.0048
921 recordings 1 0.7462
921 referred 1 0.5969
921 related 1 0.4248
921 resulted 1 0.4871
921 self-stimulatory 2 2.0097
921 series 1 0.4727
921 situations 1 0.8046
921 smiling 1 1.0048
921 social 2 1.2933
921 socialization 1 0.9046
921 standard 1 0.6879
921 subjects 2 0.9594
921 test 1 0.4346
921 test, 2 1.4923
921 tests. 1 0.6879
921 time 2 0.7082
921 total 1 0.3916
921 twins 1 0.8046
921 useful 1 0.554
921 using 1 0.4568
922 'child 1 0.6029
922 (10%) 1 0.6029
922 (24%) 1 0.5428
922 (developing 1 0.6029
922 (or 1 0.5076
922 10 1 0.2219
922 11% 1 0.5076
922 14 1 0.3324
922 15 2 0.5987
922 2 1 0.1841
922 20% 1 0.4477
922 40% 2 0.8688
922 50 1 0.2878
922 50, 1 0.6029
922 6 1 0.2521
922 65 2 0.8255
922 75% 1 0.4827
922 80 1 0.4127
922 80. 1 0.5428
922 abnormalities 1 0.3362
922 adult 1 0.2741
922 although 1 0.2318
922 among 1 0.2816
922 aphasia 1 0.4477
922 attacks 1 0.5428
922 attitude 1 0.4827
922 autistic 1 0.3288
922 average 1 0.2705
922 brain 1 0.3071
922 child 1 0.29
922 childhood 1 0.3401
922 children 5 1.0704
922 children: 1 0.4634
922 clinical 1 0.1965
922 component 1 0.388
922 conclusive 1 0.5076
922 confirmed 1 0.3533
922 considerable 1 0.3127
922 considered 1 0.2688
922 damage 1 0.3071
922 delivering 1 0.6029
922 diagnosed 1 0.3689
922 disease. 1 0.3188
922 disorders 1 0.3443
922 due 1 0.2133
922 echolalia 1 0.5428
922 educational 1 0.5076
922 emotional 3 1.0085
922 epileptic 1 0.5428
922 episode. 1 0.6029
922 etiology. 1 0.4634
922 evidence 2 0.442
922 factors 2 0.5098
922 felt 1 0.4477
922 findings 1 0.2395
922 five 1 0.3188
922 follow-up). 1 0.6029
922 followed 1 0.2759
922 found 2 0.3174
922 general 1 0.3071
922 good 1 0.3362
922 group 1 0.2229
922 group. 1 0.3487
922 i.q. 2 1.2058
922 influence 2 0.5518
922 it. 1 0.4127
922 later 1 0.3099
922 management 1 0.3188
922 manifestation. 1 0.6029
922 mental 1 0.3401
922 militate 1 0.6029
922 nature 1 0.2993
922 neurosis. 1 0.6029
922 none 2 0.7267
922 noted; 1 0.5428
922 one 1 0.1687
922 organic 1 0.3581
922 origin, 1 0.4229
922 origins, 1 0.5076
922 others 1 0.3288
922 outcome 2 0.9269
922 outstanding 1 0.5076
922 parent 1 0.4477
922 parental 1 0.4344
922 parents 1 0.4344
922 part 1 0.2816
922 performances. 1 0.6029
922 picture. 1 0.5076
922 predictor 1 0.5428
922 primarily 1 0.3811
922 primary 1 0.2549
922 psychiatric 1 0.388
922 psychogenic 1 0.6029
922 psychosis 2 0.9269
922 psychosis' 1 0.6029
922 psychosis. 1 0.4477
922 receptive 1 0.5428
922 reduction 1 0.2969
922 regarded 1 0.3748
922 rejected. 1 0.6029
922 relationships 1 0.388
922 relevant 1 0.4344
922 retardation 1 0.4127
922 schizophrenia. 1 0.4827
922 schizophrenic 1 0.3811
922 schizophrenic; 1 0.6029
922 show 1 0.2608
922 showed 1 0.2149
922 sib 1 0.6029
922 sibs 1 0.6029
922 social 1 0.388
922 speaking 1 0.5428
922 speech 2 0.6314
922 spoken 1 0.4827
922 synonyms) 1 0.6029
922 transient 1 0.4127
922 treatment 1 0.1779
922 type 1 0.2507
922 view 2 0.7065
922 well 1 0.2108
922 withdrawal 1 0.4344
922 words. 1 0.5428
922 yr. 1 0.3157
923 4 1 0.2666
923 60 1 0.485
923 9 1 0.3946
923 age 1 0.3118
923 array. 1 0.7536
923 asked 2 1.357
923 attained 1 0.5596
923 attention 1 0.485
923 autistic 3 1.2329
923 avoided 1 0.6785
923 chance, 1 0.7536
923 children 2 0.5352
923 children: 1 0.5793
923 choices 2 1.5073
923 choose 1 0.7536
923 compliance 1 0.7536
923 comply 1 0.7536
923 concept 1 0.4542
923 concepts; 1 0.7536
923 conditioning 3 1.9037
923 continued 1 0.4358
923 correct 3 1.5477
923 distinction 1 0.6346
923 either 2 0.6444
923 elicited 1 0.5286
923 emitting 1 0.7536
923 experimenter's 1 0.7536
923 exploratory 1 0.7536
923 fewer-than-chance 1 0.7536
923 given 1 0.2763
923 giving 1 0.6346
923 increased 1 0.2343
923 instructions. 1 0.7536
923 is, 1 0.5046
923 less 1 0.2821
923 made 1 0.2729
923 make 1 0.4477
923 make. 1 0.7536
923 objects 3 1.7379
923 often 1 0.3653
923 paid 1 0.5793
923 perfectly 1 0.6785
923 performed 1 0.3449
923 produce 1 0.4025
923 red 3 1.3431
923 reinforced. 1 0.7536
923 resistance 1 0.4202
923 responses 2 0.8404
923 responses. 2 1.2069
923 results 1 0.2158
923 significantly 1 0.3168
923 square 3 1.9037
923 stimulus 1 0.5046
923 study. 1 0.4943
923 subjects 4 1.4391
923 subsequently 1 0.5046
923 suggest 1 0.3426
923 ten 1 0.4542
923 tendency 1 0.543
923 thus, 1 0.543
923 trials 2 1.2069
923 twelve 1 0.4764
923 unable 1 0.5596
923 unwilling 1 0.7536
923 yr 1 0.5596
924 92 1 1.5073
924 autistic 2 1.6439
924 childhood 1 0.8503
924 children 1 0.5352
924 children. 1 0.8607
924 clinical 1 0.4913
924 data, 1 1.2069
924 detail. 1 1.086
924 discussed 1 0.6138
924 disorders 1 0.8607
924 early 1 0.5526
924 etiology 1 0.831
924 etiology. 1 1.1586
924 examination 1 0.7611
924 experiences 1 1.0091
924 impression 1 1.086
924 led 1 0.8832
924 manifold 1 1.5073
924 many 1 0.6077
924 organic 1 0.8954
924 period 1 0.5717
924 primary 1 0.6372
924 relevant 1 1.086
924 supported 1 1.086
924 syndrome 1 0.6992
924 syndromes 2 2.1144
924 ten 1 0.9083
924 treatment 1 0.4447
924 view 1 0.8832
924 years 1 0.6851
924 youths 1 1.5073
925 acquired 1 0.9369
925 acquisition 1 1.0572
925 adults' 1 1.5073
925 attending 1 1.2691
925 children 2 1.0704
925 children. 2 1.7214
925 closer 2 2.7139
925 conditioning 1 1.2691
925 consisted 1 0.8954
925 contingent 1 1.5073
925 delivered 1 1.2069
925 development 1 0.5503
925 discriminations; 1 1.5073
925 established 1 0.8133
925 fine 1 1.0572
925 found 1 0.3968
925 framework. 1 1.5073
925 furthermore, 1 1.1192
925 imitation 2 3.0145
925 imitation. 1 1.5073
925 imitative 2 3.0145
925 increasingly 1 1.2069
925 mute 1 1.5073
925 necessary 1 0.8832
925 newly 1 1.0091
925 operant 1 1.357
925 procedure 1 0.7678
925 properties 1 0.805
925 reproductions 1 1.5073
925 reward 1 1.357
925 rewarded 1 1.357
925 rewarding 1 1.5073
925 schizophrenic 2 1.9056
925 series 1 0.7091
925 shown 1 0.6481
925 speech 2 1.5786
925 speech. 1 1.1192
925 taught 1 1.5073
925 training 1 1.1586
925 two 1 0.4616
925 upon 1 0.6763
925 verbal 1 1.0091
925 within 1 0.5595
926 (35%). 1 0.3349
926 (81%); 1 0.3349
926 12 1 0.1599
926 12. 1 0.3015
926 70%; 1 0.3349
926 admission 1 0.2575
926 although 1 0.1288
926 among 1 0.1565
926 auditory, 1 0.3015
926 behavior 1 0.1913
926 bizarre 1 0.282
926 boys 2 0.4974
926 charts 1 0.3015
926 childhood 1 0.189
926 children 7 0.8326
926 children. 2 0.3825
926 consisted 1 0.199
926 content 1 0.1576
926 convulsive 1 0.3349
926 current 1 0.2082
926 delusional 1 0.3349
926 deprived 1 0.2575
926 described. 1 0.1677
926 diagnosed 3 0.6148
926 difference 1 0.1677
926 differences 1 0.1533
926 different 1 0.1185
926 disorder 2 0.4164
926 disturbed 1 0.2082
926 girls 1 0.2575
926 girls, 1 0.3349
926 groups 1 0.1364
926 groups, 1 0.2243
926 hallucinations 9 3.0145
926 hallucinations, 1 0.3349
926 high 1 0.1199
926 highest 1 0.2117
926 hospital 1 0.2117
926 hospital. 1 0.282
926 incidence 5 0.7995
926 lowest 1 0.2682
926 nature 2 0.3326
926 nonpsychotic 1 0.3349
926 olfactory 1 0.3349
926 organized 1 0.3349
926 patients. 1 0.1611
926 population 1 0.2155
926 primary 1 0.1416
926 psychosis 1 0.2575
926 psychotic 2 0.4394
926 racial 1 0.3349
926 randomly 1 0.282
926 referral 1 0.3015
926 reviewing 1 0.3015
926 schizophrenia 1 0.2487
926 schizophrenic 1 0.2117
926 selected 1 0.1963
926 severely 1 0.2155
926 significant 1 0.1176
926 similar. 1 0.3015
926 simple 1 0.1827
926 specific 1 0.1318
926 state 2 0.3443
926 studied 1 0.1167
926 systems. 1 0.282
926 tended 1 0.2682
926 upon 1 0.1503
926 visual, 1 0.282
927 11. 1 0.3768
927 12 1 0.1799
927 13 2 0.4358
927 2 1 0.1151
927 4:30 1 0.3768
927 5 1 0.1429
927 6 1 0.1576
927 7 1 0.1736
927 9 2 0.3946
927 a.m. 1 0.3392
927 achievement 1 0.3392
927 admission 1 0.2897
927 age 1 0.1559
927 ages 1 0.2715
927 among 1 0.176
927 assumed 1 0.258
927 basis 1 0.1649
927 beginning 1 0.2382
927 care 1 0.2382
927 carefully 2 0.543
927 case 1 0.1354
927 change, 1 0.3768
927 changes 1 0.1127
927 child 1 0.1813
927 child. 1 0.2523
927 childhood 1 0.2126
927 children 8 1.0704
927 cognitive 1 0.2798
927 comparison 1 0.1955
927 confirmed 1 0.2208
927 consisted 1 0.2238
927 culture, 1 0.3173
927 day 5 0.9354
927 day-care 1 0.3768
927 day-treatment 1 0.3768
927 days 2 0.2994
927 degrees 1 0.2382
927 designed 1 0.2715
927 diagnosis 1 0.1551
927 disorders, 1 0.2715
927 distribution 1 0.1937
927 disturbance 1 0.2715
927 ego 2 0.543
927 either 1 0.1611
927 equivalent 1 0.2643
927 established 1 0.2033
927 evaluation, 1 0.3017
927 evidence 1 0.1381
927 experiment 1 0.2523
927 family 2 0.4542
927 gave 1 0.2382
927 group 1 0.1393
927 groups 1 0.1535
927 groups, 1 0.2523
927 human 1 0.1258
927 identical 1 0.2238
927 identity, 1 0.3768
927 impaired 1 0.258
927 impairment 1 0.2472
927 implied 1 0.3173
927 improvement 2 0.5046
927 indicated 1 0.1773
927 individually 1 0.3017
927 intactness 1 0.3768
927 interaction 1 0.2305
927 larger 1 0.2238
927 matched 3 0.8394
927 matching, 1 0.3768
927 means 1 0.167
927 measured 1 0.1649
927 metropolitan 1 0.3392
927 mth 2 0.5793
927 non-organic 1 0.3768
927 onset, 1 0.3173
927 organic 1 0.2238
927 organization. 1 0.3173
927 p.m. 1 0.3392
927 panic 1 0.3768
927 perceptual 1 0.3173
927 personal 1 0.2643
927 position 1 0.258
927 preoccupations, 1 0.3768
927 presented. 1 0.2208
927 progress, 1 0.3768
927 psychiatric 1 0.2425
927 ranged 1 0.2897
927 reactions. 1 0.2897
927 regard 1 0.2152
927 relationship, 1 0.3392
927 relative 1 0.1955
927 required. 1 0.3392
927 residence 2 0.6785
927 residential 4 1.357
927 resistance 1 0.2101
927 result 1 0.163
927 results 1 0.1079
927 round-the-clock 1 0.3768
927 schizophrenia 1 0.2798
927 schizophrenia. 1 0.3017
927 schizophrenic 1 0.2382
927 scorable 1 0.3768
927 selected, 1 0.3768
927 series. 1 0.3017
927 severely 1 0.2425
927 showed 1 0.1343
927 significant 1 0.1323
927 staff 1 0.3768
927 status 2 0.4764
927 structure 1 0.1919
927 structure. 1 0.3017
927 study 1 0.1161
927 teacher 1 0.3017
927 test 1 0.163
927 tests 1 0.1856
927 therapeutic 1 0.1903
927 three-year 1 0.3768
927 treatment 4 0.4447
927 treatment. 2 0.3985
927 unscorable 1 0.3768
927 unusual 1 0.2382
927 week 1 0.2472
927 week, 1 0.3768
927 who, 1 0.3768
927 wisc 3 1.1304
927 wisc, 1 0.3768
927 world 1 0.2798
927 year. 2 0.5286
928 4 1 0.1777
928 7 1 0.2315
928 9 1 0.2631
928 age 1 0.2078
928 aged 2 0.6056
928 ages 1 0.362
928 children 1 0.1784
928 children. 2 0.5738
928 children; 1 0.5024
928 choice 1 0.3233
928 comparable 1 0.277
928 compared 1 0.1949
928 constituting 1 0.4523
928 control. 1 0.3862
928 discussed. 1 0.2148
928 either 1 0.2148
928 engagement 1 0.5024
928 found 1 0.1323
928 greater 1 0.2078
928 group 1 0.1857
928 implications 1 0.3233
928 increased 1 0.1562
928 lower 1 0.2284
928 ma. 1 0.5024
928 measure. 1 0.5024
928 measured 1 0.2199
928 normal 4 0.5404
928 normals, 1 0.3862
928 pairs 1 0.3862
928 preference 5 2.1152
928 preferences 1 0.5024
928 receptor 2 0.9046
928 retardates 2 1.0048
928 sample. 1 0.423
928 schizophrenia 1 0.3731
928 schizophrenic 3 0.9528
928 schizophrenics 2 0.9046
928 showed 1 0.1791
928 significantly 1 0.2112
928 situations 1 0.4023
928 standardized 1 0.3862
928 stimuli 2 0.724
928 stimulus 1 0.3364
928 tactual 3 1.5073
928 theory 1 0.3233
928 time 1 0.177
928 trend 1 0.4023
928 used 1 0.1897
928 used, 1 0.3233
928 versus 1 0.423
928 visual 6 1.6439
929 (250 1 0.6029
929 10 1 0.2219
929 12 1 0.2878
929 12-mth-old 2 1.2058
929 3 1 0.2055
929 30% 1 0.4827
929 4 5 1.0663
929 48 1 0.3401
929 6-wk-old 2 1.2058
929 60%. 1 0.5428
929 7 3 0.8333
929 80% 1 0.4477
929 90% 1 0.4827
929 acid 4 0.9313
929 administration. 1 0.4037
929 aged 1 0.3633
929 also 1 0.1687
929 animals 2 0.5126
929 animals. 1 0.3401
929 approx. 1 0.4634
929 autoradiographic 1 0.3955
929 body 2 0.4861
929 changes 1 0.1804
929 concur 1 0.6029
929 content 2 0.5673
929 content, 1 0.5428
929 contents 1 0.4037
929 control 2 0.4534
929 cortical 1 0.388
929 days 5 1.1975
929 days, 2 0.7909
929 defined. 1 0.5428
929 deoxyribonucleic 1 0.4229
929 dna 5 1.4391
929 dry 2 0.8954
929 effect 2 0.3682
929 essentially 1 0.4127
929 evidence 1 0.221
929 folate 2 1.2058
929 folate. 1 0.6029
929 folic 2 1.0856
929 following 1 0.1998
929 found 2 0.3174
929 greater 1 0.2494
929 greatly 1 0.3581
929 growth 2 0.411
929 hr 1 0.3487
929 increase 1 0.2048
929 increased 3 0.5623
929 increases 1 0.2816
929 index 1 0.3581
929 indices 1 0.4229
929 injection 1 0.2521
929 injection. 1 0.4344
929 kidney 5 1.3357
929 kidney. 1 0.3748
929 kidneys 2 0.6723
929 labeling 1 0.3955
929 labelling 1 0.4827
929 less 1 0.2257
929 longer 1 0.4229
929 lower 2 0.5481
929 matter 1 0.4477
929 maximal, 1 0.6029
929 maximum 2 0.6648
929 medulla 1 0.4344
929 mg/kg 1 0.4827
929 mth. 1 0.3581
929 normal 2 0.3242
929 nucleic 1 0.3955
929 observed 2 0.411
929 older 2 0.7495
929 patterns 2 0.7622
929 percentage 1 0.3362
929 period 1 0.2287
929 period. 1 0.3633
929 prolongation 1 0.4634
929 rat 2 0.4962
929 rats 3 0.6985
929 rats. 1 0.3157
929 relative 1 0.3127
929 remained 1 0.3443
929 resp. 1 0.6029
929 response 1 0.2201
929 results 1 0.1727
929 rna 1 0.3324
929 shown 1 0.2593
929 significantly 1 0.2535
929 similar 1 0.2257
929 single 1 0.2993
929 slightly 1 0.3443
929 small 1 0.2419
929 studied. 1 0.3401
929 studies 1 0.1846
929 suggesting 1 0.3689
929 synthesis 3 0.898
929 thymidine-h 1 0.6029
929 time 1 0.2124
929 value, 1 0.5428
929 values 3 0.9133
929 weight 1 0.2836
929 weight, 1 0.4037
929 weights 1 0.4229
929 weights, 1 0.4827
929 well 1 0.2108
929 wet 1 0.4634
929 whereas 1 0.3018
929 wk 1 0.5076
929 wt) 1 0.6029
929 zone, 1 0.5428
929 zones 1 0.5076
930 1% 1 0.6034
930 activity 1 0.2697
930 agent 1 0.4416
930 animal 1 0.4611
930 blood 1 0.2329
930 contralateral 1 0.5596
930 decreased 1 0.3403
930 degree 1 0.3339
930 depletion 1 0.4943
930 direct 1 0.3546
930 failure 1 0.4066
930 formation 1 0.3381
930 glomerulosa 1 0.6346
930 hypertension 1 0.4764
930 hypertensive 3 1.8103
930 increased 1 0.2343
930 index, 1 0.7536
930 indicates 1 0.4943
930 influence 1 0.3449
930 intake, 1 0.6034
930 juxtaglomerular 1 0.6346
930 kidney. 1 0.4685
930 likely 1 0.4416
930 loss 1 0.3653
930 maintained 1 0.4202
930 militates 1 0.7536
930 nephrectomized 3 1.629
930 normal 2 0.4053
930 pressor 1 0.6034
930 pressure 1 0.3449
930 quantitative 1 0.3985
930 rather 1 0.3546
930 rats 2 0.5821
930 rats. 1 0.3946
930 receiving 1 0.4155
930 relationship 1 0.3625
930 renal 2 0.5847
930 renin 2 1.357
930 renin-angiotensin-aldosterone 1 0.7536
930 renin-stimulating 1 0.7536
930 result 1 0.326
930 saline. 1 0.7536
930 secretion 1 0.4416
930 sodium 4 1.45
930 state 1 0.3874
930 subjected 1 0.411
930 system. 1 0.5286
930 unclipped 1 0.7536
930 unilaterally 3 2.0354
930 width 1 0.6034
930 zona 1 0.6034
931 (hypertension, 1 1.0048
931 administration 1 0.4425
931 adrenals) 1 1.0048
931 all, 1 0.7724
931 artery. 1 0.7462
931 changes 1 0.3007
931 constriction 1 0.8461
931 disease 1 0.361
931 disease, 1 0.5366
931 evidence 1 0.3684
931 found 1 0.2645
931 glomerulosa 1 0.8461
931 homologous 1 0.6879
931 hypertension. 1 0.8461
931 hypertensive 1 0.8046
931 hypertrophy 1 0.5313
931 major 1 0.4833
931 most, 1 1.0048
931 partial 1 0.5603
931 pathogenesis 1 0.5669
931 plays 1 0.7724
931 pressor 1 0.8046
931 produced 1 0.4092
931 rat 1 0.4135
931 rats 1 0.388
931 renal 3 1.1695
931 renin 1 0.9046
931 renin. 1 1.0048
931 reproduced 1 0.8046
931 role 1 0.4661
931 system 1 0.4694
931 taken 1 0.5669
931 uninephrectomized 1 1.0048
931 vascular 2 1.108
931 zona 1 0.8046
932 (rch) 1 0.6029
932 10 3 0.6658
932 10. 1 0.5428
932 2 2 0.3682
932 2, 1 0.4127
932 48 1 0.3401
932 5 1 0.2287
932 5, 1 0.4634
932 also 1 0.1687
932 animals. 1 0.3401
932 attained 1 0.4477
932 change 1 0.2797
932 comparable 1 0.3324
932 compared 1 0.2339
932 compensatory 2 0.6723
932 continued, 1 0.5428
932 continuing 1 0.5428
932 day 2 0.5987
932 days 2 0.479
932 days. 2 0.6802
932 effect 1 0.1841
932 effectiveness. 1 0.5428
932 effects 1 0.2238
932 enlargement 1 0.4127
932 existence 1 0.3689
932 experiment 1 0.4037
932 factor 1 0.2857
932 first 1 0.221
932 full 1 0.4037
932 group 3 0.6686
932 groups, 1 0.4037
932 growth 1 0.2055
932 hormone 2 0.4911
932 however, 1 0.2183
932 hrs. 1 0.6029
932 hypertrophy 2 0.6376
932 hypophysectomized 2 0.7909
932 hypophysectomy 2 0.8688
932 imply 1 0.4229
932 initial 3 0.8767
932 instead 1 0.4827
932 intact 1 0.3324
932 kidney 1 0.2671
932 latter 1 0.3127
932 less 1 0.2257
932 much 1 0.2671
932 nephrectomized 2 0.8688
932 non-hypophysectomized 2 1.2058
932 observed 1 0.2055
932 pituitary 1 0.3127
932 pituitary, 1 0.6029
932 produced 1 0.2455
932 rapid 1 0.2922
932 rate, 1 0.4229
932 rats 2 0.4656
932 rats. 1 0.3157
932 rch 5 3.0145
932 receiving 3 0.9972
932 regression 1 0.388
932 renal 3 0.7017
932 renotropic 1 0.6029
932 replacement 3 1.1434
932 reported 1 0.2443
932 requires 1 0.3689
932 results 1 0.1727
932 seen 1 0.2549
932 size 1 0.3157
932 slower 1 0.4344
932 studies 1 0.1846
932 subsequent 1 0.3288
932 therapy 3 0.715
932 unilaterally 2 1.0856
932 without 1 0.2277
933 11 1 0.23
933 19 1 0.2883
933 2 2 0.263
933 6 1 0.1801
933 absence 1 0.2056
933 age 1 0.1781
933 aneurysms 3 0.9593
933 aneurysms, 1 0.4306
933 aneurysms. 1 0.3877
933 appear 1 0.1971
933 arteries 3 0.9931
933 arteries. 1 0.3877
933 artery 1 0.2459
933 carotid 2 0.5649
933 celiac 1 0.3877
933 cerebral 1 0.2041
933 clinical, 1 0.2771
933 common 1 0.2104
933 demonstrable 1 0.2883
933 described. 1 0.2156
933 developed 1 0.1958
933 etiologic 1 0.3103
933 extracranial 1 0.4306
933 extrarenal 2 0.8613
933 fibromuscular 7 3.0145
933 frequency 1 0.2255
933 hemorrhage 1 0.2771
933 histologic 1 0.2883
933 hyperplasia 4 0.9718
933 hyperplasia, 2 0.7754
933 hyperplasia. 1 0.3448
933 incidence 1 0.2056
933 internal 1 0.2429
933 intracranial 4 1.1299
933 involvement 1 0.2825
933 ischemia. 2 0.8613
933 lesions 1 0.1852
933 nine 1 0.2948
933 observed 1 0.1468
933 ones 1 0.3021
933 origin. 1 0.2883
933 others 1 0.2348
933 pathologic 1 0.2635
933 patients 6 0.6211
933 patients, 1 0.2156
933 present 1 0.1418
933 radiologic, 1 0.4306
933 renal 2 0.3341
933 resembled 1 0.3103
933 sex 1 0.2883
933 similar 1 0.1612
933 similarities 1 0.3198
933 studies 1 0.1319
933 suggest 1 0.1958
933 symptoms 2 0.4082
933 types 1 0.2087
933 visceral 1 0.3198
934 (renal 1 0.6029
934 among 1 0.2816
934 amount, 1 0.5428
934 anatomically 1 0.5076
934 best 1 0.3188
934 children 1 0.2141
934 clinical 1 0.1965
934 consequences. 1 0.5428
934 dehydration 1 0.5428
934 developmentally 1 0.6029
934 diminished 1 0.4037
934 dysplasia 1 0.6029
934 examination 1 0.3044
934 excessive 1 0.388
934 exist 1 0.4127
934 finding 1 0.3689
934 formed 1 0.3362
934 forms 1 0.2878
934 forms. 1 0.5076
934 hypoplasia 2 0.9655
934 hypoplasia). 1 0.6029
934 hypoplasia. 1 0.6029
934 insufficiency 1 0.3581
934 kidneys 2 0.6723
934 known 1 0.2945
934 maldeveloped. 1 0.6029
934 may 3 0.4523
934 merely 1 0.4477
934 nature 1 0.2993
934 normally 1 0.3811
934 parenchyma 2 0.8688
934 perhaps 1 0.3324
934 postmortem 1 0.4634
934 prompted 1 0.5076
934 renal 5 1.1695
934 result 1 0.2608
934 several 1 0.2608
934 severe 1 0.2671
934 significance 1 0.3288
934 small 2 0.4837
934 speculations 1 0.6029
934 suffered 1 0.4127
934 take 1 0.4127
934 thought 1 0.3401
934 tubular 1 0.4037
934 unexplained 1 0.5428
935 12- 1 1.5073
935 13-fold 1 1.5073
935 5- 1 1.5073
935 6-fold 1 1.5073
935 agreement 1 1.0318
935 autoradiographic 1 0.9887
935 autoradiography. 1 1.357
935 base 1 1.0572
935 cells 2 0.9098
935 compensatory 1 0.8404
935 control 2 1.1335
935 cortex 1 0.831
935 earlier 1 1.1192
935 establish 1 1.2691
935 findings 1 0.5987
935 future 1 1.086
935 hyperplasia 2 1.7006
935 increase 2 1.0239
935 induced 1 0.6408
935 infrequent 1 1.357
935 investigations 1 0.9369
935 investigations, 1 1.5073
935 kidneys 1 0.8404
935 kidneys. 1 1.1192
935 labelled 2 2.1719
935 line 1 0.9083
935 made 1 0.5459
935 medulla 1 1.086
935 methods 1 0.6807
935 mitotic 1 0.97
935 nephrectomy 1 0.9083
935 numbers 1 0.8954
935 observation. 1 1.5073
935 observations 1 0.6337
935 obtained 1 0.5373
935 remaining 1 0.7678
935 renal 2 1.1695
935 routine 1 1.086
935 seen 1 0.6372
935 staining 1 1.0091
935 studied 1 0.5251
935 study 1 0.4643
935 thymidine. 1 1.2069
935 tissues 1 0.6897
935 tissues. 1 0.9887
935 tritiated 1 1.0091
935 tubular 2 2.0183
935 unilateral 1 0.8133
935 using 2 1.3703
936 assessment 1 0.5046
936 changes 2 0.451
936 compensatory 2 0.8404
936 correlated 1 0.4477
936 discussed. 1 0.3222
936 emphasised. 1 0.7536
936 factors 1 0.3186
936 filtration 1 0.5046
936 flow. 1 0.5793
936 function 1 0.3381
936 functional 1 0.4764
936 glomerular 1 0.4764
936 hypertrophy 2 0.797
936 importance 1 0.3839
936 influencing 1 0.5596
936 kidney. 1 0.4685
936 measured 1 0.3299
936 plasma 1 0.3038
936 prognostic 1 0.5596
936 radiographic 1 0.5793
936 rate 1 0.2774
936 renal 4 1.1695
936 significance 1 0.411
936 size 1 0.3946
936 structural 1 0.485
937 11 1 0.5366
937 19 1 0.6728
937 69 1 0.8046
937 7 1 0.4629
937 73 1 0.8461
937 8 1 0.4538
937 affected 1 0.5212
937 ages 1 0.724
937 autosomal 1 0.724
937 basic 1 0.6879
937 bilateral 2 1.2111
937 birth 1 0.5119
937 boar. 1 1.0048
937 born 1 0.6728
937 characterized 1 0.5313
937 collecting 1 0.8046
937 compared 1 0.3898
937 concluded 1 0.4598
937 condition 1 0.5366
937 days. 1 0.5669
937 defect 2 0.9897
937 degrees 1 0.6352
937 described 1 0.3811
937 description. 1 0.9046
937 development 2 0.7337
937 died 2 1.1776
937 dominant 1 0.6879
937 evidence. 1 1.0048
937 factor 1 0.4762
937 failure 1 0.5422
937 feature 1 0.7048
937 fetal 1 0.5738
937 grossly 1 0.7048
937 hypoplasia 3 2.4137
937 inheritance 1 1.0048
937 large 1 0.3972
937 litters, 1 1.0048
937 lobulation. 1 1.0048
937 mesenchyme. 1 1.0048
937 mesonephric 1 1.0048
937 microscopically, 1 1.0048
937 observed 1 0.3425
937 one 1 0.2811
937 persistence 1 0.8461
937 pig 1 0.8046
937 pig. 1 0.9046
937 piglets 2 2.0097
937 poor 1 0.5811
937 previous 1 0.5422
937 recessive 1 0.8046
937 renal 2 0.7797
937 simple 1 0.548
937 sired 1 1.0048
937 soon 1 0.7462
937 suggested 1 0.4179
937 system. 1 0.7048
937 total 1 0.3916
937 tubule 1 0.724
937 twelve 1 0.6352
937 varying 1 0.5422
937 white 1 0.6246
938 (= 1 0.5024
938 19-nortestosterone 1 0.5024
938 96 2 0.8046
938 absolute 1 0.3524
938 animals 1 0.2136
938 animals. 2 0.5669
938 approximately 2 0.5262
938 castrated 5 2.2616
938 caused 2 0.4398
938 cell 2 0.3401
938 cells 1 0.1516
938 change 1 0.2331
938 change. 1 0.423
938 compensatory 6 1.6808
938 concentration 6 1.2674
938 decrease. 1 0.5024
938 decreased 1 0.2269
938 difference 1 0.2515
938 dna 2 0.4797
938 dry 1 0.3731
938 early 1 0.1842
938 effect 1 0.1534
938 following 2 0.3331
938 forty-eight 1 0.4523
938 g. 2 0.7462
938 groups 2 0.4092
938 higher 1 0.216
938 hr. 3 0.8716
938 hypertrophy 4 1.0626
938 hypertrophy, 1 0.362
938 hypertrophy. 1 0.3731
938 increase 2 0.3413
938 increased 1 0.1562
938 increased. 1 0.3364
938 initial 1 0.2435
938 kidney 4 0.8904
938 male 2 0.5119
938 mice 4 0.9897
938 mice. 2 0.6352
938 nephrectomy, 1 0.3731
938 nephrectomy. 1 0.3176
938 non-castrated 5 2.5121
938 non-stimulated 2 1.0048
938 nortestosterone 1 0.5024
938 npp 3 1.5073
938 npp) 1 0.5024
938 number 1 0.1923
938 operation 2 0.5262
938 operation. 1 0.3296
938 per 4 0.7833
938 percentual 2 1.0048
938 period 2 0.3811
938 phenylpropionate 2 1.0048
938 relative 1 0.2606
938 remaining 3 0.7678
938 resulting 1 0.2559
938 rna 3 0.831
938 significant. 1 0.3524
938 significantly 1 0.2112
938 significantly. 1 0.3862
938 statistically 1 0.3123
938 still 1 0.2347
938 stimulated 1 0.3364
938 stimulation 1 0.2834
938 time 1 0.177
938 tissue 2 0.3488
938 treatment 1 0.1482
938 unilateral 2 0.5422
938 values 2 0.5074
938 weight 2 0.4727
938 well 1 0.1757
939 activity 1 0.5394
939 autoradiographic 1 0.9887
939 cellular 1 0.8219
939 compensatory 2 1.6808
939 dna 1 0.7196
939 gland 1 1.2069
939 hypertrophy. 2 2.2385
939 increased 1 0.4686
939 pituitary 2 1.5637
939 proliferation 1 0.8716
939 renal 2 1.1695
939 showed 1 0.5373
939 studies 1 0.4616
939 synthesis 1 0.7483
939 thymidine 1 1.0572
939 thyroid 2 1.7663
939 tritiated 1 1.0091
940 administration 1 0.4425
940 animals 2 0.8544
940 animals. 1 0.5669
940 capacity 1 0.548
940 compensatory 3 1.6808
940 control 1 0.3778
940 course 2 0.9135
940 extent 1 0.5313
940 filtration 1 0.6728
940 flow 1 0.5119
940 function 1 0.4509
940 glomerular 1 0.6352
940 hormone 1 0.4092
940 hormone. 1 0.5888
940 hypertrophy 1 0.5313
940 hypertrophy, 1 0.724
940 hypertrophy. 1 0.7462
940 increased 3 0.9371
940 influence 1 0.4598
940 insignificantly 1 1.0048
940 kidney, 1 0.6591
940 less 1 0.3762
940 markedly 1 0.5366
940 plasma 1 0.4051
940 renal 3 1.1695
940 secretory 1 0.7048
940 thyroid 2 1.1776
940 thyroidectomized 2 2.0097
940 tubules 1 0.7462
941 % 1 0.6029
941 0.0062% 1 0.6029
941 0.056% 1 0.6029
941 0.088%, 1 0.6029
941 0.11%. 1 0.6029
941 0.30% 1 0.6029
941 0.59%, 1 0.6029
941 1.2% 1 0.6029
941 3.6% 1 0.6029
941 36 2 0.8457
941 57 1 0.4827
941 activity 1 0.2158
941 adult 4 1.0962
941 adults, 1 0.5076
941 age. 1 0.3401
941 although 1 0.2318
941 among 1 0.2816
941 animals 2 0.5126
941 animals, 4 1.4533
941 autoradiography 1 0.4634
941 base 1 0.4229
941 cell 1 0.204
941 cells 5 0.9098
941 cells; 1 0.4827
941 control 2 0.4534
941 cortex 1 0.3324
941 cortical 1 0.388
941 counts 1 0.4229
941 dna 1 0.2878
941 effect 1 0.1841
941 findings 1 0.2395
941 group 1 0.2229
941 groups 1 0.2455
941 hr 1 0.3487
941 hr. 2 0.6973
941 increase 1 0.2048
941 index 1 0.3581
941 indicate 1 0.2655
941 indices 1 0.4229
941 kidney 2 0.5343
941 labeled 1 0.3633
941 labeling 1 0.3955
941 later 1 0.3099
941 line 1 0.3633
941 lower 1 0.2741
941 maximum 2 0.6648
941 measured 1 0.2639
941 mitosis 1 0.4634
941 mitotic 1 0.388
941 much 1 0.2671
941 nephrectomy 3 1.09
941 nephrectomy. 2 0.7622
941 number 1 0.2307
941 obtained 1 0.2149
941 occurred 1 0.2623
941 occurring 1 0.3487
941 one 1 0.1687
941 peak 2 0.6973
941 proliferation 1 0.3487
941 proliferative 1 0.4344
941 qualitatively, 1 0.5428
941 rat 1 0.2481
941 rats. 1 0.3157
941 reaching 1 0.4344
941 related 1 0.2549
941 relative 1 0.3127
941 resp., 1 0.6029
941 response 1 0.2201
941 response, 1 0.4477
941 resulted 1 0.2922
941 revealed 1 0.2922
941 separate 1 0.3811
941 showed 1 0.2149
941 similar 1 0.2257
941 stromal 3 1.6283
941 synthesis 1 0.2993
941 that, 1 0.3955
941 thymidine 1 0.4229
941 tritiated 1 0.4037
941 tubule 2 0.8688
941 undergoing 1 0.3811
941 unilateral 4 1.3012
941 unoperated 1 0.5428
941 value 1 0.2778
941 weanling 4 1.8538
942 2.5 1 0.4477
942 4 1 0.2133
942 5 1 0.2287
942 adrenal 4 1.4326
942 adrenalectomized 1 0.4827
942 adrenalectomy 2 0.8457
942 alone 1 0.3633
942 also, 1 0.4344
942 animals, 1 0.3633
942 caused 1 0.2639
942 compensating 2 1.0153
942 controlling 1 0.5076
942 cortex 5 1.6619
942 days 2 0.479
942 decreased 1 0.2723
942 dna 2 0.5757
942 drinking 1 0.4344
942 exhibited 1 0.3689
942 factors 1 0.2549
942 fluid 1 0.2857
942 following 1 0.1998
942 given 1 0.221
942 glands 2 0.776
942 glands, 2 1.0153
942 hyper-plastic 1 0.6029
942 hyperplastic 1 0.4634
942 increased 3 0.5623
942 increases 1 0.2816
942 index 1 0.3581
942 indices 1 0.4229
942 influence 1 0.2759
942 intact 3 0.9972
942 kidney 2 0.5343
942 kidney, 1 0.3955
942 kidney. 1 0.3748
942 kidneys 1 0.3362
942 kidneys. 1 0.4477
942 labeled 1 0.3633
942 labeling 3 1.1864
942 marked 1 0.2705
942 medulla 3 1.3032
942 medulla, 1 0.5076
942 medulla. 1 0.5428
942 moderately 1 0.4344
942 neither 1 0.3955
942 nephrectomy 3 1.09
942 normal 2 0.3242
942 nuclei 1 0.3811
942 number 1 0.2307
942 otherwise 1 0.4477
942 radioautography. 1 0.6029
942 rats 3 0.6985
942 rats. 1 0.3157
942 remaining 4 1.2285
942 renal 1 0.2339
942 respectively. 1 0.4127
942 response 1 0.2201
942 response. 1 0.4229
942 role 1 0.2797
942 saline 1 0.4477
942 significantly 1 0.2535
942 slight 1 0.3581
942 still 1 0.2816
942 studied 1 0.2101
942 synthesis 2 0.5987
942 tritiated-thymidine 1 0.6029
942 two 1 0.1846
942 unilateral 3 0.9759
942 using 1 0.2741
943 (3hr. 1 0.5024
943 (factor 2 1.0048
943 1.3 1 0.4023
943 1.3) 2 1.0048
943 1.6. 1 0.5024
943 2 1 0.1534
943 2.1 1 0.5024
943 2nd 2 0.724
943 4th 2 0.7462
943 6 1 0.2101
943 7 1 0.2315
943 activity, 1 0.362
943 adaptation 1 0.3862
943 also 2 0.2811
943 amino-acid 2 0.8461
943 amino-acids 1 0.4523
943 amounts 1 0.2494
943 approximately 1 0.2631
943 auto-radiographic 1 0.5024
943 beginning 1 0.3176
943 cells 2 0.3033
943 coinciding 1 0.4523
943 collecting 1 0.4023
943 compensatory 1 0.2801
943 complete, 1 0.5024
943 convoluted 1 0.423
943 course 1 0.2284
943 cytoplasm, 1 0.4023
943 day, 2 0.7724
943 determined 1 0.2284
943 different 1 0.1777
943 enhanced 3 0.9369
943 epithelia 1 0.5024
943 equally 1 0.362
943 exerted 1 0.4523
943 factor 1 0.2381
943 following 1 0.1665
943 found, 1 0.3524
943 h-labelled 1 0.5024
943 hr., 1 0.3862
943 hypertrophic 1 0.423
943 incorporation 1 0.3176
943 increase 4 0.6826
943 increased 3 0.4686
943 index 1 0.2985
943 index. 2 1.0048
943 intervals 1 0.3123
943 involved. 1 0.3862
943 kidney 4 0.8904
943 kidney, 1 0.3296
943 kidneys. 1 0.3731
943 l-phenylalanine, 1 0.5024
943 limited 1 0.274
943 maximum 3 0.831
943 mean 1 0.2417
943 metabolism 6 1.4285
943 mitotic 3 0.97
943 multiplication 1 0.3731
943 nephrectomized 1 0.362
943 nephrectomy, 1 0.3731
943 normal 1 0.1351
943 nucleus 1 0.3862
943 number 1 0.1923
943 one 2 0.2811
943 per 1 0.1958
943 phase 2 0.5366
943 phases 1 0.4523
943 process 1 0.2299
943 protein 6 1.3703
943 rat. 1 0.3862
943 rats 1 0.194
943 residual 1 0.3731
943 result 1 0.2173
943 single 1 0.2494
943 studied 1 0.175
943 studies 1 0.1539
943 study 1 0.1548
943 subjected 1 0.274
943 time 1 0.177
943 times, 1 0.3862
943 times. 1 0.4523
943 total 1 0.1958
943 tubules 1 0.3731
943 tubules, 1 0.5024
943 tubules. 1 0.3862
943 two 1 0.1539
943 unilateral 1 0.2711
943 unit 1 0.3524
943 uptake 1 0.3296
943 uptake, 2 0.8046
943 variations 1 0.3123
943 volume 2 0.5119
943 wk.). 1 0.5024
944 1 1 0.5692
944 13-year-old 1 1.5073
944 5-year-old 1 1.357
944 age 1 0.6235
944 boy, 1 1.2691
944 brothers 1 1.357
944 caused 1 0.6597
944 concentrating 1 1.5073
944 considered 1 0.672
944 diabetes 2 1.4845
944 factor. 1 1.1586
944 heredity 1 1.5073
944 hyperchloremia, 1 1.5073
944 insipidus 1 0.805
944 insipidus. 1 0.97
944 kidney 1 0.6678
944 lowering 1 1.086
944 mental 1 0.8503
944 nephrogenic 2 2.0636
944 observed. 1 0.9083
944 patients 1 0.3623
944 patients, 1 0.7546
944 physical 1 0.8716
944 pitressin. 1 1.5073
944 polydypsia 1 1.5073
944 polyuria 1 1.1586
944 power 1 1.1586
944 recessive 1 1.2069
944 resistant 1 0.9221
944 retardation, 1 1.2069
944 since 1 0.6558
944 suffered 1 1.0318
944 suffering 1 0.8954
944 two 1 0.4616
944 yr. 1 0.7893
945 3 1 0.1468
945 5-month-old 1 0.4306
945 accentuated 1 0.3626
945 also 1 0.1205
945 altered 1 0.23
945 boy 1 0.2883
945 changing 1 0.3198
945 chlorthalidone 2 0.8613
945 concentration 1 0.1811
945 content 3 0.6078
945 content. 1 0.3877
945 contraregulation 1 0.4306
945 days. 1 0.2429
945 decrease 1 0.1971
945 decreased 2 0.389
945 description 1 0.2825
945 diabetes 3 0.6362
945 different 1 0.1523
945 dose 1 0.2056
945 ducts 1 0.3103
945 effect 1 0.1315
945 exchanged 1 0.4306
945 familial 1 0.2825
945 filtrate 1 0.3448
945 fursemide 2 0.8613
945 given 1 0.1579
945 glands 1 0.2771
945 go 1 0.3877
945 high 1 0.1541
945 high. 1 0.3626
945 ho 2 0.8613
945 however, 1 0.156
945 hypotonic. 1 0.4306
945 increase 1 0.1463
945 increased 3 0.4016
945 increased. 1 0.2883
945 insipidus 1 0.23
945 insipidus, 1 0.3448
945 insipidus. 1 0.2771
945 intermittently 1 0.3877
945 intervals 1 0.2677
945 intervals, 1 0.4306
945 isotonic 1 0.3448
945 k. 1 0.3626
945 mechanism 1 0.1984
945 mother 1 0.2459
945 na 1 0.2722
945 na-concentration 1 0.4306
945 nacl 6 1.9187
945 nacl. 1 0.4306
945 osmolarity, 1 0.4306
945 parallel, 1 0.4306
945 produced 1 0.1754
945 quantity 4 1.2791
945 reabsorbed 1 0.3877
945 reabsorption 1 0.2883
945 regulation 1 0.3198
945 renal 1 0.1671
945 saluretics. 1 0.4306
945 serum 1 0.1671
945 short 1 0.249
945 single 1 0.2138
945 studies 1 0.1319
945 suffering 1 0.2558
945 sweat 7 3.0145
945 sweat. 1 0.4306
945 sweat; 1 0.4306
945 therefore 2 0.5269
945 time 1 0.1517
945 time, 1 0.249
945 treatment 1 0.1271
945 urea 2 0.6041
945 values 1 0.2175
945 well 1 0.1506
945 without 1 0.1626
946 14 1 0.554
946 2.5-year-old 1 1.0048
946 5 1 0.3811
946 6-month 1 1.0048
946 7.5 1 1.0048
946 8-hourly, 1 1.0048
946 achieved 1 0.6879
946 alternate 1 0.8461
946 associated 1 0.3568
946 case 1 0.361
946 child. 1 0.6728
946 control 1 0.3778
946 controlled 2 1.1476
946 days. 1 0.5669
946 diabetes 3 1.4845
946 dose 2 0.9594
946 eosinophilic 1 0.8046
946 given 1 0.3684
946 granuloma 1 0.9046
946 i.m. 2 1.6922
946 insipidus 2 1.0733
946 lysine 2 1.6922
946 nasal 1 0.7048
946 oil, 1 1.0048
946 output 1 0.5888
946 partial 1 0.5603
946 period 1 0.3811
946 pitressin 1 0.8461
946 preparation 1 0.6466
946 route, 1 1.0048
946 symptoms 1 0.4762
946 synthetic 2 1.4923
946 t.d.s. 1 1.0048
946 tannate 1 0.9046
946 therefore 1 0.6148
946 tolerated. 1 1.0048
946 treated 1 0.4135
946 u. 3 2.3172
946 urine 1 0.5165
946 vasopressin 1 0.6879
946 vasopressin. 1 0.8046
946 well 1 0.3514
947 - 2 1.1776
947 action 2 0.8744
947 actions 1 0.6466
947 antidiuretic 3 1.9773
947 ascending 1 0.7724
947 become 1 0.554
947 brings 1 0.9046
947 clearance 1 0.6466
947 clearance. 1 0.9046
947 concentration 1 0.4225
947 delayed 1 0.5888
947 determined. 1 0.6879
947 diabetes 2 0.9897
947 different 1 0.3554
947 effect 1 0.3068
947 eliminated 1 0.7048
947 freewater 1 1.0048
947 henle's 1 0.9046
947 hormone 2 0.8185
947 increase 2 0.6826
947 induced 1 0.4272
947 insipidus, 1 0.8046
947 insipidus. 1 0.6466
947 limb 1 0.724
947 loop. 1 1.0048
947 maximum 1 0.554
947 na 1 0.6352
947 nephron 1 0.8461
947 operative 1 0.5603
947 physiological 1 0.5888
947 places 1 1.0048
947 produce 1 0.5366
947 prompt 1 0.7462
947 reabsorption 1 0.6728
947 renal 2 0.7797
947 separately 1 1.0048
947 sodium 2 0.9667
947 sodium-active 1 1.0048
947 steps 1 0.7462
947 stimulation 1 0.5669
947 suggested 1 0.4179
947 supposed 1 0.8046
947 synergistically 1 0.9046
947 transport 1 0.6056
947 two 1 0.3077
947 urinary 1 0.4452
947 urine. 1 0.7724
947 vasopressin 3 2.0636
947 volume, 1 0.6879
947 water-retaining 1 1.0048
947 well 1 0.3514
948 1-year 1 1.0048
948 anatomic 1 0.6728
948 associated 2 0.7136
948 case 1 0.361
948 changes 2 0.6013
948 control 1 0.3778
948 correction 1 0.7048
948 demonstrated. 1 0.724
948 described. 1 0.5031
948 diabetes 2 0.9897
948 diabetes. 1 0.9046
948 dilatation. 1 0.9046
948 followup 1 1.0048
948 insipidus 2 1.0733
948 lower 1 0.4568
948 obstruction 1 0.6352
948 obstructive 1 0.6728
948 patient 1 0.3778
948 period 1 0.3811
948 pituitary 2 1.0425
948 progressive 1 0.5603
948 reversal 1 0.8461
948 surgical 1 0.4538
948 tract 3 1.7433
948 treated 1 0.4135
948 urinary 2 0.8904
948 well 1 0.3514
949 (a 1 0.6034
949 (val-5-hypertensinii-asp- 1 0.7536
949 -amide) 1 0.7536
949 2 1 0.2301
949 4 1 0.2666
949 9 1 0.3946
949 angiotensin 4 3.0145
949 angiotensin. 1 0.7536
949 antidiuresis 2 1.1586
949 antidiuretic 1 0.4943
949 antinatriuresis 1 0.7536
949 become 1 0.4155
949 boy 1 0.5046
949 changed 1 0.5159
949 children 1 0.2676
949 clearance 2 0.97
949 clearances 2 1.357
949 combined 1 0.3874
949 contrary 1 0.5286
949 decrease 1 0.3449
949 diabetes 4 1.4845
949 effect 2 0.4602
949 effects 2 0.5595
949 examined. 1 0.5159
949 filtration 1 0.5046
949 free-water 2 1.5073
949 furosemide 1 0.7536
949 girl 1 0.5046
949 glomerular 1 0.4764
949 gross 1 0.5046
949 increased 1 0.2343
949 insipidus 3 1.2074
949 insipidus. 1 0.485
949 inulin, 1 0.7536
949 long 1 0.3909
949 na 1 0.4764
949 na-clearance. 1 0.7536
949 negative, 1 0.6785
949 neuro-hormonalis 1 0.7536
949 normal. 1 0.4542
949 old 2 0.8503
949 osmolality 1 0.5793
949 osmolar 1 0.7536
949 pah, 1 0.6785
949 produced 1 0.3069
949 produces 1 0.4764
949 prompt 1 0.5596
949 rate 1 0.2774
949 remains 1 0.3946
949 renalis) 1 0.7536
949 reverses 1 0.7536
949 salt-deprived 1 0.7536
949 salt-loaded 1 0.7536
949 seen 1 0.3186
949 slightly 1 0.4303
949 states. 1 0.6346
949 studied 1 0.2626
949 urea 2 1.0572
949 urine 1 0.3874
949 vasopressin. 1 0.6034
949 yr 2 1.1192
950 (1 2 1.357
950 (2 1 0.6034
950 - 1 0.4416
950 3 2 0.5138
950 4 2 0.5332
950 acidosis 1 0.5596
950 acquired 1 0.4685
950 addition 1 0.3839
950 approach 1 0.4685
950 aspect 1 0.5286
950 broad 1 0.6034
950 case 1 0.2708
950 case), 1 0.7536
950 case). 1 0.7536
950 case. 1 0.5793
950 cases 3 0.6727
950 cases), 1 0.7536
950 children 1 0.2676
950 children. 1 0.4303
950 chronic 1 0.3598
950 classified 1 0.4542
950 compulsive 1 0.7536
950 context 1 0.6346
950 defects 1 0.4155
950 diabetes 2 0.7423
950 diagnosed 1 0.4611
950 diagnostic 1 0.3742
950 drinking 1 0.543
950 due 2 0.5332
950 etiologico-clinical 1 0.7536
950 etiology. 1 0.5793
950 excretion 1 0.3546
950 exemplified 1 0.7536
950 failure 1 0.4066
950 first 1 0.2763
950 four 1 0.3381
950 fourth 1 0.5596
950 group 4 1.1143
950 groups. 1 0.4477
950 hand-schuller-christian-disease. 1 0.7536
950 histories, 1 0.7536
950 hypokalaemic 1 0.7536
950 idiopathic 1 0.5159
950 illustrative 1 0.7536
950 included 1 0.4066
950 insipidus 2 0.805
950 investigated 1 0.4303
950 investigations 1 0.4685
950 multiple 1 0.4155
950 nephrogenic 1 0.5159
950 nephropathy 1 0.6034
950 normal 1 0.2027
950 one 2 0.4217
950 physiopathology 1 0.7536
950 polyuria 2 1.1586
950 polyuric 1 0.7536
950 practical 1 0.485
950 present 1 0.2481
950 probable 1 0.4764
950 recommended. 1 0.6785
950 renal 3 0.8771
950 report 1 0.3653
950 second 1 0.3839
950 syndrome 1 0.3496
950 syndromes 1 0.5286
950 third 1 0.411
950 tubular 1 0.5046
950 twelve 1 0.4764
950 type 1 0.3134
950 urine 1 0.3874
950 variety 1 0.4066
950 water 1 0.3985
951 (if 1 1.0048
951 2 1 0.3068
951 8 1 0.4538
951 absence 1 0.4797
951 administration, 1 0.7724
951 allergic 1 0.7462
951 animal 1 0.6148
951 clinical 1 0.3275
951 controlled 2 1.1476
951 daily 1 0.548
951 diabetes 2 0.9897
951 ease 1 0.8461
951 effects 1 0.373
951 foreign 1 0.8046
951 freedom 1 0.8461
951 insipidus 1 0.5366
951 insipidus: 1 0.9046
951 judiciously) 1 1.0048
951 lysine 2 1.6922
951 nasal 3 2.1144
951 observed 1 0.3425
951 occasionally 1 0.6728
951 one 1 0.2811
951 origin. 1 0.6728
951 patient 1 0.3778
951 patients 2 0.4831
951 pituitary 1 0.5212
951 polyuria 1 0.7724
951 posterior 1 0.5888
951 potentially 1 0.7462
951 pregnant 1 0.6056
951 preparation 1 0.6466
951 preparations 1 0.6056
951 protein, 1 0.724
951 reactions 1 0.4909
951 recommended 1 0.6728
951 recurrence 1 0.7462
951 retention 1 0.6246
951 serious 1 0.6056
951 side 1 0.5669
951 significant 1 0.3527
951 solution 1 0.6148
951 solution. 1 0.9046
951 spray 1 0.7724
951 stimulation. 1 0.9046
951 synthetic 3 2.2385
951 term 1 0.5603
951 times 1 0.4833
951 treated 1 0.4135
951 treatment 1 0.2965
951 twenty 1 0.7462
951 undesirable 1 1.0048
951 use 1 0.3972
951 use. 1 0.8046
951 used 1 0.3795
951 uterine 1 0.9046
951 vasopressin 1 0.6879
951 vasopressin-deficient 1 1.0048
951 vasopressin. 1 0.8046
951 water 1 0.5313
951 well 1 0.3514
951 without 2 0.7589
952 125 1 0.5076
952 3 2 0.411
952 35 1 0.4634
952 5 1 0.2287
952 7.4 1 0.5076
952 administered 2 0.5757
952 adverse 1 0.4634
952 allergic 1 0.4477
952 bowel 1 0.4634
952 child 1 0.29
952 concentrate 1 0.4827
952 consisted 1 0.3581
952 conveniently 1 0.6029
952 daily 1 0.3288
952 day 1 0.2993
952 decrease 1 0.2759
952 diabetes 2 0.5938
952 dosage 1 0.3633
952 dose 1 0.2878
952 effective 1 0.3018
952 effectiveness 1 0.4229
952 effects 1 0.2238
952 effort 1 0.4477
952 frequency 1 0.3157
952 hydrated 1 0.6029
952 increased 2 0.3748
952 infection 1 0.2836
952 insipidus 1 0.322
952 insipidus. 1 0.388
952 irritation 1 0.6029
952 lysine 3 1.5229
952 material 1 0.2797
952 minor 1 0.388
952 movements 1 0.4477
952 nasal 5 2.1144
952 normal 1 0.1621
952 noted 1 0.3188
952 one 1 0.1687
952 patients 2 0.2898
952 per 1 0.235
952 periods 1 0.3362
952 preparation. 1 0.5076
952 ranging 1 0.4127
952 respiratory 1 0.3127
952 restrict 1 0.5428
952 rhinitis. 1 0.6029
952 s.c. 1 0.4827
952 satisfactorily 1 0.5428
952 spray 3 1.3903
952 spray, 1 0.6029
952 subjects, 1 0.4037
952 synthetic 2 0.8954
952 thirteen 1 0.4477
952 times 2 0.58
952 total 1 0.235
952 transient 1 0.4127
952 treated 1 0.2481
952 treatment 1 0.1779
952 u. 1 0.4634
952 upper 1 0.388
952 urine 1 0.3099
952 vasopressin 3 1.2382
952 volume. 1 0.4634
953 'spray 1 1.5073
953 2 1 0.4602
953 3 2 1.0275
953 8-lysine 2 3.0145
953 adequately 1 1.2069
953 administered 1 0.7196
953 alone 1 0.9083
953 control 1 0.5667
953 controlled 1 0.8607
953 day, 1 1.1586
953 diabetes 2 1.4845
953 every 1 0.8404
953 excellent 1 1.086
953 hr. 1 0.8716
953 insipidus 2 1.6099
953 nasal 2 2.1144
953 night. 1 1.5073
953 none 1 0.9083
953 oil. 1 1.357
953 one. 1 1.1586
953 patient 1 0.5667
953 patients 1 0.3623
953 pitressin 1 1.2691
953 required 1 0.8219
953 resulted 1 0.7306
953 spray 1 1.1586
953 spray. 1 1.5073
953 sprays 1 1.5073
953 supplemental 1 1.5073
953 synthetic 1 1.1192
953 tannate 1 1.357
953 therapy 1 0.5959
953 therapy' 1 1.5073
953 treatment 1 0.4447
953 value 1 0.6944
953 vasopressin 2 2.0636
954 2 1 0.1841
954 20% 1 0.4477
954 24 1 0.3127
954 60% 1 0.4827
954 accumulation 1 0.4229
954 aorta 1 0.4037
954 appears 1 0.2593
954 body 2 0.4861
954 cells 1 0.182
954 changes 1 0.1804
954 corresponding 1 0.3533
954 degree 3 0.8014
954 dependent 1 0.388
954 diabetes 2 0.5938
954 disease 2 0.4332
954 disease, 1 0.322
954 disease. 3 0.9564
954 distribution 2 0.6198
954 duration 1 0.3157
954 environment. 1 0.5076
954 equal 1 0.3955
954 estimated 1 0.3748
954 familial 1 0.3955
954 gain 1 0.4344
954 gastrocnemius 1 0.6029
954 handling. 1 0.6029
954 hereditary 3 1.3032
954 hr. 1 0.3487
954 hypothalamic 2 1.0153
954 increased 1 0.1874
954 induced 4 1.0252
954 insipidus 2 0.644
954 involved 1 0.3071
954 k, 1 0.5076
954 k. 1 0.5076
954 lesser 1 0.4127
954 loss 1 0.2922
954 measured 1 0.2639
954 metabolism 1 0.2857
954 muscle 1 0.3324
954 na 2 0.7622
954 na, 1 0.5428
954 noted 1 0.3188
954 partially 1 0.3748
954 rat. 2 0.9269
954 salt 3 1.164
954 severity 1 0.3689
954 similar 1 0.2257
954 skeletal 1 0.4127
954 spontaneous 1 0.3487
954 surgically 1 0.5428
954 terms 1 0.3689
954 turnover 1 0.4037
954 types 1 0.2922
954 water 5 1.5939
954 weight 2 0.5673
955 absent 1 0.9887
955 acetazolamide. 1 1.5073
955 action 1 0.6558
955 action, 1 1.1192
955 adh-like 1 1.5073
955 antidiuresis 1 1.1586
955 appearance. 1 1.2691
955 cause 1 0.6807
955 compounds, 1 1.5073
955 correlated 1 0.8954
955 cortisone. 1 1.5073
955 depends 1 1.2069
955 depletion 1 0.9887
955 depletion, 1 1.357
955 derivatives 1 1.1192
955 diabetes 2 1.4845
955 diminishes 1 1.2691
955 direct 1 0.7091
955 distal 1 1.0572
955 diuresis 1 1.2069
955 diuretics 2 2.5382
955 drug 1 0.7893
955 due 1 0.5332
955 effect 1 0.4602
955 excretion 1 0.7091
955 extent 1 0.797
955 fall 1 0.7893
955 filtration 1 1.0091
955 following 1 0.4996
955 free 1 0.7143
955 glomerular 1 0.9528
955 hypothalamus-pituitary 1 1.5073
955 importance 1 0.7678
955 increased 1 0.4686
955 induced 2 1.2816
955 insipidus 1 0.805
955 insipidus. 1 0.97
955 irregular 1 1.1192
955 less 2 1.1286
955 mainly 1 0.9887
955 maximal 1 0.9369
955 mercurial 1 1.5073
955 na 1 0.9528
955 natriuretic 1 1.5073
955 nephrogenic 1 1.0318
955 order 1 0.7893
955 permeability 1 1.2691
955 progressively 1 1.1192
955 proximal 1 1.0318
955 reabsorption 1 1.0091
955 reduced 1 0.6807
955 reduction 1 0.7423
955 regularly 1 1.086
955 salt 2 1.9399
955 saluretics 1 1.5073
955 spirolactones 1 1.5073
955 suppressed 1 1.0318
955 thiazide 1 1.1192
955 triamterene 1 1.5073
955 tubule 1 1.086
955 water 1 0.797
955 water. 1 1.1192
956 3 2 1.0275
956 atrophy. 1 1.2691
956 cases 1 0.4484
956 complete 1 0.6992
956 congenital 1 0.6897
956 conservative 1 1.2691
956 guide 1 1.357
956 histological 1 0.8954
956 hydronephrosis 1 1.2691
956 hydronephrosis. 1 1.357
956 justified. 1 1.357
956 leads 1 0.8404
956 less 1 0.5643
956 mm. 2 1.9773
956 parenchyma 2 2.1719
956 procedures 1 0.8503
956 reduced 1 0.6807
956 renal 2 1.1695
956 study 1 0.4643
956 surgical 1 0.6807
956 thickness 2 2.4137
956 treatment. 1 0.797
957 (brattleboro 1 0.6029
957 (di) 1 0.6029
957 1/100 1 0.6029
957 2 2 0.3682
957 3 2 0.411
957 activity 3 0.6473
957 activity, 1 0.4344
957 amount 1 0.2969
957 antidiuretic 5 1.9773
957 appear 1 0.2759
957 appeared 2 0.58
957 arginine 3 1.3903
957 assays 1 0.5428
957 contain 2 0.776
957 contained 1 0.3071
957 content 1 0.2836
957 could 1 0.2166
957 deficiency 1 0.3188
957 di 4 2.4116
957 diabetes 2 0.5938
957 diuresis 1 0.4827
957 due 2 0.4265
957 endogenous 1 0.4127
957 expected 1 0.3955
957 extracts 1 0.3689
957 familial 2 0.7909
957 female 1 0.3487
957 females. 1 0.5076
957 hypothalami 1 0.6029
957 hypothalamic 2 1.0153
957 hypothalamus 1 0.5428
957 inhibit 1 0.4127
957 insipidus 2 0.644
957 lower 1 0.2741
957 might 1 0.3157
957 minimal 1 0.3748
957 neurohypophysial 1 0.5428
957 normal 2 0.3242
957 oxytocic 2 1.0856
957 oxytocin 2 1.0856
957 oxytocin. 2 1.2058
957 performed 1 0.2759
957 pituitaries 3 1.6283
957 pituitary 3 0.9382
957 principles 1 0.4127
957 produced 1 0.2455
957 rat 2 0.4962
957 rats 4 0.9313
957 rats, 1 0.4127
957 rats. 1 0.3157
957 resembled 1 0.4344
957 responses 1 0.3362
957 showed 1 0.2149
957 since 1 0.2623
957 slightly 1 0.3443
957 specific 1 0.2372
957 strain). 1 0.6029
957 third 1 0.3288
957 thus, 1 0.4344
957 tissues 1 0.2759
957 vasopressin 1 0.4127
957 vasopressin. 5 2.4137
957 would 1 0.2993
958 (polydipsia, 1 1.5073
958 1957. 1 1.5073
958 2 1 0.4602
958 20 1 0.6807
958 3 1 0.5138
958 4 1 0.5332
958 5 1 0.5717
958 also 1 0.4217
958 anamnestic 1 1.5073
958 appeared 1 0.725
958 appears 1 0.6481
958 case 1 0.5415
958 cases 1 0.4484
958 cases. 1 0.7893
958 diabetes 2 1.4845
958 diagnosis. 1 1.0091
958 disease 2 1.0831
958 familial 1 0.9887
958 families 1 1.0572
958 family 2 1.8167
958 features 1 0.805
958 first 1 0.5526
958 frequent, 1 1.5073
958 german 1 1.5073
958 germany. 1 1.5073
958 given 1 0.5526
958 infants 1 0.7196
958 insipidus 1 0.805
958 insipidus. 1 0.97
958 known 1 0.7363
958 low 1 0.6597
958 nevertheless 1 1.2691
958 one 1 0.4217
958 only. 1 1.086
958 polyuria, 1 1.5073
958 renal 2 1.1695
958 report 2 1.4612
958 revealed 1 0.7306
958 sg 1 1.5073
958 studies 1 0.4616
958 urine). 1 1.5073
958 verified 1 1.5073
958 yr. 1 0.7893
959 (66.7%); 1 0.3349
959 1 1 0.1265
959 102 1 0.3349
959 14 1 0.1847
959 15.33% 1 0.3349
959 1943 1 0.3349
959 1957 1 0.3349
959 1961, 1 0.282
959 1962. 2 0.6699
959 20 2 0.3025
959 246 1 0.3015
959 27% 1 0.3015
959 3% 1 0.3015
959 3.8%, 1 0.3349
959 369 1 0.3349
959 394 1 0.3349
959 42.6%. 1 0.3349
959 50% 1 0.2019
959 6.1 1 0.3015
959 67.8%. 1 0.3349
959 advocated. 1 0.3015
959 age 1 0.1386
959 agreed 1 0.3349
959 analyzed 1 0.2293
959 analyzed. 1 0.2349
959 arrest 1 0.2413
959 atrium, 1 0.3349
959 average 2 0.3006
959 cardiac 1 0.1503
959 cause 1 0.1513
959 children 1 0.1189
959 children, 1 0.1963
959 combined 1 0.1722
959 compared 1 0.1299
959 consider 1 0.2349
959 csf 1 0.2243
959 development. 1 0.2293
959 deviation 1 0.2575
959 discrepancy 1 0.2682
959 disease 1 0.1203
959 diseases 1 0.1827
959 distinguished 1 0.2243
959 dynamic 2 0.5364
959 e.g. 1 0.282
959 evaluation 1 0.1807
959 evolution 1 0.2413
959 examined 2 0.3383
959 experience 1 0.1722
959 favorable 1 0.2293
959 findings 1 0.1331
959 first 3 0.3684
959 form 1 0.1457
959 found. 1 0.2155
959 great 1 0.1913
959 group 1 0.1238
959 helping 1 0.282
959 hydrocephalus 3 0.5165
959 hydrocephalus. 1 0.2243
959 infant 1 0.189
959 infants 9 1.4391
959 infants. 1 0.2293
959 introduction 2 0.4827
959 jugular 1 0.2487
959 late 1 0.199
959 laurence's 2 0.6699
959 life, 1 0.2243
959 macrocephaly 1 0.3349
959 manifests 1 0.3015
959 means 1 0.1484
959 mental 1 0.189
959 merits 1 0.3349
959 method 1 0.1331
959 month 1 0.2243
959 month. 1 0.282
959 mth. 1 0.199
959 must 1 0.1636
959 observed 1 0.1142
959 onset 1 0.1937
959 operated 5 1.0777
959 operating 1 0.2682
959 operation 3 0.5262
959 operation. 1 0.2197
959 opinion 1 0.2243
959 pathological 1 0.1807
959 patients 1 0.0805
959 present. 1 0.2243
959 procedure 1 0.1706
959 procedures 1 0.189
959 process 1 0.1533
959 proved. 1 0.3349
959 rate 1 0.1233
959 review. 1 0.3349
959 showed 1 0.1194
959 shown; 1 0.3349
959 since 1 0.1457
959 spite 1 0.2243
959 spontaneous 2 0.3874
959 suffered 1 0.2293
959 surgical 2 0.3025
959 survival 1 0.1611
959 survived 1 0.2197
959 surviving 1 0.2487
959 symptoms 1 0.1587
959 thirteen 1 0.2487
959 till 1 0.3349
959 time 3 0.3541
959 total 1 0.1305
959 treatment 3 0.2965
959 used 1 0.1265
959 vein 1 0.2487
959 years' 1 0.282
959 yr. 2 0.3508
960 /24 1 1.5073
960 70 1 1.1586
960 albumin 1 1.0572
960 allow 1 1.0572
960 arnold-chiari 1 1.5073
960 cerebrospinal 1 0.9083
960 csf 1 1.0091
960 described. 1 0.7546
960 detect 1 1.357
960 develop 1 0.9083
960 disappearance 1 0.9887
960 dynamics 1 1.2069
960 flow 1 0.7678
960 fluid 1 0.7143
960 hr. 1 0.8716
960 hydrocephalus 1 0.7747
960 infants 1 0.7196
960 lateral 1 1.0091
960 less 1 0.5643
960 malformation. 1 1.5073
960 may 1 0.377
960 measure 1 0.8716
960 method 1 0.5987
960 ml. 1 1.0091
960 myclomeningocele 1 1.5073
960 newborn 1 0.8219
960 patency 1 1.5073
960 patients. 1 0.725
960 progressive 1 0.8404
960 radio-iodinated 1 1.5073
960 rate 2 1.1097
960 removal 1 0.8404
960 repair 1 1.0091
960 requiring 1 1.086
960 safe 1 0.9887
960 selected 1 0.8832
960 serum 1 0.5847
960 shunt 1 1.0091
960 shunt, 1 1.2069
960 shunt. 1 1.1586
960 surgical 1 0.6807
960 system, 1 1.2691
960 test 1 0.6519
960 used 1 0.5692
960 using 1 0.6851
960 ventricles, 1 1.357
960 ventricular 1 0.6558
960 ventriculo-atrial 2 2.5382
960 volume 1 0.7678
961 (craniolacunia 1 0.7536
961 (meningocele 1 0.7536
961 5 1 0.2859
961 bacterial 1 0.4416
961 central 1 0.4066
961 clinical, 1 0.485
961 coexistent 2 1.357
961 complications. 1 0.6785
961 cranial 4 2.4137
961 craniofenestra 1 0.7536
961 craniolacunia 1 0.7536
961 defects 4 1.6619
961 defects. 1 0.6346
961 described. 1 0.3773
961 etiologic 2 1.086
961 etiology 1 0.4155
961 expired 1 0.7536
961 factors 2 0.6372
961 five 1 0.3985
961 hydrocephalus 1 0.3874
961 hydrocephalus, 1 0.5286
961 infants 2 0.7196
961 infants. 1 0.5159
961 malformations 1 0.485
961 meningocele), 1 0.7536
961 myelomeningocele) 1 0.7536
961 nervous 1 0.4611
961 reviewed. 1 0.5286
961 roentgenographic 1 0.6785
961 significance 2 0.8219
961 spinal 2 1.0318
961 system 1 0.352
961 varying 1 0.4066
962 33%. 1 0.7536
962 34 1 0.5286
962 38 1 0.5159
962 4 1 0.2666
962 5 2 0.5717
962 50% 1 0.4542
962 60%. 1 0.6785
962 appeared 2 0.725
962 b 1 0.5159
962 bacilli. 1 0.7536
962 caused 2 0.6597
962 central 1 0.4066
962 chloramphenicol 1 0.7536
962 chloramphenicol, 1 0.7536
962 cns 1 0.5286
962 cocci. 1 0.7536
962 combination 3 1.291
962 could 1 0.2708
962 demonstrated 1 0.3222
962 done. 1 0.7536
962 effective 2 0.7546
962 entry 1 0.5793
962 frequently 1 0.3805
962 given 1 0.2763
962 gram-negative 2 1.2691
962 gram-positive 2 1.357
962 hydrocephalus 1 0.3874
962 hydrocephalus, 1 0.5286
962 incidents 1 0.6346
962 induced 1 0.3204
962 infection 1 0.3546
962 infection. 1 0.4943
962 infections 4 1.9773
962 kanamycin, 2 1.5073
962 majority 1 0.485
962 methicillin, 1 0.7536
962 mortality 2 0.9083
962 myelomeningocele 1 0.6346
962 myelomeningocele, 1 0.7536
962 myelomeningocele. 1 0.6785
962 nearly 1 0.4611
962 nervous 1 0.4611
962 nonspecific 1 0.543
962 obvious 1 0.6785
962 occurred 2 0.6558
962 one 1 0.2108
962 oozing 1 0.6785
962 organism 1 0.5046
962 organisms 1 0.4611
962 patients 4 0.7246
962 patients. 1 0.3625
962 polymixin 1 0.7536
962 portal 1 0.6346
962 procedure 1 0.3839
962 prophylactic 2 1.357
962 received 1 0.4252
962 resulted 1 0.3653
962 resulting 1 0.3839
962 series 1 0.3546
962 shunt 1 0.5046
962 shunting 1 0.5159
962 situ. 1 0.6785
962 sodium 1 0.3625
962 staphylococcus 1 0.7536
962 summarized. 1 0.7536
962 survived. 2 1.2691
962 system 1 0.352
962 therapy 1 0.2979
962 therapy, 1 0.485
962 two-thirds 1 0.6346
962 vitro 2 0.7747
963 11 1 0.4025
963 13 2 0.8716
963 2 1 0.2301
963 26 1 0.4764
963 39 1 0.543
963 50 1 0.3598
963 6 1 0.3151
963 79 1 0.6785
963 80. 1 0.6785
963 adaptive 1 0.6034
963 bacterial 1 0.4416
963 based 2 0.7893
963 behavior, 1 0.6034
963 birthday, 1 0.7536
963 case 1 0.2708
963 classified 1 0.4542
963 comparison 1 0.3909
963 competitive 1 0.6785
963 competitive; 1 0.7536
963 comprehensively 1 0.7536
963 current 1 0.4685
963 data 1 0.3069
963 death 1 0.411
963 deaths. 1 0.7536
963 decompensated. 1 0.7536
963 development, 2 1.0091
963 development. 1 0.5159
963 developmental 3 1.5137
963 died, 1 0.6785
963 encouraging: 1 0.7536
963 evaluated 1 0.4358
963 fifty 1 0.543
963 first 2 0.5526
963 first. 1 0.6785
963 followed 1 0.3449
963 group 1 0.2786
963 hydrocephalus 1 0.3874
963 hydrocephalus. 1 0.5046
963 infants 1 0.3598
963 infection. 1 0.4943
963 irreversibly 1 0.6785
963 is, 1 0.5046
963 judged 1 0.543
963 language 1 0.4416
963 latest 1 0.6785
963 less 1 0.2821
963 longitudinal 1 0.6034
963 motor 1 0.5596
963 myelomeningocele 2 1.2691
963 noncompetitive 1 0.6785
963 noncompetitive, 1 0.7536
963 occurred 1 0.3279
963 older 1 0.4685
963 patients 4 0.7246
963 patients. 1 0.3625
963 personal-social 1 0.7536
963 poor 1 0.4358
963 previously 1 0.3625
963 prognosis 1 0.4155
963 progress 1 0.5286
963 quotient 3 1.8103
963 report 2 0.7306
963 results 1 0.2158
963 seem 1 0.411
963 seventeen 1 0.5793
963 show 1 0.326
963 specialists. 1 0.7536
963 study. 1 0.4943
963 surveyed 1 0.6346
963 survivors 1 0.543
963 survivors, 2 1.357
963 team 1 0.6346
963 thirteen 1 0.5596
963 thought 1 0.4252
963 tract 1 0.4358
963 treated 1 0.3101
963 twenty 1 0.5596
963 urinary 1 0.3339
963 whichever 1 0.7536
963 year 1 0.3909
963 yr. 1 0.3946
964 11 1 0.4025
964 appearances 1 0.6785
964 aqueduct 1 0.6034
964 associated 2 0.5352
964 author 1 0.4416
964 author's 1 0.6785
964 basis 1 0.3299
964 cases 2 0.4484
964 cases, 1 0.3946
964 cases. 1 0.3946
964 cavum 4 3.0145
964 cavum, 1 0.7536
964 cerebral 1 0.3571
964 changes 1 0.2255
964 clinical 3 0.737
964 combination 1 0.4303
964 communicating 3 2.0354
964 communication 1 0.4155
964 conditions 1 0.3426
964 considered. 1 0.6346
964 continues 1 0.5793
964 csf. 1 0.7536
964 csp 3 2.2609
964 direct 1 0.3546
964 discussed 1 0.3069
964 due 1 0.2666
964 established. 1 0.6346
964 etiological 1 0.5793
964 flow 1 0.3839
964 fluid 1 0.3571
964 foramina 1 0.6034
964 formed 1 0.4202
964 generally 1 0.4477
964 group, 1 0.485
964 headaches 1 0.7536
964 hydrocephalus. 2 1.0091
964 hypersecretory 1 0.7536
964 intermittent 1 0.6346
964 internal 1 0.4252
964 intracranial 1 0.4943
964 lead 1 0.485
964 malformation 1 0.5596
964 may 2 0.377
964 mild 1 0.4943
964 moderate 1 0.4477
964 monro 1 0.6785
964 must 1 0.3682
964 narrowed. 1 0.7536
964 non-communicating 2 1.5073
964 obstruction 1 0.4764
964 opinion 1 0.5046
964 pellucidi 2 1.5073
964 pneumoencephalographic 2 1.5073
964 possibility 1 0.4303
964 pressure 1 0.3449
964 problems 1 0.3909
964 rare 1 0.4477
964 reasons 1 0.5046
964 rejects 1 0.7536
964 representing 1 0.6034
964 resemble 1 0.5793
964 rest 1 0.543
964 result 1 0.326
964 septi 2 1.5073
964 significance. 2 1.5073
964 since 1 0.3279
964 special 1 0.3985
964 symmetrical 1 0.6785
964 system 1 0.352
964 variations 1 0.4685
964 ventricular 1 0.3279
964 view 1 0.4416
965 (1) 1 0.2922
965 (2) 1 0.2922
965 (3) 1 0.3188
965 (4) 1 0.3487
965 (fusion 1 0.6029
965 (intradural 1 0.6029
965 (neurofibromas, 1 0.6029
965 (with 1 0.4634
965 17 1 0.3581
965 2 1 0.1841
965 23 1 0.4037
965 absence 1 0.2878
965 additional 1 0.322
965 aged 1 0.3633
965 also 2 0.3373
965 anomalies 1 0.3955
965 arachnoid 1 0.4827
965 arch 1 0.5428
965 association 1 0.3253
965 bodies 4 1.4754
965 bodies. 1 0.5428
965 canal 1 0.6029
965 cases 2 0.3588
965 caused 1 0.2639
965 closure 1 0.4229
965 congenital 1 0.2759
965 controlled 1 0.3443
965 cord 1 0.4127
965 cysts 2 0.9655
965 cysts, 2 1.2058
965 defects, 1 0.4229
965 described 1 0.2287
965 dorsalis 1 0.6029
965 entities 1 0.6029
965 epiphysis 1 0.6029
965 excavation 1 0.6029
965 extensive 1 0.3401
965 extradural 1 0.6029
965 first 1 0.221
965 gliomas, 1 0.6029
965 hemangio-endotheliomas, 1 0.6029
965 hemangiomas, 1 0.6029
965 hydrocephalus 1 0.3099
965 hydrocephalus. 2 0.8073
965 hydromyelia, 1 0.6029
965 in: 1 0.6029
965 increased 1 0.1874
965 intraspinal 2 1.2058
965 junction 1 0.5076
965 juvenilis): 1 0.6029
965 kyphosis 1 0.6029
965 lipomas): 1 0.6029
965 long-standing 1 0.5076
965 lumbar 1 0.4634
965 many 1 0.2431
965 men 1 0.4634
965 meningiomas, 1 0.6029
965 meningocele). 1 0.6029
965 meningoceles): 1 0.6029
965 must 1 0.2945
965 myelodysplasia, 1 0.6029
965 near 1 0.3633
965 neoplasms 1 0.4477
965 neurofibromatosis 1 0.6029
965 noted. 1 0.4037
965 one 1 0.1687
965 partially 1 0.3748
965 patients 1 0.1449
965 pedicle, 1 0.6029
965 perineural 1 0.6029
965 posterior 2 0.7065
965 present 3 0.5955
965 presented 1 0.2339
965 pressure 1 0.2759
965 previous 1 0.3253
965 recorded. 1 0.4827
965 scalloping 4 2.4116
965 shorter 1 0.4634
965 single 1 0.2993
965 spinal 1 0.4127
965 spine 1 0.6029
965 supposed 1 0.4827
965 tarlov's 1 0.6029
965 thoracic 2 0.8688
965 time 2 0.4249
965 two 2 0.3693
965 uncontrolled 1 0.5428
965 vertebra 1 0.6029
965 vertebral 5 2.7139
965 widening 1 0.5076
965 without 1 0.2277
965 years, 2 0.7622
966 33 1 0.5793
966 50% 1 0.4542
966 abnormality 1 0.5286
966 acquired 2 0.9369
966 asymmetry 1 0.6034
966 cases 1 0.2242
966 children 1 0.2676
966 common 1 0.3682
966 concluded 1 0.3449
966 condition. 1 0.5159
966 congenital 4 1.3794
966 could 1 0.2708
966 differentiating 1 0.6346
966 eeg 4 2.1719
966 electroencephalographic 1 0.6346
966 encountered 1 0.4764
966 examinations 2 1.0318
966 examined 1 0.3805
966 focal 1 0.5596
966 hydrocephalus 1 0.3874
966 hydrocephalus, 1 0.5286
966 hydrocephalus. 2 1.0091
966 infantile 1 0.411
966 nature 1 0.3742
966 neurological 1 0.5046
966 none 1 0.4542
966 normal 1 0.2027
966 normal. 1 0.4542
966 picture 1 0.411
966 recording 2 1.0572
966 revealed 1 0.3653
966 suggested 1 0.3134
966 symptoms. 1 0.5596
966 useful 1 0.4155
967 2 1 0.4602
967 3 1 0.5138
967 basis 1 0.6597
967 cases. 1 0.7893
967 consanguinity 1 1.357
967 consecutive 2 2.1144
967 families. 1 1.357
967 genetic 1 0.7893
967 hydrocephalic 1 1.086
967 hydrocephalus 1 0.7747
967 hydrocephalus. 1 1.0091
967 newborns, 1 1.5073
967 patients, 1 0.7546
967 present 1 0.4963
967 report 1 0.7306
967 reported. 1 0.8716
967 suggested. 1 1.2069
967 two 1 0.4616
968 2 1 0.3068
968 abnormality. 1 0.9046
968 age 1 0.4157
968 anaemia 1 0.8046
968 apparent 1 0.5262
968 case 2 0.722
968 changes 1 0.3007
968 combined 1 0.5165
968 congenital 3 1.3794
968 corticosteroid-testosterone 1 1.0048
968 described 1 0.3811
968 due 1 0.3554
968 dwarfism 1 0.7048
968 fanconi's 1 1.0048
968 findings 1 0.3992
968 function. 1 0.8461
968 girl 1 0.6728
968 high 1 0.3596
968 hydrocephalus 1 0.5165
968 hydrocephalus, 1 0.7048
968 hypoplasia 2 1.6091
968 hypoplastic 1 0.8461
968 levels 1 0.3935
968 malformations. 1 0.7724
968 manifested 1 0.7724
968 pancytopenia 1 0.8461
968 pbi 1 1.0048
968 persistently 1 0.9046
968 pituitary 1 0.5212
968 resistant 1 0.6148
968 serum 1 0.3898
968 spleen, 1 0.6728
968 suffered 1 0.6879
968 thyroid 3 1.7663
968 together 1 0.5738
968 treatment. 1 0.5313
968 unusual 1 0.6352
968 without 1 0.3795
968 yr. 1 0.5262
969 'syndrome' 2 3.0145
969 (a 1 1.2069
969 3 1 0.5138
969 4th 1 1.1192
969 6-month-old 1 1.5073
969 case 1 0.5415
969 cerebellar 1 1.2069
969 clinical 1 0.4913
969 correlation 1 0.7611
969 cystic 1 1.1192
969 dandy-walker-taggart 2 3.0145
969 dilatation 1 1.0572
969 distortion 1 1.357
969 exit 1 1.5073
969 failed 1 0.8607
969 features. 1 1.2691
969 foramina 1 1.2069
969 girl 1 1.0091
969 hypoplastic 1 1.2691
969 midline 1 1.5073
969 open, 1 1.5073
969 pathological 1 0.8133
969 posterior 1 0.8832
969 report). 1 1.5073
969 resulting 1 0.7678
969 severe 1 0.6678
969 structures. 1 1.357
969 substantiated 1 1.357
969 ventricle 2 1.7433
970 (2 1 0.8046
970 (skull), 1 1.0048
970 15 1 0.4989
970 1959-1962, 1 1.0048
970 3rd 1 0.724
970 450 1 1.0048
970 aspects 1 0.5669
970 based 1 0.5262
970 biological 1 0.5366
970 cases 3 0.8969
970 caused 1 0.4398
970 clinical, 1 0.6466
970 contracted 1 1.0048
970 could 1 0.361
970 data 1 0.4092
970 demonstrated 1 0.4296
970 disease 1 0.361
970 due 1 0.3554
970 eeg 1 0.724
970 epidemiological, 1 1.0048
970 examination 1 0.5074
970 examined). 1 1.0048
970 fatal 1 0.6728
970 fetal 1 0.5738
970 fetus 1 0.7048
970 found 1 0.2645
970 gestation; 1 1.0048
970 given 1 0.3684
970 histopathological 1 0.8046
970 histopathologically 1 1.0048
970 hydrocephalus 3 1.5494
970 infection 1 0.4727
970 inferences 1 1.0048
970 involving 1 0.6466
970 liquor. 1 1.0048
970 literature, 1 0.8046
970 manifestation 1 0.7048
970 month 1 0.6728
970 mothers 1 0.6056
970 occurred 1 0.4372
970 occurring 1 0.5811
970 period. 1 0.6056
970 personal 1 0.7048
970 pregnancy. 1 0.7462
970 presented 1 0.3898
970 radiographical 1 1.0048
970 smallpox 1 1.0048
970 sparse 1 1.0048
970 variola 2 2.0097
970 whose 1 0.5888
970 years 1 0.4568
971 advantages 1 0.5286
971 air 1 0.4202
971 air-pantopaque 1 0.7536
971 also 1 0.2108
971 amounts 1 0.3742
971 bypassing 1 0.7536
971 cause 1 0.3403
971 clinical 1 0.2457
971 coexistent 1 0.6785
971 combined 2 0.7747
971 complete 1 0.3496
971 congenital 2 0.6897
971 csf 1 0.5046
971 demonstration 1 0.485
971 detection 1 0.4685
971 deterioration 1 0.6346
971 disclosure 1 0.7536
971 discussed. 1 0.3222
971 early 1 0.2763
971 evaluation, 1 0.6034
971 exact 1 0.543
971 extent 1 0.3985
971 function 1 0.3381
971 hydrocephalus 4 1.5494
971 immediate 1 0.4764
971 important 1 0.3403
971 infants 3 1.0793
971 interfere 1 0.5596
971 intracranial 1 0.4943
971 introduction 1 0.543
971 lateral 1 0.5046
971 latter 1 0.3909
971 location 1 0.5793
971 malformations. 1 0.5793
971 management 1 0.3985
971 method 1 0.2994
971 myelomeningocele 2 1.2691
971 myelomeningocele. 1 0.6785
971 obstruction. 1 0.6785
971 pantopaque 3 2.2609
971 pantopaque-air 1 0.7536
971 pathways 1 0.6346
971 permits 1 0.543
971 precipitate 1 0.6346
971 presented. 1 0.4416
971 procedures. 1 0.6034
971 produce 1 0.4025
971 prognosis. 1 0.6785
971 provides 1 0.4764
971 reaction 1 0.3773
971 retention 1 0.4685
971 small 1 0.3023
971 status. 1 0.7536
971 study 1 0.2322
971 system 1 0.352
971 unmanifested 1 0.7536
971 ventricles 1 0.6034
971 ventricular 1 0.3279
971 ventriculography 3 2.2609
972 (1945) 1 1.0048
972 (1962) 1 1.0048
972 2 1 0.3068
972 3-yr.-old 1 1.0048
972 agenesis 1 0.9046
972 already 1 0.724
972 anatomically 1 0.8461
972 association 1 0.5422
972 authors 1 0.4629
972 back 1 0.7462
972 carried 1 0.5031
972 cases 2 0.5979
972 cerebellar 1 0.8046
972 characterized 1 0.5313
972 children. 1 0.5738
972 clinical 1 0.3275
972 compensated 1 0.8046
972 completely, 1 0.9046
972 considerable 1 0.5212
972 curable 1 0.8461
972 cyst. 1 1.0048
972 dandy 2 1.8093
972 diagnosis 1 0.4135
972 dysgenetic 1 1.0048
972 ease 1 0.8461
972 effectiveness 1 0.7048
972 emphasize 1 0.8461
972 etiology 1 0.554
972 examination, 1 0.7462
972 extreme 1 0.6591
972 first, 1 0.8046
972 flow 1 0.5119
972 foramina 1 0.8046
972 fossa. 1 1.0048
972 going 1 0.9046
972 hydrocephaly 3 3.0145
972 hydrocephaly. 1 1.0048
972 images 1 0.9046
972 imperfection 1 1.0048
972 interest 1 0.6728
972 kind 2 1.4096
972 less 2 0.7524
972 life 1 0.5313
972 luschka 1 0.9046
972 magendie. 1 0.9046
972 malformation 1 0.7462
972 malformative 2 1.8093
972 must 1 0.4909
972 nature 1 0.4989
972 obscure. 1 0.8461
972 obvious, 1 1.0048
972 operation 1 0.5262
972 particular 1 0.5074
972 passage 1 0.6591
972 pathogenesis 1 0.5669
972 pathognomonic. 1 1.0048
972 picture 2 1.0959
972 posterior 2 1.1776
972 postoperational 1 1.0048
972 quickly 1 0.8461
972 rare 1 0.5969
972 recovered 1 0.6246
972 refers 1 1.0048
972 remains 1 0.5262
972 report 1 0.4871
972 resection 1 0.7462
972 respect 1 0.5888
972 restoration 1 0.7462
972 results. 1 0.7048
972 second 1 0.5119
972 sequelae, 1 0.8461
972 several 1 0.4346
972 simple 1 0.548
972 subject. 1 0.8461
972 surgical 1 0.4538
972 syndrome 1 0.4661
972 syndrome, 1 0.6728
972 syndrome. 1 0.7724
972 timely 1 0.9046
972 tumor 1 0.448
972 turns 1 1.0048
972 two 1 0.3077
972 unfavorable 1 0.9046
972 unpublished 1 0.9046
972 ventriculographic 1 1.0048
972 vermis 1 1.0048
972 walker's 2 2.0097
972 wall 1 0.6352
972 without 1 0.3795
972 x-ray 1 0.6591
972 years 1 0.4568
973 1 1 0.3795
973 14 1 0.554
973 19 1 0.6728
973 4 1 0.3554
973 5 1 0.3811
973 7 2 0.9258
973 active 1 0.4629
973 air 1 0.5603
973 among 1 0.4694
973 antibiotic 1 0.8046
973 associated 1 0.3568
973 bifida 1 0.8461
973 cases 2 0.5979
973 comparable 1 0.554
973 complete 1 0.4661
973 contraindication 1 1.0048
973 could 1 0.361
973 cystica 1 0.9046
973 degree 1 0.4452
973 demonstrated 1 0.4296
973 developed 1 0.4568
973 died 1 0.5888
973 drugs 1 0.554
973 either 1 0.4296
973 emphasized. 1 0.8461
973 even 2 0.8796
973 eventually 1 0.8461
973 excluded. 1 0.7462
973 extreme 1 0.6591
973 first 1 0.3684
973 frequently 1 0.5074
973 gravity 1 0.9046
973 group 1 0.3714
973 higher 1 0.4321
973 hydrocephalus 3 1.5494
973 hydrocephalus, 1 0.7048
973 incidence 2 0.9594
973 infant 2 1.1337
973 infants 1 0.4797
973 introduction 1 0.724
973 later. 1 0.8461
973 life 1 0.5313
973 life, 1 0.6728
973 made 1 0.3639
973 many 1 0.4051
973 maternity 1 1.0048
973 matter 1 0.7462
973 meningitis 2 2.0097
973 newborn. 1 0.8461
973 occurred 1 0.4372
973 operation. 2 1.3182
973 others 1 0.548
973 period 1 0.3811
973 post-meningitic 1 1.0048
973 postmeningitic 2 2.0097
973 powerful 1 0.9046
973 prognosis 1 0.554
973 recovered 1 0.6246
973 recovery. 1 1.0048
973 referred 1 0.5969
973 sequelae, 1 0.8461
973 severe, 1 0.7048
973 shunt. 1 0.7724
973 since 1 0.4372
973 spina 1 0.8461
973 spite 1 0.6728
973 state, 1 0.8461
973 still 1 0.4694
973 studies 1 0.3077
973 survivors, 1 0.9046
973 treated 1 0.4135
973 treatment 1 0.2965
973 unit, 1 1.0048
973 ventriculocaval 1 1.0048
973 weeks 1 0.5262
973 without 1 0.3795
974 (2.5%) 1 0.9046
974 11 1 0.5366
974 14 1 0.554
974 2 1 0.3068
974 246 1 0.9046
974 4 1 0.3554
974 5 1 0.3811
974 a.m. 1 0.9046
974 blood 1 0.3105
974 comparative 1 0.6148
974 compare 1 0.7724
974 concentration 3 1.2674
974 detection 1 0.6246
974 diagnostic 1 0.4989
974 drawn 1 0.7462
974 drop 3 2.3172
974 efficacy 1 0.8046
974 filaria 1 0.9046
974 finger 1 0.9046
974 found 2 0.5291
974 harbouring 1 1.0048
974 higher 1 0.4321
974 infection 2 0.9455
974 infection. 1 0.6591
974 infestation 1 1.0048
974 method 2 0.7983
974 method. 2 1.4096
974 methods 1 0.4538
974 methods, 1 0.9046
974 methods. 1 0.6352
974 p.m. 1 0.9046
974 per 2 0.7833
974 positive 1 0.5366
974 rate 2 0.7398
974 slide 2 1.8093
974 students 2 1.6091
974 thick 3 2.5382
974 values 1 0.5074
974 vein 1 0.7462
974 vis-a-vis 1 1.0048
975 178 1 0.5024
975 281 1 0.5024
975 503 1 0.5024
975 603 1 0.5024
975 association 1 0.2711
975 association, 1 0.4523
975 blood 6 0.9315
975 bo 1 0.5024
975 bo, 1 0.5024
975 duffy 1 0.5024
975 duffy, 1 0.5024
975 factor. 1 0.3862
975 factor; 1 0.5024
975 filariasis 3 1.0318
975 filariasis. 1 0.362
975 find 1 0.3439
975 found 1 0.1323
975 groups 2 0.4092
975 groups, 1 0.3364
975 groups. 1 0.2985
975 groups; 2 0.8461
975 kell 1 0.5024
975 kell, 1 0.5024
975 mn 1 0.5024
975 mn, 1 0.5024
975 patients 1 0.1208
975 relation 1 0.2315
975 rhesus 2 0.8461
975 secretor 2 1.0048
975 studied 2 0.3501
975 whatsoever, 1 0.5024
976 advantages 1 0.7048
976 amami 1 1.0048
976 bangkok 1 0.9046
976 cases 1 0.299
976 cheap, 1 1.0048
976 compact 1 0.9046
976 compare 1 0.7724
976 culture 3 1.5092
976 detection 2 1.2492
976 devised 1 0.7724
976 diagnosis 1 0.4135
976 diagnostic 1 0.4989
976 direct 1 0.4727
976 disposed 1 1.0048
976 easily 1 0.6466
976 efficiency 1 0.7462
976 examination, 1 0.7462
976 extremely 1 0.7048
976 filariform 1 1.0048
976 greatly 1 0.5969
976 hookworms 1 1.0048
976 infection 1 0.4727
976 infections 1 0.6591
976 island 1 0.8461
976 larvae. 2 2.0097
976 light, 1 1.0048
976 made 1 0.3639
976 method 2 0.7983
976 methods. 1 0.6352
976 microscopical 1 1.0048
976 nematodes. 1 1.0048
976 new 1 0.4398
976 newly 1 0.6728
976 number 1 0.3845
976 numbers 1 0.5969
976 others 1 0.548
976 overlooking 1 1.0048
976 parasitic 1 0.9046
976 polyethylene 3 2.7139
976 reduces 1 0.8461
976 related 1 0.4248
976 results 1 0.2878
976 risk 1 0.6728
976 sensitive 1 0.5422
976 show 1 0.4346
976 slight 1 0.5969
976 small 1 0.4031
976 studies 1 0.3077
976 technique 1 0.4727
976 test 1 0.4346
976 tube 3 2.4137
976 tubes 1 0.9046
976 use. 1 0.8046
977 144 1 0.6029
977 2 1 0.1841
977 20 1 0.2723
977 24-48 1 0.6029
977 288 1 0.6029
977 36 1 0.4229
977 48 1 0.3401
977 adult 1 0.2741
977 although 1 0.2318
977 altogether 1 0.5428
977 ambient 3 1.6283
977 apart. 1 0.6029
977 aperiodic 1 0.6029
977 apparently 2 0.6575
977 appears 1 0.2593
977 approx. 1 0.4634
977 biology 1 0.6029
977 blood 1 0.1863
977 boas, 1 0.6029
977 born 1 0.4037
977 c 1 0.3288
977 capillaries. 1 0.6029
977 circulation 1 0.3157
977 constrictor 2 1.2058
977 correlated 1 0.3581
977 cycle, 1 0.6029
977 day 1 0.2993
977 day. 1 0.4827
977 days 4 0.958
977 dead. 1 0.6029
977 death 1 0.3288
977 decomposed 1 0.6029
977 degrees 1 0.3811
977 density 2 0.7909
977 density. 1 0.6029
977 die 1 0.4634
977 disappeared 1 0.4344
977 distorted 1 0.5076
977 effect 1 0.1841
977 effects 1 0.2238
977 either 1 0.2578
977 eliminated 1 0.4229
977 enlarge 1 0.5076
977 enter 1 0.4634
977 experiments 1 0.2671
977 exposure 1 0.3581
977 factor 1 0.2857
977 filarial 2 0.9655
977 fluctuate 1 0.5428
977 following 1 0.1998
977 habits 1 0.5428
977 host 3 0.9382
977 host. 1 0.4827
977 however, 1 0.2183
977 hr. 3 1.046
977 hr., 1 0.4634
977 indication 1 0.4229
977 infected 1 0.3288
977 infection 1 0.2836
977 infections. 1 0.5428
977 information 1 0.3253
977 kill 1 0.5076
977 larger 1 0.3581
977 levels 1 0.2361
977 light 1 0.3401
977 limiting 1 0.4477
977 little 1 0.322
977 low 2 0.5278
977 lower 1 0.2741
977 m. 3 1.0085
977 macdonaldius 1 0.6029
977 maximum 2 0.6648
977 mexicanus 1 0.6029
977 microfilariae 5 1.8738
977 minimum 2 0.9269
977 new 1 0.2639
977 nocturnal 1 0.5076
977 observations 1 0.2535
977 observed 1 0.2055
977 obtained 1 0.2149
977 occur 1 0.2945
977 oschei 2 1.2058
977 oschei. 2 1.2058
977 parasite 1 0.5076
977 parasitemia 1 0.6029
977 period 1 0.2287
977 period. 1 0.3633
977 peripheral 1 0.3581
977 point 1 0.3487
977 postulated 1 0.4229
977 prior 1 0.322
977 probably 1 0.2741
977 recently 1 0.4127
977 respect 1 0.3533
977 serves 1 0.4634
977 several 1 0.2608
977 severe, 1 0.4229
977 sharply 1 0.5428
977 size 1 0.3157
977 slight 1 0.3581
977 smaller 1 0.4344
977 snakes. 1 0.6029
977 species, 1 0.4477
977 sufficient 1 0.3633
977 suggested 1 0.2507
977 temperature 1 0.322
977 temperature, 1 0.4634
977 temperatures 3 1.1434
977 times 1 0.29
977 upon 1 0.2705
977 using 1 0.2741
977 variable 1 0.3633
977 varying 1 0.3253
977 vivo 1 0.3581
977 within 2 0.4476
977 worms 2 0.8954
977 worms. 1 0.6029
978 antigens, 1 1.357
978 applied 1 0.9083
978 applied. 1 1.357
978 bancrofti 1 1.2069
978 blood 1 0.4657
978 carried 1 0.7546
978 case 1 0.5415
978 cells 1 0.4549
978 circulating 1 1.0572
978 considerable 1 0.7819
978 daylight. 1 1.5073
978 demonstration 2 1.9399
978 diagnosis, 1 1.0091
978 due 1 0.5332
978 enrichment. 1 1.5073
978 filaria 1 1.357
978 filariasis 1 1.0318
978 immunological 1 0.9369
978 leucoconcentration 2 3.0145
978 make 1 0.8954
978 makes 1 1.357
978 material 1 0.6992
978 may 1 0.377
978 method 1 0.5987
978 microfilaraemia. 1 1.5073
978 neoplasic 1 1.5073
978 obtain 1 1.0572
978 obtained, 1 1.2691
978 out. 1 1.1586
978 performed 1 0.6897
978 possible 2 1.2093
978 preliminary 1 0.8607
978 preparation 1 0.97
978 report 1 0.7306
978 routine 1 1.086
978 specific 1 0.593
978 steinberg's 1 1.5073
978 study 1 0.4643
978 technique 2 1.4182
978 used 1 0.5692
978 wuchereria 1 1.2069
979 concentration 2 1.2674
979 described 1 0.5717
979 harris 1 1.5073
979 method. 1 1.0572
979 microfilariae, 1 1.357
979 microfilariae. 1 1.2069
979 modified 1 1.086
979 sanguicolous 2 3.0145
979 summers 1 1.5073
979 technique 1 0.7091
979 techniques 1 0.8219
980 (macaca 2 0.5481
980 (oncomelania 1 0.274
980 3 1 0.0934
980 4 1 0.0969
980 adult 1 0.1246
980 altered 1 0.1464
980 alternative 1 0.1922
980 appeared 1 0.1318
980 atypical 2 0.3949
980 characteristics 1 0.1528
980 compared 1 0.1063
980 comparison 2 0.2843
980 consecutive 1 0.1922
980 considerably 1 0.1764
980 contained 1 0.1396
980 controls. 1 0.1798
980 conventional 1 0.1974
980 could 1 0.0985
980 cyclopis) 1 0.274
980 cyclopis). 1 0.274
980 degenerating 1 0.2467
980 discussed. 1 0.1172
980 dissimilar 1 0.274
980 effect 1 0.0837
980 eggs 2 0.407
980 equal 1 0.1798
980 explain 1 0.1835
980 extensive 1 0.1546
980 fewer 1 0.1974
980 formosan 11 3.0145
980 generations. 1 0.2467
980 granulomas 4 0.9869
980 granulomas. 1 0.2467
980 granulomatous 1 0.274
980 groups. 1 0.1628
980 highly 1 0.1479
980 host 1 0.1422
980 hypothesis 1 0.1464
980 i. 2 0.3256
980 ii. 2 0.317
980 infect 1 0.2307
980 infected 2 0.2989
980 infection 1 0.1289
980 intermediate 1 0.1764
980 irritants 1 0.2467
980 japanese 9 2.2205
980 japonicum 3 0.8221
980 laboratory 3 0.4754
980 large 1 0.1083
980 large, 1 0.2107
980 liver 2 0.2156
980 low 1 0.1199
980 made 1 0.0992
980 monkey 1 0.1835
980 monkeys 3 0.5766
980 monkeys. 1 0.2194
980 mortality 1 0.1652
980 natural 4 0.6423
980 nearly 1 0.1677
980 new 1 0.1199
980 nosophora) 1 0.274
980 partial 1 0.1528
980 passed 1 0.2307
980 passing 1 0.2467
980 pathology 1 0.1835
980 possessed 1 0.2307
980 possibility 1 0.1565
980 produced 1 0.1116
980 progressively 1 0.2035
980 proposed. 1 0.274
980 rabbit, 1 0.2194
980 rates 4 0.6606
980 reactions 1 0.1339
980 reactions, 1 0.2194
980 recorded. 2 0.4389
980 recovery 3 0.4533
980 responses 1 0.1528
980 resultant 1 0.1974
980 rising 1 0.2194
980 sch. 2 0.5481
980 schistosoma 1 0.274
980 schistosome 1 0.274
980 served 1 0.1798
980 severe 1 0.1214
980 signifying 1 0.274
980 similar 1 0.1026
980 snail 2 0.5481
980 snails. 1 0.274
980 strain 11 1.5939
980 strain, 1 0.2194
980 strain. 2 0.4934
980 strains 1 0.1628
980 strains. 1 0.274
980 stronger 1 0.2467
980 susceptibility. 1 0.274
980 susceptible 1 0.2467
980 taiwanese 3 0.8221
980 tissue 1 0.0951
980 toward 1 0.1764
980 used 1 0.1035
980 worm 2 0.4615
980 worms 2 0.407
980 young, 1 0.2467
981 125 1 1.2691
981 1916 1 1.5073
981 1962, 1 1.2069
981 22 1 1.0318
981 animals, 1 0.9083
981 application 1 0.8503
981 areas 1 0.797
981 arranged 1 1.1192
981 aspects 1 0.8503
981 author 1 0.8832
981 bentonite 1 1.357
981 bibliography 1 1.5073
981 cft, 1 1.5073
981 chronological 1 1.357
981 covering 1 1.5073
981 diagnosis 2 1.2405
981 diagnosis, 1 1.0091
981 discussion 1 0.9083
981 filarial 1 1.2069
981 filariasis. 1 1.086
981 flocculation, 1 1.5073
981 furnish 1 1.2691
981 general 1 0.7678
981 haemagglutination 1 1.2691
981 historical 1 1.2691
981 immunologic 2 1.9773
981 includes 1 1.1192
981 infections 1 0.9887
981 list 1 1.2691
981 lists 1 1.5073
981 made 1 0.5459
981 man 1 0.7747
981 means 1 0.6678
981 methods 2 1.3613
981 methods. 1 0.9528
981 notwithstanding 1 1.5073
981 opinion 1 1.0091
981 order 1 0.7893
981 papers 2 2.5382
981 past 1 1.0572
981 period 1 0.5717
981 prausnitz-kuestner 1 1.5073
981 precipitin 1 1.1586
981 recent 1 0.7893
981 references 1 1.2691
981 reliable 1 1.0091
981 requiring 1 1.086
981 review 1 0.831
981 reviews 1 1.2069
981 skin 1 0.8954
981 standardization 1 1.5073
981 study. 1 0.9887
981 subject. 1 1.2691
981 supplementary 1 1.5073
981 techniques, 1 1.2691
981 test 1 0.6519
981 test, 2 2.2385
981 unreliability 1 1.357
981 various 1 0.5959
982 - 2 1.7663
982 1:1000 1 1.5073
982 1:2000 1 1.5073
982 antibodies 1 0.8503
982 cause 1 0.6807
982 cessation 1 1.2691
982 completed 1 1.2069
982 concentrations 1 0.7747
982 consistent 1 0.8404
982 contraction 1 1.2691
982 diethylcarbamazine 1 1.2691
982 disease. 1 0.797
982 e. 1 1.0318
982 eosinophilic 2 2.4137
982 filarial 1 1.2069
982 indicate 1 0.6637
982 indicated 1 0.7091
982 intestinal 1 1.086
982 l. 1 1.5073
982 lung 2 1.2963
982 metabolite 1 1.5073
982 microfilariae 1 0.9369
982 particular 1 0.7611
982 patient 1 0.5667
982 patients 1 0.3623
982 perceptible 1 1.5073
982 preliminary 1 0.8607
982 present 1 0.4963
982 products 1 1.0572
982 reaction 1 0.7546
982 relationship 1 0.725
982 report. 1 1.357
982 required 1 0.8219
982 schultz-dale 2 3.0145
982 sera 1 0.9887
982 serum 1 0.5847
982 species 1 0.8219
982 specific 1 0.593
982 strips 1 1.5073
982 sufficient 1 0.9083
982 tests 2 1.4845
982 used. 1 1.0318
982 yet 1 0.797
983 (1) 1 0.1826
983 (2) 1 0.1826
983 (20%) 1 0.3768
983 (27%). 1 0.3768
983 (35%), 1 0.3768
983 (7%) 1 0.3768
983 10% 1 0.2715
983 112 1 0.3768
983 13 1 0.2179
983 141 1 0.3768
983 15 1 0.1871
983 1:200 1 0.3768
983 1:400 1 0.3768
983 1:5 1 0.3768
983 21 1 0.2382
983 21%. 1 0.3768
983 253 1 0.3768
983 29 1 0.258
983 295 2 0.7536
983 42 1 0.2897
983 5% 2 0.543
983 62% 1 0.3173
983 632 1 0.3768
983 67% 1 0.3392
983 84 2 0.6034
983 92% 1 0.3768
983 acanthocheilonema 1 0.3768
983 americans, 1 0.3768
983 area 1 0.1955
983 ascariasis 2 0.7536
983 asymptomatic 2 0.5596
983 bacterial 1 0.2208
983 bentonite 2 0.6785
983 blood, 1 0.258
983 blood. 1 0.2523
983 born 1 0.2523
983 criteria 1 0.2208
983 cross-reactions 1 0.3768
983 diagnosis 1 0.1551
983 dirofilaria 1 0.2798
983 diseases 2 0.411
983 due 1 0.1333
983 endemic 1 0.3392
983 evaluated. 1 0.3768
983 evaluation 1 0.2033
983 experience 1 0.1937
983 extract 1 0.2382
983 filariasis, 1 0.3392
983 filariasis. 2 0.543
983 flocculation 4 1.357
983 following 1 0.1249
983 group 3 0.4179
983 haemagglutination 3 0.9518
983 helminth 1 0.3768
983 hemagglutination 1 0.3173
983 high 1 0.1348
983 higher 2 0.3241
983 higher, 1 0.3768
983 immitis 1 0.2897
983 indirect 2 0.5793
983 individuals 6 1.5477
983 individuals, 1 0.2897
983 infections 1 0.2472
983 infections, 1 0.3173
983 may 1 0.0942
983 microfilariae 2 0.4685
983 microfilariae-negative 2 0.7536
983 microfilariae-positive 1 0.3768
983 missionaries, 1 0.3768
983 negative 1 0.2208
983 non-helminthic 1 0.3768
983 non-specific 2 0.5793
983 normal 3 0.304
983 obtained, 1 0.3173
983 overall 1 0.2472
983 parasitic 1 0.3392
983 past 1 0.2643
983 patients 4 0.3623
983 patients, 1 0.1887
983 perstans 1 0.3768
983 positive 3 0.6037
983 positive. 3 1.0177
983 rate 2 0.2774
983 reaction. 1 0.2798
983 reactions 1 0.1841
983 reactive 1 0.3173
983 represent 1 0.2382
983 response 2 0.2752
983 saline 1 0.2798
983 schistosomiasis 2 0.7536
983 sera 8 1.9773
983 serologic 3 0.8145
983 showed 3 0.403
983 since 1 0.1639
983 symptomatic 2 0.5286
983 test 3 0.4889
983 test: 1 0.3768
983 testing 1 0.2643
983 tests 1 0.1856
983 tests. 1 0.258
983 titre 2 0.7536
983 titres 1 0.3392
983 trichinosis 1 0.3768
983 utilizing 2 0.5596
983 various 1 0.149
984 (calaccad 1 1.5073
984 (finlaya) 1 1.5073
984 11% 1 1.2691
984 12 1 0.7196
984 1953. 1 1.5073
984 aedes 1 1.5073
984 age, 1 0.9887
984 also 1 0.4217
984 anopheles 1 1.357
984 area 2 1.5637
984 areas. 1 1.2069
984 bancrofti 1 1.2069
984 become 1 0.831
984 brought 1 0.9887
984 came 1 1.357
984 children 2 1.0704
984 coming 1 1.357
984 correlates 1 1.357
984 culex 1 1.5073
984 currently 1 1.1192
984 development 1 0.5503
984 discussed. 1 0.6444
984 endemic 1 1.357
984 fatigans 1 1.5073
984 filariasis 1 1.0318
984 flavirostris 1 1.5073
984 focus 1 1.357
984 found 1 0.3968
984 found. 1 0.97
984 houses, 1 1.5073
984 however, 1 0.5459
984 human 1 0.5031
984 immigrants 1 1.5073
984 important 1 0.6807
984 increase 1 0.5119
984 infected. 1 1.357
984 infection 1 0.7091
984 live 1 1.0318
984 local 1 0.9083
984 luzon 1 1.5073
984 luzon, 1 1.5073
984 may 1 0.377
984 microfilaremia 1 1.5073
984 migration, 1 1.2691
984 minimus 1 1.5073
984 mountain 2 2.5382
984 move 1 1.2691
984 niveus 1 1.5073
984 non-infected 1 1.357
984 original 1 0.8607
984 p. 1 1.1192
984 parasites 1 1.2691
984 people 1 1.2069
984 philippines. 1 1.5073
984 probably 2 1.3703
984 province, 2 2.7139
984 rate 1 0.5548
984 recent 1 0.7893
984 republic 1 1.5073
984 road 1 1.5073
984 since 1 0.6558
984 spraying 1 1.357
984 transmission. 1 1.357
984 undoubtedly 1 1.2691
984 unsprayed 1 1.5073
984 urbanization, 1 1.5073
984 valley), 1 1.5073
984 vector. 2 3.0145
984 w. 1 1.2069
984 yr. 1 0.7893
985 (2.5%) 1 0.5428
985 , 1 0.4634
985 0.05 1 0.5428
985 15 1 0.2993
985 7.2 1 0.5428
985 a-50 1 0.6029
985 a. 1 0.3811
985 acid 1 0.2328
985 acids, 1 0.4827
985 activity 1 0.2158
985 alanine, 1 0.6029
985 aminoacids 1 0.6029
985 amount 1 0.2969
985 antigen 5 1.7907
985 antigen, 1 0.4344
985 antigenic 1 0.3533
985 appeared 1 0.29
985 arginine, 1 0.6029
985 aspartic 1 0.6029
985 band 1 0.5428
985 broad 1 0.4827
985 buffer 1 0.4634
985 carbohydrate 1 0.4229
985 cases. 1 0.3157
985 cellogel 1 0.6029
985 chromatography 1 0.4037
985 chromatography. 1 0.5076
985 cm-cellulose 1 0.6029
985 column 1 0.5076
985 considerable 1 0.3127
985 cross 1 0.4827
985 deae 1 0.5428
985 destroyed 1 0.4037
985 detected 1 0.3127
985 dirofilaria 1 0.4477
985 e. 1 0.4127
985 electrophoresis 1 0.4477
985 enzymes 1 0.3811
985 erythema 1 0.6029
985 examined 1 0.3044
985 extent. 1 0.5428
985 extracted 1 0.4037
985 fact 1 0.3188
985 filariasis 1 0.4127
985 filariasis. 1 0.4344
985 film. 1 0.6029
985 filtration, 1 0.6029
985 finally 1 0.4127
985 fscd1, 1 0.6029
985 g-100 1 0.5076
985 gave 1 0.3811
985 gel 1 0.3487
985 glutamic 1 0.5428
985 glycine, 1 0.6029
985 high-voltage 1 0.6029
985 homogenate 1 0.5076
985 hookworm, 1 0.6029
985 hydrolyzate 1 0.6029
985 iii. 1 0.4229
985 immitis 1 0.4634
985 immunological 1 0.3748
985 injection 1 0.2521
985 intradermal 2 0.9655
985 isolation 1 0.388
985 japonicum, 1 0.6029
985 lubricoides 1 0.6029
985 lysine, 1 0.6029
985 min. 1 0.4229
985 nature 1 0.2993
985 noticed 1 0.5076
985 p. 1 0.4477
985 paper-electrophoresis 1 0.6029
985 patients 1 0.1449
985 patients. 1 0.29
985 ph 1 0.3253
985 phosphate 1 0.3044
985 protein 2 0.5481
985 proteolytic 1 0.4827
985 proved 2 0.6723
985 purification 1 0.4634
985 purified 2 0.7622
985 reactions 2 0.5891
985 relatively 1 0.29
985 s. 1 0.4634
985 sephadex 2 0.8954
985 skin 3 1.0744
985 small 1 0.2419
985 studies 1 0.1846
985 tests 1 0.2969
985 tests. 1 0.4127
985 valine. 1 0.6029
985 vermicularis, 1 0.6029
985 weak 1 0.5076
985 westermani, 1 0.6029
985 wheals 1 0.6029
985 within 1 0.2238
986 apparent 1 0.5262
986 based 1 0.5262
986 basis 1 0.4398
986 characteristic 1 0.5074
986 characteristics 1 0.5603
986 clarity 1 1.0048
986 clearly 1 0.6056
986 criteria 1 0.5888
986 demonstrated 1 0.4296
986 described. 1 0.5031
986 details 1 0.6879
986 filariasis. 1 0.724
986 greater 1 0.4157
986 human 3 1.0061
986 identification 1 0.6466
986 illustrated 1 0.8046
986 key 1 0.8046
986 microfilariae 2 1.2492
986 microfilariae. 1 0.8046
986 morphologic 2 1.448
986 new 1 0.4398
986 obtainable. 1 1.0048
986 outlined, 1 1.0048
986 previously 1 0.4833
986 procedures 1 0.5669
986 simple 1 0.548
986 species 2 1.0959
986 staining 2 1.3455
986 stains. 1 1.0048
987 (a 1 0.1857
987 (protein 2 0.4638
987 0.05 1 0.2088
987 1 1 0.0876
987 1,500 1 0.1857
987 2 1 0.0708
987 4 2 0.164
987 40 1 0.1359
987 6 2 0.1939
987 a50 1 0.2319
987 active. 1 0.2088
987 adult 1 0.1054
987 antigen 13 1.7907
987 antigens 4 0.5364
987 antigens, 1 0.2088
987 attempted 2 0.3105
987 bancrofti. 1 0.2319
987 blood 1 0.0717
987 carbohydrate 1 0.1626
987 carried 1 0.1161
987 cellulose 1 0.2088
987 chromatography 2 0.3105
987 chromatography. 1 0.1952
987 cm 1 0.1857
987 column 2 0.3905
987 component) 2 0.4638
987 components 1 0.1324
987 containing 1 0.1226
987 could 1 0.0833
987 deae-sephadex 1 0.2319
987 demonstrated. 1 0.1671
987 described 1 0.088
987 dirofilaria 1 0.1722
987 elimination 1 0.2088
987 enzyme) 1 0.2319
987 filariasis 3 0.4762
987 filariasis, 1 0.2088
987 filariasis. 2 0.3341
987 fraction 1 0.1238
987 fractionation 3 0.5347
987 fractions, 1 0.1952
987 fs 1 0.2319
987 fs, 1 0.2319
987 fsc-2, 1 0.2319
987 fsc-3, 1 0.2319
987 fsc-4 1 0.2319
987 fsc-4, 2 0.4638
987 fsc-5 1 0.2319
987 fsc-6, 1 0.2319
987 fscd-1 2 0.4638
987 fscd-1. 1 0.2319
987 fscd-2, 1 0.2319
987 fscd-3 1 0.2319
987 fscd-4. 1 0.2319
987 fscdn 1 0.2319
987 fscdp. 1 0.2319
987 fsi 1 0.2319
987 fsi, 1 0.2319
987 g-100 1 0.1952
987 gel-filtration 1 0.2319
987 high 1 0.083
987 highly 1 0.1251
987 iii. 1 0.1626
987 immitis 1 0.1782
987 immunological 1 0.1441
987 infected 1 0.1265
987 inferred 1 0.1952
987 injection 1 0.097
987 intradermal 1 0.1857
987 level 2 0.1791
987 material. 1 0.1671
987 may 1 0.058
987 microfilariae 1 0.1441
987 ml., 1 0.2088
987 nagase 1 0.2319
987 next, 1 0.2319
987 noticeable 3 0.6957
987 obtain 2 0.3253
987 obtained 2 0.1653
987 obtained. 1 0.1722
987 order 1 0.1214
987 parent 1 0.1722
987 patients 3 0.1672
987 patients, 1 0.1161
987 patients. 2 0.2231
987 per 1 0.0904
987 previous 1 0.1251
987 produced 5 0.4722
987 pronase 1 0.2319
987 protein 2 0.2108
987 proteinic. 1 0.2319
987 proteolytic 1 0.1857
987 proved 1 0.1293
987 purification 2 0.3565
987 reaction 5 0.5805
987 reactions 2 0.2266
987 reactive 1 0.1952
987 reliable 1 0.1553
987 report 1 0.1124
987 reported 1 0.094
987 responsible 2 0.2342
987 sensitivity 1 0.1397
987 separated 1 0.1521
987 sephadex 1 0.1722
987 similar 1 0.0868
987 skin 4 0.551
987 specificity. 1 0.2319
987 studies 2 0.142
987 study 1 0.0714
987 substance 2 0.3253
987 tca 1 0.2319
987 tested 3 0.4192
987 treatment 1 0.0684
987 used 1 0.0876
987 viz.fsc-1, 1 0.2319
987 viz.fscd-1, 1 0.2319
987 weaker 1 0.2319
987 whose 1 0.1359
987 worms 1 0.1722
987 wuchereria 1 0.1857
987 yield 1 0.1722
988 (range: 2 1.2058
988 100 1 0.3401
988 168,350) 1 0.6029
988 17 1 0.3581
988 2,450) 1 0.6029
988 235 1 0.6029
988 24,430 1 0.6029
988 38 1 0.4127
988 44 1 0.4827
988 50 2 0.5757
988 < 2 1.2058
988 analysis 1 0.29
988 average 2 0.541
988 blood 2 0.3726
988 canine 2 1.0153
988 compared 1 0.2339
988 comparing 1 0.5076
988 concentrations 3 0.9296
988 count 1 0.4127
988 criteria 1 0.3533
988 d. 3 1.164
988 determined. 1 0.4127
988 diagnosing 1 0.4477
988 different 1 0.2133
988 differentiating 1 0.5076
988 dipetalonema 1 0.5076
988 dirofilaria 1 0.4477
988 dogs 5 1.5637
988 due 1 0.2133
988 emphasized 1 0.4827
988 experiences 1 0.4037
988 female 1 0.3487
988 filariasis 1 0.4127
988 found 2 0.3174
988 identification 1 0.388
988 identifications 1 0.5428
988 immitis 1 0.4634
988 immitis, 1 0.6029
988 importance 1 0.3071
988 improved 1 0.4037
988 inapparent 1 0.6029
988 infected 3 0.9863
988 infections 3 1.1864
988 knott 1 0.6029
988 male 1 0.3071
988 method 1 0.2395
988 methods. 1 0.3811
988 microfilariae. 3 1.4482
988 microfilarial 3 1.4482
988 ml. 2 0.8073
988 modified 1 0.4344
988 morphologic 1 0.4344
988 naturally 1 0.4477
988 new 1 0.2639
988 number 1 0.2307
988 only. 2 0.8688
988 per 2 0.47
988 peripheral 1 0.3581
988 personal 1 0.4229
988 practical 1 0.388
988 published 1 0.4037
988 range 1 0.3253
988 reconditum 3 1.8087
988 reliable 1 0.4037
988 reports 1 0.388
988 significance 1 0.3288
988 similar 1 0.2257
988 simplest 1 0.5428
988 species. 1 0.3955
988 usefulness 1 0.4827
988 within 1 0.2238
989 10 1 0.1585
989 30% 1 0.3448
989 60% 1 0.3448
989 advanced 1 0.2234
989 agent, 1 0.3103
989 alkylating 1 0.3626
989 anti-tumor 1 0.3626
989 anticancer 1 0.3626
989 antifol, 1 0.4306
989 artery 1 0.2459
989 associated 1 0.1529
989 benefit 1 0.3448
989 biliary 1 0.2558
989 cancer 5 0.8512
989 cancer. 1 0.3021
989 candidates 1 0.3877
989 cases, 1 0.2255
989 cause 1 0.1945
989 chemotherapy 3 0.7904
989 chemotherapy, 2 0.7754
989 clinical 1 0.1404
989 colorectum. 1 0.4306
989 commonest 1 0.3626
989 concluded 1 0.1971
989 contributed 1 0.3103
989 criteria 1 0.2523
989 cytoxan, 1 0.4306
989 death 1 0.2348
989 digestive 1 0.3626
989 disease 1 0.1547
989 drug 1 0.2255
989 drugs. 1 0.3448
989 employed 1 0.2722
989 fluorinated 1 0.3877
989 forms 1 0.2056
989 found 1 0.1134
989 gastro-intestinal 1 0.3626
989 gastrointestinal 1 0.3103
989 hepatic 2 0.4859
989 incurable 2 0.6041
989 infusion 1 0.2429
989 large 1 0.1702
989 length 1 0.2825
989 liver 1 0.1694
989 management 1 0.2277
989 may 1 0.1077
989 metastatic 2 0.5543
989 methods 1 0.1945
989 methotrexate, 1 0.3877
989 neoplasms 1 0.3198
989 neoplastic 1 0.3021
989 number 1 0.1648
989 objective 1 0.2825
989 outlined. 1 0.3448
989 patients 7 0.7246
989 practical 2 0.5543
989 primary 2 0.3641
989 prolonged 1 0.2071
989 protracted 1 0.3877
989 pyrimidines, 1 0.4306
989 receiving 1 0.2374
989 regional 2 0.6206
989 response 1 0.1572
989 resulted 1 0.2087
989 reviewed 1 0.2429
989 secondary 1 0.2156
989 selected 1 0.2523
989 selection 1 0.2948
989 significant 1 0.1512
989 specific 1 0.1694
989 states. 1 0.3626
989 survival 1 0.2071
989 system 1 0.2012
989 systemic 3 0.7204
989 therapy. 1 0.2324
989 tract 1 0.249
989 tract. 1 0.331
989 treated. 1 0.3448
989 treatment 1 0.1271
989 tumor 1 0.192
989 tumors 2 0.451
989 united 1 0.3626
989 using 1 0.1958
989 value 1 0.1984
990 arising 1 0.7724
990 bony 1 0.8461
990 breast 2 1.0626
990 carcinoma 3 1.4391
990 discussed. 1 0.4296
990 fifty-three 1 1.0048
990 metastases 2 1.3758
990 method 1 0.3992
990 osseous 1 0.7462
990 outlined 1 0.8046
990 pain 1 0.6591
990 palliative 2 1.3455
990 patients 1 0.2415
990 phosphorus 1 0.6591
990 prostate 2 1.6922
990 radio-active 1 1.0048
990 reported. 1 0.5811
990 results 1 0.2878
990 suffering 1 0.5969
990 testosterone. 1 0.9046
990 treatment 2 0.5929
991 (20drops/min.) 1 3.0145
991 100 1 1.7006
991 11%. 1 3.0145
991 19, 1 2.7139
991 28, 1 3.0145
991 3. 1 1.6265
991 3/4 1 2.7139
991 54 1 2.7139
991 7, 1 2.4137
991 8 1 1.3613
991 area 1 1.5637
991 arterial 1 1.5637
991 artery 1 1.7214
991 blue 1 2.4137
991 chemotherapy 1 1.8443
991 day 1 1.4967
991 days. 1 1.7006
991 deaths 1 2.1719
991 decided 1 2.4137
991 every 1 1.6808
991 failures 1 3.0145
991 head 1 1.9773
991 improvements 1 3.0145
991 infusions 1 2.2385
991 injected 1 1.4612
991 inoperable 1 2.7139
991 irrigated 1 2.7139
991 methotrexate 1 2.3172
991 mg./1. 1 3.0145
991 neck 1 2.1719
991 pain 1 1.9773
991 patent 1 2.1719
991 patients 1 0.7246
991 patients. 1 1.45
991 perfusion 1 1.7663
991 perfusion: 1 3.0145
991 preliminary 1 1.7214
991 prolonged 1 1.45
991 regional 1 2.1719
991 regressions 1 3.0145
991 relieved 1 2.7139
991 results 1 0.8633
991 superficial 1 2.2385
991 superior 1 2.0183
991 temporal 1 2.3172
991 thyroid 1 1.7663
991 total 1 1.1749
991 tumors. 1 1.9773
991 violet 1 2.7139
991 were: 1 2.7139
992 1 1 0.2846
992 2 1 0.2301
992 5fudr. 1 0.7536
992 accessible 1 0.6785
992 advanced 1 0.3909
992 agents 2 0.8133
992 almost 1 0.3874
992 ambulatory 1 0.7536
992 anti-tumor 1 0.6346
992 aplastic 1 0.6785
992 appears 1 0.3241
992 approaches 1 0.6346
992 arteries. 1 0.6785
992 best 1 0.3985
992 bone 1 0.326
992 brachial 1 0.6785
992 cancer 3 0.8938
992 carotid 1 0.4943
992 carotids. 1 0.7536
992 chemotherapeutic 2 1.1586
992 cns 1 0.5286
992 common 1 0.3682
992 complete 1 0.3496
992 complications 3 1.3247
992 concerned 1 0.5046
992 continued 1 0.4358
992 course 1 0.3426
992 currently 1 0.5596
992 day 1 0.3742
992 degeneration. 1 0.6785
992 dosages 1 0.7536
992 drug 1 0.3946
992 easily 1 0.485
992 effective 1 0.3773
992 embolic 1 0.6346
992 emphasizing 1 0.6785
992 english 1 0.6785
992 exception 1 0.4943
992 external 1 0.4542
992 femoral, 1 0.7536
992 form 2 0.6558
992 frequently 1 0.3805
992 given 1 0.2763
992 group 1 0.2786
992 head 2 0.9887
992 hemorrhage 1 0.485
992 however, 1 0.2729
992 increased 1 0.2343
992 inevitable. 1 0.7536
992 infused 1 0.6346
992 infusion 4 1.7006
992 infusion. 1 0.6034
992 infusion; 1 0.7536
992 interest 1 0.5046
992 internal 1 0.4252
992 intra-arterial 4 2.3172
992 involved 1 0.3839
992 largest 1 0.6785
992 life 1 0.3985
992 literature 1 0.411
992 malignant 1 0.411
992 many 2 0.6077
992 marrow 1 0.3773
992 may 1 0.1885
992 medical 1 0.4477
992 minor 1 0.485
992 mobile 1 0.6785
992 mth. 1 0.4477
992 neck 2 1.086
992 neoplasms. 1 0.7536
992 notably 1 0.6346
992 obtained 1 0.2686
992 occur 1 0.3682
992 oncolytic 1 0.6785
992 organ 1 0.5286
992 palliation 1 0.4764
992 papers 1 0.6346
992 partial 1 0.4202
992 patient 1 0.2834
992 patients 3 0.5435
992 patients. 1 0.3625
992 pelvic 1 0.5793
992 permit 1 0.6034
992 phenomena 1 0.5286
992 prematurely 1 0.6785
992 present 1 0.2481
992 primary 1 0.3186
992 pumping 1 0.7536
992 recurrent 1 0.5793
992 regression 1 0.485
992 results 1 0.2158
992 review 1 0.4155
992 route 1 0.6346
992 serious 1 0.4542
992 significant 1 0.2646
992 small 1 0.3023
992 summarizes 1 0.6785
992 technical 1 0.543
992 technique 1 0.3546
992 techniques 1 0.411
992 terminate 1 0.6785
992 therapeutic 1 0.3805
992 therapy 2 0.5959
992 therapy. 2 0.8133
992 threatening 1 0.6346
992 toxicity, 1 0.6785
992 treated 1 0.3101
992 treatment 1 0.2223
992 tumor 1 0.336
992 tumors 1 0.3946
992 tumors. 1 0.4943
992 units 1 0.5159
992 using 1 0.3426
992 usually 1 0.3546
992 via 1 0.5046
993 (1050 1 1.5073
993 (48 1 1.357
993 1600 1 1.5073
993 27 1 1.0091
993 72 1 1.086
993 aged 1 0.9083
993 amygdaloid 1 1.5073
993 article 1 1.357
993 cancer 2 1.1917
993 carcinoma 1 0.7196
993 cases 1 0.4484
993 chemotherapeutic 1 1.1586
993 chemotherapy 1 0.9221
993 complete 1 0.6992
993 complications 1 0.8832
993 continuous 1 0.8503
993 dealt 1 1.2069
993 described. 1 0.7546
993 fossa, 1 1.5073
993 indications 1 1.0318
993 infused 1 1.2691
993 infusion 1 0.8503
993 intra-arterial 2 2.3172
993 limits. 1 1.2691
993 man 1 0.7747
993 methotrexate 1 1.1586
993 mg.) 1 1.5073
993 objective 1 0.9887
993 operative 1 0.8404
993 partial 1 0.8404
993 patients, 1 0.7546
993 presented 1 0.5847
993 principles 1 1.0318
993 prolonged 1 0.725
993 references) 1 1.5073
993 remission: 1 1.5073
993 reticulosarcoma 1 1.5073
993 review 1 0.831
993 rhinopharynx. 1 1.5073
993 selection 1 1.0318
993 technique 1 0.7091
993 therapy; 1 1.5073
993 treatment 1 0.4447
993 two 1 0.4616
993 using 1 0.6851
993 with. 1 1.357
993 woman 1 0.9887
994 (3 1 0.2682
994 (5 1 0.2682
994 1-10 1 0.3349
994 1-17 1 0.3349
994 10 2 0.2466
994 12 3 0.4797
994 2 2 0.2045
994 3 3 0.3425
994 3.7 1 0.3349
994 6 1 0.1401
994 6.1 1 0.3015
994 7 2 0.3086
994 9 1 0.1754
994 administration 1 0.1475
994 agents. 1 0.3015
994 alive 1 0.2682
994 aorta 1 0.2243
994 aorta); 1 0.3349
994 artery 3 0.5738
994 artery, 1 0.282
994 average 1 0.1503
994 averaged 1 0.2682
994 axis 1 0.3015
994 cancer 6 0.7945
994 candidates 1 0.3015
994 celiac 1 0.3015
994 chemotherapeutic 1 0.2575
994 chemotherapy 4 0.8197
994 chemotherapy, 1 0.3015
994 complication 1 0.3015
994 complications 1 0.1963
994 critical 1 0.2243
994 degree, 1 0.282
994 died 2 0.3925
994 died; 1 0.3349
994 differences 1 0.1533
994 directly 1 0.2117
994 discussed. 1 0.1432
994 drugs 1 0.1847
994 failure. 1 0.282
994 groups. 1 0.199
994 hepatic 3 0.5669
994 immediate 3 0.6352
994 infusion 1 0.189
994 intra-aortic 2 0.6699
994 intra-arterial 2 0.5149
994 intra-hepatic 1 0.3349
994 intrahepatic 1 0.2682
994 introduced 1 0.2575
994 irradiation 1 0.1807
994 lasted 1 0.282
994 lesser 1 0.2293
994 leukopenia; 1 0.3349
994 level 1 0.1293
994 liver 2 0.2636
994 liver. 1 0.2349
994 major 1 0.1611
994 metabolic 1 0.1599
994 metastases 1 0.2293
994 metastatic 2 0.4311
994 mth. 4 0.7959
994 mths 1 0.3349
994 need 1 0.2049
994 noted 1 0.1771
994 objective 1 0.2197
994 observed 3 0.3425
994 one 1 0.0937
994 palliation 1 0.2117
994 past, 1 0.3349
994 patients 9 0.7246
994 patients. 1 0.1611
994 period; 2 0.6699
994 poor 1 0.1937
994 posttreatment 2 0.6699
994 proper 1 0.2243
994 received 2 0.3779
994 remaining 1 0.1706
994 remains 1 0.1754
994 reserve 1 0.2682
994 results 1 0.0959
994 route 2 0.5641
994 route). 1 0.3349
994 screening 1 0.282
994 selection 1 0.2293
994 severe. 1 0.3349
994 shrinkage 1 0.3349
994 significant 2 0.2352
994 subjective 1 0.2682
994 survival 2 0.3222
994 survived 1 0.2197
994 time 1 0.118
994 treated 4 0.5513
994 treatment, 1 0.2155
994 treatment; 1 0.3015
994 twenty-two 1 0.2682
994 via 2 0.4485
995 1 1 0.2277
995 12 1 0.2878
995 28 1 0.4127
995 365 1 0.5428
995 57% 1 0.6029
995 6 1 0.2521
995 adenocarcinomas. 1 0.6029
995 adjuvant 1 0.4344
995 administration 1 0.2655
995 advanced 1 0.3127
995 analyzed 1 0.4127
995 areas 1 0.3188
995 arterial 1 0.3127
995 available 1 0.3288
995 benefit 1 0.4827
995 best 1 0.3188
995 brain 1 0.3071
995 cancer 5 1.1917
995 carcinoma 1 0.2878
995 cent 1 0.3099
995 chemotherapy 3 1.1066
995 chemotherapy. 2 0.9269
995 complications 2 0.7065
995 concluded 1 0.2759
995 continuous 1 0.3401
995 contraindicated. 1 0.6029
995 conventional 1 0.4344
995 course 1 0.2741
995 courses 1 0.5428
995 discussed. 1 0.2578
995 epidermoid 1 0.4827
995 evaluation 1 0.3253
995 experience 2 0.6198
995 failed 1 0.3443
995 fifty-one 1 0.5428
995 form 1 0.2623
995 frequency 1 0.3157
995 group. 1 0.3487
995 groups 1 0.2455
995 head 1 0.3955
995 hundred 1 0.4634
995 individuals 1 0.4127
995 infusion 2 0.6802
995 infusion. 1 0.4827
995 interest 1 0.4037
995 intra-abdominal 1 0.6029
995 intra-arterial 2 0.9269
995 investigation 1 0.3401
995 least 1 0.3099
995 may 1 0.1508
995 methods 1 0.2723
995 months. 2 0.8073
995 much 1 0.2671
995 neck 1 0.4344
995 needed 1 0.4127
995 objective 1 0.3955
995 obtained 3 0.6448
995 palliation 2 0.7622
995 patients 5 0.7246
995 per 1 0.235
995 periods 1 0.3362
995 poorest 1 0.6029
995 present 1 0.1985
995 primary 1 0.2549
995 receiving 1 0.3324
995 response 1 0.2201
995 results 3 0.518
995 satisfactory 1 0.3955
995 serious 1 0.3633
995 special 1 0.3188
995 study 2 0.3715
995 suggested. 1 0.4827
995 suggests 1 0.322
995 surgical 1 0.2723
995 technique 1 0.2836
995 ten 2 0.7267
995 therapy 2 0.4767
995 treated 1 0.2481
995 treated. 1 0.4827
995 treatment 1 0.1779
995 tumors 1 0.3157
995 two 1 0.1846
995 type 1 0.2507
995 used 1 0.2277
995 various 1 0.2383
995 veterans 1 0.6029
995 worthwhile 1 0.5428
996 'priming' 1 1.0048
996 2 1 0.3068
996 3 1 0.3425
996 3rd 1 0.724
996 6 1 0.4202
996 8 1 0.4538
996 adjunct 1 0.7724
996 bacterial 2 1.1776
996 cancer 1 0.3972
996 curable 1 0.8461
996 encouraging 1 1.0048
996 experience 2 1.0329
996 first 1 0.3684
996 following 1 0.3331
996 group 1 0.3714
996 groups 1 0.4092
996 groups. 1 0.5969
996 indicated 1 0.4727
996 initial 1 0.4871
996 injections. 1 1.0048
996 irradiation. 1 0.6879
996 localized 1 0.7048
996 marked 1 0.4509
996 masses. 1 1.0048
996 melanoma 1 1.0048
996 metastatic 1 0.6466
996 objective 1 0.6591
996 operation 1 0.5262
996 palliative 1 0.6728
996 patients 1 0.2415
996 patients, 1 0.5031
996 patients: 1 1.0048
996 potentially 1 0.7462
996 radiotherapy 2 1.4096
996 remission 1 0.7724
996 reported 1 0.4072
996 sarcoma 1 0.6879
996 study 1 0.3096
996 subsequent 1 0.548
996 supplemented 1 0.9046
996 symptomatic 1 0.7048
996 therapy 2 0.7945
996 toxin 3 3.0145
996 toxins 1 1.0048
996 toxins. 1 1.0048
996 treatment 2 0.5929
996 tumor 3 1.344
996 use 1 0.3972
996 used 1 0.3795
997 (9 1 0.3877
997 (henschke;stearns 1 0.4306
997 (in 1 0.331
997 1,200-1,600 1 0.4306
997 11 2 0.46
997 14%. 1 0.4306
997 19.9%, 1 0.4306
997 20-25%, 1 0.4306
997 21.3%. 1 0.4306
997 262 1 0.4306
997 271 2 0.8613
997 39 1 0.3103
997 45 1 0.2883
997 48 1 0.2429
997 5-year 2 0.6621
997 6 1 0.1801
997 according 4 0.9295
997 al.). 1 0.4306
997 altogether 1 0.3877
997 anal 2 0.8613
997 anus 1 0.4306
997 apparent 2 0.451
997 better 1 0.249
997 c 1 0.2348
997 carcinoma) 1 0.3877
997 cases 3 0.3844
997 cases. 1 0.2255
997 conventional 2 0.6206
997 deep 2 0.6041
997 dukes 1 0.4306
997 et 1 0.2883
997 given 1 0.1579
997 gives 1 0.3103
997 guleke 1 0.4306
997 higher 1 0.1852
997 irradiation 6 1.3942
997 irradiation. 1 0.2948
997 is, 1 0.2883
997 kilovoltage 2 0.8613
997 literature 1 0.2348
997 made 1 0.156
997 malignant 1 0.2348
997 metastases 2 0.5896
997 methods 1 0.1945
997 ottenheimer 1 0.4306
997 palliative 4 1.1533
997 patients 7 0.7246
997 performed). 1 0.4306
997 praeter 1 0.4306
997 questionable 1 0.3626
997 r. 1 0.2948
997 radiation 1 0.2348
997 radical 3 0.9931
997 radiotherapy 1 0.3021
997 rate 1 0.1585
997 rates, 1 0.3877
997 received 5 1.2147
997 rectal 2 0.7754
997 recurrence 1 0.3198
997 reifferscheid, 1 0.4306
997 results 3 0.37
997 showed 1 0.1535
997 site 1 0.249
997 stage 1 0.2087
997 surgery 3 0.6414
997 surgery, 2 0.6621
997 surgery. 1 0.2948
997 surgery; 1 0.4306
997 surgical 1 0.1945
997 survey 1 0.3021
997 survival 2 0.4143
997 therapy 1 0.1702
997 therapy. 1 0.2324
997 total 2 0.3357
997 treatment 3 0.3812
997 tumors. 1 0.2825
997 ultrahigh 2 0.8613
997 without 1 0.1626
998 administration 1 0.6637
998 advanced 2 1.5637
998 agents 1 0.8133
998 anticancer 1 1.2691
998 application 1 0.8503
998 cancer 2 1.1917
998 cancer, 1 0.9528
998 cancer. 2 2.1144
998 certain 1 0.6637
998 chemotherapeutic 1 1.1586
998 compounds 1 1.086
998 constant 1 0.8219
998 continuous 1 0.8503
998 disabling 1 1.357
998 drugs 1 0.831
998 forms 1 0.7196
998 general 1 0.7678
998 incurable 1 1.0572
998 limitations 1 1.357
998 limited 1 0.8219
998 management 1 0.797
998 management. 1 1.2691
998 may 2 0.7539
998 measures 2 1.9773
998 medical 1 0.8954
998 mental 1 0.8503
998 morale. 1 1.5073
998 nonspecific 1 1.086
998 patient 1 0.5667
998 patient's 1 1.0091
998 patients 2 0.7246
998 physical 1 0.8716
998 practical 1 0.97
998 receive 1 1.2069
998 relief 1 1.2069
998 relieve 1 1.1586
998 reviewed 1 0.8503
998 selection, 1 1.5073
998 specific 1 0.593
998 standpoint 1 1.2069
998 substantial 1 1.1586
998 supportive 2 2.4137
998 sustain 1 1.5073
998 symptoms 2 1.4285
998 techniques 1 0.8219
998 therapy 2 1.1917
998 usually 1 0.7091
998 value 1 0.6944
998 value, 1 1.357
998 various 2 1.1917
999 1 3 0.4269
999 1.5 1 0.2897
999 10 1 0.1387
999 107 2 0.6785
999 11 1 0.2012
999 12 1 0.1799
999 1963, 1 0.3173
999 2 4 0.4602
999 23 1 0.2523
999 2nd 1 0.2715
999 3/4 1 0.3392
999 39 1 0.2715
999 4 2 0.2666
999 4.5 1 0.3768
999 6.5 1 0.3017
999 79 1 0.3392
999 8 1 0.1702
999 8.5 1 0.3173
999 alive 1 0.3017
999 alone 1 0.2271
999 average 2 0.3381
999 bladder 1 0.3017
999 carcinoma 1 0.1799
999 carcinoma. 1 0.258
999 carefully 1 0.2715
999 carried 1 0.1887
999 cases; 1 0.3017
999 center 1 0.2425
999 character 1 0.2643
999 city 1 0.3392
999 common. 1 0.3392
999 complications 1 0.2208
999 concluded 1 0.1724
999 conduit 5 1.8841
999 conjunction 1 0.2897
999 considered 1 0.168
999 control. 1 0.2897
999 cystectomy 1 0.3392
999 described 1 0.1429
999 detail. 1 0.2715
999 details 1 0.258
999 died 3 0.6624
999 died, 1 0.3392
999 died. 1 0.3392
999 discussed. 1 0.1611
999 ending 1 0.3392
999 enteric 1 0.3392
999 established 2 0.4066
999 evaluation 1 0.2033
999 exist 1 0.258
999 extent 1 0.1992
999 fifty-nine 1 0.3768
999 fistulas, 1 0.3768
999 hope 1 0.2643
999 ileal 4 1.5073
999 including 1 0.2033
999 indicated 1 0.1773
999 infections, 1 0.3173
999 intractable 1 0.3768
999 july 1 0.3768
999 known 1 0.1841
999 lesion 1 0.2126
999 lesions 1 0.162
999 lived 1 0.3768
999 medical 1 0.2238
999 mostly 1 0.2643
999 mth. 2 0.4477
999 mth., 1 0.3392
999 mth.; 1 0.3392
999 older 1 0.2342
999 one 1 0.1054
999 operation. 1 0.2472
999 operations 1 0.2472
999 organs. 1 0.2715
999 palliative 3 0.7569
999 patient 1 0.1417
999 patients 8 0.7246
999 patients, 1 0.1887
999 patients. 1 0.1813
999 pelvic 1 0.2897
999 performed 1 0.1724
999 period 1 0.1429
999 period. 1 0.2271
999 persons. 1 0.3768
999 poorly 1 0.2897
999 postoperative 1 0.2271
999 procedure 5 0.9597
999 procedure. 1 0.3173
999 pyelonephritis, 1 0.3392
999 recurrent, 1 0.3768
999 removed 1 0.2126
999 respectively. 1 0.258
999 result 1 0.163
999 selected. 1 0.3768
999 severe 1 0.167
999 stage 1 0.1826
999 stage. 1 0.3173
999 stage; 1 0.3768
999 stages 1 0.2077
999 surgical 1 0.1702
999 survival 2 0.3625
999 surviving 3 0.8394
999 symptoms 1 0.1786
999 term 1 0.2101
999 thrombophlebitis 1 0.3768
999 time 1 0.1328
999 tolerated 1 0.2715
999 total 1 0.1469
999 treatment 1 0.1112
999 tumor 1 0.168
999 twenty-eight 1 0.3392
999 uncontrollable 1 0.3768
999 uremia, 1 0.3768
999 urinary 1 0.167
999 wound 1 0.2897
999 yr. 1 0.1973
1000 16 1 0.3123
1000 30 1 0.2399
1000 4 1 0.1777
1000 45 1 0.3364
1000 7 1 0.2315
1000 advanced 2 0.5212
1000 beneficial 1 0.3524
1000 benefited 1 0.5024
1000 cancer 2 0.3972
1000 cancers 1 0.3364
1000 chance 1 0.4023
1000 chemotherapy 2 0.6148
1000 complete 1 0.2331
1000 continuous 3 0.8503
1000 died 1 0.2944
1000 discussed. 1 0.2148
1000 disease 2 0.361
1000 dose 2 0.4797
1000 eight 1 0.2869
1000 epidermoid 1 0.4023
1000 given 1 0.1842
1000 greater 2 0.4157
1000 head 2 0.6591
1000 head-and-neck 1 0.5024
1000 immediately 1 0.3074
1000 infusion 1 0.2834
1000 infusions 1 0.3731
1000 intra-arterial 3 1.1586
1000 lesions 2 0.4321
1000 less 1 0.1881
1000 limb. 1 0.5024
1000 local 1 0.3028
1000 lower 1 0.2284
1000 malignant 3 0.8219
1000 management 1 0.2657
1000 mean 1 0.2417
1000 methotrexate 3 1.1586
1000 methotrexate. 1 0.5024
1000 neck 1 0.362
1000 neck, 1 0.4523
1000 organs, 1 0.3731
1000 partial 1 0.2801
1000 patients 6 0.7246
1000 pelvic 1 0.3862
1000 periods 1 0.2801
1000 region. 1 0.423
1000 regression 2 0.6466
1000 remaining 1 0.2559
1000 response 1 0.1834
1000 response. 2 0.7048
1000 role 1 0.2331
1000 showed 1 0.1791
1000 significantly 1 0.2112
1000 suggests 1 0.2683
1000 thirty-three 1 0.5024
1000 time, 1 0.2905
1000 tolerated, 1 0.5024
1000 total 2 0.3916
1000 treatment 2 0.2965
1000 treatment; 1 0.4523
1000 tumor. 2 0.8046
1000 used 1 0.1897
1000 varying 1 0.2711
1001 2 1 0.1841
1001 2-year 1 0.5428
1001 2/3 1 0.6029
1001 3,500 1 0.6029
1001 40% 1 0.4344
1001 75% 1 0.4827
1001 abdomen 1 0.5428
1001 abdominal 2 0.8954
1001 active, 1 0.4477
1001 adjuvant 1 0.4344
1001 advanced 1 0.3127
1001 agents 1 0.3253
1001 aggressive 1 0.5428
1001 almost 1 0.3099
1001 alone, 1 0.4344
1001 although 1 0.2318
1001 anti-tumor 1 0.5076
1001 anticancer 2 1.0153
1001 aorta. 1 0.6029
1001 apparent 1 0.3157
1001 approach-irradiation 1 0.6029
1001 approximately 2 0.6314
1001 attention 1 0.388
1001 available 1 0.3288
1001 carcinoma 2 0.5757
1001 carcinoma. 1 0.4127
1001 cavity, 1 0.6029
1001 chemical 1 0.3633
1001 chemotherapy 1 0.3689
1001 combination 1 0.3443
1001 consist 1 0.4477
1001 continue. 1 0.6029
1001 controlled 2 0.6886
1001 currently 1 0.4477
1001 demonstrates 1 0.4827
1001 diagnosed, 1 0.5428
1001 diagnosis 1 0.2481
1001 diagnosis. 2 0.8073
1001 died 2 0.7065
1001 directed 1 0.4037
1001 disease 2 0.4332
1001 disease, 1 0.322
1001 disease. 1 0.3188
1001 dose 1 0.2878
1001 drugs 4 1.3295
1001 earlier 1 0.4477
1001 early 1 0.221
1001 effective 1 0.3018
1001 efforts 1 0.5076
1001 employed. 1 0.5076
1001 employing 1 0.5076
1001 entire 1 0.3955
1001 eventually 1 0.5076
1001 expanded. 1 0.6029
1001 facilitating 1 0.6029
1001 field 1 0.3581
1001 figures. 1 0.6029
1001 finally, 1 0.4127
1001 find 1 0.4127
1001 first 1 0.221
1001 followed 1 0.2759
1001 formal 1 0.4477
1001 graph 1 0.5428
1001 histology 1 0.5076
1001 ii 1 0.4037
1001 iii 2 0.9269
1001 illustrating 1 0.6029
1001 immediately 1 0.3689
1001 important 1 0.2723
1001 includes 1 0.4477
1001 increase 1 0.2048
1001 indicated 1 0.2836
1001 indicated. 1 0.5076
1001 infusion 1 0.3401
1001 initial 1 0.2922
1001 instillation 1 0.6029
1001 investigation, 1 0.5428
1001 irradiation 1 0.3253
1001 iv 2 0.9269
1001 judicious 1 0.5428
1001 life 1 0.3188
1001 management 1 0.3188
1001 management. 1 0.5076
1001 medical 1 0.3581
1001 methods 1 0.2723
1001 might 3 0.9471
1001 modest 1 0.5428
1001 moment. 1 0.6029
1001 must 1 0.2945
1001 oncology 1 0.6029
1001 one 1 0.1687
1001 operation, 1 0.4477
1001 ovarian 3 1.3431
1001 patient 2 0.4534
1001 patients 5 0.7246
1001 possible, 1 0.5076
1001 presented 1 0.2339
1001 produce 1 0.322
1001 protocol 1 0.5076
1001 purpose 1 0.4037
1001 radioactive 1 0.3748
1001 rads, 1 0.6029
1001 range 1 0.3253
1001 received 1 0.3401
1001 recurrences 1 0.5076
1001 recurs-to 1 0.6029
1001 referred 1 0.3581
1001 regardless 1 0.4827
1001 results 1 0.1727
1001 seem 1 0.3288
1001 seen 1 0.2549
1001 selected 1 0.3533
1001 sequentially, 1 0.6029
1001 series 2 0.5673
1001 service, 1 0.6029
1001 show 1 0.2608
1001 since 1 0.2623
1001 stage 3 0.8767
1001 stages 1 0.3324
1001 standardized 1 0.4634
1001 subsequent 1 0.3288
1001 supportive 1 0.4827
1001 survival 1 0.29
1001 systemic 1 0.3362
1001 therapeutic 1 0.3044
1001 therapy 2 0.4767
1001 therapy, 1 0.388
1001 treatment 1 0.1779
1001 trials 2 0.9655
1001 tumor, 1 0.4634
1001 type 1 0.2507
1001 use 2 0.4767
1001 well 1 0.2108
1001 within 1 0.2238
1001 yr. 1 0.3157
1002 (hemihepatectomy) 1 0.6029
1002 (left 1 0.6029
1002 5 1 0.2287
1002 analyzed. 1 0.4229
1002 anatomy 1 0.5428
1002 appears 1 0.2593
1002 cancer 3 0.715
1002 cancers 1 0.4037
1002 carried 1 0.3018
1002 cases 1 0.1794
1002 classified 1 0.3633
1002 colon 4 1.8538
1002 complete 1 0.2797
1002 curable. 1 0.5428
1002 cures 1 0.6029
1002 either 1 0.2578
1002 embolic 4 2.0306
1002 ever, 1 0.4477
1002 extensive 1 0.3401
1002 favorably 1 0.4827
1002 followed 1 0.2759
1002 found 1 0.1587
1002 freedom 1 0.5076
1002 half 1 0.3533
1002 high 1 0.2158
1002 internal 1 0.3401
1002 justifiable 1 0.6029
1002 justifiable. 1 0.6029
1002 left 1 0.2723
1002 lesion 1 0.3401
1002 lesser 1 0.4127
1002 literature, 1 0.4827
1002 liver 5 1.186
1002 liver, 1 0.4127
1002 lobe 1 0.4127
1002 lobectomy 1 0.6029
1002 medical 1 0.3581
1002 metastasectomy) 1 0.6029
1002 metastases 3 1.2382
1002 metastasis 2 1.0153
1002 more. 1 0.6029
1002 mortality 1 0.3633
1002 occasionally 1 0.4037
1002 often 1 0.2922
1002 operation 1 0.3157
1002 operations 1 0.3955
1002 operative 1 0.3362
1002 patient 1 0.2267
1002 patients, 1 0.3018
1002 performed 2 0.5518
1002 periods 1 0.3362
1002 primary 3 0.7646
1002 rarely 1 0.4229
1002 rate, 1 0.4229
1002 rectum, 3 1.8087
1002 rectum. 1 0.6029
1002 recurrence 1 0.4477
1002 relates 1 0.6029
1002 removal, 1 0.5428
1002 reported. 1 0.3487
1002 resection 2 0.8954
1002 resections 2 1.0856
1002 resections, 1 0.6029
1002 results 1 0.1727
1002 review 1 0.3324
1002 reviewed. 1 0.4229
1002 right-lobe 1 0.6029
1002 seldom, 1 0.6029
1002 simultaneously 1 0.3633
1002 situated 1 0.5076
1002 technic 1 0.4634
1002 terminology 1 0.6029
1002 two 1 0.1846
1002 underwent 1 0.4344
1002 yr 1 0.4477
1003 (short-acting 1 1.5073
1003 administering 1 1.2691
1003 agent 1 0.8832
1003 agent). 1 1.5073
1003 alkylating 2 2.5382
1003 appears 1 0.6481
1003 awareness 1 1.357
1003 body 1 0.6077
1003 body. 1 1.357
1003 cancer 2 1.1917
1003 cases. 1 0.7893
1003 chlorimine 1 1.5073
1003 circulation 1 0.7893
1003 complications, 1 1.2691
1003 discussed 1 0.6138
1003 effective. 1 1.2069
1003 experience 1 0.7747
1003 five 1 0.797
1003 half 2 1.7663
1003 hemibody 1 1.5073
1003 lower 1 0.6851
1003 lung 2 1.2963
1003 means 1 0.6678
1003 method 1 0.5987
1003 nonresectable 2 3.0145
1003 occluding 1 1.5073
1003 palliative 2 2.0183
1003 patients 2 0.7246
1003 perfusion 1 0.8832
1003 potential 1 0.9887
1003 procedure 1 0.7678
1003 proper 1 1.0091
1003 providing 1 1.1586
1003 safe 1 0.9887
1003 selection 1 1.0318
1003 short-acting 1 1.5073
1003 temporarily 1 1.357
1003 treatment 2 0.8894
1003 upper 2 1.9399
1004 'ex 1 0.6029
1004 1 1 0.2277
1004 10.2% 1 0.6029
1004 124 1 0.5428
1004 177 1 0.6029
1004 19.8% 1 0.6029
1004 1961. 1 0.6029
1004 2 1 0.1841
1004 50.8% 1 0.6029
1004 7-week-old 1 0.6029
1004 8 1 0.2723
1004 957 1 0.6029
1004 abnormalities. 1 0.5076
1004 absolutely 1 0.6029
1004 according 1 0.3253
1004 administration 1 0.2655
1004 advantageous. 1 0.6029
1004 age 1 0.2494
1004 alluding 1 0.6029
1004 also 1 0.1687
1004 anastomosis 1 0.5428
1004 anatomical 1 0.4827
1004 associations 1 0.5428
1004 atresia, 1 0.4827
1004 atresia. 1 0.4229
1004 author 4 1.4131
1004 author, 1 0.6029
1004 authors 1 0.2778
1004 average 1 0.2705
1004 believes, 1 0.6029
1004 biliary 2 0.7163
1004 bilio-digestive 1 0.6029
1004 bilirubin, 1 0.5428
1004 briefly 1 0.3633
1004 case 2 0.4332
1004 case, 1 0.4477
1004 cases 5 0.8969
1004 cases, 1 0.3157
1004 cases. 1 0.3157
1004 cause 1 0.2723
1004 changes 1 0.1804
1004 collected 1 0.4344
1004 complications, 1 0.5076
1004 congenital 2 0.5518
1004 correctable 3 1.5229
1004 could 1 0.2166
1004 data 1 0.2455
1004 dehiscence 1 0.6029
1004 developed 1 0.2741
1004 diagnostic 3 0.898
1004 differential 2 0.7622
1004 differentiation' 1 0.6029
1004 direct 1 0.2836
1004 discussing 1 0.4827
1004 drainage 1 0.4827
1004 ductus 1 0.4477
1004 early 1 0.221
1004 early-latest 1 0.6029
1004 emphasizes 1 0.5428
1004 end 1 0.3689
1004 evaluation 1 0.3253
1004 exploration. 1 0.5428
1004 exploration; 1 0.6029
1004 extrahepatic 2 0.8073
1004 fatal 1 0.4037
1004 first 1 0.221
1004 found 1 0.1587
1004 four 1 0.2705
1004 genesis 1 0.4634
1004 girl 1 0.4037
1004 girl. 1 0.6029
1004 gradually 1 0.3811
1004 help 1 0.4344
1004 hepatico-duodenostomy 1 0.6029
1004 hepaticus 1 0.6029
1004 history 1 0.3487
1004 hope 1 0.4229
1004 icterus. 1 0.5076
1004 increasing 1 0.3533
1004 juvantibus 1 0.6029
1004 k 1 0.4344
1004 ladd's 1 0.6029
1004 later 1 0.3099
1004 lies 1 0.5076
1004 literature 1 0.3288
1004 manifestations 1 0.3443
1004 may 1 0.1508
1004 metabolic 1 0.2878
1004 nasal 1 0.4229
1004 need 1 0.3689
1004 normally 1 0.3811
1004 obstruction. 1 0.5428
1004 occur 1 0.2945
1004 one 1 0.1687
1004 ones. 1 0.4827
1004 operated 2 0.776
1004 operations 1 0.3955
1004 operative 1 0.3362
1004 passes 1 0.5076
1004 performed 1 0.2759
1004 performed-surgical 1 0.6029
1004 personal 2 0.8457
1004 points 1 0.4127
1004 polyethylene 1 0.5428
1004 postoperative 1 0.3633
1004 problems, 1 0.5428
1004 proposing 1 0.6029
1004 publications 1 0.6029
1004 recovered. 1 0.4827
1004 reduced 1 0.2723
1004 relieved 1 0.5428
1004 removed 1 0.3401
1004 result 1 0.2608
1004 reviews 1 0.4827
1004 safely 1 0.4827
1004 serum 1 0.2339
1004 signs. 1 0.6029
1004 solved 1 0.6029
1004 statistical 1 0.388
1004 stresses 1 0.6029
1004 successful 3 1.2382
1004 successfully 1 0.4127
1004 supposes 1 0.6029
1004 surgeon. 1 0.6029
1004 surgery. 1 0.4127
1004 surgical 1 0.2723
1004 symptoms 1 0.2857
1004 term 1 0.3362
1004 theoretically 1 0.5428
1004 time 1 0.2124
1004 tube 1 0.4827
1004 value 1 0.2778
1004 vit. 1 0.4827
1004 weeks 1 0.3157
1004 without 1 0.2277
1004 wound 1 0.4634
1004 year 1 0.3127
1004 years 1 0.2741
1005 3rd 1 1.086
1005 50 1 0.7196
1005 activity 2 1.0788
1005 adaptive 1 1.2069
1005 bilirubin. 1 1.5073
1005 birth 2 1.5356
1005 caused 1 0.6597
1005 day 1 0.7483
1005 decrease 1 0.6897
1005 demonstrate 1 0.8716
1005 enzyme. 1 1.1192
1005 excrete 1 1.2691
1005 glucuronyltransferase 1 1.5073
1005 glucuronyltransferase. 1 1.5073
1005 gradual 1 1.1192
1005 gradually 1 0.9528
1005 guinea-pigs 1 1.2069
1005 hereafter 1 1.5073
1005 highest 1 0.9528
1005 hypothesis 1 0.805
1005 icterus 1 1.357
1005 inability 1 1.086
1005 increases 1 0.7041
1005 jaundice 1 0.9083
1005 level 1 0.5821
1005 life. 1 1.086
1005 liver 1 0.593
1005 made 1 0.5459
1005 neonatal 1 0.9083
1005 neonatorum 1 1.5073
1005 newborn 1 0.8219
1005 reaches 1 1.2069
1005 results 1 0.4316
1005 shown. 1 1.5073
1005 simplex. 1 1.5073
1005 studies 1 0.4616
1005 suggestion 1 1.1192
1005 support 1 0.831
1006 (estriol, 1 0.6029
1006 11th 1 0.6029
1006 7th 1 0.6029
1006 acid. 1 0.4634
1006 administration 2 0.531
1006 aggravating 1 0.6029
1006 amount 1 0.2969
1006 appears 1 0.2593
1006 author 1 0.3533
1006 become 1 0.3324
1006 bilirubin 5 2.0183
1006 capacity 1 0.3288
1006 clinical 1 0.1965
1006 compete 1 0.6029
1006 concepts 1 0.4477
1006 conclusion 1 0.4037
1006 conjugate 2 0.9655
1006 conjugation 1 0.5428
1006 conjugation. 1 0.6029
1006 conjunction 1 0.4634
1006 cortisone) 1 0.6029
1006 date. 1 0.5428
1006 day 1 0.2993
1006 developed 1 0.2741
1006 development 1 0.2201
1006 due 1 0.2133
1006 enough 1 0.4634
1006 enzyme 2 0.7163
1006 erythroblastosis. 1 0.6029
1006 excreted 1 0.3748
1006 excretion 1 0.2836
1006 experimental 1 0.2797
1006 explain 1 0.4037
1006 factor 1 0.2857
1006 facts 1 0.4344
1006 findings 1 0.2395
1006 functional 1 0.3811
1006 furthermore, 1 0.4477
1006 glucuronic 1 0.5428
1006 glucuronyl 1 0.5428
1006 high 2 0.4315
1006 hormones 4 1.6915
1006 hyperbilirubinemia 1 0.5076
1006 hyperbilirubinemia, 1 0.6029
1006 icterus 1 0.5428
1006 implications 1 0.388
1006 importance 3 0.9213
1006 inability 1 0.4344
1006 increases 1 0.2816
1006 infants. 1 0.4127
1006 inhibit 1 0.4127
1006 insufficiency 1 0.3581
1006 interpretation 1 0.4037
1006 jaundice 2 0.7267
1006 jaundice. 1 0.4634
1006 later 1 0.3099
1006 leads 1 0.3362
1006 level 1 0.2328
1006 life 1 0.3188
1006 liver 2 0.4744
1006 may 1 0.1508
1006 mechanisms 1 0.3633
1006 mothers 1 0.3633
1006 must 1 0.2945
1006 naturally 1 0.4477
1006 necessary 1 0.3533
1006 neonatal 5 1.8167
1006 newborn. 1 0.5076
1006 newborns. 1 0.5428
1006 newly 1 0.4037
1006 nursing 1 0.5076
1006 occurring 1 0.3487
1006 pathogenesis 2 0.6802
1006 period 1 0.2287
1006 placental 1 0.4127
1006 possible. 1 0.4827
1006 pregnanediol 1 0.4634
1006 pregnanediol, 1 0.6029
1006 probably 1 0.2741
1006 progesterone 1 0.5428
1006 relative 1 0.3127
1006 report 1 0.2922
1006 responsible 1 0.3044
1006 results 1 0.1727
1006 show 1 0.2608
1006 steroid 4 1.3946
1006 steroids 3 1.2382
1006 steroids. 1 0.5428
1006 substrate 1 0.5076
1006 sufficient 1 0.3633
1006 therapeutic 1 0.3044
1006 transferase. 1 0.6029
1007 3 1 0.3425
1007 57 1 0.8046
1007 age 1 0.4157
1007 among 1 0.4694
1007 analysis 1 0.4833
1007 bilirubin 1 0.6728
1007 biopsy. 1 1.0048
1007 cases 2 0.5979
1007 conclusion 1 0.6728
1007 conservative 1 0.8461
1007 correctable 1 0.8461
1007 critical 1 0.6728
1007 determined 1 0.4568
1007 diagnosis 1 0.4135
1007 even 1 0.4398
1007 fall 1 0.5262
1007 hazardous 1 0.9046
1007 hepatitis 1 0.6728
1007 high 1 0.3596
1007 jaundice 2 1.2111
1007 jaundice. 1 0.7724
1007 later 1 0.5165
1007 led 1 0.5888
1007 lesions 1 0.4321
1007 liver 1 0.3953
1007 low 1 0.4398
1007 management 1 0.5313
1007 mortality 1 0.6056
1007 mth. 1 0.5969
1007 neonatal 3 1.8167
1007 noted. 1 0.6728
1007 obstructive 3 2.0183
1007 operation 1 0.5262
1007 patients 1 0.2415
1007 percentage 1 0.5603
1007 problems 1 0.5212
1007 proper 1 0.6728
1007 recommended 1 0.6728
1007 serial 1 0.6148
1007 seriousness 1 0.9046
1007 stressed. 1 0.7724
1007 study 1 0.3096
1007 surgically 1 0.9046
1007 treated 1 0.4135
1008 (1) 1 0.1218
1008 (2) 1 0.1218
1008 (3) 1 0.1328
1008 (japanese). 1 0.2512
1008 1 1 0.0949
1008 1, 1 0.1617
1008 2 2 0.1534
1008 3 2 0.1713
1008 3, 2 0.4023
1008 acidophilic 1 0.2262
1008 activities 1 0.1453
1008 activity 1 0.0899
1008 balloon 1 0.2115
1008 bile 5 0.881
1008 biliary 4 0.5969
1008 bilirubin, 1 0.2262
1008 biopsy 1 0.1617
1008 capillary 1 0.181
1008 capsule 1 0.2011
1008 capsule, 1 0.1931
1008 cause 1 0.1134
1008 cell 3 0.2551
1008 cells 2 0.1516
1008 cells, 4 0.4871
1008 cells. 2 0.224
1008 cellular 2 0.274
1008 changes 4 0.3007
1008 characteristic 2 0.2537
1008 characteristic. 2 0.5024
1008 characteristics 1 0.1401
1008 cholangiolitic 1 0.2512
1008 cholangiolitis. 1 0.2512
1008 classification 1 0.1931
1008 clinical 4 0.3275
1008 clinically 1 0.172
1008 consistent 1 0.1401
1008 conspicuous. 1 0.2512
1008 cords 1 0.2262
1008 could 1 0.0903
1008 craing-landing. 1 0.2512
1008 degeneration 2 0.362
1008 differentiate 1 0.2011
1008 distortion 1 0.2262
1008 divisible 1 0.2512
1008 drug 1 0.1315
1008 ducts 2 0.362
1008 ducts. 1 0.2262
1008 due 1 0.0889
1008 e. 1 0.172
1008 extreme 1 0.1648
1008 findings 3 0.2994
1008 fine 1 0.1762
1008 formation 2 0.2254
1008 found, 1 0.1762
1008 found. 1 0.1617
1008 general, 1 0.181
1008 giant 4 0.6728
1008 glisson's 2 0.5024
1008 granules 1 0.1648
1008 hepatic 1 0.1417
1008 hepatitis 8 1.3455
1008 high. 1 0.2115
1008 histological 6 0.8954
1008 histologically, 1 0.2115
1008 i. 2 0.2985
1008 infancy 1 0.1762
1008 infancy, 1 0.1865
1008 infants 1 0.1199
1008 infants, 1 0.2115
1008 infants. 1 0.172
1008 infiltration 2 0.3862
1008 inflammatory 2 0.3731
1008 jaundice 1 0.1514
1008 laboratory 1 0.1453
1008 liver 12 1.186
1008 lobules 2 0.4523
1008 low, 1 0.2262
1008 made. 1 0.1562
1008 many 1 0.1013
1008 marked 1 0.1127
1008 markedly 1 0.1342
1008 morphologically, 1 0.2115
1008 multinuclear 1 0.2512
1008 necrosis 3 0.5159
1008 normal 1 0.0676
1008 noted. 1 0.1682
1008 observations 1 0.1056
1008 observed. 3 0.4542
1008 obstructive 1 0.1682
1008 picture 1 0.137
1008 plugs 1 0.2262
1008 points 1 0.172
1008 poisoning 1 0.172
1008 presenting 1 0.1682
1008 proliferation 1 0.1453
1008 range. 1 0.2115
1008 relatively 1 0.1208
1008 replaced 1 0.1931
1008 scanty. 1 0.2512
1008 serum 1 0.0975
1008 sgot 2 0.5024
1008 sgpt 1 0.2512
1008 similar 1 0.094
1008 slight 2 0.2985
1008 slight. 1 0.2262
1008 so-called 1 0.181
1008 specific 2 0.1977
1008 stasis 5 1.1308
1008 studies 1 0.0769
1008 studies. 1 0.1931
1008 study 4 0.3096
1008 tissue 1 0.0872
1008 type 6 0.6268
1008 type, 2 0.3364
1008 types 1 0.1218
1008 types: 1 0.2262
1008 unknown 1 0.1865
1008 values 1 0.1268
1008 viral 1 0.1514
1008 within 1 0.0933
1009 'giant 1 0.6029
1009 1 1 0.2277
1009 1-month-old 1 0.6029
1009 2 1 0.1841
1009 45-60 1 0.6029
1009 acute 1 0.2993
1009 admitted 1 0.5428
1009 also 2 0.3373
1009 antibody, 1 0.6029
1009 areas 2 0.6376
1009 areas, 1 0.6029
1009 ascites. 1 0.6029
1009 autopsy 1 0.3955
1009 basophile 1 0.6029
1009 bizarre. 1 0.6029
1009 borders 1 0.6029
1009 cardiac 1 0.2705
1009 case 1 0.2166
1009 cell 5 1.0202
1009 cells 3 0.5459
1009 cells, 2 0.5845
1009 changes. 1 0.4827
1009 circulatory 1 0.4229
1009 cirrhosis 1 0.4229
1009 connective 2 0.8688
1009 cytoplasm 1 0.3748
1009 degenerated 1 0.5428
1009 degenerative 1 0.4827
1009 deposits 1 0.4634
1009 dilatation 1 0.4229
1009 due 1 0.2133
1009 early 1 0.221
1009 errors 1 0.4229
1009 erythropoiesis 1 0.5076
1009 erythropoiesis, 1 0.6029
1009 etiology 1 0.3324
1009 failure. 1 0.5076
1009 foci 1 0.4344
1009 found 2 0.3174
1009 ft. 1 0.6029
1009 giant 5 2.0183
1009 glands. 1 0.4827
1009 granules 1 0.3955
1009 heart, 1 0.4634
1009 hepatic 1 0.3401
1009 hepatitis 1 0.4037
1009 hepatitis' 1 0.5428
1009 hepatitis. 2 0.9655
1009 histiocytic 1 0.6029
1009 histology 1 0.5076
1009 hospital 1 0.3811
1009 hydrothorax, 1 0.6029
1009 hyperplastic. 1 0.6029
1009 immature 1 0.4037
1009 immunologic 1 0.3955
1009 inborn 1 0.4827
1009 infancy. 1 0.6029
1009 infant 1 0.3401
1009 infection. 1 0.3955
1009 infiltrations. 1 0.5428
1009 interest 1 0.4037
1009 intermediate 1 0.388
1009 iron 3 1.5229
1009 irregular 1 0.4477
1009 islets 1 0.5428
1009 kupffer 1 0.6029
1009 langerhans 1 0.5428
1009 large, 1 0.4634
1009 left 1 0.2723
1009 liver 4 0.9488
1009 lobules 1 0.5428
1009 macronodular 1 0.6029
1009 male 1 0.3071
1009 malformation, 1 0.5076
1009 margin 1 0.5076
1009 may 1 0.1508
1009 metabolism 1 0.2857
1009 normal 1 0.1621
1009 nuclei 1 0.3811
1009 nuclei, 1 0.5428
1009 pancreas 1 0.4344
1009 pathogenesis 1 0.3401
1009 pathology 1 0.4037
1009 pigment 3 1.6283
1009 portal 1 0.5076
1009 predominance 1 0.4827
1009 present 1 0.1985
1009 presumably 1 0.3955
1009 proliferation 1 0.3487
1009 prominent 1 0.4477
1009 pulpa. 1 0.6029
1009 regeneration 1 0.4344
1009 response 2 0.4402
1009 revealed 1 0.2922
1009 salivary 1 0.5428
1009 scattered 1 0.4827
1009 showed 3 0.6448
1009 size 1 0.3157
1009 sometimes 1 0.388
1009 spleen 1 0.3581
1009 splenomegaly, 1 0.6029
1009 stage 1 0.2922
1009 still 1 0.2816
1009 stimuli. 1 0.5076
1009 suggested 1 0.2507
1009 tissue 1 0.2093
1009 tissue. 1 0.388
1009 transformation 1 0.3288
1009 type 1 0.2507
1009 unknown. 1 0.4827
1009 vacuolar 1 0.6029
1009 variant 1 0.4634
1009 varied 1 0.3811
1009 variety 1 0.3253
1009 ventricular 1 0.2623
1009 viral 1 0.3633
1009 well 2 0.4217
1009 widened, 1 0.6029
1010 14 1 0.831
1010 anorexia, 1 1.5073
1010 atresia 1 0.9221
1010 better 1 0.8716
1010 biliary 1 0.8954
1010 cases 1 0.4484
1010 circulatory 1 1.0572
1010 congenital 1 0.6897
1010 continued 1 0.8716
1010 diarrhea, 1 1.357
1010 differentiated 1 1.0091
1010 difficult. 1 1.2691
1010 disease 1 0.5415
1010 disturbance 1 1.086
1010 duct 1 1.0318
1010 due 1 0.5332
1010 early 1 0.5526
1010 edema 1 1.0318
1010 electrolyte 1 1.1586
1010 extremity 1 1.2069
1010 fat, 1 1.357
1010 follow-up 1 1.0091
1010 found 1 0.3968
1010 infantile 1 0.8219
1010 jaundice. 1 1.1586
1010 long-term 1 0.8716
1010 metabolism 1 0.7143
1010 obstructive 1 1.0091
1010 obtain 1 1.0572
1010 operation 1 0.7893
1010 operation. 1 0.9887
1010 order 1 0.7893
1010 period. 1 0.9083
1010 postoperative 2 1.8167
1010 problem 1 0.8607
1010 problem. 1 1.2069
1010 procedure 1 0.7678
1010 protein, 1 1.086
1010 reported. 1 0.8716
1010 required. 1 1.357
1010 results 2 0.8633
1010 study 1 0.4643
1010 surgery 1 0.7483
1010 suruga-yamazaki's 1 1.5073
1010 technically 1 1.357
1010 upper 1 0.97
1011 10 1 0.3699
1011 24 1 0.5212
1011 2nd 1 0.724
1011 4 1 0.3554
1011 8 2 0.9076
1011 activity 2 0.7192
1011 beginning 1 0.6352
1011 bilirubin 1 0.6728
1011 caucasian 1 1.0048
1011 causes 1 0.5669
1011 control 1 0.3778
1011 described 1 0.3811
1011 developed 1 0.4568
1011 direct-reacting 1 1.0048
1011 due 1 0.3554
1011 fact 1 0.5313
1011 factor 2 0.9524
1011 familial 2 1.3182
1011 formation 1 0.4509
1011 four 1 0.4509
1011 glucuronide 1 1.0048
1011 glucuronyl 1 0.9046
1011 group 1 0.3714
1011 healthy 1 0.724
1011 homogenates, 1 1.0048
1011 hyperbilirubinemia 1 0.8461
1011 hyperbilirubinemia. 1 0.9046
1011 increased 1 0.3124
1011 infants 3 1.4391
1011 infants. 1 0.6879
1011 inhibited 1 0.6352
1011 inhibitor 2 1.5448
1011 inhibitory 1 0.6591
1011 inhibits 1 0.6728
1011 kernicterus. 1 1.0048
1011 known 1 0.4909
1011 liver 2 0.7907
1011 mechanism 1 0.4629
1011 mothers 1 0.6056
1011 mothers. 1 0.8461
1011 neonatal 2 1.2111
1011 neonates. 1 1.0048
1011 newborn 1 0.548
1011 o-aminophenol 1 1.0048
1011 observed 1 0.3425
1011 occurs 1 0.5366
1011 pregnancy 1 0.5888
1011 pregnancy, 1 0.7462
1011 pregnant 1 0.6056
1011 probably 1 0.4568
1011 progestational 1 1.0048
1011 rat 1 0.4135
1011 requires 1 0.6148
1011 respectively, 1 0.724
1011 responsible 1 0.5074
1011 sera 2 1.3182
1011 serum 3 1.1695
1011 slices 1 0.8046
1011 steroid 1 0.5811
1011 study. 1 0.6591
1011 suggests 1 0.5366
1011 syndrome 1 0.4661
1011 times 1 0.4833
1011 transferase 1 1.0048
1011 transient 2 1.3758
1011 trimester 1 0.8461
1011 unconjugated 1 0.9046
1011 unidentified. 1 1.0048
1011 unknown 1 0.7462
1011 unrelated, 1 0.9046
1011 women 3 1.6265
1012 1 1 0.3795
1012 3 3 1.0275
1012 atresia, 1 0.8046
1012 atresia. 1 0.7048
1012 babies 2 1.6091
1012 biliary 2 1.1938
1012 culture 1 0.5031
1012 disease. 1 0.5313
1012 extrahepatic 1 0.6728
1012 hepatitis 3 2.0183
1012 hepatitis, 1 0.7462
1012 infants 1 0.4797
1012 liver 1 0.3953
1012 liver-biopsy 1 1.0048
1012 neonatal 3 1.8167
1012 positive 1 0.5366
1012 presence 1 0.3828
1012 results 1 0.2878
1012 specimens 1 0.6466
1012 studied 1 0.3501
1012 virus 1 0.5262
1012 virus. 1 0.724
1012 yielded 1 0.6352
1013 1 1 0.1138
1013 22 1 0.2064
1013 3 1 0.1028
1013 almost 1 0.1549
1013 and, 1 0.1564
1013 bilirubin 1 0.2018
1013 biopsy 3 0.582
1013 cases, 1 0.1579
1013 cells 3 0.2729
1013 cells; 1 0.2414
1013 centrolobular 1 0.3015
1013 characterized 2 0.3188
1013 cholestasis 1 0.3015
1013 cholestasis; 1 0.3015
1013 cirrhosis 1 0.2114
1013 classified 1 0.1817
1013 clinical 3 0.2948
1013 completely, 1 0.2714
1013 course 1 0.137
1013 damage 2 0.3071
1013 diagnosis 1 0.124
1013 direct 1 0.1418
1013 disappeared 1 0.2172
1013 examination 1 0.1522
1013 examinations 1 0.2064
1013 features. 1 0.2538
1013 findings 2 0.2395
1013 giant 3 0.6055
1013 good 1 0.1681
1013 greater 1 0.1247
1013 healed 1 0.2538
1013 hepatic 3 0.5102
1013 hepatitis 1 0.2018
1013 hepatitis, 1 0.2238
1013 hepatitis: 1 0.3015
1013 histologic 3 0.6055
1013 hyperbilirubinemia. 1 0.2714
1013 i, 2 0.5076
1013 ii 3 0.6055
1013 ii, 1 0.2414
1013 increase 1 0.1024
1013 increases 1 0.1408
1013 infants 1 0.1439
1013 inflammatory 1 0.2238
1013 intracellular 1 0.1977
1013 investigated. 1 0.2317
1013 laboratory 1 0.1743
1013 liver 2 0.2372
1013 made 1 0.1092
1013 may 1 0.0754
1013 needle 1 0.2317
1013 neonatal 3 0.545
1013 numerous 1 0.1791
1013 occurrence 1 0.1791
1013 poor 1 0.1743
1013 prognosis 1 0.1662
1013 prominent 1 0.2238
1013 provisionally 1 0.3015
1013 reaction. 1 0.2238
1013 relation 1 0.1389
1013 resulted. 1 0.2714
1013 results 1 0.0863
1013 revealed 2 0.2922
1013 said 1 0.2414
1013 sequelae, 1 0.2538
1013 serial 1 0.1844
1013 serum 2 0.2339
1013 showed 1 0.1075
1013 slight 1 0.1791
1013 specific 3 0.3558
1013 transaminase 1 0.2714
1013 transaminases 1 0.3015
1013 type 10 1.2537
1013 type. 1 0.2018
1013 types: 1 0.2714
1013 undetermined 1 0.2714
1013 within 1 0.1119
1013 without 1 0.1138
1013 yr 1 0.2238
1014 2 1 0.9204
1014 a. 1 1.9056
1014 anemia 1 2.1719
1014 avitaminosis 1 3.0145
1014 biliary 1 1.7907
1014 biopsy, 1 2.5382
1014 birth, 1 2.3172
1014 caused 1 1.3194
1014 complicating 1 2.3172
1014 count 1 2.0636
1014 crises. 1 3.0145
1014 crisis 1 2.2385
1014 crythrocyte 1 3.0145
1014 deglobulisation 1 3.0145
1014 early 1 1.1051
1014 existence, 1 3.0145
1014 hand, 1 1.8167
1014 hemolytic 1 2.1719
1014 homozygous 1 2.3172
1014 jaundice 1 1.8167
1014 liver 1 1.186
1014 low 1 1.3194
1014 male 1 1.5356
1014 obstructive 1 2.0183
1014 one 1 0.8433
1014 other. 1 2.4137
1014 owing 1 2.0183
1014 probably 1 1.3703
1014 proven 1 2.5382
1014 series 1 1.4182
1014 spherocytic 1 3.0145
1014 syndrome, 1 2.0183
1014 twins 1 2.4137
1014 xerophthalmia, 1 3.0145
1015 ('giant 1 0.7536
1015 1 1 0.2846
1015 2 1 0.2301
1015 4 3 0.7997
1015 although 1 0.2897
1015 appears 1 0.3241
1015 birth. 1 0.5596
1015 boys 2 1.1192
1015 cases 1 0.2242
1015 causes 1 0.4252
1015 causes. 1 0.7536
1015 cell 3 0.7652
1015 chronic 1 0.3598
1015 concluded 1 0.3449
1015 could 1 0.2708
1015 day 1 0.3742
1015 described 1 0.2859
1015 described. 1 0.3773
1015 error 1 0.543
1015 excluded. 1 0.5596
1015 familial 1 0.4943
1015 family 1 0.4542
1015 findings 2 0.5987
1015 four 1 0.3381
1015 giant 2 1.0091
1015 girls 1 0.5793
1015 healthy. 1 0.7536
1015 hepatitis 4 2.0183
1015 hepatitis'), 1 0.7536
1015 hitherto 1 0.6034
1015 inborn 1 0.6034
1015 jaundice 2 0.9083
1015 jaundice?. 1 0.7536
1015 metabolism. 1 0.5046
1015 morphological 1 0.4611
1015 must 1 0.3682
1015 neonatal 3 1.3625
1015 obstructive 2 1.0091
1015 one 2 0.4217
1015 onset 1 0.4358
1015 pathological 1 0.4066
1015 patients 1 0.1812
1015 picture, 1 0.6785
1015 possibilities 1 0.5596
1015 possible 1 0.3023
1015 several 1 0.326
1015 siblings 1 0.5596
1015 so-called 1 0.543
1015 two 1 0.2308
1015 varied 1 0.4764
1015 weeks 1 0.3946
1016 (1) 1 0.2087
1016 (2) 1 0.2087
1016 1 1 0.1626
1016 13 1 0.249
1016 2 1 0.1315
1016 4 1 0.1523
1016 also 1 0.1205
1016 anlage 1 0.4306
1016 atresia 1 0.2635
1016 atresia. 1 0.3021
1016 autopsy 1 0.2825
1016 bile 7 2.1144
1016 birth. 1 0.3198
1016 boy 1 0.2883
1016 capacity 1 0.2348
1016 case 1 0.1547
1016 case, 1 0.3198
1016 cases: 1 0.4306
1016 cell 2 0.2915
1016 cells. 2 0.384
1016 cells; 1 0.3448
1016 collapsed 1 0.3877
1016 coloration 1 0.4306
1016 coloration. 1 0.4306
1016 common 1 0.2104
1016 compensatory 1 0.2401
1016 connection 1 0.3103
1016 considered 1 0.192
1016 corresponds 1 0.3877
1016 days 1 0.1711
1016 description 1 0.2825
1016 distinguished 1 0.2883
1016 duct 1 0.2948
1016 duct, 1 0.3626
1016 ducts 4 1.2411
1016 ducts. 1 0.3877
1016 ductular 2 0.8613
1016 empty. 1 0.4306
1016 enlarged 1 0.3877
1016 examination 1 0.2175
1016 explained 1 0.2429
1016 faint 1 0.4306
1016 form 1 0.1874
1016 girl 1 0.2883
1016 great 1 0.2459
1016 green 2 0.7754
1016 histological 1 0.2558
1016 however, 1 0.156
1016 hypoplasia 2 0.6896
1016 hypoplasia, 1 0.4306
1016 hypoplastic 1 0.3626
1016 increasing 1 0.2523
1016 intestine 1 0.3448
1016 intrahepatic 1 0.3448
1016 jaundice 1 0.2595
1016 liver 4 0.6777
1016 liver. 2 0.6041
1016 long 1 0.2234
1016 marked 1 0.1932
1016 may 1 0.1077
1016 minor 1 0.2771
1016 mth 1 0.331
1016 narrow 1 0.3626
1016 number 1 0.1648
1016 numerous 1 0.2558
1016 old 1 0.2429
1016 ontogenesis 1 0.3877
1016 open 1 0.3021
1016 pneumonia, 1 0.3877
1016 present 1 0.1418
1016 primordial 1 0.3626
1016 probing, 1 0.4306
1016 proliferation. 1 0.4306
1016 reaching 2 0.6206
1016 reduced. 1 0.3626
1016 regular 1 0.3198
1016 revealed 2 0.4175
1016 second 1 0.2194
1016 show 1 0.1863
1016 shows 1 0.2374
1016 signs 1 0.2401
1016 since 1 0.1874
1016 size 1 0.2255
1016 slightly 1 0.2459
1016 small 1 0.1728
1016 smallest 1 0.3448
1016 solid 2 0.6621
1016 sprouts 2 0.8613
1016 stage 1 0.2087
1016 survival 1 0.2071
1016 type 1 0.1791
1016 was, 1 0.331
1016 yr 1 0.3198
1017 (1) 1 0.3653
1017 (11 1 0.6785
1017 (2) 1 0.3653
1017 (7 1 0.6785
1017 (necrotic 1 0.7536
1017 1 1 0.2846
1017 18 1 0.411
1017 2 1 0.2301
1017 3 1 0.2569
1017 acidophilic 1 0.6785
1017 action 1 0.3279
1017 also 2 0.4217
1017 appeared 1 0.3625
1017 architecture 1 0.6346
1017 areas. 1 0.6034
1017 atresia 1 0.4611
1017 atresia. 1 0.5286
1017 author 2 0.8832
1017 balloon 1 0.6346
1017 basis 1 0.3299
1017 bile 3 1.5858
1017 biliary 3 1.3431
1017 birth 1 0.3839
1017 blood 1 0.2329
1017 cases 3 0.6727
1017 cases). 2 1.2691
1017 cases, 1 0.3946
1017 cell 3 0.7652
1017 cells 4 0.9098
1017 cells, 2 0.7306
1017 cellular 1 0.411
1017 changes 1 0.2255
1017 cirrhosis 1 0.5286
1017 cirrhosis. 1 0.7536
1017 collapse 1 0.6785
1017 congenital 3 1.0346
1017 consequences. 1 0.6785
1017 considered 1 0.336
1017 considers 1 0.6346
1017 cords 1 0.6785
1017 cytoplasm. 1 0.6785
1017 cytotoxic 1 0.5286
1017 days 1 0.2994
1017 discolored. 1 0.7536
1017 dissociation 1 0.6785
1017 disturbed 1 0.4685
1017 ductules. 1 0.7536
1017 due 1 0.2666
1017 enlarged, 1 0.7536
1017 enlarged. 1 0.6785
1017 eosinophilic 1 0.6034
1017 erythrocytes, 1 0.6034
1017 erythrocytic 1 0.7536
1017 etiology 1 0.4155
1017 extra-hepatic 1 0.7536
1017 fatal 1 0.5046
1017 feature 1 0.5286
1017 fetal 2 0.8607
1017 fibrosis 1 0.6034
1017 fibrosis, 1 0.5793
1017 fibrous 1 0.5793
1017 firm, 1 0.7536
1017 first 1 0.2763
1017 flabby 1 0.7536
1017 framework, 1 0.7536
1017 giant 3 1.5137
1017 granular 1 0.5793
1017 green, 1 0.7536
1017 groups: 1 0.6034
1017 hepatic 1 0.4252
1017 hepatitis 3 1.5137
1017 hepatitis, 2 1.1192
1017 hepatitis. 1 0.6034
1017 histiocytes. 1 0.7536
1017 icteric. 1 0.7536
1017 incompatibility. 1 0.7536
1017 increased, 1 0.5596
1017 infants 1 0.3598
1017 infection, 1 0.5286
1017 infiltrations. 1 0.6785
1017 interlobular 1 0.7536
1017 intralobular 1 0.7536
1017 intrauterine 1 0.543
1017 jaundice 1 0.4542
1017 leucocytes, 1 0.7536
1017 life, 1 0.5046
1017 lipids 1 0.5596
1017 liver 4 1.186
1017 lymphocytes 1 0.4416
1017 material 1 0.3496
1017 mesenchymal 1 0.6785
1017 microscopy 2 0.97
1017 morphological 1 0.4611
1017 neonatal 2 0.9083
1017 nodular 1 0.6346
1017 normal. 1 0.4542
1017 observed 1 0.2569
1017 old. 1 0.6346
1017 pathological 2 0.8133
1017 pericholangiolitic 2 1.5073
1017 periportal 1 0.7536
1017 periportal, 1 0.7536
1017 persistent. 1 0.7536
1017 picture 1 0.411
1017 polymorphism 1 0.7536
1017 possibility 1 0.4303
1017 post-necrotic 1 0.7536
1017 presence 1 0.2871
1017 proliferation 2 0.8716
1017 pseudolobuli 1 0.7536
1017 regeneration 1 0.543
1017 regeneration, 1 0.7536
1017 reports 1 0.485
1017 result 2 0.6519
1017 retention. 1 0.6346
1017 revealed 1 0.3653
1017 scattered 1 0.6034
1017 secondary 1 0.3773
1017 series 1 0.3546
1017 show 1 0.326
1017 shows 3 1.2465
1017 signs 1 0.4202
1017 similar 1 0.2821
1017 similarity 1 0.5793
1017 sometimes 1 0.485
1017 spaces 1 0.5286
1017 spleen 1 0.4477
1017 stasis, 1 0.7536
1017 stools 1 0.6346
1017 stromal 1 0.6785
1017 study 1 0.2322
1017 suggested 1 0.3134
1017 surface. 1 0.6034
1017 tissue 1 0.2616
1017 transformation). 1 0.7536
1017 tree 1 0.6346
1017 vacuoles, 1 0.7536
1017 viral 3 1.3625
1017 virus. 1 0.543
1017 weeks 1 0.3946
1017 year 1 0.3909
1018 'steady 1 0.3768
1018 2 1 0.1151
1018 80% 1 0.2798
1018 achieve 1 0.2643
1018 albumin, 1 0.3392
1018 animals 1 0.1602
1018 anticipated 1 0.3768
1018 average 1 0.1691
1018 bile 1 0.2643
1018 bilirubin 8 2.0183
1018 breakdown, 1 0.3392
1018 c 1 0.2055
1018 carried 1 0.1887
1018 clinically. 1 0.3768
1018 closely 1 0.2152
1018 daily 1 0.2055
1018 distributed 1 0.3173
1018 double 1 0.2472
1018 duct 1 0.258
1018 entirely 1 0.2425
1018 excreted 1 0.2342
1018 excretion 1 0.1773
1018 excretion. 1 0.2798
1018 experimental 1 0.1748
1018 extravascularly 1 0.3768
1018 followed 1 0.1724
1018 forms 1 0.1799
1018 found 1 0.0992
1018 function 1 0.1691
1018 hb 1 0.3768
1018 i.v. 1 0.2897
1018 increased 1 0.1171
1018 indicating 1 0.2425
1018 injected 2 0.3653
1018 jaundice 1 0.2271
1018 jaundice. 3 0.869
1018 kidney 1 0.167
1018 level, 1 0.3173
1018 levels 1 0.1476
1018 ligation 1 0.3017
1018 liver 1 0.1483
1018 metabolism 1 0.1786
1018 monkeys. 1 0.3017
1018 nearly 1 0.2305
1018 normal 1 0.1013
1018 obstructive 3 0.7569
1018 paralleled 1 0.3768
1018 principally 1 0.3017
1018 production 1 0.1919
1018 radioactive 1 0.2342
1018 radioactivity 1 0.2715
1018 radioisotope 1 0.2798
1018 ratio 1 0.1973
1018 reached, 2 0.7536
1018 relatively 1 0.1813
1018 required 1 0.2055
1018 rhesus 1 0.3173
1018 rising 2 0.6034
1018 seen 1 0.1593
1018 series 1 0.1773
1018 serum 3 0.4386
1018 stable 1 0.2715
1018 state' 1 0.3768
1018 stop 1 0.3173
1018 stopped 1 0.2897
1018 suggesting 1 0.2305
1018 takes 1 0.2897
1018 time 1 0.1328
1018 turnover 1 0.2523
1018 urine, 1 0.3173
1018 wk 1 0.3173
1019 5 1 0.2859
1019 ahg 1 0.7536
1019 although 1 0.2897
1019 amputation 2 1.1586
1019 amputation, 1 0.6785
1019 antibiotic 1 0.6034
1019 application 1 0.4252
1019 areas 1 0.3985
1019 attitude 1 0.6034
1019 authors 1 0.3472
1019 avoid 1 0.5596
1019 believe 1 0.5046
1019 bona 1 0.7536
1019 briefly 1 0.4542
1019 cardiac 1 0.3381
1019 case 2 0.5415
1019 case, 1 0.5596
1019 cases 1 0.2242
1019 completely 1 0.4416
1019 complications, 1 0.6346
1019 consider 1 0.5286
1019 considered 1 0.336
1019 constitutes 1 0.5596
1019 control 1 0.2834
1019 course 2 0.6851
1019 delays 1 0.7536
1019 demand 1 0.6034
1019 died 1 0.4416
1019 dint 1 0.7536
1019 direct-current 1 0.7536
1019 disarticulation 1 0.6785
1019 drainage 1 0.6034
1019 early 1 0.2763
1019 elective 1 0.7536
1019 electrocoagulation 1 0.7536
1019 endorse 1 0.7536
1019 experience 1 0.3874
1019 family. 1 0.6346
1019 fastness, 1 0.7536
1019 fatal 1 0.5046
1019 felt 1 0.5596
1019 fide 1 0.7536
1019 first 1 0.2763
1019 flaps 1 0.7536
1019 following 1 0.2498
1019 gained 1 0.6034
1019 grossly 1 0.5286
1019 guarantee 1 0.6785
1019 hematologic 1 0.6034
1019 hematoma. 1 0.7536
1019 hemophiliac 1 0.5596
1019 hemophiliac, 1 0.7536
1019 hemophiliacs. 1 0.6346
1019 hemophilias 1 0.7536
1019 hemorrhage 1 0.485
1019 hemostasis, 1 0.6785
1019 hip 1 0.6346
1019 indication 1 0.5286
1019 infected 3 1.2329
1019 infection 1 0.3546
1019 infection, 1 0.5286
1019 intervention, 1 0.7536
1019 judicious 1 0.6785
1019 knowledge 1 0.4943
1019 last 2 1.0091
1019 left 1 0.3403
1019 lessons 1 0.7536
1019 level 1 0.291
1019 lightly, 1 0.7536
1019 long 1 0.3909
1019 loss 1 0.3653
1019 made 1 0.2729
1019 major 1 0.3625
1019 management. 1 0.6346
1019 massive 1 0.5596
1019 nihilistic 1 0.7536
1019 one 1 0.2108
1019 onset 1 0.4358
1019 open 1 0.5286
1019 operative 1 0.4202
1019 outcome. 1 0.7536
1019 particular 1 0.3805
1019 patient 3 0.8501
1019 patients 1 0.1812
1019 performed. 1 0.6346
1019 pericardial 1 0.5596
1019 physician, 1 0.7536
1019 plasma 2 0.6077
1019 plea 1 0.6346
1019 postoperative 1 0.4542
1019 prevailing 1 0.6785
1019 previous 1 0.4066
1019 prior 1 0.4025
1019 procedure 2 0.7678
1019 procedures 2 0.8503
1019 produced, 1 0.7536
1019 proximal 1 0.5159
1019 proximally 1 0.7536
1019 pseudotumor 2 1.357
1019 reasons 1 0.5046
1019 relation 1 0.3472
1019 reported 1 0.3054
1019 required 1 0.411
1019 resort 1 0.6785
1019 responsive 1 0.5596
1019 resulted 2 0.7306
1019 revision 1 0.7536
1019 second 2 0.7678
1019 secondary 1 0.3773
1019 separate 1 0.4764
1019 septicemia 1 0.6346
1019 severe 2 0.6678
1019 should, 1 0.6785
1019 significant 1 0.2646
1019 site 1 0.4358
1019 site. 1 0.6785
1019 skin 1 0.4477
1019 still 1 0.352
1019 surgery 3 1.1225
1019 surgery, 1 0.5793
1019 surgical 4 1.3613
1019 taken 1 0.4252
1019 tamponade 1 0.7536
1019 temporizing 1 0.7536
1019 therapy 2 0.5959
1019 therapy. 1 0.4066
1019 therefore, 1 0.4764
1019 thigh 1 0.6034
1019 thigh, 1 0.6785
1019 three 1 0.2834
1019 time 2 0.5311
1019 timing 1 0.7536
1019 tissues. 1 0.4943
1019 tissues; 1 0.7536
1019 trivial 1 0.6785
1019 uncomplicated 1 0.6785
1019 use 2 0.5959
1020 (crm) 1 0.274
1020 (the 1 0.2035
1020 a. 1 0.1732
1020 absorbed 1 0.1974
1020 accelerator 1 0.274
1020 according 2 0.2957
1020 action 1 0.1192
1020 active 1 0.1263
1020 agent 1 0.1606
1020 altered 1 0.1464
1020 amounts 1 0.1361
1020 analogy 1 0.2307
1020 antibodies 1 0.1546
1020 antigenic 1 0.1606
1020 antisera 1 0.2107
1020 appearing 1 0.2035
1020 authors 2 0.2525
1020 bacteria 1 0.1764
1020 blocked 1 0.274
1020 competitive 1 0.2467
1020 concentrations 1 0.1409
1020 considerations 1 0.1876
1020 contains 2 0.3353
1020 cross-reacting 1 0.2467
1020 dealing 1 0.1974
1020 demonstration 1 0.1764
1020 determinants 1 0.2194
1020 determined 1 0.1246
1020 discovered 1 0.1922
1020 does. 1 0.274
1020 either 1 0.1172
1020 equally 1 0.1974
1020 ether 1 0.2035
1020 explained 1 0.1546
1020 fact 1 0.1449
1020 factor 11 1.4285
1020 finds 1 0.2467
1020 functionally 1 0.2307
1020 genetic 1 0.1435
1020 genetically 1 0.2194
1020 hemophilia 7 1.3455
1020 hemophiliac 1 0.2035
1020 hemophiliacs 1 0.2307
1020 human 1 0.0915
1020 hypothesis 1 0.1464
1020 hypothesis. 1 0.2307
1020 identical 1 0.1628
1020 immunization 1 0.2194
1020 immunological 1 0.1703
1020 immunsera 1 0.274
1020 inhibition 1 0.1372
1020 inhibitor 2 0.4213
1020 inhibitor, 1 0.274
1020 insight 1 0.2194
1020 less 1 0.1026
1020 level 1 0.1058
1020 lower 1 0.1246
1020 made 2 0.1985
1020 mammen 1 0.274
1020 modification 1 0.2035
1020 much 1 0.1214
1020 mutants 1 0.2107
1020 neutralization 1 0.2307
1020 normal 6 0.4422
1020 observation 1 0.1435
1020 obtains 1 0.274
1020 one 2 0.1533
1020 pathogenetic 1 0.2107
1020 plasma 6 0.6629
1020 plasma. 1 0.2194
1020 possesses 1 0.2467
1020 possible 1 0.1099
1020 product 2 0.407
1020 properties 2 0.2927
1020 protein 2 0.2491
1020 rabbits 1 0.1565
1020 rejected 1 0.2467
1020 serum 1 0.1063
1020 shows 1 0.1511
1020 similar 2 0.2052
1020 similarity 1 0.2107
1020 specific 1 0.1078
1020 structure. 1 0.2194
1020 substances 1 0.1922
1020 support 1 0.1511
1020 synthesis 1 0.1361
1020 test 1 0.1185
1020 test). 1 0.274
1020 theory 1 0.1764
1020 thromboplastingenerations 1 0.274
1020 treatment 1 0.0809
1020 using 1 0.1246
1020 value 1 0.1263
1020 viii 6 1.4803
1020 viii, 1 0.2467
1020 viii. 4 1.0962
1021 (3 1 1.2069
1021 2 2 0.9204
1021 absence 1 0.7196
1021 accompanied 1 0.8404
1021 account 1 0.8503
1021 adults 1 0.9083
1021 affected 1 0.7819
1021 b, 1 1.2069
1021 cases 1 0.4484
1021 cases). 1 1.2691
1021 character 1 1.0572
1021 clinical 2 0.9826
1021 data 1 0.6138
1021 discrepancy 1 1.2069
1021 extensive 2 1.7006
1021 femoral 1 1.1586
1021 first 1 0.5526
1021 gap 1 1.357
1021 haemophilia 1 1.1192
1021 haemophiliac 1 1.2069
1021 haemophilic 2 2.3172
1021 histological 1 0.8954
1021 iliac 1 1.2691
1021 image 1 1.2691
1021 infarction 1 1.2691
1021 intertrochanteric 1 1.5073
1021 latency 1 1.357
1021 literature 1 0.8219
1021 localization. 1 1.357
1021 malignancy. 1 1.5073
1021 marked 1 0.6763
1021 osseous 1 1.1192
1021 progressive 2 1.6808
1021 pseudo-tumours 1 1.5073
1021 pseudotumours 1 1.357
1021 remarkable 1 1.086
1021 reported 1 0.6107
1021 side. 1 1.2691
1021 sign 1 1.357
1021 stress 1 1.0318
1021 subjacent 1 1.5073
1021 symptoms 1 0.7143
1021 third, 1 1.2691
1021 tumour 2 1.8738
1021 tumour. 1 1.2069
1021 turgid 1 1.5073
1021 veritable 1 1.5073
1021 wing 1 1.5073
1022 110 1 1.0048
1022 263 1 1.0048
1022 94th 1 1.0048
1022 altered 1 0.5366
1022 appearance 1 0.4989
1022 basis 1 0.4398
1022 bleeding 2 1.4923
1022 bleeding. 3 2.5382
1022 blood 1 0.3105
1022 bowel 1 0.7724
1022 cessation 1 0.8461
1022 coincided 1 0.8461
1022 complicating 1 0.7724
1022 continued 1 0.5811
1022 control 1 0.3778
1022 day 1 0.4989
1022 days, 1 0.6591
1022 developed 1 0.4568
1022 discontinuance 1 0.9046
1022 eaca, 1 1.0048
1022 enteropathy 2 2.0097
1022 factor 1 0.4762
1022 fibrinogen 1 0.7724
1022 findings 1 0.3992
1022 fresh 1 0.724
1022 gastrointestinal 1 0.724
1022 hemophilia. 1 0.7462
1022 hemophiliac 1 0.7462
1022 hypoproteinemia 1 1.0048
1022 marked 1 0.4509
1022 motility. 1 1.0048
1022 mucosal 2 1.8093
1022 normal 1 0.2702
1022 pattern 1 0.4797
1022 pints 1 1.0048
1022 prolonged 1 0.4833
1022 protein 1 0.4568
1022 protein-losing 2 2.0097
1022 replaced. 1 1.0048
1022 replacement 1 0.6352
1022 resulted 1 0.4871
1022 rich 1 0.7724
1022 severe 1 0.4452
1022 small 1 0.4031
1022 steroids 1 0.6879
1022 steroids, 1 0.8461
1022 suspected 1 0.6728
1022 thickening 1 0.7724
1022 treatment 1 0.2965
1022 viii, 1 0.9046
1022 x-ray 1 0.6591
1023 11-year-old 1 1.0048
1023 2 1 0.3068
1023 8 1 0.4538
1023 although 1 0.3863
1023 apparent 1 0.5262
1023 bilateral 2 1.2111
1023 boy 1 0.6728
1023 calcaneus 2 2.0097
1023 case 3 1.0831
1023 classic 1 0.7724
1023 conflicting, 1 1.0048
1023 cuboid 2 2.0097
1023 deep 1 0.7048
1023 disappearance 1 0.6591
1023 dramatic. 1 1.0048
1023 effects 1 0.373
1023 hemophilia 1 0.7048
1023 hemophilic 1 0.7462
1023 irradiation. 1 0.6879
1023 mth. 1 0.5969
1023 pain 1 0.6591
1023 presented 1 0.3898
1023 previous 1 0.5422
1023 promptly 1 0.9046
1023 pseudotumors 3 3.0145
1023 radiotherapy 1 0.7048
1023 recurrence 1 0.7462
1023 relief 1 0.8046
1023 report. 1 0.9046
1023 reports 1 0.6466
1023 responded 1 0.7462
1023 results 1 0.2878
1023 subsequent 1 0.548
1023 therapy 1 0.3972
1023 treated 1 0.4135
1023 treatment. 1 0.5313
1023 tumors 1 0.5262
1023 without 1 0.3795
1023 x-ray 1 0.6591
1023 yr. 1 0.5262
1024 abnormal 1 0.2435
1024 account 1 0.2834
1024 accurate 1 0.3074
1024 affected 1 0.2606
1024 also 1 0.1406
1024 and, 1 0.2606
1024 authors 1 0.2315
1024 basis 1 0.2199
1024 blood 6 0.9315
1024 blood, 1 0.3439
1024 bone 2 0.4346
1024 bony 3 1.2691
1024 callus 1 0.5024
1024 callus, 1 0.5024
1024 callus. 1 0.5024
1024 changed, 1 0.4523
1024 characterized 1 0.2657
1024 coagulation 1 0.3862
1024 coagulopathic 1 0.5024
1024 coagulum, 1 0.5024
1024 consideration 1 0.3296
1024 correct 1 0.3439
1024 course 1 0.2284
1024 course, 1 0.423
1024 cure, 1 0.5024
1024 defect 2 0.4948
1024 diagnosis 1 0.2067
1024 diseases 4 1.0959
1024 diseases. 2 0.7724
1024 effecient 1 0.5024
1024 embryology 1 0.5024
1024 examples 1 0.3731
1024 fibrin 1 0.423
1024 formation 2 0.4509
1024 fractures 4 2.0097
1024 fractures, 1 0.5024
1024 genesis 1 0.3862
1024 given 1 0.1842
1024 hemophilia. 1 0.3731
1024 hemorrhages, 1 0.4523
1024 hemostasis 1 0.423
1024 kinds 1 0.423
1024 lesions 1 0.216
1024 make 1 0.2985
1024 marrow 1 0.2515
1024 may 1 0.1257
1024 mechanism 1 0.2315
1024 myeloma, 1 0.4523
1024 necessary 1 0.2944
1024 pass 1 0.3731
1024 pathological 1 0.2711
1024 patients 3 0.3623
1024 physiology 1 0.3731
1024 plasma 1 0.2026
1024 plasmocytoma, 1 0.5024
1024 polyosteotic 1 0.5024
1024 pre-existing 1 0.423
1024 preliminary 1 0.2869
1024 present 1 0.1654
1024 prevent 1 0.3364
1024 re-establish 1 0.5024
1024 reference 1 0.277
1024 reflected 1 0.3731
1024 regard 1 0.2869
1024 remarks 1 0.4523
1024 solitary 1 0.4023
1024 special 1 0.2657
1024 structural 1 0.3233
1024 subjects 1 0.2399
1024 suffering 2 0.5969
1024 syndrome 1 0.2331
1024 syndrome, 1 0.3364
1024 traumatic 1 0.3524
1024 treatment 2 0.2965
1024 various 1 0.1986
1024 waldenstroem's 1 0.5024
1025 'complementation' 1 0.3349
1025 'new 1 0.3349
1025 (ahf, 1 0.3349
1025 (von 1 0.3349
1025 a. 1 0.2117
1025 ahf 9 3.0145
1025 ahf-deficient 1 0.3349
1025 also, 1 0.2413
1025 antibody 1 0.2049
1025 antihemophilic 1 0.3015
1025 appears 1 0.144
1025 autosomal 3 0.724
1025 basis 1 0.1466
1025 carried 1 0.1677
1025 certain 1 0.1475
1025 coding 1 0.3015
1025 conditions 1 0.1523
1025 confirmed 1 0.1963
1025 correct. 1 0.3349
1025 deficiency 2 0.3542
1025 despite 1 0.2117
1025 difference. 1 0.3015
1025 directly 1 0.2117
1025 disease 3 0.361
1025 disease) 1 0.3349
1025 disease. 2 0.3542
1025 doubt 1 0.3015
1025 due 1 0.1185
1025 effector 1 0.3349
1025 entirely 1 0.2155
1025 errors 1 0.2349
1025 examination 1 0.1691
1025 examined, 1 0.2487
1025 fact 1 0.1771
1025 factor 2 0.3175
1025 failure 1 0.1807
1025 feel 1 0.2682
1025 found. 1 0.2155
1025 fulfil 1 0.3349
1025 fulfilled 1 0.3349
1025 gene 1 0.2682
1025 great 1 0.1913
1025 hand, 1 0.2019
1025 hemophilia 1 0.2349
1025 heterozygotes 1 0.3015
1025 homozygote 1 0.3349
1025 homozygous 1 0.2575
1025 illuminating. 1 0.3349
1025 implies 1 0.3015
1025 imply 1 0.2349
1025 large 2 0.2648
1025 levels 1 0.1312
1025 locus 1 0.3015
1025 masked 1 0.3349
1025 may 2 0.1675
1025 methods 1 0.1513
1025 might 1 0.1754
1025 model 3 0.7048
1025 molecule. 1 0.2682
1025 mutation 1 0.2575
1025 needed 1 0.2293
1025 neutralizes 1 0.3349
1025 normal. 1 0.2019
1025 obtain 1 0.2349
1025 obtained 1 0.1194
1025 obviously 1 0.282
1025 occur 1 0.1636
1025 occurs 1 0.1789
1025 one 2 0.1874
1025 operon 1 0.3349
1025 parameters 1 0.2413
1025 perhaps 1 0.1847
1025 persons 5 1.0587
1025 plasma 1 0.135
1025 prediction 2 0.4974
1025 prediction. 1 0.3349
1025 prepared 1 0.2019
1025 produce 1 0.1789
1025 produced 1 0.1364
1025 quantities 1 0.2349
1025 real 1 0.282
1025 reasonably 1 0.3349
1025 reasons. 1 0.3349
1025 reduced 1 0.1513
1025 reduction 1 0.1649
1025 regulatory 2 0.6699
1025 repressor 1 0.3349
1025 results 1 0.0959
1025 sex-linked 1 0.3015
1025 standard 1 0.2293
1025 structural 1 0.2155
1025 structurally 1 0.282
1025 studies 2 0.2051
1025 substance 1 0.2349
1025 suggesting 1 0.2049
1025 synthesis' 1 0.3349
1025 tested 1 0.2019
1025 tests 2 0.3299
1025 throw 1 0.3349
1025 transfused 1 0.2487
1025 transfusion 2 0.5149
1025 type 1 0.1393
1025 using 1 0.1523
1025 viii) 1 0.3349
1025 vitro. 1 0.2243
1025 von 5 1.5077
1025 wild 1 0.3015
1025 willebrand's 6 2.0097
1025 would 1 0.1663
1025 wrong 1 0.3015
1025 x-chromosome 1 0.3015
1025 x-locus 1 0.3349
1026 10 1 0.5548
1026 bone 1 0.6519
1026 clinical 1 0.4913
1026 deals 1 1.1586
1026 diagnosis 1 0.6202
1026 differential 1 0.9528
1026 discussed. 1 0.6444
1026 femur 1 1.2069
1026 findings 1 0.5987
1026 hemophilia. 1 1.1192
1026 hemophilic 1 1.1192
1026 lesions 1 0.6481
1026 observed 1 0.5138
1026 pathogenesis, 1 1.2691
1026 period 1 0.5717
1026 pseudotumor 1 1.357
1026 radiologic 2 3.0145
1026 report 1 0.7306
1026 treatment 1 0.4447
1026 tumor-like 1 1.357
1026 yr. 1 0.7893
1027 a. 1 0.2722
1027 ab 1 0.4306
1027 ab, 1 0.4306
1027 afflicted 1 0.4306
1027 briefly 1 0.2595
1027 children 1 0.1529
1027 christmas' 3 1.2919
1027 concurrent 1 0.331
1027 considerations 1 0.2948
1027 daughters 1 0.4306
1027 disease 2 0.3094
1027 disease. 1 0.2277
1027 family 1 0.2595
1027 family. 2 0.7252
1027 generations 2 0.7252
1027 genes 2 0.8613
1027 genetic 1 0.2255
1027 grandchildren 1 0.4306
1027 grandmother's 1 0.4306
1027 hemophilia 7 2.1144
1027 i.e. 1 0.331
1027 inherited 1 0.3448
1027 members 1 0.2883
1027 must 2 0.4208
1027 mutation 1 0.331
1027 number 1 0.1648
1027 occurred 1 0.1874
1027 one 2 0.2409
1027 preceding 1 0.331
1027 presented 1 0.1671
1027 relevant 1 0.3103
1027 responsible 2 0.4349
1027 reviewed. 1 0.3021
1027 segregated 1 0.4306
1027 study 1 0.1327
1027 suspected 1 0.2883
1027 three 1 0.1619
1027 two 1 0.1319
1027 type 1 0.1791
1027 types 1 0.2087
1027 x-chromosome 1 0.3877
1028 25. 1 1.357
1028 albinism 2 3.0145
1028 angiohemophilia, 1 1.5073
1028 angiohemophilia. 1 1.5073
1028 associated 1 0.5352
1028 association 1 0.8133
1028 basophilic 1 1.2069
1028 bone 1 0.6519
1028 case 1 0.5415
1028 case. 1 1.1586
1028 cells 2 0.9098
1028 contained 1 0.7678
1028 containing 1 0.797
1028 granules. 1 1.2691
1028 large 1 0.5959
1028 man 1 0.7747
1028 marrow 1 0.7546
1028 occurring 1 0.8716
1028 presented 1 0.5847
1028 proper 1 1.0091
1028 rare 1 0.8954
1028 report 1 0.7306
1028 resembling 1 1.1586
1028 reticulum 1 1.1586
1029 10% 1 0.362
1029 116 1 0.4523
1029 12 1 0.2399
1029 4 1 0.1777
1029 5 1 0.1906
1029 6 1 0.2101
1029 abnormal 1 0.2435
1029 adequate 1 0.3123
1029 although 1 0.1931
1029 amounts 1 0.2494
1029 analysis 1 0.2417
1029 analyzed 1 0.3439
1029 anemia 1 0.362
1029 blood 1 0.1552
1029 classic 1 0.3862
1029 clinical 1 0.1638
1029 combining 1 0.423
1029 concentrate. 1 0.5024
1029 concentrates 1 0.5024
1029 concentrates, 1 0.5024
1029 contaminating 1 0.5024
1029 continued 1 0.2905
1029 control 1 0.1889
1029 cost 1 0.5024
1029 could 1 0.1805
1029 cysts. 1 0.5024
1029 deficient 2 0.6466
1029 dental 1 0.3731
1029 development 1 0.1834
1029 different 1 0.1777
1029 difficulties. 1 0.5024
1029 due 1 0.1777
1029 effectiveness 1 0.3524
1029 efficient 1 0.362
1029 eliminate 1 0.4023
1029 english 1 0.4523
1029 established 1 0.2711
1029 evaluated 1 0.2905
1029 experience 1 0.2582
1029 factor 5 1.1904
1029 following 1 0.1665
1029 fraction 4 1.0733
1029 hemolytic 1 0.362
1029 hemophilia 1 0.3524
1029 hemophiliacs 3 1.2691
1029 hemophiliacs. 1 0.423
1029 hemorrhage, 1 0.4023
1029 hemostasis 1 0.423
1029 hepatitis, 1 0.3731
1029 high 2 0.3596
1029 i, 1 0.423
1029 i. 1 0.2985
1029 incidence 1 0.2399
1029 include 1 0.2985
1029 isoantibodies 1 0.5024
1029 laboratory 1 0.2905
1029 late 1 0.2985
1029 literature, 1 0.4023
1029 literature. 1 0.423
1029 lots 1 0.5024
1029 made, 1 0.3862
1029 major 6 1.45
1029 methods 1 0.2269
1029 moderately 1 0.362
1029 mortality 1 0.3028
1029 nondental 1 0.5024
1029 operations 2 0.6591
1029 operative 1 0.2801
1029 over-all 1 0.3731
1029 postoperative 1 0.3028
1029 potency 1 0.4023
1029 potent 1 0.3731
1029 preparing 1 0.423
1029 presently 1 0.4023
1029 problem 1 0.2869
1029 problems 1 0.2606
1029 procedures 1 0.2834
1029 product. 1 0.5024
1029 provides 1 0.3176
1029 purer 1 0.4523
1029 rate 1 0.1849
1029 recorded 1 0.2869
1029 regimen 2 0.9046
1029 remain. 1 0.5024
1029 requiring 1 0.362
1029 results 1 0.1439
1029 review 1 0.277
1029 separately, 1 0.5024
1029 series 1 0.2364
1029 serum 1 0.1949
1029 severely 1 0.3233
1029 sole 1 0.423
1029 source 1 0.3364
1029 special 1 0.2657
1029 still 1 0.2347
1029 surgery 5 1.2472
1029 therapeutic 1 0.2537
1029 therapy 1 0.1986
1029 therapy. 1 0.2711
1029 twelve 1 0.3176
1029 using 2 0.4568
1029 variation 1 0.3176
1029 viii 5 2.2616
1029 without 1 0.1897
1030 (equine 1 1.0048
1030 also 1 0.2811
1030 anti-equine 1 1.0048
1030 antithrombin 3 3.0145
1030 cases 1 0.299
1030 cause 1 0.4538
1030 caused 1 0.4398
1030 chronic 1 0.4797
1030 coagulation. 1 1.0048
1030 compared 1 0.3898
1030 developed 1 0.4568
1030 developed. 1 0.8046
1030 disturbance 1 0.724
1030 equine 2 2.0097
1030 gingivorrhagia 1 1.0048
1030 given 1 0.3684
1030 haemophilia 1 0.7462
1030 hyperthrombocyte 1 1.0048
1030 hyperthrombocytic 1 1.0048
1030 i.m. 1 0.8461
1030 ineffective 1 0.7048
1030 injections 2 1.1337
1030 intrinsic 1 0.7048
1030 lengthening 1 0.8461
1030 myelosis. 2 2.0097
1030 numerous 1 0.5969
1030 observation 1 0.5262
1030 patient 1 0.3778
1030 repeated 1 0.5969
1030 report 1 0.4871
1030 specific 2 0.7907
1030 thrombase 1 1.0048
1030 thrombin 2 2.0097
1030 thrombin) 1 1.0048
1030 thrombin. 1 1.0048
1030 time 1 0.3541
1030 treated 1 0.4135
1030 two 1 0.3077
1031 (1) 1 0.2435
1031 (2) 1 0.2435
1031 (3) 1 0.2657
1031 (4) 1 0.2905
1031 (5) 1 0.3296
1031 (6) 1 0.362
1031 (7) 1 0.3862
1031 (a) 1 0.3233
1031 (b) 1 0.3233
1031 (e-aca) 1 0.5024
1031 0.1 1 0.4523
1031 1000 1 0.4023
1031 3 1 0.1713
1031 4-5 1 0.4523
1031 46 1 0.423
1031 5 1 0.1906
1031 744 1 0.5024
1031 acid 1 0.194
1031 act 1 0.3123
1031 activity 3 0.5394
1031 acute 2 0.4989
1031 agent 2 0.5888
1031 antidote 1 0.4523
1031 association 2 0.5422
1031 authors' 1 0.3862
1031 based 1 0.2631
1031 become 1 0.277
1031 bleedings 1 0.4523
1031 blood 2 0.3105
1031 body 1 0.2026
1031 boeck's 1 0.5024
1031 cancer 1 0.1986
1031 cancer, 2 0.6352
1031 cases 2 0.299
1031 cirrhosis 1 0.3524
1031 clear. 1 0.423
1031 clinical 1 0.1638
1031 coagulation 2 0.7724
1031 colitis. 1 0.423
1031 complicated 1 0.3524
1031 complicating 1 0.3862
1031 complications 1 0.2944
1031 connection 1 0.362
1031 consisted 1 0.2985
1031 continued 1 0.2905
1031 controls 1 0.3028
1031 day 1 0.2494
1031 defects, 1 0.3524
1031 delivery. 1 0.423
1031 diarrhoea. 1 0.5024
1031 disorders, 1 0.362
1031 dizziness, 1 0.5024
1031 dose 2 0.4797
1031 drug 2 0.5262
1031 e-aca 5 2.5121
1031 e-aca. 1 0.5024
1031 e.c.g., 1 0.5024
1031 effect. 1 0.3296
1031 effective 1 0.2515
1031 effects 1 0.1865
1031 epsilon-aminocaproic 1 0.4523
1031 equally 1 0.362
1031 especially 2 0.5165
1031 essential 1 0.2944
1031 even 1 0.2199
1031 every 1 0.2801
1031 examination 1 0.2537
1031 experience 2 0.5165
1031 experience. 1 0.4523
1031 fibrinolysis 2 1.0048
1031 fibrinolysis, 1 0.5024
1031 fibrinolytic 6 3.0145
1031 following 3 0.4996
1031 function 1 0.2254
1031 g 3 1.1586
1031 genital 1 0.4023
1031 given 1 0.1842
1031 haematuria 3 1.5073
1031 haematuria. 1 0.5024
1031 haemophilia 1 0.3731
1031 haemorrhage 1 0.4523
1031 hours 1 0.2417
1031 hyperplasia, 1 0.4523
1031 identical. 1 0.4523
1031 incidence 1 0.2399
1031 increased 1 0.1562
1031 indicated 1 0.2364
1031 inducing 1 0.362
1031 inhibition 1 0.2515
1031 injury 1 0.3364
1031 intravascular 1 0.423
1031 intravenously. 1 0.5024
1031 judging 1 0.4523
1031 kg 1 0.423
1031 kidney, 1 0.3296
1031 leukaemia, 1 0.4523
1031 liver 3 0.593
1031 local 2 0.6056
1031 losses 1 0.423
1031 macroscopically 1 0.5024
1031 mainly 1 0.3296
1031 major 1 0.2417
1031 material 1 0.2331
1031 n.p.n. 1 0.5024
1031 nausea 1 0.4523
1031 observed, 1 0.423
1031 observed. 1 0.3028
1031 occur 1 0.2454
1031 operation. 1 0.3296
1031 operations 1 0.3296
1031 orally 1 0.3862
1031 organs 1 0.277
1031 pancreas, 1 0.4523
1031 pancreas. 1 0.5024
1031 particularly 1 0.277
1031 patients 3 0.3623
1031 per 1 0.1958
1031 picture, 1 0.4523
1031 postmortem 1 0.3862
1031 preparation 1 0.3233
1031 prolonged 1 0.2417
1031 prostate 1 0.423
1031 prostate, 1 0.5024
1031 prostatectomy 1 0.5024
1031 prostatectomy, 1 0.5024
1031 prostatectomy. 1 0.5024
1031 prostatic 2 0.7724
1031 proved 1 0.2801
1031 receiving 1 0.277
1031 recommended. 1 0.4523
1031 reduce 1 0.3176
1031 reveal 1 0.3364
1031 sarcoid. 1 0.5024
1031 series 1 0.2364
1031 side-effects 1 0.423
1031 signs 2 0.5603
1031 situations: 2 1.0048
1031 so-called 1 0.362
1031 states 2 0.6879
1031 substantially 1 0.423
1031 sufficient. 1 0.4523
1031 suggested 1 0.2089
1031 surgery. 1 0.3439
1031 systemic 4 1.1206
1031 tests 1 0.2474
1031 therapeutic 1 0.2537
1031 therapy 1 0.1986
1031 therapy. 1 0.2711
1031 thorax, 1 0.5024
1031 three 1 0.1889
1031 thromboembolic 1 0.5024
1031 thrombolytic 1 0.5024
1031 thrombosis. 1 0.5024
1031 times 1 0.2417
1031 toxic 2 0.6148
1031 tract 1 0.2905
1031 tract, 1 0.4023
1031 traumatic 1 0.3524
1031 treated 1 0.2067
1031 treatment 2 0.2965
1031 ulcerative 1 0.4023
1031 urinary 2 0.4452
1031 urine 1 0.2582
1031 use 1 0.1986
1031 various 1 0.1986
1031 weight 1 0.2364
1031 whether 1 0.2494
1031 years 1 0.2284
1032 absence 1 0.2399
1032 absent 1 0.3296
1032 acute 1 0.2494
1032 analgesics, 1 0.4523
1032 anteromedial 1 0.5024
1032 anticipate 1 0.5024
1032 appears 1 0.216
1032 aspect 2 0.7048
1032 authors 2 0.4629
1032 becomes 1 0.3028
1032 bed 1 0.423
1032 begins 1 0.423
1032 beneath 4 1.8093
1032 brace 1 0.5024
1032 cases 1 0.1495
1032 cause 1 0.2269
1032 center 1 0.3233
1032 clinical 1 0.1638
1032 compressed 2 0.9046
1032 compression 1 0.3731
1032 confirm 1 0.423
1032 consists 1 0.3176
1032 contracture 1 0.5024
1032 convalescent 1 0.4523
1032 corresponding 1 0.2944
1032 date, 1 0.5024
1032 day 1 0.2494
1032 deep 1 0.3524
1032 depressed 1 0.3862
1032 depression 1 0.3524
1032 described. 1 0.2515
1032 diminution 1 0.3524
1032 discovered. 1 0.4523
1032 exploration 1 0.423
1032 external 1 0.3028
1032 fascia 1 0.5024
1032 femoral 6 2.3172
1032 femoral-nerve 1 0.5024
1032 femoris 2 1.0048
1032 finally, 1 0.3439
1032 flaccid 1 0.5024
1032 flexion 1 0.4523
1032 followed 1 0.2299
1032 fossa 1 0.4523
1032 freshfrozen 1 0.5024
1032 functional 1 0.3176
1032 groin 1 0.5024
1032 groin, 1 0.5024
1032 hemarthrosis 1 0.423
1032 hemophilia. 1 0.3731
1032 hemophilic 1 0.3731
1032 hemorrhage 3 0.97
1032 hessing 1 0.5024
1032 hip 2 0.8461
1032 iliac 1 0.423
1032 iliacus 2 1.0048
1032 iliopectineal 1 0.5024
1032 iliopsoas 2 1.0048
1032 inferior 1 0.3862
1032 inguinal 3 1.357
1032 itself, 1 0.423
1032 junction 2 0.8461
1032 knee 1 0.3731
1032 leg, 1 0.5024
1032 ligament 4 1.8093
1032 ligament. 1 0.5024
1032 long 1 0.2606
1032 may 1 0.1257
1032 medially. 1 0.5024
1032 muscle 1 0.277
1032 musculotendinous 2 1.0048
1032 nerve 3 1.0091
1032 neuropathy 2 0.9046
1032 neuropathy. 1 0.5024
1032 new 1 0.2199
1032 non-hemophilic 1 0.5024
1032 occurred. 1 0.4523
1032 opportunity 1 0.423
1032 pain 1 0.3296
1032 palsy 1 0.5024
1032 paralysis 1 0.3731
1032 patellar 1 0.5024
1032 patient 1 0.1889
1032 patients 1 0.1208
1032 phase, 1 0.423
1032 phase. 1 0.4023
1032 picture. 1 0.423
1032 plasma 1 0.2026
1032 portion 1 0.3524
1032 poupart's 1 0.5024
1032 present 1 0.1654
1032 pronounced 1 0.2985
1032 propose 1 0.423
1032 proposed 1 0.3296
1032 protect 1 0.3731
1032 proximal 1 0.3439
1032 quadriceps 2 1.0048
1032 reflex, 1 0.5024
1032 region. 1 0.423
1032 rest, 1 0.5024
1032 result 2 0.4346
1032 return 1 0.3731
1032 rotation. 1 0.5024
1032 seeing 1 0.4523
1032 sensation 1 0.423
1032 severe 1 0.2226
1032 show 1 0.2173
1032 six 1 0.277
1032 superiorly 1 0.4523
1032 swelling 1 0.423
1032 syndrome 2 0.4661
1032 tender 1 0.5024
1032 theory 1 0.3233
1032 thigh 1 0.4023
1032 thigh, 1 0.4523
1032 thus 1 0.2606
1032 traumatic 1 0.3524
1032 treatment 1 0.1482
1032 unyielding 1 0.5024
1032 used 1 0.1897
1032 validity 1 0.423
1032 verified. 1 0.5024
1033 21 1 0.3811
1033 5-year 1 0.4634
1033 accurate 1 0.3689
1033 admission 2 0.9269
1033 admissions 1 0.6029
1033 advisability 1 0.6029
1033 affected 1 0.3127
1033 age 1 0.2494
1033 age, 2 0.7909
1033 ages 1 0.4344
1033 agreement 1 0.4127
1033 allowing 1 0.4634
1033 also 2 0.3373
1033 answered 1 0.6029
1033 arises 1 0.5076
1033 arthropathy 3 1.4482
1033 arthropathy. 1 0.6029
1033 aspiration 1 0.4827
1033 assessment 1 0.4037
1033 associated 1 0.2141
1033 atrophy. 1 0.5076
1033 attempt 1 0.3689
1033 avoid 1 0.4477
1033 best 1 0.3188
1033 blood 1 0.1863
1033 bulk 1 0.5076
1033 capacity. 1 0.4634
1033 cause 1 0.2723
1033 changes 1 0.1804
1033 childhood 1 0.3401
1033 clinical 2 0.3931
1033 complications 2 0.7065
1033 concerning 1 0.3748
1033 considerable 2 0.6255
1033 control 1 0.2267
1033 correct 1 0.4127
1033 course 1 0.2741
1033 decreases 1 0.388
1033 destruction. 1 0.5428
1033 destructive 1 0.5076
1033 development 2 0.4402
1033 differ 1 0.3955
1033 different 2 0.4265
1033 differing 1 0.6029
1033 difficulty 1 0.4037
1033 disability, 1 0.5428
1033 disease 3 0.6498
1033 distorted 1 0.5076
1033 due 3 0.6398
1033 earning 1 0.6029
1033 education, 1 0.5428
1033 episode 1 0.4827
1033 episodes 3 1.3903
1033 episodes. 1 0.6029
1033 general 1 0.3071
1033 general, 1 0.4344
1033 given. 1 0.4634
1033 grades 1 0.4827
1033 hemarthroses 3 1.4482
1033 hemophilia 1 0.4229
1033 hemophilia: 1 0.6029
1033 hemophiliacs 1 0.5076
1033 hemophiliacs. 1 0.5076
1033 hemophilic 4 1.7908
1033 hemorrhagic 1 0.4827
1033 hospital 3 1.1434
1033 however, 1 0.2183
1033 importance 1 0.3071
1033 importance, 1 0.6029
1033 impression 1 0.4344
1033 increase, 1 0.5076
1033 increased 1 0.1874
1033 individual 5 1.5939
1033 involves 1 0.4344
1033 joint 2 0.776
1033 joint. 1 0.6029
1033 joints 1 0.4344
1033 knee 1 0.4477
1033 knowledge 1 0.3955
1033 known 2 0.5891
1033 later 1 0.3099
1033 leads 1 0.3362
1033 least 2 0.6198
1033 life 1 0.3188
1033 likely 1 0.3533
1033 little 2 0.644
1033 longterm 1 0.5428
1033 loss 1 0.2922
1033 management 1 0.3188
1033 mechanisms 1 0.3633
1033 medicosocial 2 1.2058
1033 muscle 1 0.3324
1033 never 1 0.3955
1033 number 2 0.4614
1033 obtaining 1 0.4634
1033 opinions 1 0.6029
1033 overcome 1 0.4634
1033 owing 1 0.4037
1033 part 1 0.2816
1033 particular 1 0.3044
1033 pathological 1 0.3253
1033 patients 1 0.1449
1033 patients, 1 0.3018
1033 pattern 1 0.2878
1033 per 2 0.47
1033 possible 1 0.2419
1033 presence 2 0.4594
1033 present 1 0.1985
1033 prognosis 1 0.3324
1033 prospective 2 1.0856
1033 providing 1 0.4634
1033 questions 1 0.4477
1033 recurrent 1 0.4634
1033 regardless 1 0.4827
1033 relatively 1 0.29
1033 routine 1 0.4344
1033 severely 1 0.388
1033 severity 3 1.1066
1033 severity, 1 0.6029
1033 spent 1 0.5076
1033 spontaneous 1 0.3487
1033 studies 1 0.1846
1033 studies. 1 0.4634
1033 study. 1 0.3955
1033 suitable 1 0.388
1033 tends 1 0.4634
1033 tension 1 0.3633
1033 thus 2 0.6255
1033 time 2 0.4249
1033 treatment 1 0.1779
1033 unstable 1 0.5428
1033 variation 2 0.7622
1033 weight-bearing 1 0.6029
1033 whether 1 0.2993
1033 year 1 0.3127
1033 yr. 1 0.3157
